<SEC-DOCUMENT>0001104659-22-050961.txt : 20220427
<SEC-HEADER>0001104659-22-050961.hdr.sgml : 20220427
<ACCEPTANCE-DATETIME>20220427141226
ACCESSION NUMBER:		0001104659-22-050961
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20220427
DATE AS OF CHANGE:		20220427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BELITE BIO, INC
		CENTRAL INDEX KEY:			0001889109
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264134
		FILM NUMBER:		22858735

	BUSINESS ADDRESS:	
		STREET 1:		5820 OBERLIN DRIVE, SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-246-6240

	MAIL ADDRESS:	
		STREET 1:		5820 OBERLIN DRIVE, SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>tm2132809-21_f1a.htm
<DESCRIPTION>F-1/A
<TEXT>
<html>
  <head>
    <title>tm2132809-21_f1a - block - 39.7188729s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">

          <div style="text-align:center; width:541.31pt; line-height:12pt;">
            <font style="letter-spacing:-0.2pt;">As filed with the Securities and Exchange Commission on April 27, 2022 </font>
          </div>

        <div style="margin-top:4pt; text-align:right; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Registration No. 333-264134</font>&#8203;</div>
        <div style="margin-top:4.7pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 4.7pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3.2pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 3.2pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:8.2pt; text-align:center; width:541.31pt; line-height:20pt;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">UNITED STATES </font>
          <br >
          <font style="letter-spacing:-0.36pt;">SECURITIES AND EXCHANGE COMMISSION</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:0.2pt; text-align:center; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.7pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>

          <div style="margin-top:10.2pt; text-align:center; width:541.31pt; line-height:10pt;">
            <font style="letter-spacing:-0.2pt;">Amendment No. 3 </font>
            <br >
            <font style="letter-spacing:-0.2pt;">to</font>
          </div>

        <div style="margin-top:0.2pt; text-align:center; width:541.31pt; line-height:20pt;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">FORM F-1</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">REGISTRATION STATEMENT </font>
          <br >
          <font style="font-style:italic;letter-spacing:-0.2pt;">UNDER</font><font style="letter-spacing:-0.2pt;"> </font>
          <br >
          <font style="font-style:italic;letter-spacing:-0.2pt;">THE SECURITIES ACT OF 1933</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:10.69pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.69pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:10.2pt; text-align:center; width:541.31pt; line-height:20pt;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Belite Bio, Inc</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:-0.8pt; text-align:center; width:541.31pt; line-height:10pt;font-weight:normal;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Exact name of Registrant as specified in its charter) </font>
        </div>
        <div style="margin-top:10.7pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:10.2pt; text-align:center; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Not Applicable</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:2.2pt; text-align:center; width:541.31pt; line-height:10pt;font-weight:normal;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Translation of Registrant&#8217;s name into English) </font>
        </div>
        <div style="margin-top:10.7pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:541.31pt;margin-bottom:5pt;margin-top:7.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;">
              <div style="text-align:center;font-weight:bold;font-size:10pt;">
                <font style="letter-spacing:-0.2pt;">Cayman Islands</font>
              </div>
              <div style="margin-top:2pt; text-align:center; line-height:10pt;">
                <font style="letter-spacing:0.16pt;">(State or other jurisdiction of </font>
                <br >
                <font style="letter-spacing:0.16pt;">incorporation or organization)</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.44pt;">
              <div style="text-align:center;font-weight:bold;font-size:10pt;">
                <font style="letter-spacing:-0.2pt;">2834</font>
              </div>
              <div style="margin-top:2pt; text-align:center; line-height:10pt;">
                <font style="letter-spacing:0.16pt;">(Primary Standard Industrial</font>
                <br >
                <font style="letter-spacing:0.16pt;">Classification Code Number)</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:172.43pt;">
              <div style="text-align:center;font-weight:bold;font-size:10pt;">
                <font style="letter-spacing:-0.2pt;">Not Applicable</font>
              </div>
              <div style="margin-top:2pt; text-align:center; line-height:8pt;">
                <font style="letter-spacing:0.16pt;">(I.R.S. Employer</font>
                <br >
                <font style="letter-spacing:0.16pt;">Identification Number)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:6.2pt; text-align:center; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">5820 Oberlin Drive, Suite 101, </font>
          <br >
          <font style="letter-spacing:-0.2pt;">San Diego, CA 92121 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Telephone: +1-858-246-6240 </font>
        </div>
        <div style="margin-top:2.2pt; text-align:center; width:541.31pt; line-height:10pt;font-weight:normal;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Address, including zip code, and telephone number, including area code, of Registrant&#8217;s principal executive offices)</font><font style="font-size:10pt;">&#8203;<font style="letter-spacing:0.2pt;"> </font></font>
        </div>
        <div style="margin-top:10.7pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:10.2pt; text-align:center; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Puglisi &amp; Associates </font>
          <br >
          <font style="letter-spacing:-0.2pt;">850 Library Avenue, Suite 204</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Newark, Delaware 19711</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(302) 738-6680 </font>
        </div>
        <div style="margin-top:2.2pt; text-align:center; width:541.31pt; line-height:10pt;font-weight:normal;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font><font style="font-size:10pt;">&#8203;<font style="letter-spacing:0.2pt;"> </font></font>
        </div>
        <div style="margin-top:10.6pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.6pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:10.09pt; text-align:center; width:541.31pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:-0.2pt;">Copies to:</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:541.31pt;margin-bottom:5.00000000000011pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.44pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Portia Ku, Esq. </font>
                <br >
                <font style="letter-spacing:-0.2pt;">Vincent Lin, Esq. </font>
                <br >
                <font style="letter-spacing:-0.2pt;">O&#8217;Melveny &amp; Myers LLP </font>
                <br >
                <font style="letter-spacing:-0.2pt;">Times Square Tower </font>
                <br >
                <font style="letter-spacing:-0.2pt;">7 Times Square </font>
                <br >
                <font style="letter-spacing:-0.2pt;">New York, NY 10036</font>
                <br >
                <font style="letter-spacing:-0.2pt;">+1-212-326-2000</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.44pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Yu-Hsin Lin</font>
                <br >
                <font style="letter-spacing:-0.2pt;">Belite Bio, Inc</font>
                <br >
                <font style="letter-spacing:-0.2pt;">5820 Oberlin Drive, Suite 101,</font>
                <br >
                <font style="letter-spacing:-0.2pt;">San Diego, CA 92121</font>
                <br >
                <font style="letter-spacing:-0.2pt;">+1-858-246-6240</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:172.43pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">Richard Anslow, Esq.</font>
                <br >
                <font style="letter-spacing:-0.2pt;">John J. Hart, Esq.</font>
                <br >
                <font style="letter-spacing:-0.2pt;">Ellenoff Grossman &amp; Schole LLP</font>
                <br >
                <font style="letter-spacing:-0.2pt;">1345 Avenue of the Americas, 11</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.15pt;">th</font><font style="letter-spacing:-0.2pt;"> Floor</font>
                <br >
                <font style="letter-spacing:-0.2pt;">New York, New York 10105</font>
                <br >
                <font style="letter-spacing:-0.2pt;">+1-212-370-1300</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.6pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:10.1pt; text-align:center; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:-0.2pt;">Approximate date of commencement of proposed sale to the public: </font>
          <br >
          <font style="letter-spacing:-0.2pt;">As soon as practicable after the effective date of this registration statement.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:541.31pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, check the following box. &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:541.31pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:0.2pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:27pt;width:541.31pt;">
        <div style="text-indent:20pt; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933. </font>
        </div>
        <div style="margin-left:20pt; margin-top:6pt; width:521.31pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Emerging growth company &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:541.31pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April&#160;5, 2012. </font>
        </div>
        <div style="margin-top:10.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 10.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:10pt; width:541.31pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8.5pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 8.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 3pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="position:relative;overflow-x:hidden;min-height:775.71pt;page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="position:absolute;top:738.83pt;left:24pt;height:30.02pt;width:706pt;transform-origin:0pt -0pt;transform:rotate(-90deg) translate(0%, 0%);">
        <div style="text-align:justify; width:706pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-family:Helvetica, Arial, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.08pt;">The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any state where the offer or sale is not permitted.</font><font style="color:#000000;letter-spacing:-0.08pt;"> </font>
          <br >
        </div>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:63pt;width:505.31pt;">
        <div style="text-align:center; width:505.31pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-size:8pt;">
          <font style="letter-spacing:-0.16pt;">PRELIMINARY PROSPECTUS (Subject to Completion) </font>
          <br >
          <font style="letter-spacing:-0.16pt;">Dated April&#160;20, 2022.</font><font style="font-weight:normal;color:#000000;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:3pt; text-align:center; width:505.31pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">6,000,000 American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:1.71pt; text-align:center; width:505.31pt;">
          <img src="lg_belitebio-4clr.jpg" alt="[MISSING IMAGE: lg_belitebio-4clr.jpg]" height="57" width="93" >
        </div>
        <div style="margin-top:8.4pt; text-align:center; width:505.31pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Belite Bio, Inc</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:1pt; text-align:center; width:505.31pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Representing 6,000,000 Ordinary Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:1pt; width:485.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.14pt;">We are selling American depositary shares, or ADSs. Each ADS represents one ordinary share, par value US$0.0001 per share. </font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">This is an initial public offering in the United States of Belite Bio, Inc, a Cayman Islands exempted holding company with headquarters in San Diego, California and operations in the United States and Australia. </font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">Prior to this offering, there has been no public market for our ordinary shares or ADSs. We anticipate that the initial public offering price of the ADSs will be between US$5.50 and US$6.50 &#8202;per ADS. In connection with this offering, we have applied for the listing of the ADSs on the Nasdaq Capital Market under the symbol &#8220;BLTE.&#8221;</font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">Throughout this prospectus, unless the context indicates otherwise, references to &#8220;Belite&#8221; refer to Belite Bio, Inc, a holding company, together as a group with our subsidiaries, including our operating subsidiaries. Belite Bio, LLC and RBP4 Pty Ltd, our U.S. and Australia-based operating subsidiaries, respectively, conduct our daily operations. Investors purchasing our ADSs in this initial public offering are purchasing equity securities of our Cayman Islands exempt holding company and are not purchasing equity securities of our operating subsidiaries in the United States and Australia. In the normal course of our business, Belite would evaluate the financial condition and capital needs of our subsidiaries periodically and then provide funding for their operations via equity investments and intercompany loans. As of the date of this prospectus, we have provided US$10.06 million to our subsidiaries via capital contribution, including US$0.5 million intercompany loans that have been repaid by the subsidiary via the issuance of ordinary shares, among which we have provided US$60,000 to our Hong Kong subsidiary via capital contribution which further invested US$50,000 to our PRC subsidiary via capital contribution. None of our subsidiaries have declared or paid any dividends or distributions on equity to their respective holding companies as of the date of this prospectus. We have not relied, and do not expect to rely, on dividends or other distributions on equity from any of our subsidiaries for our cash requirements. We have no plans to declare cash dividends in the near term, but as a holding company, we may depend on receipt of funds from one or more of our subsidiaries if we determine to pay cash dividends to holders of our ordinary shares in the future. While our PRC subsidiary has no operations and generates no revenue as of the date of this prospectus, should it generate revenue in the future, restrictions on currency exchanges in China may limit our ability to freely convert such Renminbi to fund any future business activities outside China or other payments in U.S. dollars, and capital control measures imposed by the Chinese government may limit our ability to use capital from our PRC subsidiary for business purposes outside of China. See &#8220;Prospectus Summary&#8201;&#8212;&#8201;Cash Transfers and Dividend Distribution&#8221; for a more detailed description.</font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">All of our operations are outside of PRC as of the date of this prospectus although we have established a subsidiary in each of Hong Kong and China. We do not expect the listing of our ADSs to be materially affected by recent statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers, including, but not limited to, the cybersecurity review and other regulatory reviews of overseas listing through an offshore holding company. However, due to the extraterritorial reach (the so-called &#8220;long arm provisions&#8221;) under the current PRC laws and regulations, there remains regulatory uncertainty with respect to the implementation and interpretation of laws in China.</font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">In the event that we elect to carry out clinical trials in China and/or expand our operations into China in the future (see &#8220;Business&#8221; beginning on page <a href="#tBUS">112</a> for our current plans for future clinical trials), there may be certain legal and operational risks associated with having certain operations in China, including that changes in the legal, political and economic policies of the Chinese government, the relations between China and the United States, or Chinese or United States regulations may materially and adversely affect our business, financial condition, results of operations and the market price of our ADSs. Any such changes may significantly limit or completely hinder our ability to offer or continue to offer our ADSs to investors, and may cause the value of our ADSs to significantly decline or become worthless. For more information on these risks and other risks you should consider before buying our ADSs, see &#8220;Risk Factors&#8221; beginning on page 15. </font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">Furthermore, as more stringent criteria, including the Holding Foreign Companies Accountable Act, or the HFCAA, have been imposed by the SEC and the Public Company Accounting Oversight Board, or the PCAOB, recently, our ADSs may be prohibited from trading in the United States if our auditor cannot be fully inspected. Our auditor, Friedman LLP, the independent registered public accounting firm that issued the audit report included in this prospectus, is a firm registered with the PCAOB. Friedman LLP is headquartered in Manhattan, New York and has been inspected by the PCAOB on a regular basis. Therefore, we believe that, as of the date of this prospectus, our auditor is not subject to the determinations announced by the PCAOB on December 16, 2021 relating to the PCAOB&#8217;s inability to inspect or investigate completely registered public accounting firms headquartered in mainland China of the PRC or Hong Kong because of a position taken by one or more authorities in the PRC or Hong Kong. For more information on these risks and other risks you should consider before buying our ADSs, see &#8220;Risk Factors &#8221; beginning on page <a href="#tRIFA">17</a>. We cannot assure you whether Nasdaq or other regulatory authorities will apply additional or more stringent criteria to us. Such uncertainty could cause the market price of our ADSs to be materially and adversely affected.</font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">Upon the completion of this offering, Lin Bioscience International Ltd., our principal shareholder, will hold more than 50% of the shareholder voting power of our outstanding share capital, as further described under &#8220;Principal Shareholders&#8221; in this prospectus. As a result, our principal shareholder could exert substantial influence over matters such as electing directors and approving material mergers, acquisitions, strategic collaborations or other business combination transactions. As a result, we are a &#8220;controlled company&#8221; as defined under the Nasdaq Stock Market Rules. For so long as we remain a controlled company as defined under that rule, we are exempt from, and our shareholders generally are not provided with the benefits of, some of the Nasdaq Stock Market corporate governance requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">We are an &#8220;emerging growth company&#8221; and a &#8220;foreign private issuer&#8221; under applicable U.S. federal securities laws and are eligible for reduced public company reporting requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:1pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">Lin Bioscience International Ltd., our principal shareholder, has indicated an interest to purchase up to US$15.0 million of ADSs in this offering, which will represent no more than 50% of the total ADSs in this offering such that we still meet the un-affiliated float listing criteria of the Nasdaq Capital Market. Because indications of interest are not binding agreements or commitments to purchase, Lin Bioscience International Ltd. may determine to purchase fewer ADSs than it has indicated an interest in purchasing or not to purchase any ADSs in this offering. </font>
        </div>
        <div style="margin-left:20pt; margin-top:1pt; width:485.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.14pt;">Investing in the ADSs involves risks. See &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">17</a> for factors you should consider before buying the ADSs.</font><font style="font-weight:normal;letter-spacing:0.14pt;"> </font>
        </div>
        <div style="margin-top:6.467pt; text-align:center; width:505.31pt;">
          <div style="margin-left: 39.314%; margin-right: 39.314%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4.3pt; text-align:center; width:505.31pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.16pt;">PRICE US$&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;PER ADS</font><font style="font-weight:normal;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4.3pt; text-align:center; width:505.31pt;">
          <div style="margin-left: 39.314%; margin-right: 39.314%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:4.3pt; width:505.31pt; line-height:7pt;font-weight:bold;">
          <font style="letter-spacing:-0.14pt;">Neither the United States Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.14pt;"> </font>
        </div>
        <table style="width:505.31pt;height:33.68pt;margin-top:1.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:433.45pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.99000000000001pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:1.007pt 0pt 0.5pt 0pt; width:433.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Initial public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.41pt;width:0pt;">&#8203;</td>
            <td style="padding:1.007pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; ">US$</td>
            <td style="padding:1.007pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.015pt;width:0pt;">&#8203;</td>
            <td style="padding:1.007pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; ">US$</td>
            <td style="padding:1.007pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.99000000000001pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:1.267pt 0pt 0.5pt 0pt; width:433.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Underwriting discounts and commissions</font><font style=" position:relative; bottom:2.75pt;font-size:4.5pt;letter-spacing:0.11pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.41pt;width:0pt;">&#8203;</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; ">US$</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.015pt;width:0pt;">&#8203;</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; ">US$</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:6.99000000000001pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7pt;">
            <td style="padding:1.267pt 0pt 0.5pt 0pt; width:433.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.14pt;">Proceeds, before expenses, to us </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.41pt;width:0pt;">&#8203;</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; ">US$</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.015pt;width:0pt;">&#8203;</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; ">US$</td>
            <td style="padding:1.267pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.2pt; width:505.31pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.14pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:9pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.14pt;">See &#8220;Underwriting&#8221; for additional information regarding compensation payable by us to the underwriters. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>

          <div style="text-indent:20pt; margin-top:3pt; width:505.31pt; line-height:7pt;">
            <font style="letter-spacing:0.14pt;">In addition to the underwriting discounts and commissions referred to in the table above, we have agreed to issue, upon closing of this offering, warrants to the representative of the underwriters to purchase 2.5% of the total number of ADSs sold in this offering at a per ADS price equal to 125% of the public offering price (the &#8220;Representative&#8217;s Warrants&#8221;). The registration statement of which this prospectus is a part also covers the Representative&#8217;s Warrants and the ADSs issuable upon the exercise thereof. See section entitled &#8220;Underwriting&#8221; on page <a href="#tUND">212</a> for more information. </font>
          </div>

        <div style="text-indent:20pt; margin-top:3pt; width:505.31pt; line-height:7pt;">
          <font style="letter-spacing:0.14pt;">We have granted to the underwriters an option, for a period of 30&#160;days after the date of this prospectus, to purchase up to an additional 900,000 ADSs from us at the public offering price per ADS, less underwriting discounts and commissions.</font>
        </div>
        <div style="margin-left:20pt; margin-top:1pt; width:485.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.14pt;">The underwriters expect to deliver the ADSs to purchasers on or about&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;, 2022. </font>
        </div>
        <div style="margin-top:7.467pt; text-align:center; width:505.31pt;">
          <div style="margin-left: 39.314%; margin-right: 39.314%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4.3pt; text-align:center; width:505.31pt; line-height:9.5pt;font-style:italic;font-size:9pt;">
          <font style="letter-spacing:0.18pt;">Sole Book-Running Manager</font><font style="font-style:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:505.31pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">The Benchmark Company</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:505.31pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.16pt;">The date of this prospectus is&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2022.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:385pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU"><font style="letter-spacing:0.2pt;">Prospectus Summary </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSU">1</a></font> <a href="#tPRSU"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">Risk Factors </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRIFA">17</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSPNR"><font style="letter-spacing:0.2pt;">Special Note Regarding Forward-Looking Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSPNR">86</a></font> <a href="#tSPNR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:0.2pt;">Use of Proceeds </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUOP">88</a></font> <a href="#tUOP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDP"><font style="letter-spacing:0.2pt;">Dividend Policy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDP">89</a></font> <a href="#tDP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCAP"><font style="letter-spacing:0.2pt;">Capitalization </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCAP">90</a></font> <a href="#tCAP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIL"><font style="letter-spacing:0.2pt;">Dilution </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDIL">92</a></font> <a href="#tDIL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tECL"><font style="letter-spacing:0.2pt;">Enforceability of Civil Liabilities </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tECL">94</a></font> <a href="#tECL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCHA"><font style="letter-spacing:0.2pt;">Corporate History and Structure </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCHA">96</a></font> <a href="#tCHA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSCF"><font style="letter-spacing:0.2pt;">Selected Consolidated Financial Data </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSCF">97</a></font> <a href="#tSCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMDA"><font style="letter-spacing:0.2pt;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMDA">98</a></font> <a href="#tMDA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tBUS"><font style="letter-spacing:0.2pt;">Business </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tBUS">112</a></font> <a href="#tBUS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tREG"><font style="letter-spacing:0.2pt;">Regulations </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tREG">138</a></font> <a href="#tREG"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMANA"><font style="letter-spacing:0.2pt;">Management </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMANA">167</a></font> <a href="#tMANA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPS"><font style="letter-spacing:0.2pt;">Principal Shareholders </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPS">176</a></font> <a href="#tPS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRPT"><font style="letter-spacing:0.2pt;">Related Party Transactions </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRPT">178</a></font> <a href="#tRPT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDSC"><font style="letter-spacing:0.2pt;">Description of Share Capital </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDSC">183</a></font> <a href="#tDSC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDAP"><font style="letter-spacing:0.2pt;">Description of American Depositary Shares </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDAP">195</a></font> <a href="#tDAP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSEF"><font style="letter-spacing:0.2pt;">Shares Eligible for Future Sale </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEF">205</a></font> <a href="#tSEF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTAX"><font style="letter-spacing:0.2pt;">Taxation </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTAX">207</a></font> <a href="#tTAX"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUND"><font style="letter-spacing:0.2pt;">Underwriting </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUND">212</a></font> <a href="#tUND"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tERT"><font style="letter-spacing:0.2pt;">Expenses Related to this Offering </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tERT">223</a></font> <a href="#tERT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLM"><font style="letter-spacing:0.2pt;">Legal Matters </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLM">224</a></font> <a href="#tLM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:0.2pt;">Experts </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXP">225</a></font> <a href="#tEXP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">Where You Can Find Additional Information </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYCF">226</a></font> <a href="#tWYCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tICF"><font style="letter-spacing:0.2pt;">Index to Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tICF">F-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Until&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;, 2022 (the 25th day after the date of this prospectus), all dealers that effect transactions in these ADSs, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as an underwriter and with respect to their unsold allotments or subscriptions.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should rely only on the information contained in this prospectus or in any free writing prospectus that we authorize to be distributed to you. We and the underwriters have not authorized anyone to provide you with any information other than that contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you, and neither we, nor the underwriters, take responsibility for any other information others may give you. We are offering to sell, and seeking offers to buy the ADSs, only in jurisdictions where such offers and sales are permitted. The information in this prospectus or any free writing prospectus is accurate only as of its date, regardless of its time of delivery or the time of any sale of the ADSs. Our business, financial condition, results of operations and prospects may have changed since that date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither we nor any of the underwriters has taken any action to permit a public offering of the ADSs outside the United States or to permit the possession or distribution of this prospectus or any filed free writing prospectus outside the United States. Persons outside the United States who come into possession of this prospectus or any filed free writing prospectus must inform themselves about and observe any restrictions relating to the offering of the ADSs and the distribution of the prospectus or any filed free writing prospectus outside the United States.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">The following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information and financial statements appearing elsewhere in this prospectus. In addition to this summary, we urge you to read the entire prospectus carefully, especially the risks of investing in the ADSs discussed under &#8220;Risk Factors&#8221; and information contained in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; before deciding whether to invest in the ADSs.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration (commonly known as dry AMD) and autosomal recessive Stargardt disease, or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout. </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">LBS-008</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We believe our lead product candidate, LBS-008, or Tinlarebant, if approved, would provide a novel treatment option where there currently is none. LBS-008 is an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A (retinol) to the eye as a means to reduce the accumulation of toxic vitamin A by-products in ocular tissue. This effect is achieved through the ability of LBS-008 to reduce and maintain the level of serum retinol binding protein 4, or RBP4, which carries retinol from the liver to the eye. In clinical trials, LBS-008 has demonstrated its target specificity and potency that we believe could be clinically meaningful to treat STGD1 patients. We initiated an open-label, dose-finding Phase&#160;1b/2 clinical trial in adolescent STGD1 patients in mid-2020 in Australia and Taiwan. The study design includes two portions: Phase&#160;1b and Phase&#160;2. We have completed the Phase&#160;1b portion of this study in 11 adolescent STGD1 patients which has extended into a two-year, Phase&#160;2 study with 13 adolescent STGD1 patients in Australia and Taiwan. The preliminary data from the Phase&#160;1b portion has shown that LBS-008 can achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. We are currently conducting the Phase&#160;2 portion of this study. See &#8220;&#8212;Phase 1b/2 Clinical Trial in STGD1&#8221; below for more information. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have initiated our Phase&#160;3 clinical trial, to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">STGD1 is a rare monogenetic juvenile-onset macular dystrophy that is characterized by the aberrant and excessive accumulation of toxic vitamin A by-products known as bisretinoids and cellular debris, or lipofuscin, which precedes the death of retinal tissue and loss of vision. Although an orphan disease, STGD1 is the most common juvenile macular degeneration. Dry AMD is a heterogenous condition that arises from a complex interplay between age, genetics and environmental factors, such as diet and smoking, but has a pathology and course of disease that strongly resembles that of STGD1, particularly in intermediate and advanced stages. There are no approved therapies for STGD1 or dry AMD. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Developed from our RBP4 intellectual property portfolio, or RBP4 IP Portfolio, LBS-008 was designed to be a potent and reversible RBP4 antagonist. As an RBP4 antagonist, LBS-008 reduces the amount of retinol entering the visual cycle thereby reducing the formation of bisretinoid toxins which will ultimately preserve the health of the retina. We hold a worldwide exclusive license of the RBP4 IP Portfolio from Columbia University, which contains disclosure directed to over 400 structurally distinct RBP4 antagonists under patent protection in major pharmaceutical markets worldwide, including the United States, the European Union, China, Australia, Japan, South Korea and India. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">LBS-008 has received orphan drug designation for the treatment of STGD1 in the United States, which entitles it to market exclusivity such that the U.S. Food and Drug Administration, or FDA, may not approve any other applications for the same product for the same indication for 7&#160;years, except in very limited circumstances. See &#8220;Regulations&#8201;&#8212;&#8201;U.S. Regulation&#8201;&#8212;&#8201;NDA Submission and Review&#8201;&#8212;&#8201;Orphan Drug </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Designation and Exclusivity&#8221; for more information. LBS-008 has also received orphan designation for the treatment of STGD1 in Europe, which entitles it to a 10 year period of market exclusivity, which may be reduced in certain circumstances. During this market exclusivity period, neither the European Medicines Agency, or EMA, nor the European Commission or the member states can accept an application for, or grant a marketing authorization for, a &#8220;similar medicinal product.&#8221; See &#8220;Regulations&#8201;&#8212;&#8201;European Regulation&#8201;&#8212;&#8201;Orphan Designation and Exclusivity&#8221; for more information. Additional benefits of an orphan drug designation include a tax credit of 50% of the qualified clinical testing expenses for the relevant taxable year and a waiver of the new drug application, or NDA, application fee (which is approximately $3.1&#160;million for fiscal year 2022). </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">LBS-008 has also received rare pediatric disease designation in the United States and may be eligible for a priority review voucher. A priority review voucher may be awarded to a sponsor if it develops a drug for a rare pediatric disease and the drug is approved. The priority review voucher allows the sponsor of a subsequent NDA or Biologic License Application for any product candidate to expedite the FDA&#8217;s review goal from 10&#160;months to 6&#160;months. The priority review voucher may be sold to other companies that seek to expedite drug reviews. See &#8220;Regulations&#8201;&#8212;&#8201;U.S. Regulation&#8201;&#8212;&#8201;NDA Submission and Review&#8201;&#8212;&#8201;Rare Pediatric Disease Designation and Priority Review Vouchers&#8221; for more information. In the last three&#160;years, priority review vouchers have sold in a price range between $80-125&#160;million. In the event that we or a sublicensee chooses to sell a priority review voucher, we or such sublicensee would be obligated to pay Columbia University a percentage of revenue in the low double-digits that we or such sublicensee receives from any such sale pursuant to the Columbia License Agreement. In the event that we or a sublicensee does not sell a priority review voucher within one year of receipt, the earned royalties that we would be obligated to pay to Columbia University based on net sales of licensed products would increase by 1%. See &#8220;Business &#8201;&#8212;&#8201;Intellectual Property&#8201;&#8212;&#8201;Patents&#8201;&#8212;&#8201;Patent License Agreement with The Trustees of Columbia University in the City of New York&#8221; for more information. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">LBS-008 is the only drug candidate within the current drug development projects of the National Institute of Health (NIH) Blueprint Neurotherapeutics Network, or the BPN, that is intended to treat dry AMD. The BPN was launched in 2004 to foster small-molecule neurotherapeutic development, bringing together a unique blend of grant dollars, industry-standard scientific expertise, and contract resources under a milestone-driven cooperative agreement program. The BPN criteria for selection of clinical drug candidates are based on multiple features of an applicant&#8217;s drug development program including the following: 1) strong biological rationale, 2) novel target for the disease, 3) strong data linking target to disease, 4) demonstration of preclinical pharmacodynamic effect and efficacy, 5) feasible path to clinic, and 6) IP free of roadblocks. LBS-008 was selected by the BPN in 2011 and, as of the date of this prospectus, is the only drug candidate within the current drug development projects of the BPN that is intended to treat dry AMD. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The mechanism of action utilized by LBS-008 has been recognized and recommended as a priority for clinical development in both STGD1 and dry AMD in a systematic review published by the U.K. National Institute for Health Research, or the NIHR, in 2018. The NIHR is funded by the U.K. Department of Health and Social Care and focuses on early translational research, clinical research and applied health and social care research for the purpose of enabling and delivering world-leading health and social care research that improves people&#8217;s health and wellbeing and promotes economic growth. The NIHR screened 7,948 articles in 2018 for its systematic review on treatments for dry AMD and STGD1. Its principal findings included that research focus should be at earlier stages in both diseases (before vision is impaired) and that the most promising treatments for both diseases appear to be prevention of lipofuscin and bisretinoid accumulation. Therefore, the NIHR recommended the mechanism of RBP4 inhibition, which is utilized by LBS-008, as a promising treatment in dry AMD and STGD1. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Although there are currently no approved treatments available for STGD1 and dry AMD, our competitors for LBS-008 include several companies going through clinical development for their product candidates. Based on publicly available information, we understand that there is one Japan-based pharmaceutical company that has an asset in Phase&#160;3 development for STGD1. There are also three U.S.-based companies advancing treatments for STGD1 and their assets are currently in Phase&#160;2 and Phase&#160;2b development, respectively, with the third company having recently completed their Phase&#160;2a trial. In geographic atrophy, or GA, there are five U.S.-based companies in late-stage clinical development, three of which have assets in Phase 3 development and two of which have assets in Phase&#160;2 development. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Clinical Trials in Healthy Adult Subjects</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">To support the clinical development of LBS-008, we have completed one randomized, double-blind, placebo-controlled, Phase 1 SAD study in 40 healthy adult subjects in the United States, one randomized, double-blind, placebo-controlled, Phase 1 single ascending dose, or SAD, study in 39 healthy adult subjects and one randomized, double-blind, placebo-controlled, Phase 1 multiple ascending dose, or MAD, study in 32 healthy adult subjects in Australia. These studies were conducted to confirm the safety, toxicity, pharmacokinetics, or PK, and pharmacodynamics, or PD of LBS-008 on a range of single ascending dose (10-50 mg in the US; 25-400 mg in Australia) / multiple ascending dose (5-25 mg in Australia) levels in heathy adult subjects in fasted / fed conditions. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In the US SAD study, we found that single doses of 10&#8211;50 mg LBS-008 were well tolerated and reduced mean serum RBP4 level by around 70% from baseline. The degree of lowering of RBP4 plasma concentrations increased with increasing LBS-008 dose. This study also compared doses of LBS-008 taken with and without food, which did not show a food effect with dosing.</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In the Australian SAD study, we found that single doses of 25-400 mg LBS-008 were well tolerated and reduced mean RBP4 level by &gt; 70% from baseline. One subject in the 100 mg cohort experienced a drug-related adverse event of mild transient xanthopsia. That event was resolved within 48 hours. A direct correlation between the LBS-008 plasma concentration and RBP4 suppression was observed. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In the Australian MAD study, we found that all dose levels were well tolerated and have identified an optimal daily dose to reduce serum RBP4 by &gt; 70% from baseline. Most drug-related adverse events reported were mild in severity, and the most frequently reported drug-related adverse event was asymptomatic Delayed Dark Adaptation, or DDA, which did not show dose proportionality and reflects a reduction in vitamin A levels in the eye, which is the intended effect of LBS-008. No deaths, serious or severe adverse events were reported. The Safety Review Committee, or SRC, approved dose escalations after reviewing the safety data profile at each dose level.</font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Stargardt Disease</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In STGD1, we are developing LBS-008 as an oral daily treatment to target RBP4 by disrupting vitamin A (retinol) binding to RBP4 which leads to reduced delivery of retinol to the eye and reduced accumulation of toxic vitamin A by-products. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">STGD1 is an inherited juvenile form of macular degeneration and currently, there is no approved treatment available. The disease is caused by a mutation in the ABCA4 gene, which leads to the accelerated formation and accumulation of toxic vitamin A by-products known as bisretinoids. The most prominent bisretinoid identified in human tissues is known as A2E (</font><font style="font-style:italic;letter-spacing:0.2pt;">N</font><font style="letter-spacing:0.2pt;">-retinylidene-</font><font style="font-style:italic;letter-spacing:0.2pt;">N</font><font style="letter-spacing:0.2pt;">-retinylethanolamine). The accumulation of A2E in ocular tissues causes progressive retinal cell death and permanent loss of vision. More than 500 mutations in the ABCA4 gene have been identified in STGD1 patients. Some STGD1 patients suffer severe visual impairment by the age of 20. The prevalence rate of STGD1 is estimated to be 1 in 10,000 people. Based on this estimate, approximately 30,000 US citizens are affected by STGD1. This estimate includes both adults and children. Although comprehensive epidemiological data on the prevalence of STGD1 in other countries is not available, the epidemiological literature from other countries, such as Europe and Asian countries, cite the 1 in 10,000 estimate for the prevalence of STGD1. </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Phase 1b/2 Clinical Trial in STGD1</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We have completed the Phase 1b portion of a Phase 1b/2 open-label, dose-finding study in 11 adolescent STGD1 patients which has extended into a two-year, Phase 2 study with 13 adolescent STGD1 patients in Taiwan and Australia. The Phase 1b portion is a dose-finding study designed to determine the optimal dose of LBS-008 and to evaluate safety, tolerability, PK and PD in adolescent STGD1 patients for a treatment period of 2 cycles of 14-day daily dosing of LBS-008 (28 days of daily treatment) and a 14-day follow-up period. Upon completion of Phase 1b, an optimal daily dose was identified and which was able to achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The preliminary data shows that most frequently reported drug-related adverse events reported to date included DDA and transient xanthopsia, which were all graded as mild. Reports of transient DDA/night </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">vision impairment and xanthopsia were anticipated and are consistent with LBS-008&#8217;s mechanism of action. It is notable that in most incidences of DDA, it was confirmed by laboratory measure (dark&#160;adaptometry) as the majority of patients were asymptomatic. No deaths or serious or severe Treatment-emergent adverse events, or TEAEs, were reported. In addition, there were no clinically significant findings in relation to vital signs, physical exams, or electrocardiograms, or ECGs. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The Phase&#160;2 portion consists of a 2-year treatment period with a follow-up period of one month. In the Phase&#160;2 portion of the study, in addition to monitoring the safety and tolerability, we aimed to monitor PK and PD biomarkers (RBP4 and retinol) and the effects of treatment using various retinal imaging modalities (including definitely decreased autofluorescence, or DDAF, questionably decreased autofluorescence, or QDAF, Spectral-domain optical coherence tomography, or SD-OCT, and microperimetry), change in best-corrected visual acuity, or BCVA, and the relationship between the change in RBP4 levels and rate of lesion growth. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are currently conducting the Phase&#160;2 portion of this study. A total of 13 adolescent STGD1 patients were enrolled in the Phase&#160;2 portion of the Phase&#160;1b/2 study. As of the date of this prospectus, all 13 patients have received at least 6&#160;months of treatment and completed the scheduled assessments at the first 6 month interval. Change in BCVA (early treatment diabetic retinopathy study, or ETDRS letter score), and fundus autofluorescence, or FAF, imaging results at 6-months are compared to the baseline measurements at the start of Phase&#160;2. The preliminary data shows that 8 of the 13 patients (or 61.5%) recorded a gain in BCVA (ETDRS letter score) in at least one eye, including 2 patients who recorded a gain in BCVA in both eyes. The average BCVA from the 13 patients was an average loss of 2.8 letters in the right eye, and an average gain of 1.9 letters in the left eye. On FAF retinal imaging, 8 of the 13 patients (or 61.5%) had a reduction or no change in their QDAF area size in at least one eye, including 5 patients who had a reduction or no change in QDAF area size in both eyes. There was an average gain in QDAF area in the right eye of 0.2 &#177; 0.09mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> (Mean &#177; standard error of the mean, or SEM) and in the left eye of 0.1 &#177; 0.09mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> (Mean &#177; SEM). While 12 of the 13 patients had no DDAF lesion measured at the start of Phase&#160;2 and at 6-months, 1 of the&#160;13 patients had a DDAF lesion growth of 0.3mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> in both eyes during the 6-month period. On SD-OCT imaging, a gradual thinning with an average of approximately 7 to 10 microns (on total retinal thickness by ETDRS regions) was observed in both eyes. In the Ellipsoid Zone (EZ), an average increase in defect width of 0.26mm in the right eye and 0.61mm in the left eye were observed. However, 6 patients had a reduction in EZ defect width in at least 1&#160;eye (including 3 patients in both eyes). Additional interim data read-outs will be captured at Months&#160;12, 15, 18 and 21, and a final data read-out will be captured at Month&#160;24. </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Phase 3 Clinical Trial in STGD1</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have initiated a randomized, double-masked, placebo-controlled, global, multi-center, Phase&#160;3 clinical trial, to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. This study consists of a screening period, a treatment period of 2&#160;years, and a follow-up period of one month. Approximately 60 patients are targeted for enrollment in this study with a 2:1 randomization (active:placebo). See &#8220;Risk Factors&#8201;&#8212;&#8201;In the event that we elect to carry out clinical trials in China and/or expand our operations into China in the future, we will be subject to changing legal and regulatory requirements in the PRC pharmaceutical industry, and new laws, rules and regulations may adversely affect our profitability or impose additional compliance burdens on us.&#8221;</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We intend to focus on adolescent patients in our ongoing clinical trials due to several benefits afforded by utilizing this patient population&#8201;&#8212;&#8201;namely, establishing proof-of-concept in the context of a more severe and rapidly progressing disease (i.e., STGD1 disease progression is faster in adolescent patients compared to adults or later-onset patients), and the ability to readily expand into the larger adult STGD1 population upon approval (i.e., drug approvals for pediatrics and/or adolescents are accepted for adults but drug approvals for adults are not accepted for pediatrics and/or adolescent populations due to safety concerns). </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Dry AMD</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Due to the strong pathophysiologic similarities between STGD1 and intermediate to advanced stages of dry AMD, we expect LBS-008 to have a similar treatment effect on this population of dry AMD patients. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">AMD is an age-related form of macular degeneration. The most commonly used classification system for AMD is the Age-Related Eye Disease Study, or AREDS, classification system, which designates the following categories: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Category 1 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No AMD</font><font style="letter-spacing:0.2pt;">,&#8221; although there may be a few small (&lt;63&#181;m in diameter) yellowish subretinal deposits (i.e., drusen beneath the retina). </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Category 2 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Early AMD</font><font style="letter-spacing:0.2pt;">&#8221; and is characterized by multiple small drusen (&lt;20&#181;m in diameter), a few intermediate drusen (63-124&#181;m in diameter), and abnormalities of the retinal pigment epithelium, or RPE, a monolayer of epithelial cells that lies beneath the retina and provides trophic and metabolic support to photoreceptor cells of the retina. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Category 3 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Intermediate AMD</font><font style="letter-spacing:0.2pt;">,&#8221; where there is extensive intermediate drusen, large drusen (&gt;125&#181;m in diameter), or geographic atrophy (i.e., localized atrophy of the retina), or GA, and increased lipofuscin in the RPE. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Category 4 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Advanced AMD</font><font style="letter-spacing:0.2pt;">&#8221; and is characterized by GA or neovascular maculopathy (i.e., &#8216;wet&#8217; AMD). </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The only approved therapies for AMD are for &#8216;wet&#8217; AMD which represents approximately 10% of all AMD cases. There are no approved therapies for the other stages of AMD, including GA, secondary to advanced AMD, which are collectively referred to as dry AMD and represents approximately 90% of all AMD cases. Importantly, dry AMD is a leading cause of vision loss in older adults. Thus, there is a significant unmet medical need in treating dry AMD patients. There are an estimated 11&#160;million dry AMD patients in the United States and over 196&#160;million patients worldwide with an estimated global direct healthcare cost of US$255&#160;billion. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Disease progression in early dry AMD is very slow. The American Optometric Association reports that most people move through the process from diagnosis to legal blindness in about 10&#160;years. Therefore, investigational therapies have been directed at the treatment of intermediate and advanced stages of dry AMD, which progress more rapidly than earlier stages. Unlike STGD1, dry AMD is believed to have a very heterogenous etiology, and various therapeutic approaches have been explored to slow disease progression in dry AMD. An important feature of Intermediate AMD is the aberrant and excessive accumulation of lipofuscin and bisretinoid toxins, similar to STGD1. In these stages of dry AMD, retinal lesions (i.e., GA) are bordered on all sides by an annulus of autofluorescence which expands in a centrifugal manner followed by lesion expansion into the autofluorescent area. </font><font style="font-style:italic;letter-spacing:0.2pt;">In vivo</font><font style="letter-spacing:0.2pt;"> analyses of the autofluorescent area in Intermediate AMD eyes revealed an excitation maxima and fluorescence emission that is consistent with the spectral properties of bisretinoid toxins. Thus, the clinical presentation and biochemical features of intermediate and advanced dry AMD suggest that a therapy directed at reducing the level of bisretinoid toxins may be effective to slow disease progression. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We are currently evaluating our plan to initiate, in 2022, a randomized, double masked, placebo-controlled, Phase&#160;2 or Phase&#160;3 trial, in the United States, Europe, and Asia Pacific. See &#8220;Risk Factors &#8212; In the event that we elect to carry out clinical trials in China and/or expand our operations into China in the future, we will be subject to changing legal and regulatory requirements in the PRC pharmaceutical industry, and new laws, rules and regulations may adversely affect our profitability or impose additional compliance burdens on us.&#8221; Our objective is to evaluate the efficacy and safety of LBS-008 in the treatment of dry AMD over the course of a two-year treatment period. </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">LBS-009</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">LBS-009 is an anti-RBP4 oral therapy targeting liver disease, including NAFLD, NASH, and T2D. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">NAFLD occurs when an excess accumulation of fat damages the liver. Currently, it is estimated that approximately 1.9&#160;billion patients suffer from NAFLD worldwide. Over time, the liver damage and the associated inflammation can lead to the development of NASH, which impacts an estimate of more than 9&#160;million patients in the United States alone. As the disease progresses, it can lead to cirrhosis and eventually, complete liver failure. NAFLD and NASH are a growing unmet need for which no FDA-approved treatments are currently available. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:7.02999999999997pt; margin-left:12pt;width:456pt;">
          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">T2D is a chronic disease that occurs when the body cannot effectively use insulin, the hormone that regulates blood sugar levels. The health impact of T2D is profound, potentially causing damage to the eyes, heart, blood vessels, kidneys, and nerves. T2D is on the rise, with approximately 422&#160;million patients globally. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">LBS-009 is a small molecule designed to compete with retinol for RBP4 binding. When bound to LBS-009, RBP4 can no longer form a large molecular weight complex with transthyretin. Consequently, the RBP4/LBS-009 complex will be removed from circulation by renal filtration. We believe that modulating RBP4 concentrations systemically with LBS-009 has a significant therapeutic potential for treating patients suffering from metabolically associated diseases, including NAFLD, NASH and T2D. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">LBS-009 is currently in preclinical development. </font>
          </div>
          <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Management and Clinical Advisory Board</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our management team and ophthalmology clinical advisory board have deep experience and capabilities in ophthalmology, neurology, immunology and immunotherapy, cardiovascular and renal medicine, oncology, neurobiology, biochemistry, drug discovery, clinical development, manufacturing, and commercialization. Our ophthalmology clinical advisory board includes key opinion leaders in the macular degeneration space, including Quan Nguyen, M.D., Professor of Ophthalmology at Stanford University, Hendrik P.N. Scholl, M.D., Professor and Chairman of the Department of Ophthalmology at University of Basel and Co-Director of the Institute of Molecular and Clinical Ophthalmology in Basel, Michel Michaelides, M.D., Consultant Ophthalmologist at Moorfields Eye Hospital and Professor of Ophthalmology, UCL Institute of Ophthalmology, Robyn Guymer, M.D., Professor of Ophthalmology, University of Melbourne and Deputy Director of the Centre for Eye Research Australia and Frank Holz, M.D., Chairman of Ophthalmology, University of Bonn. Together, our management team and ophthalmology clinical advisory board, in connection with our exclusive technology platform, will allow our drugs to be tailored to target at-risk patients across the United States and worldwide, who lack access to necessary treatment in the macular degeneration space. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Program</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our lead product candidate, LBS-008, is an RBP4 antagonist. We are developing LBS-008 as an oral daily treatment for STGD1 and dry AMD. </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following table summarizes key information about our clinical program for LBS-008: </font>
          </div>
          <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:105pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.16pt;">Indication </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:105pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Clinical Trials </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:105pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Trial Participants </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:105pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Estimated Timeline </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">STGD1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:105pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Phase&#160;1 single and multiple ascending dose trial </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Healthy adult subjects </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Completed </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:105pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Phase&#160;1b trial </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Adolescent patients with STGD1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Completed </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:105pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Phase&#160;2 trial </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Adolescent patients with STGD1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Ongoing, with interim data read-outs expected to be captured at Months&#160;12, 15, 18 and 21, and a final data read-out to be captured at Month&#160;24. </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:105pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Phase&#160;3 trial </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Adolescent patients with STGD1 </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Initiated </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Dry AMD </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;white-space:normal;">
                <font style="letter-spacing:0.2pt;">Phase&#160;1 single ascending dose trial </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Healthy adult subjects </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Completed </font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:105pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">Phase&#160;2 or Phase&#160;3 trial </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:105pt;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Patients with dry AMD </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:105pt;">
                <font style="letter-spacing:0.2pt;">2022</font>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our ongoing and planned development plans and clinical trials may potentially be adversely impacted if the COVID-19 pandemic continues in the future. Specifically, the COVID-19 pandemic may lead to (i)&#160;delays in patient enrollment for our clinical trials and/or other services provided by the CROs, laboratories or hospitals engaged by or collaborated with us due to lockdown measures in various countries, (ii)&#160;delays or significant increase in expenses for obtaining and shipment of our drug candidates due to congestion at port or increased freight and (iii)&#160;delays in the FDA or other regulatory agencies review and approval processes as the FDA or other regulatory agencies may prioritize and focus on the approval of therapeutics treating COVID-19 than those treating other indications.</font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Strengths</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We believe we are well placed to accomplish our mission due to the following strengths: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Novel oral therapy to tap into a niche market for significant unmet medical needs. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Pre-clinically and clinically demonstrated mechanism of action. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Receipt of Orphan Drug Designation in the United States and Europe. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Receipt of Rare Pediatric Disease Designation in the United States with Eligibility for Priority Review Voucher if approved. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">National Institute of Health Blueprint Neurotherapeutics Network sponsored and endorsed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">U.K. National Institute for Health Research endorsed the mechanism of action utilized by LBS-008. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Potential to treat intermediate to advanced-stage dry AMD with oral therapy for lifetime. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Highly experienced senior management team supported by world-renowned advisory board and influential key opinion leaders. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our Strategies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our goal is to become a leading biopharmaceutical company with an aim to develop the first approved treatment on STGD1 and dry AMD globally. We intend to accomplish our mission by pursuing the following growth strategies: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Efficiently advance our lead product candidate, LBS-008, through Phase&#160;2 and Phase&#160;3 clinical development in adolescent STGD1 patients and regulatory approval, with the potential to establish a new standard of care for STGD1 patients. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Leverage the promising clinical data of LBS-008 in adolescent STGD1 patients to initiate Phase&#160;2 or Phase&#160;3 clinical development in dry AMD. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Potentially advance LBS-009 through clinical development for the treatment of NAFLD and NASH. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Continue to leverage our exclusive RBP4 IP Portfolio, and look for additional in-licensing or collaboration arrangements, to identify novel candidates to further expand our product pipeline and utilize our global organizational structure to advance programs into clinical development in a capital efficient manner. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Evaluate strategic collaborations to maximize the value of our product candidates. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary of Risk Factors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">There are a number of risks that you should understand before making an investment decision regarding this offering. These risks are discussed more fully in the section entitled &#8220;Risk factors&#8221; following this prospectus summary. These risks include, but are not limited to: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our business is highly dependent on the success of our lead product candidate, LBS-008. If we are unable to develop, obtain marketing approval for or successfully commercialize LBS-008, either alone or through a collaboration, or if we experience significant delays in doing so, our business could be harmed; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">All of our product candidates are in preclinical or clinical development. If we are unable to complete clinical development and obtain regulatory approval to ultimately commercialize our product candidates, or if we experience significant delays in doing so, our business, financial condition, results of operations and prospects will be materially harmed; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We have recorded net cash outflow from operating activities since our inception. Even if we consummate this offering, we will need to obtain additional financing to fund our operations. If we are unable to obtain such financing, we may be unable to complete the development and commercialization of our product candidates; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">There is uncertainty regarding our ability to continue as a going concern, indicating the possibility that we may be required to curtail or discontinue our operations in the future;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We have a limited operating history and no history of commercializing pharmaceutical products, which may make it difficult to evaluate the prospects for our future viability; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">The regulatory approval processes of the FDA, the TGA, the NMPA, the EMA and other comparable regulatory authorities are time-consuming and may evolve over time, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">All material aspects of the research, development, manufacturing and commercialization of pharmaceutical products are heavily regulated; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If we are unable to obtain and maintain patent and other intellectual property protection for our product candidates, or if the scope of such intellectual property rights obtained is not sufficiently broad, third parties could develop and commercialize products and technologies similar or identical to ours and compete directly against us, and our ability to successfully commercialize any product or technology may be adversely affected; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We depend on intellectual property licensed from third parties, and our current and future licensors may not always act in our best interest. If we fail to comply with our obligations under our intellectual property licenses, if the licenses are terminated or if disputes regarding these licenses arise, we could lose significant rights that are important to our business; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">If we fail to implement and maintain an effective system of internal controls, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market price of our ADSs may be materially and adversely affected; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">Our future success depends on our ability to attract, retain and motivate senior management and qualified scientific employees; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">As we rely on third parties to conduct our preclinical studies, clinical trials, contract manufacture drug substances and drug products, and provide other important services related to product development, regulatory submissions, and commercialization, if we lose our relationships with these third parties or if they do not successfully carry out their contractual duties, comply with applicable laws, or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">We expect to seek to establish collaborations and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">As a result of our principal shareholder, Lin Bioscience International Ltd.&#8217;s significant share ownership position in us, it is able to influence corporate matters and a conflict of interest may arise between our principal shareholder and us. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Corporate Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The chart below sets forth our corporate structure and identifies our significant subsidiaries and their significant subsidiaries, as of the date of this prospectus: </font>
          </div>
          <div style="position:relative;margin-top:7.71pt; width:456pt;">
            <img src="tm2132809d1-fc_beltebw.jpg" alt="[MISSING IMAGE: tm2132809d1-fc_beltebw.jpg]" height="331" width="609" >
          </div>
          <div style="margin-top:4.7pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Cash Transfers and Dividend Distribution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our cash is primarily held by the holding company, Belite, and has been raised primarily through the issuance and sale of ordinary shares, convertible bonds, or convertible preferred shares in private placement transactions conducted by Belite. </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Belite is permitted under the laws of the Cayman Islands to provide funding to our subsidiaries through capital contributions or loans, and there are currently no restrictions on transferring funds between our Cayman Islands holding company and subsidiaries in the U.S., Australia and Hong Kong. Our ability to make loans and additional capital contribution to our PRC subsidiary might be restricted by PRC law. </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In the normal course of our business, Belite would evaluate the financial condition and capital needs of our subsidiaries periodically and then provide funding for their operations via equity investments and intercompany loans. As of the date of this prospectus, we have provided US$10.06 million to our subsidiaries via capital contribution, including US$0.5 million intercompany loans that have been repaid by the subsidiary via the issuance of ordinary shares, among which we have provided US$60,000 to our Hong Kong subsidiary via capital contribution which further invested US$50,000 to our PRC subsidiary via capital contribution. No other transfer of cash or other types of assets has been made between our Cayman Islands holding company and subsidiaries as of the date of this prospectus. </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our subsidiaries outside mainland China are permitted, under the respective laws of the U.S., Australia and Hong Kong, to provide funding to Belite through dividend distribution without restrictions on the amount of the funds. Our PRC subsidiary has no operations and generates no revenue as of the date of this prospectus, but should it generate revenue in the future, its ability to distribute dividends to us will be limited by foreign exchange restrictions. In addition, restrictions on currency exchanges in China may limit our ability to freely convert Renminbi to fund any future business activities outside China or other payments in U.S. dollars, and capital control measures imposed by the Chinese government may limit our ability to use capital from our PRC subsidiary for business purposes outside of China. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, can not be made in currencies other than Renminbi without complying with certain procedural requirements of the State Administration of Foreign Exchange, or SAFE. Specifically, approval from or registration with appropriate government authorities is required where Renminbi is to be converted into another currency and remitted out of China to pay </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">capital expenses, such as the repayment of loans denominated in currencies other than Renmibi. As a result, we may need to obtain SAFE approval to use cash generated from the operations of our PRC subsidiary to pay off its debt in a currency other than Renminbi owed to entities outside China, or to make other capital expenditure payments outside China in a currency other than Renminbi. On the other hand, the PRC Enterprise Tax Law (EIT Law) and its implementation rules provide that a withholding tax rate of up to 10% will be applicable to dividends payable by Chinese companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties or arrangements between the PRC central government and governments of other countries or regions where the non-PRC-resident enterprises are incorporated. As of the date of this prospectus, we have not received nor do we have any present plan to receive dividends paid by our U.S., Australia, Hong Kong and PRC subsidiaries. </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we did not adopt any specific cash management policies and procedures in relation to how funds are transferred within/through our group. Our management monitors the cash position of each entity within our group regularly, and prepares budgets for our subsidiaries on a monthly basis. In the event that there is a need for cash or a potential short-term cashflow shortages, it would be reported to our chief financial officer and, subject to the approval by our board of directors, we will enter into an intercompany loan arrangement for relevant subsidiary. Other than the above, we did not adopt or maintain any cash management policies and procedures as of the date of this prospectus.</font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our Board of Directors has discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, subject to the provisions in our articles of association, our shareholders may by ordinary resolution declare a dividend not exceeding the amount recommended by our Board of Directors. As of the date of this prospectus, we have not paid and do not have any present plan to declare or pay any dividends in the foreseeable future. We currently intend to retain most of our available funds and any future earnings to fund the development and growth of our business. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to This Offering and Our ADSs &#8201;&#8212;&#8201;Because we do not expect to pay dividends in the foreseeable future, you must rely on price appreciation of our ADSs for return on your investment&#8221; for more information. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Implication of Being an Emerging Growth Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As a company with less than US$1.07&#160;billion in revenue for our last fiscal year, we qualify as an &#8220;emerging growth company&#8221; pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements compared to those that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section&#160;404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth company&#8217;s internal control over financial reporting. The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. Pursuant to the JOBS Act, we have elected to take advantage of the benefits of this extended transition period for complying with new or revised accounting standards. As a result, our operating results and financial statements may not be comparable to the operating results and financial statements of other companies who have adopted the new or revised accounting standards. </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We will remain an emerging growth company until the earliest of (a)&#160;the last day of the fiscal year during which we have total annual gross revenues of at least US$1.07&#160;billion; (b)&#160;the last day of our fiscal year following the fifth anniversary of the completion of this offering; (c)&#160;the date on which we have, during the preceding three-year period, issued more than US$1.0&#160;billion in non-convertible debt; or (d)&#160;the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of the ADSs that are held by non-affiliates exceeds US$700&#160;million as of the last business day of our most recently completed second fiscal quarter. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Implication of Being a Foreign Private Issuer</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are also considered a &#8220;foreign private issuer.&#8221; Accordingly, upon consummation of this offering, we will report under the Exchange Act as a non-U.S. company with foreign private issuer status. This means </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">that, even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (i)&#160;the majority of our executive officers or directors are U.S. citizens or residents, (ii)&#160;more than 50% of our assets are located in the United States or (iii)&#160;our business is administered principally in the United States. </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">In this prospectus, we have taken advantage of certain of the reduced reporting requirements as a result of being an emerging growth company and a foreign private issuer. Accordingly, the information contained herein may be different than the information you receive from other public companies in which you hold equity securities. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Implications of being a Controlled Company</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are a &#8220;controlled company&#8221; as defined under the Nasdaq Stock Market Rules, because one of our shareholders holds more than 50% of our voting power. As a result, for so long as we remain a controlled company as defined under that rule, we are exempt from, and our shareholders generally are not provided with the benefits of, some of the Nasdaq Stock Market corporate governance requirements, including that: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">a majority of our board of directors must be independent directors; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">our compensation committee must be composed entirely of independent directors; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">our corporate governance and nomination committee must be composed entirely of independent directors. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Although we intend to reconstitute our board of directors and to have a majority of independent directors, that may change in the future.</font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Corporate Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Belite Bio, Inc was incorporated in the Cayman Islands on March&#160;27, 2018 as an exempted company with limited liability. The address of our registered office in Cayman Islands is located at the Office of Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. Our principal executive offices are located at 5820 Oberlin Drive, Suite 101, San Diego, CA 92121. Our telephone number at that address is +1-858-246-6240. </font>
          </div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our website address is belitebio.com. Our website and the information contained on our website do not constitute a part of this prospectus. Our agent for service of process in the United States is Puglisi &amp; Associates, located at 850 Library Avenue, Suite 204, Newark, Delaware 19711. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Conventions that Apply to this Prospectus</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:6pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Unless otherwise indicated or the context otherwise requires, references in this prospectus to: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;ADRs&#8221; are to the American depositary receipts that may evidence the ADSs; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;ADSs&#8221; are to the American depositary shares, each of which represents one ordinary share; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;AUD&#8221; are to the legal currency of Australia; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;Belite,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our company,&#8221; and &#8220;our&#8221; are to Belite Bio, Inc, our Cayman Islands holding company and its subsidiaries; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;China&#8221; or the &#8220;PRC&#8221; are to the People&#8217;s Republic of China, excluding, for the purposes of this prospectus only, Hong Kong, Macau and Taiwan; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;shares&#8221; or &#8220;ordinary shares&#8221; are to our ordinary shares, par value US$0.0001 per share; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <font style="letter-spacing:0.2pt;">&#8220;US$,&#8221; &#8220;U.S. dollars,&#8221; &#8220;$,&#8221; and &#8220;dollars&#8221; are to the legal currency of the United States. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Unless the context indicates otherwise, all information in this prospectus assumes no exercise by the underwriters of their option to purchase additional ADSs from us. The functional currency of the Company&#8217;s subsidiaries located in the United States is U.S. dollars. The functional currency of the Company&#8217;s subsidiary located in Australia is AUD. Unless otherwise noted, all translations from AUD to U.S. dollars and from U.S. dollars to AUD in this prospectus are made at a rate of AUD0.7401 to US$1.00, the exchange rate in effect as of April&#160;15, 2022 as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. We make no representation that any AUD or U.S. dollar amounts could have been, or could be, converted into U.S. dollars or AUD, as the case may be, at any particular rate, or at all. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Offering price </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We currently estimate that the initial public offering price will be between US$5.50 and US$6.50 per ADS. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">ADSs offered by us </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">6,000,000 ADSs (or 6,900,000 ADSs if the underwriters exercise the option to purchase additional ADSs in full).</font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">ADSs outstanding immediately after this offering </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">6,000,000 ADSs (or 6,900,000 ADSs if the underwriters exercise the option to purchase additional ADSs in full).</font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Ordinary shares issued and outstanding immediately after this offering </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">24,095,317 ordinary shares (or 24,995,317 ordinary shares if the underwriters exercise the option to purchase additional ADSs in full).</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1</font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">The ADSs </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Each ADS represents one ordinary share, par value US$0.0001 per share. </font>
          </div>
          <div style="margin-left:168pt; margin-top:8pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The depositary will hold the ordinary shares underlying your ADSs. You will have rights as provided in the deposit agreement among us, the depositary and holders and beneficial owners of ADSs from time to time. </font>
          </div>
          <div style="margin-left:168pt; margin-top:8pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We do not expect to pay dividends in the foreseeable future. If, however, we declare dividends on our ordinary shares, the depositary will pay you the cash dividends and other distributions it receives on our ordinary shares after deducting its fees and expenses in accordance with the terms set forth in the deposit agreement. </font>
          </div>
          <div style="margin-left:168pt; margin-top:8pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">You may surrender your ADSs to the depositary for cancellation in exchange for ordinary shares. The depositary will charge you fees for any cancellation. </font>
          </div>
          <div style="margin-left:168pt; margin-top:8pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We may amend or terminate the deposit agreement without your consent. If you continue to hold your ADSs after an amendment to the deposit agreement, you agree to be bound by the deposit agreement as amended. </font>
          </div>
          <div style="margin-left:168pt; margin-top:8pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">To better understand the terms of the ADSs, you should carefully read the &#8220;Description of American Depositary Shares&#8221; section of this prospectus. You should also read the deposit agreement, which is filed as an exhibit to the registration statement that includes this prospectus. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Option to purchase additional ADSs </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have granted to the underwriters an option, exercisable within 30&#160;days from the date of this prospectus, to purchase up to an aggregate of additional ADSs. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Use of proceeds </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We expect that we will receive net proceeds of approximately US$32.2 million from this offering, assuming an initial public offering price of US$6.00 per ADS, which is the midpoint of the estimated range of the initial public offering price, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </font>
          </div>
        </div>
        <div style="margin-top:0.639999999999986pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:4pt; width:456pt;">
            <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
          </div>
          <div style=" float:left; margin-top:9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:7.5pt;">
            <font style=" position:relative; bottom:4.25pt;letter-spacing:0.15pt;">1</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:7.5pt;">
            <font style="font-size:10pt;letter-spacing:0.2pt;">There are 18,095,317 ordinary shares outstanding immediately prior to the offering.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:168pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We intend to use approximately 2.5% of the net proceeds for our Phase&#160;3 clinical trial of LBS-008 for STGD1,&#160;approximately 68.2% of the net proceeds for further clinical development of LBS-008 for dry AMD, such as Phase&#160;2 or Phase&#160;3 clinical trials, and the remainder for working capital and other general corporate purposes. See &#8220;Use of Proceeds&#8221; for more information. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Lock-up </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We and each of our officers, directors and shareholders beneficially holding greater than 5% of our ordinary shares have agreed with the underwriters, subject to certain exceptions, not to sell, transfer or otherwise dispose of any ADSs, ordinary shares or similar securities for a period of 180&#160;days after the date of this prospectus. We have also agreed, subject to certain exceptions, not to file or cause to be filed any registration statement relating to the offering of any of our share capital for a period of 180 days after the date of this prospectus. See &#8220;Shares Eligible for Future Sale&#8221; and &#8220;Underwriting&#8221; for more information. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Listing </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have applied to have the ADSs listed on the Nasdaq Capital Market under the symbol &#8220;BLTE.&#8221; The ADSs and our ordinary shares will not be listed on any other stock exchange or traded on any automated quotation system. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Payment and settlement </font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The underwriters expect to deliver the ADSs against payment therefor through the facilities of the Depository Trust Company on&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, 2022. </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Depositary</font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Deutsche Bank Trust Company Americas</font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Indications of Interest</font>
            </div>
          </div>
          <div style="margin-left:168pt; margin-top:-12pt; width:288pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Lin Bioscience International Ltd., our principal shareholder, has indicated an interest to purchase up to US$15.0 million of ADSs in this offering, which will represent no more than 50% of the total ADSs in this offering such that we still meet the un-affiliated float listing criteria of the Nasdaq Capital Market. Because indications of interest are not binding agreements or commitments to purchase, Lin Bioscience International Ltd. may determine to purchase fewer ADSs than it has indicated an interest in purchasing or not to purchase any ADSs in this offering. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">SUMMARY CONSOLIDATED FINANCIAL DATA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following summary consolidated statement of operations and comprehensive loss data for the years ended December&#160;31, 2020 and 2021 and summary consolidated balance sheet data as of December&#160;31, 2020 and December&#160;31, 2021 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. Our consolidated financial statements are prepared and presented in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. Our historical results are not necessarily indicative of results expected for future periods. You should read this Summary Consolidated Financial Data section together with our consolidated financial statements and the related notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included elsewhere in this prospectus. </font>
          </div>
          <table style="width:456pt;height:359.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:323.44pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Years Ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:323.44pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2020 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:323.44pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.583pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(amounts in $ and in thousands, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">except for shares and per share data) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Expenses</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Research and development </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,688</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7,419</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">General and administrative </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,055</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,378</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:20pt;">
                  <font style="letter-spacing:0.2pt;">Total operating expenses </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,743</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,797</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:bold;">
                  <font style="letter-spacing:-0.2pt;">Loss from operations</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,743<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,797<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Other income (expense):</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Interest income </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">12</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Interest expense </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(21<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Other income </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">126</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:20pt;">
                  <font style="letter-spacing:0.2pt;">Total other (expense) income, net </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">131</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:bold;">
                  <font style="letter-spacing:-0.2pt;">Loss before income tax</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,752<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Income tax expense </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(1<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:bold;">
                  <font style="letter-spacing:-0.2pt;">Net loss</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Other comprehensive income (loss)</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Foreign currency translation adjustments, net of nil tax </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(152<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:323.44pt;text-align:left;">
                <div style="white-space:nowrap;font-weight:bold;">
                  <font style="letter-spacing:-0.2pt;">Total comprehensive loss</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,747<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,818<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Weighted average number of ordinary shares used in per share calculation:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">&#8212;Basic and Diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8,790,397</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,569,932</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Net loss per ordinary share</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:323.44pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">&#8212;Basic and Diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(0.65<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(1.01<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.435pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <table style="width:456pt;height:152.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:340.81pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">As of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">2020 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">As of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">December 31, </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:340.81pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.583pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(amounts in $ and in </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Selected Consolidated Balance Sheets Data:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Cash </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,618</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">17,344</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total assets </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,741</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">18,348</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">972</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,635</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total convertible preferred shares </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,806</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">31,806</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total shareholders&#8217; deficit </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(7,037<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(15,093<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:340.81pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Total liabilities, convertible preferred shares and shareholders&#8217; deficit </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">25,741</td>
              <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">18,348</td>
              <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investing in our ADSs involves a high degree of risk. You should carefully consider the following risks and uncertainties and all other information contained in this prospectus before investing in our ADSs. Our business, financial condition, results of operations or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. If any of the risks actually occur, our business, financial condition, results of operations and prospects could be adversely affected. In that event, the market price of our ADSs could decline, and you could lose part or all of your investment.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to the Discovery, Development and Commercialization of Our Product Candidates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business is highly dependent on the success of our lead product candidate, LBS-008. If we are unable to develop, obtain marketing approval for or successfully commercialize LBS-008, either alone or through a collaboration, or if we experience significant delays in doing so, our business could be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently have no products that are approved for commercial sale and may never be able to develop marketable products. Our business and future success depends in large part on our ability to develop, obtain regulatory approval for, and then successfully commercialize our lead product candidate, LBS-008. This may make an investment in our company riskier than similar companies that have multiple product candidates in active late-stage development that may be able to better sustain the failure of a lead product candidate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, if LBS-008 does not obtain approval for the treatment of autosomal recessive Stargardt disease (STGD1), which is the initial indication that we are currently exploring, we will have spent substantial time and financial resources without receiving a return on investment. As a result, if LBS-008 does not receive approval or fails to become profitable and receive market acceptance, our business, results of operations and financial condition will be adversely affected. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The success of LBS-008 will depend on several factors, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successful completion of our ongoing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">initiation and successful enrollment and completion of additional clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">safety, tolerability and efficacy profiles that are satisfactory to the U.S. Food and Drug Administration, or the FDA, , the Therapeutic Goods Administration of Australia, or the TGA, National Medical Products Administration, or the NMPA (formerly known as the China Food and Drug Administration, or the CFDA), the European Medicines Agency, or the EMA or any comparable foreign regulatory authority for marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">timely receipt of marketing approvals from applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the performance of our future collaborators, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent of any required post-marketing approval commitments to applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishment of supply arrangements with third-party raw materials suppliers and manufacturers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establishment of arrangements with third-party manufacturers to obtain finished products that are appropriately packaged for sale; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining patent, trade secret protection and regulatory exclusivity, both in the United States and internationally; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">protection of our rights in our intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successful launch of commercial sales following any marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a continued acceptable safety profile following any marketing approval, and meeting all applicable postmarket commitments, obligations, and requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">commercial acceptance of our products, if approved, by patients, the medical community and third-party payors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to compete with other therapies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we do not achieve one or more of these factors, many of which are beyond our control, in a timely manner or at all, we could experience significant delays or an inability to obtain regulatory approvals or commercialize LBS-008. Even if regulatory approvals are obtained, we may never be able to successfully commercialize LBS-008. Accordingly, we may not be able to generate sufficient revenue through the sale of LBS-008 to continue our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may allocate our limited resources to pursue a particular product candidate, indication, including any additional indications for LBS-008, or technology and fail to capitalize on existing or future product candidates, indications or technologies that may later prove to be more profitable, or for which there is a greater likelihood of success.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because we have limited financial and managerial resources, we intend to focus on developing product candidates for specific indications that we identify as most likely to succeed, in terms of both their potential for marketing approval and commercialization. As a result, we may forgo or delay pursuit of opportunities with other product candidates or for other indications or technologies that later may prove to have greater commercial potential or a greater likelihood of success. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific indications may not yield any commercially viable product candidates. In addition, if we do not accurately evaluate the commercial potential or target market for a particular product candidate or technology, we may relinquish valuable rights to that product candidate or technology through collaboration, licensing or other royalty arrangements when it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate or technology. For example, we are developing our lead product candidate, LBS-008, to initially treat STGD1. We are also considering a number of additional indications for LBS-008, including the treatment of nonalcoholic steatohepatitis. We cannot guarantee that the treatment of STGD1 will be the most profitable indication for LBS-008 as opposed to other contemplated indications. This could result in us failing to capitalize on the true market potential of our lead product candidate in a timely manner or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although a substantial amount of our efforts will focus on the continued clinical testing, potential approval, manufacturing and commercialization of our existing product candidates, the success of our business depends in part upon our ability to identify, license, discover, develop, or commercialize additional product candidates or new technologies. Research efforts to identify new product candidates and technologies require substantial technical, financial, and human resources. Although we do not currently engage in such activities, we may in the future seek to expand our drug pipeline through in-licensing arrangements. We may end up focusing our efforts and resources on potential product candidates and technologies that ultimately prove to be unsuccessful. Our research and any future licensing efforts may fail to identify, discover or in-license new product candidates and technologies suitable for clinical development and commercialization for a number of reasons, including, but not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our research or business development methodology or search criteria and process may be unsuccessful in identifying potential product candidates and technologies, or potential product candidates and technologies that are within our resources to license or acquire and develop; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our potential product candidates and technologies may be shown to have adverse effects or may have other characteristics that may make the products unmarketable or unlikely to receive marketing approval; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">it may take greater human, financial and/or research resources to identify additional therapeutic opportunities for our product candidates or to develop more suitable potential product candidates and technologies than what we possess, thereby limiting our ability to diversify and expand our drug portfolio. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, there can be no assurance that we will successfully identify and develop new product candidates or technologies, or additional therapeutic opportunities for our product candidates, whether through internal research or future licensing efforts, which could materially adversely affect our future growth and prospects. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical development involves a lengthy and expensive process with an uncertain outcome, and results of earlier studies may not be predictive of future study results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There is a risk of failure for every product candidate. Clinical testing is expensive, is difficult to design and implement and can take many&#160;years to complete, and its outcome is inherently uncertain. It is difficult to predict when or if any of our product candidates will prove effective and safe in humans or will receive regulatory approval, and failure can occur at any time during the preclinical and clinical development process. Before obtaining regulatory approval from regulatory authorities for the sale of any product candidate, our product candidates must complete preclinical studies and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The results of preclinical studies and clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. Product candidates during later stages of clinical trials may fail to show the desired results in safety and efficacy despite having progressed through preclinical studies and initial to advanced clinical trials and despite the level of scientific rigor in the study, design and adequacy of execution. In some instances, there can be significant variability in safety and/or efficacy results among different studies of the same product candidate due to numerous factors, including, but not limited to, differences in individual patient conditions, including genetic differences, and other compounding factors, such as other medications or pre-existing medical conditions. Many product candidates in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to a lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier studies. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain regulatory approval of their product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the case of any studies we conduct, results may differ from earlier studies due to the larger number of clinical trial sites and additional countries and languages involved in such studies. Clinical practices vary globally, and there is a lack of harmonization among the guidance provided by various regulatory bodies of different regions and countries with respect to the data that is required to receive marketing approval, which makes designing global studies increasingly complex. Differing regulatory approval requirements in different countries could make it more difficult for us to conduct unified global studies, which can lead to increased development costs and marketing delays or non-viability of our clinical trials. In addition, the FDA may determine that clinical trial results obtained in foreign subjects do not adequately represent the results that would be obtained in U.S. patients and are thus not supportive of an NDA approval in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In particular, if we experience delays in the start or completion of, or termination of, any clinical trial of LBS-008, the commercial prospects of LBS-008 may be harmed, and our ability to generate product revenues from LBS-008 will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow down the development and approval process for LBS-008, and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of LBS-008. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">All of our product candidates are in preclinical or clinical development. If we are unable to complete clinical development and obtain regulatory approval to ultimately commercialize our product candidates, or if we experience significant delays in doing so, our business, financial condition, results of operations and prospects will be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of our product candidates are still in development. Our ability to generate revenue from our product candidates is dependent on receipt of regulatory approval and successful commercialization of such products. We cannot guarantee that we will be able to obtain regulatory approvals for our existing product candidates in a timely manner, or at all, and we may be unable to obtain successful commercialization of our product candidates even if we receive regulatory approval. Each of our product candidates will require additional preclinical and/or clinical development, regulatory approvals in multiple jurisdictions, development of commercial manufacturing supply and capacity, substantial investment and significant marketing efforts before we generate any revenue from product sales. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The success of our product candidates will depend on several factors, including, but not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">hiring sufficient technical experts to oversee all development and regulatory activities and meeting of safety requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successful completion of preclinical studies and clinical trials, including the successful enrollment in such clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">receipt of regulatory approvals from applicable regulatory authorities for planned and future clinical trials, drug registration, manufacturing and commercialization; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successful completion of all safety studies required to obtain regulatory approval in United States, Australia, Taiwan, China, the Europe and other applicable jurisdictions for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to establish manufacturing capabilities and capacities, whether internally or through CMOs, to the specifications of our product candidates for clinical supply; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining patent, trade secret and other intellectual property protection and/or regulatory exclusivity for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">launching commercial sales of our product candidates, if and when approved, whether alone or in collaboration with others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">acceptance of the product candidates, if and when approved, by patients, the medical community and third-party payors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining healthcare coverage and adequate reimbursement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">effectively competing with other therapies and alternative drugs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successfully enforcing and defending intellectual property rights and claims; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintaining a continued acceptable safety profile of the product candidates following regulatory approval, and meeting all applicable postmarket commitments, obligations, and requirements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any significant delays in, or an inability to, obtain regulatory approval and ultimately achieve commercial success for our existing and future product candidates in one or more jurisdictions would materially harm our business and we may not be able to generate enough revenues and cash flows to continue our operations, including delays due to COVID-19 could further materially harm our business. As a result, our financial condition, results of operations and prospects will be materially and adversely harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we encounter delays or difficulties enrolling and retaining patients in our clinical trials, our clinical development progress and our receipt of necessary regulatory approvals could be delayed or otherwise adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients that will remain in the study until its conclusion. We may not be able to initiate or continue clinical trials for our product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these studies as required by the FDA, the TGA, the NMPA, the EMA and any other applicable similar regulatory authorities, or if there are delays in the enrollment of eligible patients as a result of the competitive clinical enrollment environment. Even once enrolled, we may be unable to retain a sufficient number of patients to complete any of our trials. The inability to enroll a sufficient number of patients who meet the applicable criteria for our clinical trials would result in significant delays and could require us to abandon one or more clinical trials altogether. If patients are unwilling to enroll in our clinical trials because of the COVID-19 pandemic and restrictions on travel or healthcare institution policies, negative publicity from adverse events related to the biopharmaceutical industry or for other reasons, the timeline for recruiting patients, conducting studies and obtaining regulatory approval of our product candidates may be delayed. Even if we are able to enroll a sufficient number of patients in our clinical trials, delays in patient enrollment could result in increased development costs, delays in advancing our product candidates, delays in testing the effectiveness of our product candidates or termination of clinical trials altogether. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Patient enrollment for our clinical trials may be affected by other factors, including, but not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">severity of the disease under investigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">total size and nature of the relevant patient population; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">design and eligibility criteria for the clinical trial in question, including age-based eligibility criteria limiting subject enrollment to adolescent populations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">perceived risks and benefits of the product candidate under study; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our resources to facilitate timely enrollment in clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">patient referral practices of physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">availability of competing therapies also undergoing clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our investigators&#8217; or clinical trial sites&#8217; efforts to screen and recruit eligible patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to maintain patient consents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">ability to monitor patients adequately during and after treatment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">proximity and availability of clinical trial sites for prospective patients; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the occurrence of any pandemic, epidemic or any other public health crises, including from the COVID-19 pandemic, natural catastrophe or other disasters that may cause a delay in enrollment of patients in clinical trials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, our ability to successfully initiate, enroll and complete clinical trials in any foreign country is subject to numerous risks unique to conducting business in foreign countries, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">difficulty in establishing or managing relationships with contract research organizations, or CROs, and physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">different standards for the conduct of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">absence in some countries of established groups with sufficient regulatory expertise for review of protocols; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">inability to locate qualified local consultants, physicians and partners; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential burden of complying with a variety of foreign laws, medical standards and regulatory requirements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, our clinical trials may compete with other clinical trials for drug candidates that are in the same therapeutic areas as our drug candidates, and this competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Because the number of qualified clinical investigators and clinical trial sites is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials at such clinical trial sites. For example, we have experienced delays in the enrollment of patients in our clinical trials due to government orders and site policies on account of the COVID-19 pandemic, and some patients may be unwilling or unable to travel to study sites, enroll in our studies or comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. If we have difficulty enrolling a sufficient number of patients or finding additional clinical trial sites to conduct our clinical trials as planned, we may need to delay, limit or terminate ongoing or planned clinical trials, any of which could have an adverse effect on our business, financial condition, results of operations and prospects. In addition, it is possible that the COVID-19 pandemic may have an impact on the workforce of the third parties and CROs on which we rely, which could adversely impact our ability to conduct preclinical studies, enroll and retain patients in our clinical trials and conduct the clinical trials of our product candidates on expected timeframes or to complete such studies, and our ability to ultimately obtain regulatory approval. As a result, the value of our Company could decline and our ability to obtain additional financing may be impaired. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If clinical trials of our product candidates fail to demonstrate safety and efficacy to the satisfaction of regulatory authorities or do not otherwise produce positive results, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before obtaining regulatory approval for the sale of our product candidates, we must conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. We may experience numerous unexpected events during, or as a result of, clinical trials that could delay or prevent our ability to receive regulatory approval or commercialize our product candidates, including, but not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulators, institutional review boards, or IRBs, or ethics committees may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective study site; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">delay in reaching, or failure to reach, agreements on acceptable terms with prospective CROs and study sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and study sites; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">manufacturing issues, including problems with manufacturing, supply quality, compliance with current good manufacturing practices, or cGMP, or obtaining sufficient quantities of a product candidate from third parties for use in a clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide to conduct additional clinical trials or abandon the development of such product candidates, or regulators may require us to do so; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment may be insufficient or slower than we anticipate, or patients may drop out or fail to return for post-treatment follow-up at a higher rate than we anticipate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our third-party contractors used in our clinical trials, including any clinical investigators, may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, or may deviate from clinical trial protocol or dropout of clinical trials, which may require that we add new clinical trial sites or clinical investigators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we might have to suspend or terminate clinical trials of our product candidates for various reasons, including a finding of a lack of clinical response, serious adverse, undesirable or unacceptable side effects or other unexpected characteristics or a finding that participants are being exposed to unacceptable health risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we may elect to, or regulators, IRBs or ethics committees may require that we or our investigators, suspend or terminate clinical research or not rely on the results of clinical research for various reasons, including non-compliance with regulatory requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost of clinical trials of our product candidates may be greater than we anticipate; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be insufficient or inadequate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we are required to conduct additional clinical trials or other testing of our product candidates beyond those that we currently plan, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these studies or tests are not positive or are only modestly positive or if they raise safety concerns, we may (i)&#160;be delayed in obtaining regulatory approval for our product candidates; (ii)&#160;obtain approval for indications or patient populations that are not as broad as intended or desired; (iii)&#160;not obtain regulatory approval at all; (iv)&#160;have the drug removed from the market after obtaining regulatory approval; (v)&#160;be subject to additional post-marketing testing requirements; (vi)&#160;be subject to restrictions on how the drug is distributed or used; or (vii)&#160;be unable to obtain reimbursement for use of the drug. Many of the factors that cause a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. Further, the FDA, the TGA, the NMPA, the EMA or other regulatory authorities may disagree with our clinical trial design or our interpretation of data from clinical trials, or may change the requirements for approval even after it has reviewed and commented on the design for our clinical trials. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our clinical trials are conducted in multiple jurisdictions, which may subject us to delays and expenses.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are currently conducting clinical trials, through third-party CROs, in Australia and Taiwan and expect to further expand into other jurisdictions (see &#8220;Business&#8221; beginning on page <a href="#tBUS">112</a> for our current plans for future clinical trials). There are risks inherent in conducting clinical trials in multiple jurisdictions, which may subject us to delays and expenses, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory and administrative requirements of the jurisdiction where the study is conducted that could burden or limit our ability to conduct clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">differing and conflicting regulatory requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">foreign exchange fluctuations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">manufacturing, customs, shipment and storage requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">cultural differences in medical practice and clinical research; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the risk that the patient populations in such trials are not considered representative as compared to the patient population in the target markets where approval is being sought. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our product candidates may cause serious adverse, undesirable or unacceptable side effects or have other properties that could delay or prevent their regulatory approval, limit the commercial profile of an approved label, and/or result in significant negative consequences following regulatory approval, if any.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As is the case with pharmaceuticals generally, it is likely that there may be serious adverse, undesirable or unacceptable side effects caused by our product candidates that could cause us or regulatory authorities to interrupt, delay or halt clinical trials and may result in a more restrictive label, a delay or denial of regulatory approval by the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authorities, or a significant change in our clinical protocol or even our development plan. Results of our future preclinical studies and clinical trials could reveal a high and unacceptable severity or prevalence of steroidal adverse events. In such an event, our studies could be suspended or terminated and the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authorities could order us to cease further development of, or deny approval of, our product candidates for any or all targeted indications. Adverse events related to our product candidates may affect patient recruitment or the ability of enrolled subjects to complete the study and could result in potential liability claims. Any of these occurrences may significantly harm our reputation, business, financial condition and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, the identification of serious adverse, undesirable or unacceptable side effects caused by any of our future approved product candidates may lead to potentially significant negative consequences, which include, but are not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">suspension of our marketing of the product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withdrawal or revocation by regulatory authorities of their approvals of or the licenses for the product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the requirement by regulatory authorities to conduct additional clinical trials, add additional warnings to, or otherwise change, the label of the product candidate, such as a &#8220;black box&#8221; warning or contraindication, or create a medication guide outlining the risks of such side effects for distribution to patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restriction on the distribution of the product candidate or imposition of burdensome implementation requirements on us through the establishment of a Risk Evaluation and Mitigation Strategy, or REMS, or similar strategy as may be required by the FDA, the TGA, the NMPA, the EMA or a comparable regulatory authority; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the requirement by regulatory authorities to conduct specific post-marketing studies of the product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the requirement to change the way the product candidate is distributed or administered; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">becoming subjected to regulatory investigations, government enforcement actions or litigation proceedings, and being held liable for harm caused to subjects or patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the product becoming less competitive; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">removal of product candidates from the marketplace; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">harm to our reputation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any of these events could prevent us from achieving or maintaining market acceptance of any particular product candidate that is approved and could significantly harm our business, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, the use of our product candidates in conjunction with other therapies, may result in unique adverse events that could be exacerbated compared with adverse events from the use of our product candidates alone. Results of our studies could reveal a high and unacceptable severity or prevalence of adverse events. These types of adverse events could be caused by our product candidates and could cause us or regulatory authorities to interrupt, delay or halt clinical trials and may result in a more restrictive indication or the delay or denial of regulatory approval by the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authority. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Results of preclinical studies and earlier clinical trials may not be predictive of results of future clinical trials.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The outcome of preclinical studies and earlier clinical trials may not be predictive of the success of later clinical trials, and interim results of clinical trials do not necessarily predict success in future clinical trials. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials after achieving positive results in earlier development, and we could face similar setbacks. The design of a clinical trial can determine whether its results will support approval of a product and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced. We have limited experience in designing clinical trials and may be unable to design and execute a clinical trial to support marketing approval. In addition, preclinical and clinical data are often susceptible to varying interpretations and analyses. Many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval for the product candidates. Even if we, or any future collaborators, believe that the results of clinical trials for our product candidates warrant marketing approval, the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authority may disagree and may not grant marketing approval of our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the dosing regimen and other clinical trial protocols and the rate of dropout among clinical trial participants. If we fail to receive positive results in clinical trials of our product candidates, the development timeline and regulatory approval and commercialization prospects for our most advanced product candidates, and, correspondingly, our business and financial prospects would be negatively impacted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The manufacture of biopharmaceutical products is a complex process which requires significant expertise and capital investment, and if we encounter problems in establishing our manufacturing capabilities for clinical or commercial scale or in the manufacture of our future products, our business could suffer.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently do not have cGMP manufacturing capabilities and we are entirely dependent on third-party contractors to manufacture our product candidates for our clinical trials. The manufacture of biopharmaceutical products is a complex process, in part due to strict regulatory requirements. If we are unable to identify an appropriate production site or a suitable collaborator to develop our manufacturing infrastructure, or fail to do so in a timely manner, this may lead to significant delays in the clinical supply of our product candidates as well as the commercial manufacturing of our product candidates once regulatory and marketing approvals have been obtained. In turn, this could delay our clinical trials, negatively impact our ability to ultimately obtain regulatory approval and materially harm any future commercialization plans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, problems may arise during the manufacturing process for a variety of reasons, including, but not limited to, equipment malfunction, failure to follow specific protocols and procedures, problems with (including shortage of) raw materials, global supply chain issues, delays related to the construction of new facilities or expansion of any future manufacturing facilities, including changes in manufacturing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">production sites and limits to manufacturing capacity due to regulatory requirements, changes in the types of products produced, increases in the prices of raw materials, physical limitations that could inhibit continuous supply, man-made or natural disasters and environmental factors. For example, although we have not experienced material supply disruptions due to the COVID-19 pandemic, we cannot guarantee that we will not experience supply disruptions in the future due to COVID-19 or any other pandemic, epidemic or other public health crises, natural catastrophe or other disasters. If problems arise during the production of a batch of future products, that batch of future products may have to be discarded and we may experience product shortages or incur added expenses. This, as well as problems that may arise during the manufacturing process, could, among other things, lead to significant additional costs and/or delays, lost revenue, damage to customer relationships, time and expense spent investigating the cause and, depending on the cause, similar losses with respect to other batches or products. If problems are not discovered before such product is released to the market, recall and product liability costs may also be incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have never obtained marketing approval for a product candidate and we may be unable to obtain, or may be delayed in obtaining, marketing approval for any of our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have never obtained marketing approval for a product candidate. It is possible that the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authority may refuse to accept for substantive review any NDAs that we submit for our product candidates or may conclude after review of our data that our application is insufficient to obtain marketing approval of our product candidates. If the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authority does not accept or approve our NDAs for any of our product candidates, it may require that we conduct additional clinical trials, preclinical studies or manufacturing validation studies and submit that data before it will reconsider our applications. Depending on the extent of these or any other required trials or studies, approval of any NDA or application that we submit may be delayed by several&#160;years, or may require us to expend more resources than we have available. It is also possible that additional trials or studies, if performed and completed, may not be considered sufficient by the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authority to approve our NDAs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any delay in obtaining, or an inability to obtain, marketing approvals would prevent us from commercializing our product candidates, generating revenues and achieving and sustaining profitability. If any of these outcomes occur, we may be forced to abandon our development efforts for our product candidates, which could significantly harm our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if any of our product candidates receives marketing approval, we or others may later discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, which could compromise our ability, or that of any future collaborators, to market the product.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials of our product candidates are conducted in carefully defined sets of patients who have agreed to enter into clinical trials. Consequently, it is possible that our clinical trials, or those of any future collaborator, may indicate an apparent positive effect of a product candidate that is greater than the actual positive effect, if any, or alternatively fail to identify undesirable side effects. If, following approval of a product candidate, we, or others, discover that the product is less effective than previously believed or causes undesirable side effects that were not previously identified, any of the following adverse events could occur: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory authorities may withdraw their approval of the product or seize the product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we, or any future collaborators, may be required to recall the product, change the way the product is administered or conduct additional clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">additional restrictions may be imposed on the marketing of, or the manufacturing processes for, the particular product; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we may be subject to fines, injunctions or the imposition of civil or criminal penalties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory authorities may require the addition of labeling statements, such as a &#8220;black box&#8221; warning or a contraindication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we, or any future collaborators, may be required to create a Medication Guide outlining the risks of the previously unidentified side effects for distribution to patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we, or any future collaborators, could be sued and held liable for harm caused to patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the product may become less competitive; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our reputation may suffer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any of these events could harm our business and operations, and could negatively impact our price of our ADS. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our product candidates may fail to achieve the degree of market acceptance by physicians, patients, patient advocacy groups, third-party payors and others in the medical community necessary for commercial success.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if our product candidates receive regulatory approval, they may nonetheless fail to gain sufficient market acceptance by physicians, patients, patient advocacy groups and others in the medical community. Efforts to educate physicians, patients, patient advocacy groups and third-party payors on the benefits of our product candidates may require significant resources and may not be successful, and physicians and patients may prefer other drugs or product candidates to ours. If our product candidates do not achieve an adequate level of acceptance, we may not generate significant revenue from sales of our drugs or product candidates and may not become profitable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The degree of market acceptance of our product candidates, if and only when they are approved for commercial sale, will depend on a number of factors, including, but not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the clinical indications for which our product candidates are approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the degree to which physicians, hospitals, patient advocacy groups and patients consider our product candidates as safe and effective treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether our product candidates have achieved the perceived advantages of our product candidates over alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the prevalence and severity of any adverse effects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">product labeling or package insert requirements of the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">limitations or warnings contained in the labeling approved by the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">timing of market introduction of our product candidates as well as competitive drugs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">cost of treatment in relation to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">availability of adequate coverage and reimbursement from third-party payors and government authorities in the United States, Australia, China or any other jurisdictions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">willingness of patients to pay any out-of-pocket expenses in the absence of coverage and reimbursement by third-party payors and government authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">relative convenience and ease of administration, including as compared with alternative treatments and competitive therapies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effectiveness of our sales and marketing efforts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We face substantial competition, rapid technological change and the possibility that our competitors may discover, develop or commercialize drugs before we do or more successfully than we do, or develop therapies that are similar, more advanced or more effective than ours, each of which may adversely affect our financial condition and our ability to successfully market or commercialize our product candidate.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The development and commercialization of new drugs is highly competitive and the biopharmaceutical industry is subject to rapid and significant technological change. We face competition with respect to our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">product candidates and will face competition with respect to any product candidates that we may seek to develop or commercialize in the future, from companies of all sizes around the world, including major and specialty pharmaceutical companies and generic drug companies. Specifically, some of our competitors have ongoing clinical trials for product candidates that treat the same indications as LBS-008. Potential competitors further include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many of our competitors have significantly greater financial, technical, human and other resources, such as larger research and development staff and experienced marketing and manufacturing departments, and more experience in the development and regulatory approval process than we have. Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated in our competitors. As a result, these companies may obtain regulatory approval from the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authorities more rapidly than we are able to and may be more effective in selling and marketing their products as well. For example, the NMPA has recently accelerated market approval of drugs for diseases with high unmet medical need. In particular, the NMPA may review and approve drugs that have gained regulatory market approval in the United States, the European Union or Japan in the recent ten&#160;years without requiring further clinical trials in China. This may lead to potential increased competition from drugs that have already obtained approval in other jurisdictions. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Our competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our drug development programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our competitors may succeed in developing, acquiring, or licensing on an exclusive basis, products that are more effective, safer or less costly than any product candidate that we may develop, or may achieve earlier patent protection, regulatory approval, product commercialization, and market penetration than we do. Additionally, technologies developed by our competitors may render our potential product candidates uneconomical or obsolete, and we may not be successful in marketing our product candidates against competitors. The availability of our competitors&#8217; products could limit the demand, and the price we are able to charge, for any product candidates that we may develop and commercialize. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">While certain of our employees have limited experience in launching and marketing product candidates, we may not be able to effectively build and manage a sales network or benefit from the sales network of third-party collaborators.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently have no sales, marketing or commercial product distribution capabilities. Over time, we intend to develop an in-house marketing organization and sales force, which will require significant capital expenditures, management resources and time. We will have to compete with other biopharmaceutical companies to recruit, hire, train and retain marketing and sales personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we are unable or decide not to establish internal sales, marketing and commercial distribution capabilities for any or all of the drugs we develop or in particular regions or markets, we may pursue collaborative arrangements regarding the sales and marketing of such drugs into such regions or markets. However, there can be no assurance that we will be able to establish or maintain such collaborative arrangements, or, if we are able to do so, that they will have effective sales forces. Any revenue we receive will depend on the efforts of such third parties, which may not be successful. We may have little or no control over the marketing and sales efforts of such third parties, and our revenue from product sales may be lower than if we had commercialized our product candidates ourselves. We will also face competition in our search for third parties to assist us with the sales and marketing efforts of our product candidates, which may result in collaborative arrangements with less than optimal terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that we will be able to develop in-house sales and commercial distribution capabilities or establish or maintain relationships with third-party collaborators to successfully commercialize any product, and as a result, we may not be able to generate product sales revenue. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if we are able to commercialize any approved product candidates, reimbursement may be limited or unavailable in certain market segments for our product candidates, and we may be subject to unfavorable pricing regulations, which could harm our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The regulations that govern regulatory approvals, pricing and reimbursement for new therapeutic products vary widely from country to country. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or licensing approval is granted. In some non-U.S. markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain regulatory approval for a drug in a particular country, but then be subject to price regulations that delay our commercial launch of the drug and negatively impact the revenues we are able to generate from the sale of the drug in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain regulatory approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ability to commercialize any drugs successfully also will depend in part on the extent to which reimbursement for these drugs and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. A primary trend in the global healthcare industry is cost containment. Government authorities and these third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Increasingly, third-party payors are requiring that companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any drug that we commercialize and, if reimbursement is available, what the level of reimbursement will be. Reimbursement may impact the demand for, or the price of, any drug for which we obtain regulatory approval. Obtaining reimbursement for certain of our drugs may be particularly difficult because of the higher prices often associated with drugs administered under the supervision of a physician. If reimbursement is not available or is available only to limited levels, we may not be able to successfully commercialize any product candidate that we successfully develop. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There may be significant delays in obtaining reimbursement for approved product candidates, and coverage may be more limited than the purposes for which the product candidates are approved by the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authorities. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale and distribution. Interim payments for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Payment rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on payments allowed for lower cost drugs that are already reimbursed, and may be incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future weakening of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any future approved product candidates could have a material adverse effect on our business, our operating results, and our overall financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preliminary interim or &#8220;top-line&#8221; data that we announce or publish from time to time may change as more data become available and are subject to audit and verification procedures that could result in material changes in the final data.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we may publish preliminary interim or &#8220;top-line&#8221; data from clinical trials. Positive preliminary data from such interim analyses may not be predictive of such trial&#8217;s subsequent or overall results. Preliminary data are subject to the risk that one or more of the outcomes may materially change as more data become available. Additionally, preliminary data are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Therefore, positive preliminary results in any ongoing clinical trial may not be predictive of such results in the completed trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully evaluate all data. As a result, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">preliminary data that we report may differ from future results from the same clinical trials, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, preliminary data should be viewed with caution until the final data are available. Material adverse changes in the final data compared to preliminary data could significantly harm our business prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The data and information that we gather in our research and development process could be inaccurate or incomplete, which could harm our business, reputation, financial condition and results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We collect, aggregate, process, and analyze data and information from our preclinical studies and clinical trials. We also engage in substantial information gathering following the identification of a promising product candidate. Because data in the healthcare industry is fragmented in origin, inconsistent in format, often incomplete and rapidly evolving, the overall quality of data collected or accessed in the healthcare industry is often subject to challenge, the degree or amount of data which is knowingly or unknowingly absent or omitted can be material, and we often discover data issues and errors when monitoring and auditing the quality of our data. If we make mistakes in the capture, input, or analysis of these data, our ability to advance the development of our product candidates may be materially harmed and our business, prospects and reputation may suffer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also engage in the procurement of regulatory approvals necessary for the development and commercialization of our product candidates, for which we manage and submit data to governmental entities. These processes and submissions are governed by complex data processing and validation policies and regulations. Notwithstanding such policies and regulations, interim, top-line or preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data, in which case we may be exposed to liability to a customer, court or government agency that concludes that our storage, handling, submission, delivery or display of health information or other data was wrongful or erroneous. Although we maintain insurance coverage for clinical trials this coverage may prove to be inadequate or could cease to be available to us on acceptable terms, if at all. Even unsuccessful claims could result in substantial costs and diversion of management time, attention, and resources. A claim brought against us that is uninsured or under-insured could harm our business, financial condition and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we rely on CROs and other third parties to monitor and manage data for some of our ongoing preclinical studies and clinical trials and control only certain aspects of their activities. If any of our CROs or other third parties do not perform to our standards in terms of data accuracy or completeness, data from those preclinical studies and clinical trials may be compromised as a result, and our reliance on these parties does not relieve us of our regulatory responsibilities. For a detailed discussion, see &#8220;&#8212; Risks Related to Our Reliance on Third Parties&#8201;&#8212;&#8201;As we rely on third parties to conduct our preclinical studies, clinical trials, contract manufacture drug substances and drug products, and provide other important services related to product development, regulatory submissions, and commercialization, if we lose our relationships with these third parties or if they do not successfully carry out their contractual duties, comply with applicable laws, or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed&#8221; below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The incidence and prevalence for target patient populations of our product candidates are based on estimates and third-party sources. The market opportunities for our product candidates, if approved, may be smaller than we anticipate.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect to initially seek approval of LBS-008 for the treatment of STGD1. Our projections of the number of patients with STGD1 and the portion of those patients that would benefit from treatment with LBS-008 are based on our beliefs and estimates, including data published by third parties, including scientific literature, patient foundations and publicly available databases, and on internally generated data and assumptions. While we believe our market size information is generally reliable, such information is inherently imprecise, and relies on our and third parties&#8217; projections, assumptions and estimates within our target market, which are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">including those described in this prospectus. If such third-party or internally generated data prove to be inaccurate or we make errors in our projections, assumptions or estimates based on that data, our addressable target market opportunity and/or our future growth rate may be less than we currently estimate. Further, new sources may reveal a change in the estimated number of patients, and the number of patients may turn out to be lower than expected. Additionally, the potential addressable patient population for our current programs or future product candidates may be limited. Accordingly, the information regarding the size of our addressable market opportunity included in this prospectus should not be taken as indicative of our future growth. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ultimate market opportunity for our product candidates will depend on, among other things, the final labeling for such product candidates as agreed with the FDA, the TGA, the NMPA, the EMA and any other applicable comparable foreign regulatory authorities, acceptance by the medical community and patient access, potential competition and drug pricing and reimbursement. Even if we obtain significant market share for any product candidate, if approved, if the potential target populations are small, we may never achieve profitability without obtaining marketing approval for additional indications, which may significantly harm our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Product liability lawsuits against us could divert our resources, cause us to incur substantial liabilities and limit commercialization of any products that we may develop.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We face an inherent risk of product liability claims as a result of the clinical testing of our product candidates despite obtaining appropriate informed consents from our clinical trial participants. We will face an even greater risk if we or any future collaborators commercially sell any product that we or they may develop. For example, we may be sued if any product we develop allegedly causes injury or is found to be otherwise unsuitable during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Regardless of the merits or eventual outcome, liability claims may result in significant negative consequences to our business and prospects, including, but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">decreased demand for our product candidates or any resulting products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">injury to our reputation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">withdrawal of other clinical trial participants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">costs to defend the related litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a diversion of our management&#8217;s time and resources; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">substantial monetary awards to study participants or patients; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a decline in the market price of our ADSs. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently carry liability insurance covering our clinical trials. Although we maintain such insurance, any claim that may be brought against us could result in a court judgment or settlement in an amount that is not covered, in whole or in part, by our insurance or which is in excess of the limits of our insurance coverage. Our insurance policies also contain various exclusions, and we may be subject to particular liability claims for which we have no coverage. We will have to pay any amount awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. In addition, if we cannot successfully defend ourselves against such claims, we may incur substantial liabilities and be required to suspend or delay our ongoing clinical trials. Even a successful defense would require significant financial and management resources. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Illegal and/or parallel imports and counterfeit pharmaceutical products may reduce demand for our future approved product candidates and could have a negative impact on our reputation and business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The illegal importation of competing products from countries where government price controls or other market dynamics result in lower prices may adversely affect the demand for our future approved </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">product candidates and, in turn, may adversely affect our sales and profitability in the United States, China and other countries where we plan to commercialize our products. Unapproved foreign imports of prescription drugs are illegal under the current laws of the United States, Australia and China. However, illegal imports may continue to occur or even increase as the ability of patients and other customers to obtain these lower priced imports continues to grow. Furthermore, cross-border imports from lower-priced markets (which are known as parallel imports) into higher-priced markets could harm sales of our future drug products and exert commercial pressure on pricing within one or more markets. In addition, government authorities may expand consumers&#8217; ability to import lower priced versions of our future approved products or competing products from outside the United States, Australia, China or other countries where we operate or expect to operate. Any future legislation or regulations that increase consumer access to lower priced medicines from outside the United States, China or other countries where we operate could have a material adverse effect on our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain products distributed or sold in the pharmaceutical market may be manufactured without proper licenses or approvals, or be fraudulently mislabeled with respect to their content or manufacturers. These products are generally referred to as counterfeit pharmaceutical products. The counterfeit pharmaceutical product control and enforcement system, particularly in developing markets may be inadequate to discourage or eliminate the manufacturing and sale of counterfeit pharmaceutical products imitating our products. Since counterfeit pharmaceutical products in many cases have very similar appearances compared with the authentic pharmaceutical products but are generally sold at lower prices, counterfeits of our products could quickly erode the demand for our future approved product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, counterfeit pharmaceutical products are not expected to meet our rigorous manufacturing and testing standards. A patient who receives a counterfeit pharmaceutical product may be at risk for a number of dangerous health consequences. Our reputation and business could suffer harm as a result of counterfeit pharmaceutical products sold under our brand name(s). In addition, thefts of inventory at warehouses, plants or while in-transit, which are not properly stored and which are sold through unauthorized channels, could adversely impact patient safety, our reputation and our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Our Financial Position and Need for Additional Capital</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have recorded net cash outflow from operating activities since our inception. Even if we consummate this offering, we will need to obtain additional financing to fund our operations. If we are unable to obtain such financing, we may be unable to complete the development and commercialization of our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since our inception, our operations have consumed substantial amounts of cash. We raised a total of approximately $40.6&#160;million in pre-IPO financing in the past three fiscal&#160;years and the net cash used in our operating activities was approximately $4.4&#160;million for the year ended December&#160;31, 2020 and approximately $7.5&#160;million for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect our expenses to increase in connection with our ongoing activities, particularly as we initiate new clinical trials of, initiate new research and preclinical development efforts for and seek marketing approval for, our product candidates. In addition, if we obtain marketing approval for any of our product candidates, we may incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution to the extent that such sales, marketing, manufacturing and distribution are not the responsibility of a future collaborator. Furthermore, following the completion of this offering, we expect to incur significant additional costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. Our financing to fund our operations may be adversely affected, delayed or fail to raise because of capital market environment, valuation of our company or the progress of our competitors. If we are unable to raise capital when needed or on attractive terms, we may be forced to delay, reduce or eliminate our research and development programs or any future commercialization efforts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The net proceeds of this offering and our existing cash on hand will not be sufficient to fund all of the efforts that we plan to undertake or to fund the completion of development of any of our product candidates. Accordingly, we will be required to obtain further funding through public or private equity offerings, debt financings, collaborations and licensing arrangements or other sources. We do not have any committed external source of funds. Adequate additional financing may not be available to us on acceptable terms, or at all. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our failure to raise capital as and when needed would have a negative impact on our financial condition and our ability to pursue our business strategy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our existing cash on hand will not be sufficient to enable us to meet our short-term obligations or long-term plans, including commercialization of clinical pipeline products, if approved, or initiation or completion of future clinical trials. Our future funding requirements, both short-term and long-term, will depend on many factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of future product candidates that we pursue and their development requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, progress, timing, results and costs of discovering, researching and developing product candidates, and conducting preclinical studies and clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, prioritization and number of our research and development programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of regulatory review of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost of manufacturing our product candidates and any products we commercialize, including costs associated with expanding our supply chain; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost and timing of future commercialization activities, including product manufacturing, marketing, sales and distribution, for any of our product candidates for which we receive regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cash received, if any, from commercial sales of any product candidates for which we receive regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such collaborations and arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent to which we acquire or in-license other product candidates and technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our headcount growth and associated costs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">resources required to develop and implement policies and processes to promote ongoing compliance with applicable healthcare laws and regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the impact of COVID-19 on the initiation or completion of preclinical studies or clinical trials and the supply of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">costs required to ensure that our and any of our partners&#8217; business arrangements with third parties comply with applicable healthcare laws and regulations; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs of operating as a public company in the United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have a limited operating history and no history of commercializing pharmaceutical products, which may make it difficult to evaluate the prospects for our future viability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a global clinical-stage biopharmaceutical company with a limited operating history and no history of commercializing pharmaceutical products. Our operations to date have been limited to financing and staffing our company, developing our technology and conducting preclinical research and clinical trials for our product candidates. We have not yet demonstrated an ability to successfully obtain marketing approvals for or commercialize our product candidates or manufacture our product candidates on a scale sufficient to supply the commercial markets. We have no products approved for commercial sale and have not generated any revenue from product sales. Consequently, any predictions about our future success or viability may not be as accurate as they could be if we had a longer operating history and/or approved products on the market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our limited operating history and the fact that we have yet to commercialize a pharmaceutical product, particularly in light of the rapidly evolving drug research and development industry in which we operate and the changing regulatory and market environments we encounter, may make it difficult to evaluate our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">prospects for future performance. As a result, any assessment of our future performance or viability is subject to significant uncertainty. We will encounter risks and difficulties frequently experienced by early-stage companies in rapidly evolving fields as we seek to transition to a company capable of supporting commercial activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As we continue to build our business, we expect our financial condition and operating results may fluctuate significantly from quarter to quarter and year to year due to a variety of factors, many of which are beyond our control. Accordingly, you should not rely upon the results of any particular quarterly or annual period as indications of future operating performance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have incurred net losses since our inception and anticipate that we will continue to incur net losses for the foreseeable future and may never achieve or maintain profitability. If we are unable to achieve or sustain profitability, the market value of our ADSs will likely decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have incurred significant annual net operating losses in every year since our inception. We expect to continue to incur significant and increasing net operating losses for at least the next several&#160;years. Our net losses were approximately $5.8&#160;million and $9.7 million for the years ended December&#160;31, 2020 and 2021, respectively. As of December&#160;31, 2021, we had an accumulated deficit of approximately $27.2&#160;million. We have not generated any revenues from product sales, have not completed the development of any product candidate and may never have a product candidate approved for commercialization. We have financed our operations to date primarily through private placements of our preferred stock. We have devoted substantially all of our financial resources and efforts to research and development, including preclinical studies and our clinical trials. Our net losses may fluctuate significantly from quarter to quarter and year to year. Net losses and negative cash flows have had, and will continue to have, an adverse effect on our stockholders&#8217; equity and working capital. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We anticipate that our expenses will increase substantially if and as we: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">continue to develop and conduct clinical trials with respect to our lead product candidate, LBS-008; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">initiate and continue research, preclinical and clinical development efforts for any future product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seek regulatory approvals for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">commercialize our product candidates once we have obtained marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">establish sales, marketing, distribution and other commercial infrastructure in the future to commercialize various products for which we may obtain marketing approval, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">hire additional clinical, operational, financial and administrative, quality control and scientific personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">add operational, financial and management information systems and personnel, including personnel to support our product development and help us comply with our obligations as a public company; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">require the manufacture of larger quantities of product candidates for clinical development and, potentially, commercialization; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">seek to identify additional product candidates and technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtain, maintain, expand and protect our intellectual property portfolio; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">enforce and defend any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">acquire or in-license other product candidates, intellectual property and technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">enter into out-licensing and co-development collaborations consistent with our global strategy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">add equipment and physical infrastructure to support our research and development </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">incur setbacks or delays to the initiation or completion of preclinical studies, drug development and/or clinical trials due to COVID-19; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">incur any disruption or delays to the supply of our product candidates due to COVID-19. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To become and remain profitable, we must develop and eventually commercialize product candidates with significant market potential. This will require us to be successful in a range of challenging activities, including completing preclinical testing and clinical trials of, and obtaining marketing approval for, our product candidates, manufacturing, marketing and selling, either directly or through collaborations, those product candidates for which we may obtain marketing approval and satisfying any post-marketing requirements. We may not succeed in any or all of these activities and, even if we do, we may never generate revenues that are significant or large enough to achieve profitability. In the process of attempting to become and remain profitable, we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. The size of our future net losses will depend partially on the rate of the future growth of our expenses, our ability to generate revenues and the timing and amount of payments that we receive from or pay to third parties. If any of our product candidates fails during preclinical studies or clinical trials or does not gain regulatory approval, or, even if approved, fails to achieve market acceptance, our business may not become profitable. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods thereafter. Our prior losses and expected future losses have had, and will continue to have, an adverse effect on our working capital and the value of our Company. This could impair our ability to raise future capital, maintain our research and development efforts, proceed with commercialization efforts, expand our business or otherwise continue our operations, and could harm our competitive position in the marketplace. A decline in the value of our Company also could cause you to lose all or part of your investment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our recurring losses from operations could continue to raise substantial doubt regarding our ability to continue as a going concern. Our ability to continue as a going concern requires that we obtain sufficient funding to finance our operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have incurred significant operating losses since our inception and have never generated product revenue, and it is possible we will never generate product revenue or profit. Accordingly, we have concluded that substantial doubt exists regarding our ability to continue as a going concern. Meaningful revenues will likely not be available until and unless any current or future product candidate is approved by the FDA, the NMPA, the EMA or comparable regulatory agencies in other countries and successfully marketed, either by us or a partner, an outcome which may not occur. Our financial statements appearing at the end of this prospectus have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of these uncertainties related to our ability to operate on a going concern basis. The perception that we may not be able to continue as a going concern may cause others to choose not to deal with us due to concerns about our ability to meet our contractual obligations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our independent registered public accounting firm included an explanatory paragraph in its audit report on our financial statements as of and for the year ended December&#160;31, 2021, stating that we have an accumulated deficit, incurred recurring losses from operations, have an expectation of continuing operating losses for the foreseeable future, and need to raise capital to finance our future operations, which raise substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern depends on our ability to raise additional capital. If we seek additional financing to fund our business activities in the future and there remains substantial doubt about our ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding to us on commercially reasonable terms or at all. Further, if we cannot continue as a going concern, we may be forced to discontinue operations and liquidate our assets and may receive less than the value at which those assets are carried on our audited financial statements, which would cause holders of our ADSs and our shareholders to lose all or a part of their investment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our ability to use our net operating loss carry forwards may be subject to limitation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2020 and 2021, our subsidiaries had U.S. net operating loss carryforwards for federal and state tax purposes of approximately $3.7&#160;million and $4.0 million, respectively. If not utilized, the federal and state net operating loss carryforwards incurred before January&#160;1, 2018 will begin to expire in 2036, and the remaining can be carried forward indefinitely but utilization is limited to 80% of our taxable </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">income in any given tax year based on current federal tax laws. The timing and manner in which we may utilize net operating losses may be limited by tax rules regarding changes in ownership and a lack of future taxable income could adversely affect our ability to utilize our net operating losses before they expire. In general, net operating losses in one country cannot be used to offset income in any other country and net operating losses in one state cannot be used to offset income in any other state. Accordingly, we may be subject to tax in certain jurisdictions even if we have unused net operating losses in other jurisdictions. Furthermore, each jurisdiction in which we operate may have its own limitations on our ability to utilize net operating losses or tax credit carryovers generated in that jurisdiction. These limitations may increase our U.S. federal, state or foreign income tax liability. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Raising additional capital may cause dilution to holders of our ADSs and our shareholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may seek additional funding through a combination of equity offerings, debt financings, collaborations, licensing arrangements, strategic alliances, government grants or subsidies. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a holder of our ADSs. The incurrence of additional indebtedness or the issuance of certain equity securities could give rise to increased fixed payment obligations and also result in certain restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. In addition, the issuance of additional equity securities, or the possibility of such issuance, may cause the market price of our ADSs to decline. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we were to enter into collaborations or licensing arrangements in order to raise capital, we may be required to accept unfavorable terms, including relinquishing or licensing to a third party certain of our rights to technologies, future revenue streams, research programs or product candidates on unfavorable terms, which we would have otherwise sought to develop or commercialize on our own or reserve for future potential arrangements when we might be more likely to achieve more favorable terms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Regulatory Approval and Marketing of Our Product Candidates and Other Legal Compliance Matters</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The regulatory approval processes of the FDA, the TGA, the NMPA, the EMA and other comparable regulatory authorities are time-consuming and may evolve over time, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The time required to obtain the approval of the FDA, the TGA, the NMPA, the EMA and other comparable regulatory authorities is inherently uncertain and depends on numerous factors, including the substantial discretion of the regulatory authorities. Generally, such approvals take many&#160;years to obtain following the commencement of preclinical studies and clinical trials and timing can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidate involved. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions, each of which may cause delays in regulatory review. However, we cannot guarantee that we will be able to obtain regulatory approvals in a timely manner, or at all, for our existing product candidates or any product candidates that we may discover, in-license or acquire and seek to develop in the future. Our product candidates may not be effective, may be only moderately effective or may prove to have serious adverse, undesirable or unacceptable side effects, toxicities or other characteristics that may preclude regulatory approval or prevent or limit commercial use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our product candidates could be delayed in receiving or fail to receive regulatory approval of the FDA, the TGA, the NMPA, the EMA or a comparable regulatory authority for many reasons, including, but not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disagreement with the number, design, size, conduct or implementation of our clinical trials; For example, the regulatory authorities may disagree with our clinical trial endpoints, the subjects of our clinical trials, the number of patients enrolled, or the disease we choose to treat with our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">delays in obtaining regulatory approval or ethics committee approval to commence a clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure to demonstrate that a product candidate is safe and effective and potent for its proposed indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure of our clinical trial results to meet the level of statistical significance required for approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure of our CROs, clinical trial sites or investigators to comply with relevant current good clinical practice, or cGCP, requirements or failure of our clinical trial process to pass GCP inspections; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disagreement with our interpretation of data from animal testing or preclinical studies or clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">insufficient data collected from the clinical trials of our product candidates to support the submission and filing of an NDA, or other submissions or to obtain regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure of our product candidates to pass current good manufacturing practice, or cGMP, inspections during the regulatory review process or across the production cycle of our drug; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.11pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure of our clinical sites to pass audits carried out by the FDA, the TGA, the NMPA, the EMA or comparable regulatory authorities, resulting in a potential invalidation of our research data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">findings by the FDA, the TGA, the NMPA, the EMA or comparable regulatory authorities of deficiencies related to our manufacturing processes or the facilities of third-party CMOs with whom we contract for preclinical, clinical and commercial supplies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">changes in approval policies or regulations that render our preclinical and clinical data insufficient for approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.01pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our CROs taking actions that materially and adversely impact our clinical trials; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">failure of our clinical trial process to keep up with any scientific or technological advancements required by approval policies or regulations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA, the TGA, the NMPA, the EMA or a comparable regulatory authority may require more information, including additional preclinical or clinical data, to support approval, which may delay or prevent approval and our commercialization plans. Even if we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, grant approval contingent on the performance of costly post-marketing clinical trials or approve a product candidate with an indication that is not desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects of our product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">All material aspects of the research, development, manufacturing and commercialization of pharmaceutical products are heavily regulated.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All jurisdictions in which we intend to conduct our pharmaceutical-industry activities regulate these activities in great depth and detail. We initially intend to focus our activities on our primary markets of the United States, Australia, Taiwan, Europe and China. These jurisdictions strictly regulate the pharmaceutical industry, and in doing so they employ broadly similar regulatory strategies, including regulation of product development and approval, manufacturing, and marketing, sales and distribution of products. However, there are differences in the regulatory regimes that make for a more complex and costly regulatory compliance burden for a company like us that plans to operate in these regions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The process of obtaining regulatory approvals and compliance with appropriate laws and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable requirements at any time during the product development process and approval process, or after approval, may subject an applicant to administrative or judicial sanctions. These sanctions could include: refusal to approve pending applications; withdrawal of an approval; license revocation; clinical hold; voluntary or mandatory product recalls; product seizures; total or partial suspension of production or distribution; injunctions; fines; refusals of government contracts; providing restitution; undergoing disgorgement; or other civil or criminal penalties. Failure to comply with these regulations could have a material adverse effect on our business. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The FDA, the TGA, the NMPA, the EMA and any other regulatory agencies may actively enforce the laws and regulations prohibiting the promotion of drugs for off-label uses.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any of our product candidates is approved and we are found to have improperly promoted off-label uses of those products, we may become subject to significant liability. The FDA, the TGA, the NMPA, the EMA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, such as our product candidates, if approved. In particular, a product may not be promoted for uses that are not approved by the FDA, the TGA, the NMPA, the EMA or such other regulatory agencies as reflected in the product&#8217;s approved labeling in applicable jurisdiction(s). If we receive marketing approval for a product candidate, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the approved label. If we are found to have promoted such off-label uses, we may become subject to significant liability. For example, the U.S. federal government has successfully pursued judgments for large civil and criminal fines and penalties against companies for alleged improper promotion of off-label use and has enjoined several companies from engaging in off-label promotion. The U.S. federal government has also successfully pursued consent decrees, deferred prosecution agreements, and injunctions under which specified promotional conduct is changed or curtailed, and compliance is closely monitored. If we cannot successfully manage the promotion of our product candidates, if approved, we could become subject to significant liability, which would materially adversely affect our business and financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if we obtain approval of our product candidates in one jurisdiction, we may never obtain approval for or commercialize them in any other jurisdiction, which would limit our ability to realize the maximum market potential of our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot commercialize product candidates in the United States, Australia, China, Europe or another jurisdiction outside of the United States without first obtaining regulatory approval from the FDA, the TGA, the NMPA, the EMA or comparable foreign regulatory authorities. The process to develop, obtain regulatory approval for and commercialize product candidates is long, complex and costly both inside and outside of the United States and approval may not be granted. Clinical trials conducted in one country may not be accepted by regulatory authorities in other countries and obtaining regulatory approval in one country does not mean that regulatory approval will be obtained in any other country. Approval processes vary among countries and can involve additional product testing and validation and additional administrative review periods. Even if our product candidates were to successfully obtain regulatory approval in one jurisdiction, we would still need to seek approval in any other jurisdictions where we plan to market the product. Any safety issues, product recalls or other incidents related to products approved and marketed in one jurisdiction may impact approval of those products in other jurisdictions. Further, the failure to obtain approval in one jurisdiction may negatively impact our ability to obtain approval elsewhere. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Seeking foreign regulatory approval could result in difficulties and increased costs for us and require additional preclinical studies or clinical trials which could be costly and time consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our products in those countries. We do not have any product candidates approved for sale in any jurisdiction, including in international markets, and the majority of our employees have limited experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, the target market for our product candidates will be reduced and our ability to realize the maximum market potential of any product candidate that we develop will be adversely affected.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The applicability of clinical data generated outside the United States is subject to FDA concurrence for its suitability in supporting approval in the United States. If the FDA or comparable regulatory agencies do not accept data from such trials, our development plans may be delayed, which could materially harm our business.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain of our clinical trials supporting our lead product candidate were, and continue to be, conducted outside the United States in foreign countries such as Australia and Taiwan, and we, or any future collaborators, may choose to conduct one or more clinical trials or a portion of such clinical trials for our product candidates outside the United States. The acceptance of study data from clinical trials conducted outside the United States or another jurisdiction by the FDA or comparable foreign regulatory authority may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">be subject to certain conditions or may not be accepted at all. In cases where data from foreign clinical trials are intended to serve as the sole basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (i) the data are applicable to the United States population and United States medical practice; (ii) the trials were performed by clinical investigators of recognized competence and pursuant to cGCP regulations; and (iii) the data may be considered valid without the need for an on-site inspection by the FDA, or if the FDA considers such inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. In addition, even where the foreign study data are not intended to serve as the sole basis for approval, the FDA will not accept the data as support for an application for marketing approval unless the study is well-designed and well-conducted in accordance with cGCP requirements and the FDA is able to validate the data from the study through an onsite inspection if deemed necessary. Many foreign regulatory authorities have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any comparable foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any comparable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which could be costly and time-consuming, and which may result in current or future product candidates that we may develop not receiving approval for commercialization in the applicable jurisdiction.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We, or any future collaborators, may not be able to obtain orphan drug designation or orphan drug exclusivity for our product candidates and, even if we do, that exclusivity may not prevent the FDA or the EMA from approving other competing products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Regulatory authorities in some jurisdictions, including the United States and Europe, may designate drugs for relatively small patient populations as orphan drugs. LBS-008 has received Orphan Drug Designation in the United States and Europe, which provides for 7&#160;years and 10&#160;years, respectively, of market exclusivity from approval for STGD1. LBS-008 has also received Rare Pediatric Disease Designation in the United States. We, or any future collaborators, may seek orphan drug designations for other product candidates and may be unable to obtain such designations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if we, or any future collaborators, obtain orphan drug designation for a product candidate, we, or they, may not be able to obtain orphan drug exclusivity for that product candidate. Generally, a product with orphan drug designation only becomes entitled to orphan drug exclusivity if it receives the first marketing approval for the indication for which it has such designation, in which case the FDA will be precluded from approving another marketing application for the same product for that indication and the EMA will be precluded from accepting an application for, or granting a marketing authorization for, a &#8220;similar medicinal product&#8221; for the applicable exclusivity period. The applicable exclusivity period is seven&#160;years in the United States and ten&#160;years in Europe. The European exclusivity period can be reduced to six&#160;years if a drug no longer meets the criteria for orphan drug designation or if the drug is sufficiently profitable so that market exclusivity is no longer justified. Orphan drug exclusivity may be lost if the FDA or the EMA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the drug to meet the needs of patients with the rare disease or condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if we, or any future collaborators, obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs can be approved for the same condition, and only the first applicant to receive approval will receive the benefits of marketing exclusivity. In addition, if a competitor&#8217;s drug receives marketing approval earlier than us in Europe which is deemed by the EMA as a &#8220;similar medicinal product&#8221; of any of our product candidates, then we may not be able to obtain orphan drug exclusivity for that product candidate. Even after an orphan drug is approved, the FDA can subsequently approve the same drug for the same condition if the FDA concludes that the later drug is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. In addition, in both the U.S. and Europe, if a different drug is subsequently approved for marketing for the same or a similar indication as any of our product candidates that receive marketing approval, we may face increased competition and lose market share regardless of orphan drug exclusivity, which only protects against approval of the &#8220;same&#8221; drug for the same indication. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Although we may pursue expedited regulatory approval pathways in the United States for certain of our product candidates, they may not qualify for expedited development or, if they do qualify for expedited development, it may not actually lead to a faster development or regulatory review or approval process.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although we believe there may be an opportunity to accelerate the development of certain of our product candidates through one or more of the FDA&#8217;s expedited programs and we may pursue one or more of these expedited programs, we cannot be certain that any of such product candidates will qualify for such programs or that we will be able to maintain such qualifications. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we apply for any expedited program for any of our product candidates, the FDA may determine such product candidate, its proposed indication or other aspects of our clinical development plans do not qualify for such an expedited program. Even if we are successful in obtaining a designation or access to any expedited program, we may not experience faster development timelines or achieve faster review or approval compared to conventional FDA procedures. Access to an expedited program may also be withdrawn by the FDA if the FDA believes that the designation is no longer supported by data from our clinical development programs or if the FDA otherwise finds that relevant criteria are no longer being met. Additionally, qualification for any expedited review procedure does not ensure that we will ultimately obtain regulatory approval for any of our product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if we receive regulatory approval for our product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expenses, and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even after obtaining regulatory approval from the FDA, the TGA, the NMPA, the EMA or a comparable regulatory authority, our product candidates will be subject to, among other things, ongoing regulatory requirements governing the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, recordkeeping data management and submission of safety, efficacy and other post-market information. These requirements include submissions of safety and other post-marketing information and reports, registration, random quality control testing, adherence to any CMC, variations, continued compliance with cGMPs, and cGCPs and potential post-approval studies for the purposes of license renewal. Violations of the Federal Food, Drug, and Cosmetic Act, or the FDCA, relating to the promotion of prescription drugs may lead to FDA enforcement actions and investigations alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any regulatory approvals that we receive for our product candidates may also be subject to limitations on the approved indicated uses for which the drug may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing studies, including Phase&#160;4 studies for the surveillance and monitoring of the safety and efficacy of the drug. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, once a drug is approved by the FDA, the TGA, the NMPA, the EMA or a comparable regulatory authority for marketing, it is possible that there could be a subsequent discovery of previously unknown problems with the drug, including problems with third-party CMOs or manufacturing processes, or failure to comply with regulatory requirements. If any of the foregoing occurs with respect to our drug products, it may result in, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions on the marketing or manufacturing of the drug, withdrawal of the drug from the market, or voluntary or mandatory drug recalls; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">fines, warning letters or holds on our clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">refusal by the FDA, the TGA, the NMPA, the EMA or comparable regulatory authorities to approve pending applications or supplements to approved applications filed by us, or suspension or revocation of drug license approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">refusal by the FDA, the TGA, the NMPA, the EMA or comparable regulatory authorities to accept any of our IND approvals or NDAs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">drug seizure or detention, or refusal to permit the import or export of drugs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">injunctions or the imposition of civil, administrative or criminal penalties. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any government investigation of alleged violations of law could require us to expend significant time and resources and could generate negative publicity. Moreover, regulatory policies may change or additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies or we are not able to maintain regulatory compliance, we may lose the regulatory approvals that we have already obtained and may not achieve or sustain profitability, which in turn could significantly harm our business, financial condition and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Inadequate funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ability of the FDA and comparable regulatory authorities (in some jurisdictions, the hospitals) to accept application, review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent&#160;years as a result. In addition, government funding of other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Disruptions at the FDA and comparable regulatory authorities may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, in recent&#160;years, including in 2018 and 2019, the U.S. government shut down several times and certain regulatory agencies, such as the FDA, had to furlough critical employees and stop critical activities. Separately, in response to the COVID-19 pandemic, the FDA postponed most inspections of foreign manufacturing facilities and products, postponed routine surveillance inspections of domestic manufacturing facilities and is conducting only teleconference meetings. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, upon completion of this offering and in our operations as a public company, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Current and future legislation may increase the difficulty and cost for us and any future collaborators to obtain marketing approval of and commercialize our product candidates and affect the prices we, or they, may obtain.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States and certain other jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of our product candidates, restrict post-approval activities and affect our ability to sell profitably any product candidates for which we obtain marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, collectively, the ACA, is a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for the healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. Among the provisions of the ACA of importance to our product candidates are the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an annual, nondeductible fee on any entity that manufactures or imports specified branded prescription drugs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expansion of healthcare fraud and abuse laws, including the False Claims Act and the Anti-Kickback Statute, new government investigative powers, and enhanced penalties for non-compliance; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a new Medicare Part&#160;D coverage gap discount program, in which manufacturers must agree to offer 50% point-of-sale discounts off negotiated prices; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">extension of manufacturers&#8217; Medicaid rebate liability to utilization covered by Medicaid managed care plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expansion of eligibility criteria for Medicaid programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expansion of the entities eligible for discounts under the Public Health Service Act&#8217;s pharmaceutical pricing program; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">new requirements to report to the Centers for Medicare &amp; Medicaid Services, or the CMS, financial arrangements with physicians and teaching hospitals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a new requirement to annually report to the FDA drug samples that manufacturers and distributors provide to physicians; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Legislative and regulatory proposals have been made to expand post-approval requirements, to restrict sales and promotional activities for pharmaceutical products and to control rising market prices for pharmaceutical products. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, what the impact of such changes on the marketing approvals, if any, of our product candidates may be, or whether pricing strategies may be constrained. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing conditions and other requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Our Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we are unable to obtain and maintain patent and other intellectual property protection for our product candidates, or if the scope of such intellectual property rights obtained is not sufficiently broad, third parties could develop and commercialize products and technologies similar or identical to ours and compete directly against us, and our ability to successfully commercialize any product or technology may be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our success depends in large part on our ability to protect our proprietary technology and product candidates from competition by obtaining, maintaining, defending and enforcing our intellectual property rights, including patent rights. As of April&#160;20, 2022, our portfolio of owned, co-owned, and in-licensed patents consisted of 19 issued U.S. patents (inclusive of allowed applications), 8 pending U.S. patent applications, 14 issued foreign patents (inclusive of allowed applications) and 29 pending foreign patent applications, providing protection in the United States and China, among other regions. We seek to protect and intend to seek to protect the product candidates and technology that we consider commercially important by filing patent applications and requiring our licensor to file licensed patent applications in the United States, European Union, China, Japan, South Korea, Taiwan, Canada, Australia, India and other countries or regions, relying on trade secrets or pharmaceutical regulatory protection or employing a combination of these methods. This process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications in all jurisdictions at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent&#160;years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our owned, co-owned, and in-licensed pending and future patent applications may not result in patents being issued which protect our technology or product candidates or which effectively prevent others from commercializing competitive technologies and product candidates. The patent examination process may require us to narrow the scope of the claims of our owned, co-owned, and in-licensed pending and future patent applications, which may limit the scope of patent protection that may be obtained. We cannot assure that all of the potentially relevant prior art relating to our owned, co-owned, and in-licensed patents </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and patent applications has been found. If such prior art exists, it can invalidate a patent or prevent a patent application from being issued as a patent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if patents do issue on any of these applications, there can be no assurance that a third party will not challenge their validity, enforceability, or scope, which may result in the patent claims being narrowed or invalidated, or that we will obtain sufficient claim scope in those patents to prevent a third party from competing successfully with our product candidates. We may become involved in interference, </font><font style="font-style:italic;letter-spacing:0.2pt;">inter partes</font><font style="letter-spacing:0.2pt;"> review, post grant review, ex parte reexamination, derivation, opposition or similar other proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such proceeding could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or product candidates and compete directly with us, or result in our inability to manufacture or commercialize product candidates without infringing third-party patent rights. Thus, even if our owned, co-owned, and in-licensed patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our competitors may be able to circumvent our owned, co-owned, and in-licensed patents by developing similar or alternative technologies or product candidates in a non-infringing manner. The issuance of a patent is not conclusive as to its scope, validity or enforceability, and our owned, co-owned, and in-licensed patents may be challenged in the courts or patent offices in the United States and other countries. Such challenges may result in patent claims being narrowed, invalidated or held unenforceable, which could limit our ability to stop or prevent us from stopping others from using or commercializing similar or identical technology and product candidates, or limit the duration of the patent protection of our technology and product candidates. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such assets might expire before or shortly after such assets are commercialized. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or identical to ours. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our owned, co-owned, and in-licensed patents or narrow the scope of our patent protection. Under the America Invents Act enacted in 2011, the United States moved to this first-to-file system in early 2013 from the previous system under which the first to make the claimed invention was entitled to the patent. Assuming the other requirements for patentability are met, the first to file a patent application is entitled to the patent. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&#160;months after filing, or in some cases not at all. Therefore, we cannot be certain that we or our licensors were the first to make the inventions claimed in our owned, co-owned, and in-licensed patents or pending patent applications, or that we or our licensors were the first to file for patent protection of such inventions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We depend on intellectual property licensed from third parties, and our current and future licensors may not always act in our best interest. If we fail to comply with our obligations under our intellectual property licenses, if the licenses are terminated or if disputes regarding these licenses arise, we could lose significant rights that are important to our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are dependent on patents, know-how and proprietary technology licensed from others. We are party to an exclusive license agreement with Columbia University under which we are granted rights to intellectual property that are necessary to our business and we may enter into additional license agreements in the future. Our existing license agreement with Columbia University imposes on us, and we expect that any future license agreements where we in-license intellectual property will impose on us, various development, regulatory and/or commercial diligence obligations, requiring timely achievement of development milestones for which we are obligated to report periodically on our progress and timely payment of milestone payments and/or royalties and other obligations. If we fail to comply with our obligations under these agreements, and our licensor does not agree to adjust the deadlines by which milestones must be achieved or we are subject to bankruptcy-related proceedings, the licensor may have the right to convert our exclusive license to a nonexclusive license with no right to sublicense or terminate the license, in which event we would not be able to develop or market products covered by the license. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we or our licensors fail to adequately protect our licensed intellectual property, our ability to commercialize product candidates could suffer. We do not have complete control over the maintenance, prosecution and litigation of our in-licensed patents and patent applications and may have limited control over future intellectual property that may be in-licensed. For example, we cannot be certain that activities such as the maintenance and prosecution by our licensors have been or will be conducted in accordance with our views or in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. Our licensor is required to consult with us and keep us informed on the status of all licensed patents and applications, so long as we do not challenge the validity, scope, or enforceability of any licensed patent or application. It is also possible that our licensors&#8217; infringement proceedings or defense activities may be less vigorous than had we conducted them ourselves, or may not be conducted in accordance with our best interests. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the agreements under which we license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant patents, know-how and proprietary technology, or increase what we believe to be our financial or other obligations under the relevant agreement. Disputes that may arise between us and our licensors regarding intellectual property subject to a license agreement could include disputes regarding: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope of rights granted under the license agreement and other interpretation-related issues; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether and the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our right to sublicense patent and other rights to third parties under collaborative development relationships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our product candidates and what activities satisfy those diligence obligations; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our partners. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on reasonable terms, we may be unable to successfully develop and commercialize the affected technology or product candidates. As a result, any termination of or disputes over our intellectual property licenses could result in the loss of our ability to develop and commercialize our product candidates, or we could lose other significant rights, any of which could have a material adverse effect on our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to comply with our obligations under our patent license with a third party, we could lose license rights that are important to our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are party to an exclusive license agreement with Columbia University pursuant to which we in-license key patent and patent applications necessary to pursue marketing and selling of our product candidates. Our existing license agreement with Columbia University imposes various diligence, milestone payment, royalty, insurance and other obligations on us. If we fail to comply with these obligations, our licensor may elect to convert the license from an exclusive license to a nonexclusive license without the right to sublicense or initiate legal proceedings against third party patent infringers or terminate the license, in which event we would not be able to develop or market the products covered by such licensed intellectual property. Termination of these agreements or reduction or elimination of our rights under these agreements, or restrictions on our ability to freely assign or sublicense our rights under such agreements when it is in the interest of our business to do so, may impede, delay or prohibit the further development or commercialization of one or more product candidates that rely on such agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may have limited control over the maintenance and prosecution of these in-licensed patents and patent applications, activities or any other intellectual property that may be related to our in-licensed intellectual property. For example, we cannot be certain that such activities by our licensor have been or will </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property discovered through U.S. government funded programs may be subject to federal regulations such as &#8220;march-in&#8221; rights, certain reporting requirements and a preference for U.S.-based companies. Compliance with such regulations may limit our exclusive rights and limit our ability to contract with non-U.S. manufacturers.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our licensed and co-owned patents and pending patent applications have been generated through the use of U.S. government funding, and we may acquire or license in the future intellectual property rights that have been generated through the use of U.S. government funding or grants. Pursuant to the Bayh-Dole Act of 1980, the U.S. government has certain rights in inventions developed with government funding. These U.S. government rights include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right, under certain limited circumstances, to require us to grant exclusive, partially exclusive, or non-exclusive licenses to any of these inventions to a third party if it determines that: (1)&#160;adequate steps have not been taken to commercialize the invention; (2)&#160;government action is necessary to meet public health or safety needs; or (3)&#160;government action is necessary to meet requirements for public use under federal regulations (also referred to as &#8220;march-in rights&#8221;). If the U.S. government exercised its march-in rights in our future intellectual property rights that are generated through the use of U.S. government funding or grants, we could be forced to license or sublicense intellectual property developed by us or that we license on terms unfavorable to us, and there can be no assurance that we would receive compensation from the U.S. government for the exercise of such rights. The U.S. government also has the right to take title to these inventions if the grant recipient fails to disclose the invention to the government or fails to file an application to register the intellectual property within specified time limits. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us to expend substantial resources. In addition, the U.S. government requires that any products embodying any of these inventions or produced through the use of any of these inventions be manufactured substantially in the United States. This preference for U.S. industry may be waived by the federal agency that provided the funding if the owner or assignee of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. industry may limit our ability to contract with non-U.S. product manufacturers for products covered by such intellectual property. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We enjoy only limited geographical protection with respect to certain patents and may not be able to protect our intellectual property rights throughout the world.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Filing and prosecuting patent applications and defending patents covering our product candidates in all countries throughout the world could be prohibitively expensive. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own product candidates and, further, may export otherwise infringing product candidates to territories, where we have patent protection, but enforcement rights are not as strong as those in the United States. These product candidates may compete with our product candidates, and our owned, co-owned, and in-licensed patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The laws of some jurisdictions do not protect intellectual property rights to the same extent as the laws or rules and regulations in the United States, and many companies have encountered significant difficulties in protecting and defending such rights in such jurisdictions. The legal systems of certain countries, particularly certain developing countries, are not as favorable as other jurisdictions with regard to the enforcement of patents, trade secrets and other intellectual property protection, which could make it difficult for us to stop the infringement of our owned, co-owned, and in-licensed patents or marketing of competing product candidates in violation of our proprietary rights generally and specifically in certain jurisdictions. Proceedings to enforce our patent rights in other jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our owned, co-owned, and in-licensed patent applications at risk of not issuing as patents, and could provoke third parties to assert claims against us. We may not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop. Furthermore, while we intend to protect our intellectual property rights in our expected significant markets, we cannot ensure that we will be able to initiate or maintain similar efforts in all jurisdictions in which we may wish to market our product candidates. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate, which may have an adverse effect on our ability to successfully commercialize our product candidates in all of our expected significant foreign markets. If we encounter difficulties in protecting, or are otherwise precluded from effectively protecting, the intellectual property rights important for our business in such jurisdictions, the value of these rights may be diminished, and we may face additional competition from others in those jurisdictions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some countries also have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, some countries limit the enforceability of patents against government agencies or government contractors. In those countries, the patent owner may have limited remedies, which could materially diminish the value of such patents. If we are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Enforcing our intellectual property rights against third parties may also cause such third parties to file other counterclaims against us, which could be costly to defend and could require us to pay substantial damages, cease the sale of certain drugs or enter into a license agreement and pay royalties (which may not be possible on commercially reasonable terms or at all). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Periodic maintenance and annuity fees on any issued patent are due to be paid to the USPTO and foreign patent agencies over the lifetime of a patent. In addition, the USPTO and other foreign patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent application process. In some circumstances, we are dependent on our licensors to take the necessary action to comply with these requirements with respect to our licensed intellectual property. While an inadvertent failure to make payment of such fees or to comply with such provisions can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which such non-compliance will result in the abandonment or lapse of the patent or patent application, and the partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include failure to respond to official actions within prescribed time limits, and non-payment of fees and failure to properly legalize and submit formal documents within prescribed time limits. If we or our licensors fail to maintain the patents and patent applications covering our product candidates or if we or our licensors otherwise allow our owned, co-owned, or in-licensed patents or patent applications to be abandoned or lapse, our competitors might be able to enter the market, which would hurt our competitive position and could impair our ability to successfully commercialize our product candidates in any indication for which they are approved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The COVID-19 pandemic may impair our and our licensors&#8217; ability to comply with these procedural, document submission, fee payment, and other requirements imposed by government patent agencies, which may materially and adversely affect our ability to obtain or maintain patent protection for our products and product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Terms of our future owned, co-owned, or in-licensed patents may not be sufficient to effectively protect our product candidates and business in certain jurisdictions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In many countries where we file applications for patents, the term of an issued patent is generally 20&#160;years from the earliest claimed filing date of a non-provisional patent application in the applicable country. Although various extensions may be available, the life of a patent and the protection it affords are limited. Even if we obtain patents covering our product candidates, we may still be open to competition from other companies, as well as generic medications once the patent life has expired for a drug. For example, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">while there are patent regulations in the PRC in respect of regulatory data protection of new drugs containing new chemical components, there are currently no other clear mechanisms providing patent term extension or patent linkages for other drugs in the PRC. Therefore, it is possible that a lower-cost generic drug can emerge onto the market much more quickly. For additional information regarding generic competition for our products in China, see &#8220;&#8212; Risks Related to Our Intellectual Property&#8201;&#8212;&#8201;The uncertainty of patent linkage, patent term extension and data and market exclusivity for NMPA-approved pharmaceutical products could increase the risk of early generic competition with our products in China&#8221; below. These factors may result in weaker protection for us against generic competition in jurisdictions similar to the PRC than could be available to us in other jurisdictions, such as the United States. In addition, patents which we expect to obtain in the PRC or similar jurisdictions may not be eligible to be extended for patent terms lost during clinical trials and the regulatory review process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we are unable to obtain patent term extensions or if such extensions are less than requested for, our competitors may obtain approval of competing products following our patent expirations and our business, financial condition, results of operations and prospects could be materially harmed as a result. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If the FDA or comparable foreign regulatory authorities approve generic versions of any of our products that receive marketing approval, or such authorities do not grant our products appropriate periods of data exclusivity before approving generic versions of our products, the sales of our products could be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Once an NDA is approved, the product covered thereby becomes a &#8220;reference-listed drug&#8221; in the FDA&#8217;s publication, &#8220;Approved Drug Products with Therapeutic Equivalence Evaluations,&#8221; or the Orange Book. Manufacturers may seek approval of generic versions of reference-listed drugs through submission of abbreviated new drug applications, or ANDAs, in the United States. In support of an ANDA, a generic manufacturer need not conduct clinical trials. Rather, the applicant generally must show that its product has the same active ingredient(s), dosage form, strength, route of administration and conditions of use or labeling as the reference-listed drug and that the generic version is bioequivalent to the reference-listed drug, meaning it is absorbed in the body at the same rate and to the same extent. Generic products may be significantly less costly to bring to market than the reference-listed drug and companies that produce generic products are generally able to offer them at lower prices. Thus, following the introduction of a generic drug, a significant&#160;percentage of the sales of any branded product or reference-listed drug may be typically lost to the generic product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may not approve an ANDA for a generic product until any applicable period of non-patent exclusivity for the reference-listed drug has expired. The Federal Food, Drug, and Cosmetic Act, or FDCA, provides a period of five&#160;years of non-patent exclusivity for a new drug containing a new chemical entity, or NCE. Specifically, in cases where such exclusivity has been granted, an ANDA may not be filed with the FDA until the expiration of five&#160;years unless the submission is accompanied by a Paragraph IV certification that a patent covering the reference-listed drug is either invalid or will not be infringed by the generic product, in which case the applicant may submit its application four&#160;years following approval of the reference-listed drug. It is unclear whether the FDA will treat the active ingredients in our product candidates as NCEs and, therefore, afford them five&#160;years of NCE data exclusivity if they are approved. If any product we develop does not receive five&#160;years of NCE exclusivity, the FDA may approve generic versions of such product three&#160;years after its date of approval, subject to the requirement that the ANDA applicant certifies to any patents listed for our products in the Orange Book. Manufacturers may seek to launch these generic products following the expiration of the applicable marketing exclusivity period, even if we still have patent protection for our product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Competition that our products may face from generic versions of our products could negatively impact our future revenue, profitability and cash flows and substantially limit our ability to obtain a return on our investments in those product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The uncertainty of patent linkage, patent term extension and data and market exclusivity for NMPA-approved pharmaceutical products could increase the risk of early generic competition with our products in China.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, the Federal Food, Drug and Cosmetic Act, as amended by the Drug Price Competition and Patent Term Restoration Act, or the Hatch-Waxman Act, provides the opportunity for patent-term restoration, meaning a patent term extension of up to five&#160;years to reflect patent term lost during </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">certain portions of product development and the FDA regulatory review process. The Hatch-Waxman Act also has a process for patent linkage, pursuant to which the FDA will stay approval of certain follow-on applications during the pendency of litigation between the follow-on applicant and the patent holder or licensee, generally for a period of 30&#160;months. Finally, the Hatch-Waxman Act provides for statutory exclusivities that can prevent submission or approval of certain follow-on marketing applications. For example, federal law provides a five-year period of exclusivity within the United States to the first applicant to obtain approval of a new chemical entity and three&#160;years of exclusivity protecting certain innovations to previously approved active ingredients where the applicant was required to conduct new clinical investigations to obtain approval for the modification. Similarly, the U.S. Orphan Drug Act provides seven&#160;years of market exclusivity for certain drugs to treat rare diseases, where the FDA designates the product candidate as an orphan drug and the drug is approved for the designated orphan indication. These provisions, designed to promote innovation, can prevent competing products from entering the market for a certain period of time after the FDA grants marketing approval for the innovative product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depending upon the timing, duration and specifics of any FDA marketing approval process for any product candidates we may develop, one or more of our owned, co-owned, or in-licensed U.S. patents, if issued, may be eligible for limited patent term extension under the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent extension term of up to five&#160;years as compensation for patent term lost during clinical trials and the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of drug approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. The application for patent term extension is subject to approval by the U.S. Patent and Trademark Office, or USPTO, in conjunction with the FDA. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or otherwise failing to satisfy applicable requirements. Furthermore, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain a patent term extension for a given patent or the term of any such extension is less than we request, the period during which we will have the right to exclusively market our drug will be shortened and our competitors may obtain earlier approval of competing drugs, and our ability to generate revenues could be materially adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In China, however, laws on patent term extension, patent linkage, and data exclusivity (referred to as regulatory data protection) are still developing. Therefore, a lower-cost generic drug can emerge onto the market much more quickly. Chinese regulators have set forth a framework for integrating patent linkage and data exclusivity into the Chinese regulatory regime, as well as for establishing a pilot program for patent term extension. According to the Economic and Trade Agreement Between the Government of the United States of America and the Government of the People&#8217;s Republic of China, dated January&#160;15, 2020, the PRC government undertook to provide patent term extensions to compensate for unreasonable delays that occur in granting the patent or during pharmaceutical product marketing approvals. In October&#160;2020, the Standing Committee of the National People&#8217;s Congress, or the NPC, promulgated the newly amended PRC Patent Law, which became effective in June&#160;2021. The newly amended PRC Patent Law includes provisions for patent linkage and patent term extension. However, considering that the newly amended PRC Patent Law is relatively new, it is unclear how it will be implemented, and there exist great uncertainties with respect to its interpretation and implementation by the authorities. These factors result in weaker protection for us against generic competition in China than could be available to us in the United States. If we are unable to obtain patent term extension or the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial condition, results of operations, and prospects could be materially harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in patent law could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patent rights. Obtaining and enforcing patents in the biopharmaceutical industry involves both technological and legal complexity, and is therefore costly, time-consuming, and inherently uncertain. In addition, the United States has recently enacted and is currently implementing wide-ranging </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">patent reform legislation. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents once obtained, if any. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, the America Invents Act includes a number of significant changes that affect the way patent applications will be prosecuted and also may affect patent litigation. These include allowing third party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, inter partes review and derivation proceedings. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third party may attempt to use the USPTO procedures to invalidate our owned, co-owned, and in-licensed patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. Therefore, the America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our owned, co-owned and in-licensed patent applications and the enforcement or defense of patents issuing from those patent applications, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although we do not believe that our currently owned, co-owned, and in-licensed issued patents and any patents that may issue from our owned, co-owned, and in-licensed pending patent applications directed to our product candidates, if issued in their currently pending forms, will be found invalid based on any recent decisions by the U.S. Congress, federal courts and the USPTO, we cannot predict how their future decisions may impact the value of our patent rights. There could be similar changes in the laws of foreign jurisdictions that may impact the value of our patent rights or our other intellectual property rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to patents, we rely upon unpatented trade secrets, know-how and continuing technological innovation to develop and maintain our competitive position. We seek to protect this trade secret and confidential information, in part, by entering into non-disclosure and confidentiality agreements with parties that have access to them, such as our employees, corporate collaborators, outside scientific collaborators, sponsored researchers, CMOs, consultants, advisers and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. However, any of these parties may breach such agreements and disclose our proprietary information, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us and our competitive position would be harmed. In addition, we face the risk of cybercrime. For instance, someone could hack our information networks and gain illicit access to our proprietary information, including our trade secrets. Even if we are successful in prosecuting such claims, any remedy awarded may be insufficient to fully compensate us for the improper disclosure or misappropriation. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We also may be subject to claims that our employees, consultants, or advisers have wrongfully used or disclosed alleged trade secrets of their former employers or claims asserting ownership of what we regard as our own intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of our employees, consultants, and advisers, including our senior management, were previously employed at or contracted by other biotechnology or pharmaceutical companies, including our competitors </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or potential competitors. Some of these employees, consultants, and advisers, including members of our senior management, executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment. Although we try to ensure that our employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s former employer. We are not aware of any threatened or pending claims related to these matters or concerning the agreements with our senior management, but in the future litigation may be necessary to defend against such claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management. In addition, while we typically require our employees, consultants and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own, and furthermore, the assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, each of which may result in claims by or against us related to the ownership of such intellectual property. If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs, be a distraction to our management and scientific personnel and have a material adverse effect on our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our patent rights, trade secrets, or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of consultants or others who are involved in developing our therapeutic programs and other proprietary technologies we may develop. Litigation may be necessary to defend against these and other claims challenging inventorship or our patent rights, trade secrets or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our therapeutic programs and other proprietary technologies we may develop. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to our management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property litigation may lead to unfavorable publicity which may harm our reputation and cause the market price of our ADSs to decline, and any unfavorable outcome from such litigation could limit our research and development activities and/or our ability to commercialize our product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the course of any intellectual property litigation, there could be public announcements of the results of hearings, rulings on motions, and other interim proceedings in the litigation. If securities analysts or investors regard these announcements as negative, the perceived value of our product candidates, future drugs, programs or intellectual property could be diminished. Accordingly, the market price of our ADSs may decline. Such announcements could also harm our reputation or the market for our product candidates, which could have a material adverse effect on our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of intellectual property litigation, there can be no assurance that we would prevail, even if the case against us is weak or flawed. If third parties successfully assert their intellectual property rights against us, prohibitions against using certain technologies, or prohibitions against commercializing our product candidates, could be imposed by a court or by a settlement agreement between us and a plaintiff. In addition, if we are unsuccessful in defending against allegations that we have infringed, misappropriated or otherwise violated the patent or other intellectual property rights of others, we may be forced to pay substantial damage awards to the plaintiff. Additionally, we may be required to obtain a license from the intellectual property owner in order to continue our research and development activities or to commercialize any resulting product. It is possible that the necessary license will not be available to us on commercially acceptable terms, or at all. This may not be technically or commercially feasible, may render our products less </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">competitive, or may delay or prevent the launch of our products to the market. Any of the foregoing could limit our research and development activities, our ability to commercialize one or more product candidates, or both. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Most of our competitors are larger than we are and have substantially greater resources. They are, therefore, likely to be able to sustain the costs of complex intellectual property litigation longer than we could. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to conduct our clinical trials, continue our internal research activities, in-license needed technology in the future, or enter into strategic collaborations that would help us bring our product candidates to market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, any future intellectual property litigation, interference or other administrative proceedings will result in additional expense and distraction of our personnel. An adverse outcome in such litigation or proceedings may expose us or any future strategic partners to loss of our proprietary position, expose us to significant liabilities, or require us to seek licenses that may not be available on commercially acceptable terms, if at all, each of which could have a material adverse effect on our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, which might adversely affect our ability to develop and market our products and product candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending patent application in the United States and abroad that is relevant to or necessary for the commercialization of our current and future products and product candidates in any jurisdiction. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#8217;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending patent application may be incorrect, which may negatively impact our ability to market our products. We may incorrectly determine that our products or product candidates are not covered by a third-party patent or may incorrectly predict whether a third party&#8217;s pending patent application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, and our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our products. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Claims that our product candidates or the sale or use of our future products infringe, misappropriate or otherwise violate the patents or other intellectual property rights of third parties could result in costly litigation or could require substantial time and money to resolve, even if litigation is avoided.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot guarantee that our product candidates or the sale or use of our future products do not and will not in the future infringe, misappropriate or otherwise violate third-party patents or other intellectual property rights. Third parties might allege that we are infringing their patent rights or that we have misappropriated their trade secrets, or that we are otherwise violating their intellectual property rights, whether with respect to the manner in which we have conducted our research, or with respect to the use or manufacture of the compounds we have developed or are developing. The various markets in which we plan to operate are subject to frequent and extensive litigation regarding patents and other intellectual property rights. Some claimants may have substantially greater resources than we have and may be able to sustain the costs of complex intellectual property litigation to a greater degree and for longer periods of time than we could. Third parties might resort to litigation against us or other parties we have agreed to indemnify, which litigation could be based on either existing intellectual property or intellectual property that arises in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is also possible that we failed to identify, or may in the future fail to identify, relevant patents or patent applications held by third parties that cover our product candidates. Publication of discoveries in the scientific or patent literature often lags behind actual discoveries. Therefore, we cannot be certain that we or our licensors were the first to invent, or the first to file patent applications on, our product candidates or for their uses, or that our product candidates will not infringe patents that are currently issued or that are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">issued in the future. In the event that a third party has also filed a patent application covering one of our product candidates or a similar invention, our owned, co-owned, or in-licensed patent application may be regarded as a competing application and may not be issued in the end. Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our products or their use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a third party were to assert claims of patent infringement against us, even if we believe such third-party claims are without merit, a court of competent jurisdiction could hold that these third-party patents are valid, enforceable and infringed, and the holders of any such patents may be able to block our ability to commercialize the applicable product unless we obtained a license under the applicable patents, or until such patents expire or are finally determined to be invalid or unenforceable. Similarly, if any third-party patents were held by a court of competent jurisdiction to cover aspects of our compositions, formulations, or methods of treatment, prevention, or use, the holders of any such patents may be able to block our ability to develop and commercialize the applicable product unless we obtained a license or until such patent expires or is finally determined to be invalid or unenforceable. In addition, defending such claims would cause us to incur substantial expenses and could cause us to pay substantial damages, if we are found to be infringing a third party&#8217;s patent rights. These damages potentially include increased damages and attorneys&#8217; fees if we are found to have infringed such rights willfully. In order to avoid or settle potential claims with respect to any patent or other intellectual property rights of third parties, we may choose or be required to seek a license from a third party and be required to pay license fees or royalties or both, which could be substantial. These licenses may not be available on acceptable terms, or at all. Even if we were able to obtain a license, the rights may be nonexclusive, which could result in our competitors gaining access to the same intellectual property. Ultimately, we could be prevented from commercializing a product candidate, or be forced, by court order or otherwise, to modify or cease some or all aspects of our business operations, if, as a result of actual or threatened patent or other intellectual property claims, we are unable to enter into licenses on acceptable terms. Further, we could be found liable for significant monetary damages as a result of claims of intellectual property infringement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Defending against claims of patent infringement, misappropriation of trade secrets or other violations of intellectual property rights is likely to be costly and time-consuming, regardless of the outcome. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. Thus, even if we were to ultimately prevail, or to settle at an early stage, such litigation could burden us with substantial unanticipated losses. Any claims of infringement, misappropriation or other violation of intellectual property made against us could have a material adverse effect on our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Issued patents covering one or more of our product candidates could be found invalid or unenforceable if challenged in court.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Despite measures we take to obtain and maintain patent and other intellectual property rights with respect to our product candidates, our intellectual property rights could be challenged or invalidated. For example, if we were to initiate legal proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim that our owned, co-owned, or in-licensed patent is invalid and/or unenforceable. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, for example, lack of novelty, obviousness, non-enablement, lack of sufficient written description or obviousness-type double patenting. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, the State Intellectual Property Office, or the SIPO, or the applicable foreign counterpart, or made a misleading statement, during prosecution. Although we believe that we and our licensor have conducted our patent prosecution in accordance with a duty of candor and in good faith, the outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we could lose at least part, and perhaps all, of the patent protection on a product candidate. Even if a defendant does not prevail on a legal assertion of invalidity and/or unenforceability, our owned, co-owned, or in-licensed patent claims may be construed in a manner that would limit our ability to enforce such claims against the defendant and others. Even if we establish infringement, the court may decide not to grant an injunction against further </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">infringing activity and instead award only monetary damages, which may not be an adequate remedy. In addition, if the breadth or strength of protection provided by our owned, co-owned, or in-licensed patents is threatened, it could dissuade companies from collaborating with us to license, develop, or commercialize our current or future product candidates. Any loss of patent protection could have a material adverse impact on one or more of our product candidates and our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not be successful in obtaining or maintaining necessary rights for our development pipeline through acquisitions and in-licenses.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because the development of certain of our product candidates may in the future involve the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire and maintain licenses or other rights to use these proprietary rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may be unable to acquire or in-license any compositions, methods of use, or other intellectual property rights from third parties that we identify. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies are also pursuing strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon development of the relevant product candidate, which could have a material adverse effect on our business, financial condition, results of operations and prospects for growth. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our competitive position may be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we had one registered trademark in the United States, one registered trademark in EU, two registered trademarks in China, one registered trademark in Hong Kong, and one registered trademark in Japan, and one trademark application pending in Canada. We may not be able to obtain trademark protection in territories that we consider of significant importance to us. In addition, any of our trademarks or trade names, whether registered or unregistered, may be challenged, opposed, infringed, cancelled, circumvented or declared generic, or determined to be infringing on other marks, as applicable. We may not be able to protect our rights to these trademarks and trade names, which we will need to build name recognition by potential collaborators or customers in our markets of interest. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively, and our business may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property rights do not necessarily protect us from all potential threats to our competitive advantage. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business, or permit us to maintain our competitive advantage. The following examples are illustrative: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">others may be able to make compounds that are similar to our product candidates but that are not covered by the claims of the patents that we own, co-own or exclusively license; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we or our licensors or collaborators might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own, co-own or exclusively license, which could result in the patents applied for not being issued or being invalidated after issuing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we or our licensors or collaborators might not have been the first to file patent applications covering certain of our inventions, which could result in the patents applied for not being issued or being invalidated after issuing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">it is possible that the pending and future patent applications that we own, co-own, or in-license will not lead to issued patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">issued patents that we own, co-own or in-license may not provide us with any competitive advantages, or may be held invalid or unenforceable, as a result of legal challenges by our competitors or other third parties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we or our licensors may obtain patents for certain compounds many&#160;years before we receive regulatory approval for drugs containing such compounds, and because patents have a limited life, which may begin to run out prior to the commercial sale of the related drugs, the commercial value of our patents may be limited; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive drugs for commercialization in our major markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we may fail to develop additional proprietary technologies that are patentable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we may fail to apply for or obtain adequate intellectual property protection in all the jurisdictions in which we operate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">third parties may gain unauthorized access to our intellectual property due to potential lapses in our information systems; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the patents of others may have an adverse effect on our business, for example by preventing us from commercializing one or more of our product candidates for one or more indications. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any of the aforementioned threats to our competitive advantage could have a material adverse effect on our business and future prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Our Industry, Business and Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to implement and maintain an effective system of internal controls, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence and the market price of our ADSs may be materially and adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to this offering, we have been a private company with limited accounting and financial reporting personnel and other resources with which to address our internal controls and procedures. Our independent registered public accounting firm has not conducted an audit of our internal control over financial reporting. However, in connection with the audit of our consolidated financial statements for the year ended December&#160;31, 2021, we and our independent registered public accounting firm identified one material weakness in our internal control over financial reporting as well as other control deficiencies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As defined in the standards established by the United States Public Company Accounting Oversight Board of the United States (PCAOB), a &#8220;material weakness&#8221; is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness identified is related to our lack of formal policies and procedures to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">establish risk assessment process and internal control framework. We are currently in the process of implementing a number of measures to address the material weakness and deficiency that has been identified. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8201;&#8212;&#8201;Internal Control Over Financial Reporting.&#8221; However, we cannot assure you that these measures may fully address the material weakness and deficiency in our internal control over financial reporting or that we may conclude that they have been fully remediated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, it is possible that, had our independent registered public accounting firm conducted an audit of our internal control over financial reporting, such accountant might have identified additional material weaknesses and deficiencies. Upon completion of this offering, we will become a public company in the United States subject to the Sarbanes-Oxley Act of 2002. Section&#160;404 of the Sarbanes-Oxley Act requires that we include a report from management on the effectiveness of our internal control over financial reporting in our annual report on Form 20-F upon expiration of the statutory transition period. In addition, once we cease to be an &#8220;emerging growth company&#8221; as such term is defined in the JOBS Act, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Our management may conclude that our internal control over financial reporting is not effective. Moreover, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue a report that is qualified if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we become a public company, our reporting obligations may place a significant strain on our management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the course of documenting and testing our internal control procedures, in order to satisfy the requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, we may identify other weaknesses and deficiencies in our internal control over financial reporting. In addition, if we fail to maintain the adequacy of our internal control over financial reporting, as these standards are modified, supplemented or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section&#160;404 of the Sarbanes-Oxley Act of 2002. We may not be able to anticipate and identify accounting issues, or other risks critical to financial reporting that could materially impact the consolidated financial statements. Generally, if we fail to achieve and maintain an effective internal control environment, we could suffer material misstatements in our financial statements and fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial information. This could in turn limit our access to capital markets, harm our results of operations and lead to a decline in the trading price of our shares. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions. We may also be required to restate our financial statements from prior periods. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our future success depends on our ability to attract, retain and motivate senior management and qualified scientific employees.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are highly dependent on the expertise of the members of our research and development team, as well as the principal members of our management. We have entered into employment agreements with our executive officers, but each of them may terminate their employment with us at any time with or without prior written notice. In addition, we currently do not have &#8220;key-man&#8221; insurance for any of our executive officers or other key personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Recruiting, retaining and motivating qualified management, scientific, clinical, manufacturing and sales and marketing personnel will also be critical to our success. The loss of the services of our executive officers or other key employees could impede the achievement of our research, development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Further, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of and commercialize drugs. Competition to hire </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous biopharmaceutical companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, our management will be required to devote significant time to new compliance initiatives from our status as a public company, which may require us to recruit more management personnel. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Competition for skilled personnel is intense, particularly in the biotechnology industry. We face competition for personnel from other companies, universities, public and private research institutions and other organizations. This competition may limit our ability to hire and retain highly qualified personnel on acceptable terms, or at all. We may not be able to attract and retain these personnel on acceptable terms given the competition among numerous biotechnology companies for similar personnel. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed or may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we do not achieve our projected development and commercialization goals in the timeframes we announce and expect, the commercialization of any of our product candidates may be delayed, and our business will be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For planning purposes, we sometimes estimate the timing of the accomplishment of various scientific, clinical, regulatory and other product development objectives. These milestones may include our expectations regarding the commencement or completion of scientific studies and clinical trials, the regulatory submissions or commercialization objectives. From time to time, we may publicly announce the expected timing of some of these milestones, such as the completion of an ongoing clinical trial, the initiation of other clinical trials, receipt of regulatory approval or the commercial launch of a product. The achievement of many of these milestones may be outside of our control. All of these milestones are based on a variety of assumptions which may cause the timing of achievement of the milestones to vary considerably from our estimates, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our available capital resources or capital constraints we experience; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rate of progress, costs and results of our clinical trials and research and development activities, including the extent of scheduling conflicts with participating clinicians and collaborators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to identify and enroll patients who meet clinical trial eligibility criteria; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our receipt of approvals by the FDA, the TGA, the NMPA, the EMA and comparable regulatory authorities in other jurisdictions, and the timing thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">other actions, decisions or rules issued by regulators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to access sufficient, reliable and affordable supplies of materials used in the manufacture of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to manufacture and supply clinical trial materials to our clinical sites on a timely basis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the efforts of our collaborators with respect to the commercialization of our products; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the securing of, costs related to, and timing issues associated with, commercial product manufacturing as well as sales and marketing activities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we fail to achieve announced milestones in the timeframes we expect, the commercialization of any of our product candidates may be delayed, and our business, results of operations, financial condition and prospects may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our employees, independent contractors, consultants, collaborators and contract research organizations may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements, which could cause significant liability for us and harm our reputation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are exposed to the risk that our employees, independent contractors, consultants, collaborators and contract research organizations may engage in fraud or other misconduct, including intentional failures to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">comply with FDA regulations or similar regulations of comparable non-U.S. regulatory authorities, to provide accurate information to the FDA or comparable non-U.S. regulatory authorities, to comply with manufacturing standards we have established, to comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable non-U.S. regulatory authorities, to report financial information or data accurately or to disclose unauthorized activities to us. Such misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant fines or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We will likely need to increase the size and capabilities of our organization, and we may experience difficulties in managing our growth.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to execute our business plans, we expect that we will need to significantly increase the number of our employees and consultants and the scope of our operations, particularly in the areas of research and development, regulatory affairs and business development. We currently rely on some of the employees of our ultimate controlling shareholder to administer and supervise some of the clinical operations of our Company. See &#8220;Related Party Transactions&#8201;&#8212;&#8201;Other Transactions with Related Parties.&#8221; Our future financial performance and our ability to commercialize our product candidates and to compete effectively will depend, in part, on our ability to manage any future growth effectively. To manage our anticipated future growth, we will need to continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to our limited financial resources, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations and have a material adverse effect on our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we currently rely, and for the foreseeable future will continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services. There can be no assurance that the services of these independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed or that we can find qualified replacements. Furthermore, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval of our product candidates or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, if at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not achieve our research, development and commercialization goals. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have limited insurance coverage, and any claims beyond our insurance coverage may result in our incurring substantial costs and a diversion of resources.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We maintain insurance policies that are required under applicable laws and regulations as well as insurance based on our assessment of our operational needs and industry practice. We also maintain liability insurance covering our clinical trials as well as certain other types of insurance. Our insurance coverage may be insufficient to cover any claim for product liability, damage to our fixed assets or employee injuries. Any liability or damage to, or caused by, our facilities or our personnel beyond our insurance coverage may result in our incurring substantial costs and a diversion of resources. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also expect that operating as a public company will make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified people to serve on our board of directors, our board committees or as executive officers. We do not know, however, if we will be able to maintain existing insurance with adequate levels of coverage. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our cash position and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disruptions in the financial markets and economic conditions could affect our ability to raise capital.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Global economies could suffer dramatic downturns as the result of a deterioration in the credit markets and related financial crisis as well as a variety of other factors including, extreme volatility in security prices, severely diminished liquidity and credit availability, ratings downgrades of certain investments and declining valuations of others. In the past, governments have taken unprecedented actions in an attempt to address and rectify these extreme market and economic conditions by providing liquidity and stability to the financial markets. If these actions are not successful, the return of adverse economic conditions may cause a significant impact on our ability to raise capital, if needed, on a timely basis and on acceptable terms or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, there is considerable uncertainty over the long-term effects of the expansionary monetary and fiscal policies adopted by the central banks and financial authorities of some of the world&#8217;s leading economies, including the United States and China. There have been concerns over unrest and terrorist threats in the Middle East, Europe and Africa and over the conflicts involving Ukraine, Syria and North Korea. There have also been concerns relating to trade disputes between the United States and China and regarding the relationship among China and other Asian countries, which may result in or intensify potential conflicts in relation to territorial disputes among such countries. In addition, the United Kingdom held a referendum on June&#160;23, 2016 on its membership in the European Union, in which a majority of voters in the United Kingdom voted to exit the European Union (commonly referred to as &#8220;Brexit&#8221;). Brexit could adversely affect European and worldwide economic and market conditions and could contribute to instability in global financial and foreign exchange markets. More recently, the occurrence of the COVID-19 pandemic has caused volatility in the global financial markets and threatened a slowdown in the global economy. For a detailed discussion regarding the potential impact of the COVID-19 pandemic, see &#8220;&#8212; Risks Related to Our Industry, Business and Operations&#8201;&#8212;&#8201;Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses&#8221; below. It is unclear whether these challenges and uncertainties and the issues arising from the COVID-19 pandemic will be contained or resolved, and what effects they may ultimately have on the global political and economic conditions in the long term. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure to renew our current leases or locate desirable alternatives for our leased properties could materially and adversely affect our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We lease properties for our offices and laboratories. See &#8220;Business&#8201;&#8212;&#8201;Facilities&#8221; for more details of our leased properties. We may not be able to successfully extend or renew such leases upon expiration of the current term on commercially reasonable terms or at all, and may therefore be forced to relocate our affected operations. This could disrupt our operations and result in significant relocation expenses, which could adversely affect our business, financial condition and results of operations. In addition, we compete with other businesses for premises at certain locations or of desirable sizes. As a result, even though we could extend or renew our leases, rental payments may significantly increase as a result of the high demand for the leased properties. In addition, we may not be able to locate desirable alternative sites for our current leased properties as our business continues to grow and failure in relocating our affected operations could adversely affect our business and operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although we have policies and procedures designed to ensure that we, our employees and our agents comply with the Trade Laws, there is no assurance that such policies or procedures will prevent our agents, employees and intermediaries from engaging in bribery activities. Failure to comply with the Trade Laws could disrupt our business and lead to severe criminal and civil penalties, including imprisonment, criminal and civil fines, loss of our export licenses, suspension of our ability to do business with the government, denial of government reimbursement for our products and/or exclusion from participation in government </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">healthcare programs, as well as reputational harm. Other remedial measures could include further changes or enhancements to our procedures, policies, and controls and potential personnel changes and/or disciplinary actions, any of which could have a material adverse effect on our business, financial condition, results of operations and liquidity. We could also be adversely affected by any allegation that we violated such laws. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we engage in future acquisitions or strategic collaborations, this may increase our capital requirements, dilute the value of your investment in our ADSs, cause us to incur debt or assume contingent liabilities, and subject us to other risks.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may evaluate various acquisitions and strategic collaborations, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. Any potential acquisition or strategic collaboration may entail numerous risks, including, but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">increased operating expenses and working capital and cash requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the assumption of additional indebtedness or contingent liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">challenges with assimilation of operations, intellectual property and products of an acquired company, including difficulties associated with integrating new personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the diversion of our management&#8217;s attention from our existing product candidates and initiatives in pursuing such a strategic merger or acquisition; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the loss of key personnel, and uncertainties in our ability to maintain key business relationships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">material weakness arising in our internal control over financial reporting because of a weaknesses in the acquired company&#8217;s financial systems and controls; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">changes in accounting principles relating to recognition and measurement of our investments that may have a significant impact on our financial results. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if we undertake acquisitions, we may issue dilutive securities, assume or incur debt obligations, incur large one-time expenses and acquire intangible assets that could result in significant future amortization expense. Moreover, we may not be able to locate suitable acquisition opportunities and this inability could impair our ability to grow or obtain access to technology or products that may be important to the development of our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The tax laws of the jurisdictions in which we operate may adversely affect our business and our tax results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The tax laws applicable to our business activities are subject to change and uncertain interpretation. Our tax position could be adversely impacted by changes in tax rates, laws, practices, treaties or regulations or changes in the interpretation thereof by the authorities in jurisdictions in which we do business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, we conduct operations through our subsidiaries in various tax jurisdictions pursuant to transfer pricing arrangements between us and our subsidiaries. While we believe that we operate in compliance with applicable transfer pricing laws and intend to continue to do so, our transfer pricing procedures are not binding on applicable tax authorities. If tax authorities in any jurisdiction in which we operate were to successfully challenge our transfer prices as not reflecting arms&#8217; length transactions, they could require us to adjust our transfer prices and thereby reallocate our income to reflect these revised transfer prices, which could result in a higher tax liability to us. Furthermore, a tax authority could assert that we are subject to tax in a jurisdiction where we believe we have not established a taxable connection, and such an assertion, if successful, could increase our expected tax liability in one or more jurisdictions. Such circumstances could adversely affect our financial condition, results of operations and cash flows. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we, our CROs or our other contractors or consultants fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and third parties, such as our CROs or other contractors or consultants, are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations may involve the use of hazardous and flammable materials, including chemicals and radioactive and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we may be required to incur substantial costs to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our internal computer systems, or those used by our CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our development of our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Despite the implementation of security measures, our internal information technology systems and those of our collaborators, contractors and consultants are vulnerable to damage from internal or external events, such as computer viruses, unauthorized access, natural disasters, terrorism, war, and telecommunication and electrical failures, which compromise the confidentiality, integrity and availability of the systems. Although to our knowledge we have not experienced any material system failure or security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we partially rely on our third-party research institution collaborators for research and development of our product candidates and other third parties for the manufacture of our product candidates and to conduct clinical trials, and similar events relating to their computer systems could also have a material adverse effect on our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the ordinary course of our business, we collect and store sensitive data, including, among other things, personally identifiable information about our employees, intellectual property, and proprietary business information. Additionally, our CROs will collect and store sensitive data, such as legally protected patient health information, when conducting our clinical trials. We manage and maintain our applications and data utilizing on-site systems and outsourced vendors. These applications and data encompass a wide variety of business-critical information including research and development information, commercial information and business and financial information. Because information systems, networks and other technologies are critical to many of our operating activities, shutdowns or service disruptions at our Company or vendors that provide information systems, networks, or other services to us pose increasing risks. Such disruptions may be caused by events such as computer hacking, phishing attacks, ransomware, dissemination of computer viruses, worms and other destructive or disruptive software, denial of service attacks and other malicious activity, as well as power outages, natural disasters (including extreme weather), terrorist attacks or other similar events. Such events could cause loss of data, damage to system and data and leave us unable to utilize key business systems or access important data needed to operate our business, including conducting research and development, gaining regulatory approval for our product candidates or manufacturing and selling our products. Our collaborators, contractors or consultants may face similar risks, and service disruptions or security breaches of their systems could adversely affect our security, leave us without access to important systems, products, raw materials, components, services or information or expose our confidential data. In addition, system redundancy may be ineffective or inadequate, and our disaster recovery planning may not be sufficient to cover all eventualities. Significant events could result in a disruption of our operations, damage to our reputation or a loss of revenues. In addition, we may not have adequate insurance coverage to compensate for any losses associated with such events. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We could be subject to risks caused by misappropriation, misuse, leakage, falsification or intentional or accidental release or loss of information maintained in the information systems and networks of our Company and our vendors, including personal information of our employees and patients, and company and vendor confidential data. In addition, outside parties may attempt to penetrate our systems or those of our vendors or fraudulently induce our personnel or the personnel of our vendors to disclose sensitive </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">information in order to gain access to our data and/or systems. Like other companies, we may experience, threats to our data and systems, including malicious codes and viruses, phishing, business email compromise attacks, or other cyber-attacks. The number and complexity of these threats may increase over time. If a material breach of our information technology systems or those of our vendors occurs, the market perception of the effectiveness of our security measures could be harmed and our reputation and credibility could be damaged. We could be required to expend significant amounts of money and other resources to respond to these threats or breaches and to repair or replace information systems or networks and could suffer financial loss or the loss of valuable confidential information. In addition, we could be subject to regulatory actions and/or claims made by individuals and groups in private litigation involving privacy issues related to data collection and use practices and other data privacy laws and regulations, including claims for misuse or inappropriate disclosure of data, as well as unfair or deceptive practices. We are taking measures and plan to continue to take measures to develop and maintain systems and controls designed to prevent, identify and mitigate these events from occurring. The development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. As we outsource more of our information systems to vendors, engage in more electronic transactions with payors and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and information systems. In addition, there can be no assurance that our internal information technology systems or those of our collaborators, contractors, or our consultants&#8217; efforts to implement adequate security and control measures, will be sufficient to protect us against breakdowns, service disruption, data deterioration or loss in the event of a system malfunction, or prevent data from being stolen or corrupted in the event of a cyberattack, security breach, industrial espionage attacks or insider threat attacks that could adversely affect our business and operations and/or result in the loss or exposure of critical, proprietary, private, confidential or otherwise sensitive data, which could result in financial, legal, business or reputational harm to us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure to comply with existing or future laws and regulations related to privacy or data security could lead to government enforcement actions, which could include civil or criminal fines or penalties, private litigation, other liabilities, and/or adverse publicity. Compliance or the failure to comply with such laws could increase the costs of our products, could limit their use or adoption, and could otherwise negatively affect our operating results and business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The regulatory framework for the collection, use, safeguarding, sharing, transfer and other processing of personal information worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. Regulatory authorities in virtually every jurisdiction in which we operate have implemented and are considering a number of legislative and regulatory proposals concerning personal data protection. Additionally, the interpretation and application of data protection laws in jurisdictions applicable to us are often uncertain and in flux. We therefore face uncertainty as to the exact interpretation of any such requirements, and we may be unsuccessful in implementing all measures required by data protection authorities or courts in interpretation of new laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, we are subject to laws and regulations that address privacy, personal information protection and data security at both the federal and state levels, including federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the Health Information Technology and Clinical Health Act, and its implementing regulations, which imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information. Numerous laws and regulations, including security breach notification laws, health information privacy laws, and consumer protection laws, govern the collection, use, disclosure and protection of health-related and other personal information. Given the variability and evolving state of these laws, we face uncertainty as to the exact interpretation of the new requirements, and we may be unsuccessful in implementing all measures required by regulators or courts in their interpretation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Regulatory authorities in Europe have implemented and are considering a number of legislative and regulatory proposals concerning data protection. For example, the General Data Protection Regulation (EU) 2016/ 679, or the GDPR, which became effective in May&#160;2018, imposes a broad range of strict requirements on companies subject to the GDPR, such as us, including, but not limited to, requirements </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">relating to having legal bases for processing personal information relating to identifiable individuals and transferring such information outside the European Economic Area (including to the United States), providing details to those individuals regarding the processing of their personal information, keeping personal information secure, having data processing agreements with third parties who process personal information, responding to individuals&#8217; requests to exercise their rights in respect of their personal information, reporting security breaches involving personal data to the competent national data protection authority and affected individuals and recordkeeping. The GDPR substantially increases the penalties to which we could be subject in the event of any non-compliance, including fines of up to &euro;10.0&#160;million or up to 2% of our total worldwide annual turnover for certain comparatively minor offenses, or up to &euro;20.0&#160;million or up to 4% of our total worldwide annual turnover for more serious offenses. Given the new law, we face uncertainty as to the exact interpretation of the new requirements, and we may be unsuccessful in implementing all measures required by data protection authorities or courts in interpretation of the new law. National laws of member states of the European Union are in the process of being adapted to the requirements under the GDPR. Because the GDPR specifically gives member states flexibility with respect to certain matters, national laws may partially deviate from the GDPR and impose different obligations from country to country, leading to additional complexity and uncertainty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect that we will continue to face uncertainty as to whether our efforts to comply with evolving obligations under global data protection, privacy and security laws will be sufficient. Any failure or perceived failure by us to comply with applicable laws and regulations could result in reputational damage or proceedings or actions against us by governmental entities, individuals or others. These proceedings or actions could subject us to significant civil or criminal penalties, damages, injunctive relief and negative publicity, result in the delayed or halted transfer or confiscation of certain personal information, require us to change our business practices, increase our costs and otherwise materially harm our business, prospects, financial condition and results of operations. In addition, our current and future relationships with customers, vendors, pharmaceutical collaborators and other third parties could be negatively affected by any proceedings or actions against us or current or future data protection obligations imposed on them under applicable law. In addition, to the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur significant legal and financial exposure and reputational damage that could potentially have an adverse effect on the development of our product candidates and our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Natural disasters, acts of war or terrorism or other factors beyond our control may adversely affect the economy, infrastructure and livelihood of the people in the regions where we conduct our business or whether our studies are conducted. Our operations may be under the threat of floods, earthquakes, sandstorms, snowstorms, fire or drought, power, water or fuel shortages, failures, malfunction and breakdown of information management systems, unexpected maintenance or technical problems, or may be susceptible to potential wars or terrorist attacks, or public health threats and epidemics, including the global health concerns relating to the COVID-19 pandemic. Serious natural disasters may result in loss of lives, injury, destruction of assets and disruption of our business and operations. Acts of war or terrorism, or public health threats, may also injure our employees, cause loss of lives, disrupt our business network and destroy our markets. Any of these factors and other factors beyond our control could have an adverse effect on the overall business sentiment and environment, cause uncertainties in the regions where we conduct business, cause our business to suffer in ways that we cannot predict and materially and adversely impact our business, financial conditions and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, in March&#160;2020, the WHO categorized COVID-19 as a pandemic. COVID-19 continues to spread throughout the United States and other countries across the world, and the duration and severity of its effects are currently unknown. The spread of COVID-19 has impacted the global economy and has had an impact on our operations, including delays in our clinical trial activities. COVID-19 has resulted in significant governmental measures being implemented to control the spread of the virus, including quarantines, travel restrictions, social distancing and business shutdowns. We have taken precautionary measures intended to help minimize the risk of the virus to our employees, including temporarily requiring many employees to work remotely. For example, we have suspended non-essential travel worldwide for our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">employees. Although we believe that COVID-19 has had a limited impact on our operations as of the date of this prospectus, we have experienced delays in the enrollment of patients in our clinical trials. For example, we have experienced a few months&#8217; delay in commencement of patient enrollment in Australia that was caused by COVID-19, which was not material to the Company. Our clinical trials could be further delayed due to government orders and site policies on account of the pandemic. Some patients may be unwilling or unable to travel to study sites, enroll in our studies or comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services, which would delay our ability to conduct clinical trials or release clinical trial results and could delay our ability to obtain regulatory approval and commercialize our product candidates. The spread of an infectious disease, including COVID-19, may also result in the inability of our suppliers to source or deliver components or raw materials necessary for our clinical supply on a timely basis or at all. In addition, hospitals may reduce staffing and reduce or postpone certain treatments in response to the spread of an infectious disease. Such events may result in a period of business disruption and in reduced operations or doctors and medical providers may be unwilling to participate in our clinical trials, any of which could materially affect our business, financial condition and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, as a result of the COVID-19 public health emergency, we may be required to develop and implement additional clinical trial policies and procedures based on new guidance and regulatory requirements promulgated by the FDA or other regulatory authorities. For example, the FDA issued guidance in March&#160;2020, which the FDA subsequently updated, on conducting clinical trials during the pandemic, which describe a number of considerations for sponsors of clinical trials impacted by the pandemic. In June&#160;2020, the FDA also issued a guidance on good manufacturing practice considerations for responding to COVID-19 infection in employees in drug products manufacturing, including recommendations for manufacturing controls to prevent contamination of drugs. Additional COVID-19 related guidance released by the FDA includes guidance addressing resuming normal drug and biologics manufacturing operations; manufacturing, supply chain, and inspections; and statistical considerations for clinical trials during the COVID-19 public health emergency. Further, infections and deaths related to COVID-19 are disrupting certain healthcare and healthcare regulatory systems globally. Such disruptions could divert healthcare resources away from, or materially delay review by, the FDA and comparable foreign regulatory agencies. It is unknown how long these disruptions could continue, were they to occur. Any elongation or de-prioritization of our clinical trials or delay in regulatory review resulting from such disruptions could materially adversely affect the development and study of our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We continue to assess the impact that the COVID-19 pandemic may have on our ability to advance the testing, development and manufacturing of our product candidates, including as a result of adverse impacts on the research sites, service providers, vendors, or suppliers on whom we rely, or to raise financing to support the development of our product candidates. Additionally, temporarily requiring all employees to work remotely may induce absenteeism, disrupt our operations, increase the risk of a cybersecurity incident, create data accessibility concerns and make us more susceptible to communication disruptions. The COVID-19 pandemic has also caused volatility in the global financial markets and threatened a slowdown in the global economy, which may negatively affect our ability to raise additional capital on attractive terms or at all. No assurances can be given that this analysis will enable us to avoid part or all of any impact from the spread of COVID-19 or its consequences, including downturns in business sentiment generally or in our sector in particular. We cannot presently predict the scope and severity of any potential business shutdowns or disruptions, particularly in the event the current situation worsens, for example, with second or third waves of the pandemic, but if we or any of the third parties on whom we rely or with whom we conduct business, were to experience shutdowns or other business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and adversely impacted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The extent to which the COVID-19 pandemic or other epidemics or pandemics may impact our business will depend on future developments, which are highly uncertain and cannot be predicted, such as the duration of the pandemic, the severity of the COVID-19 pandemic or the effectiveness of actions to contain and treat the COVID-19 pandemic, particularly in the United States and other geographies where we or our third party suppliers, clinical trial sites, CROs and CMOs operate. We cannot presently predict the scope and severity of any potential business shutdowns or disruptions. If we or any of the third parties with whom we engage, however, were to experience shutdowns or other business disruptions, our ability to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, which could have a material adverse impact on our business, our results of operations and financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are subject to changing law and regulations regarding regulatory matters, corporate governance and public disclosure that have increased both our costs and the risk of non-compliance.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are or will be subject to rules and regulations by various governing bodies, including, for example, once we become a public company, the U.S. Securities and Exchange Commission, or the SEC, which is charged with the protection of investors and the oversight of companies whose securities are publicly traded, and the various regulatory authorities in the Cayman Islands, Taiwan, the PRC and Australia, and to new and evolving regulatory measures under applicable law. Our efforts to comply with new and changing laws and regulations have resulted in and are likely to continue to result in, increased general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities. Further, there could be unanticipated changes in existing regulatory requirements. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenues from our product candidates. If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our Company and our operating results will be adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, because these laws, regulations and standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may be subject to penalty and our business may be harmed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have granted, and will continue to grant, options and other types of awards under our equity incentive plans, which may result in increased share-based compensation expenses and dilution to our existing shareholders and holders of our ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have adopted the Belite Bio, Inc Amended and Restated Share Incentive Plan, or the 2020 Share Incentive Plan, and the 2022 Performance Incentive Plan for the purpose of granting share-based compensation awards to employees, directors and consultants to incentivize their performance and align their interests with ours. The 2022 Performance Incentive Plan is expected to become effective upon the completion of this offering. As of the date of this prospectus, options to purchase a total of 1,982,561 ordinary shares have been granted and are outstanding under the 2020 Share Incentive Plan. As of the date of this prospectus, no award has been granted or is outstanding under the 2022 Performance Incentive Plan. See &#8220;Management&#8201;&#8212;&#8201;Share Incentive Plans.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe the granting of share-based compensation is of significant importance to our ability to attract and retain key personnel and employees, and we will continue to grant share-based compensation to employees in the future. As a result, our expenses associated with share-based compensation may increase, which may have an adverse effect on our results of operations. Furthermore, the granting of share-based compensation will lead to dilution of our existing shareholders, including any holders of our ADSs. We may re-evaluate the vesting schedules, lock-up period, exercise price or other key terms applicable to the grants under our currently effective equity incentive plans from time to time. If we choose to do so, we may experience substantial change in our share-based compensation charges in the reporting periods following this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to comply with certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions and other trade laws and regulations, we could be subject to serious consequences and significant expenses that could have a material adverse effect on our business, financial condition and results of operations, and our reputation may be harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Among other matters, U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions and other trade laws and regulations, collectively, Trade Laws, prohibit companies and their employees, agents, clinical research organizations, legal counsel, accountants, consultants, contractors and other partners from authorizing, promising, offering, providing, soliciting or receiving, directly or indirectly, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">corrupt or improper payments or anything else of value to or from recipients in the public or private sector. In particular, the FCPA generally prohibits us from making payments to non-U.S. officials for the purpose of obtaining or retaining business. We are also subject to the anti-bribery and corruption laws of other jurisdictions. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities and other organizations. We also have significant non-U.S. activities that we expect to increase in time. We plan to engage third parties for clinical trials and/or to obtain necessary permits, licenses, patent registrations and other regulatory approvals and we can be held liable for the corrupt or other illegal activities of our personnel, agents or partners, even if we do not explicitly authorize or have prior knowledge of such activities. Additionally, in many other countries, the healthcare providers who prescribe pharmaceuticals are employed by their government, and the purchasers of pharmaceuticals are government entities; therefore, our dealings with these prescribers and purchasers are subject to regulation under the Trade Laws.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business may be exposed to foreign exchange risks.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We operate internationally and conduct clinical trials in multiple jurisdictions and thus we have expenses denominated in local currencies in multiple jurisdictions in connection with, among other things, our sponsored clinical trials, purchase of drug product for our clinical trials, process development and the prosecution and maintenance of our intellectual property portfolio. As a result, we are exposed to foreign currency exchange risk, as our results of operations and cash flows are subject to fluctuations in foreign currency exchange rates. In accordance with our business decisions, our exposure to this type of risk could change depending on:</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the currencies chosen when agreements are signed, such as licensing agreements, or co-marketing or co-development agreements;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the location of clinical trials on product candidates; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our policy for insurance coverage.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Should any of these risks materialize, this could have a material adverse effect on our business, prospects, financial condition and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in the political and economic policies of the Chinese government or in relations between China and the United States may materially and adversely affect our business, financial condition, results of operations and the market price of our ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently have no operations in China although we have established a subsidiary in each of Hong Kong and China. However, we may in the future elect to conduct clinical trials for our product candidates in China or expand our operations into China (see &#8220;Business&#8221; beginning on page <a href="#tBUS">112</a> for our current plans for future clinical trials), and therefore our financial condition and results of operations may be affected by economic, political and legal developments in China. The PRC economy differs from the economies of most developed countries in many respects, including the extent of government involvement, level of development, growth rate, control of foreign exchange and allocation of resources. Although the PRC government has implemented measures emphasizing the utilization of market forces for economic reform, the reduction of state ownership of productive assets, and the establishment of improved corporate governance in business enterprises, a substantial portion of productive assets in China is still owned by the government. In addition, the PRC government continues to play a significant role in regulating industrial development by imposing industrial policies, and change of enforcement practice of such rules and policies can occur quickly with little advance notice. The PRC government also exercises significant control over China&#8217;s economic growth by allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary policy, regulating financial services and institutions and providing preferential treatment to particular industries or companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the PRC economy has experienced significant growth in the past four decades, growth has been uneven, both geographically and among various sectors of the economy. The PRC government has implemented various measures to encourage economic growth and guide the allocation of resources. Some of these measures may benefit the overall PRC economy, but may also have a negative effect on us. Our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">business, financial condition and results of operations could be materially and adversely affected by government control over capital investments or changes in tax regulations that are applicable to us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the PRC government had, in the past, implemented certain measures, including interest rate increases, to control the pace of economic growth. These measures may cause decreased economic activity in China, which may adversely affect our business and results of operations. More generally, if the business environment in China deteriorates from the perspective of domestic or international investment, our business in China may also be adversely affected. In July&#160;2021, the Chinese government provided new guidance on strengthening supervision on China-based companies raising capital outside of China. In addition, the Chinese government further issued certain drafts of regulations regarding internet data security which require certain China-based data processors to conduct a cyber security review before their overseas listing. In light of such developments, the SEC has imposed enhanced disclosure requirements on China-based companies seeking to register securities with the SEC. Although we believe we are not regarded as such data processors currently, as we expect to expand our operations in China (see &#8220;Business&#8221; beginning on page <a href="#tBUS">112</a> for our current plans for future clinical trials), any future Chinese, U.S. or other rules and regulations that place restrictions on capital raising or other activities by companies with extensive operations in China could adversely affect our business and results of operations. If the business environment in China deteriorates from the perspective of domestic or international investment, or if relations between China and the United States or other governments deteriorate, the Chinese government may intervene with our operations and our business in China and United States, as well as the market price of our ADSs, may also be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in U.S. and Chinese regulations may adversely impact our business, our operating results, our ability to raise capital and the market price of our ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The U.S. government has made statements and taken certain actions that led to changes to United States and international relations, and will impact companies with connections to the United States or China, including imposing several rounds of tariffs affecting certain products manufactured in China, imposing certain sanctions and restrictions in relation to China and issuing statements indicating enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new legislation, executive orders, tariffs, laws or regulations will be adopted, or the effect that any such actions would have on companies with significant connections to the United States or to China, our industry or on us. We conduct clinical activities and have business operations both in the United States and China. Any unfavorable government policies on cross-border relations and/or international trade, including increased scrutiny on companies with significant China-based operations, capital controls or tariffs, may affect the competitive position of our drug products, the hiring of scientists and other research and development personnel, the demand for our drug products, the import or export of raw materials in relation to drug development, our ability to raise capital, the market price of our ADSs or prevent us from selling our drug products in certain countries. Furthermore, the SEC has issued statements primarily focused on companies with significant China-based operations. For example, on July&#160;30, 2021, Gary Gensler, Chairman of the SEC, issued a Statement on Investor Protection Related to Recent Developments in China, pursuant to which Chairman Gensler stated that he has asked the SEC staff to engage in targeted additional reviews of filings for companies with significant China-based operations. The statement also addressed risks inherent in companies with variable interest entities (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">VIEs</font><font style="letter-spacing:0.2pt;">&#8221;) structures. We do not have a VIE structure and are not in a restricted foreign investment industry. However, it is possible that the Company&#8217;s periodic reports and other filings with the SEC may be subject to enhanced review by the SEC and this additional scrutiny could affect our ability to effectively raise capital in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In response to the SEC&#8217;s July&#160;30, 2021 statement, the China Securities Regulatory Commission (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CSRC</font><font style="letter-spacing:0.2pt;">&#8221;) announced on August&#160;1, 2021, that &#8220;it is our belief that Chinese and U.S. regulators shall continue to enhance communication with the principle of mutual respect and cooperation, and properly address the issues related to the supervision of China-based companies listed in the U.S.so as to form stable policy expectations and create benign rules framework for the market.&#8221; While the CSRC will continue to collaborate &#8220;closely with different stakeholders including investors, companies, and relevant authorities to further promote transparency and certainty of policies and implementing measures,&#8221; it emphasized that it &#8220;has always been open to companies&#8217; choices to list their securities on international or domestic markets in compliance with relevant laws and regulations.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any new legislation, executive orders, tariffs, laws and/or regulations are implemented, if existing trade agreements are renegotiated, if the U.S. or Chinese governments take retaliatory actions due to the recent U.S.-China tension or if the Chinese government exerts more oversight and control over securities offerings that are conducted in the United States, such changes could have an adverse effect on our business, financial condition and results of operations, our ability to raise capital and the market price of our ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We currently have no operations in China although we have established a subsidiary in each of Hong Kong and China. However, due to the extraterritorial reach (the so-called &#8220;long arm provisions&#8221;) under the current PRC laws and regulations, the Chinese government may intervene in or influence our operations at any time, which could result in a material change in our operations and significantly and adversely impact the value of our ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Chinese government has significant oversight and discretion over the conduct of our business and may intervene or influence our operations as the government deems appropriate to further regulatory, political and societal goals. The Chinese government has recently published new policies that significantly affected certain industries such as the education and internet industries, and we cannot rule out the possibility that it will in the future release regulations or policies regarding our industry that could require us to seek permission from Chinese authorities to continue to operate our business adversely affect our business, financial condition and results of operations. Furthermore, recent statements made by the Chinese government have indicated an intent to increase the government&#8217;s oversight and control over offerings of companies with significant operations in China that are to be conducted in foreign markets, as well as foreign investment in China-based issuers. Although as of the date of this prospectus, we do not expect to be materially affected by the foregoing statements, any such action, once taken by the Chinese government, could significantly limit or completely hinder our ability to offer or continue to offer ADSs to our investors, and could cause the value of our ADSs to significantly decline or become worthless. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In the event that we elect to carry out clinical trials in China and/or to expand our operations into China in the future, we will be subject to changing legal and regulatory requirements in the PRC pharmaceutical industry, and new laws, rules and regulations promulgated by the PRC government may adversely affect our profitability or impose additional compliance burdens on us.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As required under the NMPA regulations, we established a subsidiary in China with an aim to serve as the applicant for the planned clinical trials relating to our drug candidates in China. Our PRC subsidiary currently has no substantive operations, and no clinical trial for our drug candidates may be conducted in China until relevant approvals from the NMPA are obtained. There is no indication as to whether the NMPA would approve our proposed application for clinical trial or when such NMPA approval could be obtained. In addition, our PRC subsidiary is not required to obtain any specific license or permits other than the NMPA approval to conduct clinical trials in China. In the event that we elect to carry out clinical trials in China after relevant NMPA approval is obtained (see &#8220;Business&#8221; beginning on page&#160;<a href="#tBUS">112</a> for our current plans for future clinical trials) and/or expand our operations into China in the future, we would be required to comply with relevant PRC laws and regulations in relation to our clinical trials and operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The PRC pharmaceutical industry is subject to extensive government regulation and supervision as well as monitoring by various government authorities. In particular, the current regulatory framework addresses substantially all aspects of a pharmaceutical company&#8217;s operations, including approval, production, licensing, certification requirements and procedures, periodic renewal and reassessment processes, registration of new drugs, quality control, pricing of pharmaceutical products and environmental protection. There can be no assurance that the legal framework, licensing and certification requirements or enforcement trends in our industry will not change in a manner that may result in increased costs of compliance, or that we will be successful in responding to such changes. We may also be subject to the risk of adverse changes to favorable governmental policies, and the introduction of unfavorable governmental policies on the pharmaceutical industry. The costs we incur to comply with these laws and regulations may materially increase our total costs and decrease any potential profits. Any violation of these laws, rules or regulations or our failure to obtain any required approvals or permits may result in substantial fines, criminal sanctions, revocations of operating permits, shutdown of our facilities and obligations to take rectification measures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other than the industry specific laws and regulations that are applicable to the biotechnology or pharmaceutical companies, we may also be subject to laws and regulations promulgated or implemented by </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">other regulatory authorities in China concerning cyber security and data protection. Regulatory authorities in China have implemented and may consider to implement additional legislation concerning data protection. For example, China&#8217;s Cyber Security Law, which became effective in June 2017, created China&#8217;s first national-level data protection for &#8220;network operators,&#8221; which may include all organizations in China that provide services over the Internet or another information network. Various regulations, guidelines and other measures are expected to be adopted under the umbrella of the Cyber Security Law. Drafts of some of these measures have now been published, including the draft rules on cross-border transfers published by the China Cyberspace Administration in 2017 and 2019, which may, upon enactment, require security review before transferring human health-related data out of China. In addition, the Standing Committee of the National People&#8217;s Congress of the People&#8217;s Republic of China, or SCNPC, promulgated the Data Security Law of the People&#8217;s Republic of China, or the Data Security Law, on June 10, 2021, which became effective on September 1, 2021. The Data Security Law imposes data security and privacy obligations on entities and individuals carrying out data processing activities, and introduces a data classification and hierarchical protection system. A similar security assessment mechanism was also included in the Personal Information Protection Law, or the Personal Information Protection Law, which was promulgated in August 2021 and became effective on November 1, 2021, for the Chinese government to supervise certain cross-border transfers of personal information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Cyber Security Law and Data Security Law, in the event that we elect to carry out clinical trials in China and/or to expand our operations into China in the future, (i) we may be required to establish and maintain a comprehensive data and network security management system that will enable us to monitor and respond appropriately to data security and network security risks; (ii) we may need to classify and take appropriate measures to address risks created by our data processing activities and use of networks; and (iii) we may be obligated to notify affected individuals and appropriate Chinese regulators of and respond to any data security and network security incidents. Establishing and maintaining such systems takes substantial time, effort and cost, and we may not be able to establish and maintain such systems fully as needed to ensure compliance with our legal obligations. Despite our investment, such systems may not fully guard us or enable us to appropriately respond to or mitigate all data security and network security risks or incidents we face. We may also be required to disclose to regulators businesssensitive or network security-sensitive details regarding our processing of important data, and may need to pass the government security review or obtain government approval in order to share important data with offshore recipients, which can include foreign licensors, or share data stored in China with judicial and law enforcement authorities outside of China. If judicial and law enforcement authorities outside China require us to provide data stored in China, and disclosing such data may be subject to security review or prior approval by relevant PRC government authorities, we may not be able to meet the foreign authorities&#8217; requirements. The potential conflicts in legal obligations could have adverse impact on our operations in and outside of China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, on December 28, 2021, the Cybersecurity Administration of China, China&#8217;s highest cyberspace regulator, and other twelve authorities of the PRC jointly issued the amended Cybersecurity Review Measures, or the Amended Cybersecurity Review Measures, which became effective on February 15, 2022. Under the Amended Cybersecurity Review Measures, the scope of entities required to undergo cybersecurity review to assess national security risks that arise from data processing activities would be expanded to include all critical information infrastructure operators who purchase network products and services and all data processors carrying out data processing activities that affect or may affect national security. In addition, the Amended Cybersecurity Review Measures requires that all such entities that maintain or store the personal information of more than 1 million users and undertake a public listing of securities in a foreign country would be required to pass cybersecurity review. To comply with these requirements, maintaining local data centers in China, conducting security assessments or obtaining the requisite approvals from the Chinese government for the transmission outside of China of such controlled information and data could significantly increase our operating costs or cause delays or disruptions in our business operations in and outside China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain of our clinical research and development activities are expected to be supervised by relevant regulatory authorities in China if we elect to conduct clinical trials in China for our product candidates in the future (see &#8220;Business&#8221; beginning on page <a href="#tBUS">112</a> for our current plans for future clinical trials). The PRC legal </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">system is a civil law system based on written statutes and, unlike the common law system, prior court decisions can only be cited as reference and have limited precedential value. Additionally, written statutes in the PRC are often principle-oriented and require detailed interpretations by the enforcement bodies to further apply and enforce such laws. Since 1979, the PRC government has developed a comprehensive system of laws, rules and regulations in relation to economic matters, such as foreign investment, corporate organization and governance, commerce, taxation and trade. However, the interpretation and enforcement of these laws, rules and regulations involve uncertainties and may not be as consistent or predictable as in other more developed jurisdictions. As these laws and regulations are continually evolving in response to changing economic and other conditions, and because of the limited volume of published cases and their non-binding nature, any particular interpretation of PRC laws and regulations may not be definitive. Moreover, we cannot predict the effect of future developments in the PRC legal system and regulatory structure. Such unpredictability towards our contractual, property and procedural rights as well as our rights licensed, approved or granted by the competent regulatory authority could adversely affect our business and impede our ability to continue our operations. In addition, the PRC legal system is based in part on government policies and internal rules, some of which are not published on a timely basis, if at all, and which may have a retroactive effect. Hence, we may not be aware of violation of these policies and rules until after such violation has occurred. Further, the legal protections available to us and our investors under these laws, rules and regulations may be limited. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, any administrative or court proceedings in China may be protracted, resulting in substantial costs and diversion of resources and management attention. Since PRC administrative and court authorities have significant discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection we enjoy than in more developed legal systems. These uncertainties may impede our ability to enforce various contracts we have entered into and could materially and adversely affect our business, financial condition and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be restricted from transferring our scientific data abroad.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;17, 2018, the General Office of the PRC State Council promulgated the Measures for the Management of Scientific Data, or the Scientific Data Measures, which provide a broad definition of scientific data and relevant rules for the management of scientific data. Enterprises in China must seek governmental approval before any scientific data involving a state secret may be transferred abroad or to foreign parties. Further, any researcher conducting research funded, at least in part, by the PRC government is required to submit relevant scientific data for management by the entity to which such researcher is affiliated before such data may be published in any foreign academic journal. Currently, as the term &#8220;state secret&#8221; is not clearly defined, there is no assurance that we can always obtain relevant approvals for sending scientific data (such as the results of our preclinical studies or clinical trials conducted within China in the future) abroad, or to our foreign collaborators in China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we are unable to obtain the necessary approvals in a timely manner, or at all, our research and development of product candidates in the future may be hindered, which may materially and adversely affect our business, results of operations, financial conditions and prospects. If relevant government authorities consider the transmission of our scientific data to be in violation of the requirements under the Scientific Data Measures, we may be subject to specific administrative penalties imposed by those government authorities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to Our Reliance on Third Parties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:11.71pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As we rely on third parties to conduct our preclinical studies, clinical trials, contract manufacture drug substances and drug products, and provide other important services related to product development, regulatory submissions, and commercialization, if we lose our relationships with these third parties or if they do not successfully carry out their contractual duties, comply with applicable laws, or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have relied on and plan to continue to rely on third-party CROs to monitor and manage data for some of our ongoing preclinical studies and clinical trials. We rely on these parties for the execution of our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">preclinical studies and clinical trials, and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies is conducted in accordance with the applicable protocol and legal, regulatory and scientific standards, and our reliance on the CROs does not relieve us of our regulatory responsibilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our CROs have the right to terminate their agreements with us in the event of an unrectified material breach. If any of our relationships with our third-party CROs is terminated, we may not be able to (i)&#160;enter into arrangements with alternative CROs or do so on commercially reasonable terms or (ii)&#160;meet our desired clinical development timelines. In addition, there is a natural transition period when a new CRO commences work, and the new CRO may not provide the same type or level of services as the original provider and data from our clinical trials may be compromised as a result. There is also a need for relevant technology to be transferred to the new CRO, which may take time and further delay our development timelines. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except for remedies available to us under our agreements with our CROs, we cannot control whether or not our CROs devote sufficient time and resources to our ongoing clinical, nonclinical and preclinical studies. If our CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines or if the quality or accuracy of the clinical data they obtain is compromised due to their failure to adhere to our clinical protocols, the impacts of COVID-19 on their operations, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates. As a result, our results of operations and the commercial prospects for our product candidates would be harmed and our costs could increase. In turn, our ability to generate revenues could be delayed or compromised.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because we rely on third parties, our internal capacity to perform these functions is limited. Outsourcing these functions involves certain risks that third parties may not perform to our standards, may not produce results in a timely manner or may fail to perform at all. In addition, the use of third-party service providers requires us to disclose our proprietary information to these third parties, which could increase the risk that such information will be misappropriated. We currently have a limited number of employees, which limits the internal resources we have available to identify and monitor our third-party service providers. To the extent we are unable to identify and successfully manage the performance of third-party service providers in the future, our business may be adversely affected. Though we carefully manage our relationships with our CROs, there can be no assurance that we will not encounter similar challenges or delays in the future, and such challenges or delays could have a material adverse impact on our business, financial condition and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As we rely on third parties to conduct our preclinical studies and clinical trials, our business could be harmed if those third parties fail to comply with the applicable regulatory requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and our CROs are required to comply with cGCP, current good laboratory practices, or cGLP, and other regulatory regulations and guidelines enforced by the FDA, the TGA, the NMPA, the EMA, the International Conference on Harmonization, or ICH, and comparable foreign regulatory authorities for all of our product candidates in clinical development. Regulatory authorities enforce these cGCP, cGLP or other regulatory requirements through periodic inspections of study sponsors, investigators and study sites. If we or any of our CROs fail to comply with applicable cGCP, cGLP or other regulatory requirements, the relevant data generated in our preclinical studies and clinical trials may be deemed unreliable and the FDA, the TGA, the NMPA, the EMA or other comparable regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. There can be no assurance that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials complies with cGCP requirements. In addition, our clinical trials must be conducted with product candidates or products produced under cGMP requirements. Failure to comply with these regulations may require us to repeat preclinical studies and clinical trials, which would delay the regulatory approval process. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We rely on third parties to supply the drug raw materials for our manufacturing activities. Lack of availability or significant increases in cost of such drug raw materials could harm our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The manufacture of biopharmaceutical products is complex and requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Currently, our drug raw materials for our manufacturing activities are supplied by multi-source suppliers </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and we entered into long-term capacity arrangements with one of our suppliers. We believe our suppliers have sufficient capacity to meet our demands for drug materials. In addition, we believe that adequate alternative sources for such supplies exist. However, there is a risk that, if supplies are interrupted or if the costs of such drug materials were to significantly increase, our business would be materially harmed. For example, the COVID-19 pandemic could have a broad impact on the production and supplies of active ingredients or other raw materials and result in a potential shortage of supply. If we or our third-party manufacturers experience a shortage in supply of active ingredients or other raw materials, whether due to COVID-19 or otherwise, we may not be able to continue to supply adequate levels of our drugs to our customers, which would have a negative impact on our business and results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We expect to seek to establish collaborations and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may form or seek strategic alliances, create joint ventures or collaborations, or enter into licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our product candidates and any future product candidates that we may develop. Any of these relationships may require us to incur recurring or non-recurring expenses and other charges, increase our near and long-term expenditures, issue securities that dilute the value of our ADSs, or disrupt our management and business. In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic collaboration or other alternative arrangements for our product candidates because they may be deemed to be at too early a stage of development for collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate safety and efficacy. If and when we collaborate with a third party for the development and commercialization of a product candidate, we can expect to relinquish some or all of the control over the future success of that product candidate to the third party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, collaborations involving our product candidates are subject to additional risks, which include, but are not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may have significant discretion in determining the efforts and resources that they will apply to a collaboration; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may not pursue the development and commercialization of our product candidates or may elect not to continue or renew the development or commercialization programs based on clinical trial results, change in their strategic focus due to the acquisition of competitive drugs, increased competition, availability of funding, or other external factors, such as a business combination that diverts resources or creates competing priorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, discontinue a clinical trial, repeat or conduct new clinical trials, or require a new formulation of a product candidate for clinical testing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators could independently develop, or develop with third parties, drugs that compete directly or indirectly with our product candidates or future drugs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators with marketing and distribution rights to one or more of our product candidates or future drugs may not commit sufficient resources to their marketing and distribution; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may not always be cooperative or responsive in providing their services in a clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disputes may arise between us and a collaborator that cause a delay or termination of the research, development or commercialization of our product candidates, or that result in costly litigation or arbitration that diverts management attention and resources; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">collaborators may own or co-own intellectual property covering our product candidates or future drugs that results from our collaborating with them, and in such cases, we would not have the exclusive right to commercialize such intellectual property; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we may not be able to receive agreed development fees, royalties or milestone payments we expected when seeking collaborations.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a result, if we enter into collaboration agreements or license our drugs, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate these collaborations or licenses with our existing operations and company culture, which could delay our timelines or otherwise adversely affect our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we are unable to reach agreements with suitable collaborators on a timely basis, on acceptable terms, or at all, we may have to curtail the development of a product candidate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to fund and undertake development or commercialization activities on our own, we may need to obtain additional expertise and additional capital, which may not be available to us on acceptable terms or at all. If we fail to enter into collaborations and do not have sufficient funds or expertise to undertake the necessary development and commercialization activities, we may not be able to further develop our product candidates or bring them to market and generate product sales revenue, which would harm our business, financial condition, results of operations and prospects. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Collaborations are complex and time-consuming to negotiate and document. Further, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any collaboration agreements that we enter into in the future may contain restrictions on our ability to enter into potential collaborations or to otherwise develop specified product candidates. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks Related to This Offering and Our ADSs</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Although the audit report included in this prospectus is issued by an independent registered public accounting firm that is subject to inspections by the Public Company Accounting Oversight Board, or the PCAOB, and has been inspected by the PCAOB on a regular basis, there is no guarantee that future audit reports will be prepared by auditors or their international affiliates in jurisdictions where the PCAOB is able to fully inspect their work, and as such, future investors may be deprived of such inspections, which could result in limitations or restrictions to our access of the U.S. capital markets. Furthermore, trading in our securities may be prohibited under the Holding Foreign Companies Accountable Act, or the HFCAA, or the Accelerating Holding Foreign Companies Accountable Act if the SEC subsequently determines our audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely, and as a result, U.S. national securities exchanges, such as the Nasdaq, may determine to delist our securities. Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, which, if enacted, would amend the HFCAA and require the SEC to prohibit an issuer&#8217;s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three, as currently provided by the HFCAA.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our auditor, Friedman LLP, an independent registered public accounting firm with the PCAOB, is required under the laws of the United States to undergo regular inspections by the PCAOB to assess their compliance with the laws of the United States and professional standards. Although we have a subsidiary </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">within the PRC, a jurisdiction where the PCAOB is currently unable to conduct inspections without the approval of the Chinese government authorities, our auditor is currently subject to inspection by the PCAOB and has been inspected by the PCAOB on a regular basis. However, recent developments would add uncertainties to our offering, and we cannot assure you whether Nasdaq or regulatory authorities would apply additional and more stringent criteria to us after considering the effectiveness of our auditor&#8217;s audit procedures and quality control procedures, adequacy of personnel and training, or sufficiency of resources, geographic reach or experience as it relates to the audit of our financial statements.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Inspections of an independent registered public accounting firm conducted by the PCAOB outside China have at times identified deficiencies in those auditors&#8217; audit procedures and quality control procedures, which may be addressed as part of the inspection process to improve future audit quality. The lack of PCAOB inspections of audit work undertaken in China prevents the PCAOB from regularly evaluating auditors&#8217; audits and their quality control procedures. As a result, to the extent that any component of our auditor&#8217;s work papers are or become located in China, such work papers will not be subject to inspection by the PCAOB. As a result, investors would be deprived of such PCAOB inspections, which could result in limitations or restrictions to our access of the U.S. capital markets.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As part of a continued regulatory focus in the United States on access to audit and other information currently protected by national law, in particular the law in China, in June 2019, a bipartisan group of lawmakers introduced bills in both houses of the U.S. Congress which, if passed, would require the SEC to maintain a list of issuers for which PCAOB is not able to inspect or investigate the audit work performed by a foreign public accounting firm completely. The proposed Ensuring Quality Information and Transparency for Abroad-Based Listings on our Exchanges (EQUITABLE) Act prescribes increased disclosure requirements for these issuers and, beginning in 2025, the delisting from U.S. national securities exchanges such as the Nasdaq of issuers included on the SEC&#8217;s list for three consecutive years. It is unclear if this proposed legislation will be enacted. Furthermore, there have been recent deliberations within the U.S. government regarding potentially limiting or restricting China-based companies from accessing U.S. capital markets.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On May 20, 2020, the U.S. Senate passed the Holding Foreign Companies Accountable Act, or the HFCAA, which includes requirements for the SEC to identify issuers whose audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely because of a restriction imposed by a non-U.S. authority in the auditor&#8217;s local jurisdiction. The U.S. House of Representatives passed the HFCAA on December 2, 2020, and the HFCAA was signed into law on December 18, 2020. Additionally, in July 2020, the U.S. President&#8217;s Working Group on Financial Markets issued recommendations for actions that can be taken by the executive branch, the SEC, the PCAOB or other federal agencies and department with respect to Chinese companies listed on U.S. stock exchanges and their audit firms, in an effort to protect investors in the United States. In response, on November 23, 2020, the SEC issued guidance highlighting certain risks (and their implications to U.S. investors) associated with investments in China-based issuers and summarizing enhanced disclosures the SEC recommends China-based issuers make regarding such risks. On March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCAA. A company will be required to comply with these rules if the SEC identifies it as having a &#8220;non-inspection&#8221; year (as defined in the interim final rules) under a process to be subsequently established by the SEC. The SEC is assessing how to implement other requirements of the HFCAA, including the listing and trading prohibition requirements described above.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the HFCAA, our securities may be prohibited from trading on the Nasdaq or other U.S. stock exchanges if our auditor is not inspected by the PCAOB for three consecutive years, and this ultimately could result in our ADSs being delisted. Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, which, if enacted, would amend the HFCAA and require the SEC to prohibit an issuer&#8217;s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September 22, 2021, the PCAOB adopted a final rule implementing the HFCAA, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCAA, whether the Board is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While we understand that there has been dialogue among the China Securities Regulatory Commission, or the CSRC, the SEC and the PCAOB regarding the inspection of PCAOB-registered accounting firms in China, there can be no assurance that we will be able to comply with requirements imposed by U.S. regulators. Delisting of our ADSs would force holders of our ADSs to sell their ADSs or convert them into our Ordinary Shares. The market price of our ADSs could be adversely affected as a result of anticipated negative impacts of these executive or legislative actions upon, as well as negative investor sentiment towards, companies with significant operations in China that are listed in the United States, regardless of whether these executive or legislative actions are implemented and regardless of our actual operating performance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Because our initial public offering price is substantially higher than our net tangible book value per share, you will experience immediate and substantial dilution.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you purchase ADSs in this offering, you will pay more for your ADSs than the amount paid by our existing shareholders for their ordinary shares on a per ADS basis. As a result, you will experience immediate and substantial dilution of approximately $4.00 per ADS (assuming that no outstanding options to acquire ordinary shares are exercised), representing the difference between (i)&#160;the initial public offering price of $6.00 per ADS, and (ii)&#160;our pro&#160;forma as adjusted net tangible book value per ADS as of $2.00, after giving effect to our sale of the ADSs offered in this offering. In addition, you may experience further dilution to the extent that our ordinary shares are issued upon the exercise of share options. See &#8220;Dilution&#8221; for a more complete description of how the value of your investment in the ADSs will be diluted upon completion of this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to establish and maintain proper internal controls over financial reporting, our ability to produce accurate financial statements or comply with applicable regulations could be impaired.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Section&#160;404 of the Sarbanes-Oxley Act, reporting companies are generally required to file a report by their management on such company&#8217;s internal control over financial reporting, including an attestation report on internal control over financial reporting issued by the company&#8217;s independent registered public accounting firm. However, while we remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. The presence of material weaknesses in internal control over financial reporting could result in financial statement errors which, in turn, could lead to errors in our financial reports and/or delays in our financial reporting, which could require us to restate our operating results. We might not identify one or more material weaknesses in our internal controls in connection with evaluating our compliance with Section&#160;404 of the Sarbanes-Oxley Act. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal controls over financial reporting, we will need to expend significant resources and provide significant management oversight. Implementing any appropriate changes to our internal controls may require specific compliance training of our directors and employees, entail substantial costs in order to modify our existing accounting systems, take a significant period of time to complete and divert management&#8217;s attention from other business concerns. These changes may not, however, be effective in maintaining the adequacy of our internal control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we are unable to conclude that we have effective internal controls over financial reporting, investors may lose confidence in our operating results, the price of the ADSs could decline and we may be subject to litigation or regulatory enforcement actions. In addition, if we are unable to meet the requirements of Section&#160;404 of the Sarbanes-Oxley Act, the ADSs may not be able to remain listed on Nasdaq Capital Market. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our corporate actions are substantially controlled by our directors and executive officers, who can exert significant influence over important corporate matters, which may reduce the price of the ADSs and deprive you of an opportunity to receive a premium for your ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus and on an as-converted basis, the chairman of the board of directors, Dr.&#160;Lin, beneficially owned approximately 13.61% of our outstanding ordinary shares and our directors and executive officers beneficially owned approximately 18.37% of our outstanding ordinary shares, collectively. These shareholders, if acting together, could exert substantial influence over matters such as electing directors and approving material mergers, acquisitions, strategic collaborations or other business combination transactions. This concentration of ownership may also discourage, delay or prevent a change in control of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">our Company, which could have the dual effect of depriving our shareholders of an opportunity to receive a premium for their ordinary shares as part of a sale of our Company and reducing the price of the ADSs. These actions may be taken even if they are opposed by our other shareholders, including the holders of the ADSs. In addition, these persons could divert business opportunities away from us to themselves or others. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As a result of our principal shareholder, Lin Bioscience International Ltd.&#8217;s significant share ownership position in the Company, the company is able to influence corporate matters and conflict of interest may arise between our principal shareholder and us.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus and on an as-converted basis, our principal shareholder, Lin Bioscience International Ltd., beneficially owned approximately 76.97% of our outstanding ordinary shares. As a result of significant share ownership position in our Company, our principal shareholder could exert substantial influence over matters such as electing directors and approving material mergers, acquisitions, strategic collaborations or other business combination transactions. This concentration of ownership may also discourage, delay or prevent a change in control of our Company, which could have the dual effect of depriving our shareholders of an opportunity to receive a premium for their ordinary shares as part of a sale of our Company and reducing the price of the ADSs. These actions may be taken even if they are opposed by our other shareholders, including the holders of the ADSs. In addition, these persons could divert business opportunities away from us to themselves or others. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Conflicts of interest may arise between our principal shareholder and us in a number of areas relating to our ongoing relationships. Our financial contribution to our principal shareholder was not material during the periods presented in this prospectus, and our principal shareholder may from time to time make strategic decisions that it believes are in the best interests of its business as a whole, which may be different from the decisions that we would have made on our own. our principal shareholder&#8217;s decisions with respect to us or our business may favor our principal shareholder and therefore our principal shareholder, which may not necessarily be aligned with our interests and the interests of our other shareholders. Our principal shareholder may make decisions, or suffer adverse trends, that may disrupt or discontinue our collaborations with our principal shareholder. Although we will become a stand-alone public company upon the completion of this offering and will have an audit committee, consisting of independent non-executive directors, to review and approve all proposed related party transactions including those between our principal shareholder and us, we may not be able to resolve all potential conflicts of interest, and even if we do so, the resolution may be less favorable to us than if we were dealing with a non-controlling shareholder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">There has been no public market for our ordinary shares or ADSs prior to this offering, and you may not be able to resell our ADSs at or above the price you paid, or at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to this initial public offering, there has been no public market for our ordinary shares or ADSs. We have applied to list the ADSs on Nasdaq Capital Market. Our ordinary shares will not be listed on any exchange or quoted for trading on any over-the-counter trading system. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Negotiations with the underwriters will determine the initial public offering price for our ADSs which may bear no relationship to their market price after the initial public offering. We cannot assure you that an active trading market for our ADSs will develop or that the market price of our ADSs will not decline below the initial public offering price. Investors in the ADSs may experience a significant decrease in the value of the ADSs regardless of our operating performance of prospects. If an active trading market for our ADSs does not develop after this offering, the market price and liquidity of our ADSs will be materially and adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The market price of our ADSs may be volatile, which could result in substantial losses to you.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The market price of our ADSs can be volatile and fluctuate widely in response to a variety of factors, many of which are beyond our control. The stock market in general and the market for smaller pharmaceutical and biotechnology companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, you may not be able to sell your ADSs at or above the initial public offering price and you may lose some or all of your investment. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to market and industry factors, the price and trading volume for our ADSs may be highly volatile due to specific business reasons, including, but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">announcements of regulatory approval or a complete response letter, or specific label indications or patient populations for a drug&#8217;s use, or changes or delays in the regulatory review process; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">announcements of therapeutic innovations, new products, acquisitions, strategic relationships, joint ventures or capital commitments by us or our competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulatory developments affecting us, our patients, our customers, our suppliers or our competitors, including adverse actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply chain or sales and marketing activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any adverse changes to our relationship with manufacturers or suppliers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the results of our testing and clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the results of our efforts to research and develop additional product candidates or otherwise acquire or license additional product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">entering into out-licensing or collaborations and any subsequent changes in the terms or structure of these licenses or collaborations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">appointments of key vendors, including CMOs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">variations in the level of expenses related to our existing drugs and product candidates or preclinical, clinical development and commercialization programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any litigation or administrative proceedings in which we may become involved, including any intellectual property infringement actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">announcements concerning our competitors or the pharmaceutical industry in general; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">actual or anticipated fluctuations in our revenue, operating expenses and profitability, and any other variations in our results of operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">manufacture, supply or distribution shortages; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">announcements about our results of operations that are not in line with analyst expectations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">publication of operating or industry metrics by third parties, including government statistical agencies, that differ from expectations of industry or financial analysts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">changes in financial estimates by securities research analysts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">media reports, whether or not true, about our business, our competitors or our industry; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">additions to or departures of our management; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">foreign exchange fluctuations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">release or expiration of lock-up or other transfer restrictions on our outstanding ordinary shares or ADSs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">sales or perceived potential sales of additional ordinary shares or ADSs by us, our executive officers and directors or our shareholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">general economic and market conditions and overall fluctuations in the U.S. equity markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">changes in accounting principles; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">changes or developments in the United States, Australia, Taiwan, PRC or global regulatory environment. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect that, until we are able to commercialize our drug pipeline, the primary drivers of the market price of our ADSs will likely be the results of our research and development efforts, the outcome of our various testing, studies and our overall clinical performance. Nevertheless, the stock market, in general, and pharmaceutical and biotechnology companies have from time to time experienced extreme price and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">trading volume fluctuations that have often been unrelated or disproportionate to the clinical and/or operating performance of these companies. Broad market and industry factors may negatively affect the market price of our ADSs, regardless of our actual operating performance. Further, the current volatility in the financial markets and related factors beyond our control may cause the market price of our ADSs to decline rapidly and unexpectedly. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">After the completion of this offering, we may face an increased risk of securities class action litigation, which is expensive and could divert management&#8217;s attention.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Historically, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant to us because biotechnology and biopharmaceutical companies have experienced significant share price volatilities in recent&#160;years. If we were to face such lawsuits, it will likely result in substantial costs and a diversion of management&#8217;s attention and resources, which could harm our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding the ADSs, the market price for the ADSs and trading volume could decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The trading market for the ADSs will be influenced by research or reports that industry or securities analysts publish about our business. If one or more analysts who cover us downgrade the ADSs, the market price for the ADSs would likely decline. If one or more of these analysts cease to cover us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for the ADSs to decline. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Techniques employed by short sellers may drive down the market price of our ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Short selling is the practice of selling securities that the seller does not own but rather has borrowed from a third party with the intention of buying identical securities back at a later date to return to the lender. The short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale. As it is in the short seller&#8217;s best interests for the price of the stock to decline, many short sellers publish, or arrange for the publication of, negative opinions regarding the relevant issuer and its business prospects in order to create negative market momentum and generate profits for themselves after selling a stock short. These short attacks have, in the past, led to selling of shares in the market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Much of the scrutiny and negative publicity has centered on allegations of a lack of effective internal control over financial reporting resulting in financial and accounting irregularities and mistakes, inadequate corporate governance policies or a lack of adherence thereto and, in many cases, allegations of fraud. As a result, many of these companies are now conducting internal and external investigations into the allegations and, in the interim, are subject to shareholder lawsuits and/or SEC enforcement actions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is not clear what effect such negative publicity, if it would occur, could have on us. If we were to become the subject of any unfavorable allegations, whether such allegations are proven to be true or untrue, we could have to expend a significant amount of resources to investigate such allegations and/or defend ourselves. While we would strongly defend against any such short seller attacks, we may be constrained in the manner in which it can proceed against the relevant short seller by principles of freedom of speech, applicable state law or issues of commercial confidentiality. Such a situation could be costly and time-consuming, and could distract our management from growing our business. Even if such allegations are ultimately proven to be groundless, allegations against us could severely impact its business operations and stockholders equity, and any investment in our ADSs could be greatly reduced or rendered worthless. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The sale or availability for sale, or perceived sale or availability for sale, of substantial amounts of our ADSs could adversely affect their market price.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sales of substantial amounts of our ADSs in the public market after the completion of this offering, or the perception that these sales could occur, could adversely affect the market price of our ADSs and could </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">materially impair our ability to raise capital through equity offerings in the future. The ADSs sold in this offering will be freely tradable without restriction or further registration under the Securities Act of 1933, as amended, or the Securities Act, and ordinary shares held by our existing shareholders may also be sold in the public market in the future subject to the restrictions in Rule&#160;144 and Rule&#160;701 under the Securities Act and the applicable lock-up agreements. There will be&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;ADSs (equivalent to&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;ordinary shares) outstanding immediately after this offering. We, our officers, directors, and shareholders holding greater than 5% of our ordinary shares have agreed not to sell any of our ordinary shares or our ADSs or are otherwise subject to similar lockup restrictions for 180&#160;days after the date of this prospectus without the prior written consent of the representative of the underwriters, subject to certain exceptions. However, the representative of the underwriters may release these securities from these restrictions at any time. We cannot predict what effect, if any, market sales of securities held by our significant shareholders or any other shareholder or the availability of these securities for future sale will have on the market price of our ADSs. See &#8220;Underwriting&#8221; and &#8220;Shares Eligible for Future Sale&#8221; for a more detailed description of the restrictions on selling our securities after this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The ADSs are equity and are subordinate to our existing and future indebtedness and any preferred stock we may issue in the future.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ADSs are our equity interests and do not constitute indebtedness. As such, ADSs will rank junior to all indebtedness and other non-equity claims on us with respect to assets available to satisfy claims on us, including in a liquidation of us. Additionally, holders of our ADSs may be subject to prior dividend and liquidation rights of any holders of our preferred stock or depositary shares representing such preferred stock then outstanding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors is authorized to issue additional classes or series of preferred stock without any action on the part of the shareholders. The board of directors also has the power, without shareholder approval, to set the terms of any such classes or series of preferred stock that may be issued, including voting rights, dividend rights, and preferences over our ADSs with respect to dividends or upon our dissolution, winding-up and liquidation and other terms. If we issue preferred stock in the future that has a preference over our ADSs with respect to the payment of dividends or upon our liquidation, dissolution, or winding up, or if we issue preferred stock with voting rights that dilute the voting power of our ADSs, the rights of holders of our ADSs or the market price of our ADSs could be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Holders of ADSs have fewer rights than shareholders and the voting rights of holders of ADSs are limited by the terms of the deposit agreement.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Holders of ADSs do not have the same rights as our shareholders and may only exercise the voting rights with respect to the underlying ordinary shares in accordance with the provisions of the deposit agreement. As a holder of our ADSs, you will not have any direct right to attend general meetings of our shareholders or to cast any votes at such meetings. As an ADS holder, you will only be able to exercise the voting rights carried by the underlying ordinary shares indirectly by giving voting instructions to the depositary in accordance with the provisions of the deposit agreement. Under the deposit agreement, you may vote only by giving voting instructions to the depositary in the manner set forth in the deposit agreement. Upon receipt of your voting instructions, the depositary will try, as far as is practicable, to vote the ordinary shares underlying your ADSs in accordance with your instructions. If we ask for your instructions, then upon receipt of your voting instructions, the depositary will try to vote the underlying ordinary shares in accordance with these instructions. If we do not instruct the depositary to ask for your instructions, the depositary may still vote in accordance with instructions you give, but it is not required to do so. You will not be able to directly exercise your right to vote with respect to the underlying ordinary shares unless you withdraw the shares, and become the registered holder of such shares prior to the record date for the general meeting. Under our third amended and restated memorandum and articles of association, which will become effective immediately prior to completion of this offering, the minimum notice period required for convening a general meeting is seven (7)&#160;calendar days; provided that a general meeting may be called on short notice under specified circumstances. When a general meeting is convened, you may not receive sufficient advance notice of the meeting to withdraw the ordinary shares underlying your ADSs and become the registered holder of such shares to allow you to attend the general meeting and to vote directly with respect to any specific matter or resolution to be considered and voted upon at the general meeting. In addition, under our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">third amended and restated memorandum and articles of association, for the purposes of determining those shareholders who are entitled to attend and vote at any general meeting, our directors may fix the date notice is given of a general meeting as the record date, and the setting of such a record date may prevent you from withdrawing the ordinary shares underlying your ADSs and becoming the registered holder of such shares prior to the record date, so that you would not be able to attend the general meeting or to vote directly. If we ask for your instructions, the depositary will notify you of the upcoming vote and will arrange to deliver our voting materials to you. We have agreed to give the depositary notice of shareholder meetings sufficiently in advance of such meetings. Nevertheless, we cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote the underlying shares represented by your ADSs. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for their manner of carrying out your voting instructions. This means that you may not be able to exercise your right to direct how the ordinary shares underlying your ADSs are voted and you may have no legal remedy if the ordinary shares underlying your ADSs are not voted as you requested. In addition, in your capacity as an ADS holder, you will not be able to call a shareholders&#8217; meeting. Except in limited circumstances, the depositary for our ADSs will give us a discretionary proxy to vote the ordinary shares underlying your ADSs if you do not give voting instructions to the depositary, which could adversely affect your interests. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the deposit agreement for the ADSs, if you do not give voting instructions to the depositary, the depositary will give us a discretionary proxy to vote the ordinary shares underlying your ADSs at shareholders&#8217; meetings unless: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we have instructed the depositary that we do not wish a discretionary proxy to be given; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">we have informed the depositary that there is substantial opposition as to a matter to be voted on at the meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a matter to be voted on at the meeting would have an adverse impact on shareholders; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the voting at the meeting is to be made on a show of hands. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The effect of this discretionary proxy is that you cannot prevent our ordinary shares underlying your ADSs from being voted, except under the circumstances described above. This may make it more difficult for shareholders to influence the management of our company. Holders of our ordinary shares are not subject to this discretionary proxy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, in the event of voting by a show of hands, pursuant to the terms of the deposit agreement, the depositary will vote (or cause the custodian to vote) all ordinary shares held on deposit at that time in accordance with the voting instructions received from a majority of holders of ADSs who provide timely voting instructions, which may result in the ordinary shares underlying the ADSs held by certain ADS holders being voted in a manner contrary to such ADS holders&#8217; voting instructions. See &#8220;Description of American Depositary Shares&#8201;&#8212;&#8201;Voting rights&#8221; for more information. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The depositary for the ADSs is entitled to charge holders of ADSs fees for various services, including annual service fees.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary for the ADSs is entitled to charge holders of ADSs fees for various services, including for the issuance of ADSs upon deposit of ordinary shares, cancellation of ADSs, distributions of cash dividends or other cash distributions, distributions of ADSs pursuant to share dividends or other free share distributions, distributions of securities other than ADSs and annual service fees. In the case of ADSs issued by the depositary into The Depository Trust Company, or the DTC, the fees will be charged by the DTC participant to the account of the applicable beneficial owner in accordance with the procedures and practices of the DTC participant as in effect at the time. For further information, see &#8220;Description of American Depositary Shares&#8201;&#8212;&#8201;Fees and Charges.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have considerable discretion to determine how to use the net proceeds from this offering and may use them in ways with which you may not agree or that may not ultimately yield a favorable return or increase the price of the ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although we currently intend to use the net proceeds from this offering in the manner described in the section titled &#8220;Use of Proceeds&#8221; in this prospectus, our management will have considerable discretion in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">deciding how to apply the net proceeds from this offering, and we could spend the net proceeds from this offering in ways the holders of the ADSs may not agree with or that do not ultimately yield a favorable return. Because of the number and variability of factors that will determine our use of the net proceeds from this offering, our use of these proceeds, while applied in a manner consistent with the manner described in the section titled &#8220;Use of Proceeds&#8221; in this prospectus, may differ substantially from our current plans. Additionally, in utilizing the proceeds of this offering, under the PRC laws and regulations, we are only allowed to provide funding to our PRC subsidiary through loans or capital contributions. Subject to satisfaction of the applicable government registration and approval requirements, we may extend inter-company loans to our PRC subsidiary or make additional capital contributions to our PRC subsidiary to fund its research and development, capital expenditures or working capital. We cannot assure you that we will be able to obtain these government registrations or approvals in a timely manner, if at all. Further, if we choose to allocate funds to our PRC subsidiary, or if we desire to re-allocate those funds, our PRC subsidiary will have to comply with various PRC laws and regulations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The failure by our management to apply these funds effectively could have a material adverse effect on our business, financial condition and results of operation. You will not have the opportunity to assess whether the net proceeds from this offering are being used appropriately before making your investment decision. You must rely on the judgment of our management regarding the application of the net proceeds of this offering. We cannot assure you that the net proceeds will be used in a manner that will ultimately yield a favorable return or increase our ADS price, nor that these net proceeds will be placed only in investments that generate income or appreciate in value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Your right to participate in any future rights offerings may be limited, which may cause dilution to your holdings.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may from time to time distribute rights to our shareholders, including rights to acquire our securities. However, we cannot make rights available to you in the United States unless we register both the rights and the securities to which the rights relate under the Securities Act or an exemption from the registration requirements is available. Under the deposit agreement, the depositary will not make rights available to you unless both the rights and the underlying securities to be distributed to ADS holders are either registered under the Securities Act or exempt from registration under the Securities Act. We are under no obligation to file a registration statement with respect to any such rights or securities or to endeavor to cause such a registration statement to be declared effective and we may not be able to establish a necessary exemption from registration under the Securities Act. If the depositary does not distribute the rights, if any, it may, under the deposit agreement, either sell them, if possible, or allow them to lapse. Accordingly, you may be unable to participate in our rights offerings and may experience dilution in your holdings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You may not receive cash dividends if the depositary decides it is impractical to make them available to you.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will pay cash dividends on the ADSs only to the extent that we decide to distribute dividends on our ordinary shares, and we do not have any present plan to pay any dividends on our ordinary shares. To the extent that there is a distribution, the depositary of our ADSs has agreed to pay to you the cash dividends or any other distributions it or the custodian receives on our ordinary shares or other deposited securities after deducting its fees and expenses pursuant to the deposit agreement. You will receive these distributions in proportion to the number of ordinary shares your ADSs represent. However, the depositary is not responsible if it decides that it is unlawful to make a distribution available to any holders of ADSs. For instance, it would be unlawful to make a distribution to a holder of ADSs if it consists of securities whose offering would require registration under the Securities Act but are not so properly registered or distributed under an applicable exemption from registration. The depositary may also, at its discretion, decide that it is inequitable or impractical to make a distribution available to any holders of ADSs. For example, the depositary may determine that it is not practicable to distribute certain property through the mail, or that the value of certain distributions may be less than the cost of mailing them. In these cases, the depositary may decide not to distribute such property to you. We have no obligation to register under the U.S. securities laws any offering of ADSs, ordinary shares, rights or other securities that may be received through such distributions. We also have no obligation to take any other action to permit the distribution of ADSs, ordinary shares, rights or anything else to holders of ADSs. This means that you may not receive distributions </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">we make on our ordinary shares or any value for them if such distributions to you are illegal or impractical. These restrictions may cause a material decline in the value of our ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You may be subject to limitations on transfer of your ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your ADSs are transferable on the books of the depositary. However, the depositary may close its books at any time or from time to time when it deems it expedient in connection with the performance of its duties. The depositary may close its books from time to time for a number of reasons, including in connection with corporate events such as a rights offering, during which time the depositary needs to maintain an exact number of ADS holders on its books for a specified period. The depositary may also close its books in emergencies, and on weekends and public holidays. The depositary may refuse to deliver, transfer or register transfers of the ADSs generally when our share register or the books of the depositary are closed, or at any time if we or the depositary thinks it is advisable to do so because of any requirement of law or of any government or governmental body, or under any provision of the deposit agreement, or for any other reason. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain judgments obtained against us by our shareholders may not be enforceable.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are an exempted company with limited liability incorporated in the Cayman Islands. Most of our directors and executive officers, and some of the experts named in this prospectus, are nationals and/or residents of countries other than the United States, and a significant portion of the assets of these persons may be located outside of the United States. As a result, it may be difficult or impossible for you to bring an action against us or against these individuals in the United States in the event that you believe that your rights have been infringed under the U.S. federal securities laws or otherwise. As of the date of this prospectus, none of our officers, directors or other members of our senior management are located in China. Even if you are successful in bringing an action of this kind, the laws of the Cayman Islands may render you unable to enforce a judgment against our assets or the assets of our directors and officers. For more information regarding the relevant laws of the Cayman Islands, see &#8220;Enforceability of Civil Liabilities.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because we are incorporated under Cayman Islands law.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are an exempted company incorporated under the laws of the Cayman Islands. Our corporate affairs are governed by, among other things, our memorandum and articles of association, the Companies Act (As Revised) of the Cayman Islands and the common law of the Cayman Islands. The rights of shareholders to take action against our directors, actions by our minority shareholders and the fiduciary duties of our directors to us under the Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from the common law of England, the decisions of whose courts are of persuasive authority, but are not binding, on a court in the Cayman Islands. The rights of our shareholders and the fiduciary duties of our directors under Cayman Islands law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a less developed body of securities laws than the United States. Some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law than the Cayman Islands. In addition, the Cayman Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Shareholders of Cayman Islands companies like us have no general rights under the Cayman Islands law to inspect corporate records, or to obtain copies of the register of members of these companies, other than the memorandum and articles of association and any special resolutions passed by these companies, and the registers of mortgages and charges of these companies. The Registrar of Companies of the Cayman Islands shall make available the list of the names of the current directors of the Company (and where applicable the current alternate directors of the Company) for inspection by any person upon payment of a fee by such person. Our directors have discretion under our post-offering memorandum and articles of association to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may make it </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain corporate governance practices in the Cayman Islands, which is our home country, differ significantly from requirements for companies incorporated in other jurisdictions such as the United States. We may in the future rely on home country practice with respect to our corporate governance after we complete this offering. If we choose to follow home country practice in the future, our shareholders may be afforded less protection than they otherwise would under rules and regulations applicable to U.S. domestic issuers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by our management, members of our board of directors or our controlling shareholders than they would as public shareholders of a company incorporated in the United States. For a discussion of significant differences between the provisions of the Companies Act (As Revised) of the Cayman Islands and the laws applicable to companies incorporated in the United States and their shareholders, see &#8220;Description of Share Capital&#8201;&#8212;&#8201;Differences in Corporate Law.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Your rights to pursue claims against the depositary as a holder of ADSs are limited by the terms of the deposit agreement.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the deposit agreement, any action or proceeding against or involving the depositary, arising out of or based upon the deposit agreement or the transactions contemplated thereby or by virtue of owning the ADSs may only be instituted in a state or federal court in New York, New York, and you, as a holder of our ADSs, will have irrevocably waived any objection which you may have to the laying of venue of any such proceeding, and irrevocably submitted to the exclusive jurisdiction of such courts in any such action or proceeding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary may, in its sole discretion, require that any dispute or difference arising from the relationship created by the deposit agreement be referred to and finally settled by an arbitration conducted under the terms described in the deposit agreement, although the arbitration provisions do not preclude you from pursuing claims under the Securities Act or the Exchange Act in state or federal courts. See &#8220;Description of American Depositary Shares&#8221; for more information.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement governing the ADSs representing our ordinary shares provides that, subject to the depositary&#8217;s right to require a claim to be submitted to arbitration, the federal or state courts in the City of New York have exclusive jurisdiction to hear and determine claims arising under the deposit agreement and in that regard, to the fullest extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our ordinary shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable state and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally adjudicated by the United States Supreme Court. However, we believe that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the laws of the State of New York, which govern the deposit agreement. In determining whether to enforce a contractual pre-dispute jury trial waiver provision, courts will generally consider whether a party knowingly, intelligently and voluntarily waived the right to a jury trial. We believe that this is the case with respect to the deposit agreement and the ADSs. It is advisable that you consult legal counsel regarding the jury waiver provision before investing in the ADSs.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you or any other holders or beneficial owners of ADSs bring a claim against us or the depositary in connection with matters arising under the deposit agreement or the ADSs, including claims under federal securities laws, you or such other holder or beneficial owner may not be entitled to a jury trial with respect to such claims, which may have the effect of limiting and discouraging lawsuits against us and / or the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">depositary. If a lawsuit is brought against us and/or the depositary under the deposit agreement, it may be heard only by a judge or justice of the applicable trial court, which would be conducted according to different civil procedures and may result in different outcomes than a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in any such action. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Nevertheless, if this jury trial waiver provision is not enforced, to the extent a court action proceeds, it would proceed under the terms of the deposit agreement with a jury trial. No condition, stipulation or provision of the deposit agreement or ADSs shall relieve us or the depositary from our respective obligations to comply with the Securities Act and the Exchange Act. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our post-offering memorandum and articles of association contain anti-takeover provisions that could have a material adverse effect on the rights of holders of our ordinary shares and ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our post-offering memorandum and articles of association contain certain provisions that could limit the ability of others to acquire control of our company, including a provision that grants authority to our board of directors to establish from time to time one or more series of preferred shares without action by our shareholders and to determine, with respect to any series of preferred shares, the terms and rights of that series. These provisions could have the effect of depriving our shareholders of the opportunity to sell their shares at a premium over the prevailing market price by discouraging third parties from seeking to obtain control of our company in a tender offer or similar transactions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to U.S. domestic public companies.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because we qualify as a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic issuers, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q or current reports on Form 8-K; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the selective disclosure rules by issuers of material nonpublic information under Regulation&#160;FD. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will be required to file an annual report on Form 20-F within four&#160;months of the end of each fiscal year. In addition, we intend to publish our results on a quarterly basis as press releases, distributed pursuant to the rules and regulations of the Nasdaq Stock Market. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information that would be made available to you were you investing in a U.S. domestic issuer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As discussed above, we are a foreign private issuer, and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act. The determination of foreign private issuer status is made annually on the last business day of an issuer&#8217;s most recently completed second fiscal quarter, and, accordingly, the next determination will be made with respect to us on June&#160;30, 2022. We would lose our foreign private issuer status if, for example, as of the applicable determination date, more than 50% of our ordinary shares are directly or indirectly held by residents of the United States and we fail to meet additional requirements necessary to maintain our foreign private issuer status. If we lose our foreign private issuer status on June&#160;30, 2022, we will be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer forms beginning on January&#160;1, 2023, which are more detailed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and extensive than the forms available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers, directors and principal shareholders will become subject to the short-swing profit disclosure and recovery provisions of the Exchange Act. In addition, we will lose our ability to rely upon exemptions from certain corporate governance requirements under the Nasdaq Stock Market listing rules. As a U.S. listed public company that is not a foreign private issuer, we would incur significant additional legal, accounting and other expenses that we would not otherwise incur as a foreign private issuer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As an exempted company incorporated in the Cayman Islands, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq corporate governance listing standards. These practices may afford less protection to shareholders than they would enjoy if we complied fully with the Nasdaq corporate governance listing standards.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a Cayman Islands exempted company listed on the Nasdaq, we are subject to the Nasdaq corporate governance listing standards. However, the Nasdaq permits a foreign private issuer like us to follow the corporate governance practices of its home country. Certain corporate governance practices in the Cayman Islands, which is our home country, may differ significantly from the Nasdaq corporate governance listing standards. For instance, we are not required to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">have a majority of the board be independent (although all of the members of the audit committee must be independent under the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">have a compensation committee or a nominations or corporate governance committee consisting entirely of independent directors; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">have regularly scheduled executive sessions with only independent directors each year. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may rely on home country practice with respect to our corporate governance after we complete this offering. If we choose to follow home country practice in the future, our shareholders may be afforded less protection than they otherwise would enjoy under the Nasdaq corporate governance listing standards applicable to U.S. domestic issuers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As a &#8220;controlled company&#8221;, we are exempt from certain Nasdaq corporate governance requirements, which may result in our independent directors not having as much influence as they would if we were not a controlled company.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a &#8220;controlled company&#8221; as defined under the Nasdaq Stock Market Rules, because one of our shareholders holds more than 50% of our voting power. As a result, for so long as we remain a controlled company as defined under that rule, we are exempt from, and our shareholders generally are not provided with the benefits of, some of the Nasdaq Stock Market corporate governance requirements, including that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a majority of our board of directors must be independent directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our compensation committee must be composed entirely of independent directors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our corporate governance and nomination committee must be composed entirely of independent directors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although we intend to reconstitute our board of directors and to have a majority of independent directors, that may change in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Because we do not expect to pay dividends in the foreseeable future, you must rely on price appreciation of our ADSs for return on your investment.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently intend to retain most, if not all, of our available funds and any future earnings to fund the development and growth of our business. As a result, we do not expect to pay any cash dividends in the foreseeable future. Therefore, you should not rely on an investment in the ADSs as a source for any future dividend income. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board of Directors has complete discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our directors. Under Cayman Islands law, a Cayman Islands company may pay a dividend out of either profit or share premium account, provided that in no circumstances may a dividend be paid if this would result in the company being unable to pay its debts as they fall due in the ordinary course of business. Even if our Board of Directors decides to declare and pay dividends, the timing, amount and form of future dividends, if any, will depend on our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received by us from our subsidiaries, our financial condition, contractual restrictions and other factors deemed relevant by our Board of Directors. Accordingly, the return on your investment in the ADSs will likely depend entirely upon any future price appreciation of the ADSs. There is no guarantee that the ADSs will appreciate in value after this offering or even maintain the price at which you purchased the ADSs. You may not realize a return on your investment in the ADSs and you may even lose your entire investment in the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be classified as a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. investors of our ADSs or ordinary shares.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on current estimates of our gross income and the value of our gross assets (including goodwill) and the manner in which we conduct our business, we do not expect to be a passive foreign investment company (&#8220;PFIC&#8221;) for U.S. federal income tax purposes for the taxable year 2022. Despite our expectation, there can be no assurance that we will not be a PFIC in the current taxable year or any future taxable year as PFIC status is tested each taxable year and will depend on the composition of our assets and income and the value of our assets in each such taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A non-U.S. corporation is a passive foreign investment company (&#8220;PFIC&#8221;) for U.S. federal income tax purposes for any taxable year in which (after taking into account the income and assets of subsidiaries in which it owns at least a 25% interest by value), (i)&#160;at least 75% of its gross income is &#8220;passive&#8221; income, such as interest and income from financial investments (the &#8220;income test&#8221;) or (ii)&#160;at least 50% of the average value of its assets (generally determined on a quarterly basis) consists of assets that produce or are held to produce passive income (the &#8220;asset test&#8221;). For purposes of the asset test, any cash and cash equivalents (such as bank deposits) will count as passive assets, and goodwill should be treated as an active asset to the extent associated with activities that produce or intended to produce active income. In determining the average&#160;percentage value of our gross assets, the aggregate value of our assets will generally be deemed to be equal to our market capitalization (determined by the sum of the aggregate value of our outstanding equity) plus our liabilities. We could be a PFIC for any future taxable year if our market capitalization were to decrease significantly while we hold substantial cash and cash equivalents, or if the gross income that we and our subsidiaries earn from investing the portion of cash raised in this offering is substantial in comparison with the gross income from our business operation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we were treated as a PFIC for any taxable year, then U.S. investors could be subject to adverse U.S. federal income tax consequences (regardless of whether we continue to be a PFIC), including increased tax liability on disposition gains and certain &#8220;excess distributions&#8221; and additional reporting requirements. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">See</font><font style="letter-spacing:0.2pt;"> &#8220;United States Federal Income Tax Considerations&#8201;&#8212;&#8201;Passive Foreign Investment Company&#8221; for further information. U.S. investors should consult their tax advisers regarding our PFIC status for any taxable year and the potential application of the PFIC rules to an investment in our ADSs or ordinary shares including the availability and the advisability of making certain elections under the PFIC rules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and we may take advantage of certain exemptions from requirements applicable to other public companies that are not emerging growth companies, including, most significantly, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002 for so long as we remain an emerging growth company. As a result, if we elect not to comply with such auditor attestation requirements, our investors may not have access to certain information they may deem important.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. Pursuant to the JOBS Act, we have elected to take advantage of the benefits of this extended transition period for complying with new or revised accounting standards. As a result, our operating results and financial statements may not be comparable to the operating results and financial statements of other companies who have adopted the new or revised accounting standards.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will remain an emerging growth company until the earliest of (a) the last day of the fiscal year during which we have total annual gross revenues of at least US$1.07 billion; (b) the last day of our fiscal year following the fifth anniversary of the completion of this offering; (c) the date on which we have, during the preceding three-year period, issued more than US$1.0 billion in non-convertible debt; or (d) the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of the ADSs that are held by non-affiliates exceeds US$700 million as of the last business day of our most recently completed second fiscal quarter. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot predict if investors will find our ADSs less attractive because we may rely on these exemptions. If some investors find our ADSs less attractive as a result, there may be a less active trading market for our ADSs and the price of our ADSs may be more volatile. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We expect to incur increased costs as a result of being a public company, and will incur further increased costs after we cease to qualify as an &#8220;emerging growth company.&#8221;</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will become a public company after this offering, and expect to incur significant legal, accounting and other expenses that we would not incur as a private company. The Sarbanes-Oxley Act of 2002, as well as rules subsequently implemented by the SEC and the Nasdaq Stock Market, impose various requirements on the corporate governance practices of public companies. As a company with less than US$1.07&#160;billion in revenues for our last fiscal year, we qualify as an &#8220;emerging growth company&#8221; pursuant to the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section&#160;404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth company&#8217;s internal control over financial reporting and permission to delay adopting new or revised accounting standards until such time as those standards apply to private companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect these rules and regulations to increase our legal and financial compliance costs and to make some corporate activities more time-consuming and costly. After we are no longer an &#8220;emerging growth company,&#8221; we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002 and the other rules and regulations of the SEC. For example, as a result of becoming a public company, we need to increase the number of independent directors and adopt policies regarding internal controls and disclosure controls and procedures. We also expect that operating as a public company will make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. In addition, we will incur additional costs associated with our public company reporting requirements. It may also be more difficult for us to find qualified persons to serve on our board of directors or as executive officers. We are currently evaluating and monitoring developments with respect to these rules and regulations, and we cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the timing of such costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the past, shareholders of a public company often brought securities class action suits against the company following periods of instability in the market price of that company&#8217;s securities. If we were involved in a class action suit, it could divert a significant amount of our management&#8217;s attention and other resources from our business and operations, which could harm our results of operations and require us to incur significant expenses to defend the suit. Any such class action suit, whether or not successful, could harm our reputation and restrict our ability to raise capital in the future. In addition, if a claim is successfully made against us, we may be required to pay significant damages.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSPNR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains forward-looking statements that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the sections entitled &#8220;Prospectus Summary,&#8221; &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Business.&#8221; Known and unknown risks, uncertainties and other factors, including those listed under &#8220;Risk Factors,&#8221; may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You can identify some of these forward-looking statements by words or phrases such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;aim,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;is/are likely to,&#8221; &#8220;potential,&#8221; &#8220;continue&#8221; or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing of the initiation, progress and potential results of our preclinical studies, clinical trials and our discovery programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing and likelihood of regulatory filings and approvals, including with respect to additional indications beyond the initial indication for which we are seeking approval for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to advance our product candidates into drugs, and the successful completion of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the approval, commercialization, pricing and reimbursement of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the competitive landscape and size of the market opportunity for our product candidates, including our estimates of the number of patients who suffer from the diseases we are targeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">estimates of our costs, expenses, future revenues, capital expenditures and our needs for additional financing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to continue as a going concern; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to attract and retain senior management and key employees; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our future business development, financial condition and results of operations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">future developments, trends, conditions and competitive landscape in the industry and markets in which we operate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our strategies, plans, objectives and goals and our ability to successfully implement these strategies, plans, objectives and goals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">costs associated with enforcing or defending against intellectual property infringement, misappropriation or violation, product liability and other claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to establish and maintain collaborations or licensing agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to identify and integrate new product candidates, technologies and/or suitable acquisition targets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to effectively manage our growth; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our proposed use of proceeds; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">changes to regulatory and operating conditions in our industry and markets. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">potential impact of the COVID-19 pandemic on our current and future business development, financial condition and results of operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You should read this prospectus completely and with the understanding that our actual future results may be materially different from and worse than what we expect. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for our management to predict all the risk factors and uncertainties, nor can we assess the impact of all factors on </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:536pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this prospectus relate only to events or information as of the date on which the statements are made in this prospectus. Except as required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:78pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We estimate that we will receive net proceeds from this offering of approximately US$32.2 million, or approximately US$37.2 million if the underwriters exercise their option to purchase additional ADSs, after deducting underwriting discounts and commissions and the estimated offering expenses payable by us. These estimates are based upon an assumed initial public offering price of US$6.00&#160;per ADS, which is the midpoint of the price range shown on the front page of this prospectus. A US$1.00 increase (decrease) in the assumed initial public offering price of US$ per ADS would increase (decrease) the net proceeds to us from this offering by US$5.6 million (5.6 million), assuming the number of ADSs offered by us, as set forth on the front cover of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated expenses payable by us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The primary purposes of this offering are to create a public market for our shares for the benefit of all shareholders, retain talented employees by providing them with equity incentives, and obtain additional capital. We plan to use the net proceeds of this offering as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approximately 2.5% for our Phase&#160;3 clinical trial of LBS-008 for STGD1, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approximately 68.2% for further clinical development of LBS-008 for dry AMD, such as Phase&#160;2 or Phase&#160;3 clinical trials, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the remainder for working capital and other general corporate purposes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We estimate the net proceeds of this offering would enable us to complete our ongoing Phase 2 and Phase 3 clinical trials of LBS-008 for STGD1, and to obtain interim results of our anticipated Phase 2 or Phase 3 clinical trials of LBS-008 for dry AMD. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The foregoing represents our current intentions based upon our present plans and business conditions to use and allocate the net proceeds of this offering. Our management, however, will have broad discretion in the application of our net proceeds from this offering, and investors will be relying on the judgment of our management regarding the application of these proceeds. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to This Offering and Our ADSs&#8201;&#8212;&#8201;We have considerable discretion to determine how to use the net proceeds from this offering and may use them in ways with which you may not agree or that may not ultimately yield a favorable return or increase the price of the ADSs.&#8221; Due to the many variables inherent in the development of product candidates, such as the size and timing of patient enrollment, evolving regulatory requirements and the associated costs, we cannot currently predict the stage of development that we will be able to achieve for the product candidates in our pipeline with the net proceeds of this offering. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the results of the preclinical studies and clinical trials of our product candidates, our operating costs and expenditures, any strategic collaborations that we may enter into with third parties and the amount of cash generated by our operations. If an unforeseen event occurs or business conditions change, we may use the proceeds of this offering differently than as described in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In using the proceeds of this offering, we are permitted as an offshore holding company to provide funding under PRC laws and regulations to our PRC subsidiary only through loans or capital contributions. Subject to satisfaction of the applicable government registration and approval requirements, we may extend inter-company loans to our PRC subsidiary or make additional capital contributions to our PRC subsidiary to fund its research and development, capital expenditures or working capital. We cannot assure you that we will be able to obtain these government registrations or approvals on a timely basis, or at all. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:332pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DIVIDEND POLICY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have not previously declared or paid cash dividends on our ordinary shares and we have no plan to declare or pay any dividends in the near future on our ordinary shares or ADSs. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Board of Directors has discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, subject to the provisions in our articles of association, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our Board of Directors. Even if our Board of Directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that the board of directors may deem relevant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a holding company incorporated in the Cayman Islands. We have not received and do not have any present plan to receive dividends paid by our U.S., Australia, Hong Kong and PRC subsidiaries, but we have discretion as to whether such dividends are paid, subject to applicable statutory and contractual restrictions, including PRC regulations which may govern the ability of our PRC subsidiary to pay dividends to us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we pay any dividends on our ordinary shares, we will pay those dividends which are payable in respect of the underlying ordinary shares represented by the ADSs to the depositary, as the registered holder of such ordinary shares, and the depositary then will pay such amounts to the ADS holders in proportion to the underlying ordinary shares represented by the ADSs held by such ADS holders, subject to the terms of the deposit agreement, including the fees and expenses payable thereunder. See &#8220;Description of American Depositary Shares.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:25pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAPITALIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth our capitalization as of December 31, 2021: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">on an actual basis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">on a pro&#160;forma basis to reflect the automatic conversion of all of the issued and outstanding preferred shares on a one-for-one basis into ordinary shares immediately prior to the completion of this offering; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">on a pro&#160;forma as adjusted basis to reflect (i)&#160;the automatic conversion of all of the issued and outstanding preferred shares on a one-for-one basis into ordinary shares immediately prior to the completion of this offering; and (ii)&#160;the issuance and sale of 6,000,000 ordinary shares in the form of ADSs by us in this offering at an assumed initial public offering price of US$6.00 per ADS, the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should read this table together with our consolidated financial statements and the related notes included elsewhere in this prospectus and the information under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; </font>
        </div>
        <table style="width:456pt;margin-bottom:5.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.44pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December 31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.44pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Actual </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro&#160;forma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro&#160;forma</font>
                <br >
                <font style="letter-spacing:-0.16pt;">as adjusted</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:304.44pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in US$ thousands, except</font>
                <br >
                <font style="letter-spacing:-0.16pt;">for shares and per share data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:304.44pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:304.44pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Convertible preferred shares</font><font style="font-weight:normal;letter-spacing:0.2pt;">: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:304.44pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred shares, US$0.0001 par value; 2,377,642&#160;shares (actual) and no shares (pro&#160;forma and pro&#160;forma as&#160;adjusted) authorized; 2,377,642 shares issued and outstanding (actual); no shares issued and outstanding (pro&#160;forma and pro&#160;forma as adjusted) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">8,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:304.44pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B convertible preferred shares, US$0.0001 par value; 5,443,272&#160;shares (actual) and no shares (pro&#160;forma and pro&#160;forma as&#160;adjusted) authorized; 5,443,272 shares issued and outstanding (actual); no shares issued and outstanding (pro&#160;forma and pro&#160;forma as adjusted) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">23,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.44pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total convertible preferred shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.44pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Shareholders&#8217; deficit:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:304.44pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary shares, par value of US$0.0001 per share; 492,179,086 shares authorized; 10,274,403 shares issued and outstanding (actual); 18,095,317 and 24,095,317&#160;shares issued and outstanding (pro&#160;forma and pro forma as adjusted) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.44pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">12,325</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">44,130</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">75,561</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.44pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated other comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(196<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(196<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(196<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:304.44pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(27,223<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,223<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,223<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:304.44pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Total shareholders&#8217; equity (deficit)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(15,093<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">16,713</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">48,144</td>
            <td style="padding:0pt;padding-left:3.725pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:510pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The pro&#160;forma as adjusted information discussed above is illustrative only. Our additional paid-in capital, total shareholders&#8217; (deficit) equity, and total convertible preferred shares and shareholders&#8217; (deficit) equity following the completion of this offering are subject to adjustment based on the actual initial public offering price and other terms of this offering determined at pricing.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A US$1.00 increase (decrease) in the assumed initial public offering price of US$6.00 per ADS, the midpoint of the range set forth on the cover page of this prospectus, would increase (decrease) each of additional paid-in capital, and total shareholders&#8217; (deficit)/equity, by US$5.6 million ($5.6 million). </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DILUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you invest in the ADSs, your interest will be diluted to the extent of the difference between the initial public offering price per ADS and our net tangible book value per ADS after this offering. Dilution results from the fact that the initial public offering price per ordinary share is substantially in excess of the net tangible book value per ordinary share attributable to the existing shareholders for our presently outstanding ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our net tangible book value as of December 31, 2021 was approximately US$15.9&#160;million, representing US$0.88 per ordinary share on a pro&#160;forma basis and US$0.88 per ADS. Net tangible book value represents the amount of our total consolidated tangible assets less total consolidated liabilities. Pro Forma net tangible book value per ordinary share is calculated after giving effect to the automatic conversion of all of our issued and outstanding convertible preferred shares. Dilution is determined by subtracting pro&#160;forma net tangible book value per ordinary share, after giving effect to the additional proceeds we will receive from this offering, from the assumed initial public offering price of US$6.00 per ordinary share, which is the midpoint of the estimated initial public offering price range set forth on the front cover of this prospectus adjusted to reflect the ADS-to-ordinary share ratio, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Without taking into account any other changes in pro&#160;forma net tangible book value after December&#160;31, 2021, after giving effect to our sale of the ADSs offered in this offering at the assumed initial public offering price of US$6.00 per ADS, which is the midpoint of the estimated initial public offering price range, after deduction of the underwriting discounts and commissions and estimated offering expenses payable by us, our pro&#160;forma as adjusted net tangible book value as of December&#160;31, 2021 would have been US$48.1&#160;million, or US$2.00 per ordinary share and US$2.00 per ADS. This represents an immediate increase in net tangible book value of US$1.12 per ordinary share and US$1.12 per ADS to the existing shareholders and an immediate dilution in net tangible book value of US$4.00 per ordinary share and US$4.00 per ADS to investors purchasing ADSs in this offering. The following table illustrates such dilution: </font>
        </div>
        <table style="width:456pt;height:125.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.09pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36.45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36.45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per </font>
                <br >
                <font style="letter-spacing:-0.16pt;">ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:359.09pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Assumed initial public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:36.45pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$6.00 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:36.45pt;">
              <font style="letter-spacing:0.2pt;">US$6.00 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.09pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net tangible book value as of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.45pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$1.55 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.45pt;">
              <font style="letter-spacing:0.2pt;">US$1.55 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:359.09pt;white-space:normal;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma net tangible book value after giving effect to the conversion of our preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36.45pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$0.88 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36.45pt;">
              <font style="letter-spacing:0.2pt;">US$0.88</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:359.09pt;white-space:normal;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma as adjusted net tangible book value after giving effect to the conversion of our preferred shares and this offering </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36.45pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$2.00 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36.45pt;">
              <font style="letter-spacing:0.2pt;">US$2.00 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:359.09pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Amount of dilution in net tangible book value to new investors in this offering </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:36.45pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$4.00 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:36.45pt;">
              <font style="letter-spacing:0.2pt;">US$4.00</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A US$1.00 increase (decrease) in the assumed initial public offering price of US$6.00 per ADS would increase (decrease) our pro&#160;forma as adjusted net tangible book value after giving effect to this offering by US$5.6 million, the pro&#160;forma as adjusted net tangible book value per ordinary share and per ADS after giving effect to this offering by US$0.23 per ordinary share and US$0.23 per ADS, and the dilution in pro&#160;forma as adjusted net tangible book value per ordinary share and per ADS to new investors in this offering by US$0.77 per ordinary share and US$0.77 per ADS, assuming no change to the number of ADSs offered by us as set forth on the front cover of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the representative of the underwriters exercise in full the option to purchase additional ADSs from us, based on the assumed public offering price of US$6.00 per ADS, the pro&#160;forma as adjusted net tangible book value after this offering would be US$2.12 per ordinary share and US$2.12 per ADS, and the dilution to new investors purchasing ADSs in this offering would be US$3.88 per ordinary share and US$3.88 per ADS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes, on a pro&#160;forma as adjusted basis as of December&#160;31, 2021, the differences between existing shareholders and the new investors with respect to the number of ordinary </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:372pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">shares (represented by ADSs) purchased from us, the total consideration paid and the average price per ordinary share and per ADS paid before deducting the underwriting discounts and commissions and estimated offering expenses payable by us. The total number of ordinary shares does not include ordinary shares underlying the ADSs issuable upon the exercise of the option to purchase additional ADSs granted to the underwriters. </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:22.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:151.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchased </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="7">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total Consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36.45pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price Per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36.45pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Per</font>
                <br >
                <font style="letter-spacing:-0.16pt;">ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:151.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:64.16pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:151.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Existing shareholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">18,095,317</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">75<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:64.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">US$44,132,000</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">55<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:36.45pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">US$2.44</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:36.45pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">US$2.44 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:151.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">New investors </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">6,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">25<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.5pt 0pt 2.5pt 0pt; width:64.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">US$36,000,000</font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">45<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:36.45pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">US$6.00</font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:36.45pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">US$6.00 </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:151.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">24,095,317</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">100.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:64.16pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">US$80,132,000</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">100.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:1.18pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:36.45pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:36.45pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The pro&#160;forma as adjusted information discussed above is illustrative only. Our net tangible book value following the completion of this offering is subject to adjustment based on the actual initial public offering price of the ADSs and other terms of this offering determined at pricing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The discussion and table above assume no exercise of any share options outstanding as of the date of this prospectus. As of the date of this prospectus, there are 1,982,561 outstanding options with an average exercise price of US$0.4626 per share. To the extent that any of these options are exercised, there will be further dilution to new investors. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tECL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ENFORCEABILITY OF CIVIL LIABILITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are incorporated under the laws of the Cayman Islands as an exempted company with limited liability. We are incorporated in the Cayman Islands to take advantage of certain benefits associated with being a Cayman Islands exempted company, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">political and economic stability, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an effective judicial system, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a favorable tax system, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the absence of foreign exchange control or currency restrictions, and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the availability of professional and support services. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, certain disadvantages accompany incorporation in the Cayman Islands. These disadvantages include but are not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the Cayman Islands has a less developed body of securities laws as compared to the United States and these securities laws provide significantly less protection to investors as compared to the United States; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Cayman Islands companies may not have standing to sue before the federal courts of the United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our memorandum and articles of association does not contain provisions requiring that disputes, including those arising under the securities laws of the United States, between us, our officers, directors, and shareholders, be arbitrated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Most of our directors and officers are nationals or residents of jurisdictions other than the United States and most of their assets are located outside the United States. As a result, it may be difficult for a shareholder to effect service of process within the United States upon these individuals, or to bring an action against us or these individuals in the United States, or to enforce against us or them judgments obtained in United States courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States. As of the date of this prospectus, none of our officers, directors or other members of our senior management are located in China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have appointed Puglisi &amp; Associates, located at 850 Library Avenue, Suite 204, Newark, Delaware&#160;19711, as our agent upon whom process may be served in any action brought against us under the securities laws of the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Maples and Calder (Hong Kong) LLP, our counsel as to Cayman Islands law, has advised us that there is uncertainty as to whether the courts of the Cayman Islands would (a)&#160;recognize or enforce judgments of U.S. courts obtained against us or our directors or officers that are predicated upon the civil liability provisions of the federal securities laws of the United States or the securities laws of any state in the United States, or (b)&#160;entertain original actions brought in the Cayman Islands against us or our directors or officers that are predicated upon the federal securities laws of the United States or the securities laws of any state in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Maples and Calder (Hong Kong) LLP has informed us that although there is no statutory enforcement in the Cayman Islands of judgments obtained in the federal or state courts of the United States (and the Cayman Islands are not a party to any treaties for the reciprocal enforcement or recognition of such judgments), the courts of the Cayman Islands would recognize and enforce a final and conclusive judgement in personam obtained in federal or state courts in the United States under which a sum of money is payable (other than a sum of money payable in respect of multiple damages, taxes or other charges of a like nature, a fine or a penalty or similar fiscal or revenue obligations) or, in certain circumstances, an in personam judgment for non-monetary relief, and would give a judgment based thereon provided that: (a)&#160;such courts had proper jurisdiction over the parties subject to such judgment; (b)&#160;such courts did not contravene the rules of the natural justice of Cayman Islands; (c)&#160;such judgment was not obtained by fraud; (d)&#160;such judgment was not obtained in a manner, and is not of a kind the enforcement of which, is contrary to natural justice or the public policy of the Cayman Islands; (e)&#160;no new admissible evidence relevant to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:544pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">action is submitted prior to the rendering of the judgment by the courts of the Cayman Islands; and (f)&#160;there is due compliance with the correct procedures under the laws of the Cayman Islands. However, the Cayman Islands courts are unlikely to enforce a punitive judgment of a United States court predicated upon the civil liability provisions of the federal securities laws in the United States without retrial on the merits if such judgment is determined by the courts of the Cayman Islands to give rise to obligations to make payments that may be regarded as fines, penalties or punitive in nature. A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCHA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CORPORATE HISTORY AND STRUCTURE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Corporate History</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company was incorporated under the laws of the Cayman Islands on March&#160;27, 2018. We are engaged in research and development of novel therapeutics targeting significant unmet needs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, Lin BioScience, Inc., a public company in Taiwan (stock code: 6696.TW), which is our ultimate controlling shareholder (i.e., the sole shareholder of our principal shareholder, Lin Bioscience International Ltd.), established Belite Bio Holdings Corp. (formerly known as Lin BioScience Holdings Corporation) and Belite Bio, LLC (formerly known as Lin BioScience, LLC), in Delaware. Belite Bio Holdings Corp. is an intermediate holding company and owns 100% equity interests in Belite Bio, LLC, which is mainly engaged in research and development of LBS-008 and LBS-009. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2018, as a part of a reorganization, Lin BioScience, Inc. established the Company (formerly known as Lin BioScience Co., Ltd.) in the Cayman Islands, as a subsidiary to its wholly-owned subsidiary Lin Bioscience International Ltd. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, as a part of the reorganization, Lin Bioscience International Ltd., acquired the entire equity interest in Belite Bio Holdings Corp. from Lin BioScience, Inc. and then contributed the entire equity interest in Belite Bio Holdings Corp. to us in July&#160;2018. After this contribution, Belite Bio Holdings Corp. became our wholly-owned subsidiary, which in turn owns 100% equity interests in Belite Bio, LLC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before and after the reorganization, we were, together with our subsidiaries, effectively controlled by the same shareholders, and therefore the reorganization is considered a recapitalization of entities under common control in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 805-50-25. The consolidation of us and our subsidiaries have been accounted for at historical cost in the accompanying consolidated financial statements in accordance with ASC 805-50-45-5. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2018, Belite Bio Holdings Corp. established RBP4 Pty Ltd in Australia as its wholly-owned subsidiary for carrying out clinical trials in Australia and tax refund purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, we established Belite Bio (HK) Limited in Hong Kong as a wholly-owned subsidiary which established Belite Bio (Shanghai) Limited in Shanghai, China in August&#160;2021 with an aim to carry out clinical trials of our product candidates in China in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Corporate Structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The chart below sets forth our corporate structure and identifies our significant subsidiaries and their significant subsidiaries, as of the date of this prospectus:</font>
        </div>
        <div style="position:relative;margin-top:8.51pt; text-align:center; width:456pt;">
          <img src="tm2132809d1-fc_beltebw.jpg" alt="[MISSING IMAGE: tm2132809d1-fc_beltebw.jpg]" height="314" width="579" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SELECTED CONSOLIDATED FINANCIAL DATA</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following selected consolidated statement of operations and comprehensive loss data for the years ended December&#160;31, 2020 and 2021 and selected consolidated balance sheet data as of December&#160;31, 2020 and December&#160;31, 2021 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our consolidated financial statements are prepared and presented in accordance with U.S. GAAP. Our historical results do not necessarily indicate results expected for any future periods. You should read this Selected Consolidated Financial Data section together with our consolidated financial statements and the related notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included elsewhere in this prospectus. </font>
        </div>
        <table style="width:456pt;height:165pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:332.13pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Year Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:332.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:332.13pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In thousand US Dollars, except </font>
                <br >
                <font style="letter-spacing:-0.16pt;">share and per share amounts) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:332.13pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Selected Consolidated Statements of Operations and Comprehensive Loss</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:332.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total operating expenses</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,743</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,797</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:332.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total other (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:332.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:332.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total comprehensive loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,747<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,818<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 0.833pt 0pt; width:332.13pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted average number of ordinary shares used in per share calculation, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8,790,397</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,569,932</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:332.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per ordinary share, basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(0.65<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(1.01<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.26pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Total share-based compensation costs were recognized as follows for the years ended December&#160;31, 2020 and 2021: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:99pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:340.81pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year Ended </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:340.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:45.59pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:45.59pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December 31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:340.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in $ </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">77</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">52</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,286</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,478</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,363</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:154pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:340.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.59pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.59pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">December 31, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:340.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in $ </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Selected Consolidated Balance Sheets Data:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,618</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">17,344</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,741</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">18,348</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">972</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,635</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total convertible preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total shareholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(7,037<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(15,093<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:340.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total liabilities, convertible preferred shares and shareholders&#8217; deficit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,741</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">18,348</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMDA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION </font>
          <br >
          <font style="letter-spacing:-0.2pt;">AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">You should read the following discussion and analysis of our financial condition and results of operations together with &#8220;Selected Consolidated Financial Data,&#8221; and our financial statements and the related notes appearing elsewhere in this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should read the &#8220;Risk factors&#8221; and &#8220;Cautionary note regarding forward-looking statements&#8221; sections of this prospectus for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. The terms &#8220;our company&#8221;, &#8220;we&#8221;, &#8220;our&#8221; or &#8220;us&#8221; as used herein refer to Belite Bio, Inc and its subsidiaries unless otherwise stated or indicated by context.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration (commonly known as dry AMD) and autosomal recessive Stargardt disease, or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe our lead product candidate, LBS-008, or Tinlarebant, if approved, would provide a novel treatment option where there currently is none. LBS-008 is an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A (retinol) to the eye as a means to reduce the accumulation of toxic vitamin A by-products in ocular tissue. This effect is achieved through the ability of LBS-008 to reduce and maintain the level of serum retinol binding protein 4, or RBP4, which carries retinol from the liver to the eye. In clinical trials, LBS-008 has demonstrated its target specificity and potency that we believe could be clinically meaningful to treat STGD1 patients. We initiated an open-label, dose-finding Phase&#160;1b/2 clinical trial in adolescent STGD1 patients in mid-2020 in Australia and Taiwan. The study design includes two portions: Phase&#160;1b and Phase&#160;2. We have completed the Phase&#160;1b portion of this study in 11 adolescent STGD1 patients which has extended into a two-year, Phase&#160;2 study with 13 adolescent STGD1 patients in Australia and Taiwan. The preliminary data from the Phase&#160;1b portion has shown that LBS-008 can achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. We are currently conducting the Phase&#160;2 portion of this study. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have initiated our Phase&#160;3 clinical trial, to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. Previously, we completed a Phase&#160;1 clinical trial of LBS-008 in healthy adult subjects in mid-2020. We are currently evaluating our plans to conduct a Phase&#160;2 or Phase&#160;3 trial in 2022 to evaluate the safety and efficacy of LBS-008 in the treatment of dry AMD. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since our inception in 2016, our operations have focused on organizing and staffing our Company, business planning, raising capital, acquiring rights to product candidates, developing our product candidates, including conducting preclinical studies and clinical trials, and establishing our intellectual property portfolio. Our ultimate controlling shareholder, Lin BioScience, Inc., obtained from Columbia University an exclusive worldwide license to the RBP4 IP Portfolio, which contains disclosure directed to over 400 structurally distinct compounds including our lead product candidate, LBS-008, in September&#160;2016, which was initially assigned to our principal shareholder, Lin Bioscience International Ltd., and subsequently assigned to us in 2018. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To date, we have not generated any revenues. We have financed our operations primarily through approximately $40.6&#160;million in proceeds from the issuance of our ordinary shares, the private placement of shares of our convertible preferred stock and the issuance of our convertible promissory notes. We have incurred annual net operating losses in each year since our inception and expect to continue to incur net </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">operating losses for the foreseeable future. Our net losses were approximately $5.8&#160;million and $9.7 million for the years ended December&#160;31, 2020 and 2021, respectively. As of December&#160;31, 2021, we had an accumulated deficit of approximately $27.2&#160;million. Our independent registered public accounting firm has included in its audit report on our financial statements as of and for the year ended December&#160;31, 2021, an explanatory paragraph regarding a substantial doubt about our ability to continue as a going concern. We expect to continue to incur significant expenses and increasing operating losses for the next several&#160;years. Our net losses may fluctuate significantly from quarter to quarter and year to year depending on the progress of our clinical trials and the payment schedule between us and the CROs engaged by us. We anticipate that our expenses will increase significantly if and as we continue to develop and conduct clinical trials in our current indications with LBS-008, including our ongoing Phase&#160;2 and Phase&#160;3 trials in STGD1 and an anticipated Phase&#160;2 or Phase&#160;3 trial in dry AMD; initiate and continue research and preclinical and clinical development efforts for any future product candidates; leverage our exclusive RBP4 IP Portfolio to identify and develop additional product candidates and/or for additional indications; further expand our product pipeline through in-licensing or collaboration arrangements; seek regulatory and marketing approvals for our product candidates and complete clinical trials, if any; establish strategic collaborations or sales, marketing distribution and other commercial infrastructure in the future to commercialize any products for which we may obtain marketing approval; require the manufacture of larger quantities of product candidates for clinical development and, potentially, commercialization; maintain, expand and protect our intellectual property portfolio; hire and retain additional personnel, such as clinical and scientific personnel; add operational, financial and management information systems and personnel, including personnel to support our product development and help us comply with our obligations as a public company; and add equipment and physical infrastructure to support our research and development programs. In addition, upon the closing of this offering, we expect to incur additional costs associated with operating as a public company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ability to become and remain profitable depends on our ability to generate product revenue. We do not expect to generate product revenue unless, and until, we enter into an out-license and/or collaboration agreement with others for, or we obtain marketing approval for, and commercialize, a product candidate, and we cannot assure you that we will ever generate revenue or profits. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our current clinical development, manufacturing and commercialization plans and any of our future strategies for growth will be based on our ongoing assessment of macroeconomic trends and the evolving regulatory landscape. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key Factors Affecting Our Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our results of operations, financial condition, and the year-to-year comparability of our financial results have been, and are expected to continue to be, principally affected by the below factors: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Costs and Expenses Structure</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our results of operations are significantly affected by our cost structure, which primarily consists of research and development expenses and general and administrative expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are central to our business model. We believe our ability to successfully develop product candidates will be the primary factor affecting our long-term competitiveness, as well as our future growth and development. Developing high-quality product candidates requires a significant investment of resources over a prolonged period of time, and a core part of our strategy is to continue making sustained investments in this area. Since our inception, we have focused our resources on our research and development activities, including developing our RBP4 IP Portfolio, conducting preclinical studies and clinical trials, and engaging in activities related to regulatory filings for our product candidates. Clinical studies become increasingly more expensive from Phase&#160;1b/2 and onwards due to an increase in the number of subjects enrolled in such studies. Research and development costs are expensed as incurred. Costs for certain activities, such as activities performed by third-party contractors relating to the manufacturing and preclinical studies and clinical trials of our product candidates, are generally accrued based on our estimates of the actual services performed for a given period. These estimates are based on our evaluation of the progress to completion of specific tasks to be performed using information and data provided to us by our third-party contractors and vendors. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At this time, we cannot reasonably estimate the nature, timing and estimated costs of the efforts that will be necessary to complete the development of, or the period, if any, in which material net cash inflows may commence from, any of our product candidates. This is due to the numerous risks and uncertainties associated with developing such product candidates, including, but not limited to, the uncertainty of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, rate of progress and expense of our research and development activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successful completion of clinical trials, including the successful enrollment in such clinical trials, and clinical trial results; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to market, commercialize and achieve market acceptance for any of our product candidates, whether alone or in collaboration with others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to establish manufacturing capabilities and capacities, whether internally or through CMOs, to the specifications of our product candidates for clinical supply; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential benefits of our product candidates over other therapies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining and maintaining patent, trade secret and other intellectual property protection and/or regulatory exclusivity for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the terms and timing of regulatory approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">successful completion of all safety studies required to obtain regulatory approval in the United&#160;States and other applicable jurisdictions for our product candidates; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">maintaining a continued acceptable safety profile of the product candidates following regulatory approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A change in the outcome of any of these variables with respect to the development of any of our product candidates could mean a significant change in the costs, timing and viability of the development of that product candidate. For example, if we are required to conduct additional clinical trials or other testing of any of our product candidates beyond those that are contemplated or if we experience significant delays in enrollment in any clinical trials, we could incur significant additional costs and the clinical development timeline for our product candidates may be delayed. We expect research and development costs to continue to increase for the foreseeable future as we expand our operations and our development of product candidates progresses, including as we continue to support and advance the clinical trials of our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our general and administrative expenses consist primarily of employee salaries and related benefit costs, including share-based compensation expenses, for personnel in executive, finance, accounting and administrative functions. Other general and administrative expenses include professional fees for financial advisory, auditing and legal services. We expect our general and administrative headcount and related expenses to increase in the future to support our clinical program and research and development efforts, and the commercialization of our product candidates in the event approval is obtained. We also anticipate that our general and administrative expenses will increase as we operate as a public company following the completion of this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Funding for Our Operations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the periods presented, we have funded our operations primarily through the issuance and sale of ordinary shares, convertible preferred shares in private placement transactions and convertible promissory notes. See &#8220;Description of Share Capital&#8201;&#8212;&#8201;History of Securities Issuances&#8221; for more information. However, if our business and our product candidate pipeline continue to expand, we may require further funding through public or private offerings, debt financing, collaboration, and licensing arrangements or other sources. Any fluctuation in our ability to fund our operations will impact our development plan, operating plan and our results of operations. In the event of the successful development and commercialization of one or more of our product candidates, we expect to fund our operations in part with revenue generated from sales of our commercialized drug products. In the event that we enter into out-license and/or collaboration arrangements with others, we expect to fund our operations in part with revenue received from such out-license and/or collaboration arrangements. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Ability to Commercialize and/or Out-License Our Product Candidates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our business and results of operations depend on our ability to out-license our product candidates or, in the event any of our product candidates are approved for marketing by the respective regulatory authority in a country, commercialize such product candidates. Currently, our pipeline consists of our lead product candidate, LBS-008, which is currently in clinical development, and LBS-009, which is currently in preclinical development. Although we currently do not have any product approved for commercial sale and have not generated revenue from product sales or out-licensing, we expect to generate revenue either from sales of a product candidate if we complete the clinical development, obtain regulatory approval, and successfully commercialize such product candidate, or from out-licensing a product candidate if we enter into an out-license and/or collaboration agreement for any product candidate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key Components of Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To date, we have not generated any revenue. Our ability to generate revenue and to become profitable will depend upon the successful commercialization of, and/or our successful entry into out-license and/or collaboration arrangements in connection with, one or more of our product candidates. Because of the numerous risks and uncertainties associated with product development and regulatory approval, and out-license and/or collaboration arrangements, we are unable to predict the amount or timing of product revenue or out-license and/or collaboration revenue. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist of costs associated with planning and conducting clinical trials of our product candidates. Our research and development expenses primarily consist of: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">payroll, share-based compensation and other related costs of personnel engaged in research and development activities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in-licensed patent rights fee of exclusive development rights of drugs granted to us under the Columbia License Agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">costs for preclinical testing of our technologies and clinical trials such as payments to CROs and CMOs, investigators and clinical trial sites that conduct the clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">costs to develop our product candidates, including raw materials and supplies, product testing, clinical trial equipment and its depreciation, and facility related expenses; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">other research and development expenses. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Clinical trial costs are a significant component of our research and development expenses. Our current research and development activities primarily relate to the clinical development of LBS-008 for the following indications: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">STGD1.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We are developing LBS-008 as an oral once-a-day treatment for STGD1. STGD1 is an inherited juvenile form of macular degeneration. As of the date of this prospectus, we have initiated our Phase&#160;3 clinical trial, to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. We are also currently conducting our ongoing Phase&#160;2 clinical trial. Previously, we completed a Phase&#160;1b clinical trial of LBS-008 in adolescent patients with STGD1 and a Phase&#160;1 clinical trial of LBS-008 in healthy adult subjects in mid-2020. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Dry AMD.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We are developing LBS-008 as an oral once-a-day treatment for dry AMD. Age-related macular degeneration, or AMD, is a common eye disorder among people over 50. The only approved therapies for AMD are for &#8216;wet&#8217; AMD, which represents approximately 10% of all AMD cases. There are no approved therapies for the other stages of AMD, which are collectively referred to as dry AMD and represents approximately 90% of all AMD cases. We are currently evaluating our </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">plans to conduct a Phase&#160;2 or Phase&#160;3 trial in 2022 to evaluate the safety and efficacy of LBS-008 in the treatment of dry AMD. Previously, we completed a Phase 1 clinical trial of LBS-008 in healthy adult subjects in mid-2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We incurred research and development expenses of approximately $7.4&#160;million for the year ended December&#160;31, 2021, representing approximately 75.7% of our total operating expenses for that period. Our research and development expenses may vary substantially from period to period according to the status of our research and development activities. The timing of expenses is impacted by the commencement of clinical trials and enrollment of patients in clinical trials. Clinical studies become increasingly expensive from Phase&#160;1b/2 and onwards. We expect our research and development expenses to continue to increase for the foreseeable future, as we advance our lead product candidate, LBS-008, toward later stages and continue to expand our operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and Administrative Expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our general and administrative expenses consist primarily of employee salaries and related benefit costs, including share-based compensation expenses, for personnel in executive, finance and administrative functions. Other general and administrative expenses include professional fees for financial advisory, auditing and legal services. For the year ended December&#160;31, 2021, our general and administrative expenses amounted to approximately $2.4&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We anticipate that our general and administrative expenses will increase in the future to support continued research and development activities, including our ongoing and planned research and development of our lead product candidate, LBS-008. We also expect to incur additional expenses as a result of operating as a public company, including expenses related to compliance with the rules and regulations of the SEC, additional insurance expenses, investor relations activities and other administrative and professional services. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest Income (Expenses)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Interest income consists primarily of interest income derived from our cash. Interest expense consists primarily of accrued interest incurred pursuant to loans due to related parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Taxation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cayman Islands</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We are an exempted company with limited liability incorporated in the Cayman Islands. Under the current laws of the Cayman Islands, we are not subject to tax on income or capital gain. Additionally, upon payments of dividends by us to our shareholders, no Cayman Islands withholding tax will be imposed. However, we may be subject to taxation in other jurisdictions in which we operate, in particular, the United&#160;States, Australia, Hong Kong, and/or the PRC, where five of our wholly-owned subsidiaries are&#160;incorporated, if certain conditions are met under the laws and regulations of the Cayman Islands. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">United States</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our subsidiaries, Belite Bio Holdings Corp. and Belite Bio, LLC, which are both incorporated or formed in Delaware, United States, are subject to statutory U.S. Federal corporate income tax at a maximum rate of 21% for the year ended December&#160;31, 2021. Both entities are also subject to state income tax in California at a rate of 8.84% for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Australia</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our subsidiary, RBP4 Pty Ltd, is subject to Australia profits tax on the taxable income as reported in its respective statutory financial statements adjusted in accordance with the relevant Australia tax laws. The applicable tax rate in Australia is 30%. RBP4 Pty Ltd had no taxable income for the periods presented, therefore, no provision for income taxes has been provided. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Hong Kong</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our subsidiary, Belite Bio (HK) Limited, is subject to Hong Kong profits tax at a tax rate of 8.25% for assessable profits on the first HK$2&#160;million and 16.5% for any assessable profits in excess. No Hong Kong profit tax was provided for as there was no estimated assessable profit that was subject to Hong Kong profits tax for the year ended December&#160;31, 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our subsidiary, Belite Bio (Shanghai) Limited is subject to the statutory rate of 25%, in accordance with the EIT Law. Under the EIT Law, dividends, interests, rent or royalties payable by Belite Bio (Shanghai) Limited to non-PRC resident enterprises, and proceeds from any such non-PRC resident enterprise investor&#8217;s disposition of assets (after deducting the net value of such assets) shall be subject to a 10% withholding income tax, unless the respective non-PRC resident enterprise&#8217;s jurisdiction of incorporation has a tax treaty or arrangements with China that provides for a reduced withholding income tax rate or an exemption from withholding income tax. No provision for PRC corporate income tax has been made for the year ended December 31, 2021, as Belite Bio (Shanghai) Limited had no such assessable profit for the year then ended.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Results of Operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of the Fiscal Years Ended December 31, 2020 and 2021</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of our consolidated results of operations for the years ended December 31, 2020 and 2021. This information should be read together with our consolidated financial statements and related notes included elsewhere in this prospectus. The operating results in any period are not necessarily indicative of the results that may be expected for any future period. </font>
        </div>
        <table style="width:456pt;height:303.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:223.27pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:223.27pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:223.27pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(amounts in $ and in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:223.27pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Expenses</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,688</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">7,419</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,731</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">101.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">2,055</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">2,378</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">323</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">15.7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">5,743</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">9,797</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">4,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">70.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss from operations</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,743<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,797<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,054<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">70.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.25pt 0pt 1.5pt 0pt; width:223.27pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Other income (expense):</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">(58.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(21<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">21</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">126</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total other (expense) income, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">140</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">1,555.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss before income tax</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,752<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,914<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">168.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:223.27pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,915<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">168.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.25pt 0pt 1.5pt 0pt; width:223.27pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Other comprehensive income (loss)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:25.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:223.27pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Foreign currency translation adjustments, net of nil tax </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(152<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(158<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(2,633.3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:223.27pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total comprehensive loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(5,747<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(9,818<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,071<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:25.5pt; text-align:right; white-space:nowrap;">(70.8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Total share-based compensation costs were recognized as follows for the year ended December&#160;31, 2020 and 2021: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:316.73pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:316.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:316.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">77</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">52</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:316.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,286</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,478</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:316.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,363</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.1pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We did not generate any revenue during the years ended December 31, 2020 and 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a breakdown of the major components of our research and development expenses in absolute amounts and as a&#160;percentage of our total research and development expenses for the years ended December 31, 2020 and 2021: </font>
        </div>
        <table style="width:456pt;height:111pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:317.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">(in $ thousands, except&#160;percentages) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:317.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Contracted research expenses and clinical trial expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,979</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">53.7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6,384</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">86.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Consultancy and professional service fees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">319</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">492</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Royalties </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,187</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">32.2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">203</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">5.5</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">440</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">6.0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.17pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,688</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">7,419</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our research and development expenses increased by 101.2% from approximately $3.7&#160;million for the year ended December&#160;31, 2020, to approximately $7.4&#160;million for the year ended December&#160;31, 2021. The increase was primarily attributable to increased contracted research expenses and clinical trial expenses relating to our Phase 1b/2 and Phase 3 clinical trials to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients, which were initiated in mid-2020 and 2021, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the year ended December&#160;31, 2021, approximately 86.0% of our total research and development expenses were attributable to contracted research expenses and clinical trial expenses. In the year ended December&#160;31, 2020, approximately 53.7% of our total research and development expenses were attributable to contracted research expenses and clinical trial expenses. Clinical studies become increasingly more expensive from Phase&#160;1b/2 and onwards. LBS-008 is currently undergoing a Phase&#160;2 clinical trial and, as of the date of this prospectus, we have initiated a global Phase&#160;3 clinical trial in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General and Administrative Expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our general and administrative expenses increased by approximately $0.3 million from the year ended December&#160;31, 2020, to the year ended December&#160;31, 2021, which was primarily due to an increase in professional service fees incurred and an increase in our number of employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect these costs to increase materially in the near future, consistent with our plans to increase our headcount in conjunction with this offering and ongoing requirements as a public company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest Expense</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We recorded approximately $21,000 of interest expense for the year ended December&#160;31, 2020, which comprised of the interest expense owing under the 2020 Lin BioScience Loan Agreement and the Cayman 2019 August Loan Agreement, and no interest expense for the year ended December&#160;31, 2021. The change was </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">attributable to the loans under both the 2020 Lin BioScience Loan Agreement and the Cayman 2019 August Loan Agreement being repaid in full in July&#160;2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Income</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We did not record any other income for the year ended December 31, 2020 and recorded approximately $126,000 of other income for the year ended December&#160;31, 2021. Other income primarily consists of foreign exchange gains resulting from transactions undertaken by our Australian subsidiary in its functional currency, the Australian dollar. The increase was attributable to the weakening of the Australian dollar against the U.S. dollar. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Adjustments, Net</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We recorded a net foreign currency gain of approximately $6,000 for the year ended December&#160;31, 2020 and a net foreign currency loss of approximately $152,000 for the year ended December&#160;31, 2021. Foreign currency gain (loss) primarily results from the translation of the Australian dollar denominated financial statements of our Australian subsidiary into the U.S. dollar for consolidation purposes. The decrease was attributable to the weakening of the Australian dollar against the U.S. dollar which negatively impacted the Australian dollar denominated assets held by our Australian subsidiary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and Capital Resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To date, we have not generated any revenues. We incurred net losses of approximately $5.8&#160;million and $9.7 million for the years ended December&#160;31, 2020 and 2021, respectively. Our primary use of cash is funding our research and development expenses. We used approximately $4.4&#160;million and $7.5 million in cash for our operating activities for the years ended December&#160;31, 2020 and 2021, respectively. We have financed our operations to date primarily through the issuance of our ordinary shares, the private placement of our convertible preferred stock and the issuance of our convertible promissory notes. For more information on our equity financing, see &#8220;Description of Share Capital&#8201;&#8212;&#8201;History of Securities Issuances.&#8221; As of December&#160;31, 2021, we had cash of approximately $17.3&#160;million. Our cash consists primarily of demand deposits which is unrestricted as to withdrawal and use and have original maturities of less than three&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our lead product candidate, LBS-008, is still in clinical development. We expect our expenses to increase substantially as compared to prior periods in connection with our ongoing activities, particularly as we continue the development of and seek marketing approval for LBS-008 and, possibly, other product candidates. In addition, if we obtain marketing approval for LBS-008 or any other product candidate that we develop, and we choose to commercialize such product candidate ourselves, we expect to incur significant commercialization expenses related to product sales, marketing, distribution and manufacturing. Furthermore, upon the closing of this offering we expect to incur additional costs associated with operating as a public company. Accordingly, we anticipate that we will need substantial additional funding in connection with our continuing operations. These factors raise substantial doubt about our ability to continue as a going concern. Our financial statements have been prepared assuming that we will continue as a going concern, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities that may result from our possible inability to continue as a going concern. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect that our expenses will continue to increase substantially and that we will continue to incur significant operating losses and negative operating cash flows as we fund both ongoing research and development activities and new activities as well as working capital needs. We have based our estimates on assumptions that may prove to be wrong, and we may use our available capital resources sooner than we currently expect or on alternative uses. Because of the numerous risks and uncertainties associated with the development and commercialization of our product candidates, we are unable to estimate the amounts of increased capital outlays and operating expenditures necessary to complete the development and commercialization of our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After this offering, we may decide to enhance our liquidity position or increase our cash reserve for future operations and investments through additional financing. Our future capital requirements will depend on many factors, including: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number and development requirements of the product candidates we pursue; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, progress, timing, results and costs of discovering, researching and developing product candidates, and conducting preclinical studies and clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the scope, prioritization and number of our research and development programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of regulatory review of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost of manufacturing our product candidates and any products we commercialize, including costs associated with expanding our supply chain; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cost and timing of future commercialization activities, including product manufacturing, marketing, sales and distribution, for any of our product candidates for which we receive regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the cash received, if any, from commercial sales of any product candidates for which we receive regulatory approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such collaborations and arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the extent to which we acquire or in-license other product candidates and technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our headcount growth and associated costs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs, timing and outcome of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">resources required to develop and implement policies and processes to promote ongoing compliance with applicable healthcare laws and regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the impact of COVID-19 on the initiation or completion of preclinical studies or clinical trials and the supply of our product candidates; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the costs of operating as a public company in the United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a holder of our ADSs. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. For additional information regarding the risks related to our need to obtain additional capital, see &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to Our Financial Position and Need for Additional Capital&#8201;&#8212;&#8201;We have recorded net cash outflow from operating activities since our inception. Even if we consummate this offering, we will need to obtain additional financing to fund our operations. If we are unable to obtain such financing, we may be unable to complete the development and commercialization of our product candidates&#8221; and &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to Our Financial Position and Need for Additional Capital&#8201;&#8212;&#8201;Raising additional capital may cause dilution to holders of our ADSs and our shareholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Operating Activities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in operating activities was approximately $4.4&#160;million for the year ended December&#160;31, 2020 and consisted primarily of a net loss of approximately $4.4&#160;million, after non-cash add backs, offset </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">primarily by a decrease in prepayments of approximately $0.2&#160;million and a decrease in accrued expenses of approximately $0.3&#160;million. Net cash used in operating activities was approximately $7.5&#160;million for the year ended December&#160;31, 2021 and consisted primarily of a net loss of approximately $8.1&#160;million, after non-cash add backs, offset primarily by an increase in accrued expenses of approximately $0.6&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investing Activities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in investing activities for the year ended December&#160;31, 2020 was approximately $20,000, which was comprised of an increase in prepayments of purchases of fixed assets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in investing activities during the year ended December&#160;31, 2021 was approximately $56,000, which resulted primarily from the purchase of fixed assets offset by the sale of certain fixed assets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Financing Activities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash provided by financing activities was approximately $28.1&#160;million for the year ended December&#160;31, 2020, which consisted primarily of proceeds from the issuance of our convertible preferred shares, the issuance of our ordinary shares and borrowings under the 2020 Lin BioScience Loan Agreement and the Cayman 2019 August Loan Agreement, partially offset by the repayment of loans due to related parties. The loans under both the 2020 Lin BioScience Loan Agreement and the Cayman 2019 August Loan Agreement were repaid in full in July&#160;2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Net cash used in financing activities was approximately $0.6 million for the year ended December 31, 2021, which consisted primarily of deferred offering costs, partially offset by the exercise of stock options. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contractual Obligations and Commitments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are party to an exclusive license agreement with Columbia University, which has been amended five times, most recently as of February&#160;4, 2022, under which we license specified intellectual property from Columbia University. The patent rights licensed to us by Columbia University include issued patents with claims that recite a class of compounds directed to covering our planned lead compound, LBS-008, and specifically recite LBS-008. The license agreement requires us to make minimum annual royalty payments to Columbia University of (i) $2.5 million on each of the second, third and fourth anniversaries of the first commercial sale of a licensed product and (ii) $5 million on each anniversary of the first commercial sale of a licensed product, commencing on the fifth anniversary of such sale. We will also be obligated to pay single-digit earned royalties to Columbia University based on net sales of each licensed product by us and our affiliates and sublicensees. The minimum royalty payments will be creditable against the earned royalties accrued during the same calendar year. The license agreement obligates us to use commercially reasonable efforts to research, discover, develop and market licensed products for commercial sale and distribution and achieve certain development and regulatory approval milestones within certain timeframes, if certain milestones are achieved. We are also obligated to periodically inform Columbia University of our progress in meeting such milestones. The failure to achieve any such milestone would constitute a breach of the Columbia License Agreement. If we pay Columbia University the required fee, we will be granted a 6-month extension. As of the date of this prospectus, we have complied with the development and regulatory approval milestones under the Columbia License Agreement and requested no extensions. In the event that, after completion of Phase I Trials, there are unforeseen changes in clinical or regulatory development that we believe would affect the timely achievement of any milestone, we may request an extension from Columbia University for such milestone, which will not be unreasonably withheld or delayed. In the event that Columbia University does not agree to extend the deadlines to meet the milestones, and we are in breach for failure to timely meet the milestones or to make milestone or royalty payments, Columbia University may elect to convert our license to a nonexclusive license without the right to sublicense or initiate legal proceedings against third party patent infringers or terminate our license. We are also obligated to make payments to Columbia University in an aggregate amount of up to $20 million based on achieving specified development and regulatory approval milestones and in an amount of up to $25 million based on achieving a specified cumulative sales milestone with respect to the first licensed product. In addition, we are obligated to pay Columbia University a specified portion of revenue (other than royalties) we receive from sublicensees and a percentage of revenue in the low double-digits received from any sale of a priority review voucher by us or a sublicensee. In the event that we or a sublicensee do not sell a priority review voucher within one </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">year of receipt, the earned royalties that we would be obligated to pay to Columbia University based on net sales of licensed products would increase by 1%. We cannot reasonably estimate whether, when and in what amount any of such payments shall be made, but believe we are in compliance with the terms of the license. From inception through December 31, 2021, we have made a payment of $1 million to Columbia University resulting from this license agreement, which was triggered by the completion of our Phase 1 clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We also enter into cancelable contracts in the normal course of business with CROs for clinical </font>
          <br >
          <font style="letter-spacing:0.2pt;">trials, preclinical studies, manufacturing and other services and products for operating purposes. As of the date of this prospectus, the remaining contractual costs expected to be incurred in future periods for our clinical trials in STGD1 is approximately $10.0 million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Off-Balance Sheet Arrangements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are not party to any off-balance sheet arrangements. We have not entered into any financial guarantees or other commitments to guarantee the payment obligations of any third parties. In addition, we have not entered into any derivative contracts that are indexed to our shares and classified as shareholder&#8217;s equity or that are not reflected in our consolidated financial statements included elsewhere in this prospectus. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or product development services with us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Quantitative and Qualitative Disclosures About Market Risks</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interest and Credit Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are exposed to market risk related to changes in interest rates. We had cash of approximately $17.3&#160;million as of December&#160;31, 2021. Interest-earning instruments carry a degree of interest rate risk and we are not exposed to other interest rate risk. We have not been exposed to material risks due to changes in interest rates, and we have not used any derivative financial instruments to manage our interest risk exposure. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our credit risk is primarily attributable to cash. We mainly place or invest cash with reputable financial institutions in the jurisdictions where we and our subsidiaries are located. We do not believe that our cash has significant risk of default or illiquidity, and we will continually monitor the credit worthiness of these financial institutions. While we believe our cash does not contain excessive risk, future investments may be subject to adverse changes in market value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Assets that potentially subject us to significant concentration of credit risk primarily consist of cash. We expect that there is no significant credit risk associated with our cash, which were held by reputable financial institutions in the jurisdictions where we and our subsidiaries are located. We believe that it is not exposed to unusual risks as these financial institutions have high credit quality. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign Currency Exchange Rate Risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our functional currency is U.S. dollars, but we contract with CROs and CMOs globally. We may be subject to fluctuations in foreign currency rates in connection with certain of these agreements. Transactions denominated in currencies other than the U.S. dollar are recorded based on exchange rates at the time such transactions arise. As of December&#160;31, 2021, substantially all of our total liabilities were denominated in the U.S. dollar. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Internal Control over Financial Reporting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to this offering, we have been a private company with limited accounting and financial reporting personnel and other resources to address our internal controls and procedures. In connection with the audit of our consolidated financial statements as of and for the year ended December&#160;31, 2021, we and our independent registered public accounting firm identified one material weakness in our internal control over </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">financial reporting. The material weakness identified is our lack of formal policies and procedures to establish risk assessment processes and an internal control framework. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are currently in the process of implementing a number of measures to address the material weakness identified, including: (i)&#160;preparing comprehensive accounting policies, manuals and closing procedures to improve the quality and accuracy of our period-end financial closing process; and (ii)&#160;appointing independent directors, establishing an audit committee, and strengthening corporate governance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may incur significant costs in the implementation of such measures. However, we cannot assure you that all these measures will be sufficient to remediate our material weaknesses in time, or at all. Additionally, we cannot assure you that we have identified all, or that we will not in the future have additional, material weaknesses. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to This Offering and Our ADSs&#8201;&#8212;&#8201;If we fail to establish and maintain proper internal controls over financial reporting, our ability to produce accurate financial statements or comply with applicable regulations could be impaired.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical Accounting Policies and Estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of our consolidated financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, costs and expenses. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates. Our most critical accounting policies are summarized below. See Note 3 to our consolidated financial statements beginning on page F-1 of this prospectus for a description of our other significant accounting policies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses primarily include (1)&#160;payroll, share-based compensation and other related costs of personnel engaged in research and development activities, (2)&#160;in-licensed patent rights fee of exclusive development rights of drugs granted to us, (3)&#160;costs related to preclinical testing of the Company&#8217;s technologies and clinical trials such as payments to contract research organizations (&#8220;CRO&#8221;) and contract manufacturing organizations (&#8220;CMO&#8221;), investigators and clinical trial sites that conduct the clinical studies; (4)&#160;costs to develop our product candidates, including raw materials and supplies, product testing, clinical trial equipment and its depreciation, and facility related expenses, (5)&#160;other research and development expenses. Research and development expenses are charged to expense as incurred when these expenditures relate to the Company&#8217;s research and development services and have no alternative future uses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As part of the process of preparing our financial statements, we are required to estimate our accrued expenses resulting from obligations under contracts with vendors, consultants and CROs, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which the services are provided under such contracts. We reflect research and development expenses in our consolidated financial statements by matching those expenses with the period in which services and efforts are expended. We account for these expenses according to the progress of the preclinical or clinical study as measured by the timing of various aspects of the study or related activities and determine accrual estimates through review of the underlying contracts along with discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a study, we adjust our rate of expense recognition if actual results differ from our estimates. Estimates for accrued research and development expenses are classified as accrued expenses on the accompanying consolidated balance sheet. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share-Based Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Awards Granted to Employees</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We grant share options to eligible employees, management and directors and accounts for these share-based awards in accordance with Accounting Standards Codification, or ASC, 718, </font><font style="font-style:italic;letter-spacing:0.2pt;">Compensation-Stock </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Compensation</font><font style="letter-spacing:0.2pt;">. Employees&#8217; share-based awards are measured at the grant date fair value of the awards and recognized as expenses a) immediately at grant date if no vesting conditions are required; b) using graded vesting method over the requisite service period, which is the vesting period, on a straight-line basis; or c)&#160;for share-based awards granted with performance condition, using graded vesting method over the period based on the expected milestone achievement dates. Share-based compensation expense is recorded in research and development and general and administrative expenses based on the classification of the work performed by the grantees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our determination of the fair value of share option on the date of grant utilized the Binominal Option Pricing Model with the assistance of an independent third party valuation firm. Grant date fair value was impacted by our ordinary share price as well as changes in assumptions regarding a number of subjective variables which included, but were not limited to, the expected term that options remained outstanding, the expected ordinary share price volatility over the term of the option awards, risk-free interest rates, and expected dividends. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent the required vesting conditions are not met resulting in the forfeiture of the share-based awards, previously recognized compensation expense relating to those awards are reversed. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Awards Granted to Non-Employees</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have accounted for equity instruments issued to non-employees in accordance with Accounting Standards Update, or ASU, No. 2018-07, </font><font style="font-style:italic;letter-spacing:0.2pt;">Compensation&#8201;&#8212;&#8201;Stock Compensation</font><font style="letter-spacing:0.2pt;"> (Topic 718): </font><font style="font-style:italic;letter-spacing:0.2pt;">Improvements to Nonemployee Share-Based Payment Accounting</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We recognize share-based compensation cost for equity awards to non-employees with a performance condition at the fixed fair value on date of grant over the period based on the expected milestone achievement dates as the derived service period (usually the vesting period), on a straight-line basis. We consider the probable outcome of that performance condition when determining share-based compensation expenses and will recognize a cumulative true-up adjustment if the probability of the conditions has changed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes our share option activities under the 2020 Share Incentive Plan and the 2019 Share Incentive Plan for the years ended December&#160;31, 2020 and 2021: </font>
        </div>
        <table style="width:456pt;height:202pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Grant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Term</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of January&#160;1, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,335,794</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.1191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.4720</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.96</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,301</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,807,381</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.2574</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(727,676<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.1191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.4720</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:220.43pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Forfeited or expired </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(19,601<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">0.1191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2.4733</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,395,898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.3832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.2946</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.80</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7,834</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">41,736</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4.2254</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4626</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(706,406<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.3289</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.3311</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:220.43pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Forfeited or expired </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(748,667<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.2574</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 1.667pt 0pt; width:220.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding Options, December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,982,561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">0.4626</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">2.2571</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">8.82</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,480</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 1.083pt 0pt; width:220.43pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Vested and Expected to Vest Options as of December&#160;31 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">844,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">0.3935</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">2.3052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">8.58</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,969</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 1.75pt 0pt; width:220.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable Options as of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">356,067</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">0.2291</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">2.4192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">7.99</td>
            <td style="padding:0pt;padding-left:8.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">891</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Total unrecognized employee share-based compensation expense, which may be adjusted for actual forfeitures occurring in the future, were approximately $2.6&#160;million and $0.8&#160;million as of December&#160;31, 2020 and December&#160;31, 2021, respectively. The unrecognized compensation is expected to be recognized over a weighted-average period of 1.68&#160;years and 2.77&#160;years as of December&#160;31, 2020 and December&#160;31, 2021, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of options was determined using the Binomial Option Pricing Model, with assistance from an independent third-party appraiser. The binomial model requires the input of highly subjective </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">assumptions, including the expected volatility, the exercise multiple, the risk-free interest rate and the expected dividend yield. For expected volatility, we have made reference to historical volatility of several comparable companies in the same industry. The exercise multiple was estimated as the average ratio of the stock price to the exercise price of when employees would decide to voluntarily exercise their vested share options. As we did not have sufficient information of past employee exercise history, the exercise multiple was based on management&#8217;s estimation. The risk-free rate for periods within the contractual life of the options is based on the market yield of U.S. Government Notes with a maturity life equal to the remaining maturity life of the options as of the valuation date. The expected dividend yield is based on our expected dividend policy over the contractual life of the options. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The assumptions used to estimate the fair value of the share options on the date of grant are as follows: </font>
        </div>
        <table style="width:416pt;height:74.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:231.62pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;17,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;23,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">March&#160;1, </font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:231.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1.72%&#8201;&#8211;&#8201;1.74% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.51<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.87<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:231.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility range </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">35.50%&#8201;&#8211;&#8201;35.72% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">36.59<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">36.75<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:231.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercise multiple </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.785pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.8</td>
            <td style="padding:0pt;padding-left:29.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.8</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.8</td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:231.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.785pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:29.785pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:7.9pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes total share-based compensation cost recognized: </font>
        </div>
        <table style="width:416pt;height:55.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:316.73pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:316.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:316.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">77</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">52</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:316.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,286</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,478</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:316.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,363</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent Accounting Pronouncements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A list of recently issued accounting pronouncements that are relevant to us is included in Note 3 &#8220;Summary of Significant Accounting Policies&#8201;&#8212;&#8201;Recent Accounting Pronouncements&#8221; of our consolidated financial statements beginning on page F-1 of this prospectus. </font>
        </div>
        <div style="margin-top:10pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">JOBS Act</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2012, the JOBS Act was enacted. Section&#160;107 of the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards applicable to public companies. This provision allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. This transition period is only applicable under U.S. GAAP, which is the standard to which we prepare our consolidated financial statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are in the process of evaluating the benefits of relying on other exemptions and reduced reporting requirements under the JOBS Act. Subject to certain conditions, as an emerging growth company, we intend to rely on all of these exemptions, including without limitation, (i)&#160;providing an auditor&#8217;s attestation report on our system of internal controls over financial reporting pursuant to Section&#160;404(b) of the Sarbanes-Oxley Act, (ii)&#160;complying with any requirement that may be adopted by the Public Company Accounting Oversight Board, regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis and (iii)&#160;complying with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. We will remain an emerging growth company until the earlier of (i)&#160;the last day of the fiscal year in which we have total annual gross revenues of $1.07&#160;billion or more; (ii)&#160;the last day of the fiscal year following the fifth&#160;anniversary of the date of the completion of this offering; (iii)&#160;the date on which we have issued more than $1.0&#160;billion in non-convertible debt during the previous three&#160;years; or (iv)&#160;the date on which we are deemed to be a large accelerated filer under the rules of the SEC, which means the market value of our common shares that are held by non-affiliates exceeds $700.0&#160;million as of the prior June&#160;30th. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tBUS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration (commonly known as dry AMD) and autosomal recessive Stargardt disease, or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LBS-008</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe our lead product candidate, LBS-008, or Tinlarebant, if approved, would provide a novel treatment option where there currently is none. LBS-008 is an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A (retinol) to the eye as a means to reduce the accumulation of toxic vitamin A by-products in ocular tissue. This effect is achieved through the ability of LBS-008 to reduce and maintain the level of serum retinol binding protein&#160;4, or RBP4, which carries retinol from the liver to the eye. In clinical trials, LBS-008 has demonstrated its target specificity and potency that we believe could be clinically meaningful to treat STGD1 patients. We initiated an open-label, dose-finding Phase&#160;1b/2 clinical trial in adolescent STGD1 patients in mid-2020 in Australia and Taiwan. The study design includes two portions: Phase&#160;1b and Phase&#160;2. We have completed the Phase&#160;1b portion of this study in 11 adolescent STGD1 patients which has extended into a two-year, Phase&#160;2 study with 13 adolescent STGD1 patients in Australia and Taiwan. The preliminary data from the Phase&#160;1b portion has shown that LBS-008 can achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. We are currently conducting the Phase&#160;2 portion of this study. See &#8220;&#8212;Phase 1b/2 Clinical Trial in STGD1&#8221; below for more information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have initiated our Phase&#160;3 clinical trial, to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">STGD1 is a rare monogenetic juvenile-onset macular dystrophy that is characterized by the aberrant and excessive accumulation of toxic vitamin A by-products known as bisretinoids and cellular debris, or lipofuscin, which precedes the death of retinal tissue and loss of vision. Although an orphan disease, STGD1 is the most common juvenile macular degeneration. Dry AMD is a heterogenous condition that arises from a complex interplay between age, genetics and environmental factors, such as diet and smoking, but has a pathology and course of disease that strongly resembles that of STGD1, particularly in intermediate and advanced stages. There are no approved therapies for STGD1 or dry AMD. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Developed from our RBP4 intellectual property portfolio, or RBP4 IP Portfolio, LBS-008 was designed to be a potent and reversible RBP4 antagonist. As an RBP4 antagonist, LBS-008 reduces the amount of retinol entering the visual cycle thereby reducing the formation of bisretinoid toxins which will ultimately preserve the health of the retina. We hold a worldwide exclusive license of the RBP4 IP Portfolio from Columbia University, which contains disclosure directed to over 400 structurally distinct RBP4 antagonists under patent protection in major pharmaceutical markets worldwide, including the United States, the European Union, China, Australia, Japan, South Korea and India. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 has received orphan drug designation for the treatment of STGD1 in the United States, which entitles it to market exclusivity such that the U.S. Food and Drug Administration, or FDA, may not approve any other applications for the same product for the same indication for 7&#160;years, except in very limited circumstances. See &#8220;Regulations&#8201;&#8212;&#8201;U.S. Regulation&#8201;&#8212;&#8201;NDA Submission and Review&#8201;&#8212;&#8201;Orphan Drug Designation and Exclusivity&#8221; for more information. LBS-008 has also received orphan designation for the treatment of STGD1 in Europe, which entitles it to a 10 year period of market exclusivity, which may be reduced in certain circumstances. During this market exclusivity period, neither the European Medicines Agency, or EMA, nor the European Commission or the member states can accept an application for, or grant a marketing authorization for, a &#8220;similar medicinal product.&#8221; See &#8220;Regulations&#8201;&#8212;&#8201;European Regulation&#8201;&#8212;&#8201; Orphan Designation and Exclusivity&#8221; for more information. Additional benefits of an orphan drug </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">designation include a tax credit of 50% of the qualified clinical testing expenses for the relevant taxable year and a waiver of the new drug application, or NDA, application fee (which is approximately $3.1&#160;million for fiscal year 2022). </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 has also received rare pediatric disease designation in the United States and may be eligible for a priority review voucher. A priority review voucher may be awarded to a sponsor if it develops a drug for a rare pediatric disease and the drug is approved. The priority review voucher allows the sponsor of a subsequent NDA or Biologic License Application for any product candidate to expedite the FDA&#8217;s review goal from 10&#160;months to 6&#160;months. The priority review voucher may be sold to other companies that seek to expedite drug reviews. See &#8220;Regulations&#8201;&#8212;&#8201;U.S. Regulation&#8201;&#8212;&#8201;NDA Submission and Review&#8201;&#8212;&#8201;Rare Pediatric Disease Designation and Priority Review Vouchers&#8221; for more information. In the last three&#160;years, priority review vouchers have sold in a price range between $80-125&#160;million. In the event that we or a sublicensee chooses to sell a priority review voucher, we or such sublicensee would be obligated to pay Columbia University a percentage of revenue in the low double-digits that we or such sublicensee receives from any such sale pursuant to the Columbia License Agreement. In the event that we or a sublicensee does not sell a priority review voucher within one year of receipt, the earned royalties that we would be obligated to pay to Columbia University based on net sales of licensed products would increase by 1%. See &#8220;Business&#8201;&#8212;&#8201; Intellectual Property&#8201;&#8212;&#8201;Patents&#8201;&#8212;&#8201;Patent License Agreement with The Trustees of Columbia University in the City of New York&#8221; for more information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 is the only drug candidate within the current drug development projects of the National Institute of Health (NIH) Blueprint Neurotherapeutics Network, or the BPN, that is intended to treat dry AMD. The BPN was launched in 2004 to foster small-molecule neurotherapeutic development, bringing together a unique blend of grant dollars, industry-standard scientific expertise, and contract resources under a milestone-driven cooperative agreement program. The BPN criteria for selection of clinical drug candidates are based on multiple features of an applicant&#8217;s drug development program including the following: 1) strong biological rationale, 2) novel target for the disease, 3) strong data linking target to disease, 4) demonstration of preclinical pharmacodynamic effect and efficacy, 5) feasible path to clinic, and 6) IP free of roadblocks. LBS-008 was selected by the BPN in 2011 and, as of the date of this prospectus, is the only drug candidate within the current drug development projects of the BPN that is intended to treat dry AMD. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The mechanism of action utilized by LBS-008 has been recognized and recommended as a priority for clinical development in both STGD1 and dry AMD in a systematic review published by the U.K. National Institute for Health Research, or the NIHR, in 2018. The NIHR is funded by the U.K. Department of Health and Social Care and focuses on early translational research, clinical research and applied health and social care research for the purpose of enabling and delivering world-leading health and social care research that improves people&#8217;s health and wellbeing and promotes economic growth. The NIHR screened 7,948 articles in 2018 for its systematic review on treatments for dry AMD and STGD1. Its principal findings included that research focus should be at earlier stages in both diseases (before vision is impaired) and that the most promising treatments for both diseases appear to be prevention of lipofuscin and bisretinoid accumulation. Therefore, the NIHR recommended the mechanism of RBP4 inhibition, which is utilized by LBS-008, as a promising treatment in dry AMD and STGD1. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although there are currently no approved treatments available for STGD1 and dry AMD, our competitors for LBS-008 include several companies going through clinical development for their product candidates. Based on publicly available information, we understand that there is one Japan-based pharmaceutical company that has an asset in Phase 3 development for STGD1. There are also three U.S.-based companies advancing treatments for STGD1 and their assets are currently in Phase 2 and Phase 2b development, respectively, with the third company having recently completed their Phase 2a trial. In geographic atrophy, or GA, there are five U.S.-based companies in late-stage clinical development, three of which have assets in Phase 3 development and two of which have assets in Phase 2 development. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Clinical Trials in Healthy Adult Subjects</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To support the clinical development of LBS-008, we have completed one randomized, double-blind, placebo-controlled, Phase 1 SAD study in 40 healthy adult subjects in the United States, one randomized, double-blind, placebo-controlled, Phase 1 single ascending dose, or SAD, study in 39 healthy adult subjects </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and one randomized, double-blind, placebo-controlled, Phase 1 multiple ascending dose, or MAD, study in 32 healthy adult subjects in Australia. These studies were conducted to confirm the safety, toxicity, pharmacokinetics, or PK, and pharmacodynamics, or PD of LBS-008 on a range of single ascending dose (10-50 mg in the US; 25-400 mg in Australia) / multiple ascending dose (5-25 mg in Australia) levels in heathy adult subjects in fasted / fed conditions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the US SAD study, we found that single doses of 10&#8211;50 mg LBS-008 were well tolerated and reduced mean serum RBP4 level by around 70% from baseline. The degree of lowering of RBP4 plasma concentrations increased with increasing LBS-008 dose. This study also compared doses of LBS-008 taken with and without food, which did not show a food effect with dosing.</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the Australian SAD study, we found that single doses of 25-400 mg LBS-008 were well tolerated and reduced mean RBP4 level by &gt; 70% from baseline. One subject in the 100 mg cohort experienced a drug-related adverse event of mild transient xanthopsia. That event was resolved within 48 hours. A direct correlation between the LBS-008 plasma concentration and RBP4 suppression was observed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the Australian MAD study, we found that all dose levels were well tolerated and have identified an optimal daily dose to reduce serum RBP4 by &gt;70% from baseline. Most drug-related adverse events reported were mild in severity, and the most frequently reported drug-related adverse event was asymptomatic Delayed Dark Adaptation, or DDA, which did not show dose proportionality and reflects a reduction in vitamin A levels in the eye, which is the intended effect of LBS-008. No deaths, serious or severe adverse events were reported. The Safety Review Committee, or SRC, approved dose escalations after reviewing the safety data profile at each dose level.</font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stargardt Disease</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In STGD1, we are developing LBS-008 as an oral daily treatment to target RBP4 by disrupting vitamin A (retinol) binding to RBP4 which leads to reduced delivery of retinol to the eye and reduced accumulation of toxic vitamin A by-products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">STGD1 is an inherited juvenile form of macular degeneration and currently, there is no approved treatment available. The disease is caused by a mutation in the ABCA4 gene, which leads to the accelerated formation and accumulation of toxic vitamin A by-products known as bisretinoids. The most prominent bisretinoid identified in human tissues is known as A2E (</font><font style="font-style:italic;letter-spacing:0.2pt;">N</font><font style="letter-spacing:0.2pt;">-retinylidene-</font><font style="font-style:italic;letter-spacing:0.2pt;">N</font><font style="letter-spacing:0.2pt;">-retinylethanolamine). The accumulation of A2E in ocular tissues causes progressive retinal cell death and permanent loss of vision. More than 500 mutations in the ABCA4 gene have been identified in STGD1 patients. Some STGD1 patients suffer severe visual impairment by the age of 20. The prevalence rate of STGD1 is estimated to be 1 in 10,000 people. Based on this estimate, approximately 30,000 US citizens are affected by STGD1. This estimate includes both adults and children. Although comprehensive epidemiological data on the prevalence of STGD1 in other countries is not available, the epidemiological literature from other countries, such as Europe and Asian countries, cite the 1 in 10,000 estimate for the prevalence of STGD1. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase 1b/2 Clinical Trial in STGD1</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have completed the Phase 1b portion of a Phase 1b/2 open-label, dose-finding study in 11 adolescent STGD1 patients which has extended into a two-year, Phase 2 study with 13 adolescent STGD1 patients in Taiwan and Australia. The Phase 1b portion is a dose-finding study designed to determine the optimal dose of LBS-008 and to evaluate safety, tolerability, PK and PD in adolescent STGD1 patients for a treatment period of 2 cycles of 14-day daily dosing of LBS-008 (28 days of daily treatment) and a 14-day follow-up period. Upon completion of Phase 1b, an optimal daily dose was identified and which was able to achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preliminary data shows that most frequently reported drug-related adverse events reported to date included DDA and transient xanthopsia, which were all graded as mild. Reports of transient DDA/night vision impairment and xanthopsia were anticipated and are consistent with LBS-008&#8217;s mechanism of action. It is notable that in most incidences of DDA, it was confirmed by laboratory measure (dark adaptometry) as the majority of patients were asymptomatic. No deaths or serious or severe Treatment-emergent adverse events, or TEAEs, were reported. In addition, there were no clinically significant findings in relation to vital signs, physical exams, or electrocardiograms, or ECGs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Phase&#160;2 portion consists of a 2-year treatment period with a follow-up period of one month. In the Phase&#160;2 portion of the study, in addition to monitoring the safety and tolerability, we aimed to monitor PK and PD biomarkers (RBP4 and retinol) and the effects of treatment using various retinal imaging modalities (including definitely decreased autofluorescence, or DDAF, questionably decreased autofluorescence, or QDAF, Spectral-domain optical coherence tomography, or SD-OCT, and microperimetry), change in best-corrected visual acuity, or BCVA, and the relationship between the change in RBP4 levels and rate of lesion growth. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are currently conducting the Phase&#160;2 portion of this study. A total of 13 adolescent STGD1 patients were enrolled in the Phase&#160;2 portion of the Phase&#160;1b/2 study. As of the date of this prospectus, all 13 patients have received at least 6&#160;months of treatment and completed the scheduled assessments at the first 6 month interval. Change in BCVA (early treatment diabetic retinopathy study, or ETDRS letter score), and fundus autofluorescence, or FAF, imaging results at 6-months are compared to the baseline measurements at the start of Phase&#160;2. The preliminary data shows that 8 of the 13 patients (or 61.5%) recorded a gain in BCVA (ETDRS letter score) in at least one eye, including 2 patients who recorded a gain in BCVA in both eyes. The average BCVA from the 13 patients was an average loss of 2.8 letters in the right eye, and an average gain of 1.9 letters in the left eye. On FAF retinal imaging, 8 of the 13 patients (or 61.5%) had a reduction or no change in their QDAF area size in at least one eye, including 5 patients who had a reduction or no change in QDAF area size in both eyes. There was an average gain in QDAF area in the right eye of 0.2 &#177; 0.09mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> (Mean &#177; standard error of the mean, or SEM) and in the left eye of 0.1 &#177; 0.09mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> (Mean &#177; SEM). While 12 of the 13 patients had no DDAF lesion measured at the start of Phase&#160;2 and at 6-months, 1 of the&#160;13 patients had a DDAF lesion growth of 0.3mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> in both eyes during the 6-month period. On SD-OCT imaging, a gradual thinning with an average of approximately 7 to 10 microns (on total retinal thickness by ETDRS regions) was observed in both eyes. In the Ellipsoid Zone (EZ), an average increase in defect width of 0.26mm in the right eye and 0.61mm in the left eye were observed. However, 6 patients had a reduction in EZ defect width in at least 1&#160;eye (including 3 patients in both eyes). Additional interim data read-outs will be captured at Months&#160;12, 15, 18 and 21, and a final data read-out will be captured at Month&#160;24. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase 3 Clinical Trial in STGD1</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have initiated a randomized, double-masked, placebo-controlled, global, multi-center, Phase&#160;3 clinical trial, to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. This study consists of a screening period, a treatment period of 2&#160;years, and a follow-up period of one month. Approximately 60 patients are targeted for enrollment in this study with a 2:1 randomization (active:placebo). See &#8220;Risk Factors &#8212; In the event that we elect to carry out clinical trials in China and/or expand our operations into China in the future, we will be subject to changing legal and regulatory requirements in the PRC pharmaceutical industry, and new laws, rules and regulations may adversely affect our profitability or impose additional compliance burdens on us.&#8221;</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We intend to focus on adolescent patients in our ongoing clinical trials due to several benefits afforded by utilizing this patient population&#8201;&#8212;&#8201;namely, establishing proof-of-concept in the context of a more severe and rapidly progressing disease (i.e., STGD1 disease progression is faster in adolescent patients compared to adults or later-onset patients), and the ability to readily expand into the larger adult STGD1 population upon approval (i.e., drug approvals for pediatrics and/or adolescents are accepted for adults but drug approvals for adults are not accepted for pediatrics and/or adolescent populations due to safety concerns). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Dry AMD</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Due to the strong pathophysiologic similarities between STGD1 and intermediate to advanced stages of dry AMD, we expect LBS-008 to have a similar treatment effect on this population of dry AMD patients. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">AMD is an age-related form of macular degeneration. The most commonly used classification system for AMD is the Age-Related Eye Disease Study, or AREDS, classification system, which designates the following categories: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 1 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No AMD</font><font style="letter-spacing:0.2pt;">,&#8221; although there may be a few small (&lt;63&#181;m in diameter) yellowish subretinal deposits (i.e., drusen beneath the retina). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 2 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Early AMD</font><font style="letter-spacing:0.2pt;">&#8221; and is characterized by multiple small drusen (&lt;20&#181;m in diameter), a few intermediate drusen (63-124&#181;m in diameter), and abnormalities of the retinal pigment epithelium, or RPE, a monolayer of epithelial cells that lies beneath the retina and provides trophic and metabolic support to photoreceptor cells of the retina. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 3 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Intermediate AMD</font><font style="letter-spacing:0.2pt;">,&#8221; where there is extensive intermediate drusen, large drusen (&gt;125&#181;m in diameter), or geographic atrophy (i.e., localized atrophy of the retina), or GA, and increased lipofuscin in the RPE. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 4 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Advanced AMD</font><font style="letter-spacing:0.2pt;">&#8221; and is characterized by GA or neovascular maculopathy (i.e., &#8216;wet&#8217; AMD). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The only approved therapies for AMD are for &#8216;wet&#8217; AMD which represents approximately 10% of all AMD cases. There are no approved therapies for the other stages of AMD, including GA, secondary to advanced AMD, which are collectively referred to as dry AMD and represents approximately 90% of all AMD cases. Importantly, dry AMD is a leading cause of vision loss in older adults. Thus, there is a significant unmet medical need in treating dry AMD patients. There are an estimated 11&#160;million dry AMD patients in the United States and over 196&#160;million patients worldwide with an estimated global direct healthcare cost of US$255&#160;billion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Disease progression in early dry AMD is very slow. The American Optometric Association reports that most people move through the process from diagnosis to legal blindness in about 10&#160;years. Therefore, investigational therapies have been directed at the treatment of intermediate and advanced stages of dry AMD, which progress more rapidly than earlier stages. Unlike STGD1, dry AMD is believed to have a very heterogenous etiology, and various therapeutic approaches have been explored to slow disease progression in dry AMD. An important feature of Intermediate AMD is the aberrant and excessive accumulation of lipofuscin and bisretinoid toxins, similar to STGD1. In these stages of dry AMD, retinal lesions (i.e., GA) are bordered on all sides by an annulus of autofluorescence which expands in a centrifugal manner followed by lesion expansion into the autofluorescent area. </font><font style="font-style:italic;letter-spacing:0.2pt;">In vivo</font><font style="letter-spacing:0.2pt;"> analyses of the autofluorescent area in Intermediate AMD eyes revealed an excitation maxima and fluorescence emission that is consistent with the spectral properties of bisretinoid toxins. Thus, the clinical presentation and biochemical features of intermediate and advanced dry AMD suggest that a therapy directed at reducing the level of bisretinoid toxins may be effective to slow disease progression. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are currently evaluating our plan to initiate, in 2022, a randomized, double masked, placebo-controlled, Phase&#160;2 or Phase&#160;3 trial, in the United States, Europe, and Asia Pacific. See &#8220;Risk Factors &#8212; In the event that we elect to carry out clinical trials in China and/or expand our operations into China in the future, we will be subject to changing legal and regulatory requirements in the PRC pharmaceutical industry, and new laws, rules and regulations may adversely affect our profitability or impose additional compliance burdens on us.&#8221; Our objective is to evaluate the efficacy and safety of LBS-008 in the treatment of dry AMD over the course of a two-year treatment period. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LBS-009</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-009 is an anti-RBP4 oral therapy targeting liver disease, including NAFLD, NASH, and T2D. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NAFLD occurs when an excess accumulation of fat damages the liver. Currently, it is estimated that approximately 1.9&#160;billion patients suffer from NAFLD worldwide. Over time, the liver damage and the associated inflammation can lead to the development of NASH, which impacts an estimate of more than 9&#160;million patients in the United States alone. As the disease progresses, it can lead to cirrhosis and eventually, complete liver failure. NAFLD and NASH are a growing unmet need for which no FDA-approved treatments are currently available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">T2D is a chronic disease that occurs when the body cannot effectively use insulin, the hormone that regulates blood sugar levels. The health impact of T2D is profound, potentially causing damage to the eyes, heart, blood vessels, kidneys, and nerves. T2D is on the rise, with approximately 422&#160;million patients globally. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-009 is a small molecule designed to compete with retinol for RBP4 binding. When bound to LBS-009, RBP4 can no longer form a large molecular weight complex with transthyretin, or TTR. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Consequently, the RBP4/LBS-009 complex will be removed from circulation by renal filtration. We believe that modulating RBP4 concentrations systemically with LBS-009 has a significant therapeutic potential for treating patients suffering from metabolically associated diseases, including NAFLD, NASH and T2D. </font>
        </div>
        <div style="margin-left:20pt; margin-top:6pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-009 is currently in preclinical development. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Management and Clinical Advisory Board</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our management team and ophthalmology clinical advisory board have deep experience and capabilities&#160;in ophthalmology, neurology, immunology and immunotherapy, cardiovascular and renal medicine, oncology, neurobiology, biochemistry, drug discovery, clinical development, manufacturing, and commercialization. Our ophthalmology clinical advisory board includes key opinion leaders in the macular degeneration space, including Quan Nguyen, M.D., Professor of Ophthalmology at Stanford University, Hendrik P.N. Scholl, M.D., Professor and Chairman of the Department of Ophthalmology at University of Basel and Co-Director of the Institute of Molecular and Clinical Ophthalmology in Basel, Michel Michaelides, M.D., Consultant Ophthalmologist at Moorfields Eye Hospital and Professor of Ophthalmology, UCL Institute of Ophthalmology, Robyn Guymer, M.D., Professor of Ophthalmology, University of Melbourne and Deputy Director of the Centre for Eye Research Australia and Frank Holz, M.D., Chairman of Ophthalmology, University of Bonn. Together, our management team and ophthalmology clinical advisory board, in connection with our exclusive technology platform, will allow our drugs to be tailored to target at-risk patients across the United States and worldwide, who lack access to necessary treatment in the macular degeneration space. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Program</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our lead product candidate, LBS-008, is an RBP4 antagonist. We are developing LBS-008 as an oral daily treatment for STGD1 and dry AMD. </font>
        </div>
        <div style="margin-left:20pt; margin-top:6pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes key information about our clinical program for LBS-008: </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Indication </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:132pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Clinical Trials </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Trial Participants </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Estimated Timeline </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:19.25pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:96pt;" rowspan="4">
              <div style="line-height:12pt; padding-bottom:0.666666666666667pt;">
                <font style="letter-spacing:0.2pt;">STGD1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="4">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:132pt;white-space:normal;">
              <div style="line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Phase&#160;1 single and multiple ascending dose trial </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:96pt;">
              <div style="white-space:nowrap; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Healthy adult subjects </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:96pt;">
              <div style="line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Completed </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:27pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:132pt;">
              <font style="letter-spacing:0.2pt;">Phase&#160;1b trial </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Adolescent patients with STGD1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">Completed </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:99pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:132pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Phase&#160;2 trial </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">Adolescent patients with STGD1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">Ongoing, with interim data read-outs expected to be captured at Months 12, 15, 18 and 21, and a final data read-out to be captured at Month 24.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:27pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:132pt;">
              <font style="letter-spacing:0.2pt;">Phase&#160;3 trial </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Adolescent patients with STGD1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">Initiated </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:25pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:96pt;" rowspan="2">
              <div style="line-height:12pt; padding-bottom:0.666666666666667pt;">
                <font style="letter-spacing:0.2pt;">Dry AMD </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:132pt;white-space:normal;">
              <div style="line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Phase&#160;1 single ascending dose trial </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:96pt;">
              <div style="white-space:nowrap; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Healthy adult subjects </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.833pt 0pt; width:96pt;">
              <div style="line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Completed </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:31pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:132pt;">
              <font style="letter-spacing:0.2pt;">Phase&#160;2 or Phase&#160;3 trial </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Patients with dry AMD </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">2022</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.51pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Strengths</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:6pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe we are well placed to accomplish our mission due to the following strengths: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Novel oral therapy to tap into a niche market for significant unmet medical needs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 is an orally administered, non-retinoid, small molecule antagonist of RBP4 that shows nanomolar potency and a pharmacodynamic effect that is readily reversible upon drug cessation. LBS-008 </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">is intended as a once-a-day treatment to reduce the accumulation of vitamin A-based cytotoxins known as bisretinoids and is intended to slow or halt disease progression in STGD1 and dry AMD. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pre-clinically and clinically demonstrated mechanism of action.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The LBS-008 mechanism of action has demonstrated both preclinical and clinical proof-of-concept. In the preclinical studies, treatment with LBS-008 showed a clear correlation between reduction of serum RBP4, reduction of bisretinoid cytotoxins in the eye, and photoreceptor preservation in a relevant animal model (i.e., Abca4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8722;/&#8722;</font><font style="letter-spacing:0.2pt;"> / Rdh8</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8722;/&#8722;</font><font style="letter-spacing:0.2pt;"> mice). The clinical significance of this therapeutic approach was realized in a 2-year Phase&#160;2 clinical trial of fenretinide (a retinoid-based RBP4 antagonist) in GA secondary to dry AMD. In that study, subjects achieving a &gt; 70% reduction of RBP4 showed a statistically significant slowing of lesion growth at the end of the study. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Receipt of Orphan Drug Designation in the United States and Europe.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 has received orphan drug designation in the United States and Europe, which entitles it to market exclusivity such that the FDA may not approve any other applications for the same product for the&#160;same indication for 7&#160;years, except in very limited circumstances, and the EMA, the European Commission and each of the member states may not accept an application for, or grant a marketing authorization for,&#160;a&#160;&#8220;similar medicinal product&#8221; for 10&#160;years, which may be reduced in certain circumstances. See &#8220;Regulations&#8201;&#8212;&#8201;U.S. Regulation&#8201;&#8212;&#8201;NDA Submission and Review&#8201;&#8212;&#8201;Orphan Drug Designation and Exclusivity&#8221; and &#8220;Regulations&#8201;&#8212;&#8201;European Regulation&#8201;&#8212;&#8201;Orphan Designation and Exclusivity&#8221; for more information. Additional benefits of an orphan drug designation include a tax credit of 50% of the qualified clinical testing expenses for the relevant taxable year and a waiver of the NDA application fee (which is approximately $3.1&#160;million for fiscal year 2022). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Receipt of Rare Pediatric Disease Designation in the United States with Eligibility for Priority Review Voucher if approved.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 has received rare pediatric disease designation in the United States and may be eligible for a priority review voucher. A priority review voucher may be awarded to a sponsor if it develops a drug for a rare pediatric disease and the drug is approved. The priority review voucher allows the sponsor of a subsequent NDA or Biologic License Application for any product candidate to expedite the FDA&#8217;s review goal from 10&#160;months to 6&#160;months. The priority review voucher may be sold to other companies that seek to expedite drug reviews. See &#8220;Regulations&#8201;&#8212;&#8201;U.S. Regulation&#8201;&#8212;&#8201;NDA Submission and Review&#8201;&#8212;&#8201;Rare Pediatric Disease Designation and Priority Review Vouchers&#8221; for more information. In the last three&#160;years, priority review vouchers have sold in a price range between $80-125&#160;million. In the event that we or a sublicensee chooses to sell a priority review voucher, we or such sublicensee would be obligated to pay Columbia University a percentage of revenue in the low double-digits that we or such sublicensee receives from any such sale pursuant to the Columbia License Agreement. In the event that we or a sublicensee does not sell a priority review voucher within one year of receipt, the earned royalties that we would be obligated to pay to Columbia University based on net sales of licensed products would increase by 1%. See &#8220;Business&#8201;&#8212;&#8201;Intellectual Property&#8201;&#8212;&#8201;Patents&#8201;&#8212;&#8201;Patent License Agreement with The Trustees of Columbia University in the City of New York&#8221; for more information. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">National Institute of Health Blueprint Neurotherapeutics Network sponsored and endorsed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 is the only drug candidate within the current drug development projects of the BPN that is intended to treat dry AMD. The BPN was launched in 2004 to foster small-molecule neurotherapeutic development, bringing together a unique blend of grant dollars, industry-standard scientific expertise, and contract resources under a milestone-driven cooperative agreement program. The BPN criteria for selection of clinical drug candidates are based on multiple features of an applicant&#8217;s drug development program. LBS-008 was selected by the BPN in 2011 and, as of the date of this prospectus, is the only drug candidate within the current drug development projects of the BPN that is intended to treat dry AMD. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.K. National Institute for Health Research endorsed the mechanism of action utilized by LBS-008.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The NIHR commissioned a systematic review of 7,948 articles in 2018 to identify therapeutic approaches that would have the greatest chance to provide a treatment effect in STGD1 and dry AMD. Antagonism of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">RBP4, via the LBS-008 mechanism of action, was recommended as a priority for clinical development in both STGD1 and dry AMD. This decision was based upon the clear biological rationale and a well-defined mechanism of action which has demonstrated both preclinical and clinical proof-of-concept. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential to treat intermediate to advanced-stage dry AMD with oral therapy for lifetime.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Invasive treatments such as intravitreal injections and gene therapies pose a very high risk for early to intermediate-stage dry AMD patients as these individuals are typically asymptomatic or show very mild symptoms. The treatment modalities that are acceptable for these disease stages, i.e., prior to advanced stage AMD, are non-invasive, self-administered treatments such as oral and topical medications (such as eye drops) that are suitable as daily treatments for chronic slowly progressive diseases such as AMD. However, topical treatments are more suitable for diseases and disorders at the front of the eye as they are unlikely to reach the back of the eye where the disease is localized in dry AMD. As the accumulation of bisretinoid toxins and lipofuscin in dry AMD is a slowly evolving process, any effective treatments would need to be administered during the entire course of disease as these treatments would not be expected to be curative. LBS-008 was developed to be a potent and reversible RBP4 antagonist intended for long-term daily oral administration. Importantly, long-term (5-year) reduction of RBP4 with a retinoid-based RBP4 antagonist (fenretinide) in pre- and post-menopausal women was determined by the study authors to be well-tolerated. The strong pathophysiologic similarities between dry AMD and STGD1 (i.e., early accumulation of bisretinoid toxins which leads to dysfunction or death of the RPE, followed by photoreceptor cell death) suggests that LBS-008 would be effective in both diseases as a long-term treatment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Highly experienced senior management team supported by world-renowned advisory board and influential key opinion leaders.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our senior management team is comprised of highly experienced research scientists, clinician scientists, and business development experts who have decades of clinical development experience. This team is supported by a world-renowned advisory board of ophthalmologists and retinal specialists and influential key opinion leaders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Strategies</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our goal is to become a leading biopharmaceutical company with an aim to develop the first approved treatment on STGD1 and dry AMD globally. We intend to accomplish our mission by pursuing the following growth strategies: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Efficiently advance our lead product candidate, LBS-008, through Phase&#160;2 and Phase&#160;3 clinical development in adolescent STGD1 patients and regulatory approval, with the potential to establish a new standard of care for STGD1 patients.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We are developing LBS-008 as an oral daily treatment for STGD1. The Phase&#160;1b portion of our Phase&#160;1b/2 clinical trial for STGD1 patients has shown that LBS-008 can achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. We are currently conducting the Phase&#160;2 portion of this study. See &#8220;&#8212;Phase 1b/2 Clinical Trial in STGD1&#8221; above for more information. As of the date of this prospectus, we have initiated our Phase&#160;3 clinical trial, to evaluate the efficacy and safety of LBS-008 in adolescent STGD1 patients over the course of a two-year treatment period and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Leverage the promising clinical data of LBS-008 in adolescent STGD1 patients to initiate Phase&#160;2 or Phase&#160;3 clinical development in dry AMD.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We have chosen to strategically prioritize our clinical development efforts in adolescent STGD1 patients before pursuing clinical development in adult patients with dry AMD. Clinical research has shown that there is a higher rate of disease progression and rapid deterioration of visual function in childhood-onset STGD1, compared to adult-onset STGD1 and GA in dry AMD. This suggests that therapeutic intervention in an adolescent population would provide an increased likelihood of observing a treatment effect, compared to adult-onset retinal degenerations. Additionally, because of the strong pathophysiologic similarities between STGD1 and dry AMD, a positive treatment effect of LBS-008 in adolescent STGD1 patients would provide a margin of de-risk for a subsequent clinical trial in GA. The Phase&#160;1b portion of our </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Phase&#160;1b/2 clinical trial for STGD1 patients has shown that LBS-008 can achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. Based on this clinical activity, we believe that LBS-008, if approved, will also have therapeutic value in treating dry AMD. We are currently evaluating our plans to initiate a Phase&#160;2 or Phase&#160;3, randomized, double masked, placebo-controlled, global, multi-center trial for dry AMD in 2022 to evaluate the efficacy and safety of LBS-008 over the course of a two-year treatment period. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Potentially advance LBS-009 through clinical development for the treatment of NAFLD and NASH.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If we obtain the necessary funding, we may develop LBS-009 as an oral treatment for NAFLD and NASH. LBS-009 is currently in preclinical development. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Continue to leverage our exclusive RBP4 IP Portfolio, and look for additional in-licensing or collaboration arrangements, to identify novel candidates to further expand our product pipeline and utilize our global organizational structure to advance programs into clinical development in a capital efficient manner.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We plan to continue to utilize our exclusive RBP4 IP Portfolio, as well as search for additional in-licensing or collaboration arrangements, to isolate promising and novel drug compounds to expand our therapeutic pipeline. Additionally, we believe our global organizational structure will ultimately lead to significant revenue and cost advantages in the discovery, development and commercialization of our innovative therapeutics. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Evaluate strategic collaborations to maximize the value of our product candidates.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We hold the worldwide development and commercial rights to our pipeline programs, and we intend to out-license our product candidates or commercialize our product candidates, if approved, in key territories. We may selectively enter into global or regionally focused strategic partnerships around certain targets, product candidates, or disease areas if we believe these collaborations could accelerate the clinical development and maximize the value of our product candidates, ultimately expanding patient access. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development and Technology</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The retina is a thin sheet of nerve tissue which lies along the back inside wall of the eye. Within the retina are two types of light-sensitive cells called photoreceptors. The light-sensing chemical molecule which rods and cones depend upon for proper functioning is delivered by an underlying tissue called the retinal pigment epithelium, or RPE. The RPE maintains the health and viability of photoreceptors by providing other nutrients from the blood and by ingesting the spent distal tips of rods and cones in a process called phagocytosis. The phagocytosis process is particularly important as it facilitates removal of toxic metabolites of vitamin A and other cellular material which has become heavily oxidized due to chronic light exposure. Under normal physiologic conditions, these metabolites are removed from the photoreceptors and transferred to the RPE for detoxification and recycling. It is theorized that, within a subset group of individuals predisposed to develop AMD, the removal and/or recycling process may be compromised. In this condition, the vitamin A metabolites linger within photoreceptors and spontaneously react with other cellular material resulting in chemically stable, toxic entities. These toxins then enter the RPE through the normal physiologic process of phagocytosis and inevitably poison the RPE. The toxins which accumulate within the RPE are derived primarily from vitamin A. Therefore, reducing the level of vitamin A circulating within the eye would be expected to reduce the toxic burden placed upon the RPE. An animal model which demonstrates excess accumulation of lipofuscin and vitamin A based toxin, known as A2E was utilized to determine whether the modulation of vitamin A entering RPE would be an effective therapeutic approach.</font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Mechanism of Action</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Both STGD1 and dry AMD are characterized by the early aberrant accumulation of lipofuscin and cytotoxic bisretinoids. The most abundant autofluorescent bisretinoid that has been identified in human lipofuscin is known as A2E (</font><font style="font-style:italic;letter-spacing:0.2pt;">N</font><font style="letter-spacing:0.2pt;">-retinylidene-</font><font style="font-style:italic;letter-spacing:0.2pt;">N</font><font style="letter-spacing:0.2pt;">-retinylethanolamine), a spontaneously formed complex comprised of two molecules of retinal and one molecule of ethanolamine. Investigations of the potential toxicity of A2E in cell-based assays and animal models have shown that this compound is highly toxic and can kill RPE cells in a concentration-dependent manner through myriad mechanisms. Because A2E and related bisretinoids are derived from vitamin A (i.e., they are by-products of normal visual cycle function), therapeutic approaches have focused on reducing levels of vitamin A (retinol) in the eye. One approach that </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:42.29pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">has been effective to reduce A2E and lipofuscin in a mouse model of STGD1 (i.e., Abca4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8722;/&#8722;</font><font style="letter-spacing:0.2pt;"> / Rdh8</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8722;/&#8722;</font><font style="letter-spacing:0.2pt;"> mice) is based on reducing delivery of dietary retinol to the eye. In that mouse model, LBS-008 significantly reduced the accumulation of bisretinoid toxins that are known to cause STGD1 and have been implicated in progression of dry AMD. Importantly, treatment of Abca4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8722;/&#8722;</font><font style="letter-spacing:0.2pt;"> / Rdh8</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8722;/&#8722;</font><font style="letter-spacing:0.2pt;"> mice with LBS-008 also prevented photoreceptor loss, which is believed to be caused by excessive levels of bisretinoid toxins. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">LBS-008 is a potent, orally administered small molecule RBP4 antagonist that has been specifically designed to reduce the delivery of retinol to the eye as a therapeutic approach towards reducing the accumulation of cytotoxic bisretinoids, preserving the integrity of retinal tissues, and ultimately slowing or preventing loss of vision. The delivery of retinol to the RPE requires RBP4 and the RPE expresses a specific RBP4 receptor (STRA6) to regulate vitamin A uptake. Other extrahepatic tissues do not require delivery of retinol bound to RBP4 and do not express the RBP4 receptor. These tissues are able to take up vitamin A bound to non-specific carriers such as lipoproteins, triglycerides, and albumin. </font>
        </div>
        <div style="position:relative;margin-top:9.2pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-ph_lbs4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-ph_lbs4clr.jpg]" height="313" width="588" >
        </div>
        <div style="margin-left:20pt; margin-top:18.69pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pathophysiologic Similarities in STGD1 and Intermediate to Advanced Dry AMD</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Early </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> measurements of lipofuscin in STGD1 patients revealed an intrinsic autofluorescence which is localized to the RPE. A comprehensive biochemical analysis of post-mortem retinal tissue from STGD1 patients has shown a high concentration of bisretinoid compounds (vitamin A-based dimers) which would likely confer autofluorescence to lipofuscin due to the light absorbing and light emitting properties of these compounds. Thus, the intrinsic autofluorescent properties of lipofuscin in STGD1 can be attributed to the high concentrations of fluorescent vitamin A byproducts within lipofuscin particles. Importantly, this unique feature allows clinicians to diagnose and monitor the extent of retinal disease in STGD1 patients using fundus autofluorescence, or FAF, photography. In a recent prospective cohort study of childhood-onset STGD1 (n = 71 subjects; mean age of onset 9.6 &#177; 3.4&#160;years), FAF photography was found to be a robust structural outcome measure. In that same study, a high rate of progression was observed in childhood-onset disease, making this subtype of STGD1 ideally suited to be considered for prioritization in clinical trials. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:6pt; text-align:center; width:456pt;">
          <img src="tm2132809d10-ph_lesion4c.jpg" alt="[MISSING IMAGE: tm2132809d10-ph_lesion4c.jpg]" height="224" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:10.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An additional indication under consideration for LBS-008 is GA in dry AMD. This additional indication was selected based upon the strong pathophysiologic similarities between STGD1 and GA, which includes the aberrant and excessive accumulation of vitamin A-based toxins and cellular debris within ocular tissue. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The figure below shows a series of FAF images from a patient with late-onset STGD1 (top panels) and a patient with GA (lower panels). The images were taken at Baseline and at 4 subsequent time points out to 57&#160;months and 55&#160;months, for STGD1 and GA, respectively. In each of the images for the STGD1 patient and the GA patient, the central lesion is surrounded on all sides by autofluorescence which is consistent with the excitation/emission properties of A2E and related bisretinoids. In each patient, the pattern of disease progression from Baseline shows that as the autofluorescence grows in intensity and area, the lesioned tissue follows. Additionally, in the GA patient, the &#8216;evolution&#8217; of areas of autofluorescence into lesioned tissue can be clearly seen. It is also important to note that in each disease the loss of visual acuity does not track with the expansion of lesioned tissue. This is due to a phenomena of foveal sparing in both diseases which preserves the small area of tissue in the center of the retina that is responsible for conferring high visual acuity. In addition, as lesions encroach into the fovea, STGD1 and GA patients tend to utilize &#8216;eccentric fixation&#8217; in which areas just peripheral to the fovea (non-lesioned retina) are used for reading and high visual acuity. </font>
        </div>
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2132809d1-ph_proofbwlr.jpg" alt="[MISSING IMAGE: tm2132809d1-ph_proofbwlr.jpg]" height="235" width="465" >
        </div>
        <div style="margin-left:20pt; margin-top:17pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Proof of Concept from Fenretinide</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our confidence that reduction of serum RBP4 will be a viable treatment approach in STGD1 and GA comes from prospective clinical analyses of the natural history of disease progression in these diseases, and the findings from a 2-year Phase&#160;2 proof-of-concept study that was conducted in dry AMD patients with GA. Fenretinide was selected for the study because of a prominent side effect that had been observed in subjects treated with fenretinide in various clinical oncology studies, a dose-dependent reduction in serum RBP4-retinol, due to its structural and chemical similarity to retinol. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Fenretinide (</font><font style="font-style:italic;letter-spacing:0.2pt;">N</font><font style="letter-spacing:0.2pt;">-(4-hydroxyphenyl) retinamide; also known as 4-HPR) is an analog of all-</font><font style="font-style:italic;letter-spacing:0.2pt;">trans</font><font style="letter-spacing:0.2pt;"> retinoic acid (ATRA) first synthesized in the late 1960s as an antineoplastic drug. The Phase&#160;2 GA fenretinide study was a randomized, double-blind, placebo-controlled study with 246 subjects randomized into one of three treatment arms: placebo, 100 mg, or 300 mg. In this study, patients in the 300 mg group who achieved RBP4 levels of &le; 1 &#181;M, which is equivalent to approximately 70% reduction of RBP4, showed a mean reduction of 0.33 mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> in the yearly lesion growth rate compared with subjects in the placebo group (1.70 mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;">/year vs. 2.03 mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;">/year, respectively). However, due to its poor bioavailability and significantly lower affinity towards RBP4 as compared to LBS-008, and therefore weaker potency, only a small subset of GA subjects achieved the criterion. Based on this data, we believe a sustained &gt;70% reduction of RBP4 from baseline would provide the greatest potential for a treatment benefit and, therefore, represents the &#8216;therapeutic threshold&#8217; to achieve in future clinical studies directed at reducing the accumulation of A2E and related bisretinoids as a means of preserving retinal tissue and functional vision. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Safety of Long-Term RBP4 Inhibition</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;1987, a Phase&#160;3 trial was initiated to assess the efficacy of a 5-year treatment regimen with fenretinide in reducing contralateral or second ipsilateral breast cancer in patients aged 30-70&#160;years with early breast cancer, who had received no systemic treatment after primary treatment. A total of 2,867 assessable patients completed the intervention period by July&#160;1998. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Women were randomly assigned to receive no treatment (1,435 patients) or 5-year fenretinide treatment (1,432 patients). Fenretinide was administered in a gelatin capsule (200 mg) and was taken daily at dinner with a two-day drug holiday on weekends. Compared to baseline, plasma retinol levels decreased by a mean of approximately 71% (range: 61%&#8201;&#8211;&#8201;88%) during fenretinide administration (P&lt;0.0001). Mean plasma retinol concentrations during fenretinide treatment were &le;1 &#181;M. Following the 5-year treatment regimen, a 28-day treatment cessation period was effective to restore retinol to baseline values. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In terms of disease recurrence in the breast, the trial showed a possible beneficial effect of the compound in premenopausal women, and an opposite trend in postmenopausal women. End points considered for safety assessment were the occurrence of delayed dark adaptation, or DDA, dermatologic disorders, gastrointestinal symptoms, disorders of the ocular surface, and abnormal laboratory values. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A comprehensive analysis of the safety data showed that the most common adverse events were DDA (cumulative incidence, 19.0%) and dermatologic disorders (18.6%). Less common events were gastrointestinal symptoms (13.0%) and disorders of the ocular surface (10.9%). In comparison, incidence figures in the control arm were 2.9% for DDA, 2.9% for dermatologic disorders, 5.4% for gastrointestinal symptoms, and 3.2% for disorders of the ocular surface. Symptoms occurring during fenretinide treatment tended to recover with time. No between-group difference was observed for the occurrence of laboratory data abnormalities. Overall, only 63 (4.4%) treatment discontinuations were caused by adverse events. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The investigators of the study noted that given the large number of patients involved in the study and the prolonged (i.e., over 5&#160;years) intake of the drug, the experience on fenretinide tolerability can be considered reasonably reassuring. The observed clinical symptoms were often of minor importance, tended to recover spontaneously, and required permanent treatment discontinuation in a minority of cases. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stargardt Disease</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Autosomal recessive STGD1 is a rare monogenetic juvenile-onset macular dystrophy that is characterized by the aberrant and excessive accumulation of toxic vitamin A by-products and cellular debris which precedes the death of retinal tissue and loss of vision. STGD1 is the most common inherited retinal dystrophy, affecting roughly 1 in 10,000 people. This prevalence rate computes to approximately 30,000 STGD1 patients in the United States. The disease is typically diagnosed at a young age, often starting during childhood or adolescence, and is characterized by lesions within retinal tissue which cause severe and irreversible loss of visual acuity gradually leading to legally defined blindness at a very young age. Older age at onset (&gt;20&#160;years of age) is associated with slower disease progression. There are no FDA-approved treatments for STGD1. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:16.8pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Individuals affected with STGD1 harbor mutations in a retina-specific ATP-binding cassette, or ABC, transporter gene, known as </font><font style="font-style:italic;letter-spacing:0.2pt;">ABCA4</font><font style="letter-spacing:0.2pt;">. The </font><font style="font-style:italic;letter-spacing:0.2pt;">ABCA4</font><font style="letter-spacing:0.2pt;"> gene encodes an ATP-dependent transporter, known as ABCA4, or Rim Protein. This protein resides at the rim of rod and cone photoreceptor disc membranes where it removes light-activated or &#8216;bleached&#8217; visual chromophore (all-trans retinal) from the retina permitting detoxification by a retinal dehydrogenase (RDH8) which, in turn, allows recycling within the underlying RPE. The primary function of the RPE is to provide metabolic and trophic support to sustain health and integrity of the retina. The intimate association of the RPE with outer segments of rod and cone photoreceptors facilitates this function. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The RPE converts dietary vitamin A delivered from the blood circulation, and recycled retinol liberated from the retina following exposure to light, into visual chromophore (11-cis retinal). The visual chromophore is then transferred to the retina to maintain light sensitivity and function of the retina. The enzymatic conversion of dietary vitamin A to a light-sensitive visual chromophore is a unique process which only occurs within RPE cells and the ABCA4 protein plays a key role in this process&#8201;&#8212;&#8201;see figure below. </font>
        </div>
        <div style="position:relative;margin-top:9.2pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-ph_segment4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-ph_segment4clr.jpg]" height="305" width="543" >
        </div>
        <div style="text-indent:20pt; margin-top:12.69pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The processing of vitamin A (aka, retinol, or all-trans retinol) in the visual cycle begins with the delivery of circulating retinol to the RPE. The ternary complex of RBP4-retinol-TTR is presented to RBP4 receptors which are located on the basal surface of RPE. The RBP4-TTR vehicle serves to solubilize retinol and produce a large molecular size complex which resists elimination in the kidney. Upon entry into the RPE, retinol undergoes a series of enzymatic reactions resulting in generation of the visual chromophore, 11-cis retinal. The visual chromophore is delivered to the retina where it combines with opsin to form the light-sensitive visual pigment, rhodopsin. Photoactivation of rhodopsin liberates all-trans retinal which is transported out of the retina by the ABCA4 protein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In the absence of a functional ABCA4 protein, retinal accumulates within photoreceptor outer segments where it generates membrane-damaging reactive oxygen species, and also spontaneously reacts with cellular lipids and other retinaldehyde molecules. These retinal-retinal species, known as bisretinoids, and oxidized membranes are taken into the RPE through normal diurnal phagocytic processing where they gradually accumulate. It is theorized that these compounds reach a critical mass within RPE phagolysosomes and cause dysfunction of the metabolic activities of the RPE leading to early accelerated accumulation of lipofuscin which severely compromises the ability of the RPE to nourish the retina. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:43.17pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Symptoms of STGD1</font>
        </div>
        <div style="position:relative;margin-top:9.19pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-ph_disease4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-ph_disease4clr.jpg]" height="268" width="548" >
        </div>
        <div style="margin-left:20pt; margin-top:12.69pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Source: https://makariwellness.com/stargardt-disease/</font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preclinical Proof of Concept</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Abca4&#8722;/&#8722; / Rdh8&#8722;/&#8722; STGD1 mouse model</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In the Abca4&#8722;/&#8722; / Rdh8&#8722;/&#8722; double knockout STGD1 mouse model, daily dosing at approximately 25 mg/kg of LBS-008 was given for 12 weeks. A mean RBP4 reduction of approximately 90% in LBS-008 treated double knockout mice was achieved and led to an approximately 80% reduction of A2E, that are known to cause STGD1 and have been implicated in progression of dry AMD, compared to the untreated double knockout mice. </font>
        </div>
        <div style="position:relative;margin-top:9.19pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-bc_serum4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-bc_serum4clr.jpg]" height="201" width="535" >
        </div>
        <div style="text-indent:20pt; margin-top:12.7pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Importantly, Outer Nuclear Layer, or ONL, thickness was significantly decreased in untreated ABCA4-/-/RDH8-/- mice, compared to the double knockout mice treated with LBS-008. Macular degeneration in Dry AMD and STGD1 is associated with thinning of the ONL which indicates loss of photoreceptor cells, which is believed to be caused by excessive levels of bisretinoid toxins.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:6pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-lc_optic4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-lc_optic4clr.jpg]" height="225" width="584" >
        </div>
        <div style="margin-left:20pt; margin-top:16.8pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have initiated our Phase&#160;3 clinical trial in adolescent STGD1 patients, and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. We are also conducting our ongoing Phase&#160;2 clinical trial of LBS-008 in adolescent STGD1 patients. Previously, we completed a Phase&#160;1b clinical trial of LBS-008 in adolescent STGD1 patients in late-2021 and two Phase&#160;1 clinical trials of LBS-008 in healthy adult subjects in mid-2020. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase&#160;3 Clinical Trial in STGD1</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have initiated a randomized, double-masked, placebo-controlled, global, multi-center Phase&#160;3 clinical trial, to evaluate the safety and efficacy of LBS-008 in adolescent STGD1 patients and received approval to commence patient enrollment in Taiwan, the U.K., Hong Kong and Switzerland. In addition, we are in the process of applying for the necessary approvals to conduct the same clinical trial in other relevant jurisdictions. This study consists of a screening period, a treatment period of 2&#160;years, and a follow-up period of one month. Approximately 60 patients are targeted for enrollment in this study with a 2:1 randomization (active:placebo). The Phase&#160;3 clinical trial in STGD1 aims to evaluate the efficacy of LBS-008 by assessing any improvements or changes in visual function and morphological and biomarker changes as detected on specialized retinal imaging. Safety and tolerability will also be assessed during the clinical study period. This trial is expected to be conducted at multiple sites across Australia, Asia, Europe, and North America. See &#8220;Risk Factors &#8212; In the event that we elect to carry out clinical trials in China and/or expand our operations into China in the future, we will be subject to changing legal and regulatory requirements in the PRC pharmaceutical industry, and new laws, rules and regulations may adversely affect our profitability or impose additional compliance burdens on us.&#8221;</font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase&#160;1b/2 Clinical Trial in STGD1</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We initiated an open-label, dose-finding Phase&#160;1b/2 clinical trial in adolescent STGD1 patients in mid-2020 in Australia and Taiwan. The study design includes two portions: Phase&#160;1b and Phase&#160;2. We have completed the Phase&#160;1b portion of this study in 11 adolescent STGD1 patients which has extended into a two-year, Phase&#160;2 study with 13 adolescent STGD1 patients in Australia and Taiwan. The expected enrollment of this study was 10 patients. As of the date of this prospectus, data is available for the 11 patients who have completed the Phase&#160;1b portion and for all 13 patients who have received at least 6&#160;months of treatment and completed the scheduled assessments at the first 6 month interval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Phase&#160;1b portion is a dose-finding study designed to determine the optimal dose of LBS-008 and to evaluate safety, tolerability, PK and PD in adolescent STGD1 patients for a treatment period of 2 cycles of 14-day daily dosing of LBS-008 (28&#160;days of daily treatment) and a 14-day follow-up period. The Phase&#160;2 portion consists of a 2-year treatment period with a follow-up period of one month. In the Phase&#160;2 portion of the study, in addition to monitoring the safety and tolerability, we aimed to monitor PK and PD </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">biomarkers (RBP4 and retinol) and the effects of treatment using various retinal imaging modalities (including DDAF, QDAF, SD-OCT, and microperimetry), change in BCVA, and the relationship between the change in RBP4 levels and rate of lesion growth. Furthermore, a Safety Review Committee, or SRC, and an independent Data and Safety Monitoring Board, or DSMB, were formed to monitor the Phase&#160;1b portion of this study to evaluate all the safety, toxicity, and dose response data and provide recommendations for the appropriate dose to be used for Phase&#160;2. The DSMB will continue to monitor the safety and efficacy trends throughout the Phase&#160;2 study. Interim data read-outs will be captured at Months 12, 15, 18 and 21, and a final data read-out will be captured at Month&#160;24. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Efficacy Results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the Phase 1b portion, the PD profiles showed that the mean RBP4 level reached and maintained below 30% of the mean baseline value throughout the treatment period. Mean RBP4 level returned to close to baseline values following 14&#160;days of drug cessation. LBS-008 plasma concentration and RBP4 suppression appeared to be correlated. Comparison of PD profiles observed in heathy adults and in adolescent STGD1 patients showed a similarity between the two populations. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Mean RBP4 level of Phase 1b</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:8.2pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-lc_dosing4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-lc_dosing4clr.jpg]" height="216" width="529" >
        </div>
        <div style="margin-left:20pt; margin-top:11.4pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Note: After Day 15, data were collected from 6 subjects in Australian sites only as data could not be collected due to COVID-19 restrictions at the NTUH site in Taiwan. Mean change of RBP4 (%) for all 11 patients for Days 1 to 15 is presented as the 11-Patients line, and data for the 6 patients in Australian sites for the whole Phase 1b portion is presented as the 6-Patients line.</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon completion of the Phase 1b portion, an optimal daily dose was identified and which was able to achieve a mean RBP4 reduction of &gt; 70%, relative to baseline values. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are currently conducting the Phase&#160;2 portion of this study. A total of 13 adolescent STGD1 patients were enrolled in the Phase&#160;2 portion of the Phase&#160;1b/2 study. As of the date of this prospectus, all 13 patients have received at least 6&#160;months of treatment and completed the scheduled assessments at the first 6 month interval. Change in BCVA (ETDRS letter score) and FAF imaging results at 6-months are compared to the baseline measurements at the start of Phase&#160;2. The preliminary data shows that 8 of the 13 patients (or 61.5%) recorded a gain in BCVA (ETDRS letter score) in at least one eye, including 2 patients who recorded a gain in BCVA in both eyes. The average BCVA from the 13 patients was an average loss of 2.8 letters in the right eye, and an average gain of 1.9 letters in the left eye. On FAF retinal imaging, 8 of the 13 patients (or 61.5%) had a reduction or no change in their QDAF area size in at least one eye, including 5 patients who had a reduction or no change in QDAF area size in both eyes. There was an average gain in QDAF area in the right eye of 0.2 &#177; 0.09mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> (Mean &#177; SEM) and in the left eye of 0.1 &#177; 0.09mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> (Mean &#177; SEM). While 12&#160;of the 13 patients had no DDAF lesion measured at the start of Phase&#160;2 and at 6-months, 1 of the&#160;13 patients had a DDAF lesion growth of 0.3mm</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> in both eyes during the 6-month period. On SD-OCT imaging, a gradual thinning with an average of approximately 7 to 10 microns (on total retinal thickness by ETDRS regions) was observed in both eyes. In the Ellipsoid Zone (EZ), an average increase in defect width of 0.26mm in the right eye and 0.61mm in the left eye were observed. However, 6 patients </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">127</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">had a reduction in EZ defect width in at least 1&#160;eye (including 3 patients in both eyes). Additional interim data read-outs will be captured at Months&#160;12, 15, 18 and 21, and a final data read-out will be captured at Month&#160;24. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase&#160;1b Safety Results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preliminary safety results of the Phase&#160;1b study shows that the only drug-related adverse events reported were DDA (i.e., a delay in the time required to adjust to a dimly lit environment), and xanthopsia/</font>&#8203;<font style="letter-spacing:0.2pt;">chromatopsia (i.e., a transient color tint in the field of vision), both reported by 7 of the 11 patients (or&#160;63.6%), and night vision impairment, reported by 1 of 11 patient (or 9.1%), and were all graded as mild. All of these adverse events were resolved with the cessation of treatment at the end of the Phase&#160;1b study. </font></div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Reports of transient DDA, night vision impairment, and xanthopsia/chromatopsia were anticipated and are consistent with the mechanism of LBS-008 action. It is notable that the majority of DDA cases required confirmation by laboratory measure (dark adaptometry) as many subjects were asymptomatic. No deaths nor serious or severe adverse events were reported. In addition, there were no clinically significant findings related to vital signs, physical exams, or ECGs. </font>
        </div>
        <table style="width:456pt;height:62.5pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:168.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Adverse Events </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Severity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:76.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Relationship </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to Drug </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Frequency </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#Patients) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45.2pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Recovered </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% On-going </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:168.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Xanthopsia/Chromatopsia </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">Mild</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:76.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Definitely Related </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7/11</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:45.2pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">7/7 (100%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0/7</td>
            <td style="padding:0pt;padding-left:13.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Delayed Dark Adaptation (DDA) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">Mild</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:76.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Definitely Related </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7/11</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.2pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">7/7 (100%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0/7</td>
            <td style="padding:0pt;padding-left:13.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:168.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Night Vision Impairment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">Mild</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:76.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Definitely Related </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1/11</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:45.2pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">1/1 (100%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">0/1</td>
            <td style="padding:0pt;padding-left:13.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase&#160;2 Safety Results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preliminary safety results of the Phase&#160;2 study shows that the only definitely and probably drug-related adverse events reported were DDA, reported by 8 of 13 patients (or 61.5%), xanthopsia/chromatopsia, reported by 6 of 13 patients (or 46.2%), night vision impairment, reported by 1 of 13 patients (or 7.7%), and increasing error score on FM100 test (a test of color vision and color perception), reported by 1 of 13 patients (or 7.7%), and were all graded as mild. No deaths nor serious or severe adverse events were reported. In addition, there were no clinically significant findings related to vital signs, physical exams, or ECGs. </font>
        </div>
        <table style="width:456pt;height:77.5pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:178.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Adverse Events </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Severity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:76.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Relationship </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to Drug </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Frequency </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(#Patients) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:47.9pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">%</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Recovered </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:47.9pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% On-going </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:178.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Xanthopsia/Chromatopsia </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">Mild</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:76.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Definitely Related </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6/13</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/6 (50%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">3/6 (50%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Delayed Dark Adaptation (DDA) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">Mild</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:76.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Definitely Related </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8/13</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">1/8 (12.5%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">7/8 (87.5%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Night Vision Impairment </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">Mild</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:76.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Definitely Related </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1/13</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0/1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">1/1 (100%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increasing error score on FM100 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">Mild</td>
            <td style="padding:0pt;padding-left:3.065pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:76.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Probably Related </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1/13</td>
            <td style="padding:0pt;padding-left:10.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0/1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:47.9pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">1/1 (100%)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dry AMD</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Age-related macular degeneration, or AMD, is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula. The macula is the part of the retina responsible for clear vision in your direct line of sight. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Symptoms of Dry AMD</font>
        </div>
        <div style="position:relative;margin-top:8.99pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-ph_babys4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-ph_babys4clr.jpg]" height="101" width="608" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">128</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Source: https://www.ncbi.ie/supporting-you/everyday-living/eye-conditions/age-related-macular-degeneration-amd/</font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on the classification system established in the AREDS, AMD has four stages, all of which may occur in one or both eyes: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 1 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">No AMD</font><font style="letter-spacing:0.2pt;">,&#8221; although there may be a few small (&lt;63&#181;m in diameter) yellowish subretinal deposits (i.e., drusen beneath the retina). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 2 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Early AMD</font><font style="letter-spacing:0.2pt;">&#8221; and is characterized by multiple small drusen (&lt;20&#181;m in diameter), a few intermediate drusen (63-124&#181;m in diameter), and abnormalities of the RPE, a monolayer of epithelial cells that lies beneath the retina and provides trophic and metabolic support to photoreceptor cells of the retina. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 3 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Intermediate AMD</font><font style="letter-spacing:0.2pt;">,&#8221; where there is extensive intermediate drusen, large drusen (&gt;125&#181;m in diameter), or GA (i.e., localized atrophy of the retina) and increased lipofuscin in the RPE. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Category 4 is designated as &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Advanced AMD</font><font style="letter-spacing:0.2pt;">&#8221; and is characterized by GA or neovascular maculopathy (i.e., &#8216;wet&#8217; AMD). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The only approved therapies for AMD are for &#8216;wet&#8217; AMD, which represents approximately 10% of all AMD cases. There are no approved therapies for the other stages of AMD, which are collectively referred to as dry AMD and represents approximately 90% of all AMD cases. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase&#160;2 or Phase&#160;3 Clinical Trials in Dry AMD</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are currently evaluating our plan to initiate, in 2022, a randomized, double-masked, placebo-controlled, global, multi-center Phase&#160;2 or Phase&#160;3 trial to evaluate the safety and efficacy of LBS-008 in the treatment of dry AMD, which is expected to be conducted at multiple sites across the United States, Europe and Asia Pacific. See &#8220;Risk Factors &#8212; In the event that we elect to carry out clinical trials in China and/or expand our operations into China in the future, we will be subject to changing legal and regulatory requirements in the PRC pharmaceutical industry, and new laws, rules and regulations may adversely affect our profitability or impose additional compliance burdens on us.&#8221; Such trials would aim to evaluate the efficacy of LBS-008 by assessing any improvements or changes in visual function and morphological and biomarker changes as detected on specialized retinal imaging. Safety and tolerability will also be assessed during the clinical study period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Patients are expected to be randomized to two treatment cohorts to receive a once-daily oral dose of LBS-008 or placebo. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Trials in Healthy Adult Subjects</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase 1 Clinical Trials in Healthy Adult Subjects (Single and Multiple Ascending Dose Studies in Australia)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have completed randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 trials of LBS-008 in 71 healthy adult subjects in July 2020 in Australia. 39 (including 10 placebo) and 32 (including 8 placebo) healthy adult subjects were enrolled in single ascending dose and multiple ascending dose, respectively. Sample sizes were selected based on clinical and practical considerations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our primary outcome was to evaluate the safety and toxicity (drug-related adverse events and their severity/frequency), PK, and PD biomarkers (RBP4 and retinol) on a range of single ascending dose levels (from 25-400 mg) and multiple ascending dose levels (from 5-25 mg) of LBS-008 in heathy adult subjects in fasted conditions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, a SRC was formed to monitor and evaluate the safety data for the Phase 1 SAD and MAD studies. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">129</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Efficacy Results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the SAD study, we found that single doses of 25 &#8211; 400 mg LBS-008 were well tolerated and reduced mean RBP4 level by &gt; 70% from baseline. A direct correlation between the LBS-008 plasma concentration and RBP4 suppression was observed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Similar results were observed at steady-state in the MAD portion of the study. We found that all dose levels were well tolerated and have identified an optimal daily dose to reduce serum RBP4 by &gt; 70% from baseline. </font>
        </div>
        <div style="margin-top:5.81pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Mean RBP4 level in optimal dose in Phase 1 MAD (excluding placebo)</font>
        </div>
        <div style="position:relative;margin-top:5.81pt; text-align:center; width:456pt;">
          <img src="tm2132809d4-lc_reduct4clr.jpg" alt="[MISSING IMAGE: tm2132809d4-lc_reduct4clr.jpg]" height="256" width="524" >
        </div>
        <div style="margin-left:20pt; margin-top:12.13pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Safety Results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All single ascending dose levels were well tolerated, including single ascending dose levels up to 400mg. One subject in the 100 mg cohort experienced a drug-related adverse event of mild transient xanthopsia. That event was resolved within 48 hours. </font>
        </div>
        <div style="margin-top:5.81pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Drug-related adverse events in the SAD portion of the study</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:47.5pt;margin-left:20pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:130.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Adverse Events </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:130.67pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Severity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:130.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Frequency (#Subjects) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:130.67pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">Xanthopsia&#8201;&#8211;&#8201;yellow being more prominent in their color vision </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:130.67pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mild </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:130.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1/29</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:3.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All multiple ascending dose levels were also well tolerated. Most drug-related adverse events reported were mild in severity, and the most frequently reported drug-related adverse event was asymptomatic DDA, which did not show dose proportionality and reflects a reduction in vitamin A levels in the eye, which is the intended effect of LBS-008. No deaths, serious or severe adverse events were reported. The SRC approved dose escalations after reviewing the safety data profile at each dose level.</font>
        </div>
        <div style="margin-top:5.82pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Drug-related adverse events in the MAD portion of the study</font>
        </div>
        <table style="width:416pt;height:134.5pt;margin-left:20pt;margin-top:7.99999999999989pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;min-height:11.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.5pt 0pt; width:176pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Adverse Events </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.5pt 0pt; width:108pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Severity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.5pt 0pt; width:108pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Frequency (#Subjects) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:19.25pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.25pt 0pt 3.5pt 0pt; width:176pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Delayed Dark Adaptation (DDA) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.25pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mild </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.25pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">16/24 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:31pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:176pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">Xanthopsia&#8201;&#8211;&#8201;yellow being more prominent in their colour vision </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mild </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1/24 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:19pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:176pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Photophobia&#8201;&#8211;&#8201;sensitivity to light </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mild </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1/24 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:19pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:176pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Ocular migraine </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mild </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1/24 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:19pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:176pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Intermittent dyspepsia (indigestion) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mild </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1/24 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:21pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:176pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Migraine </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Moderate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:108pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1/24</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">130</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Phase&#160;1 Clinical Trial in Healthy Adult Subjects (Single Ascending Dose Study in the United States)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have completed a randomized, double-blind, placebo-controlled, single ascending dose Phase&#160;1 trial of LBS-008 in 40 (including 10 placebo) healthy adult subjects in May&#160;2020 in the United States. Our primary outcome was to evaluate the safety and toxicity (drug-related adverse events and their severity/frequency), PK, and PD biomarkers (RBP4 and retinol) on a range of single ascending dose levels, ranging from 10-50&#160;mg, of LBS-008 in heathy adult subjects in fasted and fed conditions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Efficacy Results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We found that single doses of 10&#8211;50 mg LBS-008 were well tolerated and reduced mean serum RBP4 level by around 70% from baseline. Following administration of a single oral dose of LBS-008, RBP4 level reached a minimum within 24-48 hours post-dose. Thereafter, RBP4 levels increased, returning to baseline levels generally by Day 12 post-dose compared with placebo subjects. The degree of lowering of RBP4 plasma concentrations increased with increasing LBS-008 dose. This study also compared doses of LBS-008 taken with and without food, which did not show a food effect with dosing. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Safety Results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All dose levels in this single ascending study were well tolerated. There were no reported drug-related adverse events in this Phase&#160;1 study. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LBS-009 for NAFLD / NASH and T2D</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">LBS-009 is an anti-RBP4 oral therapy targeting liver disease, including NAFLD, NASH and T2D. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Currently, many compounds under investigation are focused on pathways associated with metabolism, inflammation, and fibrosis but they have demonstrated varied levels of efficacy often with conflicting results. NAFLD and NASH are a growing unmet need for which no FDA-approved treatments are currently available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">RBP4 is secreted by the liver and adipose tissue and has recently been identified as a pro-inflammatory cytokine in preclinical models of insulin resistance and liver disease. Therefore, RBP4 is currently being investigated as a clinical biomarker for human metabolic diseases. Clinical studies have found a significant association between elevated RBP4 levels in the circulation, impaired glucose tolerance, and NAFLD. Transgenic mice overexpressing RBP4 had a higher incidence of insulin resistance, a comorbid condition for NAFLD and NASH, and preclinical reports demonstrate that modulating RBP4 levels in the circulation will improve insulin resistance and reduce liver fat accumulation. LBS-009 is a small molecule designed to compete with retinol for binding to RBP4. When bound to LBS-009, RBP4 can no longer form a large molecular weight complex with transthyretin. Consequently, the RBP4/LBS-009 complex will be removed from circulation by renal filtration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Preliminary PD studies with LBS-009 demonstrated the ability to reduce RBP4 levels in healthy rats by 85% following a single dose. Efficacy studies have been conducted in the ob/ob high-fat diet induced mouse model of metabolic disease. Treatment with LBS-009 significantly reduced RBP4 concentrations both in circulation and in adipose tissue, or fat tissue, resulting in improved insulin activity and glucose tolerance. Mice in these studies were dosed daily with LBS-009 for up to 16 weeks without any observed adverse effects. We believe that by therapeutically antagonizing RBP4 and reducing its concentration in the blood, we can mitigate local concentration of RBP4 in adipose tissue and reduce inflammation, thereby improving the metabolic phenotype. In preclinical studies, LBS-009 has shown the ability to ameliorate steatosis in transgenic mice, suggesting that antagonism of RBP4 with LBS-009 may serve as a potential pharmacotherapy for NASH. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and Development Governance</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The research and development of drug products is a lengthy and expensive process. We have established research and development policies for all stages of our research and development activities, through our internal research project initiation processes and our preclinical and clinical development programs. Our research and development policies have enabled our senior management to continuously oversee and monitor </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">131</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">our Company&#8217;s research and development activities for compliance with applicable laws, regulations, rules, guidelines and internal policies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our in-house discovery, research and development team focuses on identifying small-molecule compounds in our core therapeutic areas of macular degeneration and age-related metabolic diseases. The initiation of our research and development process begins with the identification and establishment of a research project. Upon conclusion of this initial process, an internal project report is produced by the research project team, which includes topics such as project background, significance, development history and research status, mechanism of action, pharmacokinetics, pharmacodynamics, clinical application, safety, drug interaction and market analysis, among other things. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have relied on and plan to continue to rely on third-party CROs to monitor and manage data for some of our ongoing preclinical studies and clinical trials. We follow the highest industry standards to select the CROs that are going to conduct the services in order to meet FDA and other regulatory requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing and Supply</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently rely on high-quality contract manufacturers to help produce preclinical and clinical supplies of our product candidate. Throughout our labs, we have assembled a seasoned internal team with deep experience in the field of chemistry to drive and help monitor our CMO processes and any external scale-up manufacturing. Our internal labs help monitor the manufacturing activities of research and development study material at our contract manufacturers to ensure compliance with local and international cGMP and applicable regulations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual Property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our commercial success depends in large part on our ability to obtain and maintain intellectual property and other proprietary protection for our product candidates, technologies, inventions, trade secrets and other know-how, as well as on our ability to defend and enforce our intellectual property or proprietary rights including any patent that we have or may issue from our owned, co-owned, or in-licensed patent applications, preserve the confidentiality of our trade secrets and operate without infringing, misappropriating or otherwise violating the valid and enforceable intellectual property and proprietary rights of other parties. We protect our proprietary and intellectual property position by, among other methods, licensing or filing in the United States and foreign jurisdictions, patent applications related to our proprietary technology, inventions and improvements that are important to the development and implementation of our business. We also seek to protect our trade secrets, know-how and continuing technological innovation through contractual obligations with third parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patents</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have developed our lead product candidate, LBS-008, based on technology that we have exclusively licensed from the Trustees of Columbia University in the City of New York, or Columbia University, pursuant to a license agreement with Columbia University that was assigned to us from Lin Bioscience International Ltd., our principal shareholder. The license agreement has been amended five times, most recently as of February&#160;4, 2022. As of April&#160;20, 2022, the intellectual property in-licensed under our license agreement with Columbia University, including co-owned patents and patent applications, includes nine active patent families, which encompasses 18 issued U.S. patents and 4 pending U.S. patent applications, including original filings, continuations and divisional applications. The families also include numerous foreign counterparts, with claims granted or pending in Europe, China, Japan, South Korea, Australia and elsewhere. These licensed patent rights relate to methods of use, manufacture and compositions of matter and include issued patents with claims that recite a class of compounds directed to covering our lead compound, LBS-008, and specifically recite LBS-008. In terms of our key family of composition of matter patents, these include compounds of LBS-008 and LBS-009, and structurally similar derivatives, along with their methods of use in ophthalmic and metabolic indications. These issued patents covering LBS-008 and LBS-009 are expected to expire between 2034 and 2035, absent any patent term extensions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to the intellectual property licensed from Columbia University, as of April&#160;20, 2022, we own and co-own six active patent families, which encompasses two issued U.S. patents and six pending U.S. patent applications, including provisional filings. These patent families also contain numerous foreign </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">132</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:41.8200000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">counterparts, with claims granted or pending in Europe and elsewhere. These patent rights relate to methods of use, formulations, companion diagnostics, and methods for assessing visual function. Any patents issued from these patent applications are expected to expire between 2038 and 2043, absent any patent term adjustments or extensions. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">In-licensed Patents and Patent Applications</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5.00000000000011pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Patent </font>
              <br >
              <font style="letter-spacing:-0.16pt;">Family&#160;No. </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Type of Patent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Issued Countries/ Regions </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and/or Application Type </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pending </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Countries/ Regions </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and/or </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Application Type </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:60pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Termination Date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(mm/dd/yyyy) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Subject to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">&#8220;March-in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Rights&#8221;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Yes/ No) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Methods of Use </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe</font>
              <br >
              <font style="letter-spacing:0.2pt;">Japan </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">11/22/2031 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Methods of Use </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">U.S </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">04/30/2033 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">3 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Manufacture and Composition of Matter </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Divisional #1</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe Divisional </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">U.S Divisional #2 </font>
              <br >
              <font style="letter-spacing:0.2pt;">Hong Kong </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">03/13/2034 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">4 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Manufacture and Composition of Matter </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Continuation #1</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Continuation #2</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">03/13/2034 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">5 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Manufacture and Composition of Matter </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Divisional </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">03/13/2034 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">6 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Manufacture and Composition of Matter </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Continuation </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">03/13/2034 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">7 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Manufacture </font>
              <br >
              <font style="letter-spacing:0.2pt;">and Composition of Matter </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Continuation #1</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Continuation #2 U.S Continuation #3</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Continuation #4</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe</font>
              <br >
              <font style="letter-spacing:0.2pt;">Australia</font>
              <br >
              <font style="letter-spacing:0.2pt;">India</font>
              <br >
              <font style="letter-spacing:0.2pt;">Mexico</font>
              <br >
              <font style="letter-spacing:0.2pt;">Japan</font>
              <br >
              <font style="letter-spacing:0.2pt;">Philippines</font>
              <br >
              <font style="letter-spacing:0.2pt;">China</font>
              <br >
              <font style="letter-spacing:0.2pt;">Singapore</font>
              <br >
              <font style="letter-spacing:0.2pt;">Indonesia </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">U.S Continuation </font>
              <br >
              <font style="letter-spacing:0.2pt;">#5</font>
              <br >
              <font style="letter-spacing:0.2pt;">Hong Kong</font>
              <br >
              <font style="letter-spacing:0.2pt;">South Korea</font>
              <br >
              <font style="letter-spacing:0.2pt;">Myanmar</font>
              <br >
              <font style="letter-spacing:0.2pt;">Thailand</font>
              <br >
              <font style="letter-spacing:0.2pt;">Canada</font>
              <br >
              <font style="letter-spacing:0.2pt;">China Divisional</font>
              <br >
              <font style="letter-spacing:0.2pt;">New Zealand</font>
              <br >
              <font style="letter-spacing:0.2pt;">Brazil</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe&#160;Divisional </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">04/29/2035 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">8 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Methods of Use </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:96pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe</font>
              <br >
              <font style="letter-spacing:0.2pt;">Hong Kong</font>
              <br >
              <font style="letter-spacing:0.2pt;">China </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:60pt;">
              <font style="letter-spacing:0.2pt;">08/01/2039 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <font style="letter-spacing:0.2pt;">Yes</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">133</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Co-owned Patents and Patent Applications</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:86.5pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:52.67pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Patent </font>
              <br >
              <font style="letter-spacing:-0.16pt;">Family&#160;No. </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Type of Patent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Issued Countries/ </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Regions and/or </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Application Type </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pending </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Countries/ Regions </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and/or Application </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Type </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:52.67pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Termination </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(mm/dd/yyyy) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:52.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Subject to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">&#8220;March-in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Rights&#8221;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Yes/ No) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:52.67pt;">
              <font style="letter-spacing:0.2pt;">9 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:84pt;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Methods of </font>
              <br >
              <font style="letter-spacing:0.2pt;">Use </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:77pt;">
              <font style="letter-spacing:0.2pt;">U.S,</font>
              <br >
              <font style="letter-spacing:0.2pt;">U.S Divisional #1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:77pt;">
              <font style="letter-spacing:0.2pt;">U.S Divisional #2</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe</font>
              <br >
              <font style="letter-spacing:0.2pt;">Taiwan</font>
              <br >
              <font style="letter-spacing:0.2pt;">Hong Kong </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:52.67pt;">
              <font style="letter-spacing:0.2pt;">06/14/2038 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:52.66pt;">
              <font style="letter-spacing:0.2pt;">No</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:11.7pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Belite-owned Patents or Patent Applications</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:58.75pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Patent </font>
              <br >
              <font style="letter-spacing:-0.16pt;">Family&#160;No. </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:89pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Type of Patent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:58.75pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Issued Countries/ </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Regions and/or </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Application Type </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pending </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Countries/ Regions </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and/or Application </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Type </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:58.75pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Expected</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Termination </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(mm/dd/yyyy) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:58.75pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Subject to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">&#8220;March-in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Rights&#8221;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Yes/ No) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.25pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.417pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">10 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.417pt 0pt 1.083pt 0pt; width:89pt;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Methods of </font>
              <br >
              <font style="letter-spacing:0.2pt;">Use </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.417pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.417pt 0pt 1.083pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">Europe</font>
              <br >
              <font style="letter-spacing:0.2pt;">Taiwan</font>
              <br >
              <font style="letter-spacing:0.2pt;">Hong Kong </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.417pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">06/14/2038 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.417pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">No </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.25pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">11 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:89pt;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Formulations </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">U.S</font>
              <br >
              <font style="letter-spacing:0.2pt;">Europe</font>
              <br >
              <font style="letter-spacing:0.2pt;">Australia</font>
              <br >
              <font style="letter-spacing:0.2pt;">Canada</font>
              <br >
              <font style="letter-spacing:0.2pt;">China</font>
              <br >
              <font style="letter-spacing:0.2pt;">India</font>
              <br >
              <font style="letter-spacing:0.2pt;">Israel</font>
              <br >
              <font style="letter-spacing:0.2pt;">Japan</font>
              <br >
              <font style="letter-spacing:0.2pt;">South Korea</font>
              <br >
              <font style="letter-spacing:0.2pt;">Singapore</font>
              <br >
              <font style="letter-spacing:0.2pt;">Taiwan </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">07/06/2040 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">No </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.25pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">12 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:89pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Companion Diagnostics </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">U.S Provisional </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">05/21/2042 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.083pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">No </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">13 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:89pt;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Formulation </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">U.S Provisional </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">11/23/2042 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">No </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:11.25pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.667pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">14 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.5pt 0pt; width:89pt;">
              <font style="letter-spacing:0.2pt;">Utility&#8201;&#8211;&#8201;Assessing</font>
              <br >
              <font style="letter-spacing:0.2pt;">Visual Function </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">N.A </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.5pt 0pt; width:72pt;">
              <font style="letter-spacing:0.2pt;">U.S Provisional </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">04/14/2043 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.667pt 0pt 1.5pt 0pt; width:58.75pt;">
              <font style="letter-spacing:0.2pt;">No</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:5.7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The term of individual issued patents depends upon the legal term for patents in the countries in which they are obtained. In most countries in which we have filed, including the United States, the patent term is 20&#160;years from the earliest filing date of a non-provisional patent application. The life of a patent, and the protection it affords, is therefore limited and once the patent life of our issued patents have expired, we may face competition, including from other competing technologies. The term of a patent that covers a drug or biological product may also be eligible for patent term extension when FDA approval is granted for a portion of the term effectively lost as a result of the FDA regulatory review period, subject to certain limitations and provided statutory and regulatory requirements are met. Any such patent term extension can be for no more than five&#160;years, only one patent per approved product can be extended, the extension cannot extend the total patent term beyond 14&#160;years from approval, and only those claims covering the approved drug or biological product, a method for using it or a method for manufacturing it may be extended. We may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. In the future, we expect to apply for patent term extensions on certain issued patents covering our product candidates, depending upon the length of the clinical trials for each product candidate and other factors. There can be no assurance that we will benefit from any patent term extension or favorable adjustment to the term of any of our patents. As a result, our owned, co-owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. For more information, see the section entitled &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to Our Intellectual Property&#8221;. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">134</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We granted rights to use our intellectual property to manage our clinical trials for STGD1 in Australia to our wholly-owned subsidiary, RBP4 Pty Ltd. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patent License Agreement with The Trustees of Columbia University in the City of New York</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2016, Lin BioScience, Inc., our ultimate controlling shareholder, entered into an agreement with Columbia University (as amended, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Columbia License Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) for an exclusive worldwide license, under specified patent rights held by Columbia University, to develop and commercialize products covered by the licensed patent rights for all fields. The Columbia License Agreement was assigned to Lin Bioscience International Ltd. and subsequently assigned to us in 2018. We have the right to grant sublicenses under this license. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent rights licensed to us under the Columbia License Agreement include issued patents with claims that recite a class of compounds directed to covering our planned lead compound, LBS-008, and specifically recite LBS-008. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Columbia License Agreement, we paid a one-time license fee of $2.5 million in connection with the execution thereof. We will be obligated to make minimum annual royalty payments to Columbia University of (i) $2.5 million on each of the second, third and fourth anniversaries of the first commercial sale of a licensed product and (ii) $5 million on each anniversary of the first commercial sale of a licensed product, commencing on the fifth anniversary of such sale. We will also be obligated to pay single-digit earned royalties to Columbia University based on net sales of each licensed product by us and our affiliates and sublicensees. The minimum royalty payments will be creditable against the earned royalties accrued during the same calendar year. The license agreement obligates us to use commercially reasonable efforts to research, discover, develop and market licensed products for commercial sale and distribution and achieve certain development and regulatory approval milestones within certain timeframes, if certain milestones are achieved. We are also obligated to periodically inform Columbia University of our progress in meeting such milestones. The failure to achieve any such milestone would constitute a breach of the Columbia License Agreement. If we pay Columbia University the required fee, we will be granted a 6-month extension. As of the date of this prospectus, we have complied with the development and regulatory approval milestones under the Columbia License Agreement and requested no extensions. In the event that, after completion of Phase I Trials, there are unforeseen changes in clinical or regulatory development that we believe would affect the timely achievement of any milestone, we may request an extension from Columbia University for such milestone, which will not be unreasonably withheld or delayed. In the event that Columbia University does not agree to extend the deadlines to meet the milestones, and we are in breach for failure to timely meet the milestones or to make milestone or royalty payments, Columbia University may elect to convert our license to a nonexclusive license without the right to sublicense or initiate legal proceedings against third party patent infringers or terminate our license. We are also obligated to make payments to Columbia University in an aggregate amount of up to $20 million based on achieving specified development and regulatory approval milestones and in an amount of up to $25 million based on achieving a specified cumulative sales milestone with respect to the first licensed product. In addition, we are obligated to pay Columbia University a specified portion of revenue (other than royalties) we receive from sublicensees and a percentage of revenue in the low double-digits received from any sale of a priority review voucher by us or a sublicensee. In the event that we or a sublicensee do not sell a priority review voucher within one year of receipt, the earned royalties that we would be obligated to pay to Columbia University based on net sales of licensed products would increase by 1%. From inception through December 31, 2021, we have made a payment of $1 million to Columbia University resulting from the Columbia License Agreement, which was triggered by the completion of our Phase 1 clinical trial. We believe we are in compliance with the terms of the license. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our obligations under the Columbia License Agreement with respect to each licensed product in a particular country extends until the later of the expiration of the last-to-expire patent licensed from Columbia University covering the licensed product in such country, 20&#160;years after the first commercial sale of the licensed product in such country or the expiration of any market exclusivity period granted by a regulatory agency. The last-to-expire patent licensed from Columbia University is anticipated to expire in 2039, absent any patent term adjustments or extensions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Columbia University has the right to terminate the agreement if we breach the agreement and fail to cure our breach within specified cure periods or in the event of specified bankruptcy, insolvency and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">135</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">liquidation events or if we initiate a proceeding challenging the validity or enforceability of any of the licensed patents. We have the right to terminate the agreement for our convenience at any time on 60 days&#8217; notice to Columbia University. In the event of termination, we have granted to Columbia University a royalty free, worldwide, non-exclusive license to make, use and sell products covered by claims of patents in-licensed by us, or derived from materials or technical information thereof, pursuant to the Columbia License Agreement and in connection with which we have filed patent applications or obtained patents. </font>
        </div>
        <div style="margin-top:10.82pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trade Secrets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to patents, we may rely, in some circumstances, upon unpatented trade secrets, know-how and continuing technological innovation to develop and maintain our competitive position. However, trade secrets and know-how can be difficult to protect. We seek to protect our proprietary information, in part, by executing confidentiality agreements with our scientific advisors, employees, consultants, collaborators, and other third parties, and invention assignment agreements with our consultants and employees. </font>
        </div>
        <div style="margin-top:10.81pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trademarks and domain names</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5.82pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we had one registered trademark in the United States, one registered trademark in EU, two registered trademarks in China, one registered trademark in Hong Kong, and one registered trademark in Japan, and one trademark application pending in Canada. We did not have any trademark applications pending elsewhere around the world. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have registered the following domain names: tinlarebant.com, tinlarebant.net, tinlarebant.org, belitebio.com, and belitebio.com.tw. </font>
        </div>
        <div style="margin-top:10.82pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our industry is highly competitive, rapidly evolving and subject to significant change. Although we believe that our core competencies in the identification, research and development of innovative therapies and our management team&#8217;s regulatory and commercialization expertise provide us with distinct competitive advantages, we face significant competition from companies of all sizes around the world, including major and specialty pharmaceutical companies, generic drug companies, academic institutions, government agencies and research institutions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Many of our competitors have significantly greater resources, including greater access to capital, technical capabilities and human resources, as well as more experience in the development and regulatory approval process than we have. Mergers and acquisitions in our industry may result in even more resources being concentrated among a smaller number of our competitors. Our commercial opportunities could be reduced or eliminated if our competitors develop or market novel therapies or other products that are more effective, safer or less costly than our current or future product candidates, or obtain regulatory approval for their products more rapidly than we may obtain approval for our product candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to macular degeneration therapies, although there are currently no approved treatments available, our competitors for LBS-008 include several companies going through clinical development for their product candidates. Based on publicly available information, we understand that there is one Japan-based pharmaceutical company that has an asset in Phase&#160;3 development for STGD1. There are also three U.S.-based companies advancing treatments for STGD1 and their assets are currently in Phase&#160;2 and Phase&#160;2b development, respectively, with the third company having recently completed their Phase&#160;2a trial. In GA, there are three U.S.-based companies in late-stage clinical development. All three companies have assets in Phase&#160;3 development. </font>
        </div>
        <div style="margin-top:10.72pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have twelve employees and four of our employees are located in the United States. The following table sets forth the number of our employees by function as of the date of this prospectus: </font>
        </div>
        <table style="width:416pt;height:62.5pt;margin-left:20pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:320.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Functions </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Employees </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:320.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance and Accounting </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.79pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:12.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">42<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:320.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and Development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.79pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:12.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">58<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:320.66pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.79pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:12.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">136</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:448pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that we maintain a good working relationship with our employees, and we have not experienced any material labor disputes in the past. None of our employees are represented by labor unions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Facilities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our facilities consist of office and lab space of approximately 350 square feet in San Diego, California under a lease that will expire on July&#160;19, 2022, office space of approximately 88 square feet in Taiwan under a lease that expires on July&#160;31, 2022, and office and lab space of approximately 86 square feet in Shanghai, China under a lease that is automatically renewed every three&#160;months. We believe our current facilities are sufficient to meet our near-term needs, and we do not foresee any difficulty in extending the lease terms of our facilities upon their respective expiration dates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal Proceedings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are currently not involved in any legal or administrative proceedings that may have a material adverse impact on our business, financial position or results of operations.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">137</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tREG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REGULATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are subject to a variety of U.S., European (including both laws applicable in the European Union and the U.K.) and PRC laws, rules and regulations across a number of aspects of our business. This section sets forth a summary of the most significant laws and regulations that are applicable to our current business activities within the territory of U.S., the European Union and PRC and that affect the dividends payment to our shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Government Regulation and Product Approval</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The U.S. Food and Drug Administration, or the FDA, and other regulatory authorities in the United States at federal, state and local levels extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, recordkeeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of and for drug products. Along with third-party contractors, we are required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates. The processes for obtaining regulatory approvals in the United States and in foreign jurisdictions, along with subsequent compliance with applicable laws and regulations and other regulatory authorities, require the expenditure of substantial time and financial resources. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The failure to comply with applicable statutory and regulatory requirements may subject a sponsor, applicant or marketer to administrative or judicial enforcement actions. These actions could include the suspension or termination of clinical trials by the FDA, the FDA&#8217;s refusal to approve pending applications or supplemental applications, withdrawal of an approval, &#8220;Warning Letters&#8221; &#8203;(official messages from the FDA to a manufacturer or other organization providing notice that it has violated some rule in a federally regulated activity) or &#8220;Untitled Letters&#8221; &#8203;(initial correspondences from the FDA that cite violations that do not meet the threshold of regulatory significance for a Warning Letter and request correction of the violation), product recalls, product seizures, total or partial suspension of production or distribution, import detention, injunctions, fines, refusals of government contracts, restitution, disgorgement of profits, or civil or criminal investigations and penalties brought by the FDA, the Department of Justice, or the DOJ, or other governmental entities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Review and Approval for Licensing Drugs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA regulates drugs primarily under the Federal Food, Drug, and Cosmetic Act, or the FDCA, the Public Health Service Act, and their associated implementing regulations. Our product candidates must be approved by the FDA through the new drug application, or the NDA, process before they may be legally marketed in the United States. The process required by the FDA before a drug may be marketed in the United States generally involves the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">completion of extensive preclinical studies, including preclinical laboratory tests, preclinical animal studies and formulation studies all performed in compliance with applicable regulations, including the current good laboratory practice, or the cGLP, regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">submission to the FDA of an investigational new drug application, or an IND, which must become effective before human clinical trials may begin and must be updated annually or when significant changes are made; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">manufacture, labeling and distribution of an investigational drug in compliance with current good manufacturing practices, or cGMP; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approval by an institutional review board, or IRB, or ethics committee at each clinical site before each clinical trial may be initiated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">performance of adequate and well-controlled human clinical trials in accordance with the FDA&#8217;s current good clinical practices requirements, or cGCP, clinical trial registration, and other clinical trial </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">138</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">related regulations, to provide substantial evidence of effectiveness and evidence of safety for the drug product&#8217;s proposed indication; </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">preparation of and submission to the FDA of an NDA after completion of all pivotal clinical trials requesting marketing approval for one or more proposed indications; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory completion of an FDA Advisory Committee review, where appropriate or if applicable, as may be requested by the FDA to assist with its review; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory completion of one or more FDA pre-approval inspections of the manufacturing facility or facilities at which active pharmaceutical ingredient, or API, and finished drug product, or components thereof, are produced to assess compliance with cGMP and data integrity requirements to assure that the facilities, methods, and proposed chemistry, manufacturing, and controls, or CMC, are adequate to preserve the drug&#8217;s identity, safety, quality, purity, potency and efficacy; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory completion of FDA audits of selected preclinical and/or clinical investigation sites to assure compliance with cGLP and cGCP requirements and the integrity of the preclinical and/or clinical data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">payment of user fees under the Prescription Drug User Fee Act, or, as amended, the PDUFA, for the relevant year; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">obtaining FDA review and approval of the NDA prior to any commercial marketing or sale of the drug in the United States; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">compliance with all post-approval requirements, including but not limited to, cGMP, CMC, post-market reporting and pharmacovigilance, registration and listing, advertising and promotional requirements, the potential requirement to implement risk evaluation and mitigations strategies, or REMS, and the potential requirement to conduct post-approval studies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to drug-specific requirements, combinations of differently regulated articles, such a drug and device (e.g., a drug delivery system or companion diagnostic) could also result in various addition requirements to consider, such as device and combination product requirements of the FDCA and its implementing regulations with respect to investigation, marketing, and post-market requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Development of data and other information sufficient to support an NDA approval requires substantial time, effort and financial resources and we cannot be certain that any approvals for our product candidates will be granted on a timely basis, if at all. From time to time, new legislation is enacted that could significantly change the statutory provisions governing the testing, approval, manufacturing and marketing of products regulated by the FDA. In addition to new legislation, FDA regulations and policies are often revised or interpreted by the agency in ways that may significantly affect our business and our product candidates. It is impossible to predict whether further legislative changes will be enacted or whether FDA regulations, guidance, policies or interpretations will be changed or what the effect of such changes, if any, may be. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preclinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The data required to support an NDA is generated in two distinct development stages: preclinical and clinical. For new chemical entities, or NCEs, the preclinical development stage generally involves synthesizing the active component, developing the formulation and determining the manufacturing process, evaluating purity and stability, as well as carrying out non-human toxicology, pharmacology and drug metabolism studies in the laboratory, which support subsequent clinical testing. The conduct of the preclinical studies must comply with federal regulations, including cGLPs. The sponsor must submit the results of the preclinical studies, together with manufacturing information, analytical data, any available clinical data or literature and a proposed clinical protocol, to the FDA as part of its IND. The central focus of an IND submission is on the general investigational plan and the protocol(s) for human studies. An IND is a request for authorization from the FDA to administer an investigational product to humans. The central focus of an IND submission is on the general investigational plan and the protocol(s) for human studies. An IND acts as an exemption from the FDCA that allows an unapproved drug to be shipped in interstate commerce for use in an investigational clinical trial. Such authorization must be secured prior to interstate shipment. Any subsequent protocol amendments must be submitted to the FDA as part of the IND, and the FDA must </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">139</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">allow these amendments to the IND to go into effect prior to their execution. Frequently, sponsors are also required to conduct additional animal studies after an IND is obtained and human clinical testing begins, and is often referred to as &#8216;preclinical&#8217; or &#8216;nonclinical&#8217; testing, even though it occurs in parallel with the clinical phase of development. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Development</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Human clinical trials subject to the FDA&#8217;s jurisdiction may not begin until an IND is effective. The IND automatically becomes effective 30&#160;days after receipt by the FDA, unless the FDA raises safety concerns or questions about the proposed clinical trial within the 30-day time period. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA may also place a clinical hold or partial clinical hold on such study following commencement of a clinical trial under an IND. A clinical hold is an order issued by the FDA to the sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation. A partial clinical hold is a delay or suspension of only part of the clinical work requested under the IND. For example, a specific protocol or part of a protocol is not allowed to proceed, while other protocols may do so. No more than 30&#160;days after the imposition of a clinical hold or partial clinical hold, the FDA will provide the sponsor with a written explanation of the basis for the hold. Following issuance of a clinical hold or partial clinical hold, an investigation may only resume after the FDA has notified the sponsor that the investigation may proceed. The FDA will base that determination on information provided by the sponsor correcting the deficiencies previously cited or otherwise satisfying the FDA that the investigation can proceed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical studies involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with cGCP regulations. Clinical studies are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A separate submission to the existing IND must be made for each successive clinical trial conducted during product development and for any subsequent protocol amendments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A sponsor may choose, but is not required, to conduct a foreign clinical trial under an IND. When a foreign clinical trial is conducted under an IND, all FDA IND requirements must be met unless waived. When the foreign clinical trial is not conducted under an IND, the sponsor must ensure that the study complies with cGCP regulations in order to use the study as support for an IND or application for marketing approval, including review and approval by an independent ethics committee and informed consent from subjects. Furthermore, an IRB for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial before the clinical trial begins at that site, and must monitor the study until completed. Some studies also include oversight by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board, or the DSMB. DSMBs provide authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if a DSMB determines that there is an unacceptable safety risk for subjects or based on other grounds, such as no demonstration of efficacy. Other grounds for suspension or termination may be made based on evolving business objectives and/or competitive climate. There are also requirements governing the reporting of ongoing clinical trials and clinical trial results to public registries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if conducting a clinical study in a non-U.S. population, acceptance of clinical trial results by the FDA will depend, among other things, on whether the non-U.S. population that enrolled in the study is sufficiently similar to the indicated U.S. population that the results of the trial would fairly represent expected results in the U.S. population. The same issue can also arise in multi-national trials where non-U.S. sites are enrolling subjects that will become part of the data submitted to the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of drug approval, clinical trials are typically conducted in the following sequential phases that may overlap or be combined: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Phase&#160;1:&nbsp;&nbsp;&nbsp;The investigational product is initially introduced into a small number of healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">140</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">dosage tolerance, absorption, metabolism and distribution of the investigational product in humans and the side effects associated with increasing doses. These studies may also yield early evidence of effectiveness. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Phase&#160;2:&nbsp;&nbsp;&nbsp;The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Phase&#160;3:&nbsp;&nbsp;&nbsp;The investigational product is administered to an expanded patient population generally at multiple geographically dispersed clinical trial sites to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety. These clinical trials are intended to generate sufficient data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval by the FDA and labeling of the drug product. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more information about the product, sometimes referred to as &#8220;Phase&#160;4&#8221; studies. Such post-approval studies, when applicable, are conducted following initial approval, typically to develop additional data and information relating to the biological characteristics of the product and the treatment of patients in the intended therapeutic indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA and more frequently if serious adverse events occur. In addition, IND safety reports must be submitted to the FDA for any of the following: suspected serious and unexpected adverse reactions; findings from epidemiological studies, pooled analysis of multiple studies, animal or in vitro testing, or other clinical trials, whether or not conducted under an IND, and whether or not conducted by the sponsor, that suggest a significant risk in humans exposed to the drug; and any clinically important increase in the rate of a serious suspected adverse reaction over such rate listed in the protocol or investigator brochure, which is a comprehensive document summarizing the body of information about an investigational product obtained during clinical and non-clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each of Phase&#160;1, Phase&#160;2 and Phase&#160;3 clinical trials may not be completed successfully within any specified period, or at all. Furthermore, the FDA or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution, or an institution it represents, if the clinical trial is not being conducted in accordance with such IRB&#8217;s requirements or if the drug has been associated with unexpected serious harm to patients. Additionally, if a clinical trial is overseen by a Data Safety Monitoring Board, or DSMB, the DSMB will provide authorization for whether or not a study may move forward at designated check points based on access to certain data from the study. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During clinical development, the sponsor often refines the indication and endpoints on which the drug will be based. For endpoints based on patient-reported outcomes, or PRO, and observer-reported outcomes, or ORO, the process typically is an iterative one. The FDA has issued guidance on the framework it uses to evaluate PRO instruments. Although the agency may offer advice on optimizing PRO and ORO instruments during the clinical development process, the FDA usually reserves final judgment until it reviews the drug. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Concurrent with clinical trials, companies must develop additional information about the chemistry and physical characteristics of the drug and finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate, and cGMPs impose, among other things, extensive procedural, substantive and recordkeeping requirements to ensure and preserve the long-term stability and quality of the final drug product. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life. Any changes to the drug product during development, and especially after Phase&#160;2, can raise questions with respect to impact of changes on study results, and whether results may be extrapolated to support approval of a final finished dosage form for which approval is sought. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">141</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the clinical development process, earlier phase drug results may be promising, but it cannot be assumed that subsequent phases of development will be successful. In fact, it is often the case that drugs with promising early phase data fail to ultimately show sufficient efficacy or safety to support approval in later phases of development. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NDA Submission and Review</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following study completion, study results and data are analyzed to assess safety and efficacy. The results of preclinical studies and clinical trials are then submitted to the FDA as part of an NDA, along with proposed labeling for the drug, information about the manufacturing process and facilities that will be used to ensure drug quality, results of analytical testing conducted on the chemistry of the drug and other relevant information. The NDA is a request for approval to market the drug and must contain adequate evidence of safety and efficacy, which is demonstrated by extensive preclinical and clinical testing. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a use of a drug, or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational drug product to the satisfaction of the FDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Pediatric Research Equity Act of 2003, as amended and reauthorized, certain NDAs or supplements thereto must contain data that is adequate to assess the safety and efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the drug is safe and effective. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the PDUFA, each NDA must generally be accompanied by a significant application user fee. The FDA adjusts the PDUFA user fees on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business which has fewer than 500 employees; in assessing whether an application qualifies as a &#8216;first application&#8217; and calculating the number of employees, affiliates of the small business making the NDA submission are considered. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA reviews all NDAs submitted before it accepts them for filing and may request additional information rather than accepting an NDA for filing. The FDA conducts a preliminary review of an NDA within 60&#160;days of receipt and informs the sponsor by the 74th day after the FDA&#8217;s receipt of the submission to determine whether the application is sufficiently complete to permit substantive review. Once the submission is accepted for filing, the FDA begins an in-depth review of the NDA. Under the goals and policies agreed to by the FDA under PDUFA, the FDA has ten&#160;months from the filing date in which to complete its initial review of a standard NDA and respond to the applicant, and six&#160;months from the filing date for a &#8220;priority review&#8221; NDA. The FDA does not always meet its PDUFA goal dates for standard and priority review NDAs, and the review process is often significantly extended by FDA requests for additional information or clarification. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After the NDA submission is accepted for filing, the FDA reviews the NDA to determine, among other things, whether the proposed drug is safe and effective for its intended use, and whether the drug is being manufactured in accordance with cGMP to assure and preserve the drug&#8217;s identity, strength, quality, purity and efficacy. The FDA may refer applications for novel drugs or product candidates that present difficult questions of safety or efficacy to an advisory committee. Typically, an advisory committee consists of a panel that includes clinicians and other experts who will review, evaluate and provide a recommendation as to whether the application should be approved and, if so, under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions and usually follows such recommendations. The FDA may re-analyze the clinical trial data, which could result in extensive discussions between the FDA and us during the review process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before approving an NDA, the FDA will also conduct a pre-approval inspection of the manufacturing facilities for the new drug to determine whether they comply with cGMPs. The FDA will not approve the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">142</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">drug unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the drug within required specifications. In addition, before approving an NDA, the FDA may also audit data from clinical trials to ensure compliance with cGCP requirements. After the FDA evaluates the application, manufacturing process and manufacturing facilities where the drug product and/or its API will be produced, it may issue an approval letter or a complete response letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A complete response letter indicates that the review cycle of the application is complete and the application is not ready for approval. A complete response letter usually describes all of the specific deficiencies in the NDA identified by the FDA. The complete response letter may require additional clinical data and/or an additional pivotal clinical trials(s), and/or other significant, expensive and time-consuming requirements related to preclinical studies or clinical trials or manufacturing. If a complete response letter is issued, the applicant may either resubmit the NDA, addressing all of the deficiencies identified in the letter, or withdraw the application. Even if such data and information is submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. Data obtained from clinical trials are not always conclusive and the FDA may interpret data differently than we interpret the same data. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a drug receives marketing approval, the approval may be limited to specific diseases and dosages or the indications for use may otherwise be limited. Further, the FDA may require that certain contraindications, warnings or precautions be included in the drug labeling or may condition the approval of the NDA on other changes to the proposed labeling, development of adequate controls and specifications, or a commitment to conduct post-market testing or clinical trials and surveillance to monitor the effects of approved drugs. For example, the FDA may require Phase&#160;4 testing which involves clinical trials designed to further assess a drug&#8217;s safety and effectiveness and may require testing and surveillance programs to monitor the safety of approved drugs that have been commercialized. The FDA may also place other conditions on approvals including the requirement for a REMS to ensure that the benefits of a drug or biological product outweigh its risks. If the FDA concludes a REMS is needed, the sponsor of the NDA must submit a proposed REMS and the FDA will not approve the NDA without a REMS that the agency has determined is acceptable. A REMS could include medication guides, physician communication plans or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. Any of these limitations on approval or marketing could restrict the commercial promotion, distribution, prescription or dispensing of a drug. Drug approvals may be withdrawn for non-compliance with regulatory standards or if problems occur following initial marketing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Section&#160;505(b)(2) NDAs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NDAs for most new drug products are based on two or more adequate and well-controlled clinical trials, which must provide substantial evidence of effectiveness for, and demonstrate safety of, the proposed new product for a given indication (though, in certain cases, an NDA might be based on a single adequate and well-controlled clinical trial plus confirmatory evidence). These applications are submitted under Section&#160;505(b)(1) of the FDCA. The FDA is, however, authorized to approve an alternative type of NDA under Section&#160;505(b)(2) of the FDCA. This type of application allows the applicant to rely, in part, on the FDA&#8217;s previous findings of safety and efficacy for a similar product, or published literature. Specifically, Section&#160;505(b)(2) applies to NDAs for a drug for which the investigations made to show whether or not the drug is safe for use and effective in use and relied upon by the applicant for approval of the application &#8220;were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;505(b)(2) authorizes the FDA to approve an NDA based in part on prior FDA determinations as opposed to solely on safety and effectiveness data developed by the applicant. NDAs filed under Section&#160;505(b)(2) may provide an alternate and potentially more expeditious pathway to FDA approval for new or improved formulations or new uses of previously approved products. If the 505(b)(2) applicant can establish that reliance on the FDA&#8217;s previous approval is scientifically appropriate, the applicant may eliminate the need to conduct certain preclinical studies or clinical trials of the new product. However, the FDA may require applicants to perform additional studies or measurements to support the change(s) from the previously approved product. The FDA may then approve the new product candidate for all or some of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">143</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the label indications for which the referenced product has been approved, as well as for any new indication sought by the Section&#160;505(b)(2) applicant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pediatric Studies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With the enactment of the Food and Drug Administration Safety and Innovation Act in 2012, a sponsor who is planning to submit a marketing application (or supplement to an application) for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of&#160;administration must also submit an initial Pediatric Study Plan, or a PSP, within sixty days of an end&#8209;of&#8209;Phase&#160;2 meeting or as may be agreed between the sponsor and the FDA, unless the drug is for an indication for which orphan designation has been granted. In the absence of an end-of-phase 2 meeting, the sponsor should submit the initial PSP as early as practicable but before the initiation of any phase 3 studies, or any combined phase 2 and phase 3 studies, of the drug that is the subject of the initial PSP. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other clinical development programs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Orphan Drug Designation and Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Orphan Drug Act, the FDA may designate a drug product as an &#8220;orphan drug&#8221; if it is intended to treat a rare disease or condition (generally meaning that it affects fewer than 200,000 individuals in the United States, or more in cases in which there is no reasonable expectation that the cost of developing and making a drug product available in the United States for treatment of the disease or condition will be recovered from sales of the product). A company must request orphan product designation before submitting a NDA. If the request is granted, the FDA will publicly disclose the identity of the therapeutic agent and its potential use. Orphan product designation does not convey any advantage in or shorten the duration of the regulatory review and approval process, but the product will be entitled to orphan product exclusivity, meaning that the FDA may not approve any other applications for the same product for the same indication for seven&#160;years, except in certain limited circumstances. Those circumstances include instances in which another sponsor&#8217;s application for the same drug product and indication is shown to be &#8220;clinically superior&#8221; to the previously approved drug. In this context, clinically superior means that the drug provides a significant therapeutic advantage over and above the already approved drug in terms of greater efficacy, greater safety or by providing a major contribution to patient care. Competitors may receive approval of different products for the indication for which the orphan product has exclusivity and may obtain approval for the same product but for a different indication. If a drug or drug product designated as an orphan product ultimately receives marketing approval for an indication broader than what was designated in its orphan product application, it may not be entitled to exclusivity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Rare Pediatric Disease Designation and Priority Review Vouchers</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the FDCA, the FDA incentivizes the development of drugs that meet the definition of a &#8220;rare pediatric disease,&#8221; defined to mean a serious or life-threatening disease in which the serious or life-threatening manifestations primarily affect individuals aged from birth to 18&#160;years and the disease affects fewer than 200,000 individuals in the United States or affects more than 200,000 in the United States and for which there is no reasonable expectation that the cost of developing and making in the United States a drug for such disease or condition will be received from sales in the United States of such drug. The sponsor of a product candidate for a rare pediatric disease may be eligible for a voucher that can be used to obtain a priority review for a subsequent human drug application after the date of approval of the rare pediatric disease drug product, referred to as a priority review voucher, or PRV. A sponsor may request rare pediatric disease designation from the FDA prior to the submission of its NDA. A rare pediatric disease designation does not guarantee that a sponsor will receive a PRV upon approval of its NDA. Moreover, a sponsor who chooses not to submit a rare pediatric disease designation request may nonetheless receive a PRV upon approval of their marketing application if they request such a voucher in their original marketing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">144</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">application and meet all of the eligibility criteria. If a PRV is received, it may be sold or transferred an unlimited number of times. Also, the FDA may revoke any rare pediatric disease priority review voucher if the rare pediatric disease product for which the voucher was awarded is not marketed in the United States within the 365-day period beginning on the date of the approval. Congress has extended the PRV program through September&#160;30, 2026, with the potential for PRVs to be granted through September&#160;30, 2026. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Post-Approval Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to monitoring, recordkeeping, registration and listing, periodic reporting, reporting of certain deviations and adverse experiences, providing the regulatory authorities with updated safety and efficacy information, drug sampling and distribution requirements, and complying with applicable promotion and advertising requirements. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to FDA review and approval. There also are continuing user fee requirements, under which the FDA assesses an annual program fee for each product identified in an approved NDA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">FDA regulations also require that approved products be manufactured in specific approved facilities and in accordance with cGMP. We currently use contract manufacturing organizations, or CMOs, to manufacture the drugs used in our clinical trials and expect to rely on third parties for the production of commercial quantities of our products in accordance with cGMP regulations.NDA holders using CMOs, laboratories or packagers are responsible for the selection and monitoring of qualified firms, and, in certain circumstances, qualified suppliers to these firms. These manufacturers must comply with cGMP regulations that require, among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Drug manufacturers and their third-party contractors are required to register their establishments with the FDA and certain state agencies. These establishments are subject to routine and periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and data integrity requirements, which impose certain procedural and documentation requirements to assure quality of manufacturing and product. Any interference with FDA inspection activities at our company or at CMOs can result in substantial penalties. The FDA has increasingly observed cGMP violations involving data integrity during site inspections and investigating compliance with data integrity requirements is a significant focus of its oversight. Requirements with respect to data integrity include, among other things, controls to ensure data are complete and secure; requiring that activities are documented at the time of performance; audit trail functionality; requiring authorized access and limitations; validated computer systems; and the review of records for accuracy, completeness and compliance with established standards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Post-approval changes to the manufacturing process, including changes of the site of manufacture, are strictly regulated, and, depending on the significance of the change, may require FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon us and any third-party CMOs that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP, data integrity, pharmacovigilance (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, post-marketing safety reporting obligations) and other aspects of regulatory compliance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may withdraw a product approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-approval studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS. Other potential consequences include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market or product recalls; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">fines, Warning Letters, Untitled Letters or holds on post-approval clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">145</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">product seizure or detention, or refusal of the FDA to permit the import or export of products that it believes present safety problems by issuing an Import Alert; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">permanent injunctions and consent decrees, including the imposition of civil or criminal penalties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">adverse publicity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">voluntary or mandatory product recall; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">recoupment of payment and damages for noncompliant drug products based on various legal theories, including a theory that reimbursement for noncompliant products violates federal and state false claims laws (e.g., the federal False Claims Act). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA strictly regulates the marketing, labeling, advertising and promotion of prescription drug products placed on the market. A company can make only those claims relating to safety and efficacy, identity, strength, quality, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. Promotional claims relating to a product&#8217;s safety or effectiveness are prohibited before the drug is approved. After approval, a product generally may not be promoted for uses that are not approved by the FDA, as reflected in the product&#8217;s prescribing information. In the United States, healthcare professionals are generally permitted to prescribe drugs for such uses not described in the drug&#8217;s labeling, known as off-label uses, because the FDA does not regulate the practice of medicine. However, FDA regulations impose rigorous restrictions on manufacturers&#8217; communications, prohibiting the promotion of off-label uses. It may be permissible, under very specific, narrow conditions, for a manufacturer to engage in non-promotional, non-misleading communication regarding off-label information, such as distributing scientific or medical journal information in accordance with the FDA&#8217;s good reprint practices or unsolicited request doctrine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a company is found to have promoted off-label uses, it may become subject to adverse public relations and administrative and judicial enforcement by the FDA, the DOJ or the Office of the Inspector General of the Department of Health and Human Services, as well as other federal and state authorities. This could subject a company to a range of penalties that could have a significant commercial impact, including civil and criminal fines and agreements that materially restrict the manner in which a company promotes or distributes products. The federal government has levied large civil and criminal fines against companies for alleged improper promotion, and has also requested that such companies enter into consent decrees and permanent injunctions under which specified promotional conduct is changed or curtailed. Among other legal theories, penalties may be sought based on a theory that off-label promotion causes submission of claims that for an unapproved use in violation of state and federal false claims laws. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Regulatory Matters</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Manufacturing, sales, promotion and other activities following drug approval are also subject to regulation by numerous regulatory authorities in addition to the FDA, including, in the United States, the Centers for Medicare &amp; Medicaid Services, other divisions of the Department of Health and Human Services, the Drug Enforcement Administration for controlled substances, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety &amp; Health Administration, the Environmental Protection Agency and state and local governments. The activities of pharmaceutical manufacturers are subject to federal and state laws designed to prevent &#8220;fraud and abuse&#8221; in the healthcare industry. The laws generally limit financial interactions between manufacturers and health care providers or other participants in the healthcare industry, require disclosure to the government and public of such interactions, and govern various matters regarding reimbursement of healthcare products. Many of these laws and regulations contain ambiguous requirements or require administrative guidance for implementation. Pharmaceutical manufacturers are also required to provide discounts or rebates under government healthcare programs or to certain government and private purchasers in order to obtain coverage under federal healthcare programs such as Medicaid. Participation in such programs may require tracking and reporting of certain drug prices. Manufacturers are subject to fines and other penalties if such prices are not reported accurately. Additionally, the handling of any controlled substances must comply with the U.S. Controlled Substances </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">146</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Act and Controlled Substances Import and Export Act. Drugs must meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. Manufacturing, sales, promotion and other activities are also potentially subject to federal and state consumer protection and unfair competition laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The distribution of prescription drugs and biologics are subject to the Drug Supply Chain Security Act, which requires manufacturers and other stakeholders to comply with product identification, tracing, verification, detection and response, notification and licensing requirements. In addition, the Prescription Drug Marketing Act and its implementing regulations and state laws limit the distribution of prescription pharmaceutical product samples, and the Drug Supply Chain Security Act imposes requirements to ensure accountability in distribution and to identify and remove prescription drug and biological products that may be counterfeit, stolen, contaminated, or otherwise harmful from the market. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Hatch-Waxman Protections and Pediatric Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patent Term Restoration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After approval, owners of relevant drug or biological product patents may apply for up to a five-year patent extension to restore a portion of patent term lost during product development and FDA review of an NDA if approval of the application is the first permitted commercial marketing or use of a drug containing the API under the Hatch-Waxman Act. The allowable patent term extension is calculated as one-half of the product&#8217;s testing phase, which is the time between IND and NDA submission, and all of the review phase, which is the time between NDA submission and approval, up to a maximum of five&#160;years. The time can be shortened if the FDA determines that the applicant did not pursue approval with due diligence. The total patent term after the extension may not exceed more than 14&#160;years from the date of FDA approval of the product. Only one patent claiming each approved product is eligible for restoration and the patent holder must apply for restoration within 60&#160;days of approval. The USPTO, in consultation with the FDA, reviews and approves the application for patent term restoration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For patents that might expire during the application phase, the patent owner may request an interim patent extension. An interim patent extension increases the patent term by one year and may be renewed up to four times. For each interim patent extension granted, the post-approval patent extension is reduced by one year. The director of the USPTO must determine that approval of the product candidate covered by the patent for which a patent extension is being sought is likely. Interim patent extensions are not available for a product candidate for which an NDA has not been submitted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patent Listing and the Orange Book</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In seeking approval for a drug through an NDA, applicants are required to list with the FDA each drug substance, drug product, and method-of-use patent whose claims cover the NDA drug product. Upon approval of the NDA, each of the patents listed in the application for the drug is published in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Drugs listed in the Orange Book can, in turn, be cited by potential competitors as reference listed drugs, or RLD, in support of approval of an abbreviated new drug application, or ANDA, or 505(b)(2) NDA which relies upon the RLD&#8217;s approval to support its own. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An ANDA provides for marketing of a drug product that has the same active ingredients in the same strengths and dosage form as the listed drug and has been shown through bioequivalence testing to be therapeutically equivalent to the listed drug. Other than the requirement for bioequivalence testing, ANDA applicants are not required to conduct, or submit results of, nonclinical or clinical tests (beyond, potentially, bioequivalence studies) to prove the safety or effectiveness of their drug product. Drugs approved in this way are commonly referred to as &#8220;generic equivalents&#8221; to the listed drug, and can often be substituted by pharmacists under prescriptions written for the original listed drug under various state laws. A 505(b)(2) NDA is generally used where there are one more difference from the RLD in terms of dosage form, labeling, or other properties, but where an applicant may nonetheless rely upon FDA&#8217;s prior approval determinations with respect to the RLD to support safety and/or efficacy of the 505(b)(2) NDA drug product. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">147</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An ANDA or 505(b)(2) NDA applicant is required to certify to the FDA concerning any patents listed for the RLD in the FDA&#8217;s Orange Book. Specifically, the applicant must certify that: (i)&#160;the required patent information has not been filed; (ii)&#160;the listed patent has expired; (iii)&#160;the listed patent has not expired, but will expire on a particular date and approval is sought after patent expiration; or (iv)&#160;the listed patent is invalid or will not be infringed by the new product. An ANDA applicant may also elect to submit a section viii statement, certifying that its proposed ANDA label does not contain or carve out any language regarding the patented method-of-use, rather than certify to a listed method-of-use patent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the applicant does not challenge the listed patents, the ANDA or 505(b)(2) NDA will not be approved until all the listed patents claiming the referenced product have expired. A certification that the new product will not infringe the already approved product&#8217;s listed patents, or that such patents are invalid, is called a Paragraph IV certification. If the ANDA or 505(b)(2) NDA applicant has provided a Paragraph IV certification to the FDA, the applicant must also send notice of the Paragraph IV certification to the NDA and patent holders once the ANDA or 505(b)(2) NDA has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement lawsuit in response to the notice of the Paragraph&#160;IV certification. The filing of a patent infringement lawsuit within 45&#160;days of the receipt of a Paragraph IV certification automatically prevents the FDA from approving the ANDA or 505(b)(2) NDA until the earlier of 30&#160;months, expiration of the patent, settlement of the lawsuit, or a decision in the infringement case that is favorable to the ANDA or 505(b)(2) NDA applicant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ANDA or 505(b)(2) NDA also will not be approved until any applicable non-patent market exclusivity listed in the Orange Book for the referenced product have expired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Market Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon NDA approval of a NCE, which is a drug that contains no active moiety that has been approved by the FDA in any other NDA, that drug receives five&#160;years of marketing exclusivity during which time the FDA cannot receive any ANDA or 505(b)(2) NDA seeking approval that uses the NDA as its RLD. Certain changes to a drug, such as the addition of a new indication to the package insert, are associated with a three-year period of exclusivity during which the FDA cannot approval an ANDA or 505(b)(2) NDA seeking approval that uses the NDA as its RLD. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An ANDA or 505(b)(2) NDA may be submitted one year before NCE exclusivity expires if a Paragraph&#160;IV certification is filed. If there is no listed patent in the Orange Book, there may not be a Paragraph IV certification, and, thus, no ANDA or 505(b)(2) may be filed before the expiration of the exclusivity period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pediatric Exclusivity</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Another provision of the FDCA provides a potential opportunity for &#8220;pediatric exclusivity,&#8221; which, if granted, adds six&#160;months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric study in accordance with an FDA-issued &#8220;Written Request&#8221; for such a study. In some instances, the same studies can satisfy both PREA and pediatric exclusivity requirements, and in other instances may request studies of new indications or other differences from initial NDA approval that is being sought or has been granted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">FDA Expedited Programs and Special Protocol Assessments</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA expedited programs and designations for serious conditions, like Fast Track, Breakthrough Therapy, Priority Review and Accelerated Approval, are intended to make certain drugs available as rapidly as possible. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Applicants must request Fast Track designation from the FDA, which provides access to a process to facilitate the development and expedite the review of a drug intended to treat serious conditions and fill an unmet need. The request can be initiated at any time during the drug development process. The FDA will review the request and make a decision within 60&#160;days based on whether the drug fulfills an unmet medical need in a serious condition. A drug that receives Fast Track designation is eligible for some or all of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">148</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">following: (i)&#160;more frequent meetings with FDA to discuss the drug&#8217;s development plan and ensure collection of appropriate data needed to support drug approval; (ii)&#160;more frequent written correspondence from the FDA about things such as the design of the proposed clinical trial and the use of biomarkers; (iii)&#160;Accelerated Approval and Priority Review, if relevant criteria are met; and (iv)&#160;rolling review, under which the agency may initiate review of sections of a Fast Track product&#8217;s NDA before the application is complete. Rolling review is available if the applicant provides, and the FDA approves, a schedule for the submission of the remaining information and the applicant pays applicable user fees. However, the FDA&#8217;s PDUFA review period for a Fast Track application does not begin until the last section of the NDA is submitted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Breakthrough Therapy authority, a drug may be eligible for designation as a Breakthrough Therapy if the drug is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. If a drug is designated a Breakthrough Therapy, the FDA will expedite the development and review of the drug. Every drug application submitted to the FDA is subject to consideration for Priority Review designation, even if the applicant does not request it. The FDA informs the applicant of a Priority Review designation within 60&#160;days of the receipt of the original NDA. Designation of a drug as &#8220;Priority&#8221; does not alter the scientific/</font>&#8203;<font style="letter-spacing:0.2pt;">medical standard for approval or the quality of evidence necessary for approval. Priority Review does shorten the planned time period for review of an NDA (from six&#160;months compared with the ten-month standard review) by the FDA. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Fast Track, Breakthrough Therapy and Priority Review status may all be withdrawn by the FDA at any time if the agency finds that relevant criteria are no longer being met. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under its Accelerated Approval authority, the FDA may approve a product for a serious disease or condition that fills an unmet need, including a Fast Track product, if it is found to have an effect on a surrogate endpoint in a marker that is thought to predict a clinical benefit. The FDA may also approve a product under Accelerated Approval authority if it is found to have an effect on an intermediate endpoint in a measure of therapeutic effect that is considered reasonably likely to predict a clinical benefit. The endpoint evidence to support Accelerated Approval may be epidemiological, pathophysiological, therapeutic, and pharmacologic or based on the use of biomarkers. Accelerated Approval can be withdrawn or the labeled indication of the drug changed if studies fail to verify clinical benefit or do not demonstrate sufficient clinical benefit to justify the risk associated with the drug. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Federal Food, Drug, and Cosmetic Act directs the FDA to meet with sponsors, pursuant to a sponsor&#8217;s written request, for the purpose of reaching agreement on the design and size of clinical trials intended to form the primary basis of an efficacy claim in an NDA. If an agreement is reached, the FDA will reduce the agreement to writing and make it part of the administrative record. This agreement is called a special protocol assessment, or an SPA. While the FDA&#8217;s guidance on SPAs states that documented SPAs should be considered binding on the review division, the FDA has latitude to change its assessment if certain exceptions apply. Exceptions include public health concerns emerging that were unrecognized at the time of the protocol assessment, identification of a substantial scientific issue essential to the safety or efficacy testing that later comes to light, a sponsor&#8217;s failure to follow the protocol agreed upon, or the FDA&#8217;s reliance on data, assumptions or information that are determined to be wrong. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An SPA request can be requested after a pre-Phase&#160;3 meeting with the FDA. It allows the FDA and sponsor to agree on the study design for a Phase&#160;3 study whose efficacy results will be the basis of an NDA. There is no guarantee that we will request or be able to receive and maintain Fast Track designation, Breakthrough Therapy designation, Priority Review designation, Accelerated Approval designation or a Special Protocol Assessment for any of our product candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Disclosure of Clinical Trial Information</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sponsors of clinical trials of certain FDA-regulated products, including prescription drugs, are required to register and disclose certain clinical trial information on a public website maintained by the U.S. National Institutes of Health. Information related to the product, patient population, phase of investigation, clinical trial sites and investigator, and other aspects of the clinical trial is made public as part of the registration. Sponsors are also obligated to disclose the results of these clinical trials after completion if the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">149</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">product candidate is ultimately approved, and disclosure of the results of these clinical trials will be delayed until such approval. Competitors may use this publicly-available information to gain knowledge regarding the design and progress of in development programs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Healthcare Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pharmaceutical Coverage and Reimbursement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Significant uncertainty exists as to the coverage and reimbursement status of any products for which we may obtain regulatory approval. In the United States, sales of any products for which we may receive regulatory approval for commercial sale will depend in part on the availability of coverage and reimbursement from third-party payors. Third-party payors include government authorities, managed care providers, private health insurers and other organizations. Third-party payors establish the coverage and reimbursement policies for pharmaceutical products, and the marketability of any products for which we may receive regulatory approval for commercial sale depends on those payors&#8217; coverage policies and reimbursement rates. Third-party payors may limit coverage to specific products on an approved list, or formulary, which might not include one or more of our product candidates, if approved. Third-party payors, together with regulators and others, are increasingly challenging the prices charged for pharmaceutical products and health services, in addition to their cost-effectiveness, safety and efficacy. In addition, no uniform policy for coverage and reimbursement exists in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own coverage and reimbursement policies, but also have their own methods and approval process apart from Medicare determinations. Therefore, coverage and reimbursement rates can vary significantly from payor to payor. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, obtaining coverage and adequate reimbursement is a time-consuming and costly process. We may be required to provide scientific and clinical support for the use of any product to each third-party payor separately with no assurance that approval will be obtained, and we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the cost-effectiveness of our products. We cannot be certain that our product candidates will be considered cost-effective by third-party payors. This process could delay the market acceptance of any product candidates for which we may receive approval and could have a negative effect on our future revenues and operating results. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other U.S. Healthcare Laws and Compliance Requirements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our business may be subject to healthcare fraud and abuse regulation and enforcement by both the federal government and the states in which we conduct our business, particularly once third-party reimbursement becomes available for one or more of our products. The healthcare fraud and abuse laws and regulations that may affect our ability to operate include, but are not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under the Medicare and Medicaid programs, or other federal healthcare programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The federal civil and criminal false claims laws and civil monetary penalty laws, including the civil False Claims Act, which prohibits, among other things, knowingly presenting, or causing to be presented, claims for payment of government funds that are false or fraudulent, or knowingly making, or using or causing to be made or used, a false record or statement material to a false or fraudulent claim to avoid, decrease, or conceal an obligation to pay money to the federal government; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">HIPAA, which, among other things, prohibits executing a scheme to defraud any healthcare benefit program, including private third-party payors, and prohibits (i)&#160;knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or representation and (ii)&#160;making or using any false writing or document knowing the same to contain any materially false, fictitious or fraudulent statement or entry in connection with the delivery of or payment for healthcare benefits, items or services; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">150</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, which impose requirements relating to the privacy, security and transmission of individually identifiable health information held by covered entities, including health plans, healthcare clearinghouses and certain healthcare providers, and their business associates, individuals or entities that perform certain services on behalf of a covered entity that involve the use or disclosure of individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Federal laws that require pharmaceutical manufacturers to report certain calculated product prices to the government or provide certain discounts or rebates to government authorities or private entities, often as a condition of reimbursement under government healthcare programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The federal Physician Payments Sunshine Act, being implemented as the Open Payments Program, which requires manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to the CMS, information related to direct or indirect payments and other transfers of value to physicians and teaching hospitals, as well as ownership and investment interests held in a company by physicians and their immediate family members. Beginning in 2022, applicable manufacturers will also be required to report information regarding payments and transfers of value provided to physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists and certified nurse-midwives; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.4pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. state and local laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers; state laws that restrict the ability of manufacturers to offer co-pay support to patients for certain prescription drugs; state laws that require drug manufacturers to report information related to clinical trials, or information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; state laws that require drug manufacturers to report information on the pricing of certain drugs; state laws and local ordinances that require identification or licensing of sales representatives; state and local laws regarding the manufacturing and distribution of drugs; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will be required to spend substantial time and money to ensure that our business arrangements with third parties comply with applicable healthcare laws and regulations. Even then, governmental authorities may conclude that our business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If governmental authorities find that our operations violate any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and we may be required to curtail or restructure our operations. Moreover, we expect that there will continue to be federal and state laws and regulations, proposed and implemented, that could impact our operations and business. In addition, the approval and commercialization of any product candidate we develop outside the United States will also likely subject us to foreign equivalents of the healthcare laws mentioned above, among other foreign laws. The extent to which future legislation or regulations, if any, relating to health care fraud and abuse laws or enforcement, may be enacted or what effect such legislation or regulation would have on our business remains uncertain. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">151</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Healthcare Reform</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the ability to profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, collectively the Affordable Care Act, enacted in March&#160;2010, has substantially changed healthcare financing and delivery by both governmental and private insurers. Among other things the Affordable Care Act included the following provisions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription drugs and biologic agents apportioned among these entities according to their market share in some government healthcare programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a new Medicare Part&#160;D coverage gap discount program, in which manufacturers must agree to offer 50% point-of-sale discounts, which through subsequent legislative amendments, will be increased to 70%, starting in 2019, off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturers&#8217; outpatient drugs to be covered under Medicare Part&#160;D; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">extension of manufacturers&#8217; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expansion of eligibility criteria for Medicaid programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expansion of the entities eligible for discounts under the 340B Drug Discount Program; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted, or injected; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a licensure framework for follow-on biological products. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since its enactment, there have been numerous judicial, administrative, executive, and legislative challenges to certain aspects of the Affordable Care Act, and we expect there will be additional challenges and amendments to the Affordable Care Act in the future. Various portions of the Affordable Care Act are currently undergoing legal and constitutional challenges in the United States Supreme Court and members of Congress have introduced several pieces of legislation aimed at significantly revising or repealing the Affordable Care Act. The implementation of the Affordable Care Act is ongoing, the law appears likely to continue the downward pressure on pharmaceutical pricing, especially under the Medicare program, and may also increase our regulatory burdens and operating costs. Litigation and legislation related to the Affordable Care Act are likely to continue, with unpredictable and uncertain results. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. On August&#160;2, 2011, the Budget Control Act of 2011 was signed into law, which, among other things, included aggregate reductions to Medicare payments to providers of 2% per fiscal year, which went into effect on April&#160;1, 2013 and, due to subsequent legislative amendments to the statute will remain in effect through 2030 unless additional Congressional action is taken. These reductions have been suspended from May&#160;1, 2020 through December&#160;31, 2020 due to the COVID-19 pandemic. The Consolidated Appropriations Act of 2021, extended the suspension period to March&#160;31, 2021. An Act to Prevent Across-the-Board Direct Spending Cuts, and for Other Purposes, signed into law on April&#160;14, 2021, has extended the suspension period to December&#160;31, 2021. On January&#160;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">152</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and delivery models, such as bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their commercial products, which has resulted in several Congressional inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for pharmaceutical products. For example, at the federal level, the previous administration&#8217;s budget proposal for fiscal year 2021 included a $135&#160;billion allowance to support legislative proposals seeking to reduce drug prices, increase competition, lower out-of-pocket drug costs for patients and increase patient access to lower-cost generic and biosimilar drugs. On March&#160;10, 2020, the previous administration sent &#8220;principles&#8221; for drug pricing to Congress, calling for legislation that would, among other things, cap Medicare Part&#160;D beneficiary out-of-pocket pharmacy expenses, provide an option to cap Medicare Part&#160;D beneficiary monthly out-of-pocket expenses and place limits on pharmaceutical price increases. Further, the previous administration previously released a &#8220;Blueprint&#8221; to lower drug prices and reduce out of pocket costs of drugs that contained proposals to increase drug manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by consumers. HHS has solicited feedback on some of these measures and has implemented others under its existing authority. For example, in May&#160;2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part&#160;B drugs beginning January&#160;1, 2020. This final rule codified CMS&#8217;s policy change, which was effective as of January&#160;1, 2019. Although a number of these and other measures may require additional authorization to become effective, Congress and the Biden administration have each indicated that they will continue to seek new legislative and/or administrative measures to control drug costs. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. In addition, individual states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, it is possible that additional governmental action is taken to address the COVID-19 pandemic. For example, on April&#160;18, 2020, CMS announced that qualified health plan issuers under the ACA may suspend activities related to the collection and reporting of quality data that would have otherwise been reported between May and June&#160;2020 given the challenges healthcare providers are facing responding to the ongoing COVID-19 pandemic. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, on May&#160;30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase&#160;1 clinical study and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical studies and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act. If we obtain approval to market a product candidate in the United States, any healthcare reforms adverse to drug manufacturers, including but not limited to, any significant spending reductions affecting Medicare, Medicaid or other publicly funded or subsidized health programs, that may be implemented and/or any significant taxes or fees that may be imposed on us could have an adverse impact on our results of operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">European Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Government Regulation and Product Approval</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to market any product outside of the United States, a company must also comply with numerous and varying regulatory requirements of other countries and jurisdictions regarding quality, safety </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">153</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and efficacy and governing, among other things, clinical trials, marketing authorization, commercial sales and distribution of products. Whether or not it obtains FDA approval for a product, an applicant will need to obtain the necessary approvals by the comparable foreign regulatory authorities before it can commence clinical trials or marketing of the product in those countries or jurisdictions. The process governing approval of biological medicinal products in the European Union generally follows the same principles as in the United States. Such products are subject to extensive pre- and post-market regulation by regulatory authorities at both the European Union and national levels. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Trial Approval</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Similar to the United States, the various phases of non-clinical and clinical research in the European Union are subject to significant regulatory controls. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the currently applicable Clinical Trials Directive 2001/20/EC and the Directive 2005/28/EC on GCP, a system for the approval of clinical trials in the European Union has been implemented through national legislation of the member states. Under this system, an applicant must obtain prior approval from the competent national authority of a European Union member state in which the clinical trial is to be conducted, or in multiple member states if the clinical trial is to be conducted in a number of member states. Furthermore, the applicant may only start a clinical trial at a specific site after the competent ethics committee has issued a favorable opinion. The clinical trial application must be accompanied by an investigational medicinal product dossier with supporting information prescribed by Directive 2001/20/EC and Directive 2005/28/EC and corresponding national laws of the member states and further detailed in applicable guidance documents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2014, the European Union adopted a new Clinical Trials Regulation (EU) No 536/2014, or the CTR, but it will not become effective until January&#160;31, 2022. The CTR will overhaul the current system of approvals for clinical trials in the European Union. Specifically, the CTR, which will be directly applicable in all member states, aims at simplifying and streamlining the approval of clinical trials in the European Union. For instance, the new CTR provides for a streamlined application procedure via a single-entry point and strictly defined deadlines for the assessment of applications for authorization to conduct a clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The CTR also establishes a Clinical Trials Information System database which will include various details of each clinical trial conducted in the EU, including the application for authorization to conduct a clinical trial and any review by a regulatory or ethics body. The CTR requires all information stored in the database to be publicly available, unless exempted under the Regulation to protect: (a)&#160;personal data; (b)&#160;commercially confidential information, in particular the marketing authorization status of the medicine, unless there is an overriding public interest; (c)&#160;confidential communication between Member States in the preparation of their assessment; or (d)&#160;supervision of clinical trials by Member States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The CTR also clarifies the obligation to publish (a)&#160;summary results of the clinical trial within 1 year after the end of the trial (including a phase I trial); and (b)&#160;clinical study reports of the data generated in the course of the clinical trial within 30&#160;days after the grant of the relevant marketing authorization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The conduct of all clinical trials performed in the European Union will continue to be bound by currently applicable laws until the CTR becomes applicable. A clinical trial commenced before January&#160;31, 2022 can continue under the current legislative framework. The sponsor of a clinical trial commenced in 2022 can elect to conduct the trial under the old legislative framework or the CTR. Any clinical trial commenced after January&#160;31, 2023 must do so under the CTR. If a clinical trial conducted under the old legislative framework continues for more than three&#160;years after January&#160;31, 2025, the CTR will automatically begin to apply to that clinical trial. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRIME Designation in the European Union</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2016, the EMA launched an initiative to facilitate development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIority MEdicines, or PRIME, scheme is intended to encourage the development of medication in areas of unmet medical need and provides accelerated assessment of products representing substantial innovation reviewed under the centralized </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">154</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">procedure. Products from small- and medium-sized enterprises may qualify for earlier entry into the PRIME scheme than larger companies. Many benefits accrue to sponsors of product candidates with PRIME designation, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and accelerated marketing authorization application assessment once a dossier has been submitted. Importantly, a dedicated EMA contact and rapporteur from the Committee for Human Medicinal Products, or CHMP, are appointed early in the PRIME scheme facilitating increased understanding of the product at the EMA&#8217;s Committee level. A kick-off meeting initiates these relationships and includes a team of multidisciplinary experts at the EMA to provide guidance on the overall development and regulatory strategies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Marketing Authorization</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To obtain marketing authorization of a biological medicinal product under the European Union regulatory system, an applicant must submit a marketing authorization application, or MAA, either under a centralized procedure administered by the EMA or one of the procedures administered by competent authorities in the European Union member states: the decentralized procedure, national procedure, or mutual recognition procedure. A marketing authorization may be granted only to an applicant established in the European Union. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The centralized procedure provides for the grant of a single marketing authorization by the European Commission that is valid for all European Union member states. Pursuant to Regulation (EC) No. 726/2004, the centralized procedure is compulsory for specific products, including for medicines produced by certain biotechnological processes, products designated as orphan medicinal products, advanced therapy products and products with a new active substance indicated for the treatment of certain diseases, including products for the treatment of viral diseases and cancer. For those products for which the use of the centralized procedure is not mandatory, applicants may elect to use the centralized procedure where either the product contains a new active substance not yet authorized in the European Union, or where the applicant can show that the product constitutes a significant therapeutic, scientific or technical innovation or for which a centralized process is in the interest of patients at a European Union level. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the centralized procedure, the CHMP is responsible for conducting an initial assessment of whether a product meets the required quality, safety and efficacy requirements, and whether a product has a positive benefit/risk profile. Under the centralized procedure in the European Union, the maximum timeframe for the evaluation of an MAA is 210&#160;days from receipt of a valid MAA, excluding clock stops when additional information or written or oral explanation is to be provided by the applicant in response to questions of the CHMP. Clock stops may extend the timeframe of evaluation of an MAA considerably beyond 210&#160;days. Where the CHMP gives a positive opinion, it provides the opinion together with supporting documentation to the European Commission, who make the final decision to grant a marketing authorization, which is issued within 67&#160;days of receipt of the EMA&#8217;s recommendation. Accelerated evaluation may be granted by the CHMP in exceptional cases, when a medicinal product is of major interest from the point of view of public health and, in particular, from the viewpoint of therapeutic innovation. If the CHMP accepts such a request, the timeframe of 210&#160;days for assessment will be reduced to 150&#160;days (excluding clock stops), but it is possible that the CHMP may revert to the standard time limit for the centralized procedure if it determines that the application is no longer appropriate to conduct an accelerated assessment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For products not falling within the mandatory scope of the centralized procedure, national marketing authorizations may be obtained, which are issued by the competent authorities of the European Union member states and only cover their respective territory. Where a product has already been authorized for marketing in an European Union member state, this national marketing authorization can be recognized in another European Union member state through the mutual recognition procedure. If the product has not received a national marketing authorization in any member state at the time of application, it can be approved simultaneously in various European Union member states through the decentralized procedure. As with the centralized procedure, the competent authorities of the European Union member states assess the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy before granting the marketing authorization. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">155</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pediatric Studies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to obtaining a marketing authorization in the European Union, companies developing a new medicinal product must agree upon a Pediatric Investigation Plan, or PIP, with the EMA&#8217;s Pediatric Committee, or PDCO, and must conduct pediatric clinical trials in accordance with that PIP, unless a waiver applies, (e.g., because the relevant disease or condition occurs only in adults). The PIP sets out the timing and measures proposed to generate data to support a pediatric indication of the drug for which marketing authorization is being sought. The MAA for the product must include the results of pediatric clinical trials conducted in accordance with the PIP, unless a waiver applies, or a deferral has been granted by the PDCO of the obligation to implement some or all of the measures of the PIP until there are sufficient data to demonstrate the efficacy and safety of the product in adults, in which case the pediatric clinical trials must be completed at a later date. Products that are granted a marketing authorization with the results of pediatric clinical trials conducted in accordance with the PIP are eligible for a six month extension of the protection under a supplementary protection certificate (if any is in effect at the time of approval) even where the trial results are negative. In the case of orphan medicinal products, a two year extension of the orphan market exclusivity may be available. This pediatric reward is subject to specific conditions and is not automatically available when data in compliance with the PIP are developed and submitted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Data and Marketing Exclusivity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The European Union also provides opportunities for market exclusivity. Upon receiving marketing authorization in the European Union, innovative medicinal products generally receive eight&#160;years of data exclusivity and an additional two&#160;years of market exclusivity. Data exclusivity prevents the regulatory authorities from accepting MAAs from generic or biosimilar applicants seeking to rely on the innovator&#8217;s preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization in the European Union for a period of eight&#160;years from the date on which the reference product was first authorized in the European Union. During an additional two-year period of market exclusivity, a generic or biosimilar MAA can be submitted, and the innovator&#8217;s data may be referenced and relied on, but no generic or biosimilar product can be marketed until the expiration of the additional two-year market exclusivity period. The overall ten-year period will be extended to a maximum of eleven&#160;years if, during the first eight&#160;years of those ten&#160;years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to authorization, is held to bring a significant clinical benefit in comparison with existing therapies. Even if a compound is considered to be a new chemical entity so that the innovator gains the prescribed period of data exclusivity, another company may market another version of the product if such company obtained marketing authorization based on an MAA with a complete independent data package including preclinical tests and clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Patent Term Extensions in the European Union and Other Jurisdictions</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The European Union also provides for patent term extension through Supplementary Protection Certificates, or SPCs. The rules and requirements for obtaining a SPC are similar to those in the United States. An SPC may extend the term of a patent for up to five&#160;years after its originally scheduled expiration. In certain circumstances, these periods may be extended for six additional&#160;months if pediatric exclusivity is obtained, which is described in detail below. Although SPCs are available throughout the European Union, sponsors must apply on a country-by-country basis. Similar patent term extension rights exist in certain other foreign jurisdictions outside the European Union. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Periods of Authorization and Renewals</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A marketing authorization is valid for five&#160;years, in principle, and it may be renewed after five&#160;years on the basis of a reevaluation of the risk-benefit balance by the EMA or by the competent authority of the authorizing member state. To that end, the marketing authorization holder must provide the EMA or the competent authority in a Member State with a consolidated version of the file in respect of quality, safety and efficacy, including all variations introduced since the marketing authorization was granted, at least six&#160;months before the marketing authorization ceases to be valid. Once renewed, the marketing authorization is valid for an unlimited period, unless the European Commission or the competent authority decides, on </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">156</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">justified grounds relating to pharmacovigilance, to proceed with one additional five-year renewal period. Any authorization that is not followed by the placement of the medicine on the European Union market (in the case of the centralized procedure) or on the market of the authorizing member state within three&#160;years after authorization ceases to be valid. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory Requirements After Market Authorization</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following approval, the holder of the marketing authorization is required to comply with a range of requirements applicable to the manufacturing, marketing, promotion and sale of the medicinal product. These include compliance with the European Union&#8217;s stringent pharmacovigilance or safety reporting rules, pursuant to which post-authorization studies and additional monitoring obligations can be imposed. In addition, the manufacturing of authorized products, for which a separate manufacturer&#8217;s license is mandatory, must also be conducted in strict compliance with the EMA&#8217;s cGMP requirements and comparable requirements of other regulatory bodies in the European Union, which mandate the methods, facilities and controls used in manufacturing, processing and packing of medicines to assure their safety and identity. Finally, the marketing and promotion of authorized products, including industry-sponsored continuing medical education and advertising directed toward the prescribers of medicinal products and/or the general public, are strictly regulated in the European Union. It is prohibited to advertise prescription-only medicinal products to patients in the EU. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Orphan Designation and Exclusivity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An orphan designation provides a number of benefits, including fee reductions, regulatory assistance and the possibility to apply for a centralized European Union marketing authorization. Marketing authorization for an orphan medicine leads to a ten-year period of market exclusivity. During this market exclusivity period, neither the EMA nor the European Commission or the member states can accept an application for, or grant a marketing authorization for, a &#8220;similar medicinal product.&#8221; A &#8220;similar medicinal product&#8221; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. The market exclusivity period for the authorized therapeutic indication may, however, be reduced to six&#160;years if, at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation because, for example, the product is sufficiently profitable not to justify market exclusivity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The criteria for designating an orphan medicine in the European Union are similar in principle to those in the United States. Regulation (EC) No 141/2000 and Regulation (EC) No. 847/2000 provide that a product can be designated as an orphan medicine by the European Commission if its sponsor can establish: that the product is intended for the diagnosis, prevention or treatment of (1)&#160;a life threatening or chronically debilitating condition affecting not more than 5 in 10,000 persons in the European Union when the application is made, or (2)&#160;a life-threatening, seriously debilitating or serious and chronic condition in the European Union and that without incentives it is unlikely that the marketing of the medicine in the European Union would generate sufficient return to justify the necessary investment. For either of these conditions, the applicant must demonstrate that there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the European Union or, if such method exists, the medicine will be of significant benefit to those affected by that condition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Orphan medicines are eligible for financial incentives such as reduction of fees or fee waivers made available by the European Union and its member states to support research into, and the development and availability of, orphan medicines. The application for orphan designation must be submitted before the application for marketing authorization. The applicant will receive a fee reduction for the MAA if the orphan designation has been granted, but not if the designation is still pending at the time the marketing authorization is submitted. Orphan designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pediatric Exclusivity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an applicant obtains a marketing authorization in all European Union member states, or a marketing authorization granted in the centralized procedure by the European Commission, and the study results for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">157</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the pediatric population are included in the product information, even when negative, the medicine is then eligible for an additional six-month period of qualifying patent protection through extension of the term of the SPC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Brexit and the Regulatory Framework in the United Kingdom</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, the electorate in the United Kingdom voted in favor of leaving the European Union (commonly referred to as &#8220;Brexit&#8221;). Thereafter, in March&#160;2017, the country formally notified the European Union of its intention to withdraw pursuant to Article&#160;50 of the Lisbon Treaty. The UK formally left the European Union on January&#160;31, 2020. There was a transitional period, during which European Union laws continued to apply in the UK, which ended on December&#160;31, 2020. The UK and European Union have signed an EU-UK Trade and Cooperation Agreement, which became provisionally applicable on January&#160;1, 2021 and which will become formally applicable once ratified by both the UK and the European Union. This agreement provides details on how some aspects of the UK and European Union&#8217;s relationship regarding medicinal products will operate, particularly in relation to Good Manufacturing Practice; however, there are still many uncertainties. Since the regulatory framework for medicinal products in the UK covering quality, safety and efficacy of medicinal products, clinical trials, marketing authorization, commercial sales and distribution of medicinal products is derived from European Union directives and regulations, the current regulatory framework in the UK is virtually identical to the framework in the European Union. The EU Clinical Trials Regulation (described in detail above), which is due to take effect on January&#160;31, 2022, will not apply in Great Britain, but it will apply in Northern Ireland (as a result of the Northern Ireland Protocol). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, post-Brexit, the UK Government is free to adopt laws that could diverge from the laws in the European Union. This could materially impact the future regulatory regime which applies to products and the approval of product candidates in the UK. It remains to be seen how Brexit will impact regulatory requirements for product candidates and products in the UK in the long-term. In the meantime, the Medicines and Healthcare products Regulatory Agency, the UK medicines and medical devices regulator, has published detailed guidance for industry and organizations to follow. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pricing and Reimbursement Environment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if a medicinal product obtains a marketing authorization in the European Union, there can be no assurance that reimbursement for such product will be secured on a timely basis or at all. Pricing and reimbursement of medicines is a matter reserved to individual Member States. Each Member State is free to restrict the range of medicinal products for which their national health insurance systems provide reimbursement, and to control the prices and reimbursement levels of medicinal products for human use. Each Member State may approve a specific price or level of reimbursement for the medicinal product, or alternatively adopt a system of direct or indirect controls on the profitability of the company responsible for placing the medicinal product on the market, including volume-based arrangements, caps and reference pricing mechanisms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC Drug Regulation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Drug Administration Law of the PRC, or the Drug Administration Law, promulgated by the Standing Committee of the NPC and the Implementing Measures of the Drug Administration Law, or the Implementing Measures of the Drug Administration law, promulgated by the State Council, have jointly established the legal framework for the administration of pharmaceutical products in China, including the research, development and manufacturing of new drugs. The Drug Administration Law applies to entities and individuals engaged in the development, production, trade, application, supervision and administration of pharmaceutical products, and regulates and provides a framework for the administration of pharmaceutical manufacturers, pharmaceutical trading companies and medicinal preparations of medical institutions, and the development, research, manufacturing, distribution, packaging, pricing and advertisements of pharmaceutical products. The Implementing Measures of the Drug Administration Law, on the other hand, provides detailed implementation regulations for the Drug Administration Law. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">158</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The recent amendment to the Drug Administration Law, which became effective in December&#160;2019, brought a series of changes to the drug supervision and administration system, including, but not limited to, the clarification of the drug marketing authorization holder system, pursuant to which each marketing authorization holder shall assume responsibilities for non-clinical trials, clinical trials, manufacturing and marketing, post-marketing studies, monitoring, reporting and handling of any adverse reactions of its drugs. The amendment also stipulates that the State supports the innovation of drugs with clinical value and specific or special effects on human diseases, encourages the development of drugs with new therapeutic mechanisms and that have multi-targeted, systematic regulatory and intervention functions on the human body and promotes the technological advancement of drugs. The NMPA has since promulgated two key implementing regulations for the amended Drug Administration Law: (i)&#160;the amended Administrative Measure for Drug Registration and (ii)&#160;the amended Measures on the Supervision and Administration of the Manufacture of Drugs. Both took effect on July&#160;1, 2020. The NMPA also promulgated the Chemical Drug Registration Classification and Application Data Requirements in June&#160;2020 as detailed implementing rules on drug classification. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are required to follow the above-mentioned regulations in respect of our non-clinical research, clinical trials and production of new drugs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Regulatory Authorities and Recent Government Reorganization</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pharmaceutical products and medical devices and equipment in China are monitored and supervised on a national scale by the NMPA (formerly known as China Food and Drug Administration, or the CFDA), while the local provincial medical products administrative authorities are responsible for the supervision and administration of drugs within their respective administrative regions. Pursuant to the Decision of the First Session of the Thirteenth National People&#8217;s Congress on the State Council Institutional Reform Proposal made by the NPC in March&#160;2018, the NMPA is no longer an independent agency and its duties shall be performed by the newly established State Administration for Market Regulation, or the SAMR, into which the various agencies responsible for, among other areas, consumer protection, advertising, anticorruption, pricing, fair competition and intellectual property, have been merged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The NMPA is still however the chief drug regulatory agency and implements the same laws, regulations, rules, and guidelines as the CFDA, and the NMPA regulates almost all of the key stages of the life cycle of pharmaceutical products, including non-clinical trials, clinical trials, marketing approvals, manufacturing, advertising and promotion, distribution, and pharmacovigilance (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.,</font><font style="letter-spacing:0.2pt;"> post-marketing safety reporting obligations). The Center for Drug Evaluation, or the CDE, which remains under the NMPA, conducts the technical evaluation of each drug and biologic application for safety and efficacy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Formed on March&#160;2018, the National Health Commission, or the NHC, (formerly known as the Ministry of Health, or the MOH, and the National Health and Family Planning Commission, or the NHFPC), is China&#8217;s chief healthcare regulator. It is primarily responsible for overseeing the operation of medical institutions, which also serve as clinical trial sites, and regulating the licensure of hospitals and medical personnel. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Non-Clinical Research</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2003, the NMPA promulgated the Administrative Measures for Good Laboratories Practice of Non-clinical Laboratory, which was revised on in July&#160;2017, to improve the quality of non-clinical research, and began conducting the Good Laboratories Practice certification program. Pursuant to the Circular on Administrative Measures for Certification of GLP for Non-clinical Laboratory issued by the NMPA in April&#160;2007, the NMPA is responsible for the certification of non-clinical research institutions nationwide and local provincial medical products administrative authorities are in charge of the daily supervision of non-clinical research institutions. The NMPA decides whether an institution is qualified for undertaking pharmaceutical non-clinical research by evaluating such institution&#8217;s organizational administration, its research personnel, its equipment and facilities, and its operation and management of non-clinical pharmaceutical projects. A GLP Certification will be issued by the NMPA if all the relevant requirements are satisfied, and such certification will be published on the NMPA&#8217;s website. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">159</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Preclinical Development</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The NMPA requires supporting preclinical data for the registration applications for imported and domestic drugs. Preclinical work, including pharmacology and toxicology studies, must satisfy the requirements of the Administrative Measures for Good Laboratories Practice of Non-clinical Laboratory. No approval is required from the NMPA to conduct preclinical studies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Clinical Trials and Marketing Approval of New Drugs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Registration Categories</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Administrative Measures for Drug Registration in January&#160;2020 and effective on July&#160;1, 2020, which provides the standards and requirements for clinical trials and drug registration applications. Drug marketing registration applications are divided into three categories, namely traditional Chinese drugs, chemical drugs and biological products, and each type is further divided into several sub-types. For example, the registration applications of chemical drugs are further categorized by innovative chemical drugs, improved new chemical drugs, and generic chemical drugs, among others. As provided in the Administrative Measures for Drug Registration, the Drug Administration Law and Implementing Measures of the Drug Administration Law, upon completion of non-clinical research, clinical trials shall be conducted for the application of new drug registration, upon approval from NMPA or authorized institutions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to engaging with the NMPA on research and development approval, an applicant shall determine the registration category for its product candidate (subject to ultimate confirmation by the NMPA), which will determine the requirements for its clinical trial and marketing application. There are five categories for chemical drugs: Category 1, or innovative drugs, refers to drugs with NCEs that have not been marketed anywhere in the world; Category 2, or improved new drugs, refers to drugs with a new indication, dosage form, route of administration, combination or certain formulation changes not previously approved anywhere in the world; Categories 3 and 4 refer to generic drugs that reference an innovator drug (or certain well-known generic drugs) marketed either abroad or in China, respectively; and Category 5 refers to innovative or generic drugs that have already been marketed abroad but are not yet approved in China (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.,</font><font style="letter-spacing:0.2pt;"> various imported drugs). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Priority Review Program under Current Reform Frame</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The NMPA has adopted several expedited review and approval mechanisms since 2009 and created additional expedited programs in recent&#160;years that are intended to encourage innovation. Applications for these expedited programs can be submitted after the clinical trial application is admitted for review by the CDE. The newly amended Administrative Measures for Drug Registration, which became effective on July&#160;1, 2020, set up several acceleration procedures for drug marketing registration including procedures for breakthrough therapy designation drugs, procedures for conditional approval, procedures for priority review and approval at the marketing authorization application stage and procedures for special approval in public health emergencies. In order to implement the amended Administrative Measures for Drug Registration, on July&#160;7, 2020, the NMPA promulgated the specific working procedures for the evaluation of breakthrough therapy designation drugs, conditional approvals and priority review and approval at the marketing authorization application stage which replaced the previous priority evaluation and approval program. According to such working procedures, a priority review market authorization pathway may be available to the following drugs with distinctive clinical benefits: (i)&#160;drugs in short supply for urgent clinical need, innovative drugs and modified new drugs for the prevention and treatment of serious infectious diseases, rare diseases and other diseases; (ii)&#160;pediatric drugs of new varieties, dosage forms and specifications that meet the physiological characteristics of children; (iii)&#160;vaccines urgently needed for disease prevention and control and innovative vaccines; (iv)&#160;drugs included in the procedures for breakthrough therapy designation drugs; (v)&#160;drugs fulfilling the requirements for conditional approval; and (vi)&#160;other drugs for priority review and approval stipulated by the NMPA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that our current clinical stage product candidate could be classified as a drug under categories (i)&#160;and (ii)&#160;of the working procedures described above. Therefore, we may be entitled to the priority review market authorization pathway under the newly amended Administrative Measures for Drug Registration. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">160</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Trial Approval</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All clinical trials conducted in China for the purpose of seeking marketing approval must be approved and conducted at a pharmaceutical clinical trial institution which shall be under filing administration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the NMPA has adopted a notification system for clinical trials of new drugs. Pursuant to the </font><font style="font-style:italic;letter-spacing:0.2pt;">Opinions on Deepening the Reform of the Evaluation and Approval Systems and Encouraging Innovation on Drugs and Medical Devices, or the Innovation Opinion,</font><font style="letter-spacing:0.2pt;"> the Announcement on Adjusting the Evaluation and Approval Procedure of Drug Clinical Trial and the newly amended Drug Administration Law, clinical trials may be commenced as long as the applicant has not received any objections from the CDE within&#160;60&#160;business days of application filing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">International Multi-center Clinical Trials Regulations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2015, the NMPA promulgated the Notice on Issuing the International Multi-Center Clinical Trial Guidelines (Trial) to provide guidance on the regulation of the application, implementation and administration of international multi-center clinical trials in China. Pursuant to the Notice on Issuing the International Multi-Center Clinical Trial Guidelines (Trial), international multi-center clinical trial applicants may simultaneously perform clinical trials in different centers using the same clinical trial protocol. Where the applicant plans to make use of the data derived from the international multi-center clinical trials for its application to the NMPA for approval of an NDA, such international multi-center clinical trials shall satisfy, in addition to the requirements set forth in the Drug Administration Law and its implementation measures, the Administrative Measures for Drug Registration and other relevant laws and regulations, the following requirements: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The applicant shall first conduct an overall evaluation on the global clinical trial data and further make trend analysis of the Asian and Chinese clinical trial data. In the analysis of Chinese clinical trial data, the applicant shall consider the representativeness of the research subjects, </font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, the participating patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The applicant shall analyze whether the amount of Chinese research subjects is sufficient to assess and adjudicate the safety and effectiveness of the drug under clinical trial, and satisfy the statistical and relevant legal requirements; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">The onshore and offshore international multi-center clinical trial research centers shall be subject to on-site inspections by competent PRC governmental agencies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">International multi-center clinical trials shall follow international prevailing the Good Clinical Trial Practice, or GCTP, principles and ethics requirements. Applications shall ensure the truthfulness, reliability and trustworthiness of clinical trials results; the researchers shall have the qualification and capability to perform relevant clinical trials; and an ethics committee shall continuously review the trials and protect the subjects&#8217; interests, benefits and safety. Before the performance of the international multi-center clinical trial, applicants shall obtain clinical trial approvals or complete filings pursuant to requirements under the local regulations where clinical trials are conducted, and register and disclose the information of all major researchers and clinical trial organizations on the NMPA drug clinical trial information platform. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Innovation Opinion, clinical trial data obtained from foreign centers may be used to apply for marketing application in China as long as such data meet the relevant requirements for the registration of drugs and medical devices in China. When using international multi-center clinical trial data to support marketing application in China, applicants shall provide the clinical trial data on racial difference, if any. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Trial Exemptions and Acceptance of Foreign Data</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The NMPA may reduce its requirements for clinical trials and data, depending on the drug and the existing data. The NMPA has granted waivers for all or part of trials and has stated that it will accept data generated abroad (even if not as part of a global study), including early phase data, that meets its requirements. In July&#160;2018, the NMPA issued the Technical Guidance Principles on Accepting Foreign Drug Clinical Trial Data, or the Guidance Principles, as one of the implementing rules for the Innovation Opinion. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">161</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Guidance Principles, the data of foreign clinical trials must meet certain authenticity, completeness, accuracy and traceability requirements, and such data must be obtained in consistency with the relevant requirements under the GCTP of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Additionally, clinical trial sponsors must be attentive to potentially meaningful ethnic differences in the subject population. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The NMPA permits drugs approved outside of China to be approved in China on a conditional basis without pre-approval clinical trials being conducted in China. Specifically, in 2018, the NMPA issued the Procedures for Reviewing and Approval of Clinical Urgently Needed Overseas New Drugs, permitting drugs that have been approved within the last ten&#160;years in the United States, the European Union or Japan and that prevent or treat orphan diseases or prevent or treat serious life-threatening illnesses for which there is either no effective therapy in China or for which the foreign-approved drug would have clear clinical advantages. Applicants are required to establish a risk mitigation plan and may be required to complete trials in China after the drug has been marketed. The CDE has developed a list of qualifying drugs that meet the foregoing criteria. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Drug Clinical Trial Registration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Announcement on Drug Clinical Trial Information Platform released by the NMPA in September&#160;2013, for all clinical trials approved by the NMPA and conducted in China, clinical trial registration must be completed and trial information must be published through the drug clinical trial information platform. In July&#160;2020, the CDE released the Drug Clinical Trial Registration and Information Disclosure Practices (Trial). Under these measures, an applicant who has obtained the approval from the NMPA for a clinical trial and intends to conduct the clinical trial in China must complete trial pre-registration before starting the clinical trial and must also continue to update follow-up information according to the progress of clinical trial. If no subject has signed an informed consent within three&#160;years from the date of approval from the NMPA for the clinical trial, the approval will be automatically invalidated and the registration will not be granted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Human Genetic Resources Approval</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 1998, the Ministry of Science and Technology and the MOH jointly established the rules for protecting and utilizing human genetic resources in China. In July&#160;2015, the Ministry of Science and Technology issued the Service Guide for Administrative Licensing Items concerning Examination and Approval of Sampling, Collecting, Trading, Exporting Human Genetic Resources, or Taking Such Resources&#160;out of the PRC, which provides that foreign-invested drug marketing authorization applicants (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e.</font><font style="letter-spacing:0.2pt;">, sponsors) that sample and collect human genetic resources in clinical trials shall be required to make certain filings with the China Human Genetic Resources Management Office, or the HGRMO, through its online system. In October&#160;2017, the Ministry of Science and Technology issued the Circular on Optimizing the Administrative Examination and Approval of Human Genetic Resources, which simplified the approval for sampling and collecting human genetic resources for the purpose of commercializing a drug in the&#160;PRC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In May&#160;2019, the State Council of PRC issued the National Regulations on the Management of Human Genetic Resources, which formalized the approval requirements pertinent to research collaborations between Chinese and foreign-owned entities. Pursuant to this new rule, a new notification system (as opposed to the advance approval approach originally in place) has been established for clinical trials using China&#8217;s human genetic resources at clinical institutions without involving the export of human genetic resources outside of China. Under the new system, a notification filing, specifying, among other things, the type, quantity and usage of the human genetic resource, with the HGRMO is required before conducting such clinical trials. The collection and use of China&#8217;s human genetic resources in international collaboration on basic scientific research involving the export of such human genetic resources are still subject to the approval of the HGRMO. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Trial Process and Good Clinical Practices</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Typically, drug clinical trials in China have four phases. Phase&#160;1 refers to the initial clinical pharmacology and human safety evaluation studies. Phase&#160;2 refers to the preliminary evaluation of a product candidate&#8217;s therapeutic efficacy and safety for target indication(s) in patients. Phase&#160;3 (often the pivotal study) refers to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">162</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">clinical trials that further verify the product candidate&#8217;s therapeutic efficacy and safety on patients with target indication(s) and ultimately provide sufficient evidence for the review of a drug marketing application. Phase&#160;4 refers to a new drug&#8217;s post-marketing study, which may be required by NMPA at its sole discretion, to assess therapeutic effectiveness and adverse reactions when the drug is widely used, to evaluate overall benefit-risk relationships of the drug when used among the general population or specific groups and to adjust the administration dose, etc. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the NMPA, a clinical trial institution can be engaged by a sponsor to conduct a drug clinical trial after such institution has been duly recorded with the online platform designated by the NMPA. The newly amended Drug Administrative Law and the Regulations on the Administration of Drug Clinical Trial Institution jointly promulgated by the NMPA and the NHC specify the requirements for clinical trial institutions and recording procedures. Pursuant to these regulations, a clinical trial institution should comply with the requirements of cGCP and be capable of undertaking pharmaceutical clinical trials. It should evaluate or engage a third party to evaluate its clinical trial proficiency, facilities and expertise. According to the Implementing Regulations of the Drug Administration Law, a sponsor should only engage a duly recorded clinical trial institution to carry out a drug clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The conduct of clinical trials must adhere to the cGCP and the protocols approved by the ethics committees of each study site. All applicants of pending drug registration submissions must conduct self-inspection and verification of their clinical trial data. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2020, the NMPA and the NHC released the amended Good Clinical Practice for Pharmaceutical Product, or the Amended GCP, which took effect on July&#160;1, 2020. Compared to the cGCP, the Amended GCP provides comprehensive and substantive requirements on the design and conduct of clinical trials in China. In particular, the Amended GCP enhances the protection for study subjects and tightens the control over bio-samples collected under clinical trials. In addition, the Amended GCP requires that trial drugs shall be manufactured in compliance with pertinent requirements on good manufacturing of drugs for clinical trial and used in line with relevant trial protocols. The NMPA issued the consultation paper of Good Manufacturing Practice for Drugs Used in Clinical Trials in July&#160;2018. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Communication with the CDE</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Administrative Measures for Communication on the Research, Development and Technical Evaluation of Drugs promulgated by the NMPA on December&#160;10, 2020, the applicants may propose to conduct communication meetings with the CDE during the research and development periods and in the registration applications of the innovative drugs. The communication meetings can be classified into three types. Type I meetings are convened to address key safety issues in clinical trials of drugs and key technical issues in the research and development of breakthrough therapeutic drugs. Type II meetings are held during the key research and development periods of drugs, mainly including meetings before the clinical trial application, meetings upon the completion of Phase&#160;2 trials and before the commencement of Phase&#160;3 trials, meetings before submitting a drug marketing application, and meetings for risk evaluation and control. Type III meetings refer to meetings that are not classified as Type I or Type II. According to the new Administrative Measures for Communication on the Research, Development and Technical Evaluation of Drugs, the applicant who apply for conditional approval and/or the priority review and approval procedures shall communicate with the CDE and obtain confirmation before submitting the marketing application to NMPA. In addition, except for (i)&#160;clinical trial of new drugs with clear technical guidelines, mature research experience, and guaranteed quality of the application materials, or (ii)&#160;international multi-center clinical trials that are simultaneously developed internationally and have been approved to conduct clinical trials in countries and/or regions with sound regulatory systems, the applicant in principle shall apply for communication with the CDE before clinical trial application for new drugs. Furthermore, where the application for clinical trials of new drug has been approved, upon the completion of Phase&#160;1 and 2 clinical trials and prior to Phase&#160;3 clinical trial, or before submitting a drug marketing application, the applicant may submit the application for Communication Session to the CDE. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Drug Marketing Registration Application</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the newly amended Administrative Measures for Drug Registration, the applicant may submit an application for drug marketing registration to the CDE upon completion of relevant research on </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">163</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">pharmacy, pharmacology, toxicology and drug clinical trials, determination of the quality standards of the drug, validation of commercial-scale production processes and preparation for acceptance of verification and inspection conducted by a professional technical institution designated as competent by the NMPA. The CDE will organize pharmaceutical, medical and other technicians to conduct comprehensive review of the safety, efficacy and quality controllability, among others, of the drug according to the application materials submitted by the applicant, the results of the verification and inspection conducted by a professional technical institution, etc. If the comprehensive review conclusion is affirmative, the drug shall be approved for marketing and a drug registration certificate will be issued containing the information of the drug approval number, the marketing authorization holders and the manufacturer. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Drug technology transfer regulations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2009, the NMPA promulgated the Administrative Regulations for Technology Transfer Registration of Drugs to standardize the registration process of drug technology transfers, which include application for, and evaluation, examination, approval and monitoring of, drug technology transfers. Drug technology transfers refer to the transfer of drug production technology by the owner to a drug manufacturer and the application for drug registration by the transferee according to the provisions in the new regulations. Drug technology transfers include new drug technology transfers and drug production technology transfers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing and Distribution</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the newly amended Drug Administration Law, the Regulations of Implementation of the Drug Administration Law and the Measures on the Supervision and Administration of the Manufacture of Drugs, facilities that manufacture drugs in China must receive a drug manufacturing license from the local drug regulatory authority. Each drug manufacturing license issued to a pharmaceutical manufacturing enterprise is effective for a period of five&#160;years. Any enterprise holding a drug manufacturing license is subject to review by the relevant regulatory authorities on an annual basis. According to such regulations and measures, to the extent a marketing authorization holder manufactures its drugs internally and not through CMOs, such marketing authorization holder must apply for a drug manufacturing license with the provincial counterpart of the NMPA, subject itself to inspections and other regulatory oversight by the agency. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Similarly, to conduct sales, importation, shipping and storage, or collectively, the distribution activities, a company must obtain a Drug Distribution License from the local drug regulatory authority, subject to renewal every five&#160;years. A separate certification of compliance with the NMPA&#8217;s drug good supply practice is also required. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">China has implemented a &#8220;Two-Invoice System&#8221; to control the distribution of prescription drugs. The &#8220;Two-Invoice System&#8221; generally requires that no more than two invoices be issued throughout the distribution chain: one from the manufacturer to a distributor and another from the distributor to the end-user hospital. This excludes the sale of products invoiced from the manufacturer to its wholly-owned or controlled distributors, or for imported drugs, to its exclusive distributor, or from a distributor to its wholly-owned or controlled subsidiary (or between its wholly-owned or controlled subsidiaries). However, the system still significantly limits the options for companies to use multiple distributors to reach a larger geographic area in China. Compliance with the Two-Invoice System is a prerequisite for pharmaceutical companies to participate in the procurement processes of public hospitals, which currently provide most of China&#8217;s healthcare services. Manufacturers and distributors that fail to implement the Two-Invoice System may lose their qualifications to participate in the bidding process. Non-compliant manufacturers may also be blacklisted from engaging in drug sales to public hospitals in a locality. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Administrative Observation Periods for New Drugs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Implementing Measures of the Drug Administration Law, the NMPA may, for the purposes of protecting public health, set an administrative observation period of not more than five&#160;years for a new drug produced by a drug manufacturer. During the administrative observation period, no approval shall be given to any other manufacturer to produce or import the said drug. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">164</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Non-Inferiority Standard</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In China, a drug may receive regulatory approval without showing superiority in its primary endpoint. Rather, a drug may be approved for use if it shows non-inferiority in its primary endpoint and superiority in one of its secondary endpoints. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Packaging of Pharmaceutical Products</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Administration of Quality of Drug Clinical Practice, the applicant shall be responsible for proper packaging and labeling of drugs for clinical trials, and in double-blinded clinical trials, the test drug shall be consistent with the control drug or placebo in appearance, odor, packaging, labeling and certain other features. According to the Measures for the Administration of Pharmaceutical Packaging promulgated in February&#160;1988, pharmaceutical packaging must comply with national and professional standards. If there is no national or professional standard available, an applicant may formulate and implement its own standards after obtaining the approval of the provincial administration or bureau of standards. The applicant must reapply if it needs to change its own packaging standards. Drugs that have not developed and received approval for packaging standards must not be sold or marketed in the PRC (except for drugs for the military). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Advertising of Pharmaceutical Products</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Interim Administrative Measures for the Review of Advertisements for Drugs, Medical Devices, Health Food and Formula Food for Special Medical Purposes promulgated in December&#160;2019, an enterprise seeking to advertise its pharmaceutical products must apply for an advertisement approval number. The advertisement approval number is issued by the relevant local administrative authority. The validity term of the advertisement approval number for drugs shall be consistent with the shortest validity term of the production registration certificate, filing certificate or production license. If no valid term is prescribed in the production registration certificate, filing certificate or production license, the valid term of the advertisement approval number shall be two&#160;years. The content of an approved advertisement may not be altered without prior approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Insert Sheet and Labels of Pharmaceutical Products</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Measures for the Administration of the Insert Sheets and Labels of Drugs, the insert sheets and labels of drugs should be reviewed and approved by the NMPA. A drug insert sheet should include the scientific data, conclusions and information concerning drug safety and efficacy in order to direct the safe and rational use of drugs. The inner label of a drug should bear such information as the drug&#8217;s name, indication or function, strength, dose and usage, production date, batch number, expiry date and drug manufacturer, and the outer label of a drug should indicate such information as the drug&#8217;s name, ingredients, description, indication or function, strength, dose and usage and adverse reaction. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Regulatory Intellectual Property Protections</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2020, the United States and China signed the Economic and Trade Agreement Between the United States of America and the PRC (the &#8220;Trade Agreement&#8221;). Among other things, China agreed to provide for effective protection and enforcement of pharmaceutical-related intellectual property rights, including patents and undisclosed test or other data submitted as a condition of marketing approval, as further described below. These provisions of the Trade Agreement will need to be implemented in China. In October&#160;2020, the Standing Committee of the NPC promulgated the amended PRC Patent Law, which became effective in June&#160;2021. The newly amended PRC Patent Law sets up the framework and adds the provisions for patent linkage and patent term extension. However, the provisions for patent term extension and an early resolution mechanism are unclear and/or remain subject to the approval of implementing regulations that are still in draft form or have not yet been proposed, leading to uncertainty about their scope and implementation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">International Regulation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to regulations in the United States, the European Union and the PRC, we will be subject to a variety of other regulations governing clinical trials and commercial sales and distribution of our products </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">165</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:192pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to the extent we choose to develop or sell any products outside of the United States, Europe or the PRC. The approval and reimbursement process varies from country to country and the time may be longer or shorter than that required to obtain FDA, EMA or NMPA approval. The requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from country to country. In all cases the clinical trials must be conducted in accordance with cGCP requirements and the applicable regulatory requirements and the ethical principles having their origin in the Declaration of Helsinki. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anti-Corruption Laws</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167;201, the U.S. Travel Act, the USA PATRIOT Act, and possibly other state and national anti-bribery and anti-money laundering laws in countries in which we conduct activities, prohibit any U.S. individual or business from paying, offering or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. This could become relevant in the conduct of international clinical trials where the sites for such studies may be a government-owned hospital. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. Activities that violate the FCPA, even if they occur wholly outside the United States, can result in criminal and civil fines, imprisonment, disgorgement, oversight and debarment from government contracts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the European Union, interactions between pharmaceutical companies and physicians are governed by strict laws, regulations, industry self-regulation codes of conduct and physicians&#8217; codes of professional conduct both at the European Union level and in the individual European Union member states. The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is prohibited in the European Union. The provision of benefits or advantages to physicians is also governed by the national anti-bribery laws of the European Union member states. Violation of these laws could result in substantial fines and imprisonment. Payments made to physicians in certain European Union member states also must be publicly disclosed. Moreover, agreements with physicians must often be the subject of prior notification and approval by the physician&#8217;s employer, his/her regulatory professional organization, and/or the competent authorities of the individual European Union member states. These requirements are provided in the national laws, industry codes, or professional codes of conduct, applicable in the individual European Union member states. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">166</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMANA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:7pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors and Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding our directors and executive officers as of the date of this prospectus. </font>
        </div>
        <table style="width:416pt;height:146.5pt;margin-left:20pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:213pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Age </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:161pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Positions(s) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 0.5pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Yu-Hsin Lin </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.5pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">44 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.5pt 0pt; width:161pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer, Chairman of the Board of Directors* </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Hao-Yuan Chuang </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">38 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer, Director* </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Nathan L. Mata </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">56 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <font style="letter-spacing:0.2pt;">Chief Scientific Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Ching-Chen Chiu </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">52 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Vice President of Clinical Operations </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Wan-Shan Chen </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">36 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <font style="letter-spacing:0.2pt;">Director* </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Hung-Wei Chen </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">40 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <font style="letter-spacing:0.2pt;">Director* </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">John M. Longo </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">53 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <font style="letter-spacing:0.2pt;">Independent Director Nominee# </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Ita Lu </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">45 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <font style="letter-spacing:0.2pt;">Independent Director Nominee# </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213pt;">
              <font style="letter-spacing:0.2pt;">Gary C. Biddle </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:18pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">70 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; width:161pt;">
              <font style="letter-spacing:0.2pt;">Independent Director Nominee#</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This director was appointed by Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">#</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Each of Dr. John M. Longo, Mr. Ita Lu and Prof. Gary&#160;C. Biddle has accepted appointment as a director, which will be immediately effective upon the declaration of effectiveness of our registration statement on Form F-1 by the SEC, of which this prospectus is a part. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:6pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a biographical summary of the experience of our directors and executive officers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dr.&#160;Yu-Hsin Lin</font><font style="letter-spacing:0.2pt;">, aged 44, is our founder and has served as Director of our Company since we established the Company in March&#160;2018 and the Chairman and the Chief Executive Officer of our Company since November&#160;2021. Dr.&#160;Lin has also served as the chairman and the chief executive officer of Belite Bio Holdings Corp. (our wholly owned subsidiary incorporated in Delaware) since June&#160;2016 and December&#160;2017, respectively. From June&#160;2016 to December&#160;2017, Dr.&#160;Lin also served as the president of Belite Bio Holdings Corp. (our wholly owned subsidiary). Dr.&#160;Lin has served as director and chief executive officer of RBP4 Pty Ltd (our wholly owned subsidiary in Australia) since August&#160;2018 and April&#160;2021, respectively. Dr.&#160;Lin has served as director of Belite Bio (HK) Limited (our wholly owned subsidiary in Hong Kong) since June&#160;2021, and the president of Belite Bio Holdings Corp. and Belite Bio, LLC (our wholly owned subsidiaries) since October&#160;2021. Dr.&#160;Lin is primarily responsible for the overall management, strategic planning and corporate development of our Company. Dr.&#160;Lin is also the founder and has served as the director and the chairman and the chief executive officer of Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder, since May&#160;2016 and June 2016, respectively. From 2014 to 2016, Dr.&#160;Lin was the president and chief operating officer of CVie Therapeutics Limited. In 2014, Dr.&#160;Lin served as the general manager and medical director of ASLAN Pharmaceuticals (Nasdaq: ASLN). From 2010 to 2014, Dr.&#160;Lin served as the senior medical director of OBI Pharma, Inc. (TPEx: 4174). From 2008 to 2010, Dr.&#160;Lin worked as the medical instructor of Faculty of Medicine, University of Sydney. Dr.&#160;Lin received his master&#8217;s degree in medicine from University of Sydney where he specialized in multidisciplinary medicine and surgery. Dr.&#160;Lin received his PhD in medicine from University of Sydney where he specialized in neurology &amp; immunology. Dr.&#160;Lin also received a Specialist Certificate in Clinical Neuroscience from University of Melbourne and a Cancer Therapeutics &amp; Research Certificate from Harvard Medical School. Dr.&#160;Lin further received his master&#8217;s degree in business and administration from Columbia University, London Business School and HK University. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Mr.&#160;Hao-Yuan Chuang</font><font style="letter-spacing:0.2pt;">, aged 38, has served as the Chief Financial Officer of our Company since November&#160;2020 and Director of our Company since November&#160;2021. Mr.&#160;Chuang has also served as the director of Belite Bio (HK) Limited (our wholly owned subsidiary in Hong Kong) since June&#160;2021 and as supervisor of Belite Bio (Shanghai) Limited (our wholly owned subsidiary in China) since August&#160;2021. He is primarily responsible for leading our Company&#8217;s finance, accounting, investor relations, and capital markets strategy and activities. Mr.&#160;Chuang is also the chief financial officer and a director of Lin BioScience, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">167</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder, since August 2018 and September 2018, respectively. From December 2017 to August 2018, Mr. Chuang worked as the finance and accounting director of Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder. From 2016 to 2017, Mr.&#160;Chuang served as the investment director of Suning International Limited. From 2015 to 2016, Mr.&#160;Chuang worked as the portfolio manager of The People&#8217;s Insurance Company (Group) of China Limited (HKG: 1339). From 2013 to 2015, Mr.&#160;Chuang was the senior manager of Wanda Hotel Development Company Limited (HKG: 0169). From 2010 to 2013, Mr.&#160;Chuang was the manager of corporate finance of CITIC Securities International Company Limited. From 2006 to 2010, Mr.&#160;Chuang was the senior associate of Chii Ying Co., Ltd. Mr.&#160;Chuang received his bachelor&#8217;s degree in economics and minor in business administration from National Taiwan University. He received his master&#8217;s degree in business &amp; administration from Columbia University, London Business School and HK University. Mr.&#160;Chuang is also a chartered financial analyst and financial risk manager. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dr.&#160;Nathan L. Mata</font><font style="letter-spacing:0.2pt;">, aged 56, has served as the Chief Scientific Officer of our Company since November&#160;2021. Dr.&#160;Mata has also served as the chief scientific officer of Belite Bio, LLC (our wholly owned subsidiary incorporated in Delaware) since August&#160;2021. Dr.&#160;Mata is primarily responsible for overseeing our Company&#8217;s scientific and clinical activities, including basic and applied research projects and clinical programs, as well as the development of new processes, technologies or products. From 2019 to 2021, Dr.&#160;Mata was the principal consultant of clinical development sector of Halloran Consulting Group. From 2018 to 2019, Dr.&#160;Mata was the clinical research &amp; operations consultant of Kubota Vision Inc. (formerly Acucela Inc.). From 2015 to 2018, Dr.&#160;Mata worked for Trethera Corporation. He acted as the chief operating officer and director of R&amp;D section from 2015 to 2017, and then worked as clinical research &amp; operations consultant from 2017 to 2018. From 2012 to 2015, Dr.&#160;Mata was the principal clinical research scientist of Acucela Inc. From 2010 to 2012, Dr.&#160;Mata co-founded and served as the chief scientific officer of Revision Therapeutics. From 2006 to 2008, Dr.&#160;Mata served as the vice president of R&amp;D of Sirion Therapeutics. He also served as the chief scientific officer and senior vice president of R&amp;D sector in the same company from 2008 to 2010. From 2004 to 2006, Dr.&#160;Mata co-founded and served as a director of SYTERA, INC., which was the research and development unit of Sirion Therapeutics. Dr.&#160;Mata received his bachelor&#8217;s degree in biology, master&#8217;s degree in biochemistry and PhD in neurobiology from University of Texas at San Antonio. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ms.&#160;Ching-Chen Chiu</font><font style="letter-spacing:0.2pt;">, aged 52, has served as the Vice President of Clinical Operations of our Company since November&#160;2021 and as executive officer and legal representative of Belite Bio (Shanghai) Limited (our wholly owned subsidiary in China) since January 2022. She is primarily responsible for leading our global clinical operations. Prior to joining our Company, Ms.&#160;Chiu has over 15&#160;years&#8217; experience leading global clinical CRO companies where she served as board and managing director of CMIC Asia Pacific and executive director of EPS International Co. Ltd. Ms.&#160;Chiu&#8217;s extensive clinical operations and research experience includes managing over hundred clinical studies in multiple therapeutic areas for both CRO&#8217;s and global pharmaceutical companies while she was at Pfizer and Bayer. Ms.&#160;Chiu received her bachelor&#8217;s degree in science from Taipei Medical University, and master&#8217;s degree in science (medical information) from University of Warwick, UK. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ms.&#160;Wan-Shan Chen</font><font style="letter-spacing:0.2pt;">, aged 36, has served as a Director our Company since November&#160;2021. She has also served as associate finance director of Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder, since January&#160;2019. From November 2017 to January&#160;2019, Ms.&#160;Chen worked as the senior finance manager of Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder. From June 2016 to October 2017, Ms. Chen worked as the finance manager of Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder. From 2014 to 2016, Ms.&#160;Chen was finance manager of CVie Therapeutics Limited. From 2009 to 2014, Ms.&#160;Chen worked as assistant manager of audit department of Deloitte Taiwan. Ms.&#160;Chen received her master&#8217;s degree in accounting from National Taipei University. Ms.&#160;Chen is also a certified public accountant in Taiwan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ms.&#160;Hung-Wei Chen</font><font style="letter-spacing:0.2pt;">, aged 40, has served as a Director of our Company since November&#160;2021. She has also served as the director and the chief operating officer of Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder, since July&#160;2021 and August&#160;2018, respectively. From July 2016 to August 2018, Ms. Chen worked as the clinical operations director of Lin BioScience, Inc. (Taiwan OTC: 6696), our ultimate controlling shareholder. From 2015 to 2016, Ms.&#160;Chen was associate clinical development </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">168</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">director of CVie Therapeutics Limited. From 2012 to 2014, Ms.&#160;Chen was senior clinical operations manager of OBI Pharma, Inc. (TPEx: 4174). From 2005 to 2012, Ms.&#160;Chen served as project manager, study manager, clinical operations manager, clinical quality manager and clinical research associate in Pfizer Taiwan. Ms.&#160;Chen received her master&#8217;s degree in science (medicinal chemistry) from National Taiwan University. Ms.&#160;Chen is also a certified pharmacist. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dr.&#160;John M. Longo</font><font style="letter-spacing:0.2pt;">, aged 53, has served as the independent Director of our Company since &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;2022. Dr.&#160;Longo has also served as a faculty member at Rutgers Business School on a full-time or part-time basis since June&#160;1993, where he is currently professor of practice in its finance &amp; economics department. Dr.&#160;Longo has also been a visiting professor of finance at Global EMBA -Asia, the joint EMBA program of Columbia Business School, London Business School, and the University of Hong Kong since 2016. Dr.&#160;Longo served as chief investment officer for two wealth management firms since October&#160;2002, first with the MDE Group and then with Beacon Trust after its acquisition of the MDE Group in 2015. Dr.&#160;Longo has also served as the president of Cliff House Capital Management and its predecessor, Cyborg Capital Management, since March&#160;2000. Cliff House Capital Management is primary used as a holding company for Dr.&#160;Longo&#8217;s non-academic activities. Dr.&#160;Longo was previously a vice president in the management science group at Merrill Lynch &amp; Co., Inc., having worked as a quantitative investment analyst for the firm from 1997 to 2000. Dr.&#160;Longo received his bachelor&#8217;s degree in economics and computer science from Rutgers College in 1991. Dr.&#160;Longo further received his PhD and master of business administration in finance from Rutgers Business School in 1995. Dr.&#160;Longo has been a CFA Charter holder since 1998. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Mr.&#160;Ita Lu</font><font style="letter-spacing:0.2pt;">, aged 45, has served as the independent Director of our Company since &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;2022. Mr.&#160;Lu has also served as the managing partner of Taiwania Capital since May&#160;2018. From 2017 to 2018, Mr.&#160;Lu served as the vice president of business development and investor relations of Etana Biotech. From 2009 to 2017, Mr.&#160;Lu served as the head of greater China healthcare of KGI Securities. From 2008 to 2009, Mr.&#160;Lu served as the equity research analyst of greater China healthcare of Yuanta Research. From 2006 to 2008, Mr.&#160;Lu served as the investment manager of China Investment Development Corp. (SEHK: 204). From 2001 to 2006, Mr.&#160;Lu served as the investment manager of China Development Industrial Bank. From 1999 to 2001, Mr.&#160;Lu served as the research associate of MedImmune, Inc. Mr.&#160;Lu received his bachelor&#8217;s degree in cell structural biology from University of Illinois at Urbana-Champaign and further received his master&#8217;s degree in biotechnology from Johns Hopkins University. Mr.&#160;Lu is also a certified senior securities specialist in Taiwan. Mr.&#160;Lu also passed Hong Kong Securities Institute Licensing Examination for Securities and Futures Intermediaries Paper 1. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Prof.&#160;Gary C. Biddle</font><font style="letter-spacing:0.2pt;">, aged 70, has served as the independent Director of our Company since &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199; 2022. He is professor of financial accounting at University of Melbourne and visiting professor at Columbia University Business School, University of Hong Kong (HKU), and London Business School. Professor Biddle earned his MBA and PhD degrees at University of Chicago. He previously served as professor at University of Chicago, University of Washington, Hong Kong University of Science and Technology (HKUST) and at HKU. In academic leadership, Professor Biddle served as Dean and Chair Professor at HKU, and as Academic Dean, Department Head, Council member, Court member, Senate member, and Chair Professor at HKUST. He co-created the EMBA-Global Asia program and taught the first class and decade of the Kellogg-HKUST EMBA program, both recently ranked #1 in the world by </font><font style="font-style:italic;letter-spacing:0.2pt;">Financial Times</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">QS</font><font style="letter-spacing:0.2pt;">. Professionally, he is a member of the AICPA, Australian Institute of Company Directors, CPA Australia, and HKICPA. Professor Biddle has served as editor and editorial board member of premier academic journals and as American Accounting Association Executive Board member, Vice-President, and President-Elect nominee, on the Accounting Hall of Fame Selection Committee, Financial Reporting Review Panel of the Financial Reporting Council of Hong Kong, HKICPA Council, Accreditation and Financial Reporting Standards Committees of HKICPA, and Hong Kong Institute of Directors Training Committee. Professor Biddle is a leading expert in financial and management accounting (teaching both), value creation, economic forecasting, corporate governance, and performance metrics, including EVA</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;">. His research appears in leading academic journals and in the financial press including </font><font style="font-style:italic;letter-spacing:0.2pt;">CNBC, CNN</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">SCMP</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">The Economist,</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">The Wall Street Journal</font><font style="letter-spacing:0.2pt;">. He has nearly 9,400 Google Scholar citations has won 30 teaching honours. He also proudly serves as Non-Executive Director of Kingdee International Software, as Independent Non-Executive Director and Audit and Risk Committee Chair of Shui On Land Limited, as Independent Non-Executive Director and Audit and Finance Committee Chair of Real Pet Food Company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">169</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(New Hope Group), and he previously served as Remuneration Committee Chair of Chinachem Group. He also runs charity 10k races. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors will consist of seven (7) directors upon the SEC&#8217;s declaration of effectiveness of our registration statement on Form F-1 of which this prospectus is a part. A director is not required to hold any shares in our company by way of qualification. A director who is in any way, whether directly or indirectly, interested in a contract or transaction or proposed contract or transaction with our company is required to declare the nature of his interest at a meeting of our directors. Subject to the Nasdaq Stock Market rules and disqualification by the chairman of the relevant board meeting, a director may vote in respect of any contract or transaction or proposed contract or transaction notwithstanding that he may be interested therein, and if he does so his vote shall be counted and he shall be counted in the quorum at any meeting of our directors at which any such contract or transaction or proposed contract or transaction is considered, provided (i)&#160;such director, if his or her interest in such contract or arrangement is material, has declared the nature of his or her interest at the earliest meeting of the board at which it is practicable for him or her to do so, either specifically or by way of a general notice and (ii)&#160;if such contract or arrangement is a transaction with a related party, such transaction has been approved by the audit committee. Our directors may exercise all the powers of our company to raise or borrow money and to mortgage or charge its undertaking, property and assets (present and future) and uncalled capital or any part thereof, to issue debentures, debenture stock, bonds and other securities, whether outright or as collateral security for any debt, liability or obligation of our company or of any third party. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Committees of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will establish three committees under the board of directors immediately upon the effectiveness of our registration statement on Form F-1, of which this prospectus is a part: an audit committee, a compensation committee and a nominating and corporate governance committee. We will adopt a charter for each of the three committees. Each committee&#8217;s members and functions are described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Audit Committee</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our audit committee will consist of John&#160;M. Longo, Ita Lu and Gary&#160;C. Biddle. John&#160;M. Longo will be the chairman of our audit committee. We have determined that John&#160;M. Longo, Ita Lu and Gary&#160;C. Biddle satisfy the &#8220;independence&#8221; requirements of Rule&#160;5605(a)(2) of the Listing Rules of the Nasdaq Stock Market and Rule&#160;10A-3 under the Exchange Act. We have determined that each of John M. Longo and Gary&#160;C. Biddle qualifies as an &#8220;audit committee financial expert.&#8221; The audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing with the independent auditors any audit problems or difficulties and management&#8217;s response; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">discussing the annual audited financial statements with management and the independent auditors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and approving all proposed related party transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">meeting separately and periodically with management and the independent auditors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Compensation Committee.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our compensation committee will consist of Hao-Yuan Chuang, Ita Lu and John&#160;M. Longo. Ita Lu will be the chairman of our compensation committee. We have determined that Ita Lu and John M. Longo satisfy the &#8220;independence&#8221; requirements of Rule&#160;5605(a)(2) of the Listing Rules of the Nasdaq Stock Market. The compensation committee will assist the board in reviewing and approving the compensation structure, including all forms of compensation, relating to our directors and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">170</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">executive officers. Our chief executive officer may not be present at any committee meeting during which his compensation is deliberated. The compensation committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing and recommending to the board for determination with respect to the compensation of our non-employee directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing periodically and approving any incentive compensation or equity plans, programs or similar arrangements; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">selecting compensation consultant, legal counsel or other adviser only after taking into consideration all factors relevant to that person&#8217;s independence from management. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Nominating and Corporate Governance Committee</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our nominating and corporate governance committee will consist of Yu-Hsin Lin, John&#160;M. Longo and Gary&#160;C. Biddle. Gary&#160;C. Biddle will be the chairman of our nominating and corporate governance committee. John&#160;M. Longo and Gary&#160;C. Biddle satisfy the &#8220;independence&#8221; requirements of Rule&#160;5605(a)(2) of the Listing Rules of the Nasdaq Stock Market. The nominating and corporate governance committee will assist the board of directors in selecting individuals qualified to become our directors and in determining the composition of the board and its committees. The nominating and corporate governance committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">selecting and recommending to the board nominees for election by the shareholders or appointment by the board; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">reviewing annually with the board the current composition of the board with regards to characteristics such as independence, knowledge, skills, experience and diversity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">making recommendations on the frequency and structure of board meetings and monitoring the functioning of the committees of the board; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">advising the board periodically with regards to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to the board on all matters of corporate governance and on any remedial action to be taken. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Duties of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under Cayman Islands law, our directors owe fiduciary duties to our company, including a duty of loyalty, a duty to act honestly and a duty to act in what they consider in good faith to be in our best interests. Our directors must also exercise their powers only for a proper purpose. Our directors also owe to our company a duty to act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth Courts have moved toward an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands. In fulfilling their duty of care to us, our directors must ensure compliance with our memorandum and articles of association, as amended and restated from time to time, and the class rights vested thereunder in the holders of the shares. In certain limited exceptional circumstances, a shareholder may have the right to seek damages in our name if a duty owed by our directors is breached. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors has all the powers necessary for managing, and for directing and supervising, our business affairs. The functions and powers of our board of directors include, among others: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">convening shareholders&#8217; annual and extraordinary general meetings and reporting its work to shareholders at such meetings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">declaring dividends and distributions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">appointing officers and determining the term of office of the officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">exercising the borrowing powers of our company and mortgaging the property of our company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">171</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">approving the transfer of shares in our company, including the registration of such shares in our share register. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Terms of Directors and Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our directors may be elected by an ordinary resolution of our shareholders. Alternatively, our board of directors may, by the affirmative vote of a simple majority of the directors present and voting at a board meeting appoint any person as a director to fill a casual vacancy on our board or as an addition to the existing board. Our directors are not automatically subject to a term of office and hold office until such time as they are removed from office by an ordinary resolution of our shareholders. In addition, a director will cease to be a director if he (i)&#160;becomes bankrupt or makes any arrangement or composition with his creditors; (ii)&#160;dies or is found to be or becomes of unsound mind; (iii)&#160;resigns his office by notice in writing; (iv)&#160;is prohibited by any applicable Law or Nasdaq Stock Market rules from being a director; (v) without special leave of absence from our board, is absent from meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (vi)&#160;is removed from office pursuant to any other provision of our articles of association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our officers are appointed by and serve at the discretion of the board of directors, and may be removed by our board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employment Agreements and Indemnification Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have entered into employment agreements with each of our executive officers. Under these agreements, the employment of our executive officers who are located at San Diego is governed by the laws of the State of California and is at-will and for no specific period of time. We may terminate employment for cause with 3-month notice, for certain acts of the executive officer, such as personal dishonesty, conviction of a crime, willful act which constitutes misconduct and is materially injurious to our Company, or continued violations of the executive officer&#8217;s obligations to our Company. We may also terminate an executive officer&#8217;s employment without cause and our executive officers may resign at any time, subject, in each case, to 3-month prior written notice. The employment of our executive officers who are located at Taiwan is governed by the laws of Taiwan and is for no specific period of time, which may be terminated at any time by mutual agreement or by either the executive officer or the Company pursuant to the applicable law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each executive officer has agreed to hold, both during and after the termination or expiry of his or her employment agreement, in strictest confidence, and not to use, except for the benefit of our Company, or to disclose to any person, firm or corporation without written authorization of an officer of our Company, any confidential information, except under a non-disclosure agreement duly authorized and executed by our Company. The executive officers have also agreed to disclose in confidence to us all inventions, designs and trade secrets which they conceive, develop or reduce to practice during the executive officer&#8217;s employment with us and to assign all right, title and interest in them to us, and assist us in obtaining and enforcing patents, copyrights and other legal rights for these inventions, designs and trade secrets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, each executive officer has agreed to be bound by non-competition and non-solicitation restrictions during the term of his or her employment and non-solicitation restrictions for one year following the last date of employment. Specifically, each executive officer has agreed not to (i)&#160;either directly or indirectly solicit, induce, recruit or encourage any of our employees to leave their employment, or attempt to solicit, induce, recruit, or encourage any of our employees to leave their employment; or (ii)&#160;directly or indirectly through any other person, use any of our trade secrets to influence or attempt to influence customers, vendors, suppliers, licensors, lessors, joint venturers, associates, consultants, agents, or partners of our Company to divert their business away from us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have also entered into indemnification agreements with each of our directors and executive officers. Under these agreements, we agree to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director or officer of our company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation of Directors and Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the fiscal year ended December&#160;31, 2021, we paid an aggregate of approximately US$0.17&#160;million in cash to our directors and executive officers and did not grant any options to purchase our ordinary shares </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">172</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to our directors and executive officers. We have not set aside or accrued any amount to provide pension, retirement or other similar benefits to our directors and executive officers. Our PRC, U.S. and Australian subsidiaries are required by law to make contributions equal to certain&#160;percentages of each employee&#8217;s salary for his or her pension insurance, medical insurance, unemployment insurance and other statutory benefits and a housing provident fund. For share incentive grants to our directors and executive officers, see &#8220;&#8212; Share Incentive Plans.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share Incentive Plans</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2020 Share Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2019, we adopted the Belite Bio, Inc Share Incentive Plan, or the 2019 Share Incentive Plan, which was later superseded and replaced by the Belite Bio, Inc Amended and Restated Share Incentive Plan, or the 2020 Share Incentive Plan, in December&#160;2020. The terms of the 2019 Share Incentive Plan and the 2020 Share Incentive Plan are substantially the same other than the maximum aggregate number of shares we may issue under the respective plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The purpose of the 2020 Share Incentive Plan is to attract and retain the best available personnel, provide additional incentives to directors, employees and consultants, and promote the success of our business. The maximum aggregate number of ordinary shares that may be issued under the 2020 Share Incentive Plan is 4,165,310 ordinary shares. As of the date of this prospectus, options to purchase a total of 1,982,561 ordinary shares are outstanding under the 2020 Share Incentive Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:7pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following paragraphs summarize the principal terms of the 2020 Share Incentive Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Type of Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2020 Share Incentive Plan permits the awards of options, share appreciation right, share bonuses, performance shares, share&#160;units, phantom shares, dividend equivalents, or similar rights to purchase or acquire ordinary shares or any similar securities with a value derived from the value of or related to the ordinary shares and/or returns thereon. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Plan&#160;Administration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The 2020 Share Incentive Plan shall be administrated by our board of directors or one or more committees appointed by the board of directors or another committee (within its delegated authority), the Plan&#160;Administrator. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Award Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each award under the 2020 Share Incentive Plan shall be evidenced by an award agreement in the form approved by the plan administrators. The terms of the award agreements will be determined by the plan administrators and consistent with the terms of the 2020 Share Incentive Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Eligibility.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The plan administrators may decide that an award under the 2020 Share Incentive Plan be granted to any employee, officer or director of the Company or its affiliates, or that it be granted to any consultant or adviser who provides services to the Company or its affiliates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Vesting Schedule.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In general, the plan administrator determines the vesting schedule, which is specified in the relevant award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Exercise Price.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The plan administrator determines the exercise price for each award, which is stated in the award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Term of the Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Options that are vested and exercisable will terminate if they are not exercised prior to the time as the plan administrator determines at the time of grant. However, the maximum exercisable term is ten&#160;years from the date of a grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transfer Restrictions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;With a few exceptions, no right of interest of a participant in any award may be subject in any manner to sale, transfer, anticipation, alienation, assignment, pledge, encumbrance or charge. This restriction does not apply to (i)&#160;transfers to our company, (ii)&#160;transfers by gift or domestic relations order to one or more family members, (iii)&#160;the designation of a beneficiary to receive benefits if a participant dies or transfers by will, (iv)&#160;permitted transfers or exercises on behalf of a participant by the participant&#8217;s duly authorized legal representative if the participant has suffered a disability</font><font style="font-style:italic;letter-spacing:0.2pt;">.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Termination and Amendment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The board of directors may, at any time, terminate or, from time to time, amend, modify or suspend the 2020 Share Incentive Plan, in whole or in part. No awards may be granted during any period that the board of directors suspends the 2020 Share Incentive Plan. To the extent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">173</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">then required by applicable law or listing agency, any amendment to the 2020 Share Incentive Plan may be subject to shareholder approval. Unless earlier terminated by the board of directors, the 2020 Share Incentive Plan will terminate at the close of business on the day before the 10th anniversary of the date the board of directors approved the 2020 Share Incentive Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2022 Performance Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">In April 2022, we adopted our 2022 Performance Incentive Plan, which is conditional on and effective upon completion of this offering. The initial aggregate amount of ordinary shares that may be issued under the 2022 Performance Incentive Plan is 1,748,667, provided that the shares reserved under the 2022 Performance Incentive Plan shall automatically increase on the first trading day in January of each calendar year during the term of the 2022 Performance Incentive Plan, commencing in January&#160;2023, by an amount equal to (i)&#160;four&#160;percent (4%) of the total number of ordinary shares issued and outstanding on December&#160;31 of the immediately preceding calendar year or (ii)&#160;such lesser number of ordinary shares as may be established by our board of directors. </font>
        </div>
        <div style="margin-left:20pt; margin-top:7pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following paragraphs describe the principal terms of our 2022 Performance Incentive Plan: </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan&#160;Administration.</font><font style="letter-spacing:0.2pt;"> Our 2022 Performance Incentive Plan will be administered by our board of directors or one or more committees (or subcommittees, as the case may be) appointed by our board of directors or another committee (within its delegated authority). Any such administrator is authorized and empowered to, subject to the express provisions of the 2022 Performance Incentive Plan, do all things necessary or desirable in connection with the authorization of awards and the administration of the 2022 Performance Incentive Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Eligibility.</font><font style="letter-spacing:0.2pt;"> The plan administrator may select among the following eligible individuals to whom an award may be granted: (i)&#160;our officers or employees, (ii)&#160;our directors; or (iii)&#160;consultants or advisers, who render bona fide services to us (except in connection with the offer or sale of securities in a capital-raising transaction or as a market maker or promoter of our securities). </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Award agreements.</font><font style="letter-spacing:0.2pt;"> Each award under the 2022 Performance Incentive Plan shall be evidenced by a written or electronic award agreement or notice in a form approved by the plan administrator. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Types of Awards.</font><font style="letter-spacing:0.2pt;"> The types of awards that may be granted under our 2022 Performance Incentive Plan are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Share Options. A share option is the grant of a right to purchase a specified number of ordinary shares during a specified period as determined by the administrator. The maximum term of each option shall be ten&#160;years. The per share exercise price for each option granted to any eligible person subject to United States income tax shall be not less than the fair market value of an ordinary share on the date of grant of the option. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Share Appreciation Rights. A share appreciation right, or SAR, is a right to receive a payment, in cash and/or ordinary shares, equal to the excess of the fair market value of a specified number of ordinary shares on the date the SAR is exercised over the &#8220;base price&#8221; of the award, which base price shall be set forth in the applicable award agreement and shall be not less than 100% of the fair market value of an ordinary share on the date of grant of the SAR. The maximum term of a SAR shall be ten&#160;years. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Other Awards. The other types of awards that may be granted under the 2022 Performance Incentive Plan include: (a)&#160;share bonuses, restricted shares, performance shares, share&#160;units, restricted share&#160;units, deferred shares, phantom shares, or similar rights to purchase or acquire shares, whether at a fixed or variable price (or no price) or fixed or variable ratio related to the ordinary shares, and any of which may (but need not) be fully vested at grant or vest upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof; or (b)&#160;cash awards. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Vesting Schedule.</font><font style="letter-spacing:0.2pt;"> In general, the plan administrator determines the vesting schedule, which is set forth in the award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acceleration of Awards upon Certain Corporate Transactions.</font><font style="letter-spacing:0.2pt;"> Upon the occurrence of any merger, combination, consolidation or other reorganization; any exchange of securities of our company; a sale of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">174</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">all or substantially all of the business, shares or assets of our company; a dissolution of our company; or any other event in which our company does not survive (or does not survive as a public company in respect of our ordinary shares); or any change in control event defined in any applicable award agreement, the administrator of the 2022 Performance Incentive Plan may, in its discretion, provide for the accelerated vesting of any award or awards as and to the extent determined by the administrator in the circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transfer Restrictions.</font><font style="letter-spacing:0.2pt;"> Awards may not be transferred in any manner by the recipient other than by will or the laws of descent and distribution, except as otherwise provided by the plan administrator. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Amendment and Termination of Plan.</font><font style="letter-spacing:0.2pt;"> No amendment, suspension or termination of the 2022 Performance Incentive Plan or amendment of any outstanding award agreement shall, without written consent of the participant, affect in any manner materially adverse to the participant any rights or benefits of the participant or obligations of our company under any award granted under the 2022 Performance Incentive Plan prior to the effective date of such change. Unless earlier terminated by our board of directors and subject to any extension that may be approved by shareholders, the 2022 Performance Incentive Plan shall terminate at the close of business on the day before the tenth anniversary of the effective date. After the termination of the 2022 Performance Incentive Plan either upon such stated expiration date or its earlier termination by our board of directors, no additional awards may be granted under the 2022 Performance Incentive Plan, but previously granted awards (and the authority of the administrator with respect thereto, including the authority to amend such awards) shall remain outstanding in accordance with their applicable terms and conditions and the terms and conditions of the 2022 Performance Incentive Plan.</font>
        </div>
        <div style="text-indent:20pt; margin-top:7pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes, as of the date of this prospectus, the number of ordinary shares underlying outstanding options that we granted to our directors and executive officers. </font>
        </div>
        <table style="width:456pt;height:212.5pt;margin-top:8.69999999999999pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(US$/Share) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of Grant </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of Expiration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Yu-Hsin Lin </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">827,814</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;23, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;22, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:163.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6.00<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April&#160;18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;font-size:7.5pt;">
                <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">##</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Hao-Yuan Chuang </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">579,471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;23, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;22, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:163.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6.00<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April&#160;18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;font-size:7.5pt;">
                <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">##</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nathan L. Mata </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">748,667</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6.00<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April&#160;18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;font-size:7.5pt;">
                <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">##</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ching-Chen Chiu </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">350,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6.00<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April&#160;18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;font-size:7.5pt;">
                <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">##</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wan-Shan Chen</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;23, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;22, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Hung-Wei Chen</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;23, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;22, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">John M. Longo </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6.00<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April&#160;18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;font-size:7.5pt;">
                <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">##</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gary&#160;C. Biddle </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8203;</font><font style="position:absolute;"><font style="font-weight:bold;"></font>*</font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6.00<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April&#160;18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.04pt;">
              <div style="text-align:center;font-size:7.5pt;">
                <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">##</font><font style="font-size:10pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:163.69pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.2pt;">All directors and executive officers as </font>
                <br >
                <font style="letter-spacing:-0.2pt;">a group</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:normal;">&#8203;</div>
            </td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:normal;">2,853,442</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:81.04pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:81.04pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.7pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Note: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:1.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:1.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Less than 1% of our total ordinary shares on an as-converted basis outstanding as of the date of this prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The exercise price applies to all options granted on April&#160;18, 2022 shall be the final offer price of the offering. The US$6.00 exercise price disclosed above, being the midpoint of the estimated range of the initial public offering price, is for indication only. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">#</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Our Board approved the option grant on April 18, 2022, which is conditional upon and becomes effective on the date on which this registration statement is declared effective by the United States Securities and Exchange Commission (&#8216;&#8216;Award Date&#8217;&#8217;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:7.5pt;">
          <font style=" position:relative; bottom:4.25pt;letter-spacing:0.15pt;">##</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:7.5pt;">
          <font style="font-size:10pt;letter-spacing:0.2pt;">The expiration date of each such grant to be the day before the tenth anniversary of the Award Date.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, our award holders other than our directors and officers as a group held options to purchase 827,786 ordinary shares, with exercise prices ranging from US$0.1191 per share to US$6.00 (subject to adjustment based on the final offering price) per share. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">175</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL SHAREHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as specifically noted, the following table sets forth information with respect to the beneficial ownership of our ordinary shares on an as-converted basis as of the date of this prospectus by: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each of our directors and executive officers; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">each person known to us to own beneficially more than 5% of our ordinary shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The calculations in the table below are based on 18,095,317 ordinary shares on an as-converted basis outstanding as of the date of this prospectus, and 24,095,317 ordinary shares outstanding immediately after the completion of this offering. Each holder of ordinary shares is entitled to one vote per share on all matters submitted to them for a vote. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the&#160;percentage ownership of that person, we have included shares that the person has the right to acquire within 60&#160;days, including through the exercise of any option, warrant or other right or the conversion of any other security. These shares, however, are not included in the computation of the&#160;percentage ownership of any other person. </font>
        </div>
        <table style="width:456pt;height:259pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:178.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary Shares Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned Prior to This Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="16">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary Shares Beneficially Owned</font>
                <br >
                <font style="letter-spacing:-0.16pt;">After This Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:178.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficial</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ownership&#8224; </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficial</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">voting power&#8224;&#8224; </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Directors and Executive Officers**:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Yu-Hsin Lin</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,463,015</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13.61<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,773,758</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.51<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">11.51<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Hao-Yuan Chuang</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">529,193</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.92<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">532,241</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.21<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.21<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nathan L. Mata </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ching-Chen Chiu </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wan-Shan Chen</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Hung-Wei Chen</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">193,526</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.07<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:178.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">John M. Longo (independent director nominee). </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ita Lu (independent director nominee)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font><font style="letter-spacing:0.2pt;">.</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:178.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Gary C. Biddle (independent director nominee)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Principal Shareholders:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:178.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lin Bioscience International Ltd</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font><font style="letter-spacing:0.2pt;">. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">13,928,597</td>
            <td style="padding:0pt;padding-left:0.455000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">76.97<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:8.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">16,428,597</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">68.18<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">68.18<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:13.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.81pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Less than 1% of our total ordinary shares on an as-converted basis outstanding as of the date of this prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">**</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The business address of our directors and executive officers, except for Nathan L. Mata, John M. Longo and Ita Lu is Room 2972, 29F., No. 68, Sec. 5, Zhongsiao E. Rd., Xinyi Dist., Taipei City 110 , Taiwan; the business address of Nathan L. Mata is 5820 Oberlin Drive, Suite 101, San Diego, CA 92121; the business address of John M. Longo is 100 Rockefeller Road, Piscataway, NJ 08854; the business address of Ita Lu is 5F-7 No. 1 Xinyi Road Section 2, Taipei Taiwan; the business address of Gary&#160;C. Biddle is Level 8, 198 Berkeley Street, Carlton, VIC 3010, Australia. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">For each person and group included in this column, percentage ownership is calculated by dividing the number of shares beneficially owned by such person or group by the sum of the total number of shares outstanding and the number of shares such person or group has the right to acquire upon exercise of option, warrant or other right within 60&#160;days after the date of this prospectus. The total number of ordinary shares outstanding as of the date of this prospectus on an as-converted basis is 18,095,317. The </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">176</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:268pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">total number of ordinary shares outstanding after the completion of this offering will be 24,095,317, including 6,000,000 ordinary shares to be sold by us in this offering in the form of ADSs, assuming that the underwriters do not exercise their option to purchase additional ADSs. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8224;&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">For each person and group included in this column, percentage of voting power is calculated by dividing the voting power beneficially owned by such person or group by the voting power of all of our ordinary shares as a single class. Our ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents 731,728 ordinary shares directly held by Yu-Hsin Lin, and 1,731,287 shares indirectly held by Yu-Hsin Lin through Lin Bioscience International Ltd. The exercise price of the outstanding options granted to Yu-Hsin Lin is US$0.4386 per share. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents 512,210 ordinary shares directly held by Hao-Yuan Chuang, and 16,983 shares indirectly held by Hao-Yuan Chuang through Lin Bioscience International Ltd. The exercise price of the outstanding options granted to Hao-Yuan Chuang is US$0.4386 per share. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The exercise price of the outstanding options granted to Wan-Shan Chen is US$0.4386 per share. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents 58,435 ordinary shares directly held by Hung-Wei Chen, and 135,091 shares indirectly held by Hung-Wei Chen through Lin Bioscience International Ltd. The exercise price of the outstanding options granted to Hung-Wei Chen is US$0.4386 per share. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The renumeration for Mr. Lu&#8217;s service as our director is comprised of cash payment and option grant. The cash portion of such remuneration will be deferred and will only be paid to Mr. Lu after his employment relationship with Taiwania Capital is terminated. In addition, the option portion of such remuneration will only be granted to Mr. Lu under our 2022 Performance Incentive Plan after his employment relationship with Taiwania Capital terminates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents 8,840,321 ordinary shares and 5,088,276 Series&#160;B Preferred Shares directly held by Lin Bioscience International Ltd. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, none of our ordinary shares are held by record holders in the United States. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">177</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRPT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:37.55pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RELATED PARTY TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Private Placements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See &#8220;Description of Share Capital&#8201;&#8212;&#8201;History of Securities Issuances.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholders Agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See &#8220;Description of Share Capital&#8201;&#8212;&#8201;Shareholders Agreement.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employment Agreements and Indemnification Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See &#8220;Management&#8201;&#8212;&#8201;Employment Agreements and Indemnification Agreements.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share Incentive Plans</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See &#8220;Management&#8201;&#8212;&#8201;Share Incentive Plans.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Transactions with Related Parties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">LBS-007</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2018 LBS-007 Co-Development Agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On February&#160;27, 2018, Lin BioScience, Inc., our ultimate controlling shareholder, entered into a co-development agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2018 LBS-007 Co-Development Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Belite Bio Holdings Corp. (the direct subsidiary of Lin BioScience, Inc. at that time, and now our wholly owned subsidiary), pursuant to which (i)&#160;both parties agreed to jointly perform certain new drug development project(s) for the development of LBS-007 from February&#160;27, 2018 to February&#160;27, 2023; (ii)&#160;each party agreed to bear its own costs for the performance of such project; (iii)&#160;if the project becomes commercialized, 10% of the profit derived from such commercialization will be shared with Belite Bio Holdings Corp. provided that a written agreement is entered into by and between the parties and a third-party licensee; and (iv)&#160;Belite Bio Holdings Corp. acknowledged and agreed that Lin BioScience, Inc. was the sole and exclusive owner of all intellectual property rights that Belite Bio Holdings Corp. directly or indirectly managed, developed or assisted in the performance of such project. Lin BioScience,&#160;Inc. and Belite Bio Holdings Corp. entered into a deed of termination which terminated the 2018 LBS-007 Co-Development Agreement with effect from January&#160;20, 2020 and the parties agreed to waive all obligations due under the agreement. We have not received any consideration owing to the above agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">LBS-021 and LBS-031</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2018 LBS-021/031 R&amp;D Services Agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On January&#160;1, 2018, Lin BioScience, Inc., our ultimate controlling shareholder, entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2018 LBS-021/</font>&#8203;<font style="font-weight:bold;letter-spacing:-0.2pt;">031 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with our wholly owned subsidiaries, Belite Bio Holdings Corp. and Belite Bio, LLC (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Service Provider</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which the Service Provider agreed to (i)&#160;perform certain research and development services for Lin BioScience, Inc. for the development of LBS-021 and LBS-031 from January&#160;1, 2018 to December&#160;31, 2018, and (ii)&#160;assign the ownership of the deliverables to Lin BioScience, Inc and acknowledged and agreed that Lin BioScience, Inc. is the sole and exclusive owner of all intellectual property that the Service Provider directly or indirectly managed, developed or assisted in the performance of the services. The total consideration Belite Bio Holdings Corp. and Belite Bio, LLC received for such development services, assignment and licensing was nil and $85,821.17, respectively. </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">178</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:2.35000000000002pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2019 LBS-021/031 R&amp;D Services Agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On January&#160;1, 2019, Lin BioScience, Inc., our ultimate controlling shareholder, entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2019 LBS-021/031 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with our wholly owned subsidiaries, Belite Bio Holdings Corp. and Belite Bio, LLC (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Service Provider</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which the Service Provider agreed to (i)&#160;perform certain research and development services for Lin BioScience, Inc. for the development of LBS-021 and LBS-031 from January&#160;1, 2019 to December&#160;31, 2019, and (ii)&#160;assign the ownership of the deliverables to Lin BioScience, Inc. and acknowledged and agreed that Lin BioScience, Inc. is the sole and exclusive owner of all intellectual property that the Service Provider directly or indirectly managed, developed or assisted in the performance of the services. The total consideration Belite Bio Holdings Corp. and Belite Bio, LLC received for such development services, assignment and licensing was nil and $25,900.75, respectively. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">LBS-009</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2018 LBS-009 R&amp;D Services Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On July&#160;1, 2018, we entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2018 LBS-009 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Lin BioScience, Inc., our ultimate controlling shareholder, and Belite Bio Holdings Corp. and Belite Bio, LLC, (our wholly owned subsidiaries) (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Service Provider</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which (i)&#160;the Service Provider agreed to provide certain new drug development services for pipeline LBS-009 to us from July&#160;1, 2018 to June&#160;30, 2019, including sample collection for RBP4 analysis and project management; (ii)&#160;the Service Provider acknowledged that we are the sole and exclusive owner of all intellectual property rights that they directly or indirectly managed, developed or assisted in the performance of the services; and (iii)&#160;we agreed to pay service fees to the Service Provider in an amount equal to 110% percent of actual costs for its performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. The total consideration we paid for such development services, assignment and licensing was nil to Lin BioScience, Inc., nil to Belite Bio Holdings Corp. and $39,408.87 to Belite Bio, LLC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2019 LBS-009 R&amp;D Services Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On July&#160;1, 2019, we entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2019 LBS-009 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Lin BioScience, Inc. (our ultimate controlling shareholder), Belite Bio Holdings Corp. and Belite Bio, LLC (our wholly owned subsidiaries) (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Service Provider</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which (i)&#160;the Service Provider agreed to provide certain new drug development services for pipeline LBS-009 to us from July&#160;1, 2019 to June&#160;30, 2020, including sample collection for RBP4 analysis and project management; (ii)&#160;the Service Provider acknowledged that we are the sole and exclusive owner of all intellectual property rights that they directly or indirectly managed, developed or assisted in the performance of the services; and (iii)&#160;we agreed to pay service fees to the Service Provider in an amount equal to 110% percent of actual costs for its performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. The total consideration we paid for such development services, assignment and licensing was nil to Lin BioScience, Inc., nil to Belite Bio Holdings Corp. and $3,280.02 to Belite Bio,&#160;LLC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2020 LBS-009 R&amp;D Services Agreement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On July&#160;1, 2020, we entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2020 LBS-009 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Lin BioScience, Inc. (our ultimate controlling shareholder), Belite Bio Holdings Corp. and Belite Bio, LLC (our wholly owned subsidiaries) (collectively, the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Service Provider</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to which (i)&#160;the Service Provider agreed to provide preclinical studies for pipeline LBS-009 to us from July&#160;1, 2020 to June&#160;30, 2021; (ii)&#160;the Service Provider acknowledged and agreed that we are the sole and exclusive owner of all intellectual property rights that they directly or indirectly managed, developed or assisted in the performance of the services; and (iii)&#160;we agreed to pay service fees to the Service Provider in an amount equal to 110% percent of actual costs for its performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. The total consideration we paid for such development services was nil to Lin BioScience, Inc., nil to Belite Bio Holdings Corp. and nil to Belite Bio, LLC. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">179</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">LBS-008</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2018 LBS-008 R&amp;D Services Agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On July&#160;1, 2018, we entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2018 LBS-008 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Lin BioScience, Inc. (our ultimate controlling shareholder), pursuant to which (i)&#160;our ultimate controlling shareholder agreed to provide certain new drug development services for pipeline LBS-008 to us from July&#160;1, 2018 to June&#160;30, 2019; (ii)&#160;our ultimate controlling shareholder acknowledged and agreed that we are the sole and exclusive owner of all intellectual property rights that our ultimate controlling shareholder directly or indirectly managed, developed or assisted in the performance of the services; and (iii)&#160;we agreed to pay service fees equal to 110% percent of actual costs for our ultimate controlling shareholder&#8217;s performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. For such development services, the total consideration paid by us was nil to Lin BioScience, Inc. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2019 LBS-008 R&amp;D Services Agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On July&#160;1, 2019, we entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2019 LBS-008 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Lin BioScience, Inc. (our ultimate controlling shareholder), pursuant to which (i)&#160;our ultimate controlling shareholder agreed to provide certain new drug development services for pipeline LBS-008 to us from July&#160;1, 2019 to June&#160;30, 2020; (ii)&#160;our ultimate controlling shareholder acknowledged and agreed that we are the sole and exclusive owner of all intellectual property rights that our ultimate controlling shareholder directly or indirectly managed, developed or assisted in the performance of the services; and (iii)&#160;we agreed to pay service fees equal to 110% percent of actual costs for our ultimate controlling shareholder&#8217;s performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. On January&#160;30, 2020, we entered into the first amendment to 2019 LBS-008 R&amp;D Agreement with Lin BioScience, Inc., pursuant to which our ultimate controlling shareholder agreed to provide certain new drug development services and finance and accounting services. For such development and finance services, the total consideration paid by us was $56,747.86 to Lin BioScience, Inc. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2020 LBS-008 R&amp;D Services Agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On July&#160;1, 2020, we entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2020 LBS-008 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Lin BioScience, Inc. (our ultimate controlling shareholder), pursuant to which (i)&#160;our ultimate controlling shareholder agreed to provide certain new drug development services for pipeline LBS-008 to us from July&#160;1, 2020 to June&#160;30, 2021; (ii)&#160;our ultimate controlling shareholder acknowledged and agreed that we are the sole and exclusive owner of all intellectual property rights that our ultimate controlling shareholder directly or indirectly managed, developed or assisted in the performance of the services; and (iii)&#160;we agreed to pay service fees equal to 110% percent of actual costs for our ultimate controlling shareholder&#8217;s performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. For such development services, the total consideration paid by us was $57,828.12 to Lin BioScience, Inc. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2021 LBS-008 R&amp;D Services Agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On July&#160;1, 2021, we entered into a research and development services agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2021 LBS-008 R&amp;D Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with Lin BioScience, Inc. (our ultimate controlling shareholder), pursuant to which (i)&#160;our ultimate controlling shareholder agreed to provide certain new drug development services for pipeline LBS-008 to us from July&#160;1, 2021 to June&#160;30, 2022; (ii)&#160;our ultimate controlling shareholder acknowledged and agreed that we are the sole and exclusive owner of all intellectual property rights that our ultimate controlling shareholder directly or indirectly managed, developed or assisted in the performance of the services; and (iii)&#160;we agreed to pay service fees equal to 110% percent of actual costs for our ultimate controlling shareholder&#8217;s performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. On February&#160;23, 2022, we entered into a first amendment to 2021 LBS-008 R&amp;D Agreement with Lin BioScience, Inc., pursuant to which we granted our ultimate controlling shareholder a revocable, non-exclusive, non-transferable, royalty-free license (with the right to grant and authorize sublicenses) under RBP4 related patents in Taiwan to the extent necessary for our ultimate controlling shareholder to perform services stipulated under the 2021 LBS-008 R&amp;D Agreement. For such development services, the total consideration paid by us was $124,785.59 to Lin BioScience, Inc. as of the date of this prospectus. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">180</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">2019 Loan Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2019 Loan Agreements between us and Lin Bioscience International Ltd.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On July&#160;12, 2019 and September&#160;30, 2019, we entered into two intercompany loan agreements (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Cayman 2019 July Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221; the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Cayman 2019 September Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221;, respectively) with Lin Bioscience International Ltd. (our principal shareholder). Pursuant to the Cayman 2019 July Loan Agreement, Lin Bioscience International Ltd. agreed to provide an interest-free loan to us on request from time to time for a period of one year or any longer period as agreed by the parties commencing from July&#160;12, 2019 with a facility limit of $80,000 to assist with the conduct and/or facilitation by us of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. Pursuant to the Cayman 2019 September Loan Agreement, Lin Bioscience International Ltd. agreed to provide an interest-free loan to us on request from time to time for a period of one year or any longer period as agreed by the parties commencing from September&#160;30, 2019 with a facility limit of $800,000 to assist with the conduct and/or facilitation by us of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. On January&#160;20, 2020, we entered into a first confirmation deed with Lin Bioscience International Ltd., which reduced the facility amount under the Cayman 2019 September Loan Agreement to $300,000, by converting $500,000 of the loan into equity via the issuance of 500,000 of our Ordinary Shares to Lin Bioscience International Ltd. On April&#160;28, 2020, we entered into a second confirmation deed with Lin Bioscience International Ltd., which (i)&#160;reduced the facility limit under the Cayman 2019 September Loan Agreement to $165,000 by repaying $135,000 of the loan to Lin Bioscience International Ltd. no later than April&#160;30, 2020; and (ii)&#160;terminated the Cayman 2019 July Loan Agreement subject to full repayment of the outstanding principal owed by us to Lin Bioscience International Ltd. no later than April&#160;30, 2020. On August&#160;14, 2020, we entered into a third confirmation deed with Lin Bioscience International Ltd., which terminated the Cayman 2019 September Loan Agreement, the first confirmation deed and the second confirmation deed subject to no facility amount under the Cayman 2019 September Loan Agreement, the first confirmation deed and the second confirmation deed draw down by us. As of the date of this prospectus, we have fully repaid the outstanding amount under the two loan agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2019 Loan Agreements between RBP4 Pty Ltd and Lin BioScience Pty Ltd</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On July&#160;10, 2019 and on December&#160;17, 2019, Lin BioScience Pty Ltd (the direct subsidiary of our ultimate controlling shareholder) entered into two intercompany loan agreements (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Australia 2019 July Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221; and the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Australia 2019 December Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221;, respectively) with RBP4 Pty Ltd (our wholly owned subsidiary). Pursuant to the Australia 2019 July Loan Agreement, Lin BioScience Pty Ltd agreed to provide an interest-free loan to us on request from time to time for a period of one year or any longer period as agreed by the parties commencing from July&#160;10, 2019 with a facility limit of AUD450,000 to assist with the conduct and/or facilitation by us of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. Pursuant to the Australia 2019 December Loan Agreement, Lin BioScience Pty Ltd agreed to provide an interest-free loan to us on request from time to time for a period of one year or any longer period as agreed by the parties commencing from December&#160;17, 2019 with a facility limit of AUD1,200,000 to assist with the conduct and/or facilitation by us of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. On January&#160;20, 2020, Lin BioScience Pty Ltd and RBP4 Pty Ltd entered into a confirmation deed, which (i)&#160;confirmed that the aggregate outstanding principal amount under the two loan agreements was AUD650,000; and (ii)&#160;terminated the two loan agreements subject to full repayment of the outstanding principal and all other amounts owed by RBP4 Pty Ltd to Lin BioScience Pty Ltd no later than January&#160;31, 2020. As of the date of this prospectus, RBP4 Pty Ltd has fully repaid the outstanding amount under the two loan agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2019 Loan Agreements between us and Lin BioScience, Inc</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On August&#160;12, 2019, Lin BioScience, Inc. (our ultimate controlling shareholder) entered into an intercompany debt funding agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Cayman 2019 August Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with us. Pursuant to the Cayman 2019 August Loan Agreement, Lin BioScience, Inc. agreed to provide a loan to us on request from time to time for a period of one year or any longer period as agreed by the parties commencing from August&#160;12, 2019 with a facility limit of $800,000 to assist with the conduct and/or facilitation by us of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. The loan bears an interest rate at the rate of 2.285% per annum. On April&#160;28, 2020, we entered into a confirmation deed with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">181</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:16pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lin BioScience, Inc., which (i)&#160;confirmed that the aggregate outstanding principal amount under the Cayman 2019 August Loan Agreement was $800,000; and (ii)&#160;reduced the facility limit to $450,000 by repaying $350,000 of the loan to Lin BioScience, Inc. no later than April&#160;30, 2020. As of the date of this prospectus, we have fully repaid the outstanding amount under the Cayman 2019 August Loan Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2019 Loan Agreements between RBP4 Pty Ltd and Lin BioScience, Inc</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On August&#160;12, 2019, Lin BioScience, Inc. (our ultimate controlling shareholder) entered into an intercompany debt funding agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Australia 2019 August Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with RBP4 Pty Ltd (our wholly owned subsidiary). Pursuant to the Australia 2019 August Loan Agreement, Lin BioScience, Inc. agreed to provide a loan to our Australian subsidiary on request from time to time for a period of one year or any longer period as agreed by the parties commencing from August&#160;12, 2019 with a facility limit of AUD1,000,000 to assist with the conduct and/or facilitation by us of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. The loan bears an interest rate at the rate of 2.285% per annum. On April&#160;28, 2020, RBP4 Pty Ltd and Lin BioScience, Inc. entered into a confirmation deed, which (i)&#160;confirmed that the aggregate outstanding principal amount under the Australia 2019 August Loan Agreement was AUD1,000,000; (ii)&#160;reduced the facility limit to AUD700,000 by repaying AUD300,000 of the loan to Lin BioScience, Inc. no later than May&#160;8, 2020, as well as the accrued interests. As of the date of this prospectus, we have fully repaid the outstanding amount under the Australia 2019 August Loan Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">2020 Loan Agreements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2020 Loan Agreement between RBP4 Pty Ltd and Lin BioScience Pty Ltd.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On January&#160;20, 2020, Lin BioScience Pty Ltd (the direct subsidiary of our ultimate controlling shareholder) entered into an intercompany loan agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2020 Lin Bio Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with RBP4 Pty Ltd (our wholly owned subsidiary), pursuant to which Lin BioScience Pty Ltd agreed to provide an interest-free loan to our Australian subsidiary on request from time to time for a period of one year or any longer period as agreed by the parties commencing from January&#160;20, 2020 with a facility limit of AUD190,000 to assist with the conduct and/or facilitation by our Australian subsidiary of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. On April&#160;28, 2020, Lin BioScience Pty Ltd and RBP4 Pty Ltd entered into a first confirmation deed which reduced the facility limit to AUD185,000. On August&#160;14, 2020, Lin BioScience Pty Ltd and RBP4 Pty Ltd entered into a second confirmation deed, which (i)&#160;confirmed that the outstanding principal amount was AUD185,000; and (ii)&#160;terminated the 2020 Lin Bio Loan Agreement and the first confirmation deed upon full repayment of the outstanding principal amount by RBP4 Pty Ltd no later than August&#160;21, 2020. As of the date of this prospectus, RBP4 Pty Ltd has fully repaid the outstanding amount under the 2020 Lin Bio Loan Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">2020 Loan Agreement between RBP4 Pty Ltd and Lin BioScience, Inc</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On January&#160;20, 2020, Lin BioScience, Inc. (our ultimate controlling shareholder) entered into an intercompany loan agreement (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">2020 Lin BioScience Loan Agreement</font><font style="letter-spacing:0.2pt;">&#8221;) with RBP4 Pty Ltd (our wholly owned subsidiary), pursuant to which Lin BioScience, Inc. agreed to provide a loan to our Australian subsidiary on request from time to time for a period of one year or any longer period as agreed by the parties commencing from January&#160;20, 2020 with a facility limit of AUD300,000 to assist with the conduct and/or facilitation by our Australian subsidiary of research and development in connection with clinical trials of LBS-008 or any other purpose approved by the lender in writing from time to time. The loan bears an interest rate at the lower of (i)&#160;the rate of 2.275% per annum; and (ii)&#160;the interest rate relating to &#8220;inbound loans&#8221; specified in PCG2017/2 issued by the Australian Taxation Office from time to time (being 2.33% per annum at the date of 2020 Lin BioScience Loan Agreement). On April&#160;28, 2020, RBP4 Pty Ltd and Lin BioScience, Inc. entered into a confirmation deed, which terminated the 2020 Lin BioScience Loan Agreement subject to no facility amount draw down by RBP4 Pty Ltd. As of the date of this prospectus, RBP4 Pty Ltd has fully repaid the outstanding amount under the 2020 Lin BioScience Loan Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">182</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDSC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SHARE CAPITAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a Cayman Islands exempted company incorporated with limited liability and our affairs are governed by our memorandum and articles of association, the Companies Act (As Revised) of the Cayman Islands, which we refer to as the Companies Act below, and the common law of the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, our authorized share capital is US$50,000 divided into 500,000,000 shares, comprising of (i)&#160;492,179,086 ordinary shares, par value US$0.0001 per share, and (ii)&#160;2,377,642 shares of series A preferred shares of a par value of US$0.0001 each and (iii)&#160;5,443,272 shares of series B preferred shares of a par value of US$0.0001 each. As of the date of this prospectus, 10,274,403 ordinary shares are issued and outstanding, 2,377,642 series A preferred shares are issued and outstanding and 5,443,272 series B preferred shares are issued and outstanding. All of our issued and outstanding ordinary and preferred shares are fully paid. All of our outstanding preferred shares will automatically convert into ordinary shares on a one-for-one basis upon the completion of this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to the completion of this offering, our authorized share capital will be changed into US$50,000 divided into 500,000,000 shares comprising of (i)&#160;400,000,000 ordinary shares of a par value of US$0.0001 each, and (ii)&#160;100,000,000 undesignated shares of a par value of US$0.0001 each of such class or classes (however designated) as the board of directors may determine in accordance with our post-offering memorandum and articles of association. Immediately after the completion of this offering, we will have 24,095,317&#160;ordinary shares issued and outstanding, assuming the underwriters do not exercise their option to purchase additional ADSs. All of our shares issued and outstanding prior to the completion of the offering are and will be fully paid, and all of our shares to be issued in the offering will be issued as fully paid. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our Post-Offering Memorandum and Articles of Association</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our shareholders have conditionally adopted a third amended and restated memorandum and articles of association, which will become effective and replace our current second amended and restated memorandum and articles of association in its entirety immediately prior to the completion of this offering. The following are summaries of material provisions of the post-offering memorandum and articles of association and of the Companies Act, insofar as they relate to the material terms of our ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Objects of Our Company</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under our post-offering memorandum and articles of association, the objects of our company are unrestricted, and we have the full power and authority to carry out any object not prohibited by the laws of the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ordinary Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Holders of our ordinary shares will have the same rights except for voting and conversion rights. Our ordinary shares are issued in registered form and are issued when registered in our register of members. We may not issue shares to bearer. Our shareholders who are non-residents of the Cayman Islands may freely hold and vote their shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our directors may from time to time declare dividends (including interim dividends) and other distributions on our shares in issue and authorize payment of the same out of the funds of our company lawfully available therefor. In addition, our shareholders may declare dividends by ordinary resolution, but no dividend may exceed the amount recommended by our directors. Our post-offering memorandum and articles of association provide that dividends may be declared and paid out of the funds of our Company lawfully available therefor. Under the laws of the Cayman Islands, our company may pay a dividend out of either profit or share premium account; and provided that in no circumstances may a dividend be paid if that would result in our company being unable to pay its debts as they fall due in the ordinary course of business immediately following the date on which the distribution or dividend is paid. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Voting Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Holders of our ordinary shares have the right to receive notice of, attend, speak and vote at general meetings of our company. Holders of ordinary shares shall, at all times, vote together as one class on all matters submitted to a vote by the members at any such general meeting. On all matters subject to a vote at general meetings of our company, (1)&#160;on a show of hands, each shareholder shall be entitled to one vote, whereas (2)&#160;on a poll, each shareholder shall be entitled to one vote per ordinary share. Our ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law. Voting at any meeting of shareholders shall be decided by way of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">183</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a poll save that the chairman of the meeting may, in good faith, allow a resolution which relates purely to a procedural or administrative matter to be voted on by a show of hands. Where a show of hands is allowed, before or on the declaration of the results of the show of hands, a poll may be demanded by the chairman of such meeting or any shareholder present in person or by proxy at the meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes of the ordinary shares which are cast by those of our shareholders who attend and vote at the meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the votes of the ordinary shares which are cast by those of our shareholders who attend and vote at the meeting. Under the Companies Act, a special resolution will be required in order for our company to effect certain important matters as stipulated in the Companies Act, such as a change of name or making changes to our post-offering memorandum and articles of association. Our shareholders may, among other things, divide or combine their shares by ordinary resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">General Meetings of Shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As a Cayman Islands exempted company, we are not obliged by the Companies Act to call shareholders&#8217; annual general meetings. Our post-offering memorandum and articles of association provide that we may (but are not obliged to, unless as required by applicable law or the Nasdaq Stock Market rules) in each year hold a general meeting as our annual general meeting in which case we will specify the meeting as such in the notices calling it, and the annual general meeting will be held at such time and place as may be determined by our directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Shareholders&#8217; general meetings may be convened by the chairman of our board of directors or a majority of our directors (acting by a resolution of our board). Advance notice of at least seven calendar days is required for the convening of our annual general shareholders&#8217; meeting (if any) and any other general meeting of our shareholders. A quorum required for any general meeting of shareholders consists of one or more of our shareholders holding shares which carry in aggregate (or representing by proxy) not less than one-third of all votes attaching to the issued and outstanding shares in our company entitled to vote at such general meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company&#8217;s articles of association. Our post-offering memorandum and articles of association provide that upon the requisition of any one or more of our shareholders holding shares which carry in aggregate not less than one-third of all votes attaching to all issued and outstanding shares of our company entitled to vote at general meetings, our board will be required to convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. However, our post-offering memorandum and articles of association do not provide our shareholders with any right to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transfer of Ordinary Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the restrictions set out below, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in the usual or common form or any other form approved by our board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors may also decline to register any transfer of any ordinary share unless: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the instrument of transfer is in respect of only one class of ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the instrument of transfer is properly stamped, if required; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a fee of such maximum sum as Nasdaq Stock Market may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">184</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If our directors refuse to register a transfer they must, within three calendar&#160;months after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The registration of transfers may, after compliance with any notice required of the Nasdaq Stock Market, be suspended and the register closed at such times and for such periods as our board of directors may from time to time determine; provided, however, that the registration of transfers may not be suspended nor the register closed for more than 30&#160;days in any year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Liquidation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On the winding up of our company, if the assets available for distribution amongst our shareholders will be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus will be distributed amongst our shareholders in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are monies due, of all monies payable to our company for unpaid calls or otherwise. If our assets available for distribution are insufficient to repay all of the paid-up capital, such assets will be distributed so that, as nearly as may be, the losses are borne by our shareholders in proportion to the par value of the shares held by them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Calls on Shares and Forfeiture of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their shares in a notice served to such shareholders at least 14 calendar days prior to the specified time and place of payment. The shares that have been called upon and remain unpaid are subject to forfeiture. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Redemption, Repurchase and Surrender of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We may issue shares on terms that such shares are subject to redemption, at our option or at the option of the holders of these shares, on such terms and in such manner as may be determined, before the issue of such shares, by our board of directors or by our shareholders by ordinary resolution. Our company may also redeem or repurchase any of our shares on such terms and in such manner as have been approved by our board of directors or by an ordinary resolution of our shareholders. Under the Companies Act, the redemption or repurchase of any share may be paid out of our Company&#8217;s profits or out of the proceeds of a new issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account and capital redemption reserve) if our company can, immediately following such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a)&#160;unless it is fully paid up, (b)&#160;if such redemption or repurchase would result in there being no shares outstanding or (c)&#160;if the company has commenced liquidation. In addition, our company may accept the surrender of any fully paid share for no consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Variation of Rights of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever the capital of our company is divided into different classes or series, the rights attached to any such class or series may, subject to any rights or restrictions for the time being attached to any class or series, only be materially adversely varied or abrogated with the consent in writing of the holders of not less than a majority of the issued shares of that class or with the sanction of an ordinary resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued will not, unless otherwise expressly provided by the terms of issue of the shares of that class, be deemed to be varied or abrogated by the creation, allotment, or issue of further shares ranking </font><font style="font-style:italic;letter-spacing:0.2pt;">pari&#160;passu</font><font style="letter-spacing:0.2pt;"> with or subsequent to such existing class of shares, or the redemption or purchase of any shares of any class by our company. The rights of the holders of shares shall not be deemed to be varied or abrogated by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Issuance of Additional Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our post-offering memorandum and articles of association authorize our board of directors to issue additional ordinary shares from time to time as our board of directors may determine, to the extent of available authorized but unissued shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our post-offering memorandum and articles of association also authorize our board of directors to establish from time to time one or more series of preferred shares and to determine, with respect to any series of preferred shares, the terms and rights of that series, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the designation of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">185</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares of the series; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the dividend rights, dividend rates, conversion rights, voting rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rights and terms of redemption and liquidation preferences; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any other powers, preferences and relative, participating, optional and other special rights. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors may issue preferred shares without action by our shareholders to the extent authorized but unissued. Issuance of these shares may dilute the voting power of holders of ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Inspection of Books and Records</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Holders of our ordinary shares will have no general right under Cayman Islands law to inspect or obtain copies of our list of shareholders or our corporate records (other than our memorandum and articles of association and our register of mortgages and charges). However, we intend to provide our shareholders with annual audited financial statements. See &#8220;Where You Can Find Additional Information.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Anti-Takeover Provisions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Some provisions of our post-offering memorandum and articles of association may discourage, delay or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">authorize our board of directors to issue preferred shares in one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without any further vote or action by our shareholders; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">limit the ability of shareholders to requisition and convene general meetings of shareholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our post-offering memorandum and articles of association for a proper purpose and for what they believe in good faith to be in the best interests of our company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Changes in Capital.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our shareholders may from time to time by ordinary resolution: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">increase our share capital by such sum, to be divided into shares of such classes and amount, as the resolution shall prescribe; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">consolidate and divide all or any of our share capital into shares of a larger amount than our existing shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">sub-divide our existing shares, or any of them into shares of a smaller amount, provided that in the subdivision the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is derived; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of our share capital by the amount of the shares so canceled. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our shareholders may by special resolution, subject to confirmation by the Grand Court of the Cayman Islands on an application by our company for an order confirming such reduction, reduce our share capital or any capital redemption reserve in any manner permitted by law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Exempted Company</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary company except that an exempted company: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">does not have to file an annual return of its shareholders with the Registrar of Companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">is not required to open its register of members for inspection; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">does not have to hold an annual general meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may issue negotiable or bearer shares or shares with no par value; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">186</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20&#160;years in the first instance); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may register as a limited duration company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may register as a segregated portfolio company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Limited liability&#8221; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Differences in Corporate Law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act is derived, to a large extent, from the older Companies Acts of England but does not follow recent English statutory enactments and, accordingly, there are significant differences between the Companies Act and the current Companies Act of England. In addition, the Companies Act differs from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of certain significant differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Mergers and Similar Arrangements</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (i)&#160;&#8220;merger&#8221; means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company, and (ii)&#160;a &#8220;consolidation&#8221; means the combination of two or more constituent companies into a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a)&#160;a special resolution of the shareholders of each constituent company, and (b)&#160;such other authorization, if any, as may be specified in such constituent company&#8217;s articles of association. The written plan of merger or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a declaration as to the solvency of the consolidated or surviving company, a list of the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the members and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders of that Cayman subsidiary if a copy of the plan of merger is given to every member of that Cayman subsidiary to be merged unless that member agrees otherwise. For this purpose a company is a &#8220;parent&#8221; of a subsidiary if it holds issued shares that together represent at least ninety&#160;percent (90%) of the votes at a general meeting of the subsidiary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The consent of each holder of a fixed or floating security interest over a constituent company is required unless this requirement is waived by a court in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Save in certain limited circumstances, a shareholder of a Cayman constituent company who dissents from the merger or consolidation is entitled to payment of the fair value of his shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) upon dissenting to a merger or consolidation, provide the dissenting shareholder complies strictly with the procedures set out in the Companies Act. The exercise of dissenter rights will preclude the exercise by the dissenting shareholder of any other rights to which he or she might otherwise be entitled by virtue of holding shares, save for the right to seek relief on the grounds that the merger or consolidation is void or unlawful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Separate from the statutory provisions relating to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate the reconstruction and amalgamation of companies by way of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">187</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">schemes of arrangement, provided that the arrangement is approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the statutory provisions as to the required majority vote have been met; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act also contains a statutory power of compulsory acquisition which may facilitate the &#8220;squeeze out&#8221; of dissentient minority shareholder upon a tender offer. When a tender offer is made and accepted by holders of 90.0% of the shares within four&#160;months, the offeror may, within a two-month period commencing on the expiration of such four month period, require the holders of the remaining shares to transfer such shares to the offeror on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an arrangement and reconstruction by way of scheme of arrangement is thus approved and sanctioned, or if a tender offer is made and accepted in accordance with the foregoing statutory procedures, a dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash for the judicially determined value of the shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholders&#8217; Suits.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, the Cayman Islands court can be expected to follow and apply the common law principles (namely the rule in Foss v. Harbottle and the exceptions thereto) so that a non-controlling shareholder may be permitted to commence a class action against or derivative actions in the name of the company to challenge actions where: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a company acts or proposes to act illegally or ultra vires; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">those who control the company are perpetrating a &#8220;fraud on the minority.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Indemnification of Directors and Executive Officers and Limitation of Liability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Cayman Islands law does not limit the extent to which a company&#8217;s memorandum and articles of association may provide for indemnification of directors and officers, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our post-offering memorandum and articles of association provide that we shall indemnify our directors and officers, against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such directors or officer, other than by reason of such person&#8217;s dishonesty, willful default or fraud, in or about the conduct of our company&#8217;s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">188</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation. In addition, we have entered into indemnification agreements with our directors and executive officers that provide such persons with additional indemnification beyond that provided in our post-offering amended and restated memorandum and articles of association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Directors&#8217; Fiduciary Duties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, the director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a matter of Cayman Islands law, a director of a Cayman Islands exempted company is in the position of a fiduciary with respect to the company and therefore it is considered that he owes the following duties to the company&#8201;&#8212;&#8201;a duty to act bona fide in the best interests of the company, a duty not to make a profit based on his position as director (unless the company permits him to do so), a duty not to put himself in a position where the interests of the company conflict with his personal interest or his duty to a third party, and a duty to exercise powers for the purpose for which such powers were intended. A director of a Cayman Islands exempted company owes to the company a duty to act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholder Action by Written Consent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation. Cayman Islands law and our post-offering memorandum and articles of association provide that shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held, and any such resolution in writing shall be as valid and effective as if the same had been passed at a general meeting of our company duly convened and held. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholder Proposals</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders; provided that it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">189</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">these rights may be provided in a company&#8217;s articles of association. Our post-offering memorandum and articles of association allow any one or more of our shareholders holding shares which carry in aggregate not less than one-third of the total number votes attaching to all issued and outstanding shares of our company as of the date of the deposit that are entitled to vote at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition a shareholders&#8217; meeting, our post-offering memorandum and articles of association do not provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings. As a Cayman Islands exempted company, we are not obliged by law to call shareholders&#8217; annual general meetings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Cumulative Voting</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder&#8217;s voting power with respect to electing such director. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There are no prohibitions in relation to cumulative voting under the laws of the Cayman Islands, but our post-offering memorandum and articles of association do not provide for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Removal of Directors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the issued and outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our post-offering memorandum and articles of association, directors may be removed by an ordinary resolution of our shareholders. A director&#8217;s office shall be vacated if the director (i)&#160;becomes bankrupt or makes any arrangement or composition with his creditors; (ii)&#160;dies or is found to be or becomes of unsound mind; (iii)&#160;resigns his office by notice in writing; (iv) is prohibited by any applicable law or the Nasdaq Stock Market rules; (v)&#160;without special leave of absence from our board, is absent from meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (vi)&#160;is removed from office pursuant to any other provision of our post-offering memorandum and articles of association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transactions with Interested Shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law contains a business combination statute applicable to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an &#8220;interested shareholder&#8221; for three&#160;years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or a group who or which owns or owned 15% or more of the target&#8217;s outstanding voting shares within the past three&#160;years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms of any acquisition transaction with the target&#8217;s board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cayman Islands law has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders, it does provide that such transactions must be entered into bona fide in the best interests of the company and not with the effect of constituting a fraud on the minority shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dissolution; Winding up</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation&#8217;s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by either an order of the courts of the Cayman Islands or by the board of directors. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">190</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so. Under the Companies Act, our company may be dissolved, liquidated or wound up by a special resolution of our shareholders, or, if we are unable to pay our debts as they fall due, by an ordinary resolution of our shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Variation of Rights of Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our post-offering memorandum and articles of association, if our share capital is divided into more than one class of shares, the rights attached to any such class may only be materially adversely varied or abrogated with the consent in writing of the holders of not less than a majority of the issued shares of that class or with the sanction of an ordinary resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders of the shares of any class issued with preferred or other rights shall not, subject to any rights or restrictions for the time being attached to the shares of that class, be deemed to be materially adversely varied or abrogated by the creation, allotment or issue of further shares ranking </font><font style="font-style:italic;letter-spacing:0.2pt;">pari&#160;passu</font><font style="letter-spacing:0.2pt;"> with or subsequent to them or the redemption or purchase of any shares of any class by our company. The rights of the holders of shares shall not be deemed to be materially adversely varied or abrogated by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Amendment of Governing Documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation&#8217;s governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under the Companies Act and our post-offering memorandum and articles of association, our memorandum and articles of association may only be amended by a special resolution of our shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Rights of Non-resident or Foreign Shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;There are no limitations imposed by our post-offering memorandum and articles of association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our post-offering memorandum and articles of association that require our company to disclose shareholder ownership above any particular ownership threshold. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">History of Securities Issuances</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of changes in our share capital in the past three&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ordinary shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;27, 2018, we issued 1 ordinary share to Mapcal Limited, which was transferred to Lin Bioscience International Ltd. on March&#160;27, 2018. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We issued to Lin Bioscience International Ltd. (i)&#160;99 ordinary shares for consideration of $99.9999 on April&#160;13, 2018; (ii)&#160;5,340,221 ordinary shares for consideration of $900,000 plus assignment of the rights, title, interests and obligations of Lin Bioscience International Ltd. under the exclusive license agreement by and between Lin Bioscience International Ltd. and Columbia University and the transfer of 1,600 shares of Belite Bio Holdings Corp. (formerly known as Lin BioScience Holdings Corporation) on July&#160;2, 2018; (iii)&#160;2,500,000 ordinary shares for consideration of $2,500,000 on August&#160;8, 2018; and (iv)&#160;1,000,000 ordinary shares for consideration of $1,000,000 on January&#160;20, 2020. Lin Bioscience International Ltd. is wholly owned by Lin BioScience, Inc., our ultimate controlling shareholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;31, 2020, we issued 727,676 ordinary shares to the optionees for the options exercised. Specifically, we issued: (i)&#160;367,515 ordinary shares to Yu-Hsin Lin, our Founder, Chief Executive Officer and Chairman of the Board of Directors; (ii)&#160;257,260 ordinary shares to Hao-Yuan Chuang, our Chief Financial Officer; (iii)&#160;36,751 ordinary shares to Hung-Wei Chen; (iv)&#160;22,050 ordinary shares to Wan-Shan </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">191</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Chen; (v)&#160;22,050 ordinary shares to Ming-Chiu Wu; and (vi)&#160;22,050 ordinary shares to Yun-Ju Huang, in their exercise of options granted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December 31, 2021, we issued 706,406 ordinary shares to the optionees for the options exercised. Specifically, we issued: (i) 364,213 ordinary shares to Yu-Hsin Lin, our Founder, Chief Executive Officer and Chairman of the Board of Directors; (ii) 254,950 ordinary shares to Hao-Yuan Chuang, our Chief Financial Officer; (iii) 21,684 ordinary shares to Hung-Wei Chen; (iv) 23,463 ordinary shares to Wan-Shan Chen; (v) 20,243 ordinary shares to Ming-Chiu Wu; and (vi) 21,853 ordinary shares to Yun-Ju Huang, in their exercise of options granted.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;31, 2020, we closed a private placement transaction pursuant to which we sold an aggregate of 1,296,963 Series&#160;A Preferred Shares for an aggregate consideration of $2,789,600 in cash and conversion of two convertible promissory notes in the principal amount of $1,000,000 each. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;14, 2020, we issued a total of 1,080,679 Series&#160;A Preferred Shares in connection with the second closing of the private placement transaction described above for an aggregate consideration of $4,002,400 in cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;24, 2020, we closed a private placement transaction pursuant to which we sold an aggregate of 5,443,272 Series&#160;B Preferred Shares for an aggregate consideration of $23,000,000 in cash. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Convertible Promissory Note</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;22, 2019, we issued a convertible promissory note with the principal amount of US$1,000,000 with simple interest of 2.5% per annum to each of H&amp;D Asset Management Co., Ltd. and Yun-Ju Huang. Pursuant to the note purchase agreement, the entire convertible promissory notes may be converted, at the option of the note holder, in to the type of equity securities issued in the next equity financing. On January&#160;31, 2020, in conjunction with the first closing of Series&#160;A financing, the principal amount and the accrued but unpaid interests (in the total amount of US$13,835.62) under both convertible promissory notes were converted into Series&#160;A Preferred Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have granted options to purchase our ordinary shares to certain of our officers (whether or not a director) or our employees or any of our Affiliates, any member of the Board, or any director of one of our Affiliates, or any eligible individual consultant or advisor. See &#8220;Management&#8201;&#8212;&#8201;Share Incentive Plans&#8221;. </font>
        </div>
        <table style="width:456pt;height:140.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:186.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Securities/Purchaser </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of Issuance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:120pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Securities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:186.25pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Options</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:81.04pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:120pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:186.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Certain directors, officers and employees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;17, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;text-align:justify;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Option to purchase up to 1,335,794 ordinary shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.1191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:186.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Certain directors, officers and employees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:81.04pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;23, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;text-align:justify;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Option to purchase up to 2,807,381 ordinary shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:186.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Certain key consultants </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">March&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;white-space:normal;text-align:justify;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Option to purchase up to 41,736 ordinary shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4.2254</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:186.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Certain directors, officers and employees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:81.04pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April 18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;text-align:justify;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Option to purchase up to 1,698,667 ordinary shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">6.00<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font></font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">#</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Our Board approved the option grant on April 18, 2022, which is conditional upon and becomes effective on the date on which this registration statement is declared effective by the United States Securities and Exchange Commission.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.21pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This exercise price applies to all options granted on December&#160;23, 2020 except for an option to purchase 6,267 ordinary shares granted to an employee in the US which has an exercise price of $2.69 per share. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">192</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The exercise price applies to all options granted on April&#160;18, 2022 shall be the final offer price of the offering. The US$6.00 exercise price disclosed above, being the midpoint of the estimated range of the initial public offering price, is for indication only.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amended and Restated Shareholders Agreement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with our issuance of Series&#160;B Preferred Shares, we entered into an amended and restated shareholders agreement with the holders of our preferred shares and Lin Bioscience International Ltd. in December&#160;2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The amended and restated shareholders agreement provides for certain special rights, including right of first refusal, co-sale rights, preemptive rights, registration rights and contains provisions governing the board of directors and other corporate governance matters. Unless specifically noted, below those special rights attached to our preferred shares, and shares of Lin Bioscience International Ltd. as well as the corporate governance provisions, will automatically terminate upon the completion of this offering. Each series of our preferred shares will be automatically converted to ordinary shares on a one-for-one basis immediately prior to the completion of this offering. For additional details on the effect of the automatic conversion and the related conversion ratio, see &#8220;Dilution,&#8221; &#8220;Capitalization&#8221; and &#8220;Principal Shareholders.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to our amended and restated shareholders agreement, we have granted certain registration rights to our shareholders that are signatory thereto on the ordinary shares owned by those shareholders or their transferees. Set forth below is a description of the registration rights granted under the agreement, which shall continue to apply following this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Demand Registration Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;At any time after six&#160;months following the effectiveness of a registration statement for the initial public offering of our securities, the holders of at least 25% of the voting power of the registrable securities then issued and outstanding may request in writing that we file a registration statement covering the registration of at least 10% of the registrable securities then outstanding on any internationally recognized exchange that is reasonably acceptable to such requesting holders; provided that the aggregate proceeds from the offering that is the subject of the registration exceeds US$50,000,000. Upon such a request, we shall, promptly give written notice of such request to all holders, and use our commercially reasonable efforts to cause the registration of all registrable securities that the holders request to be registered and included in such registration by written notice given by such holders to us within 15&#160;days after our delivery of written notice to be registered and/or qualified for sale and distribution in such jurisdiction as the initiating holders may request. This demand registration right is subject to a customary exclusion right of underwriters. We are obligated to consummate no more than three (3)&#160;registrations that have been declared and ordered effective pursuant to such request. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Registration on Form F-3</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If Form F-3 is available for an offering by holders, the holders of at least 10% of the voting power of the registrable securities then issued and outstanding may request in writing that we effect a registration on Form F-3; provided that the aggregate proceeds from the offering that is the subject of the registration exceeds US$50,000,000. We shall promptly give written notice of the proposed registration and as soon as practicable, use our commercially reasonable efforts to cause all or such portion of such holder&#8217;s or holders&#8217; registrable securities as are specified in such request, together with all or such portion of the registrable securities of any other holder or holders joining in such request as are specified in a written request by such other holder or holders given within 15&#160;days after our delivery of written notice to be registered and qualified for sale and distribution in such jurisdiction. We are obligated to consummate no more than two (2)&#160;registrations that have been declared and ordered effective within any twelve (12)-month period preceding the date of such request. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have the right to defer filing of a registration statement on Form F-3 or a demand registration under certain circumstances. For example, we shall not be obligated to register or qualify registrable securities if in any jurisdiction in which we would be required to execute a general consent to service of process in effecting such registration or qualification, unless we are already subject to service of process in such jurisdiction. If in the good faith judgment of the Board, it would be materially detrimental to us or our members for a registration statement to be filed in the near future, then we shall have the right to defer such filing for a period during which such filing would be materially detrimental, provided, that we may not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">193</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:256pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">utilize this right for more than ninety (90) days on any one occasion or more than once during any twelve (12) month period; provided, further, that we may not register any other its securities during such period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Piggyback Registration Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If we propose to register for a public offering of our securities (other than registration statements relating to any employee benefit plan or a corporate reorganization or certain other exempted situations), we shall promptly give written notice of such registration to all holders of registrable securities and afford each such holder an opportunity to include in such registration all or any part of the registerable securities then held by such holder. If a holder decides not to include all of its registrable securities in any registration statement thereafter filed by us, such holder shall nevertheless continue to have the right to include any registrable securities in any applicable subsequent registration statement or registration statements as may be filed by us, subject to certain limitations. This piggyback registration right is subject to a customary exclusion right of underwriters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Expenses of Registration</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to certain exceptions, we will bear all registration expenses. Each holder, however, shall bear its proportionate share of all of the underwriting discounts and selling commissions applicable to the sale of registrable securities or other amounts payable to underwriter(s) or brokers in connection with such offering by the holders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Termination of Obligations</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our obligations to effect any demand, Form F-3 or piggyback registration shall terminate upon the earlier of (i)&#160;the date that is 5&#160;years from the date of closing of a firm commitment underwritten public offering of our Ordinary Shares (or depositary receipts or depositary shares therefor) in the United States pursuant to an effective registration statement under the United States Securities Act of 1933, as amended, with an offering price (net of underwriting commissions and expenses) that implies a market capitalization of our Company immediately prior to such offering of not less than US$120,000,000 and that results in gross proceeds to our Company of at least US$30,000,000, or in a public offering of our Ordinary Shares (or depositary receipts or depositary shares therefor) in another jurisdiction which results in the Ordinary Shares trading publicly on a recognized international securities exchange approved by the holders of at least a majority of the voting power of the issued and outstanding Series&#160;A Preferred Shares and Series&#160;B Preferred Shares (voting together as a single class and on an as converted basis), so long as such offering satisfies the foregoing market capitalization and gross proceeds requirements, and (ii)&#160;with respect to any holder, the date on which such holder may sell all of such holder&#8217;s registrable securities under Rule&#160;144 of the Securities Act in any ninety (90)-day period. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">194</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deutsche Bank Trust Company Americas, as depositary, will register and deliver the ADSs. Each ADS will represent ownership of 1 share, deposited with Deutsche Bank AG, Hong Kong Branch, as custodian for the depositary. Each ADS will also represent ownership of any other securities, cash or other property which may be held by the depositary. The depositary&#8217;s corporate trust office at which the ADSs will be administered is located at 1 Columbus Circle, New York, NY 10019, USA. The principal executive office of the depositary is located at 1 Columbus Circle, New York, NY 10019, USA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Direct Registration System, or DRS, is a system administered by The Depository Trust Company, or DTC, pursuant to which the depositary may register the ownership of uncertificated ADSs, which ownership shall be evidenced by periodic statements issued by the depositary to the ADS holders entitled thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will not treat ADS holders as our shareholders and accordingly, you, as an ADS holder, will not have shareholder rights. Cayman Islands law governs shareholder rights. The depositary will be the holder of the ordinary shares underlying your ADSs. As a holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary and you, as an ADS holder, and the beneficial owners of ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. The laws of the State of New York govern the deposit agreement and the ADSs. See &#8220;&#8212; </font><font style="font-style:italic;letter-spacing:0.2pt;">Jurisdiction and Arbitration</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of American Depositary Receipt. For directions on how to obtain copies of those documents, see &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Where You Can Find Additional Information</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Holding the ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How will you hold your ADSs?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may hold ADSs either (1)&#160;directly (a)&#160;by having an American Depositary Receipt, or ADR, which is a certificate evidencing a specific number of ADSs, registered in your name, or (b)&#160;by holding ADSs in DRS, or (2)&#160;indirectly through your broker or other financial institution. If you hold ADSs directly, you are an ADS holder. This description assumes you hold your ADSs directly. ADSs will be issued through DRS, unless you specifically request certificated ADRs. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends and Other Distributions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How will you receive dividends and other distributions on the shares?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary has agreed to pay to you the cash dividends or other distributions it or the custodian receives on ordinary shares or other deposited securities, after deducting its fees and expenses. You will receive these distributions in proportion to the number of ordinary shares your ADSs represent as of the record date (which will be as close as practicable to the record date for our ordinary shares) set by the depositary with respect to the ADSs. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cash.</font><font style="letter-spacing:0.2pt;"> The depositary will convert or cause to be converted any cash dividend or other cash distribution we pay on the ordinary shares or any net proceeds from the sale of any ordinary shares, rights, securities or other entitlements under the terms of the deposit agreement into U.S. dollars if it can do so on a practicable basis, and can transfer the U.S. dollars to the United States and will distribute promptly the amount thus received. If the depositary shall determine in its judgment that such conversions or transfers are not practical or lawful or if any government approval or license is needed and cannot be obtained at a reasonable cost within a reasonable period or otherwise sought, the deposit agreement allows the depositary to distribute the foreign currency only to those ADS holders </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">195</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">to whom it is possible to do so. It will hold or cause the custodian to hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid and such funds will be held for the respective accounts of the ADS holders. It will not invest the foreign currency and it will not be liable for any interest for the respective accounts of the ADS holders. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Before making a distribution, any taxes or other governmental charges, together with fees and expenses of the depositary, that must be paid, will be deducted. See &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Taxation</font><font style="letter-spacing:0.2pt;">.&#8221; It will distribute only whole U.S. dollars and cents and will round down fractional cents to the nearest whole cent. </font><font style="font-style:italic;letter-spacing:0.2pt;">If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Shares.</font><font style="letter-spacing:0.2pt;"> For any ordinary shares we distribute as a dividend or free distribution, either (1)&#160;the depositary will distribute additional ADSs representing such ordinary shares or (2)&#160;existing ADSs as of the applicable record date will represent rights and interests in the additional ordinary shares distributed, to the extent reasonably practicable and permissible under law, in either case, net of applicable fees, charges and expenses incurred by the depositary and taxes and/or other governmental charges. The depositary will only distribute whole ADSs. It will try to sell ordinary shares which would require it to deliver a fractional ADS and distribute the net proceeds in the same way as it does with cash. The depositary may sell a portion of the distributed ordinary shares sufficient to pay its fees and expenses, and any taxes and governmental charges, in connection with that distribution. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Elective Distributions in Cash or Shares.</font><font style="letter-spacing:0.2pt;"> If we offer holders of our ordinary shares the option to receive dividends in either cash or shares, the depositary, after consultation with us and having received timely notice as described in the deposit agreement of such elective distribution by us, has discretion to determine to what extent such elective distribution will be made available to you as a holder of the ADSs. We must timely first instruct the depositary to make such elective distribution available to you and furnish it with satisfactory evidence that it is legal to do so. The depositary could decide it is not legal or reasonably practicable to make such elective distribution available to you. In such case, the depositary shall, on the basis of the same determination as is made in respect of the ordinary shares for which no election is made, distribute either cash in the same way as it does in a cash distribution, or additional ADSs representing ordinary shares in the same way as it does in a share distribution. The depositary is not obligated to make available to you a method to receive the elective dividend in shares rather than in ADSs. There can be no assurance that you will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of ordinary shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights to Purchase Additional Shares.</font><font style="letter-spacing:0.2pt;"> If we offer holders of our ordinary shares any rights to subscribe for additional shares, the depositary shall having received timely notice as described in the deposit agreement of such distribution by us, consult with us, and we must determine whether it is lawful and reasonably practicable to make these rights available to you. We must first instruct the depositary to make such rights available to you and furnish the depositary with satisfactory evidence that it is legal to do so. If the depositary decides it is not legal or reasonably practicable to make the rights available but that it is lawful and reasonably practicable to sell the rights, the depositary will endeavor to sell the rights and in a riskless principal capacity or otherwise, at such place and upon such terms (including public or private sale) as it may deem proper distribute the net proceeds in the same way as it does with cash. The depositary will allow rights that are not distributed or sold to lapse. In that case, you will receive no value for them. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:30pt; margin-top:8pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the depositary makes rights available to you, it will establish procedures to distribute such rights and enable you to exercise the rights upon your payment of applicable fees, charges and expenses incurred by the depositary and taxes and/or other governmental charges. The Depositary shall not be obliged to make available to you a method to exercise such rights to subscribe for ordinary shares (rather than ADSs). </font>
        </div>
        <div style="margin-left:30pt; margin-top:8pt; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">U.S. securities laws may restrict transfers and cancellation of the ADSs represented by shares purchased upon exercise of rights. For example, you may not be able to trade these ADSs freely in the United States. In this case, the depositary may deliver restricted depositary shares that have the same terms as the ADSs described in this section except for changes needed to put the necessary restrictions in place. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">196</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that you will be given the opportunity to exercise rights on the same terms and conditions as the holders of ordinary shares or be able to exercise such rights. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Distributions.</font><font style="letter-spacing:0.2pt;"> Subject to receipt of timely notice, as described in the deposit agreement, from us with the request to make any such distribution available to you, and provided the depositary has determined such distribution is lawful and reasonably practicable and feasible and in accordance with the terms of the deposit agreement, the depositary will distribute to you anything else we distribute on deposited securities by any means it may deem practicable, upon your payment of applicable fees, charges and expenses incurred by the depositary and taxes and/or other governmental charges. If any of the conditions above are not met, the depositary will endeavor to sell, or cause to be sold, what we distributed and distribute the net proceeds in the same way as it does with cash; or, if it is unable to sell such property, the depositary may dispose of such property in any way it deems reasonably practicable under the circumstances for nominal or no consideration, such that you may have no rights to or arising from such property. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the distributions we make on our shares or any value for them if we and/or the depositary determines that it is illegal or not practicable for us or the depositary to make them available to you. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deposit, Withdrawal and Cancellation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How are ADSs issued?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will deliver ADSs if you or your broker deposit ordinary shares or evidence of rights to receive ordinary shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons entitled thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except for ordinary shares deposited by us in connection with this offering, no shares will be accepted for deposit during a period of 180&#160;days after the date of this prospectus. The 180 day lock up period is subject to adjustment under certain circumstances as described in the section entitled &#8220;</font><font style="font-style:italic;letter-spacing:0.2pt;">Shares Eligible for Future Sales&#8201;&#8212;&#8201;Lock-up Agreements</font><font style="letter-spacing:0.2pt;">.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do ADS holders cancel an American Depositary Share?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may turn in your ADSs at the depositary&#8217;s corporate trust office or by providing appropriate instructions to your broker. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the ordinary shares and any other deposited securities underlying the ADSs to you or a person you designate at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its corporate trust office, to the extent permitted by law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do ADS holders interchange between Certificated ADSs and Uncertificated ADSs?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send you a statement confirming that you are the owner of uncertificated ADSs. Alternatively, upon receipt by the depositary of a proper instruction from a holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to you an ADR evidencing those ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do you vote?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may instruct the depositary to vote the ordinary shares or other deposited securities underlying your ADSs at any meeting at which you are entitled to vote pursuant to any applicable law, the provisions of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">197</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">our memorandum and articles of association, and the provisions of or governing the deposited securities. </font><font style="font-style:italic;letter-spacing:0.2pt;">Otherwise, you could exercise your right to vote directly if you withdraw the ordinary shares. However, you may not know about the meeting sufficiently enough in advance to withdraw the ordinary shares.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we ask for your instructions and upon timely notice from us by regular, ordinary mail delivery, or by electronic transmission, as described in the deposit agreement, the depositary will notify you of the upcoming meeting at which you are entitled to vote pursuant to any applicable law, the provisions of our memorandum and articles of association, and the provisions of or governing the deposited securities, and arrange to deliver our voting materials to you. The materials will include or reproduce (a)&#160;such notice of meeting or solicitation of consents or proxies; (b)&#160;a statement that the ADS holders at the close of business on the ADS record date will be entitled, subject to any applicable law, the provisions of our memorandum and articles of association, and the provisions of or governing the deposited securities, to instruct the depositary as to the exercise of the voting rights, if any, pertaining to the ordinary shares or other deposited securities represented by such holder&#8217;s ADSs; and (c)&#160;a brief statement as to the manner in which such instructions may be given to the depositary or deemed given in accordance with the second to last sentence of this paragraph if no instruction is received by the depositary to give a discretionary proxy to a person designated by us. Voting instructions may be given only in respect of a number of ADSs representing an integral number of ordinary shares or other deposited securities. For instructions to be valid, the depositary must receive them in writing on or before the date specified. The depositary will try, as far as practical, subject to applicable law and the provisions of our memorandum and articles of association, to vote or to have its agents vote the ordinary shares or other deposited securities (in person or by proxy) as you instruct. The depositary will only vote or attempt to vote as you instruct. If we timely requested the depositary to solicit your instructions but no instructions are received by the depositary from an owner with respect to any of the deposited securities represented by the ADSs of that owner on or before the date established by the depositary for such purpose, the depositary shall deem that owner to have instructed the depositary to give a discretionary proxy to a person designated by us with respect to such deposited securities, and the depositary shall give a discretionary proxy to a person designated by us to vote such deposited securities. However, no such instruction shall be deemed given and no such discretionary proxy shall be given with respect to any matter if we inform the depositary we do not wish such proxy given, substantial opposition exists or the matter materially and adversely affects the rights of holders of the ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote the ordinary shares underlying your ADSs. In addition, there can be no assurance that ADS holders and beneficial owners generally, or any holder or beneficial owner in particular, will be given the opportunity to vote or cause the custodian to vote on the same terms and conditions as the holders of our ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. </font><font style="font-style:italic;letter-spacing:0.2pt;">This means that you may not be able to exercise your right to vote and you may have no recourse if the ordinary shares underlying your ADSs are not voted as you requested.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited securities, if we request the depositary to act, we will give the depositary notice of any such meeting and details concerning the matters to be voted at least 30 business days in advance of the meeting date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compliance with Regulations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Information Requests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each ADS holder and beneficial owner shall (a)&#160;provide such information as we or the depositary may request pursuant to law, including, without limitation, relevant Cayman Islands law, any applicable law of the United States of America, our memorandum and articles of association, any resolutions of our Board of Directors adopted pursuant to such memorandum and articles of association, the requirements of any markets or exchanges upon which the ordinary shares, ADSs or ADRs are listed or traded, or to any requirements of any electronic book-entry system by which the ADSs or ADRs may be transferred, regarding the capacity in which they own or owned ADRs, the identity of any other persons then or previously interested in such ADRs and the nature of such interest, and any other applicable matters, and (b)&#160;be bound </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">198</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">by and subject to applicable provisions of the laws of the Cayman Islands, our memorandum and articles of association, and the requirements of any markets or exchanges upon which the ADSs, ADRs or ordinary shares are listed or traded, or pursuant to any requirements of any electronic book-entry system by which the ADSs, ADRs or ordinary shares may be transferred, to the same extent as if such ADS holder or beneficial owner held ordinary shares directly, in each case irrespective of whether or not they are ADS holders or beneficial owners at the time such request is made. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disclosure of Interests</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each ADS holder and beneficial owner shall comply with our requests pursuant to Cayman Islands law, the rules and requirements of the Nasdaq Stock Market and any other stock exchange on which the ordinary shares are, or will be, registered, traded or listed or our memorandum and articles of association, which requests are made to provide information, inter alia, as to the capacity in which such ADS holder or beneficial owner owns ADS and regarding the identity of any other person interested in such ADS and the nature of such interest and various other matters, whether or not they are ADS holders or beneficial owners at the time of such requests. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fees and Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As an ADS holder, you will be required to pay the following service fees to the depositary bank and certain taxes and governmental charges (in addition to any applicable fees, expenses, taxes and other governmental charges payable on the deposited securities represented by any of your ADSs): </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Service </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Fees </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">&#8226; To any person to which ADSs are issued or to any person to which a distribution is made in respect of ADS distributions pursuant to stock dividends or other free distributions of stock, bonus distributions, stock splits or other distributions (except where converted to cash) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:222pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS issued </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">&#8226; Cancellation of ADSs, including the case of termination of the deposit agreement </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS cancelled </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">&#8226; Distribution of cash dividends </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">&#8226; Distribution of cash entitlements (other than cash dividends) and/or cash proceeds from the sale of rights, securities and other entitlements </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">&#8226; Distribution of ADSs pursuant to exercise of rights. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">&#8226; Distribution of securities other than ADSs or rights to purchase additional ADSs </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">&#8226; Depositary services </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Up to US$0.05 per ADS held on the applicable record date(s) established by the depositary bank</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As an ADS holder, you will also be responsible for paying certain fees and expenses incurred by the depositary bank and certain taxes and governmental charges (in addition to any applicable fees, expenses, taxes and other governmental charges payable on the deposited securities represented by any of your ADSs) such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Fees for the transfer and registration of ordinary shares charged by the registrar and transfer agent for the ordinary shares in the Cayman Islands (i.e., upon deposit and withdrawal of ordinary shares). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Expenses incurred for converting foreign currency into U.S. dollars. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Expenses for cable, telex and fax transmissions and for delivery of securities.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Taxes and duties upon the transfer of securities, including any applicable stamp duties, any stock transfer charges or withholding taxes (i.e., when ordinary shares are deposited or withdrawn from deposit).</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">199</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:46.55pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Fees and expenses incurred in connection with the delivery or servicing of ordinary shares on deposit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Fees and expenses incurred in connection with complying with exchange control regulations and other regulatory requirements applicable to ordinary shares, deposited securities, ADSs and ADRs.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Any applicable fees and penalties thereon.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary fees payable upon the issuance and cancellation of ADSs are typically paid to the depositary bank by the brokers (on behalf of their clients) receiving the newly issued ADSs from the depositary bank and by the brokers (on behalf of their clients) delivering the ADSs to the depositary bank for cancellation. The brokers in turn charge these fees to their clients. Depositary fees payable in connection with distributions of cash or securities to ADS holders and the depositary services fee are charged by the depositary bank to the holders of record of ADSs as of the applicable ADS record date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary fees payable for cash distributions are generally deducted from the cash being distributed or by selling a portion of distributable property to pay the fees. In the case of distributions other than cash (i.e., share dividends, rights), the depositary bank charges the applicable fee to the ADS record date holders concurrent with the distribution. In the case of ADSs registered in the name of the investor (whether certificated or uncertificated in direct registration), the depositary bank sends invoices to the applicable record date ADS holders. In the case of ADSs held in brokerage and custodian accounts (via DTC), the depositary bank generally collects its fees through the systems provided by DTC (whose nominee is the registered holder of the ADSs held in DTC) from the brokers and custodians holding ADSs in their DTC accounts. The brokers and custodians who hold their clients&#8217; ADSs in DTC accounts in turn charge their clients&#8217; accounts the amount of the fees paid to the depositary banks. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In the event of refusal to pay the depositary fees, the depositary bank may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary fees from any distribution to be made to the ADS holder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary may make payments to us or reimburse us for certain costs and expenses, by making available a portion of the ADS fees collected in respect of the ADR program or otherwise, upon such terms and conditions as we and the depositary bank agree from time to time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Payment of Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">You will be responsible for any taxes or other governmental charges payable, or which become payable, on your ADSs or on the deposited securities represented by any of your ADSs. The depositary may refuse to register or transfer your ADSs or allow you to withdraw the deposited securities represented by your ADSs until such taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to you any net proceeds, or send to you any property, remaining after it has paid the taxes. You agree to indemnify us, the depositary, the custodian and each of our and their respective agents, directors, employees and affiliates for, and hold each of them harmless from, any claims with respect to taxes (including applicable interest and penalties thereon) arising from any refund of taxes, reduced rate of withholding at source or other tax benefit obtained for you. Your obligations under this paragraph shall survive any transfer of ADRs, any surrender of ADRs and withdrawal of deposited securities or the termination of the deposit agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">200</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reclassifications, Recapitalizations and Mergers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">If we: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Then: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Change the nominal or par value of our ordinary shares </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The cash, shares or other securities received by the depositary will become deposited securities. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Reclassify, split up or consolidate any of the deposited securities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Each ADS will automatically represent its equal share of the new deposited securities. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Distribute securities on the ordinary shares that are not distributed to you, or</font>
              <br >
              <font style="letter-spacing:0.2pt;">Recapitalize, reorganize, merge, liquidate, sell all or substantially all of our assets, or take any similar action </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The depositary may distribute some or all of the cash, shares or other securities it received. It may also deliver new ADSs or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendment and Termination</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be amended?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may agree with the depositary to amend the deposit agreement and the form of ADR without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, including expenses incurred in connection with foreign exchange control regulations and other charges specifically payable by ADS holders under the deposit agreement, or materially prejudices a substantial existing right of ADS holders, it will not become effective for outstanding ADSs until 30&#160;days after the depositary notifies ADS holders of the amendment. </font><font style="font-style:italic;letter-spacing:0.2pt;">At the time an amendment becomes effective, you are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended</font><font style="letter-spacing:0.2pt;">. If any new laws are adopted which would require the deposit agreement to be amended in order to comply therewith, we and the depositary may amend the deposit agreement in accordance with such laws and such amendment may become effective before notice thereof is given to ADS holders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be terminated?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will terminate the deposit agreement if we ask it to do so, in which case the depositary will give notice to you at least 90&#160;days prior to termination. The depositary may also terminate the deposit agreement if the depositary has told us that it would like to resign, or if we have removed the depositary, and in either case we have not appointed a new depositary within 90&#160;days. In either such case, the depositary must notify you at least 30&#160;days before termination. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After termination, the depositary and its agents will do the following under the deposit agreement but nothing else: collect distributions on the deposited securities, sell rights and other property and deliver ordinary shares and other deposited securities upon cancellation of ADSs after payment of any fees, charges, taxes or other governmental charges. Six&#160;months or more after the date of termination, the depositary may sell any remaining deposited securities by public or private sale. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, for the </font><font style="font-style:italic;letter-spacing:0.2pt;">pro&#160;rata</font><font style="letter-spacing:0.2pt;"> benefit of the ADS holders that have not surrendered their ADSs. It will not invest the money and has no liability for interest. After such sale, the depositary&#8217;s only obligations will be to account for the money and other cash. After termination, we shall be discharged from all obligations under the deposit agreement except for our obligations to the depositary thereunder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Books of Depositary</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will maintain ADS holder records at its depositary office. You may inspect such records at such office during regular business hours but solely for the purpose of communicating with other holders in the interest of business matters relating to the Company, the ADRs and the deposit agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary will maintain facilities in the Borough of Manhattan, The City of New York to record and process the issuance, cancellation, combination, split-up and transfer of ADRs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">201</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These facilities may be closed at any time or from time to time when such action is deemed necessary or advisable by the depositary in connection with the performance of its duties under the deposit agreement or at our reasonable written request. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitations on Obligations and Liability</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limits on our Obligations and the Obligations of the Depositary and the Custodian; Limits on Liability to Holders of ADSs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement expressly limits our obligations and the obligations of the depositary and the custodian. It also limits our liability and the liability of the depositary. The depositary and the custodian: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are only obligated to take the actions specifically set forth in the deposit agreement without gross negligence or willful misconduct; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable if any of us or our respective controlling persons or agents are prevented or forbidden from, or subjected to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement and any ADR, by reason of any provision of any present or future law or regulation of the United States or any state thereof, the Cayman Islands or any other country, or of any other governmental authority or regulatory authority or stock exchange, or on account of the possible criminal or civil penalties or restraint, or by reason of any provision, present or future, of our memorandum and articles of association or any provision of or governing any deposited securities, or by reason of any act of God or war or other circumstances beyond its control (including, without limitation, nationalization, expropriation, currency restrictions, work stoppage, strikes, civil unrest, revolutions, rebellions, explosions and computer failure);</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable by reason of any exercise of, or failure to exercise, any discretion provided for in the deposit agreement or in our memorandum and articles of association or provisions of or governing deposited securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable for any action or inaction of the depositary, the custodian or us or their or our respective controlling persons or agents in reliance upon the advice of or information from legal counsel, any person presenting ordinary shares for deposit or any other person believed by it in good faith to be competent to give such advice or information; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">are not liable for any special, consequential, indirect or punitive damages for any breach of the terms of the deposit agreement, or otherwise;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may rely upon any documents we believe in good faith to be genuine and to have been signed or presented by the proper party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disclaim any liability for any action or inaction or inaction of any of us or our respective controlling persons or agents in reliance upon the advice of or information from legal counsel, accountants, any person presenting ordinary shares for deposit, holders and beneficial owners (or authorized representatives) of ADSs, or any person believed in good faith to be competent to give such advice or information; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">disclaim any liability for inability of any holder to benefit from any distribution, offering, right or other benefit made available to holders of deposited securities but not made available to holders of ADS.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary and any of its agents also disclaim any liability (i)&#160;for any failure to carry out any instructions to vote, the manner in which any vote is cast or the effect of any vote or failure to determine that any distribution or action may be lawful or reasonably practicable or for allowing any rights to lapse in accordance with the provisions of the deposit agreement, (ii)&#160;the failure or timeliness of any notice from us, the content of any information submitted to it by us for distribution to you or for any inaccuracy of any translation thereof, (iii)&#160;any investment risk associated with the acquisition of an interest in the deposited </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">202</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">securities, the validity or worth of the deposited securities, the credit-worthiness of any third party, (iv)&#160;for any tax consequences that may result from ownership of ADSs, ordinary shares or deposited securities, or (v)&#160;for any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the depositary or in connection with any matter arising wholly after the removal or resignation of the depositary, provided that in connection with the issue out of which such potential liability arises the depositary performed its obligations without gross negligence or willful misconduct while it acted as depositary. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Jurisdiction and Arbitration</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The laws of the State of New York govern the deposit agreement and the ADSs and we have agreed with the depositary that the federal or state courts in the City of New York shall have exclusive jurisdiction to hear and determine any dispute arising from or in connection with the deposit agreement and that the depositary will have the right to refer any claim or dispute arising from the relationship created by the deposit agreement to arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association. The arbitration provisions of the deposit agreement do not preclude you from pursuing claims under the Securities Act or the Exchange Act in federal or state courts. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Jury Trial Waiver</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement provides that each party to the deposit agreement (including each holder, beneficial owner and holder of interests in the ADRs) irrevocably waives, to the fullest extent permitted by applicable law, any right it may have to a trial by jury in any lawsuit or proceeding against us or the depositary arising out of or relating to our shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Requirements for Depositary Actions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Before the depositary will issue, deliver or register a transfer of an ADS, split-up, subdivide or combine ADSs, make a distribution on an ADS, or permit withdrawal of ordinary shares, the depositary may require: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any ordinary shares or other deposited securities and payment of the applicable fees, expenses and charges of the depositary; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">satisfactory proof of the identity and genuineness of any signature or any other matters contemplated in the deposit agreement; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">compliance with (A)&#160;any laws or governmental regulations relating to the execution and delivery of ADRs or ADSs or to the withdrawal or delivery of deposited securities and (B)&#160;such reasonable regulations and procedures as the depositary may establish, from time to time, consistent with the deposit agreement and applicable laws, including presentation of transfer documents. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The depositary may refuse to issue and deliver ADSs or register transfers of ADSs generally when the register of the depositary or our transfer books are closed or at any time if the depositary or we determine that it is necessary or advisable to do so. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Your Right to Receive the Shares Underlying Your ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You have the right to cancel your ADSs and withdraw the underlying ordinary shares at any time except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">when temporary delays arise because: (1)&#160;the depositary has closed its transfer books or we have closed our transfer books; (2)&#160;the transfer of ordinary shares is blocked to permit voting at a shareholders&#8217; meeting; or (3)&#160;we are paying a dividend on our ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">203</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:340pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">when you owe money to pay fees, taxes and similar charges; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of ordinary shares or other deposited securities, or other circumstances specifically contemplated by Section&#160;I.A.(l) of the General Instructions to Form&#160;F-6 (as such General Instructions may be amended from time to time); or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for any other reason if the depositary or we determine, in good faith, that it is necessary or advisable to prohibit withdrawals.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary shall not knowingly accept for deposit under the deposit agreement any ordinary shares or other deposited securities required to be registered under the provisions of the Securities Act, unless a registration statement is in effect as to such ordinary shares. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This right of withdrawal may not be limited by any other provision of the deposit agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Direct Registration System</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, all parties to the deposit agreement acknowledge that the DRS and Profile Modification System, or Profile, will apply to uncertificated ADSs upon acceptance thereof to DRS by DTC. DRS is the system administered by DTC pursuant to which the depositary may register the ownership of uncertificated ADSs, which ownership shall be evidenced by periodic statements issued by the depositary to the ADS holders entitled thereto. Profile is a required feature of DRS which allows a DTC participant, claiming to act on behalf of an ADS holder, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register such transfer.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">204</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSEF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SHARES ELIGIBLE FOR FUTURE SALE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon completion of this offering, we will have 6,000,000 ADSs outstanding, representing approximately 24.9% of our outstanding ordinary shares. All of the ADSs sold in this offering will be freely transferable by persons, other than by our &#8220;affiliates&#8221;, without restriction or further registration under the Securities Act. Sales of substantial amounts of our ADSs in the public market could adversely affect prevailing market prices of our ADSs. Prior to this offering, there has been no public market for our ordinary shares or the ADSs. We have applied to list the ADSs on the Nasdaq Capital Market, but we cannot assure you that a regular trading market will develop in the ADSs. We do not expect that a trading market will develop for our ordinary shares not represented by the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-up Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have agreed, for a period of 180&#160;days after the date of this prospectus, not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale, lend or otherwise dispose of, except in this offering, any of our ordinary shares or ADSs or securities that are substantially similar to our ordinary shares or ADSs, including but not limited to any options or warrants to purchase our ordinary shares, ADSs or any securities that are convertible into or exchangeable for, or that represent the right to receive, our ordinary shares, ADSs or any such substantially similar securities (other than pursuant to employee stock option plans existing on, or upon the conversion or exchange of convertible or exchangeable securities outstanding as of, the date such lock-up agreement was executed), or to file or cause to be filed any registration statement relating to the offering of any of our share capital, without the prior written consent of the representative of the underwriters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, each of our directors, executive officers and shareholders beneficially holding greater than 5% of our ordinary shares has also entered into a similar lock-up agreement for a period of 180&#160;days from the date of this prospectus, subject to certain exceptions, with respect to our ordinary shares, ADSs and securities that are substantially similar to our ordinary shares or ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are not aware of any plans by any significant shareholders to dispose of significant numbers of our ADSs or ordinary shares. However, one or more existing shareholders or owners of securities convertible or exchangeable into or exercisable for our ADSs or ordinary shares may dispose of significant numbers of our ADSs or ordinary shares in the future. We cannot predict what effect, if any, future sales of our ADSs or ordinary shares, or the availability of ADSs or ordinary shares for future sale, will have on the trading price of our ADSs from time to time. Sales of substantial amounts of our ADSs or ordinary shares in the public market, or the perception that these sales could occur, could adversely affect the trading price of our ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rule&#160;144</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All of our ordinary shares that will be outstanding upon the completion of this offering, other than those ordinary shares sold in this offering, are &#8220;restricted securities&#8221; as that term is defined in Rule&#160;144 under the Securities Act and may be sold publicly in the United States only if they are subject to an effective registration statement under the Securities Act or pursuant to an exemption from the registration requirement such as those provided by Rule&#160;144 and Rule&#160;701 promulgated under the Securities Act. In general, beginning 90&#160;days after the date of this prospectus, a person who at the time of a sale is not, and has not been during the three&#160;months preceding the sale, an affiliate of ours and has beneficially owned our restricted securities for at least six&#160;months will be entitled to sell the restricted securities without registration under the Securities Act, subject only to the availability of current public information about us, and will be entitled to sell restricted securities beneficially owned for at least one year without restriction. Persons who are our affiliates and have beneficially owned our restricted securities for at least six&#160;months may sell a number of restricted securities within any three-month period that (together with any sales aggregated with them) does not exceed the greater of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">1% of the then outstanding ordinary shares of the same class, in the form of ADSs or otherwise, which immediately after this offering will equal 240,953 ordinary shares; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the average weekly trading volume of our ordinary shares of the same class, in the form of ADSs or otherwise, during the four calendar weeks preceding the date on which notice of the sale is filed with the SEC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">205</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:444pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sales by our affiliates under Rule&#160;144 are also subject to certain requirements relating to manner of sale, notice and the availability of current public information about us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rule&#160;701</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, under Rule&#160;701 of the Securities Act, each of our employees, consultants or advisors who purchases ordinary shares from us in connection with a compensatory stock plan or other written agreement executed prior to the completion of this offering is eligible to resell those ordinary shares in reliance on Rule&#160;144, but without compliance with some of the restrictions, including the holding period, contained in Rule&#160;144. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Registration Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon completion of this offering, certain holders of our ordinary shares or their transferees will have rights to require that we register their ordinary shares for resale under the Securities Act at any time following the six month anniversary of the completion of this offering.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">206</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTAX">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TAXATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following summary of Cayman Islands and U.S. federal income tax considerations of an investment in the ADSs or ordinary shares is based upon laws and relevant interpretations thereof in effect as of the date of this registration statement, all of which are subject to change. This summary does not deal with all possible tax considerations relating to an investment in the ADSs or ordinary shares, such as the tax considerations under U.S. state and local tax laws or under the tax laws of jurisdictions other than the Cayman Islands and the United States. To the extent that the discussion relates to matters of Cayman Islands tax law, it represents the opinion of Maples and Calder (Hong Kong) LLP, our Cayman Islands legal counsel.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cayman Islands Taxation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or brought within the jurisdiction of the Cayman Islands. The Cayman Islands is not party to any double tax treaties that are applicable to any payments made to or by our company. There are no exchange control regulations or currency restrictions in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Payments of dividends and capital in respect of our ordinary shares and ADSs will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of dividends or capital to any holder of our ordinary shares or ADSs, nor will gains derived from the disposal of our ordinary shares or ADSs be subject to Cayman Islands income or corporation tax. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">United States Federal Income Tax Considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a general discussion of certain U.S. federal income tax considerations relating to the ownership and disposition of our ADSs or ordinary shares by U.S. Holders (as defined below) that acquire our ADSs in this offering and holds our ADSs as &#8220;capital assets&#8221; &#8203;(generally, property held for investment) under the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). This discussion does not address any aspect of U.S. federal gift or estate tax, alternative minimum tax, the Medicare tax on net investment income, or the state, local or non-U.S. tax consequences of an investment in our ADSs or ordinary shares. This discussion is based on the Code, its legislative history, existing and proposed regulations promulgated thereunder, published rulings and court decisions, all as of the date of this prospectus. These laws are subject to change, possibly on a retroactive basis. No ruling has been obtained and no ruling will be requested from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), with respect to any of the U.S. federal income tax consequences described below, and as a result, there can be no assurance that the IRS will not disagree with or challenge any of the statements provided below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This discussion is not a complete description of all tax considerations that may be relevant to particular investors in light of their individual circumstances or investors subject to special tax rules, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">brokers or dealers in securities or currencies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">traders in securities that elect to use a mark-to-market method of tax accounting for securities holdings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">banks or certain financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">insurance companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">tax-exempt organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">partnerships or other entities treated as partnerships or other pass-through entities for U.S. federal income tax purposes or persons holding our ADSs or ordinary shares through any such entities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">regulated investment companies or real estate investment trusts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons that hold our ADSs or ordinary shares as part of a hedge, straddle, constructive sale, conversion transaction or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">207</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons whose functional currency for tax purposes is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">U.S. expatriates; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">persons that actually or constructively own 10% or more of (i)&#160;the total combined voting power of all classes of our voting stock or (ii)&#160;the total value of all classes of our stock (including our ADSs or ordinary shares). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each prospective investor is urged to consult its tax advisor regarding the application of U.S. federal taxation to its particular circumstances, and the state, local, non-U.S. and other tax considerations of the ownership and disposition of our ADSs or ordinary shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;U.S. Holder&#8221; is a beneficial owner of our ADSs or ordinary shares that is: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an individual citizen or resident of the United States for U.S. federal income tax purposes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a corporation, or other entity classified as a corporation for U.S. federal income tax purposes, that was created or organized in or under the laws of the United States, any state thereof or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an estate the income of which is subject to U.S. federal income tax regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a trust if (i)&#160;a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (ii)&#160;the trust has a valid election in effect to be treated as a U.S. person. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For U.S. federal income tax purposes, income earned through an entity or arrangement classified as a partnership for U.S. federal income tax purposes is attributed to its owners. Accordingly, if a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) is a beneficial owner of our ADSs or ordinary shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. Partnerships holding our ADSs or ordinary shares and their partners are urged to consult their tax advisors regarding an investment in our ADSs or ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For U.S. federal income tax purposes, it is generally expected that a U.S. Holder of ADSs will be treated as the beneficial owner of the underlying shares represented by the ADSs. The remainder of this discussion assumes that a U.S. Holder of our ADSs will be treated in this manner. Accordingly, deposits or withdrawals of ordinary shares for ADSs will generally not be subject to U.S. federal income tax. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is subject to the discussion under &#8220;Passive Foreign Investment Company&#8221; below. If we make cash distributions and you are a U.S. Holder, the gross amount of any distributions with respect to your ADSs or ordinary shares (including the amount of any taxes withheld therefrom) will be includible in your gross income on the day you actually or constructively receive such income as dividend income if the distributions are made from our current or accumulated earnings and profits, calculated according to U.S. federal income tax principles. We do not intend to calculate our earnings and profits according to U.S. federal income tax principles. Accordingly, you should expect that distributions on our ADSs or ordinary shares, if any, will generally be treated as dividend income for U.S. federal income tax purposes. Dividends received on our ADSs or ordinary shares will not be eligible for the dividends received deduction generally allowed to U.S. corporations. Dividends received by individuals and certain other non-corporate U.S. Holders may be subject to tax at the lower capital gain tax rate applicable to &#8220;qualified dividend income,&#8221; provided that certain conditions are satisfied, including that (1)&#160;our ADSs or ordinary shares on which the dividends are paid are readily tradeable on an established securities market in the United States, (2)&#160;we are neither a PFIC nor treated as such with respect to such a U.S. Holder for the taxable year in which the dividend was paid and the preceding taxable year, and (3)&#160;certain holding period requirements are met. We expect our ADSs (but not our ordinary shares), which we have applied to list on </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">208</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the Nasdaq Capital Market will be considered readily tradeable on an established securities market in the United States, although there can be no assurance in this regard. U.S. Holders should consult their own tax advisors regarding the potential availability of the reduced dividend tax rate in respect of our ADSs and ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dividends paid on our ADSs or ordinary shares, if any, will generally be treated as income from foreign sources and will generally constitute passive category income for U.S. foreign tax credit purposes. Depending on the U.S. Holder&#8217;s individual facts and circumstances, a U.S. Holder may be eligible, subject to a number of complex limitations, to claim a foreign tax credit in respect of any nonrefundable non-U.S. withholding taxes imposed on dividends received on our ADSs or ordinary shares. A U.S. Holder who does not elect to claim a foreign tax credit for foreign taxes withheld may instead claim a deduction, for U.S. federal income tax purposes, in respect of such withholding, but only for a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing the foreign tax credit are complex and their outcome depends in large part on the U.S. Holder&#8217;s individual facts and circumstances. Accordingly, U.S. Holders are urged to consult their tax advisors regarding the availability of the foreign tax credit under their particular circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sale or Other Disposition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is subject to the discussion under &#8220;Passive Foreign Investment Company&#8221; below. A U.S. Holder will generally recognize capital gain or loss upon the sale or other disposition of our ADSs or ordinary shares in an amount equal to the difference between the amount realized upon the disposition and the holder&#8217;s adjusted tax basis in such ADSs or ordinary shares. The holder&#8217;s adjusted tax basis will generally equal the amount the holder paid (including the offering price for the ADS or ordinary shares and trading fee, transaction levy and brokerage fee paid in connection with such purchase). Any gain or loss the U.S. Holder recognizes will generally be long-term capital gain or loss if the ADSs or ordinary shares have been held for more than one year and will generally be U.S.-source gain or loss for U.S. foreign tax credit purposes. Long-term capital gain of individuals and certain other non-corporate U.S. Holders will generally be eligible for a more favorable rate of taxation. The deductibility of a capital loss may be subject to limitations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">U.S. Holders are urged to consult their tax advisors regarding the tax consequences if a foreign tax is imposed on a disposition of our ADSs or ordinary shares, including the availability of the foreign tax credit under their particular circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Passive Foreign Investment Company</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we were classified as a PFIC for any taxable year during which a U.S. Holder holds our ADSs or ordinary shares, the U.S. Holder would generally be subject to adverse U.S. tax consequences, in the form of increased tax liabilities (unless certain elections described below are timely made) and special U.S. tax reporting requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A non-U.S. corporation is a PFIC for U.S. federal income tax purposes for any taxable year in which (after taking into account the income and assets of subsidiaries in which it owns at least a 25% interest by value), (i)&#160;at least 75% of its gross income is &#8220;passive&#8221; income, such as interest and income from financial investments (the &#8220;income test&#8221;) or (ii)&#160;at least 50% of the average value of its assets (generally determined on a quarterly basis) consists of assets that produce or are held to produce passive income (the &#8220;asset test&#8221;).&#8199;&#8199;For purposes of making a PFIC determination, the non-U.S. corporation will be treated as owning its proportionate share of the assets and earning its proportionate share of the gross income of any other corporation of which it is, directly or indirectly, a 25% or greater shareholder (by value). For purposes of the asset test, any cash and cash invested in short-term, interest bearing, debt instruments, or bank deposits that are readily convertible into cash will generally count as producing passive income or held for the production of passive income, and goodwill should be treated as an active asset to the extent that it is associated with activities that produce or are intended to produce active income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on current estimate of our gross income and of the value of our gross assets (including goodwill) and the manner in which we conduct our business, we do not expect to be a PFIC for U.S. federal income tax purposes for the 2022 taxable year. Despite our expectation, there can be no assurance that we will not be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">209</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">a PFIC for 2022 or any future taxable year as PFIC status is tested for each taxable year and will depend on the composition of our assets and income in such taxable year. We could be a PFIC for any taxable year if our market capitalization were to decrease significantly while we hold substantial cash and cash equivalents, or if the gross income that we and our subsidiaries earn from investing the portion of the cash raised in the offering is substantial in comparison with the gross income from our business operation. Furthermore, the application of the PFIC rules is subject to uncertainty in several respects, and there can be no assurance that the IRS will not challenge our application of the PFIC rules. </font><font style="font-style:italic;letter-spacing:0.2pt;">Our counsel expresses no opinion with respect to our expectations contained in this paragraph.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we were a PFIC for any taxable year during which you held our ADSs or ordinary shares, certain adverse U.S. federal income tax rules would apply. You would generally be subject to additional taxes and interest charges on certain &#8220;excess distributions&#8221; we make on any gain realized on the disposition or deemed disposition of your ADSs or ordinary shares, regardless of whether we continue to be a PFIC in the year in which you receive an &#8220;excess distribution&#8221; or dispose of or are deemed to have disposed of, your our ADSs or ordinary shares. Distributions in respect of our ADSs or ordinary shares during a taxable year in which we are a PFIC would generally constitute &#8220;excess distributions&#8221; if, in the aggregate, they exceed 125% of the average amount of distributions with respect to your ADSs or ordinary shares over the three preceding taxable&#160;years or, if shorter, the portion of your holding period before such taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To compute the tax on &#8220;excess distributions&#8221; or any gain, (i)&#160;the &#8220;excess distribution&#8221; or the gain would be allocated ratably to each day in your holding period, (ii)&#160;the amount allocated to the current year and any tax year prior to the first taxable year in which we were a PFIC would be taxed as ordinary income in the current year, (iii)&#160;the amount allocated to other taxable&#160;years would be taxable at the highest applicable marginal rate in effect for that year, and (iv)&#160;an interest charge at the rate for underpayment of taxes for any period described under (iii)&#160;above would be imposed on the resulting tax liability on the portion of the &#8220;excess distribution&#8221; or gain that is allocated to such period. In addition, if we were a PFIC (or treated as a PFIC with respect to you) for any taxable year in which we make a distribution or the preceding taxable year, such distribution would not qualify for taxation at the more favorable tax rate if we are deemed to be a PRC resident enterprise under PRC tax law, as discussed in the &#8220;Dividends&#8221; section above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under certain attribution rules, if we were a PFIC for any taxable year in which you hold our ADSs or ordinary shares, you would be deemed to own your proportionate share of lower-tier PFICs, and would be subject to U.S. federal income tax under the PFIC rules described in the preceding paragraphs on (i)&#160;a distribution on the shares of a lower-tier PFIC and (ii)&#160;a disposition of shares of a lower-tier PFIC, both as if such U.S. Holder directly held the shares of such lower-tier PFIC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You might be able to make a &#8220;mark-to-market&#8221; election with respect to our ADSs, but not our ordinary shares, in order to elect out of the tax treatment discussed above. If you make a valid mark-to-market election, you will include in gross income for each taxable year that we are treated as a PFIC an amount equal to the excess, if any, of the fair market value of your ADSs as of the close of such taxable year over your adjusted basis in such ADSs. You will be permitted a deduction for the excess, if any, of the adjusted basis of your ADSs over their fair market value as of the close of the taxable year. However, deductions are allowable only to the extent of any net mark-to-market gains on the ADSs included in your income for prior taxable&#160;years. Amounts included in your income under a mark-to-market election, as well as gain on any sale or other disposition of the ADSs, will be treated as ordinary income. Ordinary loss treatment also will apply to the deductible portion of any mark-to-market loss on the ADSs, as well as to any loss realized on a sale or disposition of the ADSs, to the extent that the amount of such loss does not exceed the net mark-to-market gains previously included for such ADSs. Your basis in your ADSs will be adjusted to reflect any such income or loss amounts. If you make a valid mark-to-market election, the tax rules that apply to distributions by corporations that are not PFICs generally will apply to distributions by us, except that the favorable rate discussed in the &#8220;Dividends&#8221; section above that may apply if we are deemed to be a PRC resident enterprise under PRC tax law will not apply to any distribution if we are a PFIC (or treated as a PFIC with respect to you) in the taxable year of the distribution or the preceding taxable year. If a U.S. Holder makes a mark-to-market election in respect of our ADSs and we cease to be classified as a PFIC, the holder will not be required to take into account the gain or loss described above during any period that we are not classified as a PFIC. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">210</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:108pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The mark-to-market election is available only for &#8220;marketable stock,&#8221; which is stock that is traded in other than de minimis quantities on at least 15&#160;days during each calendar quarter on a qualified exchange or other market, as defined in applicable U.S. Treasury regulations. For those purposes, we expect that our ADSs will each be treated as marketable stock upon their listing on the Nasdaq Stock Market, and we expect the exchange will be a qualified exchange for these purposes. We anticipate that our ADSs should qualify as being regularly traded. U.S. Holders of ordinary shares may be able to make a mark-to-market election but it is not certain, but no assurances may be given in this regard and such holders are advised to consult their own tax advisor regarding their eligibility to make such election. Because a mark-to-market election cannot technically be made for equity interests in lower-tier PFICs that we own, if we are a PFIC for any taxable year, a U.S. Holder generally will continue to be subject to the general PFIC rules with respect to the holder&#8217;s indirect interest in any investments held by us that are treated as equity interest in a PFIC for U.S. federal income tax purposes. You should consult your tax advisor as to the availability and desirability of a mark-to-market election if we were a PFIC, as well as the impact of such election on interests in any lower-tier PFICs. The PFIC rules provide for a separate election, referred to as a qualified electing fund election, which, if available, results in a tax treatment different from (and generally less adverse than) the general PFIC tax treatment described above. That election, however, will not be available to you as we do not intend to provide the information you would need to make or maintain that election. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you own our ADSs or ordinary shares during any taxable year that we are a PFIC, you will generally be required to file an annual report containing such information as the United States Treasury Department may require. You should consult your own tax advisor regarding the application of the PFIC rules to your investment in our ADSs or ordinary shares and the elections discussed above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Information Reporting and Backup Withholding Rules</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dividend payments with respect to our ADSs or ordinary shares and the proceeds received on the sale or other disposition of our ADSs or ordinary shares may be subject to information reporting to the IRS and to backup withholding, unless you are an exempt recipient. Backup withholding will not apply, however, if you provide a taxpayer identification number, certifying that you are not subject to backup withholding or are otherwise exempt from backup withholding. Any amounts withheld under the backup withholding rules from a payment to you will be refunded or credited against your U.S. federal income tax liability, provided that the required information is timely provided to the IRS. Certain U.S. Holders who hold &#8220;specific foreign financial assets,&#8221; including stock of a non-U.S. corporation that is not held in an account maintained by a U.S. &#8220;financial institution&#8221; may be required to attach to their tax returns for the year certain specified information. A U.S. Holder who fails to timely furnish the required information may be subject to a penalty. You are advised to consult with your own tax advisor regarding the application of the U.S. information reporting and backup withholding rules to your particular circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTIVE INVESTORS IN OUR ADSS OR ORDINARY SHARES SHOULD CONSULT WITH THEIR OWN TAX ADVISOR REGARDING THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES RESULTING FROM OWNING OR DISPOSING OUR ADSS OR ORDINARY SHARES, INCLUDING THE APPLICABILITY AND EFFECT OF THE TAX LAWS OF ANY STATE, LOCAL OR NON-US JURISDICTION AND INCLUDING ESTATE, GIFT AND INHERITANCE LAWS. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">211</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUND">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">UNDERWRITING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Benchmark Company is acting as the representative of the underwriters and the book-running manager of the offering of the ADSs described in this prospectus. We will enter into an underwriting agreement with the representative of the underwriters. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus, the number of ADSs listed next to its name in the following table: </font>
        </div>
        <table style="width:416pt;height:39pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:346.03pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of ADSs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:346.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Benchmark Company, LLC </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6,000,000</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:346.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6,000,000</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.5pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters are committed to purchase all the ADSs offered by us other than those covered by the option to purchase additional ADSs described below, if they purchase any ADSs. The obligations of the underwriters may be terminated upon the occurrence of certain events specified in the underwriting agreement. Pursuant to the underwriting agreement, the underwriters&#8217; obligations are subject to customary conditions, representations and warranties contained in the underwriting agreement, such as receipt by the underwriters of officers&#8217; certificates and legal opinions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters are offering the ADSs, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel and other conditions specified in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters propose to offer the ADSs directly to the public at the initial public offering price set forth on the cover page of this prospectus and to certain dealers at such price less a concession not in excess of US$&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;per ADS. After the initial offering of the ADSs to the public, if all of the ADSs are not sold at the initial public offering price, the underwriters may change the offering price and the other selling terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some of the underwriters are expected to make offers and sales both inside and outside the United States through their respective selling agents. All sales of ADSs in the United States will be made by broker-dealers registered with the SEC. Sales of any ADSs made outside of the United States may be made by affiliates of the underwriters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended, and to contribute to payments the underwriters may be required to make in respect thereof. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Option to purchase additional ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have granted to the underwriters an option to purchase up to 900,000 additional ADSs from us at the public offering price per ADS, less underwriting discounts and commissions, for a period of 30&#160;days from the date of this prospectus. If any additional ADSs are purchased, the underwriters will offer the additional ADSs on the same terms as those on which the ADSs are being offered. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Underwriting Discounts and Commissions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the per ADS and total public offering price, underwriting discounts and commissions to be paid by us, and proceeds before expenses to us, assuming both no exercise and full exercise of the underwriters&#8217; option to purchase 900,000 additional ADSs. </font>
        </div>
        <table style="width:456pt;height:67pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:308.2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:308.2pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">No Exercise </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Full exercise </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:308.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;">&#8199;&#8201;</td>
            <td style="padding:0pt;padding-left:13.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8199;&#8199;</td>
            <td style="padding:0pt;padding-left:13.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:308.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Underwriting discounts and commissions</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:13.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:13.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:308.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Proceeds, before expenses, to us </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.66pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.66pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.795pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:5.25pt; text-align:right; white-space:nowrap;"> </td>
            <td style="padding:0pt;padding-left:13.795pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">212</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Underwriting discounts and commissions per ADS will be 7.5%, provided that, with respect to the sale of ADSs to certain identified investors only, the underwriting discounts and commissions per ADS will be 3.75%. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have agreed to pay for the accountable out-of-pocket expenses of the underwriters, including road show expenses for the offering, prospectus tracking and compliance software for the offering, fees and disbursements of the underwriters&#8217; counsel up to an amount of $125,000, and the preparation of commemorative mememtos and lucite tombstones in connection with the offering, up to $150,000 in the aggregate, $25,000 of which has been paid prior to the date of this prospectus. We have also agreed to pay for background checks of our senior management up to an amount of $7,500. In the event that the offering is terminated, any advance expense deposits paid to the underwriters will be returned to the extent that offering expenses are not actually incurred in accordance with FINRA Rule 5110(g)(4)(A). We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately US$2.1&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Representative&#8217;s Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the closing of this offering, we have agreed to issue to the representative of the underwriters or its designees warrants to purchase a number of ADSs equal to 2.5% of the ADSs sold by us in this offering, including ADSs (if any) sold upon the exercise of the option to purchase additional ADSs (the &#8220;Representative&#8217;s Warrants&#8221;). The Representative&#8217;s Warrants will have an exercise price equal to $&#8199;&#8199;&#8199;&#8199; per ADS (or 125% of the public offering price per ADS). The Representative&#8217;s Warrants will be exercisable until the date that is five&#160;years after the date of commencement of sales in this offering in compliance with Financial Industry Regulatory Authority, or FINRA, Rule&#160;5110. The Representative&#8217;s Warrants are also exercisable on a cashless basis. The Representative&#8217;s Warrants have been deemed compensation by FINRA and are subject to a 180-day lock-up pursuant to FINRA Rule&#160;5110. Except as permitted by Rule&#160;5110, the representative for the underwriters (or permitted assignees under Rule&#160;5110) will not sell, transfer, assign, pledge, or hypothecate the Representative&#8217;s Warrants or the securities underlying the Representative&#8217;s Warrants, nor will any of them engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the option or the underlying securities for a period of 180&#160;days from the commencement of sales under this prospectus. The exercise price and number of securities upon exercise of the Representative&#8217;s Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation. However, the Representative&#8217;s Warrant exercise price or underlying ADSs will not be adjusted for issuances of ADSs at a price below the Representative&#8217;s Warrant exercise price. The Representative&#8217;s Warrants and the ordinary shares underlying the ADSs issuable upon exercise thereof are registered on the registration statement of which this prospectus forms a part. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Discretionary Accounts</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters do not intend to confirm sales of the ADSs offered hereby to any accounts over which they have discretionary authority. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-Up Agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have agreed that, subject to certain exceptions, we will not, for a period of 180&#160;days after the date of this prospectus, (i)&#160;offer, pledge, issue, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Securities and Exchange Commission a registration statement under the Securities Act relating to, any of our ordinary shares or ADSs or securities convertible into or exercisable or exchangeable for any of our ordinary shares or ADSs, or publicly disclose the intention to undertake any of the foregoing, or (ii)&#160;enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of any ordinary shares, ADSs or any such other securities, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position in any ordinary shares, ADSs or any such other securities, or publicly disclose </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">213</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">the intention to enter into any such agreement or transaction or (iii)&#160;file or cause to be filed any registration statement relating to the offering of any of our share capital (regardless of whether any of the transactions described in (i)&#160;or (ii)&#160;above are to be settled by the delivery of ordinary shares, ADSs or such other securities, in cash or otherwise) or publicly disclose the intention to file any such registration statement, without the prior written consent of the representative of the underwriters. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our directors, officers, and shareholders beneficially holding greater than 5% of our ordinary shares (collectively, the lock-up parties) have agreed that, without the prior written consent of the representative of the underwriters and subject to certain exceptions, they will not, for a period of 180&#160;days after the date of this prospectus, (1)&#160;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any of our ordinary shares or ADSs or any securities convertible into or exercisable or exchangeable for our ordinary shares or ADSs, (2)&#160;enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the lock-up securities, whether any such transaction described in clause (1)&#160;or (2)&#160;above is to be settled by delivery of lock-up securities, in cash or otherwise, (3)&#160;make any demand for, or exercise any right with respect to, the registration of any lock-up securities, or (4)&#160;publicly disclose the intention to do any of the foregoing. Such persons or entities have further acknowledged that these undertakings preclude them from engaging in any hedging or other transactions or arrangements designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer of any economic consequences of ownership, in whole or in part, directly or indirectly, of any lock-up securities, whether any such transaction or arrangement would be settled by delivery of lock-up securities, in cash or otherwise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The representative of the underwriters, in its sole discretion, may release the securities subject to any of the lock-up agreements described above, in whole or in part at any time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have further agreed to instruct Deutsche Bank Trust Company Americas, as depositary, not to accept any deposit of any ordinary shares or issue any ADSs for 180&#160;days after the date of this prospectus (other than in connection with this offering), unless we instruct the depositary otherwise with the prior written consent of the representative of the underwriters. The foregoing does not affect the right of ADS holders to cancel their ADSs and withdraw the underlying ordinary shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Right of First Refusal</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have granted the representative a right of first refusal, for a period of nine (9)&#160;months from the closing of this offering, to act as lead or joint-lead investment banker, lead or joint-lead book runner and/or lead or joint placement agent at the representative&#8217;s discretion, for each and every future public and private equity, equity-linked or debt offering, including all equity linked financings during such nine&#160;(9)&#160;month period, by us or our successor, or any subsidiary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Electronic Offer, Sale and Distribution of ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A prospectus in electronic format may be made available on the websites maintained by one or more underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to allocate a number of ADSs to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representative of the underwriters and selling group members that may make Internet distributions on the same basis as other allocations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have applied to have our ADSs approved for listing on the Nasdaq Capital Market under the symbol &#8220;BLTE.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stabilization</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling ADSs in the open market for the purpose of preventing or retarding a decline in the market price of the ADSs while this offering is in progress. These stabilizing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">214</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">transactions may include making short sales of ADSs, which involves the sale by the underwriters of a greater number of ADSs than they are required to purchase in this offering, and purchasing ADSs on the open market to cover positions created by short sales. Short sales may be &#8220;covered&#8221; shorts, which are short positions in an amount not greater than the underwriters&#8217; option to purchase additional ADSs referred to above, or may be &#8220;naked&#8221; shorts, which are short positions in excess of that amount. The underwriters may close out any covered short position either by exercising the option to purchase additional ADSs, in whole or in part, or by purchasing ADSs in the open market. In making this determination, the underwriters will consider, among other things, the price of ADSs available for purchase in the open market compared to the price at which the underwriters may purchase ADSs through the option to purchase additional ADSs. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the ADSs in the open market that could adversely affect investors who purchase in this offering. To the extent that the underwriters create a naked short position, they will purchase ADSs in the open market to cover the position. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The underwriters have advised us that, pursuant to Regulation&#160;M of the Securities Act of 1933, they may also engage in other activities that stabilize, maintain or otherwise affect the price of the ADSs, including the imposition of penalty bids. This means that if the representative of the underwriters purchases ADSs in the open market in stabilizing transactions or to cover short sales, the representative can require the underwriters that sold those ADSs as part of this offering to repay the underwriting discount received by them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These activities may have the effect of raising or maintaining the market price of the ADSs or preventing or retarding a decline in the market price of the ADSs, and, as a result, the price of the ADSs may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities, they may discontinue them at any time. The underwriters may carry out these transactions on the Nasdaq, in the over-the-counter market or otherwise. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Pricing of the Offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to this offering, there has been no public market for our ADSs. The initial public offering price will be determined by negotiations between us and the representative of the underwriters. In determining the initial public offering price, we and the representative of the underwriters expect to consider a number of factors including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the information set forth in this prospectus and otherwise available to the representative; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our prospects and the history and prospects for the industry in which we compete; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an assessment of our management; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our prospects for future earnings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the general condition of the securities markets at the time of this offering; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the recent market prices of, and demand for, publicly traded securities of generally comparable companies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">other factors deemed relevant by the representative and us. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Neither we nor the underwriters can assure investors that an active trading market will develop for our ADSs, or that the ADSs will trade in the public market at or above the initial public offering price. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain of the underwriters and their affiliates may provide from time to time certain commercial banking, financial advisory, investment banking and other services for us and our affiliates in the ordinary course of their business, for which they may receive customary fees and commissions. However, we have not yet had, and have no present arrangements with any of the underwriters for any further services.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Selling Restrictions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No action may be taken in any jurisdiction other than the United States that would permit a public offering of the ADSs or the possession, circulation or distribution of this prospectus in any jurisdiction </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">215</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">where action for that purpose is required. Accordingly, the ADSs may not be offered or sold, directly or indirectly, and neither the prospectus nor any other offering material or advertisements in connection with the ADSs may be distributed or published in or from any country or jurisdiction except under circumstances that will result in compliance with any applicable laws, rules and regulations of any such country or jurisdiction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Australia</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This document: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">does not constitute a disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth), or the Corporations Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">has not been, and will not be, lodged with the Australian Securities and Investments Commission, or ASIC, as a disclosure document for the purposes of the Corporations Act and does not purport to include the information required of a disclosure document for the purposes of the Corporations Act; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">may only be provided in Australia to select investors who are able to demonstrate that they fall within one or more of the categories of investors, available under section 708 of the Corporations Act, or Exempt Investors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs may not be directly or indirectly offered for subscription or purchased or sold, and no invitations to subscribe for or buy the ADSs may be issued, and no draft or definitive offering memorandum, advertisement or other offering material relating to any ADSs may be distributed in Australia, except where disclosure to investors is not required under Chapter 6D of the Corporations Act or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for the ADSs, you represent and warrant to us that you are an Exempt Investor. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As any offer of ADSs under this document will be made without disclosure in Australia under Chapter&#160;6D.2 of the Corporations Act, the offer of those securities for resale in Australia within 12&#160;months may, under section 707 of the Corporations Act, require disclosure to investors under Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the ADSs you undertake to us that you will not, for a period of 12&#160;months from the date of issue of the ADSs, offer, transfer, assign or otherwise alienate those ADSs to investors in Australia except in circumstances where disclosure to investors is not required under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Canada</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection&#160;73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the ADSs must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">216</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cayman Islands</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus does not constitute an invitation or offer to the public in the Cayman Islands of the ADSs, whether by way of sale or subscription. The underwriters have not offered or sold, and will not offer or sell, directly or indirectly, any ADSs in the Cayman Islands. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dubai International Finance Center, or DIFC</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document relates to an Exempt Offer in accordance with the Markets Rules 2012 of the Dubai Financial Services Authority, or DFSA. This document is intended for distribution only to persons of a type specified in the Markets Rules 2012 of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this document. The securities to which this document relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the contents of this document you should consult an authorized financial advisor. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In relation to its use in the DIFC, this document is strictly private and confidential and is being distributed to a limited number of investors and must not be provided to any person other than the original recipient, and may not be reproduced or used for any other purpose. The interests in the securities may not be offered or sold directly or indirectly to the public in the DIFC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">European Economic Area</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In relation to each Member State of the European Economic Area and the United Kingdom, or each a Relevant State, no ADSs have been offered or will be offered pursuant to this offering to the public in that Relevant State prior to the publication of a prospectus in relation to the ADSs which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of ADSs may be made to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to any legal entity which is a qualified investor as defined under the Prospectus Regulation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the underwriters; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">in any other circumstances falling within Article&#160;1(4) of the Prospectus Regulation, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that no such offer of ADSs shall require us or any underwriter to publish a prospectus pursuant to Article&#160;3 of the Prospectus Regulation or supplement a prospectus pursuant to Article&#160;23 of the Prospectus Regulation and each person who initially acquires any ADSs or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with each of the underwriters and us that it is a &#8220;qualified investor&#8221; within the meaning of Article&#160;2(e) of the Prospectus Regulation. In the case of any ADSs being offered to a financial intermediary as that term is used in the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the ADSs acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer of any ADSs to the public other than their offer or resale in a Relevant State to qualified investors as so defined or in circumstances in which the prior consent of the representative of the underwriters has been obtained to each such proposed offer or resale. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to ADSs in any Relevant State means the communication in any form and by any means of sufficient information on the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">217</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">terms of the offer and any ADSs to be offered so as to enable an investor to decide to purchase or subscribe for any ADSs, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017/1129. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Hong Kong</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ADSs have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a)&#160;to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), or the SFO, of Hong Kong and any rules made thereunder; or (b)&#160;in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong), or the CO, or which do not constitute an offer to the public within the meaning of the CO. No advertisement, invitation or document relating to the ADSs has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to ADSs which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the SFO and any rules made thereunder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Israel</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document does not constitute a prospectus under the Israeli Securities Law, 5728-1968, and has not been filed with or approved by the Israel Securities Authority. In Israel, this prospectus may be distributed only to, and is directed only at, investors listed in the first addendum, or the Addendum, to the Israeli Securities Law, consisting primarily of joint investment in trust funds; provident funds; insurance companies; banks, portfolio managers, investment advisors, members of the Tel Aviv Stock Exchange Ltd., underwriters, each purchasing for their own account; venture capital funds; entities with equity in excess of NIS 50&#160;million and &#8220;qualified individuals,&#8221; each as defined in the Addendum (as it may be amended from time to time), collectively referred to as qualified investors. Qualified investors shall be required to submit written confirmation that they fall within the scope of the Addendum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Japan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ADSs have not been and will not be registered pursuant to Article&#160;4, Paragraph 1 of the Financial Instruments and Exchange Act. Accordingly, none of the ADSs nor any interest therein may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any &#8220;resident&#8221; of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to or for the benefit of a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations and ministerial guidelines of Japan in effect at the relevant time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Kingdom of Saudi Arabia</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document may not be distributed in the Kingdom of Saudi Arabia except to such persons as are permitted under the Offers of Securities Regulations as issued by the board of the Saudi Arabian Capital Market Authority, or CMA, pursuant to resolution number 2-11-2004 dated 4 October&#160;2004 as amended by resolution number 1-28-2008, as amended, or the CMA Regulations. The CMA does not make any representation as to the accuracy or completeness of this document and expressly disclaims any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating to the securities. If you do not understand the contents of this document, you should consult an authorized financial adviser. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Korea</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ADSs have not been and will not be registered under the Financial Investments Services and Capital Markets Act of Korea and the decrees and regulations thereunder, or the FSCMA, and the ADSs have been and will be offered in Korea as a private placement under the FSCMA. None of the ADSs may be </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">218</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">offered, sold or delivered directly or indirectly, or offered or sold to any person for re-offering or resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws and regulations of Korea, including the FSCMA and the Foreign Exchange Transaction Law of Korea and the decrees and regulations thereunder, or the FETL. The ADSs have not been listed on any of securities exchanges in the world including, without limitation, the Korea Exchange in Korea. Furthermore, the purchaser of the ADSs shall comply with all applicable regulatory requirements (including but not limited to requirements under the FETL) in connection with the purchase of the ADSs. By the purchase of the ADSs, the relevant holder thereof will be deemed to represent and warrant that if it is in Korea or is a resident of Korea, it purchased the ADSs pursuant to the applicable laws and regulations of Korea. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Kuwait</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless all necessary approvals from the Kuwait Capital Markets Authority pursuant to Law No. 7 of 2010 Concerning the Establishment of the Capital Markets Authority and Regulating of Securities Activities and the implementing regulations thereto (as amended), and the various resolutions, regulations, instructions and announcements issued from time to time pursuant thereto, or in connection therewith, have been given in relation to the marketing of, and sale of, the ADSs, the ADSs may not be marketed, offered for sale, nor sold in the State of Kuwait. Neither this prospectus (including any related document), nor any of the information contained therein is intended to lead to the conclusion of any contract of whatsoever nature within Kuwait. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Malaysia</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No prospectus or other offering material or document in connection with the offer and sale of the ADSs has been or will be registered with the Securities Commission of Malaysia, or Commission, for the Commission&#8217;s approval pursuant to the Capital Markets and Services Act 2007. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the ADSs may not be circulated or distributed, nor may the ADSs be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Malaysia other than (i)&#160;a closed end fund approved by the Commission; (ii)&#160;a holder of a Capital Markets Services Licence; (iii)&#160;a person who acquires the ADSs, as principal, if the offer is on terms that the ADSs may only be acquired at a consideration of not less than RM250,000 (or its equivalent in foreign currencies) for each transaction; (iv)&#160;an individual whose total net personal assets or total net joint assets with his or her spouse exceeds RM3&#160;million (or its equivalent in foreign currencies), excluding the value of the primary residence of the individual; (v)&#160;an individual who has a gross annual income exceeding RM300,000 (or its equivalent in foreign currencies) per annum in the preceding twelve&#160;months; (vi)&#160;an individual who, jointly with his or her spouse, has a gross annual income of RM400,000 (or its equivalent in foreign currencies), per annum in the preceding twelve&#160;months; (vii)&#160;a corporation with total net assets exceeding RM10&#160;million (or its equivalent in a foreign currencies) based on the last audited accounts; (viii)&#160;a partnership with total net assets exceeding RM10&#160;million (or its equivalent in foreign currencies); (ix)&#160;a bank licensee or insurance licensee as defined in the Labuan Financial Services and Securities Act 2010; (x)&#160;an Islamic bank licensee or takaful licensee as defined in the Labuan Financial Services and Securities Act 2010; and (xi)&#160;any other person as may be specified by the Commission; provided that, in the each of the preceding categories (i)&#160;to (xi), the distribution of the ADSs is made by a holder of a Capital Markets Services Licence who carries on the business of dealing in securities. The distribution in Malaysia of this prospectus is subject to Malaysian laws. This prospectus does not constitute and may not be used for the purpose of public offering or an issue, offer for subscription or purchase, invitation to subscribe for or purchase any securities requiring the registration of a prospectus with the Commission under the Capital Markets and Services Act 2007. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Mexico</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">None of the ADSs or the ordinary shares have been or will be registered with the National Securities Registry (Registro Nacional de Valores) maintained by the Mexican National Banking and Securities Commission (Comision Nacional Bancaria y de Valores), or CNBV, of Mexico and, as a result, may not be offered or sold publicly in Mexico. The ADSs and the ordinary shares may only be sold to Mexican institutional and qualified investors, pursuant to the private placement exemption set forth in the Mexican Securities Market Law (Ley del Mercado de Valores). As required under the Mexican Securities Market Law, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">219</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the company will give notice to the CNBV of the offering of the securities under the terms set forth herein. Such notice will be submitted to the CNBV to comply with the Mexican Securities Market Law, and for informational purposes only. The delivery to, and receipt by, the CNBV of such notice does not certify the solvency of the company, the investment quality of the securities, or that the information contained in this prospectus or in any prospectus supplement. The company has prepared this prospectus and is solely responsible for its content, and the CNBV has not reviewed or authorized such content. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">People&#8217;s Republic of China</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus will not be circulated or distributed in the PRC and the ADSs will not be offered or sold, and will not be offered or sold to any person for re-offering or resale directly or indirectly to any residents of the PRC except pursuant to any applicable laws and regulations of the PRC. Neither this prospectus nor any advertisement or other offering material may be distributed or published in the PRC, except under circumstances that will result in compliance with applicable laws and regulations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Singapore</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the underwriters have not offered or sold any ADSs or caused the ADSs to be made the subject of an invitation for subscription or purchase and will not offer or sell any ADSs or cause the ADSs to be made the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the ADSs, whether directly or indirectly, to any person in Singapore other than: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to an institutional investor (as defined in Section&#160;4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time, or the SFA) pursuant to Section&#160;274 of the SFA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to a relevant person (as defined in Section&#160;275(2) of the SFA) pursuant to Section&#160;275(1) of the SFA, or any person pursuant to Section&#160;275(1A) of the SFA, and in accordance with the conditions specified in Section&#160;275 of the SFA; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Where the ADSs are subscribed or purchased under Section&#160;275 of the SFA by a relevant person which is: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">a corporation (which is not an accredited investor (as defined in Section&#160;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">securities or securities-based derivatives contracts (each term as defined in Section&#160;2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within six&#160;months after that corporation or that trust has acquired the ADSs pursuant to an offer made under Section&#160;275 of the SFA except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section&#160;275(1A) or Section&#160;276(4)(i)(B) of the SFA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">where no consideration is or will be given for the transfer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">where the transfer is by operation of law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">as specified in Section&#160;276(7) of the SFA; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">220</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(v)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">as specified in Regulation&#160;37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations&#160;2018. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">State of Qatar</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs described in this prospectus have not been, and will not be, offered, sold or delivered, at any time, directly or indirectly in the State of Qatar in a manner that would constitute a public offering. This prospectus has not been, and will not be, registered with or approved by the Qatar Financial Markets Authority or Qatar Central Bank and may not be publicly distributed. This prospectus is intended for the original recipient only and must not be provided to any other person. It is not for general circulation in the State of Qatar and may not be reproduced or used for any other purpose. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Switzerland</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other stock exchange or regulated trading facility in Switzerland. This document does not constitute a prospectus within the meaning of, and has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the ADSs or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither this document nor any other offering or marketing material relating to the offering, the Company, the ADSs have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of ADSs will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of ADSs has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or CISA. The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Taiwan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs have not been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which constitutes an offer within the meaning of the Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give advice regarding or otherwise intermediate the offering and sale of the ADSs in Taiwan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">United Arab Emirates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs have not been, and are not being, publicly offered, sold, promoted or advertised in the United Arab Emirates (including the Dubai International Financial Centre) other than in compliance with the laws of the United Arab Emirates (and the Dubai International Financial Centre) governing the issue, offering and sale of securities. Further, this prospectus does not constitute a public offer of securities in the United Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities and Commodities Authority or the Dubai Financial Services Authority. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">United Kingdom</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs may not be made in the United Kingdom, except that an offer to the public of any ADSs may be made in the United Kingdom at any time: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to any legal entity which is a qualified investor as defined under Article&#160;2 of the UK Prospectus Regulation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">221</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:344pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article&#160;2 of the UK Prospectus Regulation), subject to obtaining the prior consent of the representative for any such offer; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">in any other circumstances falling within Section&#160;86 of the Financial Services and Markets Act 2000 (as amended, the &#8220;FSMA&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;"> that no such offer of ADSs shall result in the requirement for the publication by us of a prospectus pursuant to Section&#160;85 of the FSMA or supplement a prospectus pursuant to Article&#160;23 of the UK Prospectus Regulation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the any ADSs in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and the ADSs to be offered so as to enable an investor to decide to purchase or subscribe for the ADSs, and the expression &#8220;UK Prospectus Regulation&#8221; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is only being distributed to and is only directed at: (1)&#160;persons who are outside the United Kingdom; (2)&#160;investment professionals falling within Article&#160;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the &#8220;Order&#8221;); or (3)&#160;high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article&#160;49(2)(a) to (ed) of the Order (all such persons falling within (1)-(3) together being referred to as &#8220;relevant persons&#8221;). The ADSs are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire the ADSs will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this prospectus or any of its contents. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">222</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tERT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:419pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPENSES RELATED TO THIS OFFERING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Set forth below is an itemization of the total expenses, excluding underwriting discounts and commissions, that we expect to incur in connection with this offering. With the exception of the SEC registration fee, the Financial Industry Regulatory Authority, or FINRA, filing fee, and the stock exchange market entry and listing fee, all amounts are estimates. </font>
        </div>
        <table style="width:416pt;height:114pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:332pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SEC Registration Fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:332pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">FINRA Filing Fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:332pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock Exchange Market Entry and Listing Fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">75,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:332pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printing and Engraving Expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">126,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:332pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal Fees and Expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,697,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:332pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting Fees and Expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">84,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:332pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Miscellaneous </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">155,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:332pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Total</font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,149,000</td>
            <td style="padding:0pt;padding-left:13.295pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">223</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">We are being represented by O&#8217;Melveny &amp; Myers LLP with respect to certain legal matters as to United States federal securities and New York State law. The validity of the ordinary shares represented by the ADSs offered in this offering will be passed upon for us by Maples and Calder (Hong Kong) LLP. O&#8217;Melveny &amp; Myers LLP may rely upon Maples and Calder (Hong Kong) LLP with respect to matters governed by Cayman Islands law and Commerce &amp; Finance Law Offices with respect to matters governed by PRC law. The underwriters are being represented by Ellenoff Grossman &amp; Schole LLP with respect to certain legal matters as to United States federal securities and New York State law. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">224</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:516pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of Belite Bio, Inc as of December 31, 2021 and 2020, and for each of the years in the two-year period ended December 31, 2021 have been included herein and in the registration statement in reliance upon the report of Friedman LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The office of Friedman LLP is located at One Liberty Plaza, 165 Broadway, 21st Floor, New York, NY 10006. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">225</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:468pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have filed a registration statement, including relevant exhibits, with the SEC on Form F-1 under the Securities Act with respect to the underlying ordinary shares represented by the ADSs to be sold in this offering. We have also filed a related registration statement on Form F-6 with the SEC to register the ADSs. This prospectus, which constitutes a part of the registration statement on Form F-1, does not contain all of the information contained in the registration statement. You should read our registration statements and their exhibits and schedules for further information with respect to us and the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Immediately upon the effectiveness of the registration statement on Form F-1 of which this prospectus forms a part, we will become subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we will be required to file reports, including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC can be obtained over the internet at the SEC&#8217;s website at </font><font style="font-style:italic;letter-spacing:0.2pt;">www.sec.gov</font><font style="letter-spacing:0.2pt;">.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">226</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a><a name="tICF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:426.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BELITE BIO, INC </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:146.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:412.57pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">PAGE(S) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:412.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tROIR"><font style="letter-spacing:0.2pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROIR">F-2</a></font> <a href="#tROIR"></a></td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:412.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCBSA"><font style="letter-spacing:0.2pt;">CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2020 AND 2021</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCBSA">F-3</a></font> <a href="#tCBSA"></a></td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:412.57pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCSOO"><font style="letter-spacing:0.2pt;">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2021</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOO">F-4</a></font> <a href="#tCSOO"></a></td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:412.57pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCSOCO"><font style="letter-spacing:0.2pt;">CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; DEFICIT FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2021</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOCO">F-5</a></font> <a href="#tCSOCO"></a></td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:412.57pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCSOCA"><font style="letter-spacing:0.2pt;">CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2021</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSOCA">F-6</a></font> <a href="#tCSOCA"></a></td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:412.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTCF"><font style="letter-spacing:0.2pt;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTCF">F-7</a></font>
            </td>
            <td style="padding:0pt;padding-left:8.215pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tROIR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:3pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <img src="lg_friedmanllp-4c.jpg" align="middle" alt="[MISSING IMAGE: lg_friedmanllp-4c.jpg]" height="52" width="370" ><font style="letter-spacing:0.2pt;">&#8201; </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the Shareholders and the Board of Directors of Belite Bio, Inc </font>
        </div>
        <div style="margin-top:9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion on the Consolidated Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated balance sheets of Belite Bio, Inc (the &#8220;Company&#8221;) as of December&#160;31, 2021 and 2020, and the related consolidated statements of operations and comprehensive loss, convertible preferred shares and shareholders&#8217; deficit, and cash flows for each of the&#160;years in the two year period ended December&#160;31, 2021, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the&#160;years in the two-year period ended December&#160;31, 2021, in conformity with accounting principles generally accepted in the United States of America. </font>
        </div>
        <div style="margin-top:9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Explanatory Paragraph&#8201;&#8212;&#8201;Going Concern</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has an accumulated deficit, has incurred recurring losses from operations, has an expectation of continuing operating losses for the foreseeable future, and needs to raise capital to finance its future operation. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regards to these matters are also described in Note 2. These consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties. </font>
        </div>
        <div style="margin-top:9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis for Opinion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">/s/ Friedman LLP</font> <br ><font style="letter-spacing:0.2pt;">Friedman LLP </font> <br ><font style="letter-spacing:0.2pt;">We have served as the Company&#8217;s auditor since 2021 </font> <br ><font style="letter-spacing:0.2pt;">New York, New York</font> <br ><font style="letter-spacing:0.2pt;">March&#160;15, 2022</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCBSA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:41pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BELITE BIO, INC </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED BALANCE SHEETS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousand US Dollars, except share and per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:518pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:359.93pt;">
              <font style="letter-spacing:-0.2pt;">ASSETS</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Current Assets</font>
                <br >
                <font style="font-weight:normal;letter-spacing:0.2pt;">Cash</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">25,618</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">17,344</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepayments and other current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">50</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">25,668</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">17,431</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Property and equipment, net</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">46</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">94</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepayment for property and equipment</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Deferred offering costs</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">815</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Security deposits</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">TOTAL ASSETS</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">25,741</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">18,348</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 0.833pt 0pt; width:359.93pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.2pt;">LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; DEFICIT</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Current liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other payable due to related parties</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">26</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">71</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">946</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,564</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">972</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,635</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">TOTAL LIABILITIES</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">972</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">1,635</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Commitments and contingencies</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Convertible preferred shares</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:359.93pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred shares, US$0.0001 par value, 2,377,642 shares authorized, issued and outstanding as of December&#160;31, 2020 and 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">8,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">8,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:359.93pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B convertible preferred shares, US$0.0001 par value, 5,443,272 shares authorized, issued and outstanding as of December&#160;31, 2020 and 2021</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">23,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">23,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total convertible preferred shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Shareholders&#8217; deficit</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary shares, par value of US$0.0001 per share; 492,179,086 shares authorized; </font>
                <br >
                <font style="letter-spacing:0.2pt;">9,567,997 and 10,274,403 shares issued and outstanding as of December&#160;31, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2020 and 2021, respectively</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">12,325</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated other comprehensive loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(44<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(196<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,223<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:359.93pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(7,037<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(15,093<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:359.93pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">TOTAL LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; DEFICIT</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">25,741</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">18,348</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCSOO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:224pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BELITE BIO, INC </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(in thousand US Dollars, except share and per share amounts)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:337pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Years Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Expenses</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,688</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7,419</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">General and administrative</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,055</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total operating expenses</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,743</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,797</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss from operations</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,743<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,797<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Other income (expense):</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest income</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest expense</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(21<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other income</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Total other (expense) income, net</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Loss before income tax</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,752<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Income tax expense</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Other comprehensive income (loss)</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Foreign currency translation adjustments, net of nil tax</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(152<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total comprehensive loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,747<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,818<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Weighted average number of ordinary shares used in per share calculation:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">&#8722; Basic and Diluted</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8,790,397</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,569,932</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net loss per ordinary share</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.17pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">&#8722; Basic and Diluted</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(0.65<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(1.01<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCSOCO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">BELITE BIO, INC </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">SHARES AND SHAREHOLDERS&#8217; DEFICIT </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousand US Dollars, except share)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:277.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:22.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:189.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Convertible Preferred</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Comprehensive</font>
                <br >
                <font style="letter-spacing:-0.16pt;">loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shareholders&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:189.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.25pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Balance as of January&#160;1, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">7,840,321</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">8,114</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(50<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(11,804<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(3,739<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Issuance of ordinary shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">500</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">500</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:17pt; text-indent:-8.5pt;">
                <font style="letter-spacing:0.17pt;">Issuance of ordinary shares upon conversion of other payable due to related parties</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">500</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">500</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Issuance of Series&#160;A preferred shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">1,833,892</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">6,792</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:17pt; text-indent:-8.5pt;">
                <font style="letter-spacing:0.17pt;">Issuance of Series&#160;A preferred shares upon conversion of convertible promissory notes</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">543,750</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,014</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Issuance of Series&#160;B preferred shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">5,443,272</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">23,000</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Exercise of share options</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">727,676</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">86</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">86</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Share-based compensation expense</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,363</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">1,363</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.75pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Foreign currency translation adjustment</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.25pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:-0.17pt;">Balance as of December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">7,820,914</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">9,567,997</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">10,563</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(44<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(17,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(7,037<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Exercise of share options</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">706,406</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">232</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">232</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Share-based compensation expense</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.5pt 0pt 2pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2pt 0pt; min-width:22.5pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.75pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:0.17pt;">Foreign currency translation adjustment</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:32.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:36pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(152<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(152<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:3.25pt 0pt 3.5pt 0pt; width:189.26pt;text-align:left;">
              <div style="margin-left:8.5pt;">
                <font style="letter-spacing:-0.17pt;">Balance as of December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:32.25pt; text-align:right; white-space:nowrap;">7,820,914</td>
            <td style="padding:0pt;padding-left:0.814999999999998pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:0.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:36pt; text-align:right; white-space:nowrap;">10,274,403</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:6.915pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">12,325</td>
            <td style="padding:0pt;padding-left:3.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(196<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:14.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(27,223<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.315pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:22.5pt; text-align:right; white-space:nowrap;">(15,093<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:12pt;margin-bottom:260pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:8.5pt; text-align:center; width:447.5pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCSOCA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BELITE BIO, INC </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CASH FLOWS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(In thousand US Dollars)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:574pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the&#160;years ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from operating activities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Adjustments to reconcile net loss to net cash used in operating activities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Share-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,363</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Gain on disposal of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other receivables due from related parties </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Prepayments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(35<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Other payables due to related parties </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(19<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">45</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Accrued expenses and other liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(254<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">632</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:0.2pt;">Security deposits </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(2<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Net cash used in operating activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(4,442<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(7,474<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from investing activities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Acquisition of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(74<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Prepayments for property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(20<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from disposal of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">18</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Net cash used in investing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(20<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(56<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Cash flows from financing activities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Payments of deferred offering costs</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(815<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from related party loan</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Repayment of related party loan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(2,450<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of ordinary shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceed from issuance of convertible preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">29,792</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Proceed from exercise of share options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">86</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">232</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Net cash used in financing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">28,059</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(583<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effects of exchange rate on cash</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(161<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">NET (DECREASE) INCREASE IN CASH</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">23,601</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(8,274<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">CASH AT BEGINNING OF THE YEAR</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2,017</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">25,618</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">CASH AT END OF THE PERIOD</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">25,618</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">17,344</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:366.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Conversion of convertible promissory notes and accrued interest into convertible preferred shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2,014</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:366.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Conversion of other payable due to related parties into ordinary shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the consolidated financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tNTCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:70pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BELITE BIO INC </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Amounts in thousands except for number of shares and per share data, unless otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ORGANIZATION AND BASIS OF PRESENTATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Belite Bio, Inc (&#8220;Belite&#8221; or the &#8220;Company&#8221;) was incorporated under the laws of the Cayman Islands on March&#160;27, 2018. The Company and its subsidiaries are engaged in research and development of first-in-class therapeutics targeting significant unmet needs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2016, the Company&#8217;s ultimate controlling shareholder (i.e., the sole shareholder of Belite&#8217;s principal shareholder, Lin Bioscience International Ltd.), Lin BioScience, Inc., a public company in Taiwan (stock code: 6696.TW), established Belite Bio Holdings Corp. (formerly known as Lin BioScience Holdings Corporation) and Belite Bio, LLC (formerly known as Lin BioScience, LLC), in Delaware. Belite Bio Holdings Corp. is established as an intermediate holding company and owns 100% equity interests in Belite Bio, LLC, which is mainly engaged in research and development of LBS-008 and LBS-009. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2018, Lin BioScience, Inc., established the Company in the Cayman Islands, as a subsidiary to its wholly-owned subsidiary Lin Bioscience International Ltd., for reorganization purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, as part of the reorganization, the Company&#8217;s principal shareholder, Lin Bioscience International Ltd., acquired the entire equity interest in Belite Bio Holdings Corp. from Lin BioScience, Inc. and then contributed the entire equity interest in Belite Bio Holdings Corp. to the Company in July&#160;2018, together with other considerations in exchange for the Company&#8217;s ordinary shares. Lin Bioscience International Ltd. transferred 1) cash of $900, 2) assignment of Lin BioScience, Inc.&#8217;s rights, title, interests and obligations under the exclusive license agreement by and between Lin BioScience, Inc. and Columbia University and 3) 1,600 shares of Belite Bio Holdings Corp. to the Company in exchange for its 5,340,221 ordinary shares. After above transaction, Belite Bio Holdings Corp. became Belite&#8217;s wholly-owned subsidiary, which in turn owns 100% equity interests in Belite Bio, LLC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before and after the reorganization, the Company, together with its subsidiaries, is effectively controlled by the same shareholders, and therefore the reorganization is considered a recapitalization of entities under common control in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 805-50-25. The consolidation of the Company and its subsidiaries have been accounted for at historical cost in the accompanying consolidated financial statements in accordance with ASC 805-50-45-5. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2018, Belite Bio Holdings Corp. established RBP4 Pty Ltd in Australia as its wholly-owned subsidiary for carrying out clinical trials in Australia and tax refund purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In January and February&#160;2020, the Company closed two rounds of Series&#160;A Preferred Share financing and the relevant investors became shareholders of the Company. In December&#160;2020, the Company closed a round of Series&#160;B Preferred Share financing and the relevant investors became shareholders of the Company. After the private placements, Lin Bioscience International Ltd. hold 80.10% of the Company&#8217;s equity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2021, the Company established Belite Bio (HK) Limited in Hong Kong as a wholly-owned subsidiary which established Belite Bio (Shanghai) Limited in Shanghai, China in August&#160;2021 for the purpose of carrying out clinical trials in China. As of December&#160;31, 2021, the Company&#8217;s principal subsidiaries are as follows: </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="LstPara2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;margin-bottom:5.31pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:106.5pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Subsidiaries </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">incorporation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:120pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Place of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">incorporation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:120pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:106.5pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Principal </font>
                <br >
                <font style="letter-spacing:-0.16pt;">activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.07pt 0pt 0.5pt 0pt; width:106.5pt;vertical-align:top;">
              <div style="margin-left:9pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Belite Bio Holdings Corp.</font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Belite Holding&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.07pt 0pt 0.5pt 0pt; width:72pt;">
              <font style="letter-spacing:0.18pt;">June&#160;10, 2016 </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.07pt 0pt 0.5pt 0pt; width:120pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">The United States of America </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.07pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.18pt;">100% owned by Belite </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.07pt 0pt 0.5pt 0pt; width:106.5pt;">
              <font style="letter-spacing:0.18pt;">Investment holding </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;vertical-align:top;">
              <div style="margin-left:9pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Belite Bio, LLC</font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Belite USA&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:72pt;">
              <font style="letter-spacing:0.18pt;">June&#160;10, 2016 </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">The United States of America </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">100% owned by Belite Holding </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;vertical-align:top;">
              <div style="margin-left:9pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">RBP4 Pty Ltd</font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;RBP4&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:72pt;">
              <font style="letter-spacing:0.18pt;">August&#160;13, 2018 </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.18pt;">Australia </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">100% owned by Belite Holding </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;">
              <font style="letter-spacing:0.18pt;">Clinical trial activities </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;vertical-align:top;">
              <div style="margin-left:9pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Belite Bio (HK) Limited</font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Belite HK&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:72pt;">
              <font style="letter-spacing:0.18pt;">June&#160;10, 2021 </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.18pt;">Hong Kong </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.18pt;">100% owned by Belite </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;">
              <font style="letter-spacing:0.18pt;">Investment holding </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;white-space:normal;vertical-align:top;">
              <div style="margin-left:9pt; text-indent:-9pt; line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">Belite Bio (Shanghai) Limited</font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Belite Shanghai&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:72pt;">
              <font style="letter-spacing:0.18pt;">August&#160;12, 2021 </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.18pt;">China </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.18pt;">100% owned by Belite HK </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0.32pt 0pt 0.5pt 0pt; width:106.5pt;">
              <font style="letter-spacing:0.18pt;">Clinical trial activities</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LIQUIDITY AND GOING CONCERN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">In accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The Company has incurred recurring negative cash flows since inception and has funded its operations primarily from private placement of equity and debt securities. The Company had an accumulated deficit of approximately $17.6&#160;million and $27.2&#160;million as of December&#160;31, 2020 and 2021, respectively. The Company had net losses of approximately $5.8&#160;million and $9.7&#160;million for the&#160;years ended December&#160;31, 2020 and 2021. As of the issuance date of the consolidated financial statements, the remaining contractual costs expected to be incurred in future periods for the Company&#8217;s clinical trials in STGD1 is approximately $10.0&#160;million and the Company is also obligated to make payments to Columbia University in an aggregate amount of up to $20&#160;million based on achieving specified development and regulatory approval milestones. The Company&#8217;s ability to continue as a going concern is highly contingent on the ability to raise additional capital for ongoing research and development as the Company expects to continue incurring losses for the foreseeable future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company intends to pursue a public offering of American Depositary Shares to fund future operations. If the Company is unable to complete a public offering for a sufficient amount in a timely manner, it would need to pursue other financing alternatives such as private financing of debt or equity or collaboration agreements. There can be no assurances, however, that the current operating plan will be achieved or that additional funding will be available on terms acceptable to the Company, or at all. If the Company is unable to obtain sufficient funding, it could be required to delay its development efforts, limit activities and reduce research and development costs, which could adversely affect its business prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on the Company&#8217;s recurring losses and negative cash flows from operations since inception, expectation of continuing operating losses and negative cash flows from operations for the foreseeable future, the contractual costs expected to be incurred in future periods and the need to raise additional capital to finance its future operations, the Company&#8217;s management concluded that there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the issuance date of the consolidated financial statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis of presentation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000003pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Principle of consolidation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated on consolidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Use of estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Significant accounting estimates reflected in the Company&#8217;s consolidated financial statements include, but are not limited to, valuation of ordinary shares, share options, valuation allowance for deferred income tax assets, useful lives for property and equipment and share-based compensation. Management bases the estimates on historical experience and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Accordingly, actual results could differ from those estimates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risk and uncertainties</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The product candidates developed by the Company require approvals from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) or foreign regulatory agencies prior to commercial sales. There can be no assurance that the Company&#8217;s current and future product candidates will receive the necessary approvals or be commercially successful. If the approval is denied or delayed, it will have a material adverse impact on the business and consolidated financial statements of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Generally, the industry in which the Company operates subjects the Company to a number of other risks and uncertainties that can affect its operating results and financial condition. Such factors include, but are not limited to: the timing, costs and results of clinical trials and other development activities versus expectations; the ability to manufacture products successfully; competition from products sold or being developed by other companies; the price of, and demand for products once approved; the ability to negotiate favorable licensing or other manufacturing and marketing agreements for its products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair value measurements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company applies ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ASC 820 requires disclosures to be provided for fair value measurements. ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;1&#8201;&#8212;&#8201;Observable inputs such as quoted prices for identical instruments in active markets; </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;2&#8201;&#8212;&#8201;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Level&#160;3&#8201;&#8212;&#8201;Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ASC 820 describes three main approaches to measuring the fair value of assets and liabilities: (1)&#160;market approach; (2)&#160;income approach; and (3)&#160;cost approach. The market approach uses prices and other relevant information generated from market transactions involving identical or comparable assets or liabilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The income approach uses valuation techniques to convert future amounts to a single present value amount. The measurement is based on the value indicated by current market expectations about those future amounts. The cost approach is based on the amount that would currently be required to replace an asset. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments of the Company primarily include cash, accrued expenses and other liabilities, other payable due to related parties and convertible preferred shares. Convertible preferred shares were initially recorded at issue price net of issuance costs. The fair value of the other financial instruments closely approximates their fair value due to their short maturities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cash consists of demand deposits and time deposits placed with banks and have original maturities of less than three&#160;months. All cash is unrestricted as to withdrawal and use. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deferred offering costs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred offering costs consist of legal and other costs incurred through the balance sheet date that are directly related to the Company&#8217;s initial public offering and that will be charged to shareholder&#8217;s deficit upon the completion of the initial public offering. Should the initial public offering prove to be unsuccessful, the deferred offering costs, will be charged to operating expense in the consolidated statement of operations and comprehensive loss. During the&#160;years ended December&#160;31, 2020 and 2021, the Company incurred nil and $815 of offering costs, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Property and equipment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment are stated at cost less accumulated depreciation and impairment if applicable. Property and equipment consist of machinery and laboratory equipment. Depreciation is computed on a straight-line basis over estimated useful lives which are 5&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Repair and maintenance costs are charged to expense as incurred, whereas the costs of betterments that extend the useful life of property and equipment are capitalized as additions to the related assets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Retirements, sale and disposals of assets are recorded by removing the cost and accumulated depreciation with any resulting gain or loss reflected in the consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Long-lived asset impairment</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates the recoverability of long-lived assets whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. When these events occur, the Company evaluates the recoverability of long-lived assets by comparing the carrying amount of the assets to the future undiscounted cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted cash flows is less than the carrying amount of the assets, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their fair value. Fair value is generally determined by discounting the cash flows expected to be generated by the assets, when the market prices are not readily available. The adjusted carrying amount of the assets become new cost basis and are depreciated over the assets&#8217; remaining useful lives. No impairment loss was recorded for the year ended December&#160;31, 2020 and 2021. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Segment reporting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In accordance with ASC 280, Segment Reporting, the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) has been identified as the Chief Executive Officer. The Company&#8217;s CODM reviews the consolidated results of operations when making decisions about allocating resources and assessing performance of the Company. The Company operates and manages it business as a single segment. The Company does not distinguish between markets for the purpose of making decisions about resources allocation and performance assessment. Hence, the Company has only one operating segment and one reportable segment. No geographical segments are presented as substantially all the Company&#8217;s long-lived assets are located in Australia. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses primarily include (1)&#160;payroll, share-based compensation and other related costs of personnel engaged in research and development activities, (2)&#160;in-licensed patent rights fee of exclusive development rights of drugs granted to the Company, (3)&#160;costs related to preclinical testing of the Company&#8217;s technologies and clinical trials such as payments to contract research organizations (&#8220;CRO&#8221;) and contract manufacturing organizations (&#8220;CMO&#8221;), investigators and clinical trial sites that conduct the clinical studies; (4)&#160;costs to develop the product candidates, including raw materials and supplies, product testing, depreciation, and facility related expenses, (5)&#160;other research and development expenses. Research and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">development expenses are charged to expense as incurred when these expenditures relate to the Company&#8217;s research and development services and have no alternative future uses in accordance with ASC 730, Research and Development. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accrued research and development expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company is required to estimate its expenses resulting from its obligations under contracts with vendors, consultants and CROs, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which the services are provided under such contracts. The Company reflects research and development expenses in the consolidated financial statements by matching those expenses with the period in which services and efforts are expended. The Company account for these expenses according to the progress of the preclinical or clinical study as measured by the timing of various aspects of the study or related activities and determine accrual estimates through review of the underlying contracts along with discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a study, the Company adjusts its rate of expense recognition if actual results differ from its estimates. Estimates for accrued research and development expenses are classified as accrued expenses on the accompanying consolidated balance sheet. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021, the Company has several ongoing clinical studies in various clinical trial stages. The contracts with CRO and CMO are generally cancellable, with notice, at the Company&#8217;s option. The Company did not record any accrued expenses related to cancellation of CRO or CMO contracts as of December&#160;31, 2020 and 2021 as the Company did not have any plan to cancel the existing CRO or CMO contracts. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Leases are classified at the inception date as either a capital lease or an operating lease. The Company assesses a lease to be a capital lease if any of the following conditions exists: a) ownership is transferred to the lessee by the end of the lease term, b) there is a bargain purchase option, c) the lease term is at least 75% of the property&#8217;s estimated remaining economic life or d) the present value of the minimum lease payments at the beginning of the lease term is 90% or more of the fair value of the leased property to the lessor at the inception date. A capital lease is accounted for as if there was an acquisition of an asset and an incurrence of an obligation at the inception of the lease. The Company had no capital leases for the&#160;years presented. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All other leases are accounted for as operating leases wherein rental payments are expensed on a straight-line basis over their respective lease terms. The lease term begins on the date of initial possession of the leased property for purpose of recognizing lease expense on straight-line basis over the term of the lease. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Income tax</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company accounts for income taxes under the liability method. Under the liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and income tax bases of assets and liabilities and are measured using the tax income rates that will be in effect when the differences are expected to reverse. A valuation allowance is recorded if it is more likely than not that some portion or all of a deferred income tax assets will not be realized in the foreseeable future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company evaluates its uncertain tax positions using the provisions of ASC 740-10, Income Taxes, which prescribes a recognition threshold that a tax position is required to meet before being recognized in the financial statements. The Company recognizes in the financial statements the benefit of a tax position which is &#8220;more likely than not&#8221; to be sustained under examination based solely on the technical merits of the position assuming a review by tax authorities having all relevant information. Tax positions that meet the recognition threshold are measured using a cumulative probability approach, at the largest amount of tax benefit that has a greater than fifty&#160;percent likelihood of being realized upon settlement. It is the Company&#8217;s policy to recognize interest and penalties related to unrecognized tax benefits, if any, as a component of income tax expense. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Convertible preferred shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preferred shares are redeemable by the holders upon a liquidation event, including a deemed liquidation event, which outside the sole control of the Company, and as such are presented as mezzanine equity. In accordance with ASC 480-10-S99, each issuance of the convertible preferred shares should be recognized at the issuance date fair value, net of issuance costs. The Company did not incur material issuance cost for any preferred shares issued. The non-cumulative undeclared dividends are not recorded in the consolidated balance sheet as the Company does not have the obligation to pay the cumulative dividend before it is declared by the board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company assesses whether an amendment to the terms of its convertible preferred shares is an extinguishment or a modification using the fair value model. When convertible preferred shares are extinguished, the difference between the fair value of the consideration transferred to the convertible preferred shareholders and the carrying amount of the convertible preferred shares (net of issuance costs) is treated as deemed dividends to the preferred shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Loss per share</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Basic loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by weighted average number of ordinary shares outstanding during the period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company uses the two-class method whereby net loss is allocated between ordinary shares and other participating securities based on dividends declared (or accumulated) and participating rights in undistributed earnings as if all the earnings for the reporting period had been distributed. The Company&#8217;s convertible preferred shares are participating securities as the preferred shares are entitled to receive dividends or distributions on an as converted basis. During periods of loss, the Company allocates no loss to participating securities because the holders of convertible preferred shares have no contractual obligation to share in the losses of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Diluted net loss per share is calculated by dividing net loss attributable to ordinary shareholders, as adjusted for the effect of dilutive ordinary equivalent shares, if any, by the weighted average number of ordinary and dilutive ordinary equivalent shares outstanding during the period. Ordinary equivalent shares include ordinary shares issuable upon the conversion of the convertible preferred shares using the if- converted method, and ordinary shares issuable upon the exercise of share options, using the treasury stock method. Ordinary share equivalents are excluded from the computation of diluted earnings per share if their effects are anti-dilutive. For the periods presented herein, the computation of basic net loss per share using the two-class method is not applicable as the Company is in a net loss position and the participating securities do not have contractual rights and obligations to share in the losses of the Company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share-based compensation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Awards Granted to Employees</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company grants share options to eligible employees, management and directors and accounts for these share-based awards in accordance with ASC 718 Compensation-Stock Compensation. Employees&#8217; share- based awards are measured at the grant date fair value of the awards and recognized as expenses a)&#160;immediately at grant date if no vesting conditions are required; or b) using graded vesting method over the requisite service period, which is the vesting period, on a straight-line basis; c) for share-based awards granted with performance condition, using graded vesting method over the period based on the expected milestone achievement dates. Share-based compensation expense is recorded in research and development and general and administrative expenses based on the classification of the work performed by the grantees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s determination of the fair value of share option on the date of grant utilized the Binominal Option Pricing Model with the assistance of an independent third-party valuation firm. Grant date fair value was impacted by Belite&#8217;s ordinary share price as well as changes in assumptions regarding a number of subjective variables which included, but were not limited to, the expected term that options remained outstanding, the expected ordinary share price volatility over the term of the option awards, risk-free interest rates, and expected dividends. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:56pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent the required vesting conditions are not met resulting in the forfeiture of the share-based awards, previously recognized compensation expense relating to those awards are reversed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Awards Granted to Non-Employees</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has accounted for equity instruments issued to non-employees in accordance with ASU No. 2018-07, Compensation&#8201;&#8212;&#8201;Stock Compensation (Topic 718): Improvements to Nonemployee Share- Based Payment Accounting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company recognizes share-based compensation cost for equity awards to non-employees with a performance condition at the fixed fair value on date of grant over the period based on the expected milestone achievement dates as the derived service period (usually the vesting period), on a straight-line basis. The Company considers the probable outcome of that performance condition when determines share-based compensation expenses and will recognize a cumulative true-up adjustment if the probability of the conditions has changed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Translation of foreign currency financial statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The functional currency is the local currency of the respective entities. The United States dollar (&#8220;$&#8221;) is the functional currency of the Company&#8217;s entities incorporated in the Cayman Islands, the United States and Hong Kong; the functional currency of the Company&#8217;s Australia subsidiary and Shanghai subsidiary are Australian dollar (&#8220;AU$&#8221;) and Renminbi (&#8220;RMB&#8221;), respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The reporting currency of the Company is the United States dollar. Accordingly, the financial statements of the foreign subsidiaries are translated at the following exchange rates: assets and liabilities&#8201;&#8212;&#8201;current rate on balance sheet date; shareholders&#8217; equity&#8201;&#8212;&#8201;historical rate; income and expenses&#8201;&#8212;&#8201;weighted average rate during the year. The resulting translation adjustment is reflected in the accumulated other comprehensive loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Transactions denominated in other than the functional currencies are recorded at the rate of exchange in effect when the transaction occurs. Gains or losses, resulting from the application of different foreign exchange rates when cash in foreign currency is converted into the entities&#8217; functional currency, or when foreign currency receivable and payable are settled, are credited or charged to income in the period of conversion or settlement. At year-end, the balances of foreign currency monetary assets and liabilities are recorded based on prevailing exchange rates and any resulting gains or losses are included in the consolidated statements of comprehensive loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comprehensive loss</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Comprehensive loss represents net loss plus the results of certain changes in shareholders&#8217; deficit during a period from non-owner sources. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Comprehensive loss is defined as the changes in equity of the Company during a period from transactions and other events and circumstances excluding transactions resulting from investments by owners and distributions to owners. Among other disclosures, ASC 220, Comprehensive Income, requires that all items that are required to be recognized under current accounting standards as components of comprehensive loss be reported in a financial statement that is displayed with the same prominence as other financial statements. For each of the years presented, the Company&#8217;s comprehensive loss includes net loss and foreign currency translation adjustments, which are presented in the consolidated statements of comprehensive loss. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Concentration of risks</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Concentration of suppliers</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following suppliers accounted for 10% or more of research and development expenses for the&#160;years ended December&#160;31, 2020 and 2021: </font>
        </div>
        <table style="width:416pt;height:113.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Supplier </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">A</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,385</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">B</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,213</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">C</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">776</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">765</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">D</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,187</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">E</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">448</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">F</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">442</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">G</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">423</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Represents less than 10% of research and development expenses for the&#160;years ended December&#160;31, 2020 and 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Concentration of credit risk</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2020 and 2021, the aggregate amount of cash of US$ 22,027 and US$ 9,973 respectively, were held at major financial institutions located in the Republic of China (&#8220;R.O.C.&#8221; or &#8220;Taiwan&#8221;), and US$ 3,591 and US$ 7,371, respectively, were deposited with major financial institutions located outside the R.O.C.. These financial institutions are of high credit quality and management continually monitors the credit worthiness of these financial institutions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent Accounting Pronouncements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In February&#160;2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use asset and lease liability on the balance sheet for all leases, including operating leases, with a term in excess of 12&#160;months. The guidance also expands the quantitative and qualitative disclosure requirements. In July&#160;2018, the FASB issued updates to the lease standard making transition requirements less burdensome. The update provides an option to apply the transition provisions of the new standard at its adoption date instead of at the earliest comparative period presented in the Company&#8217;s financial statements. The new guidance requires the lessee to record operating leases on the balance sheet with a right-of-use asset and corresponding liability for future payment obligations. FASB further issued ASU 2018-11 &#8220;Target Improvement&#8221; and ASU 2018-20 &#8220;Narrow-scope Improvements for Lessors.&#8221; In June&#160;2020, the FASB issued ASU No. 2020-05, &#8220;Revenue from Contracts with Customers (Topic 606) and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Leases (Topic 842) Effective Dates for Certain Entities&#8221; &#8203;(&#8220;ASU 2020-05&#8221;) in response to the ongoing impacts to businesses in response to the coronavirus (COVID-19) pandemic. ASU 2020-05 provides a limited deferral of the effective dates for implementing previously issued ASU 842 to give some relief to businesses and the difficulties they are facing during the pandemic. ASU 2020-05 affects entities in the &#8220;all other&#8221; category and public Not-For-Profit entities that have not gone into effect yet regarding ASU 2016-02, Leases </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(Topic 842). Entities in the &#8220;all other&#8221; category may defer to fiscal&#160;years beginning after December&#160;15, 2021, and interim periods within fiscal&#160;years beginning after December&#160;15, 2022. The adoption of this amendment is not expected to have a material impact on the Company&#8217;s consolidated financial statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2019, the FASB issued an accounting update which eliminated certain exceptions to the general principles in ASC 740, such as recognizing deferred taxes for equity investments, the incremental approach to performing intra-period tax allocation, and calculating income taxes in interim periods. The standard also simplified income tax accounting for franchise taxes that are partially based on income, transactions with a government that result in a step-up in the tax basis of goodwill, separate financial statements of legal entities that are not subject to tax, and enacted changes in tax laws in interim period. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This amendment is effective for fiscal&#160;years beginning after December&#160;15, 2020. Early adoption is permitted. The adoption of this amendment is not expected to have a material impact on the Company&#8217;s consolidated financial statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company&#8217;s consolidated balance sheets, statements of operations and comprehensive loss and statements of cash flows. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PREPAYMENTS AND OTHER CURRENT ASSETS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prepayments and other current assets consist of the following: </font>
        </div>
        <table style="width:416pt;height:82.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:326.35pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Prepayments </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">&#8722; Prepayments for other services </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">64</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deductible value-added tax input </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">40</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">23</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">50</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">87</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:12.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:12.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPERTY AND EQUIPMENT, NET</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Property and equipment consist of the following: </font>
        </div>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:9.99999999999997pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laboratory equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">92</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">141</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Less: accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:9.75pt; text-align:right; white-space:nowrap;">(46<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(47<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:326.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:9.75pt; text-align:right; white-space:nowrap;">46</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">94</td>
            <td style="padding:0pt;padding-left:3.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation expenses recognized during the&#160;years ended December&#160;31, 2020 and 2021, were approximately $17 and $30, respectively. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accrued expenses and other current liabilities consist of the following: </font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">488</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">741</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Legal and consulting </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">266</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">525</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">License royalties </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">187</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">147</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:326.35pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">151</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.75pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">946</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,564</td>
            <td style="padding:0pt;padding-left:1.485pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:12.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.</font>
          <br >
        </div>
        <div style=" margin-top:12.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CONVERTIBLE PREFERRED SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January and February&#160;2020, the Company issued 2,377,642 shares of Series&#160;A convertible preferred shares (&#8220;Series&#160;A Preferred Shares&#8221;) with a par value $0.0001 per share at $3.7036 per share for a total consideration of (i)&#160;cash $6,792 and (ii)&#160;notes principal plus unpaid interests $2,014 in convertible promissory notes issued in October, 2019. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2020, the Company issued 5,443,272 shares of Series&#160;B convertible preferred shares (&#8220;Series&#160;B Preferred Shares&#8221;) with a par value $0.0001 per share to a group of investors at $ 4.2254 per share for a cash consideration of $23,000. The shareholder agreement therefore was amended and restated to reflect the issuance of Series&#160;B in the liquidation preference. Other than above, the rights and obligations for shareholders of Series&#160;A Preferred Shares and Series&#160;B Preferred Shares are consistent. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Convertible preferred share consisted of the following as of December&#160;31, 2020 and 2021 (in thousands, except share): </font>
        </div>
        <table style="width:456pt;height:94.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:179.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2020 and 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:179.89pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Preferred</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Authorized </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Preferred</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Issued and</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Outstanding </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Liquidation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Issuable Upon</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Conversion </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:179.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A Preferred Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,377,642</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,377,642</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,806</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,377,642</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:179.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Preferred Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,443,272</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,443,272</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">23,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">23,000</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">5,443,272</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:179.89pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">7,820,914</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">7,820,914</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">31,806</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">7,820,914</td>
            <td style="padding:0pt;padding-left:3.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Key terms of the Series&#160;A Preferred Shares and Series&#160;B Preferred Shares (collectively the &#8220;Preferred Shares&#8221;) are summarized as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting right</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Preferred Share has voting rights equivalent to the number of ordinary shares to which it is convertible at the record date. The Preferred Shares shall vote separately as a class with respect to certain specified matters. Otherwise, the preferred shareholders and ordinary shareholders shall vote together as a single class. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends right</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each holder of the Preferred Shares will be entitled to receive non-cumulative dividends when declared by the Board of Directors prior and in preference to ordinary shareholders. The dividend should be paid at the rate of 6% of the original issue price per share per annum on each Preferred Shares. After the preferential dividends relating to the Preferred Shares have been paid in full or declared and set apart in any fiscal year of the Company, any additional dividends out of funds or assets legally available therefore may be declared in that fiscal year for the Shares and, if such additional dividends are declared, the preferred shareholders shall be entitled to participate on an as converted-basis pro-rata in any dividends or distributions paid to the ordinary shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conversion rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each holder of Preferred Shares shall have the right, at such holder&#8217;s sole discretion, to convert all or any portion of the Preferred Shares into ordinary shares based on a one-for-one basis at any time. The initial conversion price is the issuance price of Preferred Shares, subject to adjustment in the event of stock splits, share combinations, share dividends and distribution, reorganization, mergers, consolidations, reclassifications, exchanges, substitutions, or dilutive issuance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Preferred Shares will be automatically converted into ordinary shares at the then-effective conversion price upon the earlier of (1)&#160;the closing of a Qualified Initial Public Offering, or (2)&#160;the date specified by written consent or agreement of majority holders of Preferred Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidation preference</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, or any deemed liquidation event as defined in the Company&#8217;s articles of association, the holders of Preferred Shares are entitled to receive, prior to any distribution to the holders of ordinary shares, an amount per share equal to the original issue price, plus accrued but unpaid dividends (the &#8220;Preference Amount&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event insufficient funds are available to pay in full the Preference Amount in respect of each preferred shareholders, the sequence of liquidation right of all series of preferred shares was as follows: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1) Series&#160;B Preferred Shares </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2) Series&#160;A Preferred Shares </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:76.41pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">After the Preference Amount has been paid, any remaining funds or assets legally available for distribution shall be distributed pro&#160;rata among the preferred shareholders together with ordinary shares. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SHARE-BASED COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;17, 2019, the Company adopted a share incentive plan (&#8220;2019 Plan&#8221;). Under the 2019 Plan, the Company&#8217;s Board of Directors has approved that a maximum aggregate number of shares that may be issued pursuant to all awards granted shall be 1,960,080. On December&#160;23, 2020, the Company replaced 2019 Plan with the amended and restated share incentive plan (&#8220;2020 Plan&#8221;) and increased the maximum number of shares issuable to 4,165,310. The terms of the 2019 Plan and 2020 Plan are substantially the same other than the maximum aggregate number of shares the Company may issue under the respective plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Share options containing only service conditions granted to each grantee under the 2019 Plan and 2020 Plan will generally be exercisable upon the grantee renders service to the Company in accordance with a stipulated vesting schedule. Grantees are generally subject to a vesting schedule of no longer than three&#160;years, under which the grantee earns an entitlement to vest a certain&#160;percentage of his option grants at the end of each month or year of completed service. The share option awards shall expire no more than 10&#160;years from their grant dates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Share options containing both service conditions and performance conditions granted to each grantee under the 2019 Plan and 2020 Plan shall become eligible for vesting upon the occurrence of their applicable performance conditions (including but not limited to the completion of business and operational goals, etc.). </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of options was determined using the Binomial Option Pricing Model, with the assistance from an independent third-party appraiser. The binomial model requires the input of highly subjective assumptions, including the expected volatility, the exercise multiple, the risk-free interest rate and the expected dividend yield. For expected volatility, the Company has made reference to historical volatility of several comparable companies in the same industry. The exercise multiple was estimated as the average ratio of the stock price to the exercise price of when employees would decide to voluntarily exercise their vested share options. As the Company did not have sufficient information of past employee exercise history, the exercise multiple was based on management&#8217;s estimation. The risk-free rate for periods within the contractual life of the options is based on the market yield of U.S. Government Notes with a maturity life equal to the remaining maturity life of the options as of the valuation date. The expected dividend yield is based on our expected dividend policy over the contractual life of the options. </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The assumptions used to estimate the fair value of the share options on the date of grant are as follows: </font>
        </div>
        <table style="width:416pt;height:77.5000000000001pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:191.51pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:72.28pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;17,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;23,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:50.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of March&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:191.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1.72%&#8201;&#8211;&#8201;1.74% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:65.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.51% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:50.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.87% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:191.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility range </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">35.50%&#8201;&#8211;&#8201;35.72% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:65.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">36.59% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:50.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">36.75% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:191.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercise multiple </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2.8 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:65.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2.8 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:50.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2.8 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:191.51pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:72.28pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:65.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:50.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A summary of the Company&#8217;s stock option activity under the plans for the&#160;years ended December&#160;31, 2020 and 2021 is presented as follows: </font>
        </div>
        <table style="width:456pt;height:217.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:206.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Grant Date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Term (Years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Intrinsic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of January&#160;1, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,335,794</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.1191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.4720</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.96</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,301</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,807,381</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.2574</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(727,676<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.1191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.4720</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Forfeited or expired</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(19,601<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">0.1191</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2.4733</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding as of December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,395,898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.3832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.2946</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.80</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7,834</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Granted</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">41,736</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4.2254</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.4626</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Exercised</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(706,406<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0.3289</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2.3311</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:206.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Forfeited or expired</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(748,667<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">0.4386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">2.2574</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:206.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding Options, December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,982,561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">0.4626</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">2.2571</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">8.82</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,480</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:206.85pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Vested and Expected to Vest Options as of December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">844,774</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:21pt; text-align:right; white-space:nowrap;">0.3935</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;padding-bottom:1.75pt; min-width:21pt; text-align:right; white-space:nowrap;">2.3052</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">8.58</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,969</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:206.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exercisable Options as of December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">356,067</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:21pt; text-align:right; white-space:nowrap;">0.2291</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:21pt; text-align:right; white-space:nowrap;">2.4192</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">7.99</td>
            <td style="padding:0pt;padding-left:12.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">891</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">77</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">52</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">General and administrative</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,286</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,478</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:304.73pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,363</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,530</td>
            <td style="padding:0pt;padding-left:4.965pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:10.22pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Total unrecognized employee share-based compensation expense, may be adjusted for actual forfeitures occurring in the future, were $2,633 and $771 which are expected to be recognized over a weighted-average period of 1.68&#160;years and 2.77&#160;years as of December&#160;31, 2020 and 2021, respectively. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:5.22pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.</font>
          <br >
        </div>
        <div style=" margin-top:5.22pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INCOME TAX</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.22pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is not subject to income or other taxes in the Cayman Islands. However, subsidiaries are subject to taxes of the jurisdiction where they are located. </font>
        </div>
        <div style="margin-top:10.02pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Cayman Islands</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is incorporated in the Cayman Islands. Under the current laws of the Cayman Islands, the Company is not subject to tax on income or capital gain. Additionally, the Cayman Islands does not impose a withholding tax on payments of dividends to shareholders. </font>
        </div>
        <div style="margin-top:10.03pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">United States</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Belite Bio Holdings Corp. and Belite Bio, LLC are subject to U.S. federal corporate income tax at a rate of 21% and state income tax in California at a rate of 8.84%. </font>
        </div>
        <div style="margin-top:9.92pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Hong Kong</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Belite Bio (HK) Limited is subject to Hong Kong profits tax on the taxable income as reported in the respective statutory financial statements adjusted in accordance with the relevant Hong Kong tax laws. The applicable tax rate in Hong Kong is 8.25% for assessable profits on the first HK$2 million and 16.5% for any assessable profits in excess.</font>
        </div>
        <div style="margin-top:9.93pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Australia</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">RBP4 Pty Ltd is subject to Australia profits tax on the taxable income as reported in their respective statutory financial statements adjusted in accordance with the relevant Australia tax laws. The applicable tax rate in Australia is 30%. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">PRC</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Provision for PRC corporate income tax is calculated based on the statutory income tax rate of 25% on the assessable income of Belite Shanghai during the year ended December&#160;31, 2021 in accordance with relevant PRC enterprise income tax legislation, interpretations and practices. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No provision for PRC corporate income tax has been made for the year ended December&#160;31, 2021 as Belite Shanghai had no such assessable profit for the year then ended. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company and its subsidiaries file separate income tax returns. The applicable statutory income tax rate in the Cayman Islands was zero for the Company for the&#160;years being reported. Reconciliation between the income tax expense computed by applying the statutory tax rate to loss before income tax and the actual provision for income tax is as follows: </font>
        </div>
        <table style="width:416pt;height:136.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">(In Thousands)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Years ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Federal statutory tax rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">21<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">21<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">State taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">8.84<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">8.84<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Withholding tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">0.02<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">0.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development credit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(0.03<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(0.33<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-deductible expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(0.27<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(0.20<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Changes in valuation allowances </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(29.54<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(29.31<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effective tax rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">0.02<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">0.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deferred income tax assets and liabilities as of December&#160;31, 2020 and 2021 consisted of the following: </font>
        </div>
        <table style="width:416pt;height:113pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:317.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:317.93pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Deferred income tax assets </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:317.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Research and development credits </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">59</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.93pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Net operating loss carryforwards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,687</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">4,005</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:317.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,746</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">4,108</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:317.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,746<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,108<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:317.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total net deferred income tax assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Realization of the net deferred tax assets is dependent on factors including future reversals of existing taxable temporary differences and adequate future taxable income, exclusive of reversing deductible temporary differences and tax loss carry forwards. The Company evaluates the potential realization of deferred tax assets on an entity-by-entity basis. As of December&#160;31, 2020 and 2021, the Company and all of its subsidiaries were in cumulative loss position, valuation allowances were provided against deferred tax assets in entities where it was determined it was more likely than not that the benefits of the deferred tax assets will not be realized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2020 and 2021, Belite Bio, LLC had U.S. federal and state research and development credit carryforwards of approximately $59 and $103, respectively. The U.S. federal research and development credit will expire from 2039 if not utilized, while the state research and development credit will never expire. Utilization of the research and development credits may be subject to significant annual limitation due to the ownership change limitations provided by the U.S. Internal Revenue Code of 1986 and similar provisions in the State of California&#8217;s tax regulations. The annual limitation may result in the expiration of federal research and development credits before utilization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2020 and 2021, the Company&#8217;s subsidiaries had U.S. net operating loss carryforwards for federal and state tax purposes of approximately $3,687 and $4,005, respectively. If not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:17.51pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">utilized, the federal and state net operating loss carryforwards incurred before January&#160;1, 2018 will begin to expire in 2036, and the remaining can be carried forward indefinitely but utilization is limited to 80% of the Company&#8217;s taxable income in any given tax year based on current federal tax laws. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AUSTRALIA RESEARCH AND DEVELOPMENT TAX INCENTIVE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s wholly owned subsidiary, RBP4 Pty Ltd, which conducts clinical development activities on behalf of the Company, is eligible under the Australian Research and Development Tax Incentive Program to receive a 43.5% refundable tax incentive from the Australian Taxation Office for qualified research and development expenditures. To be eligible, RBP4 Pty Ltd must have revenue of less than AU$20&#160;million during the reimbursable period and cannot be controlled by income tax exempt entities. The tax incentive is recognized as a reduction to research and development expense when there is reasonable assurance that the tax incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured. For the&#160;years ended December&#160;31, 2020, and 2021, $779 and $339, respectively, were recorded in the consolidated statements of operations and comprehensive loss. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ORDINARY SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2020 and 2021 the Company was authorized to issue 492,179,086 shares of $0.0001 par value ordinary shares. Holders of the Company&#8217;s ordinary shares are entitled to dividends, if and when, declared by the board of directors of the Company and after any convertible preferred share dividends are fully paid. The holder of each share of common stock is entitled to one vote. As of December&#160;31, 2021, no dividends were declared. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.</font>
          <br >
        </div>
        <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NET LOSS PER SHARE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Basic and diluted net loss per share for the&#160;years ended December&#160;31, 2020 and 2021 are calculated as follows: </font>
        </div>
        <table style="width:416pt;height:111.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:289.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:289.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Numerator:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:289.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss attributable to ordinary shareholders</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(5,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(9,666<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:289.17pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Denominator:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 1.833pt 0pt; width:289.17pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted average number of ordinary shares outstanding&#8201;&#8211;&#8201;basic and diluted</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">8,790,397</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,569,932</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:289.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net loss per share&#8201;&#8211;&#8201;basic and diluted</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(0.65<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(1.01<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For the&#160;years ended December&#160;31, 2020 and 2021, the effects of all outstanding convertible preferred shares and share options have been excluded from the computation of diluted loss per share as their effects would be anti-dilutive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The potentially dilutive securities that have not been included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive are as follows: </font>
        </div>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:294.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:294.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Convertible preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">7,820,914</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7,820,914</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:294.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Outstanding share options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">3,395,898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">1,982,561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:294.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">11,216,812</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,803,475</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">13.</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RELATED PARTY TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The table below sets forth the major related parties and their relationships with the Company as of December&#160;31, 2020 and 2021: </font>
        </div>
        <table style="width:456pt;height:65.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of related parties </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Relationship with the Company</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Lin BioScience, Inc. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The ultimate shareholder of the Company </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Lin Bioscience International Ltd. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">The shareholder of the Company</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Lin BioScience Pty Ltd </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:222pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Controlled by the ultimate shareholder of the Company</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.1pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company and its subsidiaries entered into several research and development services agreements with several related parties, including: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;1, 2020, Lin BioScience, Inc. and the Company entered into the LBS-009 R&amp;D services agreement; whereby Lin BioScience, Inc. agreed to provide preclinical studies services for pipeline LBS-009 to the Company. The Company agreed to pay services fees in an amount equal to 110% percent of actual costs for its performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. The LBS-009 R&amp;D services agreement terminated on June&#160;30, 2021. For the year ended December&#160;31 2020 and 2021, the Company did not receive any services connected to above agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lin BioScience, Inc. and the Company also entered into the LBS-008 R&amp;D services agreements on July&#160;1, 2020 and July&#160;1, 2021, whereby Lin BioScience, Inc. agreed to provide certain new drug development services for pipeline LBS-008 to the Company. The Company agreed to pay services fees in an amount equal to 110% percent of actual costs for its performance of such development services and to reimburse the actual expenses for transportation, travel and lodging for the performance of such development services. For the year ended December&#160;31 2020 and 2021, the Company recorded nil and $183 in research and development expenses, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to above research and development agreements, the Company and its subsidiaries also entered into certain loan agreements with related parties since 2019, including: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the loan agreements entered into in 2019, Lin Bioscience International Ltd. agreed to provide an interest-free loan on request from time to time for a period of one year from July&#160;2019. In July&#160;2020, Belite Bio, Inc had fully repaid the outstanding amount under the loan agreements with Lin Bioscience International Ltd. For the year ended December&#160;31, 2020, the proceeds received from and repayment made to Lin Bioscience International Ltd. were nil and $1,180, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2019 and 2020, RBP4 entered into several related party loan agreements with Lin BioScience Pty Ltd, whereby Lin BioScience Pty Ltd, agreed to provide interest-free loans on request from time to time for a period of one year commencing from July&#160;2019. In January&#160;2020, RBP4 had fully repaid the outstanding amount under the loan agreements with Lin BioScience Pty Ltd. For the year ended December&#160;31, 2020, the proceeds received from and repayment made to Lin BioScience Pty Ltd. were $131 and $580, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2019 and 2020, Lin BioScience, Inc. entered into a related party funding agreement with RBP4 and the Company. Pursuant to the agreement, Lin BioScience, Inc. agreed to provide loans on request from time to time for a period of one year. In July&#160;2020 the Company and RBP4 had fully repaid the outstanding amount under the loan agreements with Lin BioScience, Inc. For the year ended December&#160;31, 2020, the proceeds received from and repayment made to Lin BioScience, Inc. were nil and $690, respectively. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Related party balances</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:52pt;margin-left:20pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:326.35pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Due to related parties</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:326.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lin BioScience, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">26</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">71</td>
            <td style="padding:0pt;padding-left:5.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="GoBack">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;font-style:italic;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Related party transactions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the&#160;years ended December&#160;31, 2020 and 2021, related party transactions consisted of the following: </font>
        </div>
        <table style="width:416pt;height:86pt;margin-left:20pt;margin-top:8pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Years ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:304.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:304.73pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Lin BioScience, Inc.: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and Development Expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">183</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Professional Service Expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">21</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:304.73pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest Expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">17</td>
            <td style="padding:0pt;padding-left:10.32pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.82pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:12.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">14.</font>
          <br >
        </div>
        <div style=" margin-top:12.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">COMMITMENTS AND CONTINGENCIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">License Agreement with Columbia University</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company is party to an exclusive license agreement with Columbia University (as amended, the &#8220;Columbia License Agreement&#8221;), which has been amended five times, most recently as of February&#160;4, 2022, under which the Company licenses specified intellectual property from Columbia University. The patent rights licensed to the Company by Columbia University include issued patents with claims that recite a class of compounds directed to covering the Company&#8217;s lead compound, LBS-008, and specifically recite LBS-008. The license agreement requires the Company to make minimum annual royalty payments to Columbia University of specified amounts on each anniversary of the first commercial sale of a licensed product, commencing on the second anniversary of such sale. The Company will also be obligated to pay single-digit earned royalties to Columbia University based on net sales of each licensed product by the Company and its affiliates and sublicensees. The minimum royalty payments will be creditable against the earned royalties accrued during the same calendar year. The license agreement obligates the Company to use commercially reasonable efforts to research, discover, develop and market licensed products for commercial sale and distribution and achieve certain development and regulatory approval milestones within certain timeframes, if certain milestones are achieved. The Company is also obligated to periodically inform Columbia University of its progress in meeting such milestones. The failure to achieve any such milestone would constitute a breach of the Columbia License Agreement. If the Company pays Columbia University the required fee, it will be granted a 6-month extension. As of the date of these financial statements, the Company has complied with the development and regulatory approval milestones under the Columbia License Agreement and requested no extensions. In the event that, after completion of Phase&#160;I Trials, there are unforeseen changes in clinical or regulatory development that the Company believes would affect the timely achievement of any milestone, it may request an extension from Columbia University for such milestone, which will not be unreasonably withheld or delayed. In the event that Columbia University does not agree to extend the deadlines to meet the milestones, and the Company is in breach for failure to timely meet the milestones or to make milestone or royalty payments, Columbia University may elect to convert the license to a nonexclusive license without the right to sublicense or initiate legal proceedings against third party patent infringers or terminate the license. The Company is also obligated to make payments to Columbia University in an aggregate amount of up to $20&#160;million based on achieving specified development and regulatory approval milestones and in an amount of up to $25&#160;million based on achieving a specified cumulative sales milestone with respect to the first licensed product. In addition, the Company is obligated to pay Columbia University a specified portion of revenue (other than royalties) it receives from sublicensees, and a percentage of revenue in the low double-digits received from any sale of a priority review voucher by us or a sublicensee. The Company cannot reasonably estimate whether, when and in what amount any of such payments shall be made, but believe it is in compliance with the terms of the license. From inception through December&#160;31, 2021, the Company has made a payment of $1&#160;million to Columbia University resulting from this license agreement, which was triggered by the completion of its Phase&#160;1 clinical trial. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical Research Organization (CRO)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the course of normal business operations, the Company has agreements with contract service providers to assist in the performance of clinical trial activities. Such agreements are generally cancellable </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:436pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">upon reasonable notice and payment of costs incurred. As of the issuance date of the consolidated financial statements, the remaining contractual costs expected to be incurred in future periods for the Company&#8217;s clinical trials in STGD1 is approximately $10.0&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Litigation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. The Company is not aware of any current pending legal matters or claims. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SUBSEQUENT EVENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The company evaluated subsequent events and transactions that occurred after the balance sheet date up to March&#160;15, 2022, the date that the financial statements were issued. Based on the review, management did not identify any subsequent events that would have required adjustments or disclosure in the financial statements.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.7pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:49.7pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="position:relative;margin-top:61.71pt; text-align:center; width:456pt;">
          <img src="lg_belitebio-4clr.jpg" alt="[MISSING IMAGE: lg_belitebio-4clr.jpg]" height="57" width="93" >
        </div>
        <div style="margin-top:28.5pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Belite Bio, Inc</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:28.3pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 28.3pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:20.8pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18.3pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 18.3pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:63.8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Book-Running Manager</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:18pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">THE BENCHMARK COMPANY</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:156pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Until&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2022 (25&#160;days after the date of this prospectus), all dealers that buy, sell or trade these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as underwriters and with respect to its unsold allotments or subscriptions. </font>
        </div>
        <div style="margin-top:24pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;, 2022 </font>
        </div>
        <div style="margin-top:10.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 10.3pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.8pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.80000000000007pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ITEM 6. &nbsp;&nbsp;&nbsp;INDEMNIFICATION OF DIRECTORS AND OFFICERS.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cayman Islands law does not limit the extent to which a company&#8217;s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The post-offering memorandum and articles of association that we expect to adopt and to become effective immediately prior to the completion of this offering provide that we shall indemnify our directors and officers (each an indemnified person) against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such indemnified person, other than by reason of such person&#8217;s own dishonesty, willful default or fraud, in or about the conduct of our company&#8217;s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including, without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such indemnified person in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the indemnification agreements, the form of which is filed as Exhibit&#160;10.4 to this registration statement, we agree to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or officer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The underwriting agreement, the form of which is filed as Exhibit&#160;1.1 to this registration statement, also provides indemnification by the underwriters for us and our officers and directors for certain liabilities, including liabilities arising under the Securities Act, but only to the extent that such liabilities are caused by information relating to the underwriters furnished to us in writing expressly for use in this registration statement and certain other disclosure documents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ITEM 7. &nbsp;&nbsp;&nbsp;RECENT SALES OF UNREGISTERED SECURITIES.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the past three&#160;years, we have issued the following securities (including options to acquire our ordinary shares) that were not registered under the Securities Act. We believe that each of the following issuances was exempt from registration under the Securities Act pursuant to Section&#160;4(a)(2) of the Securities Act regarding transactions not involving a public offering or in reliance on Regulation&#160;S under the Securities Act regarding sales by an issuer in offshore transactions. No underwriters were involved in these issuances of securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ordinary shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;27, 2018, we issued 1 ordinary share to Mapcal Limited, which was transferred to Lin Bioscience International Ltd. (our principal shareholder) on March&#160;27, 2018. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We issued to Lin Bioscience International Ltd. (i)&#160;99 ordinary shares for consideration of $99.9999 on April&#160;13, 2018; (ii)&#160;5,340,221 ordinary shares for consideration of $900,000 plus assignment of the rights, title, interests and obligations of Lin Bioscience International Ltd. under the exclusive license agreement by and between Lin Bioscience International Ltd. and Columbia University and the transfer of 1,600 shares of Lin BioScience Holdings Corporation (now Belite Bio Holdings Corp.,) on July&#160;2, 2018; (iii)&#160;2,500,000 ordinary shares for consideration of $2,500,000 on August&#160;8, 2018; and (iv)&#160;1,000,000 ordinary shares for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">consideration of $1,000,000 on January&#160;20, 2020. Lin Bioscience International Ltd. is wholly owned by Lin BioScience, Inc., our ultimate controlling shareholder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;31, 2020, we issued 727,676 ordinary shares to the optionees for the options exercised. Specifically, we issued: (i)&#160;367,515 ordinary shares to Yu-Hsin Lin, our Founder, Chief Executive Officer and the Chairman of the Board of Directors; (ii)&#160;257,260 ordinary shares to Hao-Yuan Chuang, our Chief Financial Officer; (iii)&#160;36,751 ordinary shares to Hung-Wei Chen; (iv)&#160;22,050 ordinary shares to Wan-Shan Chen; (v)&#160;22,050 ordinary shares to Ming-Chiu Wu; and (vi)&#160;22,050 ordinary shares to Yun-Ju Huang, in their exercise of options granted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December 31, 2021, we issued 706,406 ordinary shares to the optionees for the options exercised. Specifically, we issued: (i) 364,213 ordinary shares to Yu-Hsin Lin, our Founder, Chief Executive Officer and Chairman of the Board of Directors; (ii) 254,950 ordinary shares to Hao-Yuan Chuang, our Chief Financial Officer; (iii) 21,684 ordinary shares to Hung-Wei Chen; (iv) 23,463 ordinary shares to Wan-Shan Chen; (v) 20,243 ordinary shares to Ming-Chiu Wu; and (vi) 21,853 ordinary shares to Yun-Ju Huang, in their exercise of options granted.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;31, 2020, we closed a private placement transaction pursuant to which we sold an aggregate of 1,296,963 Series&#160;A Preferred Shares for an aggregate consideration of $2,789,600 in cash and conversion of two convertible promissory notes in the principal amount of $1,000,000 each. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;14, 2020, we issued a total of 1,080,679 Series&#160;A Preferred Shares in connection with the second closing of the private placement transaction described above for an aggregate consideration of $4,002,400 in cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;24, 2020, we closed a private placement transaction pursuant to which we sold an aggregate of 5,443,272 Series&#160;B Preferred Shares for an aggregate consideration of $23,000,000 in cash. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Convertible Promissory Note</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;22, 2019, we issued a convertible promissory note with the principal amount of US$1,000,000 with simple interest of 2.5% per annum to each of H&amp;D Asset Management Co., Ltd. and Yun-Ju Huang. Pursuant to the note purchase agreement, the entire convertible promissory notes may be converted, at the option of the note holder, in to the type of equity securities issued in the next equity financing. On January&#160;31, 2020, in conjunction with the first closing of Series&#160;A financing, the principal amount and the accrued but unpaid interests (in the total amount of US$13,835.62) under both convertible promissory notes were converted into Series&#160;A Preferred Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Options</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have granted options to purchase our ordinary shares to certain of our officers (whether or not a director) or our employees or any of our Affiliates, any member of the Board, or any director of one of our Affiliates, or any eligible individual consultant or advisor. See &#8220;Management&#8201;&#8212;&#8201;Share Incentive Plans&#8221;. </font>
        </div>
        <table style="width:456pt;height:132.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:180pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Securities/Purchaser </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of Issuance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Securities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:180pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Options</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:48pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:180pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Certain directors, officers and employees </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;17, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Option to purchase up</font>
                <br >
                <font style="letter-spacing:0.2pt;">to 1,335,794 ordinary </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:48pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$0.1191&#8199;&#8201;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:180pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Certain directors, officers and employees </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">December&#160;23, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Option to purchase up </font>
                <br >
                <font style="letter-spacing:0.2pt;">to 2,807,381 ordinary </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:48pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$0.4386</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:180pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Certain key consultants </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">March&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:96pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Option to purchase up </font>
                <br >
                <font style="letter-spacing:0.2pt;">to 41,736 ordinary </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:48pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$4.2254&#8199;&#8201;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:45.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:180pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Securities/Purchaser </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of Issuance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:96pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Securities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise Price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.917pt 0pt 1.5pt 0pt; width:180pt;">
              <font style="letter-spacing:0.2pt;">Certain directors, officers and employees </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 1.5pt 0pt; width:96pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">April&#160;18, 2022</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">#</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 1.5pt 0pt; width:96pt;white-space:normal;text-align:justify;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Option to purchase up to 1,698,667 ordinary </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0.917pt 0.5pt 1.5pt 0pt; width:48pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">$6.00</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.11pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:3.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">#</font>
          <br >
        </div>
        <div style=" margin-top:3.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Our Board approved the option grant on April 18, 2022, which is conditional upon and becomes effective on the date on which this registration statement is declared effective by the United States Securities and Exchange Commission.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">This exercise price applies to all options granted on December 23, 2020 except for an option to&#160;purchase 6,267 ordinary shares granted to an employee in the US which has an exercise price of $2.69 per&#160;share.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">The exercise price applies to all options granted on April&#160;18, 2022 shall be the final offer price of the offering. The US$6.00 exercise price disclosed above, being the midpoint of the estimated range of the initial public offering price, is for indication only. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.71pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ITEM 8. &nbsp;&nbsp;&nbsp;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(a) Exhibits</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">See Exhibit&#160;Index beginning on page II-4 of this registration statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The agreements included as exhibits to this registration statement contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties were made solely for the benefit of the other parties to the applicable agreement and (i)&#160;were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii)&#160;may have been qualified in such agreement by disclosure that was made to the other party in connection with the negotiation of the applicable agreement; (iii)&#160;may apply contract standards of &#8220;materiality&#8221; that are different from &#8220;materiality&#8221; under the applicable securities laws; and (iv)&#160;were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We acknowledge that, notwithstanding the inclusion of the foregoing cautionary statements, we are responsible for considering whether additional specific disclosure of material information regarding material contractual provisions is required to make the statements in this registration statement not misleading. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(b) Financial Statement Schedules</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the Consolidated Financial Statements or the Notes thereto. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ITEM 9.&nbsp;&nbsp;&nbsp; UNDERTAKINGS.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item&#160;6, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:510pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned registrant hereby undertakes that: </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule&#160;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&#160;424(b)(1) or (4)&#160;or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BELITE BIO, INC</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT INDEX</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <table style="width:456pt;height:608.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:408pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Description of Document </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;1.1&#8224;</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 0.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922048906/tm2132809d20_ex1-1.htm">Form of Underwriting Agreement</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;3.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex3-1.htm">Second Amended and Restated Memorandum and Articles of Association of the Registrant (as amended on November 1, 2021), as currently in effect</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;3.2&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex3-2.htm">Third Amended and Restated Memorandum and Articles of Association of the Registrant (effective immediately upon the completion of this offering)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;4.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:408pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-3.htm">Registrant&#8217;s Specimen American Depositary Receipt (included in Exhibit&#160;4.3)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;4.2&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-2.htm">Registrant&#8217;s Specimen Certificate for Ordinary Shares</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;4.3&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-3.htm">Form of Deposit Agreement, among the Registrant, the depositary and the holders and beneficial owners of American Depositary Shares issued thereunder</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;4.4&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-4.htm">Amended and Restated Shareholders Agreement by and among Belite Bio, Inc and shareholders of Belite Bio, Inc named therein dated December&#160;23, 2020</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;4.5&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex4-5.htm">Amendment to Amended and Restated Shareholders Agreement by and among Belite Bio, Inc and shareholders of Belite Bio, Inc named therein dated November&#160;1, 2021</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;5.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex5-1.htm">Opinion of Maples and Calder (Hong Kong) LLP regarding the validity of the ordinary shares being registered and certain Cayman Islands tax matters</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;8.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex5-1.htm">Opinion of Maples and Calder (Hong Kong) LLP regarding certain Cayman Islands tax matters (included in Exhibit&#160;5.1)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8199;8.2&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex8-2.htm">Opinion of O&#8217;Melveny &amp; Myers LLP regarding certain U.S. tax matters</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-1.htm">Belite Bio, Inc Amended and Restated Share Incentive Plan</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.2&#8224;</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922047865/tm2132809d14_ex10-2.htm">2022 Performance Incentive Plan</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.3&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 0.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-3.htm">Form of Employment Agreement between the Registrant and its executive officers</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.4&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-4.htm">Form of Indemnification Agreement between the Registrant and its directors and executive officers</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.5&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-5.htm">Series&#160;A Preferred Share Purchase and Note Conversion Agreement by and among Belite Bio, Inc and certain investors of Belite Bio, Inc named therein dated January&#160;21, 2020</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.6&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-6.htm">Series&#160;B Preferred Share Purchase Agreement by and among Belite Bio, Inc and certain investors of Belite Bio, Inc named therein dated December&#160;23, 2020</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.7#&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-7.htm">Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated September&#160;13, 2016</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.8&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-8.htm">Amendment to Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated August&#160;15, 2017</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.9&#8224;</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-9.htm">Letter of Consent issued by The Trustees of Columbia University in The City of New York dated May 3, 2018</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.10#&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-10.htm">Second Amendment to Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated March&#160;27, 2019</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.11#&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-11.htm">Third Amendment to Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated October&#160;24, 2019</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.12#&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-12.htm">Fourth Amendment to Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated September&#160;1, 2021</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.13#&#8224;</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-14.htm">Fifth Amendment to Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated February 4, 2022</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.14&#8224;</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.5pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-13.htm">LBS-008 Research and Development Services Agreement by and between Belite Bio, Inc and Lin BioScience, Inc. dated July 1, 2021</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:329.5pt;margin-left:69.66pt;width:456pt;">

          <table style="width:456pt;height:221.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36pt;">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Exhibit</font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Number </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:408pt;">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">Description of Document </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">10.15&#8224;</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex10-15.htm">First Amendment to LBS-008 Research and Development Services Agreement by and between Belite Bio, Inc and Lin BioScience, Inc. dated February&#160;23, 2022</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">21.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex21-1.htm">List of Significant Subsidiaries of the Registrant</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">23.1</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex23-1.htm">Consent of Friedman LLP</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">23.2&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex5-1.htm">Consent of Maples and Calder (Hong Kong) LLP (included in Exhibit&#160;5.1)</a>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">23.3&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex23-3.htm">Consent of Commerce &amp; Finance Law Offices</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">24.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809-10_f1.htm#tPOA">Powers of Attorney (included on signature page)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">99.1&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:408pt;white-space:normal;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex99-1.htm">Code of Business Conduct and Ethics (effective immediately prior to the completion of this offering)</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">99.2&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex99-2.htm">Opinion of Commerce &amp; Finance Law Offices regarding certain PRC law matters</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">99.3&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex99-3.htm">Consent of John M. Longo</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">99.4&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex99-4.htm">Consent of Ita Lu</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">99.5&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="https://www.sec.gov/Archives/edgar/data/1889109/000110465922042710/tm2132809d11_ex99-5.htm">Consent of Gary C. Biddle</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt; width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
                <font style="letter-spacing:0.2pt;">&#8201;107&#8224; </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
                <div style="letter-spacing:0.2pt;">
                  <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1889109/000110465922047865/tm2132809d14_ex-filingfees.htm">Filing Fee Table</a>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>

        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">To be filed by amendment. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">#</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Portions of this exhibit have been omitted because they are both (i)&#160;not material and (ii)&#160;would likely cause competitive harm to the Company if publicly disclosed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Previously filed.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tPOA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:474pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly&#160;caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Taipei, Taiwan, on April 27, 2022. </font>
          </div>

        <table style="width:456pt;height:61pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:-0.2pt;">BELITE BIO, INC </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:12.167pt 0pt 0.5pt 0pt; width:8pt;">
              <font style="letter-spacing:0.2pt;">By:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:12.167pt 0pt 0.5pt 0pt; width:212pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Yu-Hsin Lin</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 212pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Name: Yu-Hsin Lin </font>
                <br >
                <font style="letter-spacing:0.2pt;">Title:&#8199;&#8199;Chief Executive Officer and Chairman</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:382.5pt;margin-left:69.66pt;width:456pt;">

          <div style="text-indent:20pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on April 27, 2022. </font>
          </div>

        <table style="width:456pt;height:196.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:178pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:266pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:19.917pt 0pt 0.5pt 0pt; width:178pt;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Yu-Hsin Lin</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 178pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Name: Yu-Hsin Lin </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:19.917pt 0pt 0.5pt 0pt; width:266pt;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer, Chairman of the Board of Directors (Principal Executive Officer) </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:178pt;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Wan-Shan Chen</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 178pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Name: Wan-Shan Chen </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:266pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:178pt;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Hung-Wei Chen</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 178pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Name: Hung-Wei Chen </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:266pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:178pt;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Hao-Yuan Chuang</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 178pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Name: Hao-Yuan Chuang </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:20.167pt 0pt 0.5pt 0pt; width:266pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer, Director (Principal Financial and Accounting Officer)</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:490pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>

          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <font style="letter-spacing:0.2pt;">Pursuant to the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of Belite Bio, Inc has signed this registration statement or amendment thereto in on April 27, 2022. </font>
          </div>

        <table style="width:456pt;height:57pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">Authorized U.S. Representative </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:8pt;">
              <font style="letter-spacing:0.2pt;">By:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:212pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">/s/ Donald J. Puglisi</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 212pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt;">
                <font style="letter-spacing:0.2pt;">Name: Donald J. Puglisi </font>
                <br >
                <font style="letter-spacing:0.2pt;">Title: Managing Director</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">II-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>tm2132809d25_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm2132809d25_ex23-1.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
consent to the inclusion in this Registration Statement on    Form&nbsp;F-</FONT>1 of our report dated March&nbsp;15, 2022,
with respect to our audits of consolidated financial statements of Belite Bio,&nbsp;Inc and Subsidiaries as of December&nbsp;31, 2021
and 2020 and for each of the years in the two-year period ended December&nbsp;31, 2021. We also consent to the reference to our firm under
the heading &ldquo;Experts&rdquo; in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Friedman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">New York,
New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">April&nbsp;20,
2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2132809d25_ex23-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lg_belitebio-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_belitebio-4clr.jpg
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MW*GX_;_DD<'2+#\ADXN=M*B#],Y1CG\6:R%\58#*C#*WS<05\OQG\7[SZ?\
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M^.0PI;1HK>G5%LNLKKM,C%CS(R_$R^%X=/"B?M7IXZWDP@WWWT69D5:K6O\
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M53%^THV) @(GLK(:M2[FJ3K"!92! S@YE"[R<@"ZHW8 QQ'"X1%!FAE?)S&
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M]\;\:A$C.>O^2[E#KSKBG\^\+I;+O?P5G[Y^P+"WZE[6U>^?_99XJ%SJ5O\
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A#+_W/_*A*MEW\?Y[0+?JYUUG^P#'F,Y;R="_YJ'C?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_friedmanllp-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_friedmanllp-4c.jpg
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M$" 5-18(%#0V%S<8$1,2,C,P,7" (1$  00 ! (% PT,!@<( P   @$#! 4
M$1(&(1,0,4$4!R+4%2!1D3)"([-TE#6U-G9A@5+2,R2T=975%K9Q8C0EA98P
M<I)#8X,W<%-STT3%)@B&%X<2  $" 04,!P8$!@,!      $" P 0$=$2,R$Q
M05%QD:&QP3(3!"!A@>$B<G/P@I*RTA1"HL*#\5)B(S1T@&,D%1,!  $# P0!
M!0$! 0$! 0   1$ (3$005$@\&%Q@9&AL<'Q,-% @'#A_]H # ,!  (1 Q$
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M9
M                    'JGPS)C C&3<9KT^$;?-?F/FX#'SZAZYCIFQCY@9
MC9M@&0 QD]X^@://<-Z$=C=1]\ Q$RXPPR\^.8>>@;; ,5,E/P:'-OGB,F,9
M/,9 :B/HFS#5)[QL@T694;*-)F7F>@    %?AB99>5;DG23A6"2?)3%6QNLW
MD1T)/FOR#Q*LQ8ET5^EE)6X;%)>%+Y*HLJ*Q">!\@KK-^%@P(3D?2UHIB)B'
MA-?&^3%2:(*PC9!+4AB8&3Q-$&JC)B?Y369X6'$0C"2RXHH,G+ORDPWL6>@
M   %8A_"PL@8>T6"%=9[Q8>5QGY+ "$Y\ G,1\/8/EDRR(!(<@,>N6$FGB"!
M< 1 )?FN2(H+  5M'O$LC4I\(S4T>>R2F-T&NR"YX2P(K2-M%@95Z6%D=R7Y
M7R8*63%=)XBS(B&8*3O*^3X)9<     ?_]H " $!  $% LM9$<\?#_9*55]D
MI57V2E5?9*5;9SG*01:5_9*55]DI52?<G)=+X+FY@EYFS*&8'N#23&DN-FT7
MIZ-4;&;[)2JOLE*J^R4JK[)2JL?20J7Q"L@YN?XA+_LE*J^R4JIJ[EE/YQ2;
MQN:#;''N)DX;AB?)RV0$MDWSVY,,GQ5EMZGLAVY8RHI +F/N,=2'C373739.
M9 3%HH-W)R#0AB?6V2-5$J:HCLO<+)G-YWB>XZ4(D;N4,P/<&DF-)<;-HON9
M+EQL)B_V2E5?9*55]DI53)W*?R6:'=N?FZ?S1S:S0<A/S.OW,>1P-#XW+*]G
ML;5[/8VKV>QMMS#\DXZQU"'6$>U6/*<\(XZ<1W,,B/OK*9>XLU=P_K[ 'QY4
ML]*Q$,9QE?L]C:O9[&U>SV-J9V=M8&ZLW?)^,\9P9[@RV%L9KZ2?MS9B!P#W
MZ"R2./8TD8J<!%CY1C22WPV;5.Y-9$8I8.8?IVX>N-A98X LD=W'(4SRQCS2
M!GX3E^DGA^S,/QLUL[B]*XSR.? 75L<P'D _R,3]5;Q_GMWN']?8 ^/-S/\
M\>86CS-)IA[/8VJ[#F-;[<U8U985KVTNA%R61XJ\D'"PPYV6[F/(P^?R*#5[
M_9#KW^R'6%)_(ISMS#\DQ+/@D:C?V8!IT[E3%4(W'WB=2049((6NX?U]@#X\
MJ6>E6T\AI<??[(=>_P!D.L>9CFLDF6S-WR?A[XVV=P0*0F0, $W+X\H#Y&SC
M%NGIKA^4]4PCN,E/B7)HBW#,%]N'KC9W!3'A+#V\Q+B+WE*)=80[$DNZ0F6S
M,/QM@'Y#S1B3]&N*LH%08]0H<YHB?JK>/\]N]P_K[ 'QYN9_^/,;S1.!R'[,
M UKW,A_C(N3'3(1';O%S&MEV=S'D>WR-L$@KVW@->V\!IGC;!']N8?DF$81A
MLAB<E[>&#1E$U2;G2"H1'I_9W#^OL ?'E2STK#1D#)?[;P&O;> T!!X>UE[,
MW?)^'OC:K[[$K,KR@:6S7#30JSX\H#Y&S?%NHH3A:=#PU[1L<\A37+P(S9B'
MMP]<422@&/-Y0O,)/'LIS**M?OMDFC2U3S,-R[JJ&UF'XVP#\AZZ::Z9DQ+P
M*_%N4UHI;$_56\?Y[=[A_7V /CS<S_\ 'F*X<V3B3?7"#U;VXP:VYEPMCUE5
MTTTMTV=S'D>V3>S#\DXJ^/*SSC>L.Y(NACMIKI=I7</Z^P!\>5+/2K.Y*LSM
M]DI57V2E5?9*55B^9'3F-UF[Y/C&<I!%F);N.FM]27)<TEB6,,-N<C,MMMLM
MH#Y&NMM4MG\9NB,M[<HM^XS-WQAVX>N*[@)AHT1W!4)'DT@Z$@]="0>LL8S8
M3(;AJ7=*S*LP_&V ?D.E$TUD\P8IOB1,3]5;Q_GOL?.*^Q\XK['SBL09#>L@
M#UW#^OHAF*30IF^Q\XK['SBH5G26R.55G_X\[>/7V](8E'979'8?&XGO.N,X
M,]N#:VA,X-*I)+I>SV-J;P!6L*GW'\/DQK(PM$;!HD9 P;V>QM7L]C:O9[&U
M>SV-J8H\S1D*GC&T(?W'V>QM7L]C:FB#0]BOVV8M@*9]/\$B4I)9F1JCS>\,
M[:_MS! XC%S*?,>PZ2',,<9(P'LUTTUTUP_C;75.RU)-U:F][;V3'D-C9VPD
M8<T<;$^/0R=Z_$..%+_9[&U>SV-J]GL;5'HE'8I93[C^'R8WV>QM7L]C:O9[
M&U-N,((SG4]L+1) 6+'\/C)O_B!==$9%I>F=_"I^E,:BH[!D."2DFI!+(O%$
M6#($&E2]2"5QB*(,&08-*B*'=FLLX@A 1 (T)R$6DL<'>:;'9K>A':?P1A-]
MV,64T/;+( W=[98^&DJDNDJJD@DS/[#(Q3W9K:J++% %]V,64/E#&A:]'9<Q
M>V%-CJUO0>UG?V&0HU;(X]<]776V6MKFVO(3W-(=&EVN?01]*VO#ZR1X.R^Q
M2Q55)!+W8Q938[-3T*ZO3.PC44],X)[F[-;*)4@G\(BB\>F<1EFE2&=0R)WQ
MZ8126)T1E#&@B[+,X?)%:?,DX_C)C#*8U*A_^/.;H8]:144/#65:Q%'&K(KW
M-L/0R9-PJ2J V%8TSY"5FN'8?+@TK;[$L'1IGR,)EK%<4>(GC*2DS#'^//G7
M(7H'"GQ'.( )D//.+<CN+R3VS?$[A$(F[%8;AT1.>FYK;&<:5!"9LRO@MW.;
M1I9Z6@#*_P",<?Y9D;++64@= M#N4AT1:L*HP.#CJY)9WN00**RJ,0J.X?(P
MVX2'9G.4.+5&&R/A=OT_I^Q[=/,UP+)=\R9>V_X2D;2U/7<C)L+8SE#9@&3.
M\GQKLD+:)F_*6"GEP$;I9Z6P="88XXDD\;:<3Y/G40;IY$L(2P][B>,$M<DY
M"[F?B>F9$G&TH:Y!@:53R9O2L;A^%\;QWH[.T/:(A'15_$C8^F>,&&XDZ%9-
MDU0.]3%8$.>,&2/)/_&SX7MGLHG';=$M(]'BG8UCZ<R1BB2/;OG"?C #7! H
M1_)6(WUZ<\XY"2&1\..#&\D8><Y*IF;*C<Q,P$<99'&Y]#LC2=[S)/V:+L T
M5C8<7?4LYY4QI=-1<"1>1P_&M8LB[['':2E/(3!#>VN$IQYRPSICZ7R$5<Y@
MQ$P.L8QG+\'29LGE9ZB[[-,3U+6Y\=HX%.\UM"$)BDW><F;"<2KY)R3).V/&
M#DQX_(E9$/C,7?6_,.6\8&RG3"<<>8CBZ?MV1FK+AL@[A)0%CV% 8\AU2TM_
M!C</[:8(A'C,.:X\FDA%7.8,?N^=8/#FB%3Z9SFLN8TGQ<HC<?;8HP9SB[[,
M<>TDYYS@QTC:LEYB.<F\1V;HT+EW$ ;XP9.S4I;;;9;AJ+OL4:385)X9E%>R
M]1%M?<[0G2]CR+E&;?\ '__:  @! @ !!0)E:TG.[I0.NE ZZ4#KI0/:W1X8
MP+I0.NE ZUB@GX<8^2#9L:&,=Q%=@DV\ND$]%5^E ZZ4#KI0.NE Z<Q; CJ;
M(^,:#TH'72@=+1/3\&-Y0%VQ*+B7IO31HV:[&^-I$B/+(@VC;65GT<J(BR-J
M&UN&M,-NB@W\2!U15JMT_-R\8$20WK8J'K;NM#&.XBNP2;>7N-(2;@7TH'72
M@==*!T1%/_BZ"HRK: DM8HV#+VQ+_21G%!5QQUKCCK7''7:Q\J='1P1<.,NE
M)2!T2N2OM)'7LT27J+\MDO-*"\X;?<D%QQUKCCK7''6EUU25:C_*'9V<1W&U
M_=K:$E*]MRB8SB*4/<*12=]J8CL)X]OIN$U-,UNL3J5<OV667*7BH)-@#*Z<
M23D /A#MC'S59=)#1V:DW)%5)1!1/_0WR>\G_GNQ?ELEYIN1KFC^4N(#QQUK
MCKMI3 ZKGU+$;?RU&(6IWGIHZ1+_ $.;17&NFFNNFFNG]M%;MK'RHV-WEE=)
M*4C$[-+BB4&X6^[6^^HORV2\TH+SBJ=JR733773373FQ "@;(_RA\YKLC*FM
M[9);/XN=*<KCQGB@'P/P;A%@_P""2QG[9%*N7[(R#^XF3F_J'9S? G/87C@=
MC'S62\K87K^5/+18X)Z67)K&^3WD_P#/=B_+9+S3<C7-'4#5Q&Z24KI*^FMI
M1;+9078LOLB7^DF*)&KBKE7%7*ERB2=K'RIPD!PIHDG)_??^547&XWQ.R+\M
MDO-*"\X===8#Q5RKBKE2C@<M9LC_ "A\YK6FFNNK,)<$WOR^B[I2G*X^9X5P
M?VZXX?75)L 9%+E7N5<OJVVZ^YO$M!$*9P3%>G&JD[-$['T+P9U,?-9+RNF)
MZ\1H\,^AE&^3WD_\]V+\MDO--R-<T>3E6\3JIPKJIPI=_<U]-L2_TEV\Q\J>
M>:5''6GUJ\>CLB_+9+S2@O.+I:+H]*!UTH'72@=.X";<54?Y07'AC"+8J!I0
MC2 %J[OJ0MG_ 'L4Y7_U3:7XT*4F?BR/\WE7+ZC(/[RI$X7"#<1<*XBX4RNQ
M%ASZ%XP&F/FLEY76FNMNK&\Z&VF^3WD_\^E6^NE6^NE6^GQK0;;JB_+3F(0]
M?I5OKI5OH^.A"AU&N:2CEN\,:4'J4<4;O(NSB.FJJHNI6FNMNO''6E%+UE*'
M<SA$R"5BE*LNNLNXXZUQQUKCCK7''6B"ERU*0=7 9+CCK7''6EG$XC3;J\.6
MJ=#.)H=BY"Q*B"ZHRI+D:990[F<(F2407?MXXZUKK^=45E!U"',\I/9;==9=
M>].=]N]H]NNFG''6N..M<<=:)-*,UH=S.$3XXZUQQUKCCK2KNXKIT.2L*H0Y
MG%I_^P__V@ ( 0,  04"=G%1OMZD*KJ0JNI"JZD*VG/A I74A5=2%5I)":!>
MT"[]CF[K DMI=YHM+7ZIH]2%5U(574A5=2%4WDW%B4X/:XA?4A5=2%4E)=:%
M-&,MV*2$FQ1I<]7#38:_*($M3LL>1M=734"D)$K<MM.(N%%MDA'\D%TR4JNU
M_%J,@)46WKI&5I=NN;NL"2VEWFB[CD7>$+U(574A5=2%4C)/_J2J:Z9YBJ5]
MC@NCK)?Z,(8Q5<';:X.VUP=MVO',FYN"5"X4WTHR-REJEEPZZ-_[$:D/GV#E
M]%^5$LM4*X.VUP=MK@[;2**:"=/?,VUM!6!U96W6B8ZC=;9>N"2.M:2A2ENM
MY3:3X,VCB?""Z6WWU'/.[+KK;+2%E' QU;_ 7LI?B0]CQRU)%1;5M<;P%4U+
M%K+_ .@GFMZ_^^[(?/L'+]Q_Y>RCHDF<';:X.VT]-J(51I6[\.(JUU]H=ZNL
ME_H&>0#7'W"N/N%,IY!VUXYD(_6C#]2V4K)+];1AUCB;;=++:D/GV#E]%^53
M4N24X^X5Q]PIO>#2#-CWS-GY;LD%FEI[!=_)OJSF+V+X<UH*\4%(BOY*)"_K
M8XYYW9(#/U(1X3]BSH)XP-I+\(9L>.6L','EI_%-3G<#?K=;>D)YK>O_ +[L
MA\^P<OW'_E[<;H"1U+974ME.+DJX71X6])'9)?Z1\9 BN' 5PX"D1D!]KQS(
M)D#($)CR'Z;?PFJ#H)X?9(?/L'+Z+\J';;>7PX"N' 58$&E=L>^9L_+:UU_%
M.I5I9K,EJBWU9S%[%\0$RG6AK::*.!KO9:FT1SSM77:66FDZF$CNA@J7'7*K
M[M;[V<OQ0=/'+6#F%/#3^C5K=-1:$\UO7_WW9#Y]@Y?N/_+VL-,XGIP*NG :
M196]'7;)?Z1G>>.9-7+Z?6ZF=R\&KLD/GV#E]%^514U15ZD*KJ0JNI"J;#+S
MAJ>^9C/A J&LC-HER-*T;&=0B_99S'_NCQO"%QP7\WO?+(YYVG\O]0[$%:21
MX$*O A4ZMJ%X;,7X4RGCEK!S"M=--='=JU$N$\UO7_WZC-KJ,VNHS::'!8^V
MI#Y\1X)"1ZC-KJ,V@GPL@JG_ )?'O/[Q @Y5#AC"[RK:"LHFG8C96NFEVG!V
MVD[+4K*7 $)O102'LJZW2^W@[;7!VVN#MM<';:0'1&LI9M"74X.VUP=MI($-
M#7;PL#2^EP1"KD44ATUD4UTT !!;Z7;PR;T!T1K-O"&VM-/QHJDFLFBWACW[
M+K;;[;6IOLNWN$-VM<';:X.VUP=MH<0<78N (3?P=MK@[;7!VVDVP%&^ED$B
M+$ !!K__ &'_ /_:  @! @(&/P)P.J4FH!>ZYXM'-%$6CFBB+1S11%HYHHE1
MS*UK"E#!-CR1:.:*(M'-%$7'')^RB"\@\1@7\!'9+QW5+"JQ%R;JZH^W;)*:
MH-V1#1O*4!G,6CFBB+1S11%HYHHBT<T40OE6R2A,U_K2#MD1S3BUA:I[TV!1
M&+JBT<T41:.:*(_\[MW^H;11%7F4S# <![94K+CDY ."B$*:)4TK'C]MLJ'^
M84M*U">837L&" ^TI945S79L1.SH+<=)2RFY<PGNVPI7+K67@+@,UWJO=!'+
M+)"5'!D@U'%U\$\U$%AX3."0#KA;H<<G2DG!@&3I@\1R]U4=+CNJ6%5B+DW5
MU1]NV24U0;O1^W<)":I-R+1S11%HYHHBT<T41/RKOBQ*&T4067A,X(^XYBZE
M3@;0F>:LHXS?"1U0&VTH0^JM4*%*4E11?20NZ,HA[(G;#/VRZM:M/>P58MCF
M%$6QS"B+8YA1*SD.LPZTTZH-A46RXG+E9.(@?QA+DW@<0#G$+:%Y*B,QD/J'
M4(/D3(UZB=8AUQ%Q:6E$90#%L<PHBV.841;',*(+SYK.G#HD:][YU0XRRX0V
M#<%S$.J+70FB*O.)"F\8N&@Z(JJ\3#@]CEA?+KWD&;VRR)<5NI;!T0MM-U<U
M9.44WNV1'+_A)NY,,)1>G,PS$ZA"/6'RJE#:+JR9A 0=UM,ZCI)A=>U2O\IW
M<U[L@K38N^(9<(]L<K.4ZC 4Z9DDS9XQ<PG=.P]6J"R\)G! RP[Z:M1Z8R=(
M^H=0@^1/1'D5'%Y=55RN!KBV.841;',FB%M<S,7$W9X:?&\9P=FV!R_,&J4.
MAQ!P3WJJL0..$\SS+C;O.-U^'4-;?_F,PN)P88>R)VPG[F?P3S3&:_-1%Y?Q
M1>7\4-?;3^.M/.9[U6F5G(=9A?,AT"N9YJO?%L/A[XG?=)3B FTSG5!<5<0D
M7!CQ 05JWB9Y#ZAU"#Y$R->HG6(4RO<4D@]L7E_%%Y?Q0YS#05Q$C'UB5KWO
MG5#V4:A+5/X7"-1VP3_,A)V;)%?Z_P"F A5HUX>S\.BYV0H)LE^(=M_3"N=5
M?5X1D%_3JACE4[C85/YB@[-L(]8?*J4\XNS;O>;N&R!R:-]RZ?**3JA+ALC<
M5D-%^%)3;)\2:.T2LY3J,'SI@<CS9N_@5^D[,T<1N8<VF]U]1V146)EA4.^F
MK4>F,G2/J'4(/D3T1Y%1]N%5?$#CBV'P]\6X^'O@U25.JOGNA'+-W>'//E.#
MLFTRO9$[89^W6I$]>>8^6+=S.8MW,Y@?<+4N:].96<AUF'.7;J5$JQ=\)'-A
M'V^&871UWX/!5,HBXJX<AQ&"WSZE%Y./9U&4^H=0@^1,C7J)UB'EH,RPTHCX
M3%NYG,6[F<P6W75J;. F5KWOG5#V4:A),+\):<M3=/;W0X4[J?#FOZ9Y%?Z_
MZ8"%6;OA.7!IN=L)+0_OI5H5<.P]D?\ 6TC/_$PAU>^HK)[4JA'K#Y52!"+J
MB81RXO@7>LX8X_,))<RF-P_$:8#:=T":#5L7/$-HSZ)I&<IU&#YTR#D^;/\
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M+O9Y^OC^TU7[+:_'Q_::K]EM?CXW+Z><BN>B_0W=>[11C9=]]*\_7I5=>?=
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M;CD-Y2]P/4PQE5/*"K@[DK6F\L^(]XE\PE_"$07%K]E)WTO1]+&UH;N4Z_\
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M($C0EO)I>V7%7US&]3),B0O'4 LKC_8:[TM],_\ LI,:'%W>GEA)5W]F#;*
MTUC-\5_^*%L50:J3(B=2=($H)$; M7I0Z(DU(YF-[Y*H<=BIC% :R(@ (]I
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M3U%0X01,X/M?_HC_V@ , P$  A$#$0  $$VV!6V0)PVVP&VD! !B (N H0H
M  P !. !VV@(<D@ 3$P$(4E!(\$-9CP 0 %N?@  ,   @ %4DGB=L (4, A'
MM (@.@9%.!/H M0,  !@  $  L54 3_ !KN $)/V!$.@""%Q?/:%O)@  ,
M @ %;:P#P  "': A&VV(S_ 0?^'4BPL+\  !O^P'^ @  !2  ,@H!2"DEQTN
M $/H@*!R5P"0  (DJ*D@#0
M                                           ()!(   )   !((
M )   (  ! )!((       !!((())!((! )) ! ( (   )! )(()!      (
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MAEDY#A-DO1E@*+3*\A$,2).:.I*#:5N8LJVPFCW!]&"TKLN+P4242#:1)ZV
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MHL%JGQ-BP?*2C-=9)7@$3-R4&Y@I<B@%@7$0G<#!)6L$8$@"P!@#C3O/"GH
MD1)$<B;CN4 1)RS?=',&:A@")GB!>5#-@VZ"UIQ=M\I/A9/(%7!U2$D00D2\
M"1#K\^'1R*2[+ B^X4AEG .I\"K^Q:%:J([WPT< H 0)"(V1+(V2E8HY$KOF
M5;W$N2_PL>Y\NA:M6@S3@"%N4PB(WF=><Y&C/7+>*X^YU6K1P?8A$6X!MNO6
MG>^7^'-W#(R2!Y2&9Q7Y%:);2-J,WVZGS +FH 6$P!8,4!R(:IP2E^JZ/64
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4PRE;W3U]<2,@I KH;3;_ .B/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2132809d1-fc_beltebw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d1-fc_beltebw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X )D%D
M;V)E &3      0, %00#!@H-   LA   L\0  -HS  #U9__; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\( $0@!\ .4 P$1
M  (1 0,1 ?_$ 0   0 " P$! 0$!           '"04&" 0#"@(! 0$
M                $  ! P," P8'  ,  @,    %  8' P08 @@!%1<P4!8V
M-S@0($!@-2A($A,4P#$1(R01  $$ 0$#!@<&#@X(! ,)  ,! @0%!@ 1$A,A
MTQ26!S<BE-05-=6F,#$CE39V4$$RDS2DM1:&MN:'U_<0($!@46%",[,DM'6W
M"/"$Q"6%QE?'<5)#%X&11+'Q8G)38U0F)Q(!                    P!,!
M 0$!  $$ 0(%! ,!     1$ (3$00%!!42!@,'" 87&0P/"Q@9'1P?_:  P#
M 0 "$0,1   !O\                    !^?P^H                 -N+
MT                                      "@$O^
M !0"7_                                      % )?\
M      "@$O\ @                                     "@$O\ @
M              4 E_P                                     !0"7
M_                  H!+_@
M "@$O^     .4#YDU'*!T$;N02?T;B2T:T102L;";:     4 E_P
M                             !0"7_     '%)HQYS1#<"73!'C(3)I.
MF3C@CPL&)<     * 2_X                                      H!
M+_@    ?,^1]S^@  ##F7/\ 0>0]!_8    * 2_X
M                  H!+_@    <6&YF1-+,J:8;L80ZF*Y283=3#&\',9T<
M=)@    H!+_@                                     "@$O^    !S
MJ9HC(U4F4TTT@W Z$(7/F1@;V8\^))Y/P    * 2_P"
M                     * 2_P"                 !0"7_
M                           % )?\                 "@$O^
M                                * 2_X                 % )?\
M                                      % )?\
M  H!+_@                                     #\YA*H
M       -:/T!@                                     '@,<
M  5&%N8        ,J>L
M      J +?P
M       5 %OX                                        !J!P>
M           "NPL3                .LR;
M#@ VPG,                              &BG*A:*
M        < $_G0!X3Y@_L]9]                            1^< %GX
M                      !P 3^90JQ-')M,Z6(DK@
M         C\X +/P:^>$'P,\9<                    ' !/Y+!$A]S?C2
MS8R3P                           1^< %GX*TSE UL[)/,6<'W
M     (?(?        .,":"9P       "827P                     1^<
M %GX(M/\!MYHA+X           /SR';@                 .+#]"0
M      !\C"         T$X(+-0       >HRP      * 2_X
M     % )?\            5CE>9,P                !R$?J;      !0"
M7_                  H!+_ (            K .@#K\
M  H!+_@      4 E_P                  "@$O^            *P#H Z_
M                 * 2_P"      !0"7_    'P/N ?P?T?Z #^#YGW
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M$G8Y3.DSFLZO.93''=YII_9Q@=$$6F]F]DQ$2D)&Q$8G0!JQ,A%QH!V0  4
ME_P      * 2_P"      ."S:2!26#^"/R=SG@FLQYW*      4 E_P
M      !6 = '7X!QB0 =*'/9TD0H=E%<1'A<V<T$YE/!VH<:DMG4)UL<%'/I
MU6<7G<II)NQKY'Q8P  4 E_P      * 2_X      @TW$P9]S&&PG\&+,D8P
MF       H!+_ (            K .@#K\ T<C0W$P!B#U&7,J: =(F$/<<W$
MMFK&))7-K-!-9-E-8/H:*2 2V0F3:  4 E_P      * 2_X
M    % )?\            5@'0!U^    #S'&A&1UL?T>$V4Y>.C3&GM,6;82
MF     "@$O\ @      4 E_P                 * 2_P"            *
MP#H Z_    !")H!D2+3UD7G81RR2J:(?$^!TF3N     "@$O^      !0"7_
M                   * 2_X            K .@#K\     ^!]P#2C:SU &
M#,:;<      4 E_P      * 2_X                 % )?\
M 5@'0!U^                 4 E_P       "ETB,        $/DP
M  $TERH           !6 = '7X                !0"7_
M   %0!;^                     5U%9!)P        -;-D       !!Q^F
M\                J +?P                              "H M_
M              !2B;>      <X'1X         !T6=Z
M    %0!;^                 "H M_                 *@"W\
M             J +?P                 5 %OX                !4 6
M_@                   %0!;^                 "H M_!72<G'B.DR33
MO0             %0!;^#@T@XU$W8ZL.KP                5 %OX!QB0(
M#(':A,H             *@"W\'.YK8)N.?#L$             %0!;^#E0TP
MQQU*<DG=AE                "H M_ .+R& =IG'Q9*     #$'F
M*C"W,        ^AG 8$_D      %1A;F       #*GK           !4 6_@
M         _*J=F                ' A^KTT,_,X=N@              &&
M+]P  #\QA.H                !'YRP=SE_P               !1"7?$?E
M8!<^               4 E_P  !0"7_                 '/Y^8([_ "_X
M                HA+OB/RL N?               * 2_X   H!+_@
M           #G\_,$=_E_P                 40EWQ'Y6 7/@
M     % )?\   4 E_P                  <_GY@CO\O^
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MD.%H)S@=$%<YW&=5@Y_/S!'?Y?\      '.Q%YA23B*CYDDF-/ 94WXZ#
M  *(2[XC\K +GP   #3B+2"S>3/D0$XD $I&YF0)W     * 2_X   H!+_C4
MB)3<CY$9DED?&4,$9 VD\)G##$[FFF,(Y/>>,WPS!NA&YKIGR$"33 DHFTD0
MDW@Y_/S!'?Y?\     1B:F>L\Y@CX$DD&G01&)O)*X    !1"7?$?E8!<^
M  1*9<C,C$W$W$PIKICCZG19O     !0"7_   % )?\       B Y[/Y.E35
M#T$?FUFS$;G50     !S^?F"._R_X                HA+OB/RL N?
M           * 2_X   H!+_@     <Z$3&"/6>DALW(_PE,T8L&      .?S
M\P1W^7_                %$)=\1^5@%SX              !0"7_   % )
M?\     #S'I !IIG#+ \)[@     #G\_,$=_E_P               !1"7?$
M?E8!<^               4 E_P    4 E_P                !S^?F"._R
M_P"                *(2[XC\K +GP              "@$O^   * 2_P"
M                .?S\P1/AT&                <B'ZH33#\TYU*
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M:&P4^$L>EG\LP%[INS,B.%V;U,/1XKKQ^WKP909-;PUHC6SM[^UBIO6[7&-
M0*<.F&A/ $#;5@!N0K*TLJDUVWQ"<>SWQ?BA/XJ0O(.R7R#V+[">(VA6&W=^
M:'L:_L25E$5_84B$;W9/18,6C:F;ABE/$X"+Z@+5=Q7?5K2NTCXURMH!8-4#
MV>QCL/[K[1R./4.OQYB\J2'X@O0[OHO %<V5M)K+NZ%O(S3N;!RR< I 6FY1
MMOHHOMMUR.IX4_"O:RQZ6?RS 7NF[AWQ?BA/XJ0O(.R7R#]?L8[#^Z^TX"Z_
M"4'"VW,]VZ78SHK ;<._0-^U(YO[<GR=P6 *BW+=ZVCM9;Q(D*H][W3[H-<E
M=,KM98]+/Y9@+W3=P[XOQ0G\5(7D'9+Y!^OV,=A_=?:<:-/C6^0@WQ!.ZL[&
MS'TOA1MK>W[:6/2S^68"]TW<.^+\4)_%2%Y!V2^0?K]C'8?W7W'+'I9_+,!>
MZ;N'?%^*$_BI"\@[)?(/U^QCL/[K[CECTL_EG_OE.)IOR7GQ9+SXLEY\62\^
M+)>?%DO/BR7GQ9+SXLEY\62\^+)>?%DO/BR7GQ9+SXLEY\62\^+)>?%DO/BR
M7GQ9+SXLEY\62\^+)>?%DO/BR7GQ9+SXLEY\62\^+)>?%DO/BR7GQ9+SXLEY
M\4K.R8YHT#Z6NA8/.RN23/BI^3+#XG)>?%DO/BR7GQ9+SXLEY\62\^+)>?%D
MO/BR7GQ9+SXLEY\62\^+)>?%DO/BR7GQ9+SXLEY\62\^+)>?%DO/BR7GQ9+S
MXLEY\62\^+)>?%DO/BR7GQ9+SXLEY\62\^+)>?%LQ:CE;UM\\JW[O8.Y[+*4
MUEE*:RRE-992FLLI3664IK+*4UEE*:RRE-992FLLI3664IK+*4UEE*:RRE-9
M92FLLI3664IK+*4UEE*:RRE-992FLLI3664IK+*4UEE*:RRE-992FLLI3664
MIK+*4UEE*:RRE-992FLLI33FW+2:YFWX/=>+W__:  @! @ !!0+_ ,O:_]H
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MUK72%BSJJAM[.(7A@,WI%?7R)86E%(&5CPO()$>G(JM]Y4]_79[.RV_AAO\
M-L:K+H,<C1!)+E2* 5W8"@Q(H45(\=N_P]NUSN1FUSU1%^^&'; -5=+?7\;A
MR&'\Y,F>;UJU@$"RP2U6=\"V-PN.XBHU&JJIJ46JF-E)!FGK9P^&:/)@V$;<
M4T*=#DC#*AR6,(UVX1C55CVN3P7(ONG:O_PG[HWG[SNQ7\W/^(MQ[IV:!C4T
MVYC5/:?CV0W8H]<6>$%%!@7<::<XVC(TR-?-8G"1'$<B\C5U$M<"JI>%XX;&
M<AA9Q8= =0P<DL)L%8V+MC43TAS36E%,*\[YCH[$X?P:$7WM8A29'V=9/ R3
M!(K81\@MK&3.Q6(L*K)4NL<4D&N)"2R7,?=:@01VH$97HY=C$1_:!5#H;EUE
M;=LLO(:Z%YME(>52F[3:K)1V#&J--@5IXSR<NQR*FYLWU1NNV>OK:VQ&[/,"
MQ./CELH7"J"2Z.+DZ3*^QG*0/07R2S0@5COA-TV]N[J.5 W<OL]RO%[JOJ#U
MMA9YA.DRR")(/%*>FH#2K>P-8UI) %*Z0C!"5!LY%<Y49V13RT,VXH<?E9H?
M(2#ISVD.&.TQE8%6IH[(YUE*6P<W8@V$5F[O+LUD.08Y3R\6[.I.,M;8U;H:
MU\;(LSZ=Q77E5C(VI*A$#5#X1SN" DI^Q$&3ZO78Q>S::UZ'BK<_ILGJ$AR'
MVE4N43R2*N[!6C8\ME';PF,-P.(08S;41=A$;GV7R,=R&PK,SS\<Z+55,,3Y
MM54CI8T.9E%G"DR8KXD:4>M(4C?LA&*+>8CE5K,MAQ8\B7+G8W>08<:*$AS'
MERZR4",%C!M<NTAGHFU=C4V\JIK_ "T,-2V[%PZK+#R;?K9:)3R$[.#XZB25
M46Q6K<%:-',WF[/#V[GA:GY'68W;6#\?[?[O.WX_T98LV_Q2TKI%2Z?3CEK'
M%*GA'->4(7.:]5;R[%5NVPN&8J?$V6TMDIT>R@PH%]9G;&$ MI<@A&D;AGC&
MP(VF<LA!A\+8BM:WW/M7_P"$_=&\_>=V*_FY_P 1;CW-SWN:QC&JY[W*C6M:
MU-KG.<O(C432.,48FN<C&J5[6(KW?4L17*FUR_P:Y%1=B[%V?27^#_Q]P0M@
MH&QXQ1R=Z2]K(["#7X(A=]S1+PR*CF[W(TB-<GA(BIM3]DHAF$0H-WC#81CG
MAW][=XK$57#WMU=FW^#2-VIO*BN1NWPE:W=1RHGOJC5>FW_Q]S[5_P#A/W1O
M/WG=BOYN?\1;CW/M#R22)#XCV5QY; 0T54^^#+JBN2XL2G79RQJ5Q 18S%16
M=-4I7;7" K*V^RX<:]RG):\-K<S)T<4ED5+439;:&L&9"#A4U6$R!8$>QCU:
MI';2/<Y?O PVN!,+6-FW<T!)1*^LH85]<6$^'$D2Q0[(B2Y12EZ,!!J[@ 5[
MU8G#W^SR47&AU]1VB3KR! EOO&FF02UD6]L*\AX+:M@#Q[J!3(\;F2-K%,B*
MB[-KJ*I=C2'D9!D&8T\ <:["60>'BG&:VVCB6"P9&3#H(11O(+H9"*KWN&Q2
M:Q$[,339DF:3,-.\%YQXX"1)5X-;*H>^GCR+J(R%1NEFWQ0T$ C?"<[:U+O*
M:>C2]HZ><E0"1YS\WFO;=UH"C0-(-U?*#)@)=24C+(>4:.>QZC:1J-5_:+&#
MC\:8_L]AQIDJ1Y^4%>0:T:WT_P X2EIB$JUC1GA$%C!RS23EV-8C!&>RML#Q
M"0#3Z^',+!*Y'EA%E1QF)$(]&M1Y([G[BKL3:J:S#M:+5Q-S/>T<H8DYV[7Q
M8>,MMX^)4L^VGCARB0*E.@NF%)PWMVGWO>7>UC^(VE0"#(S'.H5.Z,V2VT:7
M'*"07(+JU";H\3A L*FD(,:N9O(V2SDVNV)DF355/Y[HL9-(@R)?G%8)+6UB
MRAP),*A%T"6.P9&LG]%>5Y MZ2Q[&;^ZNLWJTQZ*65A-)6W$XOG_ (< ;952
M>XL6VDOS.]U8&LBC'L<T<DLGCM5@MUIG"J@UE,WSU)QJGR6\KY]B^)"QD5S$
M;(BU]C:!KICB617\1!C8#E&!Q'\-%'OUN0DJX@)_;;FE[80"3I[J^LB1H,0=
M9B]<:Q!7V#23K:GIQ/C,1B-.0A-U=NQKNREDJN?56^53+0-E5N.R62MKV89<
M7EA#,<;$$1\2Y@0!N>U$;O\ O+L7PO<NU?\ X3]T;S]YW8K^;G_$6X]SS#%+
M0"GC7N19V2Y;RMZ5'S"WL;EG#+_YAT]R$6\WZAX]GOMVZA4!<@@SXM9%%7P[
MA]41ER^!&&R/%;*&LXE>2T%';RRMSAD>F\L?E5-=I'FW+!08.?Q]_?=5'-=U
M=BW&8^.!X=LRV -:X:0ADW4 V1L5S6%8[836"8MCMS*&SLOR(#+2WC5LFM%'
M7'Z2]Q0]16I- K"27=/<P:M>?@A8A2$>JCXYK^%:,@'B81(Q#%@^;^D"QL\P
MY#S+IF]-&LLQ^##9PTX"[D94XB\3P>SH=;:=$J.S['KJI!%'#3I<NQN 5T8M
MV.2IW!C32"!)XBN$55Z63=V.=O-P/&)F6PB0<%OZ6RBI"H3Q?.,*A;+6%YP:
M6ZE-D6S);@'814Z*PHE5T<O@JW(<>;< Z=EF7NR?([8E6YS;*.3)(]HZF)#2
MR0J1&44058WX?^99MY-[8EA5UELVLL)E?(@AN)$'S@Z*0\=X.F]#!*JQDD#<
M[?3PF,WD][9R:QW$8EC22J2HQ*1BMI665"<E=?(4%?&#8' .WXT<D<<,BN'Q
M"(?I)-KFKNO;V?R67SY=?@6'2\7 ";#XT^;(E)3");=-Z3PHY2Q:=!.;PB;!
MO<C%;MWDQK#I68QBUN+Y'66T5P:,P2V4.JM3VT=EYOW)A6$]97"?MW61>(Q7
M/"1=W<SBD;<!;9Y[D9+>ZN2UCW\2L)9PMVB)%;9,.:+'QB$E<W9(8GA.(B,W
ME;KM$#%RQ@:_/8K'O5]2_P \0K06-1L=%_O&-91HSZ=.@C*L=D83E17"1[6\
MJ_>=/OZQV.@I<>JXW^Y713X_][JJ1MM2F99[L68UB-8!7[RQN -[GE\-KDS:
MR8046LJI%-B%=($\,@ ;$H#7E],"78^-,MNB " 2HT@8HMK]CS/&/W+M7_X3
M]T;S]YW8K^;G_$6X^@O:O_PG[HWG[SNQ7\W/^(MQ]!>U?_A/W1O/WG=BOYN?
M\1;CZ"]J_P#PG[HWG[SNQ7\W/^(MQ]!>U?\ X3]T;S]YW9ME98994:BI<4M^
M$B\!LUU'F=Y9'ABDN&\;"N&C47D=N<1%5-=W=AUCC^J-=W=AUCC^J-=W=AUC
MC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUC
MC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUC
MC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUC
MC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUC
MC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=W=AUC
MC^J-=W=AUCC^J-=W=AUCC^J-=W=AUCC^J-=IUEP",C2&T>PBHJC:4LJZ/P.+
ML1KB-8[_ .7[SFI)C@D;FW=XX1EW=OO[N^UVS;LUZ-K_ !./S>O1M?XG'YO7
MHVO\3C\WKT;7^)Q^;UZ-K_$X_-Z]&U_B<?F]>C:_Q./S>O1M?XG'YO7HVO\
M$X_-Z]&U_B<?F]>C:_Q./S>O1M?XG'YO7HVO\3C\WKT;7^)Q^;UZ-K_$X_-Z
M]&U_B<?F]>C:_P 3C\WJA?'B18[USVK:KP@$)RM7'LI7=5S&HN[M37HVO\3C
M\WKT;7^)Q^;UZ-K_ !./S>O1M?XG'YO7HVO\3C\WKT;7^)Q^;UZ-K_$X_-Z]
M&U_B<?F]>C:_Q./S>O1M?XG'YO7HVO\ $X_-Z]&U_B<?F]>C:_Q./S>O1M?X
MG'YO7HVO\3C\WKT;7^)Q^;UZ-K_$X_-Z]&U_B<?F]<..$0&;=[<"-@F;R^^N
MZQ$3:NS]\%!\_P"K_%W*OWYT'S_J_P 7<J_>I87]]/CUM36 61,F2B-$(;=Y
MHQL17JF^>09[1B&GAE*]K&HKE1-?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%KY1
MV'5V[\BU\H[#J[=^1:^4=AU=N_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%KY
M1V'5V[\BU\H[#J[=^1:^4=AU=N_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%K
MY1V'5V[\BU\H[#J[=^1:^4=AU=N_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%
MKY1V'5V[\BU\H[#J[=^1:^4=AU=N_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY
M%KY1V'5V[\BU\H[#J[=^1:^4=AU=N_(M5-'B5M*G6,7+8%L81JJQ@M;"!3WT
M,A$++CB&YR'G#3=V[>7^+7RCL.KMWY%KY1V'5V[\BU\H[#J[=^1:^4=AU=N_
M(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%KY1V'5V[\BU\H[#J[=^1:^4=AU=N
M_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%KY1V'5V[\BU\H[#J[=^1:^4=AU=
MN_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%KY1V'5V[\BU\H[#J[=^1:^4=AU
M=N_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%KY1V'5V[\BU\H[#J[=^1:^4=A
MU=N_(M?*.PZNW?D6OE'8=7;OR+7RCL.KMWY%KY1V'5V[\BU\H[#J[=^1:D7F
M)333JZ+9%J3%-#E07-F@C0YA!H*6(1'-0$X:[VS9R_Q?1+.?P9_'#']=G<J5
MAV+294G!L2D29,C'ZDQY!S4%>0QSF)$<0IBD<KG.<JJJKKY#XAU:IO(M?(?$
M.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?
M(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO
M(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU
M:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#
MXAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%
MKY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5
M-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$
M.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?
M(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO
M(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%KY#XAU
M:IO(M?(?$.K5-Y%KY#XAU:IO(M?(?$.K5-Y%K(BBPO$Q%%16Q!D'CE.P@R,@
M2',>Q[8:.:]KDVHJ>]J,YC&-<7([PA7-:B*0B/CB1Y%3ZMZ"&UNU?Y+43Z7T
M2SG\&?QPQ_79I\P,-_%VN_8?*=( V,-I'$D*5B &T6U"N>57<-K1JU=[:O)L
MUTY)4987!Z1TQ#C6+P-W?X_2-[A<'=Y=[;LV:Z<DJ,L+@](Z8AQK%X&[O\?I
M&]PN#N\N]MV;-),'( ^(X7';*88;HR@W=_C(='*)1;G+O;=FS37L<U['M1S'
MM5'-<UR;6N:Y.16JGT9R7YOW/W.D:A?."]_IQ?1+.?P9_'#']=FGS PW\7:[
M6:M)O[&8KD!F[A2B5"!J9A!.VB>Q5W'HB_P;4U_EBKA*Y*^][2>SRNN&>^&9
M"2UF2TKI3/J"QY!X[7JQW(O"U-QK?,N/'_S@4-<82[5B$A3ISK:92N&OP2PI
M-C'24\7U+BJYRIX2Z[;<2KI[8PZ?ML):U@I3RL@2! LXEU94;GC83HT66</&
MY&/;QR[SF^$JZR*@RVR:_&:V[ML][0FP-Z8"#4Y-=J?&NS2OWQA;)DY#+>U9
MC=@V)'<YB[&2ADU;^;ARHLG'KR?CES6SFQF2Z^TKMSB!?T.3,B%$016/&017
ML<UVS;O(YJ?1C)?F_<_<Z1J%\X+W^G%^S"CS[&##D64A(M='DR@@//DK[T>&
M$CVDE&V<NZQ%5$Y?>U'KIUK7Q)\M!+'B2)01'(DB0D.,NX]R*C94QR!$J[.(
M9=QNUW)J/73K6OB3Y:"6/$D2@B.1)$A(<9=Q[D5&RICD")5V<0R[C=KN34.J
ML;JL@V5CN="@RIH 29/%+T</"$1[7KQY/P8__P!0G@MVNY-1JXDH#)\T,J3$
MAN(U),B/"6.V8<0=N^\,9TL2/=[S5(U%^J3Z%YS^#/XX8_KLT^8&&_B[7:L:
M:460*):0I-?+6*X;#.B3 /CR1L(01D&I D5-Y$WD^DJ:J<*9T]U502H,ZA.^
M2Q;*GG54Q)]7+AS$ WX>!*3>8I&DWDVM?O-54U(J'!D[TK)OOT-:H9C+;[[D
MG#L1Y$P[!- .<"2%FXUHD T3$%P^%X&IH*UA-^TMI][:RSN:Z597%F1"39\I
MPV"%Q2;K6HUC&#&-C6,:UK435]B5H"185N3RIDZ[+)/_ %^;/F2F2TFOE!:+
M=/!( +8^QNZ$<<3$3<8B:M65O2"R+RZGY#<SYA&%F65M8N;TB291"!'&B#&U
MC!B&,;&MY$V[57Z,9+\W[G[G2-0OG!>_TXOV?\ODIH MDERRZ&20@F(<@V0(
M"L&\J)Q',8J\B*NQ-?YO72U(Q\:#V.-KEVJG"AL0IHSHSD5=U%*JO7=7D*J^
M\NO\U!KOBBL@X_V';B+R<#^J=(_JZH]VY_6W.>NZO(7>^GH^9W^2,I(-CB^&
MNS-TIA./4MPVP#D4D]:0;E8BRU&X3T=_,N^$;Q%\#5K>Y-26$B^L<0B9G.A*
M1D<N)=G+,GA8Y35$41!.Z3?&F6I)LX*J%%/O,4JM$%-#,-V\,K&D&[E\)CVH
MYKN7EY47]T1/OLR2JHG3^)T,<Z0C#2&BV<5X@-1YG"&KD17;-U%5$VZ[PJ#Z
MZ?F-=X5!]=/S&N\*@^NGYC7>%0?73\QKO"H/KI^8UWA4'UT_,:[PJ#ZZ?F-=
MX5!]=/S&N\*@^NGYC7>%0?73\QKO"H/KI^8UWA4'UT_,:[PJ#ZZ?F-=X5!]=
M/S&N\*@^NGYC7>%0?73\QKO"H/KI^8UEU%C^8U%K;SO,'1($4A5.?HV3TLP^
MXCA-3X*-'>]>7WFZP*KL<YI(EA6X9B\"=%*4R%C3(='!CRHY$0*IQ F&K5_C
M37>%0?73\QKO"H/KI^8UWA4'UT_,:[PJ#ZZ?F-=X5!]=/S&N\*@^NGYC7>%0
M?73\QKO"H/KI^8UWA4'UT_,:[PJ#ZZ?F-=X5!]=/S&N\*@^NGYC7>%0?73\Q
MKO"H/KI^8UWA4'UT_,:[PJ#ZZ?F-=X5!]=/S&I?WIY)5WJP.%TT<&1OFC(;>
MX+RA<C"M&7<7==LW55%3Z7T-R7YOW/W.D:A?."]_IQ?LTUQ<02R[+'I#Y5+)
M2QM(WFZ23AH0T<42: *$(@6HY5:NU.1>33K.SJ12991UX92J:4(%@*JF^<:P
M5K""<<*W'7S?A I)&5!JJ[NS:NG6=G4BDRRCKPRE4TH0+ 55-\XU@K6$$XX5
MN.OF_"!22,J#55W=FU="BV8%DQA385@@.,<0GR:Z2.9#4[ %&DH(I06OX1-X
M3E:F\U=!F9!2@L9 8O0-]YI8$DUZ6,*V\VV XL@ [.M\Y5P3='D(4.^SZGE7
M;^Z.RVGF[[H5I!I*Z4T;U8]8\[*Y461PWI]0]1$]_7V%?_'I^;U]A7_QZ?F]
M?85_\>GYO7V%?_'I^;U]A7_QZ?F]?85_\>GYO7V%?_'I^;U]A7_QZ?F]?85_
M\>GYO7V%?_'I^;U]A7_QZ?F]?85_\>GYO7V%?_'I^;U]A7_QZ?F]?85_\>GY
MO7V%?_'I^;U]A7_QZ?F]?85_\>GYO7V%?_'I^;U]A7_QZ?F]?85_\>GYO7V%
M?_'I^;U]A7_QZ?F]?85_\>GYO7V%?_'I^;U]A7_QZ?F]?85_\>GYO7V%?_'I
M^;U]A7_QZ?F]?85_\>GYO7V%?_'I^;U]A7_QZ?F]?85_\>GYO7V%?_'I^;U]
MA7_QZ?F]?85_\>GYO7:C C[R1X,7H@$<N\Y QKTX1;SOY3MQGO\ [J<0CVC8
MQ%<][W(UC6I[ZN<NQ$1->DJ_QR/SFO25?XY'YS7I*O\ '(_.:])5_CD?G->D
MJ_QR/SFO25?XY'YS7I*O\<C\YKTE7^.1^<UZ2K_'(_.:])5_CD?G->DJ_P <
MC\YKTE7^.1^<UZ2K_'(_.:])5_CD?G->DJ_QR/SFO25?XY'YS7I*O\<C\YKT
ME7^.1^<UDB)8P%5:"X1$27'555:^1L1$XG*JZAC/-B )Y_O%W#2 C?L4PMB[
MKWHNQ=>DJ_QR/SFO25?XY'YS7I*O\<C\YKTE7^.1^<UZ2K_'(_.:])5_CD?G
M->DJ_P <C\YKTE7^.1^<UZ2K_'(_.:])5_CD?G->DJ_QR/SFO25?XY'YS7I*
MO\<C\YKTE7^.1^<UZ2K_ !R/SFO25?XY'YS7#!-B')L5=P,@)'[$]]=UCU78
MGN_8Y^#'XYG^@O:[_K'XQ2OW58M81[$->40RHQSFH4?2G$X9$1?#9Q!M=L7D
MVHFL<RPN;S:XE[7,G.A#HP2&1E<\C.&T[K,2D3P/?W4UWB6'5R/ZWUWB6'5R
M/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R
M/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R
M/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R
M/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R
M/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R
M/ZWUWB6'5R/ZWUWB6'5R/ZWUWB6'5R/ZWUV:XS!NY%LA;+')ZSG14KR;ME/E
M0CQ>$.1(11N"%47PO"1ZIL]W['/P8_',_P!!>UW_ %C\8I7[JF_."B_IRZ[/
M?F^'^G/]!.S#\"ONW9>[]CGX,?CF?Z"]KO\ K'XQ2OW5-^<%%_3EUV>_-\/]
M.?Z"=F'X%?=NR]W['/P8_',_N3/A&?"KNB\)OPCMUS]C.7PUW&*O)])/VBN<
MJ-:U%<YSEV-:U.5555Y$1$UM3]JCFJCFN1'-<U=K7-7E145.145-?SC.5_#3
MPF_SGO</W_J_XO?_ '!VN_ZQ^,4K]U3?G!1?TY==GOS?#_3G^@G9A^!7W;LO
M=^QS\&/QS/\ M^QAT^ DN-+@=IB3@,JS6JS.B4]&L+CP8L:465T1YW*Q58[A
M[RKR:[;9:GEUF%8Z.EM*G$)[#0;:"5M6]US,IZ"S6/*JZ6ZGN&R,Q4%'>;ZA
MHT7EN<7LL>W(Y\4EVP+2*69:4Y>'_5I=38&E4U6R%:"<5I!L3BL,+:Y'(K=W
M7^6V-98Z.WD3P5\>ELR3%C^8;-F(V4M9C -&1TM2Q(KQ[J[&IO([WVIK+YV3
M1*UO1NTN9A%)$@V1R)TL+*R(")O&J0.6$-B&F'D>$54XFX#ZAFLAKI5,:L/0
M283&RQOERZ:WB6,=TB+*J[&765+SD#PW#DBX.T!6[-KFJURQF6U6VQA'[')Y
MR1&T<B\:2:W,X(F2R0(<*<[C-C/>/C*SD:[<V^%L7MT=8PSW>*4-KE)(6!V\
MXT*]JL7#5OD3:V?'F*2RHX$] G?""1$<T?U"(FS9"QC$Z.'(GUV%4F0GKY5N
M2N@54*R&H*.H9-'5V132BMB%]\+&L&-'*OAHFJ_)*T9PQYZ2!%AS&M;+@S84
MDT&P@2V,<]B&BS([V+L54<B;R<BIKMH$6!*5?_<.1&%T#'[2Q&."M+4EZ'Q:
MVNE""'CE>_A*J<KU=LY=NLYFI"WY5WV_Y5B./PN%YN,:186X0U5<13@0U=!K
MHR/*]BCV@")^Z-7;&+VA8)>U08%W68=*NV1V2_.E;;4,^+-C@L8<@T*N-OQI
M\=PC#>!O#(B;KGHNW79/BM;!CV=Q.[*L<N3@F370(,2GATM)!>:5(9!LBN)+
MF36C$-H7;Z-(JJU&\N&,NL4#9=+[>[R)7@6>T+,8OB9ED70+(:B&Y)KJM$*U
MK6HC'_Q(NW6=V/WGH6K[.KZ)6Y!(?D(@RBUTB%53RV%5#95R6RID4%IO+&*4
M#7-;X)E<NZW.4JZ-EPWLZHX-[DO'M5JBK&F0YMHH:EGFV<.:>/50'E=Q'@8K
ME:QJJN]NTU.*%4>>[W'%R*KA6>0%J(]KOEX8*JEFGHR)/M-U6N*)S J)",^J
M155N399'B_[PJL>DSXT4OAM%/4&R.TZ;&;XH\DB*1.3:UJZIW744=O=6]+"F
MW.0RMK[N7:6,,<B9.!;>#/@O'(*O1N"\:1&(QHMQ&-1+7$,;KFY18]GN.T"7
M1)EDE025(EUY2PH,-H*VQ8:TE0(/&<UR  U3B;O\KN'A+L,Q8V3_ '_8YD%[
M1(:XB4FP^/#A/EU<YQH\P<4O%G-$I-JM:5%3PDY=9R.%V=%GN[/5KRW[%R>$
M KH4RAC9 5U<,==*Z;/CPY/(#:UK]U?A4=NM6KNZYZDK[BNA6L$CF[KB0[",
M.7&>K>7=5P2HNS]OVN_ZQ^,4K]U3?G!1?TY==GOS?#_3G_;9G<U,V176E/06
M-G7S(RMWP2XD=Y1.5A&D"8>U.5CVN:O_ ([%UV1?>UE:Y5/RNVI*O*\7?(J[
M1R4TVK+)N,I:L4+;"I=CY6HYVQ[8[]_=<S:B:5TU\ME<&XBT$V[;&<ZGKKB:
M4$>+#FRMN\-KY,H8G&:QT<)G[A",=M1.VF%:WMRVCIL6PF;#Z*+I)Z!ME!RY
MUE)IXD*"8KI']483:HC$5PTV[R)LUV68Y!'D.0Q<OQ9]U&R6S"-\V=70*BMD
M,/*X;H[G6IUM8Y)"\-&,15]]R^#40WOEB!D$^354=N6,YE1:VL1D@A*^-+V[
MS3E9#*H'$8P4I!KP7DY-MUD%':2:BTKIF.-!-CN%X K')Z:KF-**0,T8C70Y
MC_JFKNKRILUA&/8QDOWW4V10\@=E%5QZVU=CD>LAB-7Y VRA#;+@,ES2)'4<
ME[PF5=@FH36?6)\EOI@*[)X-=/B7,4[!4UI+KZ@,.BQV'T"/-D"GFF"X3&M)
MQCF\#>V[765$WI$&]J11I,ZFL!L#-9"F[_1)X>$0\:9!.X;F\4)"-:1JL?NO
MY-4F"P7.&:536.47LEF\TD:B@R8U9$BQRILX4JXM9FS?3PF@CFW=CU:]O:E2
M7V3H"GH8F#%QZNM+&+%  EY5V<FX43C<$\SX6./8A'D06]R;-J:_S&SX.43Y
M(L(BS)&&R8\P!P5JQ\,=>-X9!L>.Q8ECR+TCC^"FS6*K4Y18-93AJ39E>PI,
M4DBUNWTL:588R)KQ' %K9,QI)A6#'P-U  \-Q5#BLDQ7EI,EOH6(S0D52+7V
M5F"3YCLXY%12(.3/CLB2!N<K54XRMW7-)Q<OO:6=(K;:HJG38$V.K=X)V&"F
MU1%:2.9CF.5%:]CDY?X=BZK=\ICD=!C/(<[U(8I"!:\A".7^4][E7DV-3WD1
M$Y-9O?3<BR:QKH.>+26'G6LG/;06\L-& =+7!;6QBQ:1A;(.X4WP:D*OPB[4
M5V11G1,F6?C 8\VRK$QFV2P\U2A'.&XCQ21V/)6*R*3:]=U6.;N.1'JU%[.3
MQ<CO4\]UM[;T5;4QRNH,KKBT@YG'M#O@N&]T"*K311M,(O$*BJUS?>D6LFLL
M:W>R>WQNK@DCH^7/DUUG/KQQAH(YA/G*VN(4^QR!CC:YSG\-CGZLIKCR8Y:>
MZ'CEE5R(I?.\>^D%CBAU:01<9TF18+,$H'!4@BL(CFNW=JIVJ5LN3;I!IZ[L
M^="J+1@!MJ)%B#)R3FQ$B(L4HY2 "Y2L(;?V(BO7=V)^W[,/P*^[=E[OV.?@
MQ^.9_P!OA&80)U9&9A<;)P,@RP2C.LER>'!B&<\P2"2(D1(2*WP2;^WEV:S&
M^RNV8:?E&&K@D,-/#=!C45%TM]DA$(:5)-:VOG3=.AG\)K=U!HS9RZE1<NRR
MCO7AJY%75OK:674+-(8;1)=9&]]E.21.W&\@8S @;OO5=]58H^R.K\ZUQ/\
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M%WDV[?\ S?MNUW_6/QBE?NJ;\X*+^G+KL]^;X?Z<_P"VR^@I8;I]I=T<^KA
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M_ G_ )N]P_T_Z/?03M+^8&9?B[8Z_/\ _P#;K7;5^<;_ !%I_H%V=_WAD?\
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M*T=E'%&B]+3)\<BP[031-=OG?%,5BM*13 VJUS![=B_M.TOY@9E^+MCK\_\
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M<&,]8;*V? 4$1DN0'C2U=+1VQRL9L3ZK1,GE1TQ2J3!K_$)&Y)CR+W(77XG
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MQ=I(\>NN++AJ(Q(=;BXZP+!HK7R)1V#1S&J\H\EF?_U63CV(YYA&&V$UM?9
M/9MOY= #(9,1SKXD>O/1OR0(&M?TAJE"1SE3^;3)*RGB01K4Y)A]14.G,,9U
MW MF LKRQ&D>4%!A91\<\5Z;Z<(*%<CT=PTRS,J$%<ZDQHLVOK?.())BY=;0
M)OFLPJTL>=%; A$NOZB CF2'2#(KD8C$8I;_ !3&H.*3[6BQ#'+&4:>RTBU\
M/);DDM30SF#.,\\3HL'B!%L$1R'3:7X)V_P\,!6V0AY4+'^ 2/*FD+!K+=(&
M67D^PAS0P\:@PQ E-@\=AB32@3<8J$:FKNF!X<>#@V/2[)Z+M:*9,O,A;6!]
M_P  CHH3O7^%N[[IV=_WAD?]GJ-5O]WP_P"SCUG'S0R7[C3=97\[W?<:K]RN
M<BLE<V!1UDVUE[B;Q%!!CDDD:)O\LKVCV-3Z;ETN8YJ\,6[L( K.[7WQU0C;
M30<;@[>50U:2$ UK>61)5Q/JRKKM2MWRAV_FO',)@5L"OF0SPHCI8\AN#U,.
M2A5CN/X4=ICJ]&%/O+X+$:UF(3W4L?I^9YK98Q4P8ML\P355587+9F2QY)*T
M)SP@TM,24U' %Q-YC=K.(BZMFQZF#'BT5YD=+>-F6KXUE0K2=*\WRK2(^!L2
M/D(QBD!>-SV#CDV[2*B[,#N;2DC3YO:;D9O-=="L#!/ Q\U?,M*XT>)(@;A%
M\UUXVNXD@;.D2FD<]C7*UD&DD8['KLQ-&FVEO4NMNFUV.TK;:=75,Z;:1H:=
M*D70XN_&CL&QQ-TNU6()7:K:<E:RN^_[/G8.$()GG'IF/T5I++EEF)_1XJ]%
MDU.-V"#7=V<-PW*OA:S>VLZO@,P>NH,<#:PK.;.D6\K)GALQ8[&H4'&@CME.
M2"T?\X5[I;&[[6[=4N)3Z*$$MK0V>22C1;=TIU-!KCQ(+8\H:P MDR94ZP$U
MKF.1G(79O</>=,ECY8H<LSBNKR_^F:OK,PNH$-P$3P6QABC\,:)R(QB>][R>
MY]J/X$_\W>X?Z?\ 1[]BZI'&6,VYJ;&J=(:SB. VPAFB*9!JYB$42%V[-J;=
MFJ>U6XNHY:;%!XH%M;-)6J>,R1&D+)D&BN:5[W.B-\#ZA/\ Y;+P5;8RI$FY
MM9%PLJY<2S<&6:# @-:3X>+(E &.O8NQ2HY=J^$B;-EID<^PDW.0V\:)!DSS
MC#&CQ*R 22:)4U,$";L*N$>84B[[S&(1ZJ\CO!V5<9N=9N2FI[H5Y"H7KA[(
M"'#8%LAQ2RX^'@O306R#+X#IBNW>3>Y$T1[<^RT37D(]HF0\$486O>KFA&I,
M*(51B1=UN\YS]B<JJO+H>,U^>9U IQ1WQ0B@GQ:)+ $CW$=T>UCXJ.V 3?>J
M[[#H]/I+K%Y"95<QUQB976/1CB@S*^ZGU#3$KIEM'&"$7I#9[FD+T8L9"L16
M;&[6N&29D]K?W=[L_P!VWOG!:J5C)4(TK#8G&JVQH5(9CQMVEW"',QNZ<A6[
M46GI;K-LFM9--D4'( WCQ4$6T(M8]ZP8+UBTPP<$6U'*7<62\J;RDW5W-/C5
M-_=Q!F.^5)?P<;/*FRR_SLRPFR<>-,L)I=GA&,]Y';.5=9+&IKVZA_?&^3*\
M!E(,%/:2QO::VIX42FB1(\LQGH4B.8\9"-VN;RKMCF+<Y-=2X[=UA[>]F/C_
M %&YR4L!T#'6;J*N[NQ$W/I;.35AF$S(K>Z*:J)2T]?8,@I'H*Z7-CV-C'BE
MB18YI73)L,*[QMXC6":S>5$39JNN'L*&TJ]]D:=%,^.=T0SF.DUTK<7<FULE
M1HK@E1S$>U'MW2-:Y'R69%D5<CT8G1:^5"'%;N-1N\QDBODO:K]FU?"V;=%@
MU&2Y;"BFFV%B00[&"[>FVDLT^>?>+5O>CI$L[WKL78BKR;-8E$)<Y-*;AEZN
M05AIUNLV7)E=#L8*1[29* 63-A,!:%1&[R/1-C=[=\'4JOKH\3&)IE.0%O35
M%/T@,B1Q%*0L>1"+&EL,\JN>CDWE<N\US7^%JNI*6*&..OJJZJZ8V/%'.FCK
M8K8H9,\P0#;)EN1JO<YR<KW*NSET8%:!S7RY#IEA-D%)*L;2<1K6DG64XZOD
M3)3F,1J*]? &UK&(UC6M36.9&^20;\<BWP Q6L:K)+KP=>%Q"E5=K&QQPEV-
M1/"5_OILV+.S*1?V5AQZ1:.!4RH]8R-41S6+;&7T:3#AQI<@12A'N)(<5X]C
MO#5'(UE_E/2'$-?5>.5CHKA-1D5N.DR @S#+O*Y[Y7WP/1W(FZC/X]6U/.=:
MV+[*XM;J-;GGD9;X]+L;F9=B=B\D>ZV@=!G37$18[6<8FUQ4?O*FEP>PO,GD
MPRPP0IERMP]N1SPC,PI^F6;1)QO.#6J(Z;FZ\+W,V(FCTTZ7EEG7R8;Z\T:P
MS7*BQB0R1^C/COA,MA0'A4?\A1*W^+9R:I<?Z?,M/,U9$K6V$]S73);886A8
M60YJ(BD5K/\ []=#$-L>.T?"&.,B 0#43P. @T:@5'[[=WZE=9+;.O;F]EY(
M:M5Y;E\0A8<.IBDCPH(B18L7C-&L@B[[T4CD5-Y55%<[]CM+^8&9?B[8Z_/_
M /\ ;K7;5^<;_$6G]TQ.Y02D?1V%@CE1-Y0Q[:HEP7F:WZK>22H6JJ?4C<Y5
M\';JUS$.3Y)&M;6IATBL&F-FAP*V#(DRP1J\4S')11-Z5,>1V^\F^Y>7;L36
M35\]LNP-F->6LR*WER-^WG1"1RQ1B8=@QQX (8SN4 (XA1Q/<KD'O.<KK+'+
M'+,DMEL*&9CS;.2^KBRH$.7$?"0T0%76P8#YX1JCD.<1B[Z>_NJK=8O95^09
M!72\:QZ5BO&CNJGNM**4>!+?"E-E54@$/=E5HE8Z&R.X;/ 9NIN[MSB1#V4N
MJOLAD9!8(<XVE>23D3<B)#:^.$/P+C-X2D7;(<+DXG@LW+W)H[2K97K8 B[[
MF]'A1J^OB5XXU>!K6MCC,R$QQ??<]6M^DUJ)"QLF19(:EJ<CCY#30B/J-RL?
M'NW7S8;7MJ4-.$LMZMXDIQRM9R-<W:[>R";%)*/+R6X6ZLI$QXBFXS8$&KC1
M1$&$+N@PH-<-@FOWW)RJKE55U.6KMLFLJAMG96]5B+"58XD.==3S3I$8$P4*
M'9&A+8SBO:R7+> 32*I-[=1S;BRFF;+O\FL?.MW+9MX2/& 4.OJX.\UI$K*:
MO P(=J(I%1Y7(CR.]T[._P"\,C_L]1JM_N^'_9QZSCYH9+]QINLK^=[ON-5^
MY7]-N*99E>_= G_U+X[F2AQ5Y%\&2\"#7^)VJRU6R ^EA13D!4= ?OELI31-
M!:DL.G<JQ(W$8(7 W?AW.7:Y!JSM&M/O@9TGM Z,Y"1JE8Q:0\&B%C\$H".M
M)'2^!&CL?L5&;2HJ[41=B8ET;+TCR<2P^VQ6#(BT Q-CDFU]; A6M8 EK(;
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M<N7+ERY<N7>Y7+ERY<N7+ERY<N7+ERY<N7+ERY<N7!GA8!&"B HIB(JH\:!
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M6+P1_0'G:7OP5,$5 360&. KB&@=:0@QCA]NLPLKU$[&>%D"D$//!B]H;W!
M4N,& 3)I3"C35SRLZ_1M'-B^O8":B*$"\\2\ZKA[]B.5JFU%S"$9\7H_$/\
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M%$I<W(8 3A8*=Q3$Q39Z'3>.#E7S6O  U..IU4(I#FK/*WO"4 WAT*/G4XT
M,-\;_P F% B.EAW0,*DTKGB =-LV,"0: ?D5B0R1#]);BX/N= H9:U( ?KX0
M@EH(VG.@F_A;!CYH)X]$1O%G)&2X>67B^42"(U+$:79<Q?<(>6*M#2,])$*>
MD_1L@KK+T&+4.EK15&J&\#='4,C@-";J8>#^\V@\^(3: S6#(D GZ)Q_AE_*
MW7Q+1:G;_P#R>IH[[+Q$E,A1P+U06=CCI\>$=:PY4L8=24V^24='^)3)QE?X
MO2"*(%Y;P$'0$H'E^VO'U1I2,Q!?8!K5D(9OM!3E9< "H!5@\L*?RP#,%699
M&F31N9_W!I^_R84YQKKB$Z@ 5RDL'GYPZP$6SC* K(]HKNP%K=#0I;I"A'"R
M/SPJ$:+UAH#C6=PPZU=L<S(S$$2-;QV%.DK/RPZJ'13@'=D^L&U,9 W LUJ8
MYI!]7>RC'$4^TUX/'$E(,=%?C9=SG5VBPS"JDR0X[ B C^YZ?O\ )A?6MCC<
M1_ SGT\A:QSW\1/$5CJ[UM9"LP/O8S,-:"OQ 8;$<.BWA$4-D/7,(.+TGP)!
M.'82(,LY3:G."I9/-O3_ -)ECZC0V!:PBE703MO!IXTO*5.S)Q&V?XY_^0\<
M++$9ZYZ6!YA/9/:#S?[K-.H)BPA^YZ?O\F$V?]P2@# . ?H=E'EM]'%HXD6+
M.#J"=H X"'Z(3  U 8!A?8!UW:B(^!A2X"(/\CZ?O\F&D,7\,Y":9(*X]F__
M /\ _P#_ /[FE/+(K*'!0^R__P#_ /\ ^J%TY=AK)P)!_(TR8:?K91*[HG"A
MX((5FC:;&H%>)_;V?WWWWWWWWWWWWWWWWWWGNG^7$)"^!\>Q^^^^^^^^^^^^
M^^^^?EG5F97.QB\A_D-]:* "'CC;ZDR6_C!PX<.'#APX<.'#AQK--AH8S48]
MG#VIPX<.'#APX<.'#APX<.'#APX<Y?ROI&&?I>%Y_HW:UK6M:VQ&8GW<)HWP
ML.+WK4GV;,1P&)T5.ZT4'FN!B#G18.",DK;0BQ2L#&@K'G!'X"1HHJ3HK2FB
MP^TT>:UJ+1.F-B .*_Q(L  =,H*Y^(Q04?B+9TEQ\B0Q*]*\1^';6P13E8<?
M(;<0YTKW1.?V>&#AG2O=$Y_9X8.&X$ASJI(C/4"?T,[>5V5T8J/@+7RD<Z=A
M@KVM7<L<'[_N*>3+?58X/W_<4\F6^O\ <F4LR 5WC L*=MW\+>ZF9&^ +4L6
MK=L>? J#S.B,-2SNYC@D8T&"2C C,6XHO1?9_P NU)-,\#<J$PTEV*EJS\9S
M4J^#_))^[KX9IDSSLE:![R>(P409_IX1. =%,%$&?Z>$3@'13$_,@!&%XZ;P
MIVY,=;>NX$VPR_BI-?11$HF)3G3V!<N7+ERY<N7+ERY<N7_^[5_\9Y*>R+ER
MY<N7+ERY<N7+ERY<N;<F5QANX!U?5X[GXD0"@Z?QRY<N7+ERY<N7+ERY?_[M
M7_QGDI[$N7+ERY<N7+ERY<N7+EXH]\0 \7PI;WXYL'N'R&K5 CX+@5Z]>O7K
MUZ]>O7KUZ]>O7KUZ]>O7KUZ]>O7KUZ]=$!(_\,$ 1=%O'W$3.X5W5>KGU)X6
MEPS!T3'EN<+OD)SI5[/@*]>O7KUZ]>O7KUZ]>O7KUZ]>O7KUZ]>O7KUZZT)N
MFS<7B MO#];*8F+F#YI8WP@0                      #_ (. UH/\?FO^
M):K?X#_!\_ZJU:Y=<Z#EY6N77.@Y>5KEUSH.7E:Y=<Z#6[);:WB?-(^"6]S)
MGB9G6.Q<;&?D2'9V!!%>/:Q"PZ%1D/";ZO#S.BB:8K&-B:\F\YPM9T;RQSF?
M$<J".I'EQ"VMQ%KRE>7J*>#QZ*8S#*"?,]*=P)^23>T.1T*3B2' 8I50+LM"
MK*ZO*PK]<I%&X&&+[W))TH!3 OFE;N^8HP9GUX(9>,&4B&$;'-KN[,JPF-''
M JI9L=H.G2G'R!UK8NL&%-.27)4.P3V5=0NJ1:NKG9(PIGQ;1./:!8+*01<"
MI%^1R8B\H:W.Z6,6T(4 .0,!RQGXFB2QJA^?+3(C13D A_T^6-G1DPN\&#DP
M;4FY=^Q)>5!NK:A@F1-'T,UDGA)XO[( M<:1LA#S5KQEFPHM2AV;N5QM![CJ
M"X9Y:1XW4Y5% 4VO-J+35;K[]O\ 'D//1=41?D,IH<%0$=6G_B8X1 >5S&N^
M-B_A\<&@;0=N,,_NFG.LEAWS!>D 0R[<S<><^%C$. ,BVA>T=*AX$*<*9=L?
MI;K=]K7+KG0;-HR"N:I452N5JQOT0D0,(?G(1G'-9WZB^2 R]>([FF,[8*],
MIP^%YPR3P5"R_P ^P;\P8-%AG/X7F.J/,('([^%Q/Z/]53K*W&1^PN1Q8+B0
M$#)J1CSPV/HA;)1CW1OA/XRIXOD6@@9<JGU 4.;\_1BIB#(]NAL/I):2+04W
M1S63JVJ"Q8<&H(!7*J.GZ,0/* &%[K\5'ELFO@^,T[PM/FT<DO,:U,*!2Q'E
MW1*6!UR'&!.XY^-3M7TR.E#0.R,QE?H*D!LU,-? $HV0<8T,W4U IDF<UK'2
MJ#]SH$C)VN>C:1_%R%=Q%R[$>&VI68M<1=3TJMBZX,8)B!C'CS]C[YA"81KU
M.U[WI,98!\<[+45I5[J*M96@@C5O.A^ "H:WA0CD:9X^#(-"N?.FWU<2?*&+
MAWL8)3I(9Q#U>&+TX='[./2$:6AS)BW\GD7/-1L*IY,>#F".G8'O2N1UF5RH
M\4AOI>#CXULJ/8I>5,QC":B9L\SBL!N>;4<&>$7IV\WQORX$>^?.ZN O4T)5
M$,R(G2>"4KEO' M .GXX;A)YL.*3?A1H]IF -HX'7F"]!3]2?X3Y5>BV F]>
M^5D6\?.DA)UQ/4:7%ZKZZ6[C1CD/[[G15<,?0A?>&3Y#H25>-5Q+#2E%BKG=
M26)3=#R7_<V\F?:URZYU-J4FA9N2&<)BKLW UJMGG=)6$;8J3:I3[Q!)^U8I
MF0GRY\.%OG/'GR9Q!H-QKR&7A#)/_2#$F9G3GX: 4JX35IPUN[9N,ZWL, .@
M$3A,,T'$NE[@8TAU!D6X<S><1IDV8R20@2<(<0.J<_\ OXWW@@B6M3]K#$SU
MOO?HE/ S:>2L]1,2.D5IYC)]FVC]MT4?.0",!VX![>/ DWTTJ!T"[!QG%BJ]
M9I.$*O+""A\'S(%K0DHTLB48]74:.DX5VM36HGN=B$@)H4ALG5? E9JQ0'X\
M7US@3/@.NPV@(@V>#T1J&U))+>O<Y#AW0+HUZ*YQ<0]#CLN4;=OG0O31P> N
MU[,FT8>,1XZAA'G?U'%6I @W#YB $'1 JQ!"J<ETA>)R^F*_,"X(CC"9H9<P
M*Q_A@%<39NEZFQ#N[H.GX;2O)H?EPX!V_:R.UX,L!:"3 C7Y7*T\[C1K\"05
M-?L'8:^^#I=>FV*#D3:P85LP($Q=KQA##G,!1E!Q6;Q2/[D&_P"%9 'V27E0
MQ].K9RJQ%=()FWQ;G.C'I4/016X'VH[_ -E,K?07V@ B"Q CCS/5H5CPA3D6
MR-2%H'N:Y=<Z!V9BTAL$,)U>3)O!B%>92>CBMY/TG$?J4U>($@9@^Q,SC"NZ
M)Q/0^Q,SC"NZ)Q/;!_CQ>1I&<G=HZPK(6UZN92,%9*#1!T+5N, &,<-U$R@=
M306Z"ZXP5'&YH3+)*GQ!B(%5;&14,71R_P!*&'!>O YQI_V55V-WZ83>".BF
MN8W^E\8XLJ*^<./8IKDQ [ H&)S=IQD2('GS:5]36X (J;R:GHMQS'8WPQ>W
M!H?X5U^B76(-1A%<J5W8%W]P,725J3>+3&\-#^\- O5#'6@ZKQ,?!.RBS%L/
MH:44LWBYX$#YL!B6:#*%3NFF!T'TI8US6B[/XC '0!/B@F/EA7FSD*=PWIWA
M_I;=%2?M?@7^9P_"$2>X>9$ ;S$\@U N;%'&$3"@5,,$SL5AYC\@13 3!-C4
M HO@![&7E1PROXX@AV+A.YR$(#ZBB8E. E1O65H9A*A,,FZ?>=9_G*6,=1'H
M-LX)6X@X%Y' 1>LRICL^%=J#/$@?1?@3U =0?)NZ;D.=]%M#AG2JAM68$LOR
MU45I5OC20L$\&2-DI"^XKEUSI(-;V'-/[,\/O$!S;3?E.GG8V*6"H#UZ=HBN
M/Z(ZH,&K-348XQJ7PFV7A3Z XW_FAOC^GAEP/9.3TP%8BOI+&1J$- V,J@3>
M1O+0A1'TL/.!(NM62?X[* R(!$#B:,AW,$'ML&">DDJ>!-DHIYQF=Z(> !+.
MCUP\":V4!3D> @9#B[8"^K*&WC03@ O-1C02N@/"-<)A#D:+OH,SW'/BOEGX
MF@8:X.^:_P!.QH[_ $9E=<X'C/96P.YC_P!WH/ ./R5Y^:L2\!88FFTA$H4"
MWFN7"#X\5^24K#& !KR#=.B6.\/1:LYOL2R!O8;!WB%'*OY"JU,+A(+<Y9WZ
M FD0&4598INGR@)X/SB*-]%Z^08J-,OYT=0D\N#. !P$36FIZ1'?,[-V'HY0
MB9/*-$Q&'-[^);=!%.=+=Q02 9:W+ P,#V@++J$7PUD?#!=]^ B3WV8DF^D;
M80!PJELUTDWY8=55#QYB:E4,%! 3QG79A'0B?L'[$ZEY4@#,>P:H -A@>Z%6
M0"51%4)Y 8^$P3>"(O=F$L%_%1631?*O%$]_O(75I4]SWXRIH.5\Q8J053*H
MNI."+Z8AJ-,[F:%T2,%C0,JJ6ZXI(D0R!TU $(;/(8RS(I2%:6_<URZYU'Y-
MUB@IQ@6D[@_SNV+0>/S%<UQ%PUM&H5KD,$= U]M[ 3X4);-1Z<OX]^>PC"U:
M?AL "%SG!6*^EK']\:D?;_YD/IY#)0I&BYH<I'?_ %*0^\SHT'SUF#VF3Z2"
M4Q&X")^9?!!_N)Q_B^!A^CC'N+^Z!N/R-, L-FYJXSRV+]<,.U$1*B,#IJ[4
MJQ9E8*#YV\2%]-*I0?8S3Q7O/ : N*>9\8@5T$P>=ALPIR"T,5GJQ$^2%$$]
MX='[J4R7E:Y=<Z#)1VE@=J95U9QSK^*HYF6]=Z?#:@"44!T$BDT4 ;LUK  8
M$T5+PB5]C&4$752PB;X !+]%HJ_F#VJV890%LJ"=X.J.E>'DT'"5OB^B/F;H
MK.<1O[J$]+RM<NN=!ILK+_#27G]P_3#H'5HI(JN$1C2HHZYM8"Y>H^K/D!"*
MBH(BBX8_GK+RM<NN=!R\K7+KG0<O+O.Z7\%1!YQ^"???????????????????
M??????????????-9B&&,1V_&JGC\U7(:K+2I'ZS?K& Q4DM0KI\_I$Z*<=*O
M9\!]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]\S]%25FU ;2(!^NW"H]=DO*8OW?
M"$DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDW\N2!1N_40>;_G+1?_6_N__:
M  @! @,!/R'_ '>U_]H " $# P$_(?\ =[7_V@ , P$  A$#$0  $
M
M
M
M
M
M        !)(!!)(
M      ((  ))
M
M)   ( )(                                                 )()
M !(!)
M
M
M
M                                       (
M                                             !
M                                           (
M                                        !
M                                                       (
M                     )))))))))))))))))))))))))))))))(
M                  (
M               !)!)                               !
M             ())(                               !
M )))))))))()))))))))                        )((            )
M)))))))))))))))))
M                            (                 (
M
M
M                                                 !) )()(! !
M                     )(! )((( ))               ()!(!(( ()((
M                  !) (    !(!                   !!
M               (()( )!!((()(                  ! ((
M            !)!)(!  (!))!(                 ))(!)
M          ))))( !( )!)((
M            !)())
M        !! )  !
M
M                       !         (        (
M                              !                      (
M           (                (
M                  !))))))()))))))))))
M
M
M                               !)                    !(
M          )((               )!                   ! (
M
M             !(                   (
M           )                                     !
M        !(                                     (
M      )                                     !
M   !(                     ))) )(!)!())!(  (      )! ))!(
M )    )!)( )(          !)((! (!( ) !!  !       )  !       !(
M      ((!)           )!(!)! !() )( ) (                  )
M     (           ! (!) ( (   ))(( !      ! (  !      !(    !
M ((!(          ()!!))) ))(!))(! (      )))()(      )    !! )
M(!                ) )!)      !                  !(
M               !  (!       (                  )
M                        !                  !(
M                      (                  )
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ME) D"N[55/FY,& 4R[/W(^%6=UQITEH+7BW I( !9^76WD=EQP04D2HG!/C
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MP-3F91P8P.8BH!:$9>AF(\6'F.N*93DQ\%6DC3;LQPU0R&-+\ (]SU*G3B>
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M/Z#2VA_.IHD#[ _(.#'9L$;%'M/W3($8C5KW'V ,QT:6R7*[E@_MR!<9M;9
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MLD 8GHG$4)0,8G=0Z,>F:U7%9Z9X%:GY$HCH@DL[1.N-KLF@:*'E1# B\O\
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M<.970, D3R4/..*(3"+)U7J:IRIO$_GM$E%CJ +#I6Q9"@"PZ5L60H!6+I0
M#-8DI_!.NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNKGS4!]"+#2I&?XZZ/4T
M!521SV7ZS=KG"1J'<W4F]U)T4/\ I@>_ZZZZZZZZZZZZZZZZZZZZZZZZZZZZ
MZZZ:Z"2EL!MF?X&-,V:H.D&V5.)\(CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
MCCCC*<Y6]&,<03H=_P WHJ_XIIW_V@ ( 0(# 3\0_P!WM?_:  @! P,!/Q#_
% '>U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2132809d1-ph_proofbwlr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d1-ph_proofbwlr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!8@*Z P$1  (1 0,1 ?_$ -(    & @,!
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MLVX>*_ON/'Y-+8U$V'*[:ZOGJ[&%YAXA)#5DX589%5DXNN1L&@!H : &@!H
M: &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@
M!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!H :
M &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!H : &@!
MH : \W44FG!1=E)LT1>U#V515-^Q=T+;\/CH" [[GCW,5YBV0,<Y<8>)N/\
MCKCF7(7'',O(_DY<<'YK66=]4S,81RKRB(]6G2W^0XY<6%8]%BO.%,K'I#1
M;7>FNF,:&>X>_LP5V"0,&Y@C85*X.R!VMR#C^EM\PXF\B)WD7<38U!@L6CH*
M#+<DLI4N1CL#&:FK;CTM2V01H\1UUQL-W24IF$3=:P:.J&"[(A"JENH[$B[[
M>NW7KMH#G=/3=-U]$W30'._P^.@.-T3U5$^.@.=T_']O^#\= #0 543U7;]^
M@.%)$]51/WJB?M_WM <(8%MVD);INFQ(NZ?BFR]4T!SNGINF^V^W[/Q_=H#G
M0 T -T3U7T]?V: &@.A.-@FYF HI(**1(**2]4'JJ?,J?#0'=%WZIU1>J*GQ
MT!T]QOY_G#^&O:?S#\B]J%L?7Y5[21>OP70'??X?'0'&Z(NVZ;KZ)OU70 4A
M3U)$V3==U3T_']V@.=T_'0 T!QNB;]4Z>O[/WZ "*B[HBHJIZHB^G[_PT %)
M$5$5415]$54W7]R?'0 [AW5.Y-QZJFZ;I^_\- #N1>B*BKZ^J: YWT!QNFV^
MZ;?C\- <[[]4ZIH *J)ZKM\.OXKZ)_AT!PBHN^RHNR[+LN^R[(NR_@NRZ YT
M!PJHFVZHFZ[)NJ)NO7HG[>F@ A"7Y2%?3T5%]4W3T_%%T!SOMZZ X[A_RD]4
M3U3U7JB?O70 W3TW3?0'.@!H#JA"J[(0JNZILBHJ[IZIM^*: [;[^F@.JD**
MB*0HJ^B*J(J_N1?70'/</XIZ]OJGYOP_?H *J(FZJB)^*KTT -T_%/\ 'H =
MP]>J=/7JG3]_X: "D*)W*2(GXJJ(G7TZ^F@!W"JJ*$/<GJ.Z;IT1>J>J=%T!
MSH#JA@J*J$*H*JA*A(J(J>J+UZ*F@.4)%1%145%]%14V7]R_'0 [AWVW3?;?
M;=-]M]M_W;Z &Z?BF@..\?3N'?\ >G_'H#E2%.JJB(OQ5430'"F([=Q"._IN
MJ)O^[== =D5%]%W_ ': XW3\4]=O7X_A^_0 W3KU3IZ]?3?\= <Z XW3KU3I
MZ]4Z;^F_X>N@.= #0'"D*)NI(B(NRJJILB^FV_X[Z X0P7;8Q7?=4V).J(NR
M[=>NRZ [: XW3TW3?JO^+;?_ !;Z &Z?BG^-- <[I^.@.-T_%/\ 'H#G0''<
M/KW#LJ[(NZ>OX?OT!SNB>J[: &@!H#A%14W145/Q1>F@.=_^/0'5"%?0A7KM
MT5%Z_A^_0'.Z?BG^/0 W3\4_QZ YW^'Q70 W3\?V_P"#\= #0'1Q%4#1/50)
M$]/547\51- 1*_<\J/&"/'\:.2/*GEG#N,\ XYY2S>.WCN<XK:9C'Y.F<J<(
M<G\<O8YBV.5E1>6KN;XW$NG<C@/1:^6Y$_2"60#<9PS7IA*L98AGV4:?#&ZK
MFRRQ+G;B_FB-CD/ASAZ&?%'"/(O!]<F+<38W=X_@^:<B57(%%4_S)R_E=$9-
MV]A6(M<34&.+/<S[+ILYH$3&\W\R<?>/7$7(G-_*UR>/<<<78K:YEF=XW6VE
MP=70T["R)LP:REAV%K-]H$W[&&7#7\-856:(,(_]4I]E:2\V ^3V2/&?9[3#
M? 7.@NMH<=UXQ)'./FE4!]A=_P %V1>JHFK'4@9ZO^IK^SQ="XM=Y#Y?(1LT
M D#@/G)/;551-S)< [6T_'?IIQD2']K^H9^U9+!LFN<<M?9<1%1[_8IRZ++>
MX]V[KS^%M1VD$5W7N-.FKP?0&X<^_E]KMI $^;<@[72$15>)>2D^8P0Q39<6
M]5%=_P!VG#(2&*-]\S[;4OW?:YAR=I8^R&,CB+D^.J]W80MI[V)@G<2&BHGJ
MJ=4Z:<,A*-A'^]U]N9]41KF'($,B]L6/]EG)".]Z)NHH/\JJ2EM\-M]/K?0G
M)&\JOO,?;[NK2+51>7KYF1*4VD<F<8\D1F654=^]QP\4W';;IT7KJ_7D.2-0
M?WK/M\BW9%'Y6R>0=/82ZV9%B<4\D2I"+!<:"5.-IK%#)N& /]RN+L* FZJB
M:?7ET')&7'^\YX"2&S<;Y(RQYM#=2.8\1\F^Q(B-KTE1I 8DK+K!(O0D)173
MZ\AR"BW]]O[:?ZXYC5GS/DE):"TCK4;).(^3Z2-*;1"5%@3YV*,19@[@OY"+
M9>BZG!R)IT#4U]ZK[=KJM"WS%=3"?448&%QER%-#YE(09:<B8NX+A*H*J)U+
MKI]>0Y(\I7WM/MVPMP>Y<REI15=VTXCY-4D4?S)VKB?JBIU_#3Z\AR1I'?OG
M?;=!1 N8,L4WM]D_V0<DH1(/[/Y6V5.GPU>#Z"333?OW_;+K67'YO,V71Q:1
M?=<3AODYQ1057;=&\3).B(GIJ<'T+(\CP^\[O&OSPQS,,V\:<TNLWQW!KT,7
MR279XGE&).0[@X+=D##-?DM36N2A<C.)\X#M^"KJ-0!ZC:(C8(B=J=H[(B=N
MW3T[?AK)1K7EQY7<(>$W"V4^0WD1E$G!^*,2D5D>\R"'0W62NPYMY9-4T!Q:
M?'H,ZUG#*?GM(J-MD2*.R(J[)JI20B2=_JC?LKL.HT]Y1W:JB]IR X.YJ^F[
MTZ%VO+@9 @]WIN6^D=1(JE'_ %$WVDLEC63U=Y,/;5VR2&;#C#E2!)=4Q$A2
M.S(Q 7G.X53;M%4U>+$G-K_4.?:BJ784:9Y"7Z/V+BQ([43ASE^:;:@B?WR1
ML)>5H55?S&@I^W5X,2&MC[]7VPW&(K@<^6R?7&C42.[Q9RD,M]PDW[6V',/%
MUPT'JJ;JNVG!B0YUOWK/MTVB.+$YENG5:+L=WXMY*;)DMN[M<#^5=VRVZ[+U
MVT^O(G)&+EGWMOMKX+5QKO-^?4QNIDL2GEM[CC_D.NKU",/>XVDN9B[3;KXA
MLO8VI'^S3ADAR3$L@_U"'VO\A%',:Y2Y7RV(7<06>*^,OD3>TK[;:J*N1K:N
MXU>KIC.X]"!TA7\=.#+(?*?[W'@/?1'9=;><VI!:@R+1]ZQ\:^;*=ANLB"IR
M;,ELL%CFE?%1-S>79L=NJZOUY$E":S?ZB?[35)D'\L9;Y'9#@MNV?8RF<<*<
MUXA7S_E0B2#:6^ Q:*P%&S14)N0?YA4=U5-\\6BR*:Q]]#[9L]JO?K^?9%O&
ML4<=8FT?&O)UQ!",&Z#(D38^''%8;+X*I;+\-]7@Q)K\I^^W]M'!*]VVR'F;
M*&(4>(<YZ3#X8Y;EJ,)=R:>2/%PIR0XVZ [B0BJ$B=-'@]22$&F_J-OL_P"0
M1AD5OEE"-X2 7:V9@/)%;=QG'5)&X\VEF8C'L8Q.=JJ*.-H2[=$U./5%GN'!
M?O\ WVLMG";\AI<EA@>^5*B\8<GR8D39$50D2&,1=:8,17=4-15$TX,2:*T_
MJ%OM1PA:-SR)GJAJ'M)'XJY/D'(1TFP$ ;_E#<@/O0E(=]@12]$WU>#$C_\
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MBHD=* 7T?RILFR;)LFRIMT]-EZIJ%&8^4?GEXC^$Z86[Y7\WXMPJQR+-M:[
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M.'UK+:1<2GL@J_S)6MN"C[4)QH?])8$E0EV)$]=2W8JKW$BY*R'];B1J;'7
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MW[8PVH6-I"C,**[*)^RTBE_GJNN7DT-+8LLIZ)M^">GIKF:(0/ZA7'HV5_;
MYIHI0*Y%FY#QPS(;55$U1,[I#545/[*B>Z?L76L+D90@PKAC%:.2R_0&[5MN
M0U&2PDIPXJO@"]S@M$I- Z9"JJO3YM_CKLE!&Q?8_%$"PAL1F[$[9UQUMUIX
MYH/#$!S;8_8%5KS3\/<'HNK!F6%"Y\:N*<<>L9%[B5=37%Q83&%<PFRG8]>Y
M9<0V6UCS8S-4_'1MR8P\CBM"*BH[J2=%74XI%EZ!JP_PVX]-FIH'+;.,T"PA
M*Y.JK[,\EMZ]L9" 81X<)N0E6XU&3Y.UP3,43;56"L3DQTF+<28?Q19XY-XP
M9K^.9=1=0WYKV)QV<?DP;.*(O0I+[U<C+Z28[K B3A+MUZ]-:XHDS<55_*I-
MM.BM18U1!M*6(MW"=NK%&83C\B20)8&Z>Q',^K;[^O5275GW) 57LPFP+I)5
MO9S;VTLY9#.F0O?FDW+<<1LXS9,*XR#K:"@BF_4>NDP(%2Q9B9:7=X5M)<HZ
M^-N<.-,>:.\DNDTJ-MP8KR&S"9%Q4/OWW+MV^.JB,]:+%OY;@G(@4D:0Y:7P
M3;"P;DMSID@ZX]C=<!4=>8?M"-"<[.T4$55=]M*!RPAY1C4>B1)4F?*=D3'9
MDZ>[)=)MYGZF0;K@F\\0A^GMJ7:V2=$!-M1P5#=^6,7Q7,<6R; I)QK>#E%)
M+J)-77O#8/-.63"MQYZ&'>%:_#DF#HODHJ';W"N^LM:%6XT[A[.<@H:1.(.5
MR7'.5\*A%2PW[&5[?^T:DIVPA1LQQVR?(1M"D#):62 FIMFJ]R;;+K*;L[FG
MNK&PFG<&\S].^DB+ >)C)+&R>7M4'D5Q&JQ=^UV0:$@[CNB;: 8WS9Q<N,Y]
M5YG3257"<ZOHE#G]2ZG;!:EV##L6NLF0_N6%3W51TNFY]5]=8:ARC29?]_I:
M805GV[,\J@1$2E\JN6J,$%.T59K*;"&V"0?AWM&B_MWUG.X19-U@I#!]^"N9
MM?!5V%(:<=:+F'CIP@!HGE- :R+N$ $25305UT\?R,Y6*HF#8Y6R*0&8M,[$
MCB^HR7),!63<:51V$4,>[O)%51)/QUZ$J',/UY4UN(%6,QX$R]E7).LT\2QK
MF)E=6*XTC3CEB+C+H&RPA[JI=>J:.A%U%:P+C["*&!64D+ <)J79;?T^0W3U
M!45W?*D&KLBR9E)%%01PS4_<].NZKJI)(RY8IF5)CK4=IN+"C_IN/'#;9DQ?
M:EL73X&"268\P.]A_P!E@4W]$%'-OAJ@+ST^Z*YA#'B6RXFV^ZV33$!R4Y#?
M]D3 VS%M&0<3O0D[=UV5%T%(ZB&<C,OLP9$^-^L6-B9R98S[L76%E--NDDB.
MLA\4#WHZ]"3?]VHS2-9C3T0X5=+NG0A-P20OIX';(EHX\**(+8KNRJR?5QD?
MX@%T7JFB#G05#L8E2I,FI2/3.+%8^AE,UT99464V*.&8V;X%-8<>5>U>TTZZ
MI.X2+A:98ZV-O*;=R1E'X%DVZ]]1)8C/*OT;S0&O<C1&O<Z8]5U.Y1&S*L0'
MVHP2+"7(<!MEJIB./L"9HO:B/("C\R?@NLE&D<]XKR1C&2UW+7'U>1W%'7!6
M9%C!27._*,>)XW),<61_AG;QR)29W]?R[]=9R354:469E0>0<$Y"JX-EC;A.
M93&BLL6>,34]FTJ9Q@@S(]O6.]K[)H6XIN.R_P!E5324[7$>QH)6,LG#MH%L
M#=O DF@QXKX(Y%8;D@0RHRJJ$+NW=MTW1/CMH6?<8>_@CW'N49IA-6ZC45MR
M'F.*B]WJD:KGR%B3*]MXT5$"#+;-11%^1"V36+4-7/H^_P!/W6_IOVN> 8YO
M(Z:67);A*#G>"N%R+DQ'^_;W-<\KP$32GZ)U_M#_ (>OI_AUDI6D_J-\8K\F
MXR\:AE(PX,/D6^-(SH*6ZC2#[BBFVW<*KLBZZ^,SE2I6/J^/ZFJ;<FPYC]?#
M?C"RZT4LVX[#G>FYHUW( FFW3=%Z*NNL&)D49<+K+"J&([-*<V<J**O&ZU)!
MQDFG?F<CA_HDB.I*B*)(O54_#5A 33_8]QW13KUF#B\3'[&]60RK."37L>L;
MN0;/8EO]-7*S&.2PI;F1-KT]5U(0EF[H?&W )L*/BEA89_F=@Z@/3&\AS&ZD
MP%)U$[XOZ2U(;AR1$$0#V'8MNNG%6$L5>GXOP+CZ7&C8144^)#$=*!+B4<:%
M2DDI$0P:-F, 2E4D0U52Z?MUJ$K$ENX:9-^W)>((;$!NSJ6U.&4UX4]]Q_HK
MX(1;ON"K?K\-]608=?EP5,N"Q+5R1:2I2/2W(T=7>UXMU[0%D3[?X8;;)\$W
M7UU)AB)%@Q:"F06=W;OS8<&DD(C_ -%9.,2+6S>:^D*-#IHI(0QV]S4U>)>Q
M54AVW%=5&68M9Q_-IXDOZ#'FSJ9U]-E3$C]LRP:*4BN XP#8]INL BD0A\O7
MTT+(1;;%V:'VT*S?G [*>4B>7MEL!);5U!>C*JI$44+;;Y=TZZ1%BB"<J812
M9EAM]A5F]%F1+VH-MIAM\7Y,*6! ZS:H#:D_"D138:5L_E5.U51=9RAJ"J@@
M_ V?%E;5E@>29%7T7)V!5SL;Z"WCNUDW)8]>;T:%=U<9U1*P@V3#*+[K7<*&
MBH2HNLJM"O\ @,.9-VD=MF"<F/8V;G:]8G$+M".W)1%4'714E$4$MNJZ!#'^
M7N,3XVSBAY KGQA<<YBXQCG(5! 8!(;%Q8P[ 8.5R7Q5!:<=L938O.[(KBFB
M^N^L-0YT9I.3Z2?V:*-K%OMD^(M$RZK[-9QO-A-&[O\ ^+R_(6VQ(E3=5)L=
M]]<\J."HE%3T3?HNWHFLE*ZWW\58*O\ &4EIXMN\D_E\&@DM@X<?:#Q\VLEE
M%15%!-%%53T^.N_AU.>5RKCRA060 Y*)AE@I-,3#3.[?TT)Q41QQ?EW7O<:+
MHOHNMLB&74$&5)M7)%BD>' A6CK=-$9(29FJVT'?,FJ0[(\CR+V)\%VUDTQR
M=*RU6MDDU'I-G* 5A2$$74C$Y_<COTV%-T]-4@;:UFUMGY54(P41UI'_ & 1
M/;)D=T-YPD]'$_R55%U2&LEXG)8A]L=V+96+DQR-"!@2+Z*.;:IN\?7M< ]^
MOX:D"37U_&^207'+ZT8F0#<-H!B(+I1UC,;-.RC$T3<'A5744=^J;KJP[EE6
M%JPZS25(*O<4#KP00C%'CHV<DEZ*J&J(3O8J=?756VA!6)95F,E$F+&95V))
MC-&,TPB]L2<X(/NHV6R.D(==OCK5B7"Y37,VQM+%BNK'8R5RR#F_K(/0 DMK
M(F#%<C-(@J8E&5L@-?E)M?VZEP:++^)&^4<7L8LQV.Y'LHDNGM6*1@8T4(4Q
MLO>8F1XZ=TEUUL=NXNB_OU.,B8&$6)<H>)LJMJ8M7;\N\-E)^FAM-1WK7,^-
MV&_DG%+CLLNS+;'J]DVB:<^8V$4A]$36:X]4:H^XN<.OQO-&<<Y%IK2IOHSC
M3,^OOHI,2)3@.H^)U[9 J^P3!F*/MJJ$B@B$B*B:7J2JH(=SA45>+9[BO*3\
MEJOJ<JC%QEFZQW?8CO.V33D['+:2T*BTDN':P4:!PD[A!XT1=B74=YT*MC.Y
MSQ>BRCQ2R5FN)IN[B8V[D<2>'811[J@(I\)\#+JVZ[](8(J*FPDO7KJM)X]0
MOD6)_P#:3&_R _\ D?3^9_4?S?C^[]OIK$K_ +&O\"><#\39]@OCSROQ/Y,_
M83Y^\B^;.7,\YPS/F;FZQ/B2VFYQD'(N?Y/84-K36$^3^LP*B#BKE8S%07&U
MCK%VV$D157U4>G^24_)+)OVK,'Y8XW^W[XOX!SEB^389R1A_&D2AN<0RN7'G
M9%B\.MGSH5#0VLV#-GLNSX&/LQFE3WC<4@[EVWWUR=S2L-RYE^U!)Y*\CJ'G
M+C+RXYZX'A2N6LVY@SO!<'MJB?0R\SS7B?(N,IMEB7Z]463-';3_ -71^>RZ
M,AF1'!P?9!7!,-\J$BH^OQ<\>,E\>ZW(*N]\A^7O(6/=6%0_72N5WL3D/8>$
M%AVO?@8X&)8]CK,>'-EJZ4E'A)Q'@5%39$1,MR5*!,/NV,M2/MH>;;#Z@C+O
MCWGS;BN&C;?:=:HKWF701Z^J^FIC<K/F38+A42VH83+54LZ,$!@GTCFK@#["
MH0FJ@G<@@X*+OZ=/PUV@@Y3 \*@MI(CPJLF)L7L<DN  &@(0H31"Z*J1(H[>
MF^_HNJD9;@6]JCF8Q!AM5+5C-9F/M/U]>4D6XD28X7?)EJR!(BQA/YW1<5.B
M;(BZI)FXIF,XA71$B.W+,.OLFR"[E3 :8B2[F2;CIK)<>9[3=KV"(3]L1W5
MVW1=D74$'#WU95UU6T3D>'(C-!66%0_636+,90N."\$22D63,=AOJ*O&2/\
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M1N)5/!E0Y9,Y.RR<6T:LWDC,X^KS/N#,&+)+N=3O%5W]$U(D3[#1^=O,G >
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MNV([T60\TW$GI.!MCL WE#=I(B 6VW0MT_;JXS,D9.O#M^2QM$EXU7Q8F(#
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M=!8NPB4%S:RV+>2S,2#&KIJ0YX(K$:'/&&V9BJH*(@]J[[HG>(R,322,'/\
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MWW"B7ED+Z,1DGMRG&78QO213O*,C#/>+*N*O:BHORZWQ0-9QMXK+99&U-K;
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M1%V"OP(MMD_;K*N5GRQH]](OJ7%[:LL%2Q*OC2+SW/D<@K71C,01MQ?XK@Q
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MD(V"M@BFHB/>I=?366E<TG2 C<CY? Q+%K"SQVI=.WN6!8GXE2.=U>Y)DN.
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M8U!8KS($V""X**I(OS?'4E:FH>E@EWD/%96"U8Y!DM/>6N76LIC'[5JP8&5
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MJKOU1-9;-016^4W(%YR]?V=/0OOV.*<?75=C,M(+ QDO^4Y3[?TE8#3XJ5E
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MN0LAC>4L_2QUK9CJ,5M[],'\.36OFILNF\!=Q?-W(2*FR:ZR8:]A5LIY]Q;
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MBIDO?5*[6R6G?><-E_YB5IT?E45Z*FIDP(E7\W7-DTQ#@1*U9DB5'>D2Y;H
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MZ^V39;;[ BF![*38*B&0&BHJ+U3;0IFJ(E^9$+]Z(O\ OZ@.!$1_**)^Y-
M@$_S(JILJ;;D@JB[;H0HJ(2+MZ+OH#AMIMH4%L! 4$1001!1!'?M1$3ITWT!
MWT!YDRT3B.DV"NBG:+O:GN"._=VBXGSH*JO5-]ET!S[8?$4+JJ[E\Z_,2DJ;
MENNVZ]$]$]$Z: Y0!3T39/P3H/\ [#Z;Z \B<0%7;=40A'M$=UW)$_:B;)OO
MTZZ (MMG^*UF35V(3<RQJOR2W8F.5U%+N*^'=2VV!;W=A5DAPY$MUIP24MD
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M[]P!23MW5&Q%%W3=.U%^9$'TZ_'4*9: ">@BG[A1/^#0 447]G[E4?3]RIH
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M4E1%[D]"W1%[D3X(JKT3\-9*>V@!H : &@!H : &@(8ON<>4'EQPAD7CM5<
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M../.T&*"\RV!#1T[KYDQ'14;;(U5$3?4;;**>*((H*"@HB;(*>B(G1$3_!J
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MBAYGC54OG>[=9P:CA12X[HJH<MK\;I)DBP5U/9C.]I,"H/ Z>N"3),B=Y_\
M<'\J)WV^'N#\5Y&LZ+[A./9AR%P=F_*JU='*L*MGBK$VN3)W-LBC_3Z.C6'E
M/&EE62&G&&P:"5)-!,MB33BIFD"90K'D;Y<>0]KX3^#'%W$/.[^">5?DSQS_
M +1K#F&WFX^U(8H.)\&++<H6U9DP&JAEW/<NE5=0)-&VZK,J1L2JWHL?V=*"
M:'/F7YV6_*?AS]L#GWCGFKFWA7CORLYEP<N6<@\=Z^NMN8@QJS\=.9<MO\-H
M:NRPO+G8C]1R7C4,)Y-5,MY@8CX(VVV@NM,55P'8??\ :7Y6YIYI\1:G.^9<
MSN.16;/D'/F>)<]RUNC@\D99P]5WSE?AUKRM4XI I*:HS^.3$EFPBI$:=16P
M5YL'>X!SE"=#2)1F5-6@5P4$]NHH2$GJNR]R(B+N.RZP4]- #0 T - #0'1P
MD%LR4NQ! B4_E3M1!55+YD4?E3KU14T!76\I.4_*#E3E7[D^8\9^4?)W U-]
MM_#^+!XEP+ HV*/8AG_(]SQ31<WYK?<WPKRAEO9WC-M46T;'F*<'H[$<77I<
M9UN2(NITA)+J9U'>^8?(?D]R=]NGCWDCQL/E*DY@Y$I."<SM$X-C54ODJ#C&
M81*:[S5O%F,BKIE6%FW72WA07(SB,ELG:NVHHY= [!Z^VOR72YUQ=GE% Y>\
MJ^2LNX^Y*M\4Y&K_ ##8QNMYGP/)/H*B='QV;&QWCG *XJ-NOF-OPWFHCC;Z
M.*JN&JDNF6] A!_%/S<R? _MX^0/EAY#7^4<FGQ'Y%>7E C,<H(7]ACF$>36
M:\7\?8? $W'66G78]? 8C$NPLA(1$$0'L2Y+]H5"*TFWO?N>9_Q%6\B#Y/>+
MDCBO*,5X3K^>L&Q_%.8Z+DFMSC&)615N*RJBRR*)AV+-X7D5%9WD$IRNM2(*
M,O$XV:HT0DXK0L[C,O+'[B7E7RUXC>2,'BZIJO$GE[!^7O&_B?%N8>.N5,;Y
MO@S+7FF[Q_VWXC$W$,5BA$JX&0Q6I8>X;AOJZ"&B"G=5BD9;$^\Q_N;>05]]
MNK@R-P'R%8\>>5]UB'*&2>1&;5$;'[&\XSJ_">Z:P'R3!NCG,-P8T[-^<:J%
MC\3=8[C46V<=:(A%0,L8;+-!S7W'?+WG+#<+\<<!X.YIC<><LQ.*9'EAR38+
M)I&I>=\:<55= WDO'#@6L5]N,]R'<94RV$AI!?'Z0U;W3N31)<GW$RD$W[A?
MFI96-=]NW/\ $N>/(KB/@KGO%^4\XY&G^+=5!O>2[:+3X-B%O4UT)MW!LKL!
MK:BRGR"DR6:UX@4%0C;$D0V*B45U)0/MBY_S9REX5<+Y]S[DK&:YQE-3=6U9
MFI-546]R_CIW*\@8XIR7-(>/Q:_'8N>7O&T>JF7808L%@+1]\$BM=FYXRB:%
M0_S62@T - #0'D^BDR\(HJJK3B(B;(JJH*B(F_3=5T!"7YT0\<X:^HY1\IO+
M?RJ?PG)LPN*_BS@GQTC,X?=+)IL5RC+;:'7/X;6EEV70:7#L?F3YTB7-99CM
MLDZ2;" KTQG0S744+Q&P2*YR-32^#/,/R-R'#Z;$>(^4LNX>YP=J>1H61X!S
M3A\G(\.GU>;WU:QE<,C:8D>Z[&DDVW/BFR0;"J:96K 5Z$N^N9H&@/"0@JT2
M&JH"J*$J;=!4D1555Z"GXK\- - \K/%:D\GJ7!) 9KDW&7(?#F>5_)'%'(V+
MC%DVV)956@Y#<)^IM4=J+VKLX;I,R(\D"!P%_%$76DX(U(GG"7A2YPFU2ECO
M-_)4O(+?FO(.>^<LIL8^/?4\^9;E$6763H&81!@+$Q^EAJXP_%BU(Q&VEALB
M*[(6Z1!J.//"O.,0\J,A\J++RFY%R>\S+&ZC!\EP:VP?CZNI9>"8[DF9Y/B&
M'NRZJL:M8@X]8<@3.R2VX,AY%%72+KO>4J(H2-=3OS[X.W'*'D=C_E1QSY!<
M@<'<GT'&<GBCW\2QS#<DBV>*RKU+UR(Y"RZOL68\I98_W@(.XIV[[Z+*D.Q8
M$:F?:HPB7D.54<GF;D-CQPY'YIH_(3D7QI:@T X;E_+F/9-4<D-7C^5MM!EU
M-BL_D_&X%W)IF'ABN2&$C;?3N.-$Y>Y((]O&GQ!\T.)/+^?GE1Q9,Q;*,V\R
M.;L\YWY,NX_&V1\8W?CQR'R/D^6I38!D4NF=Y;AY)<T%A#%MHYQ.1)RN,=_T
M3330:;7$BF21G-OM)^/'(3/#3>0V^727>&^=N0N;ZN7"EC7.9,7(F53,PN^/
MLD",;4>9A"V\D"",0%U9%2ZZSS98#CE7VS.&LZ@YEC>=6MUF/'?)/EI#\O\
MD/ K>#4R,<RK(<=>B6U5Q_=0_:%+#"@R2NASB9VV>=@-BZABNRSE3T$'I??;
M(\?ARGF:\XSC-<+4?D!XZR?'GDS#>-Z:HJ,;OHS5W:6M-R&Y!98&,>7TL&\E
M1FWB%>^.X#9]R B)>3UN6!4N-?"K">*>:>/.<\2RO)HEYB'CMC?CIDE>1,MT
MO(.*87%@1\/N\HC FR9!0A#_ (;C?;T<(=^WIJ/*5 BLCX(*(,5H47N0$447
M8154151%( 1  OQ1$1$UDIEZ &@!H : &@!H!C?DUXG/<^95Q5RC@W+66\%<
MP\.!GE?AO).)55#D1GB_*,*GBYACMQ194Q*K+&OM$H8<D>X4.&\RV3>RB.VD
MXH2#6<*>&0\!4O'>,<;<U<B1\5Q*LY.>R:ALDHK%KE+D;E#(++*;KDW,ITN"
M_,2_B7UF\^S&C.L1 79OVT; 10\IT$!-\6_!G,?&?E_EKEE[R9SWE%SG&Z;R
MWDG',DPS!ZNLN<UCT-%CU;D,-V@KXTRL:@4=*U&5AHA9)54^U275>2:ZB(,C
M./!6\M?*/D?RAXZ\CN1>(+_F##N*\$Y0P^AQ;"<DQS+L=X@+*?Y?CK)R2OF6
M-6W-CYE8 \4<@/8UVV)%57*D02!$*W[5F.XF[35E?S+G^0\)\3YIG_,' GCE
M:-4T'"<%Y2S%S(;J-,DYG CAF5Y15>79++E08DE\FXJ2%15(0'9S$# _MS^$
M?E7P;G?'V(AQO>\3X;<<<<AXQY<9)EE7Q7,;RZXM*=NOQ][C#,*6B:SV>,*V
MDO2A=GS71?CJ)/J;R]R[>2C0B3DD<PS[2GCUA62>">4-VF6V5IX%\+P^#<"^
MJGH,3,Z/$X42+@%MG$("2/:S^.K?ZNTJR(21B;9N=NW7?GRI&A8]S;Q/M8\&
M65;Q-B^>V-QRAQSP_P K<T\O5W'&:1*>QQ+(\VYHRV]RR;99)$<C$Y-'#YE^
M\U %=Q5-B7=>NKS$'C8?:CX :JO(G$<!GVW%G''D5F7#.?77'6$PJZ%B6(Y[
MQ-?8K9.9-BM<8G'B2LR+#H(V+?8C*J"F"(2JNBRAS%1 [;C'QEQ/C?R6Y^\D
M<5L[2LL_(O&N+JWDO# ^F+&[+-.*H=S05?([0HTDIC)Y^)SXU+-)"[)$:GBD
MNZB*ZC=(*D.IUDH- #0 T - #0 T P3R@\.7^:.6,-YVXTYNS;Q[YMP?!<@X
MQ3-<.IZ')6\BP'*)\:\DXS;4&3Q9E7[L&TA?4PIK;?U,9YPD$E15'6DX4:$:
M"2Q]NGBJJXCQ?QC@9=GZ>+M-XV9'X_V?"+]A L:G(9679+77[_+5WDS\5<G/
MD* ]$DFDAN2,9P;"02M(1!VWE[DCV-KXW^#K/!?([7+W(/,.<>0?)=-Q[5<+
M83E><5M+4OX'Q/3&LZ-CM=58S'A5TR=,L$]V?;2 .8^" .^R=8W(B#0IX!3J
MSR,Y9YWP_P A,\QG'>?LJQG*.:N&FL8PZWP_D./2X]!Q65C<RYN8#N04M1DV
M)U@0I9176WF1<(VB%5WU>5+5$""57VL+/B_CNCPS&><LXY5P;QOPG.HOAQP1
MG+%51XCQ3=6^$9'@F&.6.9XZS%S'*OY-Q6]EU=6[/?,X;;Q*7N&#3HEE4D#0
M_MW^#7DGQY$<X6R3C[(.)>%,T\9[CCOR)L\VJ.+W,HS'E6QIW:"%;\>Y'B5'
M!R&QHJUF4\Z)6+[J&'89]T@G3+634=1#)(<'^UIP1@_D%P#Y$0[/*Y^6>/G"
M&.<)X]7RI_MX]D<C#Z5<;QWD6^JFU2/,SBEQ]^57L/$"]C$@NU41=9>5(*D8
M.&_:NX&QW'?%#!<WF6?,O&OB;@_+&(8+Q]R%3TD[%KS*>6KNND3N0\CA)'(7
M\LHH,.=6PT%$CQX]J^0BB[*CEKJ(,M/M:\#TM%R1A> 2K?C7CSD/R+XY\CUP
M7$X%9"QW',[X_@U4>4WC4+\D2NS!RJ8<F B)N\VI B;KNY:B!SO"/C)B_!?+
MOD/R1AMS<A6^1N:5'(V28%)^F/&Z//6*>%1W^1X^8A[L9[*_TP)4UE5]OZKN
M,40B55C<HJ0[;62@T - #0 T - 8TMM'&T0O030U^8@384)552%17HG[=E7U
MZ: CS\D_"*1S5R6URM@/.O('!6;7?'4_B3D*QQ"KQ^Z:SSC63**<E%81LCC3
M(]/80'I;Y1I\41>:1\^J[[:TLH4&8J'#COQ*F\.X\6'<4\W\@8C@M1P[2<58
M-A;D/';NGP6WIWK*0_R9#=M*Y^QMLHNG+%5DM2G'8CO:)(VFG+="-@O>%7AG
M:^'T/DK'(_/&9\MXUR%R#G7*3]7EN-XC4+0<A\E9==\A<A742;0Q&)TO^8\B
MR0G_ &'26,PTC;;( ([:992BI"6Q?ML5U9G_ #]8Q.>>1#XC\F,VR7..7>!9
M-#B,C&+VQRS$:K#+J(F4NP%R^IBSJZF8<'Z62VK+HHH[;KJ\NE21[#<^3_M9
MYC5<(\@_R_R]GOD/R;@'CGR9P1XI8OR0_6XO2\7X_G=:Q"N8+-UBS,&RR');
M"HJHU>W933<>!MAL47M5U3O*I&M1%O&7P%Y0RW$_(_QHS'#\SX#\+>7^"<6Q
M^UK<JQ?B*FY:G<[5F85C\C)J:5QKC].Q)PROPVL&$(3O< 77(Z1D%L7$6O)7
MI(2W)"+G[8/!%SS9S!SZ5AED3,>:/']O@*WBI/[Z6FBK22,:M,XI:LS*(SEU
M_0)'B/R4!-X\-I$5$W36>3+!Y8]]K/QO9RGCK)^4J=KF^/Q5P=BG G&V)\F4
ME-=T&'X]0OS)=K>UL5Q@VSR')G'D*:^XBJK3(-(O;TT>;=H0XF3QQ]LSB?BV
MCX9PS$\KRRNX]X!\N.2O*SBC"-H)4F(M\ET/)U9(X:JV4%QQGC7&Y_)%E,K0
M14-MLFV!5&01O3D&AQ_C1XPXOXRQN6*/"LAN9>(\F\L93R[ Q29],$#"+;-"
MC3<DK,8<BMMN,5-I=-.3R9<5?;>E'MLA:C<E@=>VG: IMMT].J^O7XJJZR4[
MZ &@!H : &@/)[O]EWVMO<]ISV]]]N_M7LWVZ[=V@(L^=?MK8]S%RARYGM5S
M5R+Q?C7DYC&#X3Y3<;8M&H9-+S'6\?P+6GQIY;J>R=]A5VN'6 4TR15.,?60
M&VB(1<9 TWRT@S M]YXT\C0H>:4W&'DWR/QC4VT/CNKXYJX&.83>4O$='@--
M,I7Z+'*VYJ)"6M=EP/,E-6:3SH%'#VR!.BR5JB_T;3Q=\9X_C;#Y"L++.,GY
M7Y*YBS5_D+DWD?*H595V.0Y$U35N.P&6*BA8BTU%60JBK88AQV6ME02(E5=&
MY(I&B4?VH:VKP+E7@^S\D^4;[QHY<ROFS,\BX1=Q[#:^##R/FG.;GDVPLJ_-
MZZ UF#$W%^0[ K" 8R.X/8::5?;4D6\]8J($>\I/MK\MW/C_ ,P38O+^>^4_
M/&1<<XEQ3BLS+PQ;"G\;XIJ<H@9!D=+C<&CBPZ"TR;(6J]KWY%BVZW*.. &/
M81"M67H2 D>,7@+R-R%Q?REP-R;0Y9PCXV1,\X1Y)XMQFYI>-:?E%SD;CF]B
MY;E=S=O8!1T]9-Q^\GU<*/'-\3D"K#NR]G8B:>23G40.=LOM!>.MED?G/D[=
M]G$&T\Z,7BXGE[:3PDP>.(4Z8U?YU)XXKI).0:USE3,U:N;=>P2=L10B4O;'
M;'*Q8%@E?;;\<,LY6R'EWF?%Z_G*VN>+<&XCQ^HY(HJ6XK>/L)P^#)BRXF-L
MK&5(\C)IDI'[!TMS5Q@$!4%-'DPD:7B3[;_&'$DCQF.GSK,[&J\5[7F&1QC2
MVS=:]!C8]RJW7L'BDV2J&Z_2XFS$ :\$+N(542WTY"!T?B?XXT'BMQG9<2XA
MD5U=X6WR%R#F>&UER,3LP7'<_P JLLMC<?43L1MM7\9Q*5:O1H!.J3H1T%M2
M[0%$F3DJ'-ZR4&@!H : ZFO:!ET3M$EW)>T4V15^8O@GXKH""'[B%#SCY(G_
M "!B_AOY?P9?&MWE,GC3R)X.Y8\9J24Y#S;C?)>+LJAQL7Y0Y$AN2L<RG%LO
MF19U9<U+;_:GO"Q[PLFO3&$IDPZBO_:EX#Y+X7Q#,UY=PCGZFY$>B\:X0F8>
M0V7<%Y+=9#QSQQBY5.'T6#0N"<HR7%Z'#,4"2XV@.^U(>D2"78^CNF;6CH53
MJ2H\@9SB/&>%9+GV>W\#%L-Q.JDW.1Y#:/+'KZBKBHBR)DMY!-6V6T5-U1%]
M=8570TQC>,?=<^W%E=]98SCWF3PC;Y#4MQW;.ICY5O.KX\IHY$-9K#S JS[S
M(*H*>W=MNFM<,OR"<D*U$\[?#VP9-^!Y#\82615$<<;R%AP5W7T00%37??X=
M-.&>PY(W+'F/XL2V2DQ^=,$=9!%(W&[HNU$395)=FTZ)IPSV)RQW-3+\X/$I
MB'+EKY!<:@Q 9>ERY#UU_"C1H;;DJ6](^3O]IJ.T:KZ]=M.&>PY8G%1YR^(=
MW6UUU4>0G&\BJNHC4^LG)>--1IL1U%!J3'60VTA-DC*_#?II]>>PY8F+(\\_
M#&.W(=D>1G%3013['U7(XO<#G<J+T[=EZZ<,]B\D8LKS_P#"N(M?[_DIQ.I6
M3Z-15_F%E5>^52V%&6RV45)/7;UT^O/8G)&2'GCX:JC8.>1?%PNN-KV >1LM
MJXC)$BJ'O-@J[*?7;\=/KSV')!>R/[CO@IBE>]:Y'Y2\,4U:UVA(E6>808K+
M9.*C;;32D"E*?<<)$%L44B7TTX9;"4;B-Y\^&C\").#R.XR5J2PVZRZ=XL?W
M&7!16S)GV4-ON%4V0D1=OAIPSM Y(RT\\?#1$1?^T;QFB*.__6%>W;]B^SZ=
M-.&>Q>2/+_M]^&!N&RGDAQF2MB). EV9H@FFPKW)'VZI\-.&>PY(]#\]_#B(
MXC#WD5QDV9()-M?J[FZBXG>!*J1]OG%=]/KSV')'=_SR\.XHLN2O(GC-E)+B
M--%^OJB&OP1 ]CN#_#T73AGL3DA7.+N<^(.;8MM-XFY QO/HM-(^@N9&.V7U
MHUTE01QMN1N(;D0&B]/@NH\6KE33L+""[@*HN^XIUV5-^GKLO5-9*(MS9SGQ
M'XYX+><I<VY]C_&''M3(BMW69Y/8?25-5*GR(-7 ;D& N.MC*-UE?E39-]RV
M]=5)NQ'0:!7_ '@?MBVY*%?YM<&3315%0A92^X2$BKNA(W$)45-O36N&73W0
MY+K[,,O_ *5/[>'>;?\ VNN'OX:(I;W<OT7_ #_HMOPT^O+\:')'H?W1/MZ#
M$.P<\L^(!B1A,W)2W,I&T%!52(E^B_*@CU7\$TX9?C1.2-+6_=F^VU;T\>\J
MO,7A>53R]O8L&KV4Y'D(IJ*$VZ, >[N/=-TZ;Z<,OQH<D9+?W6_MRN/J >87
M#7N$NW:M[*3VU;V12)3AH H.W55Z;>NG#+I[HO)=?9GA(^[)]MZ-)B0YGF5P
MA&F2X\A]B&64-^^\S'V]Q]L1C>ZH-B7511=M]/KRZ>Z)R74Q87W<?MG3GW(L
M+S3X/E/LJHNL-Y0Z1-]J=4-%B]NR?'N_#3AET]T7DNOLSI:?=W^V54U#M[9>
M;' L*I9V0[23ES;,,E[T;1LG_IT%5(U041%W)5V^.IPRZ>Z')?B9E0/NR_;A
MLV&)<?S#X;<8>9"2P^W=SH@/LO[>VXRK\%/J6SW1?DW3;KZ:O#+\:)R7Y)LE
M^Z?]NU-]O+SAQ305<[1R.0J*V")W$O\ H7P33Z\OQH<D=&ONK?;H5Q6P\O.'
M$4>Q#[\C>04[Q5SM_B1!%"^7IIPR_&B\EU]F81_=L^VR#0.O>9?!["."X0N'
ME3:(7LNBT79W,;*J$6R[>FGUY?C1.2Z^QKY7W?\ [8D1U6)?FSP,VXRRD@_=
MR^."@V:[(XJ$PBHB_CZ:<,NGNAR77V-"]]Z#[5:;G_V[O'Q!;7^)VYQ'W3<A
M$0$&&E(W2<(4%/55]-3@^GNAR[^S'C^.7DWP!Y6X58<C>.?+.$\Q81!R&QQB
M=E&"62V-0QD56H'8U3QDVV3<Z$$EM'4_RU4>BBJ:C35RIR.!U"B3<S<T\5\!
MX5.Y(YFSO'N-\!IB!+3*\IFK6TT(W6I#HB[-5MP1<^FC/&B>J(.^JDW8C<#?
M\5^X=X19E45&08MY-<37]/?5D*XI;6NOR>B6E-8QVY=;/B/"T0O,2HK@D)IT
M+?=-:X9[#D@VKYN^)OPY^XZ_PW1^O[/]']-/KSV'+'<[)YJ>*!())SSQZJO_
M "H8W*JB]B[?%H5^54T^O/8G+'<T\7SO\/IMU>8Y!\A^,Y%Q0UL2VN:UBX,I
ME=5S2&/#GRD5A0]MU].T>J_+MIPRV')&27G)XD1159'D%QDR#6Z*171=VZ+L
M:["WZJNG#/8<EN$/(/N9?;[Q(77\H\ON"J(6_:5T+'.*B.8H\J R+P/*+K9K
MOMV'\P^BZ<,BR@O!]UW[<$JV3'8/F9P=:7Y]W;5T67_KLP-C$'/J(]*S*<95
M'%V+O[=BZ+UT6&7Y ;745QCSL\/W8\9T/(3CD@>$.PUN'04A4445]MQA'054
M7T)$)/CUT^O/8G+$]97G3X@0D0I7D)QPRB_,A/7)[;?B/^CKI]>>Q>2.(GG-
MX@RD>^E\A..7U87_ $C>Y).Q5Z_^,CIZKI]>>PY8GL[YM^)<<1)_GSC=H'B%
M6W%NMT5=]DV5650?WKMIPSV)RQ.__;7\1ME0>?N--^NR)?Q=U5?PW';=5U.&
M>Q>2.D_S=\2*UA^7/\@N-6(\80 U*_8]Q/<3?N%L *02[?Y**FKPSV)RQW-)
M-\_?#*$C2RO([C.,;K:.->Y=OH1MJGRDO;'7;]N^G#/8<L1?N+^5>/>8L7K,
MWXORRDSC#[9R>%?D>/2?JZJ2_6R3A6#+3A=A^ZQ,;(5W'U3\-9::<.Y4T["C
MR$0FB$A(D)111$5)2W)$[539?E7XJO1$U"C:N>/+/QO\5XV/3/(OF?"N'XN7
MS),'')&:7*UX7-A%;&3*C0.U'G"^GCD/1-A_#6DF[$F&)76_<O\  6W:;>K/
M*WB><TXB*)L9%()"%4]4$HV^VKPS_(')&[_](=X1CLB>3'%JH7Y46[><547_
M #4C?'?3Z\]B<D>I?<$\+C0>[R3XK%LT792O?95=DW$1^H8$35?P33Z\]B\D
M:M/N/^"#%M*HG?*3B!JZB0H=A-K5R1CZMB)--]N')>!&NU&WRCF(JGJHJGPT
MX9;$Y(R__2)>#9F !Y.\3J1;["%^B[_E3_Q3&WILG74X9;%Y(S2\_P#PL01)
M?)+B]!+=4-<A(4V3;=418_7IJ_7GL.2-9+^XUX+0D:*1Y1<41_<>2()NWX(I
MNJB$C2*XQOZ%\.G73AEL3DCTD?<5\&HY&CGE#Q(",()$"9&PO141$3HRNW33
MAEL7DC7_ /I)? \-MO*3B8$).Y$2^<+HO1-E9C$'P_'?3AD.2-2/W/?M^%D$
M?&O^UEP\>06,5RPAU3&0O+9/PF%1EV6;/T_=[#1CV[DB)Z:<,B<D&5?N(^#S
M ^X7DWQ2V)(A=R7[NR@6YCMM&7HJ%OM\-].&>PY(\ ^X]X*GWJUY1<4$@+NX
MOZ\]T79-]]HOKMIPR')&.OW+O P545\J.)$5.BH5^_OO^W:(NG#(O)'@[]S?
MP#9(A=\K>(P=%M'"3]<D+_"5-T7_ %/KT73AD3DAUG'W(.$\LXA39]Q[DE;E
MV$Y.P[-HKZF=5ZNMXS;YQ%?:,D U%N3&4=U1-]M]9::<.Y;BB)OLF_KLF_[_
M (ZA1 ^8/(_@K@(Z >9>4L4XY++$L?Y>');!8A6JTI-.6YUWM@;A.,?J;>^Z
M(FWIK2Q>5B-I"0_^D9\'/_ZH>*?\%Z[_ /B^KPRV)R1[)]Q#PA/YF_)OBY41
M%7=;]U$1/BJ]T9 1/W]-.&6PY(\Y?W%/!N%7R[69Y/<2QX,%ER7*F.Y%']N.
MRRWNX^?MMJYL )\.NVG#/8<D>['W _"A^*S/9\E>,5CR&D>CO_K[HM/,ELJN
M-=T<34214TX9[%Y(PW?N+>#+ JX[Y-\6(JJ@;%?$*+L7HJN1T#HJ_'3AD3DC
MJ[]Q[P6C.,,N>4G$W?)W5EK^8&U[MA4RZ-L$?1$5>B:<,MAR1Z?^D5\&^@?]
MISBGJG<FU\?1!3U7OC"*"B:?7GL.2"M;?=1^W522FH5IYA\(Q+!TA!J&YE39
M3'-R[=DBL1W'>Q"795[>U%7JO73AE^064&EK[C'@T[_%'R>XG)LFVS!Q,@[1
M,7!0VU^>.@[J/I\?]W3AEL.2.Y_<8\&@3?\ [3O$Z[]%[<@0E_'T:CD6W[^F
MG#+8<D=6_N+^#+FZ?]ISB8439=BOD!-]^BI[T<454V^&G#(<D=C^XIX,IV__
M *S_ !*/P3;(X_HFW3^Z3TU.&6PY(\C^XUX+,@3A^47$HB/JO\PL+T_P-+IP
MRV')&I+[F_@((J1^5_$/RNBR.^1,BY[I]$ 1]GKT75X9$Y(7/_M1>/?_ ,.3
M"O\ S8?[9/\ I5G_ ,UO_P 'GY?^@/\ GOR_LUGBRRAP.H4ZE^4O7\J_E78O
M3X*O1%T!%)]S[QYQSR&H>"*OE++:*JX)Q'D/-+/EVARKD*_P#'KR1D/"W).$
M\=9 Z_26,)O)9O'.>7T.W:H7]V)K@I)W%R$VNNF!EB"_9=X K>$J[FO^6\8X
M?PBDL87#6+7=)Q3S0G-S&7<DX%C%M5YQS9,G0TC1<!A\Q.NLV+>.&#KD&<W*
ME*\ZLXD%G(QJ2#?<5@E9^#7E'7B(F4OB#*6$ C]L2[XX)LI_V4UG#Y(KL?.N
M\5^.U/R>\HCE,1F_TJ5QM$9]J*DAP^S&0,E)]2120?<WV^":[XK]FS&5D3(4
M%%*8FA[?T[S#D 5)Q8J1I$80;5?>!U"7^Y[>[;X[;:ZG-L4:9#:K*X?H#$GI
M<DD-IQY3:=4VMCER!Z?PW$)5)-4R-7YHOULG<8X=JIWZ=;\HLO0K^T-([DJH
MX]JWP/+S>%\VQ0KRK4JR*YO_  RG(>Q(*HN7L;2BNQG\M\]\38K=0Z [Z*KS
M,&% JZ#&G'\AM"C4T&/7L_3P*D7.UTDKR;!#;=1&!:3MW^9#:1$FT(G*Y#Y6
MOEG7>*<0BS2OMF_&E<B9,UCS9QVVU<&:]30*JTOF7$#KVR7&VT7T:$M27HJ&
MH5IJ$#CUGGV\3^;[&NXMQ\WH<V)C3EK8WU\S$IY#JMN2V66::MDJ4TMT5M"'
M9 3YE^#]KT'ZBC5O%.?W23G,_P"9I<(&):*-%Q_15&&,3HCS6[9P;R<N098'
MT^VQ*R_$15)-Q5=NU#=V)2JD8U+X^\94%JW=5U/#6_KG''&LLR-)&39,0N*K
MAO2+^]G3[9TS+HO830JO]G3BD.3%+;CW]@T<LFH --;(TTXLH0>V<[77FQ>(
MMN]KK\ORHNJ W-PH@MMP_IABMBR'M-R7R/O4T[E<9V3Y62-5V3UW1?QU3.I@
M1HGMRGF/I =>5H_I7635O=M4W=%'_7=/]S0IL8V.#9166"AO,_3;RF7B)9CY
M=JJZ.SY(*N;#Z)_930DP%]^LD91:-T4:<XRW4/M/7-@@H-J3KC02(]16*B]K
M;ST-YLU+JFQZD268+'7V6ZZ-4\><RQ(\$8+;>:TXG%=^:81E5=_OR"_M/'W;
MDOXKKAYKHW@3> BH HJJ2H*=5]5Z>NN)T(=_OIT2Y)]NOE:G%HS*9DW&R.(V
MP,ON;;SNFV16S^5=Q^&MX?(F3@IE<=<)59MLBY5@\]' .WZEOV_04^7VTZ!L
MG]E.B:[I'.1R0\1X^%;%D2Z: 4M@OJ ^7I*5OU!?PV1.OX:UQ)(D7)_'5!>V
M^(<.4/M1IV>R79&33Z_:#85V!4+K,W*WE!MT'NRUG24A"0JBHKZJGHNHUH5;
MF^S'$.-<2&1&LCI:&HC,C!5),P(#C%;&'_1FVP5>HMBB>B+LB:L8DEL9OD_(
MN!1X%E8T&)9[D$?'FY4],BQ_$[']'&%# GW9C5W+1(5HW':;4U;:03<V[15"
M5-8E:&JZFNHXV>9)%+)QX RN/=7#+;L1F^O\3H8^*UZH/M5)&+MK/$76T222
MM,O&*EMVJ2;:*7H/4.D/ACEO)XC<Z?E&%\=P+1HRE1\6H)63Y*@,KV*PYDN3
MV$&G!Y5'\Z52BGP1?71)L2C<4/C#AV,S(>8696N:V]8HR(%KR#D$^YF0Y>_M
M$_01)Y.5=29"ZJ$D9ML>S=-M7C!)8L$+ 4GO-6%C"8[)3KID^Q](Z:MF"@+?
MM-MBYM\-_AHD#8/<7U$ECW8<)AMWW":!EYU6_=:%=C0FDZ)W;:L(2S6'QM5.
M[]]4(DBBA,"?O "M+L@]A?Y?X_#2*"3"F<3T[3<NY=&)":=4''FQB#WM R!*
MKQ?-T]G;N3]J:0)$\3B:#9MOW#T0"@R&HI0*L&1;:]AII42>^OJXDXT]Q4VZ
M*NI!9$\R+B*'*'Z9FN8^J-'GPD1![#9*3'=B,_3EO_#<:%XDWU(]Q)<?_IM>
M/H'&W@WR+0UPF+#GDQR'-=1TU<?68[C>#MRS<<55[O<>:54_>NN7D4-&E6I8
M0US-$,?W[:^!:?;BY8@V;A-PW)"*^K:H+J#_ "KF"(39+T$NJ[?MUT\=WV,Y
M:=RKGX:8>V?C!XW3+N+(D2UX=PASZN4VGU 2G*2,T8J]U4>T %=O@I+^.O1A
M\5V.63JQ\%305].#"OOB2/$B["[[KC:[]$4_[*=?1=;,"4\P<K\=<244_)<T
MGS7')<AZNH\=KV7+'(\GL6D4HN.8]2-(Y/GV5Y))J.VL9.X2)$5%74;2N:2;
MH,]X?R_G3',/R2>7CWDY<A<FY%8Y3F5OGE[34<&C]Q2"HQ]^#717+*U?QZD"
M)!,FW^Y2B+W*J]=97+:IIK%ZF%:8MG&5/BURORK=OU+[Q/NX+QY$FX!CY-F
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M>8C3U8C,HBM$TW'9;7V&VE9?44#?T$5/9?VIJ L;?ISO_)C_ -S+]+Z)^?\
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M1B-P%B+C\',^:<CRKDGDJUBA'O\ (TR:[QZFA06R22W1X]28M-J8$;&(,I4
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MP:"(ZBR'6:EAA#-T^BR)CZC]5(,R7YE<,U5?75HJ(7,6S9N+-7\;KB5Z0<=
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MWDE(@T7C-5RZS"&784F]\BLRQ^;%P6Q!N:KD6KPBOE# D9C)>5KY[!-X:BJ
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MZU]B=["@+E@;0FJ B(RMU"N*Y]W@FP^V)YRD],=@-)XY<B]\UE51V*/Z0?\
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M;(K./(G10L,%AK$:V55<FY;21&@(?BVKC@EU].[6L:.2'R8"\@,U.%QY7K8
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MXV,:M?0VQ%%0FV^J(7RKV\>4N&8S5))R);XK%%&F4B*#J+ ]X'6W"=:+M/\
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M!1CWAWW3O;$U5/VIJ8W*['Q]?)?QSML*S.RK*5NUL(:8Y_-)RYBG-LK,8#T
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MEI406P8RBW$MD3I^=->3R_-G?#XC]R7857]B^FN9LI _UL $_P".'B( )_\
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MS84^&@"MFY6V0!BF/V,=/T$[*4,^N5]"E2@IH2W3#SII_%;!J2_V(N_S(":
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MKH]Q:1&WV((MMN#(,9\R)],#;33J$XP?N*BM%L:(&^PEUV75)0Q'SDN2GG3
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M8ZR([B*U*%]]@73<9:$A!CN DZ#UWU8)(L+$=MNJ^KE."^T:R'/IOE25'/N
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M %:@K#C32JJMCN39EKI6:61*16['@Q<RXGY1QE,9Y]Q9_%9-Y&D5YU/+]"Y
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M>^]02(LG'\MKR)^TQNY7VI)-@XHN6-2\\+K5W2R=NX'8BG[(DB.HV>XHGW)
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ML*1L"=B(I#Z[[_#6C,4-O=MI)?E-JK,AEQO=J*+K#K ^XG:1$$E),8R[5V5
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MDA@1"<MQP+_VXZ$+;BM"ZJ;*>Q;(OHNNGC^7H9RDJ!8KF<JH*7:H\KMB#_\
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MG#8-' ^D$7.PD[V_5U#4NYL>WHG[=%D&I"+R!G<=Z"DMU1<2'EF+S&F2[=G
M^KC@8F:J JBD[^;;N_;J-A*#07N4U%U)B6#;DBCOH;3B1;.$0HX\"IL[ L$(
MB&T@HJ[ +W<K:)\BIJ3KJ4)\+E_LDMU&51X[1F;K=98,-]D*<"$J(#:F1+'E
M-HFQ(1+W+Z;Z<BP:VZSQG>2RU)1"</N%HEV$T3HB*+FXKT]534D0)O89'3$6
MQ0FX\MI4['8JJTX?K^5Q%453?X;:"'Z 9SHVOX2R!W1%52>;$P0A^"==B5=O
MCH6*B;9Q^D9S3/0+.Q>C/,/!/K[".@I)K+**I'%LHZI\RNL[J)COLZTJ@O1=
M2Y;!'HN:Y+$B/A^>M1*C*HQJ$<VB5NJR6 V7;"N:.2Z?4@;V^H8)>\#Z)NFV
MI.CN(V#I:YY&".#I.HT7S;(1IVNCLNR@J+U54U1!?H^P;;I=?;*X-G[IL]<\
MF;=JJJ?P\_R($1%]/1-]<<[E1,R2;HJ>O[/QUDI5S_J:<G/'.+/&5T/J4*3R
M+D#9DRP[)[6EI&R)WVV"0D0-T12]$3UUTP=S+J5M.(^?F<=Y)QER18/OG;XQ
M+IF2E/A[#95LH9B18P=K:@"I)(E%>Y54?V:[)U,O&@\UGFFI.]K[QV0W[7T!
MM.0VG@[!=G2H[P24CDJ(KCRQ=R_!/36YU,105ASE"JLE)6K1M)9]GN*K@^V"
MF*["+B_^+)M=E1%39?CJR2!N.254!BR6WP6P"GGL2WYEI1RI*O8?DTMS8BD6
M52R0,Q)KJKM[[78B[;D)%NJYC8U74*0<H44L':+)HK.&Y!(%X'6)(M-Q);\A
MF5'?.NF%W1)L=\'Q1478]D#IZZ3O<L;&?@?(K#6-4U?-GM1S99EL(X<A6@<8
M@3I,-M]EIQT@$O99';9$3\-1.A#:S<JP>T<DE,*AOB=7M%JRCP9+S@]J 0FZ
MXV2JB*BJFK* F:8%PL\<V:WQ;@0RHABZW)_EJE<,G>[W/?+VHOM$0*:[*H]R
M+UW]-I^L6+4/5-G47'GOHV1COPY$5%;CN$#$1@ [D;!L(R,HT#?P'5F"0:?-
M6L-Y0J6F;R"1)&>2146E-(6KR*INHIB3%A5VL;L?;".J;JV:FR[ML8DBJFC:
M=Q:P3,'SQ8>07G'O(DU,NR&(CMKC.3V$A^*5[C+#C3"S7&8KPPULJ8G6V9J-
M"(DI 8BG<J)$]'<L:H61K(Z& V]'@Q(\5DXSDF08B#\I2)5;7W7W>]PQ0@5!
M155-M640TS>8UX]KCJ0R;)MQ$!IMH'6E4M]]NU4[E1-]) 5,IS])=>;0&S&B
MN$\3KI*(J@-QR]L5[>A&2(F^HVBEWW[6<M)_V_O&B2)]XOX3)42_S!R>]1-O
MQ38$UY\_D;QL2%)UZZP:*F?]3W(<BM>%LU6%<5BVYK&,: 9?3O+%XVANNNMB
MNZQA"8OS+Z+KKA8SJ5 9F5.8_ET%^5)]IJ]@/Q'F_<($1R'M):<!LU7N(UD$
MVOX"B?'6M0&]G)&&@20,QEAD^U6B$U^8G-NA=5Z"J_X-4&ZBWDIJ4#+SK!1W
MFT=1YQP21Q5Z]@CW(J[IH&C*;G1I+\T$('0110D>[5$Q)%0FNJ*)-JB^FV@T
M"] QV31OJ[B,TJ5AV2LUV#+WG5,AWN1Q\39=-'8H/@*CNV6R*J+VZ [8)D=X
ML9K^9X%;0.),LV(<R$^<ZN=;">\D=]Q3V6-[J'L@KZ*J)HI$"Q1I%JKY=UG&
M('!1$>5D%;>1?RFVO?LO9_PZIGJ9D2?-@RS&0D>6R^B@XVP:"X2(J;.()+VB
MG3KMUT!V7)P?D"A2";>@=[,6-(7M:["_M.*6P&0(NR;==ET$&0-LBLF(.M/.
MO"0DXT@*@J74@0D51$5^.@BO0(]\S8^[#NZ9YN+>T?>^RB+V1YD-!57J]U",
MM_>_LJG453IZKJ%Z!JI\ZBV\6NE V@$;"$\'N"3L28/<LIE51>YM4,T147K\
MNJ2#++(#1W^%[:H3JF?S(AJGXJ2KUT+!C3<@[OJ$%OY'!15/W4[VS'X@O7X;
M:$U+.7ZHG_+.?]R?]9^<?_:G_A_M]-2?_81_1:XUYSH>3Q*#+IBJB0M.$BHV
M;RHHBJHJ--H3CJHJ?E%%4O1.N@((_OB9!!H>$^&["X7!<+P=G-\\MLCYGY0X
MT@\HX9Q)(Q+@SD_)</%_&L@AVV!TDKD?,:J%11[R^BNU<$Y:-=PRI,8PZ8&<
MOY%8^UYY&X_Y14,RUPS_ &=Y7P[A_%'C#85&1\?X'6XU@F/>0>0<=RIW-V&8
M?95U3!H;]:*:-;*=_3D)NFE3"A]R$WLC*- KD@/EKP=(\EO&OF?@2)DQ89*Y
M6P:UP]C*AJV;LJ%VR1M LDJ9)MQ[!8Q!O[3B]A>A(J;HN$X<FBLE?_TQW(N1
MR&GIWG4=<RS#9C.0J3A2DK(+K[("#<LT"VW-Y.U"7;Y>[X;:Z?89AFMD?TN6
M5RVX[:^<]BCL29%FPWF>*JYEZ,Y&(",6S;N$^22H+WHN^Z$J>FIS$,5&N_IL
MLC@.N2%\O5DR'#155[C$U;%M$1%:3;)$3LW3?\=]7[%L.(:XO].[F++;;3GE
MM&< "55(N+R[C'?<0+;)$3M%/33[%L3B9 _T\66"Y[@>64?O$E0?_P!V3@*+
M:HJ* DN2]-]_5.NGV=!Q-5D7].CE]W6V,$?+>/#.>RVP,A.+AF.Q@ VS7V5D
MY"\*$OM^I(NV_39=/LZ%XG9?Z='*GS3WO+2"['%EIOV'>*$5ITA0D<60!Y)M
M)]Q-M^_NT^Q;$XA,;_IG\GA6*O5_F4]&J'9#LM^G+C );(R'#(R2+(DY"_.C
M1E[OE9!Q&F]OE%-UW?8MB\6<6O\ 309#9H\C?F"K"/=4(N+D>5O==]@"3D3C
M:I_ZU=/L0@T9_P!,/D[H]CGFC(,>B=B\61O:[43;M]I+[V]E_=OIS18,-O\
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MTEW-R.+F%'Y=,XY>B3#%R]6<6-*WDE3'0DB55PV]?N>ZS ,]X[@]KS**0 2
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MASO:BLI&N@>;998041%,BWW7?KK?V="0SI9_TQ%G<P[*OG^7+)0[&"<0FO\
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M'(D01$EW^5$5=M7[$(.8'],5/C03@2O+IN9$1QY1;/BAIM$%Y_WD%09OVP-
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MMNDTK3;K+A(0DJ=VC:<[""P+$55CMJO=Z;?.N[FR+T]S\#_%/@NN9HR- #0
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M4O3_ )G_ .7H#W7\P?W7J7K^;T3\G[?QT!X2/RN?ZG_<O?ZQ^7\K7]Y_S/\
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B7]W_ /9: ]&_5?[G\J?W?K^=WU_S?_GN[0'KH : &@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2132809d10-ph_lesion4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d10-ph_lesion4c.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_[0 L4&AO=&]S:&]P(#,N,  X0DE-!"4      !
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M\7GZ@AB'B\_4$,1X\6.?4$,1FESH6<NU%89HAT'M")-QA11 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!GE &_$]@0)OK'8B3A@11 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$'C>;GVH/* @(" @(" @(" @(" @(" @(" @(" @("
M!<@\!S3B@\H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @\;S<T'E 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0>-YN:#R@(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/!(%Y0>00;D!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!X+@+(H/-Z @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/!<!>4'D$&Y 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$!!XWA&$4&_*TK4JAN_)IWO:;B!AA@F*F8V&\/ZR2/YH
MX<Y8.UP0S',\/:Q _P U_P"/+_\ >(9C"[0M8:"323("\@ ]D4,Q'S)<R0=V
M<W<<+P;$PK@"#:+4! 0$! 0$! 0$! 0$! 0$! 0$! 0$'C>;F@;S3CZNU!Y0
M$! 0$! 0$! 0$! 0$! 0(B(;&TW!!O2=*U*I&_(IGO9F (=9L0S&;\PZS_5'
M_P#%1,QJ3Z&LI/Z5)?+Q]X0L3%5K @B(,0@(" @$@7F"#9IZ&KK+*62Z;"_=
M"'#;_,.L_P!4F?\ %1,QPF:-JLEIF3:68UC?B,!8.A%S$<2 8$P(LAM0$! 0
M$! 0$! 0$! 0$! 0$! 0$! ) $38$&W24%96O'U>2Z8S$@6=>22?\%LD^ZV2
M>&V>%&?(F>*18 6F!AL<<5TG7I9N[<O?OG7"NU^D5M&73'R'-D1,'6$#*)!(
M6;,<<.DL_P HD.!L!!65>4! 0$! 0$! 0$! 0$! 0$! 0$! 0$'C>$81M036
MGZ-6U;FS/ <:<GXK!$61A$B*UUZR\I;B:Y3M3PXP2HT\B;XEQM:,-KEKMUZS
MC#GU[][_ "X5*JHJJB>X5,ITIMFZ7#GQQ7+?EUU6L#&T7%4$! 0$! 0$! 0$
M! 0$!!X) O,$&>32U-20VGENF']B(\R#?;H&LDC^:/Z=T=I")F,IX=UB!_FN
M'W\O_P!XBYC$= UD?\T?T%A["43,:L_3J^E$:B0^6W-P@F%S&GO",(B*#R@R
MR9,ZI?X=.PS)E@W6VFU!O_F'6?ZI,_XJ&8?F'6?ZI,_XJ&8?F'6?ZI,_XJ&8
M?F'6?ZI,_P"*AF'YAUG^J3/^*AF'YAUG^J3/^*AF'YAUG^J3/^*AF'YAUG^J
M3/\ BHF8T)\B=2NW*EAE/C"#A!,6<K++PQ(" 2!>4'*6Q\X[LD;[L@F+>"V3
ME(-T/6'@%M),(-Q@!VP3"9C.WA[6"(_53TNE@_AA#,<7</ZR#92D\SI9_P 8
MH9C!-T?59+2^;33&M%I)%G6 F+3,1Y(:=TV$7C+G3[>5$!!X) $28!!N2-/K
MJP;U+(?,;",6B*8O/A+9->6S^8=9_JDS_BH9A^8=9_JDS_BHN8?F'6?ZI,_X
MJ&8?F'6?ZI,_XJ&8\?F+61_S29U ]B)F-2;1U=,2*B4YG.(77Y(N8UMYN:#R
M@(" @(/!<!>8)@;\C2]1JF^)3T[WR\' "!Z2B9C-^8=9_JDS_BH9C6J-.KJ,
M;U5(?+:;B19UBQ%:8(-Q0>4! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!X) O*@;
MS<^U4>8QN0$ D"$<; @D:+2ZRM=&3(<YD1%UP@<R;$DODS%F/#DOP"!(F?6=
MV,(LA&Z_?@NEZ]<?=SO;MG[*O6:=643OQ\ETMIC FT$;#&!7/%;S&@"#<8P1
M1 0$! 0$! 0$! 0$! 0$! 0$!!X+@,4#>;F@\H" @(" @(" @(" @(" @(/!
M(%Y"#QOMS]!0<K[D! 0$! 0$'@N O("8&_)TK4JIGBT].]\LW. $#UH98*BD
MJ:,[M5+=*.&\((9C @S4]//JSNTLLS71A[HBF*9DY;WYAUG^J3/^*B9C'-T?
M5)#3,G4TQLL7F ('5<BHZ(!@3;DF%P\H@@(" @(" @(" @(" @(" @(" @("
M @(" @(" @(/!(%Y@@VY%!6UG]%DNF0M):$&U^8=9_JC_P#BHF8PSM*U*E;X
ME13O9+%[B!#K"8,SA'[[8$Q$!>45O4FGUM:\&GDNF2X1+@+.O!63/Z);)^JU
MR^&V>%^-D3/%(L@6&WH<5TG7I9O&7*]^^=<*W7:56T3G/F2',DQ(:\P(V6@D
M17.S#MF?Y18(-Q4'E 0$! 0$! 0$! 0$! 0$! 0$'EH+W!C/>>[X6BV)P3%$
MK+T'5Y@WA2N@8$%Q:V(.0+FE$S&"HTG4J0%]13N9+!,76%O6"1Z4,Q'[P)A&
MU%>4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$'@N O*#<D:;7U0WJ>0^8W-H]-R8IEMC0-9)'\T=TE@[2
M$3,9/T=UC^J_\>7_ .\0S&$Z#K(_YH_HW3V10S&G/HZNE_I,ITO]L()BQ<RM
M8.!N*#R@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" 3"TH.
M4MCYS@R4TO>;FC%!)#0M8(C]4F6[&CM1,P_,.L_U29_Q47,:$Z1.IB65##+>
M+"'""'+$"#:+4! 0$! 0$! 0$! 0$! 0$! 0$! 0<Y<N;/=X<AIF3(@;HM-\
M#8I^AQRM-!PY.> :RG>T7PBT'F@7 KIUD_ZG.][X8M0X>J6>]14[RP1C$MB.
MC>)3MUDX7IVS_)67@RW%DP;KA80<"L-\\/" @(" @(" @(" @(" @(" @("
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M.X?UD$_S1QYBP]CBAF-2=IU?36U$A\L?LA#U!,4S.&F' D@&T7A%>4! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!REL?.<&2FE[C
M8 +8E,"1&A:P0"*29 VBQOK1,QY.@ZR!$TDRS+=/9%#,1LQKI+_"FC<F8M-A
MCBF,*XH" @(" @(" @(/&\T8^OL0-YN:#R@(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @SR;^D]B!-]8[$2<,"*(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @("!$9H-NFH:VJ>WP:>9,EEP#G,:
MYP QNV))]3,2NH5' W#<ELWB36J32GM;OS/KU4VE:T"^(<(V0S5U&<WP].O.
M7[1?Y<O)TOHO_FA:)43)+)A.Y42IC-Z6 "&EX#B+,8)>R]>F;M^87F-^L%^3
M'"$V8R@US2*L,>]H(E4[XAI_:F]9S6_Z^OU=1Z-^LD>5>HUOU:;7:5+9O ;W
MU:G%D0+]Q3V3^N1[Q^3?VU?D#YDU^GT-=QAH]":UK=XQIY987"W 0@K.VUOQ
MS&7ZD\(></DEYG4-'7</\<:1J3Z^6UTN5*KFB>7.%H#-TM-MUJUG+GBSA:]3
MTB=31F4,F;.I2 630PD.:;C&Z!"OK,?<G;-VA8D6.@U^+3>.B]9:>4! 0$!
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M C'<VI.V2?']7LIY8_;Z>27&LZFEU_$.D4?C $DRZ>7",=FQ6W"_USZOT_\
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MP9CF6B0(P)&2Q[-?U3Z[;W_KC^0?_P J]&_^@=R9/ZY]3_UQ_(/_ .5>C?\
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M(" @(" @("#B206C FU60\+1IVEZ95,WJBH<QV4"/3"Q6]<3+$[5*_H_H?\
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MO3YC&S),^60YKPX![B"+#85+6<[PC@8BW;VJ-/* @(" @(" @(" @(" @("
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M,T_^:YYF?_+;7_\ KKNY#-/_ )KGF9_\MM?_ .NN[D,T_P#FN>9G_P MM?\
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M32!B <PLE<7N+80$23""+)]5DT;194QLRMU*9]5IY>Z[?FN;*88DD@S)D&-
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M+HWYK4K-GK?L[/?3NIR&.C$@&W:I5SEC0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MM^9;1!O&NO 9"M=#L6G/-<O_ )KGF9_\MM?_ .NN[D,T_P#FN>9G_P MM?\
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Z*C?6UTF0T$-F.W2[
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MRG3&ZA*>6@N#26@F'WL'$E62U/9#T6GNKJDT\?#:"1XCK&P%D8J8SHO;$RL
MX4H9?Y;56-.1,H?A36E,'L?HOICOAUAAYG23V3DPL[?9HUO#K:.5XLJK94 7
M!I&]9C!I-ZLAG*N F+@6EN[F+U%>4! ,<&EW-R*"4T_2GZA,W'.\ 6>\\0&.
M=AN5QY3*<'"=&RV;JK6[/Q?:Z8%,'L?HSI5WYXEQ_;2(_P LF$]GC]$Z)WY+
M5FO/_L_\6:Y,+[(74=)=IQ@V8)XA'>9:#?EDK>OK,I.V=(H1Q!!R*RT2P)KV
MMCN^\+3DM68'9VFT=/)IX_6I;C-IG270<V#0^\_%>$SF,<7+^79^L\<(NT?Y
MD:AGB2*MHU6O(F,?O ?CC @M<LW]M=.MG;J^4W2Z85.H2I!8UX,R&ZXF%CP,
M""5;PQUG[G]0?]5FT,47D)55LR?(E>%HLK=D;X#G>(Z5+L!=]$/CT+/6;;[S
MUCZK-8T:34F=4MK90<2^9N.<T6DDP:=\QAT+ISISEPK^F:G*I*;4-+G>_P#6
MF3)3'8?C)4R4>>.\%),<M=NN=Q\COVX7V(&O?,Q3ZCYD<!RYTK5GLJ*L3*9C
M7'Q6QGLWFAAWAO0L*F/^IKVEGI'QGTOV,WS U7&XX*;2ZD*HU7U7Q_J)W=[Q
M-R/Y.%ZF4]+7V\_8C?8LZG\J6BZ;QWQK*FS=8934L_Q:EH#S-:/'<0-UL+1<
M+E9-^Q[XZ^GE]3FMZFRODTDB39]5!:[GW&-O_P""EOT23$V@$5Y8'O>UH8X[
MQA&!Z[H006F1PK+FRV39U<R3O".[9$<^\YJMZX8GR99_T8TMMCM7E@[72!VS
ME,+[/'Z*Z>Z.YJ["<@9)[)Q3![(C4-%=IY_%S14-A'>9;9?:!<47*%!)C%I;
M PM&R**\H/!= @0OAVJR9$_0:'+U!I<ZLE288%PWCS D8J83V2/Z(R/^\V_\
M7]VF#V0NI:6W3C!E0RHC#\F03;F 3!,:R2YN&;3=#_.+#,F3Q3 ??V&_ &"U
MZ:RS?DDOJE?T6TYGQZNQI%X)D@>F<%G#7M]C]%]-?8S5V$X &28]4Z*83VJ)
MU/1/S8P/9.%2TB,6VD".($4:ERA 20"01L-Z#9H:5NH3A),QLF#A%SR ,;8V
M+4Z6I;AUM\W^G2*WR(XDHOKDB6^50393 ][09N[1S&D@;T;-P1YUFG3?9_'J
M^U3THZ7\RVO2CX;B:W5_?88D@5;++X02-?)R]-OETIG5?G3Y?R&AA,S79 !?
M<VQPWA:+0E<YS']@G['_ $%FB_+SPJ^=6TYF/T&D+9(F-WCO2Y8-A=&R],YK
MI\G$?I[KFCRY514Z@VKEO^L3'/\ #WF[S2XQ(@#:(E,,Y\*L'1,!UJV85R4!
M 0$'@[V#2[F!]0*"8T[1W:B??F?5P/I/LLV15]6;VPF?T3HF_E-6:P_^S_QI
MK5,+['Z,Z5=^>)<?VTB/\LF$]@\*43_R6JM<<OQ9_!F.3"^R!U+2WZ:_<#C/
M;]^VT=,+E<&4:(X@C85E624SQ9K)40W?(&\38(F"IXRNM10R:#A/7:8U4IWC
M:3JCW/+VAK _3YC+;;F@1*M9[=LW[/Y/GV_F@ME?,3Q;6.,F>P5%7,ES&NCN
MN%5,<"(.O!7/K_)TL_8^<BCE.G5=+):(NFU,B4T&XNF36M /.2NCB_J_?JX'
M!+J+Y9*+5*JMD2PW3M-/@A[=XQD 0@781Z I&[+ZOI&XATJ5J094"KE,,ACA
MNES8.%]AC>B1UX\ACW,OW7$1%Q@;PK)EH4! C:!]\8#ETH+-5ZI1<"Z'6:[J
M+F2Z=E(ZI>7N#6[DIAFN$;(6$*XTQSVP_ER_K'WSAZSYJ>>^I<%:;J<F;HPU
M&O#Y$J870ELF .&Z'PM!@LXSVSX=+?68>G7V.7F5Y%^4?F;IW%_FYIVG5E'0
MU,BH=]=;+<+)K'.)\2(N6>V9?LO7&']0CY._G,^6KS\X1TR3Y0S= TUGYGI)
M<JFI'4['G<IY;' -:08[P*WF,WIVFZ]RM/I9LO5J&H<2Z5.K)98ZW=(\00+<
M(%:ERUG/6_H_!3]8K /RY3(C_P"H=7_*5"QV3XG\H;S,LXUUC_.7?RCU9PS\
MG\G[:?8& -^9FB>&%SOSMIM@C'\I+YT\G7'-?UO/+@?6>"-,E/C*W]*I)9+A
M#=WJ>$;87153MRV!PG02R3,U=C23$@F4!M'O30IA?9S_ $6TU_Y/5V$[#),>
MJ<F$]D3J6B?FUH?+G"I#OO+2!M BKA<Y0HCBTMYU%$!!X)=@QSN8'T0!19NX
M3^GZ :^7XDRH%.!]]8<KBKZZRYWOZ]O5(_HI0-_*:NUIR_%#\*:"IAKV<OT9
MTHV#6)9_X4C_ -\F$]G$\)4KK96J,?9$1W/\68ZQ,+[*S5TKZ2<Z3NEX;<\
MEIMP,"F,$N6MT0V%%$ [!'8%!M4E(^K>UA!EM<8%[HAHMQ-EBU)E+<+*.%*0
M",W56,,+8&7 ?X4QJF#V<OT9TJ[\\2H_MI'_ +Y,)[/'Z*4+OR>K-=L_%'H]
MV:4POLA-0TE^GOW6/\=IC[S+;N:S%,&42"3>TMM(M&5B*\H"#Q[V\&ACC'$
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MO)N1/^M2M)T]LZ_?'@1B-@D128E+[5,4NDZ91:E34.AL:RG<1+A+:&@,A=
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MY<[TQP_'_P">_P#6.O)#R]GZIPQP%J-!]=TZI?1F<W493YSWM>6Q<YA%L<@
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M<US(P@T@6@VXK6L$N4<XP!-MV%ZRJ7TZ@'@OU.IJ*>12TQC,-0\,;!L8DEQ
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M2JZEY=,J'LGU#;R2V6\@V DQVJZC.+VW54U70]0T:8)==33Y#C_E),R6WK<
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M6YNLTM+5,=*<'@^+*+WVMVI<UCB[2.ET,N9I.KSGMC44U//,O,3&4\Q[8_\
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M>!(F[NZT2R02YH@L3-YX;[6=<>KYT]>U[5>+-6?J.ISY]76U+@V+YCY[B2;
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MW#^W)UO@RMXF\L?*742VLDTU10S!2UI:&N._*)/AF( )5S+IJXDUR^$?S?\
M/KC[SKUVHX@XRU2JJ:RI+C,'UR>]AWW.>00Z$02Y222Y8[=KV=,R),RHFRY,
MIKWS)K@QC&-+W.<3<&BTJLS:W3^!.(J>F^MS-/JQ*W=Z/U6==",;EGVC=Z6*
M<]KF.<QP<US3!S7 M<"+P6FT%:8>U?R^_-_YL?+MQ!HVN<%ZO5R_S3/EO;)^
MNSV;TMEA8TBP$"Y3#<[V:\/Z,GV&7VT5)\Q_#^B\"^;&I-_/3*9NGRS55;'3
M!.8UPE^[-)C[T+$ZVS5;O27KGJ^I:OI)-7)E:[0[KJ"J$N?(=+(<TRWD-:1"
MRURMN;'.?1M<9/+N"-<&!X>J^KP)G1<NM_@STUW?R'_MX*)X^;'59[G3H?7M
M3E^\\NE@.J3$AL8!PW5QQ)=-]MW?#\1M!F,I]4I*N8Y[64TYD[>ENW';S""
M'"T!5SMP_1;1?M(_-G@7@&?Y;\+5U=+TB=2&D>?KTQC0PR_#A8239L4PW[5Z
M'5<GBOS'UK4M>J)=?7U=?4S:F=/>V?4-WICMXM9,(M:#DF9-+OO58U?1:_19
MXIZ^GG2)AC 39+Y8,,B\")27+-F$4 7& M*J/T]^S8^>/CSY4?-CA^9HE=6-
MTRIU>@#V"KFM9+)J UPW8[K6P-@6;';IWSJOZX7R$^?3/F6^7O1..*R8)VIS
M].IG5#B_Q'#>I8M),8_$KUEO/#';5S.'LA44[Z6863+"22.DV*]IBK+EA4!
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MO#T$^U>_W9N-O\PJ?]'>M1>G#^.C\RW]]_F)_;U7_+%1SO+K_P M?]O^#O\
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M-RY_5@65<)GPC]L%%C/YN?W7U_\ 9DW_ $9RMX9Z_P _\OY*/V[_ /O(5O\
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MU\M'<9Z#2T$MC=*F3F/D4X82Z67AUNZ+0X)M9UZW7E\<.MT[*749\F7\+'.
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M_J3_ *MCJ]5_\PJCIG39KY9TNB:0YY/[RS#!67UVZW?7'V?534TLOZ_IU4X
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M" @(" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @("
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MDU57.FMG4E13M;,<2T![9C<3A%(W?W1]GFMZ;-K:N9-E,+F^+[Y;]XUK=X]
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M1'A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU8[<)T_F_CP?-9_>OKO]I:I_I03KPOR_R6SY$O\ >3X$_P Z;_I-,K>&.O\
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MI]/22Q(:&-II3),MC8 -W6RVMM ;>5N7#GOLK]'KLRBFF=,#IS71!:XN(@Z
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ME_?]YA_VS._#>M.2]_)-_?-PC_XCTS^7DK/9W^+B_J_LB?9^?[HG W]E3O\
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MQBLJ\H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M5F3/ZN^&_+/\RTR1)J)/!G%<^1-8'RIDLU1:YA$01O;MX4EE7/;AK?\ EO\
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MX<N_3'?*C-^E^V*RVEM!_P!<TG\)_BH7A^,_VY?]PG%?]BG_ $=JG9OXN/\
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M^GM=+FQ:6N:R2"(.MB%)6_EY>S]00:NI(N,V:1S%Y51C0$! 0$! 0$! 0$!
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M $RK_P YG_RKUIRO+ZHOU;ESQYIZ?NO+1^=9\81M_G<S:LWEU^/^+^H'1_[
M:%_FU#_CJN?FN>KV<$<5P_[@K?\ 0JE;J3E_)!^W9)/S3\1Q)_I6H_RTQ8;?
MA9PU_K:C_P YIOY4*=N&8_JN_JX7^[U2_P!BT?\ (L4^/^;?;^#Z$?/UKG>2
MG'(;\1X=FPYX2RNG;FN75_(.^V-E5$KS\XL\?'7ZB'\<_P!2Q'7OGUV_&B27
M;X:T$N>X-;"_><0!#;%:<G=_"WDKYT\64[)_"6A:YJTEX&X*!U3>1$ -$&^E
M336>RS3OEJ^962\RY_!/%DN8+VO,\.'_ !DT9[1C_P#+?\R NX,XJ_PI_P"Z
M31GL\GY;/F1G-W'<&<4O:;-QSJ@@_P#!B0FC/:H^K^53S_I:6=73_+CB!TN4
M"Z9"G>^:0+R 0-X]*9\)BO>_[,KR-\ZY/S)\ UDW@76:+2Z?6:5[Y]91S)3F
MPG@O./NQS@EYRZ=,XQ7]?SR-$RG^7SR]I:H>'52.&=/DS99L<V8R>200<@JY
M7E-3/C=SJ.C@@();A[_7-.A>'H)]J]_NS<;?YA4_Z.]:B].'\='YEO[[_,3^
MWJO^6*CG>77_ ):_[?\ !W_B'3/])8B/ZX'V&0(^7OA8D$#P*3_1I/K4G+IV
M_B_;/BH$ZN8 G\5)_!"8OA)P@=UV1ZBF.RFX_!O+J3%,Q*Z""-7HXB'O_P"*
M]/U2\/G6_6-)%3-\G*PR?A&D-C_$J5KH_E<>8((XTXC#KQJ4R//NL6G/MRP<
M+<.\0\35K:'AV3/G5I+6METYF![G'X;98)$2B2V73O.7\M/S+3I'UB1P7Q9.
MIMT'QI9J3+W2(@Q)!@1L4TW^[E@_\M_S(?\ R,XJ_P *?^Z329[/(^7#YD1=
MP;Q4/^%4#_&31GLX3/E<^8NN(\;@/B2ICC-;.F#_ (T54N;RA*GY<?/70M5H
MJ>=Y<<1"K?,EOIRVB?,DEP=&#W6;H$+8PLNM4Y)G.G]!_P#5>N"/,'@[3);N
M--%JM(\63/:&5$M\N!?*<!8\#-.LSET^28F7V5Z_I>B<5-U3A_6*6GKJ6JT]
MU(9<YK7,/CRW%U]D?QGH6L9<LXV^.;[9+[ #1_-:3JGFYY=:'3SM0#:^HF2=
M/#A-ES7 S6-<V60]I.!QM@N=F-QUZWWUV?"1YV?9\_,-Y3:C44\[RZUV;32*
MFHDE[*><YQ;)<0'#Q+#8,U>MMVSVZ>O&WJ+J/EIQ]I#WLU+A/6J-\MQ:\3Z1
MS=US200;2+"%IA7ILC6M,)\9M71%ONG><91:<K'"!4TU^Y.</^8G&_"]?2ZC
MH/%.M:;54<QKY$R17U :PAT2#+WRP@\T54S7U5?8L?;6<=>4''?#? ''W%>H
MZA356JT=(SZ_,=-9,E3BQAAX@<"W>)%JQ)BNN9VZX\OZ3WE7QUI?G-Y9Z/YB
M:9-ESVZO3,J?Q>Z-T^'+<&@"P6/6YERE]:].?M9O=^4?B@?]"KQ_^8M4[<-_
M'OOE_'@^:S^]?7?[2U3_ $H*=>%^7^2V?(E_O)\"?YTW_2:96\,=?Y1_8I^S
MX#G?+#PVQGQGARGW87Q-* (8J3AT^3F/@L_6<Z#4Z;CG5GSV.$HZG*C&-C35
MR[>>!4O*=[^V/CMI8"IIR;A/DQYO$;%;<YR^\W]5>U;17^85)3LF,%2-1IV@
M-A$OW6@ PPBLR;=>USUUR^^CBZ7-=44[V@F6VG@XX B9,*UX<Y?"DO<TL=:#
M9F%EN<K7JSY4G@"JF5'Y%M'-=,LL#/?OV16G/S_E_+B_61]8T&M\Y:N1I;F/
MF_GUV\1 D;LY[CM%BD:^2W,CY>M+B=1H0+S52(<_B-5K/7E_1$_57I-6R:'S
M6D2RZ= __:Q4Z^73Y9B3'U?;AY@_['\1_P!BZA_H[U6.O+^19]O'_O1:M_G^
MH?Z2]2\M7E^&W!_^OJ+^%E_RTI*G3E_5Y_5LR3\L(B21^8]/L)_9TBDY:[\/
MH!U;^E/_ (5_X16^W+G.*Y\26>5_&4+/^PM:_P! *3E/+^15]MF2?F:X[B3_
M $^K_EBL>7;_ *7XF<-_[0:%_:]!_I4E:<IR_K$?J^/^[KI7]FZ?_)%)PZ=O
MXU]!_&/]+I_X$]JC/7A5D40$%QX1_)5_\&/\9(G;A\C_ .LN_P!TU=_9E;_)
MN6UO\7\RF=^4F?PLS\)9<WT)?8'_ .]1PO\ YS0?R\I9=_#^MWHG^JN%/['I
M?_P9(6G&\OFA_6*O[IM6_LJG_P!%8LWETZ_Q?RN>/?\ ;/B3^U*CM"TYWE^R
M'V'1</F4TS=<6G\]Z9:/VTE9[.GQ<OZX?DV2?)K1RXDG\W-B3>?Q-.KX9O\
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M?B8DE:9MR^U+]6J_O-T?^&T_\(+'EZ/^A_1TXH_+:?\ ^V[9:TX3AZZ?./\
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M 3)KW@45%N@N)A^)E1O.*Z?'PUW_ (O>36@/SB^P<@4[\I.$:H" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M7\QN-*^MF>+43^(M3+WV6[M5,:/0%IQWY>V/R"^2VG><7G7P;I>I.9]6_/\
M22ILMY $QIF,,(&^,5CMEU^/K+M_7*^0KY,/([RJ^7S@J9^@ND5NH5.F2:N?
M55%*9KX-E2VATMLN!<2YIC&(6_#/:XN(]UY?E)Y-ZN7R'>7^A30&G>;/TM[6
M%MQM)@II-OEE_6$/LT?)(>3>J^;G"G#>FZ%7LD:C.F,IY;)8$QDCQ"&6;VZ'
M&RV,%?#I+GJ_F*ZG2"AU'4*,&(HZVII0<Q)G3)8/_$1RP_<_[$7_ 'D^!?\
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MVA[3>UX <0=H58LQ7[^?84?/A*^5'SVTDZSJDJCHJK6J!Q?4$!@9,FM822Z
M@(*6^K?6^*_JZ>37G5P!Y^>6^B\8Z#Q#H]7(UBD8^8VGK:9LR1-F2VOW1+=,
MWB(.!RP27.V;,5?APMH\MIW]58&DQB9D@"'.9D%;LG:O47YX/F5X!^7SY?\
MBVOJ.+M)I]0DZ=44M/(=5T\R>2)<R:Z+6N@T[S;,5/LLF?W/Y$?VD_S/S_F-
M\[N+-1^O"LIJ/B"L,J8RUCFB9-:"#=]())A>_;V?GSPO1SZ_B30J*GDNJ)U5
MJVGR&2F ESS-JI4L@0V.58FJ_J._JZ'RYZCY<>6FA<75NF3Z)NHT[9H?,!#3
MXE*(7\ZS.73O=;?4%YAN/Z*\0MP.AUQ_^@S>Y=9/VY^[EUG[\_9_(R^WC_WH
MM6_S_4/])>N=Y=+R_#;@_P#U]1?PLO\ EI24Z<OZO'ZME_NQ#^P]/_#I%)RO
M?A] 6K?TE_\ #3/PBM]N7.<5SXD_NOXR_L+6O] *3E/+^15]MG_O-<=_Y]5_
MRQ6/+M_TOQ,X;_V@T+^UZ#_2I*TY3E_6(_5\?]W72O[-T_\ DBDX=.W\:^@_
MC'^ET_\  GM49Z\*LBB @N/"/Y*O_@Q_C)$[</D?_67?[IJ[^S*W^3<MK?XO
MYE,[\I,_A9GX2RYOH2^P/_WJ.%_\YH/Y>4LN_A_6[T3_ %5PI_8]+_\ @R0M
M.-Y?-#^L5?W3:M_95/\ Z*Q9O+IU_B_E<\>_[9\2?VI4=H6G.\OV0^PZ_P!Y
M33/[;TS\.2L]G3XN7]<+R:_N9T?^SA_(TZOAF_S6G@W_ %C,_@IB1>[\*OMY
M?]WGB/\ S;4/Y)ZGE9_%_)7X\_VTXJ_M[4_]+FK3D_:K[$K^_P!X,_MP?Z0]
M8O+T?'_!_6\X'_N;X._L+2UIQG+6%PYAV(T\H"#PYKG-+6-+G&X"_D$G(D>(
M>)>'O+O@'4^+M?U&DTZ5I%!/U&;,JITJ7NF47-:P,>8NWMBU;AB[[/YUWVU_
MVSG%^I>=%5HOE3QL::ET+5C2O&G32 \2' .LE&V&ZL6WM<QWN.LCVR^Q_P#U
MAZGII^F^7?FYKDJIF3]R@?-U,/8XES V7,WIA8X#Q ""+X*\1SUWN(^U?R9^
M:'R@\^.&*36-'XUT)LVI+0VG;J-+(F>^T$;KISG"]V)"LWPSVZ^KNUL[AX_T
M?C&E:,!+UC3G89B:B2ZQAO4^K:%0N,R?Q=0SP01NU6KZ>)8VVS08CG3,'S+?
MK!?SB_+WP=Y*Z[Y>U-5H6N<5U<BKE/FR9DBJ?*J'27!S6S&EV]N/,(@P.%BQ
M=7#IUWTR_E<<3ULG4>)->KZ=H;(K-7U&IDM @&RIU7->P 9!K@MN3M+Y<=$K
M->\[/+J@HZ:94S)G$5*XL8TGW6[XC9DXA%Q:_L-?9*< UO"'RX<#3ZZF?2&=
MI<B#9@W;'28"^%A*LF=KV[8Q'Z*Z\X.UBJ+3$;\(YP!6:O7A$3/A'[8*-1G\
MW/[KZ_\ LR;_ *,Y6\,]?Y_Y?R4?MW_]Y"M_MW4OP9JD:^3E^$4OXAS._!*T
MY/OQ_57_ ,EIG\',[7IUY=?^BOO1XA_U/+_A/\9;[O+\/\E#;\(7)ZJ.;O"&
MWG1%AKM/H..- J>&*Z6V;)=13&3&.@ [W/!:#&RP3%N<,XQ<OYIWZR#]G_K?
MESYNUG&W"_#=8_33J5;/F54ACG23*F&:Z)</=+3&*QG#ICWF7R%3I4R1-F2)
MS#+FR7NES&.$',>QQ:YI&8(6G%[4_*A\S_'/RV>9G#'%?#>N3]-H=,U*74U4
MN62&N8';SM[=PM6>TOAKK<:?TROLJ?MT?++Y@N!."^!N,>(-)I];II<C3IE9
M53&RID-X-(+B\ ^\2;05);PZ7K+N/H\TGBKR_P!?DR]:T?C#1YTBJ <R;3:Q
MI\H'W08;CG->" Y=,X<;F5/C7>'&"WBK3H9OUK3NTS F?T+,O7GSZ^;;RE\B
M>&YVM:WQIP_,G2F3G_5OSA33C"2S>M=)>&VG(E9M:Z]+A_-4_6"_M'^&OFR\
MS9TGANMIZRCH-1FTE.*8A[&2*=AE2VM(+CNLEL "<M9])B/EBFO\2;,F?Y28
M]_\ A.+O6JYOWY^PLK9E/YZ<-LE2O%)UIH= VB,^-HON6+R]'QS/1_6:\OR7
M^4?!CB-TG2]-<1E^/-BUX<;KL_,G[:W_ '7=8_LW5?Y%3LW\7+^0G\QG]Z.O
M?P\[_29RLX3Y/Y(3R3+!Y@:-ON#&^/)BXW#^<25._!\?+^N7]ACKG!NG_*7I
M&_Q5H\NN-'H[9E)4U])2F7+^JDN?^.F2XG?@+"ITGE?EWVT_8RJXA\NITY_B
M\7:"V8Y[MX,UK3H;Q)!@?$<+]JZ[<NL]>%=U_P V_*7@33ZG4=0XXT"2VF9O
M;KM3HYSC8#895@LVIFXVEZ6V7Z/QE^=W[<[R1^6O0>)*;2M=T34M4E:75MI)
MTJ:V<^54.DO#'-:V86[PPL,%BUUG1_-W^TG^TN\QOG+\Q=9KCQ)43^&:A]1+
ME4C2_P 'PILV82UD?=L#DF3MVF,1^21,;3C:JYOU4^RS^33BSYF?F$X8TX<.
MU]5HLJKI?$GMEO\ !/C3Y<'%PL^%I4SMTZ]<;K^N7\FOR\Z7\K'D_P /<(4T
MAE.\Z-I[9S-X$B9*II+W-=NFQS7/A Y*Z9[=O;M]G=LQYF3ISR8[TPN',ZU9
M:<#<>8]BHNG"/Y"O_:^IR1GL^1[]9K_NEKO[)J_Y)ZM=)P_F43ORDS^%F?A*
M3AQ?H]]EG_O2<,?PU!_IK4K77E_8B^3[^YOA?^P-._T:6D:[\NQIO](G?MW_
M (2#P@(.#KV\_K""2\U/[N:_^R:C_12EX9Z_RC^2!]O!_O+5?]KZG^%-2<+W
M_D_$SA&N9IW$-!63(;DB=OF-WQ!+PG75?U OU:3SWX#U#R8E\-U7$NDT.IS]
M)ERY-)4U,BG=,F,,N86ETQS0#!AO2-]NN9[>7U,S]*T+59TVKDZO3S!4.<\F
M34TTYA+B=[=<R9 B*MVQFLLE_#G"]'63*S7*"FD^$^;.GU=92R1*E2V/<]S6
MNF1.ZV)Q-B31;:_GA?K)?VA&F<::YKOD]PYQ)2ZE*HY%;1AU,]CA[N_+%K#"
M*F?#I<>GW?#NYSG$N<22222<2;STJN+Z&_L$/*RIXJ^9[ARN_-DR?3FITYQG
MM:2P#ZQ+,8BQ<[<W#K9CKF/ZNW%X=PCY,SY5"/!?I7#%'(E[MA:^51RF.//%
MJZ<5SZ[L?RD/U@3C77>*//[49>HU)FR96OSX,<8GW6S=TCI".WRS#Y\= HVZ
MAKFCT+K&UFIT-*XY"?4RY9/4Y'&<OZ0GZN]]G5Y44O"FB>8G$^B47$-14>'6
M^%.8V:P.;+9-:)@;:& BVVY9F<NW?UG5]>\[RI\F]+>*/_YG^B,#@/=D:4]\
MN#H "(="[)5RF?J]-OGG^2OR)\W/)+7J.HX T6DK)=%63*>LI:+PW!LVE>X^
M-OQW2"T$6 WI=M=+O%?R/_M)/)?2/([Y@];X2T9DIE&VLU5S&RMW= EU3&-'
MNV" *N,)\G+TV\KO]N= _P \:I>#I_)_5Q_5W_[@Z7^Q9/9*4ZM?+S'T%L_U
MOJ'^>._E5OKY<[Q'S$?K-YAY%3XW?F":8_\  >%B\M]9F/Y:W$)CJM3^W?\
MRLPJQGM,5]$?ZO#+TO4OFJTRBKM0DT+3J6G>_-<&B'C$1B4:?UD:"1HK-)H:
M&5JE--E4^GR*5DUE53G?8R6T"9",1O0C!:G;6&+SE6J*GI:+B*DETE2RJ8^<
M8N8X.#8M.+8BQ+UQMJ7VEK\(_M\/[D>(O[(;_HK5BM?'Q7\FWS/_ +P>+O[;
MJ_P@M.=Y?I)]DI_O!Z#_ &]IG\I*6>SM\7#^P'\I@#_(GA!KA%KJ0,(-Q::6
ME!'2%9PY=OY/YZGZRG\ONJTOFSJO&E/HU0:,5>I3OK(8[PX;V]'*%BQBY=)/
MV9?&/<=H71Q?8%^KZ^8/D!K6HZ/P%YH4.D/J*R3+I?%KV28EYF-E7S,5FN_Q
MX\\OO%?]FU\IG%FCZ=7:+PKHE6V?2R*MDRG%),9-9/EMFAP,J.[$/N-R89]Y
M]$4/LL?EQ! _033(71\.2MY3VC;E_9;?*U3;LW4.%M)I&-.\2Z73M$!>=Z86
MM]*S@]Y]&^/LYODPK&?FZFT?AN;5#W?#EU>DSIN]@#)ES-\$E7UN,L3O,M;0
M_LS/EXX-U?\ /FB<#Z<VH8\31/E296][GO-=8(V*8;]H]R_+O0J#A6KE:/I<
MAM-1RY3I39+1 -#&$-NR@M6>6;N/QF^W+_N"XL_S.H_D7+-Y:Z_Q?R1O-'^\
M3C/_ ,0:C_+N58O+](_LH/[_ 'A+_P 2T?X4I9[.WQ/[ 7R[?[N?!G]@2>UB
MOASO\G9'"W],F?M'>M:^/E/DX?C3]NO_ +K.J_V?J'^C%:^3E>G\7\B;S'_V
MRXD_MO4/Y=RYQ.W+]0/L@?\ >E\O_P"T*3_26*5TZ\/[#/EU_<YP%_X=TG_1
M'+?5R[<K-H_^H=?_ ,WJO]#F+/DK^;I^LJNCQ5K8Q$NHQ_Y:8I.7;OKIA\:*
MTX/O)_5H':.S4-(=5ZI(IIG_ &<-Q[FAUV1B5SQ^[+T\_&_H#:W3:5JC)1F:
ME3RW4[7E@;427;P?NW@/WOHX+H\\TZ[J-R5,+)3A-:"0'"X@&&"F'21X1! 0
M>"Q[X!C"\QMA@+H^E7KR-KB;C/@;RGX9J^+.*.(M.TR5343ISA5U4B7%_A&9
MX;99<)D;+38 JQNU\:_VNWZPUHO"VG:UY9>6&O4@JQ5U=#)GZ;[[_<$R7XF]
M*BYUT8K-CIKIKR^"/S]^9SS4\_.+-;USC/BO4-5I=0U"HJI5-.>72PR8YQ;O
M!X), XY)(SV[9U.'KK(E&=.ERA?,<&CG*K#]K?LT_LKYWSE\6</_ )TUO\U:
M:_4Z?QV39S),MTH367EP$1TK-[>&^O7.W](C[/#[*?Y8ODSX3T^NKZCAC6.)
M)/A3I=165^GL9(?*EL@^8Z9,8]Y!%@$.? V1KMW\1^OXXT\O)%*S3Z?B_AVD
MIY3/"ER:?5Z -8RV#&QF/@W8KQIRQ:C1Q#Y:FS],]"<\F_\ /6G;T</=#HK5
MSC:S.4963M+GN#]%KY&J22"3,IWLFMM/WTNPPS7-MGTV@EU$Z7,K)K::GWH/
MF/<UC19<7.@!$MQ6I4MQ</1[Y[_M'_*'Y).!M3U&OXBT6IU6BH9KV4;JF3/F
M2:AS"Z7O"6_=>X1!N-MB=J3KG;^<1]IW]N9YG_-7Q'Q/IG _%%9IND3WSZ)A
MI6S)<A\LN<'EC@/#=#>(L-ZF%]O$?.OKW$6M\3US]2U[49^IUTPDOJ:@M=,,
M22;6M;>2JQ;;RG_+W@JJX\XBH]!I"]KZJ?(D[[1\/C3 P&T&Y2W"]>OM</N,
M^QO_ %?/R]XRE:=YP>9?%.GOI13:?6NHM0K)(]USFS',$N88 #(6*<NMDZ33
M[F?*/RP^7KY?>'].X>X*J.$]'90TDBE%3^=-.943? 8V7OELJ>&LWBV,+2,U
M7*VUVA5<6^7M8[>G\<:*]H,0TZSIVZV.476!:SE,7EJS-9X!JF%M!Q9I$^;N
MG<ER-2HZDO=@ )1)"OZK$,ZUSG2_?DQ.[-%SA@8W6K%:<4! 0;-%_2I?.WM*
MDY+PZK^;_P#W8O,C^R:K^3FK?9CKR_C;?:&?[QOF-_;E1_+K+5X=7_*)_?/P
M+_XGT[^6DJ5KIP_LJ_9T_P"YYP!_9A_T2D5Z<L]^7M_PS_K6K_@'?AL5O*?]
M+Y /UDW_ &&UK_[>_D7K-Y=>O\'\TNJ_I-1_#S?Y1RTX/WS^PV_O\X-_M5G^
MDN6;R[]?XOZT7#7]T_"7]B:3_(*WASZ_R3FB_P"SVM_YK5?Z).5._$?RV?UA
MW^_OBGGK_P"6F+'EUO\ !\NU'_2J;_.:?^4"VX3E_48_5M!'R0H_[,H?Y)BO
MAUO#ZL^)=-;K&AS])= _7I8D0S!EN).R$$CE+BOYGWZSG\MFJ\&^8U7Q)3:5
M4&2W4_K)G $C<>^TY?"Y9=.]]GQZ2W/I:F6\@M?)F,>1B"TAWH5<YJOKZ_5N
M/M&-"\B/,V1P5Q=JE+14=?7RZ$.K"&-=+K)8E&#GD6>]"(3K,9RW_P#),?=_
M2EX9XOX)\T.'-,XBT7B#3:VGKZ66^7,I:RG)8YS=\L=*<_?BWQ$^S.+UN$N.
M'-%I_?G:I+:P&,7SJ>6("'TG3("P(9K\DOM;/GL\NOEY^7KBO0:7BK2'ZY6T
M$RC9*942ILUG@4TYCI<6N@3O0B1B%+6NO77L_D??,[YS5GG3YF<2\2U4]T]L
M_7=2FR7D$ L-3.:US8WAS;0IUF$[=LS'E4/(/A6MXR\W>!=!HJ695/K-=I Z
M7+:22P/M])"TS.7]>;[&?R)?Y3>0/!U7/TZ90S:_2&1\1I!/B4T!??O$K.,7
M#K\ES,Q^J7%VO4/!E9J&N:IJ<O2Z-K#4.G3G!DMS&L!,2[W2!"U;S)&,YGJ]
M>^$/F^^7/SBXEK?+75^)>%M1KI<Q\F52UT^09$^:26&6X.> PS-V$;!&^RT9
MESHO6]9E7O-S[/?Y7?.BGF3F<&\."J<)A/YO--/IW>*T^\"UTPL,<W$%,$[_
M %?C_P"<WZNYY4<?3YTS1-'TVB;,FS7MW:BFE0:\V6%XA!9O6UN?)U?C%\Y?
MZK;^AOEWQ-YAZ'4L;^:63JHLHZZ5-?+8&S'-<YLE[G,;&R-@22R,VSL^(WSN
M\IJOR@XXU[A"KF.F3-'U&?1DO(+OQ<US!$P&#59<IVZXCOSY"N--9X/\_> )
MVC5(I)E1Q%0B=,%CG 5$L0CS)V7I<1_93^3+6ZCBCY5O+W4*V89L^;HDB5->
M?I%LNEF1ZYBU/W,7]MR[=J6"5.,L7",-EZEUIJ;F6!%$$GH?^N*3^%;ZD2\/
M1?[4G_=WXY_L>?\ Z,I6NG#^.O\ -E_?]YA_VS._#>M.2]_)-_?-PC_XCTS^
M7DK/9W^+B_J_LF?9T_[J7EW_ )L/]"H%T[<1YO\ ])V?+#^LK^8/$,C@G5M#
MD53F489J,O<)]V&Y"XE9>O'[,OYQ1)<23:222<R;2CS/IC^P0^2CA'YA/,_0
M.(^)Y<BKIZ2>Q[J2:6G?\.H:/@-ICNK-=_CQC-?U N!?EV\D/+[@GAS2J+R\
MT1DC3]+H:?Q/S>9U2^;]7:Z8Z9ND 1>3"ZQ:<<YJ1XB\@/(_C?AS6=/KO+K0
MIU/6T%52S"_372IXWY#H.E%QM<#"%ZBYN7\UW]8@^2S@#R)XPUKBKA#3J;39
M=2V=-%-):QA:7370BT $0!3&*Z=\7IE\E2KB^U/]6J_O-T?^&T_\(+'EZ?\
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M]&%ZS.7;Y/XQ^]_%7^NW<TC^3:K7/KPT_-K^[C4/[(J?]%3PL_D_D?\ V[8
M^9>N(>TG\\ZH"T&T?%Z$G#/;E^+? O\ M5IG\/\ XP4[<+\?\G]4S]6M _\
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M_I!:?_J4?YK-_DW(Y>7PI_K-0'Z(:I%P;_V?77\[N93RW?X/YYRKF^NS]7'
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M,7.6JH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1]0E3WDNW6@-F-?$F(@(A7#,[6/Z87V='V^OE+Q7Y5<'<'\:ZIH[]1TO3Y-
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M6Y$?-.@M _[5GW_YW,6;RZ_'_%_4"H_]@-!_S:A_QU7/S7+6/]B.*_[ K?\
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MX0"LLO#<DZ[KY5OF]_6#//SS.X\FZOY;<8S].T@59>V7(K)[&&4'V0W9H!!
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M[P-UIB!;A:UH1),<H!%>#<>8]B"Z<(_D*_\ :^IR1GL^2#]9I /E-7Q<&_\
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M(GU$N2*!\R5N,?,>V 8&D>Z,"L[F[PGK.W#Y\>._EL\S/+ZK?1ZWH>I":PS
M=S3:AH_%F#KR4]B],<NC:G3=0I)CI=30U<AS26D3J:;+,1^V;!:8O+6$B>3
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MEP$3\<5O?,<^E\5_'J^83RMXYE><_F-]:TC5ILP\0ZA/$QU#/?&5OP9!UQ$
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M=IOE_/3^8+[._P ]/E\UG6M.XGT6OF2=+K)U.V8W3*C??+9,+6.<0[=+BV^
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MG*3J$L55'N,:&ECVAH>V   "F[6M='W?<.:)I'E[PC2<$:,ULNGTV7+DR6-
M: P-EM<(  7L"Z9PYS=MO#T7^UHH*S5OE(XDI:)LQ]1.HZYS6RFESC&BEFP-
MM-I6:UU_EA_('^9SRWXNI?-'6S-TG6)IGZK7L:XT4YXB:@D;I %ABI+(=Y<K
M5\FOE=QN[YB_+_P=(U:3]6U21-G/%%.8/">^78YQ!]TF"I.ER_L ?9Q4E3I_
MD1P92U@>V>WAZB:X3 0Z+94N,0>9),+\O+W0H=5EB;J.F5I:::LG3V.WO>&Y
M/!E3;#80YBWSPY]I?#YWOMB/L8.$?FQX6UOB?RVTH2^*:G2ZN=,=2T\N8\3Y
M<J9,B'RV N+H1Z5S[=;'3I\DLQ7\Y;YG?LQ_/CY;>)]4T?7M'U&=341FO9,.
MFSS,+);W@@O:0TP#<E<I?CO,X?GCJG#FM:1.,FNTROD$%PC-I)TL$M,#:6D)
M+EFS"'\*8;!+F$W? X^I5E:>'^">(^):CZMINDZC.>0"',HI[VD$@"!#1&]%
MDS^K]>/D;^Q\\]OF9XRX:GLTG4).@3I\J?/AITYA<PB,'.?O#=@=BG+I.F-O
MZ2'V67V7WE[\E7 &CUNIZ=*D\1-I=Z:Z;3RV/-1,:YSB26;T022I/N=KU_Z>
M7ZUZMJ4RJK3(E.C0[[?# L;N-@X6"R%JK,B2XQF2YG!.NR9<-X\/U30!?$R)
M@73-PSUUW?R1?MR_+GC'4?FPUBKD:=JE32.K-2#?#I)LV7%U22""T7P"Y9_=
MATL]MQ^*O#GEQQ=5ZO)DRM&UADR3/E1<RAGM,?%:(1@;+$M3IUN7]4S]6NT3
M5=!^6,TNK2JF3..AZ> VI8Z6^+7TI-CAL5GU7Y.N(^@?5B#53"+O&F?AE:MS
M7.<5YXD(?Y7<:-;:3H6ML %^\[3R&PVDE0QBOY'7VSOESQ=5?,[QY7LT_5I]
M,:^KF,,JEFS)9#9[S>&V@P676_Q?C5H_EIQE656GOIM%U9KYM;(ERG"@GAS9
M@F,+7 PL(-R>T<YUK^JC^KS:%K'#_P M>E2=:E5$JH&GZ>TBI8YCX^%DX!:D
M:LN'T,<7/#ZNGW3'\4/28A2L]>%81H0$%PX3>ULFOB8'PX]0<D9[/D0_6;N%
M.(^)?*"L9H$FLFS3IE8(4DM\QULMWW@*U;C;>,]</YN-1Y;<7T\OQ'Z'JL/$
M,NS3Y_Q P*Q[1CUK]X?L(O+WBW3/FQX7K:B@U612-JJ!SC.IILN6!]9E8N:+
M "IG-=I,]7];/1"!I7"0)M.CT@MQ/YLD+;A>:^:']8CX<UCB+RNU25I4JIF[
MNF26N%-+<]T6TDN-C0<5COGP[?%N/Y>7&GEGQ<.->(Z0:+JSGRZZHFESJ"<2
M6EV]> (IG$VQ>ER_7S[$_P M^*V?,1I6HOTW5*>4-;TYA+Z2;+9^+FRHDQ&<
M4SGAKXYCE_69\EVOD^3&DRIT1,EZ>QK]X0()D4X$1?@M>&+_ "6W@\AFHNWK
M(RY@'24AW?@[]O=HFK\0?+?Q+)T:743*EU/7!HIV.>Z)DON#8F]:QK*]=S#^
M4=Q/Y9<:TFM<0&JT75G3:;5*[QW&@GESGFIFDDG$F*Q>TC/K7[+_ &+WEWQ6
MSS\X+KW:=JM/)_/$N8[Q*69+EAIG67BRQ3GAUZ?Q?UH^ VN9Y,\&,?$/;H6F
M,<#8=YI((/4M>'+_ *F(7#F"-" @YLG3:=WBR#"8! $7VV=B+_[*=YE^1OE?
MY\\)5G#OF!02*V=7RIK'.FACG-<^,"&O:[>ZXJV_1G-ZZG#XPOM3/U<2OXKG
M\6\7^1VF3Z=LR>^N8:2C!%L"+&,@; I]VNWK9B<OCC\\OLX_/WR)U;4]-XFT
M2M>-.>]KG,TNI!+6XD[Y$8[$RG]=_P /2K6^!^)= F&77Z1J4N ))=0SV@ 7
MDV.A!)8Q9A5G2)[3!TF:TY.EO!ZB%4<FTU2\P93SWG)LJ8X^AI0=@<)^5G&7
M&-0*;2M%U-[W;L#^;Y[@0X@ _1S4MPUZ7'W?M7\A'V*'GQ\PG''#>I:EI5?*
MX;F&543FC3YTL.8YS=X/+]^+0PE9WVU&YTQNOZ5/V</R \ _)5Y9:#32:.53
M:U+T^6R>74\MC_&,IH<2=T&-JU)AF[_B_0'4]1G5M54-WHTQF.=+&%KHCT%6
MW*XPC0(6!0<)@B !]\$'/S=#IOE?72Y=KWZ9.:T"\D4[FV0VE+N'7^;^3)]N
M%Y;\9U/S/:I7R].U2IHGZGJC&;E+-FRP^;.;N.&Z+X J9POR=;;]GXI.\L>,
M&O,LZ)JN\UN\?^SYZLN6)US</NM_57.#N).'IM+,UFEKJ>473G,%5)?* :Z9
M,+0-\" @;%,[=<>O3?T?>IQ!-8[29;6D1$SUE=.WU>?I)G2BM^$+#J\H/#FA
MP@;D$YH^LU%%4RI3WPHA .!M$.DX11+-?=Z5?.W]GWY*?-[P!K]/J^D4M1Q%
M529DZEJFR9$QSI[FD!N[X8>UP)CBF,[B>^+BOYW'VB/ZOGY]^3W%W$W%G!VF
MUK^'W5+JBFD_4)DR3]7F3 X$!FX00UV!3B9K=D^2_MY?/SY@_+3YF^6]=54&
MO:'J39U&'&;N:;4-'NB)O+DRSZ8Y=$U&FU]*\LJ**KDN&$VFFRSU.:JPUA*F
MFZ5,.%C'7Y7(+'HW"'$&N3/#H=)U&;:T;TNBGO:=ZZ!@(J6X6;KWA\AOLX//
MKSZUFATOAS1:^6*P2WA[M,J"X-F.:! EVZ#[V29;_KK[0?LL?U=0\#UW"7&/
MG3I<Z<)$B15N-92"QY8UQCXC-J3[M?MFKR^SC@#RWX"\D^$Z'AG@"EIJ*7I]
M/(I6MELE1<UDLL<XM8QH9O'")@M3$NV+F\I!DV;/KY=1-,7/G->\[=YL>Q2W
M*OS+^VOTK4-8^6#5:/3639E0[3M5.[):7/@9! @ ";PL]N#XK^Y_)"\^?+/B
M]GFCK%.='U>;-J*J>UKG4,YXBV?--D +/?4ZW6*O>9[.M#Y.<<C_ .H>J?\
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M3S"\H=*=*U1[:FJ>:.F8YS34!\TM#I3!O0<V_%9N5MEZ[_D_GZ_,!\@'G?\
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M:*HFRIA.GSR26/+8D@7F"D[1R[=<5^Y/V)?EWQ7(\^^#*]VG:K3R/SI*FO\
M$I9LN6 :@NQ;""<UVZ?Q?UCN%P1Y3<(M=\0T72F&-^\V001_Q5;PX]?Y)W1K
M.'M=&(HZHG9&DGP[%5[^'\NC]8(\ON*M4^8#BBMIJ'4Y].Z97%O@4\R9+/X^
M:;P#$06,[RWN]'S-4?ESQ?6-:^3H>JVSFRF_S"?'?)@($;5?:.?K7]-O]6DX
M:U[ASR+HY6NRJJ5-&ET0A52W2W626X. ML6M^&L63;ZH>+YD6T3I9]YLN,1?
M;;SXJ5GK]^&K(&F:]P_6<,ZV&OIM4E3*:>QX:X/ES2"6N#H@VA"R\Q\C'VTW
MV#M+YX4G%/'ODYILR7J4Z2ZNFNI*1A<7[HF&/AL-N\$OV;]I9BO@7\^_D-\Z
M?(/7]3T7B71=1>=.,PN>W39X<62XQ)(.[]')3V2],?H],ZW1]3T^:Z55T%;3
MN;'\M339<87_ !-@K+EC&&DV3->8,E37G)K'./4&E$7_ (3\K^,.,:@4VDZ-
MJ;WDM /U">YI#B #]$PB4MPLF>.7[\?9L?8<^=/S \<\/<1<0Z97R^&2R343
MI9H)DN69;WRWNWR\.C[HS4W>'6=/7=?TH/D2^2+RV^3+RUT#2M(HY-+JTO3)
M4BI/@2Y;_%W '$P:#O15B=[.W#W2_/;G2]2IWD;E3XK).'NS200/\)7=N?+'
MKI\U/VRWV3/%OSO<.ZO5<,TE3-JI6G3YLETACW.$V7+?,:1N@V@M6>W6S;4^
M2=IZU_/H^9#[*?YB?ESUROTSB'1Z^=(I!-<V8=+G^(YDM[P=YS"UD8-R"9/Z
M[=SA^=^N\"\3\.S-VOTC4Y1:]S=YU#/8&N8;X@.(@0KEF]</-'QEQ5IC!)IZ
MRKE-: T-)J!  0 ^,*>L6=[$=63^(.(J@/GR:^OG1B R54SOBLWH0>!SJXPE
MOMR]H/(GY+/-[SXU_1M%X:T74F?G::QC7NTV>7-:Z,2#'=B",0I[1J=,W[/Z
M#7V&WV)COEYTOA_C_P U]/FNK9A96L-72AKM\>\VU[+,$ZRWE;?68?63/?1Z
M71?F#3@UM%3 29#&P ;*800 !"R(6K,,27.4(T0 &04:>4!!(Z*X,U>D<ZP>
M*WU!$O#T2^U-H:S5?ESX]I=/$Q]0[1Y[6B4"YV]]6(L 6M+T?Q^OF(\K>.I7
MG5YB_6](U:;,?K]?4-F.H9[]Z3O -@X60]W!9MDK/K5[^3CRWXOJ?.#A"HE:
M5K$D,XCTUKOYG.8V#*F423%I6.USPZ?'+A_8G^SVE3],^4;@.34![*FFTUY>
M)@+7AQH*/=B#=[P77QMQL_=?JNGS2^2/#WS*^4FJ\"5\MD^IGT$^7*!EMF'>
MF4KI;@(@GXRI9F9;Z_MN^'\NO[5#[&KSC\@?-?B+B3A[2JV;PS65NH3B!I\Z
M8UH%0^8PR_#W V+7&-\8!.W[=-7K[W/7A\^NO<,ZWPSJ-30:II]=23Z*>Z5,
M=.I9TAHF2W0L<X0%HSBI+EBSUOW=D<)>?/FIPA)ET/#6O55,R6(2Y4KZS,<!
M# ,G W;$PU_97>?!?"/S3?-/72]*H?TDU&EJYTN2^;X%<R5,#GAI@TN+G-Z8
M%37A?W]OT=I^>WV:/G#Y&\%TW%6O:;K#WS9(GS)9H7EHB 2("6UV.:D[?5F]
M.TY>A<_RXXNIZ>74/T/5=R;,\-L-/GWQAVK68GK7V0?JW/ O$NB>:6D5==2:
MC(IFSM/)^LR'RVV.C>X 7*2>7:ZZ/Z,7&9+F4&X;?QKAS'PX=BM<NO"N\0:9
M3<8\ :MP=/ <_5J"?1%IMB)DPNNSL0\Y?S9/M_/LKN/^!?,C5O,?A73JZ=IM
M1J+JZ>V31OF2G2I["XQ$L F ?$6WJ=9AOM^^:?(UKO#^J\.ZC4Z9JE%54M33
M.+9C9]/,DW7N </AVQ6G*Z_5#LES)CFMERWS'.(:UK&N<YQ-P:&@DDHCZ,?U
M>RB\RN&_F<H=7TNBU>DTM^J:87ETF?+DN<'P<8$ "(6?:9PZ_'/KP_K#\%ZP
M^IX<HJG4'?C#0TDR<76F+Y0WX@WVE;N,:<[,=L1^./VHOV5WEQ\XW &K:MI.
MG2IW%4[ZU.D3)5++<\3'L>X$$,WOB*Q73K?%Y?S7_G5^R)\^?EGXPXC-5I6H
MS]'9J]6*8NTZ<\MDF9,<T-<S=LL&:2WRG;IYC\G^(N">(^&*R=1ZGI.HR9D@
MPF.?13I; ;+R0Z%ZLN6;)&I1Z]KU!*%-33JJ6P" 9&>".8!PNYE,0G?Z$O3^
M(>(JR6&T6I5LZ:X2VN;3U,X N.!((%IS5UU,^U>T_E!\COG9YT5TN@X4T.N\
M:;,ERF^+IE2X;TT@-^%[<2I.V6KT?=G]@[]E/YZ_+%64'&'&<BODT0%'4S!/
MES9; #^,<&L<(-:,!DF/W->\GQ^OE]G>L:C)KWT EF)DA_B6_2=X<?2U5SZS
M6W1OS=2IE5\KOF5(IPYTV9P_5L8&"+BXNFF  O,%:=9O#^-Y\]OEKQDSYB?,
MRMFZ7K$Z6[7ZQ[/YI.>PCQS=!HP*S--]IF.FOE^\L^-*CS8\OZFGTC5Y31Q'
MI[BX44]GNB>P&)(A Q5S&9TN=/["?V5-)5:7\I/!U-J#9DN>RCH@YLT%KP1(
ME@Q!M2+WU,/>S6G!^H/<V[VF*5.O"-11 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! -MB"0T[5JG27?S=H>UY]]K[00 ,H$7(8RY\6<+<*^:VB3=#XN
MHZ";239;Y;I4Z3*F.W9@@X-?/)@",%JXQAF7MUNGYY^:'V/WRD>9DBHFU6@4
M,BNF-G;D[ZC0S)>],M@2TAS1'G69UVU.UMV_*GS-_5S_ "-U34'SM'TZ@,HS
M)CAN:?)ANDQ%P6L867I75FG_ *MUY3MJ29VFT>YA'3Y68.(6:M]'OMY$_8%?
M*]P0VGK=?TS3YDZ3+8/#&G4Q>X@ W/+1AFGK;MGWG74?K-Y-?*3Y(^04FG'!
M&D:;2.HF_BB^EHP_>%H.[+),24Q(GMVKN?5.(:FL\2C$N6RGL]Z6#%VZ;#$D
MV<R9)-95P- ,;8IGPKD0#84&Y0ZC/TN89U. YQ&Z0ZUI!-L0KDQG2/X^\LN!
M/.S1#I?'-!I]3)<PL,N9(D.>&F(,'3R2;%*;Z_Q?E5YZ?8=?*EYET^H5NFZ-
M04M=6.=-F-?IU&=Y[HDECY<=X1V!7UOA/>77=^8'$/ZM[Y23M4J9E+IM&9+G
M'<(T^5=T!8LS73K_ %XV["\M?U<SR1TZOHYNJZ=0B7+GM=,WM/DPW0X1O&2W
MUFL5GO>LFGZM>4WV/GRE^5,BC?1Z#03J^EFRZCQOJ%#+8)LN!$"XEQ'N[%+U
MF<LSOV\/T7T+0>'/+C1)6A\*TM!(I9<L,#)$F4P@,:&M!,KW76+6L?=G]UN^
M$14SYE:_Q9]CHV0L66\8<*[_ +4TV9HE5;13A!\;6D&(@18#\2&//EZ/^:7V
M5/RP>>=;-UCC;3*6KJZJ9X\PMH*2<X/+]^WQ9C'"U/7*=NWAUK1?8@_)?I^H
M4.IT^@T[:G3G-?3N.E:> TM^$D^-8GHGL]Y_+?R4X-\C*&GT;@F7)ETE( )3
M9,MDL#=  $&'=B((US)EV//G/JIKI\WXWG>,;P4.'"N)U6D.G5-LAS#)MNW7
MC=-^"2X/.7H[YH?93_+!YXZL.(^-=+I:O4)DPU!<V@HY[FS'F+MXS9C'"U,9
M+VKK&E^P\^2VBK_SE)T&0VH!!#CI6G@1!!%OC66A/5F=J]X?*3R"X'^7#36:
M)Y>R9,FB;*$D,DRI<F#(" (EDMC )G&FOY;KM"9,=.>^8_XIA+G<[K2GW&Q0
MZC4::=RGAN3G 3 ZT;L-TQ&-CDR8E=)>>_R9>1_S-:1/H^/M,H:J954LR0^8
M*2EFO89C2#%LPM<8$IB7]4O:S5X?@3YT?JX?D-JO$,RJX:TZ@=1F=,F-\/3I
M,/?=O0@ K9B:;ZWI9FHORJ_5O_(VAUQDWB#3J$4?B2W/\33I,(![2;^99F<E
M_KQKE^Y/D']GWY#?+'0TGZ#TM'(J**F9):9=+3R2XRVB!;X;BZ\8P6Y)Y<_:
M_P"'L-QAPAI7F7H\[A/B$,=I50SZNX3&AS#+-A]UUD(%9S9KPUCZ/0/7_L6/
MD[XIU:NUW5-$I9U=J3G/J7LTN@>USGVN@XS@3U)>L9O:O'#?V*OR=<(ZA2:I
MI&B4TFKHI[:F0]VET# V:QP<#O-G$BT*^LFZO7OA^@O"?#6G^6^@R.#>'PUN
MDT;!+E"6 Q@:&AH@T67-4_\ 9<^VTNYQ>2XWE08WB+<<(0OO6IR+#IVK.FTY
MT>LER7T4UCI,QTYF^/#?\0+20"+<5K,FTL\^7H_\Q'V8/RS?,=3:I-XGT73_
M ,XZCOS?K+:*BF,\9PC%UN\ 3;BL>LI[WB\/P[\P?U;OR8K^(:NHTO3:(TDQ
M[O#+=.E0W8F%PA<IOA?V.[?(?]77^7/AFNHZ[B73M/ I)[)P#].D1)8X. &\
M "3!7%IF3A^VGE-\D_D+Y*:1^:N%-*TV0SP1)WWTE&QQ&X&? QSC@K))=IV[
M][-.@?-?[)KY6/.CB1_%?%FDT4_49KW/+Y6FT4P$N(<;7S6E6]9>"=[Y==Z/
M]B/\F7#^IC6:#0Z>76M<UX>[2]/8W>:=X>\)T1:L^J>V\O?7RW\K^'/([2F<
M.\&,E,T^7)93M;)8V6/#E[I;8SW8>Z$:O[N5YF54V=25% _\A61\:-WO&)B+
MC<B8CTY\W?LV?EW^8>;-K^/]/I:N?4Q,QOU.EGOB1B)KVICV6]K)AT4/L-/D
MI:ZD<- D1HW-?)_[)T^PM(</W_,)Z,^]P]O_ "E^4CRK^7.3)D>7]/3R)<K=
M+&2I$F2X;EC0?#<0#TIPUFV;=^557-KI@G3X[X ;;D(00:Z @(-B35S:9CI<
MN.Z^PPY9H8= ^<GRD^5?S,T<R@\QJ>GJ)!8919.D29[G,<"TP;-+6GK5FS-D
MT]2)7V'OR72"',T&G!;$@G2=/%YB?W]/5/>ML_8F?)J3'\R4W_UKH/\ WZGK
M5]S_ -$SY-?^Y*;_ .M=!_[]/6GN?^B9\FO_ ')3?_6N@_\ ?IZT]W@_8E_)
MJ6EIT.F@;_\ LN@V_P#+[4]:>[S1?8D_)GINHTFK4VA4[:JAF"=(>[2M/ :]
MKMX$GQB1:EZ93WKWK\O_ "FX7\F-,D</<(LE2Z"DW1);*ELEM E@ #=99<,$
MSC2W?*]5$QU7,\:;'?)CMB!"W-!9M)XAG@MH:EDEU*&B5O36EWN&PAPL#FD'
M%)]V>TQN<O5_SN^0WY>/F!?-J.,]&TZ?/G/=-,V51T4PATP&)+7N:['-,19V
M[1^./GO^KS?+MQ175-9PYIVG[L^:9T&Z=(BW>,8$-!@0K)A9>MFWJY3?JW'E
M0VM#GZ;1^'$Q/YOE<V2J]?3R]V?(C]7Z^6CA&935G$>FT#C3O$S<_-U,7N P
M:';HCSE8G7*=KUG#]6_)SY#_ )=_(J9*G\'Z'IU--D/;-:^;243#O-@00UI)
MO"N(GMVKV9U/6'M8=.I62&T@:&#P988-T" @!8$R8G*KANY[S8[T0>F*LNU6
MVAUPUD@Z77R:<TLR29#WSF%X=+<-V#V$[CA Y)G:8\O4;S=^SP^6GSLF5=1Q
M9H6G3I];,=.F3)5)0/A,<8EVZX@F_,*8ROOW?E-YY_J^/RW<4SJJIX=T[3AX
MT7-:W3J<.:"00"&Q$0K)A>OK=UZ?SOU;KRI-4QS=-H]P$1_[/E=RS,K9\;V<
M\COU>'Y=^':ZGJ^(].T\,D3F3H.TZ02=T@P&]B8+5F6+ZSA^R'D=\A/R[_+U
M-EU7!6C:?3U,HL=XLRCHI9+I<($,87.L(P*28Y2]NUCVBU;B"HF1HY#9;:<C
M<)EM(&Z+ !:8- %F"75Q"3S5>I9[Z&;X\F.^(F_$@M.&14:Y=%><?RG^5WS,
MRIDOS'IZ>>U_Q,G2),YQP@/%+0F,M9]>NGIV[[#3Y*7U<ZN.@2#.J(EY_-.G
MP.\(&'X[:GJY9N7L)Y,?9X^0?RS3V:EY<T--23I4SQ&M;24TB9O1C$>$Y^*O
M#<[9Y>W1K9QD_5C'P^X0ZH!9,3EK2)CJ-_C28[X(-^7W%OKVL2S*Q5HT[C;2
M:KA_B*GI'T-7+\.<)\MLQKP6N;'=F'<#H&_:I<5,673\Z/.;[(CY4/.*EKWZ
MAH5!*U&JF3:@3_J-%,89LP.)B6G> B;[5/6+?DO-?D/YB?JXWDMJ&I5L[2].
MHC*F3WN9NZ?*^'>)$(#)-QN7I9M#\&_JX'D[2ZI23=0TVB$ECHS-[3Y4("^\
M9!:9OKA^K/D;]C!\J/E)(TRL_,^G5&HT#V3V%M!1-:V8TAPWGO<"""V-RQ>N
M\U,_1^H_#^A<.>66@2="X3I:&32R6@-ER94MGPM#6[QDD V!:UAG=[;X1576
M3M1G?6JBR8<!8 !8(#*"C;C)G/II@G2_C%T$%'X_\K.&O.729W#7%K93].JP
MYLT3F->/QC7 Q:^RT%":>AFI?8C?)GK%76U]9H5,^?J,UTZH<W2J!P<]SBXD
M$SA&TIZ1+VM3O!GV-ORB^7FJT6N\/:/34]=ILQL^G>_3:&4&O82X'>9-<X6Y
M*SK)R3OA^@>BT4KA;1J7A?30!IFG,;)IPT -#&0W8 6 6*5;^[?EL;QWMZ-L
M8ID5GC[@'0_.30W<(\7-EOTJ:Q\MS9S6O:6S&M8ZQ]GPA.>3C?EZ :[]B5\F
M?$M8_4=2T.FFU$R<Z>]S=+T]P+WG><=XSHF)*7K+PS>U6'@G['CY2O+;7J?B
MCAO2*6FU.CW729C]-HI5LLAS8.9-<Z,1DK)B+U[5[\Z'02.%-/IM&TP 4E#*
M;320P;K1+8W=$&B& 4RO+:<=YSGGXG&)Z?0@\(" 0#>@SS:F9/I_J;X^% MV
M0<('8F4P]+O-[[,KY<OF'KSK?F#IU+5UDR<ZH/\ ,:6?,#W$DEWC/8;8JXSM
M;VL=+ROL-_DJD5C*]F@2!/E#W7?FG3P!M_+*7JS[7+W0\G/EB\M_EDI&47EQ
M(D2)&XZ6&29,J2X-=O APE%PN.:335_=R[Q.J51;4MMA6AS9UN#VN88]#BF:
M8CU%\V_L]/(7YB)LVM\P**EJIT_>$QII*>=,]Z,;)SF1C%,%[63#UR'V%_R3
MB0*?]'Y'AMF":!^:=/\ B!C_ )9+TS<L^UQA[:>4?R7>3WRXT\N3Y>TU-3L8
M&M8QE/(DO#60A$2G. ZTQA9<Q[&U-9.K&RV3HPDL$MD;?= @-ER+-</'UJ;]
M5F4/[Q.^/+'O0P]2O./[/'R#^9(S:KS#H:6KF3_RC31TT^8/A/[\]F*8M/;#
MUW?]AE\E#WTKSP_(C2.:Z5_V3I]A:01^_;$]&,O;+R=^3+RA^6GPIGEU34U.
M9;FO8V53R9+P60#8^$7 &(S5Q8WGVZXKV,J:R=6S/&G1WX!MN04,8:R @("#
M?T[5*C271IVM>UY(>U\2"+#@0<%#&8W.(M"X<\S-'FZ+Q324$RDFL>PRYTJ7
M-)$QNZX-=.)#00M7%C,O;K<QZ!^9/V2GRF>9C)\S4>'Z%E5-\5PG-H:"8W?F
MVF,""!'G4]?HM[W_ *N'Y<>:_P"KL^0.LUTV?HNG:>9;I[GC<T^1\+C' +6,
M3?*SMU[3[/7B;^K<^59F/(TVD@7&'_9\N[J7.RUN>GU=U>5WZNCY%:5JE'.U
MG3J 26$&9OZ?(A"-MXV+6+6;>L?K!Y4_9(?*9Y3C2ZC2N'Z&97:86S&5!H:&
M6SQ&F,1$ET(\RGK$GR=O#]"M/I](X"T6FT+AFGHI='2R]V7+D2V,#8"%HE'<
M<0 MW'KGRQNW:OU%1,K9QJI_Y5YB86#JYEEMB0$&25-=(FMG2_C88B!R047S
M"\IN%O.K3ZG0^,&2GT=8TRYS9TMLP%KH V/L*'#T4U#[$OY--5U6KUNJT*G?
M6UY+I[QI5 X.+KR'>,"8IZ,^UC'0?8C_ "9Z56TVHTFA4[*BDGMJ)3CI5 T"
M8UP<"2)Q($0KCZK.]R]]/+_ROX;\F=%E<*\(MELTRF:UDL26,8T!@#18RRX)
MG'"V>W*[3ISZA_B3([VU3G9)CAB0$!!XW1O-=;%MH[4%FH>**RG$N0^5+?+$
M&ASPX%HYP1<C-CJ3S9^6+R;\]V&=QQI6FU<V?+>R;"GI"[\8/>!\7WB3FEDO
M*SMVDQ.'YB><_P!A1\J''5#-F:/I-!3U)\1VX_3J2._,B?=,LN!$>9,:T9SS
MR_-37_U;OREG54YU-IM'N&<XMAITKX3&%P6KBQJ>N4IPG^K@>3U-J,J;7:;1
M"4 -Z.GR87B-X6>LUA>WH_3[R4^Q$^4[RVHZ&IK]&T^JKZ9@W0S3Z-H8X1$7
MN>1 ]"UZXCG;^[]O#],_+#R,\L/(Z@;3\$:=IM()+2);6TU,)EL?A=)(+2(I
MUQQ4[]N]FESU/B"JU .I72V2Y!)/N VPL!)<2LWEKK,3/E!-:&B N16U35DZ
MBF>-)COP+;,C>AR]=/.+Y-/*+YEA-?YBTU/4>(YSWMFT\F<\[\0[\LX FW-,
M9,^LQ'JG3?8>?);1S9\Z3H-.U]0]SYA.E:>(EQB;IV:>K,[-S_T3/DU_[DIO
M_K70?^_3UK7N?^B9\FO_ ')3?_6N@_\ ?IZT]WEOV)GR:@@_F.FL_P#O50?^
M_3U2]]+)I?V-_P G6E/:YG#E-,W'-> [3M/9:W/WW*XF.$G?M.'LUY=?)#\O
MOE9.;4<-Z'IM/,9N0+Z:A;#P_ANMO4]8U?D[\/9:HUMFC29-!I=/2FGD,;*E
M"6PL8QC8-&ZQA#8E:N/"29W>54K*N;J$QTV?8YQ+B!8(G(8!2]K23#7440$
M@&]!RK2=4H_S;56TQ:Z7;:(/&Z;#L3))O+TA\T_LK?EC\]M2_/W'&F4E96S)
MQJ26T%)/<)CK3O&:]A!B4]<KV[NK'?8<_)8YSG'0)$7"!_[)T^[^/2=6/:O9
MKR6^1OR6^6!LM_EM24U+N1W62Z613S!&),1)<X 6YJ_QVWFW]'L[,JYLV7X+
MH[@.];=%2VUF=<7+711 02O#_P#KJFY_\4H7A^;/VO'^[EQG_F$[_1W)3IQ7
M\>_YB/[Z/,'^WZO\)5B\O>C[*K5:K3?/GAD4X!$[B33@^-HAXE,+0LW3K\?#
M^L]Y=_+QY<_,)\LG!>A>8>E4E=0U^BL;4 4E.]VZ9+&D.,P$$@*XEC%[6=GY
M&_,+^KQ_+KQ;J[Z[A?3:$4[WS)C6#3I <TO)=!P9$!PV15QB-=>W6\\NBO+S
M]6^\F:'5VS-5TVB%-XK2=_3Y(LWA&\+,EMPO:].LS'[,_+[]DW\KWD!-T[5M
M'T?3IFL4DJ2!.-#1RY;72]UP@]SMXF(R"MZXNV)WMFN'Z)56JLT6CD:3I$NG
M924LIM/*\%@8ULI@#6AH:2T6# +5Q)IF2WE5C[SW33'?F$EW.;3Z5AMXWG,>
MR8R.\TQLV$$16ICR)C5J#1_,;1*OAOBNFHYNGU4ITN8V?*8_Q/$86&'BG<:2
MTG)+A)GKN/R5^93[$7Y5O.FFJ=5I]&H*?6")SQO4%(0]TVV+'L)),=BEB^][
M7;\J9_ZMGY2/KIA&FTGA&H+A_P!G2H;N]G#$*7+4G3_#]$?EI^P:^5WRGG4>
MO:KI>GS-2IFR]Q@TZEW@YH:8DS"V !"W)KAS[62_M?J?4?*5Y+GA0\&2-.TN
M3IKZ<TKF?5:0DRRW<N:8 \Z3"^W;SP])=3^Q+^376=5K]9K-#IGU>I/?,J'-
MTJ@()F$ET"9T3>LWKD]ZN?EO]DE\JWDWJ$K6N$-*I:2LIIPJ)9?I]')/B-=O
M"!ES'.)B$]<'6WA[VZ5(9H&E2^'Z$ 4$EH8P-L; !H$ !"$&!%QO/ERBYEK(
M@QP]B025?IFD<=Z'.X4XFD4TW2YTETI[9\MC]\%A;#\9[H@"K:SBRYC\>/FC
M^PW^6/SK%;J]%I6GRM0K*B9536'3Z4DS9F^XEKF$[S=YVQ)UUF<-3O+<=GY=
M#]6P\J?SW,F?FRD^K.F6?]G2MW=WN9&_V/TM^63["+Y8/*(Z=K6K:503=1T]
MS9DAK=/I0\3&G>!+GEH: <5=.?MBXZOU^X8X-T#RPTC]&.$V,9I;&"2QLH-:
MQK T-A!D6V 0R4N/"[O+UV\WOD0\D/F/$V=YA4E-4NGAS7L=2T\Z80\F-DUS
M08QS4Q[%[63[/6 ?87_).) I_P!'Y&XV8)H'YIT_X@8_Y9/1C+VS\H_DM\G?
MEPIY<GR]I::F8QK6-8RGD2'AK(;N\)3G =:8PW+F/8ZIK)M:R6R='=DL$M@/
MWH$!LN"$UPPTU1-H)[*B1'>ED. -K21&\9+4NL)=\I3B#0^'O-#0JG0.+:.@
MFT4]CY;Y<^4R83O"#H&>XM;$6J7!,]>'YF>>/V-'RH^;\FNKGZ)04^J5$F8-
M\T%$]CR\.N>RT&W))USPM^3-_<_)KC3]7!\FZG573=.TVB,DET-W3Y/WQ(N&
MU3><-?LN_#-P7^KA^3E+7-F5^FT0EB8QWO:?)N!MO"J__=Q^IWD]]BI\I7EG
M1T\V?H5!5:@)<K><W3Z)K&.; VN?:3$0A!6R<.,[W.N'Z5< >5W /DQHTO2^
M"J'3J:3*DMD,9+IZ=KPQH@/>DFRY)C"WMVOZ-VMK)M<]WC0#0Z+0T0$+39"S
M%963#C+JYLJFG4;8^#4M+9F4""+<[T7&7J?YO?9\^0WS&^+4>85%2U;YX<R8
MPTE-/F0=$FR:YD;2F,E[6/7#_P!##Y)_"DR?T?D;DAXF,_[)T_X@8_Y;-/1G
MVKVN\I/DI\G/ER;+=Y>TM-3^'N%C)=/(DO'AW1$IS@+LU<6?HU+;-O9.JK9U
M<6.GBV6W<;&VR_%9'B7639+0QF] '>$,[E<TQEZO^=?R+>2GS0%]1YE4E-5/
M>[><Q]+3SYD;+0)SFY9JXSR>WJ]8#]AC\E#JAE2>'Y'BLA _FG3\/_;;%/5F
M]K;E[1>2?R,>2GRN36ZAY:4E/23FS ]K)=+3R'[P+3&$E[U=3AJ=[=>'L]45
ML^L<9DZ.\0&D'(" ]"AC#%354W3YIJ*>/B&P\Q$$+M">8?DYY>>>G#C]$X\H
M:.LDSVN;-ES9,ATR$QL##Q;R4Y3-ET_";YF?U>_Y;>.]0JM7X5TNAENU"I?4
MS98TZG#V.>YQ(.Y$1B<TJR];R]2N%_U;7RBD:]33*W3:04@>WQ2[3I4-V-MX
MA<IM?V1^RGRW_8^_+!\OE-I=9I>FT(U2@W)PF,HJ26UDQIWK7ES71!V+<F.9
MES]K?XW3]%9#)6B4C.'].@-,IFB7)#;&AK;H "'T0I>=<-<[\L2BB @YR9SZ
M6<VJE1\640YO.U!NZ_P[P]YI:#5:!QA344^CJ91E.ESY,IY<UUA@9MEH5SX9
MWUX?C_\ ,U]AK\KOG"W4=<TS1Z"GU:M8[QFNT^D.^YV\2]CI?Q#J2X]=<M3O
MG7;A^8K_ -6S\I':O)F?FVD\!LT$G\WRH;H=S+.+6\?'R_27Y;_L)_E=\IFR
M-2U'2]/FUDJ9*G!@T^EWB^6(VF86AHB%KU\LV]>M_:_3_6OE)\D];X&=Y=S=
M-TMFBNIS3>&*6C>?#W-R$-X-CNE)(Q[=K7HOJ'V'WR8:M,J)E9H5,]U3-?.?
MNZ50'WGDDWSA]\IZ+>V?U=F>67V4GRO^2FITW$'!FETM+7T&XZ2YU!227180
M0 94QSL$Q@G:\>'O0R=,DT--I+?Z+0RV29.6[*&XV&5B6Y623AKDEKV/;&+#
M$0S!!$59CR-_5]$T3S+T:KX?XPD4D^@J)$R063Y4M^^V8-UULWW;BIRDSUW'
MXV_-1]A=\L7G2ZHUW3]+T^5JLWQ7%ATZEWB^;$Q:6%V\(G8F*OM.U_<_,BE_
M5K_*AM82_3:7PO'WO]72H;N]G!)]ULZ/U-^63[#3Y6_)B72Z[6:50S-;ERI0
M!9I](#+=+W71>]Y:6VC:EDK-L\/U?X>X2T3RUT^1HO"PEMHZ22*66)36L EM
M:UH$&Q%R8DX);>4BX[SG/-[C$HKP@(" @("#G+F.E/;,9\4MP>WG:8A!UQYJ
M>2?!WS":8[0>/9<J90OE&06SY;)H+"#$ 3(-MBK-K/V\/174/L//DMU74?SK
M5:#3OJB2XO&E:>0223>9T3:IZN=N;EW=Y&_9H?+C\LW$1XO\O--HJ;4P]K_Q
MFGTDHN+3$;OA/>;U9UF<M>]LP[Q\\?E*\EOF3TSZMQYIFG5$Q].Z2YS:.E>]
MN\W=M;,<UQ2XJ>W:/P6\^/U=#Y?^(=9J*[AG3J R:FI=/(EZ=(L\0EUNZ(61
M6<6-R];_ "5/RM_5Q?)#3=>I9^M:=0BD:6B87Z?)ANQ:3&(@F[JK?23,?MQY
M ?9J?+1\N4O2I_"6BZ>RNTMK7-J7T5%*:9C;=YH!+R ;L2GK)MB=^W$>YFJ:
MY.=*.ET\J2RDEM;):Z2TM!9*AN ")#6@-%@L6Y@D\JZ&BPX[=MZEJMFDK9^F
MS#44WQDP(-H()MCL4&AYA^5? 7GEPZ[1>.Z&@JY,QCF/9,D2'3(/9NN@9U]Y
M1,WKP_$7YE/L!/ED\PYM3J?#6DT,F;65$RIFRCIU+OMF/.\03+B"V+K#BF/I
MPO7M+_/EZ1</_JV7D\S7/&K--HQ3[]L=/DPAO;0KC-6SX\9?K-\N/V+/RL^1
M\K2]3_-&G3]4H"R;*A04; Q[22"][R""", 4O7'/#-[?_DO>'S9^3?R1\X^%
M*?@[B#3M,.ETTD2);&TE',/AANZ+"YHN357WLY>D53]AK\E==/94U&@T[IK'
M;P+=)T\B.]O8SLU/5+WM=]^3WV;_ ,O/RX:E^D/E[04U'72G-F-A1TTAY<PD
MMAX+WDVA,86=[=/<B;JE5/<Q[X[TIH8V/WH,8P5EVEDJ>I===J$AVF:A(IC3
M3I)D37S6;S72W-W2',<=PP&Q+8F,</3WS<^SF^6?SKF5U1Q5H.GSJBO>9LR;
M*HZ&9![G;Y=NN()MVA3![6?H_*;SP_5[_EQXHGU=1P]IVG[LX18&Z=3@BRP$
M-!$0K996^O;IWYY>H?\ ]C<>5'UMC_S;1[@<(_\ 9\JZ/,IC$^Y^Q[5>1GZO
M'\N?#E=)J^)=-T\RI$UD[==IU.7.W(&#0Z ),,UK&8S;UC]D/(_Y%OE]^7:<
MVNX'T73Z6JE!CFS)M'1L)=*'ND-82Z_))JIV[]KUQ.'LEJ_$%54N\"6QC9(W
MF_BXVC,Q)6K9-1.O7,S>5=#0V,,3$\ZYMLDJ:ZGG-J9?Y24=YMMD6VA,X,K#
M4LTSCG1ZO0^)J>BF4=7+=+F,GRF/#@1 P$WW&DCF1+KA^=?G1]D;\JGG,[4:
M_4M$T^5J5=*F-=-^H44R67/#K2YKMX6G(IZYX/>_]3\B_,;]7'\DJ_5YD[2-
M.H3()?N[NGR80+B1<-JLTO[+M5.&OU;[RAD5;'5>FT88)K28Z?*^$$9C)*3T
MC]-_);[#7Y3?+JBDS]1T6@J:[<EQ#-/HQNN9 G><\B!B-JSC/)>TG#]0O*_R
M*\KO)#2VT?!6FZ92MD4XDR@*:E#X-  'XJUMRO#-MMVLVI:G/U1\)[6ADLD2
M]P;H@# >A,Y63#7DU4VGENDRX[DP0=#+[J<*]=O.7Y-O*3YF:6;3>8U-35,F
M9+,IS)M/)GO+2"#NB<YH-^:O/)[8>I,W[##Y)YPE!_#\@^"[?;_V3I]\=[_+
M9J>K-[VO8OR>^SR\@OEPK&ZSY>45-25<ES'- I*:1,)EQW8>"Y]R8]:U[6S'
MA[?G6ZTS63SO;\MI8T1^BZ],^4Q.'KCYR_)]Y3_,T)C_ #(IJ>H\1Q>YDVGD
MSGDNC&'C%H)5Q+&_;UF'J*/L,_DH^LSZO\P2#.J8F8[\TZ>0=X6P_'J>KEFY
M>R'DM\@7D7\L;F5?EO14U),EO+FM924]/,B2;2)+GYYJ\-^UKVUEZM5RI+J5
MD?">'-=;9![=UWH43$>NGFY\G?E+\Q]',I/,&FIJF4YAEN9,IY,YQ:^(=!LX
MM!ZTQEJ7U_1ZAS?L,/DGG2/ ?P_(+/$,S_5.G_$3&/Y9/1B]K7L%Y2?9T?+_
M /+O4RM3\OZ&EI:F1N^&T4E-(F1ED%L/">^$()BQJ6W3V_G5LZIE29,V.Y3L
M$N7&V+0UK<LF!#&'&553)#=QD81C9LMS3.##UX\Z?DY\I?F@D3)/F32T]2QP
M#7,FT\F>\@" @)KF@W9JZO)GUCU'F_88_)1.G2I[^'Y!F2B"TC2=/O!B/W_-
M3U9O:U[%^3/V>GD)\L]?^??+BAIJ2L8]LQH;24]/,+F0(AX+WW05QAKKWUA[
M<5&H5%8[?G1#@ VTQL!)':IE,1H.8([PCO1!LSBK-5?&%GTS7IQE#3:F5)?3
M.89)=.:708\'>#A$-<#O7&*MLY9Q),O5/SG^SY^6_P ^37SN,-#T^HJ-1!?-
MFRJ.A>0]PCO[KB'7X6*8RM[=K^C\=_/+]7B^7OB.NJZKAW3M/\.<(RPS3Y$0
M+P"&@P(BEZ^LRLO2O6:B_5NO*EM1(,S3:/<;,!=_V?*NC')3>%QTDT]Y_(O]
M7^^63A"9+J^(]+H)@DS&3!+&G4Q>XMW3 !^Z,,UJ36:SW[2:ZOU>\I/DC^7[
MR/GMJ^#=$TVDG2@S=+Z6B!'A_#[K+2;%))E/;MC#V%U;5GO+:>0V2V0QOA#P
MF!HW!8+C8(!.WTBR>5=  B<S$J*\H" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @XN:'0C@8CG03=#Q!
M6::P2I<MDV67"(F ^@M((L5SD]9>4%YA^4WEYYT:8VEXTT_3JH.8Z6YLR1(=
M,W7"!!=.M=8F4S>O#\Z_,[[&'Y1?,.AJ6C0:&FK)SILULQVGT+V%\R)AO,.\
M+39859)4O;MS7Y=^8/ZN5Y)5];4S=,TZA+'SWO9NZ?)^$ET+AD5+KAJ>MY=6
MR_U;KRL\;WM-I-R[_5\KN4F6_P#[N/:/R6_5Y/EYX=K*2IU_3]/#)3@YX?I\
M@DB-L 1 I)GEG]OA^LGE!]FI\L'DE,HJCA?0=/EU5#,9/9-F4=!+C-9 AVZ"
M2($)9Y3W[/="KUG\VTS-(TV33BDD2132W26;@;*#=P!K&G<;8<EJ8B8SNJK:
M]V^^.]&-L5.URLU&61/F4DT5,F/BL@1T061,ZMIVB^8N@57#?%5/1SJ&KEEL
MUD^6QX=%I;9XIW6F!OLN6]>OW8N>O;7#\>_F:^P]^5WSF9J6L4.D4$C4]1>9
MT]IT^D._,=%Q>QTN.\"1L6?6\QKWDUW?E]-_5LO*-^N>*--H_JXF?]WRH;N]
MS9),^6\?')F/T0^6W[!;Y6_*T4>JZWI%!/JZ.>VHDRQI]+O>(PM<"XS(!K06
MWVJWK_PQ>V]/U5U[Y3?)?7N!&>7<W3=+9HDNG^K,EBEHW$2]P, @"T7!3!.U
MFWHQK7V(GR9\0UIK]1T.FF3S,=-BW2J!PB\[QOG!6=?H7OG;L'RX^R;^5OR;
MUN5Q1P?I=+2ZE2EKY;G:?1R3&60YH:Z5,>Z,1DF(L[W&'O;03GZ3(I:2DCX5
M!*;(D"X;DL!K8= 4+,\J_P 7\(Z7YE:95:!Q"UCJ'46N94":T/;NO]UT6NL(
M3G1QP]!.(OL6OD]XMU>MU_5]%I9U?J+G.J)C-+H'M<76GWG303U*^LYB7O>&
M7A#[&'Y/^ ]0I]6T+1J:15TL]M3*>_3:&6!,8X.!WFS21 A3U)WL?H%PQH5%
MP#H4GA'0PT:52,$J4)8#6!K6AM@;9]%,TQO/E,4U7-HIAG2([Y!;9D;T7GET
M#YN?*+Y5_,=*FR_,&GIY[)I<YS9TB3.<2^QT!-+03;FF,T]O68CU!/V&GR4E
MU6[]'Y$:U[GSO^R=/M<]Q<?W[,IZY9]Z[Z\H/LWOEY^729)K?+Z@I:2=3VRV
M_4Z61,) +K!*>\WIC"RW&'N"VIF-I).GC^CTX EY67(N'E]5,?35%$Z/@UDI
MU/.R\-X@8[(%+;=&)R]&/,[[*GY8?.[6YO%'&FF4M7J527O>X4%)/<#,)<[>
M,V8QT8E:\)>UX=6T?V''R5T#_%D:!(:[?;,B=)T\0<TQ'[]FI.OUX2=K'O#Y
M3^0' OR[:4SA_@"5)DT#9390;(E2Y4&- :T%LLEL0!FIC#?M[1VK-GOGPWX^
M[8 ;;D3&&(19,;.;'Q)=K><6BSG06VFU:7K=).TO6)5,ZEJI3I$WQF![72W-
MW3O-<0P]2UUQY8LOAZ->='V8?RP>><^OK^)-#H#75TJ:QTZ714,UN],WC$^\
M#"+EF=9EN_)<8[/QX\W/U<_R&U75YD_0=.H#3N=,+=S3Y,/>). VK7'"STO+
MIW1_U;ORGEU =4:;1AGB,)CI\JX..S)9WG[+CX\8C]$_)#[!GY5^!Z>5/US2
MM/G3VRI;3+;IU*7[S8&W?+0!8EZY8O:>'ZH>4/RK>2WD-32V\$:3IE(ZEDME
MRBZEHP[W -WW9=L3!))"]NU_1VMJNL3]1/U>8V6V3)/XOP@6@X9G 7)23"'
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M$IC*]^_AU<[[#GY*W/+SH$C>(A_JG3[OX]6=<.?M<Y>T7DK\DWDW\KTN5_\
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M@"FII+:9FX(#PV@ 0 LN"9RMW<MHVDN-[C$\Z#P@(.#KV\_K""2\U/[N:_\
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M1C0QNATP:VX?FJ@LP_RZGK5]WG_T3/DU_P"Y*;_ZUT'_ +]/6GN?^B9\FO\
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M5SK">DJNN#G&)<ZW;MBHT\BS,\Z @(" @(" @(" @(" @(" @(" @(" @("
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M8YIB#/F0.?O%*W.$6H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @SR;^D]B!-]8[$2<,"*(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @Y,>Z6X/:8.;:"$%=XDX0T[C^AGZ+K%/+K*:JBU\N< 6D.!%L;+BM6:3.-
MO4[5_LOO(/6JVKU"MX+T2;4UCB^:]\F47%SB28F%MZSA?=-<$_9Q>27E[62]
M4T;A#1Z>IIY@GMF2I4IKFO80018+1!7K);MCOWLFH]L]/IF:)0,T2E:)5+)@
MUDMD UK6"$!#"Q+,<-2YF:R**(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MV/T._P"GLZCWI@]C]#O^GLZCWI@]C]#O^GLZCWI@]C]#O^GLZCWI@]C]#O\
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M]+]*8/8_0X_UZ7Z4P>Q^AQ_KTOTI@]C]#C_7I?I3!['Z''^O2_2F#V/T./\
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MV/T._P"GLZCWI@]C]#O^GLZCWI@]C]#O^GLZCWI@]C]#O^GLZCWI@]C]#O\
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MH]Z8/8_0[_I[.H]Z8/8_0[_ITOTI@]C]#C_7I?I3!['Z''^O2_2F#V/T./\
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M]+]*8/8_0X_UZ7Z4P>Q^AQ_KTOTI@]C]#C_7I?I3!['Z''^O2_2F#V/T./\
M7I?I3!['Z''^O2_2F#V/T./]>E^E,'L?H=_T]GI3%/8_0[_I[/2F*>Q^AQ_K
MTOTI@]C]#C_7I?I3!['Z''^O2_2F#V/T./\ 7I?I3!['Z''^O2_2F#V/T./]
M>E^E,'L?H<?Z]+]*8/8_0X_UZ7Z4P>Q^AQ_KTOTI@]C]#C_7I?I3!['Z''^O
M2_2F#V/T./\ 7I?I3!['Z''^O2_2F#V/T./]>E^E,'L?H<?Z]+]*8/8_0X_U
MZ7Z4P>Q^AQ_KTOTI@]C]#C_7I?I3!['Z''^O2_2F#V/T._Z>STI@]C]#O^GR
M_2F#V/T./]>E^E,'L?H<?Z]+]*8/8_0[_I[/2F#V/T._Z>SJ/>F#V/T._P"G
ML]*8/8_0X_UZ7Z4P>Q^AQ_KTOTI@]C]#C_7I?I3!['Z''^O2_2F#V/T._P"G
MR_2F#V/T._Z>STIBGL?H=_T^7Z4P>Q^AW_3Y?I3!['Z'?]/9U'O3!['Z'?\
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M/(^W+X+-GU^A'_VV.]/ZZO\ W7QL[?MR."X#_M"A_P"N#O6;T[97_N/B>?\
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M"BS\Y4'_ %T?NE/ZK&O^Y^+[,9^WOX%'_P!4M/O_ *X.]6_#<,7\GXOLX_\
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M?NECT[)_W7Q_9K/^WPX'LAJ.GX_\]'J<EZ=EZ_D_%Y8S]O?P3_WC0?\ 7?\
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M_K;>]2_'8W_W7Q^6&;]L_P )-C_/J._^MB[K5GPVP_[KXV#_ -:+A+^OT?\
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M .MC;MV)?BLY<[^5\>7,_;1\(C_GU%_UH*>G_)_W7Q_9A?\ ;3<(BZNHQ_\
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M_+N4L)PR_G"N_P K6?Q[UBR5,UA^O5X('BUEO_+O73KA,U*TE17.$?&K+?\
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M!=4ZA?\ UF9WJ2?5KV_Y:\SS!UAXMJ=0_P"LS._8MR%[7#$..=7(_I.H6_\
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MO\>_O4LPNV!^K5XC"?6W_P"7F;=JU,7E/:QA_/-?_EZW^/?WJV3!FUP=K%=
MGQZVX_\ .'Y?ME#VK#^>:_\ R];_ ![_ -THF:Q3=;KH63ZVXW3W^LE+-+F]
M4:_7=0!_+UW1/?GSE<.TV[=;F,7Y]KS=45W_ %B9WJ735[:<#KU?_6*[_K#^
M]2YO#.?KPUW:_J,2/K%?_P!8?#M5DUMK/EP.O:A_6*[_ *P_O6;-XB6S_+"[
M7]0C_2*Z[^L/6IKGDE<?T@K_ .L5W_6'J=NN5S6(Z[6F^HKMG\XF=Z9^AUM\
MO!URK_K-;_UE_>K=+>U\,1UZM_K%;"/]8F=ZP9S-L+M>K#'^<UO_ %A_>MR9
MF%Q^UB.O5MO\YK;OZQ,_=*<5SW+Y8CK]:/\ G%;_ -8F?NE;USMKVQ]7$Z]6
M_P!8KO\ K$SO4Q(SV[9:DSB&M _I%=;E4/R4]=KUME\M Z_J$3_.*^'^</6I
M)'HWR\?I!J/]8K_^L/6M&7%W$.H0(^L5W_6'QO6?69RLNV \0ZA'^DU__67K
M6L)>7!W$>H#_ )Q7W?UE_>%-5K&LUC_2;4!_SBO_ .LO_=*R2\,[<_TGKOZQ
M7?\ 6'?NE+,,X[//Z25I_?Z_/^D.[TQ,;;EI^D==_EZ__K#N],1<]C](Z[_+
MU_\ UAW>F(9['Z1UW^7K_P#K#N],0SV/TCKO\O7_ /6'=Z8AGL?I'7?Y>O\
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MRT?Y=^1S*N,DMLVK-;K=:-Z$^LM:?W]^-N:U.LG*W[*E6ZU7DN_'5N'[^_\
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$!
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MT[4_19VTST^EL&65QY\U.Q[V+!3:8P#V<ZF-?<MM;,RCERQ]S;W*RWBGMCA
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MMQ='M4E*HVY?1CALVJ8ZQKWN,-V522[(W@' 9K7*>U;;)#00/5L3&SW;39(
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MP/U5EHC\(P6IULC$^;KE9:3RP<\ &E9:8?".6"F*W_?UJ=IO*=SH?S.7_@Y
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M&^?-<++;?0M:NCWPU#)FS2?=-W<$[ZA[--VE3'/!W"1O>M<Y5]YA9].HS)9
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M]JL,[P2RP-OV)J)>UO%0%06-)(ACEFY8LMA_96BR>T.-N>(S5D+\E9#.:X$
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M )DP#^:NM.1YUJX7*ZT?ELYS0/JC[2,#DIE/[)-5.R?*[> C1OZCD$NV??\
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MV>'3XVX9+F"P&_:KEVRU7AXSOY7V)G)U[(V=-<VTQOV9<Q3AJ<M-VIB3>X6
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MDF:X3."9+&G\4ZXGX=B89W.42_A.0UQ!E/S^'/H569^KRSA.02/Q3H6_1_\
MG4S$O;PFJ3@VGA^3=>!\&R&6Q2PRMNG\'4PW299A9>WV*<?JUG$Q%TI.$*.
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MZE+@'66"-O39<G'ZI=7"DU;H/-N.W:I[5K,89$[\8+<1?TJ9M3M<K/+@943
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M'L*);EP;1FX#T%2KUTSOTX[I-ET<.?)"X5BNI($B&!S5FZLF%:J:-UL ,?\
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M5=5IB][C"$8X<ZMC&-JI.I_#Z D;G"-<ZTBSD5.R7G+DQH<1C:LEOT9S3;V
MLV#'K5PGLBZJA)WK!CAS]RMZS#4DYBH:CIKHF ;?M69/JNN/+:T.A+)@B!?W
M<V*Z],-?M\.PS3^X+.5IS6KUS5SF+3H5('$ @79<V6U/61N+?.TYN[\(NQ'-
M!76&IE"SM.8'?"WJ'+!<^UEKMUC#]28 3 >CO2<8;S]4>6-9, @+]F2Y=YMU
MZW+LG@@PK*>'^78/^,$\-29?LM\G@WM7IX_UFFN_;!3;KUDG#["OEI8!P=(-
MO]#D?R?,N7>:=/BF?D=^U7QCF[EX>SZ\X:JRH@(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @(" @(" @("#<T_\
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M"W-K[*5J,QLS> ,;#%7US2[F5+K)+2#S[<N=<ZLU&G(D1?&TP(]:)G*YZ91
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M"<(EH[;XCU+-F=F6&=HK6@NW1B;MO,%,^&+NJ[54_P!7CNCUK6,+B(TU<QL
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MF4XA&RR/9S;%%PBYTIP(A;U[-BK-<0TP @;!D49;DAD81LOPY9HLY;X8-W;
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M" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @("
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M$ROKEOT]46F\=7,IC*Y]>4[+U$!HM'W+/4F%]GB;J0(A$6Q5D\E[:0576QC
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MW)=,69<'X=/J6:Z=7!6W+3D&G8G7EFV,HE7&."M^B6_1R$NW#J4G/V26Y9?
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MS)3R7LTG4[IAC"(V<KU:N,MBGTYSS8TVV==J8)K5;WYJ=]YV*HV&:>6@1:;
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M3AF9\(YEVQGKAS[?R1^J,/U<G83ZURG7%PS;'6%1^4=^V=ZEZ>O#F\* @("
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M1SG6S;*Z<&YV6B,?:K-Q>6!U8YIOPCCW))AN3$#J3@"8FP1Q66<H^IUIS6N
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M]L(B>=Z.T0ZE;QDZ=LJGJKC+$1?#MBDY;Y05)6O#[<QZUKPZS'E>:.N<1".
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M:Z[BQ20' "PW8;%4XNV=\AI%D+0>5ZY=IFO3TX<)5/!XLQ]F>U7#I+A>]&:
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M! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+'I\AH C9$8^T;5N26,3=3K:9C[1Z.0&*S96IA@J:27NG.!Z[$G*=N-*Q5R
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MD_UBF_""Q7?J^L[Y<?\ 9.1_FLG\!9[_ ,77I_)[!3[V\R^;WY?4G#76%$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MAZRI,>5DUE:*>D$P-, (@<]Z9K4N8WQ0YP]"F<,S&=N9H0&Q@,,%G>6I?^'
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M*Y^5QYG",WG;W2M8F&=\MV5-<T1CBL3EK]6_*FEYO-X6[))]UEM2#)>_"R^
M6;43=#IXF0) [+T8EN<+++TQC6W!9N(Z8^K#4T;6--T(>HK4[,7'A4*X;I,+
M+>U+LGW5^9.>UT >76I=-S;DR?-,0";UT9M90Z?M4MRLDK4J&3S:(GKV X)B
M+RKE12S'.C#E"U2S"L EO:0VV_.&Q937,;]-)<XXYXG&W#8M9F,+%AIM/<^'
MNWVW<ZDTFKM,RM*.Z# 89Y#8ME9C0;EP$3FEDJ=99^C"96X6XV@7K&YI-9V[
M"X<I@^$86POYQL5SGDZ\K-6T;&-B(7<H*XEN(WC;0E08+("V'8IB)ISG5$QC
M,2-FU:FI2VJE7U\S>-^/85B3;.:CF5CG.$8V;5IN<)(3@]@!.'+$K7,9[9R@
M=29+W2X7P]7-FN6W.6U6J28X50ML)]$1ZEN1USB8KMG1Y[&M:70M#<L([5.T
MN52M;JTF5)-HL$</N*89LVZPUC6632]K3;&.=L5J96*W(8ZLF 7B-F.:G9+J
MY6_3=&?880$>6"SPSUN]KE(IG4S#A[OJ'K5S:UGZ*AK8=,<3?"SK6IUF$MO"
M(HZ'Q!:,>R./.IJ,VWPDCI0@3# \W8K-QU1TVD$LDPN!AUJ8D2V/-/5>"Z!-
MWM5Y7PL-+JH( B?1MVK-CG4@\MJ03?'IO47K6 T6Z"ZRRWTI-5K2)K9KVL(C
M8(W\RM^JR;RJLR8\S'<^U6UJR58=,.\Y@=RO4N7*WZKM32V.8(C#9L2-S7#C
M4437BSE8 M5<S"-_-3-Z) O$;EF\N><I&5ILH,B +O4,@%?L2(2MEME/(L&W
MI'>GDN&M+E[X-@Z5JXNF?7Z#J:%I'H'<N>2RM;=:TVV=*TD_:D:1XC>,.U,U
MTEMX6$3(RX67$;>U1$;4D@6G$Y*-?=4ZZ;NAUOTB+.:/58JQS=H,32;CV]ZG
MEK$;<MQMMRR6KHDRV=XBV*F$W7GQ]V\[,E8;NG@SG., ;#S\RU+O3763SRV9
M4KQ( C"V.T9)5K9^I #>LLMV6+-<^TSN-?ZXR0YK8PN[5J5F:3U-6M<! QB+
M+MFS8G+49YLP.;$D<B%FS"W"MUMMVWUJYUA,9J$W8NL%L8J3,Y7-C?D2R=WE
MA$X):GM6ZR03#GVIG1>U2M.Y]./=-VU6+MAK]0G[I%MD>TJ6,SM<[5N9J<QI
MM)O-_.LUN3ZI&DU@Q <;8C9CSJS2<;BR2=8:X0)Y6;5K,X68KG-KF/;$G#/.
MSL22)>4!53FN!A#D>?:I<1,=HKT^;",#;$=2F?#4N)OE6M0G32#")$,BF/H3
M=^RFSITSQ'1/H*S<E2&FS'F8+;"1LR"WX,?1V;H['F$8P(&.8*MX3"[LD#<;
M$1L%MGL6%TT*N2PAUF0P[MJNV+<56ZJC:=XB ]X8)A=7:BZO(\..Z+C#+"*O
M'+?72M NV^E/8S>*W)!<"+^G]MM6C.UPT\ES<[NPK&,U.U\+E0RMYH)& Y9J
ML9N<)?ZL",/1W*R1K%\(VHHX@P#;8X;"G;Z&;.44::!((%YR]86<59<MVEDM
M)%F0PYLEJ2+=)T4H+,+CGM6F.=H*OH(@D 6$\O0L68X7%5<T#P\P;]++:FL+
M.$]0R0PC> L@/1S*36F<WA/&?+EM@876+76+)]4#7:@T1 .&:O:S_+<UPJD]
MXJ'Q"QN<"8HJ5VX(9C I;E+C";;2NW+81W<CDC#1G2'"/2,<X9;4^[4N;A@9
M1NF& %\!CTX#-,^3M/,;\O2'D_#82(&'L3.4SESG:),(;!I-O.M=:2MJATXR
M+7 61]$%+NX,VO.H$M8=VZ![%#'U5<SYK7$VF'/RO4PWF2-V1J-2T?2LL[>]
M67&D_P#9K5VHU#V'XO3D.?):RF9.'7.J/G3ICMZ,'$D]$5+3.]-2AH6S)K"1
M:28YYJ8.:[2T72) 8TEK8QV)8EN%V;0LER[(0AEL3!OLA*VF& %^77FKC!F9
M5R;):TF([-F0BF,UN,<MC8W8C/-+&>R:I0VRS+_%4PFXL](UCAA>;H<L$QA.
M4W+E,MLRRV[$&O4R9<+K;.TJY,,=/3L)PZ3')7PJ:EZ?+<+FDG9LVK$SEJR.
M,_2I;F_"V-F&704G7#-^RM5FBL]ZQMYRRYEK$:B*.EL8; (B-WL"E^Z=HW:>
MF:R ,.K(DF,1BC*R4NXP"&4;N93$JYRDQ-BSHRR5QCA9,;1T^6)A-D=N"UX6
M9O*%J:'?C"%L+DD^J6;0<_2[S >G:<EG@U/U1QT\@V@8BU,I=\.3:<LRLRL3
M"_JVF1 ',M3<VUC/Z-.;XGBQ$;\.>*Y]I.'+MG/V=E<-S9K&-M-P-JXZC766
MIK5ZXMIGQP!'H*34>B?=ZK>8&KN!J0";CC_\\GEK4>I'$^IO?-F")M!L5L>C
MI9C;KV5-=,G",?BN//#F4N8[3G+M;A26?$:(8MQVI;<.W63E[):(PLE-+1]
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M+)>J<;X9SMBFL:YNV_U+GVYTU<XPH>MT)>TF C;>(86+<UPG6NE.(M.<'/)
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M>6V*$EME\,D_]U];&K.H'EMW;L6NO+&,H2HH'^\8#D#L*W;K"]>ME: HB#:
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MU"K),'NY8\ZLN%E^O#0ERW%P]G>M7%X,8Y2TFF)A8;!W;=JYV)>TO'#<93.
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M)E'3^M:^)A=&:3$9Q]:SC;6,;==U==OD^]&,=MQ329RB"WQ'[V?+!5<)*1*
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MJ[GS3*XBR?F1S6#W(=>)V\ZK*$K-++;V9J<+UBOS)'AF$.45O-QD[3&XY2Q
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M3;Z>]9D)&:1);O D=8.U:SC14C[K0!8(;5+SEN8PX.K6R[C"/1<M8S&+).'
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M?1KT[P39GZPLLXK<>[>$+MO6$1$5$DDQ&ST1&2N6LN,D[A (Y6HYVY2+7!P
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M_CL_[KK_ )7>1HFGR@(2FB'7RL5SC;/;\KK.$E*E4$LPW&"V^P7#I2SRY?\
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M/RCOVSO4O3UX9>% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M"WF/J7S>W;-?6Z[F6LHH@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MD:>UC!9"S8IC">V8JNJ2"'$-PLPS.U/+6,149M"^8_$Q/:MX\I._AY=H[S:
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MCZ2O1UU!X4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MKPWE][I_!JJ@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(
M" @(" @(" @(" @(" @(" @(" @("#<T_P#IU+_"M[0AX>G?VC']VM:,]/F0
M_P",N_QO+\O\;7PE?-@QWZ0ZF8?O-1VO7MS/5\"__*_&+CJ/YR?^V?\ A-6+
M714*#\J.<]I5\#QJKC$"-D3ZEF##IUXYUBW:K9(^%O[7UK:,Y *+ESB(+68N
M=?=Q)Q*6S#+AXC1CRZ5E</(G"(MQ&7>KM<]FW+G $0.(RQZ4DQLESRF*>?$
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M:3#T[%>MD)=-F2 #TA6I*GJ1P!;:+QV+-S%JS4LT0MACA[=BF(G,99K6S(F
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M\3#NO0O*6+I8,IOPCZ&-D%9-,_V2/8#A7R@8[P3X3(PC;+V;5+_Z-3Y9;A[
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M727ZND8)E%!N'(%8SF)<6HF=27V"_+;S+-FR:1;Z8--H]'>%,:75Y>9<L1
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$!
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M!ACRP*+9*K#J,AV-^6Q:GU:D2M)1@")V&[(;4LPDFW.HA)NV\L5,NL^B*?6
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MA?;ZU<EU,HM[3,@HS[6MVCHR]P$ ;CZ59AK.%\TO1S,<(,%PSS"DY8]LNVM
MX3%0)9\-IBT8<QR6K?"S.7:VE\%L:)49++\AGS+-RZ9CL_1^$Y<OP_Q+(1Q'
ML"O7A+VQ^KL_3M%E2V#\6P= RYADI=73GFWE8I='+9]$9]BURW[89BUK;@!
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MJH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MZI6G_)-YO4%DO+4U3^B/YEOZ)'4M3^4=^V<NT;>%D$! 0$! 0$! 0$! 0$!
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M<S>C \BI+BY;C3^K/=8 3&RY;MSM>$UIU(^6X.+3G=MC>DN\,=K;I<*>:6,
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M1!9IUZ[RB:Z7X;C#-.5O;&FO)DB9#[E\1TK<U#.8EY-(+._F"S*EFDW34;8
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MP++A+)DFX8;.9(M[8=ER^'648$&$0&60*<)U[)NBH6N+1"Z&2F_*VY623I;
MV,!Z%FW-8MK2JZ42XD# ]@6EE5.L<6DC(%(UG6$(Z>0XB,!;?;B<5TN$W_D$
MT$1CVJ7&#-;U)NO> 80)QYX9*=#M<Q:&4L@2]Z+;A=S KKEY;,U"54V7+<X
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MJJ4O-VR[FYTS69<:K2;2EIM!LB+CZBKX^Z,\N7NN%@@.\'U*9VU9,92].]K
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M<L]YY:YVY,:0#S]RSUFTQF#N]=H1'3\>?N6;R1#SS &%EOK"<\I48Z\\Y0>
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MNF9+WS' Q-O=UI+95QF9BUZ=$ 1R5[697K:EY\D3F0.7:G,7SMGTG3FRYH?
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M=7N=+887QAEA[%+%N5%KIKYCS&.=A68F,<MW2VN:X&&7J[E9A+^W]5QE33N
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M?0"<$C.+.47,W1&Z]2:J\ZC$)H:X"-W-SA;\98O6Y;LJ?$BT7GLC@4Y=.L2
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M-S@T6G ^A%:;C&"7'@N/#4(!O0:KV@1@,2B9PQ.B!RR6^LG^6^F[]D5/^/\
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MFHXRW7P*SVOT<[-L#V2C;98-F"2U+U\H^9(8ZP#LQ',KC/+6\(#4J8,!(!A
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M$.^2'.+<X7VY'+%-^6<X2E+I'B 6#D=B6K,IF3HX9>.5F?,GK5QK-34C3]W
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M85N3+/JQ,HC$V8;,PKA;+-IBFH[K#U-_9+%5L5%+!EUL,AWJ]8]GPHWZKL]
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MH;5E<?\ N@A6.$VP_2VH29B2\5SVWX';?=>%6<?5EIHEUL<<%K4X:G"XZ>X
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$!
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M55UKMYWO&\C#FS69G*VYN&O*JGN,-XX<L5MFK!1ATS=O-O/A!.#K;5BIY9;
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MU3FXC%F\.:(*S8Y!N\89I8LF7(T\;AR_P5FQJ3ZN/A;EXOV9= 5DA.UK9IR
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MT?$:'PVQPYU9V;G"08T%HY;?6I=[3VJ/K:1CI;CNQ,-N/-S*SZ59VVZRUJB
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M[_)VZ\)ZG_)-YNY9^K-Y1NLF%.?VI3K,TG+JN>=Z:<(N/I,/4O1-1H600$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@IGG28<
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MPFP0ZDB]OHBG5P!(WNHJQRLQ61E9''#,[$NV;ME-1%L=@-_M4]2=<;K4FU1
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MXC%;]LS#MT[>J&?Q.YSB X8B\7VIC3M_=,8C3GZZ]]D>5BD^Q_;E&S)\RI=
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ME2PXY;KYDN;+= 8<NU7K<,NO];+0\B&> S5[76FNLPI[ #,!@/BC<LI;M?\
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M! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$!
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MAQ>TN; <K"IX%>U64X2CS.[1M2<NLO[76T^R:=A["O5-QD600$! 0$! 0$!
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MOTX:D_AESVN@UV.&VS"*==?J;\*!Q!PE,+7%K7V-.'+!.5_10Y>D3*&8"00
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MJ\YK@^$#>,]BUF5KF)>@I]YP)!MAGLV9ICPQ9A?J+36OW2!=#!2S!+M996E
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M&.K7F4^\(=EOJ5EPSUU=HNHHHQL/*"U.R\H6HH1 V''L*MK4^RHZE2;N>)]
M7D^7G+KTN8IM1)@39CZXKA=[:QBY:8<&N&%T;.6!3&.2Y\)RBJ+K?H[-NU1G
M?%627/BT6CETJ3;774TXS)\!8<</NJRI6FZ=$F)Q/+%%Q,,;YD1"-O-[%4LC
M &Q-WI0F?\)&3+&6-RQZV\K[;;[)=AB.70M8T9D<R"+T,RM*="V.<.Q*QA7Z
MQ@=<+VE9F9^C<FL*U4R(DP'+WADNGLG#793$P&WE@G*6-H4.QRS.%X;'U(#
M\NE2-2-N51@C&X=AVK28MK>;1 X$6<R=4S)PW)-%"%]T?2%>^X3%K>%*"VXW
M9>Q<YU2\M.II(-N./8%I;F_HK[Z7WC9RAS*8J?JCI\@@7'D#L5]JLQ$/.E&T
M05YV9END'4R2<#Z<AL*%RA)].87'D#^Q1<(U\JT@ QLSV)=LL+91\01!OVY<
MRLTQ9;5HH9/N P-@[89K'->KXYB;2(ED7@^E6U<_1G:(&[!97M6P7B%A[5J7
M_A.N@S8-O)(Y\U/.3.;B,1FWF.%R>]SA<5B,_FZCWI;;5NG@$3;/9!6,QX?2
MML) CT=RM,_1IS*9I%POV=RQE9*T'TP,0(7[-NP*LM1]&+8>I:SX)/-8OJA_
M9=04S(W&673$$1C>;[,.9:ETSVYP\U%/^+,/1]Q3GDLDX4ZJH]Z:Z(-^60 4
MN$S8XMHP +[AEZU>LP9K*R0X&[#NR"=IH]J/EP!$#AGL6>%S6C.EG(V\^U3D
MW8BY@/O6&[U*V6++IHS&.]!5Z]IY3%SEK&2YV%W/W*YRU*\?5_V/;W)E,1C?
M)@+L1BG*R3EJ3&0C9R@I?_1S[RYTBI[22ZRY6-]<^47/D MC <B-A6;=X:0D
M^GM) S[#L4Q<I9,-,28'X;]A]86_5>G[JW!+$+DR]?7K9&:7+ M@+0F6_&*S
M;D<!Z%$TXOD[P.%EW(%5G6=-*9)@19AA',[%,+BUKS&[L+(9\NA2Q)MP;,AC
MZ/8IBMS/ED:[$F\+4OCREGT;#'YFR%BI/HS7A1IAF-)B0,.]5C&VC.:=V[E$
M*-9ETB)H(ON@B^-(F>RV(%Y/K5<\8:1.Y?8IWFM.WQ7>8X/FM()&RWD5Q\;>
M[.MM&:X&-HPRV)UUM-8<98#A<#;CS*W%(VI<J N%\>S.U3E?#)N!2Z8RU)@
MA=9&*FZ9M:,R8QIA$7[$Q6L2S;7?-!:1$<NDIGPSZXVC9[KX'E'N*NIPB->
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M<I,>6IU\O$BOW+R.13GA+-MS\X[PA$=9]JSBM9PQ/J6O!%D8X=Z<,9O:HV:
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MV:Y0%6Z,>=WK4O:^&>N9RK%2Z$3E[%.:MN&@RJ<QPM-^>T9\RLAC/*9I:XF
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MFL[X56MEB!@T0B<NE/U/.E2JI8$;++<OO@IF)>=J_.@UT+N05Y,-JET\50B
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MN@36,9+$!\ V*7:87(OWY8NM![!ZUG.UXB"KJ/Q=YT!<<.A;EE3*NS*/<=
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M=$G(K!#VC,IGQ4S*S.K1NGF..Q2XYG)B>4555L6D"-YQZEOB++C44VN+YA=
MF_,XK'-8[69RTI<IUM^%_3L3<X:N^6W+86F-MEHN*N6<Y2,N86F^ AS<KU9+
M>6<Q)2JW=O)NSVK5DC77/*0DU[?=M])6:U:WV5S;,K5,)]_*'U6<'M@W'IO!
M![59K2Y\54&L_&$F-I]8Z5+?'A98L=" "+(6]MJU'.\KK1N@P7<A[4]EDRQU
MI,P.&PBST>A5KAUUJE&7O/.?5T*6X2U'4NGD3;!DIG,/;,PNU)2[LGF LM&&
MVQ2I-<-2=*A,QO.(3<C76SRDJ4[N[ 8CL]J;J7E/2YFX 1RO[T3%9W3X-B88
M<LEG.;]C<_5'U%0T@]&(VK4V;RA)DT&-WI2S'#5D:#A$W*S"3'ELR'F7C *>
M6K)9I,RY\6WY7G8HQQ</)(<;P<;"J9>6M;O"P8]A1+,MZ4UONV#'UJ6?3DC9
M@ /:DM\NDMQI!U[]UIM$.05Y8F57EU.[/A:;<+L$X+=;773:HP;8;]FQ7*32
MWT]2'-&9SV1P%J6-6.51.@PW7'U;5DPJM7.-\<=N2UI;9A 3)KG$B-D=N:R1
MB )N"<KEC?3EPZ^5D%TETS8TOS<]TQI@81R.=F"S5F.%PTJB$M@) C8;K<%-
MLX^B:J'MEL(LNLPN'L5QE9/*E5]7N.)!A;"\!3&$MMU6O1USO%%IP^E[4D)G
M.79.G:C[C8D_#ZDNF\9-1K@Z6ZVT[=JG+&<.O*W43*>7$GFCM5,[1[.(X^[O
M'K.:UJM7MK#C/U8S6WF,#Z8XK.,77!G64#45+WQ$76G'I[DSBY2<?=LZ>]P,
M8F_,Y\ZUG/)*[&TF>0UL3@W/)2WZ+F82]55N\)WQ79C,*,RX4*OJW.G@&-I]
M92-8SM>-$I_&DMCD+]MG1<GE/.F_646[$ #X<CRQ23?V:5*M#I8B(B)A?W<R
MVF,JE7UCV66XX[(+%C-BN&;XS[3?N]INP1%MT32V3WLB![T#=G?V)+CA=UWM
MPMPI*FM!W&=+1ES05[-XRD^*]*;I-+O@-$!&P0PBG5Y_EF'6&F\3,DSPTNN?
M"_HZXA='CMF<NT]-XO8 !O871[DPZ=.UX\-G4-?94RX W[<XY);774[.J]</
MUC>R)/IC>LV5ZNNE$F:4)LV-D21>!G"Q3.-.BSZ5HL=R(%_+!<[G+U_'KKKZ
MNX>#-%#*N08 PG2^T*X\NM[;?L-\H\H2M3IFV?EZ:[]L%FS;OUN>KZU/EP_V
M4I_\TD_R:Q\G\:[_ !?S=_5/Q-_:^M?/[<OK=.&JLM" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M8%^[9&(BLMSKC:7;3 @1:.H9<Z1<_5AG4,MS'>XTV' 8A4MEX4ROTYH?8T
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M=F:A9TZV$1R YDN6^LQ&OO F\1*U+I7D-WB.A+A,>6_)E80-L/7DL3;-N/\
MENLE 6[>6*N"]K>&TR6+8@X9[4RGK:W-UHP[4)IR%ER++7,3=S*SUJ>ODN:&
M>+<^6Q,8A+8TY]19;=#NV)B5;,[0E14@ W7C/9L4]?+6E=JY[?>NQ]>Q7VL9
MLRKTZI&_"(N'*Y:SK+/#5WVG%/NMOL\.:""LWZDMX1TT")$.45N<-7AKB6-\
M>Z?3DLD^BRT+0&CF/+%,8F72:;4Z%D.5Z0MS&@YT!%=.UDA&A-FBWGV]RXXO
M,;YTT9TX .ARLYE,7RU/LCWSA DY<L%OB,WJT7SK3"&'/Z0DW$E\/#*@CT<K
M JOZ,AJSR+EFE:LRH=Z3B5.L-8:KIY/7W[%J<[X)-O F./(=RIG>&Q*)LYSV
M*<IVZSGRWI;B81A>%FZX:ZW_ -FVP;SA?A=SJR^&.UWI+RI;2VT9#T;5<8:E
MR\%K8FS$J6Z7EIS6BVS%9S2ZX1\]K=UUG;DK+M+_ !0\UC;;,<SESKI6)$9,
ME-@3W\V:S;X:QA'3& X8;5F19OEA\(8\NHK:]K(U9TN QO/;#UJ>K,W6C,8"
M#9BLX2WPC*@0C#E85)RW.$/-O<M^N6+RU7-S!N4LWI9<,!E;#UJ\G;M,M:IE
MAK#9@IAT^/5TJLYQ;,,$>V</+9Q %UP'*PIF)<UM2IT878^OF19]&ZQP="['
MT)Y6W'7#,JYM6?+!&-W>BSC[H>;)$8VXJ-3Z-<-AFLY2YK<D@D"PW0NVK5C,
MPWF, @;;NT*.LCF0A9X:<^6-O*"9OA?'W0E4-V/.>Q)FYRS4'/-A.0]91SO*
MNUYBTC9ZDMMTZ_'=_95G@[YL-^6Q<+I[.K9DL+MWERO6=VM6X2LB7"$3AZCM
M6F<Y2+&V7X]RN6LWAR>V YP5KP;\H>L;8XQPAV]RQ;LZ]E:G;V]9F?4M=IF,
MW=VRL^%L<ESFJC@_XCT=@6AX%XYQVH-V5?TH3EN*.C0J&_%S>LK6)C*>OE"S
MQ$PV]Q5$8\0)YUTZ[N'3I,7+6+ 71MO]:Z8P[7M,;QEW?Y9L U"7?<R_]L%R
M^3DZ\/HX^0U@-7I'^;2?P6+EVU'2;?7_ /*:(:/H\/\ (CUKQ_+]'K^*Y?I;
MI7]%:N4Y=JD"N'R?R(+.?"H35OR1YG=H6HWX=7U'Y1W[9WJ7IZ<(\* @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,TC\HU!4O.*'Z"S
MX_Y";_)E7KRQ\DGH^3KYR"!J.J6BRNGX_LWKV]7POFY?A-YN3&FJKXC]]=B<
MSD%VYKE=1ZGU#VBIF>W->C&M/+;AXG50E,L,/NYK-TY][[?\-6GU0EXMQ[]J
MEN'F[<X\+)2UY)!#C9TW05YC4X^ZP2:@S(1A" 6<:^YF1MB#NN"G"<S+B^0T
MD0[/N9I:DGU>?J[-G5[43%KFVF9&W+(*QK<8YTAC01W9(EN4#-DMW^@9]ZOL
MU.'$, %F"LVU*TJCX3S=RGESJ)DASIA@3VXQQ6[C!E9Z26]S3?9L'+!9MQ^C
M7C30U26\C&^%P4MT2PTB0"[WN>[;SI-;=.N*RZS)EAI$!"&S9%+<MR8=6UC
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M"\)!WO1VY=2U;]&N49/H0]Q,(\NM9MRSB6L4N@#7#W1]RW&"F+%],)F7);N
M 7B':M2?4PU7T)>8PASB^/0<DJ5Y92%F%WI[%,ZPO5D>=QO- =BG-7/T1E15
M$"$<"<>Y;LQ&<W*)FU40ZW',\V2SUY:K6$TN,8B_EM6[4SF-IGO")]"S)DD>
M;E;,)*SRII!(LNV;-BYV7EKGEN-FD70NPY%:Z\89;$N;:(PQOZ>9:LD1)2G>
MZ#99U6B/K659G3!X9,1&'K3%7.%5U*<=UXPB>WF6I%O:*@V9&?\ $+]FQ7MC
M#%N5TTUY(9 XG+8L"X4SB ('E:F:U;,?=N3W RS"^[T>Q)UV>WA6ZL@Q'+%7
M"8MB)\,$X\NA,-I&GI8\AMS*J8VE96GM>6V9'#9DI;@J?I=#8]I=NM/.(^I)
M,USWG-<:JG92 BP 0NZ5K#>=13=1U!C=X1,;1LMCD=JSF\F;-JE.F&>3 Q$8
MYY*)G+-2R2T[QCRZ595E66GJO# $;K,>;F2S+3,^?X@A'TYJ:G"=M[5?6J9V
MXYPC:WEBB2*++D3?'@-Z_EL3'U59I%&]S8D<L;E?LS;X>)]& (F.&.48]2B/
M-+*## 1O]NW)"?=>=,^%G,.Q#]$U.EE\LCG[ <TVU)E5)] 7U B+CCT\ZS<E
MT[2X>I6LD,C"X8"%ZUU^ZZ\)JLI);NK #:%;4S?"@:M10!$++;H;>]66-2NJ
M]6E%I=SD=NW8I?HS>578\LF\WL68=N,NQ^&:L;\H&%A[X9)C%,X>R/"6J2Y;
M (8XD9<ZMM:G#'Q_5MK:)[6X2W=FSG5ZN'S?=ZC:B^;153GASFC><;##Z173
M+PXS?LXR>+)DET#->#=><TEKMUGT732N))E7NCQ'D;3S 8VKIB8;D_<M&\9\
ML$XB/J7.UZNF:C)[O!=8+CV6[5+)S7:I&AU42RUN1&617/%Y>KX]1VSP7K(?
M5TXA?/EY&\A)RU>MSE^P7RCS?%U6F=A]8I[>D+-LR]/375]:WRX_[*4_^:2/
MY-<_D_C7?X?YN_JGXF_M?6OG]N7U^G#566A 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&YI_].I?
MX9OX02<GAZ<?:-'_ /5K6?V=-]:[_&\_>XCX4/FO9OZ_J5D?Q,\0Z7A>S'[7
MR.T_^]M^S\4?,C3][4'F ^*9=^V!6)ENW+HF?IL)CHC$]I516=2D&680@+;E
MJ,7E'TKRU_6>:$$I5YTJN+72Q$V>H+-8M=O:#J4&L]['/85(QV=CT$\30#&-
MH%O7ZT\X8O;PME':>D%4FUPI9+2W,PCTW)EBMHR++OPE,2S*7A&SI($8 W8#
M83U+6JQMI>&!?'ET+&,#DR48XW9<RHWY3+1T89Q6ND<>TVFZ=MW/#K7?+SV9
ML2C)0@+#RM2;)US7(TX-L,+[>Y69CK))/NTGRH&R-V2UF,=N7$-@8K%K-F4K
M(;O!O2/0I)FM2^LPGI%T-G82ET3=;88+(1BAQ6=C(@7]2GMLF[GPR>'S]2OL
MWIA<W=Z5)<L,>[M]"LTOLRRQ!W+(I6IVRFI#;+^42KQMG&'.H$!T'M6.SW?!
M_P#:Z[U^9N,<><]O<N7+WYP]4^/JJ)F>\?C=EM5DPQ;EZL\1S Z;,VDXC$+3
MG;CA09K-YQ,<\-JU'+O-MF@DDS6W_%"[(IPDF.KO;@ZDWW2O='Y1E\=BW+EY
M^_7%R]T_+BA+9C3NB]ANV@HQ>'NKP_++:=HA#W&^I=>L<+U\K;*$ !GZEKC;
MGVZY>)SB!'E;]Q67-<\9B*>\N)YRNLFF<8<6-B;\.Y3M7&W.F]+E"R^X>K8K
M*Y]NM<9DN&]?=ZN9:G+.+(B9TN+S"-_<M8R[=+CEO4D@@BPW[<8[-BSG2XS<
MK'3R@ V(R[1ZDZ\-7O\ 1+2V"&.">4^[A,LZ#WHLN&A,QYU%G+6>T$$VX>H(
MVU'R ^['..>Q6?\ HS9K[N'U+8WETJWLDF6-])NP]T6\ZS+DN9PUG-W8;8K4
MN&=^6:2^V$, /1[%KVP1,R3V'M27(S&X\Q5&C,$7'#%8X67#+*>0(0Q[DNW/
MM&2!-R69<V&$%(U(VJ9Y#MEG:M%^JV4,V-ED;,>9$ERGQ\/1V(S=(RKE1$1'
M'LYE)?JLND!-C+-W6(9)>=)ZYKG*JG!U\!$99C:F&IUPGZ2KW-VT_%L]JDOM
MJEDZS.%DI:K>%I-HQAM4O)[3LE&-WC'EE>KUI?HSFE#Q\-XQOS2LSOAP^H0!
ML%Q*DFS^6WAE+N6P'..1S5[3,;G#++?ND"&STA>+Y6.O*4E3@!A@;\PL335U
M$K(J!LN'KVJ^$\-HU AAARO3'E?#5G5+>0Y]JSZ^4SC2"J)T0>=V6-@6L^40
MDR:&DW71OV)VQ>%SB,;*H"-I%UW3SK-T9RSMJQF3T+4_<MDOT>'50 )^[:><
MJ_96A.K1;:1=EES+)<8:AK[[2GKFN>;G#7FU(>T[.;&Q:QC2\U5]0F0WK/2L
MW;=N-*JZ:-\BSKVGO4]LIVX3>FO;O Q%^85SIY>VW8&F.;",1\68V)G#/757
M*F>",,!?L%OH6L:RZRY2$M\",;\5+J+.6<S3&Q9S]%O;%8ILYP$0;O7]Q,UO
MK^Y$SJAY<!$\B0J683&G,,T8J-3=PEOJI!-D;<8HOJSMD- !@ 0+;-F:19SM
MBFSV4[8DW16V\[PH'$'$\N1*=^-A:1U*328N<O6#C;CEC&3Q]8-CB+]I1NQZ
M=\;<?P=4@5#H[.919O;U:XMXQ?5.>/&)BV';F%<1KJZD;4S:N?&),7=I(6L8
MBRY7G1] F5A \+>M;[<E,MR.Z= \OID\-_FS3$"\9D8*7KDSO+NK0O+%P+?Y
MJRX'X1W*2+VFLN[^&_+_ ,%TK^;-$&@6#&[8G9GSI[*\(<&M9]7C3C#;DL^W
MM1[(\,\+LE,EN\%H@0?3W+>1VQ2:=*DRPW= N/H@I[#9FADL6$=?.I-\B.FU
MK9=@<1:1RM6O6)4!5ZE>-[TY&"N,0FE9K=3#=[W[W8D+GG+>=;52KU&)=[V8
M]*U9B)S5?GUEL=^^SJ4MWAO&62FU0RC8\VP[DG7>:\_R]=+-2ZDZ: =XG#KB
MK9MX^LQM,RV>.+<1'TA9J=LVZ5O5],!!-EO-M761O+JW5],!+[!R"EG)N;BL
M2Z42YK=AVYV=BS&IT\NPM!J1(W+8&/:48O+N#3];:Q@&\;.;;SPO0F*WWZT"
M(AYC9EFF=-21K/U<EI]X^A)RN,L;-5OMYO3M6K?HEQ4I(U41'O'D1M7.S+.,
M)-FJBVTX>O:M3Z-7B,KM3(&*EC,[98S5>((QOMMP](5FD[?NF$E131[HYNP;
M5+6NG7UFTX)S0!S#++G6NMP6L\JI:VWERM5[7-9SMD=J$(6D+.<MS?+6?J.[
M;$JWAF3/ZHFHU$F,#RL4$+/K"?I'+#/G6KU.LQ<L4B?OO%L<[O4LWZ+=5.LH
M_$9O$1OA%3VQ^U+O:*JZ&+7'=%D/0(HOLKLZD <?=%D1BEE7G=<Z>G@\68C/
M:HLQ%TTZE:X,$!$D#TJS+/9<I%$UC+0+8=G,M29V9\,IIF 1@%;<4]G-KFL&
M[R[5B]KE+FQ@G5398-L"/6K+E,8B&GZB&Q&\;(B_G[E?.6?9!SM3+G&$8&/:
M5MK#$V>Y^,1"-JY]IFI*VI;'3(69;,5F3%:J4D49= %HN-I6K,M3;5U"F\%I
M,!=AS >M.NKA+%5=-@XM-D# 7+I^B299Y<P@QRY>I8UVTO'"2DS-_=&<!'H4
MG[;A*F*9EUO+WE;V;2;*<NPPC&U:O;1AX?2W@M'.LYS,ELFVN:0 QW086XK/
MKY<KVS=<,C9,1C?W;%K,;ED:L^47#'$>@JRL]NV\(:=2.?'W08QVPM6?*RXC
M69I'B./NY9Y;-H5SB8&^SAYKFP\,'W87'F3[PTB-2X6;N&$IMYNAM.:GZCJC
M6N%(AY\+$]IVJY)RZUK-&^IN<0T-@2>HI9IKL@YE0Z6XB) !*R8RVJ*O.^T1
M-X[/8M>$LQ5_TJ=X@;;&)C;S).W@QK*^4]%XS 81A=TVJ6^4DRXSM+ ))&':
M4+++]FNW31O@V7[%%EUA("0),HD"ZS88?=1J3$: KW2W%I.7;!3AC-2]+7N(
M!CGV<^Q:SIK^2:EUI,3O&[GQYTSK#-FW-U82TC>/HYL>=%G.T;.>7$GIYU,M
M6(Z8-ZS9[59)>2\-3ZL,6CT]JEDSIAO2 9)$!"'JR3.;@Z[3]+,,R .-D<;%
MU\$F4LW3O&!,(Q Y9X+//Z,YN<-6=PV)D3X8-G+)9QMTSI&3N%;_ ,5@.WG6
M9=X9NT-5Z$Z3+)W+8PQ-V<%KA'6VN27R \BR!<.;#J@%J-=9B84B1/?XX!)/
MO?XRDYPGEV?HP;X;"1'E[5;]C-J[TSVMMPZ-NW8L-3Z5LOJPQL8PYN;.)1?L
MBJG5( ^]F.H':IAGBH\ZH77$E7&6;+6=E>87F],86:<QJ);]*_.Q2Z6W+P_6
MMV/O&^& S6O"(^=K),?>-Q&&02-2Y0T[4RZ(B<NT>M7TSM+RT'5SHFTY^O-2
M]O!ZO,O4'M,=XY7CF]:3%:]=)RBU!Y+0789C%6SZ,W6EGIYKG!L<?8LM2>4]
M2#=MOC%7KO3G=W*1J7;TLC85?5J7,PJU53%\3##&/+!/5;C"'?I6\Z( Y6^M
M,?5),M^FTC= L%_:3L6.5QY3M-1-E@$@6""JSMGELE&;?##->&M(S5PD5/4#
M>>=3BMV*;55?A6#:+-D"M8RG$0,[6C+).\8VY"X>Q2S!+FX\-1W$#P"=XW9A
M2+VDSIJ.U][Q#?/6#ZU<,YO^6>FU)TUP$3;CU'F20MRM-!,) -Y/K*U=K8L)
MCN1A>,CDNGQ7>%D:<P$QL/45ZN7.Z[-.8"";#A@M347MPU9EW+8LWL=.4<YF
M^8GE>IVK7:ZQ&)]/"$!VI+;RG;.&'ZI$VB..*UEF.?U%K_=W81Q^Z%);ETO#
MP='C]$<]JUY)OJX_F<#Z(]*EK-Q'-NF!MX"DSEG$SF)&30AF LARLYE?7,RW
M+C27E2FM$$SA;PR/8&B(5B68:[[G<Q[%GLY\U4]5_=+S=N7HZ\.K=8< 7&PV
MNQVA<5=:U[SOOL'Q>LIH>:.UQY^Y8QAK.5IHV'W;S$Y;%6I,Q,,E$VP[5IFZ
MKEX,.12\)O.7";*(82L><M2YTUY8BX;.XK7@MPEY=H'.I.N=L,Y]T9V\NQ7!
MVVC:I]A$,^U),7+77A"371,>6'<M9T6XN'!AM"DY6;2E-+B1?U?M5GOFW$72
M59*/NPC?EM6IIBRV_9NMD$B,#?D>XK-K<DGAD+,HI,WE+IR6F&)[X"[%2NG7
M6_LUWS;#&'7DI.<,WMO31?5%I(#K,K.]:^QCSY1]57;K;S;9V;%)JK.-JM5Z
MG N][Z05]L:2\Y5RJU/>C:;SV>Q2M<3_  A9M?$WF\W?<2,VY<I57O0@XFSM
M6K?"9QI(RYI(%F'=S*68C<L8WQ+B8=W*U:@QBQP.U2L7.4Q3SBUEUHL6IQMU
MD]IMY?/+K[2!9<L7$X^JR(^;-(LV^I9O>UN=45-GNB;<1CLYE?#4D:$V>X1M
MRQ]BIJ5H3)SG$C!:DG*7; 7D9<NE*Q9AEE[SL,L#BHU,89'2W66*69/Y<,3F
M$B$#?D4DQRPP&48GG.!6O5N689&RB +?0I=:+]6S)EF,3&S9S)&;M)ME"%ZS
MQ5RVY+=VW(^U:LRS.6V)P:(6=?M"YYRWAK3)]O2<N]:G;,3KJ[:4VJ B-NQ7
M&5L1L^HWHPZK,CWJ^N]IU[>$:^:3O68*Z6]L5J/FQLARBLXV<QI.;$QV*VX8
MM"-[9#8LRX)F\L,Y@W<>1"LN5Q4/-LCS]MJS>1%5./+-1N(9_P 1Y_6M>V9A
MCM-Y<"V)C%)<#*R7O60C=GBM68F6<,%73D2S!OT3FLY=OBS*I=33.,QW?M3+
MWSKB9:#I;FX8PQ[E,8H\->6D#;#TK3&=I.0Z,-O<$P>V:WP8HEF'%XB(<Z+)
MFY1D]L#TGTQ[E&VEN;5=,^S>DBSH/:ID]6]+;O$=.'.HW;K#-X><>J"J??PC
MJ@0$.7T4+M7JW']L?4B*Q5/@3D1WJRYTS9C:'FM\3T6<T5GM<.GQ7PU#0 F,
M!:N+T^UC-*H]PBP&WEV+.&YVS-I"53_#!N.W.Y5)RD64YA\./[)1NP?3F%UT
M?OE,X+J(>KD AP&6W,[5KEBV]5=G4FZXV \@E[4F]M1TO=CL-T-JGC*XWAK/
M%IZ.P*^,K9AQ%XYQVHRW)1[5)M9RVM_9Z?8KZMN$QME]Y3.4MPAI\J)-]_=W
M)[>$XVCW2[[3U;5UCKURT'-_&$?LO6NLFFK,UW=Y:M_[0E_\#\)BY]X[?%U?
M1M\B A5:3_FTGL8N+MC%?7U\IG^J-'_@.]>7YGH^/A^EVE?T5JX3EUK<<^!(
MA<N??KFL^SF#$+BUE%ZK+!IW.V'TVK?T:E=4U'Y1W[9WJ7IZ<*\* @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,TC\HU!3O.<PX#GG_
M )&9_)N5CE\UQTR^2+YSJT2M1U;WC_3I_P"$]>SX^,U\'Y.W[GX+>;^K#ZU7
M")_*N[>==^MVS;F/5*?J7\Y?;?#M"]$NL1YK&PZ>9[!;DL]KAQ[ZKE34[MX0
MS&.WFVJ3;AY6RCIW #:1Z>A2ZI.5DIVD!L>S8M3>RS/#=W]P<@IV/XM:96AF
M=G+U*2$W6L[5@W$V\LU<?5K&'F7K+28;WI'>IC"=N'F9J&_$Q-W<%KU8F[A%
MS*D%T,K+PIQ3-ZW#++?O"$/3TJW6VY6*?+!%_*Q9SEF\L=)3L,RX):LBV4=,
MP,N%H[E>8UPP:E1LW28"P1]',I(S>N59^L-HG7P]TW?=6G3K,(#4=9$T$;QM
MCEB0LNLVIL^=OO)OB28]/L4:SIMTH]YIY^U$DF,K/(:W<%N Q&U:8W7EX:3?
M='$(6.<I[9=YC#FCCWHDF7*NK)8D.&,"KG37V=<5=8X3X@DV[,(J,_Q3&GZD
M=X1,+NP*-RY7&EU$%H!.78B7.=-J94AXOV6\Q[U;)C1;B*[7N@#=<H3M,[0;
M7$OZ3VI.6NT_;E.4K&N C; @6[4S<X8Z:3C)#"P6"[+VK/;JZSMM6=4I&[T=
MW//N7&S+MG6U8?+$M]F&'0LR8K'E.Z?6B7NB,(-]1"-9MF/"S2:H3FFV),0K
MOEG%8GT/C$F$>U:L:SG34?I0:8D"\<H*29IG"9TN4V5,R]AABML8JWSJV5+D
M0WH1;##UE177FK:NR6'P<;SB,TS%D4:?Q QCG'Q"+;NCFS1+-HX\4AI/XZ&'
M5T)G!=M&KXO :?QYQ[ 5,RM8Q'7^K<3;Y),XV1Y7)F2,V6W,=7ZMKQ?O$3#R
M'.M3%),\NM]2U=[G$A[KR?2LWKAOKJH/\Y3'7O/:IX:O+2FUCW6!T;X\@IC*
M9\-)XF3#&^.:D,X9Y-+,)!AB/6M8:MBQT5"ZSW?I#/F[$NHPL$JC>-VS+ [%
M);6NLG+LWA33GS)K/<C'=SSCD5J;3M9P]B]&T9H9))ECX1@8VA3U<W:FAZ7+
M:6'<:(?=]2F;--3AVIIE++:UHW<>[-:QF1.W&5@$I@$("R"MN)HDRBZR5:8?
M>E3[M3MX5BLEPB8_2."96]<Q"RY'B3MTYC/&*K%_;-KG0\/MG2FNW026QMCL
MR73KMXODN:Y3]%W 0 + <^9=)UQNLYQ52KJ9\G>. *<U+9=JM4/F-,8F /-E
ML666!D]Y<!;;M]BN#&65[7/$8'.[V)E9?7A$5%+,,8<_I!6:W+[,<DNIC$F$
M$2R58:/4BXM!)N ]*K"T4\P3&^CJBDJR_1SG26/:388].'/L3*[NE;J:%I.]
M#;<=NQ,)YPTFT;&ON%^6V/J72:B7M8LU#N,(A 6;MG3MV+%[7_#77C*Y:?4R
MV[L4RLN4^_4:5LL@PC#9S9J2EQ-16*NND/+P#Z1G!/8BN5,YK_AV^G[JN<F)
M4#5-+A9RC%6=6%;GT[XF(Y1)R2S'"XCQ(D$.QY [ LX7QA:Z$!K1T>@A+IB7
M+G4@.Z?7%(K4\$&X1Y=*N6LLK9+1"RV"MMPQ<]KALM&Z!T*6:RZ=9AG$[=;#
M+'9TJSC/EJW+B^K+?I&[E<5G*7&$?,U-P(M/*"U$ZX\LE-6&H,(Q6;HQ&]44
MH$LO.1./.M7C3-F-J)JTT2MX9!W/='UK."7"AU-7O.,#;'O5F8U[6IK1_P ;
M#"$%9SE/6UVYHU%OL:[-L,=B6&,+4)1E,YK.U867*&K*_P $$$D6'K2=;3R@
MW5H>8DD\O8MX6S-;]-6 8D6@]2RPD_SA9")N5Q.6M-&IK8B$3T]"<[)B;5NI
MJ1;#9EF%E;VRB_K#\RK=LY9&USF8\K-JO7Z)G"4I]2+86\K4:ZK70:K$BTX>
MB";=IF7[)\5X/9<I5ZR7=9I=2QQ!N^X4AVF]+!3&4YD3 W7]:921&:F^6&/A
MGLV;;D=,3'W=9:G6-9,=9\)A'E8C-B$FZD +'60/J58EQR@)FH%\R\WV=/L*
M8+NZ3%)/+VAN0MZ4C<ZRQ.2J;Q6@$1!$;>DJN=ZXN64:5&X!33I++RD:?3FL
MM@+/8F4LS4HTMDC9RV[%%DP.U/<C%Q$(^CJ3"^V$)5:QOF&\;]F).U:FG+MV
MS%CT2LWX DPB.7I4LRPN3V-FM&((CUA9%9K])$PD@7D'KYDC/;:"FZ '6[HQ
M-Q5]L3"3K4'6:+X5S;N=6;V<:0@IC*?'*'H'M6L'LFZ2>=V!<<!>,0I9Y)<U
M-2VAS>G!9+RRB6TPOO19QED\%JN:>U8W2Q9?RZ%,Y.R/J&PC#E:589TAYI('
M65LMS46Z<0ZW$C+%1;J++IK0X"(BLV;:Z[F4Q,J6TP&'J L@CI-7*+GZ\)>]
M[UUF&(RC%"U$NU[Q7#WK^;/GR*LF3VUA+4CA40)N/*U1)JY6BGH&;F]#+/;L
M3+4ZY;3I;)8L NAZ"LUN28VI>OU#?"LL,'=ZTQS74\]Y=.(S/:5,KZYK<DR"
MZ OCSJ>6KKJFI&F[Q#H"Z)ZPKAB=L\IB5IEEV'8D;QK+<^HEC8@7 !1+8PS)
M#F@GE='):8O+0.\9F[#&%Q6I-9962BI/$E^\!R"X]K(W.,-2MH]R, +2/5DL
M_P DJOSI)#CSG/,[%BM=;.&Y2.W"-EO7;ZE>4EQ5CD3P&X7>L[4X68Y>)]<&
M-,#AWIDN%/U+77,!(<;]G.B2;:%#J[I[X%Q/==ZU,W/V+IV!I]2T-:=G9TJH
MF_S@ W=CRA!6_P#HUZJ_J-7OYFW8I-)Q4#]9W3&ZV/K5SA,6[\+#I^IAH'O&
M\<L,DO;.FL8B<_.;'-'O&X8B"DTS-;0&HUC7-@,^\YA6W2VYBFNFN,^PV1[^
MQ9>6VS]5TTAQ<UL<(=I52W*U%@W,;AZMBF$5[4I?NF!/5L56S_E5'L.\>C#8
MKBLYK9I9#G&!Y1,,D3.5CD:?&$0,#U@E,M9;W@"3"SJYX\RF3MUF_NSRY@!(
M.4;U4D^B1E36CJ&6W:I=KO+.9S2,.L=Y69-M6:1]0Z,2(9]JUESS<J[627/B
M1MV8<RN=8:56KH7D$0OY>M<[J)9E'TNGN;.#B(0AGFM=<NG6XX7NG.Y):TX6
M6F"U=3+TR9:=1,$3=>,1E[%(7]J)FU $8'$6]$5<L>O:[:AJH1]YV."S;BY=
M9J,3JXB,''J6O;,9MN&K-U YFX]BS.2?NVC)FI.#Q:;QV^U%DB9HJ[Q&VD\W
M0+8="J68NG&L>UQ)C?9EEWHO"O3I;3CB,LD2S/ZM7ZN3$CU]RF5]7$TF]]PI
MRN'ANFM,"<"JSZXN$U1Z>RP' 0[=BG"V>T7;1-/EN<T0%KEJ+TDE7YVD2G20
M"+QWYJ/3%1U#1Y;28 611/.5>^I-EO)VQZX%:N,"1IYC)<(G9U6K,2R\MJ97
M2FM,77V88V9C-"7/*K:GJLH-?[Q]&:EVU,.NM6UZ6T3(3+@<]NQ7B&,Z=1:I
MQ86SR!-Q[]BS=;3&VQ1\8/,L1G'KV?M5N%X8ZSB]YC"<?3ES*7@_Z?NJT_BR
M8YQA.=>;ON*]9K:=;A%U7$U06P\1V&694R694K4-:J)I?[Y,2;\KPA)A'4U7
M4/?$DVGEVI6^JQ2Y<^:T&-AC8K'/O<:2$C39LPVMQ QQZ%;-.<[93=+P_-F$
M#PXV>LKG=1J^5DI.$)CR!X0P/6$E3.LK-2<%.]V,D&()Z^E6TU=K=I_!H&Z#
M(%D?P3WJ69VRN-#P<P0)DB_ECL6NJRX65O"LH,'XEHN]:EC4QS6LWAQ@FP\,
M0C#',+<MD9N%PTW1&,^@.HK&^47"1I[);!!H%@%G7MS0;98Q@L:++>I68SM8
MQ^*,O2M:+V<)E7N F%QY8E9LP23&454:P98-I$3W9\Z2K+O"/^MOJX@$VV=?
MW5TZW'#E\DB/J:5[;<[%UQF/+?L@*@%IN]!V#U+-.NZ4TYK9@CGW+4K7JN]#
M4RRQ@NL Y=2SY3:3J&RWRW0A;]W/8KG'"RYTZPXBH]_?W0+C"]0MSKZ.FYVG
M3&51?#$''G.">26S2]Z.]LH .-P ZK5>3.=.SM%G,+V0-_-WJR:3.'8TNI:V
M6.:."72Y5O5:[=#[2/BYKDMI:JDNK$R9#;##F]2);ZK'1301A:,PLVX.MS7"
MNF@1_:Y\RU+*U;%=FU$(P]$,UG+G9[5J.J#;%UO1WJR9VN,:KB*AYQ6I&IUC
M<E.<[IAM6;%LB4IPZPP/4<BHPE #D>I6+'(DBXJUJZX;]$\EPCE#M"QC>6%F
M8S>9?Z,[?6KI8BZV2?>AB[T6*8,JG6TSCO'GQYAEL2+>%?=1/B<?99@NLX<^
MV8SRJ1[>KEVJ9PWZ^T9G2'AIB,$NUG7PC)DDB9$X'E@L\;8LQV6&AJ&RF6W^
MQ3ET]F>97@P$/0M8\F)RTID\/Z8[+TOU8O9HS!OD_=R[E,Z65I3-/+@2 (^T
M<ZEW<I<\HV;ILPD@#JCW*_\ NW[8Z_=J3-,F@$0RSC>-BLX)PL^@Z:XO!<!9
M#E:IG23LO4S3QX;3 6 >M2);E$S*7==  "$;CM@M2-3$99$LL-JEF\I=I>4-
M[J6+<%X;&XW&)6F6*8T-)AL5SAJ6\/$I[0\-C>1ZT]FO"STM$R<W>@+;>Q<_
M:L,<Z@:V)@+"3V]RZ3MIJW&D!62 "0#"'=[%(S+M5:MNZ3S%:MS#[H-Y,2,T
MQIG#E)!,/VW<LJF9$IQ&/5#$JSZJ\SI9:!'+GOCW*U<8893;3;@%FTY;(,$E
MPMF7-K_>%GIV*6YJ68B0DSA8/19]W!;D27;9=[S<K.S[BE[8TU9E6=2'NN'/
MVI*S9BX5#=+9Q-]L+N9+<IB_X6W3INZ&QA?RQV+.VY,+5(J@!S;,XJLR;VR3
M:X;I&\>0.Q66S9A!U%6"28D^R*LN:UX8Y,\/(-_3SJ]M">IGW6>G:1ZUG(FZ
M6:T. /->,@I<TSM<J*>QLDGNRZ4ZW"=E!XFU42S,#3"#2;(9':MYS5G629=-
MUNL.?-W=XF+KNE8[7&HEOA)T$PS6YG.^^&64%)<LK0R5"7&!$1&,-F-@6H-)
M\US3!::ESRWJ5YF.;$_$1;CB?4L59A,S]/%1+,6@Q SQ.*LGE4+*X?#9I<6"
M'=T6)?MREF4F[3&RV6M A'/G6,UA7M18R6P@0'HOB<\UH0,FH =9>'0]6:&%
MSTB87AO,#Z$L;MQPNLJ7OL$1&SM$/4M3"3,:\^B:WWR!9;V06<%MK+)UAM(!
M+WB('"VW=[PF_#,S$Y)U05#![T8Q'6-BEX67#2U!HF2B81-L.72I+<KG-RZL
MUFE :]VZ+]L+>C:M<I>77U1+W)CMF', ?6M0E\)C2:Q\ES;2+ $N.5QY=J:-
MQ&^0&C?(]-L.M9JRZPN/YQ=JLLM)WH@CT+75Y_FN=.KN*]#W6.>UHC!Q-ARB
MNF/+QYKI"JHY\N81=!^W"*MF'?X^%YX79-!&]; #T$>I2.EU<NZM.I3,D-B/
MH@V\MJY]LRN_3MX1.K4[I>\&C-7K/;=>B?N5IGC2WQM$8P@G?'A[/CCL?@>=
M.-?3BW\O+P.869/+IG-P_;3Y.W$ZA3 XSZ:W_A17.]=NO7C#ZX?EQ_V4I_\
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MBS)>5ZI0-QL<O4K.L63+5K);2TV98#N4OT9NMJG6M#7&&9["M8Q&I<S#4D/
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M4+OVW<M299NJD&&SI4LQ6O:4F$ <X/8KZSF)VND//$"X\_:5,83V]ICZH6>
M3RR"A$;-9\5N.6U+I;<HR<(;W+&'J27++3<Z#KLDQM,;RR2YI!A#$8_<6I,M
M29;['1$89)=:)<5F<=X0N3U;NVG,EF!Y^]2_9SQ>$?.EP!MP*Z]-NO3NAG#\
M9']EZX+K]G>3R[O\M&QU"68X,/\ QF]RY]W;I<;?1K\B#?YWI%O_ #:3A^Q8
MN%U&N_;VN'U\_*=_J;1_X$>M>3Y>:]'Q1^E>E?T5BY3EVK9F?$>6"SV<_+PS
MX@N?;AJ-75/Z*[I6?HW'4U1^4=^V=ZEZNG#3PH" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @S2/RC4%,\Z_]@*C^!F_R16NFKEP^?\
MB^0'YUICAJ>JV_\ /ZC/[^9M7NZ\/A?+,=WX#><$]S:NO_A3GWJQCM]7JXZ8
M^95&&8LB=B]7223;A;RM5,PB6S>L$/5M5KA\F4_2>&"(N%XR[LUB//;>5JI
MRR!%\<,PI:U,8^Z:: &B&7J5ZKAJSYA L'IVA+RS9X0-7.<W>A]]F5!6ZBJF
MMC"-D=N)73PU;?\ "/EUL_Q1:;X79GF7.];$NYCRM-/.>^7&!PC?ELN6\Z8W
MUVQ%SS-@08;VU8N5_EM(RH@ \L5K?+6Y,LDQT!=@<5.4MR\TDT!UME_8-JF/
M/A.O9:*2>T-,7>G.U+]FO9I:I7,:Q\7BQIQV<ZLN;AIU;K6HF!W'7QL$#BE=
M.F569-G3C$Q-OHL%X4=&7PW_ 'I0;+)GAWV<]F?,IA,-^5J&Z(;W5[0K."XU
M&XVK#OI =)1?#4G5VY'WA>=O;SIDO5#S]2=-);O1C$0]*K&<(V933'1F;I.-
MT<RBXSMBE%\IT;1=9;AZ%,YN&>*L5)6&+1O#T;!DC<VL3)KBT;=I[T,SLTJL
M$V\K_8I.6;UTARX-O6B3:1I:H"S>%\;SMVIB8R7G$3,JN88#>%T+\NE<^W;#
MU_%TUFM.MG-?<8WX]*X><NO;IK7"I58@XNV]I)4M9]6C+JBUX$87=HYUKUO*
M>JW:7.<\L!Q('?BK(W)%\IY0,L.(O&0V[%6+UQ6O6!C <+-B2R$ZY5:9JK)#
M[)@%IQ'.KG,RW>F)A&5_$H#8>-=M6<L>KK76N)!!_P"-%YQV\^U9]5]76>H<
M0DN<1.&..<=JUN'IGE6Y_$K@8>,,[\[5?U;GQQ%3^)7O!_&^G.S"">J>GK5;
MK=;=,L\6\$WIA?55:K42XD>)&W9W;$9]<5!S=Z:8BVT[<MN2E<N_;#&*=QN!
MZDPS-L\JC<3\.6 SYDDR9VF*73?$(&Y$VYX0&">JWLLU)H0=#\7&T8;0?6G'
M+,[;6VBX>-D))O&&SF6IN9:O;:QR.''$ >#EAS!2\%[:=H\)\/EDUD9)LW;8
M6*33.<N^J/2_"ERSN'X!GD.M:ESI>%JH&B66[,ML.;-9LVG:KGI]0T0!(L.9
M2VV)VRG6S@ZZWF4Q;RU+K[L$\;P/+ K4^A[80%9*)!)^^/=DKI?;:&DL GQC
M 1&695C/;<_R[0T:?($EK7/;\(O(RVK<N'D[_P#JR5?A/#H$&PY9\RU.V8YY
MRI.JT[2UT+>@9[ 4% KJ;9&W #/F5ZV9,91S) #A=?LSYEK.4L^B4DTS7P&P
M9=P6,82-DZ<T@Q88P.9]:?HTK&J4AE%VZTWY=/.EBYPC:83&S! $6C/;ES*)
M=KA23RUMIS]6U,)UU6X:H0M=Z3CTHW+M&U-6VWWL\]NU;G"7KO*+^M GXA?F
M<^=/;!]KRD*:JM%N.?/M4NV<V5+.KWRF1:2(>WG*SX6W>5=J^)9[7N9O'*_.
M)Y\4ZQ<-!NNS7NM??MZ5KUSR3E*4]?XA]YP-@'9DIPESE)L+'QM$!S;.?-$8
MYU*QX)$/N^A7)N-)M,&F\=0[DRU:WI32!<>HJV,Y<9KMV$1RY!9'%CA&S+UA
M7#6&VQL>J/8K(LF&P))L.?/ES+-MX6L<V4X \VWN6NJ7$B,G,<1]W9L4KG+;
M<(2I8_>= '&T<P4EPK?TD$3&@V6@_@I=BVU9'U>\?">Q:Z_1K_I=5Z];O?\
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M" @(" @(" @(" @("!LQ0<O#GWB2\MSW3"'/!#,<=F.(0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$V#E%8FM&,L\MCAA@,E<7.4QAM.:0%VZ7.GG[S,;U+&RTWC'F77&'*2+!3F
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MYU+I+RCWDNZUBTZXC5+'.<0!;$XI]VK6>7+>-T0MCFF2;B6I6'>MV=JO+/\
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MC77EDJ:9OABRWGYE7HZXL_PJ.H4P@2 <<>?:J;SE4ZB40,++>K>4:^[380"
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M1'#*."N,LM"70RXD@"[FY7I9@9G4KV P:8"VXGTJ")JYKY)(NOCT )E)UO\
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M1@HH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @("
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MVB.WB3:8JDOAO4\G?()R[!SK-,3.:E/J;0V,+8'+&.U9W8QVL\(V?+<V( R
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MLK9,&HL::-Q($=WU+?7C+/7AU/46370^^/:N\;>%D$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*AYRV\!SX_Y&;_ "3E>NJQ
M\G\'R2?.E*EG4=5NC]?GY7ES\SM7NZ73\_\ /USWR_!7S=II'UNNB1^6.6:W
MUY8MG^7K$YDMM0[=A8;/1WKTQY>\YPXU[?$E0OBV'H3M8X]\H&GH83(D8QNY
M]BYSZN-LOZI8 RH0L%AY1YDMK<QA(2*US1E  *QCM.$U(K'.:+<87G;DKC+$
MS+]FK65;P+,\SS^M5US$2VKF%X$;(Y\LE+V6S-6C3F.> 3;<8J;2W"SL:6L
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MRD/TT;_E9?\ A'O27(RR^+@^^:R[[Z/K5/7#9E\2M>?C9U^U9[:_4DC>E<1
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MPT)NI!P.\8QLO66<VJ_5S&S(FPWA+O1+CE2M68S<)@/3D2DN*N=Y49M09<Z
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MM!LX[T"XV1O5N,'$2L@@BTCK&U289DMK0U&3++2;/AC#F4MVUVCJS6&L:XD
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M]/HSV?$+C][M3#IG$RL5+I<>DCZ*F%MF/\)V3I -X&/T=BLE<,U*4^AL+HP
MNPZU<.N8M-!I#6;EUE]F7W%%RMU/*;3M$("  PZ?0K-URS'F;7F5S <UW-%3
M:]9'BDU1Q?#UYDJ7EGMJVI*?4^(TQ(N]7/FKPY2W"&F$;QY<K%<Y_59<39+G
MB61;CRQ4GW+W^B4E5YW86?=)2EQRU:N9XP(OC&(Y6KK,6;Y)9A5=1H1,:Z%A
MASW=6*YSG9VL5/\ ,_XV,,<MG.MVS":QKE>M-IFRY0:< !V*3ZPS;S]4J0P#
M"P*+;)&K4>'N$^[<?4KF<,^RKUH8XNNOV+#4[2Q"B2PF[LSYE->4MW]E@TR7
M+#FW7[.Y;F.%U([,TF:UC<+^R&T9I<5FZY;>H3VN:19\. ]IS5Z1K,]5<<6Q
M-UYPV\RZ,X_X1594-:("Z!PV<\$G&S?A3M3J@"[GYO1%=)=,[M5:=4^\8''#
M+K6&LUC\1SACGRO4RWZZRU9C9YC"-IY89K<L9T@M3IZ@RW$AUU_+8IB4N.(Z
M^?23C4".]?LV[5K$\)(NFG44V CO$$#FO6>U7MPG?J[FB)CTGV*R^%EMTYRY
MGAN$;(&/8,TK<BTZ56P(B1"/8F<.?9?*.L9,L)&'8=N:Q=I.4H]LM[<+>;(\
MZLBQ1M3BR82WG]/L6L.?:8J2T6:^-^ ]6U+ATZ\+]33"98WB,+_:5G*2X:=8
MUK@ZZXW0S4RU,JI4TC7NNOVY1YE6;R4U"RRPWC YE$DVL5/3[N%G3LV++=NL
M5+RF& @%J2^226)VA&Z1'(\O0K;*62196%NZV,+LO8I(SGZ(NO<W=,-N&T[%
M%F?"KSJC<=?R/2%N68*V:>O@,#R.:S]_"];8UJ[4"00(#W3;'NYE<?\ !V=9
MZO61<?>NMO\ :KK*2([3:@?66F.66?/%:N,96.^^&=2;*D,!(L;G#%<\;2WQ
M$WJ6JLF27B(,1&\'$IM-7#IK60R;/>1"T]O7@K+?+4FD53TC06N(V]NQ6?8R
ML-/*8;,([-F,$I>$BRB9,L@,-N*DQG-27,6S2J5E,0;!8,(;0IVL3%DRW-4<
M)DN$1:(=O>LSSA?&'7.HT+7F82#;;&^Q)"80+:3<?[H-A[+HPBK,K;IO,F/8
M( W=MQ588YT^<1?9]W:B[5NNDSIN=]_2KFF^$/*TJ>^9O>]"(O!R*S>OU,WJ
M[ T6B+!+!!C >OI19FKW1R-V!.8-L<N;:M::3/@L+0#"X8IC274RB:JEE'!M
MQ-XSCDIG#,SY0,V0&$Y#[F2S9G<:MGAK/]VZRR/:M3[L7;4?/<TVGE9M5N,:
M;ZWPV)!9.,'0Y6'-8F?*3'^4Y3:?(<!"$39UPVA=(TWG:1*<VP#_  5FY9W$
M9.T9K3]&^-VS:5&6211&5<(VBX60$.>U6K$S*FS&-A&'W%.6LR-.MJIP:0"<
M,/:IJS+,EY\*5J+I\T/%I.'7$I-<-XBL2:"I,[><'7Y7VV+I.TC/:6KC2R?#
ME@.VBVRV(66<N%<9/APLCN^I63>VI+=Q0ZX GW+XX7JUFS'/+3I_&;,B(PL3
M6"2XRME&]S0PN)  $><*3:S">E5$B WB(PB<[U.WW:MPD)4Z0XV$1LY7J=HS
MB_X2LJ<S=@,A@-N:1>T1-;/:#9][ELV%5.4.V>'/OA:?6.?%#"<DEQ8($GKR
M"<G#5J'O )M,(8;%9,-S[(YE7-:Z%M_-B.Y6SRE^JR44^9/ #LX0CLZ(+#.?
M%^C:JJ6+"0#&T^C:+%O.EQ^Y6*EKF& OMYB8^I9MO/AIN:<^8' <P](]29RQ
M>78VDASBW>$1[O+T)Z^3:T3)+/!B1:+#V'#8K,K.URZ^U\ME,FD0LMOVQ4N/
M\K^CI'5]4F2I^Z";R+"49SG]4[I&JS#+:;;\]HP@F%GW6=FM/:;ST',]"8TL
MQRQU&MN+81-V>8/<KUU^J6SE3=1U$S08DVYG[EJ69,V\*LZ6V;,.TQZ,<U$M
MRM6C44D/EDY6Q Y\D,X=V<.R*>6QL0V_9@.99ES5W4MKU1+ER'>' >[A]W8N
MO6//\TTZ3U2LG/F0MZXXGFS71X)_+_+>TCQ70)C';T*?=WZVVXBU;\Q@B<!E
M&Y6R9R[;GZO#-7,@P)M%E]F>*Q8]'Q?^B3E<2'<(WHX7[$LQP[7=0]3JS9TR
M\1)SY%8NWL^+A>.#)DM]73Y^.R'^$#ZTPWFYP_8GY1H?G2FA=X]/^$%CR]/3
MB/K/^7+_ &5D_P":2/P I\G#U?#_ ">Q$_Z/,5\SY/Y/K=?XM9900$! 0$!
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MLSU2,MX,8D>A:MRSUK'-:"#9&WG6[-8:MSRAJNE#@20! &_V<ZQGPQA5JJF
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MS'-L@CE]U9PF;64-=ERZ5FM28>=UV2N,KEDE4KICN>V[GZ%>V9-+$K3T!!$
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MTZ&Z(9A<=Y6?^JRM< !$]N:N+RTP5#P!8<._UI-,W+0^L 8W<ZMVS[3+A,K
M(7]:S/NO:9:#ZZT"WK*MDJ8KE*FB86@9>KO2&$]22@0(#++EBK,>3%6.52-W
M?H]6P+6O"R[VQ5%,Q@%@C:+ ,HV]:3C9=]E9JQ .(O\ NCU+E;<_9K$Y04R8
M_>(CL%_>M>"XK))9,>;8P^XDPS9]$FVF($;(V8=ZET=LX9/#A9"ZQ-L;<2 T
M$FR]/)F^6J]S=XV]N2UEK%8'O;&_#;M4:EQ&%SXPW3SJLYRQ.+C"TX[,D68\
MO+6OC:#=B5/8N/ ]T&D$X&'0(+=DO"2X5JNF@0,1CZ(+#?C_ .OHJ534 DMC
MB=N&5JK$F:UY;P3:;O:?4D7M,<+#0@'=)P"A(ME&0-W"U(O;"<ES]P0%O-M6
MJF<.,ZI+ANB.5\8W9+M\<G*^-M1N^YV-IVYKU?\ 2YVWPW&2B8"!Z8+,M:S?
M7#%/I8X#JYDWESWE#5-,&QL%YN&PJ65N6R1"SI0&%WM[E<:=)VTUM_=-G-BL
MXK-]JS2Z@ @1PA>K,M>N8V_%&[&RT;<EJ?\ JSZXK$'@FR_V+36L82,B!(CR
MM5\,8TDGL86V 989%8L8ZVR[5^OI@X.,!TCGR2W'#KF6:4:MHXN="'5RQ5WY
M<[;+]D ZD>#9V%8L=.MF-L\JD-[H=7,%P^7.&^O;>(AM39N>FWT>M>;KGAZ+
MC&?+KS4IWO.$?I'';E!;QAQSO*'8Z+ANFVSJBBW:V::YWNVG!9ZS<1V-IA.X
M+3>,]BZX;6N7$M Y7K%8SO[-ELH.$(6K'MO[-^LK"_3@X_""+[MJUDX1%1I6
M]&#0+(W<W<DVSV:C-&-M@PP.U7&5G:QNR-')-PPPV%,23229VWAI4!#=C=AD
ML696Y:-1I>['W;""<.968_R37*!J=.=[T&V<PVI3S]D<[3W"-GH&2SGMG[&L
MO#*%XC9RZ(+5M+IE^J.%I Z02J2Y8)K-UI@+1$\L%G&]\9)C* J7EI=$V6Y;
M(=BZ9DBV95:KJ#$VFYPOR6<L_9 3YQ<2 3?#',I-\F+&2C89CX$&_'FVJX+:
ML<JC!8# 9W%2Q9/-;#:*^P88)CZEWPS"FW;@#'8GK4O60\". "OKA>NJQ.IR
M"87;%F\-9C2G2W1-G9F59F1FS&YRTWL=EA&\*;MRG6[S6L^7C;=L6IFO3.V8
MC9S"+@;(K/;,TN48\/%T<5>K.;'AA?O"_'/(K6$]DA+WC &-V6Q3$C<WEM-:
M2!9GVE:Q;&;R\F2YW9R@L7KBDMPYRZ4^G(I+X3FLAI#R!]2MVU9ZM:93NAC?
MM[E.LLW6<Y:3I!:3'-7/MPN-,3I$03"%WJ3BIBL?@PPCTK28H)4"+#>,5+PL
MN-,A:T V"XWG9M6+*3:/F!N\;!CEF59<-R8C:DV 1N]BUJL[SAN%]F"F,+C$
MRUIKA[UHN]2=N#.LH.J,3_PBIX67*OU!(CRQ"=9]6;EI+69&61C"8V&R'K35
M67 ^79:#?M6>RRYNT?-E;"+=J=-)Y>&R@ +.S-6YRN+X;<LP "++<[9VW=*L
M3MR\P;L[4LSRF:U*AK0UT0!?VK.N)PZ=;G"LSYCM\B/(*8>Z8D:$XB!M$;>N
M"TQ>4'4RP8V&PCUJ5TZU6*NG))YS?;EL4;\HE\B!NZK$S7+M/+@);FW ]85S
M64A)>X&$>5B-;QM+26[PBX*I;<L4\AI($!83U*-S/*#J:HMC?G8;,42S*!GU
M1<2(FPG',[%69CEH$DQOML]"S<Y,^627(WLL+[8JXPO/+>92BV,.I,3P36FR
M:<,%@ZNCI4[.GQ9RP;IR*Y>N7MR\%IO@5FZN"S67 B^(M3/_  SGPP/:,L"L
M]OLMN.&A-81"P\HJ2YJRY:3P;+#CAS+;+"Z,+,U8F?HTW"TQS6M4Q7 P-A[4
MQHVQ. !LN@L#7FAL(V1MQYD:ZH]QB4J68NFJXG#;=:KB++F;8#Z8I8EQX:TU
MH=&SE!7IVN<>'3I,HI[83# 8KO*W>F+EW3Y:M/YPEV&Z7^$U8^23F/3\>]/H
MS^1 0JM)_P VD]C%QY=+/5]?GRE?ZGT?^ ]17D^=ZOA_B_26B_HS.<]KEYVO
M+87.\JXS0\,) P*18KVHS'^$0<SG< D_D[2:^RB3#&:8YCM7IG\6+JN2R@@(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,TC\HU!2_.R/
M_P S^HA_D9O\D5KIRY?+,]=\/CR^=YDPZGJT(_ZPG_A3,N9>SII\3YL>V/N_
M SS6E3#75UY_&.SS.:]/3AY^TS705/3N,^W,"XYP76YDTY7*U-DELIN-G*]9
MDSRY=LXVY,],%F\_9Y^W.$?63' D1[?5SK5FF)QM79LYP<3'MS.U9GT=.6S3
M5+X7F'/S[%J33-^C/,J"86G'-,+AL4D^$QMN+>5RQY8\NQM.G1DM,1\,;CFJ
M-#4:MP! )A;BKFKGPH555O\ %-KOB&/.LYVUC66U0SW%X))ATYJRI+X7>14M
MW!'(8A;61&:C47PLMLM4,H.3.<Z:($P!VYJ=?J8E=H<,NL&_=O"\<RO;[+$I
MK[Y8DN@1T<RCIT4JGF-WK\?6,DPU;8VI[QNBW-#,QM3M2J0W>&1.0[;4))5/
MGS ]YNOL0FM5R%PY@HU^C2JJ@2QS1-AA<,4%9_.KFS8%Q^+,X[,49]<U.2Z]
MIE1C@<=B)YQ&H^KBXP)MVIEJ=<LDJ<XNO-G/M0ED6&C>;(G =JCIJ+')>-T1
M(M]B28<NT\O,VJEM; PN./,0M)^[F*_4US ;"+B;\K%&I_ZH:?JS68GKAGGS
MKGVQ)GR[=;9,*=JVM-W7 $_2^D,5GK;>5O:NJ=9UC>#P";SCM6;4EWEUI6ZD
M2]UIA'O5F&[;X:(U*%Q]*N(GMV;#M3]T^]AF?6I<T]E4U34208$Q@86[$EQ&
MIO:I,GN?-B";]N:=CV\)!S9CVF&]Z4F^3[MBAHYCI@)BEA>]LR[#TW2WO:R
MOAALCVJ;FJQ[5:96AS26>[88#X>62UF8^^4S5RT;A]SBT%HM<,,X*:;MR[=T
M?A3Q&#W6QL^CWJ6WCPD[8JP2^##XL?#'^"-FQ272VNX.&=!%-*:'-;\(%PP@
MK+IY>_;:]2Z*5+(@&V"%RFZY^VT[)\"4T'W;(1ZE8WFWEXJ=0DRV.#2VX>M7
M&2WZJAJ6I2WQ@1<1TQ*UUQ$SYO"I.GN?-L-Y]?5BG:>69VE2]%+F.>("V O'
M6D[3#IM-5#72Y?O66'OYUF3.V+;*IM?4"#[N4=NQ6Z3E59TX!Y@1:3RO4AFU
M+:?5-!'/F%G:S*Z4<]A AL'3!:YA<U+$-+2<>E+/^%GT8NQ3$_R;S]G$O LC
M@EEG!;>$=/\ >!A;:%UZ6WESM1;I1?>.S%==&,C-+\5UPMC"P0MO4N&<?1,4
MW#^^8@1YNF"EF4QA*#AN !W1<KUG_"8O+'-T L$8=8BG:^&NO_JAZC32R,&P
MALYEGAJH"ITQTXFP6;([5N,?^S6EZ2^68[OH@EN(NHD9=,X"'J*QE9UUFL_Y
MJ,Z!@(\UY/W%6;'C\P.-L-N"&'@Z3X0M C; PQ ATHC6F4)-EEV0Q16,4&X8
M@!$X91O,LNZ+\,D'$N!MB%=G#R:B6UL#> ,>91,[^S@[4)0:1$6"'J3CDOV1
M%3J =%H,1%+&NLMY5NK<7AVZ28\ZK?%BMU%-.?-B(PZ<^A0N.?*P:4)DD-#H
MQ%\8YI>R3-61DV) )OY\DMT2[3])NG(VM]22$ME3[)[9;;+X'8MX/.6E55Q:
M,1RBLY9[72I5=:Y[C NM.9P*N9A.LMK0-2\V[Q]/<IV[;;]+4_IDUSW-!.(Z
M@8*.>,5<C*_% [M\,=O6K*W+]5<KF&!$#"!3C:6[THNJ27N!#0;G*6KS,NO:
MZ3,:XQC\3CZ3L4QEG.L()^^TGXO3D$MLX7^+9IYTP1]XV<^$%<EVG**IF;[+
M3>,_V*<P]L.S-+G.,IMMXS.U0SEL3YCR;S?M_9;5TG"$ETPD1C",1?@1F5F\
MB49,<&BWMYL]B@P5,U^X;<-O>I6^O*M3WOWB1&\Y]ZO*XQ,L3*A[8VGH]JC&
M[65\V9,$ 3S*<.O7LR4]-,<Z,<1?'G5F7:XLWRME!2$&T#Z,+,HCUK4PYV?1
M;J>3NM'N]F7M3*XTXU4 W 7=I[DRBDZD\AQMS]:ERZ2=44TVB.:S*SE.4;VP
M;;VXD!;9O*RRRWPQ=\.6WFVHLJ)KI@;&W&'+K4:RK%35. @";R%+;PS))<HH
MU+CB3U]R3KG;IVNVQ)>]V9Z.;O23"7$FDO(DF9NQ&,#'FM5DPYI=E+[L !8!
MAB2%16M5>:<&V$#S<KU+<,]D1(K#,=")OSYE,UG,62FM@=D>L%6,VI!I Q%\
M;58Y]N6RV=9 '%7#I)IS>YQ @8VY;#L66415ES03S]@5L.N<[4[49DP P.&W
M+G4E:Q<JM]:F"9:77YG):RMOT6K3:HD@DG#'D%B]LZ)]%RI)N^&\P/K"Z8DY
M8[1O3BX-B-N&PK%9ZQ7JFJ=+,(G.PD7HU(QT]>XNO-I'TN?,HMEG*W41;.#2
M[9E')7VL)RE QK3 0S]29SR[=;*M6E!D 70NQV1[UG[>&K%D,R6V79"SHN5S
M(SY5/4ZHCQ-TD'GVHZRV*1653RXVN@<R>[:DTEF4!43-^,3]]RBG:YX8DJK:
MA\)ADDX-Q4YF]O$Q/7[5'2V)*BFS!"TWC/F6HQVO_"ST\^9NMB<L\S'L4N%Z
M]K.'.?,+FV&-Z+N\H68S>,2,3#H^ZB7/AGII0!NLLA=FB^,7E8J=HNY8)C_W
M+)A(ME,@##TK6?#G&M4206F P/J7G[2Y=)CE6*L%CS#-9QGE+N:8Z>< \1S&
MSM5]<+USC:[Z94R0&FRX8HS?LFYE7*W#WC(K5QC[K.=J7K.HLEL)!NC<<KEC
MG2W#I[5]=#'&TBTXY13[)XRI4_B?<<8N../,JO,:;^+ (>^X61,'(SBM.;Q<
M2T@/=C]+9S[%)%SCA6J_B=S]Z#W?X4;U2S"I5>OO-SG8_2/1BE7K$!,UJ:XD
M;SLK^?G5U@N&-NIS7?2=",#:IG!C+9;5.(!B4F:OK&K,FS3:";CFFUFM>'&7
M/G!UYL&W,*ZPWA(-K)K1 EWI[ES]<W*7%9&ZE-9])T ,UN,SK.&0:[.;8'NL
M.9S6L2.MDLQ6PSB"=9[SK_OMO.GARLQ<1N,X@G0^)]^9V;5@<9FK3IT/>=;M
M/,I8U)B-!]94BXN]/<JF+EX;75((,7>G+F0Q4G+KJDBPO].?,EA.LSMS=6U.
MZ;7]9YLEGAJ3K$=/JJEP/QV';C9LS59_1J";4'[[T]ZJ8ENV[*=4&SWKQZ4Q
MMO&FS,E3W,QB1'&U5Q[90L^FJG.@"[TY!6\+-.,O1JN:X?$>@\V2SF\%2DGA
MJK,"6GI!V>M:^QG#:_,D^3>#=;9#9DLYPN)7CZM-;S#8KRS=<-F1)>\[NWNR
M@HU;$Y2<.SJF!#8Q(^C;:(WJL)V5PA. M8;("X[>Y!(R^$IH ]SZ.+>9%N,?
M=S_1:8#<(C]CTX(B0I.&7QM NR.92\"]Z3PP3X=C;A]$Y*3[K.=.T]'X2:X2
M]YC(D#Z.SJ5PLOU62NX-8ZG,);([OWHV;%;-LV;=:ZAP6X37%K!T-VP2S1+C
M34IN%WRW@%H@#][D;/0I)]5M7[1M 8(;S6X7M]B7[,U<AHM.&CW9<0,A?#G5
ME66H#4-&E8-;=D,!L*7=7FH>5H!>\0:##(;0LY+KA;=/X9WY9):!SM.PX!6:
M+<M>JT$RG0W0+<0I4>9&F[D 0+Q@KUL2I*73,:0"!T;5+;RSBI*1+EB'NCIY
MCWIEO/U2\K=$(0OY=JLW&=LLYXW;#GAL.Q2:NTF/*M5\U]L"?AV[%;?HU?LT
M*6H>R9$DX)UW=N?R6X6:75;[86Y7Y@=ZMDE<?;_@<XD$[/4H9S^C2FS"#?\
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M.R-'U)S);02?A[5>RX^J6G:GO-/O80LZ5EGSI7)LTS9A,2?3EBKV;F)&RP$
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M&$"T%6^O@EOE"5'#NJ4S'37M8YC;26/#H#FP6:UF(4D-.Z;XP11 0$! 0$!
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M35F\1$QN]/6E3V]D[(+7PVVW\_-DK*<1O/E,+;AZ,CS);DZ];;I5=6D2]UP
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M3Z4N$ .5FTJ5CMF7*'G4+_O;P1VI>N-G7M;I%S*&8#=?$V';M2S3IF3E)T-
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M\()W[72SXYC/E\J7F[^M2>:FN:]2Z?IU3K#=-^N-EU,R5,(ERJ<S0'..ZZ
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M0S=W^:M,=TX1RN,%GRF;+A[9\%>5@C))HV_DVVV;-JWG!;A[5\*^739#9/\
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M8$>H$^M9KK,7=52=7/;,(B;\_5%),1B\I6@G>) DQLZHK-SEJS.UEII@9"[
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M<BK$H@ ]/MZ4LPSQPD?&\5H,8I-.G6W"#K:UU.ZQQ%]V0'K5SENYKA1:N73
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M !],7N?#]LVU:E9[S%^RV_.GH5=K_P KO'_#^FL<_4*_29LBFEL!+BXRZJ$
M%>VJG7]U?R3/FU^SU^:>I\Z^.:[2N"=9U.CK^(JR93F7)G@%LVJF;C@YK";
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ML@EUH((3KV\.G;%W'U9:YILNEJ(M( =*8^ VN>W_ !5;.*Y2U6AW]JC0@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(
M" @(" @(" @(" @(" @(" @("#;H/Z;2_P -+_""3DO#T_\ M$/[O*S^SW]C
MEWZ_QCS?)Y?#]\SP'Z0:E8/R,[#;,7IZ\/D=O_DOZOR+XY:/K[[!?,PVA+PN
M,U0Z4P=UIU+<)6:\&P# IVGE,9C2F,+I;@.7**<LXQ,NN.(*=SM^P\ON*X<K
M>75&I4CGN/N[+AW(O7>JKLVC(^B<3<,N93C1>NVD"9;LK0#U]"K%TN.CU\'C
MWA:0>P*>6<QWCPYJ$0R+@;!ES)C#GVQEW+IE;O-9:+ACLV03@Z[6RGG;P .(
M&/,,RM9.W"8DC>M&/=%/5F7.FS,9!M_H6OCU7*S+%+ WQRQ"[<N;=: "+,1V
MI)(K>E-B.G)2S:6MR6P0N%^05PF-Y9-T9#J"PTQ&4V_N[E9?JQVGF,3);0_V
M#-2DS4Y38<_K"OKG;?&DU);$-,<^R/K5QHNFT&G=@-H4D\LXSMX$IW*/<M7M
M(28X<G @%8E9ES5=U-Q =:; <=BU+&[J.NM5K=QLP1'PN[#SJYCGF</6CCRO
M^,EP^EVKGV?1^"9X>M.K5@>7^\/B)O.U<Z]W6:GU46HF;SC&-Y[1W*SEFZ;6
MGRM^:W; PZ0K;ES[.X.&Z'?=*]TG[FQ67PX6VO9?A'3ANT_N6[S+;<PJSM[6
M\'Z>0QGN_2;GD%KK<W#C?J[[T>D<T?#]%N [EU\EF8MS1!@&357'$RTIQMZ%
MJ.7R76&HX@7XJ_R>?UK7\9H^[W+6,\,_)F/ G1O'+K3U<K6:68NY9+<^C%GE
MMB! SYEJ7P=>MSGPR"6TB)OZ.Y9N?;[.W$#+; V89#N6\,SM<L>X.06L1O/V
M91+ O]7<L7[-7LR@#(*]8PW);8-'3AM2W*VY;LHP /.LMSAF\1NT=7>BL4R8
M#8+;#Z59/(Q[A-R6LRY9Y=.08AIPP'78$DSNENL)"5*(%ME@O3/ASQFY>7M@
M#T*V9A)BHNIN/+-9FJZ^%?GD&/.>U:QO#'%8)<K?-@Z@,N9+UW]G+OA8:&3N
M[O-DF&,7JME((;NURLF%MRF9;8".8"G8Z,4TP)YTF^J=IEIS1O X*R,8Q6H6
M81]"S<Y:SAC,D&_EZ$WY+VRUWTA)!@;H7#EBM>V)HERP&G+;A#H'J"9;G5NT
MXA#EFL\)VF%DI9S6"TY7[%K&9DSK"6;62]V\7+%ZX2=?+4G39<PX=OJ6<V5,
MXJ"K)+7@F PR[EJ\+G,4VMD[KG<Y[#L"\O>0ZY1A R'4N1<QA<W>/,2K)A;V
MQ&27+M%N?K5]L,<[2,B6! W]',I>'2-N R'4%E6-X%E@QP5B5#U4S<=9A?Z2
MI;M)U]MO-/5"(BX=9R"G-7'I4]3U3(VD<HXK<FDNTS*K9(%KA=GM5M8QAPF:
MC(#C[S;H]7W%<M>K0G:Y3R@8/:+\08X[<EFW*<(>;Q3)ED_CFV67@%3[+_)I
MNXS8+/';CB,.E:UY=OB_DQ/XOIW-,9[8DYCG4M?8Z=+>N9]%9U3BJ00XB>WX
M#B-O<KS"?'O;I+B;BV4!,A/'PNQ&;MJG"8\/67BWC"\">V]UQ"0[1Z\:]Q1,
MF"9">#[QQ'JYEF\X2=75];K,Y^^/$O<3UJT[3""F:A4.)]\X^OG4E<[,PIVU
M%0]@@3[T+LR K9C;%N)9Y=J\*\.U%0^43*<8S&BXYCO3&8Y=MO;7@;@1\X,C
M3$Q++[[(%7U^K.7N9P/Y>M:V674KKF>D;%CBX2U[8<)\$RI(EQIR(,:+0=BN
M?#%KO/2N'I,MDL"5NP:,,ON+5FLL^V%PDZ5+8&D,NAZBLY2]Y'FHIV2FF N@
M8?=6I&>W[NN5<JWM9?D=@N@KC#S]E>F536GXKX8G+G6+66Q25;8_$+MN?.HS
MVFD\RI81>%N3.FI<1@J*EN[8X"S;M5XBYRKE75@;WO WPM.97)G.$#.FE\3S
M9X=*UG"^V>$#5/-VPXGE<KG*XQM77N/B7F_/:KEJ):@87O;9$6!1=>5SD4Y#
M![IN&7<JS?\ T1>IRMQC[(8>A9LVS;)=.O:IWXUU]_J"WG2YC>T^=:P$_2 O
MPM5S]3VB]Z8_>)$,1;TK%F3.4W-80#=9#EZ5GAUEQ,M=H(Y;$_1C-O;*4I@X
MXGI)_9*MVQOF,#S%67Z)BYVB:MY:'<QQVI;GAJJS55+03%PPS[UG&&)NM*FK
M&"8+1;T>M67#7;K[+SIU4PL!B,#?SK6=89DQI/RJIGNVB[U).V&KU2S*IFZ+
M1R)VK.:LF!U8P0M%L>5Z2X2S+&VL:"(F,>?,;59M+I,4=2P[MHM/:0/6I+LM
MRME$]KK8CD%HMQ$F^;+ /PW<L-BLZ_5C.D%6SF;I$1><?8G:+UN77^JS+7PS
MCZ=BPW;,X4NJF.:\VXYGOV*6X6W#!+F/<X#:,3FF27/*S:<"[<B;=YL52XP[
M!TNG:XC>MNY8*=LL+2ZCEAD0T1AMRBKUX$)4C=B-I[U5QK**?.W3E )G"2_5
MB^LQV]?>KF>&I<HZL.^TX6'EZ4EPS5&U4%@<?V)],5B]LU;77&H59EEUL.?H
M6I<Q<XB)DZL6O!+^S8%)"]LQV5H59X[1$Q@&QA>JROM-- (MAS\QVJY$[*J1
MN#WQ99>>]9OU:Z\(RNGEP= QLO!.'2G299JK5+"\F&8[U,659<-%E._?N-^6
MT;5TY+PGJ*D>7B(-P]'0F,,KK14=@L/PY#;DI)E4P:-F[& N.:F\^5NN&BZG
M#21RO.Q7).TL;M+*;O-Y]F0V*?H=LW<6BEE-+6V8;,CL5M),M]U."TV89=.2
MQ+M;9=>50U:0;8;?5L6\^&-NNZP%LT[(^@J\1;,)/3IWA@ F%A%YP3567">E
MU@C\0O&)6L:PMGE("N@T6BX8Q[5SO+.-X1-3J#C'\9@<LASI%XJIUVH/C /S
MY7+<VU:BC73#],QZ.Y9UESN;^CG+J9COI8XIDG3+*Z<^%INMY6J7MEKUBFZ[
M/<&N%N7I.U2S)_&NMY\TF:8V]?>5;QI9<K#H[H.!VY[ I<X3R[,HYGXN[E:M
M=>'/_J;9?$$0]*WG&VG $!<[MJ7$QY;DD@BRR)]BU*S^K>DM@;\1Z3[%+4LR
MG*1H=N@YE9EC2Q4\II$(=FW8NF-+[)272-(&-D.KH2XP2RUXFT;86-[?8DDP
MG;E$SZ1K0776&_F&:S=5),;0$]H#K,(^B"Q9EO#=HZH2@!$686X0Z,5J'M&6
MHK0YIM%L<3B?:K>VDY5>NFEY-N!Q//FL-3&,*G4L>XV1,8C'&*N$S.&D9#X&
MP]2&4?62WB6;#Z<04G.5ZS'+KO5V.]\G/'F6_:8PSVQX=5:Y&+^8]A6<9(J-
M$'&H%Y][;F4Q8U>-.Z.&I+GAEAAO#L",SK7>.DT9=+ W3@;AS9;%K&-I;X7B
MCTJRUA, ,\U+/9J3PFY6DM !W(]??M4]L7"</,S3I8A[F?*];EQI:AJNC8 Z
M  OSS*:6S*A:M2Q#H"T W 8XW+-F+GPQYPI]11OM@#B>J&Q2;/XH>;)F@FPV
MF.*LF*U+*\2Z>:;QCZE<X,;RG*2F?%L0;_65+MG.5ED2BUC<"0(^GO69,7+4
MLRD);MV-G*Q=9-)V>:DQ:!M7&W?V:ERU9$DD@PQ'-?S15-?5:*)@A;:8Y!61
MG/A=:"7*+1$8#+N5P8J8\*1L5RN6E5,D[IW<A=#UA9M+%2U!K07$##(+.=D^
MBKSF>]?GZ(+3-Y<FTF\(PCS >Q2QJ7.G!VG!T?<OA;;L1IIS=(;:?"C$9%3%
MM9O9'S-*8VW<Z!]W:M,-)U*UAA"'+;%+2ZKDV4T&X79#N6LXX/;.FXR2UPNM
M@.S8%BM==:'TEEC#Z,N9>GXH7=&4;K# PRLSYEZ9?"6-Z73N %AY14NJLU7&
M8W=.?(=ZEWHM\HZ?,$ 3S]J289Y0\^>P61&5_/L6I-->,(WQ6.-I'3;ZDOU8
MLL<9CY>X8$<@5#=0-9.8 ;1?GTY;5&\>%7J9S3$"VV/I3*3KBYK5E'>=RR*N
M?"W%FDY3-(#3' =J7LQUN*W7_"IBN^=?X0\\F)Y^V"WQ'*ZJ-?-+8FV_MZ5G
M/MIK$QEY%<&L@3<"+SWKS?+^W;72>77/$U8';Q#A:2+SMVKSSMFNL^CJ.J_&
MSW9;W7:K;A+E9]#IBY\LD'# ;-BF?^%FG<.EM#);-GW?6M=:MJ;-0UHO P-O
MW%6)FM*95B)]X7YG+G4]F\>VF-S_ !&Q!P]7M2$_;<-82SO"T7C/N2W)C;=E
ML-EWQ=RA;.&VP%L;;X7=*K#=:]S<8])19KES\8[>M3'T7+#,F%P-IPQZ%<,^
MV\-'Z73VE6+Q4U2U EM%L(=VP[5+BK[-2MJ@6D[PZSE[$+JJ#JE:8/ (RLYX
M)A?9U_J,USRZW#F]>U,Y9O*KSY+YA-YM[D^R8Q'"70O)!@>;FZ-BL6:2]-0.
MLL]'[78I5]LZ;;J-P!]T]0[D3<:O@/R/5[4POLWI,E[8F!ZN;N1.$E+8\QA&
MX9IC"7<FF_+:6WY05FVYPYDP2]L#@Z9N\\(WJ>TL3+6=4%QA$Y7G'IVIC&VI
M?+@YQ.V_%.7;IVUAH36Q!PO]:E.W.45-EF,!;:?44G7RGMK#6;)(.WEL4DM9
MTSM8X0.7/S9+I=1TZ[9HD#. NBL-6?M<#.AR]H5]M.6)RV*:H)...)Y\UF18
MWYDX[N-^9R*D+<HN?.-M]^?,54QA"3W$D](OV!)FZ7"&GDW1.5_.MUE%S6..
M]#U\_8I.TXJ[1[F/WC8<.Q:U]26@EO)A VKGVY;S&T*=Y%QZO:M=>&<,3Y)%
MD(6Y9<P3RLD\L+6'>PQY7+6,Z9YK=8TN  6?XM=M1N2Y,!$[3Z.9/;,PQ')T
ML%I.*Q<RKVE1[V6BW#);]EGW<V&$>CUK.,DF1YB.6Q6?MVO"*G8]/J6JD5VK
MQYO45&K<*]48G:?0EOAG'LCB\Q]JF^$MDN&Y*OZ0MWA/NVBTN$%B3%;F6C.E
M7VX!7#V])B--1T>6.@X6*L6MZ68PY7(LK847$8WD97@X!5G.]-"=#<>88$W)
MV:FG7.M38/?"-YQA?]Q231=*H9A-]O2JEX<F>]#"WUHS-U)4\L;+LDC7:IR0
MQHA9?L&U*3-TV7-LYHX*'".FWPYT6S.VN&D<N=3O,M_'<UQ-YYRN/J]TX<2(
MB"SQ1B<(1"WS$NHP/NZ"I#KRT7B/1%9QFK;AH/;MNBM326M68.WO3'EF;:[I
M1(.-N"OC[M:D:[I)$<+K_N+-8S;6%\C>YX=/8K+K'@XW6!\@C.,#RN37A+VM
MTUG239$=8]B)FSAK/IP,,<AW+%S]W:XL:SJ?&!OV=RU,QCKCZQP;*(OLOPV]
M"Z]>/N[]<>&K-$'PVCM73PZRXV[6\N_]8LV!GX35SKKUOL^B3Y%;:O1O\WE=
MC5S5]>?RG_ZGT?\ @AZUY/EY>GXWZ3:=_19?.5P[.U2C6[VQ<;<,2,X$  C:
M/U3^BNYBMD=2U/Y1W[9R[1MX600$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$&:1^4:@I_G./_@.?_ S/Y-RO7ES^773+Y&_G3GANH:L(
M@0KZC$X.>O;TW'POEQV[OP0\WJDNJZZW]\=B<UTZS;EVZW&7JC6/>ZH>!GF5
MZ)<1QZ\[2%,Y[0TF/6?8GW\.7R>5FI)Q(@8WYG&.W:IGP\W:-YTVRT'!,ZPY
MV,7BB-QM25KKJ8;<F8 PF!^X2M-H74I_Q69\KT%9=40F96_XW.LRY6618Z"J
M@T1.&).7.M,V96*CJ!OB)Q%Y.W:4[=DZK=3U+-R$1\.>P+/.RQ':G"9+]W:L
M\59'7U13/,QQ@;SVK>4[61+Z<PM<R. MZ_8I-<D[[6MTYK9,(@'=%_0I;FM=
M[*H'$$QSP=TX$7G:<]JU,))O2JT;'NF6@W^M1VF+&]4-+ >8>M"W$TBS,!)O
M4:G#9DL#[^SG[E6<[;O@-:TFS' 9<VQ9E;]LU'5$ULH$$CX3?T;59&>W;,04
MZ8V:3"!M]?L2I(CIU$'MWMTFSV[$DQ"<L%-+;+FM$+C'TC8HZ8TOFG54J5N6
M@6-V#)5F[F%@FZY)9*/XQH@#ED,XWJY9G7?W=9<1<12BR:!-%YQ&Q2+VN)IZ
M\\3ZUOOG0F88$*LYMOV=-ZEJ+W/(#XV0PY8J-\Q6'5,TO,3&)QACT)9DFF[3
M[S@";;=NQ<O.*G>R1LF2]SA84</9)T^G/F0&[><N;$!8[?9?;ZIF1PY,F?O1
MM@18<X*Y7WG,3='PK-);^(-_WIP@,E+LO>5V+P]P@[Q&1DN^-N!V*<5.W?,>
MRO!_",KW=ZGRP*UE)VD=]T7"-/X/]'^B,\8!9\Y;O?,<G\,R6?O,.8+5VYWO
M(W*+1),MP_%^CO69/HW[^TRL/U"4)?P"[I^%7..6/[)G"FZW0M$8--VW/G6I
MMJ]I5+-&=Z(&,;AW*L^^+A/T(+ ,+MFU9S%]Y-I&96F6TC> L]2U,:RU+[;1
M,W4'$D;\>I8O*=K>(\-G.F6W+4F$S9IQ>(PZ?4L<M6X<)8&^# 6&-R9JK%0S
M&MA','T0]2"R,JFM;81B;S@ICRQ><(VNU1S!8^$/4K$J%E:F9C_>=&WMC;@M
M>S>-)43)4T XY"$?3S):MF&A526$&R\'UG+8LG72G:G3M;O0Y=:O/!B<JQ-]
MPDW\AWISICV<Y=1!HMPS/>KQ2;KDZK@#[PNQ.?25FW:VXTBGZB!-O$0;^DK?
M5>8L='J;C+AOX9!=9'.S#G-GF=O;?7%:9];6DZB<\QAZ M5OJRR]/<(<T;@L
M<T[3>6P:5[1&!L'8$2(ZIF3)=QNB,8V1S3+7JK=16SA$;QO]86LY)(L6@5LT
M@1)/5FEA9]$[7S"YEYL'+%2LU5)L0\VK+4FMMJDFO8;\O0>?8M8Q$MN4F^M=
MND!V%PAW)9<98054]\QQ)-L<SC8K'3K$89$QSL;>6:9TU=-^3+?*,3&XVW>M
M,9<[4_2U0&X"[*RWGSVJ2?1%BES6N:"K>&YC&VK4ACA=<#EE8LL=L3A$BGEE
MPB,>S[B"RZ=22MT6",-N7.@L0EAC!#EADK+MJ7P@=1J0PD PMC:>Y:^[6D/X
MWB$VQO-YQ.U9Y2S+#-%AVGUA1RNU=JR6^G-7&6YGRB0]P?&.(%YS&W8M-K/I
MM3<"X87D]ZQ<YTEN%]H9[8-C9Z,.E;\+Q$E,JV,$8B[/8>;)8SAF3.U:U&J$
MS>@;P;(GFS6IN%NL*35AY<3; PMB5B_0Q(P2G%I C&T8G/VJR$W5EHC&!V]H
M53.;AN3VQ8.GL/<KG"U0-:<&EW[8^L^M2SV)PHDZ>-]UL+>6*E-SAO44X!S8
M;.P;4QA+;>78&FU6ZQOO#F)//FKUY2K+*K+(Q%WK]BWVJSMB/$VM@/B%OKBN
M=7VSM#3M2<UQ]_$Y*%XR\R=3+B 71MV<L%O&&4I+J=\1!C&!L/M25G<8YTTV
M7]?.I6I<MW3*F#Q$P][$G/G4FZZ287$50=+@'7C,XVYI7?KN(>J:7" SY=B8
M3V5Z?)>"2;HF_G5\);ERIF$.@;.71FKC3.<58J>4TL$;;!@-O.LNTF6.IIVE
MIZ>5@0JKSJ.$SX3><-BK&<Z2]%3P;="T8;>91I9:5C8BST#&&Q1<V)4O8UML
M 0,1T*H@:Z8PL/O#D D.VU U-P]\ =F:6Z8EL[14)KCOFTW9E1TE^C6$YXQ[
M>]5-9S4O1RWSAG''[JLTQ\G[IAPKI+Y0) (L]1R@M7AY\XU5==63 XMML,%A
M-VZ3%'.=,()V^E,.G7KB)D.<!$<^.289RQ&L=+,"Z%XZBEF%Q&S(U([P]^Z
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M;2$F<)D.;U ^M$DLY2+9)@"+K[BK+AN7#:9/,@@QA 'O5FS.=):1Q#X3=WQ
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M\F/_ .*#_P %^/\ TO\ MN_Y?X_3UE[Y_P#5[ZU]/X;WSH6/>XCKL[5_I_\
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M)W")CI$J:W>8P 1+23 EN"UUF(E[YX>V3?)[R;X?<:SAO@C2-*K;"V=14HE
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M73#$Y)PSVM[W7#Z[OL9_L$*WSMHJ#S7XXT.;]0,O3ZLLKG.$L,<X3"T>*X-
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M;%E^KE(E>(?>,0N5BRYX2$NE#3U8[5N==;9S<M^6X2[8W6I]C/\ RWY6K"3
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M-)V>HK<X2J[JU2?!+8X'E<M=>6NO7$=;33&:?VWK7?&(MY>5D$! 0$! 0$!
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M+V6LZ06RHEIL&70I;O#.,[4S4:5TMSP++[[X\@GLTB*<3!,QM(Q&U93CE;9
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M*:6M  [,BMS&,GLE&54! ]-GL6;BI4I0SF%[<C;Z#L4^ZS?_  LDZ<QLJ(&
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M_JY_J\'^[WIO]GZ?_(!:\.G;^+Z,.,?Z13?P9[2LLSA4T40$%TX?_P!4ZO\
MP#_]'G+<\?JQ\O'_ /2_EK?K$[@WYB.(H_Y;4/\ 2)BY]OY.OQ__ !/QM^S4
MX)T?CKYFN%=*UVF%5IPJ*(SI+FAP=XE8P6@@BYBU7/K,]L/[#GR.>6/ OEUY
M,<.R^$=.;0%^C4'C[C&MBT4K38 T Q(47OF7'AWW4:SJE0^=+F5+W2Q,(#;
M( G  !,U<1'FTDFTF\YIFC8HJFHIZNG$AY8#,E@PVOAV(8?G%]LMPWIO$ORS
M:Y2:G+,Z2S2-4>V5 %L?")+B(8[J=N%^+G#^09\SVE4FB^<7$^GT4L2J>34/
MW&"X1J*@?XJ1GO<U]COZM(2.)M) A#?TX=%BGEN2^F7]!WC1I>:!K;21.@.F
M7W+6,Z<^JA^;.O-X+\C.,=?=4,I)VG:#5U4N;,<&PFMG>[:2+=T%+UQHS^Z/
MY'GVT7S-\0^=OGUQ9I==JTNOI--UZ>P-9,+X-E3"UMF\1> L2[PZ=^,JS]CQ
M\HS_ )FO/3AV3/TFJKZ+3N(J-TWPI3GM+9;I4RV#'"PA6];=QGIBZK^N7\M7
ME)P]Y)^27"O"_#>G?FV;I^B2953&6&S'5 @WWF[HB! 8+4^[-YQX=@U$O4*U
MWB5#WS,!' 7P'6M7KDS(UOS2[[ST'N4]3VCR-.J)/XR3O,F-M#@""(6Y;$]:
M>RX2*&7K^@U6C:UO5,FLDOIZEK@ 9DA\#N$EIC=BGKB99]I[8G+^?K^L_?()
MP_P=/J/,3@K1)U,:]\C4YTZ3)&ZZ,UDQ\7-8 ;C%8MDKIOMP^/OY//-'6?)[
MSZX+JM/J10S7<3:?)J9LPEFZ!.EGWC%H%C4NUZ=O3]7]C7[._P U:;S<^5C@
MBK=72*NN;IE/(GF7,#B3,D4[FW..,5J;<^W.7M+J5+]1JG4YC9 CI/8I6IPT
MD40$! Q!Q!B-A09'MIM5;]2UJ6^JHGQ8^4!O>ZZ(-A!O"U-1+]GG1?)#R?T#
M4F\2:5POI-!JCW>*-2]V5/WH[V\7/W0' G)6=L7.(Q<WS5UUGC+AC09;JC4N
M+]%HI3+#+JJZ@+CNWCW9C9@Z0DQ]"=;=3EUI,^8SRC$U\J9QKPR7L<6DNK:8
MVBS&;F%=?X)\??&UHTOCKRYXMEAVF\8\.S7O!(ER=0HF/ALWYP!Z$[=IQ#T[
M1<=*HZ6G<UU#K,NHE.?OF5*F2)C)@)$0"R:^P@+"VY?,S^LR< \,:W\N+=0J
MZ 3-2=HU<YT[<#MX-F5(:7.+2=ZS.Y.U_:UTN>^^'\L76*9M!Q@R1)&Z).IT
M^X,BVL$(]2D3OJOZ@OZNIK%?-\E-&IIDS\4:73VP!P\,)BY=.W\'U'ZS_KRB
M_@/\8JSER\/SY^U(_P!T_C'_ #2N_P!&GJ=^6_CX?QPOF@>?_FV<?,P_/U:?
M_P XF]ZG4[>7UM_JP_R?^7GF]KVF<0\9Z/+U&9(J'U3'OEM?NPF/F"US3@EV
MO3'7=?T6:#0-$\O.&)6A\*TS-.I*1K)<B2QK2&AL 2?=#8PR"W.OK,^&,^W;
M: FZOJ=2V$VI>X6V$V=0AV++6(U'39KA!SR;1U14VLQ+I<N%_P O_P#:[OPI
M:Z?]+E>7\]S]:M=N^9-4[+4Y_P#*/7+R[3A\<7RU<)R..//?@7A^J9XM+6Z^
MPU$N$0^5OEA:=A,P+7+'7'OM_7R^R<^5/RL\IO(+@C7=$T&53ZU4:53S/'\)
MK/??*:YSXA@)(B86IZXY:[]OH_4#6=<U&77U%/3U#F2I;]UH:&M, +;0T$VH
MSB8^ZOOJZN8XOF32YQQ)M3:XGE,\-R165\QLT;[9;"\QYP.H$HEX?A=]NU\U
MK/*3Y;>(>&=/U*GI:V925TITITP->[PY#F,LW@20 EC76:R_DR<><3ZIY@<:
MZ_KE=,^L56IZM75+"V+CN3:AY :3$D$$%.(QGV?97^K7_9HZ;YKZI1>:7&&C
M3ZB50/?J4N=-E#<:P.=,EP+F0N( 4Y;Z_MZYK^B/2:9IO ?"6G<-<.#ZI)TR
MGD4TF6T-!:V6S=F1]T %SA@M8PQS=J_,JJJJ._4S#,<0(DF)N [%,M:C# 9)
MFC?H]8U"@<=R>X2MX>X8%L-K3$+76SBL]IF:Y= ?.U\O/!/S'^0/%F@Z_HDO
M5-1K]*)H)XEA\]D]M+.E[C1 @,@3<+P%+#K;+BOY"/VFGRJUORO^>&OZ!,TV
MJH:.KU[4FTPG2W-:&";/>UHBT >ZU23$VO>;T[)^R0^9/B/R9^8O@73M.U.7
M04%7J\OQFNF%@>)M2'.!]X D[REN&I=/Z_\ Y"<<TOF;Y->7^NTM1*J)M5I>
MDOG/E.!C,D2FNF.L)P"W+Y<^T]:]+OM8O)#_ .;7\OG$.E"EG5;J/0-3>)<E
MA>1^+G.N *QV=/CQG+^/W\X/ %1Y;>>W%_#,ZCGTC:2I?X;)S"TD?6:EIA$"
M[=5G#'??9]8?ZM!\Q<Z5YF:9P'4ZO2TU,)^GR?!F30TP\0-N+@IY=;9.C^B]
MQ;)\<4DZ40\-9-$6'>$(L(,1$$'>5L<I?#0X>IFR:F3J,TADIIF,+W&#1O2I
MC023988+4F86^'QA?K2?S54N@<.5?!^B:K1O>VDD44V3+FATPS&M9+>(-?$D
MNBL=I<Z:F>G/%?'#]E_Y&S//KS\H*>ITZ?7MK-;D,<94LO$9\]A?]%WWRG;+
M723L^D#[=W[-N@\D/E$X6XTT?1JF14LTFEK)A$J!!:V7,=$!@-P*O6:9[W&H
M^='['[SSU'R3^9[0]3E:A+H:2?6Z2U_BNW!X@K';T(N'T815MP?'/W9?U]_E
MJ\PI7FKY,:1Q7]8EUCJO3)1,V6X.&]]3;,O!-[BKG,3MKN[ X9E"=JX9,;[H
M\1Q:<=P.<%)D[<9C\DOMH/F1D>4/RZ<9:)*U"FHY]9154L2WS&L>YKI3X- +
M@3:5>U:^.:S7\BSS9XBK/,3S=XNU-\PSGZQQ-J E;EL83WRQNWQ)<Q3$FV9N
MX?>K^JO?+-2Z?+D<6ZII51+F2O&KO&FRRUKS*DOF?$YMQ+0$ERW?V3,Y?=1J
M36/TG7*&0 TR]-JY+6C SZ&9NCK*U.8X_>OY,GZP9Y?\0:7\SO$FK3].JFT9
MJ:^8)[F/$LCZQ--CB(6P6>UGL[<]7Y^_93?,=P[\M7S(:-QKQ$9+*456G>_.
M@& 2:F)B399O*7+GUF:_K?\ R9_/#Y4?-%P#I%?H7$V@2*EFB4+7R#7T\F8]
MWU:7+(:)DX,#@VX0$8).WA>_7UKVZ/#NAU#G3)6L4[_$)<-R=3/!WK1 MG6A
M:N+L]K&"IX7DR&&9(JY<V& (WCT!SDG7*>V4.VKU73I@93NG2Y>\=[=!@1=E
M I9A=6)2;*X4UB6UVOTK*JH!!C42R^T8M($8Q2V5F3M.$;65+)(^I:2]TK2V
MB#) L:!=8VY)<5J?^J- @(*7=5Y0$! 0<3\<O]L.T()WS-_N^U3^Q:O_ $4+
M43KR_D6_;O\ ^]#7_P!J:I^$5+RO=6_L1/+?A/COYLN$J7B^@9J&FNKJ#>DO
M:UX(=/E[UA!O6.:LQ-OZ^7ESP?P?Y:\":#IW!NDT^D:<=$TELB3(9N"8UM!)
M+)DQMV^6VG:5NN=MM:U7J>H5<UXGSW/EQ,&F$ (W   "Y3-:Q*T3;:;3M16:
M3555*]CZ6:99!B8&%EB&(F.)^&^'/-CA75>$^)*05U%5T4V34R2&[KGSI+Y/
MB;I:YL03=M3EF?MLK^6=^L#_ "*2?)CSYU+B#A31ZC3]&-;JCWPD[LHL,[>M
M]P 6K,U5[2WK[/P"^6OC34N /.#A7B+3:D4LZCK9;GS'.W6[C9LLWQ%SEJZB
M==U_7<^Q=\[:WSH^7?1ZO4Z^77SM/T#3V#=?O[H_F\L_2)4ZVUKY;,R/U8XG
MJF<,\"<9ZL]S91T^EU>K;-<8!HE,C+,3AO*LYV_E;?;_ /S<<2^;?G!Q)P:[
M6)=50:;7&G?)9,WB)4NI#7"&_P#>A2?=OOQI^&GRK>26I>>'FCPWPU04E35L
M.M:<VH93L<^,M\^7%KH WA.W"=)E_7?^R2^4#@'Y<OEPX<U6EX=%#Q)4T=/-
MJ:J=*#)S!3TDJ8XM]QKBXN?BDF-G:V_M?I9K&NU5?, I9Q93"PL;  D7DXDQ
M6I4]<(0@.OM45S9-FR3OR7;CQ:TBR!V(+9I>I,U.DFZ/K#C/;7-=2N!@2^7.
M!899-L0Z,+8JQGM-YCXU_P!9:^SRX,K> ]0\RN"^')DG4JW3IU7/GT\D$B:P
M3 Z+V2Q&#F*<+OM'\Y'5-/U#A+7W4D7R=0TV>TM<1NO9.ES#NF%D""U&;,7$
M?TB_U;3YO-7XJX&T;RPUC69,\R)>GR!(\6+@2!+-A>;8)F9PZV3^O/E]DSY#
M97$=&Z6W=#Z*<YT+H^^WU*^7/_I?/C]O/_<+Q-_!UG^CS5F\NG3^%?R?-9_O
M-UC_ ,3ZG_I4]7PYS^7^7]*G]5O_ +N'?V15_P E,5G\6N[ZON(_]8S_ -N/
MY-BGEGJFM*_U1JW^9/\ Y"I6KPGE_*8_6(W;OS0:UMKM0'743%AV\/S#^RVX
M"T3S ^:+AC2N(*5M7IK9]#XLES=X'Q:QHM!!P8M.72X[/[#GR=>5O GEGY/\
M+R.#M-;IXFZ#0>.UC&L!:*:6ZP!HC:%/NWWN;CP[?J]8U.?-GRYE2YTK?(#8
M@- B1\(  ZDS8SB5&FTDFTF\IFJWM/K)U)421)>6!\Q@=#+> 3*69?E#]NSP
MAI_%GRE:O3U<ITU\NAU;=  (W3)81@3>"IV7XYFOY$'G7HDGA_CW6-.D,\.7
M*JJF#80@/'?W)UX3O,7#[</U9JLG2SI$AA 895 ,;O=5SX=)_#+[[^,"13::
M1?NNM_X$M'+KPQ\.5%09LAAF'PR^!;F(77*I>7R _K6$QY\OPTN.Z-*HP!D#
M2RR?2L7EN<:?SD_+;^]3A __ .3:=_+M6IPE_D_KV?8DU%0_Y8>%Y;YA,OZK
M0P;&S\C*]2U>&NS]=N**BH9JFXR81+$N7[L>:*EMX8DG/E77.+C%QB5&G% 0
M$!!Y!(,184%LX0G3GUU8Q[RY@IXAI-Q$V6 >HIFWE.TG,Y?$A^LRS'[NJC>,
M/%KK,/I)>5G\7P-^29(\W>&B+_SP?Y4I>&>O\H_K;_8:3'N^7_1@YQ/_ &%2
MW_M9*G5T^7P_8+5*JJ_.NH,\4[C:B8 -F^;.@*YK/KUY:,N6^?.E&UWXQN]S
M1&5R'BO2;[5?SMG^1GRW:WKU!7RZ&IF:=JDMKGOW"6MIF@?2!MM2I\>/;;^/
MS\Y?FMJOF]YU<1<4ZI5MK#/JJL2IC7%PMJ9A=$[SMB0[_P G[(?8+?)=3^<O
MS \.<5<2:'5:AH3)U!-=&27RMTU,ISKV$0("8RWZXF7]6CA3AGA;RGX.T7AW
MA?3I.EZ?3T%'2T\B6W=!-+22Y8F/;"'B&R-D+5>'+?:HBHK*RKG3)E3.=,#B
M=T$W"-@V0"6ML$!DIE<ULR*^NI'M--.=+;O N -XQ!SBB8C0\V?*[@_S[X#U
M;A3B>B%?*GT$^F#'-8YK9M7)+-Z!:1:YG1!+,Q.M];]G\FK[<OY-#\OOS+ZW
M^8=)J:'19E7J8AX);*LG,>TV, L /6I--=I[;C\\_L^?.'5?)WYC^#.(J"L;
M2R9=5*,YSW;K1N54AS;8B\$JX9ZW]V']A+[/7SUD^?OD;PQK<VIDULV1H.G"
M:^6X.]\RI3"203:D7Y)BY>S50PLJZEF#9LQL.9Y'J1)<L2*(" @\@N:=YA@X
M7%!F_-^E<0RW:/Q#3FLTZJ!;.DEN^Q^\"(.$"8$FVQ69NF>W[?W,_#?DQY2\
M#U+]1X?X;TC1:J:XS'U3',DS"YUN\2]S0#$Y*\:PS[7MN5/Z_P"87!_"THS=
M5XQT.F:T"$FIKJ$S81 ][<FAPZ0%J>OF)Z]KQ5#9\Q7E',F"6_C7ADO<0(FN
MICC;?-VK/M,_9K^OM-5;-/XM\ON+V_\ 9G%V@5+B /#IJ^B#XFP0:Z<"XDY*
M^T\,SKVZ6VKEH]'*I'O\#5&ULATO=;):^6X,=O AP+)CXP:".E9\M6YCX<_U
MG/@/0M2JM6UNHHWS*V755KFSGMMW@9EH):,0I;.*[=?XY? 1Y5#<\V.'"T",
MK7W%D<"V;, ]"KE-]OU?UG?L'*VJJO(716U#@6MT25N@?M&*2RNGS3#]KJ[_
M &EF_P">#^51CP_)O[<G_=AU;^Q]5_ <IVX:^+^3^17\P']Y_$'\/,_TB>K.
M$^3^3[#_ -6^^3WRTX]XGTCC3C31)>I2V.T^:W?E-?",'F +#B%F\M]=?'GR
M_HA_5-'X#TJCT;ARBD:72 $4]+(8/"E,8&M&ZUV]=<NO7UQ<N%G:W,X5R;JV
MJ3RX3:E[FDV"-@$3A@L9K>(UV3)TV:R47$F8YH.V)@DVK>XYUZA\O?+;C#6:
MVHDTWU'1=3J@^<\-'B/H'ME&TCX9A6JQOE_(V^VZ^9O7/-?YE^,>'I^IRJ_3
M)%55B4V6\O:P">]K18XM!6)+ETO:6>KK;[&[Y09_S1_,7HNF5.GU-9IU-J6G
M,+9<LN;O"H)>?A,;(*Y\)T_;N\/ZZ?RO^0NB?+MY3Z5P7HM,:1])04\N>W=;
M$3)%.&L$ T6AY,8Y*IW[2W7#L*=)U"M<YU5,F38.(&]&P66!),I[1@_-+OO#
MU'N5]3VCDS3I\IP?*#FO:8M(!L(M">M/:+;I]-,UC1=2TS5GOGRJN3-I)@<
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MC3_!%N &'1CSK,ZX9OR_1X\$/RLZ>U:PQ?D8G-$N)ROOS@ECI_;(VI.IRY!
M)%AC:1M/K6?5?[D_(XIDRV[N\W ?$$G2UB_+?#=/$$J>WXFW0O%T5GTN6O[9
MA7ZUS*J)%Q)VXP6O77W9_L4ZMT4S23"^VZ.*>K4^7>%<G</.O@;HW;/8K_6M
M^28;6G:1X4QL6XC#EDEZY<;VS78M')9)E#>A=CM*7KIFW*-U>NERI3K1<<1D
M4]/);B9\NIM4U66787NQBDZI.]PAI%8Q[[#9O1PQ@KZ2-^RV457+&[=&'J$$
M]+XX7W\I%^IB4W9SA2]=.=[R\*_7:S$@6]:EZK.WU<J/5VG=!SMM&83UI[3.
M;PM4G4V%@AD(V]*LZ_4]XX3ZUKA$=HVYJWIE+\DP@:BH!))NB>T*>F."?)K$
M<:>J:UXY]G+!7%PL[9Y7/3-3E,+22! 9]"SZ5?>+!5:M+FRMT$97C(J^F9]V
M?.5*K&B?,+A;'EL4_KL-(MU(X"-_6EZW*/+)AD0!PY>I/7_D9C6M+88\^W:G
MK;=\)G?V:<V0:@$C9ZD]5URQ2]*,=XW#9E K4Z,):CE-E.:TPO\ 6K.BS4RL
M]/):YO(\KU)UP1LF2UHB+QT)8WR\>,&"&(!]/0GKF;8\M:;56$67+%A==LH.
MH<9AYX+4F)HN+IK2J)SW YPPVC/G3UL;6?3J$MA'.%WW$OQYY/58]ULIIC"[
MU$J7KAS[14-7]^,-OI5DSRSZ3E696G/F&,,0;ML$O5GMUS?LNNE:>93 3V<Y
M3TSIGTOA(UDQLN61$>A6=,<M3ICEU]J8$U[H0M)[8JWHUUZ1BHJ/=<UV1/*_
M8L>K/IBY7>DGB4S<,,3V*^F6?2QYG!LP[PR)PQ3U;GQ_5HOGMDQCA'K5]&KT
MF,-1^IM!OPV)Z1CUPQ_7F3#9!2RQ/7VUX;DEK9MV-W*Y:PUZXX2TG33,-F-E
MW/DGK,,>OU2\K1;(PPRVK&+%OQ7+/^;/"M.%MW?8MQKK/7EP<UDN\C$<@KEU
MS*QN,MS8 MY$+?7A+,H2L:"#NPA'N@LW/E9UJH5KRQQOL)/+K6NMC-_;=HSQ
MB\AL#;L]@2Y7.9IY?2OF-CNNM!P.-B326>4<_1YE1%L#E=SI;GA?O&K4<&SF
M-,W==#FRMR4GW7&)M#AC]/?%P/NF&.$5K@Q*N&C<2LE.8TFX0OR4N3<X=J:=
MK;*N6UL;P<>;U+G@Q$K,IA4L!B('V+6+#414S2&M=&SG )P&U.>4O&6>11,E
MPB+H8#9W(F4@UTE@#<N6:8\M3?*,K)39H($+(FS_ (7>I"Q1=3TXESB(WK6,
MQF3-5B9*=*=E ]A4DQ<G;KBZ3&GUYE%H)N(Q5MTN8O%)K(<(;PA9](90[5G!
MF-R;5"<PP(B1FI[+B.6G!HG F%I%_.JEN\+P#+FLW;X@#K^XK-U9B:K2?HPG
M[S@+XX1V>M;D:[62-5W#VZ(P_P"+[%+,.><M&?IXD Q%UMV 4S&IVJ&GSFR[
ML[KK%<G9KMK&APL%^?M6+8G7E(2ZUCV@>OH]2L.UPS->'.!P]B82=I&[N@M)
M %Q4]F?96ZZ1OEUF PC<(>I;B^R!^K^&^.TGN[5FT]\INCG-;?L[E)SH_LDT
MWZB8QTNS(=A*UBL^ZGUT\2]XVX]B86=Y;A$MKFO,!#K4SO![9B=H:UDL Q%V
M>*4G;_E*NU>7N$1%V>$"IGZ%[*IJU>R;O $7$7YB'J22I_9K:@U=00;+;^WV
M+<TGM[5J,KW-,+1A>K>/NL[8U69T^;.Q,(9YQ7/MI?;,1L_3YU1<#;9V*3+4
M[1I,T.<QP)!SN.!&:WE?:)JFEOI]V(-_**79:D&U;K!#TY*^VEPRM:^<80,;
MNOF6,W*WAL2](FS"+#U<L2KSMC<;;="F@@EMG,<E%Q<.,W1W"$0<?HG8AM!5
MND.+C $@$QL.2$NM\M"7I1#_ (38<CFM<)C"P45/X&Y$&P@W=*LWNF5KIJYL
MIO5V<V:6:7,;#]1:\1V9\ZF\-3'A'F9XCX[?;LP5\);X3E XM>UUL!'UK&)>
M6%RIZ\,8!&T*?QU!J55<^<TM!O%EO.MZ:RJM=3.FDDY$"SF4EWMKF;5B;0%K
MB3C;=DF6+,-?P=TP&'+"S!7+%SEP?(<_"V$/3[4:ZS3BRE<R\=N'2H6V3$;D
MFH9)+0<@.FQ:QDZXDS5KTZ?*FAO..SH6:LW=)=TQ@&&6'?L69/(BJBG$\PLM
M$+%K#4F8C#P^7.WA&%ES2=JU)IGULU7-VEF0P6;+CGW*8IZHF;+<QQB.5RF#
M&&W1SMUS;_=AW9*++A:)3S/8&C$]'J3%.UC'^:GS"70]'1ZE>LPS>V6S)T5Q
MW8CT'-=,LWM8FZ;23+@889)2=TRUO@ 7V7]?M7/&6O[)'+Z\/AZ.M,'MG;F*
M=U5!OWUJ8PQ.\RS/X2?42RX-))!PYN?).6LQ3]1X8?3//ND0OLZ-F"N$O;RC
M12.D-M!SN/.F,4G?.G(U+93(&,;/4/4KY:]L1&3]3:T0@M<L^^4%-U,.)%EV
M>P+-FR7ZE-4A[MA@E:]O"W:=(;-+2+X]<+5+N+.^)MV#I4IE.T1(!*N/H\WR
M]MY;NI;M1++008"&'(WKKUU'C[.OZR2) ))%YR2W-=OCERJ5;7-:2(B,#CMC
MZE,9=]RL5+J(!C$616;U>CXZEVZU 0!-T+PDZW#T=<>4?-JW3WV VGGSV*7J
M]/Q\+WP-+?\ G"G=NF!J&8',="QPZOV_^3=^Y7TUL/Q]-9_PCWK%WIWZQ]</
MRYS0>$Y%O_-)'X 7'Y9F8CM\-L^1WY4CW@?V*\%F*^SUW,QJH" @(" @(" @
M(" @(" @(" @(" @*#>HJ@2?Q9NF$ Y7B*]/P?+Z_LO%>7\GX?[/WSF1ZC_.
M-Y+M\P>%JJ?02G/G,HGN/ALWC$-<< <E_ __ -O/_@'_ .LO^F[?+^/UO]DZ
M7.)^K^_?_P ._P#^T?M_XI_N^GP_E]I/COR2;KYNN+^']0X"XFF:;6TU4)<I
M[Q[TMP'NN<,0O^6'^[_UGS_Z#_9W\'Y>G?/6WQ]W_8/_ $7^T_%_\G_TW7\S
M\?OT]NTG%^S#*UB34-WVRW ;1SKQ]?R^O;>*UW_U_P GQ7UMC%4ZY)I)9F&6
MXPA8!'&&2GR?F].G7.+ET^'_ %GR_-V]9VBT^5G!.J>8_&U!*IJ:J^KS)DK>
MA+<6P+VQMA!?9_\ $/\ QO\ -_\ )?\ ??'\?Q=>_P#7<>/T?&_\U_\ )?P_
M_$?_ !OY?D^?OT_MZR^?U?3?\MOE72^6O"FF^+++)LVC83O-#3$R[<!FO^MW
M_P"R3_PKK_XG_HOC]ICY.WQSE_Q?_P#VS?\ G/S?^9?[WYI\=S\?7Y+Q^KNN
MJG&;.F_>;Y(MC85_3?F[WO\ )?H_FOP?'.GQ=?\ \K#67-V$! 0$! 0$! 0$
M!!X-QYCV(+KPY_J75?VD[_1YB1GMR^"3]9[_ -4ZS_9U1VO4G+IW_A'P7Z+_
M *XTG^TZ'_2I2MX<H_JY_J\'^[WIO]GZ?_(!:\.G;^+Z,.,?Z13?P9[2LLSA
M4T40$%TX?_U3J_\  /\ ]'G+<\?JQ\O'_P#2_EJ?K%/^\1Q#_#ZA_I$Q<^W\
MG;X__B_X?DE]EE.F2?FBX:=*,"9^G?Z;[5IQZW'9_8<^3V;,G>3.@.F&+OS+
M0?Z*%(WWW8['/Y6?_".[2AXCR@YT_P#2Z?\ A9?X:#T$^UX);\M_$!!A_P!B
MZI_)/4[<+\7\G\?_ .;(D^=_%A-I^L._TFI5G#'?^3[$/U:0#])-)L^EIW:I
MY;_Z/\/Z%^KRFS]7TB4\1:?%)',6D]BUG%8G#\L?M:?.X^57RU<<4=+.9)?4
M:;4RB"_<.XZ4]T+",2KVS6NG75K^/C\Q7&%1QWYT<>ZS,?O"LXAK@SWBX>[.
M<TF,3](+.//EG-SB\/IO_5Y?FX\BOE$XBI^(/,[\W-G&K\=\RJ?(8X'=/O S
M8B(LAM3-:F^.7V55WZP5\FT@/;3:K2S)C2 -_6*4M.<0UC3Z4RGI?*('ZPE\
MI4+:_3H_VK*_=)D]'G_[(1^4G^OZ=_\ 765^Z4R>I_\ 9"/RD_U_3O\ ZZRO
MW2N3U9:;]80^45]1+9/U"@;)<??<S5Y <+#"!<7-OV)D]+X?C5]LK]JS\LWS
M4>3]9PMPM.TVIG4VF/DR'NJZ>JJ"Y[WS7 O;"YSR! " 6;,NG3'2;?SW]6U&
M73^:,S4]*(9+E<34D^D+3  -J)$($0A&U:\.7:R]L^']1O\ 5YO.35>*_)WA
MSAVLG[[)3*-F[XA=:)$L"PDX!27;IVD]?N^DCBL :J-LJ4?0 JQ.%>11 0$'
M@GWF-@27N#1#") ]:"?J)^E<":1J/$7$591T])2TDRI/UJ:R7 2FF8X@S#"X
M)F^3^6H^73[4/[?_ ,N?)AU=P%P1J>FLUJ1)K)+9M/7L+_&9[C3%KXWC!2_9
MKK))OE\;_GA]O%\T'&&H5#=#XFJ_JLRIJ'LW:^>&"6YQW(EKG8')69X+VG,>
MG]5]K3\W=7/?,9QA4L=->7!K:VL>8DQ@(%L>I/&'.]K79_ OVU?SC\"U\B=/
MXEU"=)EBV6:^KEO<,VLFM:TQYU/59V^KZ'OLY/UF2;H_$7"6@^=54^<:W4*>
MAJ/SA5$#\;,W3%SW##&*8K7;MTQI^MGVU'S9^5_S2_*/25/ &I:?.^MZ/43V
M-;6R:BH#:ACY@;&7 AH!%D,2EV=)B9?S,N-*-]#YB3Z680YTK5Z=KB+C_/%9
MPSW_ )/Z<OZNLQH\FM',!'ZMI]O_   F=M__ *-]3&L_Z[HOX#_'*LY<O^E^
M?/VI'^Z?QC_FE=_HT]3ORW\?#^-_\T']]_'W]NUW^D3%.J=O+[=/U4_5*ZF.
MF2I,PM8YI! A:#O A:C4X?>CQ$=^@<]UKC--O0%U[_QPX]?Y*$SX1T]I7%U<
MCZQVA18NO"_Y?_[7=^%+73_I<KR_GM?K6']X]9_:4_\ E'KEY=IP^1#Y-)KY
M/S(\ 3)9@\:N('_V\H^I;CG?Y?Y?V/?LWJ^KJ_EWX"%0\N#=%IX1/_(#+F5M
MTUW>V.LB&K5@'^6=V+*3AH(JV\',A5UCLY _E&JX\IVX?!K^LZ>:&J4G$FI<
M,-FGZI,J:^46;Y%[GB$(PN6>ULN'3I9Z/A>\J]';KWF+H>DEI+*S4#*+0-XP
M+[H%6\;<I_)_6(_5\_*Z5Y=_+U2>&PRS6:'2D@RPV,3(=?"*D:^28UX?N1K$
M]\W5*YCC%C)\P-Y@\@"',K:2:1J @XN:'"!V*"\:%,EUTENG3VA\IDA^\PV@
MM^&!C'[XKIF8^[G99<^'\[G]:7\AM&T?S*GZ]0R )WYQGSV.$H-AXAF$VM%O
MNN*Y]LQTZ_O_ ,/CP\A-8J.&O.S@:OIG;LRFXED2C:6^[OO;>",6A7&6;G.(
M_K_?8_<?U_&/R]\$RZR;OB1H\LM&\774QS)29;^2:R_5'BS1J'B[0N+]$KI8
MFR9NEU=% @.W3-HIXC @Q]XJ\N<N'\G_ .WN^6 >6OS"<3\4T5%42J:?-K9C
MG^ 6L(;43G#W@T#%9X=KUU[/1S[)7S\U?R4^970]3I:MLB1-JM-)+YIEM#FU
M1C;O &((5NF.F;=\/Z^7RG^9K?.GR<T;B>;.E5,Z?IE$'/EO#QXL^E+G&,3]
M)JN=)WDG;2_>:&N?H=Y-<4<0B8R3,TS2ZNL:^8=P!S'O MC?!)+A,SVE?R7O
MMR/F>UGSJ\_-?TB?6-J*6AUNI:_PYQF "5-F;H(WB/B:%F<NOR8]'ZI?JN?R
MMS>.?,*BXQU"EG>%)U3Z^U[I!+/"D33,:8D0@&,5YK/6^DV^M#[?7RD_^:A\
MI-?P_(D39LN@T>N<R5*E[Y:R5++6" %D&L4[?9.D]^V:_D^/G5_DCYYL;*\2
MF=H?$%.^8V9&4?!EU9A&Z  :DFM\K?V=L/ZTWV'OS#:5YJ_*=H6G3:JG?7T]
M'IX#&SVN>1,HG2WAS8DW@+4QPSVEL]G[0:=I'YOU1D\V,F2YK038-[=B=ERU
M=\,2W&*^&']:1^9 Z'55/"FGU<@R3--+-ELGC>)#?#=$-</I!<NTN77K<1\'
M'DSPQ4^8'G+PMHM'+?,?JO$DN:YLMI>[PYE5OO@!&(B]:8_ZM/ZY_P!BS\M\
MKR5\@>$M4^KS*>;J6E-$SQ97ADF;30C'=$8DJX;^7MJ/V,_.TF3J.K29Q]VJ
M&Y+M$(AAEC8;"F<5SQGJ^3']8'^RYKO.KR[U?S!X.H:F9J8T_4)DQU)3&8\O
M##-O8TF)\19[<Y;YGK'\U/S X XK\HN+*CA_B"BK-.U33YSVM?44\VF#WR9F
MZXRP^!=N. C XA7EFYZW[O>#Y9_M.OF-^7*;34?#'$M3+TUC94K=955$K<9*
MA"+?$+2-T9J63_*]>V;M^^7R_?K(/F'H,[2V<;<0B<V7(ERYXG5[C[X#8QWG
MXP4DKK>W1^^7RX_K*WDEJ[-)H^*ZW2ICYK V<9E=+:ZXQ(=X@(-BUFQRN+P_
M:GR-^U:^6SSY=I]/P]K>FRY^H.;*:R;JE*]@F..Z! B,([4EET3IVNX_063I
M^E\544G5=)U&BG4]0P/EOHW-G21O".Z7RWN@X1N@M7'AC<[;5:JI'Z?/-),]
MYS"07MM:=L5ETYVPH" @("#B?CE_MAVA!.^9O]WVJ?V+5_Z*%J)UY?R+?MX/
M]Z&O_M35?PRI>5[MC["B:]GS6\*;IA_/:#^78L?]2Q_78TP[_ _")=:3H6DG
MI_-M.MN=Y5AWQOYSVN4;\.* @M7!A#:NK'WT@'G(F-]12)VX?(S^LD>1LG7_
M "YUCBMLISJH2=1FAXE"\M<^PPBIY:WZ:?S4=)FS=&UT0,)U'5/D'#WY4\,=
ME"UBMX8Z\OZA?ZL)QQ5ZMY),TNIF;PF:'* !<28RY<N;CM8G747M/^7T3_./
MQ([ACY?/,6KD.#)TS1*QH,81#Y,POVQ, K;HZ3>7\:7[1KBJJXA^9[S!?/=O
M#\Y5)L<71WI[X>EJS.<K=:?JY^KL^2%#YC^?M'7:E)\26W7:$RXRP\!LM\@8
M@X@JV97X]5_5;X7T.GX2X$IM"IQNRJ6AERV" ;8^3+:;!L:M>MD8M_?I5I0#
M6D"SWB>M8;MRR*H(-B@<6:E1/%A;.ED=#PA>'HS]JOY72/,WY?N):*HEF8RD
MT#4'-:&!_O%DYT;C"]*?'<5_'P^;WA!_!/GYQKHI:YK)6HS'2@YNZ=WQYK;K
M(#W5?#-_E_E]('ZM/YG5VG^?U%IQF0D#4-/;#?-PFM%T=JY\7+>?'A_4&E[E
M374U6RUIH ]N/NSG;PM%ESEUQK+CG>'SP?;S?W"\4?P=9_H\Y8O+T=?_ (W\
MG[6?[S=8_P#$^I_Z5/5\.4_E_E_2I_5;_P"[AW]D5?\ )3%9_%KN^K[B/_6,
M_P#;C^38IY9ZIK2O]4:M_F3_ .0J5J\)Y?RE_P!8D_WG];_S[4/])>L.OA^=
M?V1\Z9)^:OA]TLP/BZ7_ *:Y6\.?7^4?V'/E@GS9_E)PP9IB?T?H/]%EI%[\
MK1,_+S_X1W:45Q0<Y/\ 2*?^%;^$U!^<?VT! ^5S6X_]W:K_ " 3MP?%_)_(
M-^98Q\U=>(_K-1_I$Q(?)R^T7]6= \723CX=!_B*7EOK_P#&^_7C'^BZ;^U=
M^!+5KGUX:_#GY>G_ (3U*LWE\@?ZUA_L#_\ PJC_ -%EK%Y;G#^<KY;_ -ZG
M"'_B;3_Y=JU.$O\ )_7H^Q(_W8^%_P#-J'^1E+7AKMP_7;BK_6O_ +.7ZEFL
M]>$ BB @(" @M/!W^L*S_-C_ "LI(G;A\27ZS-=JO\+7?XRGEJ?Q? YY*?WN
M<-?VP?Y8JWACK_*/ZVWV&?\ N_Z-_85+^#)4ZNGR^'Z_:K_K?4/\XF_AE$\)
MGAFF;4?6'OM\)F\#?;R"Z=+/+E\F=8?.'^LB>8=5I/R\U>ETTR$LZ17%S=\M
M]]TAX=CL6.WTCITD]<^7\JC4I\_6M<G;ULVJU"<QD"3;-J"&W\Z289MR_I=?
MJU'RY:/0^5.G<63)$*N7I=#.#S*;&.ZUWQ$9A)+;IO..FWUP<7O;,ET$NP^&
MW>Z2&CU*]IBXK'2ZRJ2C0@(+AP8\^+7,C89<IT-K7.'^,D9[/B#_ %E[R(HJ
M[2]6XX=*+JW=U&=X@EMC'<+OB C%3RZ<?'E_/Z\NJ^9I?%VF5DNR9(G,A;"W
MQY6(YE;IS^/E_6._5U.*ZCB/Y8I(J7;SI.AZ<YOO%UTR0TWQS5Z_QWRO?/MM
M^ZVJRQ+K*DYSYOX;MI4O)$8BB @(.4J4ZJFBGE@[[B (<]ZOK;PEN)EO<4\6
M\->4?!FH<9\55E)2TFFR739SZF=+DD!@<2UCICOC@W*Q6_MF*QOO=/D ^U!_
M6*N"N$*[7>"/*O5*&1J.ESWT+)E/7M=,<^7[I<YS'Q))B2L9RZ23KR^3;SG^
MW-^:GC76:]VF<35?U.:(2C]?GB6+<VN='H5N:ELYCUJ_]67YOJB>U\GBZL+F
MG>W)576O=?\ L8F'0F"][7<_EI]N'\X' .HR)M5Q)75,B542YDUK-1J6S-UK
M@7-,N8&B[:I9]"=OJ^I7[+O]91X:UOBV@X2\Z*L.^OTTJ2]]=6>&]CW$2W.8
MZ8?=>US@<;1:I)9RU;ULQ.4O]O-Y\<!?,YY8U/%_ E=ITRA;ITR<? J)4Z8X
M>"0'/<QWO/=&TYI;MOKULZ;? 3Y6@?\ S6] %X_2&8.<>/,6O#A.7]9?[!L
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M)Z5'?_9"/RD_U_3O_KK*_=*9/0_^R$?E)_K^G?\ UUE?NE,GJ?\ V0C\I/\
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M'"9NV[[8[I!B1?C!9]?+4OLTVN#A$*-68>400$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$!!N:?_3J7^%;VA)R>'IO]HX ?+6K!QT^;_C+KTF8\7Y/\+]</AA^9V5_
M\1:C ?O4[']E,7MG\7Y:VSYJ_*#C*6/K[N=_X3N],MW/GE4J8?C#$#$+F3+?
MF@1Z%JZFF;:WZ6);#G[4ZK?JY3VFRSU_?*X,Y1DV3O,=&%W+!,#K[7*3>+C
M_";NK()@=4:E3>&XF!Z4SX7&5&JI@8_;'EDBRQDI*QS3?Z86=>Q1J[FG8&BU
MY+F&V[[XX6?>IFQSG#NKARO="2(^D[=FQ5J8=]<.Z@ UD2.O8G"976?/$^7
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MAP\Z;DT@-P'W0L=77-X0U0;3 Y^M3M:3[HMU_6D>GXW)JLS_ (>KKMKSQ$&
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M1&L?D.@JQ9RZLJ/RCOVSO4N_3A7A0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML88Q"QO).<5R?J@#=VRRR_V+=Q#GA3M7K73FN:#@ZR)/<DOA,^*ZWKFET?\
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MRW%LN=*F.$V9+80X%OOQ)-VQ:8O.9_%W+4TDZ@F-DSX[[XN%F!)&*B\[8$!
M0$'$_'+_ &P[0@G?,W^[[5/[%J_]%"U$Z\OY%OV\'^]#7_VIJOX94O*]V3["
MK_>NX4_SV@_EV+G_ -2Q_7<TK_8?A'^P=)__  ;3KHYWE6'_ )1_.>URRZ>'
M%5!!:.#X_79_\"8]82)VX?/S^L"U&F,^776&3O!\7ZCJ/Q0WH^#A;'%766I=
M8?R>-<+#Q9K)E_ =<KBV%T#7O]"C$YT_I7?JMS9I\N*$MWMW\SDNOA 4UL>A
M-.EF>N7T=_:$"9_Y<N/"P._U/57?P+KU<;8Z5_&N^>8/'S+>8._'_6<SXO\
M.)\?0H7F/I(_5?IC/_FN4+6F7$:O3WPC^69GM!4G.U?TR-7W_J,PX>!(NN_)
MA=KGU^SGU_E]W7++NGU!<G1S0$&6E_IU+_"L_#"AX=;?.1.HI7DEQL:WPX?H
M]7PWX0B)$Z-^Q:_5.N-OXX'VF4ZCG?-3QF:/<@*BHWMR$/Z;/W;K,"I.$O\
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M[ __ ,*H_P#19:Q>6YP_G*^6_P#>IPA_XFT_^7:M3A+_ "?UZ/L2/]V/A?\
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M9=#U+,F&\K'2DMW</>M6L9<ZM5',&ZV)$8*33KK"8WHB&'M6K?+CC?W89CH
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M1KPBZ5A<]*O6XY7O2)#O<V[#G%,,]K+/N[$I*8[C;KCAS+68YR=L[2XI]T7
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M<N^'7FHV.=TK5ZS+?,5N9-+7$$\U_J4<^TOADDU!$+3;S[.Y),IFSE-T]:8
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MYO&/+-:C6HSZ?I3Y[[8W# \L5<2LWZK_ *?HIEM:86 1NVGF4LPB9EL;((!
M]V&"FXW+]4Y)KY360]V/1RP1FW+G43Y4UAANQZ.9!0M4D#>+H=F9*N/HW,8Q
MY4]Y<9D(FW#K"RS9)&[*I Z!<! QO$<\18M3Z$)U++8V.ZW"X 7I9A+CPKU3
M,+20#"!-W-L4P;D:TI\Q[A!SB+;C!+IF9SM:--,R(B3>,>=3EOB:=E:=/:R7
M!UI@?0 K9I-\H#7*P%Y SSZ,%(U-;:>G3RZ-NVTQQAV%-TN*GG .EW8D]2LB
M\S,5#56!OB68>I/+-S'6VHN+'.@4F^5S,*^ZM<QT(FPG&'=FKQ?L8C,W4W "
M+CUG-7,5:- KS.GM&\2#NXQQ"N<QBQWEI3 Z6PW^X#UD>LKG6NL\K53 2X80
MSYUJ3*ZOZ-V;4M#"-F8R4NB]8JNI5-C^8]G-!,SBL354FKJ('K_"VJY,M-M3
M[P]<.Y02=/56]0[%<-8BU44P/AT'T*6>7'O-IQK&D7*98NKAJ5,G>:ZP0ALS
M4LE3&;I4ZN1NO<2,L(8JX^C5W,1'RR&N$=G:%OQIGBI$54L"!RMMS4D,Y8ID
MZ4\0 %V,-O2M&<*5K3VAA(@+3AL47-KKBHF.\1PC9TX]*ENFI,-1SW"%IMCB
M>]26U+(S2'%QOCAVY[0KY2_18:.0)EXLL%O0I;AG=J<;I[2T6"[*'I@KEO$D
M8WT6Z( "Z-T<5?NS).:UFR-U[2<"+A!9M7KG*PTY 8 87"]:CTS,<RQI)LQR
M'<LWE,L8E;Y W0,;MB9PF6](I@V%UT;N6:6K+GE(-9"$!;!1+G_ Z63>,,PJ
M2^&A.D.Z($<H68K.-K9B/-/*W3:(\@K>$GW3,B6TPL&&7+%26M2XJ5E26 ?"
M(P [5K.3M<M:I8P1]T7$]2N-)X5FL(A&SHV_=4_]TDN4*:B#H*X;]<)6EJP(
M1LORQZ$PS4S)J1,$,P<8Y=*6-3C3(9&][V9Y8A6)C#4FRFVB&*=OL2>4>^GC
M& O,;HY\ZS:1P;21(B!>/HG-9MI9Y;\FC;"X7Y'EBKO";M;'U!IP]!2):U)V
MFM@#NBP'!:QM;C**GR? #H=$.=6S1>%>J*C==>;-L,L^99B7C7+A*J?>!][K
MVA,99S9,K30U.]9$X"]/7;4MJP2Y1FMZN;#):O#3S^:G/MW?1T8<RYV93$RW
M)&B.+OA!M^]VC8I=<(W*G3/ ED@70M V+<N6>U5Z8XRWF)(ASY;$M\1Q9I-8
MX$7YW[0L\-]=?JL5'J4( G"-^-ZLIV[9TG65K7 67A:EUEB3>V*=4M C##,+
MGG+5NL1%OU'<<8&'3M*W),9K.XRR=7=$-#CE?L]B:7JFI$WQ@"ZV,+SL*8BQ
MN_51,P&$;%FPSO%<VZ2'FQHMQALV6KI+)/NEPQU&B>Y<,<-BG;>R32AZKI.Y
MXD6C$1AB(YJ2I?NH=7)\%SH"XFWK6I<S[GEJ2ZT2G7P(VV8=R2+<-UM2:D!H
M)NOCC8/6K&.TS&84$PB-MUZZ2Y<:BJ[3G.!C&\]J7,_1KJ@1I+PZ,(B,;AWI
M77'T6G2M,(#8MMYEGP]7Q\+K24;1N1 LA&SGZ,5SCT8F5VTJ1+!9[HB",!GS
M)7JZ3$^[O/@^3+\:3[H_*LP;GS+-SX;?IG\KH UZ0 /^<4X_XT5G+MUDP^L'
MY;O]E)/^:R?P N7R/1\7\GL14WM_:KP=^7V/C_@U% 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0>"(D'(Q194O2ZM,DM$HRVO:(#W@#GL7J^/\J]?VV/G?/_ *_I
M\M]\V=OLV'R--KB'SZ:DC?$RVDVQV;5W[_#^)^3/;Y>O2]OO-N'7Y?S?Q?V?
M#W^3U_6N3?J.G^]34U+$8MEM!SR5GQ_B_!U_^[Z]9?MB)VOY?Y=]?F[_ "8_
M6M&JU.;5>ZYC6 6#=$!"Y>?O^7VLO3K-/5\/X'Q_#?:6VHP"!)MMS7E>^W+R
MB" @(" @(" @(" @(/!N/,>Q!=>'/]2ZK^TG?Z/,2,]N7P2?K/?^J=9_LZH[
M7J3ET[_PCX+]%_UQI/\ :=#_ *5*5O#E']7/]7@_W>]-_L_3_P"0"UX=.W\7
MT8<8_P!(IOX,]I669PJ:*(""Z</_ .J=7_@'_P"CSEN>/U8^7C_^E_+4_6*?
M]XCB'^'U#_2)BY]OY.WQ_P#Q?\/R-^RV_P!Z'AG^'T__ $T+7AQG\G]AWY.?
M[F- _L6@_P!$"D;[\QV6?RL_^$=VE#Q'E!SI_P"ET_\ "R_PT'H']KS_ +M^
MO_V+JG\D]3MPOQ?R?Q__ )L?[[^+/\X=_I-2K.&>_P#)]B/ZM)_M)I/[;3NU
M3RU_T/Z%^L3FT^K:1-?8T>*"=A(![5KRQ.'Y;_:Q^2SO-/Y:^.:NFE,FNIM-
MJ9I)EE\);9;V V1Q2SZ<M].TG6OX]WS&\(5/ OG3Q]I+V;K:/B*M+/=+1%TX
MF !'WQ1SQA]8_P"K(<,^2?F[Q0>&_-$:4ZJ953)$ME<)+HO+"98 FYQ"S73K
M;X^C[I9WV:GRW5SC5LT+3729T)K7,TNC?++(1!;,$S=<V&*N(S[]I?NP#[,O
MY:S:-"TXC9I='_[U,1??N?\ IE_+7_W#IW_UKH__ 'J8A[]S_P!,OY:_^X=.
M_P#K71_^]3$/?N?^F7\M?_<.G?\ UKH__>IB'OW/_3+^6K_N+3?_ *UT7_O4
MQ#^SLU7_ &7_ ,M#ZB15?F+3]^G?OL(TND@'"T6^*F(?V=L._P#A'R/X+\H*
M652\)2*21+E0+6T\IDMPW1 ;P9$ P"U,1);>5[?/F5+C-F1WG6&.RQ9:N/#@
MB" @Y2QOSI<O![@.LP0O'W;OF)JS.#/+'C;4H[CZ;0*^?+(L.^ZC>PF.P+??
M4S'/X\]^V*_D%?;4>;>I\;_-1QA0SZRM?);65L)<R<YTH@3Y@^$N(A%<9+[9
M=NUQ/5U']E-\L)^9;YA]&X:K*>7-TUM=I8=XLOQ&%YJ7EP(((N 6[PQUU=OZ
M\'R6_+;PY\L?D[I7#FD4&GR)WYKHGS9E-3LDS7"53DF6YX:' /<Y)#OVS</8
MS]-*EV\!1R6P-^\\XG.Q,GJ#C*J$8TLEUF;AV%,GK$M1:K3\0TL_3]0HY/AU
M<J93S9,R$V3-9,:6ECI4QOO @XE$LQP^.']9(^SI\FZ7RJJ?-W2*+3Z/7ZNC
MK*FH;+HY4B:Z?(F37AS?#)BP@  Y@V+/:6;C?7M[_MK^;Y5Z>W2^*:>B9\,C
M4Z5HZ*MH'8M2YC':273^H1^KK?W,Z/\ YMI_X 4\NEW\;ZE=9_UW1?P'^.5J
M<N7_ $OSY^U(_P!T_C'_ #2N_P!&GJ=^6_CX?QO_ )H/[[^/O[=KO](F+/7E
M.WE]LWZJK^4TOE]\MQJ<5][W$'^KG?PI77Y/XN/7^2AL^$=/:5Q=7(^L=H46
M+KPO^7_^UW?A2UT_Z7*\OY[7ZUA_>/6?VE4?RDQ<O+M.'R&?)Q_O'\ _VN/Y
M>4MQRO\ +_+^QM]FM_N\<!_V+3_R 5;[\/;W6?\ 6]9_#.[%E)PCT5;>#GQJ
MZQN4@?RC5<^$[</A._6<_*75*[6M3XM;*_FDN?73"_PW'W8O<3$""Q>NV^N?
M7+X/O+/6&Z#Q_HVK.<0VCK_%W@=TP$P6[%J\,==]G]7G]7D\U*?S$^7RF8QY
MF/I-$IV@NF!T-TR08")-P6>B_)O;]X-:IIDG4ZV:X0ES)\TMLP+BX>@K1+,(
MM 0<7NW1':H+UH[9&F4@U2I<)<DR7E[S9!L-X&)(%S%O4ZL;MP_G*_K1_P P
MNC\1>:%3P]IT^,]NISI+6-FM<(2G/C8TG!JQ;;<>&_X:?(U\O.A5/%/GAP'I
M],TNF5'$E/--A=9OO. C\3@KG3/E_8,^R/\ +NOX(^7?@>=72_#;4:/*#3NE
MMKJ>&("=973Y;+)]7Z1ZG4F3KL]\LV/GVP/->G%9YC\X_MCO*5_FS\K>MZ9(
MIY4Z=*T_5B"^5XC@PT[' " )A$J=MS!\?+^0#\SW 4[RW\V=?X=FM\.;3UM6
M\AK#+W2*AP! (!%R=9B'R8ET^X;]5W^9^?\ 6^'_ "]K*B>YU524M-X3Y\&P
M=+9+/NEUT$SBX;DS\>WL=^M->?T[R[T"GX3943Y+=5IPTME3MQKC-IP!%H=;
M'>2W%.EQTV^$OY#O*BI\Y?FAX)HG2_%I7\2MKIKGL,T/F3*S>]ZPQ/OE+=,=
M>N<U_8\^2KRHTKR=^73RZHZ:3(DU T&C?.,J6V79-E[@B1 QS6HG:VZ>T>E5
M/YRDZZ'@.$^6YH#K06NDSI9!!O!BDY3L_G8?K*_R:U.BZ]K'F;34<F7XK*RL
M#Y=.0;WO^(-@HZZ]'X)_8L^>VI>4/S8\*M943Y>GU=;13)C63BQ@<VJ:'1$0
M+0Y2SRY]=ZO#^HE\X_G]PW7_ &?_ !-QI*KOYU5\&4]06MFLWV3VZ?4!YWP^
M),6^E;DEY^B=I>O;3^/+\QW'^H>9OF_QI7OF3JAC^)=4%-XLPO)A536&%]BS
MC'Z+;>VH^VG]5O\ DYH-<HZ/CO6:6G>^3)F:@YTZGBX.<]TPP<YIMWG)-U;^
MV8\OO+U<2*#1J?1J> 92%LIK6B #)1.X(87K?:3&G/KG.U0;8T+#H\.;O0M(
M@8V(+'1<4SZ&4VF^KLG-9<27-.WX;TX3UE;&J:=P_P =T+J'7=-TV;+>/^=R
MI<]P!:6P:Z8P$"U:EF$S>MT]0?,+[.;Y=O,OZS^>M!TPFJF.F/\ "TRD?[SB
M2?WP9K-F6O[.T?E9\TOZO-\M_F#HNJUW"VFZ9*K9PB)4S39<N9$PB0&;[2(C
M-:Q,:Y)V]K^[A\E'S[?J^/F;Y4RN(=;\N-"$S3M/D3:K?IJ"; -:PF(+)9R6
M+G/V:LZXSU?+GQ]Y?<3^5G%%1P[Q)3S:'5=.G@NW!,E3&/DS/C9O .8]CFQ!
MP(5RY8K["/U;GY_^(-,\R*#ROUS4=1FZ;*K=/IF"IJRYFX7-:+'/(^%9F973
M]MZXC^CKJ)I>(*:GU:B>)DGZFR8QPA<\F8(D'!I73$LRQQ<*8#&.PD++3R@(
M"#B?CE_MAVA!.^9O]WVJ?V+5_P"BA:B=>7\BW[>#_>AK_P"U-5_#*EY7NVOL
M)Z>=-^:WA3PVQ_GM#;_[=BQY6/ZZ^FM,K@CA)K['-T+26GG_ #;3K;G>57=\
M;^<]KE&_#B@(+7P8(U-6[!LD#I+V^H%5GL^/?]9/\]*?0>!]6X0\5S:UTK49
M08)S;[60W8@WK.=NGKGX\OYNNAT\W6M>:R^;65#YIQ._,GM>>?WG*WASZ\OZ
MC7ZL7P%5:'Y&-U2I9#<T.5NG<+?RK)4H7_MU)M>ULT^AWYON&_TK^7_S&H9#
M0^<S0ZT@0+K62GA]@B8B(6^&8_C4_:2<(5G#?S/>8 GMW0-2JA\!;=/?"T@"
M]RYR[;L\OTS_ %>OSVH_*_Y@:*CU&<9<J9KM!X8\0,$)CY1Q(^D2M4Z;N']7
M#@SB"GXR\OJ3B"G.]*K*!DV6X.#HADB6\F(B/I+7M;,>&;,=M*]*(+21]\1U
M+#3(J"#9T^69FI43!>9TO^4"&<1Z"?:U>:-/Y8_+UQ'75,PRV5>@:@QKA,$O
MWO#GL(M(V)3XYFU_'Y^;'BL\9^>W&6N;SGLJ*]PEN+MZ+/'G/OMQ>DX9[3]S
MZ8OU9_RHK*_SYH=6>P&G=J&G/!,LPAXH-\(*3EOM/VYC^G<'-D:E2TC;&_4"
MUH_8R70;Z&K>=8<O7_J?/#]O-_<+Q1_!UG^CSEB\N_7_ .-_)^UG^\W6/_$^
MI_Z5/5\.4_E_E_2I_5;_ .[AW]D5?\E,5G\6N[ZON(_]8S_VX_DV*>6>J:TK
M_5&K?YD_^0J5J\)Y?RE_UB/_ 'G];_S[4/\ 27K#MX?G/]DG_O5</?PNE_Z:
MY6\.77^4?V'/E<_NCX8_\/T'^BRTB]^5LF?EY_\ ".[2BN*#G)_I%/\ PK?P
MFH/S@^VB_P!US6_[-U;^1:EX/C_D_D'?,I_>GKW^<U'^D3$A\G+[1_U9S\II
M/\'0?XBS>73K_P#&^_7C'^BZ;^U=^!+6JY=>&OPY^7I_X3U*LWE\@?ZUA_L#
M_P#PJC_T66L7EN</YROEO_>IPA_XFT_^7:M3A+_)_7H^Q(_W8^%_\VH?Y&4M
M>&NW#]=N*O\ 6O\ [.7ZEFL]>$ BB @(" @M/!W^L*S_ #8_RLI(G;A\27ZS
M-=JO\+7?XRGEJ?Q? YY*?WN<-?VP?Y8JWACK_*/ZVWV&?^[_ *-_85+^#)4Z
MNGR^'Z_:K_K?4/\ .)OX91/"6X=JA3>.UUGBMW<K2M]6.TR^=?\ 6//+>IUK
MY<ZS5J67%K='KFN(82=]DA^] @%3OVUE>NIA_*9UJDJ-$URI8ZR=35\V8VPM
MME5!<WFM"S+F';]M?TE?U:7YE]+K/+73N#9L^-7,TRADAIFMM.ZUOPDQO5SB
MM8SU?8'Q<P2Y=!,NWV[IYP&DCTJ]KFYK'6295)1H0$%QX,EN$RMF$>[X<IO2
MYSB/P$C/9\,7ZS#Y^TE))U7@)TTMJO\ M&3N":TVEI:1NQC>I99=NDL[=-/@
M@\LM.F:KQGI%#*MF3YS VPNB?%E8"U.W#'29N']9;]7@X/JN%_EBI_K;=U\_
M0]/#?=+;"^0[$"/PJ]?XX.\LNW[B:E-WZVI&4^;_ "CKE;<JT% 0$'D,\0AN
MWV>M)L=3?.=Q3/X'^5SC+7:5SF3Z/2&>&Z62UP<:.I>2#808M6KK+$UVGZOX
MY_VBOFCJOFCY\\5ZGJE363YE+Q!J<IC:F:Z8UH,^=:T$F!]WTK,=/EQR]ROL
M8ODL'S*^=7">IUE+*GT=!JP<_P :29C-R74%IB2"(0:KI.DS']9OY??*;AKR
M"\GN&>'M"TV@E.HM*H6SGTU/+D.?-?+ +?$:TO( -HLN4DPG;M>UP[/=QE4G
MX:64T?MG$^FQ,IZO XRJA?2277?2>.PIE?6-N8=.XYTS4=!U;3J>=255+,9.
ME3VMJ91:_P#%Q\*8R <-^PQBKIF9ZW+^?C^L??(=Y:<#ZYJ?&&@T]!3SS65E
M6&4].R46EY?,W7!E@<(W9K.<5UG6=^OM>7Q1^4K!*\UN&Y;?AEZ[X8YF3'M'
MH"OASFNS^LY]@Y_<-HW]B2OP&*=73Y7[7UW^TLW_ #P?RJK'A^3?VY/^[#JW
M]CZK^ Y3MPU\7\G\BOY@/[S^(/X>9_I$]6<)\G\GW/?JSW]%TO\ ::;^"%/+
M?_Z-]V?&?Y2B_:3>T*USZ\*>BMK3G;NIT+OO9\H]3P?4DIG$?G=]KMY.5GFM
M\OW$\NEDB::'AZM)BPOA[LU]D!8KC65^+%N/+^0+\TG"=;P7YY\::'7L,M]/
MJS]T%I9^+$PMN(%@(*,=OY/IK_5T>&/*OSA\UJ+@WC9FFS)0U"ADEM8V2\>_
MNQLF#)9PZ7MB:Y??E5_9H?+G6S1.=H&GP(  &DTI&[9"!\2VQ7$9_L[-;_TR
M_EK_ .XM._\ K71_^]3$/?N?^F7\M?\ W#IW_P!:Z/\ ]ZF(>_<_],OY:_\
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M;XF]'K6?NZ1>]-FM;+ RAV<VQ:YC-N\)IA#G"V]<[]69G.4G('H'J 5=$LP
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M:WB'[X>A3-^B-FEGP>(PO[MB9:Q%KDU$O<$3EV<ZK-89TUIC^V./L0SA%U!
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M-8;;4FBZJO"6W?C^R]$4NV;MOB8&MYN621J77W1=756$<W9$X+7*2(42_'?
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MC]6/EX__ *7\M3]8I_WB.(?X?4/](F+GV_D[?'_\7_#\C?LMO]Z'AG^'T_\
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MI+PK5\):CY6\":].G5M%1SJ*9(IY[?CFEY((;,L]Z8G+4MZ33^>Y.FZGQCQ
MQS Z?J.IU,J4P..\YTR;-@V-\0"ZU.(SFVR^7],?]7)^3C4."/+/1?,S6=*D
M2)LZ305#9_A;KW%K!-<02P7!29RZ]K/3'E]<SI[)W$E)X9B)='.:2,R'N]:O
MER_Z</GS^WG_ +A>)OX.L_T>:I>73I_"OY/FL_WFZQ_XGU/_ $J>KX<Y_+_+
M^E3^JW_W<._LBK_DIBL_BUW?5]Q'_K&?^W'\FQ3RSU36E?ZHU;_,G_R%2M7A
M/+^4O^L1_P"\_K?^?:A_I+UAV\/SG^R3_P!ZKA[^%TO_ $URMX<NO\H_L.?*
MY_='PQ_X?H/]%EI%[\K9,_+S_P"$=VE%<4'.3_2*?^%;^$U!^<'VT7^ZYK?]
MFZM_(M2\'Q_R?R#OF4_O3U[_ #FH_P!(F)#Y.7VC_JSGY32?X.@_Q%F\NG7_
M .-]^O&/]%TW]J[\"6M5RZ\-?AS\O3_PGJ59O+Y ?UK%S1P# F!_-5'_ *)*
M6.W+I.'\YCRUW?\ YJO!^\8-/$VG"///:!Z5?#%_D_K\_8GT@E_*[PM-#3 T
MM# X?D):UG,:O\<OUKXDI:FIU?=IY9>[PY=@$3<$Q699)M 3J6HI3NU,LRW;
M;%,5J67A@O0$! 0$%IX._P!85G^;'^5E)$[</B1_69G#_M01$?%KK/\ "4\M
M3^+X'_))N]YO<,M$23K)NO\ RI6JQU_E'];W[#FG?*^7[17%CFC\Q4MIVME+
M,=/E\/U]KJ*LJM7U'ZO*=,A438P%OQGG5Q6<S#1?+J:*=*\9IEG?;O7BR.*;
MA,5ZA_:9>23O/OY=M<X<HZ.575#=,U.<UKV!\&OI 1@386IVSC'@^/E_'U^>
MCR?U?R8\]^).%M3HVT@E555X+&-+!%M5-#K"UN$%.LQ,'R<OU"^PQ^=%GD9\
MPO#FA<0ZS5T&@NF4+#"<YDK<%1*8Z]X; )A9V\/ZQ/EUQYP;YU\!Z#Q/PGJ<
MK5**ITNAJF36.:XRYM12L)EO(<X;Q<V^."O+%EZW%>:G3-0I)CQ/D%DL%VZX
MB((!@""# CI3%7,:FZZ, #'!16U)TO4JHL,BG<]F]!Q $&BZ)),!UJXIF*CY
M]>=?!ORX^7>K<5\1U@H3)TZ?52W%S!O3*64YV+A8'DC:JDGM?L_DJ_;4?.;/
M^9+YE]>J](U.IK-%E5>HEI,TF62ZH#6 >^0?=BEW<G_Q_MG#U&^S9\D-5\Z_
MF6X/T*CI&U-,VJD>*)C2YCO%J90 A BP,,>=0ZYER_L'_(OY'4OD#Y)\+Z$:
M>31S9F@:?XLN6T-'B-DRIA!$&VVJSC-^J_)V]NW^'?4]V_55#\'S9C@>=Y/K
M4,L: @(,T@@3 3RN5Z\CUK^T6E39OR><>"28.&F2S&V[\WUF2U<;<[_*/XU'
MS=2ITOSEXV\5V\3Q)J0Q_K$_,!<YRZ=^'U%?JP'&O!^B\7T6GZT)!KIM94,D
MB9N;Y<:J8&@;Q!5J].'])"N!G<)4,R0S=8Z52S6M@/=E/!+#"T0(<$_1C.]J
M.UP  )M$8CI1IYWVY]J"T<(2YOYRJ9D/Q7U9PCA$S&$<ZU)K+/9\=GZS$)5/
MHFK"IE.9,F.JW2W.A!P>UY!%MS@5B\NG7/KI_.[\J_[V^'__ !"_^7F+3E.7
M]9G[!S^X;1O[$E?@,6>KK\K]KZ[_ &EF_P">#^558\/R;^W)_P!V'5O['U7\
M!RG;AKXOY/Y%?S ?WG\0?P\S_2)ZLX3Y/Y/N>_5GOZ+I?[33?P0IY;__ $;[
ML^,_RE%^TF]H5KGUX4]%<Y;O#FRYHOEN#AT&*"1XYT&B\P_+7B_1JZGE5 KM
M&U2F:V<T.!F-T][I0N,(S%K.F.O[>V7\CS[;WY8M=\I_F5XPXBJ-.E4.F5%5
M5.E.ERRQKPZ>]S(>XT$E<Y;G#I9KVKU)^S,^:6L^6+SUTCB1NH5-%23=2TV9
M-=)F.:(LG!CR8.$/= 6K<;C/2[V_KP?(;\TO"/S/>1_#NO:5JQK=5FZ93,K9
M3YH?-]^D!#A!YANEIBG6YY.TN<SA[)UFC:M1N<YS9@E1^(.WFP&3FDC%:LG@
METCBYX,#.F1%AM)M65 7DP$Z82;K2BM^1I6KU.ZZ0R<]A)B0;!SDD!,?5G,;
M>I:MP?P;3,G\8:A+TTS -UU7.<R68PN+'@DQ6L3"3VO'#5_.&BZ]2C4.%ZIU
M90O;$3I,POEFV,6G>)ASIB87-EVU9'B2YGX\F(/THY^M9NN%O&G3'SQ2)U3\
MIW'\JFB)CM&);"/]6JO65K3G,Y?QL_GLH:VB\\>-FUCBYSN)M1W28_Y6?@5C
MKCPZ]^'[2?JYW$7#^D><>FR-6\,SYVLO$@/W8VSS"$3FE7X^']2W38S?+?17
MR&%K':?1S6M&$IY):=H@X+4F=.>9.VU::X!H#C XCM4:<M]HQ[4%EX2ES3JL
MR9 ^$)$R)PM+8>E7&LI;,/D=_66Q*I^%]4-1*<QTWZP^4YT(.#Y;RUPMM!:5
MF\M],^NG\X3@'^]G1/\ Q/._EJA6\.?7^4?U?/L!_P"X_1O[''\BI.77Y/XQ
M^Z6L2IL[6ZT2F[P;-)="V%@"OEB<(;6^//+SR[I!6<=ZM3:,R9 ,FUC]R5NY
MV/!C%;G7+%M2'#_&'EUYB41J>!M5H]9<X19,H9F\TW_%O.L@I@EO^'.?H^JT
MX+ILE\MHB-X0@>EI(*S9O3>8CB7ML,YX.0)]2@E]/US\W @L%28'W7Q-ZU.U
MQA+US<K)5-H.)>%]9%?H]+.DU&GZA2S:>?)DS9<^6ZFF-</QC+ 0[GR2Z9LG
M$?RZ_P!8Q\CO+_@'S6XAXAX9IZ&DKZZLWI]/2-EMW'/JAO1:T"Z*S.73O,=8
M_&+[-C4=3T_S]X?F:7/FR9QU;2@1*+@2#4@1,$J_#9,O[#/R25596_+7PU.K
MW/?4.TOWW3(EQ_[/E7DVWJ^&.USV=O,$ 1^R**Y(" @(" @(" @(" @(" @(
M" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @("
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M M<N-F&&:QSFW'J/=L7+&\G+0-*Z/M'<NF7F[3;/(I3'GV\RK/:2+)24< #
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M71/*'W47QA+T]>)9'O&V'HM6I<I9*GZ/4=]P,39#TB*SCP74_P KC2S&N%^
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MYJNUM6X VG$89DYH;4ZNKG%Q][TC;M4:FJV]*JB7MB[[W$9\^U6'9V5IDT/
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MF2X09"&-W>B-AA=+L=RZTS9PU.=M^6X3.KU16FF^RD:^V C?B<89)=);AR-
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M8)M.]P)A>#V04]IG!++HI9!;,&]GW;-BMNBKMI;Y; T.OLR6$F\U,3ZB7N$
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MGUBB9-=4:DR :7B %WO &%G.H8QKRK(,1%!Y0$!!Y:=U[7B]IB@G=2HI?%?
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M3P1-F:E2%X-\75;'?XROAFW+^HI^KKB'DSH_^:Z?^ %)RZV8Z/J5UG_7=%_
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M*.8YDL 6!C'%K19"( N5MS69/*O 0 &2RJY\'SMXUDI[HQ;+< ;1!I<"(?\
M"6N=,]GP6_K,'RI:A456J>9E!H#7RR=1J14-EQN#G[T5G&*Z=;^S#X2^$^--
M:X*J9K]-J9]'/\0$F6XM<Q[1ND7V0@M>'%.2]4USS6XVTJGU6KG5]56SF4\K
MQW%QC$& B<=U9QK3?7=Q7]/']6L^7"C\N?)RFX@K]!II%7,TALV54.EM+B^:
MQK=^T1)._%7KF0^2>MQ'TPZY5F96U5&+&2ITR#18![V NLBK;DD\H,6/E;'M
M[6J*ZZ^;WRJD><ODQKG#3Z9E:YVDU\QLET' NFTC6BS,EJ5.G.7\?_[5+R3K
MO(OYG-;H95$=.:ZNKYLOPO=A,D5F^TV0S2<'>Y[9>B=7YN<55>B3-$FZI5OI
M'L,LRR\ENZ6PA"-RK$Y?H/\ 9,>1U1YH_-%P%,F4+:RD;72"_?$6C?GRRYT#
M$8+-KKUZZR_L'>0O 6F>4GD]P1I5#2RJ4R-"TL36RP![U11MFD&%BW.,.5W5
MCG/\>M>^_P >9'_"/I6?.72<//%_$+?+3A#B+7VL$Q]'I4^O9$1@Z3)G.$,H
MP5D9NZ_FJ?;*?;"^;=9YX:KP%PWK6J:73:=55+S]4G3)0#9526-CNN:+=U9L
MS73WDF*]B?LJOUBS7/+/2J7R[\Q-9JZEK7TLI\[4MZ8"UQW2X&=O-<!FKFR8
M,SMI]O7RW?:%?+W\PW#%)J!X\T.DK9]+)J'2)]3+D2_QLL.<W\5:' FRR"O7
MOAS[_'BRQ[62>,/*"M F4_%^BSFO&\#*U-I:0;8BS%.3/9Y?Q?Y04+A4SN+M
M%E"68ETW4FA@M^E8#><U-&>U?E]]HW]K#Y-?*/Y>:Z=!XOT?5=:_,5=);*HY
MDFH$J?4TLZ7+\%SHO#Y?B Q$(.NS2W$RUUZYW7\IKY]/FRU3YK?._BCC>=43
MIM-J%=/;)\1Q#'";.>XD1,( O4DWDO;7J_:']7.^4[B?CSS_ *+B34=!,S2_
MSGISI=6]A<WPV36P@XB$,>E7/A9/2>S^I-0:;2<&Z!3Z#3!C9<NA9)8&B (8
MPR;+!@%7/MVM[95!HM<<SR[5ET<E4$!!Q/QR_P!L.T()WS-_N^U3^Q:O_10M
M1.O+^1=]N_\ [T&H?VKJ?X3E+RO=^*W"[^+M,K9.L\+?G*GK*9S72ZN@W@YI
M!#A:+Q%J,/J;^R9_6 /,;Y4:C2/+KS-U2NJJ'P)>G$ZEOS91:"T-:\3]Y@(:
MV,"L^N\QTU;,OO+^4K[5?Y?OF.X;TBKU+C;1M-KM2IF3'RYDV3)8V86%Q:\2
MX. CDMSMZ[\L]^DG#WR9YN^0]7+^MR_,#AE\L_O@U0@6G(@%,9N6<WKITIYU
M?.]\O'DAPSJ>JS/,#0IU73T,ZI9(IZQD]L93'%K3XE[R1A$*=NWAKITS<U\0
M?VQWZPG4>9O#^H>4'EYJTVGIGRZ^E,[3&"6V89L9?B.-.&@DM@"3@ LRY6_L
M?$5Q+Q)KO&NMU&J:M65&IU];4SIC7SG%\USI\S?+07&))*UPQ;>U?65^KP_9
MM\0>:W'VA>;G$W"9.FTHI:J1.J9-FYXS'RW&((#G-;:LX=ICUS>7]+EFFT'"
M/"_#NB:53R:25IU!34(E2&M;NB32RFNB6PB2\1Q5<9NY:6F5IE5<AKK94R?+
M=,;@07@NC;B$:LR_)O[9'Y -"^<'R5U^HHM!HZS5]-T&I<V:R5+#WS9#)CI<
M-UL8AK0IVF5Z7ZOY-/S7?+YQ?\O/FYQ+P=KFAU.ET^F5CA23BS<E.8V;,:""
M2#OAS,E9PSVSE[R_9B_:A^8/R2>8NFZH_B'4WZ-]?HW&G$R:Z0UK)@!:6@[H
M$%+/+4[ZQ7](_P"1O[:[R3^9K0Z2=Q3Q1IFC5DVDI=]KOJ].\OF,#7ET TDD
MWI.VR])C,Y?K/1^<OD)J\F554WF#PU.9/EMG-)U,M.ZYH/O @ .&*U9G;GF_
MQ5SC#YG/EZ\N]&J]:K?,/AYHI&NA+D5XFS"X V$/@S=$%;?6863VKY;_ +4S
M]8:X3\M.&.,^ _+;7I-7-K*:;I\NHT\2S,)?[ECI7O&VV]8MK>)'\\'YCOF&
MXV^8CS(USC'7]:U'4&ZS5E\BFJ9KR!XKXANY,-A)<!@K(G;MG4X?K']C!]FO
MQ=\V7G%HU7KG"TUW#U+K= ]D^JE^XZ7+?+>XQM; G;<IVWPUUF.7]6_Y=O)+
MAWY</)W2/+S2**EHSI= R6[P&LC,>:9DEL'-^\<#%;\1SMS<^'9G"TU\[6"]
M[BX^',A']HX+,W6NW#\&OMY_[A>)OX.L_P!'FJ7ETZ_P?R?-9_O-UC_Q/J?^
ME3U?#E/Y?Y?TJ?U7#^[@_P!D5?\ )3%9_%KY'U?<1_ZQG_MQ_)L4\L]4UI7^
MJ-6_S)_\A4K5X3R_E+_K$G^\_K?^?:A_I+UAU\/SG^R3!/S5</0'[[I?^FN6
MKPY=>7]ASY7/[H^&/_#]!_HLM2-=^5LF?EY_\([M**XH.<G^D4_\*W\)J#\X
M?MHO]US6_P"S=6_D6I>#X_Y/Y!OS*?WIZ]_G-1_I$Q(?)R^TC]6<_*:3_!T'
M^(LWETZ__&^_7C"VFTP;'?@RUJN77AI<.S *JF8;R\$=15B6>7R-?K5.A5]=
MY=,J::3ORSI=+%QL$&TTH'980L]OJUUMX?S9-.KGZ!QEIFH7/TK6:*I,,#(J
M)<P]05G#/;E_3?\ U>_[0?RYXH\L='\N>*^+:329]))IY$EM7/9*E^,)+6R_
M$)-C-^$=BN&^TGKI](OF5\V7R_>76FG7M6\QN'_&W=V6VFKY<PN ,!OAT&",
M;(6I[8<_2U$>6_S#>7/GC1'4.$^(*;4X1W1(F,>"+0WX2K.TK?KZNU9M/,I]
MT3&EN^(MCC8$[?48ED$! 06G@[_6%9_FQ_E921.W#XGOUF31=3=(U6O%.?JC
M9E<3--@A;C&"SY=9)_7E_/KX!U]O#7'6F:[O#=H=0=/#A= 38@\Q"U7'I_)_
M4/\ U>OYT_*SBOR8I.'N(>,M.TG4Y&BRI4J575+),OQ)+9;GM>221[DLPVP2
M.OR7VF8_?'S.^<#Y>O*NG96ZAYAZ#]<U&9%LNFKI<T/WC[SG[Q@"3< M2N/K
MFLGEYYZ<!^=K9<_@_7)&K;X#AX,QK[2 Z'NDBY68;G7TCO?3I5-J3-2T3594
MN=(F4AIG2Y[0YKY<X.EO #@;2UUZ7<PS=7VCX!OUBK[*G5Y6JZKYV<#\)LGF
M&HUC_JTJ,029PCN#(KG.<.MO[/;R^&[3*_BCR\XADUDAU;H6L4,T1M=*GRS+
M>USFD-,1!S5IQEQ7V-_8Y_K!NM^2-+I7E1YB:Q4UM$ZDIJ'Q=4:9\MGAF7+:
M]OC[[/=%Q%RG$=?_ )'W5_+_ /: ?+QY\\*:/J<SC[1*2NKZ5D]]//JI<B6'
M.9O.:?#M:8W6*SMX8[_'.8]CSYL^1#&?6#Q_PR&-^G^=# 87 15]<;9S;IZJ
M_,O]HO\ +W\O7"FIZC)X]T2MKJ2@G54N5(J9<^67LEO<UH\7WBZ(MLYEF]LN
MG7XY9M\#?VO7V^/$OS$/U+RWX,UNMD:<VEJZ/Q*+?9*#'OF,;;+@UH(ZU++4
MN.MQX?)Q3TO%OF+KQET\NLU_6:ZH%D?$G.?4S8 F)#MTO.U74C.^S^@/^KL?
M9-U.ET>C^=G''#,NCK::EH:UAJI8:\N@R8![\"22G7^7V=.UDZ8\ON X@GR*
M>BT^AH0V5+IY3&ADL0:QC6-EMEV0%@:KWF/^7+HJBC;P@("#PXEH!%\0@@O/
MO@9GFIY&Z_P6&MGS-5TOP?"-IWF4\^7:-F\EW&9_++^1_P#;-_*1Q1\N?G[K
M3:K0IE)IFI:[J,T5#60;%[ITQA<3 ;I;%23#?R<O4[Y"OF]X@^5GS<X1U_3Z
M^II-/E:S)-693W!C9<R:7$N -Q>0.E6S*=.V+A_6!^SD^TD\GOFI\G.&6ZKQ
MGI<G7I>D4U--D5=1+E/FOII8<X/>#O[X#;(Y027"_)\<QI^E\FN\NZ[\=3:[
M13FNN,FM#F87>X5>=L3VQ@J*KR\I6[]3KM)):WWB9E:UH &?N7*:/W/7SSZ^
M<?Y?_EW\O]8XIU+C_AR34T=/.--2MKY4Z=-FR99F$/9,.Z&CM/.M9TO6>W;%
M?S0/MK_M=ZCYMO,;5M X<J17:')KZZ4V=(+?!$F7,=+8&[AW0W=-@&"QC.V[
MV_K_ &3A\]'E!,,[S1X6FF^;K+)AYWO<X]JMX<^N^S^M#]@Y_<-HW]B2OP&*
M=6_E?M=7?[2S?\\'\JJSX?DW]N3_ +L.J_V/JOX#E.W#7Q?R?R*_F _O/X@_
MAYG^D3U9PGR?R?<]^K/?T32_VFF_@J>6_P#]&^[/C/\ *47[2;VA6N?7A3T4
M-H(S""<TC4VTLN9I\R#I=8[PW1%F[,:Z6[K#E9,I9E\T/ZP1]F%2^?WD_J_&
M_!7#TFKUV3I]<^8^FE_CQ,E2G/:Z+ 'QMB"%FZVWUOO/2OYA/FAY9\8^3?&-
M?PWQ%0U6CZAI]2X22YSI;R)<QS6D&(<7!TLJRY8[=;UOV?OO]E%]MWQ]\H&O
MZ/PMKFLZC-T-YHJ=KISWOD?BW[KFWEK?<SO"EUMOKVEGK7]&#Y./M/O(;YHN
M$J34:_C30]+U"KH:>J-/4395/+WIC&E[")0WFNBZRQ65GMTQP]Z9/&GD[7#Q
MJ?C'1)K9@WP96I@M(=;$1!*O+.:\3N-_)N@!G5/&6AR6R[2Z;J@ &TP$5-3:
MY[1Z9_-']I1\O?RZ<+ZK54W'FBUNH4-'-GMDR:B5.9XHEDM:SQ/>)L&%Z7LO
M7I[9M?#+]I=^L5\9>8?%(X:\O=9U 4M%.=OS*![F,;+9-(;%S7-:(AM@BG+4
M[SII^P/V#GVN'%OS*OT_RTXCJZBN<R=34LR;4N<YX<YPEN#M^T$%27>U^3%Z
M^T?8+Q-0-D36/EV;TL.@ ;P7# ;%7*6JIYJ<+2O,'R@UKA0M;.?J6FS)!E&V
M)#)PNYBEX6?R?R=OMV?E2XD\B?/O5:MV@OI=+K]>K9KJAK-UN[,^L.8XDP&Z
M=X*=9CE>]SJ/S:^27YG]7^6WS<X/XDHZJ=2TE-K=/,JGRW$-:QT[>)= _?0"
MN,LSMC3^L-]F?]I=Y._-#Y,\+4&L\9Z53:[2Z13T3Y57/ERG3GR&[\'O!\3>
M $!'*"O#7?I].7ZFR*_RZU$>/2:[0SV&T.D5H<RV'[$WJ:9F9,%14^7M,W>J
M=<I)+1[Q,RM:T0$;SN7(9[.C?.GYM_(#R#X$UOBG5/,#ARGGT--,\"F%?+FS
MYTZ6UTR#F3#N!@#+<8D+7C['69[8K^:M]M]]L!,^:OS!U;A7ABJ;7:'(KZV0
MV=3EO@MDRG.E2PW<(:&PA !8QG;I>WIJ</FU\LIIJ/,SAB>Z^=KK9IYYGC//
MI*MX<^F^T?UA?L!_[D-&$+]&!_\ H*D=/DXC]^JYDNBIN*]5<T.=24==4MC?
M&11/J!".UBU.7+/A_/(^WK^UL\QM+X\U#RKX=UBOT7\VS9TF4ZDFS);ICI<U
M[0&^&X1^!3.;AUNNKT_^R]^W_P"/?(SB+3N'./=?U.KHW55.P3*^8^;+FR7/
M:)EKW.:0(P(*<'M.VGWU?*E]IM\O_P QW#<FLKN-]$TVMJ*:FG>#/G2I$O>F
MMWG-/A0<($Y)+EGOT]9E[MR.-?)W40)M+QCH<]KQO R=3:00<;B569:R3.*?
M*.F_'3N+-'8UN,S4FAO38IJ;,]K'HW\\?VB?D9\L7E-Q#6T7'>B3M;.EUC9%
M-154N<Z6ZHD.EL@YYWA-),;+NQVN5Z=9Y?RF/M-/G5U+YIO.;BNM^OSZ[2W5
MCS)>YY=+CXKGP$3@(=:2>5[=_P#I>U7V$'RP<1^=/S$Z=7MT1]5IE/JNF,;.
M<S>:?#FL>YPO$/>2G28V_K*^5/"$GRX\LZ+A<-;)-'ITI@ECW;7TS94!_@J2
MI>?LQR[ ><^FU57- 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>
MQ F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&W0_P!,IOX9GX02
M<K.7IW]HHW>\NZRW_P"I\SL*]'QXP\GY,S\+X<_F=D-=Q#J(Q\*=VS-B]7,?
ME.\Q\U?DGQO3CZZ\67ORP(V*+>5!IZ<1N%^S9L4MPL;[I;FX0Y_N)-K[)2A<
M1Z54C>?4.9MY';L1&635N!!NL'+TH;MPG)%47#NYSS)EKU8YY,PG[MYBF4]5
M4U/30]A);&VSI&Q19<Z=2:[HQ+7_ (HWG/$ID]<;=,ZQI#Y9?[A%INB1>4QH
MM\*=*DS9,\D@B!.8Y7K4IC"]:/J+I?AMWH;I!AS6^I*8=T<-ZU\#?%A=C<I9
M.6^D^CN&AU<%@_&@W9;.933T8N%TT^L:X ;PNAEV%:CEVVN5$YKX6X#N/:E<
M>TO^%AE2P8;;;EG-NG#Y$C*D >]9Z-AR2UREQI)R938#IRRYDSER[RY;D !8
MHQZR3+G+^(<L0JBPT38D&. [E/+?5.AS VTB,%NR8RZW.%5UF>QK'P<+#GG]
MQ27+M\3H+B[4 &5 B+ >T*68>R</5'C2O!=.M%Q[()-M=)BY>MO$-7ON-HN-
MQ.U'?G<=>S 9CX7Q,.A;Z];7#Y>/ND:"C+GCW3:0,%VQAY)FNV^'--<Y\N#2
M8AN:O$3M]7LWP=I;@:?W'6,&>+>925G&LO97A^A<V7*]T^[#E<LXWEB\NS=/
M+I(;'JYK5J8JXTLM/4[L+0/82<]BF$]L)@5ONWMNY8(EN=N3*R)'O-OS.Q;C
MAVFTO2UMK1$7YG;WI9B)S%CIZ@$-]X88GOV+'6YK,YPEI4X$7QL'HZ=JWF89
M[9FVVZ8"("]9PS>V>&F\0CRQ6?;-PO6>6A,$2>?V+1Q6:2( <L(^M1;<Q)RF
M6 QQC=RR5X<Y^[3::V(O3EO^+B3!1;<-1TVTBV$3RO5PS[6N.^-OH[T1EDG>
M=E;W=Z$9YDN()CA!3AKV0\]D(VX9;!M27*2X1SF[QOPA<C9+82Z MBEZI[1)
M2J9Q$=TW#+;L4L^B8O+G,ICN&#3U#(^M23'+2L5\IX%QM#O5W+?W7'E3WL/U
MCI[U,5G+L?0?R;>;_%**NU.(AO[7L,4,XVFY,G>&=_JV+?AR[6VMQU('" !Z
M.07-G-8OJ0QB.=5SO++)I&AT.<\K$\,=IE8*>2UI;MAEAT+,N6<8C)5,:UM@
M] 6\87IRKE0V)=;B>Q1J\J]5LL-OT>Y6O3\>+U5R>/>Y9!7&&KUVPX'G4>[X
M>&*:X-:259,NV<55M0K&LB=X8X\H)=/3\=S'6'$6L-E2)I\0"TW$9DK/+K+X
M>K_%W%HES)X\9OQ=@*U8W(Z XAXL<[Q83@8C/*Q7$L+,.F-6X@?,F.A,!B/8
ML8VYV>58^MSJAX B08CTWX)(B4I=-G5!L8XPRZ KY)-KWI/"TV=N@R'&,,#R
MQ4M^CCW=D:;P3.)ECZL^UHP.4<E),O/ZNUN'_+Q\WPRZE<8[#L6XO9W%HOEO
MN>&32.'O9'**DN+MP[1W#P_P UNY&F(@X6VX&*MN'G[Z=QZ1P1*:P TYO&>$
M-JQ9FK.TG*^T?"4IAB))$ %J<.=N:N%%P])E@#PS<%9,I>TD6VBTR5*A[EP
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M23*(A#T#V)4[8CM"ATEDEK?<AN]<0 %'*WRL4BG:R !Z>DE6_9GK]5DHY@:
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M*L Y8*>VUQBLRMN6FI--@Z4IX1<X;W38DN-.=Y:)D;\+(\P'K6[?+IQ$Q0R
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M3UU6[\W3M]^_O/G^"]LIQB8N!+2N>+*UUD[\OB?\V?ED\[?(KB.=2UW"7$E
M),V=*EULBCG.<'2'P)):TN$08B @K-IVZWJM/E1\ZOS)^2,Z7)TOC+B*EHV;
MK/ JS/DOEAAL8"6RX@"R!$=JEGT.MN<WA^C'!/VY7S!\-T=/3U?$^K3W2I0E
MN,9[XD"$<8IBNG]G5GXR^W/^8'B#3:FCI.)M6DS)S2&NC.9 G&-D$LK/MU?F
M'YP?-%\P?S%:G.F<2:_Q#KE-4S-V71R)515"8"8-:\ADRPF%@@DF&+;X>TGR
M+?9C^<GS8<7:-3/X0UZATJ?K5++G3IU/-D"=3F;+=,+X@%H=;E8KSIJ=-;?T
M^/LN_LT^%/DM\L-)JJC2)5/KTNEIY\Q[MTSMZ5+EG>-N]:XGI4DPM[9GH_5+
M6-2.J5$J<PP9+;N0M%SB3!5))(BD! 0$'$_'+_;#M""=\S?[OM4_L6K_ -%"
MU$Z\OY%OV\'^]#7_ -J:K^&5+RO=6OLB_)7AKYCO-W0?*G5Z"34OU:HD22Z8
M&V>*0R\_MEBS.EQ)/9^JWVQGV W&7R[Z?HWF-Y4Z#45+:BF%5/;IOXYL1*,P
M,>),8/E3NEI5QZF/>9GA\V?"_G?\TOR\:O-H*35^+^'YNE372IU%62:ILB5N
M&!$N<U@;NNC9:;,%;)6,]H]G=+^UH^:"BT\4<WCK5P\"!_G$XP(Z2IMO/7RZ
M'\T/G[^9+S1\2EU+S UDTL]CI3V-G/<][7Q!: XD"PY%,?4O;_\ )>K TOCW
MCK4&N;IVN<0ZA.>&->VCFSICWS76#?;+:WWG;8+3G;;R_>+[,?[%OS4^:'S"
MT&HXIX4U>@TB7/HYSV5,N9*E'Q)C228AL0& WE9M\.G7K)/9_3K^2GY/O+_Y
M+/*72>"M(TFED5TBCII$VHE;DQQ-+*:'-#VN(!WGVG8M2>&.W;VOV>Q]35S*
MN9,+W%S-]Q8#@"3"'0E),1KW$$0!%QR(N4:3^G5E'44%7H^LR_K5/J#7R'L=
M[P,N;*,IS2# 6[Q23.DOV?,%]L=]A7PU\RVD<0<?<!Z$V3J_U.KJ'.HW!L\3
MFLFS9<=P[P=O&(4QBNGM.\]?+^>+\U/R$>=?RS<2OTK5.#.(:BBD3)^]7LHY
ML[=\!\ XAC+19@"K+ES[=/5T'P5YW^>'E/5,G\.<2<1:%X1:/J\R7.D2H,(.
M[NNERG"$,[%+)6<6O=;AK[6#YG]$HI5*_CS5W&5*;+!^L33\+0,]BGK727K+
ME1?,+[2[YGN/*&?IC^/M8;*JB0Z$^:YP#A;NMC:Z"U/N=NTO\7IU6SO-7S,U
M&%:SB;BK4*^;O#?II]09TPG>BUPE-EBT9A5SW'['?9V_8V><7S4<4<+UNN\)
MZWI>E.U6EFU$N?+F2)<R2R<P^]$"($+;5FYK?IK+^F']GE]GCY>_)3Y;:9(E
M:#3T^NTLJGFS9[=TS1,;+EMBX@[P,1%7P7MG]KW_ -7U-^I50G2W%LG=#-S#
MW=E]I0QAN\*0&JX#\5-V8%(EX?@/]OQ55TCY?^*74%(^KF"36'=8"XQ\";99
MM"EY;Z_PL?RBM1I]<G<<:E6?FFK-7,U_4)QIS(FM <ZLG[S=XB'NM-\;8*WA
MRDLK^D]^JPS]2G>7,T:C03*)S-)JPT3&D1]R8,<2IUN)AOO?#ZS^(X?G*?"W
MWV_R;;.A7RSU36E?ZHU;_,IG\A4K5X3R_E ?K#L[7JGYK=;IJ?2)\VG^OZA^
M/;+<X "I>18+3%<^*WO&GYS?995.N:/\V7!4N1I%5.E5T^F;/F.DS&"5X%;(
MW+7 #WO&/4M\L]9M_8P^5=SG>4'"QF-\-QX?T^+381&EEQOR3&%[\KA,_+S_
M .$=VE17%!SD_P!(I_X5OX34'YJ?;7U%3(^5?6G4E.ZIFG3M6 EL$3#P6GTI
M>$^/^3^0O\P=-K=5YG:_-JM*JI!=5SQ+ DO=O1GS"?A#LPD7Y,Y?9S^K.3-:
MD5>DR:[2YU*TRZ"+GM($?<[E/+<N.F'] CB^!I=+(-X=U;DJ!Z5:Y]5=TF=X
M&ITDPF#6S&[T;H$D)"\/RH^V1^3]WS3^27$(H:!^H5.DZ/,W&R@2YSF22X 0
MYE.W&6OCLF<OY,WS4?+UQWY(^;?%?#FL<*ZMIU)25TU]//F4TYTITL/+"=\@
MP@6>E)?#/:9N8B_)3YI/-WR'U%M5P=Q'7Z6&N:[<EO?*<TM(A#=W8A:3K<7?
M#N_S,^T8^9_S/I)6DOX^UWPMYKG"1-G3)IW+0UC/>A$XP*QZYYX;[]\\/K>_
M5QOF-\[N(=2TS0>.AJM7236T@-15,G;KFNFM;OG?)#=YMI"<5J?PWR^];BQL
MH4NF/EAH+@[>A",-R41&&/O%:KGTXJHHH@(""8T*M;I]7,FN(A,9N6[2#VA(
MSVX?C']M;\D7_F1^73B35]'TYU?JS*2JFLET\3-)FT[Y@L;%UI"?=J=K9ZOY
M.'G?Y#<?^2?&VM\,\1<-:MIK-.U*KHY$Z=337->),UX WMTP@UN*2Y3MUO5<
M/(SYN/.CR J-S@OBK4=*I@23)ES7L<T$^\V#2+".I+M>MQR[3\R?M"?F@\U=
M0TUIX\UR9]3+3*D2IDZ8Z;,+H-:6[P@WE%23$VEN;^U]IGZL?\Q'G)QUJ]%I
M'F/+U.;3_7)<@3ZQLW=<US6B,7V$*]>6[?V/MOXBE&16S*JG>)9#96]N&$8-
M;EM"W)Y<I?#K/SD\H>!/F,\O]5X(XHTB1J#JFAF26NGM;[I?*\$G?<;G;RQ>
M5SB[X?SX_M=?U?3BG@#B/4_,+RRT"M?0S:NNJ!(TZ,R7,IWATUC0U@<TB,($
M)Q&IT][E\BW%_E7YK^4?$U?1:EPQQ'H5;IU9/II=4*">8B3,<&N;-;+>!\&,
M+4ES^K-SUNG<OEK\[_S(^4TRGI]+XZURGI:8!C),Z9-E/E@1L@-P=$ E7K;.
M7LF[[6SYG74)I?TZU?>+2-[QYM_/%2RUT]^N'J]YI?.9\Q7G+-?3ZUQQK]52
MS!X;J:GF39CIH-[76/(!WK@(JR88[=K>.'6/ ODKYN>;>OT=)H_"/$>LSJVK
MDTTVK-#/$#->!:]S&N<?>C<0JQC-Q7V:_8\_J^6LZWJ^G^:7F;H%5]59^;ZO
MZOJ)+6L8UXFENY,@!:5BYKKKIM][OEKY><'>0W!^F\&\*Z9*T^5(H*>0X20
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M[=B3SP2=5[=O^F/W7US4OKM4UU.=R2R4V66Y[I>?0"E^A.,5"(" @(" @("
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MUG,;%K#G>5@IJB#1 X#U9@*8=>D;$VM+6Q+Q9&\C"&U3C3OC6%!XAU7=EO\
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M2M216'U#B2=[JYR<E9C#&\IB@F@D1,8NARL47-6ZB9OD0S'HBKE<9BVTLHB
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MC+;D:7N/!W#".1QY^9:Y/X\K))E-EL#8"Y63ZN?:YKB]K8W"\X*5TZ28VPF
MP%^2EX-YTQ. ,<DF8LG_ "P3&C+!7.5GT0U7):0[FRYMJE^C<BMU-.TE_.>P
M[5-M80TV6&.LAR)Y\EOPU'%CMTF^W)0<]_G3.&^LQNL;ID(FVQ:SF9;WXX8C
M/.WK]BEPW.,7E@F.WHFWX<>E8G*-4@N6ZU*QF4<@I=Q+F,9DDG#J'>N-[2:K
MI,X/ V#J'>I[P<'2!;=U>U2W.XLG_#4F2+38(0'*]"V8TTYDF^[X<>GG1)+A
MJF7L;U>Q2RU+<::TR7[CK&W<L$;S%!USW=\Y W;1[%<);]'7%7- -L;G7]/.
MB(7QO?O/(9WJ96;6?3)_PVG#,^I,KZNP:"HBUEOT?4-B2Y9\X6"7467X\L%<
MM3KY;S:D6WX<KE.$O8F5GAB.\!:,1EUK<F6^DN<M5^K-@1X@CT+->WKJ-&;J
M+3$[[;MF4<\UBV\'-1-16,?])MD3>%OKPOJB9LQILC@,L^=54;,:'DVV'9S\
MRS<,VM=TEMG3GWK.<KU8W4K(1@+3RP6YI,XK :1KC8U9[5GL\FGW!<+O8DW%
MZW3&YA#3==V]"9P-"9?T*I>&HYL+LDE7KVRX-%O0M5KMPVV3(&R-W+-23ZL9
MPWF598TP,/=.Q7IGVPWG*G:WJ)'TVB_%>F"3X%U*.IM]\1WF8C[[VKE\GV=>
MDS=/HO\ D%KB:K2/>!_FTK(X,VK@[S5Q7V._*)4[VBZ-;^\^IVQ>?Y<</;\.
MH_2.3/'U9D.5HV+RV[=_Y7+7<=XQ..:Y=G>:2,AGN@E21COV\1H:O9(_X)6N
MLPQ.75E1^4=^V=ZEZ.G"O"@(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @("#-(_*-04[SI_N_J/X";_)E7I_-CY?X/D,^<X0U?5?[0G_AO
M]:]W6OA?+)[7+\4O,=N]55G\(>U;ZS-RX]K,.@*Z7^,>;++?0O1USC#QW[*Q
MJ(W0,+KE;/7;GVFFKISRZ:!M': L.&)%_H6!P!LP3*8WI(O;N@BRXF[G4ERK
M2<X \MBW.&^NTC2N!(.<?3 )<-683C9S&MOA=B!ASK/$VO7%:-15-$?>'0X9
MA.>&IU]56KJ@1L_9;<]A1N1 /JX$VBTXPYTFUC+)J=XBT69=.4<EKAOK&^9P
MW+\\\^99QMULD5?4ZD /)C?GSYA:B7?+KK4*D[S[<.[8I(QG"'%3$PCRZ 4;
MFT?75@EM,7 6&^%JY]\O=\$D_54:K5FB/OMPRVKA7HO7-4O4M8 )]\&W,9\Z
M>&.W50-3UCX_>;>[$*R$Z:^ZC5NIO)=!UD<+<"M<.?;K4),K)LPGWL^U3,Y8
MO337W)LRV#CUI9;PXV3JE=,HICIH):<,",N]-R.5V[GT/30YC1N&-ED#<LS/
MEY>W;';#N3AOAX37L]QWPM-PPAA#:K7/M7L)P[PLUOA'PW?",.62LKS]^UM=
MK4FB"5+8=UP@!AS9 +7ERO;'+/-EMDP&SN4L<>_:\M03P#?Z#W*R[8_L[727
MD3HMC;@I)2]JT*ZK<V,">70NO65ZO@M\HYE8]\07>C9[%N3&WIN:V=XN%JU+
MEBS#@YH=>I)A96%TE@A';@>]6S*9LX9&2I41==D4D;SB)6E$EI,2WK&'2E9L
M-0FR)<DP<V)C<>CUKEC9)Y429J =.+=\'WH0B,#DK5EUA*R'"8!#&*36ZDY<
M:N2"V.PCICSK66N%1K&[KQ=DEPEN4QH\S=/3ZAL4QHDQ-KRRH<&1C"SU\RGC
M+-VZ[UZN>V88.N+NT8*]>6NLN4%(K9KVD1S]?,M7%KKAS:V;.> 03$Y$J8\N
MDF(L%%I0F%@+'6[#@%$LRMDC0Y0ECW"",QT9*IABJM-E2P?=%D1Z HZ:Q]U8
MJ:=H, ,#V]"KG9?\.%-0S)KP UT+[B,0B8QMK:OIDQLLQ8Z$(^@X)E9,J;+I
MBR:?=(MA:"+]M@1);&^2930=G8%&Y<M*;7.:8;WJ58YKQ*JR]P!)O[\47BK1
M0R_$ )M!AU%."7-2;J(%I.[AZD6SRC9E$#,NV7C."33.;Y2E'IK'.;[MXVX\
MUB6Z7&9I996F2]P>[E@<@HLGU1M9IK&AWNW ;+>F&22KVF(K,VEEM>;!:3#E
M8M.;;H*=F_<+^6*F6O7*?=2-W8PP&.P(N=85;4Z5A:3 ?%ZCSJ+)A1ZBD8YS
MO=QY812+VN84U( Z($(&/9G"*6X8EVL5,\R@!B.6U(UVZ^4F:L@?%=T8PQ@D
MN6$34U;@2=[#+84LRE0\R?ODF)QNL4V[=9/7/EAWMZVWI6HYWE(TWQ=?J6;R
MBSTS6;HM%WWNP+<U-B18)8)YMJF5LQMM,:W+#N46ZC(^2"R(OA'T':JRC*F2
M0V.S9MVJ\Z)SA5ZHO8'0[>4+ECMF4X_Y5FHK9S9GQ<@KBX:G:+)H^JN :'.
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MI^JH\9R]2GUVFTE>^F<UQ9X4LN;\1-A:R&*2+[2ND*3]5G\QI\Z7+-%JXC,
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MO>]KB/875-6G5,PRJ6<[ZA L;+C ;GPP@(6 !1O&$, !8!! 0$! 0<3\<O\
M;#M""=\S?[OM4_L6K_T4+43KR_D6_;P?[T-?_:FJ_AE2\KW;GV#M=6:=\W'"
M-72372IDNNH2U[3 C\?*NZEC_J+N8?UMM>\NN!_-S@+A[3/,'2*;7*2NT'37
M.95-#G&;/H)$R<]A<Q[0YSB3$A;QEC-ZZ?/G\\7ZO]Y.^>T[6ZW@'AN1IU3J
M+G3&&5(D2SO%V]"R6#%9Q77KWZ^7SV^8_P"JG\?:?J]34T%+J9IIA)8)4M^Z
M;X$;K(&P*R4OK47P+^JM^8FI:A3>-2:HQK)['3"^2_X Z)^*6<$L9FG[A?)A
M^KH< ^3NHTM=YA:,S41*G4\TMGRI+R!+(<8AS"I)6NW;KX?23Y;>1WDMY&4,
MFBX'X=H='J9$ADILZ3(:VH<^5+W6NBV5+:T;W/!:XKG,]IKA9]1KZS4)H,Z:
M7L:3N P  )$8   7*VQKKB3?+4@!<%D$"T$.%CFVM.1P]*"P4.J,J)4VCUV8
MZ?13F&4Z4\!S'-<"-UPM);!/U,>8]3_F(^0KY;?F*X;KJ+5>"=*G:M-D3V2*
MN12L+RZ:TEQF>+*)!!-X(5\).UG+YA?F6_5@Z/CJMJJW@NA?3R73Y\QDFG9+
MWMQQ): UC8P"SBNGOUNH_,;7?U6+S$H:J?+91:L1XKMW=DS+B3"YBMEJ=NLY
MB]^7OZJ?QY7:A)J*NEU)DEH!<9DIP MC:7, %@6;.W%9U+GP_<+Y//U=WRU\
MG:_0Z_CW0Y>I_F]S7SQ-E2)I=",8@L)Q5Q6[\G6S%?1/Y:^1/D7Y*Z;1:;P1
MPQINCOT^4QC)DBG#*ESVWN<6RV2P=[JVK3EFV_9<M1U6LK)SF^.]](8@,<<#
M:+!>HUB2(P  0 @$&Y059H:EM0, 6]!$$YTN,S#U&^;;Y9:;YI>"M2X3JI!G
M?7VS@0&AUDQKFXAP^DF,,R^NGS6ZA^K!R*CC2NUZ3)+:2HK'U+& R0!XDPS#
M9"SXBIBNG]G5^_\ ]G]\C5)\CNA4^ER)/AL^K.D3#!H#@]I:ZUH ^DK.N)ES
M[=O?M9'Z&5U7]=J9M1A->7#*!N3ROV;U%JC:6FKI#O\ G5-,D,C>'/:Y@(V^
M^KGPF(^=+YZ/L-J3YMN-JCC<2"*BKF3IN]"6"1->Y]A<+08K-F=MSO)IT)\J
MWZNQ0^0GF!2<<UE+XT[3Y\N=),)3BQK)@FN@&M)A[@22E[]>(^GO@2C'!>@4
M.@RF[C:*AE48%T/"8V7A<8-6K&,9_<E#:][OOG$J*\(/+3!S'#Z+@[J0=+?-
M#Y0TWS(\"U'!$V3XLN?13:5S0-Z,R:PM<80-IB%9,[\'7]MS>'R\^:WZLHWC
MCBYVOTLMTN5-K'3IC/Q0BQTS?(A#(K-E\-7Y.M?KY\B/V7]!\FM/3.ETKF3)
M#9#0_<;#\5#Z0:!9!2=:GM+,/V%U'4OSC+I&"$*:4V6<?> ;'\%7&$QA&1<+
M6F#A<=N"HG*.=IE?IU9HVO,$^FU!IE399 <'L<'-(@8QB%9QBL]IYC\-OM'?
ML2?*KYL:34=5X,T&50ZWJ%+,C/E29+'F:[>=8[PVDG>/2L]^N>/*SOCE\O/'
M'ZJ]YDT6N.9)IM6?(WW-]R4^!&_8?=EVV%9Q9I=6.]/(']58XHH-9D:MQ)2U
MQHVSY#W"IEF'AM=O.;^,9"$%J2K+)NOJ^^37[./RU^4?A^EET&AR9.J2*21*
M;4"3+#A,E-;$[S6#Z2LZ^5O?VN)P_0RHKGUC)3'F(DM '/ #U!$X:B((" @\
M&.%X,4@E6NTS6Z,Z%Q%+;5:7-8Z5-D3!O2W LW '"!L@?2M8]F?7$O9^!7VC
M/V%_EG\U$RNUO@/06:?7UM3-JRZ3)E,<YTT.+MTB6TNBXWP6;UQ6NOR2S]SY
MJ^-?U5SS*H=:KS*IM6=*G37&3NRGP +K(%LNRPK/[EN+7L)\MWZK#Q)IFO:3
MK/$]+6&CI:ADZH%4R#7M:2=TF:R!-BN+5]NO5]:GR?\ V?WES\G_  SIC.'M
M%DT>JTSF/FU#)3&N+V!H)WF-%L0K-,]NT[:>]5773*Q[WN,6OA9A9#G3-,2?
MJUY%344;O$I)AE/-A+3 PB#ZD$EJ^C<%<>:8-+XUH*75FEKFODULO?ED/$"&
M[K3"PISIFYFYP_'CYR/L6?E[^8&EK*SA/A"DT_4:R;,GNFRJ:0P>),B7;KS*
M:2-YUBO;KB87KWGE\X/G?^JK<35NIZCJ.@TU8ZEG3C,DBGEAS6-)#H RV$"Q
M<\=FLSL]7V?JM'F)]:;)-#JT"=TGP9D(QA_D[U9.WW+)'MGY'?JJW$6D:CIV
MH\04]6*:74RYLUM0P,#F-<UQ'XQEL0$Q<DLZOI4^3O['7Y=?EYT^35<3<&T6
MH:A3/DSI;Y]-(<SQI3&P+W-DN(&\V-EI73K<3[L]^T[73]9M,H^$N#-*.D\&
MT=-ID@-#62*.7N2FAH(: 'MC8LINW:$GSY]6\S*MYFOB8.<8F!M1IC0$! 0$
M!!X(,"6V.P*9/U3VG:G*,E^G:J[Q-.G2WRYLIP#FN:\$;KA#X23:%N;GW9L^
MCT2^;+[-KY=?F>X9U-GZ'Z>-=K6$NJY%-+]]Y  >XS).\'1%MIM6+&NO;'\G
MRL?,O^JS:GQ-K.J:QPE1U3:2=%TAE,P'P[;/R3/=("F*M[]:]$#^JM^:)K)<
MCP-= WP'>]5 $%V,%=LW%WX>YOD#^JE:EHNITFJ<84%3426U4B:16M+CX37!
MSF@S@3""65J=NLKZG_D\^RK^6GY7-'D5QX&TLZ_*D291JIU+*#6N8V#G[TN5
MON=&ZU)UUECM\D]L3E"_//\ 9]<.?-7H$[1>'*,T],Z2Z4YDIC6RP',+2&^Y
M8V-R>N8UU[WKJOP7X+_5BQP[Q[^E,^6Z93LK#52V'PC F9OFR"2-_P!G6/ID
M^4?Y>*7Y6N%=/X9D2#);24HIG@MW8P9N8 8JWKB9C/;M_9=/9^=.,VL=5Q]Y
MTTS8P_9;RD2/7WYL/)&E^9_@>HX+FR?&ESJ&;2[H =[TUK@XP(=BY)UMJS]F
MWS!^9'ZL<WC#C Z_32G,D3*LSIC/Q0BPS-^$"!FI95OR3L_9_P"1/[-.B^3:
MBIF2J8L?(9) >6M C) 'Q-:,0DEPGM+J/UKU/4OSF:<C]XE,8[]L -[.TD)B
MSEF3%1BJB @\!TR4X/DG<<#&(LML*LN#E9)>H46JT4_3.)=VJH*B7X;Y4UC7
M,F;UA$R WG#=YU;8SBYT]%?F/^S4^6OY@-&G']"M/;J,T3SXTFFE%I?.:8.B
M^2"TQVE9O3RUU^3%Q7S/_,M^J[RN.*VMK^#J&9)E/JITZ7*IV2X^&XN<!NL9
M& !69TMVM[SP_-K5OU5_S'I:NHELH]8W6S"&AK)P $;A!ERWBIB8RL_!WZJA
MY@:E7TIJ*/5?"#QX@F2YKFWWG>9"Q2RQ9B/UY^5G]6GX/\L:O2*KC;265K*6
MHE3I\N;+DO):QX<6D.8<E,5;VZOH[\D_DH^6_P A-%H:30N#--I*^E+)IJ)E
M*QKVS6!H:6"7)%L1>2MV8CE.V;B/9'4=7]P4>E3'2]/;*$ILL - :!N[K;(A
MNR*DNUD\J\T0OOBI<>&@C$?%9 \R2B>TS4VB2:#4G[^GS6O9.ED!P<UX/NF(
M)W23:,5JV89O7>GI7\TOV=WRZ_,UPOJ\J?P?IYUVOE.!JY--+.^XM@'.,R3O
M!X<+XD%9LQPLN+M\I_S.?JM=?Q7K>JZSPA1U#:.<'ND2Z9C3X=IW3"6SW2+,
MDVN97H#-_57/-#ZW+D"1KL-X-=!U4 8N.4(I,W28CV^\A?U4C5]*U*EU7BZA
MJJB0VHD385H<_P#%M(<]K3/!L,$O6M=>W6<OJ7^3C[)GY:/E?TNGU*IX&TR9
MK]/3R)0J9U+*W6OEMBY[G,E%Q((L (M2==98[?)/;$;GSP_(/PU\T?#<[A_A
MBB--3S*<R72Y$MK90!E[I#8LL9&Z.">N9EJ=_75?@'PM^K$#1?,!W%,^4Y],
MVL-7+E_BB XS=\V0CB5,5O\ LZ\Q]+'R?_+72_*IPMI_#DB09(I*82'AS0V(
MW"W #-:[=<<,7M_8]K:N>ZHJYE6PP<^87@X@VPAS*37)C$PG95?0:K1SM.XE
MA5T4]OA.E36ATMS2""'@"+A P5M9]?,>FGS$_9X_+1\P>@55/4\$:8[5'RIS
M65%/2L=$S6D;SO$D[S7!UMZEZ^6NO;%_<^:OYB_U8+2^/*RIJN$*#ZM+=/GS
M&2Y+)0.Z\DM :UH/H6;*U[]7YC<5?JJOF'IE9-ERJ/5]TSG;OARYS?=M^]9!
M62LV1HZ)^JM>8M;5RY;Z/6-Q^#VSR(Q&;8*;C4Z]<7A^E?RP_JOU+P!JFCZA
MQEI\R?(IYC)D^5/ERXEH=O0+7LQ"N$G?J^G;Y;_L^?ES^7+A[3I='P=I[-6I
M"V8*F=32QN/8T#>;X<G>+M[:(*X9O?-Q'M]J6I#PQ0:6\R]-9+;+E21!K0P
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M!3-\(F6?@;]$8!9OT<_D^KV#T/@W3Y;)>^RYHO:,MH3JX6RKK*X;T^6QNXP
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MY4LP!'H'<I3K,\N/U:1R"+A@G4LDL=#L6INX3&]\*5J6G@O,!B<-H5X5JTU
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M]YAO'WP"Y=N7;I,3,?1_]GY4NF5>CY&FE=C.A<^TN-.LLM?9?\H!?^9-%O\
MR(P_8G8O)\O+W?$_2ZE!^JLZ?0Y>?M9AUZRYTR &-NW%<NSTSC[IB3^3"3AP
M[<HW5Q_-R=A5B2[PZKJ/RCOVSO4N_3AIX4! 0$! 0$! 0$! 0$! 0$! 0$!
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MZ(+4L\L]IK7*5_/=-/ \>>PG(RV=L";UJ7K$Z^TY8YO$7A,#:>=+> ( &6T
M=4,5GM?H8J&F<4:L_>:'L:TV>[*:##]M P66L1!37NGO,R;[SW6D[>A%<;K
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$!
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M$^3#XAZ.]:E:F/\ +$^IE8%N.'<5+:Q;EJ^-+F6&!Y<^U,;VU-Z:=33TX&]
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MBM6L25Q?IN]'W;QDIC,8[QJ3=*QW<,@I,S3G>MD:ATX"]OH6K)'-@--X7IC
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M86IPY]N6CJO]%?TJ7F)'4U1^4=^V=ZEZ>G#3PH" @(" @(" @(" @(" @("
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MGAHM<=Z))VWJS,Y7$34BL\)L8W0Q5YKG]GB=JQ+2T.-H)^(IV=)I 5-8]^]
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MTV0U\?\ A!:G#G>59=\;^<]I66_#BJ" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MIPPC>$+8]N*S:>5BDS); T$PNQBL=6L:RS3JJ6&FT9\K5K"RYT@ZJK:28.]
MV))IGBHYL[>= D<NA&KO<3-)-:V PCMV;$QO*3[IAM3+ %HY6;%<':^&E4ZA
M+:/B%D/3T*2>6)/J@I^J2]_XA>?5L6I,S:\,DK5Y4(;PC 9=RF-M>S+^=97W
M[>70NFF1NI2W& <.C[BY6'KEFFU372[#@.Q26KBH!SP9L8B_/:MYS%DUA/T(
M:]PCVY_=6=KB3:P-8T-%E]OH3%:;U/*8;QZ!D-BUUTQ=URJ);&RW[6NQ4[7-
M;TZGXJ\,-?=\#L3DG$9NZ]3^+YS0\C:[/,;$D=.LQ,_=6]%;XKC9:2.;%,-W
M[.S-/TDS6M.X+1]Z,NM)%QA9)&BEGT!U#8/4M8TEJ=I:,LW1NP@[#FV049W=
MK!):T-M&6)S*SV^SIUN(Q553*EL<8P]TXY<Z=>M\N?:[TH.LU[7L+6F)YN8+
M66I,;=?NDS)DV($03'ETJXBYU]UOTC3X[A<T&P&T#$*)G;M?19#)?ADM:"!D
M,N]"ZTOLB?*9+$"(QY%*=>4;75[(.&]S=2S+X7$SE2JVH\0D QOP4M+4*;SS
ME;C#-*=NB.WEVI]DQO*;I*L-A;]][,%FS;<BR4U8V &\+A&P9CO5E2W+>^M-
M^^] 6DQ6A5O#FF'*P+-;D\JE62P23;<5)=LVY5JLE^Z81C'ML5\_9TXZH(LM
MB8W]BN8Y8>'/ A<8[4-_X:,V9[L 1'V%%QM#U,PQ-N66:C6<1"O>XDV]F7,K
MSI+QEX:XQ%N/K4XNB<92M,;N@?@JW9.V+E,,FP:._HRV)@S:Y&:#9GRR2]<G
M[D?/:'=,?7WK-F"HR;(C<,?7SK4Q@G&T;44KH'W<,S@ K69,55*^E=][<(WG
M8LNE5:?1OWS!IZ.<[%6;<QYD4,TNCNGIZ>9,X632RZ?0O@V+3=RN4Y)I::>C
M( BV%V/[5.&<YTE);"T;L-O6KZXVMGT>76-/1VIPRC*B;"-HY13G;6<HTSQO
M&,.70LVL\7'AD;/ NSY8)+F->B0D5 B(G+T'FR6\S"2XU6]]<E"]PY=*Q[&*
MTYU5+M(<+_9FM9S%E0\^I88VCE#G67340=35-MMP&'.KZPF.5=J:D8'Z1Y7*
MXF&>UW]D--GWW7<L%EOJBYDV)O ZN6"U&I/JW*:99>+L_P!JK23+F^9&PPA$
MPMV^Q%D:^\!9$6;0L8=YVT![;HJYQ%ERV)3A9:+SCT)V[9F%;;0';>93I&L3
M#D:0NM CRYRMYE25BFT9+3%O9D=BX]N5F;=(6HE"67"%QCRA%9O#K-Z0M362
MY+;\">I9PFY?LK-7Q-(IP09C@('&Z!RBJNK77VL<;26[T)KL183UV%1IU)KW
M& F->&3G&))L=U8I9GECM72.OZQ-J/&+9CCO1(!)V*K_ "VZCU)U7.FN@YWO
M14MI9(S46AU52 8$QV'/%3&ONRGY?"%4\B,L0$,,[,E9,3[KF728D<&5(_>Q
M9LYMBIJ)!O"-0 !X8ZO_ )U"\Z>?T8J98($O;8/9L1'#]':K[ST>Q3;6.KR.
M'*F-K!U*EQX;<KAF?]X#T)<5OXJW!PI/=;X8M'WJG63+V2UY_1.?_DQU?_.K
M=Q=-//Z(5!M\(=7L4S)I,2O!X1J #^*%Q^C_ /.J6[PNNK7/"50+Y8'_  ?_
M )U+4S&H_A:H$(,S^BDN&/.&K-X<J6".Z;(X$7$9)*W$'/TRHE.NMMPNMVP5
MO"6>6E-IZAK38Z["(P.2D(CGRZD$VN'2<E=+JL\AT]CH[SK]O>F9=+5GHZV8
MPMWGN%F9P[$XX2;3;]6#6?E#$ 8E92_M0%=K<2X;YN^^4FFI)A2ZW52Z/OFT
M'$KMT[);BZ5*HK-Y\=XDQ%]N,%T[+BUW;Y5/W]3EG9+_  @%C+K\<?47]G<?
MYUHG^:R?P9:X=W>/M+^4#_4FB_P(_!*\W=[?QWZ74GY!G3VE<9P[]_Y,,WXN
M607E^7^5=_CX;4OX5>MQU<>_\FAJG]%>K]&8ZFJ/RCOVSO4O3TX:>% 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@I_G-_L%/
M_@)O\FY)RS\G\'R+?.E,AJ6K7?ZPG^A[U]#KU_:^!\^NV'X,^;;]ZLKA9#Q3
MMQ6NG[:\US'K*^7_ #AT8WCU+T=;EQ[S/_#=?(BP0Y89K7:8C'/+'+&Z0.5D
M5QEMN5Q$K(FFR,+>\#+8M[3$;9<'6]'+K3%SM9K3:IQ"WEBGV:GTO"PTF'-#
MTI.'2=9C*7;4 6<O4IPW(T-1GM\*9^U&>7,KK_*.D]5F;U68'Z1[5?9T\)73
M!%L,MU<KG*Q/O8WP^@9Y+I)K*XVJ&IS!+:^V%IVW$K7+7ZNK=:U,2Q,&^0!'
M$PP7.K8Z=U_5MXS/QAN,+3>M34:ZZCIW5JLS7N&\3$$6W8GUK5U,MXVHU5)>
M]\6B-_:N/;MI=5@9)>TB(ARR7&G7M>MQ.$W1DQMV>F 2;UX.UM6NAI3.>T!L
M8Y[1U(Y8KLO1N''SC*(EBT1NSZ()UN$[:=X\,<*3!X+C+%\?AVJVN=OE[ \/
M:0VF:R+&B#\LH7=:2_5SYKM&G?)9*W?=$(6"SN3+/:V-.IF2R3NYYG]DDN*Y
M6M"8X$&T=>U:SEQ[;1,['F5<NR.FM!Z8K'EF]94:Z4(XVDJW+C>F&!PA$;5)
MECMUF'& 1GUC4FN@;,#WKMTXS7I^+$C+3SW PLPY7+=Q6^W7.TS+J0T6F!]O
M,%,89ZY9C7@?3/6KUPZ1K3*X1B'D1)N)[UO">S"*P$_%Z^TK.<Z23-9I=2UV
M,;/7#"*G%+ISFU0:SXH6=@Z#@NEXTQ<H2;6NWG /=Z>\KE;73$:SJIYLWB;,
M7'&*U%FN6:47DPSA@,TQ*6XB8IY)>1MLAR*SC#G,VI1E YP^'KAVE1TF]5Q?
MI),3X8Z@K$QBX:4W2H.)\,88!:P>6!U/X32(=7*Q.)IN3-RAJCW3S9[1[%CR
M[3MIKL?!P,1>!Z0M89]DQ3U$&BV^/?EL1&\Z:"TPAAVA#%1T[WKK<+,H10SA
MJ&0"8P/4>]"W*8TZE&.S+&.U+I)RL+J4.;" -]X&4,2LS;KK&N4=,TYSC8P6
MWV#/:M,6^&L[3BT1#=G*"N<IC#DVC>3<;N5T%##R[3G.!,,(]0VI+BKO'V1E
M13&4TQ!O(ZD[7.TFD#-J@PEI="T^@CF4E:NYEK":7D0.6WU*IN-^7(<\ PC'
M"[+I47K<W%912N'T?3%1NR,\N6 0#&[U*X<YJIZDD!PL$;0(7W<Y5+,W[)7Z
MD"(>&VT9".:F5]4744@9'W0.:&$.97.4K6DO$J.'([$)<,TVK#FPWAE<,?N(
MF+>$4]V\8A1N9\MZEE PB#>.U5+]E@IY+!$0SP&S8B2;Q62>QC6Q@+8Y"X1P
M@HUB*=J) !@1\1QV%5GM,<*C4/)>;KSZDS*CQ*;O6V\H)&K+8E)32 1S>LIF
M,XKFYL1;%!Y9+]X7F_L2W_E&]*EW 1Q2:VN?#8,LM%O+M2WV7K?"/F'W^8A2
M-][K2RZ1,:UK8\K>;:JYS?*4J9[866V[<QSJ0O7%R@)[]XD67@;;A'TA4:9L
M/2HW.&>5,A",+SCZE6+,73.9K80[^Y%XK0F. .?2LY=,::3YF[EBK-\N?MMB
M=-,+XVX$>I7"^R,K'EP(-UO9%0ERAFL<X@#[JC>%LTR0^#1#HZ>=6,=IO7#G
MJM*_<^'TG(JLNH=<IGM>^PWQ[>99QEKLK EEIMY>E:LRRS27%KVP^^';[4FN
M5FW8NA37#=.UN6S8A;X=IZ?,&Z(D60["KEG"5=.:&FZXX^Q16B^>R(M%V>T[
M$'AM0!&'+T+4DHS^.TW6]/L61C=7,E7NQA#KQ BL]XW-S#%^<&S26APY6"TK
MBSGPT:BD?/AN@F\]<=J+%?J=(FBW=-I/;SHMVTFTQIW1-D,_7S04IU2$G41+
M&[O$0A=$)E?7+'/G.GM(:2Z(A?L*93&(B&:1/F30^!^+>],,%4SA<Z2B?+D;
MKFFP#T"&:)=M.HDP>1 P^[TIA?;#Q3R@'XX9Y\ZE2]OHM%+!H&P0[1ZEN259
M;&_.FRVLM-\>SF"S5ZQ5=0K)3 Z+L.6:7%+FJ75ZQ+:YWO78MZ<(C)$M\*[4
M\42Y4?QA$0?I;5'3IJH:=Q?+,0)KC9GS[2DFW6YL5NNXE:^/XQUL;B-NU3M=
MKU4^OU\'?A,=UA-U+,*C5:X??_&&\XG[WF5M.RL5.L/<?RAN O/82M>$ZZJ)
MFU\Y]SW=<+(<VQ1MCD/FSID"X]=EO2I)A,>6_4T4XR"88=I*696*'64M2USH
M BW. O&1"2>89F4AIE+4&8T$&^-MILYU;<,6.R]/H)KF-BW >F&U+BM282WY
MIF/A9S1'KM4\E[6K'H_#DQ\Q@+&PWP+N89+2?RT[[X8X5]UL9;3 CZ/-L4R<
M:=LTNA2Y( ,MEP%@&$.9=.EOEQ^2ZTFY&FRQ#\6W[D5TO#C$U3T$H0BQO;>5
MC'E/W<)$4,HW,'4/6IEK&&8TTEH^%O5!;^R=;6+PY;"2 !;D.Z*K?&WELV4T
MY0LO/K6<;9KR9TLXQZ>Y7M,Q<H.M?NW;>I)$O;PK$VJW9A$;CSW=2U(EFDI1
MU[!NQ.058W$L^OE;AMM@.N(V+&=K*K.HU8)@TYW67G8M=:N:T*:8\D6QMY\B
MIG-)786G'\1;?N]J*K6L-<^9 9C#856,^:@#1/>8@1Y0V*XF%MR\LH)@,=TV
M91[SDN?EBWPG*!KF%@-EJU&>O5?M-M:/VWJ4DVWA972@Z7=@-O:=JN(N9%/U
M2D(!@-E_/@%<S(ZNUBE+MZR,3G;<4M<[-M'1Z;<F D$6\^*NFYOEVGIA#&2^
MJ_G2:,961LQI$3D,U+8S8\Q9&-G65B0SF8\MENZ]@$/2>6*W%ZS"/K93=P@#
M//+G4\K9G:DU=*?%^&S-:EQ"_5OTC0S=%UA6,YJ7:5# 1=>-N2N;4B$U"GBU
MYA]$]G.IGZK>,1UOJTHL)Z?5M*C4X4Y^^'XWY;8>I,%X;],Y^9^$8*UB9B?D
M.<(=&&9.Q1NR5,4U099M)&$1RVI&+KA/TM9$M]XFT7Q. YUK$3KM9Z>=O-%H
MQQRZ J[XEC;>?=*SG+G434R@0>C/([5&<YTA)E/\1Y^5ZZ-6::CI3F]7+%3L
MS)IOZ:TF:VPWC#:IN&<.RJ.G!DL):+1D">5JMLB9M8:UC0'PP'J]BSG;IG]K
MK[63NM==<Z_:(K4MK$F77%6\[Q@1>/6I9Y:N,88:=QW[\NU(PM] XES.8)=<
M+UMSA<Z81#>8=OM66KBI,2@X"PX9Y<ZU)Y)'!]+$&P>C-:7,0U31F%C?HG+N
M6;C">-*[54;H'W3U\^Q9G#$VA'4SPXV0@?6KEJW&F273N<>8[/:C-X3-/2DM
M%D;!RL5FJ=;<MWZI,%[3UJYCIF5L4TDM>!M%G62+TS!?M*#!"(%D+[3?TK6G
M/<N5WD3Y+6PB!8?4LW3<L:6H5LD-@'8<L%G-J6X=;:O5->7@$7N[?8I5E^JC
M5,LS'.(MM/8<>E7[,>6K)H9F^"6W$8JM:6&F?X AT^GI2WPEY;_UT$7G#-,-
M36VM-K!;;AD>]6';>$:^H)<39Z!MRVIAC;:IIOO"[E%%EF-IIIWVCHNY@LF=
MZ:\^F#Q=&-D##..*U^K7ZN5!1ACR2T-$(V 8F(R3M<-:\-JO'XN'[&"RYWE1
M*N86QYX9<KT2:N6&FGNC#;F<8JRR1J?NVLM+,<X#;'E<GL721$LO&/JN]J7[
M%K5F4#YA/N[#S=*DJ6>6LS1GN=$L&?PBVU;T3,\IS\VB7(W3+$=W(9>Q8UDQ
ME7*BGW9D8;+.;9SK4ZIVTYRXC9 GL]JEF*LY>9Q<6]!P"UE;CRUI,HO<=OK/
MH6&>NN%CHJ!S@/=OV1P5O&FI<\MFHTHN;;+%^0V+,6]8\T>G.ENL9  QL@.Q
M6)C;>J);I;+0;O45:U>%5K9CKHY^C[BSASX5F>YYF&%MIP'<J>6Y22GN+3F1
MERP5Z\XK=DME7*BIG;HB#R!VI;]&LI#P87QY=*688]98BZJ0'&S*'*U23R>,
M,$B@<YU@QSPLVJK.N%GIM-? >Z"(# 0N*F?JSVU7*IHMUGP@7769]*'E5:N0
M6DD8$^BW/:G5MK2 ?$%AZLONK?@6W3< =BSB4Y7.FIV3&B+08#$#G3'AC&V=
MU(QH/N"Z/P@I=%C3FRF6V0]W(;<H+-,H^9(%XP!]'2JB*J6F!L-@RYP@KE:X
MB-V"UAK&LJ^]YWC=R">J:SBI*B?$BRZ!]"S46-CMU@CRL"LF5DR\F>UH-L+^
M5R;E^S4F'.77L:1%V(])6\LWK]$[2ULM\/>%L.6"Q6L2;;SJF6 3'EUK*9OG
MA7J^NELC[PN/IZUK)+BJ?5:E+B?>V8[5(SVYRTJ>K:^HL,;;H;89+6-),NZ>
M&7@R&G]B#RZE(G9:)LYH;[8X'8K8RA*J>#OC88=9V+%N."3"K50+GF%L?NK6
M)9E*C?JSW&QL8]>5UJDRRY'3GEN]NFT9[%;2(JITN8X?";SMVH6HDZ5,:?A)
MALAW+/M;I9UUEL"CF,$-T\NM63R2XTQS:=P ]FW:KDQG;1\%T?N=Z+G?V6'3
M*<;PC&,1GWJ7MXC-YT[!HF!K!R^B!M4FJN'BO,&="7=7/KIUY7'^<'G/:M=9
MI)VVWZ:8 P779\LEFY\.TN7.8-\&&)PMS*F=[:EPA:J271AZL(=ZW['LAS1/
M)C#M]BEN4Q6W34KV$1!%H]003;)GA"),(@#E8LYN1BG:T)32/$-EE]MM]A@M
M(H^M:LZH<0'FV.)VY67A)R,W#X?,FM+B3=>-L/4MYDB\NY=)L9;9SV8+-6M^
MLGM:T[1'U9*0D^JDUTT/)(A$'T1'-DKY,1&RZ!U0X^Y$81MOV')7A=19*+A\
MOW?Q;;0#MMZ-JS-%N$K-T1U-*+@P6"\#:,89+5F5S.%8?/=*FN:'$0P!/J6+
MF,V83-)4O(:2XGG)YO6DM66+#)>Y_1RR6M8SY2QF</=/,>Q9Y9L:4QIR/P]\
M%,0FD?,8TX?1V[5J<M3>VKNMR])6],YRTITMIC9F,<SM4M7K;,(:ID"WE@#F
ML^S6?HK\]H;G?&WI"LF4Q?\ T:)= F$%;)&,.3)SFP$<>[8KU6]IPW&5#Q<3
M"-L'=R5J<,AK)@^D;=I69URO66-FEK7EXB\V',]R7JQW7'3IQF0!,8&%ICD<
M;5G&'&U?M,:V+8YC'-=(RO5&)8A\,+!AA!+#K=[28#"+ ".6:RZ<L$R@;-!]
MP=0P2\)C"%J]%!WCX8Q.'-FI-))E7W4/A3 -V !%T.FZ"G:+)9?LN>D[H8T0
M%^)YE86+#5RVND7?1-W,MS9*Z=X@I-Z88 VEW:.=6S1C%RH%5ICW ^Y&UV 7
M.YE)VS^BNS=)?[T6890P&U3.3LF=$TTRYK/<'4-G/=!1G?-=EB0UDIHA=#9V
M&"LGEJ7PW:%DLO$0"-O.<UTEPQWQA>*)DD,!W6X8#*.1R775<;/+-4S)36PL
M'3#U!3AOI)C+KS6:L N .-W7B+;D;G*JL<9TT# P]7,N=>OK%]T;3FS=PF6#
M?A]U.KOF29B]2=.E2I>\98L&05NX]73>,,NDS&LKY31#\LT_\8#F6-M^LFWZ
MA_*=-:=8I_\ .*;MYES[3+T])K+ZS_EQF \)TX_Z)(]#.9<N^NN'H^*SV=]5
M7Q-_:KP]GU)PU5E1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0%!QJIKZV2ZCF1=+F2W22#=NO!B#G>NF=87$>D?
MFU]EWY)>=^H_G_B?3-(FUDZ8Z<9DRB9.?%YBZ+O"=:3M4N]'OZZC9\I?LO\
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MO.)S[5G'KI9UE:\DDF&T<O2K9M<X;!81?V*]M\.=LC?H['-&WN2UJ6Q;J.9
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M$=4<$-:#_-VW9>S:D:MTC3P8P?\ -V]2L9[3$TQ?H>T_\W;U#N0DSRD)'!K
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MPS23);GA2*N47&S$QQ[MBUC2R->5)<QPOOVX="SC+4TL%*2V V%7"7:>IGB
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M1KH'=Q&!Y\BDN\%W<I=M UP AARO"8WE>-N?YI81\ *M,91E5I+&M),L"SM
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M;CL'853.TNV99==MZ<D+RX/F[PAGSY;=J%F$<]H?&(OCSHB+K*-KFN,/HGT
M\V:S;X>[\:S+JKB/3VEOPFT/RQ5EV^C;IZX<3Z=![H--A=Z(HY=N'4-9(>R8
M8--D<-L%698Y4D^9*<-EFW H\_RXSIV+H>LOEOE#Q(0)-]@V>E*Y29CO?AOB
M8M9*C-%C@<,X*<5P^3S([HTGB=KVM;XPO PR%UFQ6:K&,KK+U=CI<3,!O[U;
M<U+%;U?5)<'0>W'L*SY:ZNB^*]4#FS(/!@]WK[U;UEKOF28>M7%%>7>,-X6N
M/:59-.GQ]IET]5SG.G/,8@GK6,9>O/[4AIC"YS8"-L>O[J2-3J[/T6C<[P_=
MO>/01L6^:[\1[*<#Z626'=)BYOJV+?6;^SY?S]M[>W?">F$%GND>ZWU;%U_5
M\_G;VCX5HO#ERR0?A'-<!ZEFWP8QMV7+ :QH&2=<1CO<UC(&2WY3M=88_ :Z
MWV7\P6>UPSC#P90;=S7+6L9+IK3;BW'[H3PEX:0D^]';?9CZ5GEBXY;0; WJ
M3]K.<L$UPA"VV*MOES]:B*AN\'&.?K3.2S%1#I>\XVW*YTG6O+9<,5FWRSWN
MFU)L/7VA+N1GK?*R4@#FB(P':LR-\QLS)+!;##LMRVK<U&<M9S&D7"P' =RS
M>N\DOA'36 G*_ 9E:SK#4DPTIE."+!&W9W*7&6D?,I28C=-^05RYV8VUG:>7
M1@#:D6=L,#M/>V/7ZLDICVN6S(DO:X"!Y16<>4QBQ-RF$ &(P]"U+CEO&>K=
M!(Q/6CFW9+W"%INC>>6*8+;4U3U)  Y8[2I(WC,PRS:[=$#"RWM0UUTA*FOW
MO=WA>Y2Z6;534)[-TF(/3G;EM4F;:N-94:LJPUQ]X>G %=)C"8M:LC4/?$'"
M_-3+EVE7*@JR\-$=EVT!7.LL74RMLAQW;SUKG[5SM^K;:"X@YGUK77LF9A,4
M<G>L(B;(6=ZO:9<N:LM-161W3RBIBM3MBX2#*<-C$0C"$=G0KXTWC:5I6!F2
MF]._Q3%2Q'NGF]2U'JQB.MN)G[K9G\&_'8L]KAWZ2O3'S)JMS?M^_OMNCW*]
M=QTDM[/1#CJ>7.FF,?QC[B1BY/+U=(Z!J&F;4D0O=ZX*-]_X5VQP7HQG3)!W
M"8PM5M]8^/\ -<=J]U?+GAS>^J_B[GMSS]BGLX9KW9X2X:#9$K\5B#C>+%K.
M5O:NV*;1?"EC\7"R_H4,VZ;;:5TH7$0%YYTLSPE[7.$]I\TMZ(8K,N*ERN=#
M5.W6VX9>U5N82CYY(AMVA:<[?JT9DR MLMOCSVJ&<32'J*D"/O#'$X@+.,L\
M\H"HF-,3'/IO@MZQA<80TX@EQY_7WKGV:Q*B)\H$GFC=RR29X<[UQ<HV;(&'
MWIRV[%9*W[1@ER7!PP^Z%OX[CLS\EDFEBHG%FYSYP7T.MQ'DO*XZ;4PA$WNQ
M)R&U+M,+;)GL<V$1RAWK-Z_0E97/:6GE=:IZU=(V:T&-@NR&9*T- M#39DI+
MD96S@T0C#GCZBIZU<L$Z9$68DV^M;DTQ[;1<P&TDXK/MC3=W&C,$#'E;:L^M
MNUEQ,,6*8LAS7GQ"RP<_*U7K:MF6&;6N8([P%G?M5ESMG.)A#U&LO8;'W1YK
M(G:M<QS\Y>*36'3GPW]Z/5&U<^\UAOKM.NFDR]Z%\"O#VNWHG72-=-=O7]O>
MKC$RDY25$\[P/-CRS2W,;MQ5ZTN> X1^]QCFLW<^Z6K;+G,W&VBY.L+,\/$R
M>T-,"!T["K5DLYX1$^J =\0ZSB/8I)E?T9Z>IB =X6[3C%$QE*RCOD=M^Q=.
MNIEG[)673ES 0">KN2]MG#F*5WWI]'<I[9)CRUI](81@<[AM[DG#/"OUU. U
MUF> V[%BQ<9W'7VI_BM\7^Z>BSVHU-NOM1F%QQO.)6^W"35PU:8D6QQC>>;U
MK!<+AI\Y[6QC<.6*J+1(JW6$FZ%^R*&,Z;C*PN<!O#/J6LRQJ3U3U',B6XVC
ML[UCR8S,Q>=*E[VX8XCM6\Y3U7N33L$J)^]$.HJ689XN%:KB&S"(?? *"*?C
MS>I9KIU:$R_H73JQV1L[#EFK5ZHF<(\N?O6)=M=JPM9 QC'H1F-^3AT=I4EP
MUVY3E/W^I=9O;GU62DLZFK%:O.EGI=PX#J&1]:2R%XPVR&W0OV!:S*Q_%%U<
MIL'&&!RSYEF]OHWU5BI+6.-EQR',LXM9\H:;.:+>5@6I,:+M@EU3!,O&(]/.
MM+C23&IL#8;UH&>SG23$3=TCY^H-<#;A&_FV[%SRZ8TBGUC8V$79D9I4B1HI
M[2YIL/-'9L27+-76@G-#1S>I6W/"^V$E.GM+21Z\BM36JWA6:Z8"#S'KL4SA
MSN%"U5IF-,-MG3[%$PZNU=KY9F7WG//9SIF)BXPJ#JV8R819>.W8K-M>MBVZ
M+7S=YEOTMN0VK+6<NW=,J)DR6T1A$B_H6NN/*=IB97*GE/F-@(G#T>Q*RSNI
M'P-AY="3E9RS4U/N.B6PZ!M.2UX+RL$C=:!9=# 8$K%I)E+4SQ&P&_9F%KKP
MB>D30!E8+]L,E+JMRL\RJ]TP(PNCFI)FE_;R@JN>'"!.!LMYLU?XUCMOA'!P
MNMM*O-RDS$I3-$(\V'.K9&^M\)27/W(6PMQN@L\';MBX24BLC](70[$QGEGM
M+-QM_6OV;5%S4-651.\(BWN3K,;J9PI6H37'>MP-Q/>M6_1O,QE3:H%QAMCR
MZE9]7.2U%.I'&-A@>]2S-RW;C4;5/ICW&QIZ-D53K<QO/TF8(1:[%3K2=<,T
MO37,<TVV0Y8K-.J:IZ=P L-@&6U,+VQ(R3I3@TY;>8Y(PK%?*<<;K.KI157F
MRG1)Y7I99M<S#A*ENWP[(BWG5E\5G&\K7137!K;[ ,3M&:UAJ58Z>>70&?/W
M[4G*7A-,/NCEBF8CP\P:3L/85CMM4-4F)LLM/ICW+,TU-Q&/GEL;^WUK3-TX
M-KBT0W@,<EFUK*/JICIX=;&)LAUJRY8\H2;*>TF-D"=EY@NDK4N'F22"!'T[
M4J7=RM^GO(:(D]:Y6W.EF,86VGG0EB#L\3=9M6YBW?#/:61G,UIO$>7,M88E
MOD:02+,1?!7]6\1CKG-$HP'T3<.=2,QU!Q0[=;.L^B5G&6Y,O7#B6:0]UF!Q
MYUT\-84*34N$T<^69YRN3+MGA=[GD6X=I]"LY'?NB4Y>UCL-T=5BMN-5%Q%#
MOL;[IM'L23%RU+X:53I<&N,#$CM)2S*R8475-,=[T&E8O3>?"_=5INF3(FR$
M#L3&)BL8S6DZ@F-="V^/IYD:SX9Y5+,$+[^T052ZX3%/)>(6'JY]NU63))EO
M"2\X'J4LPMN&-].(?<[D26\5KME-B8]@[EG&$ZS;)NM N'4%8MGD$,E4FKDW
MP+('T*-YSMQ,P;?1WI&>V,LLJ8(Q,;(8QS5O!.OF)-CPX #""SUG[E[<-Z2Q
MI(B!U#(KI>&9<+!32VPA#T#([%9/VM3G+9?)805CM/*^%5U.6UF\<HY=RDN2
M;=4Z_4"5OF,(.-^V/<M3MX3#JC4=5<'. ="#H<NM2K)A$2=4<YX!?'G5]5\5
M;*"<Z:&#.SKLZ59,,9Q5YTVD=, !!PM3V2\K&* @0@;!ZD]EU=(>NHWY&\]O
M,F,IPZ_U:EF#?(%Q]:EF%SFJ-4T\USS8;^>[[JRU+*XR*6;O0V\NQ"ZN4S)I
M)D(V]7.K]CVUA)T-,]LX$BR(*GKB9/:72_4[@V2(V7]@1FSZ-??!FB&?>M^%
MYBS4-I:<P#Z I"+ &'='-Z@L^3V8#*<;O1%+L[3/"OZM2S#+? GX?5[4EV>N
M)MT-Q?1S=QT"?A.>16LDN;MZR:_13/&,2ZQY[5>8UUTM?!U*6N:'9 VPS&Q,
MZPZY>T7"]*'2Y,3>QO9#)9MWA,XCL Z>SP@8GKP@55YJHZM*$L/@?AB?4DF5
MLTZTU6:Z)@3=CTW6J9L_19,S#KC5&S9L0'1O]$58QVY^R'TW3IQJ@2"1OBV\
M7E)=M3$CO#1J7=DM]TQW6]RK%JTT](3]$XY;=BA);^C8F4KVM-ANY\#S*1J_
M1%39#P<1:</:M2X91LR6X=:E)<(VH)8#TGTJ.EVB9E86N,2!S\CDJQBQSE3W
M3+8]4>6"E:FXW0XC$]:QE9J-B74EOM)[UN5GEM-U#=C[PP5N*N'/\X@XJYD6
M3+R:UKA\0MAL["F3#$9[#;$=?L4RS9Y0U8X'/'U]Z)A79WQ<L@E7JUGX=/J5
MZM,3F[PA<K9E'#PAR"GJNCPF]/,$LIIK3&0<3&ZU1SK$9D(B&'J6;,+)K+%X
MFSTJ;+<L\DQ/5ZN];DQLNJF)$LD1Y^T*=JZ==3#-,9[IM]&Q2=L,8VK%>(1V
MB'8M>\Y,JZ^8T.(.9[2G.XN6S336Q'/LVJ<:9NZGI<YFX+18JN,;9?&&SJ*8
MC3SXF4>M2R5S_5JSG[P-F8Y=236F\9B(G2S;=9 >E:QF,75^R-F2'.)Y;5GK
M,<M9GE@-.X&$#RZEK*RS&GA\@AIA'T*2PE1,Z0Z.-YPV\Z2>6;<M)U,\PL/5
M]U1JW$:[I#P38;X7*L\UJS)3P76=O<E)RCYLHQ/-RP4VZ9TTYDN^T?#WJSMC
M1)Y:^YM]"G9N7ZA$%.K<N6_(E;P$89=0YEJM=4M*HFNOC=@1RP29=)RS&A8!
M?L5]95153N2@?> PPP.Q8QBM15JS5I<@$^(T0LYL=JM6ZJJ5?%;)1,)POLN^
MZM,J7Q!QTV5*FPJ&V-SV9+':^6X]?];\P7.GS83VF(A?LS7!TU'6VK<6S9X)
M$T&(/+T*I;'6VHZC4U)B'$@X#(W]B:3:$9254^9<2(Q3.L-YUF+YH6A3ICFD
MRG.WFQNLY6HSG+OSA;A,S?"WI!M;ES]Z%F'?.@\"RRV5&0;",(Y;-JSV^J.T
M].X5DTK!^)(YQE'MBM3PMJPRM$D1_)9'EUK64;)TRG;[OA@68QRYUE9;&G/T
M^G;] 8=L?6EVOM,Y\J_5T5/!PW!AV)Q3F95Z;0R=X^X.70K=L6V5A^J2/O H
MN_#G]5E-N:F'3XNV;AFERY(</=/HS"KV\1MMER"0I>MPS+YK,V5)L&Z?1FHM
MLSGPR>#*^]Y=28/>.#I,G[V-^ L1)<M<TD@_0CSP16O.HI!!]P6Q[DP=;XJM
MU>A2IQ)\+,>C):G6?X3A7ZGAB7A)-^7/BN=U6I-?=6*WA=G^2/TO7L6I,[/5
M3-2X=ERFNC*N)M.8@!SHEF'5>N:>V4)ONPA'FO6?*V8CIG6V[CY@'/UK2;==
MUK2YQARBLM^(@)E(\F,#>0NO5TZ=Y(RTM._?W8$VCT%=I<+>TM>TGD_0$ZC*
M,#=+[6K/>Y:DWA]07V?5*9=1HQ(A_-I-MD+F#)>?M,1TD?9'\I#H:-HPA=(&
M.PKR_)_]KV?%QE^E-)-A2LOO]9V[5Y[U\N\MR\.=$QNY>Q<N[U=)ILR7V>CU
M>I8G5._8U)_\S-E[3CL7233S9S75-1^4=^V=ZEZ.G#;PH" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @S2/RC4%.\Z?[OZC^!F_R95Z?
MR8^3^#Y"OG3$=4U4?_?"?_*/7OZ7$?$^;^7^7X6^:$O>JZ['\8?2M]>VWG[2
M7;HNGIHS_A-^$,RO1UW'E[ZNEI;0GPA[IN&.U2PZR(>MI-UL=TW'UK,U5MF5
M8J&;HC'+UA:RKE2X\WK27(L$AIW>KO6<QO.')YW1%*N,J_6U9;O#> @-J37+
M?76ZK%5J!,1O"X8\RMK5N4',GQ+G'.PX7K*Y83JHDC=WP+>])JMRH:OXC:UI
M'B@7V'J6LY:W9]G5W$'$D6O'BB\Y8;QQ&U,K.KH_7-;)=-_&QC%3M/;;I).%
M G5YF/,7 _=69VQHG.&Y2.WK<X[<UN7+6/*0F.#&B ]"SVT\WR2MNBDFIL -
MO+U+E;_P\_;.'8VB\-&>YI\(FP>B/>I[:<O:QW=PWPKN.EDR2! >@A.6NO:X
MP[XT+2FR&2HLW8 <XAWJLS3L"0]LI@%UT,,%B\K+EAJ9H># QMA?T*XL+,H)
MTE[WFTF)3[L/+:29$<XPVK?6"0ETK_=L./KV+-N-(S_579'T=R=;,;3,:\V0
M0!?CDMSKK-+/IPB*B40'77>L[%,).L_R@:J-HC=MYEG&&K)5?G%V]8?2=BS?
M_M.LQRDJ$%V[$X0ZUWZ:RY?)4U<.8+7-<(QNM@ETUZUH3;N@]BG+6<:14V_I
M*N+!K;Y%W:KA,?5LR9KAN].?>EF%J7IIEL2,#Z0.]9RGKE/2YTK=MA'V#8JS
MPRB=+_8\NA63*R:;4J8W>ZNU:LT>TX3,B8",;NY<K,EK.9Q!LCUGO6\))Y:4
M^H<";<1Z]NQ6-R3",F51)(WA:F\L>VWB)<R)O@IG+MU0U8/BYPETZ=.ND3X=
MHC"_+:IX+<:C>EM(&%P[$ZS+#9<?=!SAV+6,Z)<,3G0ZTXK7\M,LJ;N",86Q
MOLY6*7;-GAMMG[XA??B>NU(2:963S*!MOSV?=19,AU"%Y"DLJ;8OSH<QRZ4R
MUZQOT^I71(Y$JL)<5H<WXA:(<K4:D\HNM_&B%\8],8\Z32=IE3)^EE\Z(!A'
MU^Q7UR=;CE8-/T\RVM!!N.$>U+,+<9UPG!)#!ERZ,E,EU,HJN87@@8 (BOS)
M+]XV&P\L5*WUTD*%CVD1)OQVJ3E;WBQ-GD "VSG[PNF')$UTQT"(G[Z\[>]9
M54JN8YKG6F_,X].Q%C7IYAWK;;L3GTIS,%F$Y3/L%F)[%),7*)V3,$+ ;CVJ
MC>8_> YL\K$,USW"X\HJ-SAR^J!YA#JZ\@JEEK'-TIN['=V1QM]",H2;2^$2
M-I19U89A@WIY=J))E&3Y@VW]RSCRLMFG"3-:'"//Z1W*Y:LMVGJ:8+[;F^K:
MK&$E&+2=A]"$0]8(M)VI9BM];F*5J%2Z4^ , #R[4B=N<QFT^J<XMMC$PZ^E
M9K?6+E1-B(DX<^"L3M/#:FRP1&Z$,.=,L6*O7.+'&W$YIF+.N9E7IL]V]9'T
M[-JO)GUCBRH=&!QAGWIC"3O.R1E/CA?#'-3*^MY2M-ARS[D[;),-U\H$=.45
MF::TYR)0!MAU 9*_=,^%LH(!O0M7;':3PU]5FM:RTW^H*1)IU#KSVN>^!C]U
M&_9591#GAL+^\*IZ^5FH--$S<=NFUP[2L^73.>N(O^F:6&P]W):<KI:A1;K?
MA-D3<.=$B)K9#FP(:1:8V#,Y)C.E5Z;*<7<L@I)8/$N6X1CLS2M]4C+;?;E@
MB>S1JZ9TT& LNV99+/:83.T734QIY@)L]Z/5U6KE;EK&-KA0ZNR0T N$3#_B
MXHE2+]<ES&P+QC?M3.*U.%:U"?+G;SH@QB1C>;(*]KEB9SA4:BR83M*BXDN6
M]0U\NG>V+A"*LLB\S"XOXHDRJ8PFBQO1;'G.*EN5DPZ@XBXS8V<^$YN(Y6*<
MTMG^77]1QAO1(G ;.@J7ESPT/TL)<")P-HQZ,EI<ML<6.W;9XLCFIF2X7&;I
M$U_%KBUP$X6G [0C6)PZ\U;B.8_?A-M]-\54]5#JM9FO<??M.7+:C/Z(\>-5
M& B;86;2F<Z>CX]?JE*;2YY &Z<3=S*.UOE8Z719IM+3<+ON*I.UX3LG0'N
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M22/P(Y+EWF)EV^*?N>P=38YH_8KP=N7U>NNN&JHH@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,GR_Q>S/E[0,=]6.[@#Z2L?RKX/S=[+BO>ORTTQG\UB#\8_""LZN<[RU[O\
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MW3@UQ) PNYO8IJ_JF+RQMH02+!>,5<863+>E4(@+!?&_EDM6LVXN&=U*&B,
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M5R]'3<>#YDF]@A$0%BU=1Y=Y:A<!85C&LNKQOC:DF1S@"A)EKSI6]$V79#$
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M,B80'2FF9+.4G2TT81VY='8DC6/*:;2Q%G8KB3]5EQI'5U)!KHQMC@I>5U5
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M#C$68;0.M5J<J)J^O"F:_P!X6!QO%PLZE,1TZYX=)\0\<"42-X?2^EM6L?\
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M-CO4K/\ [4MSMUA4?E'?MG>I>GIPR\* @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(,TC\HU!3O.FS@"H/\ R,W^3*=?Y,?)_!\B'SGQ
M=J>KX_S^?^&]?0Z:CX?RR>^/N_$3S%836UGN_OAO&TKI*X?)-:=7Z;)C/$0!
M[R[O+9MV V2T4\;X#U+%ERG7G:DZVS=W\H'L2SZ<NLO6Z=6ZA N-T(GM3!VQ
M)IRTYHB+!?L3U3E=J:6"UMV!Y=2F/J[RSK/NT=1E>X;K]OWJ8^C6=Y=;ZO+,
M70 ].2WF7E?;2CU##OP(/I4UX9WSX1]8W=DN)@/=./+):\++;SPZ:XEG;CG
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M*8SPL[+EI_#OB;D&F_[WEFI=:269S79NB\."7 EAO%[>A,UZ/CWP[ I]&99
M'+X=@R4=UAH],:,+X8<LDX:UX66FTQHA8,?6K.OLETF)6GM#1=&[T!3UQPD[
M3.VS]38VV(Y<ZJ:KP6-9][99?:D^RYQIFDD.<!$97YE:E\+/_5MSV!DK>B(0
M]1VI;@_]U*KZ\-<1$7G'H6,Y7&(T*>J;-= N;E>$MPDN$W*DM+08MC#/VC)%
MS&.H(DB]OH]*$FT0ZLP!%^96HF9EN4L9KKQ>/0K8LL7*B:V6T1+;H[<%OX[X
M?/\ R,]N&6HGAOPD0Y^;+G72S+S=9CE%OG1,8FY+K1:XB;M[59IGVRV9,ZV!
M/8%<9VZ2V3#8<8M/1VA3,X&E,$=[G2Z3MPBJI@(-G+%9Y8EO"+9O2W'G]0]:
M7[M8M66@K]R .7*]&9RL$O4 6Q]>P*XJ\\(^NU<20X@W#/&_U)A<*5J'& EP
M <,?I=74LTDPBI?%1J' ;T;<\^I4WC*Q4,:PXVM$+(BY&=^.5JDZ4 R-EMMH
MV(DSY:\RD,LQ!NL]:WIKURQ6ML4U6\8:M0T[A,#<0I;ES\JEJ!+;#&P=X5N,
M"M?6B'P@;P%GA9,K'IM>1NYB&"UU^[;L;3=1L$3@+^<)9'/.$E4ZFW=A'D8A
M3,:MF%=J:X3'6'$QMYPLIULPUF3=XWFZ/*Y:FV+BL^\ +=@[%K.=+U[8:\ZK
M$L7C''G4J[MRB9NL^'&!%AL[%F\[:Q<-9VNES2V)MVGVI)DUC# R8Z<X.@;2
M#=S+I]D]=Z3E,[=A$PA",>8=R=YK36_#??/:&PWA@%S9RAZA^]CLOYE#G31$
MJ)PMCWK7,7&AU*3=&T8!3BK+CE'SZ)Y,+;0<-@6LPS&U0TI8\6'I&1CASJ6Y
M2W*^:>V#9=P]JLX7K+5C9+&[]&X8PN2+VGT:50QH,8MMMOYAM2R83&M<N-/
M&\8X\RSZS_*27*PT[@&B!%PQ'.F,%N+EQJJ@,8;08#-)*7>U3GU6\\C;G$X*
M^J999<K?]XY>U7B-R9C.)0NLZ25,,V5BG,$(1;>,=D?4GAJ<.$F6-_"%N>Q9
MN8G;$6.EE6@"Z#?:DN4QE/,DM#1[<SM0FKAXF2FAP,1A?$8G:DC5X;$JI9):
M!$=>P+49G;ZM2LU(#>,;K?0IS4QFJ=6:R6N-IN/I/,MQN:Y1!U@N)$3:?7S!
M9LUDQG;(ROWC[=B=;I+/IREI$X/ASFSF6KB[,?\ *1'O"($>A89W'B8[<;$
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M%E)M8M/T5T08'# <R7&%F)5SDT#6M@1]%(G:WQ]7"=0B\7?<3A>9GR@JND#
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M+;>Y9O.4D^K=94;K;89F)5Y5Q;5[SA\)-F.14=4_2/\ $ $<3VA7!)Y2_@1
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M@9G2+,+TR8DV\&466P]?J0S+IOTKX0!VX<ZLJ6^(G9+VPO'**UC.V.VML-4
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MG>NG_:MDFDDM)_%V;1M*>]MVW/Q?^$5.UFDD1MEW_?#TJVUO_L],,KBNE:Z
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M)=7BYQY\?8IGRMU_'AT]7UF_-.'O':MYR[==QK2VB:8FVWEAL6?9G'GPVA2
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M0NRV=-MJ'*2J*?QFD"Z&>:+)_P"ZAZMH'BEQ@38<(7'V(G%4*HX:,MT=TX7
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MUQ=)1TGPVF';L/<DIUZJMJX):[&QWL6LM8RZKU*E>]]@,.?(K-+TK)I>G/\
M$:XQAO;>5J8U]V?7P[GT:F$F2UUD=P=<%)GR3I<_9GKM;^K>[$" (Z<>Q7RU
MZ2(^5JYGDB-Y'*"N9-'KB)20!-@;XP]N:J-]]("R%F'JV*7C7+/KG]%9U/30
M\1V$&SIMN4ZK>EZJG^: 7_\ "]?.IVFUDU]TW0:.W>$1E@<AM5E\>$QC2VRJ
M$RVC=LNV+65GQQI5;' 0MP]%JFB=$,9<R.,>>"OW9G3-Q$G24SWW@F\=V"C7
M]<FVY-IRUIB-O4DN*Q_5E5=0+@2(E734ZXTK;Y3WDV&TD^M8O*V)/3]+=.F
M&-T;HY'UK<N*>L_RO4O0A*I]^$" </N*7ESN8IFJ5AHGS&W;NVX>U/;ZD5P<
M1.>[<WL;HD>M9+(D96HF8 8D9XVP/,M:K761*T\W?@2>5G/A%7C2U.2&;[0
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M%WH5]O"6W>$A*U 2 !998,+ I.=\-3MB83M'K5UHN&.U+A/:)A]4VO9NF%H
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M7>&*V5NZ?,H7S</"GRB;8PL:2FC'97;2XD?#'"ZX]"UK"QY65$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS6ZN3;<A&7#,'UHE0.K,#9)LM@>]7KBUOKVMCK6;^5//ZUZ)PHL@@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,TC\HU!4/.4PX#G_P,
MS^3*O7E.V/5\FOSBSMW4M5L']/GYW;[U[?CQY?(^:>UT_$WS,JA]9K;ORCL=
MIYUVDWISG[9MZ[S:T>.Z&>8R"]$OUX8YFDE*U M9:<,_NKGVDG#Y?Y_\4-J5
M6)[2(^E<>'YRY]ZH=90&<XPSC=F5,NWQV\,E#HX!C"VPW<VU'>3>UJDT.XT*
MW%>[X;AHULD,:X'F21WG*G5[@QSCRS6;?#U?#,\JQJ%8QLN8/V.86-YV[R^'
M1_%,YKC,<##W78\^7.MS.729>OG$+HEYB?I9[4KI,<>75]1-W9CK?I.QCDF6
MN&[2SHD 0].93*6ZPM-)*\6 S%ZMKS[RO^A:(*A[(-!B0+K[<^A.R=N'>O#'
M!GBF6[PV_$VR&WF6;]N7.\O8GAS@8-:TEC;VX9&W KITL>7Y;7:%)PNR2V!8
MP6 ?#E!=I=O/F7;=.F2Y380:.@<REQ4\Y5^NH&NN Y>Q(9E0)TP@QZ;H*6W+
M/;K+6U+IS)Y9I+/\M7[-DSS+!Y<KUO,)]$74UY>-V ^$W9^E4SA7JF69L3T\
MNI9MQ6;CEH!A;9 FU2W)C;=IB0X6=:0[3RF6F(%RJ3-C!.)A"%EO:$QI;F<(
MXM!3-2[;,H @<Q[5J7/+-F..6?=R%GL4MF7?I,]<WE@F2XGX?HY<_0DK=1=0
MV -A%WJ[EG&\M23"#GM.\;#",>U5),HQX-EF?J4:;-*"(6'#\(E(G;A9Z4F[
M]D.Q4Q,966DFF7 G9ZN]2G6SB),ZB (&'6G_ +%F-HJ?J,8P.$;#D+/2JF<Z
M:!J]XQ/:/7%#%!51Y#N1+IR$\.B#EZQD$&O-#3&[+KAFI8OM8CW#WC #&Z&9
M4DQSRW);M-4C]UN$!#/):UC[CE/:V8.79T*,]KB(V90A]O/R]*N)*S-,<O2[
M3#+(;$POLD96D@0)RRZ,U*WUUM(,T]C;2,,L3#H1FSRSMEM8X-@+.;)%QYJK
M:^ UAW++<%;PQ.764Z=,9,<2XPCMS69GRZ:;-+J3PYHB;",3A]U5;)8O^D:N
M?<$3?]]L5<[I?J*N$QMML>X$=J8:FXW)K6S08M!C8+-NU3@Q,_=%3Z"6\NWF
MMQ-VS8JQ4-7:=+$HEK1<;AL.R*#K>JE.EU'NYX<ZCI,U;-,+MU@(VW<_0KG/
M#FLQ<=VT60R*N-?<EVA:F?NNOZHC(*6W_"\W;!)K(/O)Z=H"9PN(L5)J>Z!'
M+/(J>"W-;CM4!:19UI&IB(*MK?$WC@39S%2W;/9 S)X#CTW68G-)N)+9PX"J
M&':/:KP7M;RVI;]\C%3-R=9GE(ME^Z/=/IS6D8YHW; +Q#M0B(GG>B#RN2+9
MCARHF?CFF&(PVK/99U^J]L_HX_:]ZYS7*55-4;\5A6;NY:U.%9G,&6(OYMJB
MS<:KF6& [%)G/V9L:DR(WAL]2VSB9RU#.>PP!.=_L4XVO#-+K'-,(FTJ9RLO
MU3%*_P 4B-T1CLBF%ESRM-(QH;[>=6,]OLR5!&Z>8^I*==<JA63=QY@;K;SG
M[5'3)2U[F.C;LMVP4\L62U:9&KO#+=F.SVK1<(K5-5>]CX;>SH2Q9<*,[5)K
M)IM-EM^U3.%LG-8JO7Y@E[N\;1"_.SU*LRX5LZO,>_XG7GZ1SVJ8P=;,MR74
MOF".\[;:3ET)MKRB:^0Z82[>=;'/!$MO#2I* NF"\P59P[@X9TMD)1<!=;$#
M+T7(LN':=)0RQ+  ;99=M2VKB,%3HS7DP:+;; -G>M3&,UG%5VIT(-==F;!D
MLV8JZQEIR]-$M]YAWF"8/;$2K9;9; (X6<\$3.=JYJE2QDMP<?3"X]P3"WM7
M56K:F&.=[Q@'8.@BY5L:X&$P<<OC]J):J_$G$$9)#7'X#'WMA6NG))EU+,UA
M[ID-]V/TB<2NOG)B.+ZJ=-!(<[K.?M5G)B<M-\F;--KG>E+%S&L_2ILP_2NR
M/2IG!<5L2N'ICS='_@\RN<\,W2>HN%WO@-P8B[HR4:DBS4O!CI@'N@D[#LPA
MM5TERM6E>7!?,#]QO^!MYD2<[=L47 O@2#%C;A>,AS;$POM_PCJSAP208,&-
MF[ZU,?4Y[?9STJA$J<PEHO&%^"REF79M,Q@E-!:P6#!N2U5ZO#Y3'O\ A;:8
M6 9JQ.RZ\,R)8>T[H^)IM *$F8['F3)<F4Z ;&S9@HWBJKJ-5O")LC'MYBK&
M.WV4:NG1<8'$Y^Q5GK429A)M=#I*C4SC3QXVZ"=[TG!#.6HZIB;2;R;T,1X8
MZ)OC9GZE&K]FY(:=X$QP3.SU_;ESK7?B81V7[%<>69<:==5].)KC?>5&]8PQ
MT.CM>\1B;5+;X9DQ5[HN'P6MPL%XS(R*9=/77W;\_0&L9'*V[VK3E[(A^E-E
MNYL(;!WJ59<L\BEW'"$;>BXCU*9RW-1O-D%Q%_+I3@N.T66AE0: 8X>KG6HY
M6?1*EL+HGEL5F/+4X:DR07D=-\?5SJ]>,,XVW:2A!<V.)RYEG.*W%DET#0T0
M[-IV*%D\M2KI( \QP V;%6+,*[-I09AZL,^E!P\#PC'V<KU9AJ<!KW22!@ .
MN)*C.+7C\[/<"(^D>Q%F8T*F;X[3CGB;PLYIP@)U&)AM L.6Q.)MN<99:62)
M3H0%]\!A!7.F;-K1(KG2Y0 RS^XG)GQ.%4U2<^=,L)A;=MAT8HU+/+E0$AUY
MOS*8WFIVN.%WHI^Z&6Y>O8<E>-,)P5$0+;P.5P0FD55SA"V%H)QR4X:E]KA
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M$QTQT9LL.=:XFV)3&FK99E^\G$=#+T]]*V4![\LQLA:# W%99ERKRJB @("
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M5L\0FNA@X^@Q]:]'7<6B@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+KG>%+L'[4^I6\1)=8550$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$$MI-E0PY36?A!7IPSV?@-^LETOUKY6WMWBV&AZC=9^^5"SVVUTF7\G_B*F
M_P#B&II@8%]<^5O8^]4%L=I$59PG>8K^G'^K;:;^;_)73Y?B%\:'3[3;^]#I
MQ5MV=9^Q]5_&?Y6C_@W_ (2E3JJ"-" @(" @\&X\Q[$&#S7;O^0W&[;H\.:@
M(\]2$\)_U/Y"WVQ-(*?Y@.,W;V]O:].-ML(U!NR6>LQ73O,=5H^Q$D&=\PND
M1>0T<14!W</^;*]D^*OZWOD\W<\DM ;?#2I(ZQ(5\,7^399=T^H(KF@(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @SR;^D]B!-]8[$2<,"
M*(" @(" @(" @(" @(" @(" @(" @(" @(-N@_IU+_#,_""'C_+T^^T6,/+>
MK_L^9_C+MTF7G^7^%?#U\RL__P"(M1'_ "4[TEXSV+TS4T^!=_,_+3BU\=1?
M9B[':K&^TF.4'13 '#/VGF3+$ZY;\V< 1&%WKYTYTMZXVRR*AL(67^L[4QAC
M++,FM,.G$=ZF6<N#7;QA##-;F,,MN7>.96Z<[RWI?T>;U+'*I"5;#E@HY=M=
MF\R5$61OY8+>86,[90 @8W\L%+,\,,3I)$+^K[B2RC Z2X"R/4>Y;ME25R8T
M@B(/4<EF\$F*E))A#EDL1GMX35-/@(8P[MJUAUZ<+%3S0X6V6"'4=J-SENEK
M7M@0.I21Z>MS%1UNB:^5-]T78CF&*N,M]>WJ]<>,=.$9\&BXW03&'6=M;CUB
MXFT_=<[W8>Z;X<V!3G]&ONZ5U63X9(A"UPNRCL5NHDU<J/4-@28XKCECON1B
M9=T^I7+ECRW9#=X\L_8MN?R6UV9P?2[U1)LC[V/W M?9YK</=[RUH?=IK&_E
M&]O.IC#EVV]P^&].A+:8##+8CEGP[5H)?A-! A:,#L6YU8[_ $3C7G=%@N"[
M29<LQF8\PM&*ETEF7@K-N%\(ZHOZ?64Z\9814YY:#S^N"N[3WPB9M6YA)CC=
M'VJTZ[VR4NH$OO-\.M%U:MDBM_%BTJ+CRQS:N^WZ.?/M4RS[2M)U9 WFY65>
M=@K ;R4M/X[;\BH:X]'+'8L9JRY3$F>T0NN&6/2NDN4[=4@V8UT+;2-F7.C$
M9(!UAN-G6I9Y5Y$AHNLYA>DN2LFX!B?1W*X7.&/>Y147+@^>($66',9\Z28V
MF[I&SJF^!ZB,1SJS;?K(C)U01'WC:=G/FG%,_1CEU!)B"21MYE=5G=3M-4/L
MOY1[TPEF$Y)JRUL"3@+QRQ2L];FLKJNR\WYCO6;6^$34UL(VGKS@I.41,S4
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M",SKA4JSS[II+7?]HFT9W6*\Z,7EUOKGS R7 [NI'Z7TNE<^WT;ZVUU1JGS
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MVRI,ZM?O$VW^S-7&4ZW;<HYQF&WK*YW7#5B5^L-E-M('(G!3.4W4!J.I2VQ
M?A<%94SA6INH,F1&]&W;A]Q61?;ZO#'-=:#V*SZL=9F[<WF##S>HI=NGC#0=
M:2K.&+/#))9%PMQY=B:B]9B93,N3[HAZ.K)9RMNV*9(+1&V\X'N5[7,+]4//
M9NF,;L(?M5EE%F:6OO@(@W].819-I2GGM+;87;-FU9\N_74;!FM(-N$,.];+
M<M6<1NB!$>C,((B=")!V^E9OV&CN-B3GS=RUA9;&]326DY=69V*:6YY6&ED@
M&^YPY7+=LQAF3*6,II9T;.Y9-\(Z;1@FX"\W''[B")GTD(P$,+ <1S(LJ/\
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M60O]UV9_8>H?RM0LWEKH_D_<1?[53O[3_P#TI6'?E_3L_5QO[F=/_P QT_\
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MYGO2TG73/)GVWQM.>2$B6ERVSFP<,.T$JXPEY8)[&4UM@LC'N41%.U5K3#Q
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M" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @("
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M)LZU9<5CM:M#.. &",R5_A'F^^7:;X<,9<_T\ _?95G[+_YY:DL/7&VI4>8
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MJ;V_M5\[OR^_\?\ !J* @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" 07>ZT$DW ).1/?\ 9?"VC5'%>N:A345%04LVKG&K>R7*:R6'
M#WW3'- )A8M7#.[<1\OOVJ/ZP)Y;^1FG<0\ \#ZOI#]9I'NHQ.IJL3)SJ@EL
MMT"QY-CL!DL<MXG3^3X7_F@^U^^9GSGXDUF9IO&M7*TBO<]LAK*FI<)<MP@
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MX4^8^;+_ #B-"XQ+6C?WS35&] 6Q N4S,M9[,#/-/YA^")@EG4^+]%?*._\
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MWWIUF+MGM)4I)D5+VQ+7F-U^U:RGHD9&G3C>U]\?A.).Q$L2DGA^;/</<?\
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MZRR<K4C)K)T/>WK.?%9^Z3U;OUZ8VX.RL*SSI)U8GZE/M$'0LS[E,XN%F.&
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M_'F!M6;*WUZXY574..&-WO?9_A9*R;VUZJO4\?,E_3;<?I;%=,^JK5OF0&F
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M-;-+0^W&SH39V[?157SG/F0Y7G:F&9VN?LV7L<61 R[=BQK.W7VN$%5B$8C
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MK%6 \F$+O3?ZEJ3Z\.&<7".$@$X=93$RU>$I2TV] ;0+/NJ6LYTE?JS&M!R
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M0P-C=YL-QJS<NN>ET^+GYT_D"\TOD]XKKM%XJTW5'4TJMJ9#)DV@G-#!+<Z
MW]T"  VIGPY]NOF*'\H/S:>8?RP^9G#7$G"^J3:73:*N:ZNIVSITH>$7A[GE
MP?NP#FPA 7JU.G:RX\/ZJ?V.WVD_#7SC>5'#FFZEJ%!.UJGTJ3+F;]7+F33.
MDL$NYSHQ@WG25;O^+]B>--/?J6@\1Z2[WJ369%11, M:636[EF!"U;F,RQ\N
M_P SWV!O#WGCYB:MQT=),R=JLR;-WQ1A\3,<XGWMTYK,=IVZ28O+\A/M%OL,
M.'/EM\B*KS#E:7X)I*6K:]QHQ+_&TTIDUQCNC"8%+IF^O;4?$;Q132J#B"MH
MI0A)D5TV3 #Z,N;ND0YE9=9<>W7&OJ^N[[)?[&S0_FY\LI7%]7IWUAOU"14$
M_51,MF,8;X'$J7-=>GKUF:_7C_[&PX?EZM25-/HSFR9087?S  1C;]&%RF*W
M>W3.8^@/Y ?DRTWY+N'I6BT--]68ZG\&8/"\*QS=TB$,UUG7UCG[3MP_0*MJ
M353YDV-CWEVP@P@L#30$!!X='=,+\((+)6:CI_!_!>H\7:CX3&:115&HS9LY
MP8QLN4X-@YQA",(=*,V[QX?SGOUAS[5OB'S XHXB\LO+S5Y4NBD5HTVJ^JUA
M+6RVN;*F$ME/M@ ;%GFM]NOK)8^-.FD:KQAQ#*DM;.K-4UNN8P^&Q\V9-GSW
MAI<&Q<XV[5MSYKZ._LZ/L(/.#YC/S3Q?J>GZD-'JZFF)8_3YHEB02QUQ;"!#
MC:LW;KUDZ\\/K6\DOU=CR@X=T66SB?0I+Z\,EAQF4#([P;[WQ,S5QK!>W1V7
MQ]^KW^0NL:4Z3IV@4_U@RGM&[02H[Q99<V-ZF*L[=(^?WYXOU9?C^CT+6.)O
M+33:V2-/FSJB4*:A>1N0F.:"UK""T@7*3/\ AF^O;A\N/&-!\R?R-\0ZWY?Z
MN=6TO3W5,^CGRYLNKIJ.8\3'->P DMENF"V!B"25J8K-G;IIZH<<<3?I=J,O
M59MM94M?-J23%QF3!OF)OCO(DN>7V8_JLE-)E\9Z>YH][\X-WN?Q;?2K.6^L
MC^BUK7^K)G[9GX#5V[_Q<NO\Z\<*W3/X)OX:Y>"\OYA?ZS1)E_\ F&KYD/>_
M.-<8_P#MRN<=O^E^%_V:=/)G_-1P89HB9=5(+/\ A5DF/X(6W+R_L>?)@(>2
M?!0%PX=T_P#D)*8PUWY=H57]-J?X69^$HK$@R2_C;SJP?G_]LBQLSY/>) X1
M'U74O]#DK5\_K_\ C<I_/J_CT?,0QK/,C6PT0'YRU+_25SZ\._R\Q]=7ZLU*
M8=6T9Q%OA4I]+$O*_'_!_17X@,-!T0_\A3_Z+*5KE.:A-*TV96S)-0+)$J9*
M$V-VZ7").%RLF6LSA^67VNGV@G#OR:>3FN_4-0H)&LSM%JW2PVJERYS9TR3-
M#1 .#HVA+KE.EF?W/Y0WSC_.-YE?-)YF\3<0\2:M.J=*KJN8RBI3.G3@Z29K
MWAS3XFZ=\OA"!N37A.W;.O#VP^SW^R9\Y/G*XETRITW3-19H/CT3R6:?.@\3
MIEN^\[P+0T804M\1>O77M>'W*_*5^KI^4W!6GTDWS$T*7-KY5/3A[I] R/B-
M;[\=]D;U.LO"]N_7K,OU%D_8P?*7+TV11.X>H/$$H,=_,*?X@R%ON+5Z:VG3
MY)VV_/WYFOU>KR1XUT75CP;H,AFHS7/=3.E4$O>$8PANMBIX;]NF'Q9?:>_8
ME>;WR?:AJG%\C3=3F</OA4ME-T^:Z4)#H&(W6C=(;M@IG%PS9[7]K\G_ )6O
MF7\P_EB\R]"UCABKGZ>:/B"DF:A(=-G4[@!/ELF;S(@" $;1<4LG*=>WK</Z
MLGV-_P!HQPY\V_D[H?"FHU]%/XHD2)$F>WZVR9/>XRI;7MW"XESBYMFU)?;4
M.T]=OV1XATWZM7M9(!#)K6S0 +@2YL##+=*N/!+K+I[YI_-"3Y'>0VO<<L>R
M354>GDLF.=N>\*.=-= V0@0$N9#K)V[9\/Y(GVN7SO\ '7S0>>7$,G4]1?/T
M>DU;4F%HJ9DUCW-J'L:R =NBRWH4Z[:^36IPZY^SX^SMX[^<7C30I>BTM=.T
MN;.#YG@4SYLL@.W8N<UIB(*[3KUE??9\E/ZOAY2<%<.\/5?F'H4N96^#*G53
MJF@9O&+8F)>V*DF]M]KT\/U<;]C_ /)\S3':>.&Z'Q"PLWOJ-+",,H;WH72=
M/LXWO)=O27S[^P)^7;C6DK'</</TK9TREG-E&702H^*0[=A!F9"SVF-1VG?I
MY?*#]I#^KL>9GE'HE7YA\%Z=7LTRD=6N#)%!,<QS)31-#2UK8%I$,EC-FZ6=
M.^)'XR_(C\JWG<WYI.%='TO2=9I*NFU%E+4S95)52&%XJY&[O7@@;IA&Y7VE
M3KUO6YK^M]\D7!?%?EAY)\*Z+QL^::_\QZ>X>-O!XW9$O>COVK4GT9[[N8_,
M/[0_[*?0_G4UVHUFLT_ZR[ZV9[2*83;1-WP18<0I&_;KY?BWYT_JZO#_  =Y
M?<6<32](,L:1I<VJ!-"&@>%)+S;NYA9W*U^R]=<OA1^:/R_D^5OG-Q/P53-\
M-FD5+I):&AMTZ8T1&'PK;SV8N'ZC_9 _(SIGSG\?R>&*BF%0]]9(DN'A":??
M>UMT#FL9SJ.O3UZ[[/K UG]6KX9FTNY1:*YLS=E@D4 O'Q7-S3;5[?';I^C7
MR+?8_:+\J'$-'Q-+T\R:FD\$AYI?#AX3FF_='WJWUZ6[O#-[];^V/H.TK4?K
MNHZ1('_-:=S'C]DVG+3^"E^S%F'RN?K,4F7,\O:@N$2-.I8?]3EK/9T^)_,I
M('_S3) P_2FB_P!-DJ^'*_R?U+?U>B6QOE!PX0+33RK?_8!2<NO?^$?1SQ2?
M^V7;94G^38K6.O#;X>TQIJ)E15[O@&0Z8W?@&C=<V)BZP "THEOA\J7V]OVL
M\KR&X3UGRNX*U2DE:S.^M4;!35C6S-YK7RVB#'1L)4\_9K7K_P#G/YJ/FIYL
M\;^<_%=?Q!Q;73]3U'4-3JZN7+C-FO8ZIG3'B6T.>_?+&OA$ *XF<N>;=5^G
MOV?_ -D;YR_.+K&CUVE:;JLK29SQ-(&GS0US -X$N+239M@IG.G2=/7':OL>
M^5G]6\X0X=T32'>8>B^-5M:TSS/H!&PF,=]F:3*]KTXCWRK/L ?E[FZ=44\O
M0*7Q'2G-EPH)48EI ^AFK<N<]7Y7_-I^K2R.(J"OG>6NDS9,X4E0]OU>@MWF
MRW.;\#=BESATSTP^*KYT_D \U?D[XLK-%XLTW4C22YU0UDV;03F!K94PMMF0
M W0-D59?JQ>NO;PZW^4?YKO,+Y7?,G0N*N$-3FTE+3UC'UDEDZ;*!89S)KID
M6OW;"RZ&-Z6)U[8_1_51^QL^TTX:^<;R?T:CUW4**=Q!+TNBW]^KEOFNFB5+
M9,!#B7&/:DS-MV3MOKP_9;5=-?1E]5?(J'O,J'P[KXO;#"$"K;EG.4UH=O#>
MM?YM6?Z&]2)V?SD_UFN4P:YJ;@+??/\ ]%*DY=>_\(^/WRO\P*SRYU_\^T3G
M-G,8S=W3 QEESA"%L8E7&7'-G#VKX?E_,S\[?$5/P)P]+UROTQ\R4QD@2JV=
M2#>>&21,#2ULP$W@667J337[K^CZ:_D(_5GO,/5**EXG\U=-K9XKI%-/<*B@
M>UC1-'B!C&.9!K&@V8YQ4N;=+UQUUV?0SP!^KU>0&BZ;12J_A^G^L,IVMFEU
M!+CXD!O7MS5F<-=KTQKE0_.W]7<\G.(^'-4E<-:#);J+F/\ JCI=!+W@^  A
MNM2RIU[=?+XOOM5OL=?,OY+-6KN(YU#7MT-X%3)::.8V4*>8&OR $&E,XY3M
MB[G#\&M+KJ[0-8H-0I-^574%5(J9%KF/$V7,#FBP@@DB"OAC<OW?TK_U<3YT
MN(O,;@S1?+#6ZT3)<CZC3^$ZH+W0+6R_A<<DEWB<NG;$Z_=]='%M,)-93>"(
M-=)#B!F'N$;!D%;O;/6MOASP'5%.!#Q0)A-WT6./J5UA*^%/]9[XH\^N&=1U
M:3PH_5G\.BKG&HET?UC<,G>=O1$NR$"LX;EMF8^)OY?_ )9/-3YJ_,0</<+Z
M9J<W4M4U!OUNH=05,YV_/>-\@N .\V,+04SAF=;VW'V0_)#^K.<24^A<-:YY
MFZ953F5[)59.^M4+B2QY)=$.;]\%+EOK>F-OWH\O?L!/EUT3362=0X?I3.&[
M$NH)4?A$;VQO5GW9MZ^&_P ?_8$_+EKVGSY%'P_2;[J>:QD*"3\9:0VYF:OA
MKKVZS5?-3]I)^KG<7<%\)ZIQKY<:96RJ#375$XMI:!Q&ZQCIK+&-@1!BQOE<
M]>TQ.7QI^9'ESQ%Y7\25G#'$M+.I=0HY\^0]LZ1,D$ND3/#?!KR385J;<K+U
MNWT:_8)?: <9>37F[PMY=3-0,K2:R?*I-R95/:UTET]K&^XYV(-RG%;SGKM_
M4LX?U:GXW\N>%^(:-S'G5--T^J+I9#@7/IHS1$7G>6OY,<5XTIIEU#9;OB;,
M9'_""O7D[/P0_60O]UV9_8>H?RM0L7EKH_E'U\^1I_&SZJH'XN37S9QC=%D]
MQ;?M:K$[\O=&9\[7G)Q'P+*\DN"YVI3-/KY;:&5)HILYQ+7 2;)<N)( -\%G
M&\KU[WA^HGV?_P!@'Y^?,\REXYXCTW56Z?4R)6HEDVBGP=]8>Q[WS'/;O/>X
M/M)*N_\ !B2Y[/JN^7W]7&\J^&])TUO&6A2WUDJEEMGF=0-B9HEM!COM^^3%
M:O;H]B^*OU?KR#K]$JZ6BT"F%2YA;*W:"5$7 7,3'T27IC;\$_GH_5L.+J+2
MN(^(_+K3:N524-%/J@*:@==+:Y_T&PN"FXO:];P^-?S^^7_C/Y?N-=0X-XKH
M*Z344,Q[#-J*29(!W'.:226AN&06I<N5EG+W*^S+^>GCWY1_.KAW4=,U29)X
M=F5U!+J))J)DJ7*+:B$3%Y:0]KLA#=2M=;G5X?UO?D.^9;1?FK\C=(XPDU5)
M4UATVCF3/"GLFO!G4Q)<8$F >D^Z7,NN'L=4TDVC);-C[]K8[;DMSPURU/-3
M^XCC;_P[7_Z2$\)_U1_(?^V0_O\ >,?[>G?Z05F<NOR?P6;[#W_>$TG_ ,0T
M/;3*]F/BY?UNO)N:ZG\F.'YK+',TV21#]D)#?6M==,7?9Z2_:N?+YIOGW\K^
MOZ0ZE,[4&:?6ODF7)$U[F/H=Z  ;$0(]*=KY7KSCP_C[_-SY0S_);S?UW@Z?
M3SJ=U/6Z@YK9THRB6MJ=T;H(%T5(OR8SI^__ .KV_.YJ?E1YN\->7#ZUDFBJ
M11TSFS:G<:6NG2F6-)A:"LV[;ZX]7]1&562N+N#^'-7HIC)DNOH*2L:Z4X/:
M?%I&N> 6Q$ Y;PY9]=56"-QQEGXF6$<UBC3P@EM%H#J$R; $B5[QYB0/4D9[
MYFH_&#[=GYJM#\H/E=US2)%53MU.HHM3)8:EK9@_FS); &@@BT%2[U%G7UZ^
MU?R3/-3C2J\QN-=4XAF[TR=7U]3,;!SIA+9\_>EPC;BDU-I=OM>_5I_D$/%;
M]*\TM;HIWBTM/(K6S)M+[H W)@@YPL 3'M?LZS^'^'] K6@S3M%T;3J:&[24
M]/( $ -R13,DBP77*\:<IS53VF^ BC0@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @(" @(" @("#<T_
M^G4O\*WM">3P]./M&@3Y;58'_=\S_&7;XYEYOEUUOZ/AX^9"5_\ $>H'='Y.
M>,,WKUS.,7A^?NOG?F+Q3*'U]Q@+WY9GN4SX=LR\JW*:PNN;$1RV)&.V;<3A
MI5[!&X7'LAZU'*S%:=/3DF,(=/-L*L)RFI$C=()%T/5L15FI'M:V%GHNY!68
M2X<IKVDV''U+6G+<K%OC.U8\M6RS;(QI<0>5EJ8N7F[<Z;TMK@!8>45NV9PG
M7.=MV0\L,3Z4O7*W'A-29S=W:(=@VK,FV,WA(R:N4![Q$8"_HS*U4Q:\SJEC
MF^X1B;.;G6+BLW.<-03SGVJ>L)F7;*VHV\H<ZO7$Y>CIBMB74VCGY8K6KPU9
MM)2II>TP*G;5=>FM1&ZCO>&^$;C=SE+QIUZYSMTMQ/.,OQOVIZB.=8CT]<X>
MO7%E6(/B3\#EKK+C9?\ U>L/$U0U\TB-[G7\^9*E2.L*@$N,,_6BXQ^KG3M,
M;CRBDKGVQG:WZ3*<]S;+AS)-/-\EQ'L!P/3%TVGA;:,=IV):\O;&=O>'R\I)
MFY(L,-YO:=BUFN/:S.GM-HM-,;+:2# FSH'-D$QES[2KK(<Z7?$"'W%UZW6'
M/MQESF58!O-@MO&)VK3GXTPFO8VPD]:K.:SRM38#?B+W<LE9OENW,2DO49>[
M$GTC(;%CM;G$9G69>9E9*>#;;Z;UKE)?6Z0M5.!-AY=:DF]MVRM22\"8#$8G
MT\ZN)EC.$\U[#+%T8##F4NNWV;]IA#U0;;=Z-BWCZ,<W2"J) =O0 M)RR.Q9
MNRVHQ]!,)B!_Q=JSEK5&:?,C:/05J(DY%,60B,!9T$9)ZLXK?8PM(B+!MV)Y
MVWB2-IK-X1 CTI8SG-TU:F02UT!ECLYE)XRG"L5E+-BX@&!.!V'8K-KNH.=2
MSHW.Z]IV;5+F+>&)DB:#;O=9[E+69:DY!F-A:<#U%8Y;TF*>H+8 G9V;5K;.
M+%AHZ\2R'$FZR/-!6-9^K>JM;#)9M'7]Q7SDRI]3Q#+:YV\1C"WVK5OB)V0\
MSB*2[Z0 MC$J2:9SA&3]1;/C#&S XA1O,1+Z:;.<"V-XVWA6[F*QY3^F:9,:
M8D&^SW<HG:DZKMVAHTAK&C>OW0.5B65>VH[(TX2R&77#L4X?.^69N?NMTCPF
ML%@N'K4VX_9IZB9;F/N^$Y*Y:]?+K;4Y0<\@ 8CMV;5J1N=?IRK\JA<9H=#'
M+D%(WVZXF^5TTRDW8 BVS"'J4MQ69\?GPN=,QC  0+0!VJ7;?K?'"4EN$/=(
MZ.E21TDRP5E:)$IV\;=IAVQ6Y).6L=G2_&7$,F3+G[Q ]W[X8 )F.G6/3GCO
MB>F+I_O?O;OI#$E&Y+>'J)Q5K,N?,= QB"+\UJ2+GU_5U#/D/J9Q#8GWN>]3
M&]\/1T[SE?N%]#GF<PP-H&"?^SK[2O</R_TUT@T\1] "Z&27>XY]^TP]P^%7
M.E2).0!LYK?4L_9X>_;;M"BKVMW1M-\.Y,89O"9^N->VPVG;DFZS.N]<.+&N
MF.S!,$O#I;(F*.F<' PRY7*S&&+M8VM;NB(%VQ8L68\H>LW(P]VX98!:F6;C
MPV=/EM,-L,H7\R5>O*3F[DMML+.F[T*]>5[::OUN6+(W69>M:NES*QS*QA8X
M VPYUBVII3M4_& POB1S9YJR_P#*R84&LIG.<86F)Y79J^6;6G*I)H># X>V
MX*=KK1+FKEH]/-#Y<08;8]RDWRW<3?EV;32 93;,!ED-BS.6?;ZM@2 +H<NA
M;ZS-9MC*R0[>$.4!S;%JXQCR9O#=9+> .G/N6":K)NS!G=&]3-FF^6)[7.O!
MA#'G6IIJ7#6F2V0,=N6VY9MTU9]56U*5 Q'1:MRRKUZRJ_,WFC'E:I9BZ;]<
M\(Y]06F\X=B6QJ_'7%M68@1-^8*B8LTDY$[>ON^[M2=L73=ZQ.4[FQ%HQ[5;
M?V_<]<IRFFL;".$/5M6<_1J=>T;QJ6[MAPY8K/9S^2:VP_6(.B3$=/>N;P=N
M4K0UTICAO$8;,.E3M-'6;=AZ;J5-9'=ZQW*=>&\>%J;J--NCX;LQW+3'JC*W
M4:<$D;O^$.;)3K=._3K,?=%_GREEN&\YMD/I#8FHZ]94G^E]#3RB=YEQ^F,U
M8Z>LQMUYQ!YF4-.7C?98'?O@!O*MB]9]'27$'FW0M!_&- @[]]&2S=O3TF>>
M7KOQ3YNT7O%LQL0YUTT;5-X=/T>N_$OFO(F";"9'WG?OOL23:R6=G1.O>91F
MF9!YONWSTVJ\._,^SJ+6N/9CS,W7.,8_OFR*U,6,SK<Z=:U_%]1,<[WG6V6.
M.Q2.DZV*].XDGS 07.OQ=9S+IUY8LO\ A"5>J39L;70M%YSV\ZV8TJ]4Z>\Q
M&]$NPCCTE#6&IN5?[/TK/%TQFLS'58!CO^GO5[9\+.-N4*M]GO\ IYDGW9Q>
M7/ZI5O%@=?'$IC&VL^&9^EU)9'\9'FY]J;RJ*=IM67_OEXP./2K;+I,>4I3\
M.UD["9 AOT3FF,<$LFEAIN"JAY'NOB?V!V]:FUS)5@H_+ZHF0BQYL_R9OM5+
M?JM5'Y:53]R$MQM'T#D!DJQ))RN5#Y5U;VL&X_(?BCB((GM:LM-Y2UKB!X;O
MB _)=5R7A.TO,=F\.^25?4$?BG6PA&5'E>N?:Y>CXKIW'IOR^U[]T^"Z$!^\
MYKE-.MN':6A_+U6AK=Z2;F_O)3+GVN].T-*\@)S/#+I.'^1V[53-QIV/IGDJ
M9'A[TIL 1^]0-Z.-Y=F:/Y729(9&6VP@_D@/4<$+9':&F>7]%*:-YC+"(_BQ
MM5TX>TRM?Z*:?(E08QD2!] 8 P4O!;F(F9ILN0XAH$+1\,+BLO-V[;3^F>#+
M< 87 >@\RN?#GVN9OEVWP[44[?# +(GFQLS5PQ+C3M:DG,?*$(6XC[J9K/9J
M:DPN8XB[=/8HXV[=;ZK*FVAHSN^XF(Q;_P *ZR1-WOAMB>WF5F(QUQ>V^%TT
MB1/ :866<KEUZW+Z/PR2:=GZ3-?)# ^^%EG['O6L>7>YJ\4M<P, ,!9GRS4N
M[HF+IF?5RW1@08QC<;UKB;7&]M5SI3HEV[S0S*SFI<(RM92EOT?A.&0ADKX^
MZ1U]JU#3S 3!ESA8T%28Y,O7KCGAF55R9H#6VN</@"UGQ&IVSR])^./+8/?4
M%LL?E7'X.<Y*96X\O5_B3RR<^;-A+'Q_>;89*_<SA6-/\IIDR<T>'$1_R2.=
MSG+M[0/)29-:S\4($@?DHWJ9VU<8^Z]CR!?.99*%Q/Y'G"6_\BLZG\N=5,L;
M))L/[Q<"DIFQ1J[Y9M1+CNR70_S<XJ^#.:J=?\LVJ G\2\V_Y \RX7M//U=^
MMTKE5\M6IB,9$RRS\ASCUK-OT:S5*U7Y<M5:'0DONA;(-F&$5OUF#Q]W7.J_
M+QJ\N)\&9 -_R#KA$KG=<,[EPZQU?R)U23&,J98#'\2=JG6VK,\UUMJ7E#J$
M@%SI<P&T?DC@3S9KI]D]L*=4^7E;)!WFS+"1\!SZ%.VFIW^J$F\$5<8!LR(L
ML81:L]5MD:3^!M0<?=;-LC]$^Q:FU]IZ_=KMX!U0&UKX?P93$C,LRWY?!U;)
M%K9D=K",RLU9VF?LS'0:E@@YK_\ !*FUSUY:4[0JHQ@V9T-.!6LGO&B[0ZYI
ML$V%]Q4S4O;Z/+=-K67^)?'X3@GEGVV\/I*L60F8W CU+69_EUZ[X1LZEJXD
MCQ(1.>?<EN6N.6BZ55B_Q+\W<L5.#M<\,LB?4,(B7C._O5Y9ZZ34BOFM+3%\
M=I/WO3DDAV[?1)R]9J!")?88?$;E+M9PV1KT\?2=UN5FF<I2CXBJR(M<\9>\
M>V"-8;LSBRLDBUS\+W&U2+VX8#QW4"PN?_AGU!7##FWC.JF7.?;^R)/JS1<5
MQ?Q/4S 8N>;##WCBF#>$-5:W/?$%SCC>=F:(@Y]143S %]HS,(V7=*$Y:PHZ
MN88G?AC82;^C-3.'3A+4FA3Z@-#0\DG[T\KRKFGMA;M.\NZ^L=%K)D#_ ,F<
M5;<1K.8O5'Y/ZG,:")4RTC]Z.PG-9Q6;B?HG)7DUJ>Z/Q3X_P1RYDM^J^_\
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M]8=NW7_*G:E(IY@=8R)%\ ?4E<\NMM9T6DG[UC(D$?"+TRZ3M+RZ@UW@J35
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MUD_?:ZWUW]:N<.?;E7VN_&")^EZU+<<K,>$SXC/#$87#+-<;RW)VOZ(.NW'
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MH\NE<.]N<.DXRQNFWW0MP*REEJ$U9[3(-N!5G+773K6;^5//ZUWG#=>5D$!
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MG.F3"6QA$W&*C5GT9Z&KJ ^,70C@=D4Y,S"[T&KOEB+G'Z/TBF$UQ&>LUZ(
MWL_I9".:OAE5Y^KL<3%T8_LM@[TQYC?7Z5%SJULQIW3Z<@>9"YXB'G,=-?9&
MVSTV=BS<^&;I+T&F.?N1Q<!8,#%5J<+O0Z-$0 -^71ZT2SRLLGAETP1#8?\
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M@!(VV\^03SIF[J,K*YDT'=.>,<^:U2\)C".IIQ;,$39CZ-H64N+ROVG:C+9
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MD^,\S7O&][SGB',4DRO:WK</HCJM;E:)*IM.TFGI'4M+)ET\MK&%C);936L
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M=X?I?75,RIJ)S9GPRYC@T6PAO%%:B@*@@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @SR;^D]B!-]8[$2<,"*(" @(" @(" @(" @(" @(" @(" @(" @(-S3_
M .G4O\*WM"'AZ<_:,F'EO5Q_[OF_XR]'Q/+\W\;^CX?/F1>T\1Z@(_O<_M>O
M5>'Y_M<_-A^8'%DT"N>-KACB2LNV+Y5&5.@Z\7FZ.?3DF&<[8JJ:'F)(NQZ#
ML23-3M.OELT&X<L5+F,S[)0[K=D5;*SVKD)T+CU1P4SAG,<@]^];''/;G8KR
MQ>6TRW=ZU<5+PDZ>V$>5RM<;RWV@1 PCZUC/D9' "$%TZ76T_0#W"-M_/ZH(
M.+ITP0@3Z5F7ZKIL4\YY-IR%IV]P5Q]'.\MQTP[IM%V"SBI9;&FZ>X.L)Z_9
MDKATZS&FU3S'.(B?3SA)IVE6:B<=P;8=JG\J[SK)MPK_ ,B_.WM5NI]F\S+H
M?C!^[XV$6GT)UF7;K=;>K_%DYQWQ$_ [$I<MZYG+UOUXN\4F)O.W:L5/.5/>
MV+G$WQ6=G:^6Q32MYPOO[UTDF7#MVS5_T21 MLP^]V\ZUC+S_)7L5Y?TV]/I
MH@?$,!GSK/;K.?+S=MO?/R\HF&53V"_O[TCGVDD>SNFTH;($ +.;+G5<V:J(
ME@B[/TA;ZN?>6_HK=14P-A-I.)75PSCA#S:UV]>;LU=+C+&*R9>">L^I3*?Q
MJ1IZ^9"!+KL^9,;;B1%8XXGET*L=ICAQF5$1&)C$8G+F422UXE3_ 'Q:>LYC
M8BR7.THVH(;8<,SES*<M>K Z:77]ZN:2R# '1C;""AJMV6QCHQ ZE,;21M"F
M9@!U>U=)B0Q)MBFRFM!L'5L6/:U+?HTG61YU?+7AL27#=OY02L]9<LCBTVWV
M'!3F87M--&;*8^P@79="U)B:(TYE&PX"_+/[BSG>V>V9<M%]$T7 7Y<ZMDK/
M6VM=U.!& V8#'.*F,.LQ_EJN!:38;,?:%+I;]G$U+Y8%\.?O6I-9\L\H'4=2
MF>&X-)Z^;;L4-2Y=<:KJ<\$F+Q YPS3)S5=;JL\O +GWP^),KB+5I5<^86!Q
M-IQ)SCAS*LW3M31Y;)N[$ VMR-B$R[$H]-EN#8!NVS-,W@RL=-ISFP@,E<K;
MI9J2694 <.[K6*\/?E,L>[=^ZC..N,M2?XCXBV'M.U63-(AYE"Z88D7[%N.O
M7KMFIM)M!W8VY9DJ8TZXEY6.FTPMM#?1RS6,9YX6=9G'AO?4Y@PNV*Z=+UF&
MO.F.IFQ=AT9Q6IC#/Q]76_%&OB5*G0<X;L;B(7PS4N*[>L>I?F!Q8\"I'B/^
M'[[VJ7KCA9UG+TKXSXHF/G3??F0W7"\[2+W;427#HRJU69.G %SB"3>[:JYW
MK>USX6G09#)[PYT";#:-I5Y22R8CV,X1TJ2XRS!GP-^B%,7ATE^KV.X:H6R7
M22T" :,,ON)QH[8L=ZZ15"3*EMP#<\UFZW'F[XE621J/O"!,8G'8%J;Y8MN5
MEHZPNW28WYPY7K%MG#ITNONN5#,8Z!B+2%N7;'?=RM,A[ V\1M]2:RO6LSIH
M#8 \H\R5+,\(>?O%T3$]&P*S@;%+4>$+</4?8LC!7Z@(&!PS5ZW#6+>5>=J#
MHF!QS'>KVVSAD;5N>+S:,UE9,UPFG?:8VWE23;I/NC'TS2ZT#JSZ5;E/7VX9
M9-$TO$0.I6)ZXBVT%$UIED 88<\5,,6Z7"GIR)8LSN$$S'.[;K:4[+LE<KUF
M_NVY=*[W;!_@J-UN,D   BWF"'6989TMH,(8=W>K-M7]L:,UH L'*U9N6NF[
MM&36EUP.*N,NVJB9\C>!WAUY1 2SUX=.O7S%;K*>^&WLY\E9G*\*K4RRTD6V
M GJZTLCK)F913IA8XQP)S4\8B^L;M-5&P6]?[93UPN):LE'.+PTQSQZ=B<M>
ML6&G8]XQM'=TXIQIT\-]TI\L&/1V8K-LO+S?/)C+1FS7;;\RN?E\KM/W.#'S
M8B!/+G*OA>M\++I\^I$(!QL&*SC$;G*?.H5$ID7;V&)'*Y7G;I>LM4[6N)GT
MX>2YX@?OM@CBF&I,.F=>\R/JCG_C7B!P?[=BE=NKJ[6?.<2F3&^/-/N?Y2XP
M_;)U:YTZ XJ\Y9DQTS<GSK6GZ=W_ !EO+OTZ1T#Q#YNU#FG\?.^G]/FVI)Y6
MZNG16N^:%3-<[\=.O/[YL]JE=>LN,UUE7^8,^:7_ (Z=:2?C.,=NU3+KUF54
MJ>,)LV/XV9;'Z1[TYVZ]9)$2_7)D\D[[C'-QR[E)K34DG R>Z;:7&Z..S%:+
MFMD2G.%_6%>N<G;4;<BA,R$3?##F77#C:G:;A\S0#NMN!%F,<X(SF)B7PFY\
M/<;?]Z>[)"WZ-N7P5,F&QC</HX8X*LYJ<I/+^;,(.XV)(^@>?+,(9N%IH_+5
M[MW\4V\_0Z!&S:E^R+)(\J9DYL!)828#X+>Q2++8WZ;R-K)TP.;3M,3_ ),G
M+(*8WIJ7ZNPM)\AJN#(T\N,!^]'N6LQS[5V)IWD-4^[O2)=P_>CLR"+RO>E>
M0LXEI-/+A#&4=FQ1NX=DZ-Y!/=X8-/*/_LCGS)>-)BWEVAI'R_$!D::381^]
M;>9(7K]%SI?($-+8TTF\'\ED?VJN&;<:=N\*>2M/3N:9E-(A%M\OFV+GVQ([
M=9C;OG3/*G3&!L9%/</WMO<N<F>6\YB_47EKI<J6#X%/%H'[V.Y7$SB.7:[2
M X)TR4"/"D1:+MT#;DIN)[5&SN&:%I($J3=]Z-HRV);&;EK?F"GE_#+ECF V
M*9E8[Y>?S4&@P:,+FPQ4ES7GLVCJK3WL$=VS"S*.6PK1G2FUU.8FZ\X!*X=K
MM'RY4QK@1'H$.5RS)ES[7RO&@OGM?+OL("U<N>7<FDS9AER]Z.'K6I$[=LI^
M;^,:00#ET]*RX*_5Z?XEL!<<,;E=,6U%C2@'Q@+_ +V"UC,:ZQ8**5+IP 87
M#L2:KW_%9ZI853!"%D#F%K=T]$N6Y*K7W G"%JWPF,;2#*B8Z,"<(>E+CLNZ
MV7.G0LBGA,:VTI[9KFDG>Q[(^I61FW"!J9+W1!Q.1S.S8L5%3K]'%4TM+6F)
M<;1[%-Y,_P#+J'BK@Z6YCR94NUQC%FR&2O-RM[YKUVUS@V0)DW\3*O\ O1]]
MS+4^E,UJZ'P=2>,P.E2?B/T1SY*75R9KV!X5X1H82FB5)^(?1YOV*29S:EKO
M?2.!M/F,&])DF.[]$9<REGGPLJZTWEAI,^$9-,;&_O;3>>90S:E!Y.Z,\"-/
M287RQB!L5\$S-Q'5'D?H\Z,*:DO'[V/W*Y=HZ]>UEPB9_D#I,T.A2TE_^2;W
M9A27K'2V\JQJ/RX:=,:_=I*6ZS\2+XC8M:/:>'6>L_+/3/$P"BI/A=#\2,G0
M^B5FR<D[9X=%\3_+'*]^%'3? XV2L?\ !VJ31FO6_BGY:BT.#*2GO==*/[G8
MM3G-8N<O7S7?EOJ6[^[22OB==+.V'T5+,W[+.=NLJSY>ZJ2]Y=32Q:?WH]P4
MOV:[6.=%Y S)A -/*MA'\4;^I:ZZVDN])[_R[S"PD4LF,+/Q1%N.!5TO:JQJ
MGR]U$N.[32Q9&R4<;,0%C]4D=?5OD+5,/]'EC_V7/L3FEN/T1O\ \PNH@8T\
MO^+/-]ZLXVSG>/#6F>1-1A3RX0_R3OW*M:SK2*G^1=3:!3R[H?DCCS-BDJ2;
MVA9WD57QLIVW_P"2.W8KB/1UU$94^1E;+829#8BW\D?W*<-_R4W4/)VKDDQD
MML;_ ),C8?HX*XS&/*A:AY:U-.X_BP.9APLR"<'66\JY.X,J)1/NW7>Z<R,D
MWRUB(^=PW4,!]W#+KP*)9].$/-T6HEF!';LS")BI73M++6G>L@,B>U7M=8=)
M8UM4TY^ZZ!-QN'5BL99M\*+/HY['FUW4<%923+-2[XL<XV=& /J5P6W.%KHZ
M)\\!H))]JU%GT6NBX/J*PB#?HCZ).(V+-K.9:O.E^655-+29;2"(VL./05.6
MK))GR[#TWRAJ*D,:R2PD_P#)DX@?>JX9SEV[PG\O]?/FRC]69#?QE&ZS'=V)
MDD>VW!7RXS',9XE+)CO-%LL[/V"E-RX\/9#1?EH:YC0:2G-C3^2Z/O5?;Q2V
M\+,/EI A_-*:P?Y+9^U4NVI-,G_EME@>]1T_1*_^=VJ>K.+X:\SY<90$122+
M(_O([E<6-:D0U1\NC0[^B2/XG:56<VO,OY=&N%M)(L _>E+U9S<M:H^7%HB?
MJDC/\D,AL"<-Q!3/EW;O'^:R?XD&ZS *[9]<;;%+\O#=^!I9.'[SMC]ZF%^Z
MZ:=\NTHN;&ED?"#;)V\R8,_1;I?RYT^XW^:T]W^2'<A[5'5WRZ4I#HTM-<?W
MD#'F4L^BYN$#*^7RFDS;:6G@#_DASC",59ESMVM-!Y%T@(!IJ>%G[V/6%UFH
MYYWM;Y'D;0@?T6FN_P D,(;%>3.$?J7DI0L:84U-$1/Y,80A<U:DB9KJ;7_*
M"EE;P%-3WFYF1(^]5TLKK6I\JZ=DP_B)(M^\":Y2]LI&A\M:5CFCP96'T0,C
MZU@W'9&B>7-&PL+I,D6XL&9V;4RWEW!I'!6FR98_%2,/H@8\V05N:E^JU2>%
M=-W@/"DW1N&S8F?#.^:L5)PS1,ANRI-@!L [DS]5O;Z+/2Z)3LW?<ECF:,(K
M/-UPF4[+H94D"#6Y6 *KUB3E.9)N#<Q=>F$[-P5[)8,.:_:G7Z);F(FOU;W+
M#A@?8M<5GMPKIUEX/Q'_  BF)7&\Z;E+K#B;2<_B.<.Q9LWI9<+SI>HM<&DF
MT@8[%FS%2]K=?9;)5>&RP03=&]:Q3<06KZO,#)D"8;IQV\RE;E=1ZWJ#YKG;
MQ,"#>>?O28_RG-=2\3RV5-,YI ),M]XC?U*_J:F_+U#XNT$"H,QK6CWGFP6]
MD%N8,YCJZ?.J*%SMQSQ!T+(BZQ6XA,Y3VA<2UK)S&F9-A\,-XYC,QN4F/*WA
M['<):[-FFGB]QB 2"[FYUC+.7?>FS3.DRS]\+>M)&IVLY3#Y)<V[(^OG6O/V
M8O9H3*,&.]#'T*=L^&LRQA;*9+P A&WGZTZY>3YN*W93I9A$M^YT+O+IX/U;
M(F2VXA#VPUYM2&BSM5SF(BIM= VX$XYGG7.YS]EG'W:!U$''TI^K.Y=.3=0;
M$6^E65;PDJ*M89@CS]BMOT(MLNHE.8W.&?+!,6]<U6A4.:X$ Q)(SP4A9E7*
MB,70S]15JRXJ(FS',.SJ4JY^C%*JCO?$<<\N92K4[251WOB/Q#/+F5D86>FG
MD@6G*\[!DEZZ9WEN&HF"XF[ E8^SU=+;QR"IFFPQRO*>KM+K;5G/F$&$<<\C
MM6<XU&=WE!U/B'?ON&14N:WUN8A)DATQQB+(XB."8J27/V9)&C2YQ$6--HO
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M^Z^PXG'GVK6,+F+'I]8)A@[MS^ZEN$[5;)1DN9;NW>H+.<K+B95O6F2S+=N
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M,)CS\KDQ(UB,<FB+I\OGV[<TE3P[PX0TH3)3"YHNQ'/S*]N-+U674=+8S>L
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MXK#8#:LY;G6N8I3.!(!M@KR]'6:Q$?5:0XAT&"XX X-5IBRJ?7:2]KB=W X
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M\-4$V(--*-A^BW/F3ATO:<ND]=X'T^9&%+)/Q8-Q/,F?#'OMU#JGEQ03'/\
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MIE;\N9APE\/4#7#\1*QP 2;X3^S6%DHM"H&D'P)5T,,AW*TGR25/-TJA: /
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M/-ZPI73HBFO+71LQ4YTW>NDY13"2#9\0["KQ'.Q;*29GL[8^M+G"SKEOOG-
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MT+S']+S]6:_N?H?[)H_Y-BL;G#ZT.+OR-#^T]04K'7A3!<.8=B*\H" @XO\
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M6R$[9K!IW^L:3^%E_A+*O77Y_P#^X/CO^P:O^0>M3@Z/XX/S[?[S?'G^?/\
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MUQ)Z+^J]&>TQ5?G.J*@P#B;Q?S]"ETO3>F2GT6JGF&Z228=?.L[=)SA;-/\
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M_1./*,_2-O\ E/\ C>U2[-_=Q=Q8V7'\:<KXW<Q3UTO6V:K1G<6L?$^*>L[
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MPU8(A'EZ$9Q]FI.<)EH.STQS19<- 2G$W=O<I>&ZDZ4%D.>/J]:<QG"PT\^
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M+.75E1^4=^V=ZEZ>G"O"@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M8]VS:J29C:;)=\>VZWF6:W/XX8ZFI,N66Q/7SYIR\O;.<J7J%2XO?!QMVB^
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M>LWATZQ]8GRWV<%R3_T21^![5P^69CV_C?SP[GJW;SVV0@#ZEX;R^U.&HBB
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M7OU_]7*G_.C^&%OKRYW^+\ _UD+_ '79G]AZA_*U"Q>6NC^3]Q%_M5._M/\
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M2XBU5G&=/,^?*=*A'Z(VX%$XTZ;XOIF39;P&VDN]817J-QI0&7X[@T_&Y67
MZ%JJN92SWD&$">A3R+APUQ=-DS)33.A!W*-FU;NHN8]B^'.,'3);&^.#$B-V
M04ER7>G8LG6GU#0/$WKO5M6;,L^V*W65#W0MQ![ NO2^&/DD[;2,F:X"_E;M
M72SPY=>F4Y2SB2!M*>N$[=(G9/O ;?8%:Y>E2DJ3O")%\,%-U9T;S*5IA8;N
MY:];UVLZ6<LHI&@W%,9+T:>HTP\ P!N(]"N,$Z6.K:V0]LZ,#\1[?8HOK]'%
MM2Z7CC%1?5LRZ^)AO"WV#UIZU9TS$S2/,V$3?8KZX<KTWE+2Z8.MAAS7]&Q2
M=5LMC+X6X>;N6Y,0WC#@Z9N8PYUFSRGIY\L+YQ=C'FL]"\_R1OKF<M68XYF[
M/)<NL;MEF&BXN)C'TKKG3%HYQA>;\SM6*O2YK4<78GJ3&&^S7FN> 2UWI.2U
M+K#%[8C1?/F@'WLD[0E\N,N9->1[V*S)L[=]-@,G.MB3A>KVQU<YEN2)$\.B
M";QZ2%G.6^M66B\1NZ22(''EL4W&KWPMU'6F6 TNQ]'(+6<QF9Y3S*YDUL"1
MEUI(G:M>91T]0[WF[P)CLM6LS&"<90^I\)T=33.C(C8>PJ$MR]5O,'RVHYGC
MN%*3%Y-PS.Q6669>_P"'M.7IEQQP!2R34PIB(1-PR'>LW[O1V[QZUZKPC3RZ
MAWXG/#;!7'EG^R-C2>$J5[F@R(Q?ETK-F;I/[I-.Y] \OZ2?N_S4GWA@.6"2
MXA>^7>/#OEM1!S8T>#3& S;L6YPF7?&@\!Z?)#-ZDMW0;ARQ6.Q.SLJCX6H)
M+&PIX$#+-:EP>^;F-U^A4319(Y04NVI\DRT#HM'$_BH6G/O4QB;;O>5X;I-*
M' "4("*L9O?&VX-/I@VQ@%BOK7/^S?EK3:&5 P;@,L^968FF_?RK]52-M !M
M]BE9_LF5;K*<RP\PN/J4QE9\L435*AP+@+AW*.D^50M0>7AQV=JU+G2?VJO/
M <Z!%Q*G:,=OE^C-3,:#S^N 4SX6?)I9Z,M@+!<,-O,J7O,)4 &%@Z@G+4NG
MA\B,("-]PA!5SMPCILIS"!NG'!,KUSV:GA.-[2M=K/"R9HRB+G [IMB;\UDQ
MX2,G3 ;2#=W%0[?'GA(R].: #RO2LSXK*V'2)<MM_7RVI/NE^+.XCYDV6PF+
MP(1QO@M6PGQH2OU&5)8^$QH@(]_:N?9OK\5MS]76NL<3RY9F#QP+#9T07&[N
M'LZ?!B.GM?XR#=X_6!<XJXQJ-3XL5TWJ_'99&%2(V[<BI;AJ?%G54&K\PIC2
M853;SBK.Y?BL0-3YDSA8*IO7^U3[I_7;^BO5?F541="J%A[0E3TLOV5JM\RZ
MIS7CZT+CGF5BM7K]'76L<95=67?CXV8'.(6IKE>JGSM<JIP_*QLAV*7;4F\H
M>=4U$UT"=ZX1Z/:F=-RX<95'.GN'N$W&S98K*>V%UT?0)LV8R,EQ! /8M2>6
M+\N'=_#G"\3))D&Z-VR*?9G^R.]M X:EM;)C)NY9J6X:Z_([EX>T:1+W8R8>
M\.R"9=/C[2UV=*HI+98 ;=#(W#F5YV]7AX?*9+%@Y6X="F=_9,XB.J)T+MHZ
MBKABJ_553@".;"W!9NDDS4#-JG%UO*_:IRUG&F 3<QZ?8K.6I?+.X M-F&68
M]JS4QE4=0E#>-V. 6G.1%&7 $QN4:LQ&+>@80Q"UCR2>7.,4R9R\;J>IAKS9
M8-L<3AG]Q1.$9.L,-L>76I=(Q-O6NF[E9RUIWQ=(_"7IZM.SO+_^GL_]G^$%
MCNZ].8^A#Y%_Z7I'\!*_!:N/;AUKZXOE8_U/I'\$/6O%\O+T?$_1/3?R#.?_
M !BG7^+T)5>3Y/Y.LX<7.#1$\K%/ @=6G RB+80=VA)JNLDQEUI/MFD9N/I*
M]7749>%D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!F
MD?E&H*?YS"/ 4\?\C-_DCW*]==LL]_XOD6^=(;FIZMC_ #^?^$Y>WKN/E_)?
MW9?B-Q]/W:^KA9^-)MC]\NG3ECMBQU'7ZAN@B(L"]4X>>3;KS5]0W]X1P(7/
MY(Y?+,J=];<V823"SU<^Q>:UYKTRJFOZLYK'>^+CGATJ>,+UZ8>MW%FKN._[
MX^)V?>G7+KZWET3JM>Z8Z9!USB>76NF7?I%.GS2][HYE8QC;?JD--8'S&"$8
MD<^"EN:W)K,=S\,Z:)QE-W#[S@.L!:LRF7L=PSP7XK63/")&\VVW,'/:D<;=
MN_N&^'6TA'N$$0[E;VP=OXY=\Z)/E4DL1@(-'4G+Q=NVUAG\02F2OB;9SY]R
M>V'+Y.VG66O<0,F&: X7[4E>*[=8U==]8F. -]_6 K*X=]0IJ1\XQ"EZYVX=
MKA,?4GR6@E;Z/7\/>73"^5$$QRY0765Z*US3@F/L]2A'-E,(=.?-L5A<UM,I
MQ Q]7<IA<8<33#'M5Y:F$;44(=&PWP[.Y:F2V1'2]-(F P,,ND*9Q6;V3<ND
M#6]_1SI?JQU8*F0&CK[ <E,:RWG6%;JI,0;8QAZN?-3*R:0QD-:[;UX]%JE)
M&]33C*(V>O9T*RX2Q+#5PQMX$/6=B9RMF.&A4\0"!$;QMP4G;%PS]ZK%36FI
M<3&/O1].=JU?J]/2RS$Y3>DG=()PAV%(7/EV;I4UA#8D"P=G,K9A)M8G29<R
M7SB.Q9;PIVLZ8Q[)A B0+Q#;L0QO+JK4M*(F$AIN]9]2J808I'RW6 V0]146
MQ/Z:V9O6Q%UY59JY2VGPQ$_1[U+?!UNW RSF.70I;(UC+$]ALMS5SEF7'+%:
MR^V.W+H599V.A:<0C4OU;#9Y$ .KHS*<1/+8;5%L/> (-V-_K6?82,JIB(EP
MB V%^2T689_K)P<#S JIAY,\F],-8PB:Z8XM=?=F=JS8U9E2ZYSB;S="_:0J
MG"(DAPF-)[5BV\1I<M+82X7<B%9?"=N%WIW>& 3D/08K>&9'BHK&%MX^Y;GM
M3A+I"SJAKR86WW=*S9M9MKA[1AZ%+,M61L2W@G*Q:G#GQ<,-3/8T0NY$*9VW
M)I3M2U%C&$1%Y]:I.N*I1U4?6 (B!/+8FHQ<VKWIE1XLIIC'W<,(VVK/+?76
MTAXN<>U7![8X>/$C]]U^U5F3.GG?.WK4RU.DK/*?=?&WM3F)>MZ\-MKHP4S9
MIKK?JV);P!=RY%:B=[FZ:54\M!AGZD9B-9.?&\79*-7AY,QSKSC&R/>JRCJA
MYMLP..P(MS/* GDG._/G4:C T6CG"-8UE(T]XY??*^'._P ECHW-9NQP'K4O
M#?C*2JJ^7*D.]X"SU'N7"\X8RZJU[7F,,R#Q\.?+-3&*LVZ2UWB"+G0>.1<5
M3#K^IUPDDAPM/>IJM3C"-?K3]X^\,.P*LWKI'SJ^9.C[UG.=FU%FH@ZATZ:Z
M-I!M$.E2\823+/2T,Z8X>X2">Y22PDS5PT_0YC]S\6XQ<,KH[5O,K7:8=AZ=
MPJ^8T$R28P-NVWF427*QR^"H@'ZN[KV<ZEVF-LWZ%V_T=W7[5)"ZK,SA%LN'
MX@],>6*N/);E*4O##0X?BK <N;:KX+,+30Z%*E;GXN!;#8;X]A1*M]+12@T-
MW80V#E@KF,^MO*:DTLIL!#+T*8;EPEI#)0P=CVA$9G>$+.]3#4[81U1+DGZ)
M]&Q%FT)4T\IT;+SZDAVF8COJ$LO!W,?V.)&S8JQBK/I]&T-'NPLY8*+>$JZG
M !NLYL^96LWC35<P@FZ"<0XFW M,#=<5,DLRUIC";++NU'67,8#(>,#U>U$M
MPX;AV>GN16G4L.?*Q:ESI+<,E"SW[\1@NTX8MRO%!+^&W[W#]MM593.YM]"-
M2QY\/;Z/:HUB-QDL 69Y#8B6N1E@X^A5,_1'3F6WXY9@%3R9TBJBP':"?0MV
M:95BM;$7X^U9:E\*\Z7[QMQ.&U(=N=-ZF=NN&SVGU*6M]>NELHZF ;[PN%]N
M(5RYV83(J1 >\+AB<D-M">\N(OOSR@%&I/+;H8!P)S&&Q5F\K;2AKKH0,;AR
MQ"E;ZXGZM;4Y0+##(V69!"YY=,\0TTQSGP!^+M*N$]E2IJ*:9[;#"W$;4B6_
M1VGH5 0&Q!^Y9ZT1=OJ#=SX?H[,N="3*LUM,V7,)A=]U,:RW-,5),:UXLN,.
MH\Q42KQ03F;HZ.5RM23RF?K,O=A$7''V(MGE%553+$;1CCS[-J)(AIM0PVQ%
MYQ]B%OA'S)[+;18<]L,MJEN$GT1TR>TD\_+-+3UQMLR9WN^[Z\AL2;-L50\N
M,#CM_:E4:3VEP@$67"JZI(?NOL/5MYU&I9>%#J&N9-,;#W*3.<LWE8](GO;N
MVV Y6W!5J<.Q9&I%DF&\/A]2K%:[]1+W$;P!)AZ8HUC&WD;SR#&\[5FQOK99
MAG;*)QQ3K&;<,OU5^16L)[,$VG<1#;##E@LXN6M8:1HW$W$PYNY&]5FE4NZ1
M9;;EG'U)NL=M)"7*(A;"_P!<%J3$WRY6_N>7L]X6X9;3M17CP2^ZW!3&;AN=
MY(Y,HR8Q:<, <U?7#-LO ^C, -T]0[E<9.N;RU)VF.<-Z!MA9U+-:Z?RPCYV
MC;T?=/HR@I&KRC'Z$X.,6F_(8K3G>6S3:06NL!%V69."+E::.@< VPW$=< F
M&;VN<)EE*YC;H?<3*^NLH/4Y18'6X'T01)+5(J]Z-^>)S4Y=+/698Z>.] F^
M.)V(S<69733J?>W8F-@R]:86=M+4VB;X=WT=F7.EX8[6^%4U2G+20!Z I.7*
MW>*I]3I[YCKCR$/4MY:]?+G0Z2\/98;'1](VHOMO"^Z;(=* !%T+3W]*5B[X
M6MCRUD-AQV0]2QZ[9QX1587/!$<\=JZ>%]<*Q5:<^;&PF(CRN53+8T[09C[=
MTW9+/:8,YJ6=I$RG:3 W<NQ265OPTS-,AT'7" QR*9PYV9X;DK56-@(C *RY
M65/TVJ27"V&(QV*7.3[Q)L?+J!9D+E>(UQ/NXOT45 $&Q#CLV#U*6Z)^[EH3
M.%2PF9X<+08Y>G8IE+&O.IOJXW;MT)$EPB7/+3[=BN,5:WZ2N,HP)&">ODS+
MI8Y6J1'Q9^I2S2R8<*C4K/BSQV).4O*K5E<7;WO"^/8K:UXR@9U4X@P-^S)+
M<\,<]E9KO%FDP,8V686E9ELN6]8PC6">PQN'W>9;L@W)=1,:1;EZ%G&(E^K?
ME5[VEL3#GYU9$GT2DJO)A[VWM4X3&-I.3J($(D&V'+K6LE^R2;J<1886YJ2X
M1BJ*EU4W=%MG+M3.5SF(MFES3,,S=,"">N 4W4YY2C:*8UED19'N5]L",JJ6
M<0ZTXY_LMJW,4FJC10S2>7K"Y5OV3VGZ?,#A??LS6YPEW=+U0TTQ@%I$1RQ6
M;FK.V>5A9*<&B)P'8%9MG%:E1).?*S:M3ETSK"N5<@@1C@<=JSG9;,*_,:6N
M,>=2[<_NW*6L,DVGE#-:ZR<K>T6NCUH2]TEPL &/-ZDL3*8;Q*T  /:(#:L8
MEY6733J.)VW;[;]N94Q,LR25H#7&S8B(Y7]BO"\U :G4M<"Z^\XXK4FEXVHE
M4^)NQ]7M5O:88_E<H:;-W23#E8%.LSKPZ8PT7SP7P)MLA?CSI>=*M>CS&AS>
MCL*N<3;/;MA=Y,Z6R422,2LI-J]J%;++R <NT[5%L:=-.WGQ!C BXG/VK>65
MUI9@#(FSW<=EJR9OABK9P<R%\01Z%,W+<XWRI\Z7O3'&-_K6\L6[PLNBTP+V
M6<NI9SA>LSMVE0R&2V,/-S7!:ZV716Y4U,N7+()%W<EBWAUSK%2)I,#&_'"U
M)UPD^BM2A ])[(*MU/4TL.(NPPS"Q8EN$XRG! -G(\RLN&>;E@J*'?!(!QNZ
M2GM/+IK&$+-TL3";+K.JS(I[(YR=$WB+,=F,=@2SRSY66@X>,1$&!(&%PZ-B
M2YU5SFK<S3&RF"RVR)LQ@KF326Q'SY3V1W(V >@A9NT]L*OJ1J?>OA;FDLC4
MWM1:J5.F3"3&\]2W6;^Y.:+IV\\$@VD=ZYX7VQ'8LK2V&40!:6C+:M9,QUMQ
M)I;@Z !-_J6EO"CLTQPWH@V.<C.<3[O/YO.^+#>%.W7-)VTL^F4< /=<LW5)
M/*S-I!X9)!%A[%K-;F](Q\@!YNZ1'!2W*=OHE*1@:0>;#:L>S/7?*Q1!E0V0
M]2U(=IC;6ES1)F1)@(CFLL]2F<5)O:;DZPR(&\VR AT%:SENS,2 K&S1>.Q7
MF))AJSVB9;A'MBIC'*W$:+F-;;"V,%E/;//#C]9$NR(&!!S5EP3=:E16DQ@1
M9ETE.:>?LKTR:YTXG:=F:N"]5PTUWXJ[#O3!Z^4=J@+H@9K1[*742';T=T]0
MS/<I[?1)<.5.PM<+(0A?TDK%W6O9:M/.[#9#U(F<Z6V2\0A W=RSE,XN&9S0
MX<ZU+IJS/Z,+I@E QSC'J4YVRU_KK-B7;7JP.GRS"X\N8JQG&&(AKS=C%%W-
MM2=)!!AZHW(GW0%72.@3NY99G8M3M&O&5,U&@>=XP-Y5MRY;RJ[:.9XP%OQP
M66EVH:$^""03[O<K--=8T:VCM(#3=!:PMQ$0ZD+;=T]JQ=7#-N>'$QEMCD.Q
M7"3=:$VK,2(C#EZ%;J+>N.'F1/+C?&W"R^Q8RLZYY6W3Y/B;AOC;S1M6I,GK
M]%A<SP6#D;$P6-*95P]V-L=N$0EEC+1-7&XCTE2[)9$C1SP2(VVC/)(O*YT#
MFWV6[L(\Y4LVUF3E9654MK8<KE95F&O.KI9$.?T0VIQ6;RK6H5$M[7@6DW>A
M6M>%(G_E"<^\JO+VF*QB;X8)C"[F6>V25'5.H0C[PN-VPJQJW,0L_4"\D!V-
MW,2E2;C19OSG]/K3,D7,Z]?NL%%3N!:2TG'!7EGK<Z7*D:6RXXPN6;]%OT06
MLUDR4?=)^X3M5B;DRB:74)KR 2<,\SM6D6FEJBZPYB-^5JA)E/R9[ (1%V?-
ML6>TR<,KJE@LB+N5JQ@:TRK:#\7K[LUN-2:1TVK(A @]9OZ\E?;,9\Y;.GZE
MX,QL2+"(]62GG*]?NN<O7Y;Y0:'#X88K6(3E$:A5B<PD#E J><+;BX46L#Q$
M@&^/H4[:T9SPR:95/ES1'FY=2DF8F++]W<_#E;O^'%PN'/8"5J3$V8\NWM/E
M2ZB6P$7CHL'L2R7<6S/#-5<.2:AKCX<;+\2LV)/VJ7JO#C)8<1*ANM)C=FK)
MAK3JO5J7P'.:++[^E:3&%;EL+YD(V&-G*Q,,YVLM)IA?NN@<(J8BV-R?0.E-
MW\@?4DF%]HKTZJ>PEL;BX=2N#VSIEHWNJ"1?'TK-9PC>(:"8R27-!M&'3S+?
M69K7A5-)IYGC .!AO>M=KUU]VK<1VG0:=*>P1Q [UB:T2E=H FL]UA-YLY;5
M;6Y-JA5<)3S,);+=?LPZ%G3O)<-ZAT"=3D%S2-V%J:69JVT]>[3V_%N[H6+B
M/1\?7.UEX9XXF-KY,OZP+9[1#I"SGPWVT_7[Y/M0^O:O33"[>)J*:WG< LVK
M-S+Z]?ES>!P;*;;_ $21^ %Q[[ZO9^/G^R.Z*GXQS=R\':8K[DX:RBB @("
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MZD_/_P#W!\=_V#5_R#U9PWT?QP?GV_WF^//\^?\ Z54*,>7[\?JT+7'SMHH
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MIZ/N5XMG&3-I),DAK!((+1<!O$-;?D%O.)ARZXJH*-" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW0,;;<_4GZ,V6\MJFJ02" ?1A&."U3%_PL])-#@8BTP],-BS<KBX99U *@P
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M"UL6D 9CIQ6.S5S>%II:84P&$#RR233?Q9G;:5%:WX8]G/DM28T^C+GJX/J
M^(ZNK8%,+F2(NH$2><GL6LN=F;E U<EUO1EWK%W,KU04R0Z,?5[5/LO:9W]V
M#=+3:M1.O+8,UN[#8%,-(:LE[UMEQ[%)JEUM!SFP!%EI[PK>6,YVBGO =]WF
M3:YT"8,SZ5J;IS&P' JW$27ZL4V)%F:R>43.$.?[BQV:OU:K'0<8QA;VKKTX
M9C!.>-[I'X2[3.-?_6ER[.\OC'460N]S\)<^V9R[]/\ Z_\ 1]"GR,N'UK2+
M_P A*_!"Y<QT];R^M_Y5G!VCZ1#_ "(/:O'\O+T?$_1.@<&T[+\;MA*2XF'H
M2 = VQ*\_P DSN-2X<II'AD\KBN>?#I)E6M4<#*/2/2K.6\XF'7L[\KTCM7I
MG\4%D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!FD?E
M&H*AYR_["3_X&;_).5Z\L]_X/D5^=@PU/5/\_J/PIB]G3A\GO9[/PR\PG 5]
M7?;,/X2Z]>6+VUATCJL\M#CA#9][')>CQIYZH-9,,USN5_4L=HQ=<H"H8YD7
M?L2>I<+NX<[<W3JWBBH< ZTP@[U;$UY.'K=Q//<[?MQ<?3S)ATZW'+I^NF'>
M>#;%Q[0,E.'65#.!+N<]JGMEK&=K5H<G>F2X@7^OG"1TZ\7+V(X)IFE\B+?W
MS*& %Y6TO+W,X3D2&TC(MML[!L67'M^W;L2G>R6\0SC<?:GG#GV[93;:PAHW
M219!5XN\_<T:NIG&6X1L/W$N''O+AU_JCYKG.OOS"D>2W%J!E@AXCGWK4<?E
M6_2BT 1A@;>DJUYLRI>LG,#"8^D9J];X>KX=((SP8W0YPNKV./BMY01,LK)S
M0#S[,@K.<GM9IGESFF,=GKYE;<K;63Q6J83+"][;]N7.M>#=X:^^QI+K.J%Z
MP6:P\/JV@$1NYLN97))B_9&SZP.B(QZN5R7C[-V9X14TAT8'#N65XC2=)+LC
M9S]R8R=7 TS@+HQV%7#.ZU)].\@P&>',F/H<H.?0SW.B&F%HN/>LR-8TVZ/3
MG"!>TQAVP6W3HG9+!)(L@("[G4X=+,K#0UQE%L"++X[(*YRS>OJM]-J0<P6@
M6<L=JF&O9BJIS9S7#.Z[,Y(6X5*LI&O))'(B&,?OE6+;G2!F:8TQA&_U<RC<
MNLUL4FG[AL%^=ET>95FW-RG R#=VS##F4L\^3,SEB+=VPJ>N5[7-87-NN2SZ
M&NS6<V%\"K+EE@<V%MD(JCB7;MJ(XMG$NAMY8+%F_LW.MLREI#B6V' 9;5N8
M9W;ALM= VVVA+9>%]:V@8W)G*688:B07-/3V\\<5*W*K5326FS$Y[$SX23ZM
M231#Q!%IZ8YCG3"YS5PTNC]^X8YYA-?Y7]4U6#P)<;H1[.E7:9WA4YU42Y]I
MQ[.8K.=G:>&KXV\<8\M@6F=R:;$NTD[$66UGWH7+.XW;U1==/.Z81C ]O,I,
MY1UMK%0X W^C;L6F;GPI GEU3'([.[:K/NR[4T.<?!9&/P#+)2M]$N^?SX[>
MT(7$KB)_/Z$)9*SMG6"TW<MBS]FIVVV)<ZZTX^M:C/;MENRY@@#$XV6\RMCG
M.6TV8"+(K+K.N8XO;XHAVYFY65.W7##]3.SK/>JPX_5N7(J6X7#0G4IB8^O+
MG6\RS,)?JA:FGOLY>]M6?"><HYS0R^%F74HZ9<Y4X,,8]?3F$3$;3M2;*][>
M %UO(*6Z,XTK&L<1!LN8T/;$0'Q#,;<EQN[EB\_9TOK_ ! 7/FP<#?C' J;C
M4W-.HM3U-\QYML(.9V9HUF28\J\9DQ[H6X8\PNO0]FQ*DO?>#?MV<RN$N]IF
MGTQ\RP--N43ESYJS'^5MS,)RFX;=-<(RW$$?>Y]"2LRXF%RTWA/>W/Q3K88;
M89*<I[8=E:/PE\$93KP+C@2G"S/;;M?2.%6AK8RG7-P.W8HN9/U763PO*#8E
MD+/4%>#/MPPU&@2)8)#<(796J7)Y04[3)38V;,-@Q53MKAIFDELPZ[>Y,KZ^
M6>6QD3 90Y14J29;S)<+LN6:-6X;;3"$<NY"S,9/$W19'U>M7*>M87U%YB>7
M0A]FLZJ!ZMG<IRLTQ%X?=AZT.7EK8N VA%Q%FHF!K =G+':JQFUM/O/1ZD\K
M_P!+7=+!)-ENSUHRQF3;R[U,;:F'CZJ76B'+F*J6S(ZEA#E_C(6Y:3Y&["[+
ME:<E*>WJBZN7>1##!:Z<_P#+7,R4,L[^%_+!=DQ%THO=A',>C[JK%Y2V^W/T
M'N0<A,;$6XC/N3#7LS-G"VT^GV*''+8WVY^@]RK+0FVQV$=W:@@ZIPN$8[I3
M-6*_4B,1M]94;F)4#,]TDG,]J0MG+@R8(V&[VYIA)V\)FGGD;H!-D.T;$6V8
M34F:YP B;8#T<R,YB0;+WQ'ERL3"^SP^;X  N-GHL3/AF;J9TZNWK=[TY\ZI
M<Z2\T^*T6X'U<RC6<Q3-5TULTDPORA"TV%:Y<T3(T0>(TY&VP8V)9@7O3*)L
ME@V9]$<L5%DREIKFM:1=?GE[5'2:X4[4G@EW3ZT\,9_<@I3H38[?6$FS*VT4
MXM#866#KCS9!4C?F51 L)%A]6Q1M"U=6;?>./85J8PSPB7U+C"!../L6<S++
M"^>88^CN4O[M$YVU"8F*U)@RW9#MUL;;H6<P5QD<IAWW8Y6[8<ZS=:;ZS,RW
M9$C?;'ECM"K"-KZ,;CXMB?\ YX\Z'G#KRMT\B:3NDQ)V7J-X;='2EL"!",#<
M;\3Z%6;F1,S7F5*MR*C41C:D^)?B>5RGMX2RV_99J2<'M!C<._)+RF,)RGA8
M3=;Z38NDLPE;\Q[ ,/0,#TK*R91[WM,+1CB$+,. +8X=J8)<5D; $9*-7<<7
MS ";=O*S8JQC;6F5'O0C@.5R&/#>IYK3N\OI(N-9;X>RV%G1W*W/E,8<PYIR
M/0IMK,9V-:Z @+LMG0G*<7+/]59",!='E8HU=QJ3J>7 V#!5G%C6$AHNAU>U
M$25,&Q$(61P.:-23&;RD)@ :8;;N8I3JK.IB(>++C>HN<.OZX;INQ-W.A=QB
MIGB...6S:GE..JY:94!I;'+E@KY3$L7)E4UTJ$1:!B.Y6IC"&JI0FDXQ,0F/
M+CVF;IH_F]KS=V9IAKVLB1DZ8UL## Y9J2XTE2K:5LIL8#E$J6DN6.;,W6D1
MY0*39:U [?,(\KUJZ3VWA*4U"V9#>$<<+K<T]BR+'2TDJ2 (6]$+]BE_<=9Y
M:NH^&&$68[<U,8I;K3K_ %&627;L+;;.<=Z,Q#LIYF]&V%_*U-K;)$E3-FM(
MO'(+6N6NN+,K/05):X-,0;,NY2_7PEEJ\T-7+#F;Q$.CNVK-V<1-SJF1,E>[
M"V.6 "DES@E474Y>\YY$(&)%G,M682*E4LW219AZE>IN[:326F*W;B,25N,J
M' "TW<L-BQ/NL[8U7B95&!!)N';S%74N5]LU$3IQ?$#U;-BEWPZ3K<-<27.Y
M$J8<[JO)HMX6CM]JLF6MS;2FT8$8 "WEDK6LR<H]U.03#/EBI;X2\,7AN#H;
M0HQ*WY$MUGLRYU;,NEW,)*3(>8?MAF>5RCEG>&^RG>(]Q1;<);3Z:+QO 8>H
MYJX2<K=+II08/=ML'0(A16I.IP(PAZ;H<ZUJF$=-D-(='EAFLXK>--<4S(BP
M*X^J82M.UDN!B,>5I2ETG:::SW1O"RSTA3C;*4;4-A D6;1W*>WT=)<QAG3&
MN%G?EES+?'*5"U/8"%+P<Q7JE@MS^Z%(EB.<T@GU<RU)K+&/W9\/+7S! #$Y
MA,M7'AD+YNWES K-7,:\V7.<8VVQY>E73+:I)<QIB8W9G&*3;4LCE6,<YI_:
ME7!?W169U.238>HX1VIC,23&D!52BV/3LQVG8IG#6\;5Z<7,F=7H3,3V6729
MY!9'E8=B6YX.WU6TUA$HP)'NY<W,L\)UFE,KJYQG$1/5M.U6:;SX3.FOW@''
M&$?0GESLN%PDU$&7GD!L4Y=))C;%43XM-]Q],!DM>K-E1C&ES_\ !OYRIC#/
M-6[2G"46D[(>GH1J]?5<&ZDV5+M-@S]D$G)JQ6=5UW=) <(0A9';W*\5K&9A
M7&5!JW9[Q'-@%?9CRWY=&Z(L[<N=2_5UEQKRF:>3N0NP] Z5FWRSVLRE&S T
M ';RNVI-[9ZL4ZL:QL(YY9$)A;I&?7F F)SRSYE?5+=:Y2U#52W.'1CS[-JU
MGPEN5UI:F6V6#9T0V;-JSYRMK.ZM806QMA 70NYE#'F\/$NG%1$7^T152XMR
MX5/#WBLWH6&"DGU,J1J6A"G<XPA[05;VPN?HT**:VDF0) W23ES>DIX96ZEU
M9C@&A[;A<8F^&9S4DRDW43JDME3$PC9[?4KPZ=><54'Z>&$B!-Y]/,M>V>#O
M9X:;Z4!\("]I[-H5]M?=A-T%- -@(6'E\2Q><M=4TZ66M.4/5TK4LQCRLWP@
M:D@//1ZTP699J>:+!M&>9V+$Z[9D\)KQQX<-A[>9=-0WQ4!7UOA-)$(Q-_(+
M-F5QM!R=8<)D(B\8G:IPN,KA0:@YX;$@=/M6O:%X6!E3O-%N660R"=IF,SC;
M%/F@-C'';F-BP8S4+-G<]XP&2I=-0N+C;BHU+_R\LD^(^,.4-BWU;S)%STZF
M(E=$.W;M3>?LY6[Q'"JH]^)VQQ2_1>%?J-/;&XWX#:5BDF6!E"(V-(Y>U5+A
M+TM(6F,,1GGSA1<86"3*(RM]BN,)C.VT)9NL6:W-1%ZD/#83U= ]BL^S';?"
MI&J.\X6V$Y9JW1,UGESG%VSHS&Q1J[B5D.B-MW5%5F\X; ;O6*6X1KU$AI$+
M,,\SM3G:RXJJUU,V)%D"3GWHMWN*]]38)PL$8QO]B+)*M5+3CPAD!RQ6_!UU
M;:T*NG:XF %Q[>=2<IS4%/I@,(<AMVIC_DP@:QFZTW7&Y1G&%7J8CWN;UJ^&
MLS#)1$E\=L%GRN?VZ=E:*(M9S#L6X=4_62B6B&?+%3.&M6*O42W-=RVI6>V$
M=N.R]([U&$S02W1C"XCN5K5X6RFFF7 ",+#?S;"LW[LMF97%@-L>?HYDE:FM
MHJ=J1.5@S_\ GEO,2W>4>ZLW_B)M]?6EFRW6FM-:' N@,[N6:E<>TRA*MY;&
M& ]7>F<Z-<*O43B3#80>GH6:EC1:USG])QS^ZM9F$6.AI(VPRSV<ZSR+;248
M C"Z/*V"W./\'Z)8 ,:6YQA#F1%<U*B=4D0$8BR'.CI;K"-DZ<Z5"(((SZ<N
M=,L8PDI9,OG$>V_%5&P*TLQNO!NMVV+-^BSG;B_4''&%D+#S[5FZ6L'UESS>
M3<,KR>=672,X<7FV^P=?0I9@<2Q[+>Q:]HN*DJ+Q7$"V'MYE+=-6?1:Y- Z:
MVT'++-)/)C6&O4Z"Y[3!I/1&_F5MG#&+*ACH[Y#B=UU^(AD-BG6^%SM<=#F.
MIW-B80AZ$[:+]([BT75V-$MI<T&V\POB<\BKUW%Q>5]IM6DO9:]MN$1ZUNQ*
MB]7FRIDN86D? >R/K669:]?>)IK6SWC(G/,[%<++O:DTD[>GMM/Q#TP[E%QM
MVGI#6O8+OA!NR'1FIEK,\MC4Y0$ET(=6SI6N-IIU=7-(G'G6<RL8VEM!E1<V
M.) ZPG;=:Q5OU+2A54\ (F&'**UTF$]O"@/TOZA,WBTBTFT0Q7>W;5EPE:#5
M@QP;&ZRWGY\EG#<QR[,T67+KP ZV+=EY,"HZ_HO4OA63,8'P%HC=V+':R:CK
M\?\ %3M>TF302YI!:-VVV'+%<\XJYWIT1Q'K,NE,T"8SX3](8 JV9=NG;7^%
M%X8XA=-UFF F-/\ .FB /[(>I9]6LYK]Y_D=J73*NE<X_O\ 2W?MAWJ7AVF)
M'V-?+B\.X/D6F)I)'X 7F[ZCT_BW/R.\JGXQS=R\=N7W)PUE%$! 0$! 0$!
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M0RB2^KJZ:0Z:6M)+&-,W>L#3$X8IG"27O</A3^W@^W/T'BFBUCR<\L-2I'2
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M\NGZS!_=Y4_V=2_Z'+4[.GQ/YDQ_O-D?^*J/_39*OARO\O\ +^I?^KU?W/\
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M7KOEUU._*GG]:],X!9! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MGF5Y=\1>5?%^H\*<04=71ZAI4\,<ZHIYE/O/8;V;P ,'-P*2Y<[,5[Y?)O\
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MJ\N2H(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# B
MB @(" @(" @(" @(" @(" @(" @(" @("#<T_P#IU+_"M[0DY/#TR^T?,/+6
MK_LZ;VN7H^*R/-\N?5\.7S'&'$NH1_R<[M<O5=]7Y^W/ROS%XK<#7OM%I?VE
M1;SM4Y36EUN9QVJ-7&-$]C8W8'L&:N,N=DO*1H) . QR[DQ@F/"7^J9#T'U
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MJNM>8DK=?[[;O\I#/:IETZRY=&<1^94M@<0_!UTR%P6GLG&'K_Q+YGD%P#W
M$O\ WP)".A>(/,MSVO F.^(WS$[8=^OT=&<0<9/J1-&^[WB?IQC&,.Q8G+?:
M.E]:K7U+IEKCO1Q)&,%ITZ7RJ(DS7O,-Z,2>V&"BWMF)ZBTVHGP #K2!='E:
MN5KE78FB<$5%:1%KHQ:/@)O)!6,IF/8O@_R@GU,"99-C#^2)M/4M3?ZF7M1P
MAY($>"72KV-OE;&E+JN?=[(\.>4#:8R3X;;&M'Y+EDJY8CV X:X";1B3%C;+
M_P 7#/UA,9X<NVLNZ='T"6QC 6LO^\R4X8VNE%PZUQ!@V%GT!S^M9OV<>U=A
M:/H<N5 [K<#\.(21SNYIV?IM++EM%C;ETLUARLF6_40#+( 0V06/*=L*#K$Q
MVZ\"&R$<BMX<<10YA>9A)C=EMV\RF?"=L>4UITN_>VY*35TQ,8<M5IPZ79A'
MU')=>N<L=JJLND<'V^O,8KIMQQVO":DRR +^0AS)+AO7%9R(!+<P\::<R:01
M \K=JQ)4F;R\2WDF^\>L*72]KF)>G=8([>JX*IE.29C6")AGZ5KKK9ZVS"3D
M:OX3@!#;U@X)=U/W=;A8*?67N ML]BEUR9P\U&JO>V\PA;=FIS=-3M+JJK73
M?%)YXW8!7'EGRB&4QF/N!CTX^U,UK*8IM*QA:8_1YUK*>V4_)TN C"V&7.I?
MJ6S_ "TZJ29$#"WFZ5F[E>7Y<WAGHY@(MA8!ZEQQ7/KF:3+6L(!('(IA=H^K
MD-?$@8\L%+J[=)-?=!ND&)OO/;S+><M82E+376<K=BRZ=;]?JM-+3M M C?Z
M.;-/'W=YVRE9=,TV60A'LV*^-MX0^J4K!+-C<>T+.*Z3M/#JC598EOF;MEIN
MYQ%-_P"'3K<QH:?XCIPO()Q6I-.LQAVGH],7MEQ N'*$%,WPO7=7N520EBP8
M7;8[%G.+]W65AGR@P&S#L'>IFMYS,(ETT@FZ$<C<M3"7^/W<O=>VV'HY\5TZ
MUXOEYTBZF4VVP899!=9AQS>$'/DLWC8+]FW8IDG7.V$21@(V<K@KQMGV\)"G
MDP-V ]94:TL%.'#K'4+$7$2K'D0MN&6Q-IF8Q'"=/@V$?5B-H3'U9PCV$N(A
M$V\NQ7!G&D9K$K>DN)&'JYEI>M^CH;BB1[TRP8[,.92X,?1UY((9/9&R#EG]
M&KG#O#@^HEC<!A>T7[1M4F]LZL^[V-T5[2QI!%P/H5]O#?7$Z[Y3-3ND8$^T
M8)O+E\G"N5,B(-EYY8+E\D^CYOS2VU 3Y.Z3$9CMV+$E>>SS.43.&ZXP MCV
ME,,8MYX99#]WGYMI."F&^ULFEBI*EUP)C$"SHPBNDN2<;6.G<Z8(&-QPY&Y7
M@];G3;^IOF0LOZ=J9RW,\5%5^EOW20+QDI;O9Z94#4].<"_>'HV[5FZX3&)I
M4YFFN+[,ARN5ZS.+?JQ;4_IVF-@W>#8@JV2++:N=-1-:R%F'8LW<TOECJ*8-
M-@MO,,H<RS^[#2*F2G;]L;\.C8M3&&+*R,E NA!),\KUEG:1+R:+>;9#V69I
MA]#IJ,SJ!Y$(8Y=RLZX;DGEHS]/@#8(\V6ZIQPU>LJ+=0M!)(;?B.62>V64A
M2TC!"QMPNLRV+-JIN3)!@+.41EL6Y/)PSOI760&?*Y7,,L9DEK'1'HV$'!7&
M=F:Z_P"( 8NLP/8<UB8,X=9U;W-=?CVW7<RE3/EK/J7>&1$QW?5;BK"]M:=7
M<4LFSF. !N(QO,,+4K,YR]6N*]-J'3ICFA_Q$V-,+3SJ?=;?'AUK"JI9Y)WP
M!S[?2C4Y=L<&:_.DSZ<.<Z$6WN(QQ5XFCM9?U>XW"W$P--)B[+Z7-WI)/+QW
M.?L[4H-79-M!%IP=DK+]&<7A/_7P1[I/7S;43U\ K8XF*%Z5LRJHNLCCC"/:
M$TUN3;A4S0&X88<Z>M9Y5&OG6N ARMS3-A);M"&8;S"^RS[JS9+QR[=<XQ6F
MZ8=Z-G4<EKQM.V<:;LB:+(PY0*FK&)G.'FKG-$KZ..67.I.N'3B.M-<G;S7E
ML+S"SVJ_9RN<YCKL3YGCFTPMS[UGM+X:F<;=F\,3C&22;R,]FU;ZW6^4XX=O
MMG?S=O1GLVK<<^V;40^8YSC XV+O+/+&V26Q[H1QY!2S/!9>*WY4AQW3#$=O
M,I-Z62R8C>;*(;<,3RL5X,7AAFS_  A#H/.KK"7K4-55P;$XP)%V)21KK+C:
MNU6K;Q<T0P%GIQ6;]/"XPK$^G^M/+B!U9_<6<7ECMTMV\RJ1LN @+SV^Q7&6
M?7MX24IC !=&$%+F1;ULGW;0, I#K.UY8B(WK68U^[AH5$D..%MEXS*6>8=9
M<(F;2-=; <N96=IP=^O;.GF52M9; <CS*>=/1^/U[35Y9C*:;(>GD$X?1DMF
MW.73,,+!?GL&2LV>J092-+;AERL6;F+BW4:M11 -PPSVJS<RQZV<JG7T0]Z(
M$(<LU?M%QF*U/H03<.HX06?6Q,5B;IXL@ EDQ]UF<X;<B@.\.6(*SEJRRI:7
M10 AZ^6"2YI9O+5KM,$R40X#.[*Y;T<NCN,=!9N3S 7DCW>03#4ENWJUQ+I#
M63IIACD!8G#._P#" TN0)4Z7$".\/P@B3,=_<(39;=TDC#U;59S]FY/^7>^G
MZA+E@ $0]WZ6%O6NW27_ "96"7JTH[IBW_"V<R[9U]R3LFZ;5)41\-QN='E>
MK+F'JN&G5\@[MHB1F$U@_=:N=%52B ++3##:DLE:\)@3I)$;.H*YGAC#',FR
M=TW1Z,N=,S&%S8BYDZ670]WHAF=JSK+767E%5S);FV0N-WM4X9LMKK?59 /B
M<YQR/,NLFC7"CS909,-@Y="S9%O6MRC+0YMO*Q,,XL6RFFD- !YO3E!3,7K*
MW27N;"TQAW(LSEH3I#G1LQ]=N"NCMGA 5-#O/)@+\EY/ENWC^6=I7*GH0+("
M\89DKSW=<?6YRW311R',%)F-8[5HU%)NAW.?6M];O:[B#FR7-=9V[ M]KF;9
MQVNV2F8[> (-_H^ZN>%QV6BC8!;L';W*IZW.4NZE;.9 @7<KDSO[-XL1<W2&
M@EV=^42F<37#%EJ-F4[)-AA&V/H6;OA?W?X:H>T7'9RM6IW,=F_3F6Z!L)V\
MY"TUBQ8*67*LNL+1>%FRLWVO*88R5[I.[=F,E,,[X9G3)+6FUHLV=ZW.%].W
M*J:O62 QXB+QB%GS]G7IU[<1T7Q?.DNEU!&[<<OO3M5\K.O;R]2.,JR5+F3C
M[MC2;QD5OPEZ]G2+^)64]4!$"#CCD5B7$6=;';7"/F!*D/$7"]HM>,K?2G)>
MMN_+V&TSS3IY<ML7M^ 1_&#(+6(OKVX:&L^;M.)1A,&7Y09D=BEY2SMAUE4>
M<<MLQT'C/\J%<G7KVC1G><DHM/O_ /T784M+UOA7:[SCE^_[^ _?1M6<YTLZ
MU5:OSD9'\IG^^C-,+Z]O",'G"TN^,W_Y0'%7+GCMA-4/FRU[A^,)N/Y0;-JE
MPLG>.Q]*\SY;H OB(?Y0; K,>$_<["TOS$D.+ 'MB?V>$>Q7DF<.R-/XZD/8
MS><VVP^^-O0G$3UM2OZ64LWZ3.EPV8Q6)]SUK0K=>I9DL[I9<8G>"MD:ZYX=
M<:QK$@ F+,?I#,)K+I,Y=:UW$,F7O.!;C<X;5K.W7K+C-X1DKB^2P_$VS]D(
MXYE+9ETZRK!1<=26-'O#"]XS"=I]&[>R*UGS"DM:[WVV G\H,0"LS34G:NJM
M8\R)8#X/L@Z,)FSF3+IC'/+IGB'S-;[P#S\!NF9$JXECIUZ_3ET7K_F0Y[C!
M[KW?OF%J8=)UKJ75>/GO+O?=C<\\V/,I]W3KG"A5_%;YY=[SR22?B3V=.MS?
MLJE5JLR:70<^^R!.TI.WU=,(:=XU38"\QA?&/*U9[[=/BLE^[".'Y\XAP#[8
MX%8[/H?'9)I+4O"=0^ W77C Y16+)>&NUZ\^5LH>!9LT"+3&R'N$]J;CEF9R
MN6G^7,P[IW#A]!66U.]ZKOI_EN\N;[F ^@2E^[E.W5>*+RW=NMC+P^\4SAS^
M2Q9:3RW;O-BRV/WG,K?LY9F<KYIO +);6^ZV-]K,C%9W&.U_X6FGX,#"(,;>
M+F[4Y<K9E;*#AELOZ+</HY0[U<?1R[XFUUH=+ER6" ;<,,E?W,9B?8&26?1!
M ,.5BF+_ (<>W**K=1$IKH&V)RR5ABJ5J&N/87@&%F:U8XRXJJS]5F5+G-<3
MAUW+&<5ZO@U6"6+0ZW./0K+<OL=>TG7[I*54;D+3C'[L5;/)[2ML5@A>8VXJ
MSC3.IV89M87"PF$,XV]>Q2ZY;F*CYDXN-]]ZF8MLG & X1Z?:L[K.8RB4T@6
M6PV=R8:Y:57*#18+P3ZMBUA+QKE3M1(%FP^B 2=>V'//FJ-7..\0#B>Q3A94
M>QSFF\],5>TEC28D.<0VTW@]BYSE)ANN,0,[.Q;,5J3&F%V/>LM3Z>4?.WF[
MV'*/:NW2QC-0\UYWC;B,-L5Z-87]7:?EZ[_M&7;]Y'GB%Y^]\.TGF/H4^1=W
M\ZTB!M\"7^"U9Q,;:DMNWUR?*D2='TF/^2"\GR:X>[X9(_16C<?J[+<^U>:W
M;T21M;Q-Y6.T\^6Y<,S28"&2SPF/:Z:VIRMZD+B+0T]D5J<9)^VNJZ@0FNA]
M\?05WZ\;;%D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M!!FD?E&H*=YT_P!W]1_ 3?Y(J]/Y)VX?(7\Z)/YSU:__ %A/_E'KW=<8?(^:
M_OU]7XB\>LWM0JXC]]/X0[UOK8QVQAU374S=TG,<W8%W<Y<J+JTEK X[#Z!S
M+%[9U7+OQEUIJD\-#A&-AA9[0N7ESW72/%,\$.NN=V\Z-=,YR]>==?O.<0?I
M'L2XL=,*09>]O69CK^ZL8RZ]252[SQ8+CRP5X;S)IV3PS0DS*>[XAR]*W#,C
MVRX&TT/$D$"U[?4C%>SVD</L?3@P%P^CDKMSOK*DYFDB2X0%QQ&Q9LTY][,,
MC'>!=9RZ%)7A[66DS4?=-N"M<?DFM*QJ%:Y\81OY6*_9X.ZIU&]-<8B,;# ;
M4CEVGT8Y=%O&X6CV\RF-N%Z]LX>9M 6B.SUA=)G#U?!+UK6^J.C=VK3W:PV&
M4=@L'(YVH9UAL,I!9$"_NV*XSOP;QIL"D;D.70KB5.OM.6=E&(W"[):_5JV8
MQ&[+I6G 7#E<IVGT9G6\N-51M\)T +CV68*VM8Q'7^HTT'D;7>H9+&;2R7]5
M5GM<UQOO./3ZU&Y))ARIYSFN$3R/2G+%U-++25A&[ FT#';#-#-J=E:B0+2;
MAUP6NWV3KUWE(2M4 A$V$;,CM69:UV^W"4EZFQP$2+LQRP73B;3/T1E?6->2
M1"_9CT[%G,KITS)M5I[]XG,D]H1O=8Y,HO=:+(CTQV(G%35/) #;+H1MV@[%
M.6K<MMQ:P60OAGFJSC/"'J:K=C$G$^CG4NUG.%<J=4++CV7Q5\$Y:K=7<XBT
MPLR]<%&V\VL<X V\N?8B8<Q5P%L8]'<JS7,58./8$5R%0Y^-W+ J+,.+YCH7
MWG;WH>LK7WW1O[56<^&,S'DP!/1%.*U-Q.4;W!H))POCD4Y9MQKPW'37 BVR
MSM6<PS6](GQ(M^]Y7JS,9QE+RI\1:<&WQVJ\JY/(()LOCZ43,:)<T.M/TO7%
M,X7"4I:EC1?]&'9C',I]SG2,UFJ!E/@3D+>=3.:W)A0!//B.B?I#E>F4D2DF
M:# QNARZ4:LTDFSK+[@,/NIA)IR,VR^/0E^E2W6$=4D&-N!'HL3]%G"%GRM^
MV OCZ.8IF,W,_5$/IFQ-T0.FZ*72RS&V'\G8##F4RU)YCSXA^^]'L1<4\0G'
MT>Q5+&=KG66FY,2,35;<G>B#;Z<TSHO*08YT1;CZTFVNNF[++K+_ (MNQ,X7
M.6V)SI<"">5JF94]1U<3 $D*ZJ>G;PP/JH"PF_/O5RS>M\L+J@D$Q].WG4RU
M.MFVC/G&!,=O;MS4MG^6^?T5/4*F6(DF^/*]29K%UIUYJ5:P1()^+/G*W4DB
MEUFH@N<";(Y\_<L6Y_5N=?HKE7.;-#H&\&Q<;%X5:HIGS'D@'#L)1GSOANT.
MF/+A&(,1<#DK-G$TO%%I+BT6&W]CF$PF;5KI-)@!9@,-L43A<]-T_=<(!OPY
M<W,FH;P[-T6AM9[K>K]D$6367:.F4#2UD6LZAFF,'NG_ *LV6+@.:'=M3DQ6
M&;,;+C=9]W/:F*LO_*&JJUHC GKVE7[,_N\JM65S2ZUV)Q"G"\H*?5M)@#UG
M8.91JV8PUV[CXQA&S+VYI<QG#Q-;N#W<1WJ]?K4L89,YX<+;('/O5Y)KA8J=
MQ<V).7I'>LW@K.XB!VJ,R6\(&MFAG6?7M"TTK4RI=O6$\NE+A?7,;=+4'>M)
MQSV;5-LR86214-W+3EV#:DEK<M1]36@.=? 0AU^U7CEGRU6UX+A?U^TIRN*D
MJ:N$1:1S<P3%72PT]3&V)ANB_J.*)REV3ANQ&,3ZL]B93'E@GU(#>C [#M4E
MULQ;PK-957AI,2()MK&.42V8YSC?U?=73K=L=>V;CPF:5T/1V+KR7?"8ESK!
M B,-O-FICZ-];)RXSJ@@0CEV\ZS8G:YNFC]8=MY=*VES&>14WQ/*S:LW2<Z;
M[:@P-L+O7D5<M]IB1R\4NLCMQRVDJL8N,N;@?#CL],$)=JQJ.^![L86QAG *
M-6Y4ZH=-B;[S;#:GE,8_5XIS,+P3&&,=B59-+70@61R'L5)/JL].QL 86CV*
M0[3"4ED-&5WK58\,<V4)L;(Y>O/-7"X:,R3X4;(70PML4)RP?6O#MOA9U69[
M5G-RU8Y-U2%Q[/:DSG;4Z:9?SJTXQZ05ISPRC4R0+2B[C>E3O&]0VQ*)G+;=
M2Q9&%M]WL1=8:S6>&_(1MZX=H1&X)H O$!U^DA:DE&A5U(W;#ERO6&I-*E65
M!)=?><\N=5F3-:#*@[P$3;9RM4;Q(FJ9Y="V-F7.F%G:>4NQME@M]JLGECM=
MM2I<]IRO'1;DL]JB"F3G;Y-O4<SM5A-I>DGO@+<\QZPENVYVUA+":7--N![.
ME65>LC1/QVYE9U:G:Z2,D,W<.N&:WMSQ.4=J4MI:8 6BSUE8\M9Q'7=;*<'1
MPB3RL@M<)G>:X4MCK;(P[5GS]FL[3GB%K1$V '-)?"XUE#5M18Z&V[H_9+3,
MY5B=4S-ZPF [3TI%[7Z)&AJ'O(!CA>.GUJ7C1,1:)3W$"W ]J0[70\N)-IP5
M3;9IY!? GTQVG!1J7ZK!34Q $,".WFV)@O9N^ [;Z>Y&?:M28"VRT6GU+,YV
MU>NLN#'0(M@M7C1U[6Z;/B#=^(W9G))=,XVT*A[@"0<3WCL1N8E5:KJ7M)M-
MF7.-N00MF6;3:ISGP!/3SGN0DE=CZ89DQK;S&P]:;+Z_Y6!U&YPA"P\MBK%Q
MAH5&F!T8PQPV [,5645-TR =#/UJ87VO#0F4);AMVW(LN$<^0]KL;-NS8-JF
M9C!VLK:E%S87W;4<NU2<B<8PC$1V[!FCCC>8E63;(QA=FM3$:G:\5XG.BTDG
M/L2W/![*W5N@28X ^@K/.EFVBV> Z$<^5ZF-M6:TL%'5 .;'U>U:Q6%KED5#
M!S=Z29:D\L$^BW;8;3#GSP5I;*UF'P7#9R&23'A=1-2-09*9A@+PLW;-^K3K
M-7C$ V;.M3A=77E3J^M=-= $X^OUJIC>VI3R7S'@&(B=O,D,3PM=-0%C X##
MO6LX:PV3-<SW;>5F>Q+P69:KG%QMM66("628JS>FIO3D91A;VJXQN<KZQA=+
M@ZT0 A?T9IXSY+TC9IY8<ZP#T;=BFO*3JME#2DLNP[N92:6]IY:NITAA<+CZ
MEJ)-JG443K8 =7[5748]<("HI7-PPRRZ%BQK<VCX.8=OM6IPWC,RS,GN81&-
MG/ESJ6X9Q?#9%>1B4SEG&.>6!^L3&71VQ]BTZ-5^L3)D!$VV6'I]2Q+4XX;%
M).GS'CXB"86Q.86\9B7C-7?3I,R9 &/-R"EF%F+N+&*(!OO 7'UP[$]HEZJM
MJ[1*!A9"-W.!LS6<Y9]<NKM3FOWWP)CO;<\$\ZX=,8:M%/FNF $N@3MRYU;D
M[;W'8ND^\UL<8'EUIGZ,587'=9?"$.U26VM>$'55!!A?8[#(G:M\+G*(=5P<
M>>-VU9N[KAFS6F[25L77D6<V)4Q6>%QH:D^YENC#8,8J-3'^5FIZMC6MC"P#
MKC%6:,W+:^OLV*R_5;?HCZRO8X$#;=S!:NHDSR@C-B<+>[G6<KQ'G>!M)'+9
M>GEF[JKZO, !Z4]=F<:=9U[RZ<Z'WW?FKB8+-IW1@26[W*S8LK9A>&R-Z270
M%QY7%$QE4:^FA,-UPNC&\\Z(P2V/:T0!Y=629K<VD:;?WH.C=<4D\I<K)32G
M/@(9>D<RL^J>OE,,I"T1AMNRZ"M9E6VW<X:E2U[ ;P!'T13$C/M:@ISG.<1;
M;&/-@L;REQY:II1,(LMW@<^Q#/T7_AR0)>[$<K,U<X7E>YLQN[A -%W/U*S:
MS2*F$$DCE<IV^YVNM(JI:'-,=GJ4E\19%7JZ3?)W1>3V=2TM:]/I'B3&V&_)
M:YC'#L;0^'=\-.T8=!7.ZK4QAV6.'&,IHD#X<MB8REYTZZUK313N);=&_8.M
M:EQ/NMZZRJ\JN?33+";]MMJS:2+-2:^[=#=ZW]MELZ5J59?JBM<U3QI3]Z\B
MR&Q2U+N.FM5)F3B;;<N=3+$TVM&:0]M_QXGF6Y726.X]&EM(:<3#$9-6,[+<
M)^;(!:+,(X8]"L[7)-Q"3*8;]POV9\REY-82-++#0++O7?@E8DN=MB>UNX;,
M#ZD684>O86O.Z,?7U)C*S"*EM?O",5N76S3=F@B5&T67]"S;%J/ER73IL+XD
M[5&4X=*#&[T+81NYH[,4)RU#3EED.>%EH2%U6:7O",(X9\L$S@E;42L]C-:$
MTN#K8],<@%N;)CRY2'&(MQ[E;,31G%TGZ686D'8/1;V+&V\RK"RM:QD"8&&8
MRZ5<L<;B*J]3A&!-^RZ"9JS&=H*9JAWC?CEF=JF:U+]&Q(U.T6F[9ESHSVJ9
MDZBT")<;L\BM9J2;T\S=3!%D8=&W;%36/NU-*]6ZN]H.Z3;''+FV*]8:J/DZ
MK,FF$PGKV'N6M&\ZX2(J\CUP]90DPSBI+L19RP*Q*DF6_(GQ@(X#L.96M+GP
MDVD$WX)>$O#A,:#&(P]2EX6<(2JD,<+L3V[ I+A<W.(A120F@@"$1ALYEO,P
MQ9;QPLDF#)5D!8>Q8S5NKA$5DP[SK;AW*6DXVA9CXB!(O]JUUWM9FW[-=[&N
M:;+_ %\ZURO*'K*9L#W[3L4LF$NE<?*W'V"XQLZ0L8)<\I"GJ#+<(DW'KP]
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MOI?+Z,OL_OU</B^OXJTC4/-[27-TGPJ69--7I[]V)?+<\DS , INND]>N_\
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M57+<T"80&G=E/#K+C8M?JQ>MMUPZ:I/L\/F6K7B7(X/J'.+@R'U>L^(F 'Y
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M" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @("
M@(" @(" @(" @(" @(" @W-/_IU+_"M[0DY/#TR^T@_NUJ_[.F]KEVZ/-\O\
M7PV?,J2.)-0A_DIW:]>O_I?GY/\ [VW[OR_XJ>17.,<7]I4=+):JDN>X.Z3C
MMV!3.V9-X>9M02>6S8M2IWZV1,Z9.)%L+5<RL3.<+-*<2+;/N!3$JWZQOL:T
M1@,MJTY]AY@"=JEOAQO+"9[AT<LE?#69AS;7N9 9;>C%<[RYV^&5NIS(B%T1
MC%,Z3+;EZB\F&T8K76?5FXRE)4[Q0(PN[N9+KAJ1O,8'1@(\Q6<WRQV^CS-E
M -!ARL5MGAOIIJM.Z;(8J?=UO6<^6_*?$"Y,Y;Z=,[KF^UICD5K#IZ14]9<&
M2WGG2Z;Z=*]?>+=1=+$\6X^O8KG/+IC->L?%>IN<Z=8?A)O2_1TD=):C,WYN
M]GWK-:N9^C5:V,O;]P^M2W+%VS4K#XL"#?R[$]=%Q.KN+A20'3&0^]':U63&
MGE[=_P!V(]M^!=-;-=31A\(PV;5N=9AQ^2XCV]X/TQLMD@P'5RR4O6//G'+O
M33R)4IHR';%21Q[]XWY[VS&F/;L@K+8\U^3.D!4-: 1L]16^N]LWMO7"/CNQ
M]:W9LYF6M.J=V-UQNCD,E2364;,KB+(X''OM3$Y3-RUOK9/W2L\M.<NIB[[N
M1V)PE3,BK 'M&WFS6F6U]?=='TCO3,'%U<X@W]?M3[K,Q&S:HF/-9?W*^&FJ
M)A=T0]?,I+A+?HS2H[POZMH2YNJ2_5*L=N 0Y[=JF%TS>,6MCL':%)<WU8K4
MF5KAO7]:O;43[HJ?4;T22;SB<QL7.]J]'2>S1?,)-ALAGSK.73TC XQR-BU*
M3XYY>/ :<$Z]C^IR-*R'L2=R?%*QODM8TN'*SH2]OJU_3$7.J3*NY7I[R'7X
M8X2-5W77G;UA+W=9^/&].U=A;?RB-JLNLK_V^?"MUVJ,M]X_%W+&<G]/V475
M->$KQ(.=8(7K<[82?CYN^'76I\:ND%\'NL!/Q;(9[%.W?Z.G_:]:ZKUSS#F
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M[!LV+.;R]?7XO^%"UC462&O.1S6O;+T]?QIG3J77>*F2)<Z#C$#/+I2Z=_\
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MF%QYCK[B#4G,ES6"-YQA@M2XY8KJ*96S'U),;W'/-+MQW>5QTEKYK61_8CK
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MFKT9C8:R7^$/45)W:P^H3Y!J6$RC_A:3#:U2_+76:C[+OEPD;G"D@P_YI3G
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MH=1*TYE3I^G<043VF;)=,:[<\![G [A$(]B7?"=+C5?UJ/)GA&7Y;^2O#_"
MDRJ:9I.E2Z8RI30QN^62F[T ![T!Z%?#'/9OASG1+B223>HV\H" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6.AJY1#;?2,8)N);A:*:?)(/O1^Z=JN6ONBM7F2R# Y^F"S7H^*X=3ZQ,B7
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M=-9_.'V.^_[SL3U7&'=_#'F=2!LL&H='>;]('$;5K#/M]7;]!YF4;F#\>Z!
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MX8P!X*SVX;G:\..IVTCSL/8L,NGZK\L[]N?4GAV\.:C(@(" @(" @(" @("
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M@.;/UHSC>7(S6P-UV<59?"_='S:T,=!I]&16:UC/+=IJL/LYSEZ56<2<)>0
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M:F2Q[S'('K6<?\+C#)24$HD6"X86V="S=,WEMSY#9?PV;.E:ZS,R8TVZ*WH
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M/A"(@!"R*M<Y)C*N 0$$:$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&YI_].I?
MX5OX00\/3S[19N]Y;U?]GS/\9>CXGE^;^%?$%\QTL#B34#FR=VOV+U]M=7PK
M,_+M^8O%LAIKGF O=;C>5B-]M*C+IQ&X7N]>S:KAG.F&IIK_ '?1S?L58S=M
MN@E0CA?A!9L1(N!:(ICVJ9V,F;QA!)I+&^QX @=B9PX=Y:QS'@QRLMCL5Y9F
MIA@+P-NV*74R: \'[JF=976,M^4\ 9]*WUYVXWE,4\P ](QYE;MJ:B9DS@!T
M#+'I4C/;?#S.?O"Z_P!B:K?QM$FV&TJ8=+)C+/+=  04QY=.FXYOF0:;/3M$
M4=>)]U%XAJ V5,MQS'WO/M5]96_C[7.WK1QA4#\>(YY0[5/68=<>7K5Q),#I
MCX9>H\ZSC%=.O;3K"H/O])49MR\M_)CF]:GES\I33AO/'+8MQ.VG>?!TJ,R7
M^U;AS8JO+\G+W X(E%OU<_L1^##):Y<>]T]G-#<6RI,-BSP\7:9M7 U):V\X
M8CUG:EKE9BHZ?6EOTL<2-F7.JY6^2GU",(OA;MV+IU27RW_KH(^.,>?N"UY=
M,S#AXX<;[[+_ &I=UFR8<"(P527#2FL(%EL(X<LE)]73&9]T=,808[3GW*]:
MQQ6JZ:Z$(99]ZODL^G#$)K@Z,3?GM6<[8O;PWY-68 ;QOA>, JL3%/,#H9QC
M?SE-M:J5EBP\Z))Y9(P4:MPU9LZ&.)Q]NU7.&9U]JC)U5"-N,;QESHZWK,(Y
M]7$D;QOS'L2[<<.<N=';&'*]<._+V?#)AFWMGI7.S+OZF]L4P>H7PPY>A;A.
MK3GU8:#;"&WFRBM:BR85BOU-K6D;]PV]RS/JW)A3ZG5V--LSE E7;>=.O.(>
M(&RV.+9D/>..76A*Z8U#BQP>\"?#WO64PW)*J>H<5O(?^/Q*>LM69BAZGQ2]
MQ>#-C'&(R@I9BM8QM0*_7WO>?QIMV=&2U.TPWS,H0U[YI WB>GF4[?5/;6$G
M3RWOM C>?1#%%SE/4>G3)ACN1NR4LS5O\<KSIG"\RH+3X,8PMNPR7?KP^9\U
MN<.Q=(X+>3+/@&WN6L/-YP[5TG@?W6?S>_O33?C*^TG P#&QD#'+O5PD[X3D
MC@YDN$9$+!;S02Z9MS4Q(X>;)(_%PMS4FVYPG9%"&0]W "Z-W,EGDO;$PN&E
MTS?<,!8!GDG5FW6EXII36M98,+N<;%;,I)GE8*,7<\/00L6>K6$PQVZ8[%9<
MS!UN*S>-"WEVA,3ANW+P:D"X]1'>GK&<[QX<F5),+3\4+^;(A2]::X;3)Q=<
M<<_:KU[8K.)&\R:(6FV.SUE>KK<QR[8SIS\1N?9WK4OT2RMV0YIA;Z1M6\L3
MMA-2(6=!6.KI=S*9DM#@(X#9D%NZX9F.'*;+;"[#9W*>U+PCIDML.@Y=RES$
MZH:IE-!-F)RV[%.6K,([P&N, !RAD%9<,UM,HMX#W0;!A#TE3ROAO2-/<TCW
M.SGS6I"7"6ET#R 0S#9D-JNFLYTV!0/A\&>2S;.&/7;"[3YCKV;,%GRZ281T
M_29AB1+OCRQ5[?Q9[3,J&G:?,E;Q+( 1/I7CMQ7D]<UH3*@T]YW8>H>U27%R
MUTZ2(J?Q,RGOG0OVW*Y>F=)9]U6U#S E202:F$,/3@K:]/Q=(ZFXD\T9;6.A
M6&\V1RB/4LWJ]6,1ZS\7^:.^)P%6;SB>6*33T_%,QZQ<3^8<V?-F@5+B"<S"
M\'L5P[>_K77L_BI]1O SH[W([5'7KVRIFHZ@^>7;KR8V7G/+I5E7MVT@)>G5
M%3,!#"Z+@,]O0JX^UKLCA_@RKJG,_FQ=$M],.Y:SECOWSIW_ ,-^5U3/+":(
MD%HP2XCR]N]CO'0_*&9^*)H+V@QAL&V"EVQ>]M=GZ;Y3&6)<:(#VQSLP4KEV
MN=.Y^!_+MM//E;U*!"8#AA \RO$3K</;?AGA:3)DR_Q0; MV6+-OET]W?/#M
M!)IP(- M;'D4SESO>VN\M'JY4IK1O"QH'-#:IEB]_"T'4F&'OF[E@M2IC2,J
MJMCP2"#<<<MO,F/:L>V$/,F@F-]^/M*MU,)GG+7\486]7>HY>VVQ+;O6^KED
MM9TY=KEX<R#B8^C8I>&;PX;[0X1-Q&([UE,5N2JEC/I=73E9BGZK.GM&\R<Q
MX)B.7.5TF(YWKC@>YKQ"(]"QVN4G5$SY(C$'$\O0I+5]9]&>DE $'F])6I-[
M:Z]-K#(:S$W;1A!.T=I)(SO<P V]F:S.OEK$0\\M!C'TC8M<Z9LGAJ'=<1U8
M<L5<21G$;TA@AC=LV;%.SG;MG,MO*'<F;=,VXVP&6T&.TY*R1+K:5HF2W &
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M5-(\0]9[NQ2NDLPLU/1M<T-@+0,#D<(*QF_^C+-T]@;'='5#U(GE7JNG#"Z
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M@(QMM](&:F5]<;97P($1Z%<6KU[-*;+!CSY!,88[7:+FL#B18.CF2DK1GMW
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MARB"DF>6=Y:<B:?K+(Q^)L;=HP45W'I+V&B;[PCN(G/*.U #?(VD16ONW^B
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M<Z4UQW3[HRO'0F<UKF*[K>GTDF7,<(#=B<-N0V+IXRYRXKIS5*V5*F/:'@$
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ML[9J! @(+#;R@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @\$1(V&*"QUVK@:/4TM/[DY]!426N%AWW,(:8["%ICU];FO@[^V#
M^QL\TOF<\W*CS T2FU*>[ZY6SFS9#)KO=G/+B+ 6D$'%9=ICO'X>Z1^K[?,!
MJ&J_4'T>O-8)@82:4 6NA?X$4SBI_4_9[Y*/U7'7CKVA\7\<4]4:.G$N;4MU
M"8]K'.AO%I\5P8-XBX*66[3$Z<\OM ^5#Y,/)SY1^"-*T?1.&:*EU2DIFR75
M<J4QQ+P/>(<PCWB<5KPS;GA[*:A73*RJG/8\_57N)ERR3!K8Q:(80)477^6B
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%/:(^%,Z <8[$RZ=<Q"S]'J Z E3+#D>[:HUFL?YFJ2(^#,ZBIA,ULLT"K?
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ME++F@.A?9V9\RQGPUZ^6Z=.E ?#V=RUV.=(BII6,N'(0CEDLIC&T/.;880Y
MA7%340-5)+C;=O'LYPH3:KUM%[I=#'(XV]=BLX;DWM7Y;_"G 8]06HU?LO\
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M&$"<+MO.EWI-7ARH*"T;S3:;>@V0L*GV3">FT#=QUCKN6"LB6:4;6J0 78'
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MP1@LM/* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$!
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M)V\]T+3ACS>M;ZW2>M9)=/"TQOC"&S-9[8M,>&VWW(87W1VJZQCRUZXC.:F
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M9C&!ANWG-9GW9S%F$N7X8-EVSN2LXMJK:I)8]KP-N6)BDM=,R2.J-:T_?<\
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M."S)BF?#JS7_ "GI9;71E2[-[][&2WG)=1Z]<3>6U)*<0&2[W'X!FFIMG?\
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MMA]//M*)9M4]1UAKB;1&.'W0A9$ *@371CCVVJI+>&RT"$1#H6:Z=>'F8YK
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M-*;,(C;A!3RW.OT0M?4CP7"/W8.VK4^YFNK=4.].<1='MBLYM7.MM>FFD.;
MY1CS>Q7*]9/*\:2]SRT',7<]JNEOT=C:?2;P!ABWG[$K'%RGG4EANL!Y6J>2
M8SEJNIHDB&$,_4I>2XRY,T[Q+2!?RO53URC*V0ZF?'(PLZ_4F<:7%2>D37S(
M#:3Z2ICR>J=G2GAI)%T3CLV*S%63"#FU'ANM./-@K>OT9O*9HZ^5NAI.RTC$
M==ZPOW;4V=*>V-GW8!:G&%R@YQI]^)A?'L*B7'AC?-D[IA",+.44Z_\ HMLD
MQ$5XI+X V>WN6\S"2W*4E2M]@)]/2IY7&8\S:,PC *6Q;<3'ARIJ/W@2!?TX
M*9TS-U==+E!I;8,,L!S*67#5ZZS%O;N[HNN23ZL8:=5/:P6\WHY]J;:ZW$VK
M576- =:19GG:M9UA;?HIM;7C>=[QZ]J29Y8SAIRZQL1:?7>%GR9N=K105K6@
MVFW=QR'>KBF,K(W5)?AP)PSV<^:*B*FL9,$ ;\X; ARB'4/UDV"PB-W*"VU/
MNR_F42O> '5""G!)A&5(W(LNA!3&"U!3=XFR/8C&;;MYE29DPP$<_0D^[-ES
MF)>1I,Z;"PW1N.U7,\.TFF6;HE0+@ZXX'8IVX9O*"K-)JV1@'8YY>U(O"$=0
MU8<1;?MSYEKU9LOA(TM',,-\6VWV]2S8OK<:3DJC((@-O*]&9)*E&2RQHLNQ
MZ I6K7"9/$L;(8=*F,F-;1\S4VL-_K]>U)$F7*3JC'.A$]F2W.N8U,XVGZ2H
M;,AM*SVF%N)&^9S)8WD8SE%U.H2P#[V&?/WHOM.(HFKUH)L)@0>;/%.$EWFN
ML]1J&E[LHD\K4F]NG%;&DS&^*!'$K5FF;NNZ>'W-+)<(1]BS^K/C'5;S#<?=
M<$-J;JDT2RXX 1YH$JX7]5(?JC&S@TG'UJ>37,Y3]#J#'0$3=#9Z$Y7&5III
MP= @X##8?65M4NPDCI7-C;S&:,UO+4QX:51-F,:;80CV\ZEVJK5U?.8X %UI
MC?FM221BQ9- G/J"-Z)B;8[$S#-XBR5\@!MPNCAES+%M_P -9BISANQA88GM
M"DF\+XTQ->0#;CZEO42RW<:=35[C7",;-N!/2I:ENE.K*GQ'NO%O:>LJ,[1)
ME.F&R.SET)+6YQM*TVBS*AL +3'".7>K?K%D3U'PE-!#MW"-RS^K/;,6VDTE
M\@-:1E>(812DDQGRW)FE.FMA"W8+;+4G*2;8I/#TUIB1 $ BSVK56Q/Z?2.I
M7#Q!8"?3=V)>--3Z+ W4)4H ;!WY[4W8QQM&5=6R<?=-X*8DF%^Z'F!SB81Z
MUG<W'+MN[^J.G,G")$;MNSO5G;+$DEVU6NFM-Y-R5?\ V3-)53)9;&-D/5WJ
MRSA+,;7"CU)P:+3BIS2;Y2AK7/&*O.FK,Q%58F3(FW9UX*;X9EPT:;3GSYUH
ML)[5O%FSFKQ2: -T.W18,AD>Y)]VOLDSI&ZVP"P6+)9/*#KJ(,W@0+CAMBI9
M?"9D52ID-:[EBJG/#S3T['0)ATG]LM)BMITIC1A=9=W16:805=,8 6[3;#GQ
M2?7RLY4VOI7302T8QZ+E+MVZ[5"HE/DN(,1;GS03[KBQ(:=5^',:'$V$>D@]
MJLV3&=NR=.U)HEM$3'GY]JM^[5PE9]>QS#$Y]GL4TF9X5N?,:]T0<>])?JLK
M9HY!F.%@Z=OL2GW6:73/E-! N&&2SA+=Z1E=/<V(VJRXTNT2R<][P!&_*U+"
MW"UZ;1S9\,8B&?J3-\)F5.3-(F!KC W>K/H5F6]84O4Z3P7$D9Q4O+.O*M%\
ML3(67Y)C27G2?I/!@#9$0Y[B4S#UU]V^)H;8T\N@JR9)'(L8ZW*VS:L[7$8Y
MDAK1';G[%;MBM":YC8W8W0P.:EF-P:+JIK38>:!AB=I4DOEJ68Q7'ZP9E@)N
MSBKM=,C9#WD0%_+)7:7%XY6S2*-S "0+(F[& SBE^B8;M>T-9: +-BDTN^4&
M^8($<KPK[&:K^HVM="WW3Z%=+F>75.L2 Z8ZP7NY7%6\$1M'3CQ00!ARN4ZW
M$5VQH+0!+B +-F(6L99OV7Z66;C;KLEA+<(RJ(@_F]93+':]?"MU;023"_GR
M]JN8QE79[!&[M2[X2VVM8-@ZZR/K4U_EOK/JE:1^Z;^5P2X\IVLXBXT$P>[$
MW =@[DEK$W5HIIK=T Y#MYU;<1J]=:<JB< QT#GRL*F<S9(H>JR9DUSBV.(O
M.9MYE+4O*JG3IN_$Y[<XIFQKB)VAE"5\0]EOH4OV2R5*N$MS2!")ZUO,LVF^
M&F-/\5P( .-W7AL6<9X3%\K-I6E[CI<0(67@W=2LWLNE[ETTF5)B0W# =RMP
M8OA$U(ES=YK8;/1W+,W5[3$4G5.'ZBJCX8.5@SBMV2,^ND#)X2K);RYS76'(
MW)XTO6;^SLC0J0T&YX@A!H%HA<LVWPUJ+=/XDIZ>5NEPL$+QS*?JS-UU_K.O
M2ZISF2S:8W';99S+66]1!4VGU%9,#VAT(V0CRN6<L[R['TR4ZEDAK[P,>6U6
M5+O3).\29,]R)&Q:^ZR82VER*HO%CKAZD7$=GZ89\G<<^[=&/0I;IK]L9=7U
MJ5)D$.+8"^)AWY*=9.?+%^W#ULXZXNI93:B#A$1^D(VP"=KC7A,5Z>\8<?L8
MZH#'GX'0][$XWA,:7,_R]3^..,'5N^T/<1ND?$<?4IA>NZ]?IL\SZB)),7#M
MM[5<X=;([FX*T]M0YF\!;N&T8_=7.[JS3V>X>X69-,L[HAN#Z(&%J87V=\<.
M<*,;X1#1'=;]$9;%+/JZ1WMP_P //ERVP%@R:N=QY=>LX6Z1H[VS!8;^5T5S
MQAWDQ,.TN$]-+)T@F'Y5MEN8[DY.'Z@_*I+,O7:<0_YS3_AKE><.DN8^MGY;
M_P#8Z3_FDC\ +';AZ/QO_D=X5/QCF[EA]^<-9 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!MZ?_
M $ZE_AF_A!#P]/?M%WAGEO5Q_P"[YO\ C+M\<R\WR_QKX?OF-F!W$VH 8RYW
M:Y>SUOJ^#VG_ -YE^9G%E,7USR!]]GF=JD9[?92OJY:X\Y]>92KUMXJ*K"08
M<K_8LX^K7;'ARH23?M]:W'+M?"3(<8>Q2Z8[3#!N.R](55O2M_=A;</6LYQ7
M/M&3?+3:38KX8]<GC;3Z>Y9Q<_9,89)<TF$#B%;I+IM O=='L[E&<QML#Q&_
M#;FK&>T;"(S2BZ,+868(WTTE&2R\0AAW<RU)'?.6;PBT1RY9I<.G72L:N_<E
MNCA'UK.?#?/Z.A.+*T-;.'[(X[2D=9,</6CBFL&].AB<QF,EJND=-5\P/FN)
M(R]*Q9AT]9A%@1,%<I9I)4LH$=+?4DEMRQ)MV/H5(7/%F [1M5Q,Y3O<Q['\
M'T[F^'^T;ZLRCP=IBY>S_"XW6RA@&BT]"9PY=[F9=O44S\6T68]H6;<1Y;9/
MU;<QY L/8M==\N/;M?\ #6,W"(5LG^'GMM:%028PR73I=:=?CW<(]^\ <X17
M1WLO$X:CW.C?AWI22R/#?$<<5DEK?DR'EPOPPVC+G57/A.2*8@7<C':INLXV
MF9$F%XY15X7K+4E):V(LY14NHW;<MISV!I$1=#%9Q:F5<KK0X[8JR1.>55J7
M$%T,_44VSB2YB-,TB-N.SN5PLF6Y3DOOQ]2697<X;3I<01:IA-UIS9!$8 PN
MPRMQ6_!)/\H&M=N1CA%<>]?0^#I^U0]4U 2@X$P@<#SKGR]-ZUU+Q!K36";[
MQOSA>89K6=8/5TKKFMM<9WONQQ]JQPS>KJO4-1+WN@XD&RTYP]2U(>N9]T5*
MWY[Q?:1MO*6X)^V)^DT6?40@VR(P.WG@IG;EVW^KL;0.$ZASFQ8+A&+3S[56
M))Q7>&A\'S=UD98M:/H[5GAO&'<O#O"[Y1E1EMNRA@K&+,;=S:-I#9;9<6-&
M[#"-O4EK-OE>:=DJ4R$&B'MZ%)?+.<Z;7UJ4-G2M>,^6<QQ^ML,0.U9EMJ7M
MAA?/?; F$,S#L5NR=IA U=20Z\Y7F^S8NT>?Y+EA951C&.&)VK>HS--Z55 F
MWM&Q6S,628^Z3ESFO%]OW<@I-:2S>(V,%6O#',B&F'*PK';E)/JT9A< 3;AA
MM6-Y7].$5.8]\;#</1',KIE);E@;(</1RM*6EDETV PFP@W8+,[+>&]+8X@
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M+)U<'0FS"22;7$QLAGM5_5JNO*Y]553"=YT#=>8Q$4[3Z+[-FAH)SP-[+&.
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MM3M-M==1>*736RP-YK;A@F*WX9*EE.P6AEE\0,;^Q1SSO[*_4RZ>;& ;?$0
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M,J2Y5>LTH3V/#F!T3CTB\HEF74'%F@AC9Q;*:.@;.Y.6;U>NVNT<VGFNW1"
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M @(" @(" @(" @W-/_IU+_"M[0HOAZ=?:,?W;U?]GS/\9>GXGD^;^-_1\/\
M\Q3VMXFU '[R=E]\Y>JW,R^#>V?EP_-CBBL:VN<V(^D,<SDLQKMG_"G&:U[K
MXDV7Y<YBK=,(^L%O1'K(*2Y2QM4$L8VWX?=4LM7-G#?FL&[?CZBK;AB[:&[
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M9LRW27 6'TE.MR3KEC?,<!?B,3WJU<8K%+J"'VDW]%A&U0;[JD>&3O0L!O\
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M=P6CU$X+5[9/;6U>_1QH<3X4+=O,D8O&DW0Z4V21^+]=T>?)2LR_59)4@2@
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M(_[/)B&F, <.=)L]G;NB?+C43GL_[,L@VV Q,4QE>OR21W3H7RRS2U@.EF[
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MSO*U7%T<NN]9F6I96/>.?:M,Y_1R9$GH2];@RR/:=T\KK5)ULVSF5%^*\38
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M8S_<FD7^]V%9SI>=N2R@@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M^)WHQLO5SI+=HJ8"\GG/+T*3ZD[8VYR93MX0';F-BWAK.=KEI>GE_P!&,!C
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M!8\DF$?.H_#PA".'.MV99K'2_&(YA7&9AKHDZC<$H66PV9!9X=<3M<16IKG
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MS6=DC8$AI9M@?7L5QO+7KAJSJ9N[=Z=H6I<LH2IIA%]AO..PK.=KOZ*QJ5.
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M7Y9W[<^I/#M.')1D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MMB2HM-=[MAO&>2U&\96:GH8 6'/K"E/7'"<HZ=H<(@]>TJ,W/"ZT;6LE@P]
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M]DQ:T);!+)LY7(S97"=.:6%IV#HY%5/7"F:NR6]ILO!PS&TI&>TJCS]+9.B
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M]^4Q"($(+E>7JZ76W(6!%O*/U3^BOYCV*5'3]5^6=^W/J5\.WAS49$! 0$!
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M>CPI)AZ4KCUYJH(H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\BF=L2)0US(8*^RXQ=HBKKR6N$?3L"86WZ*7J$^))CCSX]*E6<*G5S;3;@,
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MNOJC+  (]>."S<+,9S6:3J!N)P [5+<-6_1FF5V\PW&SU>U3-2<J'J1,R>8
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M<[R]'2:VY"ZU%O*/U3^BOYCV*5'3]5^6=^W/J5\.WAS49$! 0$! 0$! 0$!
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MLO=C#X@8=2FV;EW'3L;X;;!<(]04EVLMQA":G):YI$,2>WO2\Y3"B5-"7S3
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MEG?MSZE?#MX<U&1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 09I'Y1J"F>=IW?+VH/\ R$[^3=W))MGOOKA\77S_ %217ZS _P#U1J+H
M_?S=D%VDKY'?79\P'S!5D*[58G]]=CMZ%<L]I+USY>@&JU6]63+<1B<+-JN'
MGN;</,@[X:#CEL6.V;P]/Q23E9M.I XC]LWMS5DKU3M';&@:>TP! ^CVA62Y
M<OD[3C[/8+ABB:S='[%N&W;!6R_Y<99'>VBL:QK(_>CU9+IT^CR?+VS<K@R;
MNL;"Z'+!:]=N%PBJZM$L.M/1T\RW.OEY_D[?14Y^K$S" YVSE%=.N(X7K6Y3
MS731O'$]ZZ1BR2-YK1 '8K)F[9X';K0<%K&+KAJ9J/GSPT'9;V;%K,G#KTZ8
MN42^L<";;!M*M[/3.L[1A^N.P/I/<K.V5ZSZLK*IQ-O:<ETUATDZUR?+\8>C
MM*X]MN7>YN)PX-HK1T8>Q<F)SM(R:)MD1ALR,<4+&PZC8T1(P.6'2B(6LD,$
M;!><-B+/HK-3(!=9ROVA"S62FD6W=?.<"5/)C2>=2PD[T,,AMN523-PAV-/C
MW&$<N92[=)/"RRI+'RQ'(*2X7TC3J:*602!EEL6G.S#1E26,C' \V67,KVF#
MJ\5#@UCMW$0[5EK-SM7JAN^[G]5OK58XNF[0TLLVG.-PS@C4N\).:)<NZ Q[
M<N93,-HR=5[L=TYX\V01:B)E5/<8-CR@KG"=;>&(/J7$6&$<O:I;Y:DD2$H/
M=N[POAEDI+(=NLQI),=N 778K3,EG+,:LL$0;1SXGF4SA<2O#-4?+,2XB_E>
M,E<QG%SIQJ=;>6V.=CV<ZF6IU^JMS]2FS2;3;MV=*A96JV>\Q[_8I:KFTET8
M\HK4I>MO+PX6'EBF(SZW.&DX;I)VE%O6SAS?/EMDP-\(7\ZF<?HF+:ZCXEJW
M>(_=/TCCLYER[7>GT/ADPZYK*YPWP2;^5\%G?AVN(J594%Y=:<<2M:)94(_?
M>2 3?ZXXK%SEK]K8IJ";,<"!$1"L2]HN.GZ+-?NDM%X,>CN*M8EGA?*+AI[O
MHMNRV1R4QE98NNF<,O:0=QL(9%7&)]RV+Q2: 1NCPQ<<%)=;7,6:DX>!W?<;
MA@%.O*7%6JEX?: V$MOQ&X9+1,)AFC"6![C>4>]/+4O6L4Z@8V-@NC8HGM)4
M342&-B(#+#:F%]I6E+E-$T1 O&672KG);U\+-3RI1DX7'++H3#G<1'S93-\^
MS,J7K?#-Q6Q3RF6>S)3B_=F8SM*&5+W>C9ES+6+AN^N-<JKJ\AA;!H$8;#FI
M.K$OAUM5R""3M.5UIS3MF<-8C6E1:YHMA'O[U-XVSPG),UTN&Z3ECC8DM6=I
MC[I:35F$"?3S9B"UFI;FM:IG@DP(PAT="EMJ3%Y:DMYWA;EVJ3,;MZU::6=N
MRH&^Q,6W*>TFHUZNH%G/RP6O"9E_5$LJ'&:(9CLY@DFJ3M]5NH)Y#+<N6!5Z
MS!WLLTDFU!,8>OUA=9AXN^JRD[U_.KB,^UL:<^5&) ./I&U5,V*Q6"8TD0LA
MLY8J-S-5>J?/!=NQO(]?:D&B'5#S;&-V6U6R,VV,[9528V'I!/J4+65KITJ.
M]&SG'*Y3@L^C7FULV( V^I5?M25J$YI CEVQR6IPS9$]3:K, @=Z^.=EG,LY
M7KC#;.K.((B[J 1IHS-0F$\XV\RSFI9Y8OKDWD2IA/:IC2Y\QSVQC:1&-V"T
MW5YW6^$";[%<QSLD5C4C80-J9AG2H30XNLNC#TE6S)+GE(T-*7N!.,,.GF4X
MTUB.P--HFM#3 $P$;-D=B<L]M1.F4UHM%P.05XF$S+M%5;MUK@(61[?8F8G/
M"I5!<Z8[$="C5N4WI\ENZ";_ '2>L;8*IPL7U=A9<+C@IB$1%72,P&9Y6IGP
MN9=JU/HS&+;^;*&2?JOM8X2Y<QL01E#EC<KJIN7+;$S<CO<H+,OU6=IY9&SF
M., ?3'U)GZM7#8#00+#=@KIC-RV)4DN]7H(QVI;B:18*60T-M'T<1MYTF^5S
MX3LB1(@-Z%EO:M9\)C6^2IE4N[>WKZ^U04S4Y<JT-R]-O<FB:VI%0UP>;+%)
M8UVWLDQ$ -O:8*7_ -&4K*\0[L ?1S)KPW(E),F:\ 6W99Q5_P#=F]O#8^IS
M<CU%)?JSIA?0S VT9YXCH5N&^MQ4)54YEEQ(N!/65"]H@YT\,+A&Z/9')9ND
M^\4O5:EY<0TF$=IR[U>MSR>R5X??,,(QO':JL^CN+3) ?+:7# 'U=B0[=L.%
M=3,#3 #.[9SII9FQ2*RG.^89\L4MB33%)ES0YL 8689=MZ9:YVL=(U^ZW>!N
MV=':F4OTK=J)@EL/[4]8]JK%UPA:;5G2JD6F\XCO32Y7$:\WP8[QCNIE,3E@
MI==+G_$;\_;M0Q9=I:9JSG2[R21C 8)F"L5]0][H_<[%,M3%;6D36M=[_=D!
MV)DO5;'ND/;A:!CT*L^VL,(I)$P1$#'OYPKF.?;;5GT\F5D/81SK.F*C75+6
M'W3Z=G1FK%DS-\,LO4GM@ <0+^;85<R+.OK4Q3ZDZ#=XFV_F6;9:7MM)-KFN
M MM/-VE-1+<N3BR8(QMLQQR]*F8D_P#1B-,)CA$6'FR)SVJRY2]=H^MHFR_A
MN(AV"^Q!6YQF,<0V-ALZ(=:#=H:B>YP!!A$>KKN6L.DS(O\ I8,P-#\\MBEP
M=KF)YU+)+3&'H7/EGVN-<H2JD26Q%EQ[.E:+-*_/=*:XM$+R,59969)DDR#-
M-@LBM:;DF4BRA<!=BEN'33C-EOE-)RB8PY[+>99MCEVY0\^J+'&VV^\XGJ5G
M:8VQB6H\UKG&&>$4\_9<:8ICWN!//A9B>U6R'6>$-5OFM!.V%G/L3,C>&[I%
M:YLT;Y(@>62D]3C'T=ARZ^49;8'#EB5<]5>#70N-^U)B\N=MRQNK8BW//O4N
M(U>&JZH#R1&VT>K +.66+P#,NC?RR2W$3UE<'41(L'H/<I.V]M>MD^SG)I2Q
MXB,1Z]NU=+4G*=; 2N@]G>EPZ=;]5&X@F09-NN/^*LV5),W3I#6ISO$F<VS;
ML5PMX5B1-<9HA&_,YJ<.<CLGAY\S>%]A;M6I9V;XP[CTYQ@.9,82XOZIJ -I
M5JS<25#,#" 80^ZIF%733YTIX;O0C'$\R=N&<YTM<B93!ML.L+GC;4T\3ZNG
M;'=.!R[Q%5,8N^$!45;7W&_FOMV%"_R1CI?B&, ;>5ZL7VQ?LR2Y+6",,>7:
MEOB+F5F=4A@#1#$<K%,^4Q,90M=.BUQR!]>S8K[1+.U==:K4N_& ' XG*.29
M3UJD5-3,+H1...WF3K9=M>OT>:9TU[A83;W'F5O!9<;6NCIWO#;, ;CRN5FF
M=X27U-XO:!T=Z6]:DE1\ZC]X6<]@Y8+/DDOE)4.F2YL(@96\CDMS4:G6U/R]
M*DL NNPA[,U.%]4A*II+ +LST*7M]&_7$>)TV3+%A%@P/.L\L8JM5M?[Q#"<
M>Q68C.,7'AJR)SYLP1SVX06M->WCP[!T6AE3O##\8 ]<<UF_=JSZ<+)JO#U)
M]6<0&1+.V.Q/;,8L_P"754_193*E\0V$3Z8[$S]#K<5Q_-\E@B.S,\ZOM2SR
MTIU->&1O/HB<]B>S.&EX<UAA WQN&Q:ET6-J3-++'9^OFVJ:PSUTSF?+=",+
M-OL6)6[<M*9!Q]VT1*N8S6:1,W# P]>*UVVO6XB;D3KB(7\L%AJ9YJ7ES26@
M\KAL3.EU7-TQ^Z<H'#UH>K1F3W@1V<W*]->69F::@K]TG?/K[EO$:K/+U.6(
MV]BG:FJT=1J952R$<,QZE)<,53)[);"3' GJBK++5F.57U&J8VXWF-AP(@I[
M;;\91M+6!TR$<L?NK69X3+M[ANK#?#%\87GO@F85V;+U"6V4+<";(=\4S%5_
M4-7\,G<)QNY[,;%CFL6J_5:]/+" 78Y;%J8_RW.%*=7SWU)=;:[;W)F)EV+H
MM>\,$3;9CLZ%+-I;X6V;JK6RA:;H>@'-3RLXVZ[US6O<F0-L3VG:E[6);]'4
MNH:Q.?,=NEQOSRZ5;VR29Y8:.KJ9S@'1M.U3/T)RM]&Q[PTN'TH7"[KS6O?$
M7$RO^DS'20(#$>I3-I;B9=AT6I#= <3:(88]*G'ZI>TPV)LZ5.(MPA>%>69W
M<9.GLF/! '2+,MJDY:SF_9>=+TF66,W@W#T#FVK5N*L2%70R);'PA=LS"LDK
M-TZZU5[)3W!I%@LY0V+/DUC*H5%:ZT1OVGF4QD\9<:2K F DXQ].T)C%6=I5
MPI]0:&@Q-P]>9VK56WZ(?6-1WF.W2;\2LX\)[QUAJ%5.F/>!T0YE6<QCT][]
M\;^>*87.%RI9HN'*PC)++.>"7#9>Z<8AH.7H5A[QP9*F./OQSZMJG9S[=KPD
M&2F!HB.S/F69'/%_RCZV1++#"'5L&U;G!BJ'J%+%[X99=RJW-14NF<UX/J/K
M4MPS,^5BD"#+;S#N4ZVVMWKB,53,W6P!MA'&^*N6<6;;>BU#FU#8F\@&TYI<
MM9KL_P"O$R86_#G[5)G*;Q]D>*D;QB;SZ^9;G!UF=O%1/ 889'E<I%[*-JLX
MDV'',YCF4[;9Q9RCZ&:=]H)Q&9O4QY;D\NW>'FRGM$2(F ZXI;XJ8N79]'I\
MAY:8#X1@.]62>"YRM#9,J1)@ !9E]W-<_:NLF%#UZ< 'PA>1RLVKK+F;7V=2
MZE4?C)G,?5^Q645\5(+R(BTGU[$,)JB89I@+;1!3&:W;I8V4SVB(%AC@>6"<
M)B8:]1OL;E[(]RJ:8)-6&F$?2=O>KUF5LB2%7O",?2=G.I='6Z:554%S70R(
M])V+4DPG;E7*J>6<N;(*7=:E18K=UP)/I//C!:QE.W_JEZ;4F$#WC;S8PVJ6
M>"8L2C*ICVW]*S@XVQ3);7D;1S[/4B9M8YE%+W8Y X#)7'U6=;G*$GTK ZSL
MYU"YNF"5(<UU@Y#I3/@]>V-)>1-?*OC<-EW,ET2;VWFZF !:Z("GW+GAL2]0
M+R($W\LU4Q:EI%6X7GTG;L@FVL8FFXZI+Q 6\B,DPS+V:CYD =X7ICZ-V6JS
MJ-5+EMFDV>[L6L1/2XTZ0XJU, NW2;G98GG2Z_5G%CH#4]1FFH)!-KG0M-T1
ML1N=;5CX?U#W@7QN;W[%CMPQBQW!0ZO(93MBZT-NC;B<U)5Q:V:;790G"#C?
MF%TZW*7K=NP:+790E [QN&.P)9Y<+UN6.MXCD,!)>;!F,0I]FO768I57Q3)#
M['F[[[;:KF89]>UOV;.G<6RVN^,B['*.U3VBWKVG"W,XTE-8!XCKARO4S%DM
MY:L[C>5&'B.Z2,AM64F62FXWDB/XQUNT;-JU.WAJ2M.MXNESC8\VC/;SJXGA
MF2QHR^*I(<-YY '[+:-JLN%];RN6E\4TK@S\83G;M6.W;PGI78%%KM-,$0[#
M,&]67_AN==?=O3=5D;A((NL[<U+6.TJ#FZHW?,"8<MJO62LXJ6H*Z2XMWC>=
MFS:KJ+.O:IFLU6FI9&]+=[T ;(<L%+77K.T4BKXH?,F%@+H1A?SK/#OTSC:3
MTN?]9(+C](7]"9R65VYHTF4& F%H!]"LYVDZVW#1XGU&524SK80CCSI=;;DL
M>AWFSQ6V6*H->X$/(^+,E67ZF+R]!^,N)IU143@Q[[21?MBKF+BJ!2SJZJFB
M&\8V6QM6>UB6W&G8^B:'5SRPN9>X"XYE)4F7>?"O",Q[V%TL'WV_16O"R;^S
MW)\O.$)32POELLW?HC9W*6X.TU,/<7AO0J*3*E1:RQ@NA&Y2]LI)C:W5-)1L
MDD-#18>Q28R3M8H]9)D-=,NA$X\X6\PS+6G3LHPXE\.L>M"VX07$=?14,ASI
M3A'=P(R"?^[';M]71FJ<1F<]S0XP@1?S[5+?+C;'7^ISS/C:;23?FL6Y2*T:
M-TTV9^B,5EVF/\IS3M#>]S7$7P4TZ3L[.T/1A+\,D"()Y8K':Y;D=L:5.GT3
M6F6/A,;%RU'7K/+LKAGC+4&54F5[T#.:W&Z*-[C]3OE1JIM;J]/-?$DSZ;\(
M*7'EK=?67\M[2WA21?\ T62?^(N7;AZ/@UWP]@ZHB+;<#ZER\OT'Q_P::JB
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M0VG&\X'WA W*]9EFV3E*Z]Q'P5Y<:(-=XWK:?2Z4,,QU15.;N-:QL7&!>V,
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M67+7LO'#>KN+VM+C<!:=H*MA>VGLCPLYDX28XM:3&R\16$F>7;#*>6)3"!>
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M,XRQO5#XP:+]FT[4SX/ZYG"[T_'\N:V#JAUV>/6I[>(7XHEI/%U,_P#YP?\
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M?X$+/;=>KX;I^C%"/YNSI[2F,QUZ\I47+/#K.&ZWX1RQ6*J+U=P%.1?85?\
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M4K?QS"1II+1#V9$9*LV6-I\IL#[.;)+,S#&\Y:+Y#2\]P[EF:TUG"3I&-:X
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M7.X_ 6M?7/GN.H.GNJ 2'&I+C,B#:"7VV%5S?<Q^K)7Z/_F]#^"Q8O+T=?\
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M,+=,!KF#Z0N7/-R3K*Q'4VL^DV'. K?N3KA'5.LL ?NS&@PL]X9G:H*_5:\
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M:B93.=232/&;]$YMV*99EWFOUP\D_*=DIDISJ28(.E&UL+@,PL^<E[6U^G7
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ME^_WR/?TO2?X"7^"%>O#L^M7Y5!_V1I/\$K.'J^"8?HS1_T>7SGM*QU>F_\
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M_07XH_U7I'[1G\C)6JY=>:IR*(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#/)OZ
M3V($WUCL1)PP(H@(" @(" @(" @(" @(" @(" @(" @(" @W-/\ Z=2_PK>T
M)Y/#TX^T::7>6M7##3YO^-W+O\;Q_D?Q_P /AE^9H0XCU$?\C._">O5>'YGG
MY:_)[C@$5TS]M,[5F0LLKKID=X=ZI,L55$XDW8\RWU.TS7.D?NF\W$>D]Z7&
M,MR6I$3!$7WK%VWNZ2-/-M;SQZ^A2_5B]+-_9/RZ@!@M'7E'8BXN'B95"!M&
M&([EJ.?:7+0FU7Q6Y8C9L6:DF6D^IM(CAF%G<K<ZX8#/Y<@M:J^N61KXQBF/
MHS>N.&=H)N6YJ;9G+A/!((CAGS+GWX>[XNJE:O[K71^]-W2N3TNH-:>+;_B<
MBR5U5JTPG>M-^0R*7$_5BRJ756[T;?>6?*(=T >6:U9E++VW&_2"):#FL=OL
MY]I;5NTT0<-N[V*R6[8[=:[)TF42&F%L<N[F5XOV8XX=K:++<"#L'J2E[3&'
M95%,+&MA&,/1;ZUB\N?ZI7ZT<SZ>Y;ZW$VS9]&Q*K(1[Q[%JW+$EG+<^N\M[
MVKF8<'5X].?M72;C/%S>&(U>_9ZP>]7K<5KF/+)\"!''& RV+O-QSNKB)"5-
M!$2<>6$$FN%^S9#P<?6F4Q?!XH-_9W*XCO+AJ3#EFL);,[1\Z:+;<^[)23_W
M=>O6>N8CB^+B(DVG/-;7;9E0L!&/J4P[29FDO(> ;(BTW<R8RD^Z69.W08''
ME>%,M29:-75#==;GB,SL2;=9,1U]K-4(3+1:,QE')2S-:QY=,:].WMZW!V.P
MY*\1KKIU1J1&]G\76%973MFS2JS"1,)&:ELSAX>_6YWROG#KB2R,?@]:F'/T
MM=]\-$?BOVO>K&+TN7=6DN@U@!AV7K63%6^75M8T GGM6?+I)9&*=JC6B <V
MT$W[.=,1C&;]D-/UEH)&^VWV[5<5KKUL0E5KC6".^V\]2EN#7"OS^(P(PF-N
M-D1D%GK9G9=(J=Q( /C;<<1WK5K.;4)5\40#H/9<<=O.G7!)CE5JWB:UQWVV
MC/VJSEG%56KXEB/C'PG':IO+?K9M5ZKB0F(WQ=GL.U6=:>ML0U1Q XM(WAU\
MZM,7"L56KO>3!U]MYY\UBW;?77+2_.DS/T__ #RK3"[49A M'I[U)IG%8?KT
MSD/_ )Y7]&N>6,U,PVVV[4]JU.W7AP,Z8;@8^GL3.8S=\ F32(Q=Z>Y9VQ=<
MO(E3)V!,>6Q/)+EX_-[XQW3U+6<-Z<FZ>^VP]2EF.&;OAOTVEN)M#LKN<9*^
MK73%66BT!TT@[CB(V6>Q3SA9=XKL#2.#C,W29;R/=P58[7Z.U='X%<-T^#,A
M!OT3ES*S[LS7+M31^" UTN,MWPC#9S*SE,XKN/1."Y8;+C+==&[('8N\QASO
M:7;L32.$Y;7,&X1 Y="6?\,VYFG9NF<.RI0;%OHYA@I9GAR\KM2:7*E0@,0<
M,$GTJVZ6&GIY;/>QAETX+6HXVIJ1-:R!B,!A@LQS[<;3$FN8UL(^GGR@MW[.
M68P55=O"PW[>?/G6<YCE\G/V:LJ=%T2>6."EOAPO;&HEY)WKN5JDS.7+MM*2
M91)NV=%BUCR\W:<-UM)&%FVX\Z9SICUN<^&PRC)PQR2Z9[:;3:: NQC<?65(
MX=JQ3F[C3ZD=?BG[D,)I\2&9AAES*VS&GTNLTFJ7WH>OI"SSRUPDW2HM-V&)
MS5GTJYMC3G2!NQ $>O [5+I9C#2;()^X5+6+B?JF**48@0P[UKK,[2VS7A<*
M.G^'F':=JGLB?;3^Z+,!=$X':IC.V;UL0M?0.<TV9X;8X\Z>4DS51G:>\/%F
M(]:)K.$MIDETIPLAUY@>I,LWKEV#1SW, M,(#';S*RYF/)ZV-;5]2W)#A$6#
M,G#G3A/66;Y>O?%FK./UCWQ?F=NU6\.?K8])_.#5B9%4-X&,IW*]1[?Q/Y/S
M)X^KBZKFG8[$YG:KP^[+GJZ$JIIF38?LH>F&2EN3M<1W'Y>T1GSFV'][-@S*
MG#D_3'R;T,.?3>X[\E+-Q_8GUJRY2YY?JAY5Z(QLJB.Y]!N'[$)@SI[BZ)0"
M53RK+( F(^YDKASYKCJT@;K[!<=N!PBDLK-F'6=;IIF/C VDW9>E+ABY>*?2
M+![KNK8-BD3*2;I8#8;INV9<RUC/#./+!-TW=%@,=O1L6<65GMVG$0E51N;O
M68PQRYUKAB3-1#Z1SL,3GWJYEGW;QAK?FQYO!ZN^*QY2VK/HND/+P=UUI'H,
M<E3V6Z;I[Y;2"#=C&,,K((O.U:JY$P&P'XCLL@AP@YDJ:#&!N348MR29DV6X
M&WLR5RUUUI;=,U&:'2QO7$9XD%)9=>71W-PY6%_A1.(%^W:EFF^8[ITZ7+FR
M021<!AVVP6+&I]'BNTJ14M+2(B!%P-_0%>N,NG627+J'BCRUI-2EN'A.<2'0
M ;'/8MX.:]+_ #.\B*:;+GGZI-)<\G\GA;L@IVE\<->V-/S;\VO(9LKZZ64<
MX>\?WOF&6U9D:C\[^/\ R?G4L^JA2SP&@_0/=M5A.^'K!KG ]313)GXF:( W
ML.1&2N&^O:*!/HIU(\$M=8Z(C&X(=N5UX9U^HHWMW3ND$8G"W-8[M]<<O:C@
MKS'J*5S-Z:T;H9>\PL,,UPVG:6W3WK\L_.5TGZN#52A&6T6S(6P;^RV*REZY
M>]O 7GA++*8.JY'P']]&S:KICTKVGX9\Y*>H9)!JI!B?\H,>E-1CM*[ITKCV
MDK6-_'R23^R'?M3.G+%7.FU&16@ /8<H'.U+,N7KBMUU)++=X0MML%BS-7:W
MKK[M=TLV@<WJ6L_1PLN6+ZM,=@<KE;6>_2L;J2:(6>A(X]=,#I+F6.!ZN=8]
M5[]<QB\,8INN4^*LLN5+,(@6Q[>=.*G;X^TK9;1R3[T/0.Z*9V3I5EH7RI$L
M 0[-JK4EE:U=/;,MCEEL3)V_]E=FEI<>?+G4RG6RO,H@.M3&5[<)^E>V B<?
M7[%UEGEG%Y2XJ6!L 1Z,^;)8]<W?"[L<'50 -HCSCN3$AQ5?U&;O,-IN*C=X
MRZ,XNM$P_LCV.6Y_'#/,>N&OF,U_[;_&6#JQZ P.GL)^^2:IVSP]E.#6B$NP
M?$W#:NELPY65WWIA$&@W6>A8Y_1J=L3'E+3BS=LA=ZBKF0QVJ(W2)HLLBL^7
M236$S+G!D@MV0PS@N_7&,^6>TVINJS&Q>8XG+-;S'/T[5 RJA@F-B<5CCAKK
MT[>5PTJMEL#;1&.8R"N<Z=?2\K[2UK2VPWPY7*8K<ZVM]LUTP"$;?NK6L-=?
MCVS,DS'YVK#T>OHG*"7X4-_LY!:F8;[72Q,U>FI&@O>QN[ >\0,0K>"]++E&
M:EQ[I]#(F1J) @'$Q>V[K69?#K\<N7JIYH^=5!32*H,JZ8$4[X?C&X!QS4\N
M^,\/Q[\^O/UHG3Q+JY'P30(3!^R_9+IUX2=>V7Y/^9'G;5U<V:&5+' OFPA,
MS_X27Z-V5ZHZ[QO7:CXD7QB\DP<3?9FI?HW)BNM9S*K4)^\X..\XDPB<8^M1
MJRYR[.X4X4G5CY ,J88VF )SV6*5F]H]P/+/RR-3/I"Z1,MG#Z$<0;X)+AGE
M^G_DYY1L:VF)IYGY64?@RW3][!+A+CA^F_ESP VBDLA*<+&'X899A;ZX9>T>
MF:1,II3"W>'N@;+K%,R:&Y-=/EB!+MF5\$N$]D;,GSQ?''/$+GC/9FW6D345
M$QA),<<=I6IJ8<^6D:Q[[,DQAGVK7F[[XW]?,K&9V^J,FT[C&PWC#/IVJ7:7
M%:IIK8D=O?!7PQF9;5/(8"(@6'+GVJ-6R19*0,&Z3"RQ7ASMWKANSYS)<LF(
ML&S +5:]IA6*C5F;[F@MA9C;?SQ6<?5Y[4=,GMG78Q/08)+$D\M3P6N)L&>/
M>M^TLPO#&^4&7 7=O6DL9N]H6LF[@-^7KVY*6Y84+5ISW;V[GG##F"SEN3+K
M^N,U[G@QMPPN&/0KG6DN<[0S-.F39HBTPC@,STIEK5Y=D\-:<9)EF!'OX]',
MK#4F7L)H+V2V ']CLP*GDECL^@K)8 $1<,L>B*EN6KBMZ?62]PVC;=LV*&)A
MU9Q7/EOD3H$>C/VJN>^'IOY@2VS'5,!&_ WQ*U=M6O62OD/E53G $6DX[88G
M%9Q8S;%JX;K9DN:QI($'-O/,,QDD)I[-<):H0 '%N'*_:KG:=OL[\TS46O:V
MT?"+CL'.M0D2-14!XA&\9Y0V)?LWC_A 54P@DC&,.HK%N;A,9VC'/)Y!+,&?
M%>6.,1:;-O1ZU;-+[1+LJ=Q@MN&8CV+/7M(NJUWUL7WXY[5TPS[3AM4]>0;Q
M>,8W0VK':8J]:G&ZC[HM;C>-IVJ--2HJR]I OV%:ZN?:9[(-Y+G$DQO[4JX^
MG#)(^+ED5)GPU-1L3*ETH$1."8O)?JU_K;WV&/6F64O0N<2(G+L"N+=LVZ69
MH'AP@+BLVR5OK=*%Q-2-FRIL,8W"VVS&*WUWH_CIZN\8:(Z9,G$-=<>T[,BI
MWTS9B6QT=7:7-IYI]TPM-O.>;),Z9WG*4X>J#)J #]^!:8)/NZ^TQA[,Z%52
MG48#H$P&67-M4YNDU6Q5F6XQ$+(GMR3AFYD0,^4QPN%MO8,U;EB7>%:K:4NW
MH#';W[%F^6U.K]+=,WO=<2<KL=FQ.NN3-5Z9P\\F.X^_ =RU>V5QEDD\/S06
MD,?C@<.A9:FHN&E:6Z3"((M%_1WJYUA/66K=+8V7#F&>'24E3M](DI<UD+\=
MG>JQUGA)TU8UCA$C9;S#)3+4E\KCIVH-&[;Z2K-I?HM<NM8]D(BT#UXJ^O;.
M?"XLB-K&,GQ%EQ[RE/;PZ9X[T5LVB?!I/NON&8V<R>LL3->BW%O#KV5,U[6.
M \5UP.9CL4S(Z2.OB)M',-XA =40M:L8S<XO"]<-ZK,\26W>'T?1;GL6,6;\
M-ZKV-X9KC-9*WB#S'G]05QF)G&G94N7XLN('HML@>?%/6\)QM'U=$X@P&!SS
MY\DG7"YG9 /I7!YL,8[<>E+M/*RZ?3'P_>%O5ZUE>(D#3V1A='E>G!RT9LFV
M$!CW)X.TRC9THX9FX;4C&++A$3I!=AVY<XR6K'37JC9U(;?=RPV<Z3;$N.4>
M^A?$V=O?DM\+<W?@E2'271(.:EOAG*594P &6T>L+&,7"R92M)4B+8G$8C+F
M3M*7K]5LI:H;OQ#'$9C8G6X/5EJ*P;CO>O&?L*O:RW2S5VZMXA>)A,#&QWIB
MIX:=*ZS3[SG68FX':<%DYVI@I#XWPXY'O6^G+?\ TKUI$J8UK8 W#9S]B]O6
M.6,Q:96^(7V$>I:RYYVEI,UX&-PY9IC+73-C8^M.&?65G?"7KAQ-63GZ4Q>6
MNO7?MX<I<]SC>>4-FU:D^KIB-UAN)S]BE8[/$Z1XPNV>A:9EF,5PEZ8""=TW
M[.Y9LLX6V15.(J(2Y,ZRS=QZ>9,YY29EV]7>+VPF/YG!2S/!<^754J7O3Q8/
MB]:Z2:3VUAW9PA0-F;L1@R$!GUJ<.DQC%>Q&C::QDF62#\ ]6Q9J=I/"5JI3
M&2X >I9\5.O*JS9<)A@+XX[3FO)V_EMZI)(D*:5O@6#'GL^ZGA,_1N5% V;+
M<'-LW2+-HZ5FTFMNG>,>'Y;Y;X,/P.N'+%8S4OV>H7&>A>%OD,</?,8#GYUH
MZRQU+3A])4&,?=.-EQ5RU9F.V>&N(S3F4"\" A?#'GR6N7.9COC0N*A,9+&^
MV\?2B<%+&^'8E%K8F-;[[8DYYV!19_Z+')K6O$(CKYRKEF]=Y\,%0YKXD<K2
M47C]%3U*1'>,!C<-J)S<J/5RW NLQYL1W(8UE%.OZ%*O7AOT;MTB^\=B5)<5
M9Y4T%@M*UC#T]9B,4UN^3RL@F(EE:3Y-IA!6S$RDM:4^GC@,.5ZQ[*KU72F!
ML[>])V7A7ZBE(<XP-A.!Y\]BEV2X1[V%I@!#I]J,I"G-@C''TQ@M==TY;8='
M-:NMKN/!M6,[R3EP+596L9F7#=L6L>:S.N'EC3;'9?TJ=K%N(S" P'4N=RDQ
MY1>H-+@Z&7J5B55VQ9-MSA9SA:Q6<;35-.@ 8Y7_ /!.(6;IN;X;AJ&F\CK]
MB?:)C#2J'M<TP-_J@K-<NDW5?J6[Q==:3V05N/#7ZH:;+$;87GE@K+,&<(N:
M(79X<MJEKIULL0E2\YFX\RFW3IB;J*>XF-IY%2NW:S&FL1%VVY)PS,X9&L,<
M+PK+AOK,MD2P<NE,XX=9TD>'RK,+_45<TQ$7.E&/2;AS+.5S.'B7+A>!TA<?
MEN8UTSG",K&@.-@O&'.O+/HZXQ=KUP*/Y^/^!VA:];AW^/#]_?D=;&JTDV?D
M)?X(2?MU7;$D?6O\J@_[(TB,/R7>I;]'?X*_1F@;_-V1S/:L=,NGR7C#>-ZM
MY;Z_Q;C?A'+%<JVB]6E[U.2, >]7.L++74M4?QQ_;'M"GAUG#DHR(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#-(_*-04WSK_N_J/X"
M=_(N5Z\IW_B^+O[05P;6:U;_ /5"I/\ QYB]$KY/RZ[/EF^8"HCJ&K?PQ[1L
M6JX]YEZ3L]^M=#%P'64<K+Y=H:/0ES)1 RPV]*=,VZ<>^9,5W7PO0EKI9(^F
M,.9>N9]7EL>S7#$OPV-_X/HZUN:9W79TI[0QMN"RZRZ1M:\.:;NN.2TYV7PJ
M%3*WW.L'*/,EF-I+XJ)?2[T+/1]U,)Y'4+6LC"Z%^SH&2&T)- EO(ZH*-R?5
ML2)@AC=W*LW5TW#6EC(8^U7&LIR@ZS49@#H' 9\L%EN3:MSM1FN>1O61,;]F
M94;U6217%SF@YCLZL%*SKPL=',#FQCRM6IPQ;E@U"J\(&!'7L2K+C7E6CJ+X
MWCK_ /GDFTN]AU!Y!!,>@]%L5K"2_5JS:LFS9F5G#68U/'<;^T=RK+9E..\T
MY6X*5TZXPGZ1[H-Z<NY,GKC:;:X[HB>4437+&]X(()N&/+:DJ6YX:$QA<"1=
ML&W+H4R2[PQ,86G'JAFEF5M3=#4;CFVW67PQSZ5IA:J;4=R6 "(XQ,?7M0DR
MU:ZL=-:^V\&[F*%F'7.KL?,<81-A1=XRILV4YKC$9=GL7+MJ$VUP'>(",]F2
MQB87<TO.AS' LYAEB.;8LYDN&W9E+4?B;\/5S+7"?JA-1G$[U^.7<F8[=9/\
M*Z9IWCSG+N57UCG,FN\/HV9'8HWC$:#)SC,Z3EG#+:B;28<\",3Z%J868_RP
M/J'W1/7[$N)MTZHNH>7 F.?85FW9<Q6JP&#K,!CSJ3MFM3M(I.J32S>YA'GM
MV%:N:M[9X=8:S4.%L3#=./L4QAJ.L=1F[X)C;$\KE+:UC64$QGB/@1&U3#P_
M-VWM<-&TYSGRXBPP-G1G%:XCS^WT=T\/:4/Q-ANV9\RG-)?J[RT/36-8PP-A
M]F25B\NQ:.G8QH'JV0S&27;5G[=)9LEKH771QV;4PL[#Y @1C9GWHO*PZ(UK
M)K8PPY6JLW/-6C4YTKZN!$6 66(CJK5YC2Y]O*&R*-2Z51S@;CGFA-UL26..
M&$,,_8B<TFRG&/-@(X*79VF)I"5,F9$PC:3GM"8)<<HTLF-.-G/]Q63;6<MV
M3,L@2<.5BZ]<R8&Y&.*7+&XX%A-XCU+3;1G4A=$@97@[-JE2S*/=1&)B,<ON
MK4K'KAY91D.&4<C[$IBWA(2Z6T0&.1"D^[4OKRL>GTT +,,CWHLN6U4R/=N-
MQP/?L59MS4%/IHF,/0<.G:LR+-3?#7\)PL&'+-,K[9Y9Y<IQ Z=N>2LVGLSB
MF<0+#U'/G3%_PF?HSLIWM%V.V[TIE;UMF6Y+!:,K46<_9N,>VVW+UH73;ES6
M1/-L5<_+(Z8T@B/9GL**T:AP+;\O1%"2J_4L!%PO)ZXJ-6Y5JI;? 9]H2TFN
M4-,)$WI"OABXNU]X=(@T<W:LXN6L5=R1NCHPV)O)/NXN> -J.F<S$1=5.A&W
MD"=BN6/3'*J5TV)-]I*MX3-MTJM1O.) CC=M,<%)]RRM!TJ8XXW;54S7.3+F
M,<";+0L]L"UZ?4C\6TGZ0Q&?,N-ERS>78FDS6&%WT?6G#/K<97FF>R&%VS()
M,\I,Y<Y\Z6T8=F(RBM6M*U6531&T7[,^93,PGK;=("?5M+C C'$=RQFY:]<3
M'EK.G!S2(CK]BU*QN<H*K9O.):.H))]6YMKMEN#;N44U+GPMFF":QQC9EDK>
M-,R2M!U-$W7[#WK._)>MY<Y=$Z,0W&%WMVI+/*3,Y3=))+8 BX >GG5U6IUE
M3DEIZMWT7I<0LPD&PPOA:LW_ -#&'";,(:1;R"LGDD1<V>]N]:>O;S+688:+
MZL[Q'?ES*F:\-J7$WF$1RN6;A94G(GQ(MQ;EAT;5>)EGRFJ>JW-TQN()M&04
MS+"Q(S*\&46Q'PPOV0OYUGRJGU4TS)IM]L>@+75J<-REE$@1%WJ@%=9REZY3
M#*3>:##T1QZ2F9PS8P3]-81<8FV[*&Q),%0%9IK(N]UUYP&12M=4$^@W2;+(
MF%D<>9+8EF'%M/NX>@^LK.*G::VVV2A 1 NVI>69*S;S9<,('E?S*RQK?'E,
M4%?+;B+(;,@JWZVQ>:*LE3&,M%PRZ4_5B2\URJVRGM-Q]ACZDNH*572F%Q]T
M<BL0LRUJ9C0ZT"%F>:UU[-3C7*RS'2VTXA"[E>M6Z9ZRYVI<^L(FN;'$"]<Y
M=M7K^[*9H'^(8[ M9\)VB]:=):=TG$#LY\UCA)B[6Z3+EA@NPP(VYK4BQRG-
ME[AA"X^I6:.5=JH#>P'O%6L]M15JFIW70!SV8\RFS&9KEPE.$X6VVVVYJ))B
M[;/U4.@1CL'-SJ-O#J$QB!AE#/F5G7649Y)=)(O$#W=RE9Q?"Q46H.EPB1GR
MN73MN-2:3+M1#V$$B)'+-8LT8Q51U1[71,<.\X+4XV<J9X8,R-E_L4_1K$D2
M)$&P&2D^[GS6DZ.\M5UDQ,-F1,MMP(]2SVN.&;)-M_Q(71]"3-3$\L+XNZ\<
MEK.)L<&2RYP'-VCF35V)273>X+.4!^R01\^60^P9^@K.$C;D,="$+^\IC;3+
M,E.W#9Z#D5JX(AIU*7FP8Y':ETO6X)$B#@(99Y\^U<[GPSVVL5-+(R@#W+?7
M.$DPD-V(P5LS#.W)M()F'5?U]"DTJ(U2A\,%P!Q-HV15S+,-2R*PT$3!A;Z(
MK-D3-7;0QO;O[;UB"DR3[.QJ9K0TD@7##8M79VZW&4=7S UU^&W:4K774_RI
M]5/B\@8$\KE.LQ?LG;%N:\2F%PC8MR[QX22_X; (:(%=YA.\PK^JS V5,YCV
M0]:)'3.L3P)SR,_7M"8E:N6AI-0/K SWQB%<8FC]>'<VBU$ #&R Q&?,I$O_
M *+NVM'A@1^CF/N+-G[DQY9)-8 8DXYC;WK6&I=83]%4,FP]/6,K4R6>4FYK
M2 88[423>*TIX;!P($(F'6%FK9XBKULAKR8 8]G.M1-\*W.H@38+>;:5FYIZ
MV$FF\-UHRS&,5)U-YPLE'/;+<(6 0C</1T+4RU(L U,,EP#FV YWP*7[F)$-
M4:D7.M((NZNE<>USP3MA#U57OQAM%^R&W%9O"^RKU;W.QSRQZ%C*RRW:- .\
M#M]:WGP9F4K2M)(YAR]*74)9&Y,D%\+/0>C%2.EL\(:HT_?,2+]FQ,99[=I-
MM>72&68@80%GW$NCWB3DN,L6QZ$RQ;,Y97S208$^A9Q,NT^2>6A-&_''GYO:
MMXKCVO[M-)U/:3#;CESJ7G#4[:997N7YCM5PE[1NLJ-VS"/+!2RYTD[;VX5%
M9NL,"(PS^XK%[=I>$?3:B]TV!-D=IO)VIVF/^4YU%NIJEQ;><.SF4D3&.6_]
M<<T"VZ%_5L5MPEW^C9IM0),"19MSCMVIC.TU_A8J:HWQ>+=HPCWIN:,:TRSI
MC0R_E I)ESMN58JJD,F QLCF,XJVX;YB6H=1E[C8D1YQMS!4G7-:2?UYF?9W
M)J7[HY?6FD$Q%QR[E;?!B6M2=41%AP&(SYE+?#5B"J9N^UPMSZ@L\(@WRG%Q
M.>R*MMKGBL4NFF1/-DETN*DJ64YA,>S.*U.%D^K2U2:&-=;@<ALQYU<X8LF<
MJ'4:F6.L($'0..)V[5+8DMSA)Z?KKA#WQ]Q<O+I)BK=3ZQ,>P0<+H]JT9GJX
MSJQTT6FW'TPOC<KOPYSMAJRY+IKQ&Z.1/,MQ?;*?IZ$AD88##:2F8LY:5=/,
MF+8W B_)6<'-Q% U$F<3C'ELR7.]LW,62M"DTL3YEK28P(LR5R6_M7S3N&6.
MW26&X?1Z<E,V,2K,SAUC&CW#9LV+<LPO;[-J5I[)4(-((]0AL6?*6Z3M(S=R
MY1[E+?"S,C?>"08;.U=9ICO+7AC#8+(VK5XRQ)9?LY/:6B-BBV9K1?4N8;#A
MWY!6<;7#*RN=:(Y8^U26YPQMN?6M_FYXW]:W#"'KG;S3 G'O]:MF5F+I5F!P
MGQMM.?+)+I,6+C0SVEMI$2W,9]"Q<))EFJ6"8W.'+8M=<29I.5;G4@WG67QP
M]:GZ-7?#8HJ(;PYQAL2:Y3]4G4TS=PP C;AS;5KDD^JJ:A*#;(#Z7*\K-C6,
MS*+E Q$++^V"25F9DVN6GSH 7W9#N5Y=NO739J9Q/5V0V(Z]>L]=\H:8YV]?
M@JSY<Y).]:>40I4O*58T.%PC 8;%,$URV&R(W@0ARQ4^YSPR-IV Q@.KVJV7
M!)43JLAKI3H 1N]'.LYPE=>.IW":1 PCD>_-:FYE/.%CTZ3NEMF68[2F5W'8
M6D^Z)9/*!2X\+ROU(]NX+1<?4I.V*N6R^8W=)C@>Q:[W)G/"O5DP"V.'8L8U
MA,_56:JLW01C$B_N6YAKE"?7W[]XY#G5_1=2++I]87@ G#EFLL7$NDZY^^PB
MVT6121K&E<K91WG$"^%VTJX8]=H;=+3$V*7Z+.6Q*F/!; F_9FDW,&_9N[KW
MB-\?NX+4GA:-HW/(<1B,.62LZXY9X>)]'!MV&1QBF,-==J[6R"(P%L";CGTX
M%,*B#*?EV]RS6>S/*EN$.8]L<4DRF&_):6[I/*V*B-DS]W&ZW+U(9S7"97EK
M#:+C>8^O:G%PU.N*BW:B"X@D7I=O5\?:S&4O0U,F()(O%\$X=[VEB>.ITLB6
M27,NQ(A9?8EN7.]E$XBXGD,ED-F,L:XP!&$.U:DS&YVF'K]Q!Q:0YQ:]OTH0
M=S^M0S,9=957%LXO<-\?$<>8>I1S]D-4:Y/J?I7P%YZ<4RZ2RS2JZEX\\V;U
MIY;;5>87M,Z:M'ID^=,$6NM,+C'UJ3/DL^B^Z5PHZ<6DRW7C#,]R<W%9N79V
MD<$,?NDRG1BW#$]"MGTX3QAVKH_ DB C*=]' 9902:;CL6CX.I94L RC'= C
M ;,@$,^&V[ANGDC>W/\ BCVIP>WA ZAID@AS0V\W<N9,YC'>JC4\-2IKR[<,
M#LSO7GPX>WT*?A"3&)E'##:1DI4]XM^F\'2(M/AF$0;AG'))IF]MZ=@:;PK(
M80-PX0LR]JMVL[2?JN=/PO(@(LL@/HCO4AVLL;+^&*<0@S/Z(V+76,3MAJ'A
MV0+V_P#%'<KA?9@F<.22/AQR%UNQ9Y;G:(UW"].XF+(C+=&2N%S&Q+X/I2+9
M>&7L4NT[=FCJ'!5&Z63X9O\ O1ES9J28K/MX=:ZCY?TTR83X1O)^';S*XBR_
M\L%/Y:R"X'P3_@Y159SO*3?Y=2&R_P B8@0^'9#)2Z;]L3:GZQP3(DLF?BB(
M FUHV[%<Z:^+M^YT+Q?HTJB;-+6VAAV6P[U-5]&8O7#U7XKK'T[S X'//9S*
M8_X2]L.K':@^:\@F-MEISAZU.%ZW,6#3Z/ZQ"R,8&R^P9K6:Q:M4CAY\S=W6
M.M -V:S=$LQM8Z/A6I<6 2IEN33=?DM=:Q;+=+OIW!4^8/>E3#$0^$]R6XK-
MNL1+RO+VK<\;LB=",;&G/F6L3&N7*VKUI?EY4 -WI$W_  7=RY_^ZV23*\R>
M '-EC>DOZCLV*_\ NYS&<H>OX$FAI+9,S_!VQNADM7K9$O:>%(KN#ZJ67;LJ
M98[[T]/:N6&+9EI2>&JIK[9<P6Y'!)%LQ,K5IW#CG?&QVV(R6F)%C9IK=/:'
M!I$(&W./M73I]W#YL6:9F<0"G)!>!LB1D%TNWADWAV-PWQ(V:?C%I:+XC:LV
M8=>N+7<VFZHUP$7-N!L/-MR*RWN7:QRIS9P!!%MW1Z5S[7%>SX^$K2,@YKK,
M]MH"S7HZYTOVB:@)+Y0#@/?%YPL&Q8KT=7L1PEK&^)7O")>P7[88%3+I>M?H
M#\M\WQ>()+H_\YI_2\=RS<.O6:?5+\N/^RLC_-9/\FL=N'I^#E[ 5/Q-_:^M
M<Z^MUX:R-" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
MM/!X_P"T*H_]&=_*R0DY.U_;A\4_ZS5Q954S-6T@.!DOG5K"W>(^^%P,,5F\
MNO3_ ./#^?-P#ILK5_,#2]-F-!EU6J/E%M]AFNLZ@M7APZ_R?U4_U='ROTG@
M?R+I:NED^%45&BRW#W&B/B!@=; &UI*G66-?)K#Z#-<J9DW4ZV2XQERYS@T9
M0L*U4DQ,HA11!P?=T^HH*S\Q3W,^7[B-S3!PTJP_^PJ$\)/Y/Y"WVO\ .F3?
MF#UPS';Q'$&I0MC]*?C!3JW\OA[0?8._WW\-?VR?]**5.C^L)PC;Y5\'#/3M
M*[2M.?ET'\\?%-1PAY(\4U5&_P -[N'M09'>(L;3S<1!-UOI,U_'0^T<XLK.
M+/F@XUJJQ^^Z343MT[Q/Y6LJ8WD_Y-3&&>TQVP_2O[#[YF/*WY6/.G3O,#CM
MM%]5DU%#.>:GPPW\3-#B8OV!9LLVW.TNIR^[VO\ UB_Y1)&Y]6JZ&9O6_C-4
M8?=LA\);"(*U+*Q>G;PBO_LCCY4_\MI6S_M$_P#O5,M>CQ_]D<?*G_EM*_\
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M 0$! 0$! 0$! 0$! 0$&YI_].I?X5O:%%\/3O[1?^[:L_L^9_CKT?&\/Y/\
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MT5_,>Q2CI^J_+._;GU*^';PYJ,B @(" @(" @(" @(" @(" @(" @(" @("
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M4 WY9(N RR3/AYZ[NT&A;NRB&W#+:>Y)B+7:FG-$MK1D;?0EE8E_Y6.34,;
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MH:"(%P$-EBF)6%UIY@FL!B#8%<^##Q-ELA&&!RRYD."GW6G 0[P4&6I<SPS
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M=SS3>\#^-9B<P1BL;K<M]OL_4+Y7)YFZY(,;ZBG/_&]JN,<O1UV^KSY<'?\
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M&O[9/^E%*G1_6$X0_NKX-_L[2OPBKX8G\GJ']I2R9,\A.)?#!/\ V%J=T?\
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MJ](_:,_D9*U7+KS5.11 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M)>8%7(F2-Z9,$'#Z9P]BS=<,=X]P. /-N9*^KM=-F6/9^^9$;<DGW9LKWMX
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MW1_,3P#H_%!D?FS4=9DR9PG[NX=^>"8[UA]U++:2XGW?UF/)3Y(OEIX_\G>
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MD^PS]62OT?\ S>A_!8I>6^O_ ,;^@OQ1_JO2/VC/Y&2M5RZ\U3D40$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$!!N:?_3J7^%;VA)R>'IO]HVX#RUK(_\ =TW_ !EUZ\//\FY7
MPN_,^\_I'J,/\E.NYWKVS75^=MQ\U?DMQP^-<;1\3^T+&,+VMMTZT;,(=>,>
MPK1F<>6G63H&$1=AT#:I9DQM@IYEA,18>9)JK;.&P9T<;MGL523#;DS(B\7)
M;ABW-TV(J>U',6P4G+<X;$IA.!Q6LX2S*1EL@!?>IFUF2R[;$#D59,<-YC+$
M8027ZLV8X<_$($;(+&<-=9)$3J-0 UPB+CV\RSVM>GXKO3JO7*J&];]$XG;L
M6,O?)F.E==J@=XDXNQ.7,4NXS9<NMJJIM=;CZQ^Q6,(C#,#C>JQ626(N'1VA
M;O#.,K#1,+@P0/*Q1FRQ=='EACFG'>'IAM26Y<Z[KT.>&RVQ(%T?3L*7ECM,
MU=::I$! X=VQ3]6,1(B?C'EU*<.=[8<OK A>.70F6.VW*7.C&[EU)AF9C8?-
MLLA?WJXI,QJS71$;+2F$[=GF4XV761Y>E;ZKUF8S.F6&T7+J68OV:YFPQ5R6
MQK3)\ +<#B>Y,X61K&J&)ATGN4NN'23#@:D$0CZ_4K3KFW;"9UI,;SFF':33
ME+G>\+?7ZE<XBX24N= -,?5ZEC.=-SLR_60/I>D]RLF&_9&5E6 WXL1B<AL5
MG734TI.K5L-^!PA?^Q6>N^6NLRZVU:O(W[<#CLYUN=9*WC$46MJR[' XGVJ6
MZ.J",X1-L>>*QG,=&:1/@Z_+';E"*O6N/R;OV7'3:X,<VTW8'FS6X\_:?1=J
M35 &MB2.K,;4,3P5>L@-=[YQQV[#L3A/7/*AZGKI<7@/=<1Z$S$Q8I]3JA>?
MB=TGVK-^SKUQ)FM>74&81[U_/GU*2TFZR3 X@FW#M!Q2IVYTCG2R8GEVJSM4
MN*X"43=V>U7V9Q6S)I7/< 0;2,-G2L^V6Y)(FJ72W&%@R]62;\LW:UT6B.>!
M[H-HV^A63ZM3A:J/AQSH>X,<!A=V+6,)I9*;A0EWPBX'X2H7A;:/AC=:T>&#
M 7[NSH3>7D[7%OZI^FX6^$[C;AAM"G#A9;:LU%PL;/Q;+Q]'8I6XL]'PI$"+
M&7_>[0KMK"U4O"+8?DY=[?H#8IM,>4[3\'ML/A,_P-@/:D$DS@]I A*9&WZ'
M.MZAF\-*MX6$MA/AM',V& 3,X1 CA^)(#&F&S:ICZI,M"MX>W6N]P=6TI(WQ
MPIE;I9DO^$"&SV04[7Z,VE%,\)PNL,-N/.I)]5YCN'AS46M%I,;,?:KXTN;A
MW)I>J,W 8GX6X]>*S<IE8Y6JM= ;QQN([\UOJSVFLMZ74[[08X;5TG;#R=^6
M-\\DV&Z.)]BTSUOU9)=1:!'"%Y%P]BLB6Y2D@EQ!OM LYXK,NT[9D6*DEEQA
M;=LYMF2WC#.;C-6FDI]F [L2I9EB]MK'(H YH,+8QN]FQ23ZN?;/AJUE*6DV
M6 G"%PCLS6LN5RT9;-TF^['[BEX1*4[@TBWE:<$<.W*S4E3" C9$9CU)+BKK
M'W6*GJX-%MEN)R![43#<%2"(QOVGN5<[C.$74U( -N6)Q',JQ?LTI-0'/ B#
M=B<QL6:>N]+-3$;HZ8>A'><)>2X B$.0*LF28\IRG<#UCTP4M\+(EY$L. SZ
M\!GM*C6-Y;7U>RX=0[U/+6)C+Q]7V#J'>NGK&6-DK=<"(X99K-:]9.4O(G>&
MV$<CZ.92+IE=5]N93#4DFW.54!^(OV[-BN%N/'*?H6!Q&-G+L5OT8]<UGKZ8
MF3\-D<HX'&*D=)UD>M?F/+\*GJ3"YY] //DBOS7\V=1\!]<-YPA$V%7.#]7H
M'QIKGB3YS=]QL.//S+7,7KRZ:GS?'FB)O/3FL/5UN([:X"TSQZAE@,9C+QCV
M8JVWEFV_X?J)Y)\,![97XMEK)9M;S*=;A,[?IWY?<-B5*IX,;^28;H8!+<UG
MM;E[':91>#*EV0]T"P<V-BMZDURDIT\L8[8,R,(*<1CO-J?4ZA"=:3?Z^=)<
M)VNEBT_4F[D-XW9IGRS:D#J.UT-G?%,YY3QEB?7A]D3TF"LD<[WKC]:Y6]R7
M5TQ>VJY"H'*/<F7.=JW94T"/++9L4N6Y<I234-Q(N'9S;5>OTJ]NWB,KZ\,Q
MR%A]5BMQ4\;:KJ[?)M-NWGRCFL=HSG.D=5S2X6;3UCF"=9@SK"J5<XMCRQYB
MM=N4D11G.+H<R?9VZV82=-++BTC$^H;0I)]4SE:J6D.Z#SYQNVE:F)73JG*6
MG>'"PVD8<^U6ZKIQ5UT]Q8P#F'4"N=7GE>-.F/+1?<!B<$G+4S*M$IS@W'"_
MF4[3+K<UAJ8>&;L;TDR3'EU_JM.R>9C2T6[++1:M<K,>'4'$/!4K4O$A)EN+
M@X6M!OMR3A<X=*:[Y(&NWBVCDGW2/R8-_P#P4EEYY9O:Y>NW&7RUSYC'%M#)
MM#C^2_\ G8+';3U?%]WIIQ[\N-3(;,_F4H6S+I>TV_##!<K,\/1G%>A_F/Y)
M5=&^?_-I8 F.NE[?VJN-';%>IG$7ES4T<R=^+ W2; TC+8,TF8=9]77TS3:C
M39F(W;;++5+4FT[I'%,[3IDN,V8(/M@XB$+L5>1WIPSYL.I0P&IG#WFV!Y[]
MBN;PY]NKV,X3\]Q3O:XUDX0W#^4//G'!3%3K+P]J>%?F.DM8QIK9_P +?WRR
MZ&+E,-8^KV1X0^8B3,?*'UR;#=;?,AEDXIE,1[2\+^><BH;( JIAB/\ *;/V
MVQ22^4[=9'>>C^9TBNEROQSSO$ Q?'9G<I;BX<_7-V[%TS7Y5:1!Q,2+SGTK
M4)UF<.R-(D"JA  Q<WF4]=M^NG8]%P^Z8P?BQ:!'I'L6M99[2290NK\-%KXA
M@O.'-FI8^?\ )CM:J$_07L).Y=L5ED<+-HB?ICA@VR/HCL2KPC_J9%F5EQ[E
M+GRQAL2Z.[]KES;%$MTE95#!L;.@;24F'2;Y;C*8P%AN.&72MZX9[1":NTRI
M9=^V%NR,%,3*8UAZ[\9U <9MOTW9YN6N(DZ^KU\U::73GD'%WKV+/EUEUA8.
M%8NG2HXD<O0KV<;<VX>UO!U/%DO+>;VPS4LU]VNGW=TTE-!M@RRRYUB9KI,>
M$E+D$D6&SU&&:OK<X9O\D_3T^ZT660&6W:M2XTLG[F*JF2V-(B.M=>NH^C\,
MRHFJN#FS(0@2>U:N+IWRZTK9+73288\NU$[=)?U2&AT._/9 ?3& V%6DZ^'L
MOPG1-ERFDMN@>5JF,;76<+%K^J2M/I"YWN^X[$8-CF,2KGP>L>CWFMYQR-(E
MSA]8F-#7O%DR%P.W""F(S9/#\O\ S;^9&0SZXP5LX0F._?<B1]^KUOBMS6GY
MB>;OGJW475K&5<X[W_*$X#;?$*=OLW)E^?W&O%D_6*B=NS9CM^RUQ,1UIPDT
MZSI=&GULUKC$QA?M)L*N2W+MCAG@Z;,>T&6#[PO$;X0PVK'KMN</<_RS\NS/
MF,;X,LGW+-R-]F6Q7%7.L/TA\LO)9U:R0!2RC&6P_!&PC]KM5W":>X_"ORZS
MMR1-^I2?@!_)"/7NK4LL^[-F8[EHO**9ILEC32RANM@82QES*=IG?AX^VJTJ
MWA!]#ON\-K=VVQL,8=B?9BW$RJ=14NTUQ!<6PA:+(&T=5B,\_JY4GF)]2>T&
M>\6Q/OFR$!FI6^([3X>\UV.<(5$P_"/C.<,U)SMRMV[RT3C]E:6-,UQB!>[.
M(Q-BU8SMV+2:NVI#8$F(C?VXI-F<K;0NCND[%FW$P=IK"3>]@&$><YK'ZN7K
M9N(*JG"T67'/(+I"]LQ4Z^I%HB+CWY+-<\XY4:MG?1C>3RN3QIGM]E;G2B\G
M:3ZMHR6L,RL)H'O%@C8<^;(K.%S/\K!H6EED^47- $1'U8+6Z6.\*%DN53,!
M#;( ]6Q3.%F*T:^OD20Z! -MT+KEJ9\L[RZ[UG79+0?>M@X7Y"/K6L9)<W#J
M+6=?88P=B;NE8SB_=F]9*Z\JM8$QS@'''U$+5NLLRW+/15!>X6W\^-B3;I-S
M-7G3VQ#7&-X]%GJ6.VM>&=9625JK*0 $P@(7V<K5>NN6\S#8=JDJ>V(=$GUG
M:MYC.=M&HJVP-HY [%SK6=*]4:LR4?B-YBJQM@9J\N:2-XW0OY]J>4W-I!D]
MCQ&*UE9V'SI;6QLZ]AV+.X(*N+*MKVV'W8^A:EET8=.<6Z?X3)CH#\FZ[F.8
M2S$TF<O6;B&L^K/B'0,777K/EN73'P]KCO% WS?G[<DLA;_R]K.!Z_QA*!)_
M)B\\W/FM=><L2WA[*Z++WY$LXEJ=MK,I.HD$,=$??;,MJPU,*M7  NZ/1%4L
MVK4\@.Y;$LN&1A&Z.6*O6?5+F3+FV\':MXQ&.=I>EF0<T67^LK,F>6Y/HN-#
M;N<RRMN5B;\(YAV!1TQB-6J(#;>=/#%N*KTRH#2;1WCJ6L8A<?Y&ZHR6+X=7
M?L63-C4J-;8#\6/J"W)HMTAIFK->Z))Z+,MJEUJ,MFEKMXW[;3M]BA<Q.-K6
M>&;HD >@=ZK.-[4W7)S'M> 1\)';LVJ\+US'1_$,C=WGP%Q-ROAN=MX=;#4F
M2:C<+H0.'W5+]5N*[#T?4&/#8&P-!,>;O6?U,1>J>H8]K+1: ?1%:SB8C-OA
MORY@-F9]BS^B3>TS1,WR.?EV)EK[5-&2=VP&,!ZMJLY8QBY1]3*<T.LPV9#;
MM5[595?GQQY6E9DG#I/JT7RFN!LS.=O(*WG">K$VF!P!MR'>EF$LQ6=E(T ^
MZ/1W[5DLPXF4&7@>@>M6SZ%C+(G-88$B\8[2<EK.L1;O]5LT^M8UP%\"!RN6
M=W]6%ND5S7"'="X#"U."V<(36VLFRG6#// \RSO*S[/6KC?3VELZ ;:YU\;R
M#B+%KC]"[>I?%4GZM-G$0@-G-BI>V6]6.MV:S]7J -XB&VR_L@HOV=H<+\5
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M9B<!MSAFETMRJM8S<,-I[8J22NDL1+_BZD8<A-(OAU*QTZUY\;:/0I;AK.7
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MG%RWWZ02T^Z+MO<HU9F94W5=(+3$-%\,=J93UUM2ZJD=*)S&73S+4F9EKAI
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M_H+\4?ZKTC]HS^1DK5<NO-4Y%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M73&(;RO YU,V5+99A)2:$N@(1MVG&Q3.:23A/TFBFPENWT)G#4F-18J>C\$
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M'=VY9K3-^C-,D^&+L._N4KIUK2?,$2VS*_,(MN6!TLS! 6]F",V1J3--<^)
M/IVJ<59,?HC9U"Z6#9<,8^M54>^H,C&%P[+U<99G9B;J3IIW(WP"S9BG#;\
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M&%IOY9*L:MPPB<\XGK*MF%LPY"<08NYN42H?^S*^LE[IB&Q[D27>$!75TNX
M#V_=4]?/EOAU_JE0T@D0Y [=JW.V#&=J#6327DPNCZMNU9YIVFF*FJBR:T1A
MT[>E>WXNNF>MQ/N[2X>KFM\.)'65T[7&EOU=OZ97RW2V>\!:,<.M9SBY/;,P
MGC6MW8 B,!ZMJV8UE@-3$FV/+G4[6'_LPNG-M.,-F7.N>;DTUGSQ&ZX>W/:M
MR3R?HCZM_B"PPLP.7,588RBA*<8DGMVJ6SLY]^M5[4Y/NOWA@<-AS":63PZ8
MXDEM:76?1. V[%>MRLU<.GJYX:\B&)'IBKC>6GBBF1="&R_EFJCLK2&[S1;A
MZP5SMQ3+L#3)!]TVV0V^I.UMC4N-KM*+62Q9<-G/L7A[S%>CK<1&U-5N.,##
MIA?TK&TYK!)U0,<(NQ&.WVK4B\1:*'7F-@"Z%H%H59QG:9=KK'M #\ (B %E
MJ8\I_P"ZIZM/\=I$8XY^A21K.(ZPU?3!4-F_BXQCLPZE3UT]>>..&@]L\^!&
M%D>I.TREF'I]QKP],DS)Q9*ANM)LV#V+/MA,.BYLNHIZ@1);[_/=S\RTLT[L
MX'U=\H,#YF(VXGO5SIN?5[7\-ZVR9*:"^YC;AL&Q9\89QO\ R[$D5K7EL'QC
MMSBM2:2S.UDT^=[S#?=V\ZN(87,SF&1A=V +/&EZZ5][F;[O=QR"QC-=Y<&^
M!A8NEZS&#C:*K#$D[?7[%)J8:52L:7$PS/=ZU<:2S-1WA3-OI6<)8\F3,'WW
MI[RDF9E&NYCA>;^=2\M92%,&D>\([;,]JUC1V8ZEC(F#86' 8@;%<,YPB'L:
M#=Z!W*?9O&LL!9$^J"S=<,;_ ,O'AY=BLICLQ3&[L+8I&NJ.FX=*4[<HZ<\-
M!CF<1F%,I4+,GG>(MOS.7.M>&;,M*=-<=ZW+$\^:JR:^Z-FN)C'(YXK-ZK.V
MT=.9O1CD;.CV)-.DF4?,D@F$,,ACT;%6;*U'4PLLSPYOV*E=.FN02(6@>CV*
M-6RMR4"VS8K(Z=9Y9U6F":T9<HCN2M];<(&L @ZP7# 9)+AOKM6:D0+N<]BF
M-M68N6K+,7="K4N4M3EHPPR&TK.*UBX<I\"TPY6%</E6*M5?&><>M>=TG"]\
M$?TYG_ _""GETZ/WW^1[^E:5_ R_P6JWEZ9_%]:'RL?ZGTG^"4KO\+]$-/\
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M5LUM+"2ZS X;#LV)C!.UKJ;6Y30^;9; X#;L2W"(+2+*@?MVI;I9</8+AAT
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M&%M3%/,98TPLYMBSVP3C"8D4[*@?!'F%OH6;2QG=IK(? >72K":1T^F9+!L
ML)N[U;<M2Y534#N[([VS+N4]=);M2JQ]_O8G'8IC>%F*@7,#G6F_V*\,]JY"
MG&'8!ZD23*P:1+ >W>P,;AZ^=7#K\>G9E).D"4T>[$"."9R]72:2;*F2+B!9
MF.6*SG>"SUV.J)1!@X=>Q69G+,MSE'SI[!&T8XY0V+35VB9U5*82=X6!8RSZ
MXY8?SO(81[X'7AT%7.#JRGB:2R61X@L&S*"KI)A4*_C)C)AA/'([$X7OBU#3
M./6-!C/%Q^EL2W,<K<55M3X]ED#\?@?I<VU97.LNNM2XU8\N'C@VN-^=OJ57
MWE5L\3"8_>$ZPGUG(+4VG6I.EXA(A"?EU1&S:IA;OA-RN(G!L?K!Y *I8TJ_
MB5[6NA4&[,[%G.\.'RRX=;ZGQ%-G/(^L&%MT87HX72J3M0<]QC,CC??:=BE:
MZSR\RJ[=A[^,+^6:1.W+?.J/#3NO%Q[%<DB#K=3J'$D.Q/8596^O5%?G2>#:
M[EUI:Q=M^1K;VPBX7CM)62:66AUXX/%KMG/GL52[7G3N)9C7637"[U*YT9UA
M=:;BV>T ?6"+,8[5!-2>*YAL^L=HSQ5Y7E8*/B4D-C4$QA&TYQR4K4VLDCB
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M(" @(" @(" @(" @(" @(" @WM-KWZ;5MJ28L8UXW+3\8(]:&,O4CYX?DDX
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MO7-.G;US*_FE_/\ ?8Z><WRL<4\5-T/A#6]4TFAJYTZ1X$N9.8R07B+9<"1
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M69+ESJNLG3:]XB"Z)A9$FU;=9,3*X:/PD^K.\9+C\.&8RP6;<,]G>7#G 8:
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MO;^U*\UY?7Z?Q:B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MU/22(_T64R6?VS0!U^ZF,))A'H" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MGF_;W;$\)VN:R.J'60/J]22XY1S%03=R]"DENQ(4TTO(&<!AD1D%<K)E9&T
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MHWY>E;]4RK]9Q,RF!_&,Z]MN,$:]E9G<?B2X_C9<(N^EM.U:O'W3.W4/''F
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M^^,8G-,U>-1P0$! 0$'*6]TEXF2O=>+00G!9G53$OB369<!XS'-_9L8X[+7
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MQ;>($Y\RWUFF<Y7;3>(G2X")^*SWDQ_[,]KX=BZ;Q/'=&]E])8Q<I/LO-#Q
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MV.7(X+-QEOI;_AJ4KOQH_;#M*SBSGA??%=D:2\;HMM@!VK<KIF7:^T#H!MN
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M)^CIS5ZD;[KK8^@G:C4EJ E/WG @F_UC:HZ=KX6K1@?%!@;VX'9%&+-9>W'
M%9X,AD"+&-[/8F<?H\/RYMT[KI]5B&$N%PQ_8\Z//+>(DQJ>\"-X98Y=*9:]
ML=<7E!:C6[S71(A"WESJLJ!J#PYQ,<AZ3&Z*QO.US:BY)@\1NY=ZU;A%NH*O
M<-A%PQV=.2QSM9UUI*SZD3)9!(N*TN)C[H4M!-U_.JGER\#;RZD,//A;EIMC
M9Z\MBBR.*K.)ED8ZT GL4QY:EG^6830+-X>A,'O.'A\V+3:+MBLFR]IC2O5S
M[70.(77K-)GZJ]/))(B2;?6K<I;*CQ'>,8PMS@M3AE+4<TM(MR[89[%,-Z\+
M7350 O%VW(!*;C9=6V&)%V946W*&J:PVW8YYA(36RCJMXQB+(XX]:TS;6W43
M2\#EZRLTN&ANNR/I5S#%Q]FW*D%UNSEAL1K&FR:>#8PP]7,JSO.D15APB #>
M0I%N,;Y0[GD7QC#(*7.3KD:7#/IBE6V^$A2SG-<V.?J&T*IKRM]+5'<;\...
MQ-K/6I8U$6V'#"'-G%5FUH3P76W]QL6;RZ=;^UH.8039RYU4Q<98)C3$6&[U
ME+P(N=3N>Z)C=AT*=8E^[<I"96[$V @]=^6*J9B99-WA?@,O:A^O#P]P@8FV
MSU(L^R-FS0'$ XGM*<);]'F4[?,"8^CE:I<W@DK<-,' F&!A 1]2N5X0==2"
MVSZ60V(9RJU13EKK(\H[%GMN+.OTR\TON/!.!!](BO/<RN\ZS"X:?6-;NDEN
M%]EJMO\ RU)X6R16M</B;CCS*XU]S"/KX3-[=MC%6;,;4ZJI(DFV,2<,2.E;
MD:]96U0-$IXC=@=I,%F\+C#L+3*]DH-!+?7G@=JRG":G53)DMUHM!NYCM6K8
MS5!U6:UKS:,>P;5,LYRB*2I'B@V?$<>;:F%WPONGU;-T6MN;ZDMK?63#=J:V
M6V43%O6I&:H=?J[&.=%PB#G;VI6?7RTZ7B0,= N%D;=[*"QCZ.DD\O.H\4M,
MMT'"&Z?I;%O-DQ5Q%&J>)X.^+ _2VI-I9)$+5<5EL8.Q^^VDI<>6?3S55KN+
MG7%WWU[N=68O!.JI5G%I(<(Y?2Y]JN"179_%3XN]XVQ/Q<^:BXSPAYO$[B?B
M-I/TML4Q&<8:LWB$N%__ !N;81@LYPU/K4+5:LZ8VPGX<3MLR3/_ "UA7*BI
MF3!;$PYS?%+25'%SHX^B*S:S9;PW9+781^+"*N;2]:W!)F.%QA=>4LK.)&N^
MC=>0[I&:U<XTU9*P-D.:8P/IRY@L[6R)JBIRXVQA8.BS8DF$G*4?0C=,!@,-
MBUG*V^&L:8,M[AL5Q]$FYAQ+G,%QN.&5OK69E$=.J)D;C98(QVI<X6S33$Y^
M3NH]Z3G*R)BDJIEE_)WL5ROK%STW47RBW>.(C;AZ%?#%^E7.7Q"1*A&P#[XY
M1R4E^K/K(UIG$!)(C@/IGGR@M3EJ<N,K6[;S&SZ02S#?\ECH-=@6$FS:[EFL
M_IRYV>*N=%Q(&!L7"PQ^+GV*7.3">E\3DBQV'WRO5.+AE_2?#>MN^)'2283%
M'Q"U[(.(C#[[V*<F)PU:O7I;7WB%N(SYBK.MP3C"2TKB)C9K($7??#,[$O7R
M6>8[KX>XFE[DN+FW'Z8VJS[,^N%T?Q5*\,C>;\(^D(8)BM8BFZGQ,QSC[S2+
M?I#:IF,XV@Y.NL<\6B)/WW[+F3&6Y,3[I1VL-,OXA:!>>06N(S9Y5VLU,'%N
M-QV\\,5*S%=G5[2Z\=>8"DK7JYTM9%X$1:<^;F6L2[+)A=M-J![MHP2UCKTM
MJQBI:&WM^'/9T)+&O3UVK>J5@:TVB[/HVK-F])S^KK.LK_QYM$-XI(U.,>5W
MT&<V:R,1<,>;-:QY3U7*7N>[\-^S-0LQ<)269>[ [L;.Q,GK>7)[6$87YJIB
M(NHDM,80'2,H99J0ZS&T.930XW>B%HYDN+6K-?8\-M]G6%+-,R99I-.)G7S]
MJS,_X:LLY;WU&R,#U+<Z^4QG;1GR'-B #?MV[%9))ODQ_P (_P $DB(SY7+-
MRMQ->4WI]&'.$1BK)I,:7>DHFA@L[,E+S]APJY0EM-T.C+O4UG"S_P!5)U":
M&N)!Q]NS):ZS?V:Y5^=7%D80$#ZN]=YPYX5/5M1)9,MP&/['V*;\M33JC4:X
MF:8POS&2U+BF)4SP]J$)K!O#XQCM"7ZI9E[!Z!J8#1[S;0TW^U19-+I,UR6)
M<"[Z(^D,D7"O3]<E&/O#Z6(V(ED\(F?J;9CHQ$"JSBY8Y=<RWX<,>=,X,.3J
MZ61"+>M7!BHNHF2S$Q&/J]:RW)F81;W,$3$6&/:IG/#-F-1C-<R6(;S; <>B
MU.9MJ==-2;JS6MO'1SA,)AHRM7:9@M'7MZ$O&TQFZ6BEU67N#WFQAGS+CVF]
M.LZ=;-)(:M+%Q;T'O*SSI?ZWA^LM -H_PE?#-Z;0M3K8!/O##Z7.C4^-#S=>
M:21$?X6WV*2;R7I),O,G7&M,21TN&15VDZ3LEY/$,G=B7-C9],7A-\K?AWKA
MJU7%S937;KF_X8V^I2D^/ZJM6<:!Y<-]ML1\>PJ]>$OQ]?\ *E:EQ47;WO"X
M_2P*83^M1*[B/>-KL3]+.'J3&3^O*MS=:+BZW_C XJZD;Z_#>6#\\VBWTA68
M.WQLS=>(N-VT]R92?%+<O%1Q 2PVX'Z7<L?J7ICA4ZKB!^^X1_XVWF3#GZSE
M!S]8F3";X\\1ZDLQN+9C?A%/K9KG8Y =)@K/JPS2IDU]^]F>8A7)ZMC=FY.Z
MU;<\HUYC)L!8[%2WZ.F--(,F;P)#K#M43%S]D_1S)@:UI)N-_+-7QM+]DBRG
M?.<+"8$76X@>M9WG[$Z^5FT[A\SS$M,2X8';S9JM.P]-X*\5H)88P'T.I7+G
M9YG"TT_ (@/Q9O'T=IV*XJQ+4_ 0C^3-X^CS;%FW!>%@H_+QLR$6&T_>QSV*
M64]?HW*GRR;NQ$O_ .AG8DQY>?YF]I/EO+:YH+#E\  6L9>'MC+M'3/+Z4P6
M,C8/HC:, DUIOK=+-+X'EM@=W#[T);/#5DO">HN$9;(1:+/V,.5RGG3'M95E
MD<.RV- @+ /H\^U%]L(+5]$8UCR (P/T?:M2_P#"W;JK4-'!GD$"%OT;+RL\
MF*X4_#(F0(;'_@;;%<82) <)" );_P 7V*5O.477<%L>TD-LA]Z48BA:EP#$
MO]PVD_1A?S!(MDNU0JO+RUWXLWGZ)RYEJ25CKG*&F>7E\99O^]/<I9(W>$3/
M\NKX2W61^AL&Q.LEVF;C$5ZLX'=)B0QV?PK<GT=_CJEZAP]-D@C==_@G,]RZ
MO1BJI-H9\E]C9@Z#F<>E,>6L1GDMJ ( /O&:F\,XTSN9/+22'XV6Y9+*2;:'
MB393XG>$"81CT(GZK#I>LS)#FQ)C$&\BR YUOAN=9_AV;I_&!E, WA?]]S)B
M<LWKA;M.X\.^ 7C;[VR&>:S?LF%ZIN+A/:(N%H^^&U#/B<I*5K;)IM(P^E$0
MC:A)B+3I-7+FEI!; Y'):POJOM/-E>&+1Z!DIQNM2)"57LDEI#FBT1MM]"DW
M23%6W3N*&R0!O#_"'LS5PMZRS/EL5G$HG8@Q_9!3&WE[]=H]FK[PL../W=BZ
M.%Y9?KCI@OC[;/4LW@NV(.<XV1M.2RN)-)2EDNL)!O./+-+<Z:O:8TF!3.<T
M1QV[<E8Q;FM>=1M-X/*.:5)/'A3]5HPW>A&$3ZTSIKM<3$0%)3[LX>[?SC$9
M (P[$TV5[K;+AF<R5J62863:>($(0">72S$:,T0. $3D,EFW;%C'O 0,5%F+
M,-R14-:!$CD ,U?#/%;GUU@%[+!FD^YY5S4-28T.]YO6KKPWG2GUNNRVEUHP
MO<-HVJR_4F+=*_.XGEL/Q-%_T@IREZU&5'%TL ^^W'Z>T'-1G"E:QQF&L<UK
MVP@?I[.I/?ZD=1:UQH\V;XQ^GS;,U;]4KKBNXNF.+@'&]WTCB2DMI9I4*W4I
MU=%OO'>VDYIY9G;#+I.C3*B8TP=!UMQ.5W0M7AO.79>G\(OG-82QUM_NG;"*
MSQI9I<Z/@G\F=P_$/HG!3%RMW':?#7"K9+F1; !S?H[>K!$N,/8SA[2V2I8$
M!<(0$+,.Q,9)-+C.EM9+ $+H>CF6I,)+X475(!SQM*69,5&TP._&!NLLR66;
MCRN6G3" P$P@879JL>5C^M[LN$1U[8X(UO"KZI6'=?="!QY%/6<L^V\.OJRI
M<XGGVXFWL5P7MO;A2DN='E?W(EMM^RZ:;++@PPP&:SVFS_V642=OI]BS+?HU
M&Y) #@,H>H*RE2S'$-LR&"U5G;'+4J9A ,8X]D%B\I>V=*AJ$\B$(_2]$!FK
M+EG<N55FSWEYL=C@<^=:Q#-KG*>]QA ]1R/<I,'MK7*:I@YP;$&T1RQ5MDA+
M;=MR9(!:21<N-=IUB)>62R;K%D]?#+)U1LH?$+!F,[%+]UGQ?1SF<1RY;3%S
M;+/B&"'IX4K6N+V,:2US;-X?$+[U5])C;H_B/CD@3 'B_!^W8KUU=L^F74&J
M<=/ F^_G]+:G;A/33JC6>+YL][O>)CDZ-T%BUTZ_'C?E7/SU,G&\VW6DYA7B
M)?CMKF!-J?OC'G6-YRGI)7AVD3)N#NK8NG7<:G2<LU/P^XO)@</H[89JXB^N
M9CP[%T#07,FRB1@WZ)RYTTS?C>S'!NG-EB1 6@6V<ZS<,3ICE[$Z-(@R6<KH
M]&Q,ZPU9AVYPW!KV1A8X'TQ5C76UVS)FM\(VCX1ED-JK5[84O7]TLPQ.&S)6
M,^V?U=9S9,7FR\D8\W2LW=S&>>7-C7L$(&_+F6;G*33A->YL+[(X?<5E9[6.
M#)SBX"V_$'O(5SACMPGZ.D$X!Q%^S-6USRGI>F, $!GAMYEE.61VF2R+0(]&
M?,KG6&,8N;PA:G3)8C8,<L^9,+>U\(690,!$!<K,)+E&U-- 6 W98V[#DHQV
MU58KY+FF.>W:#ZTL3NS:'2^+42]X6;X[6X+I-+,Q[;>75!+8YL0+VY9*LVW+
MM[69LN1)@(6-AU*=KX=_BXS7K%QA7%TU[0?I&/3S+,E=KO<4*EHW5>]83$Y<
MP6.TP[_%,Q@K>&W/:XP-H=]'&/.L.\DE5V3P\YE2RPF#Q]$Y@YK%=^E>P7 6
MD;CJ>(M\9ANAB,XK.,;CM/N_4/Y89/A:[( '_.*<9?2R5D=NLN-</JZ^6UI/
M"DFS_FLG+[P+'R.WPZ[O8NHO;^U7#A]KI_!JJ@@(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @*8R"< J" @(" @(" @("G()C
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M??=>U+F:3BY6*15.< +;A>8BY)RU>-/-1(\66281.87J^.YU&)PI&H49#WP
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M:S=;ZH][YAA:Y)27V8&39CB 23UY%+MN=?JE)4J9-%D>WFL4F,LW3;9ITR9
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MZL?EN@.%)/\ FLG\ +';AZ/AS>SV&J;'-_:^M<J^QUS)AJHH@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(DN9]TO,F%S1=\(NZO6KA/:^4--!!,1R@K&.W[M5@W@!$V);6;).$165)+7
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MIFG^:RP-T_O9]'NJL^=.H]:\IJRE)(IV"'[ X [$Q,-R^'6==Y?5#7.$R2T
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M-2X.M)ZSD<@J9\+7ILV.[;A#E8IRU,3E=J"#@R.)4NJ=NV4R&MR])52-2I
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M "G>XU'I^#7;+V)J;2T_L?6N.7U^N^N6JJ" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@SR;^D]B!-]8[$2<,"*(" @(" @(" @(" @(" @(" @(" @(" @(-S3_ .G4
MG\,S\().2\/3G[1K^[2L_L^;ZUW^-Q[<5\'?S@3&MUS48G]XG[?I/7JQB/C=
MI?[,OQ5XGGL_/#H&/O./I(S4N&D9*J&!T21R@<U,R<&+RVS42RR,>45H4C6I
M@<\[MOQ=J:(U**8 'QV&SH37*V7PVR0X]9ZU.W:7AG'U<FB-AR4SB+AX<+2
MF=&,Z<+!BIGRGJR-F "%BU+*N*XNF D0RQ5MD2^T:,^8(6'TPP*Q[::Z];Y5
M^KGGW@#@,EJ6-67B<95?4)KB#A9?T\RQWOT>C\>>:J50^)/3Z25QN7T<SPKU
M6XQ,!B>SVJQBU'^([+T)@]Y&S+(-NWL3A;9W;TMH=RYDOT<[4Q3>ZYH%H!5D
MEF7/M5IHC$=2C%X3;7$0N5QY<IRVI,PB$<SRM1KMPVO'AB>H*Y<W U -Q/4
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M"4?J<NPY#+GVJO/;BN\-"\O*.2&1II8@0;0,(9+-2V.U]-X.H);1&1*$!D,
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M1)E@G2A-/N6B_P!*G&VLX>::@G"8"&F">WLRO6FR'-:S>LZ-JUUA;E>:)P:
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M;X;0X6D-BKG&XSVN=NUZ.1*\-ILN&(R6>'@^7KFY<:EK=VRRZ[;%7&G#:(F
MAT,N]9EPOKV&%[3$1N3.=5<6\I60]P%NS#G"UPUC3<,WW8QMA'#**25CTLW$
M;/J'VP)R[5+R=>MYKS2N?,<8Q,.62K5ZZ621+.Z"8X'TE5C%NFSN%,K_ %5A
MF2X@WIE,=O" JY1B81QP4KI);JH"8PM,3RY02<,WK96($1%N*J8MTS^*T2S
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M6*JU"2UAB;8=^TJ3MAKT[*-JNMT\H&,R%IRSCASK69=LWI<8=8:KQ92RG/\
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M&]3@EP.%BS;EY._7/;_*X::V+P-@]22L=NDLP["TQD-U+<I/CDU5HEM&Z.6
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M4])U=':MY>L=4.=]4!_X,=EZO,;DDVUJ#R_:YX'U3$"[,E23U.UR[ HO+;W
M6T=FQNPIS=LR?\HO6N#)U$P[E.1"^SMYEFS*WKITYJ;:V@F.]US8.(]J8P2^
M&+3==J93@'S'"&9YBM]:EU79NB\4,;X?B3Q':<S!.W;*\UVQI/$E*^6(SV^B
M-D<81Q69-I&[.U>GF.LF D67X]BZ6XBY9I%:';L'6<^?W5SJ)N1437-$''T'
M#FV*RIYP3G3W-/Q&S;LR@F=_9=H28)^^3NNOCCWJW<TN/JW*>LF2B-YQ$(98
M"&*DVEZR;6>DU8/ 87]G:L_QN:O5)3:Z6)9=OB,,]G.M^V=+C" J-29]\.OG
MVJXTG;MABE5\MQM<,<=G.L5.MF$_2UL@_3'6,BKG"^S>-3)+2-\6[1D=J7MF
M8:^ZHZPV7-#Q8Z(V8@96J2X.8ZJUS1&3VS2)<?=/JQ2Y9FZZ$XAX>F2YCBV4
M00"8^A+P3OBX41[JJC=NP<W'&%FZHN=)S3-:G[X:^8Z$80//W+6-,NW= J&S
MS+:\AT6@]8'1@L697&LNUJ/3Y#I;#N@EP':K/VIZYK?^I^&(M;#(]9VJ]>W@
M>6S',.(PQ[PK>K4F)$A(JS9$D6B\[2IFRZ,934F>UQ$7 PVY0S3-JR83,GPW
M-PSPRZ4NF:R3)+7"$!Z-FQ.NS"#K)#0777G++F6L8)56KI1$=W(\K LVX+,*
MO5@Q(@8B&:LX)_Z(EH?O @'TY=ZW"]<UGGRYSI!&ZXQ  OA9UK%Y3#K76M/G
M1<XM,(GU803USL\X4&IWZ<N)BV!(MV#J5]3B_9NZ7K9;,:#,AND#T&\+.,+>
M7<O#NK";X0\2(CL%Q/2K+A,YQ'<6F/;-EBT&[T\_.K=M3A//HI4QD'-%HC=L
M6<V4QC:(J*&5*WMT"^"6KUQ4%4'<,1M'4DC':[P@:JK<PF!(PZ^O)-\)S$1,
MK7/LC&(PV]2WUF9MK$FW%C6S+76^F^]9QO!C+;ET$M]S8\T5<7FIGUK.W3&@
M@^''K5\+[)"EH0'#\7"_ Y#:LYV;3,[363)0&Y@(WX@+63"E:CHLL;_N?2)N
M6+<LH$4+9#S!L+>P]*L:B4I)PEN#2Z%MMO/M6K<?J<)^1/DN'O.'6-N:LN$L
M\I.6*5P$2V[8+K+PL^T1LN;3>% ;EC;+;;1#UK%LM5U/Q9HTJIEN(9O6N.=\
M<=B6X633T^X[T,2'SR)=SSV[,DR33I(,F2:P0!$'9&^)[EJ4R[VX+K9T*<;Q
ML<W+-9ROKY>R^D.F3J9L8F[EDNDN:QANU6FF8'1EDV&!@<;<%5F:@YNF-83&
M6<3CM7/M5QAJS9 EBZ%D+N8>M)/+6=-$37-,,+,^]6YK/,;3)YC&-Q&/M66I
M,)*54 @6X9[.=67$3M)E*2=UT(D70O'+!+;G,92#62X"T7#[WN08YNZT6&^&
M(Y8*Q,;RU/K :2 ?3LV%:QB?=J5N2WES<QSQV>I2=\+?LQS)#)EI O\ ;@MS
MM:F:T9E'*8TF LM6?[+;A+N(F<6M);$7[,XJ>V-^4150&NY#..U3^RNDDX0%
M71!P)#<8@PY9+7O4SC2KU$J=))W6N',#D>C!/[#&8T!4U$1O%UXO'L4O>W@G
M7$N7-T]]EIZUJ?)5Z]61DQSA:;]IR2]ZQWF=,513F8TQ&>"GOG376XU76?$6
MEM(,67AV>PK4[6Z6\Y=%:WI[6S'$,A[T$O:S7A+P@*<^&^!NC#F6/:\I%^T:
MI@YD'871MOYX*_V6Z:D^CMG2YKGL9?GCMVKT]?C]IEWG&ULII)>18;8B[+H6
M[TDC&-IJ73P )&8NV\RGK/HU^C88 S!9OQRCR][;^[/G3TPN=81E1,:6WW\V
MS:I>MRDTJU=/#7&!QS&W:M>NEZS-:$NHBX6QZ=HVJ3IAJS,6&A<UQ9&%IAAB
MKZL^JY4C6 8>C$)Z?5;J-Y\ECF&(%V68Z,T_KGARMMJAZ]I<M\L^Y&QR3X]-
M>MP]<N,-"E>',/ACXW",-BLZR&/J]0>.-*9)=4%K+MZX<P[$]93.'25)5NHZ
MX&.[NO';'H6.W23;I\6^V'L5P9Q:);*=KI\+6@QV@+R]N7V.GPR]<O9/ASB6
M1,8TNJ&VD8\P5MF/NO;X9;J+Q-UB3-E6308CT6GH6),UC^J3A2=4JB_>+71M
M)L*G%PS>DX5;?<76V1(SV*X3UDB3I+($\W9WJ\.':9N/NFI3FPAB(99),T]9
MC3<9,#1;B!EWJSZ.7;7_ "Y$!QC&^!]'2KG#A;FM.=+:8C(9#([%+VTQG%0%
M9+#8P_99;5)=98[=KE4ZLN:'$&[EZDY8O:J]/G3 XFVR.:DUI9WLG+1,^8XX
MB$<]BU9ZN5^6QY#G&VT6[0LYV[?#\E[7;,QUL#&XB_)6S3Z'7XY8SM8'<O8L
MX+UDX>)DIMMGT=FW8M32R>$;4,:!"'H&,-BMY:]4)46%W.?0%>OC]$LPCG3'
M V;<^]9J=;BC9SHCVY<ZN=8;]DO*>'-M">&IVQMQF,:Z-G9W)Y9O;-PQLI9<
MQPB!>._!7'EKVLZMDTDM@ @,<^]9\Y8]ZCJ@"4"!M"N5G>Q"OJ7-<1'$PZSM
M4RU>]GEX95QC%PPQ]J5F][=90VJ3BYIAE#E:DZSR]?P=LZ468USIAB#>,\UO
M^J5[?7$=M^7U-&O82/\ )X<VS8N'?I)PZ]>V'[^?)'(:*S2HC]YE8#)NQ<_7
M'5N7+ZP_E<8&Z1I &,H>M>7Y-5[/AFL/T/H6-;3LVQP&96.G:UWO7#>=*!'W
M.Y<_D^6\-=9>6G$[VY&SVKC,UJZ<-28/J9S#3;#8K/DO71)O+JBI_*._;.]2
M]'5MX600$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1
M^4:@I7G<=WR\J#_R$W^3<G7=3M=/CG^=F:]^KZLW :A4#'[]XS7NZ]?VY?*^
M;^67X:>9$@&MK"8?E#^%S+?7K'.W3H^?+:UYL'H]F:]'7X^MCSV[:TUS +"+
M]@6.W7#A\FHCG.$3SKG;.'GO:-6:(QZ%)<)CVVUG%[8EL;.<=BGM;67*5,FF
M^-XQ<>[)79&R3&\I[:VVAJXC=="&-T,RD[)G"K.$SQ6D1@7;=D$O:Y.5OHY;
MC3AQL]W;DIFQ+%<U6<YC@,HB\\V>:U>]O!CRI514G?,2;S>>;:F;C:/$J8'P
MMMB,L^<Y)E<Z2U/-((AL[1M4M9MQ4S(JIC; 3=SVP YTS6I,[3$FHG/C:;LN
M?)2=JES.&K7/G!L1$6&V)SZ5K-6W7W5R8Z<X8GKV\V:9TL^C4<9EH@?^,LY,
M,<9@(R%OTO8M2Z2S%>3.>/NGO4),O'CNY$]ZB^KRVJ>TF!(LARBM9S,,[<OS
MA,/NEQA=@GMX\MXS'@S6D[Y.V_VJ9UA,::%76;K+'@0V\V8*K*DUVJS0YX#X
M^]Z(E+<FT?(JYDV8T$F_LMP25FYRONCTQ>&1:3O;.13V=9<KS3T(:V(9#V\Z
M>UI=,$]CY;C $7''8,$M9]<I'3Y\P$ DX8G-27$P]/3KI>J-Y<P'(#/OVJ9=
M9\<<JQQ$HG84R7XYAUCK55,89@!Q/;[4C,Z2*A]9FO? F\D=N0BIAJ2+)IX+
M@"<#MV)=\)>N\K'XAEMLP[;TGT;]9AX9J;F'=WLQAG%6Z,8C%4ZDX@'Q,=F0
M1%"UO4W;DSW\3EM5PN'1O$5=,<Z;!T8PNAE[55=45Y?-F.C$D\^<5.W"O.GT
M'BN;%D;<K<3ASJ3KG?E.W#M70]+# #X=Q&?.M8U@FH[?TACI0  (A# [,EGB
M82WPO]&^860@;A]]S*R99]?9MNEO)M!-G*];B7I,LHH]ZTM/4%C^+5Z2S+8;
M1!HM&6"YYVYWIUHZ4&"SF6\Y:])A@>0 >CU):LZ3EH37-B><99=ZO,6=)EN4
M+Y8-I MV9J<,]^DSA994V5N !P-F85SX3K\<QEE:]AC=A=!+<-3XW(RXK.,L
M3IC:.J*6)-D;#V#8M9/3%SA7JNE.[8T_"<!FL^<M>L5VH8Z7O"V\YX6K5J3I
MGAH-F.\0 W1A?T)E.W21/2I#'2RX@1(Q%UZL[/-WF\HZ87L<0 ;SGT=JOLPF
M-.=-<6WV\ZF:LN%ZI*9SV1+3=DK[-69<*RD(;8V'NG!3VQMFYFE==O2W6C;C
MBD[9,W&%CTV:V B8&&)2]EZ\M;6H/;$'"_G!6?;$P7^651:R#G6YX;5>O;:W
M4;0>T1B1UI>WT3M$=430XD WG/FVJYMC,MC5;3F:?AC'9MYMJSFRE^R7I-(#
MH.+(7&XWDK7LU/JLM)22Y$'$ 60MY]O,K>VL&,[;\VJEAFZUPC#/N*1KI,XR
MAIN^YQ@">O,\ZS+]7LZ_'.6JZ6\#X3?RN5S72].MC&-\$6&_:GL?U18-.]XB
M-\4RQU^*97RAIY)@' 7#*^]7.8W_ $R;<M1\"G9$$"S9??>ID]9CAU3KG$CJ
M68YK)I &72<+$]JD^'K6OI_$[9HA,G1B!?RV)D_JGARK>(Y0:^$X?#GL*N5]
M(ZZUCB1I#H3<'=G,L[SE/ZXZMU363-<?QF9O&7L5ET?UQ3*G5WL<8/O.:9MB
MWX^LTT'<0S6DCQ3UA2YBWX9AJOU^:ZPS2;+;1CT[%<G7XI)PUG:J^TE\<59<
MN7;KZL+]1+A#?OYMA6]1X^_:RHR96DD^]CGLZ$N)%G:L'UPET-[$XA2]=97W
MOU<A4/<81OVI(S>USG+*-XWGTE63+4^33B01EZ4QA+W:TR>]E@S*=IK"7O6C
MX\V,0XCJ[EA?:XPFJ.8][8&VX"^^Y:G7R>]2WU<N9:V-F6(^XEZ9/?[HB?1.
M+CNLA:<-OL5G76%O?'7[N,K3ISG -8>J%X*LZ88_LJUT6AU$P-_%&[H3URW/
MD]:L$OA6=,#8T[C&PV;$G5.WR9VLVD\'ACFF93PM$<%/1G^RXTMYX1E.9!LD
M7'L*NI^K']EX:1X+),!31MRVIZRM_P!EQAMTW [MZVE.&&U,86=[A;J'A"5+
M+ Z1"P#I'I23![7&UNI.':5FZ?# LA;RVIB68+\E3C-(IVM #!A=G"&2SZK.
MSP[2F $AG**OJ3MBYK4^K2I;[@".6)6<,]ODMU$M33F,ANGTC#JR6Y)4G>I$
M5SPWW7&R-T-J6-SM;SRQNU*=F;MBDZ,]N]RX"NF.,"7=<%/19\EJ5I?QY]['
M-+UPQ[59*/39,R!+ ;N5JWZQJ?);<)&;IM/)BX- @(\NM9G5)WL:$PRF6 @8
M<NI7UC77Y+;MQESFM,(\H':M2+V^76$M(F-< 8XB-HSY]BF/HS.VMMF9,:&F
M$8\XR.U2];Y3WMX5S4*@C>A&$,_:I>NM+U[VJ?5O=,-L<L=ISVJ3HWVNLHN1
M(_&B+<<0<U?3+']E2\ZEEND.$!\)'4#W).B3O9766MZ-*F[_ .+B-XPLCFKA
MKVO+KN?PQ+?,=^)$(G(7PVIB+.U;M%PM+!;"2/1D1FKZRI?DO"X4?#C T?B1
M9S869K$Z[/>_5O3>&&N:?Q'H'-GFMX9OR6W,5^JX08?WB]I2S*7OVJ$?P9%Q
MW:8F^$.<J>F6;W[1N4O!Q%AI^N.1&U7UPG]E3+>$6%L#(MM"SZL_V]JC*K@Q
MAWOQ(Q/:$]5_NL56LX3;+)A(%GJ*GKG]#M\O:*[4<-N:3"3<>X>M7UQIF?)>
M4:_0'$D"3RL5]'2?)B(BOX?>R682<3Z1%7UEF"?+5;EZ#,=,@97TCZ8[4G2+
M_;4P.&9A:(2;QVJ>OE/[;436\*U(#BV0ZU+&;\O95I^A5LIT!)=R*QC#?3Y+
M.:VJ'2JH.&]+=A?S[5KUUE;\BSR=,-F\S X'-/7/+']W;+),TU@;\ ZK;8A6
M=9+]FI\USA7:FFFRWD,:8=.<,$[1]'XK[:KS)I)S[VG# YPR22.W;KCA(LH9
MEL6FV$+/8EUPSZ#J1[!'=/5[ H3IEHS)<QL8 WE;D),(]SYV\;_3W*=NLYC<
MZRUP_'.=<3RZ%)/"7XYS&I44=3-L:PF([>=;O68:F&"5054@DEA%FWU6KC>N
M\IV3E'439>Z"XC=LMAL[UJ=)C;%BQR=0;N^],'6!W*WK#KU)M9*>+'MZQCTJ
M>OE<;14VIM]UT8Y':59(G;HU7/GO/NQ,<DO6,SK)MM2*2JF0@UQCS[<RK.OE
MOUS4[*TFK+8^&ZWV[%SNF.TSMX_,M5C*)Z%GVKFY2N&YLUP!D'TYIS,M^,K9
MIO"<WW2*<X8>U67#5D7JAX,F36@FF. NYEGMVLTF$XS@(N:":7+". 69;!D'
M!'A6?5H$6W0AT+<N=I>!_"#3#>D9W6*7M]$ZM"9P?+A^0Y=:3O6KPAZKA8,W
MH2!8"?1'U*WMG;'%5V?HKY9@V5"V(Z>G:I[-2Y*?29Q,#+Q[LE9;3.*ME!PZ
M9D"Z3&,+X;-J>U9MN5TI.$6.@3(O[N?:K[X:D2[>$91%D@=8YDO;3/R9Z3+7
M=P@R-LCUKG*^5\GY/?K6C,X3:;!)AR"WQMGK^7WGEA_0\$_D>F"F6_\ N;RY
MMX09$ R!SV)EB_E=I?+..$6B$)"SC>3_ +OMG+P[A7=M$CD%K,PG_=][>:PG
MAEV\")%T,,BL\K_W?::RE*71-P@.E8Y16O6<M?\ ==\7=X2\O0V/A"5?L5D8
MGY7?ZIFEX7:X1\&\A9LV?]WVXE6*DX6:(?B,CU0'K25?^Y[XS:M%+H;)< 96
M V[=JN,,_P#=]_JF95%*EWMAS]/>HO\ W7>7ENM,AHA8.E7)?R^_U96SZ9AC
M%O7S+5QC#4_+[=LRUN2ZJ0^P.;UB^U<['7^RW;+,9+F @0*=?H?V7K'&302I
MK@"T8\O2NDD2_-VLPM^GZ#2O#8RVF('J6+K>%GRV3&6_4Z'32@"UC18L^VL)
M?DMN5>GN;3/ ;9 PR%A*LC-[VUNR=2.X6[]A%T<UJ1/[.RN:G34]4XN> 8@W
MPRC;UIVGT;_MJB:CI5(P'=:P=614QY2?+<J'6N92N.Z0(1]"SS6[WN6K1Z_.
ME38"80 X8[?8NOAC^SM*[(TG7'SS+#ID;&B\<_I6/U6_)VF\KQ*>R:QI,#$"
M-V02Y)\]O*,U%NX"6Y!(U>]L:&G5<QDZ!)A]U2ZX<._?M8O4B<V>V!(.%_>M
MS4>:W,RR&DE&V M6;<M>U]6I-8R3=" YL_:HF?\ EQE3FQ/O##UK4N$]JEI8
MES #8<</NK-NRWV8*B4T-=  &W 9C8M2?5J6Q7VS9TN=82!&&.'.$/=V+I-4
M?"9O&VR\\V14XK-[;67Z[+W(;PNSZ<TG)[5#UDYKA80;[CTK6(WU[7"IUC'O
M<8 VGL4L2VUJR9#@^UI'1#$>A9LJ3OA,26M8!: 81PQ6HU.^>6>9,EAHM%ZT
MQ:V*9K9H%W*U,X)VQN,=5.=3$EIA:I.U=9\]<J/5YQLWC81CLAEM5MRW/ESS
M5AESW3V;SC&(/<I[5GM\MG"-K)9]ZR\'M&S8GLQ_=5:JV.!L!N%W.-B96?/V
MB'J)+BTDM-QPYD:_OM0DBCWZBUAA'ML6LZPE^6YP['TW1I+I8)E7C)2VX/[+
M-MBKT*660$K FY9S<Y9OSU2=0X7;,<X^#9$<KUKVL)\_;E$2>$&Q)\"W[B7L
MO_<6O%9PDULMWXB$ >WV+/M5_P"XKJ_7N&#%T).&2WG6"_+77E3PB7$GP(V'
M#.)7.]K#^RR9RZOX@X:=)=^1N=V*2VM=;[3*DNTB<R);+@ 3E[;E<EB'J65-
M.3N@C=R!6YV=.OW>*;7*NGF-&^1#JL*S<I79.@<6SQX8=.(MY9K6Y$R[5IN+
M"95L^$8;/4I.V+DX1>J<50:XB>;CCM(5]USG3KBLXJ)?^7-Y5Z]F<XN&@[BI
MT?RYZ_8F6L9VC:OB::YIW9QPV=MN"S[4S*I]=K53.<Z$PF.VS*WJ4]JLN:@P
M^KJ)D/>(,!C:KFPM6#3M+JIQ$9;C:W;CTJ2W+';<76CX9GO@3)-I'I5[=O*]
M4Y(X4F1!,DYW;5F?)O!V\+_HO";GP'@1,,L^Q/:RO-W[8KM#2. #-,LFE+HB
M-Q.(6LL?V9CLFB\O6LEL)I (6W',K76GMAFG\*29#2#( @(]0CZDNJ?V?56J
MG0I&]#PACAM'<LVX9]KECI]'E2Y@W9</>!ZK%)VKI+:OFF.%+ BR ':MRYVX
M=ODLN(M)U 3&0<Z-D+3T):G7Y+Y1SIDHN+@1:8X=RF6O[.S/*GAIL==#%/;6
M'6_)E(R:QT81//UJ7,W&9WN>65^H3&@@.-GW>=3-LR7Y+PCYNK3(PW^0B%9V
MLC']EKQ+U5\([_TNY3.:O]E3-+6^*/><+^62MNXZ_'VMJ4!#P/8GMA]+X^LO
M5KOIVNATK/;Y*W_5U\1IOI0+AC#E ).U3M\4OAB+7MN!OABK[86?%*X%\UN+
MO2K_ &4_JF<.'BO-Y/+J5G?*_P!$:[Y8F$1Y7*9:_KZK!I%+)LWH78PR4]JD
M^+K=INI%/*:""VS*"L['],XQM!3-09*) >!"&6/I5]D_IC$_B%DIELX66>A3
MVSHOQR:PJNK<8RY;"?K LWE/+4^+K9PZ1XFX[@U^[5?2=CT>I&?Z8]>^(>/Y
M\9N[4DDDXG%:RU_5U^CJZOXUJ9Y>#/)!)QLOCB()G+GV^*2*O.U-]222_>)!
MQ!R77^O+QWM>M8V4[IQ$!&)AVI.K/;Y;(M&D<-S:AX/@$Q(2]5Z_-;R[IX>X
M%?,(#J8GX<"KZQ/[>T=VZ-Y=M+6DTN PY]BGK#^VKI*\OV, _FL+L,NI3T\I
M_9V<G<%-8;*:&Q9QMK^RQ,4?" EB/@9^I:G6683^WLV9W#>Y=)A#TW=ZDZR5
M?[JVJ+1P# R_I#"/I5QE/[K/T7.CT>40(R\!AM5LPU/EMY;DW1:4,B6-$8Y8
M6J7IEF_)<\H1^FTS9AL;81EA!9O3%:_MN$UIU%*#F0 3T)\UK-Q)3@4C]T?O
M<;,RK>N#WMNWKWJ$J>RJ<6M=CFM698Y;^G3:N($'7Y;5/5<ZP[BX:G5(AO;P
ML;A# J^L8[9Y=L4]6\2FQ)N PP^ZEZR,RV57]9G>('B-\>BSG6,;=/;,=9UM
M+,F3"6B-IN'.M]8SRS4U+6M'NRWPV="6)-:I]3J]^,QCKQ?',86Y*>NM)CV6
M>DI'"4-YIPP'K6O62+ZL573.P:;#D, %+UREF=(84,QTT'=,(Y';L4]9C[DZ
M)F50!K0'2\,1D2IC-R?USP3:1@:;N0*F(EZ2(F90^(X[K8X6#(JSK"=)6F_3
M)TD;PED>SF73K(QWZSK$]I#)@>W>#@"3?%;L<+O3M+3F M$<AZD]([]+AO3W
MF6(-C;WC)/28=>56U&=.;O $PYB5F])7?X[4#N/GO]\1CF#B3ZEB_'IU[7Z)
M*ETECH.++^XK/;XX]OQ72Y\-Z?X=7)@RSQF8;6C'G4]9':25^J?RGRPW5J?/
MZQ3G_C#8L]NLKKUX?63\N# >%)!Q-+)_ ]BY]^DG5V^'^;V"J?B;^U7@LQ7V
M.E_;AJHH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M[,EJ./>^5_X?HI<YTOW(Q(%FV&"EC.=8>S?!7#$BIW-Z23%[,"M28C%Y>ZO
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MJ,J=+:\%V["\^@Y%6S%)<(HZ:T$C<]"UF)ZYVWJ?3F-^CR][,J7LUG+?%&R
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M>?IS+1NC+##;>DF_L=LRYC4FZ>QOT1E@KCRO6YB,F4C8_#A?$;4RF+)E'39
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M\Z63RZEXIX6:]SMV2Z\]IV*73O\ '<.NG\)#=</ =CAM2.MGGPIVK<)[H<?
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MO[<NOPW/9[%U/T>8^I?.[7/9]GI_%J(H@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MK=(XT[<0+>6:QFYTU,.;&;O4M3%_4Q/#FL=KBZ5R9:Z'+)7KUMY9MG"V:7+
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M$<X>M<N\SJ-=;MY$OWMZS%2<+C;3U2RD?#);6.I:G\H[]LY=HV\+((" @("
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M]RUULCE\N9*F&\'N('XM]WWA[EUFYEX;<5L2^$#8/#=C]'GS5D2V6)>EX/A
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MF_VCD?\ YF5=#_NZ;_C+I+ISQ;G'T? !\\$S=UK5;;?J]1VS.9=]^KY]Z_\
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M7W%3,2]*E*:=  QPV9-VJYR>ESE::.HLM. Y7K.-NN-..H5<&F$+MN72F/\
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M\QGB  "-P/.IA9FZ<)VGQ ,,O6MS4N2RJY64H8#?877]*S;FZ7%X5Y[6M<1
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M&^!&RTP4[;.5_H12-EC>W;LAW+,^B8VTM0F4L?=W;.;F5Q<?=Z_C[217)[I
M!-F6&(6;GP[3O.%<K72B'0ABM]?NQ>\5*I$O>-UPRS5LVOM*C6R93G",-O*$
M%FGOXB=HJ22;("\8!;QI;\DG*ZT&GRCNQA" RYUSS%GR=<.6IZ?+##NC"%V8
MYE9<+[]:H\_3]]S@1B<.9:LRE[M!^A2GBT#JPAZ+E+,,]>^\(V=HE/+B2&V&
M)]U(UV[17ZRFI)(-C8@$W#[JQ9?\,_V27"I5,VG:^#87[+XK4FEO>89Z0RWW
M0MAV]REY/>>5STREB\.M^'LAL2PO?Z<.Q:*61+:(8>L+EZX8[=I;ENBE\0Q@
M<N76K=)[1+4E) MOORVG8N?Z-2R\K;0R"QH-]UO2F$O>96!E29;0([/9?DF$
M]HBJ^M.Z;L5J?19VE4#4*LNWKKT[:XX.W:-.DFQ-IQ$.72G7!.TK>FS6M;@8
M&.!6I#M\G6-7ZW+&75[5<.7LVF537  99+G9<NG7MU\L[:A@@8V\W<LX;S,_
M9D%6R(NOR]JGKC9?DC9E5+=Z%F?H.W8NDK,[SRW7SFEIA#'L6L_5GY/DEB&F
MEY<=TF'5BI=S[O!WDSER;+<1M@#?F-BS<XTYV6;ZN+Z5UI@<]B9UM.>6C.E/
M;&S+E<%J->L\(V;-=+C?&(S[UFYJSKK-:1KW-O-VU67'+.'G\[D8FW$$PMS3
MMB[3'EI39;JXQ$3$GUA9S2WQ6U3:6]D# ^[CU]."VWB)^1*F,%QAW1P5\)8V
M'U$Q@(B?NE3,9];AH3:UYC$VPVY]6"?HUUXRU?&+SC'EMV(N=-I@:3;L4QF&
M,\+)I%'+G/99>Z/:K+)RUUGT=P:)I,IK 2!@;MG2IF5Z)QI8:^1)DRK /AMN
MOO4QMGETWQ'6-EAT(1M'*U:\_9J232BTU=O/)B/BSR*G:XNDL7O2ZEI:P$BX
M=@VK.[M)+C::?-8V!LQP!R6NIC#!]<E1W8-OA'T15MT,1E2IIWK+;>VX+%QX
M:\.#Z>4&DV7'LYEK$Q]V;F*SJ4B66X7'L!R5FEZ3EUAK,N6S?(A>>V.03=Y6
MW%PZWK*MLI[H0L<>H77%)I.VN&U0:XUCV>]"%]NSI6.TRDR['TG7V.:V)LCG
ML%JLP=>V:L$^N95,&Z1U[!ZTPY?(QT4DA^\19';W!6S'#EUFUZHBR(N^'O69
MGRMRL($LM$<0,ULDUMH5$F6;H6]UN"DR2:0L^6 # <H'F3#E9<M*T9]"F*8K
M8IM[?!MO'K463:]TX:^F ^ENGGC!7%;];$!7:69I):#F;-FQ22Y77'E&R]*?
M*>"0>>!R6V<>;PEI<U\EO-=?M]2S8UQN-:IJYDP0C808PZ8;4F/+$N:C&R73
M'6BTD6\\>A7SF<+UESM8].I0R!.<>B'L4[9=/LLP8W=P^'/8IUTQ>EJ"U&02
M'$ 0MQ*WR;FD=2TQB;,1GW+/:7*7K<)YDMS6V7 ;<([%)]+RO7<1M4QY<+[S
M?',[%9+&I&-LEYPPCB,EN5),5SJ),S<-UQQYEE5:=+>V=_PL"?4JEF:LFG!\
M1RQVK-9L^JULJS*8!'E *<IB-6=K!9&),80,##-.&N'&1K!=$1,;K3S04RN*
MS3:Y\QL">@+4A(C)A>XQYSV*_H2)&BEO=81LQRAEL2K=+/)TKQFBR-D3$='J
M65Z3+2K=$+&FP0NNV12XSF.UGB.N-;TGW7V8CZ.Q7.6'1_$V@AXFQ C?8V.*
M-29= :]PZ?$F6&YWT1WI(F)G7"HR.'29@$'7P^'V[%=+<>%_T3A$S7 .;9[L
M;,S>5$CL^FX-9*E[Y;A]ZK-&9*G--T.2)@$!<,(9*Y:R[2T?0Y4&& NL]T#%
M9E8Q%_I-+DRV@D"X0@W;''8LW-X),))LN5+.&.SU*QNSS&=KFX$0A@K,93J\
MEI>##*/H3MO1;BH^=ITR='=C?&,++^Y/6R)[.=)HLYLQKR"1C9M]BEMQIF]<
M\+Q0OF4K6BZ$(1R%JL2RQYKM5?X;V[#CSK6,,^KJ37I<RH?,<(VB\7W!/NW.
MMX484#V3"XAT8Y;0IVSC">MB9I6N8877]B3C[IBIYCPYD#?" Z!WA5?6QGD!
MC;3RO[U%G3M>.&],F2K+L<MBF3TK5WFGD.]2[/2UR9'#)(Q_7<[89K"[>LY8
MK34ZWB(QTCW^8Y[5*UZ61OTLAI="S#+/F5G&6?7ZK++D,9++C"P>KF3)TZ_N
MTA:S4Y5.7 EMD1?LO4P^AUX0%1Q)*DAWO#$CW@I@MVIVH\:R96_[S; ;W7FP
MK;3K[4O,.4P.&^VR-SPEI+]'7NJ>8TLQ#7CZ0^/F0W%#K>/P\N]\7F]WMS6;
M+>#[JW4<:ET6Q%L#8Z-D%G%,JKJ'%+ID2#9SK>,U9OGE5YO$,S>C$V_LSMZ$
M[3PSG#2.M/>8$NCSG[N"S#+(R;-J(#WBM^%G+9;I$ZHA .(B(V$WW=BF,K;(
MD:;A28\Q+78'X3B>9+E,[TN.G<(O :2TW _#L&Q+I+VLN':O#'"WXZ2"W[T'
MW=JO7-QEGO9ZU[(:)P?*9(E/W1']JN]FGS._:V[6^GTJ72F %H.0%H4G7ZL+
M70SA*@!"-A ZAA<KZMSA9J>O=$6B_P#<IPUZXF4Y)FOF0-IQ/I1)<MOPYIMY
M=B82XRXNDS-TDQL&9Q'L3@S%-U6JF4[X1L&V&/<G*^S%1:DYQ;$WYF/K349S
MO2\T-1O-$2,,N]-6_=,7EOU6XZ3A=ZEF\XC4S+]G3W$TF+7D#$POVJS6EN'2
MU;*=XYLQ.>?,K<>7/$M6'1I;_$EV99]RD[8X;LT[TX8B!*WKMO3@K+C@S':S
M9S&R@ <!V\ZE_<6Q'3:D V&!CS9[4D65SD50)@3RLVJ6XX;QF;;+ZAFZ8G \
MKU)FUC'JK&IU$OWH$'ESK5K':WPHU;JXD%Y!NB+#B#8M>T1$RN+7LF-:7$6_
M?>U&O&EWT[7754L6VG;'""8,Z;<\NFVMM,([/7FL65&&GIGF9'+V=ZOC[M2K
MQI[2&!N,/6LR7.^%MCGJ6GOG2'  Q(Y;<%O4TSG>OJZFU?0IC9KS W6^[[5B
M9JV:^[CH<AU'-$1\+XF/.MRI^B_3]7E-D;KR![N)5KE\GA5)]72U!/PVF%F-
MZW)IRY9J:@IIACNVWW<ZU'3K+.%QTV132( @"S(*8\NN?JG'5M$QN[%MG<5+
M;7I^+41DZKHGFS=-NPXGF6<O1K+?H7T1<SX;\F\L5F_5ZNFW9O#U30A\IHW(
ME[<HV$"Y3*V8NN7Z%_+,9;]=IW, A]8I_P )<[FO3TU'U:?+>T?HG(L_YK)_
MDUGO_%W^+^3V!J?B;^U]:^?VY?6Z7]K566A 0$! 0$! 0$! 0$! 0$! 0$!
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MHZFF;*F-WV!I>YCFNM:6N:TM((Z$PDOU5BMH9VG3#*GVN&+;1T':F+%S+II
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M! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$&YI_\ 3J3^&9^$$G)>'IQ]HY_=E7?V;-_QEN<,3R_G
M[_/)_KK5?\WJ.V8N^;ZOG?)?WW#Y[^,YCOS\\$_OC\_OE,RI)E5)KX.)WCZ<
MTNFO&%GT:=" B>4,U)4B_P!/.]QHYN5Z5=MITP$7CI4RLW6C,=O97E9MRWGP
MPQVKI,8<\TWAF/0EXTLSG;P7;1Z%C!<YTQO-]OT>]:DT9^K2F.(-]D%>#$K3
MF.%EHQ2V^&<-1SCGV)9IGCAH3G&V)Y0"ECI)K2'G&/+G6I.4MJ/F7NYO4C*/
MFW]"SVX2\H^8X@V'!(Z1SD/()M'3T04N;?L8B4ES0;(BSN6;,;B:;+7Y.PV+
M4I.6PUY@/>[%O)C]V?#.V9 "T<BN=DMR8^G#SXD;(BVRY62Y3%>%O,1YWMWI
M6;OA<6N(?#$+-GU7-NG%TPYV$K4P6:8XQM6LQ-QD:1 1(Y%9O.C]7*(S'6%9
MP$1F.L*HQDQO6=1TPXDPR6<%OT:[W9$1CWX+?@_5BF'W#&^'I@F6+NHI\W=<
M1'E$Y*1J1P\3>(B1ERC:FEL<MX9K/M9J,X-X9A7",TJ_H2+&X ( B];7M]G-
M@M'/ZU"28VG*1[@(76"%_.IC;-D3LBHN$23S\_2MQS[]=93-/4@;M]D,=J=I
MRYX2;)\8VD77E9P9PRM<8WJ6_1+<\,K2+P1%:Z_<Q&S+?<(C'UJYPEDPVY<T
M6"(Q]>U8N;<L7K,,_B?LO2KFL9Q,2,C)IM]X88\^U9L^C&/JW)<^V^_;S=ZL
MW/NY68VD94XB%N'LYUJ,=XF*>83CB.H?=2QB7/";IYD0!'T; ,E+3'BI6F(W
MK\NU99[3''"X40:0W:/\5=>ETS<)1L&C*W-=)<K)Y9K!L4G9G=:TTBVWZ1]:
MU;F(TG!VV_O6(Z=>=\-B1,<V$3##'8KAJS6D]3U4&B$;1"PY!,7+/7[M:NJ2
MYIM,=IV#*"U1#TY>YY-N&.U23ZII9J!IB+#\2U4ZU<:+>@V.:DB]IM<*-Q#1
M XCO5.LB<E32 !B>X=RF-)>TS]F0S3 C>%HS]JS5QHDO.^ "3':=JLFTQI9J
M1S@&PC<,\QWKT]<8>?6=IJ5$VVX9K-YTU)UMF4K*$0++A]ST*[+C&$W3@@6X
MD976)M9UF$HQX8 ;+L[;DF<F)-L[:S=S&-ZU77KB\LC-3:UT(GKV+#IZ>5IT
MSB.GIFQ<X87N',;\%<DGAJZOQK1ME/\ ?!,/O@,.?8G"NF^(./J:7XFZ^$&F
MYPPMS5_;Y=>DWFNC->\RI+7._&.L:?ICUF*>,-YWB.EM<\S@7$-FO^DWX\.M
M1OK]W36O>8;IH>/%F7F'O^U9R75TZ6UOBZ=.+X3)EKA]+.W-:Y=,9469KD^=
M,(WGVF%YMB4GW9O739:Z9/:(%WO"V_TJW$W'E[8&Z3/J'6!T"3@<E&9VQPD:
M;@VLG$$--X^@<>8*1K.9EVMPSY>ULTB+#]&]KH0A#+:M6,/:?@CRQJB^7O2A
M\ ^@=FQ8ES^C'MC3V]X-\L"&R'.E,CN#Z&)Z%JN??A[ :+Y:RV2Y9=*E6-^\
MV'8M:8ZW&5RIN#J2F$#+E1!/T1LA@E2\MX\*TCQ[LN5L]T'%1C=89G!LMS8-
MELNC8WV*>7.ZJN5W!,ZWPV#.QIPZ%<L>UPI.H<&5S =UKA%V (SV9A(95:HX
M;U*0YQ ?9&X."9S&+VL:+J'4V&^;8/V6"YV8N4E\^4SHU?74$UIF.F@!PC:[
M,[5TFI,<LWM;J\.U-/XV,MC6&8^P_?<VU+GEQMW5\TGS$ELW8S'6&XNV#:IC
M1,NUM&\SJ=M\UP.[]^+^N^Q)E;;Y=ET'FK2 0,TW#Z0V?L@MTQA8&>;-$!^5
M/^&.?/:FHE_;64>;%"?WT_X8/K6;5S]&*=YI43F&$VW]N.?/8F4W-J7K'F?(
MF->&S28M('O#;M65Q.70W%'%YK=[=>[Z6.RY$D_X>O\ K555SIA+'3/B-Q*N
M*23+%H\VM;/#MZ9 0)M=G!:AVF'LOP1K,Z4ZGWW/L:V\G <Z7MX3'T>UW#/%
M4MDF0'N,=IAB87E8K4WR[,D\44KY8BX6YD=Z+F<-&JUF1.^ BV.(QBM3!;EB
MI:C?=TXFS-6S3GY773VAP$0+@N=CIA;),E@ ) /W/:M]<68O+,EE^S,YC "8
M"XWPR5N<::5[4'[K70A<>SO7/@O&77>J.B7VVP/9!:S;^CEC>^%)J ][H6V1
M!Z^E,-9TQRZ.<X@@$]"U)]5SI9*"AF"!,8V8="F)G"5>-.I)D1S# YJV?1KJ
MN^GTKSNY 9%2:Y/6+4RD:6-L%PC8<@LWDEG#/]5!P'+F*LC-KPZB:1AAAR*G
M#IUN-C:)IOAC@KG$=)BS,Y<74$HFYN&'L7.YO+<X9)=%+;=NW\NU7KSA+=IN
MDIY;0! &&7.%;5\92;:=ML +>62L[,9RX&F8#$@+.9='MXC9E4[+" +AE>K/
MH7M;&Z91:V,(0'JYEK&#F80]54N8( G&X\ZDFCUL_15*VJ?!UKK;O2I:W+E6
MYM2_?/O'J.962QYE5;VNO.=D1Z]JUU$U3UI-KBX7X\ZOZ)<^$H-1:VYQR4W6
M</!U3WH;Q]*U(LQPFJ2I\5D8X8VK-F.'+M):PU,X,-ANAR]"1F6RM%U;NPM(
M%]_+),V<+VS6E,K99/Q1M.,47QMQDU+'O@#V8K3G[5/-FCPK/O3RO4NFLU2N
M))[&TYC]Z[L*?=.UMZO5?BZL!\4#>^-PO-P)6I"<.E*BJ G/C$6GZ6U3./T)
MC&TWIE>-]EN&9VI+?"]>'=7"M:V8Z2"8Q.>96KP=KA[#: &.EM( /(+G[7_)
MCS%W8QI@"!R";;ZR7KFL_@RL@K&+;+]GE\IGAGW18#R]*W[+)<9=;ZY*W7NW
M1B8=94E^J13*D.$1:+\=A4\L[J$FEX-A(M*Z3%BRO$I[PZTGE')+CPLQV3U*
M\GZ1O;FN=-SGA.2B=T&.78%C.*US&<.LM*W[,V7PS,F;;!SJRYUY3&_W).06
MD8$GV=ZEF/T6[FF9S1"[')6))BH^>6MB1#/LRYU-^6K,M;?YN72DL3U2=$YL
M03"X&[-+F_HLF*M-.X6$9#L]BRO;"5$UA%I"N8QGQ&O,:TP,!;L'+%3EKEBW
M69#T)@Q(PO ML$ <@IQPEGT:KY\ID00#8;;,E8LX0E54L).[@XE:DGE<[0\V
M;?==D5N=HQ9EHOFB-XN6.URWUD8'5#0#S'$9<ZQB92W2!K*@/W@(W8VKMTXV
MS,SE5JOWR<1;<EDETOK+M$?5B3 9V7]RS6>.6W)HG'=-G5LVJ2XTN/HD64CH
M#N.:NS;*)#QGU>PK./)?NC:QLP!U\ #CD5J1,*M42C,?CAV1]2MN&K<);1M/
M>^8VSZ<,><*2[8YV[OT#2IK6Q ,?=A?ES+5K4CL25(FL9&V[:N?;'DOT159+
M>\$"/()UOAK6,*I6:>]X<",<L#8MYQ#&)EUOKVA[XF#=:8C+I6>6<NE-?X3W
MG3#N-M$?AV'8MXS#&>'5]=PV)#C!K08DV"&U9EPL^C4IM.<U^["PDW++.:O>
MGZ<^ OA9GD.]:SB?<Q4I/;-IY=D;.T ^I3KODSA$,U6;*G0BZ%MD<_1@M23&
MS%_P[%X>U033*#CB+SM4OV6=NKLB9,ES:<770PQV\RN,;A;,(F1)EB<# 7[%
MK&8QBKGI_A,$8"-GH"YV7PWO&%NIILH &RX8#E@I,Y:DPV)LZ4^!&Z(#8MWC
M!]T%6F6\./NQCZHK'\>$ES<54*^4';T!9" /W.9:Z[VS=72O"DF>(-AC=L2U
M,9Y6>AE$-@X8<KU-M:DTP:E(#VD0%SC</4%&N73O$=&UK7& QPYCZU<,<.D]
M4+93YA@ 0XP]:SC%66V_9CTO51*G-!)@",8??!:N"S;N;0=7;-$H;QM@+U<Z
MTSOR[6T]K*I@NC"'4K;F+<>&>LHVR&[\ +SZO6I+6L1'T\X;U^>>Q:[<)ZQ8
MZ:8+;1\(S69,Q?5,RWV"T7V]:619ISF0('2LEF8TRPXCT^U;M^C&<.'@@X=B
MSN$N1U*7-( %H.&SJ5LUE?;&E?U'2IFZ'-;F;(\XPV*2V)SMUUJ5-,EN<#&P
MFRWU68J7-:F,*I/I'S21",=F:26)A"5NC.+22-MQ6K)X/.U#U*@,AY(%T+>8
ME23'*VS!I<US9C&@_2VY\^95D)/+O'A.69I$;;1>M4U:[+F:,Z:-X ?".L#V
MKG?LSPQR](,N\#E'O6NF<-<QOLIA)!,!U)<TGW>)CMW)9B=HAZNH%K1C'TGN
M6LZ<[U^B&FASA&%_L69RZ33PRCF/M(LM-RMVEN*Y_47,]^&$<<]FT(N:U)LQ
MTL&TW;?N(GZHU]5F38,[>U%LQ7B74[S@(GI,<1DK(NDU2P<1$ Q-J=L4O&(L
MU/3-F-$87!6]<1G%C*ZG:S+D-H6<[PF,;1<[<$PW+<ZS&V,W+@ QQP[$X;K)
M,HVS91L%YLZAZE/;*]?NZLXLT:,NH.ZT96<P5F(M[2QZI<6T#I4Z>80W1'J^
MZLTTZG^O>!.@7&(=W]ZFXUB1V;PUKIWFM#G?$!?S!/.TS9NN_=$K!4,$3&QO
M1:2F5S*NLMH :X"R B<.5JD3UD;39C7"_EZ5+,)^C/)<TNA$8=H[UTGW9^Z=
MI0WW;!\1P2SZMS%U$TUC-T6#:I+]&>^8\36M:PD-$89;"IG>R;0%468P^(X+
M7C2V=<*S5;IB!#'#,I)IC/T5VITPSR3 =6R':IQ<DVU#IKI=X SLRZ%+URU+
MA&54OPX@[#&X*1JW2)\9H.T<LU+<)G.DG2533 ;1&[8I*LUSPGY!WH<WJ 6F
M;NZ9IDAS^KEAL6L9C4N&NZ29>&'>DA-M=^'3ZEE<8<Y! >(YCUH+'3.]T77
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MJG-6R=?W/BV^S=^U*\U."OFAX4U+C;6*Z;HM;72IE2?SE.?+8\5,K>\3Q P
M.#[.96?MVS[7M^WP_JU_+?YS<-?,CY4\-<:Z+-ESY<W2:%\U[)K)Q\>HIP;2
MTF%K%<Y9L];B<+E-8Z7.FRW?0>6]1(*C3@@(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @SR;^D]B!-]8[$2<,"*(" @(" @(" @(" @(" @("
M@(" @(" @(-S3_Z=2?PS/P@DY+P]-_M'?[LJ[^S9W^,NDX<W\_?YX_\ 76J_
MYO4=LQ=O#YO?7R/GMXS$=??_  C_ ,*"SC#4JJ3A:1F0/^,H)C2WP<+18!EB
MDY,XVO5-.]UHB,%NXPOMG3?;,OM'2L8^JS3PIBM9C&[UJQF<N"TH@X.N/,58
MSVY:4TV<MB)+BH]UYYRHWX8'W=/>M.,Y:-1R]"S7;KPB9EN]S^M5CFHZ:2"1
MRR1;,1HSK+<8=RSVWIG&:C)A$;2+DX=9)AB$S=NA;RVI+]4Z[Y;DN9&T7P]?
M-L4L3MUPW),ZV!(L$.W9L6IUS&,MP3#80F/#>9AG9,NC <]ZF,;\KXTR!]HM
M'7[5,LYSIF!B%,EF'!YA"T8W]"LI+AC#AF.M+<I+ABF/,,+^])+EO.LO,M\8
M D8\ZMFLLVXN7-SX'"Y)J+CVVX[_ #<NE7)ZF_S<NE,GJY[XS"S=F:PO>=EZ
MU)C:=;&#>@8V)?N7MG3%/FP81C?VK.O\(@'SO>,87GMYE+/HZ;<?%C<0IBGZ
MN;'DQC#!6:/:,S+3RS73PSVX2+&PM$38%F<LYPW)0WH1R5[7"]>65MDP#:/4
M4Z[7MPEZ>V',/38EN(PD&>[=FIG9-\M]CS; C"Z"W+K-9L^B2DSS"$<.[8EO
MAS[=<U)2IV]>1<.PK.,;9QZQLM?"VRT*2DMM96ONNBI:7+*)D,0"K+B.7;/^
M&03[;^74F69UVS,GW]'KV*U>TC;ES;[1Z$^[E>OLDY$V,+1R!4Y<NTO"PTKQ
M=9>!V=RNW*=<5/T^'+)1OMUO*7D>Z8YYJR,3>EDI:C=;>++!U0R73K)-)VZ;
M;S:N,8D<NA6SZ#;;4[V/+J5Q]3K+7D.WSZ;%>3MU<]PN$$Q,F+(\>&1#V*DN
ML.8>6&^[#GVIDQ1Y,WE''H1&U2R(.N-IV[-J698DVLE'+#0"1;[/8F?#IZXF
M5AD3-R R]NPHF,[J9DUK60MOMP4RW.M2$G4&$BT\NE:F:G;XTFRHWH6Q[HPR
M6K(Q)4A3&+VGLYUFS:KA2-BUO+)=)<,7X\IF398>0@KYRQ/CN<)-C@RWE8M9
M:_JMC;-<V6R_#9DI,Y;GQHRHUV7*!BXB]:MVM^-6JOC"5)!]]PO!@87'G6=U
MTZ_&K=3Q])E[Q$U]AS]<8J5NSUBE:OYLLI0X-J)C2++'81.U/NGJZRU7SC\3
M>'UJ;=#XS^Z6M5OUPZFU[S6<_P 2%3-M:ZW?/9O%8PTZ8UKS$F3GF$^8?B'Q
M9$[5OPU)Y=>UG%\Z<3^.F&).)R*GETLUI#OU2?5&Q[R2<2<;L5JR,R5R;03J
MB^-MNV_8L2[=)<:;]+PU/>]ONY&ZVR'>K>&?DNE]T;A&?-=+!8#$@0()M/0G
M7%>.V9=W\,^6,VK\/\0PQF-^C@3S)Y<L^(]C.&O))TYLMQI)5I:3%FP;#FKC
M">WU>PG#/D;N0/U238&_0'[E$O>/8KAGRD;3AA-+*$ /H#UML6;,,6R[=VZ5
MP7*HF2XR98W6Y61AS*^4]I>5D-)(I93AN,&Z+X#"./0E^SE.SKS7-2E4\P@$
M7X<\$9O=AT[5F30T1Q ]>:K,^3EV'IOAU $0TB[/)6XCGV[[76ET&1/ _%L,
M0,!GS+.[6+WTVW<!RZEOY"6<?A&W8E8GR8VA*SRL$P$BFE@F$?=CSX)_[GMG
M=52I\I9AWMVGEVD_1V']BLY^I>TBBZ]Y63Z=CW"0UIW2;&^P+3G>^74]5P;6
MR9K@&D0. )5FYA),\L#>'*^3:-X'9$<KDG;%^S7$2%/1U\DCWWWYG*.U3.-L
M)-M37R_WR:(;3@.<YJYRN<::S]9K99MG3>L^Q39,5C'$-8+!.G=9]14N?+7K
MAG_2&K/[]-ZSWH,8U.MJ'@";,.&.,5<>4[+'IVD55<?>BZ,+3''M1G*W4_EU
M.J3'PFD$1B6QQ.S:M2Z:X_5-2/+*;) (DMMO@W"-]RSG+-VGJ3AB=0$$- W3
M@#9:,,E<:7K9%@E5<ZB:T;[ANY$BX1YEB9R7MEQF\9S*;W#.??GSK6$QY26E
M<<>,]H=->?> ^+:=NU2ZWY,5V;IW%$J_?,8CTP/K6NMMU>!V3I/$\EQ$7W *
MV1GVLX7VFU^2]H@XGT8>Q8WG,=<_5N'5&/:;3C"W9SK6:S>T1M14^(" 1;O7
M\MJS8EN5<JJ,SB2+SG'8=JLTEVBVZ2YS[0+X^GF5R<32<IM&$![H/7L5SK+4
MFD[3Z9N0B!</1T+,N4YJRTE% M@WJ@4S8WC"V45-N-;$<]@V!2YJ\)9C&@$0
MRS[U6+/+.9(PCRZ4S@DR\>%L<IG-RU9K##,(9$6771YTQEKIJHN=4AIO$;=M
MT,(*NSA+K6Q@XWFRSVIJI?JF::K:=T@BT1](YTI$LRL %XPP^XI)FG:2;CB:
MH$WWDX>PI)LLGKF<I"GGMS%XQZ<E,X8N<?X;[IV^PM$+MN 6\DJ%J*<OMMO/
M=FL9K7MG2N5E"2#9#&TGG27.CA".TUY)L%^WN6I(EN6>3I;L0+N[8LW7#4Q&
MXW3'B-G;AT*VEKD=-> 3W]RS[)+6@ZB>UYQM)[=BW.VC%O99M/EN;* (P4O+
M':8:]8"V,;+O:C*N5DTMB(XD## Y<ZUUF=I:@)M26NM)O)O-W5DK6-URIZX,
M>"'$\Q[RI-I(N%/5-=*)+L/4LWET\*7Q),,R2X X&[[BLXPGG#U=XQ8YGB.S
M>[#G.U6)G%PZ U&L+)TR)A!Q&.=MBEX7#C0:M":T$FP[,N=6:FDNG=O!NK O
MD^\;QEMVK?$)OE[3\+ZDTRI=IM./W5QU+DG9V0RN86VG#(=ZU+Y;O&F)^I,8
MXP)LQZ89J7=RS>'-FJ,<($FTP[-JNO\ *SMB80^H2OK'OM$<>B]2;F5FXJ=5
M2VNB,3ED=JN'/.$#,I"7?";SRQ4]L:6SR,H'.(@ .?;T+7MHD62ATMVZ+!?E
M[%SSM>4P-,? 6"X8>Q;3. Z:_9=M3![,#J1TLP.0NZ<TSCAJS*1HY.]?@1VC
M:$[7,28B0?( 8XY#EBI+,KF*Y5C=)&SEV+=2Z1!G0-N8Y7+$Z9XY,Z^Z0IYU
MQ!P'H@<EK.)B\IE/R*[=9\6 ]:7KETQ+&=FH@N )-^8]13T<])85;8 APM R
MRYEEJZ8)U4QHB'6]:3_T3M+9E$3]2#8@1Y0.:N$S8@JC4 ZW>-T.W:IG"Y1<
MZN:(^\8D;=NU7E)+6FZMWKCA#'[BS<X;S&K,J;K<#GW)U8S<Y:3ZBR\VV7GN
M6I,UJ\-":^-L;?N<RWQIGEHN8'&V*SDW-,LF3$BST;88G:I:N,I633W6"XX#
M.&:DYVJ5921 @/0,UO,*Y_40?HCES!9D8N43JE#NRG& Q%G,<P,UK,X:NII0
M?#'UC=AB0G:>4OW=B\-4'BN9!H^-OJYUG%+/IP]@M$TT!K1N-N%T<#S;4Q:S
M+94[4T>Y+^$ PAT#G@I>K6=Y56?* <;,7>KG&*G"X\M"?):YEPPPY^9)FFU(
MU6F9%\0+=FSG6N$]:Z_U33Y3FN)8T^Z;PW+;%6=DFG3FMT#&S'P8!9A"&/,K
M)GE?NJ4ND F?"+\MHVK-U<)OE>=.D-W-V B1L3&LM>VG'4Z3\22&WY 9=:1F
M<NKZV2Z5-?L,%;6[PDM)U$TSVF)]TCU'M4RYSI/+LRAU]LV6QA<3&$8GVK<J
M;S]EBI*EKX.!C\)Z^@J6XJWMF+31O)M!L+MF7,DN6I?VI^5/+0T$X9G*.'.K
M8LN8Y3*K=%A-QQ.SFS6;*EJ/?4[QL-^T\V(6?L29>1),W#+E:M99\MH::XVA
MK?2LMR/#Y7@BZWNM73&9MB\HJK(<QQLNA?S]RY\5N<.JN(I1>T@1A;W;%NF9
M8Z(X@HG@S'0^D<\8YA83.'73YCY$XF)LL]/2C6<K]P[K9EOE@O=>+SM6K,1F
MY\O8+A;76.#=XGXAR]"B1=ZVO9428-(Q&&/,M20MRAJ?XCSGU+5X19*<D <P
M'K6)=XO#4J8ES"&X<B=J=L>%N67QLX<NM)URF:\&:.7W$NDO6UY;,$>7<K9F
M$EZ[;<B8TN#>5IYE;+A9,W-X251(:^0?=%UEV$>]<LNF.O$=;:IIGB3'>Z!:
M[G[%ISLQ4&-$M%@O&:MNC+6K]&:)+O=;&&4,>93K=+S'4'$.FECIMC;+<<AL
MOL5[<N<RI5'2F54 G!PNROQ3+I.SNGA&H:QP!.+>7I5S7.VRN^Z.?*?+ $([
MHOS/7DLV;SX7F9<YX9NQ]W$*R[TU+A!U$P $#MYMBU;E;9)E U$^&\-I[#L4
M]8SG.T4YKGNCCW=2OK&<UN4],7WB-FS;MV*68A<^$]3TL+(668"ZXXK+766\
MLU72 220!\,<-IS1;,3*AUT@[QAF>5ZK,WRKTVG=;?=D,N=2_M;N*Q26%KK>
M5HY\DMRS(GZ*<&D;T+X]'I3!YTL<BN8UM]PR%UN:<Z:S69]:U[3;@DEG9F_N
MY14]V];L[UUS*QUFV!DPM<-O-DEZRNF%EHP'L;&V-O7!<NVLDF5=XAHQ-D3K
M!CZS@F6+UQ=O53CC2234$-%SKHY<RDR3->K6KT,R75$X1]JZ.J:X><Z5,9:8
M[[<>;G7.\EX>R'"LXN $;?=Q5Q6+JNX)#8R1M':%G.*N<\L0;N1$5JW+4Q(S
M2W;D3RY6);:F(DY57NV1P]?0ES6)JY2LNO;NW\HG:I=-R^SC.U!I:1$\^%QV
MIC.TNJK]551-]D>;U+48N](1U0'3(1'*.Q:BR>%EH9 F2HD81]/M4PWAH5[&
M@/LNB/6M>&/.%$U2 #BN?;7#=DPHM5-W)A@;R<>Y23/*2R;;-#/]Z^V(Q]BU
M>NE[;FEYHIQV7>W),).N(L$MP($8#I3.$YNVK5D!MG*(@LYQ&M1"/FB,#ARR
MV*9VS;9?L\-F@&,>74K*3M:EY%4 !;AEMADKDN;&Y]:!%XM Y7*7@DJFZ\P3
M)1Z>6"IQ=O7OBBAW_$L^FXW6>CG4=-68=!:]IQENFN@+'$XQO.Q=NMF<,3K>
MJ@S*MTB:03#=M"]/3KJ8=NO&UCT_77LW/?<.F%W25J[:FEOHN)'" ,QUXQ*W
MX)BU>--UWQ0 7$VB\QRS6/L<73L/3)S9Y;"V('/A8F<:6[F5ODZ?XK00!<#S
M]JF=H\3>'C,:3X8/1'(7E7-B<JKJ.F.IB1" ;ES1YE.=KG'* ?%IASJ?JLVD
M*29&$<PMR2)Q<KI23&"2! ? <3C#8EY3,M1.JO9N& SQ.U&;+ETMQ!4P<_\
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M7W6);LF94[I9^MB)MRY16;-9C5NFY526RH@"$#W*,YS-M-D\,@ 1RZ$PL_\
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MG.M1)<)FAXC=-<P1P]>U+-Y6;7FBJOK#6G$PY>A3M3'KM,M<!TP69POW'S@
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M)1D/?*<(.EN+2.986[<$!!BU%XT>A.K3SN2&!SR]UP &];T!67"S>GH3YO\
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MFD8P-]Z),ZTP 6NW7UK,[VO3KS^^T-\A?(:1-D3N.-"JYM+(>\L%1*F6L!)
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MNEG)P(QVJXTHH,LF0ZIF-D,$7/,((.H_-+SZX;\AJ"IU+B34*:@E4X>2:@M
M(AO?2P(*LLXJ^ON]#O\ UH/(?](/S%^DFBF;XHDQWV?E([L/B^^4MPO]6N=O
M?/RD\^= ^82BIJWAJKDUU-.:V,RF +6,-[B6BP +?M,:<_6]+FN^:QW!/"<I
M\[7^(:#333RS.FNK:^GIA+8QN\YVY,B]P '3DLRXVESWK\XOF(^U>\@/(JNF
M::SC/0M3=3B8TELZ4_\ )Q$/<(R4O;;?7XM;Y?G]7?K%_D;23G2FUFC/W7EH
M($;B1]_L4]FOZEQX._6"/(OB;4644S4]&IVOW??(W1:X"\OVI[']3]=O(GYJ
M_)?YC^'J;4=#XUT6=5S93)HH9=;3R9L' DEH?'>+2;HK4NLL]NMZ:=UZMI,O
M3VMJ*)SJJ1- +)C?>:0;;'-BTCF5LUEF=LW%0S22 2('$9++3R@77H.4B545
M$[PY4E[P<6M)CS0BK)DNIE89\GA3A^2VMXAUJFTLAH<X5E5)I6L(M(+9L7&$
M,DLDK$[7M,1Z/?,-]I-Y">0;*BGF<;Z%73:1WA&6)\J9!S;P(;I(CL5SG]6^
MOQRSE^;G$/ZPWY&:+5SZ=NH:-,$HP#H1CM^-9MPU_4B=._6+/(VMGR91K=&;
MXCMV,+HG]OM4]C^I[P^07VO/D%YRUE/1OXLT33W5$]DD$S9;#%\(?$XYI[)?
MCUJOTPTO6?+_ (YIVZEPWQ-I^K>++\26:*MD3B2]N\UKI+ )@-JU_*L9O7E&
MU=)54DS<?3S&MC87,<VS V@8*^N%ERUUE0G*^%@Q/0@D=.TV=6O;XLJ9+D6&
M9,W7$,;B28606IU2W&F#B3CORO\ +2AJ]2U_B_2M,-'(F3WMJ:^F\0F6'& D
M@$BT8E.M]6.TO=^5'G;]M-Y!^4^K5&FR^)M$K_ $R+@]CXEF\+VN%\%G.:ZS
MXM;KU+J/UC3R-DS-P5FC$;V[&&V'WZ6X7^I>^#OU@?R)XFKF4C]5T60'.:-X
MD#XB!B[ )+D_J?J[Y(?.;Y&>?NDR)NG\=Z&VIGR&36TOUR1))\0-, YP= B.
M*WF2.7;X[.V7L35:7ILVF%=H54W49,SWMZ1,;4L#;(.$R5%L#%9DRU+]5=!>
M'.;,899;&(<"#?#%2QJS#DB" @(" @RTS"^LI6PB'3I33TO ]:AC,>H/VF/S
M 2?E_P#(7B;6!7-TZ;6</ZB);[OWN=+]4%M.DS7\?;YZO-BN\WOF$XPXHJ:X
MULN?4S?"?A^,J)SG8<RG.SO,7#Z.?U;3Y76ZYYU:7QIJ6B.J:85FG36U!$6A
MN^'WQN7+SAJS67],#772-'IJ*AHV-D26R#)8QM@#&"7+8.@!=LL295"@I_KE
M=+IO\L\1YC$GJ66KQET+\Z'S \/_ "X^0O&FJZAJLC3ZZ7H-=+I#,(WQ-J)+
MG-<V.QRM9DR_CZ_:*_-'Q1\POGYQ_6:CK4W4M*E:]42Z8/B6%LN:)C2PD0L)
M%RDGEKOWS,.L/DW^6/B?YE_-3A[A;0]*JM0IW:WILNJ$@.@YAJ)3IC'0O:6W
MI;AGKU]G]:W[+'Y!O+OY8?(3ANJU+A"CIN(GT5/4S9LV6#/ENDR)1WR(AQ.]
M&$<0DF:UV[8GK'Z>ZMK4VJFM%!.FT]-+8&"6U[@WW;(P!A<K=:236T$Y\R9;
M->9AS-O:HKA 9#J"! 9#J"#(R;/E$&3-=*.;21V(+!INL2729U!K)?6T]4/"
M,N83,:9;@0YA:YPBUT5=6&,\<OGR^W!^RZX)^8'R?UGBS@S@VG=KTG3M0=,?
M2-'C;XIS-#K#O0<281R1J7WGK>7\L;SU\G.(?)'CW5."N(*"HHZB@GSI3!/#
MMYPE3G2R(G+=1S[=?6X?JC]C/\ZW$_R^_,CP=I<[7YE#H-5/II;Y1BV3NRJF
MG;NF W;GK-F\M]>V?VOZW'DKYGZ-Y\^6_#G$VDU<JK;5:7154V9*(AXDVGE!
MY.USB2K+EGMU]*LU W<UVGEPAX=6QO4^'H@GE;P_.3[7O_=^XI_\/5?X,Q3L
MU\7E_'^^97^_'CO^VYGX2OASO\GT2_JW7^\!2?VQ1?R@6+_)TZOZDSW._,\@
M;Q_U=2Y_Y(1QV+LQ?Y*&TGWK3\1Q7/$5RB<SUIB#R'S&VL>6G @F(YC@AK_+
M;DZGJ4AS7"LGAC3$M$QT"!>(7+4IB)?4M%X+\RM+K-'XFT6BU654T<VCJ)5=
M*;-WI,^69;_">ZUKH/LVICRS<O@W^W_^Q+T_AR5JWGUY=<.M92396HUADT#Q
MNRWM+YI86RS[KF@W7P*QC%=)^[KCR^#'4],U/AW4IU'6R9M#74D^;++7P$QC
MY+RTN%Y%JURYV7K7V4?JX_VD.J^7W%F@^2_$W%;OJM9)HZ25*J'"XOERQ&P"
M+0["%JGETE_;CR_H[ZC,I-;T+2-2TZ9+J9=332*IDV2YK@^744TN:UQ(LB8^
ME;DRY355*!'NF\6'G%A6/.&Q4$%QX4IQ(?5SZ@!C/!9!S[&@%T28X6!6,6Y?
M!Q^LM?//5T6H:IY.:)Q-"2^=J-,::6Z ANF6;MBQ;?9UF/3'E\$^B:56\2:O
M(TZG:^HK*R9!K8Q?,>Y[0;<7$N6G.2VX?TXOU8;Y3*#A#Y>)FJ\7\.PJ*C2I
M,YKJ@6S7U#F@NM-Y\4E.6M]*_+S]::^2]^E:O(XXX6T5S*61,DZD]\CX0R<&
MO<+#"$)B6X2V]GPUZ%5UG#7%>D54N8ZFJM*UG3YY<+V.D54F:Z-]D!:GC+/G
M#^H1^KL_.HSS:\M]#\M:_7FU<[3Q3T[)!-SFR);2WI+0I.77O).KZ?N*J<MU
M,3&M]QTF4XD"P$%S3Z&+5GEB<*XHH@D=$_UQ1?P[.Q"\/R8^VL_N XK_ +%F
M?Z.Y3LU\7E_(C\Y?[X.-O_$T[MDJ^'/_ *O\OLL_57/[U:;^TJ;^48HZWA_0
M\XI)$]L"?Z.W\.8NDX<)RI()S-YQVE<\1UKS$YGK3$0B<SUIB!$YGK3$")S*
M J++PG/$JNGM<X!LR66B.8<UWJ5FV>UT^:G]83^36A\R/)'6O,"FT;ZU6RZ:
MOGNJ6F+F'PW/!-L03>G:27#77MGICR_EOEVH^77&]6U@?35N@ZI44['$$EKJ
M>?N@C,P8HS/VW+^F;^K+?-G*XY\GJ7A#7M>EU55,TJGDR9<P@N8^5X;RT1$0
M1N$)%[;CZI==H6L>_466RZN;,>TBX@N)'6%:G7MG2NBT YA1H0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$!!N:?\ TZE_A6]H2<GAZ9_:/_W:5G]G3>URZ3AS
M\/@<^<EF]KNJ70,B?VO7?$P^9;GY*_ 3S0EANJOA#XYG;TJ.DNG45,07P_9'
MU+-BR/%?L4QM=-*DW@Z$;XXG(*VX9MRL4@N:&F.0OYCBIRN9=)B1-,!&/(6)
MPEB3:_>SS6YQE,URBBR_5X<<%GRE[6W$:TQU_P"U[TPLZWRTW6V[%;P>K1F&
MT=*SG%J^S5B5I6O.NY;%)RS=UJ.-G+-6KUN+AKO=>(8*8N6[9RU7. ,+;EK&
MG*W/#3>($<RY7MM),-.9AT^I;]IAU:1*SREN'EGQ=:,7EL"Y;;G#R@1(Q*!$
MYGK0Q")S*&(("#/+N'3ZU+P7AE66!9O(UGWCF77PZ.-REK4URP/>#=&^*QS6
M+<,2K#BZX\L46<N'T3S%3R[3AB;>%J\%X;C21&U(Y=6_)NZ.Y6\Y.R3EX]'K
M3K=,L[+^CN5[<#(!!T<+/4LYTO.F]*,2.6"U+(Z]9AM!X;8>=+MJ1D^*Y9VS
M9ED:Z%\3THLPW);X9W*S%<]6MQCP;;;NY6\.?>63,9!,@0?6DZYF6,_5N2I@
M?"^P^M.'.XE;K7PLMM*O#%MM;#'[L8QM@IRN?JVY4V#K(\NM)<.<N\>$Q3SQ
MF>L[=BT7A-2)UUI].:ECGA+T\^$.6(V+)CRE&5,0!'T;>9:C%N&U*G^];'LS
MR"Z]:<K)1SFC=_:[>;):LRS9A9)-4T-MCZ3DLWKGA,8)U7O",8='-W*SK@1,
MR:XDVPM]7,I+BEFF6G>[>C''N6L3&2:6JC,?^+ZE9P6Y6JC9O%O3@I<86<)Q
MLL 8=4%G+-FV0R&N'()4ZM=VGAYL&:O6ZVTDZ+1]XB+#>,",%O#.<Z6^FTAC
M&@[L+#?LM7.UIYG4S932+B594JIZE/$@3'AX&Z<\HX%:RLYTZRUCBTTPF-$Y
ML1A&%W2%WZW+OUN74VL\;/B_\<S'Z6T[5JS52<NMZWCB;ON G,N^^)S&:QY=
M>VJJE;QK->"!-:3!V)V[4\N5W5(U+B.=.C^,&-QY\+<E,-:D5AU9.G.-I,3R
MR3@MEB8H=]]['6QP.*$N%EE:6^H@!*<8@QLV)G"7%3M#P>^I<W\0\Q(%C3A;
MEM6G.S%=DZ!Y:3)SI9--,AO-'P9D1^CD%;,)IW;HWECN,$::9TM_^=6<EU/L
MLPX!9*_>'_X-EMF2U-L6Y25!P6ULX$27WCZ(&(V*7EJ<9=Y\)<+RV3) ,@_"
M+PI;MGR]EN'M#DR)4H^&1!N2N<N?R:F7:.BRY<IS!" !Y=BQ)EX^UF7:VFOE
MB6+-EVP*\L=KK3<JYH# ?V![U?2\,SLJL^<[>Z1VPR4X8QE):>YSC?\ >X^Q
M7*8QNK/*82P1A=WJ9PQWOT1U;3 AUE\3?!:FW+-EVK<^F+'6>HWK*-JFD;T/
M=Q%W.5?7/ZF9]5IHZ*P'=O(QS3ASMDJUTM.&B[K,5C+G;%BHI1C&SZ/J6\N%
MZVW*ZZ8TP;;VJS<=9VQ,+]IS=YK+N1*66,W=RD*YI9*)V*$[*543W;\.?M"U
M;IWD\M8S"<^M3/AKV9Y1) M../2D[25>8WI-XCGZEOMOABZY99P$(0P[UF28
M3KRKM=+;!UF?:IPZ72I3VAK[!@+=JU-L^TNFQ1U#Y;P 3"SUK.5E=B:75.<P
M;88<RNJS?JL/C.+(;!EA;DIC%6=LQHG>+L;88I9O).TXJP:73O+VNP MZ^?:
MI<68:[<NPJ:0PRF1;;#UE.DLY/;ZL55(EAC@6VP(PQ%B=IBY\$VHNJ:'(K=Y
MIEDQLB!L/.DA9M2ZC@&2YQ>)+H<PVG)+$XY4C5^"VRBXB2Z B+LK<$3+J_4]
M ,A[H2R(&%QS]BLZK;EI2-ZE?D19Z8\ZD2ZJ]:-Q!,I2S\9"!SMP-R9S2QVK
MI7'QDM:!-:-TB,3?"W,9+=Q@E\KG0^90F/W/%;:0/BV<ZQ@ES5LD<0MK98/B
M Q Q&)M[$*U*B0:LF!OMR53-:S.'YKS#=,;,/6K[1K'E.T/#TV46DM(L SQ"
MGLUE>J&4:9K(B$(';WJ6YB_JD_K &)ZSW*#$^H#A#>%_3ESIUFTO2<M;ZX&.
MAO-LC?".(Q@M7C377Z,4W46FP$&ZZ"QCZNLGAHF$TV>GEL5D-RXK;DT),'0O
MM]*6XTN4U*HQN_##IA@%),LVMDT4![59<K+X<#20C9=MBKP?RN'ADDRW1LA]
MSG4^YZW.$C+G'= CD.Q2\Z+UV3&&8+.5W<KG!G".F4<QSHPCT;3SI9E<_2MJ
MCH)F^#NNM.7-L3K/KX9O9V#I=(\-;$0Q@=G/!;G6<LK',;NRS'*'H5XJ9WA5
M-1F^&TF.WL[UGMVS<-9TZWU/6?">0)@%I%_0LW3G9M OUX/:07@DB'(JR9,X
MX574JITX/MB'1/I,+>A,5/;*FS)+YLPV1!LSNC<M0TLNAZ<7/;%CK7C XIVQ
MC3,ECNO1-'&Z#X;HQ;@=BY];MMV+1:('@$L-PP.P>I=<1C,ZJWQ/H<N73O+F
M''UY[5B\Z)WR]/./:*2QT\ 0@]WK6L:7#U&XN8UD^;#$K"\3;CP>UQJY$#87
MMQ.8"5F/?7RQH1,E2B<7MZ[TNC+V2E:,TRG'=N:!'H6I?:?=+<U4-6TYDIY$
M!GU=:S=7#4NE=FMERY9($+_0I8UG,PIM76$32!]\86;>9;]F<8;='J!9NQ)L
M NVW*6G*R2]4:6C[OJ6;UOA*\S-5:P1CZ8&SG5DM)43.UASKG1$(60]JMTMG
ME%S=4F$D!QM[^93KC.5G#$VNG.Q[.=:[63D<)DV9,O,;^RQ<[VS=)AL4DF:Y
MPVD&]=/7$7=U%OHI;V 1..:S87K^W28:TPP2;9X:\YH)(]70F<+=Q'36 Q;9
MU)*O5K"2(@6+3>L9;DJG;&.U9[7PYRYN$B*>+=F5V'3@L;6RR90]=1M>'0OA
MW+627*H5=+NN<+,;X'):L6*[/ISD/1MVJX8SMK"F=$<^Q7+-EO"3IZ<8@?<!
M6,K.L2K*>P0$;>?UIAKV;3*<DP+3V+6)"3"5IJ#?$=W9GRN2V>"SS&2;ION_
M ?\ !.1V*93%5NJI!+= MACVWA:ERL^C1$L BZPY+-FS.\-QEW2EZUJ\,CIN
MX(VPY8*3/#'J@Z^OBUS08&!PY^]7..5O"+TJH#JEA,8[X.67.F4G6YV[RT.J
M:)+08X''8,E&L;^RPU-4"P@99<^*EELRNE!U.<3&WT*\1.W3*M[XVJ>[/K7@
MN!!$$G9?6HBL8"18+SVE=,^QBO$FE:X7<AL)VJ>V%1>IT8:QWNWAUT$_DQ=7
M;J;5Z,%Q@R\D7C()>MBR6[527IY\?X<?6$EUA+JY=F</Z7OAD6_1$;+<UJ7%
M+<\.RVZ(U]/#PR3S'!,6S)ZNL.*N$?';-+93H6FP<Y[%+_ZF,.CJWA$R)Y(E
M.$(Q)!YM@4X6SZK/PQ3_ %2:T.$(/;?SQZ+E&;F\/8?0=79) !>( #$7 %*>
M%GGZHV=#=>#9F,19SFU23,RZ3"'>TS'$YY\Y*%TE:,>% G!$Y3;=0:UNZ' <
M]AN[TG)9K2(J:LN+CO6<T<5;5E5ZLK8C=C@<,E$QZ[5"M>7DGG-_+ +<K-OE
M79E+,F/+@+"KF,Y;]/I[W$$M/3T]RU,2-2Z;L_3F%A.[CRN*S=\+ZUUMQ'I@
M+)^ZPW' ^T+-F&7KAQ7I+W.?NL-@.&TIZK+)RH5 ^?IT\.,6V@V["KC$6UW5
MPSQL9!:QTQL06WGV[%)MGKM[%\-\:LGM:#-8+!B.]3'A?XW+LR37-KVM@X.W
MA'ET)PO\GA^CF:"[=/O6B'3B.=,K8TIFE> "2TV9].)4W7/MF-%[1+)& [T=
M>O$I2O:Z8!M'K"N,IAV#IM"V8P.@(^[Z?NJX+-K$RG;*9'(>SU*9SPWUQ$?4
MS0&N,2(0SRBK;C27: ?4A[R#;T0O)3.$PV9;&38DCER*S:=8B]6TUDR5,_%F
MUI%@V;%9<,XPZ)XGX?+G.+9;K [ ]RWB6)9Y=)UVF3*>9\) !RR,%G!-QYI)
M3^K;MBI+BGJ[!T0.!9@("-NSV*]KF:67$=KZ1.(\.^X8[%K&(3MA>I%7!@M]
M$<N93"R>6P*HG'T?=4RN<@F!QYUJ;C%CC4,'ADV71NYTQM9PKN\!,@8WGUK/
M;EENAXVJRZ7&496.!#N7*Y7E>VHJE4T.=U8)C"=;EKRI+"Z[D;$]<KG*PTE&
MVPPLWABIKAB]?JG6432T&$+-F7.EZV:6-68WPGP'+!9NFN*W9,T[IOZ]I5G&
MVFE61F,=#$^LG8LX2ZJ@ZU2.>V82";#=SE7&*7C#H[BJG,H3!"'NN-O,>Y*F
M,O7G5ZLR:F^ C'TE+;R3G:8X9UMS:EOXP7M!$1MV[%/!>7L%I^J.GR6 .C[@
M-D#G@.=(B5828DVQ]JLF:N<3#9E,=O=(RS6\:93$M@<,.I<LV59,LG@[ M[7
MUGW:T^G!!LZC^Q*ERG""J*7>)@+HF_(E/5+O2(FT3M[X3CGLV*XR9LNG 2"V
MRY20M:L^6X VBR/K4GT7K/*(FL=;SGT+<GEJS*-F2B(G;##O6M5+,1Q8PQ!A
MGDL6+,299FM,18LELPD&"#>696G.3#A-=NV[.]3PU,L+)P=%3&*UG#.9K2(
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M<KGWWMM)RO@'+ + CM7_ *,>9W8J3^3JFH_*._;.]2[].&WA0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*=YT_[ 5'\#-_D
MRG7^3/?75\A/SI._[3U:_P#I\\?\>8%]3I/VOE?)?W:^K\'O-Y\:JN@3^5=V
ME2)WX>HNHS#]8?&-_>NT>3.ZAZN<6LO-V-O5>L]^&/DXVKOC[SX$^@\RX5Y+
MPS %UV*GJS*R-IWF!Y6=*N%S+ID^KNY0[U/6F'-LMS3U>CFBM0[,HF 9IR<<
MN0GPQ[1ZEFU+7/Q(VPC%63>49?'@VP'X<[+E<KZHVIGNA$9E3/A*@9E0^)MY
M[-@3]4D^KE(JB# G'+:$;]=93<JH!:/;D-B3#,N=,CYK0.68YTSE?*&JSXD8
M9$<KDP[]*A'M,NTX6]O/DM9CORXBIW!$X%+,U,^',5F^#;F+MB72>J.J)D0Z
M^V)OYUFM=),(9P+71Y^T*VYX67&8EZ&IW=VV$+;N?&&:.=F\K0*_\5#?;=FD
MY;Z\H:IG!YCO1Y'9L5M\+59K7"R&9[2LDU4!-FA@/+*':D3MFW33-?NDC?;U
MPS"Z6ZRDC7F:JUH,7BRV\<RY<M1!5FIM<'0>+L2,.G:MQ<7.8IU;4N>;#?$W
M<ZF$\H&;-F9X]ZG#<N*\2Q,F8QZ?5T*\I><^&P:)[A:TF\1$>Y92UH/TUY=\
M+O3F5<6K-Q)4>E3-YONN].06L2%^ZWT>FG=;[CO\'F[EC!E/-T^#1[A_P3F=
MB>OEJ;36CT'XX'<-XP.W8KGPG:.U::B8)0L^B,LBKG$8SB-V11MWOA[,E)4E
M6:ADM;NF%V$<Q#UJR+)Y6:4YFX+/1L!6IHOT1]:(AT,8^@16>VZ=;A2JV07D
MXV'T)G6$5FJH"0;";3<8W ]R2M2[09C3S80Q&.U:2KOI$\$-L-S5+%Y7&46N
M9=>,LQ!8POLB*R5%Q(RCRB58?RTBO#=&&TY=Z3ZM=IB9;#6D +/EC&LL,R?N
M1%UXSS[DLWE,HR;6DD@'T+I,+.$EIU2[>%HORVJ=N65J97@- C<!ATI)E=HV
MNK'.!@=EW.%K&&IP@_K,S,\NE9PF$O15CA"WZ0P.13U\IFIYE>&@ D87B&"S
MC>48:BOLL()V=&*9VOM,80KZY_B"W$9[%J,=N<I:75%S1$X 7;!L682U@J9P
M+3F>?/F4\NG6(9[Q$FV'L3^6HF=X;E(1>3 1%XS"UQI$DZ;+W"-X7 7C8LXV
MS>56U&:UK20\1WLQE[%K"RYTHFH:N:;>'B"^-X]J%N%1J>)''?'B#$7[2<E+
M*LN50K];?,+OQ@Z\#L6K,"HUFH3'XDX=:F<&<(=\Z8\PV]^/2I;Y;ERR2]^$
M3&^-^'(+/M;2V8^[<D@P!W<8X7<@NO6N>:D)4@S[-TGFVV8)6I=+)I7#+ILQ
MCO#)%^. @IC>6+9X=RZ!PRUHEQEF\8%3LSP[@TSA^6UK?Q9B"#<<5)&>:N=+
MHC !^+(A#U*82\I:7I3 !9G>>C/):E,Z8YVG,%@ Y0.:M^K-S_A7*[2X$EHC
M#*^XIG+ITXRUZ:D?+<T70A??AZT:62G:X-%N)QYT)ENN=$&]%LOE&3Y9>2!#
ME'O4PY>7"50%SK6DW&RV].7;&DU*TLD? ?\ !.U3#G-1D?IKF@^ZZXX$<BM0
MFV.FHCOVM-^)YMBWC#GVSN5.-H(@=ZZSAPO+E^;3][Z$,5A?IIB?<.&',I9E
M<XGW830EI^$V;8*2;3+R*8ML]86L9/?#=IY+HWX^MNU!,,E B!MA#LY]BEN!
M&U%"'N+A@<]I"HYRYXIF!I@+(Q/[$6(9<)FN-8-W>&5X-^*S73KUEB/F:DR>
M8 QM.1L/,GMAGMU8FTHG&,+[ON="U>MK/Z-C\V.%NZ>>!4=.9EK3I1D6' 12
MS$9G9#54XNLMO[ ,5=)9AH,8XGT^I1KF.3VEH,<O8B27+0G8G8.U3&RW>7B0
M"7<L![5K![+)2.@UHMN]86>TSM>MQMM3'>Z3DDY6]M:0LZ9!YOOMZ@JSUWRP
M3*HAI$=EVSO0QBY1$^=O%UAL[U+O1F<M2,769JR8Y+4[0W@<ZM3K=X72AWP!
M$FV&,<1SI#MRGF3'- QB!EES(CC,J2T$1]$<0A,U#SFF>[GCR'0HU)8WJ!GA
M.'./1#O5S,%F5E97AC8;P$,[#8%#BX:\_4FD$;XSO!3#7M(AI]0V;$@QOM&=
MN7.JQ:UF@F,"B,X)  B;AB@P3W$M+8W"%^<$$)/DN))C=#U[=J<#A)DNWON9
M':D$EX!@8PA Y>HE," U&4!O78X*867",HV_C0.6*<F)':&A2&P!.>!YUJV8
M)ROLJ0T@0R[ECAOM=:Y9O 8!:(]*N,[<.WW:TV4P6 8*SACK-H2KEQB01A9#
M85<YJ\:1+I <8PB=AAVJ^%9)<O<(A<(<ZQC8E632U@AE;UIAC=KB^=O"!6I#
MAXDM:YUHY6)9Y,S*<DTS#"SD0=BR9K%74K=RS+-1<9=<ZO2#>>0,,QDM>N5D
MQ%;D4Y$T7"!]F:O'*6YCL30Y1@T1QR3,2:VO;*4.9MW<##!9SG]%QM 5NF'?
MB&F_ >M:D2SS7B6XT\HLCZ]@5QFY>3Y+E"S&S)U0"(V^NRY2]:QU[XF*O.C!
MTILLN.,.Y9SBX;SO*XSJH> 1O"T;,8[(JY7+KK4C&<3'&'5%:QES[<LNF/;+
M>"X_2YMM_0IGPO7I;MV%3ZA3B4 2(PS&U9QAK<6;29TB:1<=@MRR4G6Y2H+C
M*B;-ENW!>+(=9VW+42\9=&S=,<VH)W#80;CL5YV3M;I:=,E>&R!&"8PG:67+
M)6O#;SLQQ63&G"B8V:X1NCVP5NXQZU;&:6V9* W8^[A[.99FG3TQM0>(.'X@
MD,/I5QF-3+I;6]*FRG/W9;K#@-BX=I:[=?NI$^3/E//NNLV'GN6<8=,:REM,
MU&;3O:"2($<MB9\,QV=I/$VZ&@O]*UX+RN<GB4/;#?M.<,0/64(VFZN7P._&
M)%@A8++2G@NV_(U':<>PYJ,\<E34MGMA&V!5R90KRT$Q-Y.![MJ+RUIDUHL&
M?-ZEBRY63+@9IW;,A>8XC8M^%G.VC.G/][FYL$SAGOJ:1,R>2XQCR)3+,LO+
M<I9XB/;MV*2_4B;8X36@6G>'L5SCAUZ\.4JA;OAT,8X<L5++9EV^.8Y\K50R
MF,W1@+>HQ3'TY7LLTN=+8SXFV;0%;RUUN)MBFZC+8#[[>4>Y9N]-XG,0M1JT
MH?OC+R+PM33"-.M2 8>,WK4PUF-AG$$IHLFLO^^%WH523.T;6<4RY0=^.9:,
MQB8[42S"JU?%<MY/XYMIS&'W5/7&U]<HS](Y8_?FJFYMM2^)I8:/QK/\(#9G
ML6\SREVPU/$\LMAXS<_B&7.L6[TLBL5.NMF.,)K;2<LX^M27*XS'"3JH+K9@
MO&(S&27[,>N;E(3-;9*9'Q&CIR^ZF<Z7I,(T<5M8^'C-LVC[J<NTGE,2.,)8
M%LYO6VX69+.&\S"3E\823",UO6W);QX3'EE=Q5)> 1-9=F,UFZ+N81,_B:6Z
MSQ6X8A7.%ZW$VA*CB%L2?%;:8X;=J7?"(I_$8$/QS<8VC8HSF<,7Z2M_RS>O
MV+4TK..))9 C.;& 4M\17C]))<?RS5,WE,[PV9'%#&NMG-PQ'K6O9K$QA+MX
MNEP_+,_PAW)9G:<:1.I<52G2YA\5G6/8L\4DPZ?XAXB:]S]V:(0[MJN,Q?Y1
M3:7B RYP/BBPY\Z1R[:J\Z?QF)=GBMLA>876[,E6;95DE>8@E#\LP8?%S8QV
M*7+G>N6&I\RHQ GL_P +8-JF*LE0$_S#>YT/&9;^RV#:DS2S+9I>.2X@F:PQ
M_9>W8KVVDBV4/&MWXUGQ??#;M69/JUZR[3,SC4NEP$UEV<<-A6Q2:SBESIQ)
MG-M)Q'K*S;<K)E)Z7Q4 0#.;&S$+66;IV9IO%\O='XYE@S;ES+,S27*>?Q>Q
MS(>.RP'Z0YUJ62M>NLJMJ'$['%_XYD"3B.>X*]MS"(&3Q"PS1^-;?LS66M6+
MQHNO %OXYEXQYE67:5!Q1*DM!=/9 #[X9>U2SRSS2MXTI]V GLRO:F=9:DWB
M*V>,F;T/';?F,^=72W22D\72]W\LSK;F=BN6/5QG<62RT_CV=8VJ9+/_ &5.
MMXM <=V<V'[9N86NN+ROAJ2>+(NMGLP^DWGSV+%N%3LCC25*;$SV9WBVS.Q4
M>:SS&E-DP$^6(#[[$<SD7B[4R;YBC>)^L2\<?:G$+PTY_F/[L/K$O/XLH[4E
M8Y4O6>/9D[?+:AAN^ES[5+<-('3^.)K9L3/9>,=H_9#)+(?JNE+YB[C3&HEB
MP"_VYA63'ZBKZ]QZZ=$B>PWFQV?3;<L6W.DO"M4W&KF@DSF7_?8V'-=)FQB\
M.<[CHVPG,NC\7MV+.,7:3MXK4_3N8+I[.O\ ^>2[,M6IXYG/8[\>RZX.Y\8[
M49OV==:YQ9-FA\9C;0<;;.E:FV9F7;J+4M=?,FD[XQ M!S4KIV1<K5)N^(.L
MVC:-BG#,34K6)[&[V]@,\AFEN:U?HU:GB&?: _ 7=&*L2(A^MU+B3OF!37"Y
MC9D:E/F1MC&$.HE+-,-W\?,;<XW&R/:I+BMSIEH3J.IF1W6/].Q667DMWACE
MZ=51$6.C'(W6;5J7>F$Q2TD]MAEN%D+BK6NLVE!25($0UUW9]U8>SIB1@?-J
M9!))(MA;[5F_2-Z>&Z_/E. ,R$-L,?8I.-\M:B09Q7-(AX@B!F>]:Z]?*9CA
M-XDG/%CXQ&%M\.=.+DQ*AIFL53W0WCRBK;YA9H9JE1$"-MJYV6W*2X8JC4Y\
M#G#N6Y$MWE'-K:B838Z_#HRYU6IBN9=4/$-UU^1R*8SRMLC7F4T]UNXZ\YXV
MJ=8S[2MREH9KH18;QA"\)/Y+VB[:7I)> #+,?=P.=J6;9=@47"YGL#O!==D>
M6*EAUJ9IN"CXS7>"_P#P3S+76';MF8=FZ+PF)?AQE$0 PYEK/AY.\SP[0TKA
MZ4 S\4;#]Z<UAS=DZ=HDEC&_BS9L.<>91<8VM$N@D2V_!!:D6[F6TVFE0!#>
M7(*V^$SK#;E2&668^A9R28VDY,@.%F?*]7V:FY]FI6CP1S6687J2L]M<-*GG
M[SH1-MF.S8K;DE^K8G1W25B[+-YBKU0<7YWX[589F/NS4!+7B(O.>WVJ8WE'
M8FG.;X8.P87W*KBI";-!881Y=2IC%5JI<=YQB;SV*SML[1INFC,]$?8O1UFM
MO-9AXD$[UYY JG7E+R9>_B+H6A<ZU;GACJ=/,UILCZ<,DRDEERJ5=HC]Z(;B
M<,EKJ6S#EIVFNDS!$8\PQSYUO3&+VN7:VAELEK"X@;L!EECTJ9=>N)$]7ZU*
MD4[P'",-BSC%3,KH/BFN-5/<YI!!CVQZ%J:3,SA4*.:]CP<W#(X@(MQ'96G:
MANR1;"#1L5<W"MU4QL.8CA9'N7/%FVI;;CPK\S5HNM>,+(C+VJY\-72+KZSZ
MPQX!C$&'W54ZHS2J)[ZF.X[XL 1CZ5<K>OEV,:<R:=I((LQOL/M6;O3#4E5@
MEOOA;EZU?7"QRJ*WQ&$ C[JE+RB6,>]\8XDWYQ27P>N=K/0%TMHZO5M3B+=%
M:\N OMCCSK/G+-YRQ44HE[2<U<M<Q>Z!K2P-@+X7<W<KDSC2:D:*:F9$-,"3
M"_D5+]23-RO^E\+A@#BPW9'9M2?1+=M[4:*332"=V! (Z>CF6FI73&OU+6NF
M@6>]EA;@JSG.E&\5SIA.WFQ1>)EN[X#1'9V+,YPM[YBP:/5ME.O C;:<X9P6
MIO3CWX6:>]E4R$(V<NU=.NGG[76$4W1!,,?#-IC<?6K>V<NO1,4^CB6!!A'0
M86"&S%1U99^F L,&CF%JY]\UZOBF4&[07S'QW"8&(L.:LDR]$QQ5OT/3'T[I
M9W2-UT8K.';X]7[.]>%]0\(RI9= ^(T7PY7JXO+M)FY?H-\M4WQ>())C'^<T
M_-\067JZ</JQ^6__ &4D?YM)_DUS^7^#T?#_ "=^57Q-_:KYG9]2-511 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&Y3T[9195U#A+
MIR273'P:QH;%T238!8M3'*7;\N_GZ^UX\H?DUX0U^16ZCH\W7*:GGT=,'U3-
M^7/#7-+A+$T-W]T&\6$YK-N3KU\U_/:^>;[=KSR\\];XGD^7W%=5I^FZE7SV
M4WU:=4-EB1X[@U[ R8 \;@B(6%3%_P +V[2\<X?BSK7G?\PWF)J$ZKKN(N+=
M9J:Y_OMIJ:KG,<YUD&[LJ80.=RK/MVY<I'!OS':K+^M2]"XSFLP>ZEG-B(!T
M0-V-H*:7/;'Z(74Y7GMPE";J=%QAIC0=[Q9M'4E@A;$N;+>&@9F":/;M$YP=
M\T?G[Y=ZE(U'0N.M=H9\F9+<)<U\R6QWAN#@T@>$X=:699S>7U0?95?K!7&7
ME[QQPQP=YK\1BNIJQE-2/G5\Z896\Q\EA&_-?NQ(<3S!22^73VZXQY?T,/)'
MSMX-^9W@#1^,>$]1H*B74T4BM<RDG-F;HJ)<ET"0]Q#07%:E9QZKC.ENDS9T
MD@CPG.9$X[I<W_%459M-:UW"NOO(B\46H$$WB%"]S8<Q1F\OYJ/ZP_YJ^:?#
MOF9KE+H'$%104 G3 \29SVO9),YPF%@WMW>#(PB#:LR;=NW;]FN7X1?(GYW^
M<4WSTX=II/%VH5--,K].^LRZF>8"-20W<W-R.\(QC&X*]F?CMMV_KN?9]UE9
MJORV</UFJ/\ 'JYFG4QF3"=XG^91O)S5C'?E["M-KN?O17)!LT%NHT;3\)G2
MXC,;XBA>'JA]HW75VC^0_&-7I,SZO52^'JY['M)!#VR9T#&(. 3"_'M_(1^;
M[ST\XV?,+Q]*G<8:G3_5]8F,I9-///AB4)LS<)W]XAQ?$&T6!73%O:7'W?3I
M^K+^9GF=Q5YR4-)Q7K<W4*/\X4(#)DY[_<,ZX@O(B0IUNV[?V_=_02^9&9.I
MO*S7ZBD!^LRJ2H\$M^(0IYALA;> EX9Z?R?R2?M>/.3SUH?FGX@HJ?5>(-,T
MZ16ZFZD?2,J'-FO%4&EI.X]K=QL("PF.Q28:[WM+]GY'ZWYI>;.M2'R==XBX
MAJY$P'?95LFAA&,8RFJZ8M[7EUBV;-\5T[><9Q?O[WTM^),>>*K+LCA[S-\T
M^'V-9PYK^OT4MOPMHF3"T<V[*=<BYJQ.\[//69.9,?Q7Q6^:V8US=Z7/)+P0
M0(>!$DD8(OMV?T./U;CCKS)XLX1T?].OKI<74&]]:\6[PF;T0^.)69/^';O_
M !?8+QENRJND,IL8R/>:V)C^-> 5:Y=>'C3--I*24S7=3JI-'1RF^(]U0YK)
M8#03[SGD  03@MSI^!_VK/VVGEE\I'#7$'">A:WHL_7 Z;0MG2*ICYK7!KF@
M0;.]V!R@F?HU).MV_GL_-M]K]\Q/GCQ)Q&_1.-JVFT?5*I_@,E3YY#)+G6;C
M!- =98%)/J=N\XC\SZ_S7\ZN+:J945.N\3ZK/J7'>\&14S]XNL(:)<EY@M,9
MLVWI/#_G_62OKDG1.,YLH#>\444\"%\8.:'>A32^_9$GC;SFX8GF6^OXJTB?
M+=$B;25,ES7-Q#IDB!AF"4Q$]NU>X/R\_:5_,IY):O*=+X]U2;02W4Y,NHG3
MV/:)3A%I F .BT9!*UU[8_D^Z[[(G]83X(\TJ#1O*GS+U;37ZY,I:*4VJK*G
MPYLNIWI<IY<YTUKHP<8@IG"]Y.USUX?6W3U>A^8.A:;Q'PWJ=%7TVH4<FM8^
MBGRIK7-FRFS/WMQ(+8P,5J;CGGU;NG26-X9U=LQL)DJ75MB;XMD^[T[RD:MW
MI_.M_69/,SS=X9XQ92<*56K4>F3*N2RHJ:%LYSI4LU#1$-E@BTP!B( &*D^C
M?;773Y!:GSF\[ZF29-3Q5Q3,DEFZ6OESMTLA<?Q(L@F(Y^W;'V=3ZCJ&I:G6
M.JM4GSZBK='?F5 (F&,28Q -ZK*=X?XMXQX?G";PYJ6I4,UL-TT0>2(?##=8
MZY3$7-=ASO.[SXG-:V=Q;Q8YK6@-#I<ZQHP$9%UB8B^W9]/GZN[YJ^<^N>:=
M#0\05.KUFDMKGLDU-8V>TS9?CB)(<&BQQ($ (@13&].O6YZ;?TEO,$EWR_<3
M.=\3N!*ASN<TH)])5_5Q\OX\GVNG^]-Y@_VG5?RSEGR[7^/^'<7V%O\ O*Z=
M_;>E_P#TM6N?3E_6[\G/[J-._LUG^C,2<'?^2>X1:U^K/#A$"3-(!SL[T6\/
MD_\ UD'C3C7A/A?5SPGJ3Z A\_X)CF0_$S#]%PLBI9MOX^V.N'\Z[A3SV\YO
M_FB:8^7QGJ;JYW$!;,E/G_B"[ZQ,\=D1!^XT;V[;@%;PYRWV?U$OU?7B;B;B
MCR<TNHXHK75U1^:'.WGO<_WO#-MI-RD=/E?OMK@#=8K&ML;XMV'P GTJN<X1
MJ*X3"0!#,*$1GGHYU-Y,:O44WXNH9I\6/%AWC2SXGK"M3IR_DP?;(><WF[IO
MS+:S0R.*JZBTMNI:L);*:>0XS&U$&-(<7-W-PNPO@I&N^95H^QH\Y?.#5?F,
MX,H:[B>KK-*?JLEH;/G/,Q[/K#0[> <&V.C"RY+RUUS>O^']9OA3W_*7A":^
MV:[0M)>YV;WR 7GI*U'/K_*M$7#F46I#3-+F:M-=+$98E0<YQN B+8Y6HEN'
M1OS3_.!Y6?*#P%.XEXKUK1C-IZ:HG?4YU9*9->9$K>!<&36NM."MU"=;=OYZ
M'VGGZPAQQYQ<8:GIOE+Q*-.H9%76R2*">]K UKRQ@)E3-T @V+.+72]NO68\
MOFBX]^:[Y@O-#5:O4-:XVUVL=45$V<)-,Z=-8-]Q(!CXI= '8KX<K;FJ;0__
M #<N)RZ;047&&I;QB9DNAJ@'1Q#GRF-<#'!-+[=BN/GEPP1,KZ+C#3=WZ<RA
MJB&\[F2GM:FCW[+EP#\UOS >5NK4FHZ+QIKE&ZFJ)<XR*DSI33N.;%MGA%M@
MVI8F>T?2A]F7^L%\>>4'%6D:7YK\3#4*2HU"CDPKJB8YGAO>QC@/%?#!8WUO
MV;UWF/+^B#\J_P VWEE\W7EW3<4\,:UHQGU%+33'4LBKE.FM=/E;Q<UKIKG?
M%@%N7.V+/5W7J6FOTF:V2Z,P/B\.%T(W\UB-9RR:( _5J5K[6F8(C"[)"O4'
M[2FNK='^6_CVKTB9]6JY6DU#I<QI+8.%.XQ!!!5T=>'\?WYGO//SE_\ F^>8
M<B9QCJDETKB*?)I9%//_ !?A;P\.._O0<7DQM 4QK;/MVM?6[^K3?,QJ_E=,
MUG7?-_BRD?1LIJB=*;J56 =QTM\(.F3&P= X+/%=/2]MKI]M#^L)/=Q'KOE9
MY+:W2T\VAH)]"R=IE2YV[- >PN+Y<USO?F$FTWK6<I+)J_5\57F#\T7S#>:V
MIU.K\3\8\0Z@^IFS9OARVU#Y#1->7;H+A-<8 PC$15PQ>U?K/]A=Q1YI5_SC
M\*R:V7JT_275= Z;/JI%1*9ONJ1O ;X:'#<@8PQ4NFI>WE_6X&Z.%.&B;7C1
MM.B+S$T%-O>DK?7AC>4?I.C"L=]?GS!(IY+SXCIA#6@ VQ+H-"PU;X?FW]HC
M]J?Y0_)!P;KPK-9T.JUJGTN:VGE_7)3GR*ATJ'P-FAKGB.13*SIG=?SF_GV^
MW%\[O/GC#B!_ 7%M12:/7^-3R&4L^=X;1->]L6ADT!T ZX*8WFG;M/63KR_&
M.N\U?F#\R]3<^9K'%NO5M2Z.Y2TU3-:2XD_%X;@T$G%RN)&?;LFY?E+\S56W
MQAPYQ>X0WXND5 ,#;&R60FFL]D)7T?S$\$QGUE#QKI;6'\N*2I<V(_:RWN$.
M9)CE+>SV.^77[1?YE?(+B:AJI/'&M.TV1"7,IZQ]1*<P,<TP@'2P;!"&ZEF2
M=K+FONM^QZ_6#.$?-.ET/RI\S=7T\ZU4^%1B?75'A365#7B6U\9DUK[6F-MA
M!4XY;LG??5]=39VB\7:%1\5:!J--J%+J=-(K)+Z29+FRWRYX$=TL<ZUAL,<E
MTSX<I<5 0+'&6X$.:2#'KNPL6;&TEI>F/U::^6(RQ)#7EQN@7 =5JAG&WY[_
M &AGVD/EW\F/EUJ,VJUG26ZQ+HJB6R7,J)8FA\J208,WP=XN%\(IGP3I_P!7
MA_-=^?W[:OSX^8GB/49/!'&M7IFC3-4JANTLZ>&ND&9,:TRVMFM:X.  $++4
MP7O,:Y?D9^F_S!^8U7-?+KN,N(9]3,=.<9--43&.=,<22)GAAA$3]\JS[=LK
M3*\F_F?JY3:IO#7%[FS!O ND56]C>!*(P6=-X[X\(>OX=^9/@UQG5.E\:T I
MXO,YE+4/:R&-DLN]"NF;[2NSO*3YZ/F?\D-<TZKTSC7B"ED4=;)G3J:N^MT[
M]ULQN\(DR80 N+5?!.USOA]>7V5OZQX_1N(M-X&\V]4D5SJY]'3[^H37CQ/&
M=X4P,?,>#O-LC Q$>99W&\SO,1]Q'E+YQ\/_ #%\'TO&O#!E.HC1R9X,A_B-
MA.:9C1O;SB8-(Q5ERQCUJZND.D'==>;0K5SESIJ=]952J1K3"<X,WX& )VP@
MH(7S6\VN"/EYX#UCBKBK7-+I?S=3NJ/"K*B5*>[<EEQ; O:^!AL3AG^5?"3]
MK7^L/5>N:WQ-Y?>4?$%-13J.7,HY,W3YYO!,N(,J9$W7IG,PZ:ZS[OD/\V?G
MF^8[S@U6IJ-7XYU>9)F;S!*IID^:YP<7$DDN>+0Z$()AB]K>'2=-K?G5Q--#
M*3]+=4F.,!X5%5N!)_9^"UD3SII/;M$C4Z-Y^:1*-35:-QG32Q[_ (AH:A]D
M(QA+8\F[)-+[=F?0//KSXX#KI5;I?%?$NDU%.1NB=+J)#06D&#FNERG7C,*I
M[=LY?O\ ?9R?;T^;'D9QAPE2>9?%,W4-*DNIJ.H^MSYSI4&E@B\S)FZ-[=QS
M6,8;G:68O+^B=\FWVB/E9\Z'!FCUW#.I:2*[4*&GF3Y<BI8]WU@28S2&&8[=
M+G@W#%;G;"7X[-O<J?1OD.F3+3*#G-:X?"0+! W)=[/;PVM*TMVK3'"/A,DG
M><YWPAL;2<(042W#UQ^<#YVO*OY-^ *GB+B36]%=5R*&IFRZ2=621,+Y,HEC
MGL9.!)WA<8I=3)UZ6\OYV'VD_P"L!>8_G1Q9J5+Y6<3&AH)536RMRAJ)@EPW
MRU@C+F;H]U8DMN72]NO68\OG9XM^8SYB/-?59M5J7$O$VK5-;4/FMIZ&35U
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M! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU<5SO2W;?DU$3'U["NL8L]5AHZF(;=<,1GS+7"VY3S*F#0+,,1D%92S-9#4
MB\9WCN6;2XQAB\7WC:;2=J2)-W#?I7 N Z>N"7,GV+U^BWT(@!M [E>K4F.5
MJI7;L#S^DV*5,;^R7$X9^D))]5Q&1LZ!O[$SE+(DJ8Q,21AEFM>-,65:J-S
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MI8,#:(7;-MJN<W))K#-+T\N<+#9L[N9+M),+/IE%NEL<A@,UF:=+8O$B4QK
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MR:Q\O\'I^'^3ORJ^)O[5?+[/J1JJ*(" @(" @(" @(" @(" @(" @(" @("
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M"KF 28QL;9?Z%6IJ)#7]?TGR[X!U7C75IE/)DZ+0SZZ;-J7"6P!CMS<))%L
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M[;II6 0$.704O"UK3&AH($,N70LL^JLZE1">#$8'"(A8M3;U_#,*#5Z TOC
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M<WPV^]:3 A/T8N[BOK:_5W_LLM*\\^*M'XV\QZ NHZ6O^ORS44(?+;+E$SA
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M\1]:F)"L KG-) /I":3U\MADY\R!QMCRN6=>%S,,QD39@L'H^XL\&8U9M!-
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M%KVSRY]I<JS7T@#R1NQCDHS,Y1WU?]KU*8PZ6Y8S266;O5WK4[?5EQ%/NF)
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09I'Y1J"G^='^P$_\
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MISMT0Q(M'0LXS<M7K/"ST>BF#;NKI5M<[I89.E%I$1&)&&U265J19Z#2M^P
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M,+II<YTK=%O0I[8CM)M=J6J$QL,XWE8[9>KX[X2>F4PFU<IT!^4;SV$)-?\
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M/#^D1JC/J?"FDT0:V7X--0TX;+$&M%-3ME0: +!8KN,3'M]E.;8T<PO4:>4
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M=E1.$-V,(6+EOV^SM?X8\OS)^SR\HQYP_,#P_P -S9;9E-];T]TT/9OMBZK
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M]C;\OU!Y0_+UPCJE/2TLJ;J6ERP]\N4)<R,VG /O0!MBDZX:[VXQ7ZD\0/\
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MG.<ZBT^5NS)I(N N)2X=,?L?:15LAKNDO OD5 /1+?ZD<IP^7']8R_NRU?\
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M?RR][JV>^JJJASXB,Y_I>38F<DF(UT!!Q<P/A$D0,;$$W3Z_54L@4[6-<T"
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M<O<_ZOHL+71ANRSZU)RZ?+Q'[B:X"-9K;/WTGK:#ZU6)PC$40$! 0$! 0$!
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ME@R[/+(Y$(EBLU32QT.5O6ILDE>)!B8[1VE%FJNFDRX$.MM,>76KG1K+M/3
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MTMP@F%]LW"J:K1F;O;HL,;3S]*LD:MX5R31/DS Z%QPY!8O)>V)B)>;63)3
MQKB,K\?N+6-98SBY3'#-9,=4@O<3[PQYMFQ2_9?9V+J%6!3")A=V<RF?!*JD
MDF>[W;?9#F4DPN:V9^GS2V,.W,;%TDA<?Y5JI:Z1.@1"W'H"F/+/#LOA1[7R
M1'"/HCL@LW!G.F;5V-+CS^LIXTUQ&&1+;X=V SV[5K/@DQ<H&IT_QYY$!"-_
M2>=2PL2U!P\W>#H"(V914WA-X6*=I@D2+A<?0 <5>JS3K[4IAE.?##>'J]2U
M<2I;AK:;7S3, )L'/@%BXMTU;+,3EVWH1\4,+N]:\)ZZ6>MDLER2X 1LV9%)
MF7;'?%TI-55@$@'H_P"%L@5T>7MRTVS3,QY=*G:Z=OAOA*T]('P)$;K^:*=;
M*[6I:70- M&W!8[3-=_CXRX;@E.]W/U^Q,._3?*<T][MYMN)P"5ZOC=BZ'+!
MF2S G\8#CL4DS':<OT ^6:S7I _Z13_AK.,5Z.MS'U:?+?\ [*2/\VD_R:Q\
MO\'H^'^3ORJ^)O[5?,[/J1JJ*(" @(" @(" @(" @(" @(" @(" @(" @("
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MG^YC2_[&=_)E(UWXC]_M=_US6_PO^($2<(Q%<)GPC]L%%B.\]?[EM8_L[_\
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M=3C;/G+UO\PZ>6^4\@#X7GT=*EVLN=/1CC66);G$"'O.]=JUUC7&E.X=GO\
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M?:YJR6;:3)C6OO%XQ'>%BQTSF.6I6T;CLCZ(K?6Z)'4M3^4=^V<N\:>%D$!
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MEJUSZ<OZW?DY_=1IW]FL_P!&8DX._P#)/\'_ .MW_P #-_Q4B]N'R8?K*/\
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M\NG2;C*+B6PYC9=L5]C&=-7B_P O_+7S7TBHT?B#A'2-2$]CFM-5048>QSQ
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M>CI&2&20RFG!C(,$!8)P[%/5T_L\+P_[:_S^<8_G_B ?_;$<O^63"SY,./\
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MS#77X[&A2:W-D/;O3" #&T[43M'9F@\6RP6!\\1BT7K<[>&;FS#MVBXBES9
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M "KS_%Q/_KRW]+_V5XA_S+4?]!F+G&^S^97^L<.)\Q^(A^SG_P J])-NO?\
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M _NWTO\ S%_\B4G+7;^/^7TW\3?Z[G?P<K^28A.$*@X/NZ?44%DXD_N[J_\
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M"Z7+^MZI*DU+A[TE\Z5*<UQ^CN3"'$IA+;*AM1I?J,X&A+JB1'\NUI+86_2
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M ,GN(/XAW<GL?U'_ *''GU_\GN(/XAW<GL?U-R5]A?Y\/D5<XZ!K[?J\E\T
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MO!M'YOF=A72V3I'+>:^!OYX7-EZSJI98?J]1VS LYN'FO7]]KY\>.*ASM;F
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M_##6F5)B/H#L64Q';>G2&%C3"^'>K/NEMX2512Q9[@MMY6<ZS>?LZRH&?33
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MB28&B;"-Q[%KKNMSM</7WB.<XO=:?A/K5NHS[W+JRH=&9;$VCM*G);<IW2G
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MTD9O.F9SY19%T+A?S="FK/NLLLQY5'69DEH?N0C##"SI4G6YSX,*-^<'RYT
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M69!V6N"?9Z.O.7U6?+<(<)R?\UD_@17/Y/X/3\>^\=^U7Q-_:KYG9].-511
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M6)8YWR/7/2'LIOF/YL>7GDAP=7<3<0\1:/(DT3'. J:ZF$V:6-<YS0QLW?:
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MS1?K&7]V6K_YFW_15+RZ=/X/Y?H_O1/_ (K=_II5<KR_IW_JX']V^E_YB_\
MD2DY:[?Q_P OIOXF_P!=SOX.5_),0G"%0<'W=/J*"R<2?W=U?^:3.V8GAF?R
M_P OY9?ZQI_?56_V],_E7I&ODYC\O?LP/]XKR_\ [>I?])"EY.O#^QM\O?\
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MW+5LPY=F!TXN-N)&1]*SR?\ 2Y1WAWK/#EQ7EC"XW9>O):VO?%F8VOJTR8!
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M;N&$(V[;HK4WMGK)9MU=6RSXCH0Q5S*Q=77&6UIK'!P_X*UA.U^BXRY9F-@
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M@<K5KK8L[:PJE1JCGQMNCCMBK,96731^O%YLC'I768PY7,VV&"9-A '##.W
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MVA)K7-8V!P%QV+<62M*KK'.!WB.O8%-735NE;GS99<XV1CLNM5D\L;ND5.J
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MRB 6S&M?*>UP AF%ISELX?OQ\K7V^WS"^6FE:5HO%'$LY])I[@PB;75&Z6"
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MD_\ +GPWPM*ENE3:/3(S0Y@ENW_J4EC(@ 6@Q3A.V^SLU\QU2?$FB+HD6VV
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M! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$! 0$!
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MXQ$8VX#F7286?=;:+2YFZ ;.CVQN5S)PM66GHO#AT6X>M8MRO63RWG@-EF(
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MA9& R@Z-EI![\HI,K9IQ%$7"T7V8=RUG+,OT/S<3==S);)I;,N4O^;.$;(&
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MC&WG[<[5S4J[>N(QVGU9)6+)-JA432]SH;?3E:4<_.6LUKR>GE<HU/LWY;7
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M>N/*?;2^Z+,^W."2>2M*JI[#9=WG8DY76/\ "LU,F$;,3VC9%6W%2?1 U,B
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M4.^ +[AM6+3K(FS.<T=WW5OK<+<9VCJJM(!@<#ZTUG;._"!^OO,UHCB<\QA
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M;#$*RRZJV1TI\Q_RA^2OS;<,56E^9.ET%7455(Z6R:^GIYCY$T#=87MF?C'
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M=\9Q.'] W]6F^9Z;JVDZ7Y>3IX\<C3I!:^HB?@#/@-JGENR3H^V;C-L)U$_
MRYC>EK@>QRK'7A4440>( /;,^DP@CG!B$%LH-;?729FG:FV2:6?*?3S#,9O
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M]WV2<05TFJGDRG1 E,8.>+B>U;MOCAPDVJZC8@(" @()#2Z-U=4.EMMW07=
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MHQ< 2!</H[([4:E;<OA]T22VR'WOL37^3M<LSN'CNQW++/HC/F2IUY:S^'W
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M].7.IG-PSC;!6M:X&P7'#;W%5K%4>OW6/P $?6F6?+4HZ]C)H$86V6[5,_\
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ME5\3?VJ^9V?3C5440$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MQ@UVY2$@F,8F_O1)SA9J EQ;L4S]6\86J4P!@L-RQ<TEOAKS\1RO6HEY1<R
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M<\B%<+'9^B<'39HED2FF)& V))A<5V[H_ CSNQDL,3]Z86#F4;S<.R]-X%(
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MO_V4D?YM)_DUGY?X.WP_R=^57Q-_:KYG9]2-511 0$! 0$! 0$! 0$! 0$!
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MQ;S<@@>__E'=9[T#W_\ *.ZSWH #L7N.PD^LE0>500$! 0$'@AV#W#9$^HA
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M;][YV>.?]H)G\)-_"6I,1TSFY=>ZA<[G*GW*U*5\+(;;_P!MW*6VHY5,W"&
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M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(-^@U)VF^/"/\
M.&.E]+@0.D12)=ORE^TP^S.T[YU_+N?0LHY4^MG4]0TD >(3-9"-D#>M7KB9
M\I.V;A^"GR%?JYDWY<OF HN.N)])G5NG4FIRI\IL]SYC)<B7/+Q+:'N(:P8!
M8];VNW6XZ3,?:I24NC<&Z%I&@</TLJAI:/3Y%&),ENZT"5)ERV[PMBX%I)YU
MO^.G"2][E FU[WXO,39S]ZRZ" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @(" @(" @("
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MZ &6*1RMTVVR1"V%JUC+S=K<I*DE;KL,N5^:74)5IHW;F['/VK$7OG&4_+F
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M\Z721+"6FZ-L0+MH@B7:X2:%CF?#<<PEN%]O55.(Z,2Y3BT6[KCRM3)O&76
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M&V@&6 /IMNON",7E[)\*.+0!#[T6]"-2.[J&9O,$(? ,#ZTG/V37EYJJ<31
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MU_HB%K*55:RI]XVFXB]7PSFH9SG/=&)ZSFL^=HEJ2E\0V[/3!3><KX^RRT]
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M"7.<5Z4R+@O/W=8\I.!':I_1'\RZ?0CJ6I_*._;.7:-O"R" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @S2/RC4%,\[/[OJC^!F_R15Z
M\IW_ (_X?&E\^#_^T=8A"/YQJ?Y1Z]W377#Y'R7]SYN?/%T:[48W"<>U;Z:N
MG/MN/36KF?SE\(7\^*]'AQ[3#G,?O2P+.CH7/O-,]<-5GQ=!7'E&;=,(PLOP
M0<77'F/8@UHVPYE<::QK*2D@. CCWP4\LUL>$WE'O5PS[,<V2W=L&.7M4FMK
M[9TC72H$V&_EFM2YCI+&Q)]W=Y\><#U)B<ISKPFZ5YC"SX0EVOC#9J708<;.
M]9\L6>5!U>: 'QAZ?;FMW4:ETZRU*8USW\VW9L6,X)]4,PAS@+^:]8W=KE:=
M+DDN%\(^OG"Z2ZTZS&EVII9 A#E9M5^_EM+R26!OKV16;:7AG\7F]*F:SBS;
M ^I%GO81N'+!;ZZW6WAE4V/Q89#,+(E*>NEMA[V$>W8<T23#<J-38)3O>%Q,
M;KE<2L>=J56ZTW>+0]UY^ET*8VW=1!S]6C^^''$K:3_[$'4:@'WO-PO)PZL$
MF/"SKA$S*L1^(XY[=JG:Z;QK-:;JL#'M]BQEB4%9 Q#B.OO1<QG&J.A#>,(9
ME7*22U&5549M@<3SQ6:[SK,-:6\M/3LRYDY6=)=I!CHB,8]2DM@\PBJ69:SY
M>]?$1V;8JXLX7QAKMIH&V-RM+,\.7U2-L/2LYL3#-)I=UUUE]\<1M"U+D;QE
M -(V&"8R6?5B$@Q MM/+%,$TF*2C)@=V,8'/$=R83"Q4M 7 18+#D,DNM?4]
M8E1IP^\;U)+I9UF4E34#8#W&QB,MBI<9^RP45'!X]T7#)3-X2R<NR-*I&;@B
MUOPY!,U\S\CMO$3GU>7]Z.H*Y>?VK893WV## ;=JREQX;C9,,+^6!4E23+*Y
M@(LV%;SC;.[VPTZB+&D#+)2WRW+XJ%GSGV\_-=]Q#$E<)$UY.-XSVI/J>4M+
M+W"W/+EDK:G:>W#?E,<3=RB.]1<>4O3M+8;">SV*9^A;+J<)5D[<%A'6.[:I
MU[;.'&95.M ARZ%UF+$N;M$5+YDPF O,;MJY]M<-2:1#I$[>+MVP&_V<Y233
M*1IYQDP!LM@NW2ZQ2U*-U#=$ XYXK623KC;!/U,EI&^<1>=BO&V<S_"M5M4Z
M82;XQ%M^:F5S$ [Q'&['(=EZTQG%;])XC3'FPZ,+5GSCPW;F?X7C3:V9*W8N
M<(#,YCF@M,2^%E;J,0(N)LS,,D+<MF76M?&WE9WJ+B,4US'1/K.?0JEMX0LV
M:&.($+^[8LXVU)G:3HZ\#=$;B-F'M5+F)E^J-$J!=9"ZW(Q0G#K#B:O:Z6^!
MC:3=S'+:K]F;,UZW\45&\9Q/WQ-V<=BQ;AJ36'4M5.:Z<Z)Q'9S+GVWP<5)4
M#=XRQ^R]:R=?K7<'#-.Z+(#Z8QMO&"J7ZO8OAB2_W;#]'#VHN<.Y*$.8 (7-
MQ",V9VFO##FB.U+%EPX_5I9A$ X6CVH7;(--8ZYH/4?4K)]6I6O-T\-^@T6\
MUBB6>43.I(;T!?MYB+DNV4)/I)AM@81M].Q)/$&N*5X-QY="67BG*1IVEOQ6
M7FW_ (22823"=I'L&[$B[-+RW./\MRJ,J8P@$?"1RZT94RKH@Z87 "$5*UUL
MX>)%$ 18+QVJXTSVY^RV4$EC0WGYLTDLK4DFTC.+6-LAUY*W[I+O*I:A5M;$
M;V/KZ%"[TC::J#I@@8X<KTR72\Z8]K@R/K[E3*PES0+(88IVN(UF80M<\$&Z
MXF]9G"<;4?4F;X-F#O28!7![;^SK35M-\4N.X#[SK8#-,89LS<NN]3T+?$P[
MC;S9 YYK/.R?=UUJF@N;O$,:('G]$%9G.^!1Z[39DISB&QAT9X)+[+[*W.$R
M2<1=L]-ZWTF:O:S#<H=2=+=:\B#AB>17;B3#E9%ZTWB-TMP]]PANP@;X$[5<
MZRQ78VE\8NE[OXU^&/M6;M+:O=#QCO[@,UQBT8[+^I,U9)%QH^(A. 'B.MMO
MV9Q4G7;7A9J:L$X QC$\K[5JXC%GT3$J#A;A 7Y1'J2;K*1I[(#F/48=B7D6
M"DPY8!9;\?Y3['0:.CL",R2M>?4;H-W*&Q,6DOK4'45).]"%D>P[%<87V1AF
M.<>O+N5O#.;;AY#)CC8/0DK76;3U%-=(M-D"/0M-7&4^W40X6FTC;B.I8M9Q
MO#DV>'GG-]V',HEQX;TIC'0CGFC7Z<-P4LIPN!Z/:A;>(X'3I;H^ZV^. 5PS
MN-*=IDH1@UM^S8A-\H2LT]C&1#1&&$-JN'3MC#K_ %-F[$".(ZA[%+<5SSC7
MA4)LHN)Y8G:M9EA[?1M45(2\0;&WEFL2;;=A:30$;GNB[(?>\RWB+,+G)I"Q
MHLA]S*Q2U+AG(@L]?VL]I'%TV$199UK?+?6_7A$5LYQ! '9MV+/;AXOFN\*/
MJ$R87&S/!.L^KC+8AV3GMF Y0PA?%7[-RQ;M.J''<'-V)C>5[7"YTKRYHCC&
MSD%+M9<LSZ5S[8&!5O#I.R-FZ6XGX<=FWO4X=.MO:[<9= 9+@XB "DY=>N)I
MDGU?@MAO$60LLP6L.N<11=9X@,EK_?</>./1G%1J7+I?B/B[<$X":ZR OZ2K
MFU70'$O$SICIGXQ]K2+_ &I&NL=0ZCJ[IKC^,-HS-YBF'7&*KPF.G.M),>G'
M;SK/EOT^B3D4#II W<!?SK6L'K,;3M+PW,FW,$+#=[%S[26Y<;5YT/A*8)DO
M\6+8?1VKC<N=MR]C>#N&O"=3N,MONP)LMLZ%J)VF9]WM=PO(ET\F2W=:"T@W
M#8JSCR[1$Z2)-X!AV6;%CRQ51U4AX)&7K5F&>TS,.O*V7,^B#>3<#S8JYSIS
MN)&.BJYU*\6D0AGV="358O"ZT.KOJ UI<3=9:M6.,[5*O,R8V)%A&6PK/EFV
M^$!6S72C';S7J7&&/>Y1\K4"7-!<Z^R_&*8SMS[=K-Q;=.<)S03CZX)(Q[:3
MGU=N['9&[9%5CV5_4:D26.$8$1%G?S*XTWTN:H=9J;M]S=\V& M.*Z=.7TOC
MDQ$5-JGS?I&$,2>Q;KI>N-M<ASKP>I2:9LRS2F.:0Z&2JXD3$FJ,L?$1G#V0
M2<'K+NL-77$M^(XYY<Z7>DO63A1=4+YQ=C:2LV'62Q!R-*?.<3NWG&W+J6I,
M\M^LBSZ=H;@]A+1>/H[;$EPSAVCHFF-:)<6"\8#,6J9+%T^IM#(;HNC<,X\R
M3M)5Z_'FM-U*S>-@OR&:W<<EZ;X;TBE :(#L&$,U+M;TG^4?JFG.F2'$#E!9
MEVGKMT]J^F3)<USH& =;>.T+IX:]=9J">0!N'F.%RYL<\(&ND>(# 1B,\^G:
MI+AO&*@I=%,$T'=LB<=O2M9)=KKH\EX,(&R&6U/NEN.V8MSI4S=Q^$8#O5GW
M7VS/NCWRW[QLRRR4LPY^M671BX/9',9;5=.D=K:<]KY0C"P9[3S+-UP3#0U,
MAI>1@#CL4WY2R>%0GSPPW@<@,E=F-X99-> T#>])ZEG-S@QX>9M:TM^+U]I6
MC&$+-J"76<WH&Q3"YSIN4M69;A$PAB.<<P3#.4X-4=N@;YPQ.2J8\L K2YT=
MXF//EFK/NW))PDY-07"S+U\RUF%VW XD<X[0EIB(^I:3<,_25),[;\(*ID/=
M@</1#:G#GC"$GTSXGW28GO4R6YTC)E(_<=[F&U2U,6J_44P:_P!X0M/8,;T,
MIF@ERPT0-MF*L)RM%.+.6Q6R9RWY9ITLN;"W'T]2%UPKM73OB;#AZ5GM6?Y-
M&73/+A9&[M",283]%1.? %NSL[D;L2S]'#VVM$;+X;.E1,HZ;H+1$[@ORP]"
MIGPR4^F"48!HZA@K,<M=>N]K70TP9"R-W*PIC.U[:3=C1L"C$W4;4UC61$1C
MV9J;:]4*_4BT^ZXVDXE=-89]K/T;5)J!<X1)//$YA9[=9X,Y6^FW)K8G$6=*
MQ+5ZM2OT[QFF#01S<LUO&L^4LVZIXAX>F.8YPEM^(F[9S+,WJGETYJ&D3)#W
M$M ]XQ LQZ%N33?,;6DS&R)C0XPA#U]RS=5F3+MC1JZ6YK '1,>6"URO.ERD
M@3@(;.6"EZYA?HL5'(W!&&WT1SS4GT<^UF'"N? 87]EGJ5TQF*Q-GP<?9GS)
MIALR*ED81Z/2G6EN8G9!8X-B;[<<X*V93EF=227WP,-@6<V::SX:DS3I#K-T
M7Y+776ZDU& T<J3$L$",ALCVJ7MFEVV),R9$ "SO,%:27EAU!DQ\HV7\V16*
M7-=9:E0S7EYW<3Z;<TF9<-28C6T[2IKIH]V%N()Y7+>,%F)I?J/2GA@]W;8.
M6:F:DE23].<T7&_-,::LRY,H2&BPXXY16+JD0U>!)<Z'IYXK><S(T:=PF3 -
MH]) V9J];]6+GE>]+E-W6G9M[U;M?98'-A+<!&Y1+M4*UCG/-F/:>?8EOB-6
M::LJF>YUQY1[ESV22QL3]/F&48-Y6[5K.&<.&G4KY4\.(@.7<K/K5G*_MJ V
M5"RP<L$S.$[9Y14RJB\\^7L3'EKKJ#*EML3EZUGM]ELSPQ5$YI8>G/'H4S>#
M"BZN0Z,;+'8Y!;ZQ/XQU7JTL$F_'U*Y,3.5&+ *@FWX\>>*YU?.7;G#-5+E2
M TN$=T+?6)VJ[R9OB/&[:#=!63#,WPN.G$M;+B.45,XK=F5TIJB6V6(FU2V)
MZM+49C)C#N&)(..U27PU-*/4T\U[R0W'O6[N,8S<LM'3O8X;XA#O4G5++%8X
MLD[\ET!:0<^]2Y\+G.GKIJU/-DSIA#<8YYI/JU)Y5>;7S9#OB(Q]:5FWPE:'
M7GM,L;Y^(8PY7J=8LN>78ND:X7[L7D6C':1@EY9O.E]I*QDT!V]$[>8["59R
M)Z2&D QN@>NU:)NX3E%)]]I%\3RO3)8N-.7B6.88*RZRUB335JIL [>R/;S+
MGVN_L2>TRJE?5,!(W@/9%6)E6I]: (!UQ!B!;=LYUK43FN$FNF$P#C9;><PL
M=N5_C5CH:B83:28@7F/J5QI+?*X4<P>Z#"VTV\LU)%_E,K!+9+>W>LNY7J\:
M6U":DQH!LSY604J549NX'\VTY!7VL))6[)J&,;>/N6*9\G6;<*BJ:1>+N_G5
MEUEJ\*G73-Y]ET2M2YC&&M3M.^!"SD%,QKKQE:J1QEM!&0O2Z3-9W:A40(BZ
M'.<#S*ZL^Z;RQRYKIKO?.7/ECL"S=-1.T88TF)RQ.Q7*YB2FS6,;%IP&WU*I
MG:IZA4O<3"[8LZ5$2A,F/%GHR@IGP3:ZZ3IQFL!<VR CZ3<KN<%K=KI+9#3A
M =BF<\I.V:I5=4#W@#ASW1V*ZY6W"K3I@<;2.1*>R6Z<Z:69CQ"T1[MH3-NF
M<+MI]+8###/U*^,-?]*R2Z>P6'D3M4P1D,L##M4LPS8K.O/=+EN+,L.=)?#I
MX4S2]3J)=6(ET [;FM7KFL9Q7<>C:W,:R)<;P;SW*<1KQE)5VMETNUSNL^H*
M<I+Y=;:MJ.]'WC:3GRQ4B9MJL&>Z:8C,X6F/1L5I8VY<A\RX<K$G*<,C=-F1
M#@TWQZUOC1*N6@DR)LL.L@\1CSA2M7A[ :/6L-* 3]&'H"3ZK/W1':M-:YS@
M,^P*EU4=ICPVK;&$+.T%8LQM<2QVJVKDBE WKF@>A)MCTVZRXE?*F^* Z,8X
M[%;5M5'1=.E3JLDAIBX"V&)]JF,M3%B]5VFLIZ?>8T#W<(;%KHX_)QAU3K-7
M-EDM!(L.?-=8NOAY.RK2JZ>Y\-YQB?6M<._Q\K;0>/.;;$V"^VQ8[7R[;M^S
M;J),QEI$/N!<^UR]'QS'+%2U+I;Q%Q%HN)26QZNLDKL+1Y[9P:"Z,2!:;<O6
MM6O1TKLK1-/ENG2GD _C&F)AA#N6-NO6Q^A/RQRQ+UV0T7?6*?\ "4QO->GK
M=/JW^7#_ &4D?YM)_DUGY?X._P /\G?E5\3?VJ^7V?4C5440$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!!N:?_3J3^&9^$$G)>'IY]HQ_=G7?V=,[7+?_ $L1_/\ OGJ$=7U;_-JG
M_P"F*?9Y.TSW?.7Q[9Q _P#;S?PUGE>(ZZJ_BZ>]:\NDV4]W+]DEX+P3KQS)
MU88HJX:]GA5ER 4:D\O*C0@(" @(/"G;@%A1 0$! 0$! 0$! 0$!!X-RZ].8
M3EQ79IY%RE<N_+$5>J=@)V.KRL-,@N',%IB\N8N4:G HH@(" @(" @(" @("
M @\@1("HS&5 1BM2LY8P[=$(1Z5.W+3@LC*UV$,.Y:E9NMMV2Z[E=%+?HE[5
M(,?<(=,4B2^6](F;I'+'H5DS<KVX6R@G"#19<.5Z[=;IX_DW;?NLM/.;[MUV
M8^^&U:YCA;BX3U.^(!YL<H+,Y_RW+I(;UD%IG&\M9]YYU;<0[,#GD$@0].7.
ML6Y8</$?&PPV!6,WE8M+FNWQ$Y8["MXF,^7+O;9]UZIIP@R,+ACM"S-L9LY3
MLB;\,!B,=B>TX8[<6IF2^.'*)6;SEBVYRE)%XZ/28K7MDB>I!:.8]@4,;RM-
M*V(!C@$*L%-R]*W)FN=N(E66M'+)=^NH\W>Y[-V6+89P4\I.NLIJEE76Y=I*
MMI=Z6BD9"%N([%.8SQ5KHF1-^7?ZUBQ5JI3NB&P=BW),./;=RL--.:&&W'9M
MVIABV^$1J#@\NZ5)#MV<:!C=X='8%6.?"^Z9)$!9]*/H&Q/;PQVLG#L+3J<P
M;9EGW+4Q]&>V,+93R8"%N.',IVGF,2R\LSY)@3ZBLL]NL[<(R?*)!ON.!Y8*
MY3UQ&FQI8Z/5?FK>&>O*;IJEP !<;=HV%<[G+O.WA/4<YT00<KCM.TJQ;=+C
M2/+F [6^WTIDG65,-?8+,!CL5YT28<A,(-REF*O,2U+4#> LQ%XQZ5=\DTN=
M#,:)=]X&(V)>WLG734KYQ)LY6]*?9CM45]8?F>OV+I-#F*IU@WNS#I6>W70\
MNJ'0,2806/5/9HNFN)L/*'.M3$:MRRT\QQFMCZ^]:U8F-KMIUHE] ],%.K79
M;F2=YC2(V\LDM\.>;$[I$LMF".!'JQZ%=8;Z_5V#)>"RVSW<]@6+URU4-J3=
MZ(&?.KZZ9EQ5>%.[D?8KU/9B)?+LM$>=:N*U;AN29T'L!Q(ZNDKEAG.5XTWP
MWM9&!M%Y'-FJ+6^AD^#'=!)&2C4FU$U?30Z):T?2]6Q;S^TSMUK7Z9,#K)>.
M6WGS4ZZJ>6K3T$]K@ PWCUKI[96W"TT=/-9N1%H$>8KG9B,)68V:&0!A"S'(
MJ2;ROE!U9GAQMROV)ZX6V6/%":CQ!C;@=I2=HU)78>F-J' 7X8^Q2UWFHO-)
M(FEMOWNW-+O36)RR3:>8;".5G<G$9QFL,K3GNF#W8V'K5ES/ODDQI;*#2WEC
M3X?*)42S>4B[37;IC+A=?S\RLF-L[1\JE=)G1A ;V Z5B\MR^%VI*R7+DP+@
M+/4 KUIB6L537,-H?'I6_9FHA]2'1@<+(\W.EJXS&N7N-_K[UG/T27#C%9NV
MO9Q<\M%F:SFI;EJS:DM!&\>OFZ5=X.O7+7WS-Q]?*]:G"X]*TI\@QC;U'/F2
M7>UM]IIK!GO"W$+;G,RK%IX^'F4XK7;OG6%GDM!;RR"U8<,KI /T8VQM'<%&
M6'ZN/O?1[$]8UAX,D 1A#HZ<E<3!BM&8YP=8(;;<RLXQ&6K-FN L.&'0L+YR
MTOK+L7'T=ZN5S4I0U +A%Q-V60VJY2?5<]/F,+1;AL[UUSIF[J8F"4YIL$>C
M(Y%8:QB(*KD2X$P%ARRZ=BWJQ)_)3*N8)<TBZT]O0N=F+I>T\I*AG1+>GE>M
M39/NN5!6F5NF)A#V9K6,S2VR+!,UB$H@3("&W)<Y$L\NIN+M8)9-_&$^ZZS.
M]6G5ZI<1U;YE03$WG'/K4Y;[3!PW/?\ 61?\0[0IPQFW7A[*Z#6.9(9$FQK>
MQ27:\+.-5  !?"'/FNEQEF[K!^=6_?\ :EN1X97A\8N[L.96W/ TJB;O@]O.
M ,RL=A5ZU@<<;N7:G5;;9A'-I@;F@]!6+S]F^DOE)R=):YF]N XV\W,F"XFF
ME54+941NBR&&9V+6/*2:5:MDB7OP$+<+KB$R3/E6ISBUQARB5<YN&<X:?COS
M/7[$O7:;O 9SX&TW''V*8:]4553W[IB2+78\^Q5<:5"NJBV,7''+&*9VSG$:
M5).$YT"2;1>M8)%ZTC2!5;IW08@'IM[5)<-_^R]TO"X+"3(;U9GG4M3MP\3=
M%?(<(2H0,+!E:IC#,F5TX?DNE%H/WS?5W*VM7$CVHX&I9<\-W@"8-OV8^E)P
MQY>U/#O#5+/9+)E-,6# 9CT*KY7"LX+IOJIF"G9=&X;4EBWJZ1U[0F2ITP"4
M (D7;88+5FF,84FMTAK6N_%BZ-V9"RMJ@ZII[6DV#X;NDI+BMXS'76HTS0X^
MZ,<#M5[7RS8Z_P!18 #L7/)E2ZR8YL0-IB%J734FE9FS)F^?>*OAGOF73G)#
MYE\2=O1WK,FVNOW;K:1[KA&RSG6_9=5G.D/F-^"_VA2W-3$:,[AM[H_BA9W$
M^M0MTC7\.S&N,9(&V&2UKEF3+-(T]\E\-R&WH'<LMR86[3XRVMCD>45,;3&\
MKUI%2)3V0.=WHQVJ3:7C#O;A756-\&+X0>%OAY[J[>SW!NOR&E@,S%ML=H4I
MUY>Q^DZ]2OD@&:+&@VGF&:CIGPA>):^EF2C!XMB?0>Y;G;+G;.'I[Y@SI)$W
M==&+W6]*8DVR]/N*)@;-G$']\-MG>IRUUF\^'5U55N!F .)ZLHYYIZQM5JMT
MUSH@DQMR'85>L8CC*;.+1'+$[3L4[VRZ3.;B,,^3-=&S'M![U)N;.*QT]"]\
MP B.-L5GU7?+L?0=))F-):/HWJ\5TDEF:[DTS2V>&R+!\.2Z.=N.&Y540:QP
MW1RCW+."3.W6^OTUDR#0( YY*W%>CX9O#IS493A,-F9]'M4SX>W&D ^PGG6/
M+.-M^A!<18<,#G%:.*O%#*=!HMMV$8=.:-)QLDM'L*K%MK5F4KW0(VQQ4;Q*
MTYNG3ID&L9O$DPQC<47$DVG]$X0D2C-K=?#J&DDRW3_%F-+6[K(F()LP3KUQ
MNN?>VZZ[K\NOM"_M&N$?(;@^JT'A+7)=1J4NFJ9&Y3/:Z9O"66M #8F.]TKS
M_/\ D8GI'U/P?]=>^._>/C \W/-OS#^8CCRKUB;/U?5*FMF/=3Z;*FO<X&?-
M)</#:\-=O$@8P7@M^K]+\?QSIUQ(^CC[%G[$SC/Y@.+^'/,7S$X4G4VFR9-/
M6LI]0:\2BUSY;P=R81+BYM\%BW>([]9,9O+^E9\NWRV^7OD!P)H/"_#/#&D:
M?5:;I]/33JFGII.^7,E,:X!P;"QP-O4KUF&>W;->QZTR(.+FM>TM>UKFD0+7
M .:0<"#$$(/QU^U ^S6\OOFZ\K=8DTG">E'79=%6GQVR98GN?,E$AP-CS%PS
M4KIUN=5_*>^?#Y'O,;Y._-G5^&ZS0=2HM'E5]>*2OE&:V7*;*GES6"87 RV!
MET#"Q)4[]<<</TF^QM^U"UOY>O,;AK@;BO7JQVBU/@4IG53W&4V6'2V.!<[W
M?=!7;X_E[=.TMNGS?R_PNGS=+9_)_3J^73SA\J/F%\N>%-9X=UJDU&LJM,D5
M$YDA['NWW2MYT=TWQ7T.WR>_7,X? Z_@_P!>;VUAVAK=+1Z7+J6/8&2V AKG
M"$86;$Q<O)\EF;UCU1\P-=HI)J-V8 -QUQ&2W)AYODGT>EO'O%,DM>&SC\$R
M%HP*N7'MFO3CB;6A-GD^(2(NQ.WN6;]2:TZ@UB>9^]:3?9SK/-3M-8=7:GI[
MYIF>Y&)/;Z; M..-X5IVDN:^/AD6[!C%:EPG;6DUIU.)#FQ L(,>I9LRP[+T
M=[26 GZ0RV;5/4=HZ>91EB MW1:<[-JS<Q9MQKQ!A(OCZEJ3,:D];F*'J#W
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M737@$G"$>;)<ZN,:8::US#M;V^Q3/AF<K_I %D=BLF(Z]9E<F.:UMXN.(O\
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MAF3ER--5BTR7 ;6GVIBF8QD%I@1 Y%!X0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0<VRITS\G++N8$IL<C3U+;7R7-',?:F*9C'=8@\(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @SR;^D]B!-]8[$2<,"*(" @(" @(" @(" @("
M@(" @(" @(" @(-S3_Z=2?PS/P@DY+P]/?M%_P"[2N_LZ9_C+?\ TN;^?_\
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M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @SR;^D]B!-]8[$2<,"*("
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M(W6V/>O1\'S7I<7A\3_9?Z_K\D]^D?1R/.FG\TM('$6E5,F;+K0'L\!X<(/
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MVX^M6C\'7.'Z'BFD+33:K(EU<HL@6%D\D-W886*\UB=O#0440$! 0$! 0$!
M0>8$W")P&:#Q]?HM->)VHU4BCE,,7/J7M8P"V,2X@*RR<GA(CS5\LY+!33>,
MN&F3X &6ZLI0^-@N,V,8KI[=>7/^OM;EIOU[0M:(?HVJT&HM,(?4ILN8"3^T
M<Y8[8RW+BXK@6EI@X$'(K"N*H(" @(" @(" @(" @(" @(" @(" @(" @("
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MCQ62YLW>Q]V+?6GW3_JP_GF?K!'SS>=7D_Q]J'#7 W$]1I(J:\T\MTJ?,86
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MJD!DF:$!DF:$!DF:$!DF:$!DF:$!DF:/! @;%>MN26Y<0(+T3AJB((" @("
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MU]%K"& 6?1QV;4Q:LDKL6EK"0+KLU;+)ISLPV'U3LQ_A;5);Y3PB9]4Z)NC
MXQP"UA,>S5;,>\C8<(;$REZ2-V6'9&X>E;MTX>4M2B8"#;AVG8N-N].DQ5YT
MMSXMB3=LV)?X_<UEV-IPBX1M!AZO6$F<,]K/\KE34<J8 8#;$;-FU;E9;3J"
M4&W"/+-.S?7"+?2[LP$ V&-VU8[61<^%NT@AC8.LL*O6SRS9Y;]1/E@FT?<
M72WS&=1"U-;)N!$80O%]RSF-RRJ[55#'QM$=XGK/-L4LSMFW>4#/MC9F>B(*
MF*L[=:PR0=\6&XK76X.R[:1,$LLWN;K4N[]EG#LS2JJ7[EHP[.9:ZS7^7/?6
MY\+O35+=T1(RPVK/:^&^MEVLVG&6]S=Z$ 1>=@261IV'02:<@0A=A#V);!GK
M6RVRK(=M\5+<F'5NO2?$+X71LLZ4E8[9ETH4R@+GGW3U9$A3+<F)FI*ATQS-
MT[KH1.!1FX7"BD-EWC&-HABMZQE)M.LFRVD;M]OK.U/:2.FL-SZ\6LLL@,#Z
MEB\IXQ6B_4IT3:;K+>C/8AB/$JOGN>(DXXJWC36)C2RT5:X!@-]F>WU*9K.<
M+C0:@T-$3Z=BNDF;N\)*HJ?&9!I$3'N]2<W2SZ,5-*G1B(WQ[.]68\NTED77
M3+-W?(N$8]'<M7'AE<Y IRT$ENVT>M9:N?#;#Z5H,-W$WCOV*5>LQRB:NKE,
M#BTMSO Q*&9PHVHUI<YP:;+K,KEOB)F*7JDPOEF$8[IQ6+9$G;/;#K*<PNJ2
M'#Z6-V/>F<3+=6W2);0X @6@*23MREN+B.UM&9* 9&'P[,PKC!;+?N[!HG2&
M-:?=%G;]Q#$2;JJG O;EAES)DLGA UE73DNM;:(88@[%9#7"HUKY,PNA V'E
M9L6Y'.S"FU^ZVZP6CL[UCO8O,5B;,WG&W$\O0L76HZ]<3E&3S$V9>H+4F)MB
M\M-V^#9';BIF+F/($\QAO*M.7A5.3O3W(C,)=3 ?%<,^Y9LJ8F?NE]*$YLWW
MB81 ].U:C3L5I'U:\1W>F)ATKIF8PY]KA1M7ESG[^[&]W+)<>VJO6.NJ^AJG
MO=8XB)P.V%RN=$MX18H)Y,-UUFS),9NT]:D9%%,9\0,>;G&86.+IN721$F8!
M8.WG5GW2W_EQ,F>3  V[/8M:)=?=+4=),(M#HB!N*X][MKA.4[)DE[;'6<NQ
M9F;MC+LSA]X+I6_<0+"M91V[22J29($0+0!=LBF;.6I>%/XDIZ7PYFZ!'=.
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M+Q7Y>W+KK.UNTVDGTQ$0Z[&.$"N'?\CO*]'63U^RYRM5?2RHN=" ^^RBN?\
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MIK&G=9!Q^(C +E[>LVZ7K.]QU?,9]K?]L;0:51\2>7OE+J=))JF27T,X4=2
M7.@)1LEOM7A^7Y;;B/K?B_B]9)>_+X\P[S&^9[S/IV.DUVK:YK^H2Y =3RI]
M4))J9S&#>/O#>]_8O-=/I=>N=3A]SOV''V!=5H$_0O-GSOTBLJ-*K:VDKI+*
MVB: !*;*G0 F2PT?E!D%.6[9TFN7W9\%<$<.>7V@TO#7"M S3M'HFAM/2L#(
M, :&BUC)8/NM&"N,.=MO*VJH(" @(" @(.H/.3SGX%\EN$ZWBGCC4Z&DTFFE
MS/K4NIJ9$MSI6X2\&7-B'-<VP@B!4RU.MK^8I^L1?-S\L'S$^86MR_)^1IGY
MWI=3<VIF4/@Q=.:\![HRL-Z*D;[OFO\ )CR^XS\P.-='H.#*2NFUTO4*,F=2
M2YKMR$YA>TOEB BT1(R*KAV[=>L_?P^XOY$?)[S#X:\MM#E\7-K(-ER YM0V
M9O? (Q#@+%[/A]NLS>'XS_:=_C[][_7R]X=1X%GNKYDUDM_AD@CW2NG>W+YG
MQZFVU3\+SI%FZX$;"+BL9N77F92;--G4X%A%^!&$4S4SIR-1.ED FR(4]F<3
ME&ZC6!\MV\1A&W;U+'M8S<9PZ:XJFMA.(.%G3!9]K='KO;IB?-<*EI$8;P]6
M2E[6-:D=J\'3MXL!S;VA3WK-Z2[>RFALWV-W1$P:O1\5MND]<<K+,T][A$@W
M' KU)<*CJNE/]XM:;SAM3K8QG*ESJ29+F&PWY9*XS^BR6<\+-H4KWVEPQ&:M
MOCPECM>C\$2@#N]:QUN]L=I;PBM8=)##"%QNY^=-9;Z];C?#J?4)C0\F(A$Y
M=ZU5SX0D^;++3 BXY8I&>V<X5FLF"+H&R(N3*>OE%-)=<3U^U629V6)JA8TD
M;PQ5OV.%NIJ>40"1:=@VK$F6_&DJVBDFT!6<[),S ^BE;ILY?<5L^B^N%6K]
M-DN,0!?[%,V:3$03J5DHV#U+>8Q9FMNF<UI@=G:,US[;W&JE6S6!L21 PR27
MPEJOZG-EPB#9NX0S.U5.775<S?F$@1!]1'3@F2;:3*)[R( WBR&U68R<+KHF
MGD/:YP-F,.96WZ)Y=E4S?#8R&$#9L]"QC,=4@R<80B;XX9=2F^O*69X0VK!D
MR3,#L60NV'N4WG*3?+UPXUII,9QO(ENA9SK>*Y]KMZI<3'PIKBT7.<.76G"S
MA#:76O#P"=E^T(LW?L[UX7JV.W=Z$0T8K.,G;J[YT2;+=)8 ;V 89<^U:$Y-
MD,<T]-W,D9M\*W6TK??A'#!5F95>93/;,-AO.'M2UN2IW3SNP!L([5,-8JWR
M7MW+Q>5N6?\ HQF-:JF-(L.!RV*M2*E71WG0S[UR[7''#5^S0E"9$WX;,>8)
MFU+=I%A OR72<?=KPS%[2"(K.&9JH2M=+M^&XG#E<5F9REJM5#99.%^%N)YU
MJI-\(F;+O#1V[%>LSRO%>)+'[V/I5QC;6DA-/XLAWWJ>_P!$Q76VNM;^,)&'
MJ*S>U3==1ZA/\*:87QCW>A7WMC5FG"AU=['0B(1SYDG;//*8LV[#T[5B\ .<
M+OO@5K/T26VIV96 RX BXXGG3-JW5RIVI5$P/.Y&!/9S(EQ6&A=.F.C;"SL6
M;V\"=9(>Z\8#/'J4O:^&LS#;92V6@P(&',K+V2W36GTK;8QAS0Q*6UJ(2IIV
MMM'WQ6/;MX2RVHDM,;!R@NGMF;9WEMR7.!L.2S[6'_LEI;C ="U\?>V[=>N+
MIRJ@SPB;(P/H"]LD=.NE"U5KH.AM5QUK6?HH%:Z:QY$3GCG!8LB29VTVS9F=
ML;(IZR)=)>DGD.:"<4F%WA9Z:>"&@D7#$9K4G5K$2S)C-PVX'+(;4Q&+RJ^K
MS)32^ZXPZ IB)RZ]KZEC?AA=GL3$:G*N_7G[]D8*^I;M,TL]SA W6>F"SB)V
MWPD'.:6F/I"Z8F,I+8C7S& D<^'.N=Z2W*7MFY<Y$UN^(G+):G63AK,3U//:
M&WCKZEGY>LDRUUOT)]6 TVCKV;%XK7;%DRI^H56\<(6XYD+698<S:F5SA,C&
MTDGE8LZC,U53J:=ACU]A2->R'FT;< ;8PLC@JEOE%3J9[28 V;-L$/;ZM("<
MTB]2QKVSPFZ.8\")C:0F,QFYBPT\P$Q)Y6'%9XY/:U+,J90:!$=)V*XR>]G#
M0JJA@!((LABMS&%G>JS6S@XG=./HQ4F^6_?6T&[WB8YJ'M7$2 [MP4L8]^V<
M5+4M.V[U;5Q^2V33U?!;>VV"NIVP<1?'U!</:Y?0S9&_PO)(U!L/V/X6Q6]J
MWT[7_#]O/DO:_P"MZ7_ R^P+%RW[9NGU5_*VQ_YKTFS]Y'*Y9KV?#V?HWIC'
M^!+Y]HQ.Q3,NJ]?6YPLLD0$.6*SVW'3KRYS7[C28V^Q8GT=,6J_JKR^03' \
MLUUQK"28N'6D\1G6VV^M<;PZ/* @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(,TC\HU!3O.FWR_GQ_R,W^3*O7^3/?\ B^-+Y^6M%9K-
MG_U1J/PYJ]3YW?\ D^97SP_UEJ0/^7/K3-2SZO4&O;NSG'K6<WPYZ\-'Q(66
MIVO_ "UUZR,,V:YMH,>?H69FKB--\YYB<^?F26YPLC3F%[B0MK9./+@UA! @
M;2.U+?).D;(:01 <NQ3V6].N$I3E\,;O4%G-C,F4DU[HWX*];]5D;8G$ 7W9
M!;O;_A&G4308Q.!RVJ9TN(@JJ;NV@XN'<I%]9(K-95&#KL!?'9M5RS.LJLU#
MR\G;$CJ.*C7K)$:6-."G:IZRZC'N.%W-?AUJ2_4QAMRB; ?5FM\\)VDPV"3"
M"FY7+$Y:LV8YL8'#N5RS):TW37G%3*W$_5PWW9]B,O$24X7=<A+<ZR$<<?4F
M5G+/+IW$B /4>;%6W1B6I.7032T6.RN. 69I+-XC9E:9.<18[JY_6$M7^,2T
MC37@_">HY'8M9J6INGTYT&V&X8;0IE-U-2=/(%V P3-K4URWY=!NVPPRQZDW
MY,QL"C$!?Z.]7+/EE92EI$(]7<M])GE/;&HD)-,XPA&^-WMV+IQ,K[=DA+IW
M0^''+VJ3"9LKDZ01;#T%:N*U>U\-)S"W"'L6>T9OM7*6UQ=T<NQ9P3VB5II)
MB++C#TQ5NC-O*TT#6->"X"$/7[5>O"^U;U;+ES)1W81 -WH53VKK75=+GS \
MLWH1)L&9BI;X);:I<W1ZO?=\5YP"N,M6_1L2**HE%N^#".1A8 I)?#7A+2"6
MPC$6CT$GG6ISM=Q9**?&%H^(98_=6.U2W*VTI<X7GD>Y:DS'/M[>K>%,'F+N
M41#%68CY_P TVDY%(VR%]N5UD5FL==1O?4R<R.;O0FYEQ-(\V $<N=5F;U61
MM%,LON3@YTY&EF 7&S9ZU,>6I--2=*FMNB+/6?4$S&+:Q2F37.MB>O;L5K/E
M+-EN N1K%<O$?*MY>CF4S%F?+R:TMM/:LYK5OT8)E>3C9'/VK7C[L]<Y1\ZI
M+X@=L<.I,%U6A-!>TPM-_:JEN6M34GX^,#@;MJN8SUZW.?#LG2I(:QH@+L;\
M>=6/?TQQ^BRLDB&%_J"S9<M^O7[N9DN4RS>DJ.G!S8\L%NT]9$1-F.!OOAZU
MB7!)/+Q*?;:;?N+?M<-8EXX3$G<,(PPPYU.=QF3'+5KMX6LL%EW**EK6,\(8
M";,./I4W/U))+M(R*=Y(B"M3.&K)9F)AC3+9&Z M]O0L^V\.=BOZMJ7@M>(B
MX@6PNAWIM;.N/NZ2XDULQ=[S81/TMA3-XB>GET/K]>)YF6QB\XQOM]:WX6==
MJ=)ELF3R87D8+'7=3OUUIVGP_3M/A#;EL/-DNTLKQVXR[RX9HF$RK#\0PVK6
MF-UW[H-$UK&W_$,-@C>F%N%_EM:Q@NS]"WK#'MX:=34RVMA&Z(OV+/EJ3R@9
MC]^.Z>H[1ES*7K"7>VN:6:\'=!NP!VJ22KW[9X5VMIZN7,$ Z%D;\8+5F6.M
MF<5/Z1(FOW-^-X'I4Q*UV=@TM"W<B;[/2KB<)QPUJNA>"2R,(&$.E,+/NB33
MU0)$70CMN4PUG_AGE2)\?>CE;T]ZLFLI9+PRNI'$&PQ(RV<Z8E9LPUY5&]CH
MVWQN28C766M]P?N;HV#EBFG;K/J@:VC>\6 Q@;A]W-7&8N-JW,TZ<'1(=".7
M+)/61,3*2HJ9TLB,<+]@"GJO[5YT_< 9O0L'<KJ,7KG<3)W"#\/HR67/M+A"
MULEK@Z%EF"LD\IUOA3YX<QYL-FSO6<;<[G+-3MFF!$;]M\5KU<[=K)2B;C''
MM&Q6233&;E-23 #>.'W5+]FO9LNF,-AMZN]9]7*VRZ:DUC'W"^/I6O4O9H3=
M-F/!W080L@.?U*8Q=\LVVM$:1.!)(=#F/.%>7I^&6UK5.EQ!!%X."33Z$ZS'
MW52NT5KA:,?O=@4IB*C5\.LF$^X<8^[U).-IZ[S%3K^%&N#H--Y^CF21VJM>
MNE#U+A$[K]UCK#'X<47K(ZYU7A6<TN@QXLP:=N2)Z[4.LX<J&N<XM?9;<1W8
M!/;!>OA#"DF2'[I#K#D1<ISNKCK>$S3S"QL8'$VV9*I>L;8U.9*%D1T[4\M3
MK+&]3\0OEN!WO^-9:5FRYTQB87W0^*1O2RYPR/O; M4G29S'=6@\720)7OBP
MQ^+ E%O6>79VG\:R&"!>R\P][F1,2)T<9!X]U[<(0=FN?:_1KK)EX;Q/,>[X
MK"?OC=R*Y9=+TEBW:5K1> 7$6P-^<4W5G7KA=9-?*\*)+;1&_8M]>T9]9$/6
M:I)!-K;SEDE,=<[:DC5)9=>W#$*7-C7KULTF16L<R(<VX8VVJ8M3UG**JYSG
M@@$70L/,M283UZWCE5ZR3.<"(\H9]"Q:O]<P@S1S 3&_F/.K[,?U7*P:3(\.
M8R,(#/*/L4RU.D=I:=,8&,@X"[KL"9:O6>$Q,J6 ?$V_$CFP.U,LXB-FUTL7
M.%^:96])6(:E+:8[S;-J'K)H=Q=14HA,?+%F+AE[%TG&/+EV^/J@:_CZ@+2&
MS)>-SQG[5UQMB?%.5 U3C6F<7#?8028>\/4F6I\?6NNM6XID.$R#F7G$9]27
M:>G5U-K?$\'/+'"[[[:.Y9WE9UCK+4.,)[7P:\"S[_.*LI/CSM"?I9/<X!SQ
MC]/VI>%G6<,-1KQFM,3&('TN<>M231Z]5;J)[J@D","=N*TU9EL4.G&>\1:;
M;;EF[9]<.R>'N&C-?*]TV[.<*S1C,=^\.\)>XSW2+<A^Q.',F8LCM2@X;$IM
MK3\7WMUW<J83S=-;+C &'-W(EO::9/"+1 8=:);9-LDBBJ'S@6QA9GFI9I\[
MY>US_EV3HTFIE2F@QL:/0+?2I,9Q7/VN&QJ@FNE/!N/>M8GAGKWOEU)JFGF=
M/?$&!LNVIB-9KGHV@-,QIW3>+V[ K(SV[.V]/T.$H%K3$#+9WK-C/M;,-#6M
M'J1*.X'=74LX:G;"DTU%52IA+MZ\V]70K9AFW-VMU$^8 VVT K4EG*V9X3DN
MJG-:+;;,=@3$\)>K@_49S;W61.)SYPLWK)3$YCE)U($@/<([2,TG+6)8L=+4
MTTQGO%L21D</8KY9DF6:<VF<V(W;8Y8BQ7"^O6ZJJZDUH8=R^T6=,.Q%].LV
MI^_/$^ C",,>6*6:7V7&@/N-+^F/2L<).URQZHZ3X;[OA29ROMCAU!K,P;Y#
M<>ZVU=+OEGVN5>I9+YLT7PC#KL6<;:E[2NPM+TU[H0!L@;HK.*N5SDZ3-W00
M'60P*O#-MRAM5I)LN(=&$5;_ .IV[6\(2FI!,?:#?ETJ3)?DO"P2-/9#X?05
MJV8);>7&;),K> %D.J&2S:9[9T@:F822,(]ZLL7VLK0<Y@C&_O6;L]KPC:@$
M@[N6'0C.;*@YTJ8]Q(!MC"PXP6L_1KV2^D4<_P 1D0ZUPP.7L4=)<QV=2:?-
M,EN\'6V7':%;?HW,5&ZOH;7L)+21 _1.6SF4F:NIIUCJ>@2V.B&GZ4?=. VA
M:\?<4VHI)LAQW X0.1P*G&F;/*6TFKJ)<S=B1&'H5PDCO?A.L<9#?$(M&)V>
MQ+SA;JI+6IK(@BW&SEL4L9Z]F"AU(20VVV&<.5ZF<-6Y;=3KIW2 X7??)F\K
M.TX4^LU"9-?$'&-]EO:MS[L[S_EGH*A^_$W1SV*6QO$=F:9J+6L8"6B#=F2C
M&LI2=J(<P@.!/.,E/U;_ $1<J8Z9,)CCRM6KN8C/>ZVYU>^)>/6CCG""EU#V
MS!O8$"T[0I^C-S5XT>H8XQ<1<-N)6I-9I=18:I\IS!ND7=OW5K,D)N.K.(-[
M>?NYX;2L7%7K<14:9CW3F[UT;8Q[DPN<NUM IZ7PFEX;&$;0/64REK-JS:=C
M'[D/@2W/#,MKIW77LWSS'(>M+J+N.N9TYOBFW$99J?\ 2F;G'A-Z?NO(QN2<
M-YN-+5+I=YH(!SNS4SE,V.+Z28(0!5SCA;VRXRS/E1A$1NO5MRS,^'*;4U6Z
M+3Z=FQ22M7#A*?.>6AT<1CB4QM+=))DN#;0(WXY*^?LF^7!X -V"TSEOT36E
MP!N]IM4;U%RI*.G<UI(:;,1M"SVENHL>*NBI]UT -EFT[5G%G)F*97,$J8=W
M*/43Z$DRE[--FJNEP;$6$8[5J3ZF\)FEU668%Y%V)QO5N+J,RU+,U"0\"!;U
MK&,-W,VT:N>R8T@$&/3@%N6,^W:J%J]),G!\(WD^E65,UUGJVE3CO&#B88#;
MT*5KKVQI2JC29[#&#KX7'(+-N8OOF[X3NC2ILIPC$#>!ZN=:SHQKV=Q://:&
MM#B+MFQ3?A.?T7BGFL+! X;,CS),YVG;$)LQI,(X>Q:M)=,(<R(Y\E+43='X
M): 81/<L7=7B929DRRWGR *WZQ,YN^&.33ADW>PC'T\ZN(LY2DZM\*1NQ$80
MO2)9BZ56973733 Q$<\DJRSRL.GS=[=+N<K&+5L^B:G/8&60%FS9M5N,$GU5
M>MK '$"'0=HYE.OW::,NH#S;#KQZ]B689D^KC.FRVQMPV9%29I<>%<KG"8X[
MMMOK6I-L^$)]6<YXOA&VSI2W#4LD^ZQZ=3,;NQQMPY"]68L)O=6R0ZG8(&$0
M!EZ+DX9S;65E9+:X;I;?9:L[RUF6862BU$D  Y8[%N76TF?\):;6ETL[QV7Y
MJW'*V^%1U&:UT=PVQL]*QF71UR@Y,NH<_P"E"./2KB+:L,B0"T;V&Q/T21DF
M2)36Q[1L/.F4G.T-5B4T.L%@[N;)&E3U!TOWLH&SE8I<5+'7VK/EVW8Y=ZLT
MRZ\G5#&U,;+QCE;VIEJ<.X^$*^6); 2WX1CL"9TEN78S*J0]K8P,1FLS[$F6
M"H9+=\(%QA#G[E>%QCE7I\F<7$L!RLC@I=)C+E3451-= !UXSVJ^#&%CDZ1.
MA<['#F4D6\9\D[2JIOPAUEMQ]2UC&ZO6VH*ID5<DG>WLL1>(+-WPSV<J,ES@
M'VPP*L6<+'+HY$UEHY[.6*B95S6M(I72YGNVPP;S*];89>O'%^D2V[^XTV-=
M]'GRYDLSM>9IZ]ZO3/E/):UUYPR3K*SC6WC3*N?))%HA!2W;4QC+N3A?6W,?
M+#B/A&/-S+4MJS'^7LMPMK<MS).\6VC/9BESRESX=O:=J4ES&6MB3;;SQ6;=
MZ7,\IB9-8]A@028Y&\&[I6YPS)YG"J5\MT3#;='U!9M:SE$>&Z-V.WN6,^&?
M+=DP9"-G+O6LMW&-\LSZEK,1U\W>K&9P@:ZJ+Y@W87PO/+%59GRMG#KF19O0
MMA?RV*VX3B[=D--.9+A[L=TC#(A9MS,$M=;<026S'O+!@80VA63$Q5NW7_YN
MG/F^Z##>C=M2<LV8BZZ5I-06 >]\(]*MF?U)VPF9^DS/!-CNI8XNVMVJ;-T9
M[IKH@VNQ!SZ4SEFI6FT5TIL8&($;L_8$SX2:C>ENF4Q(C "S*[VIB\M>V&>9
MJ3BT@NV7]&"3Z$GE 5LUTX$1$=AOLQ5[;X:4RMHYI<2T&TDW'O28QMS\_9J2
M*2<UT2'=15F%\Z6[39;FEN\+(6]BJYBUR6;TL[HP[@I9E<X5;5Z2<]QW039M
M[UF2QG/F*4ZAJ0^YUX.*N*BP::V?*<-Z,(B$8\^S-0G*Z4U:]C1: (6V\Z;Q
M]V[9&9VJPQ]*EOU-UR9J9<;'8YJV)MRJ=1(EF+L#CS)C!;*J]1J;"\@D7G'*
M'3BNF,QGQEIBIDO?;"\P]G6L=N&YC#>DS941NP4DPQ=W3>;-%D,?N*YC6;)A
MQ?O$XFQ+6&>0""(QO[E<XY=),18I=3+E2'[Q'PQM3EGRZRUO4Y(J7"(O.(Y\
MU>(R\Z=74Q8TDMB2,L^Y8MS6L86B1J# !N$70C'EBH9S/NEJ?59N\ '61SYQ
MFK*ES-+5I^H[V[OF)OO6\M=>%ODZA*:P1(N&(RYPF2[X8:K5J=K"#NFS-5A1
M]5K951O!A%Q%A]'I6<W*=N'7.HRYH)<(^E7V_P"7FO.F.B=-C")P[5R[6N_Q
MV<U;),E\QD;;0.6"S&[<W2L:S2S8N+0[J6>W:X>KXD)0_79<YD-X0NZ(KG[N
M^*[YX,K*IG@^(70#AB5F]MO3TN(]F^&:QK_#WC]-I/H4MN,NO6>7OG\N+VNX
M@DP_K$CJB%ETZW]SZH_ER _1&59_S63_ ":=K</9\/\ *.]*GXQS=R\]?5G#
M611 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 02^@OE2Z
M_>J+9<"!'KL2)V?FE]LCI'%VK_*%Q0SA/ZP]SJ"M ETV\7'^;S"(!EMRUVN>
M#IQ?J_CK^<.C\1Z-YD<94_$]+6T^I'B+5C,-;+FL=,!K9Q:6NF ;P#"+EF5.
MTLNWO9]E3P_QGJWS2\ 3N%J+4GRI.MTAJZBF9.,@ALT1!<QN[%HL-ZEY=.DS
MUK^R'Y+2JFF^7_RZDZC'ZW+X7TQD\/\ B\3Q'&!C;O +?5Q\Z2+X%Y+?AB8>
MA9O+I.'% 0$! 0$! 0$!!OZ/+;.U6DE/M8Z: X8$;L2A>'Y:?:Z^<'$/DKY2
M:_K7"L]U+5R=+\:66O+"'>$UT8M(.:<+TQ>7\U?S4^U]^;J7YQ:JS3N,*B3I
MU!K7U-M']9J8S6F:V)#FS=UL ^P0P3[L9OMA]LOZOS\V_F3\QDFAD\?U\RMF
M>++#O$FOF1 EM)$7.=BLYW_ET[R>N?+ZG^)9,NGU$,E-W6F3+,-I#NY:8G"O
MHH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @MNC?[.:[_ )K6?Z'-
M2)V?R\_UB6BIF^=/%,YK?QF]6F.W>FGM6?+K?_C?B']G;(E3_F*X9$QL0*O3
MX;(U8CV+5<NG\G]AWY )3)7R\Z&R6(-_-NG_ .A3$G"]_P";OP?',_;'M*#D
M@(" @(,DLM#AO7(.M?FUIM2KOE?X^D:'O_7YF@SA3"5'?CNSA!N[;&*UF1BY
M]ON_C8?:*:#QEHOS&\<_IC2:C+J9NO:C]6J*QLULIS#/>XL89@@7$",!@%SZ
MNGR<3/+U[^7#1N)=8\Z/+R3PQ2UT^O;Q-IKM^CES7>'+%0S?WWRP0&PP*WIS
MDOA_95^R[T[B/2OE/X!9Q09P>*"B!94;P>#X$H6AUMZDF.%MUOE[KZVZ6_4Y
MSI4-PFR%UP2KUX1B*(" @(" @(""P<-?ZUI^:=_(S%J<)VX?(G^M.4DBHX08
MZ<V);IM%N\XIY,$[\0_'W>V?J_G"\.4TF;YG:%33&_B7<4:;%O[6KDO'_&"S
MUX9^3FOZRWV$5-)I_(+A5LEH#?JM+_H\M/+5_B_<WBC_ %P_]I)_ :A$$BB
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MRJ"#B58SV L]CJ\JSAID%P7*\LBB" @(" @(/!N5Z_R6<N*]$X:%4$! 0$!
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M"S?"2-,[=/,<?8I[8U2RHB?3N:2;<?6<E<QB2U@EM<'1N^ZF5G6Y;'C%@O\
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MFNM9]DXQS["N%W-.F'E 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?%2LU<6\8-9*$7"Z'Q]"F_!+K:LZAQHQKB-X6DP]_8MYRS:X47&#7O;[PO\
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M5&I]R998(D[+U99.3C42NFUIEC,PA?"Y:MSPG99A7[S+;+/OHX!9T=9I6M2
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MYE>NN2W;KO6)+P#?CGLV+>JDZW.76=5*>)\;?BV[-BYM6?\ #L/AE\U@;>!
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MS/P@DY+P]./M'/[LJ[^SIO\ C+5_BSUY?S]?GIMUG5O\UJ?_ *8M?]+Q]O\
MY*^<[CX0UY]G[Y-_"4SIJ9=>3@"^!V+/5T<I380@#>MV88[,DR(ATK-DNR6Q
MQ4F?+8EN 5,P53,$,P0S!#,$,P0S!9O"N8N"Y7EF\O!O77K_ !6<.*G;E7@K
M77AGMR!6G5R4:$'A8O(**(" @(" MSA'E4$'$JQGL!9['5Y5G#3(+@N5Y9%$
M$! 0$! 0>#<KU_DLY<5Z)PT*H(" @(" @(" @(" @Y-O'+!5+PFZ8'=CT]JS
MVX<>U2$I^[&)'2N4NTY;S)N1Y06^=M=;E)R)NZ1;Z<HE9O9.VT[(J.>\8JS;
MGVG'Z)ZGG;S0.6 23%<?9OL><(7Q7:?=KKNI6F ,.E:R=])=K1"[%:E>:VY;
M+ 8W&[);EQPG;A(RH^[T^M:Y<<X6"D)'^$%6<VW?"VZ?-@8&%X/1:%<5FXEQ
M'8&ES1[MV&:L^Z]95TI)S=UH_8C\$;%5[7]MC>9,]Z\"T=NU=9</'WF])VC<
M3NQ/TE,R\'$6"2XAMD,/6F&>V/#;:\M =' 1]"NC-;DJ=$"!QV[%G%<^TM6*
M@FDXY7Q-T,U?UY7QOE;Z/>>&Q&$<MH49LRDG, O$.GVI7*M;<&2SZTSV2E)*
M$0;<.TK4F6,;7K36%H;98(9*?HO*W2B6LLY8IAFVCYCAC9#;MR5PQG,RP^/N
MX[;^Y7#.<U.:7-\1[.OT05O&%[2.Q:.1O,!@!9C:DCS]KX24NG][Z-XPVK-Y
M18*, $##>'8IB"V4;]RT8#UJXE,Z6ZBJO=@;P!CWVXIQPO7%6"54-<WVC,Y)
M(63PV&S03 ;,^X9K6IR=<_X2C&%S8@<K4YY3M?JKVIRS;8;1ZRL=IM>NXIDZ
M0XS(C/GP.2U,8VEU4EI],=X$VW89\]BEOAJ365RIZ8$ P%PRC<>A2);X\-DT
MS8$P'+I6I&<QJ&E!P Z$W.&\R<L)E&7;V6;.=7P7[-NFJ'!P )O&>W83@LW>
MDLO*Y:?4N !B8WXK4Z^"5>J&N.9N&/,%+K4,[3/YP,($W[5C?+K+I@-0UQ]L
M>]:RY=MI2@ +FDXD%(DMEPOM"(L  '4,DLD;U&X^C#XD@6F-W(*%X:;Z3=,(
M"'-M.)YD236'AM.(BP>A:G;6R]?HFJ2@8Z$0V\8;.]8W;I..5EI-):X-]T71
M-@YU9,EF])ANA->+&CJ'M6YB:)<S-<SH< 3NBS]BM3:8GA5]9I/JS'&X@'9G
MW+%MSB\.W3K*H<RL<UQM=?F5FW$TZ8D:LS47-N<X=)SM5F<;-.#-3<81>Z^%
M\+$MT8F4C)U)Y=#>,+[_ &J2YBWA8*2L+X")O&)R5NMN>-Y6BG.\ 3C9U+?7
M:YO"1J)#7228?1.67L3MU:]?+K759.Y,C"[>ZX#"^]<\:PJ%%2)./IVI.LO!
MF<+%IVHQ> 38!F<U.&+JK:VH#VM()M&?+-:Z]KPLGFHVL<^#H$W'M5O9F[Y0
MN\_>M+H1*S<8SY$]IYMZ!V*]+4Z\N>H,+A"%D+^KN3OCGRWFRYBFU,G=)-MI
M-W0IS%S[<HQ[@#"*LX9F6Q(G;KP-AY7%3U;GV6R@<'AA.*LQ&.TQRLDH#=L
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ML^+A!#\ITKK'3OQIO5K1]1=S>Q<.]NF.O7#J>J_+']L>U)PZ3AR49$! 0$!
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MV*3KO9<UQDUOUFR,8@GM[EO&$VD6RBVT"PVJVYT,%0_=8;HP*BYM4_4II.]
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M;=$_\HDK?IUS]G9OEE^LB\$ZSJ\JFU[6W,IW3)38OJV0@YT'7S$9O7H_=SR
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M?LGY=^<'E%YT4+:OR^U:CUCQY?B2WR?!8X0$3$2YSQ8 G7%NV+[2+!J&CUU
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M'  -+'SFWN-X,0K.UD8[=)FWJ_43A_B'@SS&TD:EP34TU?)< YL^0^6UNZX
M@D"8\",43<Y:-523Z"8)-6-R88D"^(C9:,$6;VU9GP.YE%G*UU?^P=?_ )M/
M[5?#/_5'\QK]9:_O+U#^V:;_ $N6IU;^3B/PL^ST_O\ >!/_ !)0_P M*2\I
MU_B_LB_*!_NN^7_]A2/P)"W?'Z.5Y=G3?C/+$K+HQH" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @(" @(" @(" @W
M-/\ Z=2?PS/P@DY+P].OM&@#Y95\?^[IO^,K>(SUY?S]OGI;#6=5A'^C5'_T
MQ6WP\5M]]_5\Y_'PCK[XQ_*3?PU/#KG6G74^Q_2 KUC4W_PSTT# <L5>VTK+
M/8+#;<I&/+5*K=N'B*SVA+D@D[>*>L>8!7)ZP@$R>L(!,GK" 3)ZP@$R>L(!
M,GK *9WM>&07+GVY9O+B;UTZ_P 5G#BIVY5X*UUX9[<@5IU<E&A!X6+R"BB
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M?]U.';7E[6S*:;*WGF^%I7ROSOP;9G#Z_P"%\\P]QN$->@V5%Y^)N/0OE?\
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MJ7@Q/TLK1BK/]=;<UW^'YY:QCS]E-A_.G_X0[UK_ +#7#T_V2WEL,^8.2/\
MG3^E_>O/W_!^SU_%\D\-H?,%3D@FI=_A^U<+^%7IZ_)E/Z;\P<EQ:WZT^UT+
M'^U>7Y?PJ]_Q=H[.T/S9E:FYD*AYWB!'>SAMVKS7\'$>R69>S7E?JK:_42\.
M+OQ1OMOLS7A[?A_O^[V?_H_N_&[[;;2I@\C=;JZ.JFTU3]7JG!\EQ:\082""
MT@K\U_N/Q_1^A_U'B5\I_P!F=]I'Q[\J?F[HU'6Z[J[^'JW4C*K'NJW^&PBI
M80'-<^QNX'+\O\7;T[ROO?D?C]?F^.]<;?TUOE7^;[RV^;3RRX6K]-U=M9J9
MT>3,FL$Z6]QF_5VN(($PF.\OTWX_P?%^5\6?^I^:^7\7M^+WQUXRN7$VGU4B
MHJ1-EN93ESVRG.$(@& ]"\?R_P"N[=>V;-.OQ]?:9G+JC4*7P7%^!M'-TK/7
M\:](S\DO5QT276ZA4"51RWSBQP+PR) :+[,%WXU'DO:779/>;/S">5_RT\$3
MN*>)M79I^IR]/J)IES)TMA\27+!A!TP8E<^_R=?CF?+?P_%\GS=_2?P? Q]K
M1]LMQ?YW<2ZIP'P1KFJ_F+ZQ72W3Z:K+)0D.WY;""V8(QBOD?-\]^2OTWXWX
MO7XNK\0/EK^6/S9^:KS'TO1] TO4=:E:I7&?J&H3C/J&O$V;NS/>&^0\OF1R
M N7F>Z3/Z/Z/OV./V%7 OR\\-\-^97&VBZ1-UZ92R*XR:NF\6>:J<6SH$3)9
M=$!QM-BSCV=;9TU'U::;IE!I%%3:?IU)3T5)22)=/)D4TIDF6R7*:&M:UK&M
M%PZ5MRMRWT00$! 0$! 0>B'SK?/#Y7?*;Y=:SK_$?$5-2ZY2TM7-IJ/Q9;9K
M74LESSOM>YL=YT(<REK?7KGGA_,'^U8^V9\T?FWXVXBX8T;7M:D<-T\ZMIY<
M^76.9*=XDUX:&M9-!<!+AABI.N\KV[8_;.'Y7?+C\K/F#Y]\64E/+T^JJM-J
M"Q\ZLG.GSG/\>8V+W3'!SHD$DDF))6^LR\?Y'S]/AZ6]KM]HGV?GV??"?D)H
M6DZG7Z3IDVN.GR'DS9+#,$P,83\3(QBO3TZ2;O+\?^?_ +#O\G;TZW67[>\-
M:Q)E4]%1T\B71RJ-HEL$D!K=UH+0 &@9+T>VL1\[KT]=\VNX:+BYE/3 &8Z(
M!C:.]8]L-X5C7/,*6P3/Q[A8;-[VY+I9F'5TSK?F(R8YP^L/M#OI;5)?!C-=
M<ZCQ:R>"?$<8Q-^<#G;:IZ^6IUENW5_$&K^*QT'FW>-_-E9@IC-:_CPZ;U&8
MZ:]Y)O=ZUTG3+GSRB9<@N.<".5Z3IFHXU-/%D(6PQZ5J_%87,1TNBB\;S1".
M(&)$<,E/ZY4NX[%X9H&[[#N-^)N6?,59\2]>,5[:\#TS6!H+8?#<!EL5OQXX
M<^^MN[F;C6,%EC1CL3#G.^\*]JTQK6.ZK\BK/HW;K+H_BNI8ULZWZ1O&T[4[
M<:27+UQUZLA-FF)Z!!9,.O:BO=OGWW7G/O6NLRS<0E51?"TF)A;'/;%2RY^Q
M*SS&&<V&SECM6O&&K,[:@TIY,88QN!VYQ6";UA-T>F/$(M^^R*&(GY% 6@6#
MT#)2Y7,EPWFR]P61RY=226\I?L\/FA@,>4#W+6/7:YC0?7AI^+TP[%K.F>TG
M+ _5FRQO;YLCB<CF5-V895+5-=:7_&Z-N.S]LI)AK*&9J;9I,798D[,4)/+*
MVH:[&/H]2LCE;<L\N)*O9UES$G)E1@8&P8]6Q9EPF(EI+0T@PQCZ$R<)VFJV
M2[S"[;=!/5/>YTW/SC+-F]Z/8K+>%MSIHS*YH, ;QLY8J69VO33C+K!;$Y8<
MZS9EK,<IU2TL="T\WM5G5)RHFN2Q.#P1&+3M&/0MWA+'0G$%&#-/N B!P&94
MU>N/+.U1D:>T/CN-L,,,QL69K15VTS3VN ]P#W8Q@.Y7.*3:V2*3PPV NB+,
MHY)^JSEO-?X8A]W#N5Q)MNXKB^L#1?'H5RF414UF_$1SPV+-F4O;*N5$PFV(
MC ^F*32(\S=V\X6<H+7LF*X"HB1:/1W)>V.!NT]1NF_L.9P"<JF!467\NHJ7
M9;ECWM[M6>Q[6ZK0GB,>5X3K,M6RH6HE$9V;,HKI;(Q-M.Z]<[<[=)K3)+F[
MF4.7>K+C1ZYK=%4#CZ/8I[8F&;AA^M-^^CLAW*H\SYK7RR!C$=!4\M3=Q5%U
MFF:X.= 6@VP$; <UN682RRY=1:Q(##=C#E K-F\QKV]IA7)+@UQC]\>T+*YP
MO&D5#01S9'9S+?6;<[<NU=*J&&4TDPLR3NC'J-8UL;;MFU7$L-HB77B-^"S.
MK4C9%:(?$.KVHF*TJFL:;(^@9E2Y;TJM;/!<><]G,M];,?=FZX0,R?[QA##'
MO6;<DGU>1-C=!:ZX9VV@^-ZUUF.V6^G:8<F.B8+U]9)'2<MP2RX7&X)CRW),
MM>HIXB$,!CS[59<)>OE2=5I@TFPVQS/84^XH%<S=WK[(]L4G"]=\H<N,5)I;
MK3:DS#8"1AZETG&6<8VEY)C;9T=*Q9BK.6\V5O0L-J=?K6[9$A*D;K0Z%UOH
M!S5[.=VV=\-;"&&?0L\$TCZBH8!:0.0YEJ1K&E<K:H&,#]++[J<,]<^58JJL
M,)YLO9M2;:[8P@YU3XE@QA?L6/DIU1LUD03;U9?<7B[6VNL1<Z471Y_7S[59
MB':-=LJ%\8Q2G7KINR98%IC>/6%(UAOM,!!+B[23ZLJEDB,<SX>@I%BO50B3
M9AZU=5>]^BN54J)(M@+5>W#/7/-^BL5E*YQL&)QYUSGEO$Y5^?0OC=GGD-JV
M7AK?47Y=O>I9A@-(\8)*U*US(>+Q 9\H+<TG9*4)?+([MI7G^6O1\/7;:JJR
MVTY8<Z\U>Z2XQY67A&HC7MM%[,A](;%F.O28_P"'[K?)14#ZYI5O[Q+[&;%-
MUVOV?5K\KC]_2M)_@@M=;B/9\/7$?HKIT/ EPS]96<Y=^TPE9C=Z7#E<5RSB
MY>KI<1"%F[-VQ]:Z>';KVRW:YH^HN.SO7+O-X9M_<ZCJORSOVQ]2>&YPY*,B
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @S2/RC4%/\
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M[592I6140A;@,C@4OV<[]F^R?9:<=ARV(F+ER-1MY=2%C4F5(LMSCZ-B+]F
M3,H%4QBY9&DDVY++5FGDNW3ATKI."3RSR9IB+L;H9'85UE8[S-2K'NW1;V9I
M5ZW%<KUETW6JYN]Z<,U4PS2I8B+3U;"I^J3:;I)1!C&PD8=.:TPDIU)XDOG
MMNP)N05"OTYX)(!OAZ_4IPLF:@S2S 806I,Q?5+:?33-]D;H=^Q9OT63"ZT5
M,=P1RSYN96:+6U.HVEABT$P-\,E.4O.5.U*C$'!K1T0'9:565.J*-X=8,O3$
MJRX,ZPR4[W2+S#D<KUCMEY?EZS*<IZPV$/=ECB3M27ZO+<Y3,K5G-$-\V"%I
M/>JLW,I"7K,7#WS;9>5%DS/NGZ/5=Z$'G#$YQ]:F<W"6+33UV^+7$W7VWK4T
MLZU(>*'-LML]44S?+7KC;6\(O-F*R6R)"GHW!T2+.GO6NO"7:PTM(!NQ&4;8
MXA:S*3[K%34[ !%HL)P&72K:LZQ)>%* ^!O4LVYA)AH5+6", T7W0&8686J]
M4%H<;L1?SK>4Y5^K>' @;?19ZE,G6*W.HWS)A(!@2%.7JZ68^[>IZ%[0+[/5
M!9M:X;KI3@W(B PV;5<);E!U<MQ'7ALY\U9,)G,PA/"=&%O5ZXP5MRB7T^F<
M7#W8].W8LS%;ZYP[*TJCCNDC#/:$NB[X2]53AC08>F/K6IP9S,*I731*#XF$
M(P])4J9_=CPZ[UC61+,P!Y^$W'9ML4Q8MQAT[KVO[Q>/$=<<L0=I5LM8DQOP
MZ7U?4#.>8/<?BQ-L8]R2X;MS,J[(EF;-AMAEL]"B^':O#NGQ+?<!C"TB-X6L
M9F6<N_.&]%#A+_%BUN0V;59V<^W;,=N46BME2VNW!U#-=97DNZFI ;3.&$#&
M&2J6R1-2-1; "(MYLSWJUE+R'"?$"VV_T[,0DV):7IH> 2P=0RS*N<;$A+IA
M($8 0R@.Q2[3&VS+U-M/ ;T(# P[HJ.F=Z;S:UM4PVQC"^TW1O0MBDZXP$S(
M1^'"U:TYRW+K*NDN<ZRVU9=.8XR*281'INV!%;@I)F[T'UJ^&+_)AW'2W7^@
M'T]*C5J;T^?X;F1.&S,=R+G"<K*L.E 1^CELZ<UJ<'2[0M'-+9X)-[AEGS%1
MW=@Z=4^Z+?O>T;%;=8:ZI6?.#I<++AV'8%C-3M]E+U/W@ZW-:D\^7.JC,IW%
MQ[QS[<U4;$B6YH/-!9RSVF4S0Q;,EY@CU*N=F';VBSV"0 3#[@4N7/M<-/5A
MXI=NY$==MJSFY<N?U4U] ]SR0-OKS"WEB]<W*SZ/ICO$!<,&C/%%MQIVQI=*
MR6V7O-;8!@,KE8QVN$],=+9+P$++-L!S8*^WA9]51U6M:TN =A"(L3ER[7:L
M-JC/>1$GGM6,;>C\?3S-IW%L81L]7.LOHRX1$R3!QCF>T[4X:GU\LU.R#MEB
MLJ]N]6:D<&@#*SKL&>2UB7;EG.TCO @VC'%/99<HNJ <'680Z18M"L3Z<.>;
M(B./MBL<UOKVC)+TV7,%LMIQPV8+35QY8YVB2W6>"R$/O6[5FS&V/;PJNI\,
M2Y@,)4OZ7T>89)*LL=8ZSP@UPF0DLC$_1V\R6>2W3I_6^$MPS/Q3+S]$9[ K
MU9SX=8ZGPX99=[C80R-GH6;<F<*C4Z*<&-ZOVNQ)-K[(_P#,\S+#(@>A9[3E
MTZV91=9I\R5$P-_+$KE+A;K:-;XTNR+A"-W2MK+AQFSIWAN]YW65+AKWTJ57
M-G;Y]YU^W:L7[,>U9Z"?.#V$.=83GL2?<]G8-#JDV5+$7F,+N@+53M=,E5K\
MS=(\5XLP<5FYK,[9F%7GZ[/WS^.?A](_=5EPZ288CKT^$/%?_A.3)=[:<[6)
MSA9.?<?I'OV*ZB3O>&M+U.<YULUYYR<QM4:ETG**OG/@-]UAYLTL.O9)S*B:
MYGQF[,Y>Q&99>RK5KIQ?\3H1S]NU%MPE=*WB&[Q)LQ[UVEQ&.W;27FL+H 7'
MOZ,EN5RE]JP-T]\PV-Q%QZ\4:SC24D:*]\/=!C"\<V,-JEK.DQ(X;>Z!+&XB
MP9="F6O9/T/#3MX>XWJVG8KECW=@Z9PW!K?Q;<#CLV)*>U[5V+IV@- 'N-LV
M$X<P2S-R7.5NI]':T#\6(0'8?6HN<+)0:<V60 QOHP)YTD+VRNU#(\(--U@(
MASK5N\+-3*5\9[!>1=LN^ZETM[Y:-55/'TSCB?O1M25B]\HQLYSG")C:+S'$
M),Y)WG"2E'>:/5S15IXRQ3:=[[1DF;'A^;=<)5),+Q&Y9M<9JK=ING%QEQ!]
M2U+GEJ]]+S3Z6T2P2T=("MJ2Y:.I4FXUT !880V=(6(S><.NJS?$P@%PV"([
M%<[6?1K2Y$R:Z\D67VY!&I,1=M&TYX+2X'*_.&2"UU$D2Y6T CE:LY95.M>(
MO$1CV JS/-255*II<2!C"WH*TN:CC1.<8POYUGL22@I'2[87=X*O69BYQ<.8
M>6&^$#C#G2SPU+C;(VO$HAV]"%MEG9SIAGMVREY7$(8R&^ZS;ETJ>IU:LWB
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MFR9#G^]!Q<3&SH6O;-3MUQN/TTU2B=15TZ0P?B6$!IP]YH=ZTQY)9?U:"BB
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MW5ZHK4N,+G$PF)3(61P6Y<QRLRD)=A;S!2<X2]=)*2Z,!"XCU+5F&(EI,PL
M(/*T*\M2_5.452[?;[QZQFM1S[87V@F&8&1RC$\T<]BU'#M%OHOH_MEIBW"W
M4KHM%F"Q8QVGE)"7= ^A),I.&Q)DGD.;8M8QP=IQ8L-$R&.6',%'.U;*,P8"
M,/6EN+AAO3)F_ARMY\TMP,E.Z+VV706^L\LR[733!$-_;>H+%Y9[7#L?3I8W
M1?AVA7$L3K-Y2Y$!S!7&F>TS4-6-%]N/>I&.VU?G.W7$0S'H19<)G1?RTL[1
MV^U7[,VN\M*J )#19EAESJ7KIPO*5$UKB;1='#FS6<++AF:^,!#IZ%49A,+
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M\2:C3Z)33*FG\6F>Z7*(F3'#=:183N %?'^3YK\ESX?K/Q?Q>OP])+-OSO\
ME'^3'S:^;/S$T_A_2]!UBOT^K?)%1JCWS71$Z:QH<V<'N?"!,22N&7NG6\5_
M35^R"^QLX"^4W@GA_B#BKA73:K6)FF4<R-2UDV=XSI<M[_BBZ((MVIRMOKJ/
MHVHJ&CTZGE4E#32:2FDL9+E2)#!+EL8QH:QH:W)H58;2 @(" @(" ;+<D'YQ
M?/S]H-Y7_)OY8ZMQ/J'%&E_I!345;/DZ=O2YTUAE2W-872W P?XH,!L4M;Z]
M?:[X?RXOM3/M8_,WYU/,'6:72^)M6D\/&JGTWA29DR3*GMFSGM?+EP(M<T@1
M'7%)/*]NVO5Z9_*C\G''OG_Q7(EU>AULS3IM13%]3.+COA[XN<]T2';PS)5Q
MEXOR/RNGP=;;=OM=^3'Y).$?(;A2D96</T<RM_-\@^*YK"\/:UIOOC$KT=.D
MDR_'_F_F]_G[8ET_0NDI60D2Z63]6ER6B6&M,!N@0 YETY?-DWO=7.CJ#2,:
M=XCW2([;>E'5K:AQ,^1+>!.(@,S]U61;<NI.(>+YGO\ X]WPYG:%VG!'3FH\
M4SG38^.;\SMV[52UI2^(WN,#.)!V\ROC!+EXGZ@:@?&38<\>I3K/)GPB7R?%
MY68=RZ3E6Q)T\QL:#R"Z3C)'FIH"&_ ,/6KG1;,<HOZM CW0+<(J2;RYVXJ[
M\-P9,:,G#M5]L-8]GLOPK6MEPMW?AZ>VZ*7ZN??6G9+]78U@B_Z)%^R/K7*U
MSQC:KZIK<LM?^,].WG4^[G[6Z=,<2UPFMFP?&))LZ5F7+KU= ZZXNFS=OJ (
M5XY:M4&=*<7D\^>S8MS3G)FMNEED 1LM;@?8KG.CBK-I]/XK@V^X77;P ]2=
MII?9=*;2 X F6#<8V6V>Q<\-9Q$@S2PP6L#>KU*\),UD^I-:+AZ>Y,RIVEQF
M(^HE^&#LMV+>L'67.U;JYCFDPNM[%BW.BJA75CI<3$V1O.WG"UUZYT8RK%5J
MK]WXW"_/$'M5NBS6?*F5NHS'3#[QZ^BZ(4SO[)&>AJ'O<+3"[T]*S6\96JGC
M[MM\.T+4MCE>N;E.R##=V0/H6;<Z:D34EWNW>G:5<+ZMO?@R.0&.Q3R7KK2*
MK*YTH$AQRL//D5>=,=9BYJ)EZR\OAOFPC-:DDFV_;+?.HDXE2Q+8Y2]1-MIP
M]:S-T;@K;#%Q@M28F6I<\JWJVHM:UQW_ *&W;L3FX9[5TUK6H,>]\3>#@=JS
M>N%Q,*]3U,LO,,R?2%*LF-K]I,QKF@1O&S,;5J1,[RMK&CPP;;1WI>N;EI'5
M!A&&$?7W*X$).FOC".)]2SY9SK#3>'$$P/4<T<_.T74>['F[TSETXVA9KRYQ
MP$3VE19B[>)>'[8>I5.W+>EV6[>Q)RGC"18XDAN%GJ"UQ,IAOL; #&('8L69
M5X=)+HW]1[E?&&9$152X$B.!-W3ZU;-9:FD).$"[E<5%SMI/F[MFR*GDO:\-
M=]86,/O'K&*6,V6HC\Y'Q(1-\?\ C*JEY59OL!)/-$=\5FZNFI43JE0',/,[
ME>M29,YTZAUN> 3=>>P;5K[$F*H<RI@]Q#H0-PAWJ6+:L>E5S@X6X9C9M4EQ
M4QG;LW3=3@QH)-Q]:6QF1EK:MTP7FT>OGR*C<FD?+FNC?AM[UJ4UX;@FN@.8
M9]Z6F(TZF8X6Q[<8I&+?"N54UQ-_TC?'O2Z(B7S#O6[,?NK#IJ.4J88VVVC'
MGYU=I<82+7>[=AZEV^.L3K^YSDN]^[->OQEZIU_:G)+[+1RB5,GJ\3R"WH]1
M53"EZH(QZ49MPZYU!L'/R+O65<++E7G-M4LQ6I,N3+7 9V+76[7MPLM#3EP&
M,8^GH4NV,^JSR*'>A$#E'N4X,V[;OU7<9#=%@A$114-5-+.>+CZ_4IRUC"M5
M3W''TG9MVKI)AFH*H8YP-^>.1V+-Y6V8Q%:K)3_>_:[>Y&>\\HIDEQ>;,3GM
MV+G\FXO6X;3I/NF,<,%Y.V,_=WDRT)LD>\(98<VQ<]PQ<[:QD$6W0MNRV05S
MX:UC#RQG:,%J329PV@(+&,);EQW]GI1<8:,ZH );F=FPYK<ZZRS;_P (J<^.
M&;4G7"(]\G?CM4M::KZ$.-PM'3Z4DTC1F:22?@PV<L%IJXK [239^+&. 2IU
M:[M+WKFQMV*7:^MSMJ/TDFS<Q.2L3LUIFGF0"=V%E_W%Q[QZ?AU%:KMZ-V0N
M*\MF.7OZ7//"T<'D_7V_\'T%,.W69?NK\E?NUFEG_D)7X+>Y9E\.G&GU<_*Q
M,/YITFP?D6GE;M4M>[X'Z-:2?Q$L[8^GVJ6X=[/9/A\1"&"Y]IK+OT^GT1CY
M1,[&_;AT+?7^+M<3<9J^RA</V/>N?;=RYR^VW4%5^6=^W/J3PZ^'-1D0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@IOG48>7]
M1_ S?Y(J]>6?D_B^,?Y_7?SW6C"[4:G\*8O5+I\[M,?\OF+\\YN[J>I6?O[O
M1'F3,RQ8]/-2FCQ'\UT1L6+,W+EG:%=,B+L<U<-=;+<-<.B>=7[.V,1N2W[K
M1'+/9[$3K=MJ7.A"!QC?RR23ZM6S+<EU$,?I;-FU2R+KEL"H!QY=:G5,^WU9
M/%&SK"MN&9,L\F:W>%UFT9%2=MKVFL18I<YOA7_1V90SV+4VEGK%7U2:V^/W
MV67.E^A)G;KO4IH+S#/,9Y+,NQ6IIWB1=Z<!W+5)JL0;#'T+G;ENS+E%,)[,
M;G1B(7'-:D\KG$RCIY/I2WZ./;M?_1XD^]T>Q)QEB;JPT<J.VQL+.;G1;-Y6
MJDHP2WW1=&XYG8M33/;MX6.GHQ!IW1<,#GS*=KXB3.4C+IQ:-T89[5'34F'@
MRX$C(PA"Y0KA"V"HV) ((L-_<D2I&7>.GL*W.$G#<+H+.#V873H8PC&XPZ[4
MX,RM,S2=O.5+8LQ&Q)=$QS]JN4[8\)B1++KL!#E?DC%TQ5$IP=[#MV+KUGEN
M68VYTTLV1/H_;+2\\)F5+NM^EES(F,-DRHXQY=*<DOJX>%MY=2F:F8S2I%MF
MSE<K%RL5+3B%H$8C.-@YLU7.WZ),RP&0MNY8)Y=)-;:4ZD;,$-T=6R"683.-
M(\:,'$GPQAEWJR_1;9.&W)TH2_HPA#+9SY)[3PEN&Y[LAIV V=(YL%$J,J-4
M;++@'876V6'9L1$!,JQ4.)%L8@]/4BS=>#IXG,WPVTVPZ=O.D^Z6;UP@:N@<
MUQ$-VTY6W%*\ORZ:\NG>S;=RL4G7RX2Y9'M>(0LOC8=G,M]>OU)/JX O:0=X
MV8(U]_"?H)[VEMIM([O4N?:;9YN%\H)SG-;$GZ)[%),->TFE@ES &B)].P+7
M@O9,T ;-= W6;<8^M-.=S:M+*>6&-L%H6+VN<-==,K9K)=YOVC9W*RMV8X9/
MSFQ@L?"/1ZENLVX8)NML:"-\<H;5GKRDN4?/UAKP??PA&W$I>V*G")G:AO1@
MXD"%MW;SIGR3EI,?XLS=C&[',]*N<MXWE;:'2&SV-=N Q$<+$X=NN8D1I  L
M8&GESI,>6^W_ *->;I0 ==?Z^A9M2\9BN5FF0P&/;'U+<N9_]?1-H,Z: ^,!
M>/4IA9]4G1TS&&X60]$%&LKO0/8QH).$,,H]H59E;%=52MSXA=M[DP2.L]?K
M6-;-@^'7LV).=G:NC.(=3AXT'V[KH7K6JRZ6U?4)DQ[AO&V..TV*VR-=;X4R
M9OS)D;[<>;/I7+ETDS<)W2J!SYD=R,86\Y"UC&T[7#NOANA(\.+!8UD>I6]M
M88NW??#LD-$KW,!@=B=?NSVF':+"UL@60LCAM&S-=^LQP\7>_N5ZMJ"UY@88
M^F&>U,GK_P -2GJWO>!$]?3ZDROIK+L#1)A+A'$!5BZ=C2 (#U<P0GU:6H3?
M#9U"-F14;QFNN=2U-\N88.(YN:/K3E+CJD=)U@[L'/C9<8[567.OK!.WK8[T
M;3MA9?;"*69%>-.'O!A'MMY@HZ3Z):FH&D7;+CL&2N&;V;SM/:&$0RP.?,F#
MVR@:JB#8D 6;#G[$9FJAB\RGFV$#S99J2NG;JRBK,SW8G)65>G7%2E%2NF.:
MZ[WF]N'6CLNE%++1;=9GSY!!(.M:>;LM00E53%T3?><>965S[7;0;0;T?='4
MLU+<,C-/OL&'K2?=GM:SRZ3PCO0 MP58J=I=0,@-:3"S;"ZZQ75<NVZG:=_U
MJ!-L8+/ECM,3*P4VC"9!VX#&%MF8VA&9N+%3:6V2-[< NZ;.FY5FS#??4B0V
M LAB,!8.I5(B*O6( @/N)SP$0L7:>VL*E7UYF.,'&VR/-'-:FV+,O.E2_$F
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M(4G!VUVKVH\K>"/F2^;?7-'X#X89KFK:3/K::B=*E>,9$N5,>QKHPCO08[8
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MKO+S5_[!U_\ FT_M3P?]4?S&OUEK^\O4/[9IO]+EJ=6_DXC\+/L]/[_>!/\
MQ)0_RTI+RG7^+^R+\H'^Z[Y?_P!A2/P)"W?'Z.5Y=G3?C/+$K+HQH" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @("
M @(" @(" @W-/_IU)_#,_""3DO#T\^T8_NSKQ_\ >Z9VN6K,QGK</Y_GSTL_
M[8U8Q_YM4_\ TQ1Y.TSW?.=QY_M!,_;S?PU%DPZZJ/RG_"/J72<I7*G^(<X]
M:=W3KPW:GX>KUKFRBT[-O(,.E3URSV>81MSM3VQHR;NU/?[+DW=J>_V,F[M3
MW^QDW=J>_P!C)N[4]_L9-W:GO]C+R!!2]LQ+<O*RCB;UUZ_Q:G#BIVY5X*UU
MX9[<@5IU<E&A!X6+R"BB @(" @+<X1Y5!!Q*L9[ 6>QU>59PTR"X+E>611!
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MWB) A#I6DLR[(TO56N:P;S;+?25<Y8NJL,VN:^61$6V7YV+4F+E>V^JFZI4
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MB6S>@8K/+?7AN"6W=CC X#;L5C%Y8BQIO'4!W+4N$:KPVRP=066I<,/AMR]
M[DP>U964TMUIR!ZT2W+1KJ)K@=T''T KE\FMO3\'6V[X4.OH"TGW3?FO)9FY
M>^21-<)4A;7M]TWLR^^&Q7[.W3MA^X_R6L+:O3(_Y"5^" LV3.G:3VKZL_E8
M_P!5Z/\ P+?4L=GM^#A^C^F?T:7SE.W+OT_E_E.R\>A8[<1UZ\L1 \4V"]/^
METE:VIF%(=H/8L&.7455^6/[8]H5G#K.')1D0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@IGG;_=[/_@)W\FY7K_).W#XO?M
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M$\,QA#/FBL59,-'ZX/OAZ>]3U9S4O1/WH'.';&*TFUOHA'J'8E6,E3+;O=6
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M-^KNF!KY6\=QPW76%MRYR[:O#\8OMSJVME>0?$TJ34S9<H:*?Q8>X-MEM)@
M86DE.S?Q<5_).\S'.=YP\2N<27'BP$F-I/CR+8WK3EY?T)_U8*JJA(I)?C/\
M-TQK2T.< 0Z0T$$1A @VK$Y=_E_B^SOB;4-0IM1;*IJN;(E^ P[C'%HB=\DP
M&)@M5SZXQN*K45E74#^<3YDV) ]][G;<>9-EQG20XDUZDX%X$JN+9Q9)%!3/
MJ9DQT  TL??A"#5?#//9_+]_6+/G9UOSA\X-0X4TG7O%TV7K-3(G29+@X"7)
M=,)! B!8R%JQ)FY=/DN-1\\WRV^3FJ^=OFUP?P=14<ZJ9K&LTLJ?X37$0-0
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MGIJ.GH*>322PR$JFE2Y3#-A$%T&".96I&,V\H69J^K3)KWBNGACOA;XA@!?
M 7*-Z<1J>JBT5\_^,<AI,:;KQEB=)U>;-JY$]GA[KR7B!,'"!O!!5REGF/13
MSM^S?\BO/CB-W%>K<':=/G3:@U&]/ERMXN)WB??()M2P]\:KV3\GO)#RL^7O
MA:5POPSPS1Z=-8P-,R3(8"X-9N,@]MP$>E3A;FW7#M;AR9,?JTC?<7-'C;@/
MT6^#,@.@+43MP^1G]:5LX/8<M-HO]'DIWXB?C\]OU?S<:/3!K?F!1:419J.O
MT=(1LGU$IA'45F<'>_NM^[^FI^KS_9Y^5O WEUI/F1Q+PIIVKZC726U-+-JI
M#9K63WTS72W.%]CR$FG3O_&6/JKK)^E\-R6Z)H5*S36RP/Q5*WPI3-YH+0T1
MP"N-9<Y,[5XZKJY^+4)YOOF..*C6(Y2]7U64_?-=/+;(CQ'&/:DN.3$J@_,Y
MH&A<8_+IY@2>(:"7J+)W#%7X8F-WG-GB8&AS;8"XJ]L7AGKF7UK^.O\ :<<
MZ9P5\P''C-,I&TDB=Q)6;K&@  &<\X+'5OO).KW>^P/U:?IOGYI7@OW!,X@D
M [;)2WG"?'<9?U@> )KJCR@T.:\Q<[2Z<DY^^SO49_ZFM+^!O,HW>7)5! 0(
M"^ CF@W*2NKI-33LD5,R6PS)8+6O< 6E]K2+B"@]-?M/ZNKI_E[XF935$R2U
MVA:HXACW-!)DO!, 81( 4[+\7+^/!\ZDR9,^8?CA\UQ>\U)BXF)/\YJU9PS\
MG\GU;?JT=552_,S21+G/8WQM-L:YP.&6U9QFNO;^#^C-Q76UE(*+ZI4/D;YF
M[^XXC>@98$87PBMN77'F*145]=4-(J*J;-$+GO<<<K@%&M>%QX< &BU-E[K>
MI6,=OY/@\_6FS#3-5.5&3Z$O#?\ TO@Z\MN&#Q?QIPWH0NU#6:"F>+(%CZJ4
M'@Q^^:2%+<,=>OL_JS_8@?9J>3_EKY%<*^:6N<(:;7ZQJ<BGG2:B?*8XA\BF
MD3FDV[Y:'S;8))E;WQF/H9U#4*+1Z>5IFB,;12Y<6B7(;N2V" :!+!C"'0MZ
MZZO+&+VOMX5G\Z:N8[U?/-I-LQQ7-TTV:#5M3EUTDS*R<^4' O8YY+7-Q!!O
M"IB.COG8\K^&O-SY=?,.FUS3&:BZET"MFTS7C>$O=; [K3=[SH\Z=HG2XN'\
M;+[0+R\D>7_S,>8VG4<CZM2#5ZCPI($ S<>YM@YH)*7K9M^T/ZMSK^H:;Y[T
MC*>>9;?TAIA99>Z44L^B]+XK^IUI50:S@V74S8NF/HI1+CF9<NWTE,Z2S'9Q
MT23(T>GFZM63&RI+J:<[Q'F#0&%KX_X+2MX_;E,YOJ_GG?K-WSSZ[,X_KN >
M%.)]W3YFJ55(ZAD30YNYNO8?=;$P O7/G;I[>D]7R ?+7Y5:MYZ^=G"W!\FD
MGULS7=5WZHRV.(<9TT;Q) Q?,CT+3GC-?UGOL<?LW> /E8\CN&=>U/A*D'$V
MLZ/3U$JHJI(,Z5XT'NF@'WHD1@;HIAKMK4?L+K6L:B^IF4>GB?(D20); P.;
M[K&AML!&$>=7,D2=<;J$$_62!ONJ7$8G>*SFY-.7UO76@"7-JF0(-A>.Q,Y/
MVK91OH^)J29HNOT#:^4YA=,EU<LODS0 6D3 0 3!QO1+,;CX0/UE+[-#3:NL
MU;S9\O."YM%24U555L^;0R'B6!%\TG>8 ""/0I>=.O63MUV^);Y8_,?6_)?S
MZX1UZEK)FF/TG7G4]6'Q8&"5..^'@B,0^2!$JWARF^V/&7]=_P"R0^;"E^9+
MR&X2DS=2DZC5Z7HDALV#FN,9,D-MAD DNFN_7'#](]6D^#JE5+#8,;,=NY0-
MH ZT\DX:" @(!L!.003N@T9F5M-5.'XMCQ$F[Z5^R*LFLLV^'S*_K(GS?UWD
MGY7:CPSP]Q$S3Y]9I<N1/E2IH:7/FR6[S3 VF+E.SI\>IFOY??%NMZEQWQUJ
M&KUDQ]?7Z[JTMV\/>=--1,EL:T0$?I).&.W\GW)?JY?V7NCZQJ&D>:'F#PB_
M4-/GUM)6,?622Z6&@RYL8OL  3#?\9E]]%-I_"O -"-"X9TJFT=GU>6V5)HI
M9ERV-: R7&TQ=!J<.<SVYX0CM6U=U^H3X9>(ZQ*UB.!U/5@#"OGQV3'=I0TF
MJ+7Y+Z:9I^M;]9)GL+)@F>_O,=>UUQ+3#-6;2]?,>EOG9]GG\OOGMQ%0<5U_
M VF3*JFJ&5$Z=,D2@9KF3-\PWS$DG!+U)VG%>SO!OEWY7^5/#5!PMPAPS1:0
M=,IY<B7]7IFRWB9+ !>^8# DFX 7*R)<W;L3AIK93=1K:PB7*#&.+IEC6LA,
M>Y]MEC6):EN=/YX?ZR=\\.O5W%FK^46B\3@4C':C3?563 08'PB"T'(+EG';
M#MSUQ.7Q\_+CY5:KYV>;7#W!-#03]2GZO5,$QLICG.B:B2"XEF+M\K=CEUW7
M];/[&'Y&.!?EQ^7?0_SIP134_%59I>EO=65E+^-8SP_%?N.=!PF%^[T I)B+
MWF+B</U_UC6:^=,-/IS:BGDR#X;0P.9%K/= ,!&$ A),909J-9=#>=4N(SWB
MF<'[05>NM+#+F53=UP-A>.Q67>::6Z@%)Q305.E<04#*^0&CQ)-7++Y,UA!:
MX/! WC;BM=L7<8Q97PA?K'/V7NAZ:_5O.G@OA-U#13)6HU<QU/)<U@BXS0#N
MB&*XXN77_IS>7Q%_++YE:WY,^=/#O$U!7/TN?I>H"54//N6RZJ2"'1$=YKI:
MZ9QMGIG/V?UY/L<_F)F_,+\N6BZKJ&ILU.KHM%TQI)<'F'@RF$]1">,GR7/9
M^G&G4[I&NRH@AIJG!L<@\@*SS^B9S,OF+_6<+/)D'_[S-[5._P#&'P__ "5_
M+]UFF^O<;FC(LK-8I*8C^'J)4K_&4G"_)_*OZ,WZNC]G5Y8:9PKI'FIQ=PK0
M:W/J'TM5(^M26S6";X3)DO?'Q;@F&V$+%9,5N_PS'V.S9>@\'TS=&X?T^1I(
M<UI;)HI?@R6-W2&  $@W]"6:RYS:N_G76#'>U"H-IA&8X]62C6(,U759;M_Z
M]/@(1_&.MM,>U"R-?S/TC2>,_)[BVBU^D;J-//T'4Y,QDT;Q\2#@QS;A$$MC
ML3PS-7#^1U]M5Y/:/Y<^?O&=9I- RBE5FMN(:UH;8^I8,-A6>O+IWDG5TW]D
MA65%'\P?#TRG?N//$.F@NA$PWI*U6?CY?U\_EIFOJ/EVX8F33OO=I$23B? I
MSVIX9O\ -?\ 3]0KY!#)55-9+WC[C7D"PP%EV*+9IZX_:(54^7\HW'TQDUS9
MD[3)?B.:2"[>H*IQB1; NM5QF,]>7\:_YS7O?YS<8%[BYQXBU(DQC_SB?FLQ
MON^IC]6%KJ^FU_3&TU5-DM,Z;$,>YL?QK\E;6NG\7]'*JK:R7PM05$JHF,J'
MRZ<.G!QWR(.C%U]L$8F,J:^NKZE@;554V>VVQ[W.%^1L1=+9P: 'UT!#W95W
M[>8D3MP_G;?K+W]XVK?YQJ'X16;RZ]?_ (WQK>4? K_,CCO1N$)<=_5)S98@
M2#^5DMO%MSUJN/69K^G9]A3]EAY5^7WEKH7'G%W!]%J5:_1Z.=+G5,EAWILU
MDMS;76DQRM@%)MOMCK,>7T]4TWAKAJB&D<-4$K3)=*ULB7*I99DRF-E L#0(
MDNA#%:S(SB^>$._6-7,PD:A4!IN'B. %MT HN(UIM34U%M1.?..;W%W:@WM*
MKY%&^:W4&"?3SI?@^&ZT;KOB$#F$EP69X>B_FS]FWY)^=?&OZ<:WP?IM3-F5
M'C@SV2023,\0N >1&)6NV+<PZ]_7]M\/='R@\C?+7R-X=I='X3T73M##)363
M)S'2Y!)8"-UCMYK=T K,F&;;?T=@U,_2"X^+Q;)E")]QVJT;0(FP0=.%RJ2X
M:[9>BSC^*XKD3"?O=2HYA_XLZ*BY^SS,I:FGFT[Z#5Y]8QTQN^R7,\0%I< ;
M93G-((5DR9^KTD^T@\EN&?-WR)XFH]9TEE?/I]$U,LF.;O!K/J\PM!)N(,4:
M^/E_'I^?7R[IO+7YBN+M!HY IJ43YYE20(!OAU<]IAT.",]_Y5^]/ZMWQ[J%
M+\Q.DZ6V?"F^N::P2Q=#QX+,Y=+,]</ZA?%.[44E%-^^EOF#_A-DN]:WZY<^
MMQI'5EG FH#*GGCTA9\+_P!3^8U^LM?WEZA_;--_I<M3JW\G$?A9]GI_?[P)
M_P")*'^6E)>4Z_Q?V1?E _W7?+_^PI'X$A;OC]'*\NSIOQGEB5ET8T! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ME4>$'@JL6Y L]EZO*LX:9!<%RO+(H@@(" @("#P;E>O\EG+BO1.&A5! 0$!
M0$! 0$! 0$!+P !)!R*YV^*EY;\H[QA;AZ%,8KGV^R;D,W6@QY0&U5S]:EI
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MWA><,TXC&?W(JIM)Y9JYM3RAJFG#@21$VGKZ5);*Z3:/%*"80]/M2\IIM,I
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M,[AT;Q/AO/1M.Q8MT[YF<,DCA9LTB,I^%XV\VQ<NU>GXIX<Z_@YC*9\SPW1
M.!PCL7H_#[?_ '\^CC^;UD^&NCM<I_J4^8(%NZ8&-F*_J'^LLGQ1_+_]C_\
M-?U=%>:/$4NCTJJ_&,B)!-^0*^M\5Z^W^7S/D_A_A^.'GSYBS)-34M9-;9+F
M8\^V"^Q\6/7+Y'R]MOSWK>/IU5J);,FM^,B,=O.O;\/:2O+\FNN?*TT&L,J
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MM2+V&#KM[TVW!9F[AEU_75&^XWX\KMJU;C2R5H2 7/%F(]?>N;6-+;1L< V
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MRX"'"DC_ #63_)J]KIW^'?9[ U/Q-_:^M<:^KUX:R-" @(" @(" @(" @("
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M5KGTY?U]_EC_ -W3AC^R#_H\A/!?YKQ2?$/VSNU"\/77[1/_ '1..?[,E?\
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M%F969PR.KQ.Q!Y^=+F)9O+DQK7PC VW]$5.4SO[)FE8&N%T.7<K+,-<KA1N
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M8M3%F"H^H<V9E FT=>6"S_'2>$-,IF@[T?1M5F+4SA&SX"(Y7+5Y9YK2#8W
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M"(H86^FJ3NWY8G+G4:FF2IG$R[[2.?/-)O2<U1=2?:Z^)*UZ^4JKOF%K\<,
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M<7_">CM"#=XS<6^3_%+A>-'K8?QS4\,_]3^3]]O+43)_GEQ#X@(W=<,"8X3
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MP\01A'&&"OW-X9Y<PB%MEO8K,4GUK.Z8TB]2S"S-K3*B6,*-.;+^A#&6Y+9
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M)B;HY_<4SDN>:ZCU2E-1-?O?2)CB81RO6\3"8RASP^UPW@+>;:.Y9Q<MZQM
MZMHQDRW%H^B<,0,8+:6:=4:H9TAT!$&-N.0MN2L..G:G.:]K27=<%@=C:;J#
MG&7$D'<&.PW]2GEJ.[N$*JV7$WC'IVK<N8N).7=E'6-$IL"+MF958F?\)(5
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M^->&NB'1BLYN<->O7#[P]<_5P/E3?0Z/,T_3=/\ $=0ROK4*&5 SC*EN= P
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M1Z7(HF2R T$ 7 #;ZUSG6>&Y+5QTK49=*YHWH0.!YX+<Z2K>]DP[/TWB*1N
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M(Z7U;4@^8_WCG:Z-R^-_Y!\G;K^/VOV?6_T_3KW^7K]<JW+G>)-L..:_@_\
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M'9F%UDQ'SNTWI-2)[7")QB+\HJICRD8,?E"^R"59=LTEC0X6<HC*"C:6EG<
M(R"'+6JYI(.7W$D9SB:474X%Q(59:5,UEL8<H=*C5MPY3'RVV67G#+H1J7'Z
ML6]+/WO5[$2UR\!DP1@,R;/8JQ>6"=1L#06@1MP![$S@1+F.!( ](RYT&]3@
MET+?N0*S<Y,I1^^Q@-MW/@%J?=OI<W;Q23AX@NOMO3[/3.,+ ^?NRX[, <MJ
M,WA7ZF>28X6>@'8NF9AG-NF.340-^/=LV+%VEF&P^HB1;AGW*3,8Q6U(JMUX
M CCBK,6)VN%YT:N+3+-H$;;=IVK.#3M*FU%GU6\1W#CL@GZ\./;.?LZVXAU&
M$Q\#?O0M1CM)E2Y-7XDT1Q./0K'*W>'86DOEF6V);<+U:68X2=7-E-E.A \T
M,5AB?=UKJ]6 9@&=ENV"O727Z*W+J'3'WFT\L%JW#-UPE/K)E-!%^S;]U8L:
ME^CDW4W$@$F!_91Q4QBY=LZ2$FH\2 ..?.%J?4SC:1EP@+!>KG&T]K=-YDQC
M1A?S;<E,9VMSED%0WD0A)AF;5BWO"LC/=LR*J+NKMA@$636UC<6NI[86CU9H
MF?HZYUG\I9F>T!)%S:KU.R9XKC;?=;FK;3.\5=**(:R/WN/,!ZE#-\-^;4M:
MTQPVC(J-RXV@)]6USX<V5]L?2DPG;M;&2ED^.1"WTX]RO#.;%IHM)!@2!>#=
M[5S[<NL[7LLDG1V&%@/1L&U<>UKMUF(W!HLDBT".4%87,F6J_3I3#<.KFV*?
MJO6Z8_!9+LAV>W)7[QCSIP>X-MPBLR9;GW0E4]I)NQ[.9:NHG:J;J9: XV=2
M9TF=?=UE6U&Y.@+BZ%G.F,[6=KAC;/WNN&/L5S(<CIAV7)GZ'KYK$UQ!C=<E
MN8U+I+4<QX+8$WE27#/MM=-,F.<!'/U!.U^C?MM<J269A%F(6NO"><K;2T+"
MVV%T+ETZUQ[WV8*VD8RX",,@MO/57J936N,1===L&"EC4OU14T@'(6PZSW*8
MPK6\:&/45<Y5Y$_(GK/K"8J7#%,>XVQO/J5WA,[QX;NG OG",3:#9L(4:7=L
MHB6+#\.Q&=RHZ:"V.%F.:O)VM:PJ",8QV^Q+BI[WP\_68V=OW%#VMY:CG!Q-
MUA]BO![V:;=*]K7")%X[DQE;V\K)2SFAH@<!R]*83.F6=41QP/IZ%BZ9LS^J
M,FU-A_:GU[-B8\L-(S0XQ]16L^%F?#-)<W>M(Y!:QK*Y^J78YL(C'GS4EW@W
MXX<9DUK6DQ]6!2_1+GFHJ?7%MT;R#;&Q9W"7"LUVK.9O6FS:1Z.A7VW]D<]*
MULO=")L_9'/I6EDB?J*][V$1)!! MY8*:6J=7L=/<>WE:L<,YPV])H7EPL^D
M,,R5MMV1I]$YC0870[1T)JB98PAP$#R"<)ZY;-0P&1 1N/;#L*-9=9:U3.+G
M[MQ,;CM1.%.;3N$T.R=&XX$YIE;B.P]"F!@E@X$>KH3EBUVC353!*(QLQ&*E
MU4QK+5JGRGQ)A';M!3-%0KY(>2&@7Y12Y7>,.M=<I'Q,+HG#8DQC?*>746MT
MLT/=NQOC<?NX)9&YI"TC)S'VQOCV+*<\K'(J9K0 7. &T[1M5F8EFT[3:A-$
M+77C':1ZE?.V9:N&FZB^-I/T<?:M6:TN78-!7.<UL28;H%^SVK.=+,8RDGS=
M\"%UOJQNP63*!KI.\UT,;?1UHN,<*544TQLR(C"VZ*MF73K,<,3ILR6T6F(%
ML>A3U;F^4/4:A,:;2;\SASK4^B7EB9J;HB^RWJZ%<(L%#6[UIC<,876J8K6)
MC*7,W>QZS'MNN1)GPC:EA<(VXG#(I,Q>W.6DP;I(-G.JF<DQ@<+H^FSD%B7-
M1'3Z00)@.K9'M6O)9E!U4G=#K.J Q*W,3DXTK%3/,N.<3LN^XKVQPN-ZX>*2
MN.^(QOS[ES_1:[*T2KWO"YAC'O2RDKL)C@Z4".5GL6I-8:MTAZZ8Z621$8XI
MB1Y+;>R%EZE,9,;$NM.9VJF%YT74B\P)-I%YPA#':HLOA>&N9-8(PM$<%<2Q
M<ZPJ&M48F;^Z!><-IYUB3ZI(I?YE?,FD0O\ V.W8K=$MBTZ9PNYP!<P7Y<VQ
M8Y)F)UVCB0T@M W8X;.M:XA]_*GZC3N9,) NR&Q73-F=HZ3O[Y!&)'9W*RS+
M<ZS"PRP!*M@##&_!6X9\JWJLXRV/AA&$-EBYXJX^CKN?J4ULUX!-YQV\ZN<(
MLVA:FYQ B3;GL5ES6N5NJICITH0Q'J5LGAKK<:1]%*F,F F-KHY<_1!9LN$[
M=IX7BDJ-P $F[/OVI)C;-VYU%5$>T;,K<%82XB+WW%PMQ'*U6\)RFJ-Q]V)R
M[>Y8VN;-K32U;98;&%A^XGDS;4@_4I+F;L1&$+^;N6^N93"%FO:]Q<%.WU/&
M&24;!TK,NRV8;(= 86+I+,,8S<AG-Q]?<EQ&L6<HZHG-B8;?3'N6;N+E UDZ
M ="%PYUGKRMX5V?-+C$0Y <RU9IG.=)+3Z[P2(G$1M@LXTU[8BTLU9KV@1%N
MW+G"WUN&9O=1U?/;,EV<]_1ZUGM<M<?HZGU^F=-$P@8GM3-+NNJZ[39SII@#
M?DE,V-C3Z&:QS 0;#EDDK6<QV3I>]):VVX^B"2.><+C*JW%H$76P%^P)5S6W
M(FS'O$28<@LW.-+-KKI1:7-+H8#TA:FHN,<+[2S9#)8,&QZ$E)GBM34*IH8[
M=&!A;E%2[9QMUGK,Z8\OW8V@67XJ96=58ERYSWB^,1?S]2K.%JH:>9 1O)$;
M#SIBBS2GNEMMOA;VIF\)PTJF<YY,,ML<#L4G+IB- DQ]BZ<I+9=<.>Z<EFZ=
M)8UIK"<#>HY[RUVTL76@6[!ESJ8RF<Z3-%0,.4;/5ZDQ6OLMLB2V0P.LP.6U
M6:76,>2=7@"$<,\BKEC-1$ZOBX[8X]&*WK'W69O+7#VO)*Q:ETWY+&FV NV)
MG_DN.4C+8QM@A=LY8JRU.LRS>.&96*W47.*Q56H[E.;<#C]U8.:Z&XKJFSIS
MP387''&,>=;+NX=;5%.QQ<Z LV8(U.MPCF5(IIK=CN;E<B37+L70N(6!LMI<
MZ,1CMY[EF9R3G+M6AU%DZ6''MQM*UN<);<X2C:R4RZ%N9Y9*6^:U$_INH,+F
MVC#%2V68)F=M\)BMF2YLHPOAFG6XND[XM4>J8\O,(W]ZWVW"2(Q],7N$>S,]
M2YY^K4QA:]&HFN+-X"\8;2NEDD3ZK_*I9;91 :(PR&U<[CEG-RZXXGEP<X-&
M!!NP28QD]JZ4JZ68Z>0/OLCGM6R6K%0Z7,=+C"R&7>5))9M-M'4M-<UDPG G
M"'I6,;6J#44[?%(<,87;5UPF<).DI)4QH$&Q.P<L5%DSRPZMH G2'%C026NP
M[D)GRZ6UW@V>]Q<)8O)L;ET(GZ*6.%:J3,)W,?O2-N2S8U)/*6DT4ZG(B#!M
MEW.+UF?1+KCEV/PWJ+I!9O$B$,59HOW=JT6N"#!O&^WWEM9]%FIM6#FCWK]O
MLVK%R8S4I+K-\B'3U))]5Q,X3%(\N(]/H]86CA=:"8&M B+AVJ7.=)9*EQ.L
MPZBIBK.$?4S0!81CV%)/JF;E7*V>TAT(7#;V*>4LPHVIS(ET"+O5M6Y,)M1:
MV)../K@IG-&@QLPD0WEK!FS2PT4MXO!^C?#8ANK=0RB=V(-T3<+<5GM2:NT\
MQK0(>M9D:N6I4T_BV0@/NK6DC#*TT;T8"Y752Q*2:4,RNC=E85F]5SX<)XW
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M!_6!=_J'1/[&I/\ 1*==.K'E6M#_ ->4O\,/P7+G.6^W#\8OMT2!Y#\3Q/\
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M/Q1_KB9^TD_@-0B"17AWPE18AO//_=ZXT_\ #M7_ "KU?#,_F_D$_:Y_W_\
M&'_B*J_E'J=73Y>'L%]@_P#W^:-_X@D=DI.S/Q>7]9#RY_N;T'^RJ?\ E):O
MAC_J8Y?P-YE&[RY*H(" @YT_]+I_X67^&@]-_M1"!\OW$L?^X=3_ )*8IV7X
MN7\>7YTO]X;C?_.?_P!)JU9PSW_D^KK]6FIIG_S1])F[IW?&TTQB(7@+,Y=>
MW\']%KC-P'U")A;.[92U7'JI#C%I@HVOG#O^I:GG]2U.'/MR^#O]:<_U7JW^
M9.["EX=/^E\-'D!_>GP9_;U!_I$E2L]>']C/[(O_ '/.'?\ ,Z'_ $!7KR=N
M'O\ :K_21T>M.W)UX1ZBLDK\HSG"G_47AI^<7]Q/F-_X:U/\&6M=^&.O+^.-
M]J[_ +TOF#_:]7_+%9G+MV_C7Z1?JXW]^])_XCI?PI2U'/IR_JDZ#_L-)_S.
M3_)RDI?Y(7C?ABD\PN *SAF<&/%1I\^6]CQO-!$ETH1$#B\*S&&?:SL_E+_K
M!WRRUWDW\Q%=72Z=DN1/UK4&O#)+F#=FE[HQW0+' +.=M]\]KF</S9^SD^8>
MJ\C?F-\O]6GSGRM*EZG*%06S-QHW9K'C>M AN@IB6[26\/[$7R/?,=PG\QGD
M7P5Q'PU4LGS*7A[3I-<&39<S==*E,DAQW'.()(@M7'A++'LIJ7$6I:;5S)<V
MDEB2"?#=[QWFBXQLC%*8C0'&TX_\VE_\;O65]8\_IK._JTO_ (W>IFGK!O&E
M0\[K*67O?\+O5F;P7K)M8:*MURH#9KJ&0)3@"-Z8&.(S )!*U/NG[<:Y<M0U
M+4Z1F^R@:6B&\XOWQMANF"6?1F?=2-1UN9J<63)3&;MA@+1A?>LY;G7%RB T
M"Z*9\*\H" @\.M!YE!;M$GRZFC&DS;65#G-<TW%KA$V''W5N8PQVSG/A\-WZ
MT[\JV]IM1Q?HU-)#)C)%<7LD>]8R7-M+6FV(6;ITD]IM\!O"FLUG!/&NBZK3
MO<RIT76*.<2TEAWI,^67PQ!A%)QEBYEP_J@_J_/SUZ/YS>3O#GEE-JWU&I4C
M*.G,J94,=NO$J6R&X7DWE27;?;K+U^[Z/^)M+J?KGUR4S^;;C2XC!P/O Y*L
M14_$9]\%&L4\1GWP5,-FFH:RNF-%*TO&R[&,3<K(N9C:SMD:1HTJ6S71*ESZ
M@[LDOF2X.))$&^^+8JV3PQOPC-1T2LDN%;)E@48(F2]US7$,,"TD-)(B$D67
MPSZSI%)Q[PMK6B5K6O$_39U)!X#AO3Z><QL0<-X!2<LYO6OY1/V__P MU7Y<
M_,KK6NRY,N50.J]2.]+DEH+3-#R2=T#Z*S;O34ZYW>'YK?9J?,G7?+9\R7"7
M%TJ;,91BLD.J2V9N >'422V,2! [Q3&+E)<O[!OR'_,]IWS0>2W#_&-$X3)@
MTG373I@FLF&+Z=C8.W23>%9<KWF.'M+7<2:EILY[*JCEM;O.$L^\06@V$$&!
M!";226-,<:SC_P UE_\ &_=*;7UCR>-9W]6E]&]WIL]8#C2>XP;3,C@/>M]*
MLS3U6.@KM9J0)LRAE"2X M/B!CH&%H#B(A6?=FX>=0U'4Z1IFMH&&4VTGQ \
MC_!,%=$Q=*/7ZW,U,D/E,9NV6"W*%HC8LS6VO62Y>=  &JTL,9K5J7)9I\RO
MZSC_ ',#^QAVJ=OXQ/A_^2OY@E9_>%2_^(=-_P!-D*3A?D_E7]3W]7S_ +DN
M&_VE%_(2D\K_ -#Z-.+?]:2OX)G8E3KPKB*XO^$]':$$IQ'_ '4<3_V5J'J3
MPS?Y/Y37V^_]]/$7]M,_TABG5T^3B/2;[)C_ '@>'O\ Q%IGX<A6L=.7]?;Y
M9/\ =TX8_L@_Z/(3P7^:\4GQ#]L[M0O#UU^T3_W1..?[,E?_ (.JEJ<5F<OX
MVGSE$'SFXPA_\H=2_P!(GK,;[\/J9_5AZ6HFZ]I;V-BWQ9IC"-GBO4LWEKX_
MXU_1JK_<X2T\.L@R0.H/58G*G,M:(8]Y3"KKP=\==^UE?A3$B=N'\[7]9>_O
M&U;_ #C4/PBLWEUZ_P#QODA^47^_C@O_ #MO^D4RU>'+I_)_8*^R9_W>>'?[
M TS^3E*=>&OE_D][JG^F57\--_E"JC&@M_#%FEZR1?N/]$B=!(G?P_FZ?K)V
MM:U.X\UZCJ)]2*(#4 UI<_<@'3 ++K%GRZW^#Y3/EPHJ"O\ ,W0Y&HAAIG5E
M'O!\-V/UAMAC8KV<_CF:_L%_8R:;I^F_*-P[*TRGD2Z8TVD$3)(:"\BDG6'=
M%H"=>$^28[/T(J9CYM1.,TNCXALCCO&Q6ZY.K&BN# TU=/%Y;^,EV1L^(*RX
M$?\ ,>ZN;Y2<7?4*275N_1RO!;,:' #ZK-A>"F,IU^_+^.9]KB*C_P VG%)J
M9#*>:9VH;S&  ?TTFX 9HS>7Z??JXG^\QI/^?:=_I"Q7:</ZH/$'^K]/_P U
M/\G(76<./_4T*S_834?\WJ.T+'AJ?S?S&?UEK^\O4/[9IO\ 2Y:G5OY.(_"S
M[/3^_P!X$_\ $E#_ "TI+RG7^+^R+\H'^Z[Y?_V%(_ D+=\?HY7EV=-^,\L2
MLNC&@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(
M" @(" @(" @(" @(" @("#<T_P#IU)_#,_""3DO#TX^T<_NRKO[.F_XRU?XL
M]>7\_;YZ/]<ZK_FU3_\ 3%J_Q>3M_/\ R^=3CK_:%_[>;^$L>&_#KZL^+ED4
MBSFO%/=R_9*W@O!.O',G5AP1T>%GL!6IPG;AX6F,4@HLCS<L]JW)@6%%<4$Q
M0!@IA+MD%H6;IFN)O77K_%9PXJ=N5>"M=>&>W(%:=7)1H0$'A8O(YMNZ5/+/
M9S79D0<'W=/J*#@V\<L"L=_XC:^AT#U+'Q\K6(IW_D.#KUKIPU'%.RBRKRNB
M,TN_H[EQ[<_Y9<_I\LEUG\67"9?T>LKE>5<$! 0$!!X-RO7^2SEQ7HG#0J@@
M(" @(!N/,59R,"V"SV')F/1ZU(SV9 E.O+RHTRMN'+%5B\N#KSRP6O#4X<F6
MF"Y=OJG9MM:&Q@N<N7.MZ0P;S3;>.7I52W%3DAH $(\HHLXRG*=@.=[5)G/V
M<^VUCHV",+;BNTM<;?"Q29=K;X<V<8*YR18*7W($>GEL6^L9[ZB6\9PY#N6Y
MB.3$YY)MA>5K#-[88G@D6#'O5D8M9I$ASB#M'I723$9]MK7I[7,,(7^HJY9S
MY76CF;K1<+!VI+DMRL5/5>[NQQ.'/C!6,=DO3C?()V7<X6IEP[?19M.E@N:+
M;RK$[<.Q=*DMW6\^W(;4L<[5YIJ8%MFSLYU@[8G#.^FW1=Z_6M^&9MYD#</?
M9F5F)VPGZ.>V6YMMW,;BJQJ3"^:;KLBF:W>?" %Q QAL5QERJ2J.-:>6WW9I
MLACES[ IC%;SI6ZWCV6-Z$]^(O\ ;L3C;%BCZAQVYQ=NSGXW'VI?JQ+GGA1=
M0XGJ*@@MFOQN)5<[JYBL3M3K)KC!SR#;;$]L87(<[8OK=:;/>MLN6L>4TG=*
MKJJ3,8XN<(*>U<^UO'AWKPMQ3X7@MF376.%D;KLTQ;RXX\O9#A?C"G<&ATTB
MW/:#GM2S#?C[N[=/XFHYC -^-V7?%87.EJI-:I?OQAB,#SI+AF[6:GXCE, #
M7F[!VR-T;$[7*\,5?KC9\LPF'#$K.:9\.J]<E/JYWNVQ[E9FKUQ$SH&E.:&E
MS,8Q('K6I,I>V_L[,T^1X4 1CMV+7KM<Z^[L32JJ7)#8D8*ZREWM>J7693(>
M_"X6;",N=8OU9EN$LSB"4-T>(;\SFKC,&?\ 2"7_ )0]96?2JS-UYAC^,/65
M9<-6R->JKI=8W=WMZ-FW'%;R:J'9IH<_>#&V[!S^I8K$Z[3=/IP/T&WPNS@M
M3AT^R59I[6@#=;=D-F"Q2M&KH[;!AG#+!67'"3A"S&%A(6H9Y8PXCI53-G+?
MHIKM]@)^ELV;%FZ,3MOR[<TBKE,D-WG0LM6;?:+UN-([5:Z69A+70Q]?:KC2
MJ+4U[M\D.=><]F*A;&2FJYI<#O.O&)VK4U&?;/"\:753?=@2;L8^I9:Y7NBJ
M'083SF[,G),)G'Z+!)J &VF', 4TDOU5[7*YX80PFP&ZS#**2[=NO6.NYL^H
MG/,=X@DBWN6I9E<65EE4(FB+VBT1MYRL=N6_NRMH)$LQ@T=6W/G4EPEK,VL;
M30##AA?UK5F5;\C6W@P#S: ,=BN,IV^R8EULZ:T$.<8PSS(6>&9?*6HI50Z8
MUQ:2(MM@F<Z7MQ]W9>B$M(!'WH73&LLR8F7=7#]86.:W,##H4E_X7[N\M$KY
M@8P6PW!EL5MS-,RV\IVOKRV23<1$CL6)N[:SAT;QEK!8R>-YWPFZ)P6XG;L]
M2.--</B38O=:QV8OBEOA>O&7KQK>I">X@F-]]ILA9;M68W=(F@J-UP#<QZ.=
M."5V-I5>6M8"XBP1M(].*EGE/*WRM5+&V./^$<$S:K'.U,OO>;8XQ5$;,U$6
M>]GCS+/:;T.8U(!HBZ%@Q*U!KS=3'O>^>LX#V)E+?^4'5:D71 <;<B=N'.AX
M1;9SB[>!C;'E9%/*9SI8*.J<2 <>;F]:EC4GE8Y,S=:'1%O+U)-_X9G;>*RO
MJ+!;CL[E?U;ED:DZJ&[:Z$-@S"D,YTAY^H;M@=RBGK.7.<[:;M0W[SZ%9B:;
M8_ \<;\(QM[.M<N\E/#S+D^"X&$"#'L7+.)AFKOHFJ"GF2B7D;L+B>?F3K=K
MAWYPKQPZD=3PFO #L#E&Z)72;8L>R7#OF@1)8TU,R,1](X]*G;KA=_X7.?YC
MF=*LJ)A,+!'IQ*LBS:AZOQ.:L&,UQL-YS YRK;_PEU8Z6XEJQ-8\EQ,7F_KO
M42O7SB$->9I.+HWW+-=)=.IZ^6S??#,X\ZISRCY4L.)$,L^]3M6>6&?IHFQ.
MZ#&RT9\^U273&++HD<(FHM\-IB181&'1 JYK<^Z?D>7AF2_R++C;#V;5<I^C
M0G^7KI<T$268X;<+%<8F6\MMG#L^CE&#(0LL&$!S+<^3_P!$O:=:J]=43Z.8
M8ES=V/;&[H72=NN&IWC?TCC TTQC73GB#OON?:N/;5TU_;'=&@\=R7L:'3W6
MD6%W><USO;.G6>MQ78]-Q!35K #,C$ 6G.&U8KMU[R1,4LFFJ'Q@TQMPQ7.]
M;>&^OR3.5ZTG2:8O:=QMP[.>*S_7VOAW_LZ8Y=G:=2RI 86M%C1D<(WJ_P!'
M?M,2,_V]9=\)&J>XML$(#MYU>OXOR3PU/R?CDU5<GUT^2Z(+K/:O3U_#^7&H
MX=_R>F]L(XHJ*> ,Q\19CD5J?@_-?#E_W?3K<.)XYG [IFS,K\NG8O7\?X'S
M7PY?)^7\<WELTW&,V:\?C7]</6NW_P"#_GXPX_\ <_%=Y=AZ)Q,_?EQF//25
MK_\ !GSV?Q<[^=\<O+L=W$C31VS#\.?2O3^/_KOGZ]Y^T[_E_'>O+U^XXU$5
MGUAL28QO7ZS\7\/Y)UFMOD?+\W2VW+U*XST 5PGQE-,6$6CGV+Z'P?B?)[</
M'^3\_3KULCT_XZ\O3/\ '_F[#^+=]'8=EB_0?'^/\GI)A\#Y/DZ>UN7H_P"8
M7EG-#G;M,SZ<+-O-DOI?B_C_ "3MP^9^5\O6];7KC.X&J*6>3X#6^\;AM R7
MWNOP?)C&/#XG;OUES]UZT'3IU(YL6PNNV'):GQ]NL;Z]YVY=A-GP8W>A8%?6
MW3?M)=,DN=)^DZWG7@_)_;R]_P"-V]M1CJ6RIK'0-^W!>&]YA]'K+G_*F:G2
M#WC"X9Q7SOF^7IUNZ^O^/UO::=5:U-;(<8F%_H7G_P"Y^.>7>_'VG9U+J^LM
M9$>(?B(O/L4OYOPSFM7XNW;AU9KFLATMP:\FTXE9GYWQ>W*?]OW]>'1'$>HO
M/BD.=\1Q*^C\?^P^&8Q7D^7\7Y.TN(ZIJ*N9,FO$2<+8XCG7Q?\ ??F_%\GP
M=I+O#Z/^E^'Y.GS2]HD],D/>YKB#\0[>9?PS_9=+W_)MG#^O_@_)UGX\=LZ!
M0[Q;%L?>'J7BZ?%VD=/E^?KC$=Z</Z6QP$6#Z N&-J[3I7DOR=<Y=OZ9I4IH
M:0P?",%TZ],<O-\OR=:O%+2L8!!H%EX Y_4M>NWB[=Y(GZ>=X,(67C->CXM1
M\O\ )OLDI6I.:0 ]UXQ/,O1[;CQR8E6.@UU[-V+S8?6OJ?C=YA\G\OK<W"XT
M/$,""9AO'HAW+U3OUG9X.W7MZYCNC@7BB6VL>'3#^1?CLZU]O\/YNN'P_P _
MXN_;K_E^"OVK&L,JF5P:\N!F3K[;W=*_(_[[O+\VG]-_\+Z7K^/M1_L(Z7Q/
MFIX5F;L?Y_1F.(_G,J[)?F)+[?;+^C]K^V?H_K[<)V<+<-#_ .\&C?\ X.IE
MU>9/H" @(" @(""N\3\5Z#P;I-3KG$>H2=,TRDE39TZIGF#&MDL,Q^R.Z$7%
MO#XP_MM/MZ='\K=.UWRS\H.(:BKJ)M+6TD:":W>,Z=O2)8+F3! Q;>;EGG3K
M).D]O+^?9YD^9'FA\S_F+5ZW75>KZYJVIS_Q-%/JIDT2353G1@T/>V#W0!ON
M6I/$Y<N_;_JO#Z;?LB?L7JWS!U72>/\ S'T:1+$N11U&Y6L.Z 2V:XALQA W
ML5]/\3_7_+\MSVFGY_\ V7^VZ?!UL^.[??1Y'< \$_+MPEHW"W#&A:5*\+2I
M-),FTDF4' MEL:;6M!C8OM=_@_J^/UZOR5^;O^7\OOVKN"16.K'&8Z8XM>2X
M-)L&\8P',OF]_B[9R^K\=G7KCRP:@\"6[*!QYUR^3X[)AT]I:ZEXAGAI?^U.
M$<3WKR7X^V73VS'6-8WZP80S[8+Z7XG2Y<OEF8J&IZ>0#[@MWKAS!?8Z]+8^
M=VY=8ZSISBYWNF]W:L=NEFI"1UAJVF3!XAW3><=O.I)<89[1USJ>F3G!\&'T
MYC:I>O;*.LM8TJ?";[F&W)<[*UUKJ77=*F@.]TQW7=JYV65;UM=95.FSO&$&
M8\L5*QZ5/Z5H4YQB6 _#"-N>PKCVMSAJ3#M32.%YDUC?<:;!A#/9L7*ZJKO2
M^7\VH#3X#3O"-UMW,I[VW#.4Q*\LYTL;QIV 6PLV#8LW&5]FP>$S1-=&4T$9
M#+H$5S[82]E3UFE$IKVP ]TW;(Y&]8O?&HL=%<34OBDAHP<+_:K.T_RMF'3&
MH<,3:MY(E@Q.7L6ICPY6YTG-#X$F0B9+,#\([EK.G"RRNSZ'@AS6-_%,L:/H
M[,P%.O[G7ICRSS^&/"M\,67P!VY\RU9AGM)+I'G1VL/P"-N V<ZS$;\C3G#X
M6X1LZ< C<D;;J.: 3NGK6L%8!(F;T"(6^OH6,L>=)"GD@$1&/+':MS36,[;4
MR4T-Z#GWE2W*V>5<U!HW9E^':DN*F<S"F5?QGG'K6KQ_AGRTV/.\+N0*S&L8
M6&AG&P',>D>U;[S63&\U8),X" V=VQ9G#7*6E.!A:.O,%:QB.7:8CG,<!#'I
M6+C!UB/FO#1#EBL8SVRW/JBYLP")LO[2NO6X,Y1DR8'79\L%:F-_9@<-[/H4
MDPUQ'@2HV0-L5<X2V(^LIB!8/3L&W8LXR9UE%2I1WH8^PJUF[3$J0\,M$/N!
M-?Y:F(C]1)EL=L O4F]I<<SEU1KM4=XB,+#9@FY^AC$RH$Z<7/%U^S$G8I4Z
M_7PL>B^\YL<P.Q2?5NZ=R:8UID '[T&_G5N6>6I74.^XG=!YQ'!)RN,3/E%?
M4G-,=WU#T+=FDESSX>3*<V^SH]JQBT]IG#A"U63&ZUEQ((-QZE+9EGSIYC9:
MM3A<N)G-8;]MT>5R69.6A63!,$.;8L3MC32N3Y=I(CCZUJ2,1AD@AXCGWIB>
M$MMJST$P"P\O0K.%]8DWS6EI]O<I9EI5M28WWC?&./<IY<^%-GR022 <<]FU
M6Z&FYN[@>E9K<X>1/:V,3#D>97)B.;:F63?RZU)$LPR"<T\O8NEQ9]TDM:M0
MUCVDDWQQSM6*N%"U>F:=X# GE>DN%U%!JJ=H+H9[<QM3.4LO+29+%L8B[UYK
M6)RSM,4,HDB&8PV<ZMC77E:J26YNZ;3:<.E83SA9J6P=7X*SFY7M,1($@,M.
M 1S0-8<K;2M-SE5JL"#N;VJ-6W"O3F@N-^/+T*YQ&&N%TZ+C+$1:>=>GJ]5F
M(\+;(ARQ/(;$[%.:U+)&A-F"VS#E@K=,R>UTTW/:8&/;W(U9AK3)K=W#KV'8
MG*2X0%6071&/L46%.T$"^\=JU+A.W*98!NCK6;ETZXPX3937CK[(9J2G>8FD
M-/I!;$>GF6O;+'3'EI>"UO(]ZU*O:?1YW!M6I<*PSC%IV=ZX?+Q?T55J^:1$
M67%>.SRW-*M/F0MLY13CDN:Q2II)MA>FJUC$_P I1DV#1=U[5,7.F);'";.L
MB,!W[-BTU)F;1DR?=;GD<DR>OT8C/B( QYQ!9[)A%3@7&/*U7.(DVP[A3,7#
M5GRR8WW9<P5F$ND%4-^CRP3_ -EFZAITL@DVW'#:4\K;K+7:TN,-D<U<,W7+
M>ER8POL;W*9PU)Y2$J4&C&[VKA\MN'J^"R]L(VLO/.O,]O7E*\,?T\?\'\)6
M.TX?ME\F7]+TO^!E]@4=8^JWY6?]5Z1_ M7.\UZOBX?I#I?]&E<_K3N]/3E-
MMQYO6%CM_%Z.G*%JQ[QZ>U:ZW3U=>LY0]<?Q!YCV.6:N?"D3/RIYQVI>'+MR
MY+"" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @S2/RC4
M%,\[?[O9_P# 3OY-R=?Y)VX?%E]H+96ZW_:%1^$]>J33YG>[?+_YYN_[3U./
M^7=LSBLRXN&+?6?=Z8ZJ\B=,NN[UNV2,2Y5^8\F LQ]6U8N]M[FV-KP8!9EO
M#K+K;*V\+>=9+PS!\ !8IC,S6=_X>'.,<+D_1TDTQ[YR">L2\-"9-M%V*UF.
M=ERUS-<>0[E&Y,5XWCL3G1B/!<88*8QLQC<8U&:0B@R-;?&*U(O'#:ELWHQC
MR@ERDK9W!"R*-]KY2E'%I%F(O"35<N^XL#'DM%RMKSR9<@]P,5&IIF$X[+]B
M)<L[9]]H[>P*2-9Q'/QMH5P>QXVT)@]OU/&VA,9/8\3F4]4S/\L\F:;+1")R
MR[U*U[-OQ>;ETJM<\/!=O969( ,%,9+,MV0_>A=RCW*F9PF90!'1ZU6,XJ.K
M99,0(VGV+?69=.N]M:GE.;:<3RQ7>36&>VTJ+DC,8W3(7*>T\IFL\J;=GN^F
MQ)<;2RIB1-]V[E$I;E,R-LS?<NP&/-L4P>VVI,=O1LRQ1K&9ESD/ (!S[+?6
MB1.4Q;9:,?6IY;RGJ9X %UPQYETLUEBI(3!A#K6&IB<N+Z@!IMMYMO,I(S4=
M-K( V[;MJU9%RBIM<=X@.=>+KK\0L923;;IW&8V)Y^5RN?HQVY3E/+)@.5Y5
MRSFRMMU,^!$,#CL3KQE>W;/#4^J/#KC:3RN2[.TTE:2F+2"1RB<%CVMTDML6
M*78(<LEJ++BL50X$0LNSYTMPMMPU936%X&W/GVK,SY9D66B,M@$<LRM7C3-F
M$A,JY3&$QP*DN:U,\14=5U.7NO\ >'(\RUF1O$==:EJTIA/OB,-F,>99MVQ>
MN_LIM5K;1&$PW'$Y\ZWX:D_X5JLUMI!_&&.\<3W[%8EU51K=8C<\XXG:LV'K
M>59J=6<YQ&^8$YG9!328:+JF9-Q)C&\G&."2TDPP&DFS71AAV*XS&^WV;LC1
MILPQW(VB^&>U9Q7.6W53U-PW,,#N"PP^';')5+JX6.CX8>0(L%H&'L5BRX3L
MKAMUGXL979#G5TU;EM_HX]D"V6#$VV W066,MF3H\YCA&7 ;(9CN0VG:/3IC
M"WW388]HS0D^JZZ9+<P"(A:/4K)DO.E_T^8&-$=G9DI9BZ.O*XTVH,:T1=]'
M9W*<U;;.&T-3E??CT=RUQI)VO-8YNK2@/C&.2O6I\G?,PBOSL-ZQY YSFNLN
M7BFNR6I-6B6C?-YQ<KG"X^JSTNI-< "Z.%L<S"\*L=IO*<IZMD1:.1"&6Z:V
M6/I!2IFR:1-9J; UPWA<.5R2Y29\JA6ULMQ=!V(Y8*K+A%BO#(P=#FL[%;-9
M);$=/U(DPWSU[ H9P\2M2]X#?/7F?:G"S=3]+6-(OQA=S=R&-X;QGM(/W-JS
M9E<--T-[J5G#,Y25'*:7-.=O*W8JMF$A7,$N288#ECL4I.55IIKO'(V@89\R
MOEZ9PLA>XLZ+O0K-%1\UKG$B'*"9MK,^[S(IGN(LQ]BF4[W>FS,I7L$89^I,
MY9E:L'-<+#'FBIC"=YE:-,GO:&@V0QN59D6'\\/EL+-\W0O.SJ3EBJMJ%5.J
MGD@D@@]JF/#CVU49)ES&/!(@/7$;%IQLSORM%)J+I+6^\; ! 1A8-BC3+4:N
M7LW0YUNTY^U3[LZRJ]6Y\]Y(MMCS\YZ5>MG#-W,M>GIGM=$@B![M@3LS,VXK
M9J);MP<LDRW)A'M:\D<XRSYTF?*RY3=*7C=CV<QP5:B6;,(:+DL7.'@SG P]
M7L5Z\+[3R\B9,)@!Z%,0MC<DRYKS=&.SF35CG[[PF*6GFV>Z<,\SL6>'2W,6
M,Q;)@;]V"DN;MSNHJU92F=-)(Y$K>6LZ8Y&G &(8+\AA:C-F;E*F0);!A#V=
M"S<Y:EQ,*GJU2Z5OP) !C9'.&',KC1>TNE7DUSIDX")/O&PD[<#?<I(9P[,X
M<E":6DVP<"<H""NBW+L?<E298)@VXY8>Q<>U=NF)'.572&6%PA]SN7/Q]W>=
MYY<IFIR&BQPY05ZYJ7MG41$[4Y)/Q"[/V*=ML741DVOEF$'=FW8DOA9]6I,K
M X6$=7+):]<'LA*JI.$";<OO1L5PEN52U.>72S=$C9V04PF76E<3OQ_9$Q6;
MG+<N6HV<6Y6&.'+!2YK3?DO,P@9Q5CG[)FFH73"++P.U6M6K#1:8^+3NFPG'
MV[%&5KHJ"8V'NG ^F&U63&VLQ<Z&26!L1;8GG"9EN%FDO#&]>*Z]=N?:X:-;
M-8;8Y_@]ZZ.%JF:C/$3#/;W*I+E6IT^+H1'HS*RZ6XC%XIV*X3V;4EI?SPRY
M9*W!;&TZG):(#+L4FDG:83&D4Q\01&>:7#>8OW@@2[C</5M*QC-:\*W6L(+[
M#"(P6IK3%B">7!T!V;2JQG'+B'.Q[%G$:F*PN>03=?RQ5AVD@R8X.!$+P/2.
M=:X93--5.  V0]$<DN:9C=\5[Q=U#V+.)S6;=M*<71V<VQ:E^J6Y:;G%L(8K
MGY67#/+FW6CX>Y:S9$NTDV>0T6B[,=RDY;\,$^<7!PV;,N9:NDMUA"5+W0,#
M;$X#G5Y84C5YTP-=#/"PXY*8Q<*T-%J)WB6N=UD8E:'8TA[IDML;X>SU+';3
M4NL5LLI=YS01&)Q^Z5.NXS><KAI-!+]TEK1:#<+K-BK<7:7(EL8  !9A9RN3
M&%:D[=8^PBPYY04SH> YLQN[M(ASPV#)7J(NNTGQ6%VZ#'& .>*OA+-*)5Z8
MZ3,,&#+#&W"U2<Y3EGHVOE$&%H,>J*TSCQX6677O8R&\ZW:>92S+7_2R,JYD
MUUY(.<=BF)#K);MNMD.F".[&(&>62OAJXX0>J:07LB6",<AB(YK+FZYU'A[?
M+HRQ>,.A+<K[*U-T#PR3N#'+;W*+S$=-H-PGW86\RWG26^&NQAENAA'+I4QG
M:R)^CFEL(YQ]!YTEPSCZ+G0UP:UK8X-V8P5O7RBQRJH%MIRPSBL-S$C,'"?9
M?<,C;LZ5KU)<N,[36EKG%C;LAG%/LZR8N51U&DW"^ A8<;O=/-FM3AJW2BU\
MIPCS'TQVI.6,YJ):UX=Z,.]7'E,I^A>YL.C ;-BG:[PZ3A:)$S> !ARB5),D
MPV2(@A6K>$9/9!T;;3ZRLLXK+)E%\+/5GMV*8O+7JVW4+G-ANGKV*\)+4+7Z
M8\,)W<'GJAMVIVO_  MGT=;ZI2/:YUF)Y8JS@B"EM<V9;9"'8I$YOV7S1)[F
MNEQA9 8<^2W=PQ':U!,,R6R.,/6I+M+<LVHTQ=+):(D@X[$T\]_DH\^GF,?=
M"V-NP]"SG"\IC2ZE\EPB2!9=9MM6I<LX=@T&HA[0"^,!C;AM2VQK$2;F,GY&
M)%AQ@L2U;=M^CTR47-<6MMYMJUC*\Q>=/H:9DN!#1R"QO)+IHZG12_>W&@Q;
ML]"MML23]WV=<ZCIQ+G'=SP&4,5-\KQ,*\:,L?'=A;'K2,YKD;&GFAZEU9JM
MZK*=,8_=&?I*E;Z\9KKNJT^;XKC W]^U2XL23;<TYCJ5[2<XGT*_8X=A:7.;
M50;?A#H[RIE;M:QI[6MW@UM@PA%,LR;PP.8YH( N[U5QMC\.8\W1PN4ROJVY
M=*;"1CFG*2X;H9X8.P1MV#V+-S2W+2GU[F P<1 1LNBJU)C:'&KS3,#=\VF&
M*W]V+<7*WT,UTR7O&T]:G;;6,MSQ"UW-W<RQVU-->LQD=4D61A9LV\RG7M6<
M3PUWU<+(X'!:S;4N6A,G%Q!SYN[:G*\S#2F[TP0S.7.=BG729O".=3/)(@;U
MT9QO+']4GQBUIL/J6;5QK)_.I1MWA"ZVRY)Q]USAGE3ILSW3$\]N9QYE<0QG
MEG_,SJL'W(Q[R.?!2[7&&A/X-B"\RF9Q(B>Q2W)4#4:$VE)_%M$!99S*2;C,
MNFF-R20(P%G+TK<X2I*CGL>Z&]$Q'JR4[<*N-/) 9$9<L5)IJ)"54F39&$80
MA?9!6JDY6JO #=XX"\J298[6UG=6/FB\D0A;ZE=37EKJP"B=/=:V,0+\UG&:
M9;4K0K0?#'4K:EYQ$]3Z8)=FXWJ&$ M3A)F$^@>8[K;("Y+P7;2.ES3;N.Y=
M*P,;M+?9[IZ_:K--1KOI7MA%I%\>CG6[)A,-"8P"$8XE2ZTUXPPC<!C9UDKG
M.52E)42I<"7<H!=+]6;VPW:C46>'!KK80$/N7K/)-[5R95S'$^\XWWDXK-F*
MU>&(/<^T\RN=L9K>IRZ.-^7,M8RMQYY3E.7@"S$X*WI&;RD(.%L$O"2_1H5$
MQPC#;ZUFU;M7M0J9GAN )N(@">Q9QMOKJ.I]8DS)T\DQM<3VJXQPSG>45,T]
MXDO< ;(YY1S6X>^-.M]7$R3,>;1 ^R]2W'!;EK:/J$X5#!O.@'#M"S[&=8=Y
MZ-J,SZNWWG1QO^]'>MYF$QG:5G:HYK;7.'.2I9IJW'#9TS6W";#?-XSS&Q8Q
M@M7N7J^\QN\\VM$02<E9]F?.*SRZB7.M!!/5BNDF8WC$9/";&/?WK'9B[25-
M5,IBV)A"!ZA%2W)+A8Y6JRRPP<+6]ZF/%%8U9S*DQC&(CUP]13%D%/\ S4Q]
M1O;H^+(0Y6KIUFDMQ^J\Z9I4GPF@M;=##**5>MSRA=?TJ4R1,+6MN.6"86UZ
M_P"M 4\^9# GHNP4ESI'#2:D.>P$WD80]5BEK4KMG2M/;7, +0ZR%MO(*R^6
MK/";G<!R:EL?!EFPFUL;P-D LYVDZX4[5/+N7+B1(ECXKAW +<Q8S?JZGUWA
M4TN_NRF_%@.?9!2S>23ZNNZC?H'N'PP)NR'J3SEJS+;H-:.\!XAOV[-BOC"<
M+_IFJ&:&>^;P+"<3[%+RO7G:_P"FSC,(,8W7J6R)9BY7:C,.KVK/ME>8LTAY
M %UHAZ(K?5FS>FZ*@[/1W*FY,-&KG%C(DV<PLO'K2K+I3JVO@YPWHV >G)93
MGE7:B;XD39;U]72K*6Y1CZ;Q,^Q9SM)ISE4($/=:23>;[\\EN6%VFZ:E A'(
M8QPZ%*U.$[(:&PAGVK%K.<UNQ69WL=&:66N-L.M;G&T]6_+$L=4+RK<,;<G0
MMA=WK4^Y.495-B#"./K6>UQIJVV85&MHGS7&PV'N5G#.T6W1G%P]P$[0(V=>
M2N%EQ%AH=%W2UQ8+ ,!B2/6DY2W*XT>GL:T%S0 TY#)6PE_Y;M0^32,," 1
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M,%G+A;MCJ=&$T>ZP&)C<,0LWC[M].<M"3I,^1,!:P@76#;&Y8=<;=@Z'-JY
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MKI6C:I.#9C=X /IB<0<6IVSA?AQ[;?QZ?GW\K=0\H_F*XJX?GTC:27(JYSI
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M *UCKRIXN',$:6W1O]G-=_S6L_T.:D3L_E^?K$W]\O%7/6_A35GR[7^#\/\
M[.C_ 'B^&_\ .]._TM:O#CT_D_L-_('_ +O>A_V9I_\ H<Q)PO?^;OD?',_;
M'M*#D@S4G].I/X:5^&@]*?M2_P#=_P")O_#VI?R=0IV7XN7\>'YPO]X#CO\
MS]_\O4*QCMR^N']69_O+TS^'T_\ E N<Y=.W\7]#OC;XJ/\ :3/P@NE<^JO<
M=?W3ZM_9LW\)Z>%G\W\HC]8#_O\ Z[^WJGLG*=6_E\/3S[*7_>!X&_\ $-+_
M *0U+ROQ_P 7]A'R(_W=^!?_  U1?RK5J.?_ %_Y6&FJGTCM]A(WP089&ST1
M4SBKVF:]9/G\^6/1?FC\AM5X3FZ=15U:-+JA+\66QSHS:5L&_"23OI=Q.O\
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M.R4G9GXO+^LAY<_W-Z#_ &53_P I+5\,?]3'+^!O,HW>7)5! 0$'.G_I=/\
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MZ;\9Y8E9=&- 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6Z>M6NZG,$QPWS\1LY17S?G_ #?EG;5KU_#^+UM\.OZNJF30Z)-Y]8]:Y?\
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M25C&:M%,WP&!KK.JQ6K)BY<IDQMICEB.]9OT7M<HZ94B)MPV9<ZG:88VU'5
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ML>(V6WX[%J[6[C#J C(<=B6N<N'5U;-/C.!(O-A.9LQV(Z,#!O=2KGQ6U+;
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MEDR.]<,1>M,;FYP]_/E%^U7\\_EGJ:%C^+-=U"DH/Q391GS9D);/=#7-WH1
M%L EF6NO?&J^@GR=_6E^)=#TNAH=;U"KES)  >:J7.9$@VVS&"*S,]2]X[$X
M_P#UJC4:S3:N3IVIS'SIDES6MD->YT2+(!C"Z*NZWF3;\=?F<^WS\[_.ZFKJ
M+2=:UO394^FFT\N:U\Z1^4#P'0):X0WL0F&;\D?B?5U/GIY_<03:R8[BCC+4
M=1J/A$V=/DM,^82UH:7ANZ"Z^!*NF,=J^J[[#7[+[SSX>\U-#\SN(]+U31**
M4*"J?*F,FR6&$UDPQ'NBX*>73&LOZ0E#.%#PUP]03'>)-I=&IZ>83$GQ&2)3
M"3'$[BWG#%FV'0K=6IG9S0?6G7R7^+YB/UGJI%/Y,-B6M!T9L2YP O.?,G;^
M,3X;^^OY@]=4L_3B74RGM>V7K=%,#FN!:72ZJ2XC>NL(6>O!\FZ_J=?J\U4:
MKR-X;>=W>W*'X3&^1*3RU==7T@<6_P"M)7\$Q*G7A7$5Q?\ ">CM""2XF.[Y
M3\4F^&E:C_BIX9O\G\HW[>^N9-\[N(I+GL$PZT UF\-\[L]I,&QB8-:2IUKK
M\L_;*]*?LH*N7(^8/AQA?+$QW$.F.#'. <6F9) (!,8$@]2=KAGXYE_7_P#E
M?<7_ "X\+...D'_1Z=6<,W^2Z-):V(^^]J-*C\S?!;_,OY?>)>$J=GUB?J6F
M-EMDMM<7,I*F7"%_TD[;C,Q>^7\AG[6KY:.-?(WY@>(J?4N'*JBTJKUG5)S:
MHRR&;_CO<S><; TL)6>NFODWP]"_('SYXK\B>,](XIX=U.KHCIU2V>YE,]PW
MH3-\V--L5;URQ.V'T>:%^LJ>:>A>6M/P5)J=8F5%/0?563O"GQWA)W!!Y:!?
MM3U;_LO#7^0[[9#S;XO^8J@9K?$6J3I6LZW2[M%4SIA'AU-0QMC22V$7$*68
M;Z]LS#^F+\L7%<WCCR>X8XIG_E]5D-F3";S^(D._QUJ./;E_/I_67M0ERO,K
M5F39DMC14:C:][6_2VJ8VZSM^S#Y,?E+FLD^>O!;GN:T?7&@;Y#03X].8"-Y
M@%;PY]/Y/[ _V2<WQ?EWX==81^8-,M%H^"5B+%.K7R\O?6I_IE5_#3?Y0JHQ
MH.3)KY4R66.+??&] PB 0DN!TA\Z_P MVA?-CY+:SP%6T,BLGSM.KYLK?#-X
M.G4X8& DVDN9<K>&>F/;-X?R>_M1OLW/,[Y7O-[5I6E<#Z@>'9M97N^LTTDF
M6&MG$M=$D,W0#SK,TZ=YG<>AORZ?,WYF_+1QQ2:_H&M:KIXHW2_%H9<US2#)
MF-<&AC2(?#:"JYRV<OLC^2?]:;JN&.&=-X6\P)WBSJ"@DTKF:I)WXOE,:SQ&
M&<PAT#B"IG"_RK]()_ZTKY8RJ)M3XFB;V[$M,BG'^(F=9:GQS&<OSF^;C];&
MU6OT;5>&?+2GESYU?3&FWM,D,8V5O-@XS)DIC6ML,;3:F?;3/\:^<GC+CWYQ
MOM->+-8U*JD\3-X>(F/#2*L4_A/WGN-L&0+7*67JUF]]</S-\[O*'4_)KBF=
MPKK;B-4D/>)TI[HS!NV.<YI)</>6HQ9A]!?ZN-J3)OS0:5*:^6[=K].:1O#>
M$*AH@6WA8MO#IG6/#^JAQ!_J_3_\V/\ )R%VG#E_U(^M_P!A-1_S>?V@+'AK
M_JC^8+^LMZ@X>;=31C=W9NLRXP<(QESFS+!_P%.O+7R\R/PS^S]K)4CS_P"
MI?B2Q,/$= =QSP';IGR@" ;8%3M<'3A_9/\ D\=O_*UY>NST&0;/VDA=+_\
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M3TC*5OOMA#/I7YSM\TQ7V9UL[2J_K^H4S)<P;S1[A7Y+_9?D]>O:[?IO]?\
M';TSAZD<=ZA*?-F;I!L=W+Y/;\SX_3F/JSX>V7K%K<X.FNA ^\?0OB_/_L/C
MG?=CZOX_XO>S*JS'M ,8#D%Y;_L?BF\QT[_B][>%5U:?*:Q]HQP'.N';_;_#
MYL6?@_)VN,5034RW5! A\2UT_/\ C^?76S;5_$[?#,WPNVDC>$L@8B[G7JGX
M_;O,SAQ[?D]>EQ79VD2WD-AGW;5SOXO>$_+Z69R[(H'36,%AO'-RL7'_ +3M
M;A.WY?1,"KGL%\+,SL6>_P"-VZ,=OFZ]IS&5FK3&$1?"WM'M7GOP=KO#G/ED
MF<IRCUHQ;O/%WKYT_JLUY3M\D[+92ZLQP$7MN'=ZE/Z[EQRE6ZK+=9OM7?I^
MUR[2]YIM2ZP/(@X<BNG7M,Y/Z+A?^%]^94.(M'A.-G[4=R]OP_).KQ?+^+VM
M_P OQ.^T=>6FL83:9LP;3[Q@OD?G]_;OE^S_ -#\=^/X\6/9K[ :B\7YBN%Y
ML"85=*>JIE+Y5_EA^ME_;/T?UK.&+.&N'AEH>D_Z!3KHXWE.(@@(" @(.O?,
MGS*X4\L>%=8XIXFUO3=+I-*I7SW?7*J3+<YS02U@EN>'G>@<%+<+UF;A\%/V
MZ'V]PXBH=:\F_)OB*10U-&R;IKYVF.)=,>^863GE[7.<Z+;S&P;%F_N=?6=)
MM\2--*\R_F&X[EU6K3-3U_4-7U!OCU3FN>V7XS@"V6[=)N=M77I\?R=[.OQR
MVVO/\GS?'TE[_)VDD?5%]F!]FOH?!HT_CCC;2?'C4T]4954-XB#6.N>(QBOW
M7^C_ /'.UQ^1\\\^7X'_ 'O_ )+US?@^"S_#ZH.&-7X4X4T]FC\-2&:?);(E
M2@R6-UHW&PPYE^V[_'T^#X_Z^DQ</PW7Y/D^;Y/?Y+EV3I/$8F0,ZH$QUAWC
M@.07Q/E^/MVN:^K\?:=>NG:.C\2RV%H$X?",(]J\OR?%VP]'Q]LW+M'2>*I0
M#2:AN6'<OF]NMSA]+K\FHLL_BZG$HQJ&79#+F7#O\=QFNO3MYCKG7N-*-OB1
MJ&7&\#FR7D[_ !WF/5U[Y=4ZAYA44AQ=];E"QV+<%[OQ.EEQ7/Y-JE4>9U&]
MQ K)76W"(S7U_6QQ1KO,"DFN_I3#$X0(]%BQVZ7POMK%2U%Q/1SR!XS'1]O>
ML7K8Q9]%LIJFEJ6 AP,;1"&2\_?K;IGUOEAK*"1-82&@V=<.:"YV7%:E^KKC
M6M!E/WH2H^Z?2(KR]^6K,Z=6:KP\R5O/\*'Q&ZZPKE4LQ%/+13S=T B!/:3L
M7D[3>7+.:O/#]1[PB3<.SG7+O-9=9B?J[]X<U-LL2XN$( =?W%X^V%]EOU#6
MI3:<@/'P]RY]MPDSMZ_\:ZLR9XP#@;#VKS=NV*QG%^SUPUF8'S28QP]*Q>\O
M*R^6/3)$E[VQ%Y!](6/><)V^KLS2J"GA'=^]Y9+Z/PWKC$8LS%TDTTAC!9"R
M.&2]#'%4_B*?+ERWAIA:8=?1DDJVX>MG%VK"2^:-\"T[,$SA.L\NJ#K!?/'O
M@B^R/W%;VPN79.@5K9@9%U[AWK/7>UR[/HITHR[2+AM5[1+=-/5ITKP["+C@
M-BS-+)GJZPJIWXTP)AO.N*OM@D8'38PM)ARQ*U>TLTDF$;/=$8W8\Q6)-K;A
M$F3XKC9TA:DO5FSRYLH;?A-W<F;4LP3*<L!LAA$\T41$5#O"),<3S66JYUAJ
M5IFN(LWA9M4SC37C+C]>+OI ^E-Q+OAB,YS[S<LVICU82'''TE)2W+@=X8GK
M*TF/+FVH+,0(9]=ZLE_PN)8R-K]TB+A9W*6+,338;7"9>[ESJ+/LF*6=+WFG
M>%D>U$MPEG5,LR[[NXK6?5I2M=J);F3+0/==ZUK.'.S>72NMS6F80,CRNV+$
M^J7A4FR]YX=F?8LW>FI;ZX6/3K'#H]-JW-)-+Y05(E^[O >Z+[=J9^BVY6ZF
MJV[@!<,/2M<S)[89WSV'$7Q7.\LV[:;WMA#;V+7K5QE'3P+3RN"UURY7,TAY
MXB#S=Z=N7;KPAYXAU]@7/;64+-<8D>O)6=6+62F871 QMY=2MB><MF=3OW;C
MU;#M3&&[]41-EN83$&^]93F-<N<RT'%;FV,67;=E/+FV\KEG&*WVU,N9!<+!
M$GO4LO/AF;1=3)<(\OO=JLV9F<*[5,(#AM"N%FXKE1)+B;(W^O-9ML&BV2YK
MH\L59V+OA,4S#9=RCL2B6;+L!LNR3%PWRTZNE$QI$(D_<N4V8BKU.FPC[O*(
M6I?JS6BV@$1[IO&"B83E%2AA%ET+^OUJ<':Z3C6AHA 7# 8*6L9:<UV['H]2
M9SPZ=8BJAU_3CL*Z3C*VH.<8EW,?6E\?J1$U Y=06)&L:RC7-B;X605<V!P]
MT\L"NG68K729K4(M/.5ZNLP[69F&)QO&U=,923#5FCXNCU*X\-8\H^;CS#M6
M+HG*(GM-MN&W8F=-V(:?$1V6>@E9F<[X23"-F1LM..)6O4LSP\LEN-L8B SQ
M5N)$]:\F(,(W9*(VY,P@ 6F,<<ON+.++D;S'$P-N-D5T\):\S"=WK]2YV^&N
MF]HF<3O'I]:L.W#!>M.6,MJ3++OB%AS7+Y,8=OC^[2U"D&X2 383VKR9N76V
M>%&K)$(Q$(DWPYLMJ76UZHBXPV^M/"UG#PUO-'UKE9;69<-=[][.R*UOR6YK
M1<X'HBKU:R\!:J]9,O!L3P=M5C>X!IYCV%)8Q;EI.,;;K%JW#.$7/,+>5H"D
MN2_1%N]_9Z<TK75B9>>92S+6HWI(C#FY=B2>L<^6=XB"-GM7#Y>'L_'N;A7:
MT0-^(]"\[W_]24X8_IX_X/X2L=9P_;+Y,OZ7I?\  R^P*.L?5;\K/^J](_@6
MKG>:]7Q</TATO^C2N?UIW>GIRFVX\WK"QV_B]'3E#5GQ'F/:KUX>N(6N_('I
M['*5+RI;V^^3''L*EOASO(LH(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @("#-(_*-04SSM_N]G_P$[^3<G7^2=N'Q9_:"_P!,UO\ M&I_
M">O5X?.[OEP\^'?]J:G9^_N]:SASG2\O2O5WPG3+,#CMYE<82Z0X,5.JRY92
MR#8Q6F_5C1'F, BSM>&,S",[LUF\EGAK$Q6FI,,#G;T-FV*@Q*L.;;;-BETN
M7DM@IE907CG':JK:;=TK-9O+;E-C&V'1E]U:;QY;;#$PY<K4L8SENM;&&%BD
MESM+,329I6[>4(+>6.TQM(8*>7'MPXHP("#,S%1TPV0R&WH6;<CQ, #+AU;%
M8MB'/Q](]2WE&Y*,-WI]:SA/;#9%XYT5R<8PZ5),+9@:0(Q2S*-N2^!%E^W8
M5)]&Y;4Q*?\ #RQ(5R>N?^$S3'> ^[@ NO7Z.>LX2#6B NZMJZ1+UVU9\LP@
M+8[,H*\3+4U,H6?)<2;+SLVCM3+4MS]F!DAS3%3E;<I20P@6Y=Z7Z.5;6"EX
M6-&IN,.5I4;\(>+@;S?F5KPQG%RD)4UPLCR,5)MN3.TQ35#AZ,-HVIAGMI-R
M:EQ'0,-G.KPD_=<)24[?[^ON4KIUN&VRG+C:"01A!3A.V*S,H(O!W3?%6;VD
M[8F%NTV6R2VVP@"_#NO5_P#9E8!.E@#WAR*,XWENMJ9;1",45PFUDH-M(&-O
M;Z45!5>J2I8)WQ<>R&/,LWZ1G.%3JM<8"1OBYV>W:M3A4+,UMKG'WQB,<SM4
MMQI4)7ZX +)@%L+.?;%9EVQ)<85&JXA>'. G8\LEO[-R80%5Q%, ="=>#VJ6
M99LS<*G7ZU,F1_&1LOLQZ(WJW4:DTJ=56S7VQ[<QSYJ9W@L1CIDQ]@MB<+^M
M22P\-F1(FO(L.>=]BU+EFRU8*+2YLR8T%AMW3UGF1O.L.R-)X<+FLC)), >N
MU&;9.79&C\-!QEQD$&!]:69X9SEVOH_#3 V7^)^D<-A4QG3,GEV#1\/2VMME
M9<KTQB%^J1.DRF @2[@>R.:GK<99RBJF@:TV-(MAASX+<L\KXRB)E.T$GUG
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MH\S-6H3K5#K<JB-53B;*F-,IKF%[2\.W9;"6D&T*_HS?C]:^Q+[.G[!3RO\
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M7KM<7F+B1M[2BN" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW:LX=,S#=%(3;9;S]ZWUPPQOI3#FCRO3MIOK$)4RW,QN'+M24MV@ZFI<R,#
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M:;_R^67SZGM;J>IVC^D.OYUKV\.?;[/275J@/G/ (N-W/UK-[.=:M,Z$#'E
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MU!R A8$! 0$!!QW&G ( 8T6@(.2 @(! -Z@X[C<NU W&Y=JH\@ 7!0>500$
M@&PH..XW+M4#<;EZ2J&XS[T(9>0UHN"#R@(" @(" @(" @(! -Z#CX;/O0HN
M:Y  7*H(" @(.)8TWB* &-%H$$') 0$!!X+6F\*#QN-&':J.2 @(" @X[C<N
MU!Y#0+@@\H"#P6M-XB@\;C1@@Y(" @("#P6M-XBH/&XW+M5#<;EVH&XS[T*&
M:Y 0L"H("#P0#>%!XW&?>A#-<KK J" @("#B6--X4'D-:+A!4>4! 0$! 0$!
M (!L*#CN-R[5 W&Y>DJCR&M%P4'E4>"T&\10>-QGWH4,UR A8%00$! 0<=QN
M2AEY#6BX05'E 0$! 0<=QGWH0R;C<NU W&Y=J!N-R[4'*Y 0$! 0$! 0$! 0
M$'$L:;Q% W&?>A#)N-R])0-QGWH0RY(" @(" @X[C<NU0-QN7:J&XW+M0-QN
M7:H.0$+ J" @(! -Z@X[C/O0AFN0 %@5! 0$!!X+6F\(/ 8T7!0<E00$"^PH
M..XS[T*&:;C<NU4>0UHN$$'E!X+0;P@\;C<NU!R0$! 0$!!Q+6FTB*!N-R[4
M#<;EVH/(:T7""#R@X[C3@% #&BT!4<D!!X+0;Q%!XW&Y=J@Y*@@(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @("
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M Y<Z^5>]]K^K6G:VC5#")5N'J.U;G=?;PO$B>-T77Y>U:G:YF.'7KNIF5-)
MAZ]N17W/PK+'7IU[2N<U[]T^U?7ZMWAU_KI>X6Q^E@5]W\/KULV]'Q1TAQ!3
MM.^7 6N[8[%]"].N-8=;USV=8U%/(,XM@RUUM@S7S_D^+I>V\/;\73K9FIV@
MX?D3PW=:SW@#\(^ZO-\_Q=)\=K'S=.N%CIN%F,+7;K;"/H^P+\=^;_.R/D]L
M2K'1Z8V1  "PVV8QBO+FS;R?D2>NECEM<QI RPY9KEV^7MQ'YOY=]U6XAKGT
MTDNC@<87 +]'_HODS\TE?._*S.N8]9.+^.C0MF$N-CG#XX7&*_J7Q=>EZ3]'
MPNWR=L[>GW'OG))E&H89ESR/RN$5_1O_ !+XNG:]7C^;Y.SU0XH\RY>J&H:'
MD[T?IQV>M?V#X_Q?C].O#YW?Y.UM>NG$\\U[IKHD[P/7:OO?Z_\ &^/,SAP^
M3M>W#J&NTMQ?O6W8C:5^AOP?%.GC#GWSC$Y:DK3V-,'!M^(P*_&?[?KUZ]OV
MN,N\5OLTZ0]PB&0-ALCDOSGSV_TW#I.O7_+=;I5.0(;O4-O>OYA_NOF^7KWO
MKSEC.+AE--*I1OG=W1$Q@,?1@OG_ .L_(^7M^1)VRSWMG7*.J>,:&@!8YS(M
MB/B ,1!?V[_3=?;X.N?H^/\ -\MS4&[S'HXF#VXV[X]2^G^1TZS4<>O?;?IN
M/J6>YK=]IB?OQM7S+TN;]&?[I-.P='UNFJ0#%ML/I"-J\WSRSKEZ.EZ]IGR[
M,TV?(?"!;;;AS^M?)[=K'6]=9KL'3*ZGIX$PC#,9=Z^=^5VN-OJ?@X7ZAXQI
MJ8-;O"P0^(#J7R?;GZ/M3URVJ[C>1.ED-=A#XN?F@OC?G;R_0?ZZS6'5G$G$
M,F<V8"08MA:=B^-WD];A]R3>7K_K\R3533"%OM7Y+_8])[;?H/P9VG6*[1</
M_6IGNM'Q?>Y\R^%\WQ]/3_#['3^6W:NE<!S)L@.#/HQ^#EBOPG^SZ]?[,3C+
MZ_P7MZX<=1\N)TR60&7Q^AL7P/GZ=;TT]76V7;KRO\HI]1,<!+OB?R6:_(?F
M:[5Z^EO^$YPYY%5+YTIW@_$[_)<^Q?H/_%[G\GIGZOB?[ZV?C]\?1[(<,^1D
MZGERG.E7$&V5RS7^I/\ 2_'UOX77+_/G^T[]_P#NK]';NF^6WU 1<QH@8_!#
M+U+U?/TZ>V(X_!\O?$C>K-.D4,O=<&V QL @0O%>G7GR^C._?'E0Z^=3N)'N
MFTX+P?D=)A[OQ[VS]D0S0)>HF#6M,2(^Z#LBO!.G61]2=^S>'E.^N&\V6#O6
MC\6"OG?E3KG%?0_$[]M-&H\BZAWO>$,_R?L7S_7K<OHS/*'G>43J-I#Y8L%O
MXO)?-_)D\/9\5PI^K>7;I;7%K(6?>=W,O%V=<UU_JO"E112)C@UT!3S?HD?1
M/<O'\EL9G>WMA\W_ ,]E41QFZD<3O?7)I@?V)<OF?+VS</W?^HZX^'+](/L8
M/G'X!^6CBK3J[BZHD2&2#+WC-G-E?#-:;W?M5Y;G.8_1=;)UDK[K]#_6 ?E5
M9P_H,EVL:=]8ET,F5/'YPDQ!ERVL$;?V*O6WRQCJO&G?;X_*C/#-_5]-MSU&
M3FI+9RS9UBZ4GV['RC5&Z':UI[22 8:E('4#%6=OJGK.5NH?MN_D[JH"9Q'3
MLB0(MU6DLCL,LJY7TU]UQHOME?DQJ_CXVIY LM-=1O\ 6Q7VE9];G"P2/M=_
MDQJ+)?F!3$V?\XH\?_;ID]:G:;[57Y1*N'@\=TQWA$?SBC_]\F8OIVJQTOVE
MORLU8:9/&M,X.$1_.*3G_P JI[3@].SJWSW\[_DA^:CRYUW@WC_6-!U6FF:7
MJ$NA=7NH9DV7.?3O,MC'N<\EAFP,,#:+REQ5G7O*_FD?:^?)MP/Y5^9G$7$'
ME5*I1PY-J)E53&D$H2S+WR8#P_=@6*2_\-_)UDZY\OS9^5[YD=>\GN*J)DZH
MG#363I!F!TY[0T2Y@#MX&R$%]3_6?[#Y?]?\T^3X[>7P_P#;?ZWXO]C\%Z=Y
MO%?5)Y#^?/#/G!PI*JZ6=(?7/IZ?]^:YV\YAZ8Q7][_\>_W/XW^S_'].UG][
M^!_[[_3?E?ZS\CVDO].?_M=T^)5:9/:'EP!@1!UD">Y?L^GXLZ3>.'Y#O^7>
M]_:O&E\4F2UD7.L C[QP^XN_7XOCLWAB?)\DNLINHX_;+E$%Y@/V95GP?%]B
M_+\N?+JCBKCYM0R<UKS&!'QQP7/M^-TLMTWU^?Y<XV]7^+M3FZ@^9N%_O B\
MF^*\M_&^/V\/?/G^3UVZYH]*J9DX.._\4<<25]+\+\;XYVUAX/R/R/EF]X=I
MZ+H4XM%AC8;LNI?H/^V^/&\8?)_[KY<\W*\2M)FRFM)!C#N7R_G_ !_BSXP]
M7P_E_/Q<K'I%7-HY[([P   M_9+Q=O@^*2\/7_W'R9\O:WR[XQ%,ZF#W?"!'
MWE^=_.^+IGQE]3\7YOD>[_!7F-)9)D O&'T]J^/\GQ=)+E[NGS]K<;T[EH^.
MI-2V&\+?V6<(+\Q^9UZ]>V8^O^/\O;'V3>GZ]+J)X ,1$#XHX+YOS27H]G3Y
M.V?N[>TB9+FRHV7 \NM?F_R.L]WU/BML7>AEM.Z !<.6*\'R]?VO3U[=I4Y]
M3:X"(%L#=%?)[3;W];GKFJ;Q%IC/">1"/-MYUSN^727#UPXNH=TSX 0 *\]=
M,O7S7*6#G6"XY;=BY=YETZ3%_P J-,DAIM'(="YX\.UW,MB1(<;6BR'=L7T?
MQYB_Y<K$[*:]HML@.BY>VZB7C[O,\QEF."DN_LSSNNNM<8U[9EUYY7%;U>$M
MVZ7UBE/B/+1AAUY)J<K,*U*IYH?C8<]O-M3+-VNND2Y@+8QPS6=59'8-(V %
M@C"'I]J-XQ5EHG-:X$PP4MUAFS-TM,F?)W6[Q;T\YCBL[E:Q$=JDZ46D,AU;
M0%9WSRGJI=5-BZ . /K]:U]TD:4O?)M!Y;(JY2R3AYFQW3?R!4G)O"MUH:(W
M7E4:<M[!EG=VJ6.7;KO+::YM\1>I,9PS;BZ;+9X:(1&'*\+5F"UY=6!MY-^U
M69O":\H^?J+;;3<1?F!W*>EB^%:K*O?L!,(0Z?1:I$GW5JIEEX(&WU\Z7[-:
M<:*E(?$C'ILMR5D-+!NM %@L'K73KB3:=LU ZK,&XZ!N[USLR69CKROF>\03
M#[O.IPS[>&A*<TN'1VA.M-5V!HS6EK8PA9ELBNEN\DD66;(:9?NY6PYCL6:W
M=12]2D;KHC;'MRV++");,\+>!S[^97-&,5<#>3RYRG;"R5(TNI-8YHZ;3S*=
MOLBPRM6&Z+;AGMYDQ$DN61^I,>VTF)V[,U<:TW>&F:L%UALB,?:I<XPF=-R1
M,:XQCR@>=26QJ)RFJ62Q?U69W+?6WR6-F=J;-T]\,]J7AFSS4'4:D#;'TY06
M),IVGT:3:YL1$^E:VF(WY-6TPAM6>>722>&\*H;MD;L%N2,V7/V:LVHB8F[;
MAZ0LW[-:PCILR5,LLCZ[.=6?5SMWA&3I376C,^O85JQ)$7-DMR%_+!2S/#76
M2W:&GL$2(7=P6.&O;%PA:AI$;#RB$C?**FL=[UE^W9!;M9J)G@@GF[@L^4F$
M9,G.:Z$>WU*Z9N?"8TYY?NQ,?98ELRN+Y60,  L%PQ"RWZY"P' >A)3UQPAJ
MR3:87>V&2UG+''ZJK5RGX1^(PY"Q0R@G2YF_?B,3LV+7KF9,I"53.LB/3[%S
ML6=I=7Z))E(2!9ERN73XL2M<;\.;*>TB%P[.8+W=9B9=+<,W@[HMPA9R 6KC
MB<K]VA4M& Y6ICZMS&%0U"623 9]A4TS<6*56RG^]"-^9SYE,L^B!?)F$_2Z
MS?U*:67UTX"0X8GK/<M3KMO,C?D2'V0C<,=AV*W]I>VFX*9Q-QY="Q.UKGBV
M[;#*< "(M]/8K>UX\-SK&3<+<+MJG+69*\%X%Y'+I3!>^FC-F[8V'+E9!7.(
MQZ^W9'F>8FW$W?=4;]=-*?5[H/.<1F-JY=I:28V@*NJWA?\ 1/*]<,.N9A5J
MMT8V\K8]BSLF4!- B>6*M,[QX<&M!%V*Q>2S+:DAMN]#E!+?$.NN6V&-Y^I5
MTQ*&79$#L5D8[28TTID&QC#-8K/7/E&SG-.]</NK4=-81\PC,7#M5SC3%1<T
MQ,.6'<F,\I))<WE'3H60Q]JSBI?I48^-G3ZE<4SAA>3#&]62^3-<FO<!:2!
MYY+S?D</7\'6RYJ U%Y)O-^W!?.MN<>'OD2G"A/U]MIO;C^R5\.G5^XWR5_T
MO3(_Y"5^ U)RW>7U=_*G;I.DQ_R0]$8*W3V?#;QX?I+I?Y"7S^LI/#U]$^\%
MS(#+U*=OJ]$0;Y;O%-EMG;UKG+EO.L%=+ HSO"W=_P 5:EL9G+K*HLFNA]\?
M1<NK3PL*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#-
M(_*-04WSK_N_G_P$[^1<B=OXOBP^T-_I.N?VA4_A/4\OG]N?_K[OE.^8%Q&J
MZI_G#NU;9\6O2>N<?K#K5>SS^7.2_P!T0/HZL$Z\;;ZUME_NWY+I+MVF;?LX
M%YA?9RZ5O,J6673 XB)MY04N%S]>7$N$#;;"Q%Y8K3M3*:CS[NSK4VF:.,!8
M1VI)O:,1MO4\G/+R%J<$Y<V_$.=&VX#DI-7;.XW6&P\Z6_1)JLP)"K>&=CH7
MG +&<Z9S9KPX/F1) .7+K4ZRR[X7/U8HY&WG725+)XY9I3R( G'G6>V;PU)]
M6\Q^W'+FV+76?5GMU^C>EO:+B+^Y.V;PQB9PS&8,".I)IN]?H\>*1C'H^XKE
M+USR\.FD@VGETJY2=)UVU[W)X3GM]F9@,1",+>Q9RZXC=%XYPD/#*JYMB4 7
M6HWVX3M(UHA8+SVCN69-LK+(#=W#E%74:C2K"03"[9TKIU^KG\GK)]VG+>X$
M6XKI.'*3+::2>>*<I9MF;O6^Q7$G*22<L^Z<(]![EC5;U3<><\[RKZQBS+P9
M#S>3U]X5XTG&GCZNYMN6T=R*R-8ZZ&*E9LS6TRF>[#&SE!,3AJ3&XW9=$\QL
MO(A?[,U2UO-HW-O&6SMBI6NKPZ2Y@)$8W6<XV)E<8:;WS&9B_.[K22<L6_1I
MOJWAQ$7=</6K8U.&E4:INB$;>?FZE,8+)A6JS5?BA^QQY]BK'Z*W5:H27;2?
MI;/8L:)GRK]371#H$VB M"U;]%5^=-<]Q,;,$VQWX:TN67OQO]?3@M7.&8GJ
M.B<XBS#+%8FDMPME)ICGBT960V="OMEC.:L='H@):89FX;%KVK':K')T8!HL
MN&0V*9^CG>V&P[2V@#]SWI<4S;QRYRM.$1 8CZ.U7&F?>\>5NTW3KC#K"SF\
M)[5V+IU,U@ @.BS'FS5QEF][G2V4Q8R!LPRRMR5G)G,^Z>EZI)EM#8CKAU;%
MUDUM)<,$[5Y<#:,86^Q:6YSI!S]4).,.?FYE+)>4EOAJ,K7N(M=#GVHU>U_R
ML5%/)W8V>\.5^Q3$3[^5@EO:6",+<^89JX7WQI@J)[ V_E$)B,YN5<JJH-<0
MV["'(I@[9O#Q3U9+A??"[9T)^BSM<?N6J@F@EL3B<.]2PSGA:Z68R MRRVC-
M:QAC=J5#6O%D(P]7M19+E@?3N+B0##83W*:+VQIY923"18;^6"5KK=%12/\
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M3PI)9,>V(%KFW@9@+Y'R_A7T_P /=_WV.SVLX8TV2^G:/#9\#, OQ/\ L?\
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M3A8F_".96S+O$2_\N>CM7/CA6/4OZ*?VI[ K".K:G\H[]L[U+K&WA8! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09I'Y1J"F^=?]W\_
M^ G?R+D3M_%\6'VAO])US^T*G\)ZGE\_OS_]?=\IGS!?ZUU3_.'?A+HSXKTG
MKOR[E>SS^7B3=T#UJ2VKUY9O$P)%BWB\O3UM"^R%BUXSY9M_=EP)&)"FT>(
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M %O3YIM\WY?]O\G2X\.X= ^SRX=U%C7NI*.T[OY-FS8O3_\ @3X[VQKES_\
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MDF9GRD*2C?-(!^E!&=IQNE0;%S!;B0.=7&6NJ,K:-DG  VFRS'&',H=E<F3
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M(+=XFXX@60.%JTRN]%J :&^\;\-D=BN$MQPM5+JH@!O8;=NS8L_Q<[NMMVJ
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MN@MA<+LNY>+Y?F];AJ=L.U=+U3ZHQA\3=@!V+GT_*SV7.>$E7\:OD2'@5!$
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MU(^9A'E9?!+=-;D;NGZ<[?M8+QD%F_9)O:R3*3=EV"%PL![BK)IO.L(*KD
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M>9H^+'/:%RNCV;K:'Q!$BV.7/FKX27%RUIVF;H/NC/#U+4[20QG:%J)#& V
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M" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @("
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M" @(" @S2/RC4%-\Z_[OY_\  3OY%R)V_B^+#[0W^DZY_:%3^$]3R^?WY_\
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MP7"6E 3))+3$36DW9A1VDS7Z0?+'(,K7I#80 J*>_P#;*YRZ]=<OJY^6X?\
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M5Y:D[A9DX1#2;23!JN9EK&E9K>$  ?<=B/AYX8)9EF56:CA!F\8L.(N6&O\
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MNUQ,>3&-^5&U73' N]TWGM7.4ZW>W7NITIE;]AO="R$(?<6X7*(I*KPY[;1
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M#=O]TYD),>5F?*!K:5X:X$.B!&T;2$++5%U&66NL&'>?4DY9SA'4Q=O-OO\
M6M]K]%J\:5-(LMP[=BP37Z+U2 S&1-MF?M4MQ&.V+=-B9*$+<CZ%)VRS8@JN
M4/>NQY7+28JEZA)(WB+;.5P2S#*I5,MX<;#>?4I2?=ADRW%XB.N.:OAK5TM%
M!)82-Z$( VGF[DFN7/BX9=2E2VRCN0)A@?N+6FIRK5'$3C&(][UK/Z+VBT%[
M#)$2+L?VL5<6.6*IFMM:6NA#KY^]9Y='657):Y^7IN)SYUFR^#++1TXN%T1A
MLYE9+Y9]KG"^:?3 @ QNRM[%<UN93;:4M(L,.;H5SI<_1N27-8\1L]JS,^6;
MPL<J=*W!$BY6TZYB*U&9++7VBX9+7/">77-<UQFQ;=;='/8KJ3;6L-O36$$$
MWB&)699G"9MU'8= 60 <1<M7@QO*1FRV/$+.OF7/;7[<J%KU)*(=SY; M=4N
M+77\VC87F SRS4\K;AC;2RP>C(*^K-[5MR9;&NA9ACL)V+7K)M-U+2FLLNL&
M>T(MLQAS>0T67J6_\)ZYTA*F:8$1-V0V+*R85^>]Q+K<SZ%&IMHF8X8J^Q;(
M&<39$\NE9RQU[8NWC?.95=/:,3]XBR)]*>=LXN<M">V:1<8*Z\+<JU6,?!WN
MGD2M2S+'E7)\HESHC/,8*][]&YBQK-D-,8]_:N7L62<,$RD!MVG+%=.MEGW8
MPQMHV;PL..&Q+C!E(T]$/=@'<B-N2D58*6BNL=<WM5M]8U.&\ZBL)MZDEEC.
M=[1DZD !B#8"/AV+&-MZJ$J:<MB6@V1PAB<EOIRUUT@YY()$39WA>WX\XSX;
MX14TDQMN<KQ1@!$;QUI5G+F)K6V1$;?2I*U>MN_#R)T+W=G>MV.;6FS26PB<
M>SVK"R(8N?XHOA'+:5N[FCA<=(F^X(Y8CGR6/7M%]L)"IFDQ@<#ERN6XQC>5
M=JG.(ORPVE9K>-Z5:KWHX_$<U&Y,3%5^IWK?BPSV+I)/&&+RB7,)O!M6;JX7
MM)6JZ41]&_8?6%&++X9Y$LM=&"Y=YB.G3423GN#;#R[5Y,S+MX:KYQ@8[/5M
M4N[I)/+#X@-L8;+?N*R8F&J\A[2+3'J6>TN=)^B/J@V!NQVX%=.O"2ZVKE9N
M[KK!U;2F\KF*M.)WKSR 1FM%TV!(MOO].:#(R9$"^-OKVJC)$YE2\##-NY;%
MSG+75#U./3_C+?*XBOU(!W[KMF94T95^J:R)NZ^;:M1BSR@*G)N4;.;/I7E^
M;A[?@L1)COVW[WK7@MGA[>7:7 G]-;_P>U1UZ\/WF^2J'UO2HP_H\N_F:K-+
M;M]5_P KX;^:M)N_)"[IR3,>[X>V)I^A=!_1V<L2N5N]/5?"?DW=7K7?_IC?
M3PS$@")6>'5#ZL0ZG)%T'+$Y:CJNI_*._;.]2ZQIX6 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@IOG7_=_/_@)W\BY$[?Q?
M%A]H;_2=<_M"I_">IY?/[\__ %]WRF?,%_K75/\ .'?A+HSXKTGKOR[E>SS^
M6K,^!O,/4LS;4:P:8VBSH76;TZ7C3,! +>"<;<A"SG4K6L?=F%B3A'D*U>KG
M$YJ8C6(\@CZ7IM4L^AJ,9O,%J,5Y:8$$\K$O",MXLQ6.%8R(+3<N7-I C%2Y
M\+ISM%Q66+'B)S51Q<3"\]:L6<N;'"R)M^ZJU>&[*<T;L3GZUISX;C71M!67
M33;EO!!M-_<N=S%U&3><,3V]JKFY;SLTVW.'EI.]>59-I>$A(==$YWK6-N=M
M2DDMB+1Z,E:Z3%;T0<BL;3;'-%T K"7ZM*8#98<<.9;9>&-=&XW<V(6>VHK:
M:TBTC#-(U<XTU9TPM)ZNU=>L<N]TXRIQ)A;?&X<L%MQREI,TMA'/UK-N*<U(
M,J@! [O7L"N;>6XXNK8"]O7WJWAJXPBZG42/I0YC^U[U.O);,:1$W5#!T"+S
MCSC/-;MG#$F-HNHU-\#$B%F.P[5BXC2"FUCGDPMC'':G,9MF/NU)LYSL[0;K
M?2L\5,U@W)AM(/.M:3&6W(D.>YH@<.P+._#4BTZ?IQ<![IOAU>I)G+57;3]*
M)<(MA=:.9:3.-K92Z3!\;8"%D!"^")JQ>*&@#)8B"+,N>"K-FVS,I6M/1D.?
M:@R-\)OWHY#N4N?#-K8\6 O!Y<ZN96<YVQ/F;P-]O5VJ8LX&)H?O1@81LLVJ
M35^Z=M1,4CA$ G "WHBM5RSO*0FSRUONFV!]2SB5K.4=];F"_GM6M^'*Y8'U
MILNLCR]"SPY;FF!L][S"'5$\KD:ME3E"]Q<(Q%V"S=)]U^TV: &AQQ ] *Z=
M;DE6R2^66PLMYL@5+G#GVF9]W)S)3LN5GJ5ZW!U[8F*UR)48>[UKO+*ERRM9
M&Z"K.<W#()#G8>B/;!#&'EE,YK@8'I'<B-Z6"V$;P/7M4;MUHG37-%^ ]!CZ
MDM27"I:E/<281O.>1&>U3AKEBTZ?,:X0!].9BG)G3L'3*I^ZTN[=IQ6F,V58
MVUHW;VPVE2M2:WR@:ZH;,)M&/+TJEF-1%LE![@0!?RV*+?JL5%)E@ NA&R^&
M$#DKCZ,929ETY! A<>SF4;U4/7T$M[7$"RVX?=1+<<*A.HI0>8BT;-L5IC,;
M5/22[ 80@5FL=KGA*"CE8 79!,98Q?\ +*VCEV6>@*^,+;K$Y;$N0UA$,;,N
MQ-,S7*7IQ:,ONIK#6=)Z5O!H ]2S;$S496AKC!\.G):FB6>6O)E@D;D,;MBN
MBXPFZ=CQGZ=HRVK*-P;VWTJ-ZP\&SXO2KFFD;45+6Q@1<;]G-M1BM!U=NCW2
M.@IC;?63EXE54UQB >4"K4[</%;43A+=$&.Z8WY&">'.=?JI-:^8]P'O>G#V
MK.<KF-B@870!!C9G?&VY4MTN-)2-< "#<,-L%6/_ '2[=+:ZYO4.62ETW.V)
MCRE:31F$C>!NB+.E3-MTS%JI]'E,EDN'6(+4X+C&D!J%/(D3"!"^'41DKDS7
MFD;*(!LO;CLZU)9P?JFA(DEHNRO]*IY:4^CDO,+"8G 8W=JRU;)PC)NE-,2!
MA@!;9S(D[^$7449E@P!ZN=6Z3-RK%<^?+B&[T0.78EBRHZDJ:ATT!\86;<;4
MYU#..5\TQX;NF-L1VQQ3U^KG[;UPOU#-86C>(M RQB%*EW6Q/DR)@),.4%9-
M-R:0TRAE;T6@=', I;%QM(T3&RR!D+\8]'.I;O2:\K?I[PX@$V1QL6MF(M+J
M*3,DQ.['=V9'N69OME.TUI1-4HI0>Z MA[<UOPS-7:M.I&;]@Q]JFRI6ADM8
M^V%D-F05LS$76F,EK&1W;F^BQ3KIK=8ZN;+#/=(NV>LY+<W$QBJK5U18XP.V
M/W%G"\S#2E:E-:3;AR[5GBDF'.9J,U[2(GK.1Y\TMC<QG-0U5-FO!C&_;C$H
MU>,H]LI[[2#>F6&TV6\-)(QV\V2HT:J9NB$86'K"F\KE7)DS>F7WV=26-9TL
M>D,#RP'[[N29RSY=ET\MC) <V_=]5BEL=,?17J^NG27&!,(G-688N5.KM0,Z
MQQ$+08[;.?%5%7J:"35M<# DG9B(*-22\(G]$9$PDAIMM@ ,>A.349&\-?5A
M%C76"-R73,PPS!/IH@!PQRQ3?AJV>$6_5JD. !=\0'H]B)+;IV5PU6&<T>(;
M8 VWW6XK5_B\_?E;*PRR!=<;EB6N6(KD\R]\Y=*U-PX2E&9'N_#&SKO[$/NL
M&\P2R 1<(<_(*W"VH&H(+[+;3=UK,6[B7T7>$UL8@;S3T1@J=9BNYM,G,;+;
M:"6MMN@I=+9F82CZAFZ?AML4SGAGUQ]57U2:7-=NGJY1Q6]1J1UGJQFDO^+'
ML4N^3,5F4QSI@!!R,8W7*))F[X7K1Z.60-X6_<A<<DWX2Q>)%$P-B,HV;(*6
M+C3B&%E1 87=:WUNMG$=MZ UCJ81A\.S8/6I<-])F(G7I;!O0@8\V6Q2;9[3
M'9UK620Y[H"R.W+*Y7MRU,>N$8ZG!%V.0/8$L3CAHSY&[& QQ!V=ZDOU67ZO
M%/+@\1 O2\EYTOVCSI;'@DC#+(*Y,R;JYSFTE7+@=T^[LV=RSG&EUV4/6>'Y
M$W>=+:(DX 7CHS5C"HMT%\F:#NN$#&Z^!.Q;U2<_9V9PQ*;3F5O7!PO]-ZS6
MM.\=)G,,L '#9D(IASO;.F>M ?&XB'?DLV[=NMDFU9F4LHS+;HX\Y5PQ>VW&
M?I\EU.XMA&W+:KBP]L.OJZD+*AQ:#8[+-9NF;VTF-.FS6!@MLLN/./0ELJ>M
M_P +E2%T\ ''VJXQPN?"3-#+(^&TXP'J19?JT9S'T\=P'&&&SM4QMGE@9J%2
M3 QA:,<!!:NMFIRF*>2VJAXEY$;>92[C4PR5.E298BT"-F &*DF.5EGA 3Y&
M[$ 8GUJZC-GT0=3)>XFPP/W"IG-7.)A7Y^G[\8@WQ,>CO6DN<Y1KM-I8D.W>
MF%_4KGPF\-&KTJE<PP#;(Y9#8LV[68PZUUS2F@.+6V1.%F>2N,[7.)MUK.I7
M4\^-H]X>@Q43,RLM%4N#&M& @.FWK52_9+,=,<3?=RO3-C><QCGN>QI+HBSU
M=2SG;-MRA'UC 2#NFWMCW+3->65#'D$0'-U)?H>K=:TONM69/JK7GTY:TN(/
M-"RXK6,M2JY4:C-HY@W3"!&>Q#,X6S2>)IAEMBZ,6[3GM1FX\-ZLUI[VD;UL
M#BEULF.50FU\Q\Z^(CWJ:Y7&\^%KTJJB&Q(MABLY3'E<6SI1EP)%QY=:U*N;
M9A UHE'>N^+-+2:Y0;/#+R!"\[,?8K-M>8S31NLBVQ5UO".-3,:890M]*FY=
M)%@TJK+W0<1>,>FSJ5NFK978='12:EC0_=M RR6-\LR(_5.&J5["8-B03ALZ
M$E\WAUU)]W2_$W#\F4)A:W$W#V+66,6\\.D-8IC3S7!H(@>X\RMX9G.(Q4-1
M,86"VPVDK-S*>5YT_4=T"+KB!?BM+K&N5LE:FTL%HC;BL7DXF+RQS=0+K&G9
MV*R19PUQ4/)C;&.$3ZUIA)4]3-!A; &%IA98EQY69\)R56$-PCRS6,;7=9C5
M/F"#?1[$W%M^C@9LP")!]/>F:RV::H>#W]&U)F\M3A;:*J$ '$7!7'GR9_Y;
M4^HE^&;0EMC.^RG:C56O@1CC#%259,16S4Q-IY=*9OA/*3IGM,+1Z,RERU.O
ME8*5S@1",.8\ZU%[7'"RTU<YEYA=CMBLV)C66S,U4-:07",$PD0=5JL=X BT
MCT=*O3G?T6WS$>S4'%PM](S"Z6YF$NYI+2=0?  G 8C)<Y/+/68J29J#X7^D
M+?%:[8RPU&I$-(WA]P%+/).%<JJETV-N>W!<NTF-)UU47$@PVA3KG&:[8TE:
M:H$MMXCSPO6Y?^'*YSMKUNIEK'@&WGR)CB%*UC6:Z]U+4YSGN@3?MSYU>DVS
MVN]-.BK9SG@F/3',]RK2WF:YU,2(Q@K$LM=4<3F<6. WH^]V]RK.+(Z?FMG"
M<Z,8[WKYE,-3M.'8G#,?$E[UT!?L 4P7$V[IIFL=3RS85/)S47J,IS02T'T\
MH*]IB,^4'+=.:_&$>P[-BEQ@3]+.G[81VY+,MG"[_P .4WQ)CC$$W+4OU<^V
MTS020 (C+-2RVN?6Q)S9$M\LB%JLQ(O;-5R?IP+R0W$F[EDG+/#?T[3!O,);
M<[UI,<-<33LK3Z24V7 P%HR[T68QM*3Y$C<A9;!6)JZ\JO5^%(<2"/B)]'L5
MME/6Y0L^O?: >H\RSP?J@ZFOFB-IY"*;M+?IPBIE<\P-N/J5Q$DRR2*A\P@=
M^&Q"_3RL%))\6 (.$+-J"P2-&;,@2# PLAM";K4^K>F</RA++]W#+8EC/EUS
MKLEM,YS6V6D=2F<._7&-J0Z+IAA:"X>E+?H+3HU."Z439$VCI*F<\\&<?H[G
MTFFE"2TF%T<,0M6-<FIR &.+;1ND\H7JW@L=?50FMFF$1;Z#'I7+U_Y7]5BT
M1TXO$8V *YLGV28YB_EDQ[(&)L%XYE,+[->7((C$7YV*YK-NT5J'N@C9AMM6
M^&IOEH4Q >R)Q:K&;CP['TR9*,D@D6MQAM4LC772@<8R)<P. A<XV;3[%C>3
MMB/5?B'2M^J=>!O$V#:=FU7PS.,M[A_2F-G-<X6 7F'K&*U&H]@- IZ1DJ4/
M<B&B^&Q.8+>V7)W3N[N>&7,L]=<M=K,(:NII;@[:,+>5ZUVN9F.4YRJ4W3 ^
M8+,<L[NU9DN,M9FTSIFF-EN!(LBWLM5AJNR-.<R0T0@+(>@*WZIC::F:F9;(
M B%O=FL];E9J*'KM:VHW@XC9Z%KL9TIC6L:XN]W&%MM\5KKVC.V[*J!=$7#$
M;5+N_9<8Y92Z7,O()/W4LUA+?^&K-H9,T6@71%@Q C;:LXL&B[2*6-H;Z.5Z
MLRUB8<Y>DTGWK;]BG:;7$>:C1I1EQ:+8&X1P3,ND]MX5>9I6Y.N]WFQC$V<R
MN%QY;TND8QK<"!DEN#ELPW0(7^S:L\U=3GAO4TTB$2<,!L6OLY]L>$XR8"RT
MW@7P& 2\DF=JIKD"R9#,J7E>WV="<1;_ ([Q;CA^R2Z3E+<+2M]\H$0B;>N"
MSC*R7E[!Z#1_BFF!PP& BMSA/.N5DGN9*8\$B($.62S>5WPJ57/:YWNFTG!6
MW1Q'&3O7F[V%68O7"RMAS)3Q P@=JQA-\.$O3I,T@P$##+$K7"YPL%'IDF2
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M5PO*N!O*[3AMX6+R.;;@L7EF\O*((" @(/!N5Z_R6<N*]$X:%4$! 0$! 0>
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M 0$! 0$! 0$! 0$! 0$! 0>#=TCM"#J[YR&A_P KW&C3<='9_HM0EX3K_/\
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$!
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M;>M=HQ4>^6YT1"\I)Y3MPX?57FV'2K:XR6]MI[2Z!SG#>;CWK&;PO:XB[2Z
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M1"D9>/HC,[5^M^*_L>;$J?D>6LR6?Z*R\?1'<N/>>7J^&8N(E&<$/D"VG:(
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MNOQW.<O19O2=!L2O3UXC2?\ $5SK;2U+^BG]J>P)".K:G\H[]L[U+K&WA8!
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MY==U\@EQA=$WV8+?*685]]*_>-APQV#8K,288;E/3O:1LAZE,VM]>$[3RW$
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M^.U3>=I6.FF&9!N=G6>8*D^E6&EX6%=NO,EK@2+2V*BW$X6*FX292@.,AH
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MXF_M?6O/7U>O#61H0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[7#4G3@21W=Z;L2YK$Q@>Z)&.RX#F5FHD^BP44IL6B&>6S8GEJ\K33M:&"&
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MU)KU)+DB: T1#G89%:/XW[.LZGPFS"#F?O=A1,_1BEB438T7;.\JQ$C+F2F
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M&1*_$N$!D=F87YO_ &TD^&W[/K_Z_/;Y)*[#TW0',<(,</>QL7\A_P!AW_\
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M?.X<+ %+VP>OU?SN?G4^V9\^_/OBW5ZWA7CC4*'2*UD^5+E2ITUDL-FOF6M
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$!
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MY>T2IU(,9>.1V':M7MF[>'M\F'7O%&N[@F0(Q7Z+_3;L?&_V'R22QU3/XM\
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MWFBS9!?0^7X[ZX^SY_7\CKX>WGEYHU16T[8L>?=9@<2OR?YOPV?)_E]?\?\
M(Z^N'MKP/P$9U5(<^3,,6-C[N9&S)?&_-^._TU[_ (/GZ^\KWHX(X*DTU-(/
MAN$)>(]EB_G/YWQ7^V_J_2_#^3UL_P .Z-.T&7NL8UIZLX9+\[_M?B[3X>V?
MH^S_ *OYIW^:86NBX7>XM(EOOR.W8OX]_L?B_P#O[R_J'X/2WX95\T/A-[G
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M(A?WC:5;?H85/4GEF]".*S]S/A4JBK()MN)Q.TI;E<81$ZK)QQ..T<ZQY:C
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MVY6:28B*WVX>GJP3?C/+$KBZ-'4OZ*?VI[ K".K:G\H[]L[U+K&WA8! 0$!
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M<'2'%O ,H^*YLE\?#=<VRXK/ZEWJ/4/C[A!U.QX;*>#"9>U:EVEZWJ]%./\
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MX6XG\R^&7U576,D5KOK5-+WBQK&6'?EQ@2"L27+7;MUG7'F/WSHODF^5/1I
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M!(WYTBRSEFOZ?_XQ)?7+\S^??7IVM>_?E;32PZDBVZ:,%_6/P^O6=9E_,?\
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MF?,%_K75/\X=^$NC/BO2BN_+N6GGO+!]$='8K\?\ECRNKK.!0$! 0$! 0$!
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MF3:.4Q[7-DRG%SG/&\!O#:G6-7M].7[<ZIQ-4RJCP]/,HTX: '>&'$V6VDD
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M,@F<Z8TEU7.WB+86 #K4G"]\];CP[S^R8^3Z=\RGS$\.Z5JU'-GZ"Z?1[_\
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M+TU]&)[SSK]':U)+E</4@T?1RUM!+:&-:Q@8-UK=QMC;![I6;;?T;D\WEK@
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MK?B,6WGPUY^N2Y41' XP[UC'E9VU]T9^D3"^_P"EGMYDP7MV\I>DU5LYPMO
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M^7_7=HU_WTZS+$9\!8/3MVKP=OP[[8)_LNN=O,MYF=??L7Z'_5?C7IVCXO\
ML/\ 8=;,1R=+/BMNY%?LOB^.YC\K\WYG62N_/+2DWYU-8+3ZE_5?_%/AM]9]
M7Y_\GY/[>G:OT.\J-%=.-,0/IMZXA?V3\7\*]NDOA_+_ /;?+.OS=I.7OUP5
M*-#*8'6>\/\ %7W/Q_CGQZ?C_P WMV^1[.\$3I<RL8;/RLOT%>OY^_KTW]'S
M_A^*Y?K/Y'2),^AEM(;^3EX;&K^<?[?_ &,^/Y;/N^_\/P6]=/<S3>&S.ERG
ML:/@%N[L"_-_D_[7KVZ63A[OQ_QNWO$S,TYU"R)$("&2_(_E_G];WM?J/Q_P
MKVZ?X;>B<22M.J6;Q'N.Q=D0OE?E_-_W/2]9S7U_P?A_H[SM]*]B.'O,RC9)
ME,<]EA;],;-J_(?/_H?D^7Y+WDY?O?QO]WT^'XIUR[OX3\R*.=-:T.9\0^D,
MN=>?Y/\ 0?)TCO?]UT^7>7>U-Q735$GW2WX<PO#/]9VZ=IGZMS\[I>KJKC:N
ME3Y#X0MWO2(8%?9_#^._#VWP^;^5\T^6?M>HO%+&O$X"%LQWK[U^@Z_DR1\S
M_M[>7JCQ_I+IU/5@B\NA9M7N_'_.G69?-_*_#O>OS,\Y^#9M1-K3NFT'Z.17
MT.O^TZXP^=V_U]P_/_C/@N?(?.=NF#6$_">=>GI^?U[/!\WX?;J]<M9)TZ:Y
MCHB$>WH73O\ ERQYY^+8U-)UEDRH#(Q]\#TKYWR7WN7?KV])ZO:G@+3Q6B6Z
M ,6MM(YEY_EZ9ZO1T^3KUN7L92Z,::D;,W0 &#"&"_._D?BWO\GV?1^+\J3]
M'2GF'K#:"DJ1&&X7"^%W<O-\_P"'?6O7\?Y<]I7YG^;OF%]5FUXWR-T'Z4+E
M\+Y/]=VO:OJ=/S9>L>B'$_FD15O F/L$?CVG:O'\WXO;X.MM=.OS3Y+IK\.>
M:SFU$O\ &S(;[?I[1M7S>WY,ZW%Y>OK\>L_=[7\$^:3IH8/$?] ?$<>E9_M]
MKAUZR1[.:#Q3,U%C0'/.\UN,;UBW%=/=8JJEFU3+-XQ%E^/L7;XY>U<K\^.5
M#U;0IPWB8^]' ]Z]/3I^[+%_(GKA1*O1)Q+A[V.!V[5^@_"Z7$P^+^5\N[EK
M4O#D]TUD-^_(YP]:^K\73]TM^KP_)\L[=?\ #N3A;AFI>)0@[XFB[FV[5^M_
M"[>O3;\W^5\7MVMCVI\ON *F?4,.Z;7,/PGN*^I\7R9^3'A\_M\=],/T@\M/
M+::VGEN<P0\-D?<V!?I/Q[)T?+^;\;/;/AW%JO K95##<$0V'P9"U>KI^[M)
M'G[?CV=M</5/CGAOZH:D[MSC]&%T.]?2Z?C9F7*_%BO637-1;ILZ8(PW8G+:
MM3\*]ZU.DZ\H:DXC%>_PFDY7Q72?ZGLW.WJC^(:CZC3FHG[H9NDVN#;PL?D?
MZF_#T]_E_BU\/S_V=_7X_P"3H/5>*Y4Z=N2761(L='IL7P>WXO3OVOIP^KU_
MLZ3]_*,8Y];:(DFVXXKP_D?A=I?L]'Q_+G2<HM.GRB'>]:"<;KUX.WXMP[SO
M<NP="U>903I3'.<(0O)&*^%^;^/A]'X+[;KVGX!U=]9]6;$^^X 6DKY/?X,2
MO7)FS#W5X+X3GZM(E.W2=YS1<3?]U?G/R^N.]CZ?Q?'GJ[]X>\JISIH(EB\?
M1VKYWR=?V[>CI\6WL%I/E>Z72C>EMCN_><Z^+\O;'?#W]/Q\[\ME_ [Y#H;@
M@,FY%<NW:8;OXU\<N3="?(L NV9\R\7:[:Z_C6QN2=(>XPAZ%<I?Q;.>4M(X
M:WR#NX_>Q3.T[?CW%BPTG#KY$'%MVR&$>Q,YCE_3<K)2N%$!A<>@%;G5/Z*L
ME+JK2(D^D;(Y+<_;<5WZ?%Z\MZ;Q)*IY>Z7"P9[,EOVCMZ_1U?Q)Q7)>R8W>
M%A/TN6:U[2,^FW0'$-?*JIDPB$23E='KN4G?/*]NNE+(:]V$;EKVQ&?1R=0>
M*+ +?7>K>\PQ.M:4[AHSX^Z+;K.F]<_=OM$#J/!Q\(^[9'%O['H4S)4EDGW=
M;UO#?@3'&&.61&*L[7+G;<H]S6T=AA99ZN92]HWF81=172W @7VY;<E?>)[?
M\*]5@30[=O@.NU/:5CWWM4ZVC?$F%G=$^M2=YP?V16ZB,K.P&/.-BZ3O_P ,
M^\:!UELJPDC!9]IG:SY?5S9J/U@C=)-HNV^I=/;3-L[7-;0)<+>;E%9B75TT
MYU*7M.9C'J]BW+@VK]3ILR+C"X#T+-N:F?J@IE)-EN,8P!@+5%_1M4@<PP,;
MQB=B3M]%Q.5VTZH:#:<.[([%<V,3&=IZ?5#P[,CEL33>,\*[.K&L+HGU7IK#
M/;G2!J]3:-ZTW$7\QS65DLBF:A.^L$@<K4SA;.*@3IQG.,&QA]S),$PV9.DS
M&D>Z+-FT;%J2299O*8D,%.-YUD.VR(6,VU<6,[M8:P[H=ALYLQDM68TF<N<G
M66NF %W+GBIZZS!;*/5);F-@;QGG#:DF]I<^&>?4>,T[1ZQ<M8^B2[V@9U*9
MKH0$,%/6M>TDS&U0Z60Z,! D8;.96]9/U7-3QH2U@)& P[E9=LJWJ<SPF$1A
MR./0I=TE=;ZE7!KG1)OQ/,M<32WE!&I$^R,;US\X;PSR].=/+8 &/+M6^O7S
M6;,U9*+A^988& W3\/-%3BIC&EIIM-,EL"+![/64\[6.%4YLII A99MNZ%;=
M+;I2-3FAX.<>]89SO*C5LO?>01CWIG1<=N&@:?(<NI29\M2O#Z>(NQ[]B3/E
MG-8_JL+2/1[%O6/N8O+$Z1 F Y=2DY6<?=FE,<!<;_4%N2&+E.TC3"XX=A6*
MUZIV1+N&[GVJS<WRSB\MJ93[P$,#RN23>^%O;Z(V?+# 8Y]78I>4ZHJ?-;+C
M=><DD:N,M+Z\T61[%;&<^'!U<TW'#EL5BS=1M1/WFFWE9SJ9V=U;J7Q<ZW'+
MGV+>EDUM6M0=N-<3D?6I.S,U5(JZH!SNCMYUN?)AUOR3BH&94ASH X]VU=9V
MEFV9WENG*7*,P@\\>WF5GRS@]\7"2E43@ 0.4([$[?)&_:7]69T9(ML@(^M8
M_ME9]L,'U]HO)ZT_L;]NS-+K Z)$3=MS4_MGEKV8)NHM8;S&/>K[KM&SZAL^
M/,?0I_;@G5#3I0,8"[V^I.OS8JWIII$^&Z-W3TYK?]TSLG5Y_.PE$ GK5_LE
M:];Y9?SVQ_N^L%9OR8/3+PZ?X]QOL-JU/FE)\?U1];*+&%VR/6L=^^5_KPJ\
MR:22 <=JX]N5ZVR[:,YA?'ERO6-96XG'*.FTX$281ARPVK64FVD^7NF[#-2X
MR2:WRQ@)QPLZ_5R$@NN[?8BYE911/-L!=E%->&<9M9'4^XVT"( Y7)G:8PUB
M0PQ&'W%;,M3AB=.:3;ZN]23"9S<>&9FZ[(VIO)9MS-('"P#'#N@IV:QB:1M1
M2!D3 66^G;L6+<,8P@*J8V62+.5NQ:ZS2Y5^KGAS2++0>5ZX_-P]?X^^VE7G
MM+W&&??WKPXF7T;UMY7#A&G(KVP'WG:$[8=.G3;]Q?DOD.^MZ9'_ "$OL"SX
M=+\<?5;\K-+'2](,/WEO*Y29>GX?CP_232Z<BFE67'LZTO7>GMZ=<7:P2]YM
MEPYN=:MU]W:=<?HXNW2XFSE;ZUS=9TTT=3A]5-WPG'8$3U=5U/Y1W[9WJ72(
M\+((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#-(_*-0
M4WSK_N_G_P #._DG(G;A\6'VAQ'UG7/[0J>V9ZU)+G_Z^KP_)UV^4OY@(G5M
M4C_6'?A+M,>OW9O6S]'I;6M'CNCW+G[5Q[]-Z:CR&-$;EOIVWE)UL8FS03"(
MZBNV6V9!R#2;86(L>0TFX*9PUZQR#0/BZ+>Y)<I9CAQ<!9N]-JJ8K@B.;0(V
MW0S1<5SW6;.OVH8INLV=?M0Q3=9LZ_:ABFZS9U^U#%-UFSK]J&*;K-G7[4,5
MB<V,1A'UH8KCX8R]*9/6N36P@,(IHQ67W18.]9O)BN+H&$$C4<FO^^/H[@JT
MS^(T8K.&)GEP=-!C:.HK4^BWZ^6LYS=XVX[<56,Y9I0C &Z*SVBXM;;)9P&(
MQ"LTU.OU;K 6FT0M"<PNN$M3EIA&%O<%G%RSY35.T&%@AT;?65J-:2DNEWH$
M 78YH8C(^3X;;ASA=>D<^\G+! X K=U6#=,18;Q@5$N/\I*0TB!AEZD27_A,
M29C6BTX=W-DBVX;)GB'+O5EWIB-.=.%MUL#RM5M^K>6E$S'0P)]$5DY;<ND(
M()S]"W,)I(2I<+QCF$O"YQ&\V0'7#EU%8F?+'+991[!<,"DY3MKAO2Y;9?+G
M6M9.F>:W9?O0QL6.VN'2WZ-B72ESP0!;;;M*3]SG?JNNFTA$NT"X&[F6M1RO
MR3KRWW-:TP/J4SF,7YF64]I,+/1L69-$^>8^Z4:VR, 8PNY!7!/FRQS7^$";
MN0."O,/[9G-X:1KA&\]:;G#E?ES665-$XWWG'FL4S:>Z[Z)*W'!QARA!,,_V
M9F%IJIX;+ RY9I%G?K?T5:;5#?-_(G:K93WZ>'.5-\2Z^SK3#'MO7#C-I'3(
MP'K4Y+C&T%.TR8'DP/IS.Q73-MDUPWJ&1,DN$8V>JWU*9B:O+L?3JP2I=IM
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MTNE)$>5RDEB>U\N$V,J^R"UC$RU[8FVI*U)HF-;$W@'D2LYN2W65\T^%1)!
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M:I( 87@&.\^RQ3-;]?C_ ,OJ<^2C[6;Y;?FMX?ETW#W$-(=>8&RYU.*JG?\
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MG.%;C'W<^FKFOY7/V]/R \8>3'G7JG&VGT$W\Q3:[4S-=+I)FX)3IGB;P<T
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M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB
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M(@Y"Y1N</*BO"J7AQ2\,.2QU=')M_0G:XB5R7-EQ-Z[=.(U.'A= 0$! 0$!
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M=-*K71_>W&\9'N7]\_'Z2].DLG+\3WUVME?E[YV<3M?,JPUY_)3,<XK^E_\
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M+?\ TN=Y?S)_UG/^_P KO[1K_P"6<L.\X?@3]FW_ +TG!G^=2/\ 3)*TX_\
M4_L<_)/_ '(<$?\ AZ@_T>2E;[\.W:S_ %A5_P ([\)97PP*H(" @W-.I#75
MTJF^B\VY0 !/H1+<1ZN?.[\W_ _RA>4?$FK:M7BDU>12S9U"T3I<I[G.E^(P
MMWGM=$B"O$R=)>V_H_EJ_:D_:O\ FA\VWF'QEH$O6]<IN'V5LVEDO97O9+=+
M:\&#0R;$C='I4Y:[=L:?E1Y0^0OFAY]ZY3Z5P1IM1K%;653:=TYYJ9[Q,<\,
M+G%K)CIA!/WR9G#$ZV[?O)Y!?J^'GYQQHU-J7$^AU<LU)8?QE)4-$'!I.Z#+
MN$5G-RZ2=?+V<UO]6J\Q)-(Y]'I]0)O@N< RGJ =Z%GT4VUCH_,CS[^Q?^</
MY=ITSB[A31M<F2=.FS9DJ=1R:Z14RO!<'M\*HE2S[L!:UP<"KSJN?;K)?VNW
M/)C[77YE_E_\I-5\@_-2HUV13/IIVC/;7S*AH,&NDF(FV1@%FS%Q.#.MOQ8\
M]N)J/C;CFOXFI'B9,UJIGUDX@Q._.F.F.C;F2M28VFJ^X/\ 55P1,TT8C>'_
M !GK/EN</OSI0#3U<<9LX=4MJZ\8<;R^2S]99XGK9/DK64C)LQLL:15MW6DP
M/XF9A&"E^M6:FG\OLN,_4MYY),VNBZ)B?QD\1B4.:_J"_JUNG4[?):AF"5+W
MOS30P(:(_",;E-.G'5]4O&/PT P#4K'7E4$:$'$_'+_;#M""WZW_ ++:U_8=
M7_(O6[_%.O\ )_)B_6"O]Y?4_P"U:_\ EFKC.6^SUX^Q2_WK= _M"@_EF+=9
MZ\_Y?V!?*7^[+A#_ ,-TG^C2EWZ?P_PY_)_-JRW^#7F>(QE3=\0S#EP\NEX0
M/G5Y;Z+YS^4_&.B:Q34U3]9T35Y4KZS*;-:'RZ!\Q@M!A%WI6M9^S/7M>K^0
MC]KU\L-;Y'?,OQU5MII5-IU57SYDCPI1EL]VIFM8![H;BLM623/E>/L1OFHK
M_E_^972#4:A62=,J:_3';K)Y;+WW51:X$%P%S0I9)M>F>U?UP?)/S%I?.'RL
MTWC.G=XK*[3I3VS'.#R7"F$[X@2/IJS<9[3U[87W2&4^CT_YYK7B3(\.87S#
M"#6EI()B1@THEN;A_/8_6@?G%HM5XVJ^"^'-5JOZ?-I3)DU/N$2B]A!:U\+
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M]$.NY96<96^FK'6#>.'8<5=X^QSM,29CG@1,8D;;.01&X <CU*Q8D:"8YCQ
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ME^KJ?P'3-$9%S7$[DSZ)V2$]=82]_$?IE\H7V6W /R84]..%FT!9(9+EM?3
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M%._]RGJ>T>6?JO?R_,,0=#_BW9Q_R"N,K[1BK?U7;Y?ZRIHJDS=%8ZBFMFM
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M#> MC<(1VJ]9AG.5THJG> LP]7.K8N,)R5/LNQY8JS;59OK!VCESJ5EI3*T
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M!^D?6O7\-\/-\O;;HC4*9\V:^TGWCGD,^=>V=MO+:4>D/F%M^"^K^-9A\_\
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M]BUCZN-N+A8)$HV$V6F-F$.98_ZL>&+O?A-R)(A$VV#+;L6Y&LS&/+E/8 V
MV9;4MR2>5;K&P!M^D5F1>=H,RW$QAE@<N97U9G*3IZ<EOPQCLV[1M3AK&497
MT,P$N#>:X7*W<9LQ<-6G9,E$1;"%N/W%+<1KU\I:3J+Y-F]#GYH*8SMEMMUU
MS2(FZR,#S9*8\'*0IM>WC\7HSL6^&L862DU-LPM!??G'TK-*LE/-ES&BT&.T
M;!CSJ9;E<YM,R8"  8CO*O"7LC?JGU1^^&P#2#Z?0LL29Y;LKB!TCW-[&%G/
M8C6/#=-=]=MC&-G- PN5W=)(CZBAW@3N9X9JXL3M]E<JIKJ,V60/-C!7.UZ?
M5I?GZ9'=WLLH6V*7)>6Y33'5CFDVQ(VXX;%8LX6ZCTUA8"6X9=H3[);BX9IE
M,V4=H!PRYPEF5E:KIF['"!SVIQ,)?JYLJ2(>\;\#9VJ92W.FW+GN)%I-N)[E
M?;PD^E;S2YPCW^U63.W2,A\3(^GN4DSRU<1C>7&\8[4QCAY^W+G)=NG/D>]9
M]G*\LDUT1&%WM5R2*GJ3_BLSQ]B-S2H37'?*9<^UQ?\ *4T^8[?8,(;=NU(U
M>'9&E/&ZRQ5FRKK*>WPNAN6?.F6O7_E6]1<"]T+;\=BS:9QI7)SH@C:?6LYS
M8>S#+EE[ON]Q6KPMX3]'21<TPQ.&WF"2X8VLLJB;N#W<,CW)+6O5IUFGMW7'
M=]&T[%NW+/&E-U"D@3[N6![CFHLVPT>F?6'@;F/-BIRU-.PM*T<28#=ML.>0
M6LS@E\NQ*&2V6QH P'9S;%)IG.\MN=+:6$0OYNY+M?;>U,U+33/WX,O)'KYU
MFS*V2U3ZGAATXN_$DWB/2F<)V1[N"'S+1)CRVJ_<ZV<>7/\ 0ETAH?X$(##H
M.!*-8VT9M',IANEL+39A8!TH, #A D7<_<AINRF;\-O>M9RYW=<Y]("VX=1R
M.Q2W"V*U6R'--@]![EB'5QH:&9/<V#";0+N;I6V[,NRM#X4G53VCZN3%[1UD
M87*)XP]L. _*$5[&N=1AQ+6NM%EXLM4MTYZSAW0[R>ET\MH^IAMF607/'W/7
MRHVL^6K96\X4H&Z>SIV+>73KVQIUAK7"HIF3@).[ 68+6IMTYL= \6Z:Z7XH
M$L?"?6LY>KI_&/7O5J"9XSCN0QB(<ZM:DQ58J6/#-V!M!S6<^'6=LZ:5)(>9
MPB# NRS*D_EEBYSEVYP]1Q+?=C8,-@[UVSI+NNXM.TYQ:R#!</2.<*9RX]TC
M54,V2W>#;HFSE%:P\_M.$4RLG27M )%O*$8+IUTX?+/69=C<-Z[-EF7&8?B'
M*X*\N#V+X;U\O:T&8<,.<)QMYODN[';E/J<J;3AA=$EN.V(6^MSMYI<]O\NK
M>*-,^MO<]HQC& QBN_2S&'VO@Z_M=65] ^G<\W0B;.89+IIWQA7'UDR6=W>*
MLDJ>C5J:V:66.-L?4M3&6[,13]5JI]KMXW>OVK69PPH%155#IMKC?EG%:TLN
M8WJ%DZ:ZTDW''8=B8G^%ED6J7,?2L!ML$<1=]U;ZR2M:L0.KUSZB+08PY<ZU
MJLXDBH?4YLR:';MA/=GS+<DPSP["X?IWR#+<01 CE8FFYK;M6CU3P)>[O0](
MY6+<L:MF49J>L.>3!V!]:LLM3$L5";OSWQM-IVX%7,37#/\ FHS99.Y@,!CV
M+'>Z9U[(J9I!;,/NXKX_S=L]M/;TF)KZ+#H](^5,E7B$",K5S[;G+=WX=Z<.
M3O!$J)N(,>D;=J\GR2WACGP[HTK5I;& %]UJX=K?7"6^K/JNN23*/OQL/J"\
MN+E)9V=$<3ZNTAVZ8VN.5D%GL74>O7$&J.=-? $^^;CSKGPYRYC:X;U!]@,1
MSFRQ3VK/;<6#5*ATU@(<;(X\ZU.7.;57Z]/D/$'D0(/5GUKMTOLY]UFT[C*=
M3, ^L%MV.4>Y=)JY<K-):?Y@S7RBPU!NAE@;BO?\6+)MP[S;JOB+B&;5QA-+
MK3':NTQE)IT5KKITQ\QV\3[QSQ7JZ7,VQWWMH\/LF3J^6V!/O#EDG>SU:^*W
MV>Y/!.@>)34SS*!CNYY[%\[O=VOJ=+IW3(T27+D6RA8(]5N:Q;O#I;F;==\7
MZ>UDM^ZSZ)PYQZEKK<3"=;EZM\0R'-F$0Q.'/DLV9N5NKE5:1I$RT&PY',JK
MG.UI8(-"K&<J]JTL[DR!P.'W41U7J7B-FOR!A]+8BO&GSIC7LB3\7-BKG.D7
MJBGN(@<\SG!!8&,#VVC"&&0V*5OK=O#J5KK8#ET+,;[3,8Q2,) @+3RP6G%*
MT]!+,#9[UMVT!%2TK2=_X&1CL&4>=2L]N$U1Z#.<3^)-QPYUG<>>ZK)6\-SG
M,,91^$X072[F"]?^IUQJ_#3FNB60@2;>@K./"YTCJ"D^KONANF'/"*J29=D:
M75 -8T$"P8[%,IC>%_TZ@_.&Z-W>WX'ESJQ>SL/2/+;\XF6[ZOO;QRYU;LE\
M.W]$\F7;K7?4A81ZH[,$NH8R[!D>5WU67_1(0;ER"F#VQI2^)N%C22G?B86.
M&. $5,);F/43CRB+1-!9"#WB[GVJXQ#J]5=?T@SITT;EA><LX^M3&UN/"KMX
M7!?O>'E&_..:N9C#.\IJ1HWU>!#;!TPNZ5G.%L7;0OQ+NKHLZ,U9VR3G*\S)
MK7RCGT=ZUG6%SM!3Y>^39&_#G&2QC:>,M7ZM^Q'4>Y:1J36EG0-O/L3&6YKA
MA-01>?3[5GU9NF[3/+W-Z/1T[4NC.9A8I,OW;\NTK4IC3C, M'-V>U:X8EWE
MI.9:;5F\NN=9<Y+/>C&[9SJXTS;E-R[0!M@L=1S=(!A&WES+><KV832 ?1'4
M5SM\))EK.IH$^Z!:<#ZP5>L6S#P*89#I^X%HQEJSH2CLC#E<KK">F\LM-5@$
M"(OS.W;!),KA;:&>U[!:+L#WP6;E<XTV9LUNX>G+([4+<*K75HE;QWH #/+K
M2I[(/\[@.MF&\YIS$S4G2:JUY$7G#/8K)X);E.3IDI\F.\+N_8LV^(U[?15I
MKV;_ ,0Y$J]2S+PXV&%MA6Z9PI?$$I\QKPT1B(=A7/.$NXZQFTTYL^.YCF-J
M=F5YX9G/IG,)BWW@3A= *S<)<7[._M'XH,F4X%\+ (<PYMJUUU6K,[0>O<1&
M>X@3(^PF.2EFTQI7:74B2?>O.>PH8N,K'2UY]T[V&>:>5Z\82#]1]T^_GV%6
MSZ'"!K=2@7>]=#')1)NH/\XDOAO8Y]"1<86+3ZDNA;Z=FPJY9BUR6^(P1A8
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MNP]#+6NEVCXQEC#F4K4SE[Y?+8X.U^1#^L2/PPDKMUY?5/\ +I_LC*_S23^
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MPPZ/6K5Z\)ZF<:F OB>4-JUG2SJG9.A>. =PF,+K;^C)3E/XI25PHTB/A.M
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M',/6NLG#ES<I>G BVS'U!::^U6&D:;#G#\+VIA/:+AIWQ#G"GERO\EYHIFY
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M8O)G.D+4:& 3[AN/H$%JF%?J=)$OZ)C"/;LVK)_[(PTP88PNV0Q4MVOALR'
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MVD5;]<\^.*R)3V <1:D=X@@'\9.$(XQ6>MRW\K]5/U>:L\#SBT26Z4^#M8F
M/W?=.]4/N,%;%^/^+^I[I!#O++AUPN.G4!ZPY:<I_) C>_%N;>UT;X7%27#5
MVG]<T'AOS2X=K^$^*:676T-71S)$Z2\-=$SI;I3G@/!!<P&[%;LRY[ZW+X"_
MMP/L&N(I/$.H^;_EAI6HLTDOU&M,NAHRYI9O.FP+62BTV%<\>KO)_9UR^);B
M/ACC7RCXMJJ&OT_5-%U;2ZF93RY]325%.7/E/]XRW.:QI.\RZ)*O+E9>M^[]
M1_DS^U]^8OY;JB3I$_B^LG:#)ELERP^HG2PV4PMA+<TS=V+=V\6;$\M=;/\
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M\+UN+BOY4OVI/V9OGKY%>:''G'?$&CZ[J--5:E45(>RCGSFNE&:]S??\-Q
M?@8+.<-7IF9?E1Y6?,!YN>1NJ4=3P7K-=H=1I=2V:*5[*F0YKVOWRQ[=Z6^6
M8[+,EK3$[=II] 'RQ?K!WG7Y>Z3IFG\9\23YPI)DD.$^KF'\6T,WOBF76*3E
MVG;IZ[Y?L?Y9?K0_#$FG\#6-3H'SO#;^4JFQB&P-\R*8K%O7*C>=/ZS_ *9J
M4B=1\,ZG2,GB7-:#)J8^\X%K?A?FF*U.W3#YJ?G0^UA\]_F9U&NH7<1U)T2I
MJ9\TL^L3YC"R9$;H8)@!W@Y)/JQV[?\ Y/#TR^6;Y;./_F?\S]-X:T;1]8JQ
MJM>V95UU/13WRGF:\E\)GAN!&\1:"4MDT=>OMOP_J6_8>?9OT_R:^4VBZKQ)
M03I.J:GI6_*-7(\-S9LT%Y)WF!T;5KK_ !3Y+)<1^Y6I5SZC5?!8?YM]8'AM
MP$'"%G0KVLLURDFGJ)]I)/$CR#XE<03_ -B:G #9(F;%FS+7Q<OXZWSS33.^
M8WC=QEOECZR^&\"-[^=U<81 N2)W_D^E;]6QU$?_ #8]&IW27L)FZ?:X$?OS
M1?!<_P#JPW9^W+^E;QC^2T_]M-_^DKI7/JI<F8Z1/94,L?+M!QB$:\(SS-\L
M.#//?R_UWA'B^BDUWYSTVJH9?B,8]\MTR6!),L.:8Q>('G6O73.;/T?S=?MI
MOL+^._)GC/BGS:X(TC5)FA5KY^IRY-)1/F2G2W.WG#=9+(^%N"S)9MU_;WFN
M7RB%G%GEOQ&Z%/J&B:SIT_W#44\Z1-#I3_=F-#FLBW>&":KCN7'E^N_RD_;*
M?,9Y#RY6D5O%E2_2Y#I ;&JGL8YDN ^!TT[L ,RICZ.L[2S]S]@]%_64^*Z:
MF8RJUYAF"4UKHU3C%P%I_*)M+>N7K[YZ?K$/FWQ?H550\+\2/E3YIF >%5S
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M.( JI1.]NQ!MF%27>&?7KC+\3/G<_6?)O&>E5FC^5,U[:]SI\N4=.FN+HO\
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M;L0G;C'V3K-YJUZ?2,<^)$?A]-ZYRV3;=[.T-%HV@M@/HM]>U<[\O:?H^/\
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M>F7;.@5SCN,83:YHL)V+W_#\UZ]7C[_'/:U[&<&Z6ZG<-1KG,%.)?B'Q'0$
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MYQ(Z22N3H\(.)'O,=]ZZ/-:.Y#[(OSDX2T?S8X"U'A/4VLF2JG3*F7!S0_\
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M3Q]5HX RWO>YL-QN17.^S>>MT^>_S6^P.^:'@&?J!I]/U&;+IYCVRVS=.F3
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MQI.+?^Z9G_4)G[E,5,_']7C_ .QI.+#_ /4F9_U";^Y3%/\ [MX_^QH^+?\
MNF9_U";W)L_^[^Q_]C1<6_\ =4W_ *A-_<IL_P#N_L?_ &-%Q;_W5-_ZA-_<
MIL_^[^Q_]C1<6_\ =4W_ *A-_<IL_P#N_L?_ &-%Q;_W5-_ZA-_<IL_^[^Q_
M]C1<6_\ =4W_ *A-_<IL_P#N_L?_ &-%Q;_W5-_ZA-_<IL_^[^Q_]C1<6_\
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M]2S6^K2<#$G!<WJE\-+4?Z*>8]BL8[>75U3^4=^V=ZEUCF\+ (" @(" @("
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MG)]$Q34#6CWH8).5Z\IN5(IX0=NV1]1]:EK>9Y<GTLAUC=V[)-I<-)^G-M(
MN*U)]>6<6[<)=$&@Q [<UIEH54J0 X& L/;S*+4,^BESG#< ,28=,/6EJ]>J
M0H](FQ!:W$<KL@L7E<?1=*'3ITMH)'/?<$SA)F)T.,IH!@(!=)-9IFM&HU%C
M(CF]*YF48=5EC$>CO6X=MUM4U3+JB!88E34K4LPM-%0L8&O@,UJZFCE<J!K6
MP$ !9RBL6PNHD:BCESF"P70Z2IUS6<U0=;TMK YP M+N_(+5^C7AU5J4\TKW
MMM$'&'0LR)+F,-!JV],#23T\_.K8S,UV/I^Y.E[QMLY6\RWUM:XY8:P-82!
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M])4S*&<)\F)<W V^A,BUT_%L^8X,FTTH V%WO@=(+H*S#-B'UW@'@?C.2_\
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M&L%/(EL(#6P%K(CJ6[9.LQRQU]KVWP@)TUU3--1-_*.B3E;'O7-U<$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0;=!_3J7^&9^$$/'^7J!]HI_=M6_V=,_QEUZN/?A\'?SC-:-<U,_\
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M&8[?9UY/HY]5-<UXB''$<X7Q>]QVN'W.DG;JBM1X*DU$MSW2V&(-X]A7PO\
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MN#1:BI@+'?" NG_;=''^_N[*H*NH:T$@CE'U+?3X.F6_[NUF^4\W61*'XXD
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$!
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M^/E,[P\+T2S",C'7-LQ]95T:_P MD'W>@^M7PF?W8<5EU$! 0$! 0$! 0$!
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MC>E5SF$")Y#V*6-3ZN%34F=9$FP7HMLPYT%,7.!LM.)AZTMQ4EPONG4Y:&=
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M%S;";+$;B.V!5B>RN:E2L<U]@[,>E%DPI%=IS7E_NBY3"7[<.MN(]"?,;[C
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M*UT(#0T1ZR%SDN6NW";<T&6<8C-=,9CEG?V47799E,+X0CO>J]3AVFW5L[4
MV:6EUQ(]/M5G*9B9H*ADUP&\+;>1Z5:KLO1A+EAAS&'/!8EM+CA:)M9+9*([
M>9;<L8KK3B%K*HOA V61YBIRWQ%*E:>ULP'=%A/+%$DMN5^T=C)8NRNL4;N,
M?=;W2)<^4+ 3#/HM59ZZW5&U+2V^(7;HORSVWK+M+IQIF-E,(A"$ >6*MF!K
MU%0UN\!M-W.IRUPB'30"3"_:MQ.-M&LJ0R7?"(-UHY6)VFON3>W7VL50<"(Y
MX;%S_4OV4*9[TTC:?657/RB]1IG/8Z&0AG@K.<.F:GN#J.:)K8@_$,(*67.F
MG=LO37.D-);Z#RN"L[ZPS<3A!UM Z6[X;H9\RU]USGEMZ<V! R5QK*IB8-YL
M-@_!687/A&>&T38G/&SUI;?#$^ZZZ-5296X"X0@!S0M27ZMZ73\[TPD@;PC"
M-XPZ5GMMG$RJ&H:C)<Y^Z08^KI4+$)*/C31NXF'7$>I;BZL7+3=)?.@=R,8<
MO0EV:X6)W#LS<CX=D/4H2JMJ>D/D@DLA G/EBK)B+X=?:@UTK>!%Q[%+&9M3
M:UCIKB +G=ZD:Q(CA2N9;R[5K&4[<.$R:Z63#VX*==:8>9-:[> WC81VJYQ<
MM3,6F@K77;QP["%>=KE=:*H<9<-[#,90]:AEFG/<6^KJ6>UN";Y5VJ>X%T1B
M<-B=9$[<*[6320X;/7L@KAQ[?97#3%\R-E[K^;*.Q5A/Z=)\-\"(6V0V(NU@
MF3 UI.$.V*:63_E0=;=XL89N]*92]+RI3:,OF&P7QZ[;DQFIPNFB4I8YME@A
M=?=[%;)%SEV9IK98=+W@/B%]]Q43]7;^D3I+) @;A"&'*U,M7A5^)*IA+X'
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MPOZ-JW,'KETIQ!KLX/>&SB+2+]GM5]DLQ52DSIU<\Q)?:!UK-J\QNG3'@1+
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M6II)TD99;K19AW*X8O7?^4I37]"\WS</?^+S_EYJ+^G]TO$^I.%QX2_IK?\
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MQ?LAIHF.LM].U:F&N7B72N?>";L,U<I)BIJEI0T"+1?D<R.99O+6,IVF:R7
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M'^R<G_-I'X 7'Y=/9^/_ #=_U5[>8^I>'MR_2?%_!I(H@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#JYTN82YUX3#9-ED%,S#I.LPU*BCW@XY@B_G6I7.W%PAWZ?%QLBIAFVUOTM
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MO-\O+U?C_P W?U5>WF/J7A[<OTOQ?P:2*(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+:$C>PNR^Z%:O#8\,[/2IB&,<,;I/-?RO@LV1.+EP$BV)ARYBIQHMUAM2V0
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MREND9/T=XC8;R+QF-BF-K+IBDZ8\/%XB1? YKIFKB)V3ITQK6D'(XC++F4O
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MN7?IUG#OUW&K5<4:,)/B!TG$X8KCUZ=?=>_;'7;I_7?-&@H:ATN7-DB#B/B
MSVA??_$G7#Y/Y$S,X;NC>9U)6$#QI1)'WPYLU[._2:P\4ZYOV7:7Q'35C 6S
M)7O;=AV[5SO3#K,2(ZM\*HWCXC#',C'F*YWJZ?'VG_HJD^@DM?O%[( G$916
M;UEUY=YAGI*FCI2"7,$+<.?U+GVZ:QY=NF*NNF\8Z;1O;OS)5@A:0/6N%Z8V
M[8F%?XO\X-*T^F=^.D1:3](8 [5R[R^';X^G7MMZ:\=>>,BK^LMIYTOXW ;K
M]NPKC[^MQ7KZ_#,/4WBGS$KJZ;-\.;'>N@X]ZY]_EF,/1\7Q=9=1UP[6-3JW
MDEY][:>_:N&;V\O1U^/K-A9J$P1WC;M.*Y=YV=.LZ^WV0]3(U)IL+KLSSKY_
MS?%\MNJ^K\-^/K,UK2G5[7>\39F2N'6?+TNZU\E^+O<R)R76SFR]UY7H[=^U
M^/EY>WQ=+>-(V>'SGQ&)PZ OS/Y7?Y;WW6;U^.<1)4M,7 1V=BQ\7?M+)7'Y
M+U]>$@^D@(\NU?8Z=N_KJOG?)ZHZ8^;*^&_GR7H^'O\ ).TVY=_CZ=^O&TII
MFNUE),:0ZP%N)PZ5]WXOFMCYO?X.N7L1P/Y@5%/,9OS !!HM=[=B]GQ6VO%\
MWP=9?L]U^!O-N3)9)$V?*'XMM[L@,W!>_;R^O7KI[!Z3QS3ZTR4)<V6Z('PD
M&,+\4I?6+M32A4,!!!#H=@Z%S]9BY8U>VFK6:+'W@#Z-B^3^5UE[5[OBFM-G
M2V"D>T&SWAZ#;&S8O!W^/KZ_?#U=+B[=Y\/:Q*$D,BVX#KVQ7Y[\OIU]M_5]
M+XM]=+%-EBL<"VT'+EL7@[=>LZNLU?NF=%TDLJY;X$"P[+2%\CYOCZY?4^+M
MF.^=/U5FGTC8N W6XG8O/W^.8:[ZZYK29Y@MES_#$QECL]O/M7A[7U[/E][F
MZ7F@XU%5);%[3O0%AZ,U&;MDKZC\X2B00?=-W,$)77FHZ6X.+K?I$79C8AC:
M%$UE&\[T+#GCBHUQ$[1<02VN: YL!9V9K4^YE9Z?514.:6N!LS6;-L]KGA?M
M'U@R6MB19[%=0F<9;57Q2&@MWAE?F%,K9E5:GB$37?$+8XY],;E9<LV6-45?
MUC&_[MUN 4Q,NG6ZS7E^GMF@DB,860YCM6F>USQP@*[AAM2#[IQPYU+<1C>?
MLIM;P R;$[IM=D.[8LXM;M==\0<"MI)<Q^X;!EET6K1UW<.G*W33*G%H!@,_
M9!*]774VR44C<<++8MS]9V)(N95_TIP:1$7;OK2\FL.S=(U 22#L;?LOLL6;
MB$Q8[IX=XF;):P;S;&@7P&)3V63$RN%3Q.V=)(#FVC/EDK*EWPZ6XOK_ *PR
M?"V^[9UYJVY2=;*]7>*27OFP!^$]A3!G%WPZ+U>6\/CNGZ2S+M;$'2N+)H,"
M/>C=A$+2>J\T>H.ERP&F$!MR4YX:F)RQUNKS72G")N'?FD:LGA3OK\]TTQB8
MG".8VK7+';2ZZ!/F%[+'7[=FQ*E^KNO0J*=J7AM <(.%IRL"G)B=9MV=J.OZ
M#Y6:/-UC6:JC 92S)N[->P&+6$XD8J7M/CF:SUZ=_P COZ])7X!?/-\^U?Q8
M^KX4X4K9?U=LR=*W9$TP#8E@)#77"*\'R_+>]UP_7?Z__7=?AZ^W>?N?EIY=
M^=G&'!'%^F<1LU&:_P"KU39DX.+V[P+PXNCO7@CJ7"6RZ?8[_%U[]?6\/J+^
M47YU^'O.3A.AT75JVC-?)H6T_P"-F-WO$:T,(@71C%?1^'YI9B\OQG^S_P!=
MW^/O_9\>?7+LSS&TWPA-K9,QDR54N+V&601NDQL@NWWCYO3OG]M>N&I F81C
M >DQ1OMQIJ449,UCLG _\:WM1AVQI.L;LEK"X70A=LS3RU)F:Y3[2RIN(MZ<
M4L6?1S?ITL-+H6POL^ZHMF$;-E,9&(%EBK,M1LUC7FX6;.?F5EPN+G;3F4C"
M([<AM2?9,5K!K948V<H[<U&=JSJOB31[D;0>6:$L0LJCG.^(&\WQV+G96LZ2
M,K3FN'O WPN]BUX3-9G:4R$6@W'E:$EGE<6HV9036.@T&&'03M6KB\+_ !2N
MFRI^\V_XO7S*65G?EV]P_0B;NAX-^6WI5AFNT':));2[X%N[LY8(LKIGBZ1X
M;2&C%PZHJ>"QTJ'3)5476V./K"S)E,[=GZ#K,R4V7[T/= -L+K,UOP7";U?6
M73I);O V#':5G.:W,*"7OFS"X8D\LUMS[?9)2ICY;3S'UK,U?LUU=:\45<R)
MYSBK;Y*H]-4N)(MOSZ,DEF&<9JRZ;+<^H:3C#U9);IJZX>QW!D)3)48"#6GJ
M O6,YTMX=E5E:P4KQ&V&S(;-BLF-^$CI35J@FK>1GL[EO7^2WPF=&J'#=Y[X
M[!T)-;3KRL^JSP^B(C]#84OU7<=!ZU2B;-=#[]V&PPSQ6;B)BWEMZ'1MES6F
M!@(7Y^C-7E([)L$EHV>HJ8;EF5>K9 <2=OJAGL4X7O<\,^FL\-PCGV?=4ERS
M)I.S-US2+^M7+6%:JJ:,RZ\C F^.U:\,XWE8=,C+E@76#L'I2-2R7#'J[=Z0
M3>?9[%+NXCKUL=&:U+>*EPVY[%;PU=S#8TNE<]S##$0L.SN6;<IB2Y\.P95$
MYL@1P&64#V!:EC*J:C3'>(Y^SG2TW58=0N=,LC?EMV[%)88>)M*9+38K>,KZ
MX5VJ>ZT GD5.MSM/L@IU7.D&R/2MI^C-3ZO-):"3>(WY<ZS5F5JTV?,G.9'[
M[UPQ4]L?JU/H[4T#W7,)^^;VK7M+HOT=ZZ$^498!(C >KU+-F\IC"4U.5)?)
M%T0";!F%E(Z1UFG8RI<3=O'#:>];ZM\<N=+/IFM@=VP0[$L3GAL.^KS?A#;3
MEFLXOG@O5B-*1:W'(8):>NFI4LGRFDB-Q/H5ZV<4QC]%6JZ^JEF$3Z<([;;U
MM,9X:;-5G%P!.-O1TJ?=<ZPM-#J <&AQ$2.6:SF7:R8:NKS]]I@;[/7DI,%[
MQ1JH/<7 1NACAS+7LG\D+,IWO=8#C@<AW*Y\I>J0I*-P@2+B,^]8ME:D6BCI
MR"+#;L.R&.U:Z\)9<K)(:6CG "9B;XB287.L'J6<-SI]7&HDG<)/ICM5Y8^3
M6D UL)H&3L%<8<<2K/3.'A-$<%)RSC-TQ5A#FP&15)<54ZV3%ILN.'-#U+.6
MLY0QI[S YW'O6OLF+G+)+;NB%RU)A8Q/?NN;?A=SK+&5ITB4V;N[V!]2C=W%
M]II4J6P"R['G]B5G#!5[@!A"$";HXI.%WG:L550V68@^D;5,)G:+=K(:=W>$
M>GO5EOAKQEN2*YTT0B(FZ%]_2K=IGZI6GHILZ! ,# V"VU2Q<RI=FFS&-)(-
M@$8A2:)&E5TP(W8",>[,K3/-:]+IS"\&'TMF<<DBR+QIDD2G #9Z%:S>5BF3
M0T QN&W8,EG+<C$-V8-F(MV\V2%ERTZF4&,)& ]?.A;I1=4GN#RV.75'F6M8
M3JBY3!-<(WQOAM]BG-7M,K72TK1*S]W9]U3[$LD^Z(U:F:93A 1M';M1>73N
MJZ>7S'67N.&0(Q3A+J8-*TLB>TV\BI[,XL=UZ!1AK941<(7;8[%KQI9IV/3[
MC96 A[,^=68/U4KBJK;+EN@;@1?T+4OA.USJ.J96H_C;86$XG. ]"W,WEQN;
MI:J.K!A;<!B,P<E*Z1N3JCW+,0<MFQ8Q>6\6JCJ=?-E[T#"'3>L7-NG7I+X4
MZ=K4X/(WCV8^U;PZ9WA)T6HSII;$QC =<=JYXS7H^/[NR>$Y4R;5R'&)'C,[
M1S*\<NF=X?K)\J#"S5:<'"HIOPE,Y=>L\OK'^7'_ &3D?YK(_!7F^7EZOQ_Y
MN_JJ]O,?4O#VY?I?B_@TD40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'
M8B3A@11 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!MZ?_ $ZE_AF?A!)R7AZ@
M?:*"/EM6_P!G3/\ &6K,R./;A\''SBL(UW4K/WFH[9B[=<2/G]I^_P#R_#?C
M<ENJS,"7S.76M*ZJKIUCK?I=RL,^&A+GB%]L3EEL*QVF?T:F,?= ZK/BXV]F
M/.5>O[8F/*)9,]UT3GEDLZK6?HIFM/:7&W$>M2S"RH>6P$ PC9MY8+4:MF,,
MS98B+%<:8MTW95/=9>>6"LN&.:E:>5=8/1^R3)A.29) %F(SSYEF3+<U&UX4
M</2KC"S%8)K#"P7$A3>4WEKF OPO6._5UEC1FN:2ZU<^)MUFD15/A9&R)ZH*
MYS'.V95N? OLVQZTFN5PPKIUD2UYBG:9X:E^KRN=URT\ &*6R1-R[X"3=AT*
MRYF6;R\0)P4O:351YW79>D).W7(VF@$;04N1O2P#$$<RS?JDE2$N5O&,(6<L
M"IRUANLE"P;(7Y#F6I%DPV6R# <O4NG7LG:;>74T0;X\MBZ9J;X8VTIA<>KV
M*5<XY<33DY\NA9NRX8GTP:+(W]_.M=/NG+4-+&\'J]BWJ<&+(XFERWNI9SO?
M!+]>&(TD+;>E7,QHS<ZX<V2H0$+8K/KO*>N\M^5)C>,>_8KYPMO_  DY<O8(
M1"NI,+SPW&28QLY="S+AOK98\F0?O?PEI*&5 ?#RZ5FKF88S+A; *9\.7ESE
MRXW-Q.S!+GACNV!*M'NXC'VK4<FRV68V"]7&#GA(2Y41RRYECBLYMK9ER8&[
M"%_,MSAO&DC+EV"S!8MG^5]M:9FRC$6>E:\&V[*D1W3"%_KV%8QDVV_!LN6I
M%QIS9+A&S)6]<IMD:R^STJ3KA?U;+0;.9:ZYGZ))O[)*2PG#$"_ K%N;]CMC
M&N4O*9 "RTV^@%3&\>&)QFMJ6R)$1BM3J6V\<)273;TLQ&=@V\]J]'5R[1#U
MU!$.L-ZN<,RJA7:?\5AN3.>.6LS&U9G41:ZP'JYEG%<[,-,2YC'0$1 ^OFAB
MF4RE:>;,; '>]6"F/)+X3,J8\B\W#/OP6IRQ9_[IFEJW2R#M5MCG9A+?G0X$
M9<K5..6..6N_4W8'%+FU+FUK_79IMB;;;SBM8C-^[)+K9UD"['[[:,E,,=KA
M*T];.$([V&)V+%C$SVW$O*K9ONVNO&)S6H65*TM;-#VVG'$YJR,YG"\Z9J+P
M6%UP]8AFNW6>L2U>M.ULLW;;(YP[UO,8QGA;)7$H:R__ (VTK%N-QKB8\HS4
MN*6EI =A?O<BISPEENZZVU+7G3"8''[[,&'8MXU]TD^C3HJZ9.F 6W@@CH4C
M/=V5HDI[WR[#: KPY;[.^.%VF6R7$' ^M$DP[2I:@^'"WETJPLRP54\F-]_<
MLN=[>$=)FDO MZAF%J=6'9.BQ\,&W#LM6?*W'KM;2#X9A][ZE7.<H6>#O$PS
M[ G73;6?$M(OO[%:S9]'.BEN\1IACMR4DCC9X=DZ.[<:(V7#LZ$S<Z8MJYLJ
M &"VYNQ7/CRW+B9J*KZH%I((QN/M"7K_ ,L9W]E1G5(WG6X'U[5BZ:S&_05@
M:X6BPYY=,%9F<&,[CL#3-1(#!&RPV<RU;IF9BR2JH32(F_MQ4JYO*QT+VF$#
MB,L('-9.9I<:(1 -]HZEK6$Q8GF,BT0 NV9*>6IO]6"?+(;\.!]2MOT8DL[*
MQ6V1&T)UL_RU5:JJDRR8&XG9ZU9P9:U/J!<^$<L>=9I)O:9;61:#$=?.IGP8
MZS;9EUIL@1CB=JEQC);>9PD9-8?=NQSV[$BZYO+?EUI,(P^+N77)KEO,J01A
M?A%8M^B7=TV15C"'02KA&PVJ:<KMJ<+UVDI=>&MA$<B<U"[:%96;V\ZQ9LS<
M&=*S53M\Q!^ESJXQ$LMF(@)T7$X\@4.LO7=>:9KMZ[/L"L6[JYZ4'^Y?\6?[
M):TET[)TS>&Y&-XQ3,\&9)OE>*&<UN/-T*3K3-L2YJ@6FZX]G.LW3>=X1TZH
M:2=D,#WJ8AC;5,YGW;/6JG:X:LRI;N]!P.7.FZLB!JJII#[1CVG:M8K/7/E1
M=4>7E]\('/*"S]UM\147-<'W&PC [%<IB\I5D[<E='JV;0IG-+))]T7/KB(P
ML))MCDM5GK]VA^=7-C:-MI/K466MNFUUS70)C?C#O2R_X:Q]4])U^P".6.P?
ML5KKKEB\X;HUJ.-AY9A6[X68\M>;J@,3&RS/9M3.=7E+K?AH.U&+C:+2>U9[
M9FHU,XRV:>L)=; BPB\XK,^_*9JPR:BP0B;L]NT+66O#9-6\--N!A?DK+]6/
M65"UFIN9O1-X..T[4Z\QJ?MTBF:GO/%HM.9QZ5>"6V_9==(G&:&9DCD2K+K:
M]I.)P[1TC3IE7!H!^C" B+1[%SSLSK#LO3>!9U2 =Q]L/H9D)LS,8=CZ+Y:S
M_=<Z6_X1#W.C)/T9N%X;P0ZCE!Q8X0OBQ7#-SG3K3C*F912)XL&ZTX0N;L4C
M6X]&_,?5A+?/$1'PW8[##%;RM^KU!XDU*9,FNW3&(=G&_G6>;]F52TZ?.=4P
M)=\;<S](JVS"]+^Y[E^6$/!E[WWC8QV0[U\O\C-N'[?_ %'2]NN:]LN')TMD
MR1:WX&Y9!>?XNMGR/N_/\7:_$]K."*AH%-:+@OWO^JG_ -W/T?S_ /VO3'R7
M]7L315(^K"ZX]I7M_*F.M?&Z=;E7M2GDO< ?N]:_$?G_ "_OL?0^'K<;5"<R
M9.?"V$?0N'X_R<.?Y>/3#4=I!FFT8';RO7T;\_[,/RORR>[UM\X.&7/H)Q:/
MO_H["OZ9_P"#?)[?D]7XW_R&8^&U^57F#PS.95UA+3 3W?1VN7^J/]?<?C]?
M_P!U_%?ROEG]U^N7KIKNDF6V<"#U81YE]C\'/OM];\#M[1ZK>9&EDRZF ^B>
MPC)?I._3W_'[3[/L=?DOQ_+T_5^>'FOI1>)HA=+=AD#L7\'_ /,OAOQ_+VOC
M#^]_^*?D?V_B]>MYT]1*_3W29IB#]*_[B_DWY'27K_A_09UU]E-KVEKXP(M[
MU_(__)/CO]EQ]WT?Q\->2USV'&T]X7XWXOCW7K<8"6<CUKZ_P==?9Q[\MMK@
M;BNUT==MQI@+3DEM\%GT>'.!!$;?:LV7EE&3R;H\_40M8F\".>0TDFY8Y'#?
M:<55PR!I-P4FT""+U<#BH/(*-2_5D:_=-ZU+K%2XOZLS7DD&-G-[%<Q)SEL-
MF"  -OK5FXF_9D\6##$VP,+ER[W!WWPUY-.^:_&!ATVKY_R_-)=?5Y.\S6U/
MI2QD1&, L=/R-S*_%,6(!\N8U]L<3CB%]/X_RYZX>_IPFM+#M\<L L_/^5U]
M6>]SI= PEEV"^5?R)SGRQB1&3VEI7WO]7\TO:;?(_/Q>K28[\<!:OU_P?+CO
MU?DOR;-O9+RNE$S)#AL/4%_9/_#NWM>F'Q^WR3K\?:1^A'E77OHG4YC8V8";
M88C%?W+\;KGX8_F_^S_^:U[Z<)<;.E4S&;V+?I'9ZETOQV]M/A_+C#N7A[7Y
M^I5(:TD@O8+"3>L_E?'_ /=??#R_'.U[8O#] /)WRYG<1&7%CCO-E_0C>!W+
M^-?^1?'>OR7MXR_2_A])Z/T+X:^5D:GI\ISI)._+#OR -[1#M7X/Y?R<9ZWE
M]CX/BOO+'6_F#\GI925+FT[HQ)$*<9GG7SNW2_+<Q^N_&Z_LF?H_.SS'^5BL
MI:BLW:>= &R%.=F6U=?A_&LL=[)Y>J/$GR_5E&9F_(G>ZTFV00,\E]/I\=ZQ
MB:OV=':YY63Z(NWI<RP$VRX7+/R=?HU+O?#KR?PF^4_=W38<6[2%Y?6NTDPM
M.@\+O+Q[IP^CS=ZZ=>MM9[V28CV0X,X6FETJ+70W!86G8NEZ[PX3UQI[8\)\
M*0;(!;&+1]&ZY?0_%F>7ROR\YQX=_P##G!0<Z2YS;!;:R"^A)]'@O33V3X1T
MJ1IS)0,(@@W 7'N7T?QY]7R_R-=J[FI*ZDDLB2S.T"\#N7JOT>*=L5':YQEI
M])3%N_*CN.'Q-P'L7G[=L7![YWX>CGFYQM35$M^X^61%]S@N?RW]CO\ %<U^
M:7F)JOUB=4N81#QGFPQQ*_/?/WQW?>^"XZ.F:2OF-K0228.&)Q^XO!^3\DG2
MX>S\:?\ WDR]B>#-1,T4S7&RR-O/MS7YGYODSWK])\>^LL>TW"9E!LI[H?$+
MX+P?E=I>F_H]'QW'ZNWY%72^# EF&2_._)9[X\/;[XGW:\]E%/\ O+>:^)BN
M/>X3VSM4=2T"EJ28!EYLW0;_ +JS,6,>V/T4"OX/D.WSNC_ SM6.\G$;_LG"
MHU7"\N470 O@/="XXLF6;VM>=.%5I4QLJ282GN'B>[&(#A'L6LL?)U]OU=4?
M,3\M_"GGMPGJ4JHDR)M?^;IH9"0QSO$,MUQOO*QVZ2[CM^'^;\GX_P DG;C+
MY&/FM^4?C'R0XGU2I?1U!T3>F393A3/&Z&/</=<#"&Z!@O/VF*_=?A_F=/R.
MDQR]T/LM/M1O,;Y2?,W2:34]8FNX-=/T]CY<RLG2Y<EDJ>&N:YKGEABTK%GT
M?1Z]O%X?U/?D2^>WR[^;OR]TC6.']0T\ZA^;Z*9.9+K93W/=-D[SR6WEV\DO
MU7MU\]>'Z%JN8@(" @(" @(" @(" @(" @(" @(""A^:/]W?&7]@5_\ )%%G
M+^2!]NN/_P!?_$G]J3/](6)R[]OX/;_]7IDB=Q-IX.%9+C_&-7I^"7V?G?\
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M[C,PW,\KU>.5L^B>-:86D0&9*3%8NVL:N.(Z$[:X7U>/K<,NF/K6=GK*X/K
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MWFG/WO4F,?HWC'Z.N:]CG3=A<>HE:E^BRQCIJ8.FMC&_GN^ZBU=*:B9NML.
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M[]L[U+K'-X6 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$&:1^4:@IOG9_=]._@9O\FY"\/BM^T._I.N?VA4_A/5\/)\G\I^KY3_ #__
M -;:K_G!_"42\/2O4"!/='-7L\]F4=,BYH@KTDM26\. 8("(M7;U^BO :[>
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MW6[,4TN+C-2DVFW6..,,8>JU#AU=Q%0NF.N-YYK;K>A1OQE3:?3RUYB"+?\
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MDBB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M /EY(ZZ7_P"ZTS#^OL?^HI\K?_R\D==+_P#=:9A_7V/_ %%/E;_^7DCKI?\
M[K3,/Z^Q_P"HI\K?_P O)'72_P#W6F8?U]C_ -13Y6__ )>2.NE_^ZTS#^OL
M?^HI\K?_ ,O)'72__=:9A_7V/_44^5O_ .7DCKI?_NM,P_K['_J*?*W_ /+R
M1UTO_P!UIF']?8_]13Y6_P#Y>2.NE_\ NM,P_K['_J*?*W_\O)'72_\ W6F8
M?U]E:XV^T,^5Z?P;Q,T<8TU:)NCU\AM.Z92L;-F3:=\M@+A4/(W7N!NP3,)T
M[9?R_/MO^/>$.._.[7-5X5FRYE)4:D^9*,M[7@M,^-[28V!9G+KW_B]V_P!7
MA8YG%-!OP'\]EW_P@@O3\':YT_._[?']?^'VI\9!IGU%@AN,R^]"]UNLOR/7
M/LZ4K&@1@+B>]<ONZYQ%/U"K\)I!.>/JZ%J7+C?JZHX@XA$@3(N<('/;A;DL
MV_0_5T3Q%QDX&<-]\ 3]/G5DSRY]NU\.D]>XN=,\2,Q\2/OHXC:,EF_9GM;R
MZKU#B S'F+G76^]B3SJ9CG<HR3J[0\$G',#'G6I<S#.,\_5:Z36VP@";LPIQ
M<KBX;,VO\<6G D=,2NLN;GPWUF9]VBZ> ><9?=6[,[;DG7EX$^V\81L/K3UR
MMLJ2I:D MY_1#G6I]&?.D](J6@;>C;M3=;S/\MKZSSV\R>LHU9TW>.%T>U3&
M&<7_  AZDBVT9]A25*A9Y:!A'FYE=W?A;I'$ DQ 2V^"8\I"D:W>;8.H9!6\
M,V9JXT#PP"Z\=@6=-W>HLLO4&RV@@[;\O8F<Z9_CRCZSB!DK'&VT9\ZW-39-
MW[*M5\4QBT/-^?,,\EG.+F-;FHKM3J7CAQB;3GGTJS?),1!3II>3;9$^M9LC
M.<M0-+KN45FZ:]IQ'&HI=^68PZ;^N[!/*W<=?:O0NB;!U<ZZ8E2_MX4@T)\0
M68C""EF$F;5PT>C/B-$!=W)UP68KM"BI@QC#9<<88E6S,:S&U.! $+MA&W:I
M+C]4Q$145394;;0<#M4LMI;A$3]5#;"8].T;5>MQRQ*BYVML@X GKV%.S76[
MS4-4:MOXXGJZRL[+)=JQ65Q>81.)],.Q5E7ZISYN\!&V.!Q!5E^KI),(*IT6
MHF>^(V\^15SF,ZSIH,TF:UX!!B+XQ[EG%_PU;C]5HTK3H&T"\*XLC$NW8]!I
M;',$6MN&&<%;,MU).TF6&D;K;L![%G#.,M/\UP=8 !9RN6NM+B)JAH',(@(6
M>F)4[)RL<B06B#AALR&86:UUE8:N6W=(A<-FS8DY.TQ<JI6M#28#/+:M2$X5
MJHNZ.]2\JCC.W;+^;[J,9D>140SZ#[5,&6XRL:!:3?GS+4ZU+<O$^L]P\QQ^
MZDL\L=I]%>GSMYYM-O3D5GVM3K/+5+XQ$08E5T>!++KA?RYU<KGPPSJ4N%PZ
M1MAD%,X626;0%33[D;.KG"9RF,(KX#9>.]66NLDNTA(G. A'+/9M5S]4MDNF
MK4.+SF8^I8Y>CKVEA*EEP$1@>TIBM6R<HZOE7QCCZEKQM9VS^BC5LL>)" ^+
MUK'&XN+S&2CD@3 87$Y<RU+F-==U<J<#<%@N& VHZH[4W!K3"%W:(I-I=12G
MS=Z81'$]FVQ5SN>8\3/@/+ I5EL0E43;RS"8E9J'>XDF*?MC.*X*\H\A*UU<
M2T8#T]Y4;F/+5F "//;RYU<9CG;O[-)TW=,##ETK.,$VV)52( =WW5J<&&?Q
MQLY=*7@PC:JJ]UU]D,1DL8V8RJ]14Q<Z,<;SL.T+K<8TUJ(PU8!QO.*XS,+V
M<I58T.QZSRQ73F,S#.:GQ!8<.=>3YH]OXW\D;47]7K"\CZDFEQX2_IK?^!VA
M9[.WQ/V\^3+^F:7_  ,KU+/AT_ZGU8?*K_JO2?X)JLX>_P"#^/\ A^DFE?T>
M7RQ6NO#IVY2TSX1RR7.V9PZ_&PJ.J.U/^CNYG>I"\.KJG\H[]L[U+K'-X6 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@IOG9
M_=]._@9O\FY"\/BM^T._I.N?VA4_A/5\/)\G\I^KY3_/_P#UMJO^<'\)1+P]
M*=2_I#^<>M.S@TC\(Z.Q7X^4P\ $W+TSA&5K;K/>MQY"Y!L >[#&U9]O^%DF
M<O 8XX)EMXW79%57DC(*2LR_5X@3@F8KSN.R]([U0W'9>D=Z!N.R]([T#<=E
MZ1WH&X[+TCO0-QV7I'>@;CLO2.]!X+2+2.Q!X0$! 0$!!R;\0Z>Q!F@81P3,
M3,$5X-QYCV(,"#P58SV<49$ .@8Q6^MS'/M9:VI3MZ!V^A.'-)23:MS=;BP4
MD3N\P[0M73./HG)5W0.Q1,5NM]25>L<A85)RVDZ)SB\8]&V'J5J83=0!N".V
M-NQ3:^RK3R1,(!3$K/9):>T$MS(/98IA9B;BXT4NP&&,1;SJK[3A,AMP(L[A
ML2YC-Q>$M22VD@0Q PR'<D9Q9RMM-)]R&[@1@JMF8CZZC!),!R@IB^'S_FEE
M1)D;AL&1LL5>:?=NT\>7_!5J9N4]2-WRWGMZ@LNEX6211ES!8#9EM/,JR3Z,
M-88@ _=&U3&\KBJQ62MT1 Q]0[U4*!^Z^,;01SWJ5N<+=*J#N-ONS/>KF,8<
MHEVWVISH>/JQ/;:(^I3@87T$1$ 1)R]2:JYK)*T[,7@]O<KI.6<:?"X#T*8C
M4O:3#*VE< /:G&S&ONVY,AX=><!CCT+M'"Q8:2G?[O1ZL8+1F?Y6.10.>VT9
M^B",.;M,WK-W'):F%QK37F:86@D#E".2I;_RQ,I#+<#UI>$YU>&_+FED+3RL
MS5QK)ZXND1JD_>QA9SV]F*S&U=;'>-^/:FDT.<0+";]JQ3$NF)LQP<#$W[<T
MG:W2<ZJTZ6\N<VTGWMN8SYU<)9AVEIS8RP(6D>M0E_X2$ZG_ !9B+P?4K)E>
M+E#TU-&I%@M<.1L1.UU]W:.GTX9(98+O3=BKESQ]6YXC6DB(Y=(4W;M+(RM9
MXUED(=MR22\&(YG1A,$=T1VC&$?6G;,TS)MKG2#+)L&=G,L9:QC:3HZ.#FV-
MR6IAG]5ZT_3-^03 6#OYU;V^C6HZ\XMIW4SGBZTW6<RF9B8Y2UUY*WICB#$X
M\HK4[9TES6P: NMAZ.627AK$FVA4:63%T!RB<E)PGW1QH'-<8"[N6?NF:F:*
MG<US3SW1PAW*Y/9V!I,LQ:(88PS3E9B_JM3F-#!9< IC!=- LEO,(",5>$S6
MPS2Q- L%H!RP4)B\L,S1+[!G>.Y;DQ-IN<(N?2"FO L)3,;E1;]1;*)$8=.5
M^.:+;EAF5HJ  #&]/7RGM&A,H?K)C"^/H@K,L6Y;%-HQBV(Q;S6&)PV*8N3A
M<Z'3 QHL%D-JDS-&?"1FTSFLV0'85K66L8F?*LU,MV\1;>?3#8EVDY]F.13/
M<X91R.U9NN&KVEB2?3.:R./L6L,Y^BHZP2QK[[ 5BS/"R_5UY43'.FNB>JS)
M),.??%K'*>6N!B<,3G[5O?+AB<+=I59NFTF\8\ZF5DP[FX;KVDLC"YOK[D7?
M^'>>C53'2Y?-L]4%F\Y)$]4O8Z4Z,+O6.=0N'57$M0&"?#(FRR^"UQ&I)9ET
M1KFK.D37&)  ]9*F(85:CXLW9P87NC$7GVJW<P:X=JZ?K+)]/'>^B#:=AVKG
MBYTU--+4=2 8ZW XKI.'.\H&DJO'G- ,8^E6';7#L#3Z%TQK"!>(BS8-BLTL
MOU6BGHGR0"+!9=M6<W.UU9E;=';,!/Q7G'85<W#/#6UX3 #\77M5Q,&?KPTM
M)I9LWWA$VX\Y5Q.&LSB+#/DSI#8^\(#L6>VD^WA7YNNOI9H#GNLS/7BI?LEQ
MX731>(W5&XS>=;A'8-NU26D7VGHW5TJ,(Q&)2Y:F(AJ_1'2BYV[<"?20I,KF
M*E6![ 66V V=*UM-<J3J=)O#>,(Q)NZ>U5G5OV59LILN9&R,3S8YIMK$7W0=
M093NE;Q NQ&$-JF3$=C_ *2RV20-["&& .U6YJYDCK;B?763FS(.O:,=IV[5
M+GPQ,NJ9U0)LT$8F'+K6<TRN>AR@0"1B";KX=Z9JYJQOJVR)A!,($=Z^Y^%G
M&&;MVMPK4RYTL$PB&BTKZ4Y+9A;=3G2Y=(X^[<;1Z=B^E\%T\7?&7K7Q?K(E
M39XWKB80Z,5]#X_Y1R[?MFG5'YX$ZH ),-I7Z#\>?L>'OFW:Q,$N9(#B!:!>
M<XKV_!CV_P N'?&'7_$U=*I);C$"QT8$8!?>^+K/7+Y]M]L^'JSQ?Q\VC+@U
M]SG"Q^2]'3K)<^&.V>UQUY>N/$?F3XV\TS'6N/TXXKO?EZ3KI]#\3\2_)?W\
M.E-;XK;4&;[YM)-\;XKY_P GR9K]#\'XOQ?')9]'7<ZO\=[SO&$3C[5QU=UZ
M_;XY&JXO=<7=BQ>LQFN7;MTSIA=/F2\76;3S^M8U.''VZV[8QJLV6;'/ZSWK
MS]NW7BM>DYG#=9KLTR]TOF?X1RYU+VZ^NF+\<YJ$JILRHF;T7'&T[8K\M^?F
M]\QQ[62XKPSQFM,-\0VY6KY_6]IRX]KUM87SZH&QSX<Y[UCOW[<._P ?K)IK
M.J:PP =-M_9'!>:^W^'IZ]NLY;M+]<>;73(B'TBLSVR=ODF-<)MLFJW;3,NQ
M=T)W[=I/LY].V>R'KS4RP;7PB<>17AO;M?KE]'I)>OW0;7S7GWBXW@VGUKR_
M)V[O7\>$K3O\"!]JXSM7>3K=_9.R=18YNX<AD,(+EW^2\O;\4ZM:HD_68EN?
MK"\_;OVQB/5]T%4T#Y=O/CS+Q?)W[R^7?IUEC5;7FE(8XGT]ZY>_>_5VZR9T
MVV:C]:@P'EUJ>]SY>CKUEGW;\C2731XD-O+&XKA\W;MZNWQ].OLWA+^KMW38
MOS?Y7?M[:R^W\/3IC;4F,))-N..WVI\'?M;'7Y>O7UUAI^"Z.73!??\ C[]O
M2<OB_+TZ^S<D$LOV7\Z^E^!VO]DSQEXOR>G6=/\ "1;5@0C? +]C\?:3H_._
M)UZSMKEBFU(=$"-NU?3_  ^V:^?^3TEZ[0\UDQ[B1O=!*^[R^3GK-.S>!]?F
M:/,EESG#=_9$8^U?0_%L>+\K[/:CAGS8W#32_$=80/CRZ5]'6,/F7K?9[;\!
M\?MU&7)!<3O/:VU^%F?.O)\DF4XXY>P^GO97,WK#=>1E8O/WU,NO3UN,M@4Y
MDS[+/>C9TA?)^?;T=.N_L[*X<K?#+02;@O%WF>KU=<<NTY>H@4M]S?4%\SY9
M?=ZNN+%*U*L-0]S03:<]J\'Y4QTK5ZZ>=,T=T^;+?",7+\I\UQWKA;B_9W+H
M>D.D2Y;BV%HCS+C;;PQI<IE>*&222;&Q]"S+>/N==*=JG%C=W=WS&T7\VU;V
MWG>8HE37FM<=TF!)]2N;&;PUFTCV^\>6'K6IVC,GEGDZF:&:TDD0V\L$M;EE
MF*[GX2XK9X30YUN9^ZKF.?&HD=7XJEOWQO677WV0S6>UG^4N?*IMXA;,? $V
MN]).%J3E),W'A<])U#Q6BTF['G"WG>VYUN=+Y2ATV6(9#&[D%+JK=7'EK5%#
M,<,>4%>V,:2R]JA)^E37.,-ZUT1:<NI<L99L\(?4=-FRI)W@0 W&.U:WET^.
M;=;:E(#GEHP[]D%;7KZ:Y9-*TXO>(B-H]?<I&[MV[HG#QF@'=;\(PRZ+[569
MQA-5_#!:V(8+LO8I<9VLFMJ74Z1X+S8+"1Z;,%+G.F8D].T\N<P$ @A)9Y7=
MJ\T.A^*&Q:#<.KH3CA>UB;J-"EMD/BUEC<A@.8K<X))71_%U!+EOF1:R$'99
M&Y3'EGMO3UJXBF2Y$T@0@'.!A!3QI=XPI'YP9OD"$(E/U:G7UF?*QT-7*?",
M,%<R<L6VK?IM.:I\LRFM<PD;UP5QE)VG68OT<>/?-'A?RJX?U&KU)\F742J8
MS&1F-!WFM)LMC>G?OUZ=?OAO\?\ '[_/\DDXR^=KYO?G/UWC[6:_0]*J9_U!
MS9LEKF3B&!A+FW@KYGR_+>^O#]G^#^!T^#K[=OY.M?DP^1SS=^<CS TO3.$-
M-J:RCGZE2-JZDR)\\S&SYQWQO;I:&!NTQ!7GMQ-<OK3KYO#^I)]DG]DMY9?)
MWY=\+\8:AI-(?,1TFDF5!=02HRGR);2[Q'/ <'.F&RPW)USS>3MV\3A^NGG]
MY+\/>?'ESK' /$<BFG46H2I@!J9#9P872GRSN[P.[O1$<X*V93K</YC7VWOV
M.'%WR_\ '/$/'GEOHXG<.S=9JJRJ%-2O;*,F:9CR=Z6P@;H=$<RF9&K/;A\W
MWEAYE<0^5'%#&2)DZ2VGKW2:V3OOE[CF/,N: P@6!X*Z].]ZW,>/\G\?I\W6
M]>V[A^Z?DOYLZ/YG</Z?*$QLRM<UOB S 2'$6QMC&*^C\7R>\P_%_G_B=OQ_
MD]IP[PF:).IWN=NPE@D B[E:MWKMY.O?K9]WF32O:X9>WI5)RL=',,N$2;AC
MBD.WU6>GJ-\  FX8]RMW-M2I*33&<0>:S9:IG$2\I%FFV1W;UF]K;B-<3;S,
MHH-(@.KN229+PA:G3R\@P$(Y0PVK3,QG*7TJ6*4B-A%O0"LGV<]7J6O:=V^!
MZ[5<1I09\ETQQ)]>>Q27%9LG^66EIB#'GY1-BU:2?58J6>V4!'*SH5M+*D)>
MJ,!@#A9=L4RN)(GZ'4!-( )RLZ>]3)B+%,FELK>),(1ZQATIC*7$_54:BM:^
M9N$VQQZ KA,VHVNDM,ISX#/T%/T26\5U7K52V49EMSB!#83Z%&KF<*Q3:K&=
M $W^OG4DSRLW%^TFL:X-)MN[%?"9WA*U56T,,/5LS3.+M+RHFH3/%>8PA$PL
MR/4F<KG6&C34OB/B(8&'2J37Z+SIE 0 Z N NVA9MPNK4O-FBG9 V0/+H4F;
M<KGU0CJ\F8&M)^*'I6K9Y9[;6;39'CAKC"/(=BEJ<)B?3"5+)@+H]G>K.%NX
MI.JU18+SC!7/@Q8JDF;XL[=B;X=9VQ0_<F)S3*EQM!A9SWBY,EFVG1U+B_=B
M;X<L5$NJL<MA>T'E<%NW"Y^C0K2Z7<80]?,LI,7=9=->][Q$V;P[59?"Y=D4
M-'XDN,,(7;!C!9[3)<H'5)3I$PPLM.S8I)A<_57ZJK+)#@2<<=AYUJ<.O33J
M;5*J-48$_$%+5X6G0Z@PEDY#M&:DQ5PN515@2"/V.!&6Q7%\&<<*29WB5-^.
M)C>5(22Y=@Z'3"9 P$2UL>A,S*6.'$U%"G=$-NRYU"2NJJ>1NSC9],Y9G8$C
M5OCPPZX 6BP6B'H6]1,?1%Z/2B9/; 8XVY0V*19G&W<VCZ<T200!&';!7;4V
M@]?C3QA9 .C#F1GS]E0DZHYCP(NON&V&U2S+%N].PM&JC/EMM-PQ29PWGZI2
MMTWZQ+-F?I^ZF::4&MX=F;Y<!B8PCSY)S=DQ.&Y0:<^G<R(-ABK>L27ZKUI\
M_P (-CA;Z4EG!=K*-09N",(>U4QK[H6OJ);P80$(^J'8A-3:F5DL3"8 &T]B
MF8N=HP4;B; +\,TF,,ZS]DM2TNZ&[P%@':KUPU9+PWW4X $>7H4O;"8!*;EA
MFI)Y2==L[=UHPNV*9Q4L:=1/#8W6<V$=NQ:SF-23E%NJQOQ)-^:96K#IM4U[
MVB.//A%9W.6=\I^J>#3N,1\(-Z<I=NJ]2F[LY]HL/K'>KRYV3K4>VK,0+>L)
M)A+=)JBG%[@"3>%<I9F9\K1(D[XNYH]$%+"3,9)E( TD@7=A2:7"NULEK=ZR
MZ LARP4O:UFY5N?+M<0,3CD"FZLQ-(2?4F2Z\W]ZUC*6_5M4-8Z8]@B;2+>F
MQ$Y=BZ;(=/E WV=T.Q%QIAU;37>'&%X=ELBI8U),;=55DDRJD_ML(V(:77AV
MHW9C(X0] VK-B6_1WSH5>UDJ5'"/K4W.#:5U.O;.D.:"(PV>I)=YI+'4^LM<
M'N=RO/<NDV68W%<D53A, B3;[,5GB[3/U7K2I[GD6Y<LL$EW]EW9]EI(@+/O
M8]*M7K+AA%295D39;9U^M"X\O)KXB%MJ+,>$)5O;,)NMA>I9:S9BM!K!$671
MV=BWCUC20:_<:;?HGU+.3MB3[JUJ]8&--IMV\ZSVQ>&9)9OEUK5ZC&:1O'D5
M9,\IQ4SH]9O3&6FVV_[B8\QK,DP[-HZC\6R!M(%W1M*3G:1KZE5$--IY1CFE
MF>%GW1>G2C6S2#;[2M]9AGM;PW=3T@2)9) %F4.>-B[2Z8L4V)EO(N@?6%G&
M4ZW%7+1XS2UIMY!61Z//V7'\TB=*!(!B(]2S;F:;E[<13M5T=K'.]T8G'N69
MITZ9SFHNEIA*F-B+ 8]2Q;7?I,Z=E\+30*B0+/RC.T;5FS/+5ZV/TX^5SWM:
MD&^-13G_ (RG#ITSE]7'RX_[*2?\VD?@!</E>[\?^;O^JO;S'U+P]N7Z3XOX
M-)%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$!
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MEY'8$Q6MR.4JK.\ #LO/<DA+]4[2NW[SD.Q&;A,2:;>(]//9MVK<U&4DR@!
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M+" $%/7,7MWLN'7X^=SS]GQ?3\1<1O9?O,K*Q[>MKB$];#^V<1X_\Z_S!_\
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MR[KX9XEE.;()V8C8OYE^;_HO3YKUCZOQ]KWZY\8=W:3KTF=+8T;!?RS7EO\
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MP'P[J\G1='F\5U%+*J*@_49+GR'^"QK';YEQ$QDP.*LGE._;_IG#]H0 T0:
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M,Z??Z:ZX:JC0@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MT)9E)F:5O4-*@'?BA><U)*LXVIE5II#C[L/N%6S"3EI-T\QCE%3-;J4DT(<
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ML75;NNJ?I*>7*@80A?T<_.F7/*S4E7+E.!WAE?A '9DMXS,+_P"R;_.<LRP
M[X00;8>M9SM4'65#7[UHMVY"&/,I6NJN54QIC#]CEWJRX6W"%^GT]JWR1-4@
MN_;!<[RQC:<DN A'E"'<M3KG:6;)Y!M'*Y2ZTU.4)5.#6NV'8LW.?U+UO;:E
MZDZ+G@9>H+4N(LF$+ X@J-,+Y3G6X69\V2SPSC&VN^2XQ$(]'L6IPF<_JQ_5
MB1<>KV*YQI/7.W@TT,(='L4M7%AX$-G+F4]IX1BFR1NF-O([%J;61#SI#02;
M+]FS8KC+OTU,(R=+#8PVG##H"+943/G!L867;,#MV*>27$:PJX#XO3]U5FW;
M8D5<76OZSL*<-293DB>'@6Q).?,DN:7KA*2B""1C#EZ54QH?)#NN/*PJV891
M]:&RY;LMUV7-LR6<8F72[CJ'B&<!O6W;;+N=+=,SET3K=9[Y@Z[>N/>N>"S"
M"IZS\8VV/3S+?7*5V!I-02QM]NW8-JM;E6(OW@.OT*+RT9IA'G/+TI6>LVU-
MZ)NO6<N_KB/)$1!6:1B>(6;%K.LIPC*F:6B V>F&U)6N:A9U0ZV_Z6)[U+Y3
M&-(:?-<Z(SB,<^=61=M$22]UHB"2;CW+2)J10;S =WT+%NVN&&?IT8C=P[T]
MC'GZH>?1%I,&YW#*S:K/K5EB#JZ4P=[IPRRYEFVISM3J^F?[UAORVA:E-56G
MR'AQL-YPVE7*>K>I&.!$<XXYG8D.RV4<TM$.;&&'.O)\^]O9^-,;>:J??;_Q
MN?:O#><OI2RKCP9-'U]MO^3Q'WP.>:O,=NLC]U?DL=O5>E[9$K\%H4XC5Z^M
M?5G\K?\ JG21_P DWL*Y^VWM^+^+]%=*_(2^<]JW:[18)>/0MWB-]>6!_P"4
M/+%<77IRT]3_ **[]J>P+3?U=55/Y1W[9RW$>%D$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*;YV?W?3OX";_)N0?%C]H6(U
M6M_VA4?AO6LO)WNWRJ_, (:IJG^<'M]B6L6Y>D^H>[4/QM[U,.7;;5<Z+1T+
MI\<9QAB74$'(7*-SAY%XYT6\,BPPSNNZ58LY<%IH0$! 0$! 0<7_  GH[0@P
MH" @(" @(" @(" @("#,QD0#'T=*WU<>_*2IO5V ]RZ8PQ-+#38<LU8N$U('
MNCF[E/*6>&[)$'<MJE3&$K*A$<RO7JLNDQ)(LNN/:M287;9A9&.$5<LY:LXQ
M$-GK]BS4]D>9.\2>78<EC+694C22860N@+MHV+>H=ICA/T[=T<UO6%J7+,;;
MIL-G2I;G5.UDGW<#.!Q]/M4LCG;VO#G*=ON ]*G"];9,U8J:C:^6"6QZ.<[%
M=5CMB\L,VC+3$-(LRZ5&'"5+>P].1S'<L_RJZ\IF1-> +[.?$+<B7JG::I+8
M1.5Y.).U+,L+;I]9+!$7"^Z.WG21+<1V5I.I4S0(S +O4DN\,V9Q5BJ*^DFR
M_C!LY[X;%K.'/MPI&I5$AN]!X@2<A@.99PYRX4*OU%K'/W7BR(O&<-JSA.TU
ME5JC6)@<83+(#M73.L,6^$1/UF88^_'[@"QAB1&'49KG"TWC+"PJ<5OA-Z?J
M#PX N%PO V')7;';G3L&@UDLE@%^&8YU.LQ<HFY6O;WNF9CELZH+OUSPE6"C
MU%LP@E_Q6W\V YETQHF[A<J&H8 #$9WJ87^*3G5LMK#[P%AQAA#/:IPSRINI
MZG &$P686'%2WPLF:JQJO$<1&,7'')(UV^B>TZ3OD"^,#=M5N;M,^JSRM,$Z
M!\,VY13.TDRD9.GMD0]V%HOV!63)9A-4\YDNPD8]B6863*49.8ZV(NSV[4YA
M:S!P-L1G>%SWE&Q*F,;>1:<^9=)VTF$O(FL/TAU[#W++=F(EI#630(D8F$0I
MQIC&(S/H)6Z3 6QSR*MNM.7\M(>IH6@G=&4,;^=,EU$1.IG 6 WY?<6N&<::
MADOM$#U>U7PU)Y<? ?D>KVK%OAIR;*<T6^E7JELC;ESBP0C9RVJ]KA.K(X-G
M7NNA>1;?SYK,WM,9:[J)AA=9[-B6%Q&251,B!9BKX,:3E+1 6 CJV 9;5<VD
MJR4TG= B["'KR5A[)#>#6QWA9M]JZ3<3FH^;5 ?3$!'$]ZY=KX;G&4-5UC2'
M /!L)O.9VK&"W"H5,QV^X\V>?.G+,OU1;JD@P)]/M6I2W+?I)V_#H'H&TJ<T
MZK[I,ELP $ Q:/3S+6-K9E=:?3 \"$N\#/(K7A/5SGZ6Z6PEK+^6*Q=KUFU?
MG4DYDP>[B.V*O&CMUQ,I:DI7E@WF&[+FS5RS(UZJC>28--QPQ'0L6YTZ1%BA
MG%\ /I90Q6I]$M2U/I\ZPP-O3<.95C&4B**8!:#C@IC36<7#5F4\# ^G/J20
MFF(R6#[@[EJ7!+E(4U-*FB!'+;!<[=N??2.U6AE2V$@"X]B9<YRC=-IBZ9[K
M2??;<,H[%K4Y7.?T>RO >G.\1N\R(W6VPA?#O3.4NKI[I\$4,@"0' ? !#J.
M/.D2W+V6TCABCKZ5H\(.+FC+(]$5FUKK)-NN./O+J0*:J>VF!]TW 91]:L2]
MGH'Q]PO]7JYK&R"-UKN>\JX)73<W1?#B3+-I<>J.2BRY1-73MEL@1C="VSGB
MF$S4-326/GP(%_82<(*]>N88>PWE_H\J9/D$LC%K3U>G%+JF'N%HW#\HT<J$
ML?!#J*)+C2K<6\/[DN<1+PLRMZ8J=D>M7$=)-IWS-UI #2;.8XCF5C=^KIW4
MY<R<^#@3?VKY/YTY>CX>^)A*:$TT]MUVS!?$X[?Y>G^QV-)XB^JR@WQ($#LL
M7Z;_ %GR68KS_)V]D'J7&%X\4G#E8OO]/R+>T>;MY0LGB SYH]Z,=O3SK]+^
M%^3Z]9<O'\GQSM79.BU!J!+(MWNFY>WO^;8X3XIAV/1T;IDL'=MAES9<Z\/?
M\V^SR?)\4M<:S2G$1W/HDKQ?E_FW^N[8GX\Y=7Z_0O9'W#C@OR7Y'Y6?DMRM
M^'$^SJJKIG;[@6&.]EM"\/S_ #^W5VZ=/58- TLSYTL>&;8;+U\?M\EM>N=M
M?H[_ -"X=9X,LF2+A;T]*]WXVZ[?%WQ>7/7]&ERI+_Q8$&D^OU+ZTZ\/=T^:
MX>NW%@ER"X"SW2>H6K[G^NZ2UZ/C_)LKI35*MH:XAP^%W^,OM3I^['W>KM^7
M?5ZQ<;:O-;5.8Q]@>Z[G7]#_ -#?7XX_!_[OY/[>URD>":297O#GM+HP,>KO
M7ZOY/DST?E?C^+U[?Y>P%+1-HZ0/(W8,M)V07Q_F[YK[/P]/;JZ-\P^+_J$B
MKEMJ V$1E"T!>+YNW[*]?Q]/W2/ST\QN-9LZHJA]8WMX&'45^8_)^3/>OO\
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MYQN \3=TQ]XCM5\N5N*]<=2HGS)TP[A(+CAMMNYUKUEN%S7&DH!+A^+A" C
MYCO6;,1J=FQ4PD2YG-=TGF2TME=3<2 S?$@/HNNYB5&70NM4LUTX@-)C$7)Y
M;UAYT'AV94SQ]98Z5*^(S"T@66WPVK4Z^USX8[]\37*C^>7GWPOY.<)U'A:K
M3.KY+)C1*WF[\6L=A?>N?R_).DQ.7L_!_P!?\GY7?W[33YP?/3S[XJ\Z>*)T
MZGJJU]-,J9YDTLC?WIWON$O=:+7-+3&Q?,[]KVN:_<_B?B=/@Z>LDSA^H/V5
MOV1WF7\Y''G#6KZWPQJM-P^W4&U3C4,?*E5$IDP[LQX) =&^!Q7.U[^O6/Z?
MOR&_9_>6'RD>76AZ-0\*:9*U^EHY0FU?A2GS632S=>26Q._#.Y)#MWS,1^C[
M6AK0UH@UH :, !8 -@"TYO* @(" 1$$&XV%!^<WV@'R#>7?SE>6&K\-:KP_I
M\W6G:77RZ:J+);9LR;X4R93M!=:9AFV#H4L;Z]\<OY3?VFWV;7F9\G7F[Q%*
MI>%-4E\-2JR?4RZR7*F.DR6,G3&E\LVM@W=!,%)6NW7,S'K;\L_S):QP'K%/
MI>KUTQM.)TJ7NS8@;H>&F(-@(%Z]'Q?)>MQX?(_/_ Z?D]+9/W/W2X1XKT+S
M(T1NITU9)FS3)EG<:6QBYL;ASKZ'7M.\?A?R/@^3\7Y/7&F_*H#15#6[I -Q
M(PBM8\L>V5WHZGPFL(=ND *Y;FXV*G52&P\06 G#F27*9VK=3J9),7Q!@,,(
M]RN(GLU957$_$+LS[$7.FR*JZWT^U3M=.G6\)&EU#P[=\" AAV]*S/JU=K-3
M:TUH ,R%@[#L5/#;?J,N8(!_23S\RE:Z\(FI\.9''>YC9;TK.+%Z?= SZ5KC
M$ =7/WK5J68K0+72SEACS[%,_P#)SJM8U4TGPXF'(\ZU-L7[.,23O$8Q4;G_
M *MJ7.W1=CRMZ5,99[?1*TTP.==RZUJ3Z-2K11RFD-LRRSYD3ENSVLELWH=E
MD+4R>JEZQ5M8TP<!!N?/W*\;,.J-6US<<0'[,\\1S*9RN,J!5U[IY)#HP.!&
M:F=L68J4T=SC-&]EMQMQ2T=[<,%OXH.,/=&7[%5J<5VU3.DB0(O$8'+N6LS"
M2XJ&K:BG#C[X'5FL8PUF=D4*F2#\8ZQESJL^<3AYF5K=RQP/2<CM4;ED5ZLJ
M=^,#B;B>]5B[TCY,QV]]W([4Y:XTFY+R8<_K 3UF,IEN7J+S&JX[AMVCJ5RG
MJRRJEK8 N$.R_;!2[6_9O2ZH'=@X6QQ.W:DF-5FW6&[3SFOF 1B>?;M5Q]$E
MQSPO>GZ<RIE-<1:6CUGUJ73>9A&:KI4MH=[IM.W:DLO#.-.NZ^AEL>_W1TQR
M5QF&5>FT[6$W9W9\ZS*N7AI#>J"TEN7E[@6D0S["A.49/$5GE.TVKU8+'<L2
MKC"^4(&.>39VX]!27:XE;LJ1!P,+H8;0M7C*8F$_1/,N V=\.Q2BTTA=-@.;
M/&W:IG$618)6GB8!%I)LV9>FU27+5TW6:3+8(ENWK$$RS+EEBR2(6#' >U:X
MF2\HZ=5;L1OYB_9TJ2YI-(J?4!UD8[VWO*LJVX1,RTQV^KV*XSRSU:4Z6($\
M_7#F4SC7A>$:93HGG.?<M8E7*0HY;KX98'N4QX9\K[I5-O,9O 1( NV<P4L^
MBVN>J4<&N]VX##:$EPO,4BJI"2?=-@& 3KR280TRGW3"$,[.;9M2[HQ^'#'T
M)X9XKP1"*F&LZ82T[T;(1'H582%/))<"#R$=B";9():+"?N#,+.,.DN8CM0I
M=UCS"X1M PBM698\NN=4<9;G0Y^5V2GK,83M<:5^56O9,'O0MA;""747-NUF
MHM0<7 ;PALY^99FS:RLG[X!OZ=D=JWQ%E\,4XQZ>X!1J\(M[MUX$(VCM1(NV
MB4S)S6ET#$]EGJ4]6)<5<S1L#("%@]JU+CETSY534I36EP%XB(V9<RO+$Y0U
M/[LT']E'TA3RW=+G336^#?<,QMVHQNQ#5[6S-\QQV8J<7#5N--#3VM9.:;O>
MMNP'0I96%TF5+6R![PN!O/+%:BS-_1J4=6WQH@CTY\ZU>%JTBIWY8 ,8C G)
M8YI+K"/J&%Y-OW3]U6\)S?LT_J3W6B/5[%F.EPA]0I7M:;#U;!S+3%F%!KVN
M8Y\=N>U2I$=)FEDP'O[T:X6^CU42Y8;OWVX&_P"XBW#S/JQ.!(,;#CF4^['-
M1QOYSVJ_<QO"5HZC<(!,+L3G#/8ICR7MZZ\+90U@&Z-Z\9GO6K5_E$TVJ M!
M%H!O*RMF7"97N8TEKK!?;&XJUF<J9KFL3937>_AGEFK"\NL*K6YKW0+HQ,+]
MOL6]LLU)5OF.B=FS$'""9O#IUU%\TR:X-C'+$X0VK5X=)_)+S)[RPVFW:L<O
M9TGEK4KG3)[ 3CMQ3PZYL=^<"4,N:^FWH6O /3#O4N*]7QW,>YF@Z32B@80&
MV!N.Q<ZZ26\.XO)F4)?%\L-N^LR;.9_L6>'>1]0GRV1_1*59_P UD_@KGWN>
MKO\ %_)[!5/Q-_:^M>#MR^MTX:JRT(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MM1J@T.:7<C;ZUN3RS.5#U"<)I=;'VV*R8Y:SK"LU$NTPACSV06:B/;O;\+8
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M;PR+##.Z[I5BSEP6FA 0$! 0$!!Q?\)Z.T(,* @(" @(" @(" @(" @YM?"
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M3IVZW<JG<$5TVHJ)'O1C,;Z2%SO3M]&[UOKG#WBX(TR94TS#NDQ#1Z/:O?\
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M9P?*A_59.WZ"Y?+QB._P;[N\:GXQS=R\%F'UYPUE%$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?T3OLT-(;-^7^CF0B?J-)==^1"_HG^H_(O3\;'V?R[_==?\ ^Y>[NJTADN
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MI1>YWNNMB;L[,EJ[3+3_ #);'PW)F"0I]((A[CL,.<Y+?/#6<Q;].TXC=L.
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MIU=4_E'?MG>I=8YO"P" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6"9J+YDJ!,1""_(?)WQWP_I_P?%U[?%*@YLGQS$C'GO7Y_\ V?RV=;8_<?\
MC?X'3Y?DDOV=[>6=$R7.EDB'P7A?COD_([>W^7]9Z?Z/XK\<N/$>ZNBZC*I*
M25[S6PEB\C 6KR_-\E[<OM_Z[_2_%;C"D\:<8-ETT]@FLR'O;>=>/$O9^D__
M  #\77I+AZ0<>:T:ZL>=X&)SCZU]#\;\;KW?'_+_ -3\?3MB1:/+0A\^E!_R
MK<=MB]_7\'I:^=\OX'2=+7Z;^5U))F4DN.[]'*.U?3^'_7],</PW^SZ3X_EQ
MX>PGYGI'MA 7#+%=>W^OZ3>'Y_Y[_P#=HQ_#]-XF%^0QN7'M^/.E?C_S/EQ\
ME_5M_FFGDRS"%@V7;+%Q[]<3V?.^7Y;>M9M.,F1.;!S;#L&:\/?Y[UN'Q?D^
M3]V5Z?JDJ73?$VP9C):^'Y^W;MC+K\7R7LH6K\0M:3NO9<;S[=B^CUML>W'T
M55G$CS,LF-OS.?.E2Z62CUYTRPN;8,]MF*N99KE9/+5U/66@?&P7\KTE;URH
MU7Q P3"/%;><L^=1CMN,]'J JB!O!T3"S*RSTHB?.B_76B#'$NR$;[LU.O.V
MK,-JEX"/AU%34S629=/+,T^+!H@T%V)A<%KUF<N??Y<ZGE^='SA?-[PQY0:3
M5:1IU90_G%M-/EQESFA^^UI'T71O7G^;YYUF)R^O_J_]9W_([SMWE]<OEX\W
M/.+C3SGXFJGSIE77R)]0YE-24[9T]TSQ9@+8-;O0!, +%X.W:W^3]K\'X_3X
M>OKTCZ'_ +&S[$CCSYCN,-%\R.+M'U<<*RY-)5S*>HH2V5X3ILJ8^Q\JT$#%
M<\YFGK]9U_1_2Y^6'Y6?+;Y:>!]#X=X'TAFGS:72*6DJGME2I1<]LF6V8"UD
MMKHQ;FKUF&>W;.IP]HUI@0$! 0$! 0:.IZC2:1I];J=?/DTU'04LZJJ)\^8V
M5*ERI$LO<Y[WD-:(#K4NH29N'R(?;-_;T\,>2>B:YY7^4.OZ?3<64M#72WU5
M-7M?.-4?$E6.EO$ -T0"S[9=>LG69[/YR'G7YS>9'S3^9]=Q;Q;656L:SJ=7
M-+7CQ)Y:)TYQWR27?$38M3_U8[]IN_\ 2_1#Y3ODQJ@VGXJUJDG[[&RIP,Z5
MNP!@XW@617J^+X;?W5^;_P!E_M.O3/Q=*_5=M-*X<HI.GTH#&,DME$"RQH (
M]"]TU,/R/R=K\O?VJLSG;\QQSMZ3;ZU99(N+?T8BP.PC!9Y:NIB-=])O&XXX
M=Z9.LPXMI2UUQZN?(HEM\-^1)MM$+.[:MKTS_P"K%5RH0@!?AS!1UE^JNSY+
MB?AMB<\QS*35=.7*EIW[X]TX^I:S&;B+E0R7,W+#>#ZEG.4F;5KIVP;[T.5R
MJYG#+,+0V$1@A?K&!CF[UXOSVJ>6K?V_=EG!AE6;L89\_J3))K-5*K(:76@6
MX='2B:L8*>: ^^-YOAVK6\88FJM5+4P:+1\.>U8L=99>7BLJHRW6B[-(O;'A
M1M4W9L8VQ!&>:N'/.9]W7U5I GOCNDQ. SAL4Q4XJ6T[1Q):/=(Z,+.]+)AK
M,\-Z=3>&;H]',D(YRWF6+%9USR2-6LJ'B6^S XG:K;AFNOZRHF&<ZPWG/-.4
ML3&C;SW,!!CO##FV(UC&Z[<TV1&4VPWC _>]"K//"P2I&ZT&%PC;'+I6/+<E
MR.<& VP[UJ?1+;EP950C$@\Y]BLF&G)U39?U'N"5F]M:153,<Z-N66'1M4L)
M]U>J'$&/+Z*GZKB,]&Z,,RX)BVI)A?=-EQ:'0$0.Q7BX\%S-K/+K'RI9:(V#
M/8K+@ESRBJRM>X.C&_-26K<\JG5U+SO7W0OR^XIVZV5,Y0$R:_>MCTPR'.JD
MF626^XDX*UGTQ<I2GW3"[D1WIX;F$O)EL.[&&.>W.Q,:SY4J),O=PN-W1M7.
M[+)=^5/U0"426V<WMYE.NN45KZS[V[S\]\%T2VY6K1W;[F1,;1UQ'<F5]?+L
MS3Y+0V,!=RQ4]DVVJF;X3;.J[/O6N2<X5.NKB21^R(OV)-7:V(J6\S)@!O-W
M5:I=UI8I=%O2HPN!PV);&.>%9U"7N.>(8&WESJ3!A#M?!POQ["FRS'*?H1OG
MI%^6*NVLZ6.73 PL/4<^M$EP\S)1ECKZX=:&<UHNKS*LC \^U3PG:XX<F:@Z
M99&/,>CUIG+4^[2K)TR!,3:#CML]">L7.%<J9CK;>S]CL5PS[-/>)Q/6HO)$
MYGK16267;S3$WY[%>4M6&E?[S;XVPNY7HPGI;CNBTPPYH!!K59WF.&SO"-8O
M*D5]*'O?ES<LT9S<H Z2'/CNF^."G/#<LO+89IOAD$ V;%K&ON8<IDIS+@;M
MO+%28_R:K1F^G=*MSY8PU(;%%Q6JZL?3V P.:9\%EFVQ*U>8Z WHV!3%Y;G_
M *I>5-=. -MW/:M9TS=;<IC7 &P]2QYRS+G:%FU$QCB,+<=JUF%S-USD3GO=
M"VV SSV*<-S<28ES(;P!'**SNLR92-&'3' .C &V/1S+6H>JV2)$N6S>LC >
MDJKQR5%6)+3 X''GR4NS'T0KM7F!YW766X^U)-)+<[3%)K$YP$''#LY\RJ7E
MCK]2G/:8DY7[ I)(BI5+WS9AC&TC;9$J287-NI]$Q1:<9LHD@VC+9''G5DWE
MJ=9G-0=?H@\7>+#R/,IG>#,SA+:=3-D, (QQLA<IA)JY3AF,#?B%WJ5SB8\I
M;Y1TS=>_ Y=-JLX-I:BH=]P(&.2S+X:DSNKI3436,;$7 8==ZVSHJBR4W 7=
MZB[B&,N35$M,#=SK7K4[?5#5^DR98+@ ("PV&TKMC6&%?+9<HV%O.GAUZ)N@
MJ6X$8>CH6),.N5KIR)C1 W@J5Z/CENWE](Z(,#U',G-9W7:6-VFGS*8MA$0]
M28R]72V<+QP]K]0VHDLB?RK0;3F(XJ.DN;E^C_RO59J-=IW/-OUB0<_I]*YW
M;T2?M?5M\N[A^B,JW_FDG/[Q<ODF)MZ/Q_Y.ZZGXQS=R\%N7UYPUE%$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0;FG_ -.I/X9GX02<EX>GOVBW]VM;_9\S_&6\W$PY7A\%_P Y
M#@-<U/\ @)_:_)=>N<;>*V7Y+A^ _F<\C5IA!LWYOX6U:9MKI<3_ 'X1C:?7
MM6;;.S4VA-7G'<< <>6*M^M7&%9IYD7$$WIREQ8G::58++2,^96I$O)D1M(S
M[.90Z[2\F1= ?>YY[ I%NKI::*G]T&&([>:*U;A)]T\R3!H!&&W+F6,[7&\P
M,B)NLLY705R7%VX/DPA9?RV*9K"/J&G=NP[U9;6_VJQ5@MWC"%@5[)C%^RMU
M)=$PV^I9DWOA<9B'F$P,>5JZ:9WY153:##;ZPN?;/^&XTV,S%N%OM4G*YQ$M
M3,,0(9GJ^XNCGFWE.4\NP6>G]KM3C=:M^B48R$;,EF[X-WAXF,BTV<KO6FX3
M*#GRK1[N6//M27_A+RUBP $0MARM5QE&G-81:19!2_2&\81,Z%L+P/4?6LM2
M?5QIW'?%MQ!]2LN%Q(LE+-@&F.)P]BW6>LPL%+.)+1'$>ON4Q"Y7;371:+8V
MCU)?MPY]IA,*(RMEQ%HQS]JF4S'+PQEZ?:F89CP9>0]/M4M2WZ.+I9A=Z?:D
MV2YY8X0P5Q&L1Q<T$&Q/"6-=TB))ATV9<RU.VL,X89M.2(6\B-B2S.TL_P"4
M144A@;#;'#85K]JS41,R1NGX<3L[EB_9J7+&!NF(L69E;)4E(F6#WL1AM.Q;
M<\)F1/B;\3ELR*NDEN5CI(N QL'K6^L_X=/:),2SB/2NOV\,6WPRM9##%6S+
MIG6VXQHA=;9%8N<Z<+-Z9@V-PM@K(LC9ELA:1:0JEOB<LXEQMAZ?:IF-3,_4
M=+]T^[Z=O.IEN7ZO$J5[UV(QY]J82I&6PVB&2G"XF/NW@R%X&"L9[2<O)9&X
M+<GE)-LTEL(1'*)CZ$N"S:6D,NLY?<4TDB5EM&Z+!BLNGC;PZ63;# KMTV\_
M?7# 9;L1VKI)'/=9F1B5,8<]I&0(PYAV%9L^C6Y/LE)=F[M'JBM,MX"#01DG
MV+UUEYWR+S8F(Q*V)$T"!CB.WH4MIF92DJJO!AR@I-L]NV&VRJ=;T8#;M6G*
MMF7,<\V\]G,I6:VF,<XBP^G%9SLXGW;DN0?=S,?7LV*YL9Y2M.'MSO/H25FI
M>7-(@#G?#VK6+C3,N$A+G9G),;VZS<C>95!H(B-D?84L^B9K*ZLLM(@>6"9^
MG*9MY:<^IBTPAT6X0S4S<ESQ&D)AC9&U7;.*DJ0D"V,;(1YE.6;]UAIG^\V)
MP.&U7;/[5WTDM(;&&-_[563/+GVNUNIRV++1>/2%KUAVY6BA<V#;1>,L@%BR
M0N+Q]%IDSFM;?AV *9RY730JZFPD9GJ'.5&IC_*H5M6=Z (C$IB7EFHKQW$\
M^SVIC;.+RDJ1[B0;;2,.;N5K':+33.=NWY^I99RE)+C$6X#L*NV.UB:DO&)Y
MKKK%O,B2MZ6\"!B,<1M6;M<WPW)<UHQQV=Z%SY24J=&V-D1ZQZDRB;D5(#81
MM'<-J+VQ6O43@XW[.HG**<(Y4\YH($<1VG:%J9Y6;TN&GSVD#9;U#G5]?*+C
M3/;NWY]JQQ3#?;4!C;".14MRS;9<1A=5QMB+L#[4M=),-B74[T8G*'*.U$W&
M]+<VTQR[U4Q<I"FM/+:NELPO$;,XM#3T'T=X7+/;P2_51-;G@2W0.<;LN=;S
MFHZ=U.?%S@#](^L9JX+:T*)N],B;3=:LW$JS+LC0Y).Y9GGW*?H6Y=G4C&B7
M"%UGJ5PSRT*NK=*= ',7PQ6<[^QJ-=M8YS0XF,=I5]JLF65M22!?RZ5,MS4<
MQ4]>%GM5S<8B69KE]:=L]"S*F&1DZ,<+NGTE;]JRSVD61Z%,WLWVX-PD@N'6
MK<QG..$U0!@(%EA&*6>5M=E:1N-@;,-J3_T27:X![=T0. [%<9C<W^BM:O.@
MQ\#&^[F.1 66-<QU3JKW%[X<]RZ2?5K,032^..."YS.=%QA/Z>QSW &-^,5J
M8E<\6KO3TS/##OI0CV+6&^(X5#Q*;81$1'H6>-+F7A6ZK53+:X1M&1YEFS)I
M69^JN<XP-YC?GZTX9<&3WS;23Z<?NI+FI;]&R"V%L,+UN:9F?+4FS933$D6D
MD);E;]DQ0ZG3RFQ):.G(;5G,9F5=X@XQ91@ECFPV.PLN4=,:RZ.UWS5FR7.:
MU\/><+'Y$@9*S-,J>WS,K*J:6![K39[^</4M8^K5F8O6C:O6:@9<2\[Q -I-
MAM6;C"3[NU],TJ?42VO@_;>;S8L3)E9Y6E390M#X@1QO%H]"WBW;++N3&G=]
M[K4S5G(93GP!!V7\V2C68S2Z-L/>%IS5QG:?:,S:.4(Q Z;.]"RSEKU$J6!
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M_P ;Y>O>XCV?!+UF*_/[S>X?+C.(!M:^$!A;'%?4EG;KC[.T[7IV]ON_-GS
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M_&N.D:$R0\6$8]G0O/\ E]^GIEWZYMS'&53F,;>70ORWS_+/;3UR:2%/+<'
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MK/6W.?"6XX7B7HS&L$ ,[N]:MODU8I^OT3);'P&>7/"Y:G":RZ,XA+6F9:+
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M?2O/_5W]M9?H^W?/Q_9TY52ZK4:@.;OF)CB=B^]_K_Q_DL?FO]A\W7I=NXN
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MI@W<;($\@%:ND*:"6)@B-GI4_4Q_^2N&F4LH2OHW#&& V+,Y2Y:NHT\F)NL
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MQK(H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,8=VW$+$F\LR[7O2JUDMUAM!&/.MVIWNM/8G@O6&CPP3]%HO&S:O%\MP^/\
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MS7]%^'\GM_9.>7._E=NTV_1SR==.JFRW1=\,O'8OZ[_X]^7W_P"W_P /PO\
MMNL[?/G[O>7394RGTUDQT1"2#&[Z,?4OI_['\CO?AKY\CKK6=9/UATD.=\6[
M?9>0OY?^?^1;\UMYRY]I^U6M0TJ972G/ )+FQS7YC_=_D=OZ+CZ/;_JNO_WT
M=<5?"]4R<YV[8"<#=U+^-_G_ )7?^^Q_2OQ/CZWXH\2-+?)(WA#G!PBO-U_)
M[XQ'IOP25SJ9;0TM(MAZBM3\GO-M?T]>?+K'B.G:^687V^O)+^5VJ]?AZ\O7
M?B:A]Z;?\1P.:?\ <]VOZI->'5DV1X<TQ)O$;?NX)?RN^-NW3X.GCE8=,F2V
M!@)M]JQ?R.V6Y\77E<9&H2);+QUA<K\W:UJ?%UO*/K-;E-^%QQQR"?W]I&Y\
M4GZ*Z[7PZ9 /=:?OMO/8N';Y;ET_KF%DTFL=4. WG71M)S"S_973I\77.'<6
MAZ8Z>&.,3%K2N/;MEO\ JZY7MNCMER@7 79+E\EN%O294O6WT]*'[Q @#LOA
MWKCFUK^N.L:K7:9DPC>S^D,.E5J_'(V*/7*>80 [(?$,N?-8LVG]<JZZ;42)
MQ$"#"&6*[?'QE.W22:Y=@:;12YF[ #"R]>R=O$</7_EVEH6AMF%D&M,0,-O5
M<NGQVVN7R3%=U\/<-AIE'<;_ (/LVKTY<.V,:=T:11MHV2S "$+MEOJ7?I)8
M\?S6^5TEZZVDEP!AN@0MACSK7IUX</D[Z_P@=2X[,L%H>8P,?>Y9KT]?Q^EF
M?#YGR][E0*SC-T^8??<8G/VKO\7X_3V>3OWLB?X9UKQ*QCHFTM/K*_0?#^+T
M]/\ #YO?O;V>V7#G$#I5)+M(A+ OAEW+W?B_B_'.\OER^7MISU;B-\]CF!SC
M&(M,>5J_3?%\4G6?H^;;O;4X:DS:VMED",7#;B%[_P 7XML]^_K,/<KR\F5.
MCRF"6P.;.(:_>$1 P![5^G_%^7M\/QV3S'@^;XNORWVO@\WOEHX)\Z=-E3=3
MIJ#ZVUPF'^;RR^-AM)$;U_,/_-?]7\'S]+\^)_98_6?Z#_;?D_BV?%O^MW;\
MOW E-Y-:#+X<TX!E(P 08-QH !%PL7\D^'M?Q[_7.,OTOY7RS\C]]Y>S%3Q'
M)F[KBZT-&(OA!=/D^7M7G^/I$)4:S)>;#LOYL5PZ_+V\NOK,[;5!7ATQD#?M
MV+A\O?/+T].LQ';.@5&]X4-GHB,UYO:^6\8NW;%!,#F"/+%>?MC+T_')X2\Y
MTHRB/=C"'HAZESF+<.MF%1J:=KIQ-D(@^KU*]ND\<KUNF>32M($(=71ZEOX^
MF&>TQME?):QMPQRZ.Q>R=<S;G[?17]0FMELF1PZ%OIUWIR^3MCCEU+Q!J@E^
M*(X>I>[KUS''VRZ-XBU7X[3\.?/D5OIUVY]NMKIW5=1WB[WC>['->GUS/\.%
MMEPI\VN)="V$<UX/R9)'3I=L]/.\1XOAMVKYTT]699M>=+D,>6& C 1CM"U9
MY9N)-+Y2Z>QS!8#9ES=ZQ"YK--TQK6QW1;;<-F2WQ"5%3*5C3A$FZ"GE?(R4
MQI$ (QRYTJ^%HT:8V7-:XPO;Z;TZ\;X9O&7>>@ZI3@,!(CNM[ ,UKQHDRO@U
M"29;80^$\K%+2==NO^)JV2)<VT1B<=L.:Y:SK##UNXGKVETZ!-L<5FQN3S72
M^J3'3'/@3:T^M3$\EQ-QT_Q.R;NO/O#W79[2-BU.&:];^)'S@XB)^)V>S)8N
M;6L:RILADR:XDQO&9[U<//WYRMVF2G-#1"Y7+*YTYW6MC98.U2X,9C=;.CB!
MRYTA,]>6[)J0"!;=@=A[UVES&Y4W3U,>RWK6+U+VD;PJ8"$.SUIP2YC7GS3,
M%G5CAZECREOA'B62;E=PN$E32=TYVCU7K-M[:2\I-H N$%UZR8VTY1@EPOZL
M$V;NQM&'J"D3,B/G3X[T>?E;FKF5;PT?&]^'HZ.>"QVZWPSK#8C9O#HZ%.L3
ME$UVH&6QXB;H7[4[3>EVZAXFU'Q!-$3:'>F/>M=?NF=NA=7ENFSR;;SF;X]*
MLPUG+%IM-X<QI-P<,(*5NW]KN;AVH;*+1L'HL4<I=NW]/J/$#?VH-O*.*SMK
M_P#&N>G. W8D0]"O&DS4S/GRFL,87$X<V"IE"S:J4"89YJ=LS]$SEH.J@20,
M>;G5N,?=9,7?#!, ?;?S=*L<^UN=(Z>PG#&'+K4K4O\ [*M7M>P'=^^AT7\Z
MSB<M>UJE:A/G,WB28<_W5J3"3ZJE-K?QD"3'GS)7347=WX3-!5DEM]^:9AG$
M72@JL-N8S7.I<X6B5.$ 1?\ <4W=+UN=>65]3!MMW1A:IZV';45RNK6!I@<8
M7\ZU/NG7*E5M8TET";QBMXBWM9^JFZC4EQ,";8 6[/8LXQ5Z^UY:M)-=O"W
M9]ZF?'@[36UHI)CX69MS[U9A)JK'3S' 1)A?GL6I@M\1M&>0(DQZ>\I>&<>$
M3558W7=XR7/#6<*E5Z@&ET3 DV6^U6:,6\H&;7>(2V),=NTJ]JWUQ/U:SI6]
M[PC:>6"DWRZ>V&%\@PC;?RP5IUN\L1E@7CEVJ-YET\>$"+!L59N(X_5XX=GJ
M1EY^JG9U(LE\!I'0-@N^]S0Q5:U206!YV$6<Q*L)77&J1 <#?NGL4\F:ZWU
MDO@+;QZ0JSFYPP4S ;2-MO5CL4RLZYN5EI&MR'4,0BU*LL'2HMUPRKHK;D3-
MS*[IM6+RO69Y;SZAKVPV;%G==+).$7- <3"W[I5PUUQ>6'P8X<NA.&OV\ E[
MF&U+5GKX8)KCNF&WL*E8[7-5VO)<'8V)USY)G&U9FR2YW7CE#8KS6;?JD:62
MT"#AC'#(YC!:Q@S;-) -:(&RS'E8G,)JL,V>QD>:'2L67PU/7+5-9+S](4A;
M]&:54L=9MS"W9GA/U<JALM["8"ZV'+:LRXJXBHUTJ7%UG9W+IG,:[:X4FODL
M&\0,"O+\^IAZ/QLY5.>V#H@&,?65\^_=]/><U?\ @AH->TD?>?A!6:=NFW[S
M?)0P?7-)L_>)>)R;M3/U:LN=/J]^5IG_ &3I! NDM[%)9'L^"6S%?HKIA>9$
ML6PB>U=,ZT[WKF[3XN',N;K-1$SICO%(CCZRL3EOIJL-?;1GF5O+O?+J^I_*
M._;.]2Z1R>%@$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$!!FD?E&H*=YT_W?S_X&;_)%)RG;A\7_ -H.!]:UO^T*G^4>MVO%;;I\KGGX
MTG5-4LL%0[M69CSR8Q,UZ5ZDT^.^S'O3,<9<H>='=Y9A7I;G:V81R]#(@Y"Y
M1N</(O'.BWAD6&&=UW2K%G+@M-" @(" @("#B_X3T=H084! 0$! 0$! 0$!
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M3;*YK94(X''9L@C-UPK-=.\5SB-H/8C.=M*GD1>VP6D#.\I<>'3.(O.E4C1
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MEWW=.DNGU=_+@QPX4D1'_-9/\FL=_P"#O\/\H[]J?B;^U7S^US7UNNHU5&A
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MW:JS<RH"HE/+KCR'/M2QK,<)8+# X ]<5,&JSL?[]I$/:%9IBKGI=0UK ++
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M"O+?7,_1-4VE32+6X X\V/,LYLN#&ULTW27"8TEH LSV;%J\'9?Z2BEL8V(
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M]O?*WK.'2FO::&F9[HO[8A:_M[-3I(ZPU"E#'/L'/T *_P!O99UD0$RE<ZX
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M )'T>CXW9W"VDN>YKBS 7QV+Q8>O#O[1=,:V4SW +!ROVJ^N5LB0K) DL,!
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M4SEQ78$'(7*-SAY%XYT6\,BPPSNNZ58LY<%IH0$! 0$! 08G.C$0].10<$!
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MVR&:MK,MPWI)[5G.&I,I25.W1"^'+-+<IQ6XR:8G.&:DSDMF$G2O<Z%IRO.
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M)<(BLX>9.EO_ !48MRV+WW\KK[3]7Y_M^-VGAT?QGP,*ALV%/'\6[#-?N?\
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M4AP\U[JATV5+FNDL#'[SWMC%H<&$)+X:[?%B9C\^/EY\]]0X#UJ3I^JU#V2
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M@-L1SYKGBW;V?'VS/NS:8QQK91_Y5MMOWT<MJZ2Z;G+](_E9$-9I_P#.*?\
M#7/SAZ>DQ'U@_+E_LA)_S21_)K'R\.WP_P W>=5\8YNY?.[/K3AJK*B @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)AZ6:WJ;ZBOG-WX^_P"M?E_]Q,?!?T?2_P!;)_9+]V-TAQDAVSEBOXW^?O\
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MWK],5)=-XE3]#4C?$=AN1),1W!PU6R@6&(^$8[0DFTMS7LWP9K<B7X.\]OP
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MH:E;3..P\O0CK=3#JZI_*._;.]2ZQS>%@$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*;YV?W?3OX&;_)N0O#XK?M#OZ5K?\
M:%3^$]6<O)\G,_5\I_G_ /ZVU7_.#^$M7AF\/2NO_+N7-P[<M?Z(Z.Q=/BY9
MCPNZB#D+E&YP\B\<Z+>&1889W7=*L6<L:TU;AA+2238F8P\;AV<NA/:!N'9R
MZ$]H&X=G+H3V@;AV<NA/:!N'9RZ$]H&X=G+H3V@YGX8;!ZDSE9RX(T(" @("
M!"-B<)>#<.SET)[1DW#LY=">T'G=.Q3+67)AA'H]:O"VX91;<IE/9D:T@VPN
M4MRTR;L+;+5,93/AN4XC#E:(+ITU<.7>8VL5)+@;,F^I>B229<\YVL]&P^[;
M@5.U9MWE-!AA8I)[;=.O;6V.8PPPO3C27EHS)1/7'#O5PG:8:IDFVY3RSUZV
M;>6RG CGV=ZE=,ZPFZ0N M)N&.SV*26HF9<PMA&-ZZ8S&9CEE=.!A:>L^Q),
M+R\>,WE'N48DRVY5>&"&\!Z,UGM<GI97)^JEL3OB[,)&\ZQY1D_5G/)&^#;@
M=I6K=,7G"&FRWU;XP)&,-I]BQ'/LDJ/3G!P]UUH.!6L9F7-;Z'22=SW3A]$[
M42:JZT&G>'NQ;"V&2WF1+QI9I$H2P(6>G,++.&\)X8(XA9K/%VUYM>&Q,<L-
MD5>OT+VSPG-'/UMP&?1BKF1G&;M?&Z6&2VNW;86]!62R?X<2ULKEEM4F8X]Y
MEKNK PPB!?>,EOF,>N-L?UT$_$.I,-<.;9H? YK%B9;#)9<0<#W*\3+':Y9C
M3/<VP6'EFD[;9QY8I>GDS!8>45WE,YF%GIJ&#!9AGFM,>62HHAX9)R.(4^RV
M84^NI&QANX'$9$+7KY62U"-I@UT80M&(/H4EPN+*VH[HY@!ZE%P@JR:^),1C
MAM6I-)9'&DK'L=".:LFDE^JW4=>[W+<L]IR3;7;';A=:#4!!GO"\+,VSBK3(
MU)K6B+FW#$;4W*L[8K:.MAHAX@@(;2M>%_DU9FN@D@S!E@L^K.+*P_G-KS$.
M;E:0K-+EGDU[0?B'8+4K';<2PU9DMOQ#K&7L6=N",JN((1 F##8K5O"M5>M[
MX,7M,8XYD=Z9S,$BJ5569Q= Q%HCTJ&-90[P\N-_7MYU8L35!*>]P&5M\;X;
M557?3]/+@(B)AZ8*3LQ5FIM!#VQ\,VQPV@>I7[M^&[^8@VT,(Z#W*I)]04.X
M1$0@,X89=*93U;]-+#' <WJ"SM9,+KI<(MC<JJ[R9;7,!LN&&SV*>V&;,[:5
M3+ && NYTRF=J1K,D3&O$,#LP"FUKKI]"6S7'=-A-IVV)C),UPG-+ 0>5RUP
MM:\H N%G*(2=I678G#[&G=LP;V!7MC"+\^EEOE[H%I OYES50M;T<.+SN$[Q
M)B 86V^I619,J7-TAS'$AIQP.95P8K5E:8_Q&^Z[XA&PYP43.'9.A:;[K8MN
M+;QS*2_5N<.TJ"F9+9&& ]'-SJY+PWWS&LO5D9DRAJJ<'1 C;#T0[U9]U];=
MJK72G38P%AY>A:\,J/J=*^+H" AESK,BYQRKTN27/(<,^?%,8<^]TS3*<!IY
MCMP1RNXK=:V9 [L; 8PSAW*X\KUN-5#-ESG/@&NOV\ZQ@\NP>'-+JISV>X_X
M1G@1TJY7'A[5\!<+5$\TX\&8;!& ,#8J</;_ (/\O)\]DG^;S#$Y'8LXJ.[:
M/RDJ'R@_ZM.L'WNP')5;O41=?Y>3*8ECJ:9$ _1-P:K#%==ZYP/[AC3/L#OH
MG:KVFLLXP];.,^"VRVS'"0Z&\XW';G8L]>&I7K5J_#WA39@\%P@XQ,#"P^Q:
MZM,NE:=+E36;S(7W[(9K.,\L^SM;39=,QC(M%D+^8!9S@E24Y\@-@(6Q]$%J
MKJ7-X5ZHELFNA"P]"^__ *Y9BW/A,Z10"((&(/:5^EG&'76-1W7PW1$[GNV[
MH]6Q?,_(Q+_ER[29=Z:%0O(9%KC9ZEXNTSPY]M33L>FH'[@&ZZZ"\'R]=[>>
MWMC+S443VL-A%EL>6Q/B]9=N7;MV5&O#I9=$\K5];X^LO73A>W;ZJ=7UPDM)
M<\?"Z^&U>S\7X^O]F+]7.]NTWEZ^^8FK2YE(\-F-)W7V1&U?K?Q_BZ>F<)>]
MNL[KT*XM$^=432V)'BNNZ\(KZ7X_3X_;&''-\U'\.T[Y=0QSX@1Q]J^]TZ=/
M6:7&9]W;LW4Z2CHXNF2VEK1>1DIVZ2\,9Q7KIYD>8LB@94"542P0TPM@;MD,
M0N<F)RG:2O2OBWS;J'S9C653+6N%CL3':O+^1\DZZE=_C_%GR3AT]6^8554N
M)=/:8Q^D<8[5Y+\OMUY6_BSI<8==ZUKLVJB?$!B77'/F7X7_ '?R?NNWZW_4
M]>GI)CPI1G3)A,3>>TE?DKV[65]OMCJ\AI.2Y^]_R3=;TMN[:=B>U\.W6359
M7O$+ ;UP[6NG63AI.= Q-OW%RO;,9Q^YFDN:2+/0,X+A9BNFFV_X#S+EWN:Q
M)MI$P7GLVZ9\..]&Z(4QCEGMMP67-R:;;8KGVW-$C(N-ZW*O"SCP/!-AYBKU
MFXF8UGN LMNARZU[.G#48%U! 0$! 0$! 0$! 0$'(7@<_8N7S3/2M2^$C3R(
M[L<;^L+\[\_:SM6IEN/IFM$8#EU+E.]SM.TN&DZ1OFS;CS+O.U<;F!HK/A7H
M_'[6]ML?+<=7$4IL@TQ)]:^KG6N'S;VWG*4I:-T1$98[>9?2_"W=O-\UN,Y6
M2FHQ9$=F1VK[W3IF33Y][]IY3]/HQJ"W=83&VP+ZGX/3KQ7'Y>_;&JMNF\*/
MF0/@OA9<.62^Q_7UQ).7#V[?5,3N#YS6.(D/N<18[+VKZ_XO3K/#G>U^KKW6
M^'ZF5O#P9EQP.6:^A_7U^C,[]LXRHPTJJ\7=\)]XP/;!>SX?AZV/3T[7&W:?
M"/"\^?.:#(F'X,#FO;U^/IRX]ODN=5[I< >7)J&2=ZGF6RV_1SAF%Z.GQ]$O
M:X>U/#7EX-/E2IPIGC=;$1%UF8"O?KUG'+?P7V[8JV5E3-HY+I+8M# 1#&RQ
M9E[3BOT?P_#\5Z2V.JM?KILPO]ZT@@KA^1[>KT_%\?QRXDWEU?4B;.FPB3;G
MM7Q?DZ_NR^EUZ]9UTMF@4[F/!<,1Z%Y_DZS%M<^ULNG<VGZE+II8)<UL!;&S
M!>*_'TSPD^;Y),95/BOC.7327 3V @D7C =MJ^I^)TZ?1^<_VGS_ "R7%>G'
M'O'TYTZ=+9/;:XP .'7M7UIT^//#\S_W/SV62NL:.HFZM-#GG?C;RS7VOP^G
M6XP_._[#Y_EF;VOEV#H5&94V59"$P=H&/,OM=.DQBOR_Y/Y/>ZE>WWEX7"5*
M'[)OI@%B]9*^9V^3O?+VZX?E>)($<F^I<?R)_P#=_P"&_@[=IW_REZK2M_W@
MV^-W1ESK\9^9UE^7_+]-^/W_ &?X1TO37,=\)ZH;5\;\V>OQU];\+M_]Y+5_
MTV6Z3HM6;H-)]"_$_D>N>S]?\,_C9]'S\_:13S,UQC28_CY>>$UI7Y#_ &&/
M9^X_U._C_P /U)_5BOK5)\PAJ)3IC951KU*R9N1@Y@,ACA_Q5\KM</M]']$'
MYY?D<\L_G'\E=9X1J] I7ZWJ-'-ET=<);!/C4TP:X37S 1%A#8$0O*N,Q9WO
M7MOA_*1^U*^S=X_^2'SBU;2F\/:W^9W:C6[E2*6:^5*$N:=U[2R6?HY)+XIW
MGM<]7HQ\N_R^<?\ S)>8^E<#Z%I&LUDRL?+ES:F123B)'BSI;&C>,HM)<(\T
M%;?'ESZ]<U_2S^QA^Q,X&^7K@_ASB_S-X5F5>KSM'I:B7,KI#?$$Z8R7,#=Z
M9+)!BI)?+K[>LQY?4UH>@Z5PWIU/I.C4DNBH*66R5)D2A!K62VAK;+HP"TY6
MV\IA$$! 0$! 0"0 23 "TDV  8E!ZF?-G\W'ES\J/EMJ7'W%^MZ++^IT]5.E
M4-372FS9GU>47EWALG-F!H<(6WJ6X;Z]+VN'\O3[8/[9+S*^:OS*UO1> ^*W
MTW";IU7(?)H9TPR]V=.F,<&M8_<+RQH Y[E),NG;M.DQ.7X[_+U\NG&/G_QB
MV3-T_4IS*JHDS)U493QXSICQO/>=VV("Z].E[68X>'\G\GI^-TO;O?W/K_\
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M87/Y>'7X/YN\ZKXQS=R^=V?7G#565$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^B.CL73XN68\+NH@Y"Y1N</(O'.BWAD6&&=UW2K%G+&5;GPU9EQ48>% 0$!
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MRT\HN$>6*^)?FG$?5[?!;NI*7(B(P%ZU/DDY7^GZ.>[ *7Y9AN?#9-L#W B
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MJH9-DSYM&P/ EN<YD"^6(6K,ZW.:UV[]?#Z.-.H*;2J&DTZC9X=+12)=/(8
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M"((NZX)EBW%4J=4.,T,S@!;M2W-T1<]#TAU8&O(-IRV#GQ2::N+J.T*#0!*
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M2\Z9DMX4KB"8'!_[4J7&&L2.IZUX:\=RDF=LW5VW]*K2U[1$?$.P+<Y2=O\
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M0?B?[:7\J8>'\SX+U_'KU6X^X'%1+GO#&6N<?@V\R_O?_B_YO]GX\OV?P_\
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MG;I.J]>UOZ- RW P@N<Y>B1LU8(HC'+O6O+I_P!+K.I_*._;.]2ZQQ>%@$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*;YV?W
M?3OX&;_)N0O#XK?M#OZ5K?\ :%3^$]6<O)\G,_5\I_G_ /ZVU7_.#^$M7AF\
M/2NO_+N7-P[<M?Z(Z.Q=/BY9CPNZB#D+E&YP\B\<Z+>&1889W7=*L6<N"TT\
M1&8ZT"(S'6$"(S'6$"(S'6$"(S'6$"(S'6$"(S'6$&(DDD81]:N3$Y<5 0$!
M 0$')GQ#I["@R/\ A/1VA!@0O#BJYB#9DBT1CV8*6-^,^4Q)%E@P[UFYX2Y_
MPD)3+6D@V]ZLS=%MFHFJ:2( PPV;.E=^LWAP[6_Y3E/+_8FX9Y*N<FE@IY<
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MK;CVF)N&/+->'Y_S-8CY/Y>9R[IT3B(-$OWC8W/N7AGYF\/F=YGK;%O?Q/\
MBOC-V97IZ_D9FGYS\WY/7M75_%7$I,NH]]WP'Z6Q=?B^?]\_5\_O\TG5Z><>
M<1$/G'?>/<?]+VK]G^'W]OCE?"^?\GU[W+UHG:L[4*_PBYQ]Z$"<XKZ_X??_
M .]Q]V.GY,[?HO5!H7AR?K! ANQNYCZU^_\ P^W_ -UGRM^=UUQQQ2-+HYC
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M#=9?\/J&Q5G.T]+ :.6 5S]6>US7!]_24E;Z\.0%@Y@L]OHN(U)@@YW.M?\
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M.GL*3@9E1L2IC@8<L2DDE<_DF6^)AV+5F6>MC;ENC:2+NY<]RXC/?$2$IT8
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MWE^[\_.(Z\OJJ@"8X_C#82<R<RN=[]9'[;\;K_\ =R7Z,&C.\2:V(!B5^?\
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M_9KX^WM6A52=X&R-ASQMP3#I=<*Y4RMTFR )(Q2S+* J70C9RL2:63RB9E5
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M'O\ B^"=XS& RZU.OS>UQ&NWXOK,N#CL7NZ?N>'Y.GK7$%=>O3;CVU,LA,0
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M\O\ RP-/)IW&F8/Q3<!D-FQ;_P"S^SYE_P!E<^7= X.=*EL:)($ +!]U?/\
MRI_0[]/RK\C$>!'U9W?"!B8=?K7R[^;C.^'HS[82=#Y3/?,8[ZNV_+:,2%\/
M\S_;WX^W-?1^#\&?-)7=/"WE8)(872&6/!N&!!7S?_P_V^M>R?ZF?1[#:%P1
M*I)6\931  V[ OG_ #_^0]IVQEZNG^FEG$25?32J)M@ A$=07*?^1=L<M_\
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M5_I/_P 8Z>GX?QW[/L0_53:3PM3IYF["+QZ6A?F^D\OU/S7,?? NKS" @("
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M" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @("
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MR[FR6Y3MU=HZ76@AGO"_,[.Y'.;TNM-,$QHMC'VE+,K9A(>'M]"-3AL2I6]
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M-.27I=->4F[X.8>I9[5;PJ&L37 .AZ\QM6F5)G3'[U^>>0VK%U<MR-NDJ'1
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MFESK*S.T8O82&'$X[4ZW,9X0U30NIG;T(6[?7:LW.6LYF(V*#5GT[_BA" Z
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$!
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ML]F.W6Y0%3I0E1.Z1>8VC',JXPF<5%>)X+B,CT6&U<^UQ6K-)[3*D/>P1!!
M%GLBJP[<T&D;/$LPO([E7*[=NZ1H;'M(+#?D5JR88G6^TK#K/"S)@)\,FR%Q
M]:\O:7P_6?ZC=BH-X5ER[?"(A$W*;DV_8S77?T:-=+90RR/AA&^RX&"\_P N
M+7Y;_9W]SJ'B'5Q%[!,'Q'$8KATZS^R/@_)VQUN'4.MR75LJ<0"X$';?=S+]
M;_KY/2/R'^QN>U>KW'.DNENJ';AL#C<<E]K\2?\ WT_5\O%OZ.G]!<).J2VN
M@(3@#_A#H7]7_P!5UQ\,>+Y.N>SV^IZEK>&P6N$?!P(.'6OJ]M5KX==L/0KS
MAK9SZB9:8;TP&[-=9?V/T7XG:9]:]!>+'.=.FQQFN])*_._[>W^FY?H?ADS*
MI%,=V:#''N7\S^;MCY+^KZ_3K^U8#6;K (X9; OA?[7OGI7I_'QG#%)F>(Z^
M^SE<OQ?R7]]?5ZS6?"5ER@\$G$<L<5+;C3<4S7J:UP:,-G?FKUOU;0E%*++#
M"_V[5Z.BS%2T%VRZ^I!,GJ03)ZD$R>I!,GJ03)ZN+FQ!A>G)Z^6+<MM@KAB]
ML:<Q8DC+(9@&:F+%F:X%\!&U67)>V8Q.<'#&,<566(B(@BRXKB))^*SJ'W5C
MLU+^[++NC' 9<Z\W;K,OJ?!\FL/.\ ,4Z_%+WCKW[:8W&U?6^/I/5\CY.W[M
MO+"&FWE>NO7IMP^2Z;+O> A8O?\ '?#YO?EY;=#&U/DS)E>O7,R\Q L7E[=[
MEUZ],N#B8V8CFS7D_(^2X>OX?AS<UQMS/6OEWY[+7O\ Z>K4F/W;">W:N7?\
MBUK^F6-46F %^U<.WY';/*_]O+X2=/*-^T8KW_!^1</G?D_C]<+%22\#GZEZ
MI^3VSE\^_C=<<>$VPAL!L]J^M\'Y5]7Q?R_QI>W^68/!/-R]2]GP_D]NW?%<
M/B_'G3MEXGN;NFT+]-^)\4[]<_9]W\;Y[\4PK]5$QAM]:]O3\62NGS_F6]+E
M&T],Z=.;!I,70L',OJ_C?%ZZL?F?S/GYV[YX"X==43)/XIQ_&L%@)R7WOQIZ
MU^9_.[WUOZ/T1\H?+UM1-E%TAYBZ5]'.W)?:GR7TT_'?-U]OER_7+R8\KI49
M#OJ[P/#EF[8-B\GS?+9$OQ2SU>\5)P!+D4<J$AXA+ ^'( 9+P7\G&7._C8OV
M=><2<-"3,<!+(ALYU^?_ -E^1<5]7\+X>NG+AC06NF,!EF_+:OSE^?M,U]7K
M^/FR.Z]/X<E>$#X9ZBOSOY_SVVOO?A_!B1BU'2I<II]R'NNOLN"^1?DT^I_6
MZFXB(DM="RQR\7R9M^SKUZ8VZ$UJH)>X$XFX<VQ8:LTT-)DLGU30<8>A>CIU
MGJ\W?OZUV/5Z)(F::\[HB6'E>O7^+TE[R,_)WUEZN<7Z(UM14P8;S@<!%?JO
MA_$ZWI*^?V_+O6X=":_IAEE_NGX2;N<+]#_I_P ?K/EFO+Q?E_EWUSGPZ[F4
MA;-^$W[1DOZ3\/QS^K#\M\OY-OR7:=TRF.\+,6\Z_5?Z/ICO-/C?[#\OMZ8S
MIV-04)>T6&X8'+VK^B])))GZ/RGR?F67&6W/TD/81N&/,O;\'QRV/#\_YG:;
MRI]?P]OQ!881NM7T_P"GK>KPW\[MGE 3>!9%4R:72[8'#-?)_*_#Z=[N.D_*
M[R.H>)N"123'.9))@";!E'8O%?\ 6].TQ@GYW;C+K]KJK37C=8]L'1N(^%?.
M^?\ TG3M>'J^/_96+31>85;02PWQ"W=LO. *\_7_ $GQSQRZS_9=K=5),\U*
MJ989X,/V71FO=\?^I^.=<8=+^?WQG.EIT;BN=J,UL9F]&V_->O\ '_U/2?+-
M>7'Y/]EV];<NZ7R?K'!FJS77^ \_\3V+[G^R_"Z_%_H?FN/^BO+_ *W\_O\
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ML;!9$IORMW6@9$H&$(;5&K<,3I4J! ]<+^97AG><HZHDL,>6:DK5NONK5=3
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M @(" @W-/_IU+_"M[0DY/#TO^TD_NQKO[-G=CUUZ\./;BOY]OSO@NUW5!?\
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MC]7_ *>R(6HT]CF'=AB; N=L?KNW>7IC[.B>.:6?)8_<#KWX<LEY?ENWY?\
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M8%MWHV',IQRLYPJ^JTH@Z-W,%+OA;,*3.I6[UMT;+!D%G.&+;>&U24S!#G&
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M4QY6XRF*:FB;C<W WFQ7*2+!(HB1CU;2DEK6I&"KI7LN!)O]"FR8NW"E\0.
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M\R_1_!QE_4J^4GC)W%'E#PU-G.#IS*>5+^/>.Z6-/:5/"W'M9'M.@(" @("
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MFL9X1,+(<C:M9Q'+M<QV'(KI8E@>[T%<[CF)+>*CZK5F-<0#AG[(*.=0M;K
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M_=JJ*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MG>EQ@2V*QG+G^J6I90>1NB_9G!:TU.JV4-!,.Z8&_N4]7262+]HU-,DO:3&
M=V=R928=MT.J&FIX1,0#CE'T*>6_769RK'$O%1ET[MUQC!UH.05,WAZP<4\7
M3ICIC2]UKW?2-UNU6XPWUEKJ>?JLVJF. +C$F\G,P[%C=;X<3IE567!QWMA*
MM3K+EMT_"M7O-=NG#Z)4W73M%ZT71*JF=++@X0<,(8A:NCI,U["<'B9(=+WB
M;'-)Z%9BS?+K'MKP;5M]TDG"\K);BZ>R&A5=-"7\,=P1MYE+J9+GEV)1Z@ 6
M!IPY>A>?M9RS;E<*6O>0T7B QVKG,6I)8WJB:7RR1ERR77KVZ\>4[=;E0-9D
M.F[XA>(>GN77IVF6/1U3JVC/F.,&X'!>N8QE,>%%K>')IB=W'+KP73X>\SAQ
M[=;G7"M5&B39<?=Q.&V"]T[=7#MTLX1,RBF2P0X9KIT[]8X]IVX=;\4-+6S
MW 9\Q7JGR]?*3KAT;K(>73 (W9[5[?B^7K''MUM=;ZEI\Z?&$;MN,5Z?[NEK
MEVZ]LZ=9:KPQ/FN)W</O;5UZ?/UX\,>MO/*/I.#JA[Q[MYC#=.)/<NT^7I-Q
MF].V5]TW@:8YHBP8?1Y9KK/FZ>6KTJ3K. ?YNX^&V,#]%=_Q_FZWY)]'+O\
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M/)#06U,ET28  C?S25G%O#W,I*J36T\JJIWA\F<P/8X$$%KA$6M)"TC80$!
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@IOG9_=]._@9O\
M)N0O#XK?M#OZ5K?]H5/X3U9R\GR<S]7RH>?W^M=5_AW?A+53_I>E==^7<N=<
M/+$VX<P6OCY*XF\\Z]#4X$! 0$! 0<8JLVTB43-(E#-(E#-(E#-(E#-(E#-
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ME@MMCCZU6<YVCJF0=Z(S/5?FKB-2R<LDNE+FW$\N=3.$]FE.:6.AM2W+4_\
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MAS!:^/DKB;SSKT-3@0$! 0$!!Q58O+PB" @(" @\B]%G+DHV(" @("#DP1<
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M5N<,3S GG[;5*Z==HW4K:5QY^7H0NM.KZG\H[]L[U+K'-X6 0$! 0$! 0$!
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M=7I^*2=W>=3\8YNY>"W+ZDX:RBB @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MZ15@,:-X7#$Y+;%U<NP--GL="T71OYE+JL6^U6V0X;C0 ;A@,25.;ECLS/\
MAZ?456+PT<5.Z3EY;\76K);MF\I*2X0 (Y6#U)><LWAF,L/(L&5VU1B\,C:<
M 0ACE_\ .IS<LLK9#1&/H^XEF4>3+:,.SN4Q]6IM@<QHM O.SN27+-YP\RR
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M @GEV)X+)9B,/A-&'9W)CRSUU<.;8 =*9;[8ZM&HD&>Z(C?<KAGVC?TNA+7
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MVP.,.]%OT=]\->70)8Z;(=<PV@]-_,I.V*W/VS#N>@X/TVEE-WZ=H(8!\(O
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M/<!NN!NQZ O3/D[7BM>O7KK",U72Y;I9#I<;#V$9KT_'W^3'+?KUQEZU\?\
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M)ZWVKKW4*@!Y@X<T>;;!;BW/;<**L.^#O#T+>86KA)U#W![PN"SA..4=7ZC
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M>TX2=#(<7"(.'?B%I5OII6["%EEG2.;8IG";732''W8Q,+;]BUC,63*R3)L
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M2WRW./Z*2K392R,3]XI\DSU>CXI^Y[$S_H\Q7S?D_D^OU_BUEE! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$&YI_].I/X9GX02<EX>G/VC7]VE9_9\W_ !ETZN/;BO@L^<1A_/VI
MW?D)_:_8NMW'R;_\E?B+Q:/^UW?MW_AE)PMTK@/O=/8F6?6\I*6X;HO53&5:
MU8^^>?N4;EPXT/P="%W6.H;O.MATB/*]3#4<98A9D/6D.S.!&"LY/#;E,! N
MY!+?$3[MIDLFP0O21CM?W9C8;(YK^6*L3M,[9PPLOQ]2BS'AD:8&)R17"9-$
M("-\.5FQ68\M=9FM8O(B23UJ9WAVD-\PB">M,^%LVY,F66QOS2S*7,<)IWA9
M$)-59A#5,LG?NN/:=BMLL:4W4:8G>]G>42XBHU=+:;/OL=G0F,)RKTR3 D$"
M_OR6;PMX:<V7"Z&'+')26Y9:9> 86K=N#;;DU #L;QGW)A9VQ5@HZD1;S@>C
MF4D;[=EXTRIM;;Z/8JYW:[4=3MY0.Q)M.LPW)WXP6' &WI6^LO#IYPA*JDB#
M9;:;\X]RZW$C5VJ%=2P:ZS$\L%F[9]5)KZ;<+K,<;;NQ9NA6I[#O&Z_UE:FW
M.7ZM86%5J\).5,! %N765CBN5Y3FFO\ #F!VT>LJRY8MF,>7:6E:D &Q>+AC
ML6W&NQ]+KSO"#@1# V7A+,L7G3L&BJ=]K;;K;H;5F,V92I=',K4C-ZVQA+2#
M&Q3MMCI-N;&QRY6)/VS;-EG;_+;E-,0+.13[JEJ>5&$88<L$LS,QS[?_ (V\
M)0&/+K4F?+&7AS=W&*U)E&I,L'-$K+4[2S2,FS(.A;>?4JD^[")\'8XXGN4+
M+C,;DF>008GET1P3&#.9BI&74D@"-MN'L2;,^&3Q";X\NI7)ZGB;7<NE,GJ\
M;XVID]:\@Q3+.7(")@BL[&F %F/K*+ALL&[?GAS*-8UAD)BNW7423#$\"RP8
M^I;QGE6I-9O!9G.&>M_X1$^41&[E!+$N%?J9+H_\%V7>M>&4#4TT8Q%@/?MV
M+-RU(A)U'&,&G.RV\@X!4]:UVTQ9<"#ML[54X89KIC (8#,;>Y#-1LZ9//PQ
MMNAE'8JFV@Z;5-^^L,+C[5F7+=NM.<JKJVN$2[TBXQQ"8)VPG*75:IICO&[E
M<=JSBKG.EHI=9GB$2(P&!VG/8M)BY3C->G-827#IB,3F58G;[,<OBF<R8!XC
M>DQMC#-1J9E7S1>*7N=+!>V_,Y#:DJ]NOF.V=)XA#FMC,%L+.@1Q*E9LS,+U
M3:U*+8F8+X8;>96'$;1UF20??;=RP6L'KVPU9FL2A'WQ=@LKU^_+5=K4L&&^
M.G[AR5D7MU]F]1ZI*?:7M(,.T)PEZ^$W*U>0P0#VBY2<LXKF[B.7*M\5EFT>
MS-.73UMF4;4\82V@PFR[C]+HS"<)9G2I5W&33=-9$[1WJ_=GTPI]7Q;$D^(T
MDY.V@9E"Q".XO<'63&P$,]FU0LRC]0XP=X+MV8V[#[J2XY<^TTHD[C&<)KH3
M!UG/G3VN'ESFMN3QC/=#\8+H7^W8DJ2QNMXMG& \1L89^U:3%H>*:DGXQ#G/
M>IRN<<N/Z45/W[?3WJX/>-R1QA4L^F(#;[5GM]69+E)LXSJ=TCQ!'GS$$ED;
MXB(K^)*Z>#NO-^9V[4Y3,5Z;K&I$_2O(^ERP3&ONLQ:X-U7470^*WG5QK!F9
MPD)=9J#V1]ZT;<AG%)R=K,Z:E0^O<T_%:#UV*6,_RJN5,FN<7$AQC$V%2M9\
M(YU+7$_"_K5F^4\[6C1*2L#F&#KQZE9&.TP[5H6U;66;UG.K9ARN.4GOUV!?
M;DLKX<32:C/)L>;C9$WJLY2VG\.5LYXWI;R",C;$A%SIVUP[P9-)EN?*?:V-
MV<#D5FI;EWIH/"C)(E%TMPA&,1',9*SAF3>W9]!I5/)8!NV@96X<T%?+=XPW
MQ02PX;HLB#U=*)BS:>HJ=K8<XVY(+K0.:(6PL&"C7C:8FSRUEAP.>S""K,EY
M5#4ZUWO6]J-=N%"JZY^^^W';][S(SF\-637/#C[W*!V)>WU2]4A]9=.$,X<O
M0F9Y2[CC  JZQEGBX3-!,#<2(0]62Q4[8NU[TVI^&W(\HP6L,XRGG3-]EY,;
M59U9LLN(KM=)W]XXP/;!8L[9UPW>,*U,E%INC'FV;56&Y0CPW!QNB##IV*5O
MK,;=@T5>&RX;S;LQATIC2=M\-B96-F8@V88'G"89D\(^>X.NQ]BO+6$-4& )
M'*],XF&O"'F3MTPMQY7')9E2,?C.OSY9)(EF-MJ3-) ZNL\VQ:92<@D%MIY$
M'U(L^S<,T;;N6:F,MYLTQ.G&-G+K"68)]VK-G@MA$XYY<VU5F]?JC3,!)O-I
MY7HC)+ )!@+HW9J<$F4M)8'0CS=96\7ECUQ4S+IP&1 Z[< K-7[M\I.B8[>'
M+$J6SA;,1<:5H:T$[/P5BG63#%65;9;'&(&[F;[\#SJE_<H6JZZUI<!, A9T
MJX)+%-GZOXA=[X/,0IN+F::0J7S(P-_+:LXLV3EB:^9XO_"S&:U+2QVCPU*+
MV#>^];?:K=O/VFW9TBGE-E-)A\(C'8,UG#'LK&N5TJEES"US01$603!EU3-X
ML+*K<#VWPQ[TXF5E\N[_ "_XC%1-I]YS8&8R/6#ZU8;M?HCY<3:%]++>_=B?
M#/H"6MO9&DU6@I9+2)DMON@7C!:S,.F$+J'&U*R+6SY5A+?B&'2I;I9-J%J/
M&S"7PGR[R+_7%21VZXNJJ=1QQ+:\_CI9]L3GL4L7]"3QG+F$?CF&.$>G.&*D
MS:6?1,R=1^N"(<'1LLVVK=MLP3K>6I6Z*^K83N.)+3" V>E3&FLR:4FMX;?*
ML\)X)Q(( AU(L^JH5\N91,)@6PB+<Q;ZD\-^T=;ZGQ7-HYKFF8!!QQ]J\G?I
MEKI\F&O3\<S/\JWKYMJQZ7*WO+=U8:3C.:=V,UMX%^R&>Q6]+4O?"9'%KYC3
M^,;A[<5T_K:_LTU)FNF:;7MMACWI.GU2W3E*K!,<+0;C9M5]<;9O;6EITX@D
M;8+>?JY=;BKU04C9H;O $D=J3MBMKMI]#*E[I($8>S:NG7M+6>TS%SH9+1#]
MMSKK.V$DQ5LI*:6\-LMB/1 ^M/>-^LDVM^GZ1+FP(;]+J%]MZO\ 9AF]?;A;
MY/#[&M^ F_ XK7]L^S%^-$:EHS0V.X1;D=JG]N/+7JZZU+3PU[C"X]BZ?'\L
MRQV^.XPJNI4[/#<,N]?4^+\KK)XX>7Y/Q[:ZQU:CEN<_W;$[_E]?&,LS\:SE
M6Z>BEB:/=A]WF7.?F]9RE_&M\5V-HM.P;L/OFWIW_,Z8)^-7<&CT[7;O[4#L
MP7G_ .]ZXP?T5V-IU"QP%F /I6?^]Z_5K_MK]USH-+:YK8C"/4I_W_6,7\6]
MN,O-;P\R?$[IMLN]BZ=/]AT7_MNTF$<SAMDLAQ83A=LYEOK_ +#ID_[6^6Q^
M:Y4OZ-R]/Q_[#I)]SK^+9M@?*ERXD0NY=B]73\_KG&4[?BW*O:DUK@;L?6O7
MU_V'23DZ_CV.D>+J#QI,SW28EUW-D%KK_LNF6_\ M>W+TTX\X4=4OJ");S%[
MHP&T[%ZNO^RZ>N=,_P#;W#TYX_X'.[4PDOB!EL'<O;^%^?T[]YCZO#^7\/:=
M;7J)K?"<R75S-Z5,@(X9="_:?C=L_&_*?D63OA!G0),H>_+.,;!AT+IVN:Y=
M.\1\Z@IF1A+M/-S8;5R[=IPW>TPT'41)_%RSLA';LMO7#O\ )MV^.RK#HVCU
MLZ8 &/MLN,,UR[=\[=L;>QW /"=4^MHB^4^$6.)@<(%<;\_KWE\.F,]+(O'G
M]Y'_ *9>7^K3&TDZ:64+H[K8W-!R7PO_ "'K/ROAOVC[?^B[_P#;_-,^:^.;
MYJ."M1\MO,/5644N=1#QGA[B"UT"XQ(L"_C_ .5U]/FO5_7/Q.WO\,JC^17!
MVN^:O&FFZ;4RZG4J7Z]2RW>ZYWO.F"(L!'PD+CUZ7OVF/J[?+WG3I7W-_9W_
M "F4'!?!%)J3],G4[A3TLR#V0MW <6K]W_J/BZ_%\<[WE^"_VWY'?Y>_K.,O
MU6U+062G2VR6. ;+#;LAS!?H._YDQJZ?G^OP?NVC)="^6=QSGAEEG0;@>=>>
M_P"PDN[IWOXUQJ;:6L\ <)\24,VFU2C\=TV(,6-=$]+5P^7\K\?Y>N+C+?Q]
M/F^.YC\QOF9^S@X'\S*35JFAT+>FSF$M+938D[HR8O@_F_C_ !?++>C]#^'^
M=\GQXG:OFL^;#[+/C'@VNJM0X3TFMDMHV.FM\*4^'N.+A<V&'.OS7Y'P7XKM
M^B^#\_IVF[-O27@;S1\]OE1U6EWGZC3LIJMLX[_CB#93VFVT6 !>7/7_ "]T
M^6=YJOHR^0[[>+BGAJ?24O%FO2I<H3J.4YM5-(L88$'>F+.WHZ]YZX\OLN^4
MW[67RL\Z]-H:2JU[0_K+J6F(?]98UP?,@TQ(FB-I73$Q]V<7.?#]=^&N,.'^
M*=/I]0TG5:"L942F30V14RG$->(CW=\N(@;UC'E,[PLX((B"",P8A%>4! 0$
M! 0$!!Q<X-:YSG!K6@DN-S0!$DQP"#\&OMA?G+H?)WRRU33=,URBI:G\T5\6
M^,T/,QTMX^_!C8G.B_M_=7\N?SD\T^)OF5\^9LFKG3M2IINLSQ&47/;NOJ3^
MV%RUAQ[]L?N?2E\B7R\4'!7"]+6NH9DA[J*3-)>V%I:'1M;C%>SX>GE^6_V/
MY'M?65[X<73MR7*E2S[LMH9#*$0O7I\22SET[6.)F..9MMSBIQ-->7"G<\.$
M!B,0DVZ8GKE-L#W"S9CRR5ZZY8O;.F[1T;ILUOND^\+@5K.8CLC3.'IDV6#X
M3S:VX$KG<2KC>%@9PW. ;^)F0LS[LE41.H\.S@TPE/%F3O8JN'7.JZ),87?B
MW6'&,;X8K-NL$N%6?0OE$^Z1C&W%8F,[:S,Z>933&&0@NEU$^[=EN+2(DV;=
ML4F^$J9D5NZV_P!$,D]<.=^GA7M8KVEWQ-Q&&Q<[=N:KMJ_?-N1NRCW*\\"P
MT=3!H,<!MN/,NDJ)-E8"ZWLVA2W,-SA(R:IK@!# 9[2LR6UJ7#?\1I9T'T!7
M&%MSPA:HMWB<(Y<ZUK#&&AX[1'V]RSC;7&G@5#2.7<MVQ-S33G3&NZ8Y]VU<
MZWX1%0QLSEM4FF>V8BS(9BVU+/H9RVI$AK($#D"KGPDN:F:<M$.62+VZ_1)R
MR<.76NG7[L1+R \MO[,RL]M-]?JR363-TVYX["L];]2W*F:S3OF,F"TV87W]
M.:UC"68VZ=UK3'E[O===M236:U[.O*G3W,?8PV;#GS;5.:29Y>9#7R=D._)3
M>6L2Z6[2GNFO:TF^'+J5O#&/6Z=F4-,UC&N($8#TA3/JO.W*NJ6RF.$0+ +8
M;<UKKM+75_$%<TEWOMNV<V:WX9=:SYH?,%OTN?TKEVERZ];Y73AZ!+.<*XTG
M:_1WKH1:&-%UC<,H]ZC$F:O.\P2;Q\.-G:F%XJBZO52VO/O-OS'-ZEJ0[( U
M4O%S?\()ZX-U&5-4T1((V6@VK.,+<2("HJS;!W4.;(JL_HB7UUIB\7XE),ZP
MMECPVJ#S?$;-D,HJ_P ;AC>6_*]ZSIMVCV);EJ/$Z6YPLLZL.G:LM6SPT"V8
MTQSVY<ZWU9K,V;-:+\!C%2S%R@Z?,W3[R29HT)SYCHV\BI>KKUPAJB3,='''
M-:XPO;KE%S)+P39ARYUARXY:CV/:"3EFK.6IVGAJ"?,8^_UX^Q:QIVDMB4IJ
MQY $<^6"C7:82WUMY; G#%3>3GJKNJ5#BTB.$.97RS+AUGJ;W&-IQ4LF=-3Z
MJY+=[YOO'842SRM>EOA"TVP52W*U2I@+1&/(#:B]>61SP19&]3E;B-1\S"V]
M:QB)BUA=- !B3Z<^9<]Y^QQ,>6%TT$0$;5TFILE8Q>.=9^S7+,98<,,8+,_;
M6>S-24L7@P^D,AWKIGZG7E/3&PE0R 6/.G?KFJQ6P:3LWO65>8O96YTS('#M
M*F-LS-K4>XP-_6EY;PBIQ))A'KYE<)Q=L+2X7QPA:E/9OR7N!C&P0."DNB;2
MS=1,J40YX%AOASX[%>RW/AU]K^I":7 /!]UPO%M@N26,7[NI-1>)CR+[2#RL
MR4N^!KTD@N=9C[-JO7[M=9]5XT^G.ZP_L1EESJVEQ%B93Q;:(GGAZUEGR>".
M4>],]AC$AL3R]:W<R9C?2(^ND>[9"X^O:GM]7>7PHFI4]UGWW*]9_E2U3JF4
M6N//LSY]JMF&<L,N6^\66Y^U3+763RWV.+8<LNY6;.TRSN>88]:<<IPU28'I
M4MSPMOEN2INZ!S<L$EPSOLVA5W".0N5QF93AG;467F_F]2DJ7.63QQF>L]RL
MF58)DVZTGEM@M-RY:DQXLOO*YL>6HZ&&:URUU:LS$<KEYOEZXFWL^"S.$1/^
M+I]97CKVQV)P+_36_P#![5AVG#]YODI_I>E?YO+_  6JQ+R^L#Y5?]4:1_!#
ML"GU?1_'XC]']+_(,YS^$M1V[)@_#U+-;Z^&DZ\\L%S>J<-+4OZ*>;U*L7RZ
MNJ?RCOVSO4NL<WA8! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 09I'Y1J"F^=G]WT[^!F_R;D+P^*W[0[^E:W_:%3^$]6<O)\G,_5\J'
MG]_K75?X=WX2U4_Z7I77?EW+G7#RQ-N',%KX^2N)O/.O0U.! 0$! 0$'%5B\
MO"(\HLY<E&W)N*E3LR#%(=7)51.!Q=\)4G:*PEP (V%2];;GPQVN&!S8VY!6
M?1G5<0TNNP6AM2\>7*]3LU)EM,!!M.&:SS-'7EOTS=YP&WUI)C1;BK724@<!
M$>G,A:7.8FY-(T0@+X"\8*LRI>52M !(].T^I%MRV?!;GV]Z)FQQ>RZV-^',
MBRX8?!;R'M1,@EP-D%BK-W?#GN$#!;ZW36/HP/%O0MK98X(C=IV$G"_UC8MP
MMRG:9D +K?6%=L=Y*EF2@Z)LPY8*<:<+]GDR(FX=0[T6<./@[IC99RS4SA+B
M-F4UQ@(XYGE@MQQMS4K(I2^_'EA%*E2<NA!%W6>;-3'ECMIR=0[L.^".;G+D
M[O5#E:5<,Y;+1<.5R<(V9;2 +<_6G+-OAO4[(N$<QZPNDLQ]W.WUJTT<AKF6
MXB/*]:QY,[<IU QWT1:3EWJ^$O7+5E:>P/;[N.SO6<?4G5-LHVMEM,,-@]:U
M,-,#VAAY]F<>Y9NV<5O4+F[XCV;2DRF<<K4R<UK1 X Y8*V4SG4X87SB8^]@
M</8J73%+)+A&WGYPB)J1(:0-MF5RF*LN&^:9K1%7G1C30FM$;AAAL2S&CKNM
M<E@,("/-[%%MPR2IS6O'./7L52U)OJY8DD&_GYU+MQ[W:DUE2TS'P!O(ZONI
M-)EMZ5,(>QW[(&_:M92[F'<.C3HRV QZU,9,)RNW'2^=IPYT\KZVNK=;DRW,
M<(8FU:N&<V7[.HM1I27NW1B80MV8':I8W?I$OP]0O<\ M=;L(V*69)]W;^ET
M! EQ!$3"VS%1G&-UV%I]%NAI]>Q1<YTGV4IA"%VU5-R::E31V&S/Z7[96\-1
M#NI#O'G..U9B6W.F612&/_SW.F;_ (6<?=.4M(=YHY\=J7AC-NO"5GZ<7R2
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MD03U@%:SF&$HVDWG 0C=CM'.I.MMTMF%QTC3F61;RLVK=F(U+G2U,T^4!\.
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M#B3 ^\"]P-ZF6)+_ (?H[I&LZ?K='*K=/JZ>JE36[P,B<R:!;CNDIE,I551
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ML=^G&51U"F+[L-ZZ)O\ N)UL7M-Z52HT]QC&/(K6,LM44#Q8(K-F%>10.R]
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M$5T8O7)NX9IKE/7#FU@;&P6PV]JS;D9A+A<!U]ZNNRRX_1L-%T!;!,-:Y2-
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M+T?#VQVV[_J! M_:KP=^7UNMS&NLJ(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#/)OZ
M3V($WUCL1)PP(H@(" @(" @(" @(" @(" @(" @(" @(" @W-/\ Z=2?PS/P
M@DY+P]._M&0#Y:5O]GS/\9=)X<.]T^"_YQ6G\_:E9^\3\LWKKX?*MG]E?B%Q
M<TC5W_MW_A12':S*K1][_A>M%S>&Y+?[H$;+1<B:EQ4!JA&^><>I1K&>'.@!
M++!@JF+'F>P@W8Y\_<E65B  YT2W+;D $CE])#-3$D#W>6SL2)V;[+QSI69P
MVR! V"Y925I.(!ZUJ-7.--28X&XXQ52VQJ/N/.DMSAUZS$SYPU9A-W*Y:G+I
MUGGRQ@D8V*67+HV)1N_;#U+';.6,-QHWC9;:K-<EE<WRK+L5K,O#,S+FH^=)
MB+!C"S[BEGU;G9"U=*=TP!Y#:-B8)=J?64@WC&,8'M@IA;8K%93[H)A<XG/U
M+&-IF85&KE1B8&R.>8.2W.NF<S.$!-8YKC8?3@%+IK.9ILTTZ!:+[1V<ZO6L
MK70U&Z&PV^K:K=+>%JHZL@BW$=D-JSG:]78^CU&^!;@V_P!JZ]+X:O*VD-+1
M<3 9+HF414R"0;+\NC84%+U6D!#K,<^?F0S>'7VHR(%XLN'9S+'KFIVGT5J;
M*M^'$XD7PYDEQIG#@+()Y<>*S-<&B(-JU=S269_1O4E3!XB<NWG22N5S+]G8
MVC57O-M%PRS&U:\?=;<33MS1:D0E_M1@<QM4S]7/%Y=BT4W>:RV_/GV\RSAB
MWPF01 6BX*]<^7.RY9FD7[%KRMFG.-D5+=,N!J0PPCRNS@I-L=M;\/(KK0!G
MRL2QC,K(:O:>H]ZF*RCYU3O&^_V[5>J;:9<3;%5O,G#BB3.=<LLL$N%A-OK&
M2+;<?=,TLHDPA]$*8I.VTPV3 #W?3[0JEY>?"_8^GVHAX7['T^U!L,;8 !@(
M]':@VI<N$"1;!&KB<-QK-X" 5TQCMEE$L@77*9VW.LY\L;X1Z%VZ\&(\;CLO
M2.]4QEQ\']CZ?:F3&7A\DD0ACRN2[,-"937Q!OY8*6XX2S34G4H@8##,X#F5
MFYMGCEH&E$;;^=2QK&>&:31M<8$=AS2:6:TFJ?3FG=NMAAMY]JJ765@HM,:Z
M%UKH?#Z^A7&&>4_*T>61$AL>89G;L20RR.T.603 79)5E\>$94Z&PQL'4+K5
M.5MQPKU5H<,!:2+ON)A9<S-04[0R\V#T6W!,8335?P[&!AFCIUDK1GZ&Z4'0
M%G-M/J5S,?=?5"55$Z5&PG$0L]"QG?V8Q95.K)DZ6YT-[$W&]=/_ &=9)9]U
M?G5T_>/Q6\^?,L3;-EC$*Z<+8FPQV]BU/H1)RJN:X$DGKC=':%9H<IE=.;"U
MW3'VY+&=F,L?U^<ZSWL\3ZD3&.7-D^<XPB_TXBS%,5>4C(E3GF,'6WWYA:L,
M>$S(T][P+QT1P[UG%+,?HWY>D/,(@VG(W6*XJ^NFS^9G9<NM:9PV*?0WO>!#
M$60Z\PI9MGO)C-Y6^@X7W]TEI_P>;,*V8X?/[VY773N%&666[V0NL6,7+"]T
M'"#7 1 %QM;S!=,8B+)3\&-@+&_X(R"E6)*7P4VPP%\?AV^Q2?2-W%C=E<%M
M)A 6G[U3OK;$FV\W@AH+3NBPCZ*D[9K6K%GT[AV73[H(%@$8C/!6;N&5FI]!
MDN@2UMO['..Q6Y\+-I^FX<D&W=980+N623AO"89P_)#(!K;LMF<%,;8O+7G:
M#+ -C;LMO,M63"3*O5FBRF;Q@+#]Z-BSJ<\KBJG5Z?):7#W;(_1'?M4D\M:1
MLFEE"9<WIAW+5VQ\EQ%CHJ63&T,PRV;%GRXYS=KI0R)+0!!MX&&(YHIA.;I:
M*=\F6 3NBP8<V:N&I?%3<C4I,L@1;AD+NM5FW219JTK=W;+X7\VS:LW:XLC0
MK*@3FN#86QNVQ3..3"EUE*]SRZV\X[>97)&O+G.D0!B+_6+TSX7&TK2ZD2;+
MX_?8V;%4W:MNGU9<6DG #U9A7:7"WR9N^P0*QVM7K(X396^-MOLSR25+,(N9
M1!SC$>L7GO5MP3@ET WC &[+EFE[8.LRV#2[HN(,.6"M9[SPT*F6($7G[JF/
M+E+BH9Y+28V0/K4MK>:V::I+388<CM5F<_9CMFKAIU5'=B1Z,>E;E96J2?$:
M#?9[.U,19KGAS=*WK[.6P*687,\(;4988QW,[T*RI;EU[/FN;/($;QGWJ=FY
M)8EJ.<<<ARO23,URYW,JQ2YX+0(\NM,XY;ET\39T(6]BS>V9I>6F7@WD>A3"
M9C?HQ[P.9(Y=:F-I<\K51R=X<LCL6N)@FVU-I_=,+>G8=B0[7'Z(F?)-ME_/
MF.Y6:65%SF "ZV&?,EO_  3.-HJ8T@[+?0LX2635Y8Q;<C68D) NYE)*SF3E
M,2G;L,+NN*W9,?=)VSPFJ2HM C&P]@VYK+>(L4JI :+1R &:'M&C7UVZQT+;
M+XPPZ4FTYOV=5<053IHFVFVZ%JN2SZ.KJAKWS3 $DGUIN';KE8]&IG!S'.'T
ML><[%.4XQAVAIFZQK;@!#O6NL6\93TRH8QA=$1A'#%3M,4SIU_KO$_U3> -@
M)$(P^ZH\_P CI_5^-7/>]N\28F'O<L5JS/#,1^GZJ^OGL$2=YUMN:S<\-2Z=
M^<):,*@27N'Q$ @CEBF<I>7>5#HIII+7M$(6V<UBN?HWUQ<M6NKYM&" 7 P-
MQ(YKE6M*55\23WN+-YU_WQZ,;+4QY:FD6=:J Z,70B#\16;6L3EK5'$,V$-Y
MUPQY9JS!K**_/TUSQ:ZVWXB,>=6NF-:=E<'ZO,=44\2?C&,/I*5>)]GZ"^3]
M29QIA&^<RPD&R(L]*>%ZS-?I=P!12YU.TD#Z&$< KQUTU9CA;^)-&E>";&_
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MZ73XI9&O2Y5V?(+S&VWED5>WPR2X.)AJ-HX&,.Q>>_%VRZR3&9RL6GRRR%X
M(]*QV^+,Q$G3>79.D.-D#AW+AZ6-:DWR[4TF9#=$;=WL@N??I<)C+L+3YT&M
MMA9RQVKS=NE3UTF&U4!:>76F+$DK#-JHM=;GRO5Z\EURK=?4QQSY1BO1TOU:
MYDQRIU94 DW7'E>NL[_3ACUN=HSQK[;;5WZ]K=+]F"8SQ&DF&'HLR*[]>TE1
M7JS3V38V"TY1NLV+K>_[=NDD\NNN(M ES)<V(:8BRS."]_\ K_F].\OW?/\
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MM&$?=YE_ES_RC_89_)[Y_P#RG]=_U/X./AGZ++I/"?@NEF%Q'T=O<5^0^?\
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MIHWA9&'O+Y7^X_V,^+XK?L]_^G_"_M^:2?5UCQ#QMXS7 .^C]]' K^8?D_\
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M=RO!_+=5KZP6/CD3=8LZGZL?)CA,4%<2Z'-CETI,XRY?M7>CJ"6@VX8G)/\
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M.O;M;-NX]/U[>8"23SG9T+R?)O:],<-RHUIA9$FVWZ6P[5SXZMV[4;5-< !
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M'*(GT=]@OC\)R)6"W/+69*W7 0SNL6LQJ:X2\AVY [>Q9EN?L=IG?E9*"?8
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MZIPTM2_HIYO4JQ?+JZI_*._;.]2ZQS>%@$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*;YV?W?3OX&;_)N0O#XK?M#OZ5K?\
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M]Y/+O5ITQC'$D^XR^.Q?TS_46?UQ_+/]C,=O6<9>U/#FHN?X33"!:T=A7?\
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MQ(&S!?"^?K)\>'U_CG[_ +)V53M< 2!$PP]J_$_FZ[_9^E_%G[4]IK&LF D
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M]5D_@%<?DMG6O1\%_?AWS4_&W]JO!;E]:<-9%$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MF]4X:6I?T4\WJ58OEU=4_E'?MG>I=8YO"P" @(" @(" @(" @(" @(" @("
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M" @(" @(" @(" @(" @(" @SR;^D]B!-]8[$2<,"*(" @(" @(" @(" @("
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M-Z.O69RUQJ!)%IO5]8Z9>9E47,-YZ1ZE)REQ(KU6XG>B+X^O]RM7<PY>RO\
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MQ_)GAY?GQ>J@<4:ZV6UXE/C"RSL7OG3O]'RNT[?^KJYO$,QSWQ>1;R[%]O\
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M_P"DR/PECMK3O.'U0?+C_LG)_P VD_R87#Y?X._P?S=\U/QCF[EX7UYPUD!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MRZSAP?\ ">6!6:WUY0^IN_FKAL/J6,[PZV>764[\J?VQ[5VG#AV%D$! 0$!
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M>$/6O$@[S7#WK;#SK/?XOZN$G^NZ_+S&WI#WS9TL$$Q,.P<ZX7\GMG&>$_\
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MKSV^%_[?KVN;AV8[4'SY0!,8A;UATZ_!.O#9H0]KMYH)M%W0N>'>W$605%4
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MZAPB(Q,.N*S(UE<=&T\S'@[IORZ5J).UX=HZ=INZ![IN'8LV[/;"7?2D8&
MO S3K/*SO>'.1+W7@V6<O4M6Y.U6ZC>6RB1EZ5);E)VVJFO5SY9<(PACS]>:
MJ]KP@Z74B;"X'[I'K6LLYVFFSVS ;020<>C%8W_AJ;:<^4TQYMF9V(LM1LR5
MNDD'E=DKH]ML\B>Z601AZRKDO;PLM'J<V#81%@NYPI+ABW"R2*^8YH#CCCS!
M/;;?7M;66:6S@03&SNS3.7:3$4S5J00) C83Z2,58SVG_#JK5I\VG+FM!%NV
M-X',F-Y9S8U-,U2H,S==O0CV*U;;7='#4MM4)9F7%L3'F"S;A9?J[5I].HA*
M#CN PC;#*-B=41.HOHZ<.:V:P&V B,X*5?#KS4)['O)8X.!&!SBGL3309+#Q
M%:QI;=.6X6V##EDLV?1+]1OB[PL,(C-7K4YJ7IJ,SP-YIMM]%R9+&W,T9K6Q
MW18#A!+6N%;U!SZ)DS<L(:3M4NS,YCJOB+5ZB?O,)="!YE+J)VQAU5/JWLFF
M)A;?Z%9VS'CN;79G"FI"S>>(^[?!7B\N_28_X=Z:?5RW-:=\7-QYHXI>U\.\
MQ:L\B>US1 A<>_>RNOQI!C!,!CD?5WK/]EKU=;AL4%.UL^63]\,LQL6.W>VO
M1UX>PO"4Z6V7*&\+'-]06I\NL-SG[O>GY=G \127 Q'UF1=^V"Y=^^;AZ>L?
M5!\N1CPE*_S63_)KGVNL.OQ;^1WM4_$.;N7!]B:C611 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M&YI_].I?X5O:$G)X>FWVCH!\LZRS_P"I\W_&7;HX]OXW]'P2_.&R.OZG" _$
M5':]>Z3$?&N?[:_"KS"8?SH\6?',_"4=[51TML'X8]J9VQK*:J[AS+';E:BV
M]RU$Z\LX,<^E9QAK&' / .*99ZRRY3=.\;@,3& Y\4S6F0OC$6\NE625C$]G
M VK5U%Q].7'=YEDQ7,-LP5XY3CEE8(1Z/6KJKJMBZZQ99>-_:>72D7UR\;^T
M\NE+I+,3+D'&^)ZTE_X3[LK'P@"3?W;5KG<X&P'#:LU9+AR:^$;U9AB];U;
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M15C-M6NFXV-.T#QFBS[[VJ7[-=9YK%6<=39K2&SVGW2/BCZU];\-\[\JNO\
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M8,EVZO'\TGAL3*=H%F1O]BZ6/+UGU:I9N*-6?5QB<SUJN6,.;+^CN1J\,S2
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MA_(^3N\GR_@_'U\/:O@3PY@EEQ'Q,[0O=\/R?NQ>7#Y/P^DZ9\8>T_#HI T
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M\:7V<ZB@;*$80 V<^:Y=L\+=(*IF"GYVW]2LZF<RH2HU[P00' 0B;QFM,;J
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MLCZO/EO)_163:?Z+(_ "QWX>CXOYO8NHO;^U7G?8Z?P:JT" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MPV \9^CV),^6IGPR;T,5O,7,;#'1@(X9+':>6;_Z-E@M$1FLS#I)IN2F@D0
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M6DB-T;ML=JYYLTUZV3,=<:C6..] F-ME_K6VM7E6GASW&,;[+QZ4925"QS1
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MB5K-BP/\LY1ED[HNC^3R6<8OV9[=LNN=?X!E4[2=P8V[@&:,.CM<T&GI'/,
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M;MUC4637?MCZ%Z>O&W&O"R" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_)UDCY'Y/2_Y4K7>$Y<]_B%H,3'X8[5T_P!E\G7M^-9'/\/KV_NF5$KN%I#
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M;NB-]JQM,9F6,S/$(CS=?4MXDB;X;3)37"P8;%GJN-;; I1D!T>TKHSPW9=
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MLB5G-L7.4G1ZD#"+LL=BNDVN-#6M,/VHY7),-:NTR:II!YCD%K&&4)5U)#B
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M3"\1VCHVLOE>&=XW#'L2WZ)UD\NT=(XN\ ,)>;+8[T3:8VVBRU6K+E<Y/F&
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MQA<YIOA=M3)B>&!TF4ZT@>CV9+.TN:@M5I97AS"&MA X#9M6N5U'6QHA]:,
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MS2?AZ!V!27>*O5LF6"(6K6C-8C)%MAOV]ZQI?7RWZ62! PR..S:M2I?HF)0
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M26<H_4?Z([I]:1.WEU?4_E'?MG>I=8YO"P" @(" @(" @(" @(" @(" @("
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M-=$.A#*Q;BR82LK5"&@;YNS.!*SY3LQSZY\V/O&Z%Y6IP;D5>MDOF$D"-I]
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MLR_"K*H"R&]R]*Z?/U[>E>WX;BSZY>O8<XO'+)?D?R>G;^ROTWX_:?U_?_\
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MIRW_ !?IE\KU3X^MR' QC44]O_"M4=NDSM]6WRYD#A.3;_S63^ L=MO1\/\
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M.>&2DW27"1TFH:P^]@0.74M32YJ<F5DH--J,J_55TN-D#[I4SK#<X0<ZLB3
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MJG\H[]L[U+I')X600$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M](?,+[1[C7B-LR5H[:LA['L&XYX W@0([+5^?^3_ &/Y'>8M?H/A_P!)^/\
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M_%^;\/Q[[8=?^T^;OOKG"GRW:/1O$R:Z182;2W =*Z?+_O\ \;IUQ,/1\/\
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M<(B.W;DI>/NDEFVF^4' V8;,H8KS]I77I_ZH:KIB;8??=AV+,TZ^,53=0I3
M_MO41DKRLDQ_A1=0I3[U@O/*R"EY/?%4ZLD;N\0!8#ZMD,58M_=$),8<L2$[
M1R\M*9-\.V)%OH]"FFYBMBCJHNO^D/2-A3.L0L6ZFGQ&-PP]JF\K/NG::=&
MV^L[5O7AA-2;8;7#U(8RRS)(<#M]NQ%Q9_R@JJE(<ZS+MYD_4NYE7*BF(-UE
MIORZ%FQ>(BILG=)=#&/*R*=6<,/B;N,(>M=9,Q#ZQMY=:OJB5HZG=(V<T;+<
MUKJLQA=M+U @-&1Q<K;]&,U>Z'4XAO[KF3'U2[7+3*^+FF)C$8[>92S_ (68
MQAV3I%1OFVXP/;M21BV?Y766X.:!L5WX<KRYB7&! LCFI;8GAS+,@G2UF=?J
M0A@M;<KGRR!SA>;.A9M9]L33-+F;Q CARM5G"RYF:WY! (Y8CU*6Z)8WC C.
M*=?J5$U4F)L'+H"Z]8\]S.6LV3?8<.6"ZUB_NX9VLOB%G*WK]&RQI&%D+/0B
MXUME$(VW(7C3.P@0RM]:J9UOEF!&8ZTIUF6O47<MBRZ34VU&8]'K6HY]FRR\
M\RC7ANH37#88XP$3ADD9[3Z,H.(59X<@5,-SMIYWA"_--SAS[_N-W>PC!1QS
M8RME'$'TK5Q"3(^59<;]JF6NO6RL#F0!L3[IG-QX8X)BKB-B2TY8GL4,Q,T]
MA'2.LJQF_9.TQ&Z+?H^M:BR,DXQ A:JTT'-R%JDM8W7)ED,(1]:EW2?=)4Y$
M!'E8$NFOT2#7M@!W0M2<-=<8>'>\#"VP]:MF6+,_HUY4IV]9RM&Q63"=I,)E
MD@AHLP$?NK.K7"]MN(:0XQ%EH]*OK$MO#;DN(<+;/:I6I,QM$[P.-BF9%QAH
M3@;MBS+GEF_9HN9 PAASK4F5F/+;D2RYS21B,88*6;9\KSI;8, (%W/@L67/
MV=)PDI@M,,QV+IUDPE^[7)MMO5PDLG#8DDV<Y[(HU<V?9ORHDCG[E4;983AZ
M1WK5LHU#*)MAZ5S[==_8N?#0JI40?=SQVA,^'/ON*]42A&T<K%7*\ZY1<VGC
MARZDB=N/NQMD0LARZ@K6>OW3=&P MLR'+I"C6?HM^GNW=VV%BF<$QC[KA2U(
M]W8!'KYU;HD^J2%:!B>76HW;*C)U5O/O-_;TK/G-9^R0I' M!C;'EV),Y^S5
MGB)V4PE@,.S(+;GAD+7 &SL37 UW3=V\W<R+9/ *L#$\NDI95C<E5>W 9=ZE
M)JLSJDD6GEUKM\,S6>_&7ADZ+A;GALZ5ZL7#CSILMFD$6V6\KPM29FTO7Z.,
MR87&P\H#G5Q,?=KKF<M*<19;GV*8EC/;=TTXC,=:Q5>0X WCK"1++AF#_$$!
M=R"M9];'%E+[\8<NK)+,S3<E2,N46PAC9#FZ%N36*N-):27 8X#J6=2L[ETV
M/$<,3Z3V)9E<Y9)1<77E9EVW;,;3U')+]P[;;<.HK=NG/KN_9:Z.E):!"V+>
M5RDNUMF4Y+I(0B(6^BPY+A\EEC6;E-TDBPVX#'V+R63(G)%/%P.$>_8GV,YZ
MIR3(&X( 7<K@G%8F*B-6IAX,R C[A[/VJU9,$KU^XIH]Z:_"P]FV"2(I%%I7
MB5#<??'T=MJN&IBN[N&.'VN#8MRPS(4NK*68X=LTV@EDII#; T8;!ZU9)G:>
M=M.KHQ):ZR[9#O2QG>=.O=8>&>(+,<#ZECEUO\75VIS"'/AEM]5N"KGG:L39
MCHVG$YX6+4VMS26YQ(OA;S8I<.G3AM;F\([/4L[E+VQI'3G;IA&WV]R]7QVS
M]&9VQ7B5.A9'';WKO?W+;+$M(<"!;>(^D+.*S,2IB0TD& L^XJS;ENB7D/2K
M)8DECQX;H^U7/AN=;=O!E./W5+B;7<VV:=SI)B286=L-B9EV7M,;3DNO$ +;
M-NW*Y2[8SIE$_P 2X\NE9EQRSRWZ<B+2;XB/4M3?!]D_3$"%O*U-NDU,I^FF
MPM!^D,%+VO%+M-R*FZ^,,CLVIRSBRMTU/NFW#;WJYTZ2Q4=;JX2YEIQY7E>'
MY5QY=(\05S0^;??LV9KGU^[':J7*KP9HOO.(S3-\M6VQV1P_5_!;87#+'I6L
MLXM=L4<WQ)0MM@(]72HWQ,-EUQ@MXF/NQ?Y;8A-W7"W$60^XN?+6,.3ZB,('
M/U9%)HQ*S4]1ND\]OHS*IC6F]]<AB[ET*LXK6FU8=&W'EDIPWC6VM&-N:KG7
M*!A&!NL]29O"R2S[M"?6F2#?99EC:<4DR6(9^MP<6[VSXMBS8GJE*2L\4 YB
M.8MQP5U%F<IVE@YPYTG*]N%STV6V ,!\<(="MVG6+U12V!H<0(6960@%9G&$
MO*1F/EAL&[MP5DDYY9]K+CPK%?/8V_=O.6W:K;I<YVH^H3V.)A"_#[JQOJU%
M(U&<!O0VGU9J=KDX00J'$^SVJ-6Z!/=O;(G [5KU8EMJ0IIKHCNV@I8N:LU%
M-) $3<.V*2>6;G&*G X^'?@EYTW.$!7W.YSV!.65#K1O37# F'H@4&*30E]M
MV5D<+5.&KN89YFE'=)V9;.=,SR3,5#4J/PB>J,(=ZLYS.%O"K.F%CR8V ^B(
M76X]7-:M)G[SFQQAVC:N7#6=8KLS3;6-_:]ZE7KPEQ>.<*R9BM^26PPL[RI9
MBIKA(2IX9"W 1AFM=;GE+CPWVZC  0RQ"LQG[K.,T_.1)A"$;+"%+-LYVSR:
MV+Q$F\;;XJ+F^4_3U <T71,#RM27Z&ZEY+@Z_LYN=7-J>N'B:]K-[>@(6]'W
M%N:_4G*&FZBV6\VB&TK-[7MPWEIS-:#-X@BS)VSH4WY8M151KYP.)QP4AA$S
M>(7VC>-@LMV1SS6[(DSG33.M.F8G;;FLW$X7%\L!KG/O)ZX^O:IK_*>_AXES
M]YX Q(NV]*+<XRL0D&9()A9N^J&2ETO6^'6G$M(6[]EEL(<BKF^%N,X>O^O2
MG,F&$;\_8%9?J7'A5952]DVTN@".76MV6S,(NVE:@06VF[$[0N6,KZQV%0:C
M!LN!ZSF3LV+4N>8J;_.%@-\88G+:HYXEN#\X V&P<X4RU.L<75@=$ G#'[BL
MGGP7G[,7BQMC#E!6W%PFJD:8@PN-_HBIG*)N0 !& PY>A3LF;+]F\PQCT(U;
MEQ?/;+O/+K4ES<&XCZJO8&D V0.(V+7DS;%%U6K:ZT&^//AD<E+%EDFW5&OU
MX:#>;3&V"U.$\?=TWK&K%IFP)OSC>>9+]TL\JDW473IF[$VG/;E9@F%N^%ST
M:09SI9S/K5C'7-_1W#HNFM@TV$Q;AS*QN]L.P*27X#1LARATJ7KFNDQA,RZS
M=@"3V+T?')'*Y\-EM7$@@GET@+T3"R7RD9$X/A:.4=I4XK.<5)RS$<\%8UGV
MQ]4E)@!;"[9L6>_V3.&-[S$VV!,3'W3MVSII39X$<^;VJ1?6R(.NG"8PM%\3
MR]"UBSA)?JHM?2%SKA:3?Z[ DO\ RUBW<X5BKHC;[HPN">$YJ#FT3@;>F_"*
MSC-)/HQ"EM]OL6IGRMURDI,O< LAEZ>9)_Z)]TG)G;L 3B#U=(P5L^BY;@KM
MVP1LVP6,?4]9>7DZDX WW9^Q</D=>G7$RP.U-P/1F>Y<.&KMP=6;UY,=MO<L
MWMDDL/&W_I7<^/2<EHQ6Y3OC"W+M(5PLF.5CIA$6#$>I<_)G*P4<D&$0/AY8
M%7>5N,816O 2I1-@M/HZE:=;,/6CC&L:?& )CO$9_<69+Y,Y>OVL3RZ=,@;X
MYX@;=BUF<,,^@DF;+,3\0SS"IOP[QT0EK&P)R5TU-\K8^9[L8VC..2Q>?LN)
MA'/J"'&)Q-T>]7*3'#C];LO,!S\^:UX^ZZE:<RHB?N]ZY\<I&>540CLAA[5O
MKJ+;*WF5-\8^GO1B9\.;IT6\O65+<-8WMIS9OQ6C#+8KJQ<R::3IHMMM]BLB
M6WPQB8?O@I83.4E(G7'E?SJ-8_Y99]3 0CRMVJ\S28N-H>HJ!;RN/.L8N6>;
MA%/J"#?CRQ6OU7-QIX^L;S81OARO*DZ[RSGMG#CXIS]"UAK;B7@FTQYH(S)E
MI5,P>&3'E:L6;;F.%1J:K=F&TBW#K6H>KQ+KA<7&X8K4K.Y6TVN;B3"%EO,H
MUG3**QN!/62II9VT\_7! VF,#GWJ:;EEC":HD&TW0Y6H3$K 9XQ/+I*DS6\2
MM.9,C")SPY9JXJQED-)-UAY\ 5?#4EO#/-I-YIL&.>1YDQEM5-0TZ)CL)^%6
M2RM8SJJ-J%$6DY1RACTJY7'T5*K)E6VP%FR_H2\+,JKJ.H^&'0)ASPNML7+S
MA9KE 4VK.?.W8XY[>9=/)VF5UI9F^QI!O[E<YCG=18*1A>Z[$9^KG5Y_5C'E
M;Z&F!M(Q.?<L]IAOQ%BE20W=,(V<^&T9K,MQM,VZCQ4C=;&ZQ%DJF:G,L=[V
M/-GESJLV50ZTQF$YP[$W:Z2S$C9H[F\Q4_5+F72>E8<Q[5IQO*1E$P$.5B2N
MG6WRD)<=T14MK><N3C )+<FF@]T;SFK6.]B,GW]/K*C'5'EQ!$#FK';K;EN2
M&;\#"-^,,_4CK<-QLJT1%G/LYT,WAXF2A V89XJ[RE^Z(J&!K7$"VR'4E^YG
M"OU#S%PCZ.=9K769J.<(WVHMSX8GR6N%UM^'<B5#5 ,MV(O*BR^&J9IA $\M
MMZJV98]YQ(B<1VHDTS(LY968]'K4C79E;BE8LM9@W85J3ZIK_*3I6[UD(\N]
M>;YL2._3&6*K9!QLLB,8Y[5XKMZ))RNW!+(Z@T@?>=H6<?5VZ9?OO\D#0:O2
M8@?D)78U6-Q]9WRJ@#1])L'Y()V>KX;=/T.HVGP)<!9$]I6>N?+UY_Y21 #1
M8LUZ^F<#28@8*+9,9:VI_P!%=^U/8%IR^KJJI_*._;.6XCPL@@(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,TC\HU!3/.S^[Z?\ P$[^
M3<DU1\8_S].(KM9M_P#JC4?AS%JR5P[W.GS#^?[R:[5+;/%=AMYEFQQ[/1N>
M-^L?"WWN:Q3<<K-IF4(,: ,%OI4YX;+" ;<EVOV:SB;9O%L@"+H7'[B9QREN
MLM*>W>Z(E)4S*C)DJ_W<(W^U:9G+7\*.!'H[5'1J3)9<(0(C9;]Q/!C2/?3$
M&,,3RL"D9F/+8^%D+H1]<%;I;PCYCSO&WE$K.<PG&W$/ QMYEC%\)<-J3,B;
M2;]NWN77-D7F;;X,;E>MSRYV8X;4B67%MEY]0*S>N%FUBHZ6(%AQSRV!5TG"
M5-- 1AU_<2S3EVW&66P-@(#'UJ,>-,^X#@K@G&W+PQ][Z?:I@S.&G,IXPLSV
M^HI@X:GU8\B.Y,&F9M(2! ",!RN4P:C;=20EW7=5D=BO*M9DD-=&&S#'TIP)
M>4P0!AR@M9TS,Y9S<LK>&/?:<?2.]7EG%9Y;=Z-D<D3.'-].2V'L]2<+FHV9
M2.B8C'/V*W"VLLB660&V'5!:DUIS[=LI:G,#$[.]=2?==-.J6-W!$"P"[$7X
MJ15QE5LO<&Z<+;MNQ4^R)KY^^UQC>.Q5FZX4:J9O3'91LOV]ZEN.&>UK:H6A
MKA$"]O:%,Y<UXH9@$+H0ARM4LREDY24U[2PP.'K4FJY7:NUGO%T+;CVKIX9N
MD4);C="S:F8J6I&EI;',JRLZL6:D-@CEWJ9WMB7ZI%TL.!@-MBF-&;+]F$23
M'I/*Y9FKIK$QGRFJ:#9<#9=>O1T^['C;2K)9F1L!C"WM6J3[(&92^]=8;NLX
MP4.&67*W .5L.8*6>6/*0E3=V CAEL*U.,-28W4I33&EPMQAZ\U)GREN\K)2
M/:(6X#+-7R;NT])<'0NY"*C6?JE90%E@^(*N>L_=M>'&V ZX=R+C##-: +K0
M<T61A81O"T8X[$SAN3Z))CFEH'*]6<[8MF'&: 6FP'[A3M]DB!J*>,;,^_)9
M;[5#S*4!U@ZON)^KS]K<O#*<M<#;?'E8C,N>5@HF$;D<R/NIRGG"S4V] "W[
MD>Y6\.F-,\W>##>.O(J35VE^W*(FO(),2M9SPY[SMB95.:1",,>42I95RL6G
M5D2(DQV[>I6=?JLSC7"W2)S?<VPP_:]RDZM<\K9I[FG<@1R@K)]6<5<Z,-(N
M%@LZO:K9(27RRU(:&W# X9E8EW]FM13=0+8F!$(X<Z;RTJ<\Q?9F<.9:B->>
MPO80!Z/8LX<K;E$2:)YFW8[<^A3+E<\+5(I82@(7<LHX)N(C-3_%L(N[EJ<Y
M,*5/F^]9]]?TD9JWZ$F4GIS#,(Z/5SK.VM^%YIJ;=:## =A&26QK-QARGS!+
MRCV>D).&9=[:/C@V"'+I6HG9JN@YV!,8"[F4NN&8LFF^Z&X"Q9Q6MSA;I<\L
M8+<.662Z]<8PN/-8)E5%Y,>SO6.R9^G#+*FE^)Y=)5Z_=9<.%2'&64[3/"8S
M=*?6R3ODP,#:?1L6;%L8Z.0?$; 8M[>;:I)]6=XPNM#+W1$CE>MM8Q$C/GB6
MV^V )AS':N?G"V:S%)U2LM= G&[G,+DQ4Q]5'JGN>XVFTG9M73K=).<^&ENG
M+L0N*YRPX$7P]HR4P7&-+#0_0)S!/00DSDE^JZTDYK&6$8%9O):S3-0:V(,#
M=CZE?;6EYC!^<&N) LYB,59?J8D:5;&:P[;.HPVJS;/:ZTH.H4CW.-YMA><^
M9+<$X15+1ELVXBT8[>9671E>=/<UC #A[4\.?:6U+/K&L:8=$"!MAB5F98N.
M/*/.K%CH-L ,+QGS(3'^6Y(U7Q+";Q?&Z^."SVA+6_+H_KKK!\42;(QLCU6J
M=6Y]ENTG@9]6^46M,7'[SK73+->Q_ _E?->ZG.XZUS?H$[5FXC/+V@H/+";+
MH#!CK&?Y,_>]EBNKM;GRZ?XIX(?*J'M+3]+Z!A> $X3&76D[A=\MQBVR/WNV
M&1P1<XTWZ'AC?<(M%AQ;' 99(EVL#^#VNE1W1&T_#'VX(LB@ZWPF97B$-%D?
MHPCRBF5O7Z*=3:.Z5/A @@Y=0PR58SBZ=L<+4[V/E"TP>W/8L9;U9F/;G@:C
M,]C0X?>WB."^C^-C+R_/UUMV!K/#XF2;!$;APS7T/T>"Z_1ZF^8W";O#FN#?
MI/\ H^U?J?\ 627IMX?FN:]!>.M/^H5LVS]\(NA<Y?<G;]SRV9BN:?6P9NQM
MALQ7Z/\ "NGC[];:ZQ\Q9?B4-:Z _).A_@DY+V?)-)C>GY=>9$L'59S89_A'
M8OC?-F=GV/QY^UU]2T4);7D=R^;^;,_$]OP=I_9ADF-#8@07X#\NW^Y^E^"Y
MZM29=RY8+XWYLG]=?0_'_DCW-=&XK\E\G\J^]T_BQ.EQA9GC[5J-RY<6R\@K
MQMO%;#08#-?0_%F:\_R3PS-@.K%?5NHY68FN417D>G!?-^;E.N;=HD"T<Z\W
MAWK(+QSK#%X978+4:ZN8N',MUGFLK6$F[#-8M74_5GL:V @'0'/M4DS<IEQ$
M2[:M^%Z\LNZ<E)CRZYANG)7]IF&Z<D_:9ANG)/VF8;IR3]IF&Z<D_:9CP6F%
MR?M2W32F@@VJRO+VX88I;]'.;< X1A&TJ5ZNM;TIL8$CEBEEL7K)>S;9*)PL
M6-9QY>_I)ZCI%ALPS"L3MK2.G-<(B!A[87HLTUV@AP2+JI.78.E;QH;TMT,;
MO9W+IUT\OR]<QD<]Q%Z[RQXNTTU7KKUKQ_(Q%;EN>7G[28;4@EN,(B"[VZ>?
MMSI8*.82\-CAZQW)\=_?MY?RI?Z;5LI:<3 +!:OT7XUGIA_,?]QWQ\EQ]6Q5
MT1E2BX8#!>SXOY/+_KN]OS3]5!GU\ZEJ2 7 !QQ(Y7K[?Q]Y.DR_JO\ K^M_
MHZ_H[%X2XSG4TU@+GV.;'WS>OI?@V7Y,N'^PS>MCO:5YD/ETP&^?A'[Y[5^K
MZ=NL^/+\?\GQ6]_LRTOF(ZH<1OF\?3Y@OJ?@?/UZ]X[=/P;\DT]A/+W7OK;Y
M0<?B#2?>C?N]Z_8_C_+U^3I,/F?E?C]O@[XKN[46M?*EN%L1R[5]7\22/V7_
M (U[=;/LBJ0!K^;;M*^QJ]7]'OR?_=3-2M3KGU&GF",(,SA@5\_Y9+=/S7^Q
M[[UR];..>,9SYLWWG0(=](W6KQ?E?+T^+I_A\SX_B[?+KM]'K?JO%;_$/O.C
M$_3.*_GO^P_+]OELGU?EO]Q_J>EM[5GTSBR8 #O.P'QKYU^;/QOQ'R?Z_P#K
M[WMU^KL[1.-C*W'%Q%@^EE!?E?\ 86YK['X77M.KO;@_S.#9TAA?99]/:K_K
M?_FZM_G=[_77L_I/'4NII9?O-M$?B$;?NK^I_@]I/AZOPGY5_P#O;A*-X@9.
M=$$&)A>.6"W\O:+\=N$W2ZLR$8C_  N=>#M9EZ^LMFVU.UQC6VD79KR_-VZX
M>G\?KVO?[*3K.NL<T@%N.*^=>W6W3Z=SUCI7B"J9/WX0^,[<3=UKR_+VDNWL
M_'W_ ,.IM2HQ.F.NOC=%>>V>'KQBYJ*^HF2"1MPAWK76/=\-F$7-JW29K8Q]
MUP]7.M:ET[7'5V)PSJ[_ ' "ZUPQ.?,OH_CXPGME[0<+5!J);8Y,%O.5ZNDZ
MWLMFLQVS1:.VH , 8M;AF,U]CX>LD^SA>TXO*Q2>%6N ]UMMOP\Y7IZSK[3#
M-EOZ-L\'L+;6MR^!?5^"2QQ[]_3ATOYG-I.$Z*IJ*B#1+EE]P&'M7X[_ ,Q_
M/Z?@_!V]OH]_^M_%OYG?$^K\[N,?/W1Z2MJ*23,9X@:Z $P1B-[!?YV_/_WU
M^3\BV73]E\'^BZSKF\O6OBGSFU?4YA;IKZ@QW@/##G7P N7QOD_VWR=N,OL_
MC_ZOX^LQ8K.EL\T>*)H;2-U$M<Z'NR9QL=S!?.^7\[OVCZ7Q_A=.MQ,.WN&O
ME0\YN/*QD@2-4<V:&G^BU!COP[UXNWRWO<[>N?CWKP_2+R1^Q@\TO,"53NK*
M"N<*J2V9[]%.,2[=.(VKE<UVZ]<<OUY^7']7DU"57Z57:_IA\"+73O%H'PA;
M&.\(*26._P"R:?1'\O7V+_D9P3IFE3=9TV@=4TA8Y[#ITHS#NF) #B+>E;F?
M+G>V.'Z=< ?*5Y1>7#)#.']#I)9D.:]KC0T[?>;"!@(PN5]8>]>RM)22**0R
MGIY4N5*8(!LJ6V6W*.ZVR*K#H3YB/.O2/)K@+5=>K9LMLUM)4F5XDQK(!LIV
M\1'&*#^7G]M)\\$SSJ\RM7X9TRJ?,$S6ZN2&RZK?; S7LA 9Q2;9[]K-3AT5
M]G9\ME=J.K2=?K90/U@MJ09DO>/O'?O/.M29?"_V'Y7IUL?3?PAI+>&-"TVD
M8U@\*2)<&M#;@1A<O?\ #<8?DO[;\GR9^[L+2=18QY<Z%I)MALOOS7JYCV8G
MJE]4U65-D0&[&!N(P "EZXS]7+Y+B.N:NH87&XV' =ZSUUR\MNU;K:AMMT-[
M9LVIG9.5:J"R8#"'9B5BW:VJY5T+9I<("TQNC9Z%J7,<[-Y4;6.&FSV/(:"3
M$W1V)6NLO^'4>O<$>)OP9&(^\4W'273JRKX">R=O;MP^\,;8]RUG_A)NXKRS
M2'4DL-A<+H>G8F6^TDX8 "R8 ++>78I>'.<KEHSG>(RWLV++;MW3K6-_:^I5
MF_1J:P );H9K?5GM,.G->B2[F[E;CR9J@SY/B$B%MOIM6,?\-<Q$U.B>/&PD
MEIP3./T;Z3'+JWB+0'RX^Z86QLZNU7EO&W4U=0.8]PACD1;$9<RQ88TRT%-!
MPB+MNWF5_3A;<<+932R&" -@]NQ:9LQMG\;=O/7[2F"=OHW:6?OD"(]EHS*+
MB\KE0M;N@P%L, M2K*L+9P$O",.[;DL7M<EK5,^W#ETK68YWK;MOTSHFW;Z/
MNI+*Z9F&^]HF-@+5FQE#5NG"9W0CSY),M==<HMFB!SA9B#=M29E3-JT4.C!K
M0(8C#KR6M5=^4O\ FH;N%V60YT^\3RTWZ2(V"SFV#:ISRM<1IHEF,+>:'*Y)
MHDS^J4IG>#NBZ$.6"7[-:O\ )*_G-K6$<P^+)1FWZ*OJVHAX==:TB^)LNP1K
M&L^73G$#]^/_  ME\#FB7K+M0)5(Z;-W;3%W/CT)9Y8S.%KI=)L%F PV':LS
M(MFEZ8YKF&VX&T','-:LS%CLO2Z8RV,@+8^L[%F;K5U%LDS"QL">70MXDX9F
M&.HJ1NFW ^K&,%GRUC_A$NG$DVF\FS[JWBF)&:F>3, B;>]29G8U78>F2RZ6
M# W$^CN5NX9QIYK6ALL@P$(W\VU1FUUYJ+AOOMPY\E8UE".FM&74!W*>6;SI
MPFSP)>%WJYUF_9;<HEL_>>!@3RQ5G79S,.S>%6M=.:(9!:J3Z.P=8IVBG%UH
MCUCF4,;S'5=3*A-?9<3CSKGVFF\YFD)5- !V ]JO5,6\H"HF[D;<O5M6J9ET
M@I]23UCOP*EJ7'ABESR70CVYC:4F<:97+29H:6F.6'W%OF;:F^78#*C^;;L?
MHPQA<-JA9FZX4RMEATUQA](V]?.LVEU-,4IFZ19  Y\RN<K,I#>@T0.5QV*Z
M\K+CAKSIVZ#;:0>SGBIF9^R=J@JN=$$1-_K.W8KG!G2L53S:(F\IG*29V@9C
MB";3=GL"%C"R09SP.WHPQL0NMKYH4@2O#) %WK,5%S,.RZ6I8)8$1RLS5FTO
M7'"-U"<U\8$7'OS*)UGU5&?,+71C8/5'N20[6^&(55D(]F<;XI69+C*NZH1.
M8X7Q[3#GS6,M[KK#5=+\1SS>2<L8\ZUU^Q4'3:<630;+[(B%Q2_9F.R="I?A
M$/I-Y7;5=8.N?9V=0R@UHCL[\EG+6LI)X :>6!279&@\C>ZO4M=M\+EL4^Z7
M88X<ZDE\I++I/TS X"P7#M 5[<::F)N\MUS ,/3[5$O&474,!CWG9W)P91;@
M XV!5FVMB4?=@39#V*7/@TP50B++1;V=Z2XYY,90?U<N?O0RCR@5JXPLNL)^
M@IAO2[,L\G;%CK-IN+2VGW98,+@#V9A6Z7K<\JUJLO>$(8=_.G6UVLMFN%;I
MV^'-RMO6[:L^Z>95>Z!$QAZN=9LF#.'!\X.RNARM*QBG,VTZA[0PB/I'>KS$
M\Y4^O:'OC","8I,]6NT;&GU&X0TGK^ZIG9B86FD:9D#;"([8[5TQ_P I.5KD
M31*E@7$=*DN%N:Q5E:/#+8V\NE3VS4Q9'7NHN?->0(PB3C[5,7DRC9=(YSXN
M%_;U*;RUC:2^K[C18,.SFV+><-7'A :D[='+!2W#'Z(W3]Z9-S%GK5G:<,]^
M,+1]2]R)%D,5+NO+VSG32F:?ODX7P@(YXK-G_+KUW$=4:-O F!ZMH*SQ';$P
MK]9HY;O&'H7.\N_Q7$Q$.T&0\ X&'*[)3$DT]$BXZ3J?A[@&>?3=T+C=UZ>F
M9'<?!^KA]5)!-\Z6+\S'UJ7&'7'U?JQ\J;S-UF0X6CZQ3=H4UY=^NGUC_+@(
M<*2/\UD_R:QVXKT_%_)[ U/Q-_:^M<Z^IUX:R-" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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ME]AC]WUJ>K=QAJMEDFT'!2Z9X;0L"U-GM6=CXQC <O:KG#CW<]XK/]N*\_\
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M^Z\?2VJ_)_ONUYJ_#_J9Y=@TO%X\/XW8?2]J\7;_ 'W;+VS_ $\QIBK.,!"
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MBN-IB3A^N?EC]EAY-\&LIJFITW27SF2I8W64$ISMYH%_N 89IB19W[?X>]_
M_D-P%P'+D,TG1M-_$2VRVQH9+;&@# ')4R[GDR)%.P2Z>3*D2Q<R5+;+8/\
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M+(S.<799HY?=JSF@".V/I]JS:-)Q(ZUF7+%Y;E,\V78?XNU:9Q$O+>8-NO\
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MNW*S#(UVZ1=]VQ2_^CG;?9F+HMVK73&7+YIGHXR]]LP&T6\V*[];KE^0_/\
MCOM?U6.76N9+@7&P#'8N_P 7:7MRX?B].W]LU.49-JMYUJ^QT[=?7E^W_%G:
M?'-)/37M#]XG)?7_ -?VZ>_.\N_;.>&_J3Q,E;HR[0OVG2_'?BW6/Z^^,X4^
M33'ZP'6_%'TK['^KO2=M5X>_3M_9FO8OR]U)U&^5[Y$&-Z+CZE^Z_&LDGU>#
M\_K+,R;>XW"FKOK&4[=\NBT7E?JO]=VZ:WX?E/R)^ZYT[STJ1O26DB_[J_1=
M;U]<Y?/S/KM@U?3639;Q $EIRV+Q_+VDM?,_,L\5TSQ'PL)K7O#&F+'&T<Z\
M7Y'3KVZ9^SS_ (_Y=^*XEKU=XSX8=)+G>&T?$;N?8OY[_M/CG7Y+A]7K^3V^
M;^7#H"N>:.>YI,/?(]2_/?D7'QX>_P#&Z6]DC1ZB'2_C/I7X;_8;^2OV?X'2
M]>FIX2])61>TAYOVYG:O/\,DN<GYO3M>ET[&T?47RPPB8ZP@BTKZO3MU]>7X
M7\GIWORW6G9.F<0.E;I\5]X-^V*=NW6S.:QT^/O+QI=*?BIT(>*__"Y]J\W;
MOUFLO9)WDX;1XB=-!_&OPO.WVKCV^7K;R]'Q=.UO#S+K3.MWW$G;SKE>_2W.
M?+VX[8QAD+SFM].W7G*]9VZ\QKOJC*(.\>CEL7>?)TMY=;USX;M-K$"&[QML
MO/+!?<_"[])Y>?Y.L7K1C+JYDN,#%S+X+ZG7Y/C]IOR\W:22U['<':%)>UCM
MQM[28P]$>9?K_P#7_)\?]<?%_(N.V'L1INFR:>0"&@6 ^@7=:^O\7?X[WP\O
M;MUG3;6KJ@228&&%FPK]C^#VZ?UOB?D6>VD=)U:8)@;O&R'IO7T_B[_'>[Q=
M[+URN>G:A,>&'>-PS7Z#X+TU7S?E^3IN6IK6J23JO#.MR9[6O\2DF,]\1OEP
MQ7\__P#VC_U_+^!WEQ_%]W_QOY)\?Y/7UOE\OOSA\&MX-\S96K2)36,F:@)S
MMP ?DIXG-)Z6K_#/^WZSI_L?DZSA_H?_ %7R7Y/Q>LK[?OU:/YA.&=?HM&X2
MU.53SIK:BBDCQFRW[KO#8T&#XQ@<%\KK:^OVZSU?<VR33P#I<F4 X @MEL$0
M1$7#)='-F  N$.9 0$! 0$'I+\S/R=\,?,%I=13:I+I)LR9*J&[D]D0?$;8+
M008E%G:SA\B'S[?8&,J:35-3X6X>H)DU]74SM^131=:'N!BV62K+B'I.VWR7
M^?OR(^=7RW:IK%?1T%93,T^JFLEB5+GM@&/<+(, N"?=R[])VN)%6\B?GB\R
M?*_6).E\3UM=32M.<);_ !'S&@!IA;O05Z]KUN8\7Y/X73Y)Q'[@^1GVAG#/
M'='045=K9=/FEK'ATYI.'[)?0^'\NS'5^<_*_P!3>N>W6</?;ASS"X9XFDMJ
M*2M\4S"(0>#:0/V2]=^3KWF;R^+W_'^3XNWV6:OB^7O2 XMW;#?8?NKEQ6?:
M\.OZ^KFRA!Q<+\3A%9N;5SA6GZRYKB"\B_$X6+4FEQG;9IM?W2"9CKCVE:Q+
MHN]+-2<1M+0"YUPQV\^U3"=M721&MRS]*/.%SQ]1YF:E+FB (,?8DRLW,5!U
ME"RJ:7;H/IV]*O+5N(I=;H(!B&"^.',K(S[(^3I1EOB& <P 6M31[9J=E-$I
MHV?<6>3M]$5J3FS&/MQ]>T)G"]8IDVGWWPA'GV*VY9LN?LW*;3&D@A@O%D!F
M1DI&O77W7G3M-8&1+&_#D,HK7&G28G*D<7T+"T@,;]+ 9 ++IUX>L7$>GM:Z
M9[C?B=EFKLO.76M3(#'.,/1 #JL3A.4<^T$;#ZUG+.;+I%S93B8C,X>U:FTN
M?#/2R'AP=#*-NTHLVN-&UQ9NPML1K=J4&G3)C8EIM ]1V*9TF/6N!TQX,('E
MTI-M9C;D4+VNN.6.*U8S+M8Z2E<-RS+'G[U"Q/2I+F"[#MMS4LRU*YNBT7=:
M*UYE6)0O@<KMM]ZF6+RK]3K?AO/OF_,E6MZB>TK5O&%KC"&-NRXJ93C56%T]
MKI)A;Z,UJ9\\,]G7FNU!9X@NMRCL3$G!-NK-0JSON@XWYD"_G@I&NTUA#"L<
M2!O'K/K5O#-[:<G3G%HY^_8I>#KF[JR<.1=4M)&758DTV[VI93/ EV?0;V*W
M9.V/HV&,;'I&*D.TGAMJN;#.(W;QU\R-1IP;GZ5,&;:GM.IV/(!M]X"'-9C%
M%MV[)T_3F&6#NMNV9H:P\U+!*B!S=?<JF<32KZG+\25,Y[.HXJYPSG#H_B*2
MYKYQ_;;<^92]LM=>75L^;,;,(B1LM'80H73:DS7O ^ZKKPDWRWY<MQ@;>KF5
ME63:ZZ'-=+<V)A#=V'O3M]ELRO;Z\[@@]WPVVDWP"Q/W<DF$8^K,PD[8FSV%
M)%S(T*IY<UW-Z_:K=,^VU4K?B=SCM6<Y9\H82SO"V\Y9K/+I9<)FEIHP,+[,
M=@6XQG6%CIY8:T<T/7C%:,:;QG!C"(]5N*S>=(@I]0=XD9GLYEJ_=9G+5-81
M?V*<M6_1A-4"8[WH"3+-RR2YY+O1AGS+49[2X2$MN_".5JEFSKURS_5FO&TX
M&ZPI-+C%<?J ^\9U*62KMJ54@2&$@ $"X76K4ZZ)RH.KUA:70<1"^'(147MI
M"4E1,F3F>\XQ<#>=N"<)T=S<-4AFRVDV_#Z;[$M^B8WE<ZS2VB2YVZ([H-PV
M[%)O=:S727%$GP7O-QWCVE6[9KK&;5ELXC>(@[".>PP4A+5HTJ;XY:V^X70]
M&-RI]W8-)I >P3-P8$6!+I999MO_ %/P1\($,K%/NMX:D\[C70R/9[5;,LQ6
MZVH,#;C'#*.2DF*UK"LS9S]XP,+[K,3E!7RGARE5,QMQ-G[(XHB9I:V8" 7.
MLVG8G/#4N%NH*QQ%KB;[X[5<IE)FI)Q'H[E<Y3MVTQ/FES3=@5G$G*[PT9D_
M=)B<N5R3MX6?1P%4,_0KE+UEJ1IJ@1%N#L.=8K6%II*D,#1F!MQ"U)E<IOZT
MV ]Z-UD!ZDB]6NV8)A*MCI+G2O:PT!KH#/IP4D\M?94Y3HNZ2M=HDN*F&-!:
M+^5JQFQ+RT*F9NF&8]7,M)+<X>:>6)@/+UJ=I,-WA%UC6R7@C/EFL,R93VF5
MS&L:"[$##+V)-K)(MM)NU#A;9$7<ZZLWEV!I>DL> 2P6VW#[Z"EXP8S4A6Z1
M*ER"[=%D;X8J336<<.D^)WBG$T-N#CZ\%<)FX=1SZUYGN )(CCM@N:==W:Y<
M.T?UHL+A&+A>,X6PZ51VK(T=DF5O!K<#AETC!$MTA=3)8"(7#O6I)-N';2M&
MI =?B3=M.Q<\Y;Z<)2FGN>(0LL[$G5UYX:>IL<Z6;+[?1SK';J]'Q:TZIUFG
M<9CK!UP]:Y8L>B:K5TZC+W,LQSVP]:Q:]77>H[QX*TL?69!W1^68;AF.]9MQ
M'21^LORIRA*U>G:/ZQ3?A!9SAWZ[KZQOEO,>%)'^:R?Y-9[;E>GXOY/8&I^)
MO[7UKG7U.O#61H0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11
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MW#T69TV0[=.=I]:S>^7IZZF&XTQ 2#0U/^CNYG>I"\.KJG\H[]L[U+K'-X6
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&:1^4:@I/G
M@8>7=1_ 3?Y-R,WMC3XL/G]/\_UK^T:C\*8MSC+S=NVWS&>?+X5VIV?OSL?8
MLXQ4[S$KTR:W>K'V_2'+TJN$Y7*3))DB_# [-A5Z\K>,M"ID$$X7YX0V;%OA
M)V0[Y=M]]OI*Z0MRVZ5FWT;8)9E,X2S6P$%)I9,M:; $)XR>WAYD'WASA9SE
M;]4_*:-R,>42MR3"9]D76N'-\7K1+,*W4$0(B+L_VR(C' $FVWG4RES=.#F0
M5ER>NLM>880Y<KDJ])EA$PX=JY[:D^O"3I)SR;SCBM3@SBX23G%PNCT+7K''
MM<[9I,IQ@89X'NVJ73GC>4C*E.@.G [=BQ=[;QIG\-PO["HC&YQ$(06VWELU
MP-IPV]ZA4G)G687#'GVJRLV7F-YLVX0P[ JF-,K&A[@[/U#V(C*681O1,[PT
MYTJ&.!V]V:+OEK"63=V*8;EEY36GL@1;CDF<,6X7*C?8T0P..Q/"<Q+F<T#[
MG>DOA)D\=F[$G Y=Z[=+@WG"/J&MFF^(OZXWWK=OE4%44423NC' Y#-25+/+
M2;2EK@88CMYBI;E,U/T9#-T',;,%$F]K"R<T-O[.]:E<NTVU*J8T@VX'+GS0
MNHK\X;SK_7FJPY4\IV]=?#//FV*36EQK*VT+]W<B+A#*Y:CEVTM%.Z(;9D?2
M E7JEVR!,:+(\_L4Z\L]KAD^H&_<$,U<QSO;,;,N5X0Z0>I8PSC3:^N[C2W>
MA 7='2%9B5N8QFH&J<9\S>'?CC#F7:&9PD:(^$VW;V]"UIS[<Y;SJL-:;86&
M[FYU<'LC9DX3#&-L>RQ/L2X;E+3":X0 ,3TV'J3![+92:.YS0?#-I!N&2AE(
MG2G-'P70OAS+6-)+M&55-N Q %XLZ-BSCRO6YN;P4#0#>LYK7?7"Z44QK6B)
MP!O&?/L76S#FVICFS!#.,;L>E95"U%.TN-@@3Z@4)IK?5!]Z(<Q3#7L\&4&"
M&0)LNQ3#-NVK-F-:TVVPS&?.IG>!"SGO+[">B.Q;EQIG5K:I3,)%D;1?'(=R
MMD<[V];A<*"4\[IA"WMZ%G-:F]K,QK@UH@;K;"I+ABS%8:ASFM-ED-N22[)F
MZ13G.<22.W-7/_"[C<I03"PWPN.U2W"RYF7*K<^5 M!ZB+U+=G,RAYNHS&F
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M\?J]V/L#O/;5?+/S?TNFG:E.I9/Y[I6!D7" \5H -F07RN(_1=>WMWP_JO\
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M9WZ3#ZP/EO\ ]E)'^;2?Y-2\/3\7\GL%4_$W]KZUSKZG7AK(T(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @(" @(
M" @(" @W-/\ Z=2?PS/P@DY+P].OM&O[M*S^SIO^,NWQN/;BO@I^<O\ U[J?
M\!4=KU[/^E\6_P#RU^%'&YAJK]KYGX2S=NN,UU^X^\3M"PS4I2G> PN] 6YI
MOKPT:ZP@\W8B69;- Z+;H6*8R7ZO%9?T#M"N<:9: L6%FFY(?"%GIV^Q7R<U
M),?8+/2M6XX;NMCW=G>ISLG;3"7PP]*<I-L[,>CUI;A6_*?"_E8I[98MR3Y@
MW++;[,K%OK"91>]$K79TQC9!T8CJBI)F$LG+(UKB-L<5FS;7M+PWI(-W*_VJ
MXQMR[3#?EMA';ZU.US2R?\I%@O*3A+ILM(L&Q:8QO+([X3S++KC,1\QMI,;O
M7;ZT),-<WK-Y9O+)*OZ0M\;1*RCNCG]BL_=IN<-]CQ WX<KUGO,,V8>'.O.9
M6<YF"3(UXC"WE:L=LNG73RXW\RY9WAKFM2=\/+,+7JT@:RY_.M=9B89O,4_4
M2(OY8)ATG:>L4/4('>MN6;H]IX5.K%XV.4Y9M\H)DESIVPGN2W"SM*E-P!D(
M"[(<ZDF;E&C,EP)A"$(Y+=F1Q8\L/2%/M5F$M(J++\.[:GKLN)Y2C*D6^^,,
M]NU7$3+,)\<8B&=G:5FQJ8FVO-=O.,.WEFKUN%]IG+PV7O0!ARMR7:7'7+4N
M7";)A:.5VQ7.6>W+2>R-IPB;DSA?6^4?,&[T1]"O*R81LV80ZS'GV*6X62-J
MC>X.!S(Q.2F<QCM9+I?=(J=P@DPANWVXJSMX<NV[AV5INI !OO 6!:EB8DB]
MZ=J;7%GO@P:%-9SX<^TD=AZ76A^X-X6]RO,87JC=OM%M_+U+$[8IV[2)+<)4
MY<K8PF08FS$Y=RZ3$8]ONV),O=(%UN7,G:K[:2K(!MXN]2S&?:6(RIF%I@,=
MO+->CK99IYODG_NU/$.,3TI=LR8<=_8EGW8<3-:+[.=3#4AXS,QU^Q7!ZO&\
M'6C%)CCR<:<PPN$0(IG&FL1O4K2T@D0O]*TQY33)K +2 HMN-.8<"F8S=,S7
M P&04XN33FM()E1,P>6N@>E3)++,-Z6Z(AZ^8);+MR[3%;C";<+L5/8]<3;*
M39<M<;)U\M*>"8WP]BS:8J(F!PWK#?ZU,Q;+G[,!BK]S'AY:7#-=)VE22SEM
MLOCM">$J4IW[N[L,?1%8SM,6+)1U @ 2+.\#U)E-K92S6O%X-POC?#UJ9PU.
MMLRF9<ACFQQV*>QFXPPU$A@;T'O5E)U\JS6'<WH8=RWK#?KC:+E5C@^$>0(&
M"RQVN8WY\UQED[.WFYEF3+DJM<^822 3>,;XK>,.>,U%R1-#Q8[KVA.W!G6$
M]2F99$.%V)_8K%X$Q+C!M]_K73KR7.&_*)!&7<C?6?\ *9E.W6]6.P*8RSVY
MPUY\XM.,+<<ST+)C3&R<7''ETIG%,:2-.7Q;?Z<QZEOE,IVEW@02#" OC>K>
M"933'G='3CM*QAKU<7S"!CCBI-KC$1$^<22.?/:M\1C-J)G.)-IS[4B=F#PH
MVWGF6>]OCZN,F;AR^KDCX3U#N6):G:?1EERBRPB%N*W*2).0=VWLZ5K&%NZE
M9-4 (;PR%IS.U,>3U^C(ZHQ!CU]ZBS+"VK+G!HA:IVB27.%AHR7 'F]"DF%G
M*<E. -N4>Q;8LN=-QL\  ;P'/'U++I)K;E]8;BX=93DMPQ.FM=#WAUJR8<KF
MO#9C/O@KY:Z1O2YC(?$+@G9TO+'-G!U@,81N-RZ?',7+CWKS(CO1.?K"]$[.
M-F-K)26M'[4=JU;M9M*-88"'*U9]I:S9<N7A1OMZ%K,7UOT:LR2##GYE,XX=
M)-8K!]5_8GT*^\^J>@ZE(;'=.'>I[_HOV1KY0:Z-E\;MJOM.$L;DB=X=QA8!
MTC8I[2:9WE-TVIEI$'W9<WL6I8W>NEAIM9>0WWS<#>,#S)<8T>J=DZH]P^*/
MW!M6/?>'/UO/AL_6'OC$\BM3M+%Q<8<"-^/+);TFY$/6RW#>$#"WUKQ_+OAN
M2V(H1:>9>>::DQRSR2XO$(WC$[5<L]IGA<-/;,(%CK!F4M9Z]:E:EKVR'DQ$
M!MRAZU?9N1U#Q!.A,F6P]TWQVJ293GA4*6LW)S?>%X[59JN=EMP[6T#4MYK1
MO"-G>MW?Z-SKAV3(G/=+;S1QQ&PKG>6L)2BF'?$>W:LV99NG8VBSV-=+!.(Q
MYUJ1;+9'8\BND2Y0.^/N=2EF4W-JSK5?)>U_OBQI%_+-7B),VNF-?,N:70(/
MNG*.'<ABYPZ[?1RWONQ':LXMK6*LFFZ#*F@$RQ; \NI>[XL>K-ESI)U'#$HM
MLEB/-M6Y:N+-H"HX8(+MV23>(B.TYJYR=NR'F\,S+Q(-A.?>IFIF\M Z!-9?
M)<!=9[5JINS[N(TES#$M(A'I1K&.K.RB;8"+DU6>?##52A(82,AVK-:F9JN.
MG5;GO R/>>A67$'9VD,;,#(_>CHL/<M%F%M&GRRW>SYL1S)5DR@Z_39;MZ#?
M0%G#&,7:C5](V23 71[8I+EOJCI4TRG;P,+3V^Q6S*6;3E/JQ  WA9SY':IV
MED3URP5M8Z=*<01R@O)\G:2M7K_PZMU>:0]\39_\^N5N>$]8AJ.H:)S/>^D,
M3M1<8=N<.U;0)?O"]N,;K?4B6^';E#6!TIHWA<.Q,9/;#<=4$M-_I[TPU;K+
M@V=:">THS[9FGA[M\I=-36UFT22/$9O"\#E<I+]6;7;FCR)/AC>(!NMV!:.6
M_52)0#MVVS#F:F"S#K'6W/9,(9& CZ%9]*GA0*BKG-P.6.%JSVF+HDUEHFN=
MO6W"!,>A1N<,[:MKA'>],.]"-B35P=\0[<1BI<EE\+'1ZE+&[%[0=ZY:G5+,
MIHZI*W/C;=VJ^IA"U=8'Q]X7<KE<Q+U5>LGWP)O-UUT,UC-X8MN4=+J#O $X
M[<E:U+B)>5-#@V&/>IYPU+[-UDA\SZ)/MZ\U<8BYO#=ET#A&+2+ HF+RXSJ=
MK&D'(Y9<VU"13-2:T$X=2LDK/M<J?43&AT0[' \Y3AJ9M*:<-X".(QYUN682
M];G.%LHW-<&VQL,<>M9M2]*D)C1N&$!9DL7;7K]$!-!#C;?SY!6:+URRT[X&
M!B?;'O5Y),)$2_$!&PV<N=,82[5W5J)L'68[-NU#;K74)3)1='$PMVP[DX29
MKGI.YXH]X8V=-B6_1;FUW7P[(:^6R%L87<X2W/*YQ^JS3Z%I;:.OG"G#-YTB
M7TVY<#9'!+LO6HJ>]\N)$1'O2:)+*KM?J,]@,"1?=[5K$Y:DMVHU?J=0_>&\
MZ_8M7A,6U"RZ^<7@$G/'-8YN6_6V+EI!=,,LDVDQ_P"-9Z%+I)?#LVAE[LMI
MV1NY9IG1C%3+3;T*XUEGMVF&4+7KF,RS+S%3U;]HQ.>UH() ,"F*PUS.:+W1
MZ5F^S77[-1U9N?2!CRVIMJV1@F5QA81T<_,K97+LCO&?,F1)Q'/>%?6Q5AIW
M?BP#E?U*67EN7$5?79C6RW1(QQ6I+8EKHC7JEHF/][Z;L3=Z%/4RJ]/J#1.
MB+#LS3%6<.QM*U%DQLL!PC9VP3UN,LWE<Y,\.8#O^D\L5)G+?AAGSH1@2;(W
M[!M5N>1#S:A[23EUXG-3KFZ8K0FU[FDG>[<(!7#77K:\2M6<TQWX"S$[=J6?
M0PFJ;5X[H,P60C&-\>=3%2_HG9&IAP^,7#T?=0]:D&UP=9O!:ZS1AH:[.:ZC
M= Q)8X^A6V31Z7&?#U-XMG.;4NRWW#TK-ZRW*\3"@-GESX&/Q>OG5PDVO_#D
MOQ)C!?[HLZE*ME=_:'I\)<H[IN]06I<Z8S<K3.E"7*Z(*.BL57QNZ.U:<VJQ
MN\X!3TUDN;PW&,W8<MBZ_'K9XPG:2<UH@3"SEV+O;O3<ZZ6>CJFB'O9XG *^
MT2]4R)[7"PXW [ F8DC5GS'%IA''$E9O:92=<U!S]\DQ!OS.0[EJ=NN%WA&/
MF;AMLC??M6?;-VN--*IJP&$!P[<U<L69NE-KJ\AQ]X7E:S)&IJ;5>MKR0[WA
M<%GMVF2<95FIK'Q<,R>PJ=;+<VK-M1E5,)OP[N9;MGA+,I"3/<Z$<N99SCE9
M,I25,A#HQ5O>4[=<-P.!MB%9VEC$EM<'5.Y8"#?G@O+\MF7IG6R,1JW'[BX2
M-2L?UEQ^Y#L*K+AXQV]91K+,PQMS"%X9$99I9:-TF OMZTSX%8U^=+$@C>Q/
MK6;/(]>N(ZEA?,@1\1[5KKU6ZX=>.F@S# QMCZ8+-WPN)%XX;F'?EW_$,3FK
M(E=XZ--)EVY#'8IVU=+*V:^:;L(9[%DM4BK,3U^D*S.4G+4E@DW&\+<7LD&"
M MS2K(%I.2G71)@:('H6K27*0DF(&%GK6)$L2;)C !:+EMSF<CYLL ^\,_2F
M&\(B?,9;[PQ6;M8BILR7#XACZ0IBIO"#JG-='=,;#Z8]RLB>4)-]9[0C?AHN
M$P1(:;\U<N<MNFU(=,$(@^E0DN4K*WW-%CL<U6IJM@2'D1@>KVJ-N0IW1%AZ
M@AB5M> ?O?1'U*QCM,<-"?)=> ;SAS(LW,(B>QT38>K8%<L>MB,<UP)B"+2H
MUMX:2VW(JSM>%DLF6Y)G.LOOS/>EK?6I!M1 ?%CF4FV[<\;<WS39 G''F5DR
MU+GC#'XKN165_5CF5#@(967(Z].T<&5+HB)L]J>,M^TJ1ES8@;1ZHK,B7M.O
ME"ZG\!Y_45*Z=;F.G>))<6SH>@;5N;/?ZNEZZ46SW&%QA%9MRSV[)#39SFN8
M,B .@\Z2N>+7:6C3G%K>C&&)P2=MCL&D=%@.S/EDENUQK+S5$AO79'8DN3PJ
MM7,L-F.>T[%6?*%)B8HK*P.N -V">V73KC&V8L?#X2IGZL6R\/+26WQR@MS&
M%F&>7.@0+K_6K?6I9O+:#]Z'3Z$F)$LQ,O-INZEFV,S-K"YKS"P^E6WJZXC6
MF V=*EF1RD?$>6:DNL-3EM3F-:PD;3RZU=-9J!J;8\LT(AIH]XE1J?1P#8VI
MB%N'!\MIA9G@%)2;1\V5 1C=%.W)ZM$B!ADI[-)2F<($6X=BUG3.,7+),<!$
M[!W)-ENFG,>#'F"MLB2>6NXCT+%OE>:Q@C-/:-RR<O/B-SASJ:<MO FQ.Q:S
MC:^K8EOB>C->?Y[GKF/1\41U:^UU]X]:\'AZ<5=N!IK1J+1'[S';S*SAU^.7
M+]__ )'7 U>DD&^1*_!"CKC;ZVOE3!=H^DD?Y(*YQI[/BT_12@!%.WEB5CO+
M9IZ9?+<AO.R]BY[D>GK,MUH@ M]>$K0U/^CNYG>I4O#JZI_*._;.]2ZQS>%@
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*3Y
MXC_]7=1_ 3?Y-R,=IY?%=\_W]/UK^TJC\*8DED>7MR^8GSZ(%?J8_P"6=VJ]
M9:UVQVCTYEF%8XG[X>DCN73^+S6XN%^I"Q\AL"(\NY2<K+_PP5TL!D1? X+I
MZY)=Y5MTMP.]M'+T*R6+[1MTS8GEG!6Q)<)$MABF$O?"+J&D.Y9)@MCC)+@]
MMAO&:EF5S.VEEEO E6QN':L[G"72MU\\[Q@<\_8MS*95Z:Y[HV$PLO.?<L=L
MRDN=-7=>71@0$F;M<3+*;%N+VNFM-$1T'EZ5;+6>EQ6NR6X&T0L[E+UN'3,C
M;E$,-MG9<5.LPYV^4]339;K"1>%<6LV:RG9/A$7CJ&0V+-F+&9(W9?A  [S<
M< DW<-:<WEAN(QRQ6O5->6A,$8*7JEF6MNG-3">S8EQ!%N'J5Q>6N8DY8B!U
M>E6,3G*4E27P%AZMG.K)EGM<W#=;)=N78'#G4OT3UC!-D66B-AR4Q6O;&FN)
M&[A".8'J39=<).D86EL<_4%9,B>E.W(=O7ESJ6>!E=/,#?Z>]9DN5Q,M1U1,
M)@T8@>I>CK-)B2MNGWS\0V]8*T6QNF6R!+LK[ E^B(R?N--D+.:-D5G"S$C4
M$X@V=OJ6L2N=L\-^74/<,.I9QASO+C.F/+#ZHC#8GE,9:TECGS!83;W''G6M
MLW6EBE4T&@[IPYKO:DY9MTW9+'-(]W9UE+IRQ:L=''W1F!Z(GU+.<M8JWT3
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M&2\U^&_1K_+$9?9DL7I9X3.:U'6'K6+UJVL3R(7B_O2=<,L&[M5]_LUEQ<(
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$&YI_\ 3J3^&9^$$G)>'IS]HU_=I6?V=-_Q
MEUZN/;BO@H^<O_7FI_P%1VO76]K.L?&O_P U?A-QP[_M9P_93/PE.O>NTG-4
M)WQ'G5S6*E:4P;#F[$]LW.VI,W+0KS%XR]B9J73<TZ 83L"M[)BW]'BK]YQY
M8^Q9SCEK,:.[S)[S[FF5GNP]6U,^88RW)3P87V1'H*>U/6MH"(CVIFF*%@.
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M\U+K(6X]BLNDL_X5>J(CR^^3-66<-)DL.<! 8'E<M>V&?6\IJ33LW8P$>;"
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MV!NYN;)6S2YS,+?3TC=QI+;<_2I/H==7+'5RFM:>G//GV*W]J=N<Q6YPEN=
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MTEPST\IC3[HQ^YV*7AN7ZI$"9ND-CE9RVKFN<M02JDSF_%#>]?6MRL7+L&A
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M'PO]CWSF1Z=^:NLRITV>=YI_X0[5][Y_S?C[==8?-_#^7'R8[.B]-U.2:J7
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MWH#%"6SE6JFC+8D@7$]<<XJ-YB%F2RTF CS=&Q&96 I#M,,9>T&$54D9Y;[
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MK7"^_G7D]5OR>'G<:\X6Y)G$65Y^KMY'V*2_0M8W4X$("-^WU+4OU3A%5,N
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M5.E3Y[R8&X9\L%.*DJ3T_0YS($BXY'/F]:2BYTH=3-W71%G-DI;O*SZUE^N
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M" @(" @(" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@("
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M)&6\QPO;ZT+,Q+T\SX;1R;SJ[8FJE6S2!@E^C4FD1JE1NL)CAE' K/K5Q/\
M#IGB'4"-[WC>_&& 6Y-97ET;K^H%V^-]UYQCF%J<.=U5$;-,R<?VW<IA+,+C
MI;"XRXQ%G:-JSCZ+)?#LK26;NY??Z((GG#L"B^$<_:&J-^$G,EC=,(\@5OJQ
MYRBI[;[#RB%.T=94:X;KK,(*1CMRVI5K>7-ZDGW7U<G-A"$2MJPA<ZG5K3A?
M^V0L^C0F".]RP5X25$5+2 ;\<-A2;*C7 P-ANR5LQ<)+&LV86&/,>JU+&L1E
M%43CUV=H3^*68;DN?A' 9+-S6;NMELT[+E<:TUQ'(38F\)BR,VW+E?TJ3EG/
MEA>SWHB-V45OV7V9)+(NMC>,%+OAJ=KV2S&#=%]P[ I-1WES&G/EMMY^P@*M
M90<]@$;\#Z!WH291$]H,>6U5GFX0U0(1.T^BU27-;]8C7N-O,K8F<5K1M"Q>
M4Y35#,(+8PLAZ8+7A;$N9L!&([.V*F5]9C-875 ]/+!,+.WAY9-C V7Q/6K,
MI>J5I_>@-@]-BGEF=9C/EM/EC=-_(I=FYM4=5D!P< (V^H[55SIU1K=-NF99
MGV<ZEVWUDFU*D2X3Q8[XO7S+SV;=^DR[%T80W>CUJ8UE>WT7F4/=!Y7 K4XR
MQGPTZWX3RP"DN:BG58A'I_"6TQ9$=+-_0LVX=)<I61CT^I%9W/(ZTL9G+$YY
M,;E.(N<1P#H$),Y3/BL[:C=(MQ[?3BK9<-9C-]9$#;Z%F=;Y,QKNF%PAL/+!
M;2XO".F"/I]*7<3"-FRX&(C><.9<[+:WUGJT7 DF.>2UANS+!,$(]'J6IPLF
M*X,;&VV_L5NID[6QM,:/2LRYVG7C+.!!0MRX$06I<M2Y8IC06F_D0I=+(AY_
MN](C;F%G*>J/>XF-RN&\>L:<RV/-[4EQ69<M1[B+,QWK8PQ&8ZTQ0BLVV&8\
M@PR4S35>2_W3=9[5R[6YP[?%,7/A6=2G0RL)["?4II[Y?*U\!3#^=&FR'XOM
M]JF<QOK<OHI^0R9&LTB$/Z-)VX,6I,QT?81\I7^IM'_@F^M<KR]/Q>'Z5:=_
M1F=/:5COR[=O#E,?$D%9=NG7$RQD@7HVB=4<TR# A6S25UO/_*GG]:Q'+MP*
MH(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#-(_*-04W
MSKM\OJ@?\A._DG*]>4[:ZOBQ^T,$*K6_[0J/PWKT2/F?)=OE>\]Q'5-4V5#D
MMPQV>F6I?TAW./6CEY9J(P#>;EV+?6?^ZXRL<ET&CKYH'VKIQ$DS4O35(B+=
MMW[559;-)^FJ+1;@W+N4YTMX3+3O ;>^"N,,;C*),<.76LWM]2=OJU9E/=9G
MGWJMYGEJ-D0,3<DBWMK229*&Z/;GSI[6.<[7RQ/&Z2$SG;5NG!5EX+8WQ3)*
MUGF$.7*Y.'27#7<Z$.G%8F:EF7)GO>Q639UF:F)  $<?8F=G=RF0(.P<NU=)
M@ZZ1T]@(NP]:Q5NX@*B41:(\MU3ASLSI"SI+GFXY^I;]M82=;G+4?)=9TY=Z
M28='#P')EGV9I3#+<+[QAM4Y)=K%350: "Z!AD-A6<W*^VTI)K6V1=V816LY
MTS;[-YM<T6;V.S8K.,M>K,-1:VY]_+!2]OJ>B2IJ\.W07<H!1+*M>GU#7%ML
M;>:_F"6Z3:ZTLP%INN&.R"9$'JT ^S;V)/KY<^U:U"?=)Y7K6<I-Q8)3X-PZ
M><[5+$LPRF<1EZ/:I"7()Q-T.70M.F&VTE[>>'+T+-C-N&*92O<"81Y0P7/B
ML(^91N;O&'IS6IVV8;-*_<= [.>R_L6_9%JHIX!8(W;.965TZ[F5JIYS2T#,
M##:IVD27+.\@BPX]ZSJLHNJ:V%V>)R6NI^BOSH-'1'J4O*XS,WE$SIHMNCS[
M5>MVG:8:A8Z821RN7:5Y.\_X2--2O)%EX)ZB=B89ZW"PT]$Z#;+P,]@5PE[)
M(4;A>V_:53&6)TDB//S^M&;'F6S=<+[QVI3K+E+2F[V[?AV#UJ+;AN->95MT
M,QS[-JN$]DW05IN#CCGVQL6>*O;:5F39DQL-XVW8WJ^$F+6C]6FSGBPF)%JM
MDPUU_:GZ/3)CA\)LLY6J)G-WPRU.GN8VUO*T(62[5"L!E/C=;V1-Z'_22-4+
M' ;YM-MIRP52++3Z@U\L.+HV"WK.*:C':[<75S,^Q:_DY=[CAP;-\0V6]&*S
M$EPDI5,7",(V9PQ[E=5OF,KZ3=;O0@89Q-RRRC)[@PG*/?SY+6-&=81SM1;*
MBW>V^A9V;\,1U$3!?GM5B>N>>6E-G;V(MCR]*F23#'+^-O.M=2\++07#H]25
MG_J6NG?"PPRO_:K+3?:\6"^V^.U2U8WZ>8T$ YX6YI*M>:^<ULAQC<NDX3MN
M:=4:M7;KY@WR+QDI_)Y[RJSJI[W1#SUGO23![)"@F3ICP(DV@=?/A:E:F:[&
MTJGF$6C+L]BQ;HG;6%G$EX )R&W!1.+IIS9SI<8&S[G>MSA+FHR;J3F.@'F_
M/F5VU)CE9=(G?6=T.,8D"W*T=*33/;:]4U!+=NG<:8G8,%+M9)A."AELE;VX
MT6;"I;X3&]*EJLQLHF%F4+;H*8TU;I6)%67U&[O$^\+^?V*RDN'<G#-(^;X<
M!&+1R]*JNVZ?2'&0T[D(@X#)9LW]F;+[:X=<<7Z;,9*G0!N/IB,UK#=[3AZ\
MSY#I=6XNL@>RW9"T+3CG>%ITVJ9+ WMG+TK.=M_:K?(U&FW;7"/L&T*9Q<G#
M6K-4IMV&\,>SG5O;,7[NL]=U%AW]QUD76B^T'%8AC.W3VLULXNF;CW7X$QZE
MT+<*#75%=-.ZV8\[UEYRR7.YS]DDRAY6DUL^:'N#G N:;8G$G.Q;ETMZS+L/
M1:%U.&A[;MV(_P"%!9O+-T[+T^3+>R!:V,!"P8^G!;2Y3TG2@XAP8,[ADM-2
M96&CI'R"#" %G-!<K<\+Q,+ S5?! :7&R&)]2L^JX8YVIB>(%T>?-:MPPB9D
M_<=$''"U3.6.W:_X6K0J^+PTN,-X7\\<4MQ-.>=Y=D2*IA9?]$X;!M4C6<Q&
MUE7+:3;;$GTB'8K6<;3W#NLRY4]OO0  %FPPOO0LP]O?+SBF5)%.?%-@:(1V
M0Q0LP]H]$X[E2Y+!XS[Q<<+<B,D.&3B#S 8^EFCQWQ\,CXLP=JS9L]MO47C'
MBUTRJF.;/?;OXG;E9@K.,'EU;4\3S' CQG?X1.:OZF-H&=K1F/\ RA)C'')%
MMK$VO)^DXQLMM"F5DSORY&J!O-W[%#&(C*J=XD1'U8E7"7M4,^09F'JRNSN1
MEB%*6NN]/+%8Q]6._:Q)TE$Z:YHW8PAZ5F==N<[ZY=M\,:.(LC+!L& V+V_%
MIYODN>7L9PUI\J5+E$L'P9# +TRY[1S]L3"UUID-IW@M:(#)?5^#M9-/'\LV
M]?N-YDB%1"'PG\%>KK\G;+S=^LP]0N,)<N;,F0 ^%\.DF"^M\'?M)IY^_P <
M=.NE-IY_B0 &]&/_  MB[?V=L_=.O687O0]8DO(DE\;A# 607LZ=^V&KTZVL
MO%.A2=4H2!*8XO!-PQ![U;WN73X_CD?GYYN>7!8RL?+IV"+WW-VDY*RYY>SI
MIZ$<0</5&GU=0/#W=UV N@>8+EW^+K=O3\/S]I<>%4=/F23NDPL%B\]^+J^A
M/DMF6I-GB8;87F^RQ>;Y?CZ8XCW?C_)V^[S)+&X#E]U9Z?!\5Z[D=._S_)G5
MKS,<"8V "SEUK\I_MNG7IVQ'WO\ 7=NW:?NY9Z=T-O3L*_.S%?;LUE( ^[T%
M2XRX^VVC,? PAFLVS"\R,3 8FS#UA<;VS33.1N@D<K5B7-.TS&A/!,;-G6$O
M+'$:8:6E62./:Y9FF(Z5UQISXN&9HCUK?7&6>\S7GPQM7?#+CO$9+M\<C':8
M-_E%=W*R.+GWGF]077I,U?;QX<0\DBY=+,0S]'DVD<L5Y._7->CIVOJY!HVK
MC>K<[7 6'"/4K(E[X9V2X#&X8+/:2\.7;M>N_NR"5C;=D5G&GGO;;,V4#RVI
MC$<^_>XTR;@A"':FG'/;.020<_3WIAJ=[_EQ=3EV'I^ZF$OR6N/U:'**>N6N
MG:UC\$[?0IB.VV%\K*-_>NDD\NO7,V\!D!BED=NO?Z/!^]'+%9G6<NW7O7$Q
M8#]Q=.G7]T3Y?DLZZ<I,UV_UK[WX_6>L?G_R>_;VYJ;\9QE0CRW4^?I,5SZ?
M+;>:K=9+)>XVWX\Z_/?+KO7NZ=[C.6*AE'Q&Q&([>=>3Y[CKF.G7Y;:[!H9;
M0QM@N%X&2^'V[]KW=_;LV9[6AIL%WK7;K\O;JX_+VMBNSX"('*XKI/G[\YKQ
MXS=\(*K;O.-IQY>E?8_!^;O?+S_-,<-B@E&V.S,^M?=Z?-VQ-UX^UE[1L5,N
MT0OCM[U]_P#"^3O</3\=GKBKCP=2S75,J'^5':%][K\W:=<93KUS\G^7Z.>5
M.F3)M++!;&.YW+V_#\ML?IOPNG6=,O9=^@PI@XRQ\-\-G0N\[6W#Z73IUO9U
M/KU*::8\AL(/A9SQZ$[7$??_ !>DDQ]D9IVH&7.:TO-A$5Z?Q+GY)'H^3X>M
MZW,>Q' NH2M^F+C],=J_8?C])/CCX'R_C?'>UN(]GY&I4[].+ X'W(0Z%X/]
MCTGK7A_)^#IUZ\1ZM^;U$VKD3BQH=&4_+$67K\EW^.7O?H_/?-<=L1^9W'V@
M3&3'.,L?$_ 9E? _VG2>MP]/X_&7K1K-(Z0]T6P@XK\;WZ]9W?1G:U1:F;N/
M<(X]G0O+\TC[?X$]K&_IU2=X&.V]>/'7VT_23XNO]65\H*MI,J)QCZ2OL_A3
M$P_*_P"RZR6NWN'',F-9=>!UP7UNO7K>\_5\/\CI/ZNU_P#S78#9(#26[,.;
M&*_8_P"MZSTF'\2_\G[]NORW'&V.6^:R9[I<(&%G0OK].N.^7XW^SM_7JNVN
M#*B?X[ YSKFWQS"_3?C27H^%^1\_RSOYY>Y_!HWY,G>B8RV[1</4NW7K)V>W
M\+Y^][S-=N2VRQ)$6MNV9'8OI_')B/VGXW:]OCF?HU*27+=4CW6GWC@.Y?E_
M_*NN?Q^WZ/K_ .NL_LQ]WL/Y<TLEDZG=NBV:R\#%P*_SU^?F?E6/VOQ__%I[
M;\:\+4'$?!$^G,B5,<-/F_$ ;V+S]L7H[?C=_3Y?\OE!^:CAL^7_ )KS:^3"
MF:W4RZ,KW?AFAPN 7SODF\>'['\;O[=<^7UC?88?,I+G5>DZ-.U*>_\ F]'+
MW7/)'T&D6NVKEC#Z?69F7VG\><?:5PUY85_%535>%+DZ'+JY;@8.\0R&/OB+
MK5J3V8[=L<?5_-#^W/\ M -7XKX]XGT+0.(M1E3*;4)E/)ER9SQ=/#8>Z_(+
M,DG#IWO$C\*O(7Y\O.;REXFT[6!K^NFDDSF3=[QIY:6AX=&.]!7EF=IUW.7U
MD?()^L"SI+-%X?XHXFK0_P"O4\F8)\]T=V+&'XIF2?HO\OW7R^P/Y8/M"_*'
MSMT>3.F\3R&UDT2@POF2S%\P"QP#XWE63*=KCC;]#=+UK2]:E>/I=9*K).Z'
M>)*)+8.N,2!>H)1 0$! 0$! 0$! OO01NH:/I>JT\VFU#3Z.LDSI;I<QE13R
MI@+7 @B+FDB_!!^=GS'_ &<GE-YZ4=7X_#VA2ZF;(GL:U]*QI+IC3"!\'=C$
MYHN<1\B7V@_V D^FHJROX-X?I!!]9.!I)(!%I<V&Y+VILQ+<U\H/F[\E_GM\
MLVHZC74U#7R64E;-ELW&S@-V4]Q 'NC[U)=.?;I.WC39\GOG8X^X/KI>F<55
M553,HH2'^*Y[0-WW3'>(R73IWL>+Y_P?C[3.(_3O@#YOM XVH*>6_4Q-FO;[
MPWP3$C&)7L^/YIQ>7POROP+TN9X=EGC+3-7_ !DFH+A,)A:#ASKU>W7M-/C_
M "?'WZ=DKITR7/=&(+?;'I49EN$I5EDEIW0(0C9T8!7F&76.M5322(XY#:/4
ML-9TK4@ES[+8F-G2JS;;,+51RG^$+EF[)IK5,B87"S$]I5BXC9T^1,+Y=GTN
MV'J*4YT[BX>ICN,,+8C';SJR[PEOB.SY4AK9-UL.VS-2]<DN$!7M&_C>L3,B
MYSI79[0TQMY06YOE,X1SJ@ WPZ(^I&I=,LJN!)&]RY%7"9F/ND631,%ACCDI
M>2<LQE!X@1D;?NA6);]>&"9):QA,+>6W8G-QX)77'$/PG9]U+JM6.C]9E;Y<
M<=[HQ]2ERQ.<JO)D/;/$!9'/*"1NW3M3AV>^6)=L( \NLIYA)AVS05Y;+;%Y
MN'9':M^-'G+<F5?B8QY^8"]<;+E;BL4N4)CH0CBM2Z3B83=-1,A:QMHV;-BU
MUL\LRU,2Z66T"#1$Q^B-O>F$MRXU$L-; "%WIB$:S:H^K[XW]V-G<E3=_2J/
M.9/?,C;"WEBF<::DGE.Z93S!:1B.U9]ML]KO"Q[Q:VW ;5O&LM<1#UM8QI(C
MB<LH*3;$GA7#.WIL0<<AM.2MN)AKQA8J2I+6"W##V!8X,8<:BM-OO&SGVK49
MNZC!7&/QNQQ*NHUC66Q,U'\7#?/2=A6>=I[56JRLWS:ZR %V?W$+<\-:GGC?
MLA]SH279)K;EJ#XRG0AAMR[E5DR@)$U[9I@<_6B2+903W0;$XYC&W)#[)CQG
M$?<[E+]%]6K.M!.R"Q>3BH:8T[WLYUKKU7M/+9II>]GGZE<D^Z=E2/<C#/E>
MG*S5<'"!R5F(W,LTD;Q S,.A77+7LD#1%[19D8QV*W9[(^HHW,MAMQ6:UG##
M3RSXD#F1=S;59J99O;VBSR*>($!UDCZ/.LWM:DPCM1?X <8P(ZXV=R22\MXG
MAJT4]LXD.,8@W[-J3!PDYDN40(-;?@!D=BTQG*.G2Y8WK!CCDG:Z_P ++5(U
MH 1A=NN6$="\3,<XNW=O:5>(W-1U4^5.;4_\./I.Q6;8MKMSA*9-9,E1<X0
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M" @(" @(" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@("
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M,=M]M.V]*E!DEC80L'I^ZEN:Z]9+UVW)\ECFN,!&!PYNY2;.TPJ6I2!%T!9
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MX#F'HMS48Q5PI)C8#V9<Z8M;QANNG-'(=ZTLB-JZS=!@80!N(P/2F-B J-0
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MFZQ.E$1/*U9W;]B]?HU7B!/1ZEKB).N:Q%X%]D+;U<GIMC-1M]/_ ,\DI>N
M3QLZ_:I5ZQR\0.'-RS4D:O7#7FV1Y9+5X:ZSV14PQ)&T=BCM)AK/-XYK>HJY
M+,O#3"SE:LV92]<S#88[M2:CGCUTS;VSTJX7U<7.NL]*N,+UZM:<\0YMNT+,
MY.V8AJAT>70AUC2=<4SO#I9F-*:Z$>9/LY7KC_EI/=A"\=ZUPUUZZ8]S;Z/:
MI[ T7I2]7(A98LPP3C 'F]BSV=_AW<*EJ4R$;,3CL*Y7+WS$TN? #XZDP0^\
M[4D\NG5]%?R%&%9I&VGD=C%J=L.LGE]B'RE&.BZ-_!-6.^W;XKN/TIT[^C,Z
M>TKGVN7I[>'B;\1YSZE(]/3AP(WFPNY$)Q2\H+599;*-M\3CS*^V:63&77\S
M\J?VWK3PX7ER6$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!!FD?E&H*;YU?W?S_ .!G?R+E>O*=N'Q9_:&C^=:W_:%3^$]=YVP^=\G7
M?_U]WRM>?,P-U35(_P!8/+!6X<.UWAZ8:E,'UAT+;<^?G6?:L.5),  Z<N]:
MF>6^N*G)<Z,.;/[J[2Z6ZTD9#C8<_7 JI)FI^DF$]0&/>LYQ<L]M<++3NNCL
MQYUTG;*6_P#V)1CQ"%]N:S9G;,VY%OB60NZ?4I(O:.+:4DW>KU!:$FVC]R,,
M#F<\HA19UB(J93@?3<=I."2)YPU&BT<ZU9I?5E,LD^PK$F&IB-&I; >B[85J
M;3JBG&)YB5%;E*+NGUIC*Y]4DUQ;U02QGVV\%T2=JLTEK&YL8\R8R2X:DRGW
M@;,#A[-B?9<3PTW4,3'='9VI>M:EQ,,+]/)A!D;\1LVE8ER,/YM/WGI"UEGU
M8YM"9;8[L/3=S*[3MUN$27.$P-NMV[1ZD\L74PV&%T1 F_;WJ\+T;#WO:(AQ
MN/HZ2K+ET8FSWWEQL@IVF3.$A35I#FC>N(MLRY]BRLLFZN6EZB&;I+\L]B69
M.^+-+_0ZJT@^_AM[E8Y>,M74*H328'>MLCT\R7ZL=NNLO%!,,+A?ZPI.6,Z6
M668M'3VJV81X=,W2!!,->KPR9;=AGM"NEMOE-4KXPLY6JXR93DMC7"T!<KUW
MA+]6O5R6;A@!G=S\ZN#*M.&Z_I]<$X9K?DU1ED6G*$1CTJ]>V_LU.-)ZFU'X
M1O9#',;%;CM"7";E5>^!;'OYH@J8Q2DU^\">6"L[>%DPAJIAA'9ESK/9GFY\
M*[.82\I)5MTF:&FWQ$B-V![MB[].-\O)\NM+714;8-]W X'9L6W#RL-/1 ".
M[AD<F[$7&&292@-^$7Y'N4:E1$Z6&QYX]FS:AC>V@+71S,46)2G,(='^*F6,
M9K<<TS! <KE2S"6TZB?$6&$;[,^M&=K,RD+6B(B8 W1P&PJ-R1(2)+&EGNBV
M&&Q&EPT]LD,$6B_9ESJ3*7IAJZKX6ZZ $0,(9\Y5FZLQ.74VK_$>?U%7AB[5
MIDMQ?9GMQBGE;/69B=D"8V5>;MJEFW*W.JU73W@D1-^?L3ASO*9H:@;S8F-I
MOA&_G6NI)E=:"8U[>F&&P9E),7/AK&L-VJ #8#[TJ3;"C:B\L!ARB"K:LN;A
M2:N<_>)WC><=H6<MS3:HG.=>2;TGT8[)4R'. [CW)9IKKPV)-,=YM]D,\N9:
MZIC-66BDN AS9[#DI<<F$\T0 Y;5&7DS_#O-N<;;><J8MOV7KRY2ZOW@=XWY
MA6S"]KX*NI+Y+@''KV')6W.DSB.N-0IGSISB!&)/J.*DN'GN;MJ2M,<YWP7<
MV1OM5]K:86S2M,(<"6"QPMLS5Y7VQ'96G4S&@>Z,,/N+-FDMREILI@;=AR[%
M(O6J[5R"X&$;3EMYMJV755V;ITUS]X"_;MV%7+5N5@TK>I2R(@0>W;<L\L;S
MA?J/5&AH!?GG>!S*<+9I-/U1CI9 ?AZ>I3DZ\J-J\\S#$&-^,>PJVEFT'ITI
MQJM\V .R.84QG2/8[@YTMO@[_P!Z(W=&U:QAJ5W9(J:84[+1\&6P[$D.(ZQX
MRJ*<RIUHNRVG8KDLEV]7M;J)4JIFO!A\1N-]L, JPI]1Q(RFNFPZ?5BL>JS:
M/'&Q!_I&SE8F--8Q7+]*WU%@FDWCE"U2<IF\@?-K;(ET=L?7M2ZVOLS,X6FU
MI/XO>WK;N?IO6^O#-W4G3^6DR=!YIHVV<B4[:(WW<!,HV&-. 6@VPYNE2ZC6
M:KM5HYI7V2X &.5UL>>*SS4OU9M/:63('[X#J).Q7A;P[)TTR]QL8$P&6S:M
M<QF<I:=X?ADM !MA=LV[%SQB-7G*GU<QX<Z!AL'2K.%KA2O<7"),#[%/+&-M
MZ>PEH/3V)&>UQ$EI+W,>VV'O"*UG;GRODNM\*7$N/P]UEEN"S=W28SI6]2U@
M;Q_&$=)6I%SAJZ;KYESA^-(NQR,<53EW[PAQ@^2V5^/(L$/9 *39[.[M,X]F
M,EM/UHV#E@JR:AQY,GM>WZR3O CT>U%L=5:OK3ZA[G&871CC"^WF4:O"IS*]
MQLWL!B,#SI2,+*ASGB#C:<]D$DQ%3<ESG0YXXYE$S9PW=P\H]RF3+@V0YYMV
MY[-BN6O67:3I=/+[F1$"(V86JRX8DY<JC3C+$2V'W=BEF:\_S=I$GI-*V(]W
M%N'L6Y\=\/%_9,NY-!E2Y3&N(A!H[\>9>CI,3!V[>W#L*GUB73,'OP@(7W8+
MKG#.D#K/&$MDN8T3L3FO;\7S8CGW^/-="<5<2B>9T)I,01?^Q@O3U_(ZN/;X
M:Z"UVJ\9[CO1B,]IVA>_XOS)UF*Q?Q;VF'6.KN+99W;X&X[%Z.GY?7.<I_VM
MDPJFF:Q-IJT S"!OYGF7T>OY76]6/^VLKNW3M:DU4EK'/#O=%A/M*UU^>=JW
M/BO5U]QQP]3:I2SH20XOCZ?0O3.T7AZ&^8GEH?$JWRZ46DP@%TG6]KB-=>TZ
M<O5G7. ZFGFS/Q!  RVK?_:WEW_[N3A1:KARIDN/XNP GTKE?];W[O3\7^PZ
M]9BU#S:*;)O;"'J*QV_UW?I'J^/\WKWK2=&)'*_V+\?_ +7\'O;N/TGX/Y4D
MSX9Y+RT=.WN7P)_K^V.'U>WYW7'+9$XBSO4O^O[_ $<O^]ZWRPS'"RU<NWX/
M;Z-_]WU^KRR;#JY8+A?P>WT2_D3G+>8WQ!GLZ^Y9OX?:<1J?E2WEY?3Q!]W)
M<K^+VE7^Z6\Z:#Y'O& Y=2S?@LWY8_MF7ELF! NB;H*?UWROMFY;'U<[>70M
M]>N-M6QQ=)+!&WE'8%N]YPG7JTG-M5GRSKL[?%>U:3R0XC;[5TGY.(QV^"C7
M1LQYUOK^7)Y)^-;&:6(D=.W!=+^7ULQE?^VLY;88"%SORYW%]<:<O#VJ?V?9
MKUP\P6;\F&9TRV&"/4%F=YRSWZ9U]VT&" OY="S?DF7FO2Y<VR[1RP6;\LPG
MI;IF$B(6/[HS?C^SR)>Z>F*O]TP?TYVY'F6+\TB7\?+&YMUBZ3YHZ=?B^S@6
M X)_9&OZ_LU9DJ!L[\EUGR>VG;KUUPQ>$3GS02]CUQ<O'A&,+>I6=M.DVQS9
M)@3;=D>Y=.G?%9^2?MPUI32)@!QV+ZWQ?/,1\7Y^FT\QGXN_E *_-^1+U_PX
M]/BMJ,GR(NC"-N7,OA?+\D]J]_7X\=7&ED[LR,(6Y;25X_D[>\PO7I<K-+FB
M6P"[I]H7S^WQ;R[R;:57J36M(W\QZO6NG3X+;PX_-4 :[>C!T?5UKT?]K?H\
MF8X;WB&)Z3S_ '%]K\#\6ZT\OS]L)>B;<,R%]_X_P[9-/FWO,K%3Z),JG,+6
M;T2!SVA?H?P/Q;QATGS2>7>G 7 \USY3S(_?)9ZR%]._C7/#?7\C';+] _+W
M2FZ93-+Y8; ,[%ZOB^.]=/T?XGY,]7;5?KU+)IMPN .[#T;%Z?3#Z/Q?D?OY
M=$<1ZQ(G3'AKHDO/:N7>^/#])\'Y,G7.51IG.=/#P;(KK^/W].\KO/R?[?VS
MR[9X:U9U(9,7EL'#T%?J/A_,DZ3;T=?]9V^:>T\N\]*XMWY(E^.3$PA%>3\W
M\KKVZUX_R_\ 4=_7B\(WB/=U*1,)]^+#?S6+\QV^;/9^9^7_ %?>]\8>G7F+
MPR U[O!%SS<OC_G]?[.NG3K^!?CF+'HWQGI_@/>-R!#W8;5^6[_BVW+?]-GA
MTG54Y=-?L=ZX>I<NWX/;OQ'N_&^3^J[2NF4#R0=WE?FN,_UG>=N'UK^?)\=Q
M=+52T$X/EV8^LK[OX?\ K^V.'Y7_ &O^QZ2W;N;A>EF!LL'[YOJ7T.O^N[^T
MN-/SGS_[7X[\5F?#N;3M+?4, W(QW1V+]5^!^+?CZQ_'_P#R+\KK\ORW'W6:
MDX.G3GQ$F-QN]70OI3X;.WL_)]?DDZNT>&^$YM/,8\R80#<%]?X?EG3KAX/F
MZ3O7L9PX#1RI8/N[K0/1 +K/FF<NOXGQ_P#WD7"9J[62B-^T"&.7,O5\?YO6
M>7[?\68^.3[,&F:NTU(]_';L7YS_ ,E_,Z]_@[3[/J?@=+/EE^[V*X&UQC'2
M/?N>TW[0%_!/SNU_[FU^W^"?_=YKW2X1UUNLT511.?OCZG,;NG:TV+CUZ^W4
MM_K[9^[YQ?M1.$:G0JVJUJFIH0J)LS?$?HF,5X?FGK7ZC_6?)_9UW]':7V+G
MS$U?#G'NF-J]2F2&RZB1+(C #<>!"[""X?>OO?QGK'UC_/3]I;1\)?+_ #]$
MI^(W2:A^CF78Z!/\V( NC8LTZ=<S;^?!YG:MK7S0>=FKU;ZN9J,BJUF8\[QB
M'-,\DY7A7K'+Y>_IUMK] Z;Y$Z34. *6>S2Y+*DT31O[C=[>W+3&^\+T_P!-
MO7+XO?\ V$Z_)C+\[./OEL\PO*#B*?JNAU-53RZ5[JE@D;X +';PAN\RY?UV
M6ROH_'^9T^3IR[W^6_[2GSM\B]?I=/KN(=7IZ:362HESYH;NRWB-X-D L67.
M'OZ=^LZYY?7_ /(/^L#:;6&DT/BCBILQSFT<APJ7L=$V-<"'C,J<+CWV^K?Y
M?_G<\J?.FAI)M-Q/IS*FII)4\,WI;6[TP VA@C><D,5[I4>H46H2VSJ*IE5,
MIS0YLR2[>:6D1!B,XH-Q 0$! 0$! 0$! 05S7>$^'>)*2;1:SI%%7R9K'-+9
MTEKC[PA$.A%!^3WS4?95>5/GAI&H"EX6T@54^9.G;GARPXE[7W1A$Q."F%O;
M#XXOGX^P0UKA5_$.L<*<+^#*%9/<Q]+*-C?$<1#<V!3K:>LO+Y?O-CRR\POE
M2XLJ-,U!M;2RZ>I$DAWB -MAC<M3M;MP^3X>O?EVKY*?,AJ^M:A2:;45$USQ
M.:QS7DQ@38>8A=_C^6S3Y/Y?X/7%LC]9. -;?J.G2ZB88%T(D\PO%Z]_Q]\S
M+\O\T]._KX7/5*]H#FA_T=JUY2X]75VI3B]YM)!.?.<"C&<3[MC29.^\8QAA
M=;TI6NN/+LFAH 9;;, ;CC H7ECK*%K?HYX';L2%FF"EE-9,;9=LY@C.*[.T
M2<R6UICRALMQ1J3S5_;62W2X @F&W84,(*LF!SR0+B?1UHS=*[6.@.GEV(U(
MJ-94%A<(PMS[TL.R-DUQ:_XKX;<1D"C*TZ;61A$QCF1"WJ*EVW)BY65LYL(Y
M[1GSJ=;3M,S#5JZEK6FZ :2<;N8KI/NQ-:=/\2ZHUCG-WL2,;+U+RU:ZRGN%
M47$6C>]1%PYT9X<J?2R]X(9@87*8S4F^5TTS3IDOPX,A:.V*6.G7C*XR);VL
M [^Y3KSMB]O5M,B'#JY=2WB5C-SE*TSPPQ//ZESO.':;27YR9+;'>ANCV)@Q
MISD:W+<X .Q[0M93U2?UH3V9Q /I*72R8B*JZ038V#WH",-D.;!+<F=(8Z4T
MF.Z.H)IB^V=)"11ME"[ 8;.9)UWE9,M"O/AQA@#Z K=1K#K35:QS)I]ZXYCO
MVJ)EAHJCQ' FTQSZ-J+)A:J9T98.P>M6PM:=5,/O77'M)68G9$&:Z)YSRO5,
M_JY/F.\._#;D=J&(@ZA[NS/;M0QC;G2&+K<N]9\IG+?J;6PS'K]JM7JBY4N#
MXY]Z2%UPL-(V,+<1V#N0D6&3();[.?8I+E?:O$VG,#?ARN6L3DRB)TO==ZND
M[%G/T3)(<UCK3Z1A:F,[.=IUD]FYUXCO6IJ+G%1TZ:W>-N>6S:L75T[=-S;<
MH'A\QHV@=G.KC2V+[34@F2FG=Y"/,%?8QAJZE0ALKX;8$W9<T4E+-*Y3T_XT
M"&)P]BOEF8XO*UT]/8VST;.9+BM85?B*7N!Q_9&SK6+F+)A2*:N,F8Z+H6P[
M+H6JR;+PEQJ@(^/+-7=TS(.K/$%CK]O-M!P5GTI-(#499F@@9&[G'<M:3.\N
MM=6T5TWZ$8[V$5B\X2W2D3.'CXWY,7Y'-7P=:M^BZ8:=S1N0L NQA'"*QG+I
MC.W9U*\2Y+0<H<K0M8\LXPU)D]H<>\=Z9\)>7)E4P0) %F8OPN5DRMF)E(R-
M4EL<+1"_U8\ZLXPB=D:[*8YI#AG?L]B7:-QW$<O.[;[5),-2HZHX@80?>&&.
M4-JU[9N%SA7ZK6FN<1O7DYY0VK/JRT1O51$+28=F?2IA9M,4M \");"S9'',
MK4X7MAM39+@#[<CL4Q@D\JW6LW0;;B>Y+V3RA&.+IG3#MVJX6W&UKTZW=YAV
M!3[&,Q<J6G:YK1N@W1LV[.=23>6;IXKZ*+(AHN/+!6\862JL* B:26B%NW#8
M2L7-_0G.&29I#9P^ &(A<,;<5>N8GEJ_H^6FR6!"V(&SF6\Z)UWE.:;2OIG-
MO$/79A<LVX:MPN$B6*AC6N -APCD5<Y2<Y:=9H$N:'/\(&(,.L>I:DRO;A6*
MBA^JN,&;HNL'-DI9EAXIV^\#''UP4QIJ1?-+@UC3S+7C#29J7 R;,!VA9A>'
M6&NRPYCQ"-ILY[<EGLSC673^I4WO.]WZ1P.?,M==Y9K#14@$QIW1?D=BEZM=
M;AV)I$AC (@667; LV6-UN:J\2Y8AEVV;,EKHY=[AJZ*T3IGO9KT//=W2^_F
MMCV_"+AA 9Y*<-]<U#S]*=+<2UL+\L]BQ[5VG*Q:)*<US0;(1&.'H2W#U?'<
MS+M+2I<OPVAP!CFH;]DN^FIW?O;3;"X9+E<Q[OBN>?HY:;1R152B&BR8TBP9
MQ3^4=_L_0_Y7(2];D ?Y>GL_X86>TQ'7KQA]7GRWS#^BTC+ZK(L_X 7+O;ZX
M>GX>LO9['5!CN_M>V"\%F*^OTG[6J@(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#/)O
MZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @(" @(" @(" @W-/_ *=2_P *
MWM"3D\/3C[1O^[2M_L^;_C+MTX>?Y/XW]'P,?.?_ *^U/^ G]LQ=O#Y,_P#D
M?A1QL[=U5^/OS/00%BMWG*B.?%QLQSVJQCM+=I&FL Z/6LUUZ<-"N^(='8JS
M>6]I[O</,%.VUY<*GXNKUJLO$JX<Q[5.PVA<HZ3AGDW])[%1OL^$=/:4') 0
M8YMPYUFI22W>/LY9+K\<21N^ V$<8#E""]%6V8>/ &SET+/ZL^SD&;MD;U<>
M3.F5ON[;E<D[;;K#?L@N?MO*6M^5-W;R1 7Q/,MVM8TW'SXM-L>M(Q/HCB8O
MY9*WAJ\/*RR\H3EE;=TI%[<N2(YLOZ.Y3MP,YN2-WA%U3K39R,5CM$PAYCC$
MCUY?<7)9/* K,>6*-7A4M0O/.K>''J@'_$>6)68Z=>&_0_&S]MZU8=G8VDW#
MH]:OE/"^Z9^4'/WHSY7Z2W\6-@'9[$QDRXN9''#)3.&<8K3FRFFS8>M,>71&
M3Z1IMOO-^U3PEOMJ<H2IH Z,&G =2UF$EFT).T^R&Z<1=F(H7:.G::"(;OHV
M%.&IPJ6H:1O/(W";;+E9]3%5NHT<B/N$88;.]737L@:K3BPGW3?9U07.U+9*
MB)U(0#%ILM[0KX3=0E13P)@+>@Y+-EF_"YWA%&4\&$"G.U8'2W;QNP[%9D>6
MRW6&*N&;6]*-O+)6\,\;2\EV'1UP69-Y2_N2]--\(AT;K=EP[EO+%UI9Z'5R
MPM]X>Z0<<#[%+<LXPNU!Q"YA:/$ N[(XJRY,_9?-.XCBRV:#=EDY7.\)KE;)
M'$(,L S!=V\REW6;,W+ _4?%>/>'+[B[=9]&I9Y3= X3-V!PATK35VM]#+!#
M2;8N!N&WG06233C=PY$_L4&R98:.:"SYP8C$Y,;8[8PXJN<VWI$JZW'L)4]O
M#/;KC;9<W=A;&*VPQE8QA.S#,= 7>E3+/7:,G/OY\^A)*Q=5&39NZ3$F_&,.
M5BU9E<M-\YI)]Z%F:SC%<[SMH5-0V6S?WQ9MYEK[+C>51J^(?#<6[X$''UYA
M+JM3A'/XGW1^5'*S+:IG)+]49.XHB(B8+3LV;%>$:OZ3V_E!&[#N1<5O4W$D
M8?C!G</V.28,^%UTSB!KX1>(B'*]3RGA>J'6FC<]]MVW('-5J5:J75FD-@\8
M71S'J4P=EBIM0#H>\+3#T))A),IV3/:\$[V -_.EJWKAAJ)[6Q@1'GV$9;$S
ME,57JJMA'WFX^L^M4B-^OC>O%X0LSN).FG^(X;89[>A.3BIYHW6!T8_<!5ZZ
MI=L!JW-,.]=^8XX9&U1('-EWP4SX8L\MML]Q &SU)+BF--F7,B!$9X\ZUG*3
M3<EFR&WN2Z:]M-ELK>QQARO4RO+8\ ;.KV*Y3+FJTS"<6BQ<_*69<C4&%_;Z
ME9/))X:<RI.\;4P68C2F3R77]40K-,S3@)I)QZRKJKE(271OR'I@LV[Q#G:6
MD$@@CE )C,8NM)^E?& ARB0I>N'*W*>D6F&?L1$@V2+#';RL5SK"YUAF :T6
MD#G"SMFW#7GSV,88.$5=Y52]4U9LD/!F 6VWXC(+><(ZSUCB9K2X>,! 1]!S
M3,:]5%JN-A*/Y<&V[JV;$O"3EIGCP$?EAZ.Y9PU(QGCL1_+#ET)G"7EQ_3R!
M_+-6IN97JW)?'\/WX7X*6EOA)2O,. (\:[EZEG*9VWF^8Y$83@%K35ZSLXS^
M/WSF0;.O&WF4RY66*[5<73W1(FX>WU+%8M5^9Q)43'$>(3?=SVK4F-L\W#:I
MM2JIQQ-WIYN=:RN)*LE/+J)XN)C;T0QS46W#<9HE1/(]P_=M4IV;3>&*AW[V
MZ[(*^$S,-Z7PC4. _%NNV"ZS!7![,CN#)^X3X9NCCCTK-[8T6YB(J.#Z@?0=
M><D]DSC://"E2/H/]'L6C&LI"CX6J'.AX;L< F(3LN&G<'SG;D91,87\YP"M
MU%YBXTG #WP/@DQRVQV[5,ZB26Z6.G\M#,A&G=9 ^F*S>OEJ:Y66C\OVTX_(
MD1@3C=?:G66\LU/R>')<B ,J$ +>:!SO6[,(LVFTLJ26@M(PPC@HU,XP['TJ
M1+@T $6>M)4G7RMC*<-;$''U!+"=\Z89CG,N*QC#5^S4^MS6N^(WQO/.M2IU
MGE)4E:^8X,<8W#'85<2S26[2TVF;-9=&R/HR4FN3QE4M1TIKP_W;[<,>C8MY
MV9WE1:_06G>]TWPL(2XI;:INH\/-=O08>DIA<:4VKT RW&#";@+L(1PR64DK
M4E:2]CQ!CACE=]U$Y6.EHWM%C87^J"8\MV:PQU-7,I3"Z'/@O5TX8XTT!Q X
M'X@.C[J[2X2W>(L&G<2G>8/% ZMNQ2M37+LW1N(6OW!X@'7ZN9+VQI:[#HM1
M9-:"'@V]O7FI/JN8FI4)I@'1M .*U;B9,^$A)TXO=$8>S)8]LKG.G&KHW261
MARL5SG3%ZJVZ:YKB!@>6*LB?:MN7,= G;F5+%2-//<=T'.VS8K),M8O*8E.#
MK1ER[%O,DVEGELM(!MR2[FD>2 3&-^Q3CE+7!P@L]\8RLN4-J$L.EN'J^ZO%
MW<^^+<NG>)*>!FV\H<Q6;,\).,.G=2E@3'VW X;2EF$ERC9$0X6Y7<ZG4QM=
M-,GN9NY1&'+).:LNUXHZMPMC98;MJG%5;J+4;(;PP]7>KG+/:9W$VRK+H&(-
MN'/#8I=I+<)Z@F@[A,=OI4DQ5ZW:T2:AC67B_/I5L6S*'U*O# 8.^B#ZLUJ=
ML3#-CK/5M7#7.]X8YYE3M*G6>L4\ZGOOA$6JXQ&K^[:S:9-$PM%\8<K5)+3C
M5=CT$IC6-?DT=B'7G:5E:FR20-X"! ](QZ$R[68;YU.6YL-]HBK+A?7*"KZR
M4X?$#AZ(I;FKCUBG5-0S>O%^>T[$8N[EYIJE@-XQQYD7.(F6Z@&@"(LQ4:G#
M7J=7W&PWA>,^6*8/:*O6U)K7&!C$GTFQ61+<M$4+Q;R[%GUN4SCEMRI19?[;
M#%:)<))E0UGTH'+V*7Z+C.VTRN  ]X=2S)<X\&</+JS?]T$&,!MO"WA+<L)E
M[]L=D-M_K1$=6R/#878@'+:$D:MSPJOYQ:V<69$^M6S!)C:P4E?+F-AG#EZ5
ME<[PE8RWMP-F'4F/*8VUY@ELB8==UW2BS/!*K&2S&(Y1YLTR>F4S3ZFRP1'(
MA7E)K28DU<J8Q[3"T6=,$NMK;K"IZSHK*O?<&QBT\O2I+EFRY=5ZKI+J0F#2
M( F'25K*\J>ZOF2)D-X"V%NU3PG%VLVEZQ,>6MW[X>K:KF+EV7IU3XTMOO Q
M$8#J]:SG%PO,29N/,>Q5A"5?NQ/.?2=BSEN]LS2(=5$69<N9=/CFW/M6:3.C
M PY&(S*]N+ARMS4U2SS'H(] VJYDB^L6^@JMT 1PVXV*RR\IB9PMU+6PQ&'X
M*F9#$;;ZS>:1O#D"GL*_75VZ#$B[MM3VRW)A5*JO.]\65T<O:F6,9X:S:MS[
M,_N)>$QML-EEYC@5)POM)IS%. 0?4%>4O?,;]/[CQS]Z7JSUSG[++)=O,:!&
MX>E'9#:O)WI;SL]BN9Y8SBND.**8>]GNY^Q9MB7/,=7//A3!SDV<ZY?)<1B[
MB;T^H)-\3$1_XV:\V9>7%V'I4PN(CDWL5N)&L:R[&H&[S6V_1]06&.R9A *+
MC$:4S#G*K-Y1LU^Z;L>7:DN%DQ$7J;_YO'9GL*9;SF8=$<0SX3B(_2NMC!'.
MY5.FG1FFS'UJ^,M2>79.A/\ @)'T1ZEG.2Y=GT4P;K;#RAM5DRDJS4CQ%O..
MP*SK3M5HI' -M,.16?+4X8JV:T P=@<\UOB;2H!TGQCS^H%7,PWTN3ZH&#;S
MK-V[7,F6"<P@'HY7+'\:=.V4#5"&]SGL/>K+E%:J7$$VFP E:B^$%5.C&$1R
M"B;RT!,(-YZ_:KAB]_#R^<2T"V_U%,8V>V9A&N?%W+**8UEOB)&G;%PMO!]8
M2IUWI9*678VW 8;0LRY63"RTLIN[;MRV;%I)&]X8S]"GLZXC1J/=)YCZ"F6>
MW7RA*B9"-_+>VHS(J];5;KC&V_/""G+U?$U65[6QP2=;R]-K<EUH+KQ>/25O
M#.98EI-8  =X89Y<Z4DXRDS7@,O%C<MBS=Z67PHG$&I ,>=X?"[L*7^/W,;R
M]<.+=7#6/@X?2&/,N<ESM.W+IZ5J'CU!;?[YYX1.U::G"_Z9(+@P[I,0#AC;
MDC#LO2*;\G[IN&62U*LZY7ZBEAC6V7;,DPOJL$FP<LRGJSQ6P7#=-]WJYU/2
MY,H2N? $VWD]73L6YHDSM4:BJ+7GG-_1SYHO# -1W1"(&*Q=KES&H[T;18KE
M)7-M= VD7+5E2;9/K>\+]N)4Q9R<7?#EX[=V^TCMV+%,^6E..]$]/I6NM,^S
M66T:\YL1?@?0%BW-POG+69+%MOH4O7!;ELLE1)MPR6N8UZLP9N]BUG6$LPR!
MD1&*,O!$#!!X0<FF%NT>A9NV^L>7U6[9O"_'I69U_5Z.D:DRI,/B%^1VK?$6
MXRCYTS>C:;UG.&9]$=.=81;]V/>IC-REY:AM!&:J,9EQ!$;]GM16,R0,NK[B
M8RU+EP<W=A;&*U)A7!Q@([4LR-5\RTV8Y^Q2\)V<6S8$$#T[5.68FJ.;O0),
M! "_U*\::M2KYK RQPQ[5F<X8G*I:G4B#H."UZ^6K)C3KC5)@<YX!P]2F;Y:
MZ_M0=(W\:TQO<.U<NTR]/69CLC1Q8.CUK,YPEBZ2I<6WW GL*G;2S2,U!ONF
MW/!67#7LHE:V+G6XCM5RQF5%;N\X=':L-SBI*G9\(CB.Q7#G[<Q.R)(<VVWV
M'IS0LR3) ]X689;-BN#.$-4MW2>CN4QE)U\H&?-()A9T[5;,-M)TX@WD69DJ
M,V#9QS.%T?64IPW);KS$JRXFW3,>9[XMQO[E,KUGJBWW'84]LNLOEJO?>(>E
M)UV6XVP[YC"W#%7[)G66>7,A9;?RQ4L3G;/O@Y\NE69B?R8S.B+8\NE*U--*
M;--M_P 4+^="[N:CYCXQLQS]BS8736>;^6"LFESGKA'SS?S#M ]2K,F&LEX6
M[F'![H0A&V.Q8ZQF=<,0,%NS+5F6P#$1YESXKGVZ^K4J3 $["G:YT]'PS&U)
MU%\2>?-<^*]<7CR_/_:+!^T_"3ETZS>7T8?(3_2])_S:3V,1Z(^Q+Y2/]3:-
M_ CM6.SK\7,?I9IW]&9T]JYUZ.WAXF_$><^I(]/3AQ! "6+8C-4,9$=BEFF;
MK_AUM/\ RIY_6DNG#MP* @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(,TC\HU!3?.NSR^G_P$[^2<$G*=OXOBO\ M#7#ZUK=_P#K"I_"
M>NT?-^67_P"O\OE0^8!\-5U2$?Z0<88E:ZRUQD>E5=,)GNB(]/,K]F+R\T\X
MMAS+4BRX3E--WR!S8KI)IO,NUEI1$#G*U(Q[8JPTTN&-\.P<RS=&<U*LF%D(
M;5K*V9B2DSB3TCM]JB:B:I??(%UWJ3&$F[E9*6A:X G;ZUJ$B0F4C6-)V'L6
M>T\).55K9(#W77'!67PMF-HH2_>PO*WX7-PV_#$#=<<%C#&;8B*ID=ZZPGL3
M'J3,0<QD'&['M*G+4N.4C2-C#IPRCWK77KAIO3&^Z8)9Y9Q(UFL=$606<+;+
MJ-IDLF *OMC3/MK#:%,",+>;N6I]6IP\_5&[>M,PRXFD;B.L_=6,++EB=3-&
M&.?L4ZW>TSBM*JIP6$ 1@#Z1S+IIJ;5>;0DS+&F\8YGVK.=L]NC;I]-=9$'/
MM4LRSC#+-H"T7$V'$XIUF&NJ(J)1EQL@!$%#%SE'-FEKC#"/H59Q;I)4VI.E
MPYQGFIBDN-5;J+6# >] V9XCG4W/T+BI^35B?"+A9[%-UBZBQ4,(88>I=)<,
M:Q]UA9\(Z>TI[1EK3'7'8<4NHW[9:[:@AV/IPZ5B<EXRFJ6J(A[=O/DM93.L
M+!)KF@?%@<\^=9NMGMB,QJ&S1"-O+GS24_EM'3:86NB,_3S;4M\)9X1K_=/,
M/:D,>KE(J'-=#;E'$;546&AJ'/@-OH5MRMN5AE^^!AR/<IC!9AQG20X.%_1L
M3'EJ32"G49WR8'T9P6IV9O6_Y25%^+L.SH@5OKO;R_)J[6_3R';FS/H6V/NM
M,CPRP1(%@PYU6+<L4XM#7W8PVVX(DF58JW0)LS[8J-91+9GO"S/'9S(M2$E]
M@V;5*Z=9)%GTZ0)L(G#U *QCO9PO%#0RV 8V=,3%&9PW9^Y*;'I[1>JDEJOS
M]6;)($19]R])5G[=L\GB=K1NAX%G3ZU&N=M2LXD8X&+P;#9:,>I5BYMU]5,K
M-2;/>6B!.\ID]:VJ"2)SP(7D&R^[VJ<[+UTN#-(_$1@;O7S+>?#E>ENU2K:5
MTE[H P!)Z+%+]6+/6-*EJG2Y@;"XGNQ4P2X7+3M1,!$0]Z/85K%L^[>L93TV
ML:YA)(N]7.L\,6[56O'BV#[MZ))BY5>=0N<38?NF*F&YVVEM-TUT8D$<BK-,
M=OW72QB@L @;ARO19/HVY-%:+'7#LYU8L3U-0P$8'D2IVWPN<Z;;Y.ZTPL,#
MED<E(G;Z(6I;"(C>2%J3R2>4;XVZ?BA XV\ZUC);MF;,\40WHVX<RQC%.W#R
M* /MA%5RU+ML2].8T]\-JF4ERF:=C)-PR/5!:B<ZB597B2">_&&:9)UF7,ZL
MTWD7;5/!B9RV)#F51A&V$>N%OI2:.T\K%2Z(V<S>#28BSK.2SVAE&ZGI9I8D
M-A"/?V*;,S"NFIF2W0!L'K'0IG>&4Q2UCY@W2;X+IPUQ,MQ]+XHB<>16:S=L
M<JE9(F[V]"T<O0K(8TNVF\02Z%K?QH:0 -MBMNUG9-3_ #(E4TK=^LLLLM(R
M.W:ENON7':X=8\1^9LN>V</K##8181V+,NRS#HK6N,6SGS2)M\3_ ,7F6\Y,
M2;=:U^O/FN($R(.\.Q,%LO#4I)E34N&Z2;L\1SJ=N"?5V5H>BU,XC>:[#K6>
MMPUJNZ-!X:>0S?83[H[=BU9M,8=P:'PU*'A;\L8*6X3MUS'9E)HE'+IR?#$6
MM.<;BM9SM>LPZ]XC93RG3&-;"(-G65;BF9'5>HZ>RH)+1GT7;"L8QRF-*E.H
MC3$&$(D]$(JVPSK!+USZL=V(L %JGW6?=*RN(&3X,WP8Q&.)."<UFMGP14D.
M!CO'#; +<FF;;&U)H3*()C?&/1M6;US6LYD;ADAXAR]:EFF>^YAMTL@2C'F/
M8G,<L8;-35;K=T$&#1SXJ=9B[,X_<H>IU4QSG 8EP'J6^VC.6E1/G^,(]9Z5
M.>$X=R<-.FN$OW@+O4I(UUQC+MF@;.,L>^/3LV;%9MG&VS-ESA$[V>.03MI>
MOU0U0XB()OB>H02+[3RAGO\ ?(VP5U6;;X;U&PEX-F!VWIG34W%OHZ8N#3NW
MB.&4?6L\K+B)+ZN_"7'F 5PGM&W(I7O>/Q;H&_T>A9DQRMW-+KI.E1!+F$68
MP]JW<4_C$?Q!2-IV$@0.5F2Z_',OF_DVHO1YC8B)A:/0N\DG+YUM=B4NH-DL
M^(?"/0 E^KIT[6Q&ZIQ$94L@3 (67]ZQO+4EE=5ZOQ)-F.>T3KXF$=JU+7JZ
MSRI%95S*F)+HQY=:UUM^K6(K4_3YD\DF,"O5UMLU73KUD5S4.'9DUI !.'I7
M7IW[9PUVZ2[PZWU3AN?1N,[<(@2>H@KZWQ6^O+A>LY:5#KLVCFACG[NZ8$<Q
MQ7K^'M?;#EWZYZZ7FFUAFH,;+<X&,(KZ_7KF9^SPV7:!U_A*FU&4]WA;Q>!Z
M@O=^+,W%>?YK<:="\2>5,N<9A;3./,(YY+['7IUP\?7MVSMTEKGE,^7ON%+,
ML!-QPBO5\77IQAS^3OWETZ&XGX&GTF\&TK[ <",25T[_  =+,X>K\?\ -Q^V
MW;I+4:"=1S3O27"TBU?B?]O\'6=KB/U7X/Y/O.6G*BX'W80*_.3XY]'U[VOU
M<R%GMTZSF,;MU6K,PZ5Y^_7K,XCO+6%LPQN7"_'.<-V]L)FFF9CE$K';KUQP
MD[=OJD'N :5X^_7KGAZ^G?,Y:H;O'>VFST^M>?Y9,8D;Z\L@9%PA9:.U>6]/
MM7HZW3,)9SY>A8[23AJ2UXF2_=-OHV%>:O1UF*B)[=TGGCUKAVMRZQ%S6X[5
MF76':8P\,;<5F]KPZ]9,?=LR\.E8]NV>6>\C;;<.6)7M^*ZR\G?^3(UL1&.*
M[>SFY"7''EZ5Q[4NFXQ@:%EF[9VMCC@N=RY68N69K;@L]N$UG+D6'!<KV\+J
MSC;@06@QOA%8S5G#'X@VIGLRX Q6YVM;ERX@17?+=TYB63?#M77K]3GAR\+E
M!:S3'VVYMD1MLY="Z=4F929( 820+!RP72;3ON;5^8[=FV"XPRP7?X[9Y?-^
M>8[)^G>',;9>!ZD^7MKES^/$Y<W26NMY>M?,^2W+V]<8<I-(-Z,-O+K7+UO)
MF9<:N66-L.'>I>,6*IU8]\3;9O%>CX)OAYOEQBL-+)?,,8$_<7TIU^SP73?<
MPRR(WK[?X'3&-/'\UTG]'E.GSI30"=X^LE?H_CZ\:?(^2V5[0<!\%G4OJY,D
MG>F-'I"^]^'))G#EF_7P]W.!_+"7)D,>9);NEKK>O(+W:MX=.G\N79VHTLK0
MJ<P<&P;<=@5G7?#[WXW?]NKX>M?%_F/]5FNE"H; .(ZK%OM-/H?%WOMRZYI>
M,3J=6UIFAT71ZR.Q>+Y</T'P=[ZXSX=SZ%2"IDRYA,=YH/H4^/5S]WTOPKGY
M9/&4Y,G&B!@8;L3TB*^AT[7'+^D?A=.O]4TDM%XCF>,UAF6;P[5Q_(M]>6OR
MNGQXO[?#N73:\5<G=<X'W .WN7QNW;]V7Y;YOBZ7Y+B.KO,>DE"E>[=^B_L*
M\?S7]KP_D?')UU'YR>8P:R9-(%TQ_:%\W$?+]9'0\J1]8GS++W0[5ZOCZ=>;
M'G^:^NX[!T/1O&W!N&V!PR7J_KZ2S3P]OD[3I=NT-+X1,_<=X1-HARBOK?B?
M'ULFGXW_ '%[VW]SLO1N%IDDRX2C8\=0('-@OJ3X^DLT_*?-W[^MGMX=_<+\
M,NG-:/ ))+5]/X.G7UX?S_\ W'M_9FO8SASR[;/8USI!%C2O3WD]<OA?%G,S
MP[$9Y?RZ24'B41[O8%Y\XN';M,\<*]J%(:"( @&F ]*775Z?Q?CS\D4ZJKYN
M\6Y6=8YUYO>R\OU_P3]D_1L:5/F&<QT;W9+X/^\MOQ=LWP^M^!/WQW_P?.FQ
ME0=],9K^1_E6?WU^Q^+?QQ[J^4TV;]8>'& >P-CGO-,>U8ZUS^6>(]*OM%_(
MP\6\"U->RA?.<9,^9O@'_)QYEY?R>F;[>'V_]9^1ZWT\OGJ\@/,B?\O7'S7.
MF-HA)U![?QED-R8<^9>&[?J^E\UWS\VWSHZ[YNTU/PW0:JVH9.D-E;DLQ^)@
M;"P[5,-WMB_9*_(MY(S_ ,]2-?U6F>]U5,^L;[@8>][T;5Z/B^/-E?&_V/Y,
MZRR5^]-.[3-/X?IZ M]UC PMPL$%]"22/R7:]^_R6Y>O?'OE]PUQ6VI$^B9-
M=-EN;[P!C$'-8O25W^/\CO\ %9,OSL\Y?DSTG5Y4VIT;2F2YXES'A[& '>@2
M+0(WKS=OAWE]K\;_ &.9ZVOS;U?R:\U_)K61K6DSZN1+DU#IL&[_ ,,M^\V[
M8%YNW2S;[GQ_E=>_7$L?H!\KGVM'F]Y)<1TE'JFNU5/34C9-,?$+P/Q;F@WF
M%P6,9>GKWF'V:?(3]O-PIQ51:'HO%/$VF3)LZAD,G"H?+CO;K08EQC>IPZS'
M9]*_DO\ -7Y9^;^F4%;I?$ND>)6RM]DME0P1,"8?$Z$56+,7#V=D5-/4L#Z>
M?)GL<(M=*F,F C,%I*(SH" @(" @(" @("#UH^9>D\OJ'RPXDK^*J.A(93O>
MQTP#Q#-#7$D[Q(W8'K@B69X^K^6W]M=Q;Y>Z_P"8W%>G<-R:,3C7O9*,H,#@
M=]@$"+K2G79\M]),/RU^5_R@KZO6Z76)LE[I4Q\I[219  &%@S7?X^F:^5^=
M^1)TO7R_8K0:/\Q:<R1\): (?\$+W=.OK'Y#YNWOWRW9]:Z>/BC$0*VQ,X5J
ML,##:>R"K.-Y3.BS V8 1@HWAVM1SFB4T_L1ZMFQ65+I&ZA7,8'&(,(\KRLM
MR9Y5H:RUDUHLO"+<+9I>MP:VT7[<@IEBU>*36O$$-[MR ]2N6L9DB7;.$QN\
M2(G)7ABY1->1N'H[%,M3G#KW5'EI=#V*Y.T\JRVK<)EWH'WW.KA,:6O2*MQ+
M;-GH4LVLN-+8VI.Z.;)7.&N45J-?!KF[PN([5,Y9O7RZ"XIU8^.\;USCVNVJ
M6,SG/AH:--^M.A$=&V'<I+B;+NY=LZ3I F,EG=C%H-L,>C:M9:L7>FT=K6M]
MVX=QR4WY)QAM'3@W8KD]8T)L@,)(VGEUI*S>NF@^I,H1V':E.LQ4)7:F0QP#
MH6G/9M"-6U'4&H3'3K71$-N8S*,W3L2BK2&M)A="[V*YG%:C>F:DP-B<#GSE
M+,$F&A^=I<86*8\&K=MAM<QXO'IY8+4K2/K83@2#GV*7Z)C+KG5=/+WET<0.
M>"QFY9QX15,#)>!M/1 G):_19K2UT\R,L0C<F;G:>OEKS\=L5;PM1XE[Q-M\
M3RO49;;I W(6<H[%;&I+4-4TX:,+.;;L66L9Y>*222_8>;:KK'W8QC]$I44\
M&QRYL_8L^RXMW.$,VQ\,B.U:JR86*A%W[92[),+?2RFN:/9SY)J,VY<JB2&@
MG,1]$,E<Y)<*G7$-Z;.JS/:L^N\KG.D&:K=?\0O-]^(5MPEF&?\ .<!8ZY)M
M9:PNK2\Q$#9!,.TB>T>87S6 XN]<+DXC6<:=UZ3):^G:3S9816:N,[IJ]*UL
MLG8[%6737:R12I4H"> ,_6%<L8S<Q<:.G#VB)^B.74M8SM;I3^*Y 8UX!Q)[
M5GM"=LQU!,DO=-?NYF[G2:TSG#9E4TT'&X9IQM?;PDI,B8,+QWK1)Y;WU![V
MVL)LZ%BI>J,JM*#H@MQV9G8F-%BK56FRY;S%L+\!W)G1$=XTNFMA<1ZPDC5U
M<MN1J@FN$L$>\2,L M^&;=I5NGS)K0\1@ZW#&W8L4MRQ/TR:(FV_9FM2X+PU
MC236XD0Y%)<[6\,99-;'W[H>I:8</QOWWI]BS9;5<#3SYQO,.7<DF/U7&LN3
M--G/>!$V6VVY+3/E?-"T0NW=[9? X*.DX7ENB!C+L!V\VU9]L%F477::&@WB
MP]O1@GLDOAU[JLD2R1&Z)[.99*J>^ ^&(=@MY9Q]5CTV<1NW]95;SBNQ=->'
M-:+8D#LCZDXC':Y3%2UKI1LNRLP7/]6O;6E/KYS*9Q.T\O0MR8AZ^6"BU:6]
MX:8'W@+H8(O$7FCI9=6P66D =?.%G.V<[>*O3FTQC=Z,MBMW%LS&"FJ!*=#G
MSYU)]%ZQ9Z4MGRX$?1'I6LX7M9G"#U320\N<!?[3D5?;**P:7P7])MYB"F6?
M7:PT4QH8 3"Z_8F<+G#=GU;6RH;V&W )=\)G.E"U:<QP<0<<.8K%BYQ,.NZQ
MC9CW -QB(0!3RPQ4\H-=U0ZPMYS,K+A9*6<)8^( W]8*F,M3M/\ #S63!4B
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M! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$!
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M]KW-ENM8[Z.<=FU>^]<S'V>&?)>O;V>G?F!Y*3J)[RVGFF!<;&'+F7YO\_\
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MC3:X#9M6.W3KVCU?%^7W^.YMUE^:_GE\FFFU--4U>A:;N5+IDQ[72Y9!N<1
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M."Y7&=.W:2</,QIWB2%'?IVUB."-(K5?R'0EX2NMI_Y4\_K68Y=N!5! 0$!
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MOI]+X+9-O6VKWF5!#@?C]=J^9\T_8]77MVO;*?T^J#&B MAV+\O^3<_(^O\
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M3>9C$3?CM.75W*3+G>V&A4U @\67'MYTQA>=J_43 YUL+?4!WJ-Y\-/P]XF
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M" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @(" @(" @("
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MU&^W""U/\D[E]%*PH<S\J?VP4\.7;ER6$$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!FD?E&H*=YTB/E_/_ (&=_)%7KRG?^+XN_M"9
M4:O6R(_ZPJ<OOW]R]'A\OY+^[#Y7//V0?SGJE]D]V(SZ%F8\L]KAZ0:HPMG/
ML..1SR5O+CVN8BK3MYETDT8PSL):!#+VK4&PV<0!$VCEDK;M<LS*LM(@3?M[
ME)NGM8N&D5K@YL"<.T=ZZ96=J[BT#5'M9+B3@;\.A6V)>78E-JKG-Q-F>P!8
M_P#99C'W8:JKWI;B3:6G&-PZ<TROJH]7,=XQ,<3EW+4<[MMTDPD",.6ZE_\
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M'TM12DAP-G.%\?M\??;W7OUN,L3WF8"UW*]?,_)^/OG[O7\??KC#5=I[)UL
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M69;Z_)U1M9139HBP9X%?4_!Z=O[,'?Y.DB =HU=-=!K3"-\#A9DOV'Q?#_\
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MT[4)$ULZFICO,+;6-C:#L4O65OK\G?IQG#TN\W?E?T?C"3-;+IZ9A,N9 L8
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MRX/-BUTFG/O;-]>'6/R:^1<VA<W5*N0R8:MC9^_-9$DD;T22#:O7\/3;X/\
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MW+Z*F;6:H<S\J?VP[5?#CVY<EA! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M'J^#_9]KS:U::>X&! Y.7DG^BZ6\1W[_ .T[8Y2)G$ G(+/R?^/?%?$<NO\
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M>;;>%F])V:Z?D_)T[3;T1\Z?E+TOB&DJ3145-)?-?,<'2Y;01$$V0 Q7+O\
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M4S;!YQ%YYU,+>J#=6/F.(!)M(@8X1[TN/'*8Q$]IH<2(QPPSC%8X.=NSM':
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M#:D:[8=@Z74M$"2!"'?@=BLY<[GP[ TVNEP8"Z[GS*=OLQ)9RM<NH8]GQ1L
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M3&6;+RV);GZA[M^];L.'859<-]?HD&\-B6?$,N\@QZSC8M9UE6])D,E0:+(
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M=^6W_9.3_FLG\!<_D_@[_'_-W]5?$W]JOF=GTXU5%$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS76N(/B-/7BKGPN)RE96JRW$0<++.F"O"R92,JM9, BX?=/M4ELN5]6ZR<R
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M7PZ\U?@&HE!_\UF"!A\)L7Q>WX76SA]B?D]N<NL-4X3J)+GQD3!9D>Y>'O\
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MN6,YN'JZ7$?5/\MPAPG)VTLG\!8^7^#M\6^[OVJ^)O[5?,[/J1JJ*(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MWI](5P89FZ<^WW78*2'+$ZBFQ@081.!%R8LX:<!0S";!V]ZN;.6=Y;$NA>(
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MHB2>7KVK5[2W+==?31":>=3F.7;ZO*R@@(" @(" @(" @(" @(" @(" @("
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MJ:Q[6POARR7UOQ_VS;S=KVRZEX@TDS!-<UKCS<VP+W_%9.T.9]W3.LZ).WG
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MF_E_[C\?MTO7/5Z?@_UGR]>^Y5IT;1ZF:\%['F)&&97Y[M_LOA]N8^C/]?\
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MWZ:C]Q_XQ9\7R9[?5=],+# /(B /4OQ_?\/O;F2O[!\7YGQ^O,X2=7ITBI;
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M7XT'DPB1CC]U9F6/6YSX2LYSC+O-Q[0M9S6N+B(V7-?+?$Q $<NQ1JQ8Z/4
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MFUXC87VVY!6,]I]&M-<7@@;?6I8O7&-M3ZB9UX/(=*L3M]&%^@/F'W6.SNV
M7P6-98ZZ9Y&@S)9$6/P-W-L5D\M3&4_)I1);:+0,>?H6HEU6*HF-W;-H[ LV
M;$.YKBZ,++,0I<D2E$W=<V.8CU0]:2MZO"W23)\,1A%6=HG;Z.+@P&+0+S<M
M5)?JDM/JILMWNG$=FR"F_P#!-U=*74I]Y=9"&.'W5=7]6KIAKJU[Q#>ZNCGS
M4NF+;C$0)G&-IY=2QEK#=E3 X7VD]L.]=>FDLK!64AFM<0(^[A9S)>3JIU13
MSI$V(!$#'T@;5->%\_9;='UB=(8!O0@8>G;%$MG"_P!/K-5.;!KS"&?,,%<R
MK-PGMJ9P)=O0(C?9@N2^$1]5._[XY^I=,N?KFMS<DM N[,.=7EK%PCJNIERF
MNM ORQN6.U2;N%&U:N;,C \K5KI;6.TN<(6B@Z9$C%=L7&'G[8RL EM@"88>
MI9MPZ];,F^QM@AUA3.7IF,QGA-FL/AQQ@LUVZ<_96=0DUK'EP$R )P-U^2DV
M[^K+I=?4R9C \P@X7QPZU)B/7TF(]A^!N(AXE/+<]H/B,O(S"67EN7%R_4GY
M7*D3];D.C'^<4]W[?K4QC;U=;F/J_P#EOMX4D?YK(/7+7/Y/X/1\6N\=^U7Q
M-_:KYG9].-511 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$!
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M'7L<4RS<1O/G,F.+G$6\N=,U<N(;+==#H]JN;S1M2MQ@P%O2I;FYB;;(J8"
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M=9,-^CJ63_CA:+]MJN2=8G1(IB 8-Y!&?66HFOF2Z<$LAUC:C4ZR(63J<PS
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MTW2J&218V-D+L"L?_A7\G.<MS_7?!A:PVD8RS=^'(9*7_:_D766;_K?@^FU
MXA8QX?X>=D-JQ_\ A+Y_+?7_ %OP\X4!I\*<1,A?C9FL7_8?-3_\'?C_ $7C
M19--4AN\!&[!2?G_ #_59_K?AFUK=IDB'N-C'9M2_E_)6NOX7Q];PR2-*:YP
M&[9&%UUXR4_[GY&NWXGQQ;:;A.EJ9(+F1( P&,-BY=OD[6YK?3I.DQ$%J7 T
MEA)9+=;&'NCT6;5G/M-\.O7$N6GI_"A94-!8Z%@^'IRVKAV^'KVVZW\CMUU.
M'=6@\-2I4J6XMM#!'W1>%KX?BZ]>V?NL^;M\FJGY]'*EL( %FP+ZW3Y.W68B
M_P#:_%VW>5)U.6V+P;H%3Y?DO:;Y=>GXO268=;ZK32W%Q(Y=2\-Z9KW3X.LZ
MS*E5<N5+@1"\DW9]R\WS?#U[S%?4_"O]5SU1K*\RGD-(Q]B\%_"^)^@GY_SR
M++I^I[Q >1=GU+S=_P 'XL[CZGX?^Z_+^+^-N,+M(92U5(YK]TES=BYW_7_#
M]-OK?_K+^?ZR9>L_F?P6VNFS)DEA.4&]RU/POBZ\.5_\A_-[7F_\NH]&X<KM
M-J)6XV8 UX/PD;8JS\;XY6>_^_\ S++,^'LUP+J6J4NXTEX]YMY=A#:O9\7Q
MR3$?GOS/S?D^?M[=GN+PMJE1420V:Z/NML).((S7?KUQ7B[=[VZ8^RQ:I2R9
M\F+H6B.V/,O=\=DZO@_D?C].W;]SJ+5M*D.FN( CO>N"Z=+MXOD_%Z8UPW-#
MTZ4V=+B,0%[)VF,/#V^#IEVB^EE,I 6PN]2X_(E^+K(H]<6LFFT"TKQ]L/-9
M^[#1EU4K> <6WPOV[5S\F;:EY;*>>("%@AAM6ULS,55=?X>%3*<6-,3O&P;.
M:Y5)K3UXXDX(JWS9I8R9#>,"&DV1YE,KB3:,T?@JK;/9OL?"R,1"VW8IF+.'
ML5PAPF)<N49C3&R\=&6U)<UG?AVW2Z=3T[1<"-@OADKJDW<)^BF%C@V61>!
M*]5[3Z.R=(EU4]@!)-PQ-YAV*=K+IGK]4GJ?#;JFE.^(Q!/H5F&K]7JMYA<&
MM;*J'%ICXCL!MV)?LEN9AZ.\8:&::HJ( ^Z8>FPIRLF'7%.'4\X[U@&?.F9Q
MY2]LII\R3,E .@;++<^>"C75 U3)0!W87>E2\8\NLQY5RH+Q8R,1]SM6NO"X
MZTIF5#R(1S[4WG+.)E:J#3YTS=WHVP-NU%O6+9)TD%@)!M'W<%>(>J/K=/\
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M! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MNRZ6$8[,QFM9CC,V,OU8<ON(NV&937P&7*Y3+<NMM1TH-L@(]'<$3/\ P,:
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M-J.%Y$7>ZW_!VP6OL8D5ZKX6D$?"W'#]BGJ8SM6:OA*G<(%K?A. P6.*N,1
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MQSJ7*26UL_H:QMI:VS]CTJS$BXGAK3= ER8M@+(?1Z-N2D2?=%S=%E/)! N
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MWH$B#1G9VJ?][UYAV_&[7EIS=*IZ$%S VPV0$++#U*S\[IY+^'5:U'712->
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M:M<]>&9L_=C:,+MG6I)DF+RVF5#3&)&SE!9];$SEG9/B;\-L/2(*\KPWFS@
M(D7)UY;S*S,># @C%6W>/!C+,#$*,7EIU0!:1S*2&<12-5IMX.[AGSE7PQ+M
MUWJ.GQ+XCT;.91UFHHM9IL'.B!G=E':M3L8D52LHMR/,1=T)9]%5J?*W8P!Y
M16>)MGM,U$3#NNML^ZF?^'7IPV)#P3&(CT[?4N?:^&L)NEG[K@,AM[EC'EJ[
MJXZ=/!#;<1F?4DI<?Y7:D@Y@(MC'EUE3&%F,) T>_:18=F7,JF<\HVKTUL#
M"_+:4+)X5.LTZ!)@+SAL5FV9G*IU]*6$PP="[F'J2Z;US]D0R(=;RM"F&9:G
M*&HW7-$>W9D%,;:QE?\ 2*V!;^V&/-M6F9JNV=$K8@"W#'9SJ>$OU=OZ/4M<
MT6B)W<8X;$QF$MPOM([>:,MT+/%626IAK&@1Y6%=>DS3Y.'#>:";?7V+V=9B
M/E?-_)F;-;R^XG#GUSX9-]N?:KOPU;A@?- C=ERL4D8N;OPT9C@23$=:UY:_
MZ6,/:#&*,X9!/A9R["DF!K3W>)TY;5&I<Z:98<(GJ]B-8KSX9R*DY9ML/#V'
MJ]BTF<AD VP]'>5%S,8>/JXR'4.]79^T-*#;8.@*+-/'U09 ]'M"EF5>!1-C
M<.GV%5,99FT#'0L%T8$;/:JS-4=I;2#!K>H9K.&I-Y:,W2K76#"YO-M5SK#4
MY:<W3(1]W#)2';.<M!^GP-P%FS:JQ=[:[M.)L$#&-P^ZKP2YY>!H+YMNZ,[1
MG;DK;3,X<#PT^/P#_!]BD9[:X8W<+S7'\F(<VSH2KUMP\LX7F-^@.K[JC5W&
M3]&I@/P#J]BK&*QS.'WV>ZVP1NSPNV))@:<[0W"'N#J'<L\GKEDHM*\&8'%H
M $"++S'H6C%G+L;1VAH:,B/4F6?6<NTM*F0@++_4%K[^&)9C:WLGL#6B(NS]
MBS;?\,8PQS:AF8NA?[-JBSEIBHM%O+_!66W,SCLZ.16I&9V8C,.?+J6LQ;VR
MSRG%QY;5FVQO,O5N-L Z_6CE>6W+FD,Y8=&Q3.\+B8>#.CCARP6LI+AC\0G&
M[EDK&\^W#DV="-V&SMBBR?5L2YPM,1<,"JCFZ=#'JY16>V+-.?:^&K-J+"(F
M%F)YLMJSUS_ASLE:3IAM(/+M73/EBS;AOEUI6+96;.T;4ET8Q([%G<K6JF:4
MB(M%XQYEN6KU3]-" YSZT;GW2['[G-#EFI6;KAR=5  B.!RRVA3.V6C.GAP,
M"/:>I=$OV:@WGG/L7,F?+=DR'..,"1U=:UEJ82TNG+0#"Z'9M*S[79;]&5\W
MPVVFZ'+*Y,V+9]$;-U(2S:2.F.2Z==\I9AED:@V;<8]/,G:R)/NV73HXV0Y8
M).V%MDTPNBXV6V0L4NUFXX^%&\%8_BG#5?++>;[NU)ETZ]L\L).[?9SJ8QPU
M;K+6?4!A/W.?TKI.''.:UW5UXMRO/,G,/+@)P>8QMBLV6%NL1)2'F-X]&U)I
M9-)F2Z,!'G]"MMQHXN8VW%UD/0(I+]6;EF8XV Y*ZY1(R'M:!$Y=I4EVZ9PE
MI4]@ QL&.P;$[)F]HQ3JP-,!V\V7.DFLN/;;A+K0>O/9M1F9RW)=0""<X<K!
MM6762?Y;(F$W0ZBKEG&'!TRPVMY'G3;.-Y1$Y[C&W)7&4O;Z(F?,?$WW[=J,
MU@;,?O 'UY<ZO!/JEZ:<X. B>L[5=8WRU,=N$[*FDM$#?;CD/6L+ZX;.^[/L
M5PGLRL<<\-F:C=DPR^(X"TV!,L^N6O-JMV(B;L\C[%4Q959U'42&FTV$XY02
M:;NY]W6E?7QFDDD^\<3ZD8FKBMO3]1#G,$3=GS[ DN&KQM=J"N$&PC>,2K-U
MFZX6216!P$3Z>=7!=Q*2ZIH ,<,^\+,W3&ONSLJP2+;#M[@KA-R-EE0 ;QCV
M<RSK*[Q]TU33FO M$8DWY="LQ*DF6VZ8T $D<NM:O:8TN,-&=5M$1EM&</6L
MX)VUMH.K.W-8LRMUPU7U ))CVP[%9,1C=873HQ -\/5L5EULQ7#?.?8KF#DV
M?N.!3,O!N;3<G5X, WC8 ,, C69>6&=JK3:''E!#;3&I1)M]*5.L\-F7J!):
M(GK]:DJXQ4A+U#=W;3CCSA67ZG;'CEL#4FYGK]BUIC;',U.61#>P/TL^E9SM
MJ2HJ=5>*3 XYG&(46:Y8F;SC;$]"-S%;S:>(CR_"2;+JO!I(V^I7'U35N*P.
MH;2?5[%<?\,V?3@;2;I!]4.Y1E(RI>[9 WCEZ4C5D;+G.EM)M'L2G7G;697E
MKB(G+M3VSRUVFLI:371$;>N&)[D<WF;5[P(R&<;ATIC$7&LJ[736D':3W9*9
M),JQ,$71%M_:J8K9I)9+A'&WEU*6TPL]+3D-M& P]NQ6R.F9-1N"61MZDC%L
MO#7>]S#&)%IZD23-<Y== @;QQQZ46R\-P53IC0(X9\_>M3">F(@]1I_%8;+S
MB(X>U9SM9U=7ZOIA_&.@+SAL[U;5LSPZXK9)DO?L%ED+;_6LP[:1\FN\-Y$3
M9'T_<19]4Y(U$N $<L<RKC#MUFDY3U48".,+SL4QE;$]3 O C$P@;,XJ7EF_
M9*,EN;:,>;:%%D^K>;&%N:;RUPVI3R(]&Q;S(EVVI4Z#K8]9R.Q9MRJ89/&Z
M#SYY\RUX3#5GU882?7E$;%FS*^LQKE$S]8E2B23=;?D>?))-)CPCYO%$B6#[
M\.GFYTW6<8U$+5<<R)37>^1A\7M4,2\J3JOF-3M+_P :;!=O;.=:QIJ2<.N]
M1\RJ9OB1FNM:?I#+G2M8ETZ8XP\PY,YCMV:[X3<[GVJ2Y>CX9)IZ^ZGQGO.,
M)K[W1&\5JQ[_ &^G#J[7^+'O)A,?>[Z1.>U2QBXO+IK6=3F53Y@#W&+HBTXW
M+,NDFD+2Z?.JYS1:=XVQ5FHU;IVUPUP;.J#)(E@Q=BW ]"O-<[9EWYP_Y:3I
MS&$R6WXM.8V;4_BQ;G3MS0/+&;*F;QD2_B!^#+HVJ[9LD=]Z+P@RGD!CI4L&
M A[N=F2ECGG>ELIN&9<0?#EV!OT?8E:MS%EI>'Y;2(RV66"P9 9;$G#AV[65
M8:?1I3(>XP 67#N4U%YFTW3Z?(:6^ZR_(8A5G$SI8Z21(:!%K;#LP(4F!9Z9
ME,&W,P[()G:7Z>&2::=MP;AEW+69C?+%YUPUO%IP8$-O&7=%7$QEB]8YEU*1
M<S'E:%S\Y7KCK&L339,ZO8EN5LN6I,\"-S+S@.Y6:=))AJS/!(N;?@.?(*XC
M+3<R42;&WE7<X)<.<ILIK@8-Y04S?)NMXSI0'T;N6"DPS=;:[ZN2T7-CT)+<
M_99<\HR;6R1&ZS>QY9+7,5$3Z^22;NL9K7AF2]D+45TFWX;SB,PL6DU<(:?5
MR#'X;!##$+)+49]9D[YL%YR3*=N5MTJOI6,(<6X9+I+3QF\I*;74KH?#]S[J
MMNM%J/GOIYK38RWFC=S9KEY.+F*U5T,B;O>ZVZ^ O]*WEJ;JJ5N@RIF\1+8;
M"+L+U&\Z^ZGUW"['Q_%RXP^]]BLV=<YVK,_@]I=^29_@C:/4E;LQM4]5X*WV
MNA*8(D_1'+%,3"]+FNO*W@&87.A*:8D?1V_M=JCTHQWEY-?^\M_P8^I$\LTK
MRUF$Q\%EWWOL2QO&.&Z[RUG0/XEG^"?W*::G*(K/+:< ?Q++C]#;#)6W&V\9
M5R?Y;SXN_$C_  ?V7,G)C#3?Y;SPPGP1_@J6204S5. I['._%-O^]RZ%QO#A
MW5YW TZ-LML?VI[EC-B2I"BX(F[[?<;?]YL5MT8TO&F\$3(#\6WXOO%?#,N*
MN-/P*YP!,MMD/HYW]JC><Q*R>!B(?BV&_P"@JQ/*1D\$F(C*;>?H 8=*CI;)
M&^.#=VWPFV6_",.95S;'Z)ML@UG4.Y!OR>& V'N,L$?ASZ%),;B_JF)'#[1#
M\6R[(;>=6RFDM)T&7_DVW1NYMB2+[?1L#1)8@/#9U>Q,)NW+*W1)9M\-E^7L
M21JVQLLT:7#X)=^7L5LD8SF[<W:-*$(,9U#N768Q]UQ&M-TJ5 >ZV_(>Q:3%
MG*+GZ;)M]UN.&Q%E1,W3I)WANMZDL)VW&N-+DQ%C>I8N6_:<)*FTB6;=UE_W
MHVYK6-L=N=)Z1I,G=N9&SZ(S*7#,EP\3M)EV0:S_  1M5U26>&A,T>5#W6L)
M_:JS"^6A.T>6!\#+XW#9WJ6?0]FG^:I.3/\  "(\C2Y(-S/\$(-F3ILF/PMZ
MMA3"^U2\K3Y31 -%AA<+K,TQX)VWEBK*.4)9]T7' *=^N)IVZ=LNM-:IY>],
M]T7&X0P7F\O3)<:=9:C*EAQL&/K6L-XF/N@Y<M@<" ,>_P!2>J\+;IC&$"("
MEC-Y6^1*E0%@P[%)-_99;EM;C!@%;]C7EX<&?L?0K=)=<-.8);<K^?-2VUK,
MK""R)NZMJ22\K;CKF/&^S>PAS'):S),,YS',3)>SET+-VQ9;3Q&1P]*37))8
MRM?+MB1T_<6KV==7AE\67^Q]*YI[=6.9-E[N%^U67"7M/#7-3*%@OYU?;64E
MMK5F53 7689[$]K5[62(JHK6Y8E31UB%G5+3&,+L^Y7&$[;1[I[ ;Q=GS[%J
M<,S,X&U+8V0Z_8JU.WU;;:AIORCRL4XX+)X9!.:3Z[>Y99<_%:!?'K[EJ9X:
MGT<73&D7PZ\^9+-GE$U!!!&</4$O&6D%4  NYSZUF;Y2XJ-)&8ZT9-\-MB,N
M4$QEFL,Z=%I$<,CES+C\CM\<0KIOOD1$(KAEVV[M\LYH&H2[1<P7'[YO>LYN
M77IOE]&_R'S(U6D0(_HTGL9FCIJ5]?ORED?F?1[1^0'80G:XX>KI<Q^F.EN)
MI6;%GJZ5GG 1CRP2NWQW6&$")@LNEU&OJ5E(X?L3V>U:<;NVNJJG\H[]LY;B
M/"R" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @S2/RC4
M%*\[S#R\J/X"=_)N1+C#XT/GK?#4=9C_ -XU'\H]7]'SOE[2=L/G#\[IT:W4
M!9^6*G'+CV[/32M>143+KTE<Y<[8GRP^7"^(AUWK?7K;=\-3%5C4=.!:3#T+
ML63PH.H4 :3=?"[F1)?%5R9+$O>CA'UH6?1J/-Y&7>HUUX:Y<28Y(K>D.M;'
M"'8C-UQPLM!/$6"/TAB<"-B&-+_ITPD @Y=O0JDN=+=2.<>OEV(EY6*4PEHL
M/(*$FV0M(P*J]IB:1LYSF[(>U&>N;=M$3";G#T(K9EVVXP'I"#,ZI,L',=X6
MNL8O+'^<GW1LNO"Z.?-8YE87B$<++<39@DGE.VF@\DDQY6!&I--FGDQ='EAM
M2Z29G*Q4S-T8YX;.],Y7EONF  BS 8YJY9G3>43/>2>L=:%Y:\N3XCNO)2HL
MM%)W(67 'T[%KK-;:DUE990 &7(I:LYTQ5DSW1"&':ITTN,12=2>?>MSR5N8
MGV0#'.W[\3@,^9/!5JTV?NEH)N('*Q7.DUR[#TVI9"W)N(YU-IN[2<\LF@&R
M[8=F2DV8VK]70^*'0 ZL^;G5P6(&=HCWD^X+;8PY]BN9C1,\5@;H;@8^&%FK
M94G(TP2X1 C99"Y;B[6*ED2V"T##+""F4S>:GJ5LHD6#E!2S.VOT2YII99'=
M;<#<-FU3#-SY0]11RW C=;>,!LVJ6>21#S-.;O& '5M*:2_=K_FS]B.I6-:\
M,1TJTV 1)P72,;RU9VEF!@ >C8L=LY:F,8O*-FZ4\Q]T=1PZ%F??AF\_9'OT
MB8?HCT=R[]</+\O5%3]*G-!@,AUA;Y<95=JM.G^]9B<(X%,K>M\(@Z?/B;,3
M@<TTFTM1T$X$&!LV9GV(8JU2:6:&X]1R"5J6\$ZDFN:;3U'(]ZBZNG.BTN=,
M-Q/7M[TS!;*;0)S@TEM\#:,XY#8AC229PW,(CNCJ.7,M.=SG3A-X8F ? +XW
M#NVK+I$9/X9>TF#!U<VQ#&6G^B[RX'<%X^B>Y%QI)4_"3W0A+%V6<#V%5SG.
MTQ^ACVRHF4,OA&,#ZU6;;X0[N'#*G#W&WPNAZEGF9K-SRN>D:*!X>\QO3T[%
M*DN=5V!1Z,TM: QIPLYEN7ZLR93TG0@;?#;=D,]H2XL:E\-R7H#003+9U#N6
M4M9CH;=T^XW# 9\R3DEWA U.A@N($MMY[>9:N/\ *=JL_#VB!@'XMO2(X[ L
MDF5HK=*:UEK6B(RRCGSJ+9$$RB:Q[8 7VV9=2':?1:=/I9<+6MZAESJYRUE(
M5,N4UES8PC@I?_1CBNOM5>P$W7QN(S.6Q6;/&55^L2]^)(L)QRNPV*V81/4L
MV3,:UI B;.SO4SB+QIO_ %1A]Z A?8!SYK,OL2^MR\-F-D&-EGK]"UA;+6]*
MU=DL6.@3#;U*R;VEOALG6FN;\9B0+-L-I4OV(AZB::DN@8QZ;RM335WRT1H\
MR<3!L<19GT)=GV2LCA6:]N]N"V'T>=6:9L:-5H4VG<(M@(VV6@7Y*7MO2)K2
MJ$M+,8$"[:LU9):[9T63NAL1UPVK6)AN7"^290W 0+(;-F"SK.RSVW6E62(W
M#/ 8A;UAC%S]E8FT^Z^)%D<AFLF(E*'<:6W7#!2QJ+!-=*,KZ/P\L%.&>UN%
M0U)[&;[A"XW681R3K]W*_=1ZO4=PD1S%_0M6QG.--%E9XI^*PG/:IFT]DC*E
M>(0>M,+]V2;(+;88&X0]JIRTW,C9##M6;/HEF]-BEI-Z:R,+QAS<Z<<+;7:^
MC4S)<D1 @(WC8%<9_5)E&:J^4Q[A[OTNV&2F,+F_Y52=6, (LNSVD*83VK0?
M.;,C"[EL5N8;KE32 ^:V %^0]BS+:O,7.EI8-; ## 8GGV+I(SBX:^HRC+8X
MFRPPZSSK57KSB\*/,>[Q#;GZLH+*UEEESKXW1QS2W$TF^&0@D*3/))96K.WF
MYW<KEK&4[(V:3Z,DXFEF6M%V$>KV+F5F .2UU3%;DF6YT++H>FS-:)]UII&#
MPX0."-9W]F:8RP@1N]*SK*_9#55&Y^>/9SG%:3&L(C\VNC'FPRVWHS-<I6FE
MF4L]KK2]9-9>*ZM\-C@#Z=N7,LS,VVZUUC4XN@218;SS[%NW1S$50SIDY[=T
MF\>E2//\DQ786F2ZAAM+C\/M5<\5VAHM1/E;IWG" &/W<E,WAJ9CM+2]9FRM
MPE[Q "-I(NAFK@O9<Z7BY\M@'B/! 'TH>O8B9K,>.)G^5?\ X1[E.=+)$=4\
M63IT=V8^T0OVC;M28X,V1RTO4:BLGAI<\@O%Y-MO/L4DVLKMJ1HQF4F^6@^Y
M&)YH)9IFNN]<T@C?]T"W ;2KU^YGZ*9^:3XI]VXY;+$:E^JXZ30B699A; 8;
M/8K)ABNWN'6EAEB'TH[+D6;=X</ALS<;9$EHAU#%26Y6XG#NS1](;.8#N-(.
M8'/M53;=K=*HI0A-;+!@3:!DCEVN*H6LZ?0>"YTMLLD.-H R48SEZY\7O93&
M;N0$"39LZTO!+BNB=0UJ=+GN:U[X[V!.5F*:\MYRFM-U6J>&>\_"\VK-Z[R<
MK93:E4 #WG&[$YE6?<MG"TZ;6NG. <=EICDM8VS[879E$)LDD"V%EBUJZ9SY
M9:31IDQQ]T;.:'M6+B<-;MVM$C0'[K3N"V'T=O,B=II@K]*$IAB (1PYPK+]
M$D474)$"X0PV=ZSBRM\*Q4T+)EI ZN;G6I2=<Q#3=*:8^ZVP991V*VYC/\:B
M*C2P\[C6@VD0AGT+/37?*=Y.W5%.\OYNH/WFRFN%\=V-L2<E^F_"^2^NGY_\
MSIU]MMD^6DR3+)=)9"!^C[%]'K\W>61\_P#IZ9UPINL<'RZ43(RV @_>]>"]
MW3YN[?\ 5TCK>NH*:E<X.# 1'#EDN_Q?-WG;RLZ=+I6ZVJIV,@TMQN(7U>GR
M]L>6;TZRZ4>NJ?$<0P\W4O3\7R]^-I?CZU&2Z.LG3/<!,2<#T+W=?F[>N/*S
MX^LN^'8&A\/UTQS2YINQ!N4_N[Q>WP]?'"3USANI$@P9Z-BG]O?LSV^/JZ+X
MBX8KG&9!KKSASKS?-\G<_JZ.M)_"E>)KCNNL_8G:%Y9\W?SEJ=.N?"<TK0ZF
M0YI<#8<CW+P?D_)WSYPGIUR[3TJ1N"!_8CJ7CZ_-WA>G3&?*^4E"V>V$ ;!>
M/NKQ?+\O>T_IZ696#3N%/&GL<&-,8?1VKR?-\G>];-M_!\73WR[YX9X5+&2O
M<;</HYD;%^:_+S[5^L_%QZ3"ZUFBLIJ=[BU@W6DV 90&&:\D>FW'#I;B"L93
M39C8PAO7;!!&ICRI=-7&HG[K7$B/?ZE=I9/"RNT^<^5O"VR/2B76U.U.FGR=
MXDD>\>7H3[+JS3'I=5[P#G7;2,ADIP3,FTW44CJUS V!N'7$(KM/@;0W2G2G
M.:+SAU*L8N7L1IFE@RQ!HNRVE,9,XY3\C1 9@.XV\9<^6Q9S3[NRM!TH, ):
MT78#$ Y)+23?V=@R]/E^$-YK;L@,.A+)RWXTI>M4TN43!HL)RP3?#GY=<ZC-
M#7%H..WTV+76XK755:TN<'$QA#)>OI-:=>NN5)U%H]^^X^M.TQ'3X^U]G6.M
M1]Z&3EPS7MG:^KJ?6=Z#K[SZES^3&/\ #U?!;>T=6ZBYX<Z!=\1S7BN7U9VQ
M-(N54S&N$28\Y[ER[</1\6:MFCZHX3I0<YT8Y[%Y[R]<M\O9S@2O;,DRP^WG
MRM'J6I2W*ZZI-EN:_=W;CM5E9[=K>N*Z\KJILHD@C$V&$%Z.OU>#Y+<H<<0&
M0?C=A<=G.NW6[<.]N$O3<4AUAF.N'TO;M7JZ\/E_+9[+)2ZS*F0)>;0#?S[5
MTZO+\DMBQ4FK2VEI+B+,_:O1+,:>/M;G_+SK'$#&T[P'.B&FXY1VK'R9X<NV
M<NBM?UI\Z9,#7NM$+]I/8O->6,J(Z;43I@(+OB L.T16:W.'97";*EDUI)<8
M[N>%JF;ABS.Z]C=&U R);-XFQ@] CL5FUW(S:GQ1*EL=%]UEX'/=SK2.L-7X
MRE@OA,N) ][,P46:JLGC)TQP:)CK39!QS$-AO4\M^$A*U2=4#>#G'I.,;K[@
M%6,XK8;KDVF^)SP1;>L^=<$K(?, T@MG/$!@\[=JO69NVL9FT%J'FV6-(^L3
M;(C\H?45JQ-S4=0\1^9;JQLT>/,))/TSM&:G"6Y=)ZOQ!-K9CR'N=O$QM.U%
MFE<#)T]T?>CTYP2';>T]IVGS'.#B#?EM4K72^%K90%H!@+HW=*N=8=9]&U+8
MV7 $ 9QAS>I))G*7[).15LEV66[=BE^K<X2S-1EAM^R^"ES>&<M:;6A[28G'
M'8>]7-G*9PKM:][]Z$80PCRN6^MF#K]U>F4[YKB+;\NA9[7>N&\QKG1IQ!.Z
M;H^C."+X1=13/D 7V'L3-SAB\M)E<^4\ DPC;U;>=6\%GT3])J!<6VFXQZ5)
MK2SKF96ZBGAP: 1$PVG;V*DURGK=P'8+5B3-)G+5=.>TWGK^ZM>K5TF=,KW,
M<+3?W')2]JX]KE:#5^*V_"&>"LVY2V3-1-5)\4&&W:,.]/*ZL4_4=)\0N]T'
MVI9]%QK2J3]%>'GW,3RN3]$Y&::6 6#JQYUG:4?(<T6"[OYTDQ=K*T)I<(BW
M[JUJZ+;IH_5W3G0&,>TD>E3&%S]6\S19DP#W1;'UY#8F3$MRT:S29DEIBV$+
MS#8KPG;;K/6Q,D[\(V05SA-QUW4U$QTP@D]>2S<^#.8G-%8Z:]E]KA;?ETJR
M,]M.[= HCNB/['#GV*Z.N<[=B2J EH@/0.Y+CAZ>CA.TUQMA@?HC(!1M'/TT
MQM NRVG:M22LYKA]1YNH*<)>U[<LCJ. ]D.Y<\Y61I3F;O+F[UN=<<DEB+J'
M$ P/*!5S$O.6"GFN9,B28<Y6+;X:S<9733ZO>+;<,SF.?-:D29S]DY/F[S,.
M74LXBW%5NJ?!P@1>1VK4TSNMG3YX:8DC&&"=MZ)+E.F?O-,#Z>069RZ3A#5,
MMTPV#9RZEKUE<_LT?S7,F",(QSZT[3'#>(T)E'-E.#1&^V_/G29J692=)13G
MD?$8B/5SIJ,6V?HG&:7/+0=TX7QR&2T(FLTRH8'>Z?ACZ/8IF-37*EZA2U#8
M_%<<"D^Q=ZO"M.EU(=")PSBI;CEJ.;9=01]+E:LYS4L\IFBES&$!T3CU^E6]
MDQMM55W1WJQOO4#-(+C \HE5F\/,E[0;3RMV;4N83,;PGM%L>72%.821A?4V
MG+EL@K(E^C)*J&F\B_/N"4XB9I2PPN/(KGG"SA*MW8&$+\.976":Y:D^I\.[
M#:=O,M2Y/W--^HP%AMCFE[;3=<15F8;3?MQLR2\93-FG/=,P9Q@LR;;_ %8W
M4I.&&1]15SC4X9U+EJ/D%INLY9E76%R\RQNF-O3RV+-9SFMX30!U9J]?HW;J
M->;5 1MQS[U>U)]6G.U26QI$2+,]G>LR7&2V<*+K^K-=*(:XF+2!RBD^[%>M
MW$L]\R>X GXW=L!@M7;7AH:+IDRHJ6Q$8@&WGL6-IC3V,X=X><R3)>6-^$$V
M9#F59WG:VOH_":&C/*'*Q61<5H.E.%L+SLQMS6^"; UX(OZ(?=6*W;K#8MW;
M;X>I98:4YA=&(-P6NM:F<L#:>RX>CO4I6S(E0F 0-L>7H5RG-R[$T2A,R5&&
M!P2S+?ABU1IIB["%IPN5D\,]N%5=K+9;H%\#RVK6(Y6]IINR]7ES6 ;T3"SJ
MYUSLWAUZXQ]VG5-\=L1C';>KZL]KM69U$1,WAE&ZS%+E9F3[+'I4P2',+K(0
M'H"SR2UV)2ZM),H-+LH71N5PG*-U2K$QCMW+UQ5EN6W758YQ=&)].*UC+.<W
M'APIICVOO./J3!;CA)O>YP()-QQ*&=J]7R)DPF$>J/8IEJ2<WE!&@GEPLQRV
MK/JUF283=+13FMC[V.?+%;FMN7+:<7LOB#MCWIF+U_\ 1L4;SXA)-SAZ$PEN
MW;6A:AX+ (GX1<<AM4N,MRYF5IGZR#(AONL!QV#:LV4MTZZKZQTQ[[3:3"W.
M-ZGV9SO+'1O<YS;;^X=ZO6[,WPO&GLWV$0P$/7>MVU%:XKG_ %.4YPL,#=E:
M>97K/+'?C+I2;K;WS8![HDPOVG;DMY\O-C/9XWWSW6DFT;;X9\Z9R[]([=X)
MH Z<PN -@-W,LV_1UEV]U^"=-DBCE'<:?<R'3?#)9[/7TS)EI<:-DR*><8-$
M!W!);([=9[7->HG%&K2Y%2[WH0C9'**E>KIPVN$.*I1JJ=F^8F<S':,+E(W.
M7Z\?*'4-J=8IGQB#4TQ_XP2_9WZYD?7?\MPW>$) _P"B4X_X@*X?)_%Z_B_D
M[ZJOC'-W+P=GTYPU5E1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M/J\N\X#+F69NMY^B7_1:06Q\"7:!]$+7#?5%5?"DAP/\W9<?HC$G8F[&[KA
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MM7"#X5X<J9M8R+(_C(9^S%,M8>R-%P1,F4L? 'P##.WU(SSI0.*."9K)9(D
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M<UN<).<*C5ZOXXLF$D1%\>5RSA<*A.T]]9.WMV,7<]ZU-%=@<,:!^.EETH6
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MGX2S+BO7UD]7V&?+A_LC(_S61_)A<OEX=?A_D[XJOC'-W+YW9]2<-5940$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M1#3'$&R'(E%O$<6S2TQ A9RR5924@>)U<]OW5KI:Y=Y6SX,+80_X*ZN;/(E
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M\1H_4Z;&4T\Z\OOW^J^G7Z,$S1Z:? "2+=FS->'YN_?ZG7IU^C-2<*4SG@^
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MVSFV+!*KFS +1" [%G+%C>;-:0",<N06Y9'/+=EN!BI(LEK?E7GEDK5O*3E
M9"Y9RU.&ZP@0)R5CG>6VR8V YE,[6:>7O#@8<K8JV^2W*.FRHY&([%F;J(N9
M(A;##9MC<MR963*.GR00[:(>DIPNXKE92VN=NFZ-^8*N9PLLNE&U.F!#[#<<
M1DI9;PU/HZTU6DM/NGZ6*8N&;,7-X4.LI8/M!OS6;;(3>YP@Y\F%T+.X+CVV
M[];+,-*Y8XI=-VFF0<V_#LM6^8N,+EI57X;I?O"_I4F9RF,NT=)U .#?>%A
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M*(,L-AS6L,XMVGY5,-P6=F94MWA<9;0E  76; G.E>1+MA&Q2Z76'GP]TB[
M^GF4]DBU:,1[IR "ODMF,+6X@L'7Z%4PBY^Z2;!U9'N6>UP>K6$H$P]GI4FV
ML1N-I&D"STIFM:89U,&"(]2N<Z<^T\JO7-AE]+UJS6DQK*MS#";TA7.%Z?=*
MR9HW19AGS')9]<NEL9?&&WET+3GBLK*MLLW]%OL4:U=)"57AT+0+(=BGMA+O
M49C5@X]O>M2YVS9VFFA4/W[!EZ_8IAJ=I)A!5,MUIAV9>I(MYRT1%I!NQ6I$
MU4W133%HMZ^93RF=+513"3:/O<>9"6VK"U^,/2KX.U\.#WQ,+K(7]*AUGEKS
M+CRQ6;VW@OU:.\<SUK25PF$EMIY0*5>O*&JFQC"&'H3#I)C:"GR'.CCAZ ,U
M(UCVB$GTCQ<+H=AV+>7/&+AAEL<PF/*[N6.W?#4ZU*2*H2R!$#8;[ 5)FS+5
M6*BU)K=WWA<5K=8Q9?LFVZJV ][MR5F>NG3K)AK5&JV6'T[0IC>4[3:*G5A?
M;RM"LTGKG2,?%UMW2K*U.N&:G>93@2?6,2F2]<K?0Z@&[OO"RSK@?4LYBXQR
MD:O5&>$?>&.'L2QAUAKVIL_&^\/I8<VQ85T!Q9K3)7B>^![I]JL[8=OBZND*
MWBD2IQ_&-LCCLYU>=O;ZYZH6;Q]X1/X]@QOV<ZUACULN&D[S.\,P%4T'G"G+
MI.FMN!\TW&/\[9=F%9(S>N\H^H\RGO:3]9;:<QW+-Q>%D\*;J/F,^+_YR+_O
MAD%<+Z*-6^8LUQ>/K+;01>!?$*9P7HJ]1QM.G1_'-@=NS84RS.EBOU7$\Y]O
MBQLV\L$FU\JY4ZS.FEWOX[<1SYE7#7KG2!G3)TXWQCWQ239_7AXEZ?.FV0O!
M*B>J6I^'IDZ^6ZTC J^$LPFZ?@U[X$R7&.S('8F;.&?3-3M-P4YL#X3X1&!S
M/,L[KK,18J7@XD_DGPYK+0.Y,,WNN6G\&" C*?=#E8ETS[9KL+1^#VLW1X3K
M6@79#F3*6XV[BX?X=;)=)/AD7#+-;F,'OFN_>'M-$IDHPA""S9I+V=FT;=UH
M&4?19ZUEG,9JF<6L/-'/8MS<8[W*ISZEWBGN4LPQ!E6X0-F."DN\)VN7-U:0
M#=<<#W+>,N=N$?-J'.B>?8G#.?*(G3S'I.)2W#/MX:[:DDP]BQ@G;%;$N=$@
M'9VJ^NEO;[Q:M-?&-]X/:I#-NTW, #8[(]BU=W!]D#5-#H]%_+:GIA=Q"S6$
M'"R/HBLXP6Y:5UB>M7V<F/+2K;A(W9=0008X8A)M?LVQJ&X+P(!3@G7>6-VK
MPB X7;<EJ<-,#M3B?BPSVE$:<VN#X"/*W+G4DK&4;-J8CGYTDQRW9+$=,?$6
MC'/H6K,N?&FB]T2X0Q/:I)A6NX6D\W8%<KZW&7 /W<,8WJ5SO+G]8(L]95Y,
M9;#:HMCMV?=6:U&W]=.8Y="BY>/K)-L1;;=[%IN;>#.C'/9$*-R?5C+X@BU9
MMVN/HT:@F%YY!([?&B]]P(MN(6L.F=X2U+/>"VVZ&'+-"3RM=)5N:V,<3A#9
MZTPUE*#4H?2]*EZNG6X:%3JHC\>.W:K./NU<W]&NW5!$>_B,UE9&^-3!EGWL
M"C7A6-3JQ,WC'$W6=BYWK7"J/5SVC>][$XG)*YVY13*J,P .%YYU%ED62AG!
MP!B<+HJI>TNEB8^+1?U[8J99]L#YD ;3]U,RK-\H]]2T$VW#;E%,+,<(Z?.)
MC;A&RRX$)QIK$NVB9G/UJV6,V_1K/G$=<,\\$MS$FFLZHC$1%^1P4FEN*Q&<
M(J\I[V:<F/C V\K%,86=[VTSM-QR*<EF&0S  ;[05>N41L^< #?"W/&/<NTN
M9M/*$J9PB3'!N9N*JXTA)S][ES=R4ZL+;PHU>&W*^CS]EJTYMUK@ +XK%F5F
MGDS]W&$<]B26-7M/+"^INM!Z^C K7*2WJQ>..4>Y-)FU@FU!SQ%X)P47K)Y:
MKIH,8Q*EF73.L,#I@WC?AV<Z28B.'B-VJZ2W!XHVI@]D7J50!*=:!8<\RIV[
M;PO7+K&MJQXK@7"]<+-Y\/;UZZRT!";;F<LTEP3KBY;]+2-<0<]N8!5RM[:6
M6GIVM YL]B6YVSCRSO:&CH."S]F^O?&JURC-N6RUH=&.&R*G4;+7A@MV#MYU
M6I6.9. !-OI6IC!?MRT)M2/>Z,#A!,)BM)]3$EN!@,=B8\UJ7$8_%RBI<5C.
M\L[:D#'JCWJ>MI;+PVF5%]N7WVU"W/#D9P<(6GEM6Y,)):T9U@<>5D$;^R#J
M9EAL./\ C)5L\(ATRTQBN<9U&24\$X\HJEW$O)FM#1?ARQ5C%FVXV:T]'+8M
M5VEQ,,CIK2(<NP*L691E3)#VQ-MA&2QVYTLZ[5RIE%L;(7=ZB6>44]X#C?RL
M72<,O#9H!LCRYBE&X)@.?+G@N<5S\1IV(MN6C,(B3MARZE8Q9E'5'O PR/>N
M7R7,=_BTA'2??-U_+TKQYV]'M<NZO+1D-1EW7,]+@MY\-R[?1U\ADL_7-(M'
M]&D_@L4=7V"?*5+_ .Q]'M_>!AL.U9MP]'3A^F>E?T5BDY=*D'B(YO8M5>MQ
M6O<5EV:FIG^:$9-/8KX<[-UU-4B,TG]D>U;DTN=8>5E! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09I'Y1J"E^=PCY>3_X"=_)N1GM,
MQ\6GV@!\.NUK^T:B[]L_;M5DR^=W_D^8?SXJ(5^I6W3W9X'TJ=N<1+C'W>F$
MZJC5N@X?%DFYMYK+%[T:H.[*M%XP.:Z=;(3<7RGF[[2+[H7\^*Z3ZIY8JFF$
MP$@8&$++XE:RN+G/AUYK=&1O'=-A=C[%&I<.K]1E!KIAN][UHMW$$HN7D"*%
MN '=*',25/6F6X"(%HV;(;4,:PN.F:E!WQ?>X[%>6<>NW8FGUOB!L"+0W;M0
MLS+5CEN+Q#UYQ*89'T[WW#J0DPCYM&Z&]NFS[N2*T72'@W'J]J);A-Z=(<X@
M$1MRVKIUWPS>TJ5G2"T?"18+^I;LQ,N=F6*2PA[;KTZ723]O*VT/N@1%N[ZE
MJ[:NTR# +.$L\HBLG[F]S1QOC'UJVG/"M3ZUV]?V[-BGKC:Z86UIWA=CALYD
MDM3VD2<FK#P!O##9D$QA+<MJ,1'/-$O#0J X-)CZ>;N4O*RS"/9,@XQC9MR(
M3.D3-+-#H"V)@/0$B1N36!S#W9K6&^(J-9(/B;([,UFL7*?T>G:1;GZRM2Z:
MG;2ZR*9H@>;&.',LV^$2S)7NV0LV;?:DF%PQSFD-ARN*EE/*"GAV]?9S\ZLC
M5W&KX.\0( JXP62QNR-.W_HVW'I*DK/;KINNTOPV[T"+/1#8K]UG\?NCW^X8
M7J$F0.((YQC[%5]$G3NB1T?XJ;2632PTKS[M]\;U)LO7RF9<XM;CR)VA:G6,
M\4?/(B>5R8Q=+MK.J3$F.6"GG"^N6>5J6XV$;>K8NW69_1X_FZXK@[5MTP+N
MU;<I,\MN3JK70.\+2/5WK&&^NN4JRJ$QH,8^Q:QAF[N&G/,8\LD:QI%^)NN$
M+XC'F0J<H*G=<"3@.]-1G'LE:FI\1EF4,<56<8X0;G'>)!(C;S*5J;@9KQB.
MI5+,-6=4/ ()QRYU&Y-(YSW.,23V*N8TF(M-XQVI6I$Q3%T+#AGS<ZF6IURL
ME$XDBW)3/AS[19V4PF2@3D;N0R5G+CVVK]93@%T,-X<NM:LSM)<(QLLAUXQ6
M?5N5,TTEUGL_9;48J2\!VYT#+#I5G*,/AD.A9>.6*VEX;]/()O$;=FU8PU)A
M/TQ^K@; >S8F&K"?J_A@@N @=MP!3#-TBW:Z'&&^,1CL4L3KVF?NV)=;XQL,
M?NP5]9>5SFX3=,+!RR*S=-<1OF<Q@@3@M=>T<[+AH37LF6 QPZX)>O\ PZ3A
M :E1M=+>6M)C;Z"LLVYU'7\V0\3R VR/[GO567"S4(=+8TD$0AZ%>I.4ZVL,
MMMUW(+2VMJ3JY; $\K!GL4J9TFZ743- @<SG?%3"8RWGL?.;$1P]1SV*>K4F
M$+6Z9-F6PVW\LE8DF$'.T^8QKANFP9C."689MM_15JW3YN\;#Z,PK-M>R*9I
MTT.%A]'.L]K>%Q%ETZ1,E&)B!9LN!*U.$DJ\4E09;1$@6-OV0[DMPN=X;_UU
MILWA;L]JG,7AKO\ QD8&^%N=D$ZS:9S$GILDL>T[1ED%JR1ROU6R;, DAMMW
MJBN5YRQE6)\UH?TD]HR4FRW+>HJYLN B+".7I53'E)/U,$0!P]:U-;7.%5U&
MI<_>AB87>NQ:YCG9FY0)+BZ,3>,5C+<QC"=TV:\%K8V1&V_:M8SR9PO=-IWU
MJ5$B,0%.R]D/7<.;SC[A*DVRCAPV08B4[J]@6VK=,QT9TEH]PCJN"ELS@FW*
M272'@70,".?8E63">EZH9+0-X"R'()+EA7M<U\^&X;P^'U<VU+!UP=4?/GF!
MC;#KBLXL/NLNFS)CG-C<2%G%)UKL'3VO(^$FQMO/%;ZYSFM]9X6J5)>6#W3U
M; K>V])=5IU +021R($%K'E)PB'S8&$#U[5FW!,>6:56>' DW&-VR%Y6<9IG
M"PZ97":^6V(M=VD)C:.TZ.C8^FWR 3NQC9?NK7A9%<U-K)+B+K^Y8O+?$5MU
M0PDB.SU))MG.V67(\8=?H6K<*V?S.'?1/H4]K6=Q.Z1H#1,;O-LCL2W;?:YF
MG='#NATI9:V%NS9D$SASF9=_1N:YPQ*FRSN,)@,(%:XF7/OVM=,ZOP^ZG+O=
M(M=?9MZEC.6)76^IR72MZV$"1U%:G+6,U3JLO(> <?9ZUJS27_T5*KIYQ+C$
MXYY%1+,.-$)LF:RTB!CV=*$T[TX/U5U+X,7P]]I/HZEFUJ8KVAX=XG$V0)?B
M-/PB_, 9J9]DFKA8M1;,J9!F")&[VI)MK$="<6"9+;,@#>[FC:+MJW-L68="
MZG5S9;Y@C;O'M/>ETN-HVDU":^8!'M&!2%T[)T)TV:9>-L+,+/8I>23R[?TA
MDYC6D X>I)J&;Q%^I-1G2 />A"WJ*DY,7A=M-X[^HM#7N%D/1TXK6?#GVF*G
MCYF2JAOAAS;H7VVV9J2,V2M9^I,U6)B/>A=M"68)QA'S>&A4'Q,S$7*2Y8>6
M<,[@A'+$>L+3-Z[RS#A[IZE9VLY:TWJ?2?J]NZ;('#"]9MS<DTB]:JS)IG-%
MAW3U@)%M=7'6YK)Q]^Y\.JS-:J2K?INOO(;%X-D,?6N=SG3?7A9F:DZ8(ET>
M[TJIQJC:G>=[QLO3@YU$U05S);@2X0B#=RA<M^VC'J[4T35Y(#8S&W@WCEBK
M*Q:[>TK4Z=[0=]OPC$;-JQWF)EKK,K;3ZO(E.'XQH%F(R7S?E[SI^KU_'TM2
M$WBNGIY9C-98,QMVKEU^>9=OZK(Z]X@\P*,"8/$83"'I 7HZ?+,,7I72NJ\8
MTD^8\Q:=Z(PVKT=/FV3I55GU\BLM:R\0ZS[%[^OY4G7#IZ-5FF"<ZQA^(9+I
MT_)F6;\?F+GHV@3"YH%EV/-L7LZ_ESDG3,P[4T_AP[@WWPCM'+!+^7*G]6*C
M]=T%C&0!Y[DGY77RE^.VNG]9TCPW3"#=ES>Q<OF_)F&Y\=O*CSF.E.<(P@3Z
M2O-_W4DRG;X]L3*]LHP)NAGG%>7Y?GG+,^.S:4I==E2R(PO!ZH!>6_-,9;O3
M678&C<<2*9P]YMD+8^U>7O\ /&/ZMNT*#S,DF4)0F-M'8(9KGU^>7MA.WQVQ
ML?I(VL._O@QB;[HPYU]3X[GJYW4VX5.KR9DHM+VF,1 $'##I7:7#,JDU%-3U
M,TO(C$FY3.UL\I32--DRIN\&XB%W8JQG+L60YH9NC(]UJSY;ZQ&ZA1-J&$;L
M8]O(J6+C>?"I_F)C7F,LW@X<ZN6:T-0T^5*88-@18>J.29),NKM;E-#W!IY[
M(YV*YRMZX5ZF]U\< 1Z#'U+&*8621JGU9CO? AU06K-,\*[JO%GANAXC;SB.
M88I)8549O%3YCK)@-INMA&S!&Y&&=Q [P][>$>G/V(5UWK_%[FRYC1,:(9G;
MS@K4U7/M]73&I<5S'S)@$P6G/N6_:1YNWRSA6)^NS9L??C&&:>V5Z]][:!KY
MKC$G;BL9WAZNO=BFULS/TG:L]L8>CX_DQ<U"5>HO%A.+NQ>:S->O^Z*O4USW
M$V\NO:IZUZ?C_(ZQKRIKWS1C8LWKIVOY'J[,X8J)LHRS PC'T^U)TM+^3*[M
MTG5WRFM<3#W@;=GW%9UQI/\ N%R9Q&/#(,QMK<3#!;DP\_?YL\*OJ.N2YCH;
M[28\LU7*_)K:O-J&3IF\"#;'TP7;K7B^7YIG"UZ=3"<6]!ZPM^T>:_+B;6N7
MI F >[EEC8MSMB;>:?*UZ_A<53"ULLF(W;![%CVS6NO;*FS_ "_F,F&9X3KX
MW;+[E.V^'KFNN6LWAN93?1(QZB<X+'K5SB9<'R)LFRZP#K%JN*Q:KU>V:[Z5
MA)QR,?4MZPLJE5^FOG$FTQ)=V'UK*H4Z0]IN.?*U#.8D**BF,>UH$+>Y:D\I
M+MV11:9,=3;QC8WU1]:SF6X:NE"XAIWR)CAO0L/6+%K+-X=:5%3,$QS8W$]I
M49EPS4_BS!<3M!LQ"-7[/%5)G;AL-V9VHS%)U"EG.#@(W]EJ-<*O-TN?-<#;
MZ$X96+1--FTCPYUEL;;5+,[;Z7:VU,Y_AEL?HY;!WIF8=\S_ "JM4QSXB..?
M1CS*RQ,9VXTLEP//;Z?8JETN.G.AN[ !U*L\:6)E8]C.8>I9=9-90M?JLY@<
M >N/M4LR<*FW6IXGVQA'G48V[$T[7)@I0"86>I:R;:U5JSIA,3&V/1&"T3,V
MB/K9WMXD 1R6+?"YWE)4VIM!%HL!P]BG5KPL--KK)8'O@0 %L>=;B9F<-[\_
M1%CQU)VVG.FA.U8S/I1MV[.Y9SAK.:UFZLZ4\'>Q ](5FW'O]%ITS4_%(BX'
ME[5<XTS)]5]I98GLYP#U@+&2XCE4:4UXVWX8!;U-LSZ56*S0A%Q!%D3AS>M2
MV+ZJ[54 D1S',I8EJNU4UTN[;Z/N*8QRFVK15SW3PW-X[>I;ZU9IW)H$\M8U
MQO@#U;.E3M<EF>'9=#J@8T NA8/7W+.--2,&K:FU\EPB.359I,7+H#B]_B>-
M#ERBF;Y:>O\ JP+9KC9RCL6NW;6&9RQ:=/+7MAF#GC#U+'4L\QVYH=6_= B;
MAVNVK1G.E[EN<]HB<!V*-29N&C52WVW\H;5O+KP@ITIUO-ZN=9\Y6S35$ET1
M[.]5EOR*<V1$;-FU9_1KF)ZGHVD D=FU65G'A)2J ..P):LY>*B2RF!=DDK5
MF].-'J;&O:-X<CS*YQPSA,5.HM,N\6^M,Y.KK[6JN)> 8QCAL]JSBYRN+G*C
M3)SR\FSJYEJ<)VTUIE3,%@A>-F"EZYVRP-KYC7"!-\.5JS=-2X6>BU>:]@9'
M 9Y*2K9G;+-T]]:X/-MOM]2U+AGRS2M"F-.\(V67K3?A),H)LL7P.?1[%SW>
M$F>MSX<'A\OZ7*SO6V[98BZJ;,%N]@>P+,WIR0<V9-/TKN\]ZN"<M":)SP81
M/W%+HND_HKGRG#>LY;%<::G7*S5M2R9*A&[N*SAJXZNOM1(<Y\.5@5FF)<*^
M^P]:U>&NMW:Y,>&WY)*O;KG;(V8TF'+L58QBMZ3+#R,;CAC#-6);FI84A;+W
MMV$(F/(+-WPTA9\PL?#EZDPSEGD2S-(AC9#G5LRDJ8DT3H1W<(<K-BGAO#=$
MK<%T(7QO4PLERPNJ"P[OM2Q,L1FOF6#&R%RLN(DGED;2S'VP-O?#TK.[6I<I
M*FIS* );"%G3>M31<5SK*ILJ4^T AI2S+%F'2G%NH@F9!P^$^FQ),+,<.C:\
M.J9S86Q)YK\D:6;0=,<Z!W3:1CM1KQAW!I=.)#&Q!'NMOY8+/-TY9L6B16LE
MD '9VA7#4VM6FZB'.8-Z"S9LQ]78%!.9NM).(/H*Z9UE/6IKZY*:V\8=NQ<[
MNK.V(A*_498!@X79%:PDWI2=0KF3+ X61S'Q6^I)+EKA69H+R=N=]\5KPF9G
M# :5QO;Z LX+&&;2N B&GE%.#A%NGODN %F*OLRLVE51+1O.QQYAC:K+X/U6
MI[94V6<21'HM6<XKK+.%.U2A:3$"ZWL23-9MPJX:9,PPP-G;TK3/\ELTW4-W
M=:2++.JSU(357VBF2ZAK&QM('82D7M]C4].8Z62&Q,+[,QL5K-N56I))IZB,
M("/IB%FW36,<NP:#4FRV $BRSKMR4MSP2Y<JVJ%4V#;?N%:]=&%"U&A>7%P8
M;7'&&.2Y8:NXKI$RF?=#EVK76XTS9K+?EZHY@@# P%Z8R=:VVZA,F#TX\L58
M2?5Q^M.)AMAZ8*R9J6)QDLS)$0(V<Z=H8\NO=<D3&N) LMV7 'UK"32E2YCV
M5$+K?3$E63.ZU[9=AZ;-<&L/[$9X!:U$[)"HK"&]!P]FQ5,801JYGBM(.,.I
M*O7AVIP57.ES6EV#@5>L9^3<QY=_RM>8R003] YY$+=CAZXVZ$\QM>9,EO >
M+WY\L5/+ITCTEXHG.JZF;!T8S#Z4LS<NG#;X6T2=.>'0)B(V<ZF,/1\4MCNG
M3^'GMD@N:80Q SNMYEF7$=YRUJK2&L/P=G<L9N:]?2ZQ$]PAIX9J%,=V'X]G
MX0YEJ76*ZR^*_:[Y,Y<-4ILO'I3_ ,8)Q7IG\7V _+A_LC(_S61_)A</DW'?
MX?Y.^*KXQS=R^?V?4G#565$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQ
MV(DX8$40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;FG_ -.I/X9GX02<EX>G
M7VC/]VE;_9\W_&72>&,9E? I\[0_[:U7_-ZCMF+O/XOF=I?[?\OP-XL)_/C[
M3^4FX[5EUX4O4"/>SBI<IS=-*GOY;5GKS_E+RV)F'3ZET98B8(LF7EKA'&Y9
MD.TN&T#SK57KCP\J-,K'@0"C/KFY; NBM3[IC#S%%E^K.DN61!S;?T+<[1.W
M#F;EN.=X>6JY_P"#HS--G2IRO:R5LR3$=7:5GRQG-;*TVV$'EK@'8XA,9,:R
MV!; K:R>7,-)ML4SX2\LC69PO2IV[,JC#FK)]6W("*MLG*9P\D6816);[?99
MUO/AS9AT^M7LQWTSLO'./4I&9PWFD;HZ>U:PUBM&H^$G)9XJSM)<*Q7'XAD#
MV^U7.8Z6YBH5EQY@I)E%9J =XG;W)C%:S,.$EN\[T(Q[3*U4<J#1[N',K^K-
MNTQ*IXPLQ^]/+!3.4DRV?JVP]3N]9PUBM*;*<S V1P/+!:F?*7/-808X05JR
MMV14NEF!)P]!C@,E#MPF:>N,1S;=FU:MT8DVM5'6^[>+AB?W2SRX]I;4](K@
M81(L.>TYQ4LK"8D5.\00;#;AGS+?2ZQY=,:RFY50(#H]6Q9YOV<_.$E+J( 6
MX#E<ED;XC8^M6#F&([EC&V;/+B:P#/ES6+<FL>5DUEED5/B. MY="F/":REB
MR(C9<5KTPG:Y:3VAP,< 5>+@EPC)S!'I."G;ZK[9FT/5R 0[:"/0-JDN6)+:
MHVJ4_P =AN=@>];=>'6^J4V,#]+ ]ZS2[Z_=0:^G@28&\X'+G6>TN$FE0JI9
M$8"ZS+%<;]';K-9_^N$3,L/,.]9[+Y<9;X.QN4G;:^M3U!/+7-B3 $99\RWV
MW,Q,_1V1H]28MMQ;B,##+8I)B)EVCI,S> )<+FF\;53[NP*(M<V%AL'H 01.
MM4P,MYL,;>OI0GT=0ZK2@&9$1OP/WR-5UMJTK=C9'HY^=0E\*LX0="&:N4O6
MW:<T[XASH35=S<..! M'T<=J%KOSATB#+1\ QVA9RQ.7;VE0.Y:+AV;(K4YP
MU\G\5R9)!E@QPVY<Z]GQS3YOR=[FQ#UC-W>'['L^ZNC@K52Z#CS]R+G6(U6S
MAO#VY<R&XWY,_P"'I]>Q,GKEM?6.7(*962/!J.7(*Y2]6>541C;RZ@IAO+D^
M= 7GJ"ETO69Y14^?'.\^D@Y;%>8Q_'LBYDR,8QO[TSX69Y8=Z)LBLV>4O7-;
M$J,1'-:Z[3&*D67=/J"-M^79$[0B8TDI;P(BVX)9:QG;>:Z(B(A:ZXQLL<)S
MX-/O'TY%+CPBN5SXQM)][N4:F:K<QT7$(5RDM)=9RA]U$\IZEEN,+,LOV.U3
M+KZY62FD1 L%YPV<X5Y<K,)IDH,R/W>=!M!S0+[AZK=B#5G50%@PVC,HL14V
MH),.?O&"CI;(P^+SJL:K;E0?TP]/W43<;4R2W=!@(GU]*N6.S%)$'02SZ.-G
MFI .@,;K8?=4PN-,,V?NYPARSR5ZUFS,8F5(<86\H[%JTZ_MVG**HA#F/*XJ
M<[=)V]HGY%39T>H;%GMI6Q]:Y6=RPF6!U3$GG/+X5TQI+<Z<?K!Y?<4PF*Q.
MG1)M/(*8F3'AK/<";.E:PU(XM:2;,PI8OA)2)1B+!]'U*8TQC-3,B3%ML.KG
M[U-97&"HEB6W#JV K4F-L_),S,1L;;[+5+VCAZ7'W>(VXPL5FXF,:KR2";$D
MPU+)&0027'+.<MIK08PLZ%E6RT1LV*XD)?JYANZ8F$+5;P>7%M8&N CZ1=R"
MO6B7IYPF 1R]6P+*[D2'@M>V-EH.'1FM$S4544GQ& @39TB&:6IC"&=)+7'I
M[>E9[&?#-3NW78]',>Y9X;PLU)-'5 6GHR2<G$28 ?VXK5Q?U,X/# NAGRBD
MTDGMMS#MT6K'>6UNZC :DM%YQQRZ%6+CA&SZL0=;GBW,K4S@GT5VJG[SC;>>
M[9M3D[3RKM8USA9$W^G[JO"S<8:"2?%B6GXA@>E6[C.;G#L*B9NRVV?1'+T*
M>"8REY-@CM]:EY*VQ,&U7&%F^7@N!S6=]6Y8QDQ6I7.VULR9.]"[;TI;*F;$
MG)H0Z!//9SC/G69I94O(8)0 PV<Q5QG:6[9)CQ 7W%)UN41TV:XPZ>5RMUJ-
M1H3*B[I]6Q2&&%U1''EU!7&TE<6G>MSB5;HEVRAKHBS$8A3EN\)"F8=XW8=J
M8)9C:<8(0&U*2^6<.++S?T]JDQ5M^C&^9"'O9\K$Z[8E]7F7,),=[#FR5RU+
MG;'/FP#O>]?T4Q>6LZPI&KSH@BV,#ZM@3-S]F,?1U96N/U@VGXL]H5YVGMA<
M-#8'L;'(<KPG#CWYRNU-)$&0R&?WPVJ,S/A9::3!H,!$1/I&U9ELN^&L:TEF
MM(ZEK,LSY3&L#W"$,04XVUQ&(S6M!S'K^ZLW-VQG?V8C/!Y^6Q3U\M2Q,Z?5
M"481Z]A/H5N>8693SM1LA9UFZ'.G6V\LW/6-3Z\'8CKSY^97M-DSV;]-.:8$
MGTC$D;%F<F[I.R@'",1=FMXE_0M\.-0WW8;PNSCFIB3:S<PI>IM@"=I[ KDO
M6S]%1F@F= 9CM3[IBI>7*]P7<@,DE,V,$YI;U]Z&YM'F:Z)]G<KC1N[;M/.=
M >S9L6.W4C?8YSR/9[%9J-6:RWF2"0";_;SA7+#RZAW\#"VX=\4:Q4544?AG
MFS'W%CVVLF&6BDP<(P[<MJU+E.TWI:Z.6 !"%PPV%+3KRFF D =*J7ES,NPW
M1@<-F:BRM5S;Q8I9O)SOPQ^$-G4JUB,,Z4 TD$7'#8=NU7*]<(68V+C'EBKG
M-TW-,3J7>&%L#Z\TPF?HCZBC%M@M[B,UFM8UE6ZV7X1,+($W9=::L^Z;5]]4
MYA-_JRP5F)HYK8D:B_>LAEBKUA=5.R*]Q B1=GL&U3MPU+AD?5[T+?7ZBIUO
MA+=:;,OWV@C+%,[VLLX9=P@1LY="JM.8\M<3&$.^"C<L9Y6H"5"+FB%MIYQ>
MKAFM74-=8R6?QTL0C](9<ZOABNHN(N)98$[\=+N/TAM6?7*\<O7CB[B-LSQ0
MV:P^ZX?$.6*OKK;M\.^W^7KYK.LO9,<0\7$V'G4Y?1QIUCJW$KY=H=F+SZH*
M[3U\J%5<7S@\^\/B(O(RVJ8N6YCRQ2^+)S_ICK.W&.06LW#/:9X;9XCG.:;<
MQ83EE':LR&$-5ZQ/>'&VXWG:KE>%8J=0J'.N.&>7/M4N(<MB1.G.:+'1A;VX
MQ3F)VX; \5]A:ZWIV8<Z8PSCRV644^9^]OMA<TXJRXY:DPF:;1ISB(RIMNS9
M'+:I+E5QTWAZ8XM)DS!9]Z=G,J.Q=+X8):P^$X<[3FL[G+-ZY=@4/"S'-'NN
MQP&7,5J;C6I$V.&&,$=TY0('/A!2QSO;:4H^'V- &YU"."D8NZM5)H30 =QU
M@&!S6F+JZ6RATIK2#NN &S(<VQ,1F\KSI=*QKF&$ +;0-G2C/;4T[-TP -EP
MACVIU3.5PIOAZ^T+-F%<:V&YMAZN]65CM*IT]I\4F"M^[EQ6,-,18I/JU;,.
M>X3DG:YX<6E.:6B_ W=/<F&;,\(F<TD])Y>E6L28:H!4RDF.6>7O1;SY[4RN
M+;]EQTIX%^P&/2HZR8F$[,F B^P XA:D_P"2S",G0-V1PYNY=+G#4VCGR][+
M'TKG$LWE'S94"( &^/(E6LL#Y9 NQV+G6Y,-?WM[I.2W)A-7CE@J)A8V.V%_
M/L*EVUBSKM!OJSO'O.?,K)CE)<MB5.+A?CL[EF]ML[\LP).*UK&5ZLID%W+/
MI2+?LQOI21 #';WJLXK$:(X 1YBK*LERX_4CB#Z>]9[W6FML+Z*^P?#CT[5B
M9<\RUJ.HS'"[EBMQJ8D8G2B(<N]7&>4N/#! J88V\[T%/.'3K;!LZ)A$B_$X
M="KI,\LGB#[X^E3#3',<'61CUJ8=.E:_A#9U>U5W;DJ7 DB%A&SE<E292\IV
MZ(121UFX\3JG<!$?2!AT*X617:FM,<.L[=JS6K<(_P#.#]Z$1?#%628:E\I6
M3J+BR!A=TX[=B8TG:M*LJ26.,>72%CM=N/:S*DUU2X.?:<<1S9+&8Y_=$2JL
MAX))ARV*+BQ:-/K!$#FQ&SH6KA%JEU7N QVWCN7.V-3#A-JQ"_+$9HG;51,R
ML WCLS&0R"VC"VH$RRW+L[UK,,UY?&P@\N04M),M-Q.:Q%[ZB.>0"2>5BTS.
M&/Q@+(\NI8O+7K.7.7.]X6X[.U:Z\,V2<-YLT0OZDPL[>*\/G -C;TJ]9M;=
M:0%350CTXC;F%WLP=4--J(VQ-^?L1+,HQU1[Q$3R$<E&N')DV+A:['L.U#EO
M2YL #$X^OG0LF&0U ;>?2.Y7+/KK+1FU8$.8Y>H(27+5-:-O+K4:X>15@\AW
M(.#ZBR,<<_5!7#.<5K.J+S;RZ%G[-9S6,U!MYO5^U6DLN<M=U08]&SN6;GPE
MWL%3:+<1R^%62X1$:Q5?B9D#]',9<RYW5V]'QXU'4577%U0\67FX^TK#U2X;
MU%4 P!S'*Y3E.5MH_>((S]2W,2;3"P,(#1'9V!9ME7%:L^> (<L-B8VUB(_Q
MR".7J4NZ7$TD),^(QN&60V#-3#/EF=$B]:A.6I-?81;RL4SM;,7*.F?2Z_6M
M6^6N6B^8!$8J66SV/LQMF.-L<=G<LS>F+,,@=?>M[C''+;8^^$<,E,8Y;EGE
MN2(N/1ZBF?+KK#9GRAN$V7'!,N659JP ".;UJ6F;:KLT>\3S]I1;+R2G;IQZ
M.GO3'E)FI67,!;><.P*2YTGENB8!<3T+?6+*\B8,R%<-3MELB!;?]''F3$O)
ME!5P #MA] 4Q%JH5#H.,(\BG$8XN&L)A!M)P]"F4[?6,XJ,N7H2S!-QE=4@C
M&_E@I=+ZM>94V=/+Z*1FSPUC,+HWKC\G_L[?%+G+ 6G>C9>O+AZ+?#NKRV;'
M4)=T8,P_9-@KCRWTZ[V^C7Y#F$5>DW?T:3V,V*9\.TF7V _*6(:/H_\  #UK
M/:/1TF)'Z8:5_16)UY=*WG7E::G# ;SSE9=9PTM3_HKOVI[ JQ]7553^4=^V
M<MQ'A9! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09I'
MY1J"F>=O]WL_^ G?R;D2\/BQ^T%_IVM?VC4_A/5E?-^3E\NGG[, U'5H1LGG
MM25C/CP])IL\_6W1^^V=RF97*Q>]'J8"7;B,L]H73KMGK/#L[2YK7M$2,+R%
MU\+9M8?#:X7CHZL\E/.&KC"D:_3 !T(6[WIZ54F'3&M2RUSP!]+OZ5/)C&E4
M(()!S18SM;&Z N59<'B'/'O2M=6IO0?$??>M3"Y6;2YI)A;>,MO,G!VV[,TI
MQ 9:;AV*LRX=B::W?#8XM]2E9QO2QRZ+>;$C*X1[U5MPP3: 1A!T(G =R+G,
MRC)^G@&P.O-X!4OV3&4SIFGQ(L/4,>A=.E<NVDG4Z>0T^Z;AEMV+KSISS?;[
M(]E$X/!A9&..4,U)/$6K+1TX@.G/ <ZU)5ED2#Z;=:39EU]*EN>%S%7U*6?>
MNQ3#,4^<QP>;/2,@E*QNEN#0[NRCFI&;/H\29SFNA;99>,P,E<PFN5GI29C!
ML&)47R\54L[ANN[TU_E9%?>"UYYRLWEB\I"BF0< 8WY[ M>&Y?JG [?99LOY
M;$,HRIIH] [CFAC+9H9HD6&^ST*)9C2UTM8'0M-P[LE,$XVGI,P.  V^OF5K
M75RFM!%L.KG5X6SRBITL1-W5M5^Z9SIJ2A[]N14^QBQ/T8 )LQ"F/H1O5;VB
M23#Z PV%:XC6HIDYP+SSGEZ%G">SBTQCT*VQ+VM2=/?T^MJS<W<1/TUPY_4M
M+U2S<4\'9BF8IG'*=>4=-B"<N\JYG+5N&LZ:6B[T^Q=NO#Q?-;V0U15.:^%M
MEE_=#)7#CUMFF:DKG;[0<]L80[PJUNKU03M]K;[>[VIDDPDYDLN$1#E!9Q6I
MVF<(F=*+3SGO[DB75>9#W2SZ,.C-5,_1,RW[X'+NR3)ZW&7-TF,#99&[D%:G
M6X:$QA! LLCR]"C5N&C.:3"&959Q<_9Q9*W@(B\9+.\_9>L_Y;\FDC#9S^LJ
MU<R<I:330W>6'.BVYX2U)++7"ZSOZ49LTMLAP;(M.'?WK;SWZ>57U"<&O> <
M^5Q1)/JCY$QI>-L/7L6>\7/A9:2T#H]:DVG*2F"#.612-28:8OZ5O,C/E,4I
M;LY K.2U(/E[S"1MPP$4]FN5#U^:^1OD99XF(PYU?:,XRHWYSF^*!MCU]*N9
M>#K(OV@SG3VL)!C$>KG3:8Q<NQI4LLEQA; \^ 4[2-W?"(K*HRR;[">KHM6<
M;TELD^Z/E5IF3 .F\\V,5K..27PL)D"=3P-\/48]-JQ5ZS'*MG2 ^<3 VF'I
M&Q7&"S*>DZ)&6V$>H*'7Z.%1HK@VP&XG#9SI.UEPNN$7^;'M==<1?UX05SEG
M&L)S3J)V\T0RSRYUKK8U)A>J6B]UM@N]1YUFC:F4,LMAW=RDS-L[O*!K-,:8
MPC<1AGS)>V3,5Z?HX<8P-OLV*]?L3KG=:)T4-MW39S<RU<-3MB[X87T/A7 P
MNMZMBF4S+6A.JS(BWMNN*EVEU6JW53O0LY".:G![^TPFZ.N$PMCB,#''I6NM
MR2<K?030_<.9]8YE;I.T3<\$2R881]"Y5YU2K7$.) -W:0M3KH:TJ:YI$8WG
M$9#N3UQ%G;"09,<\0Q@?7L5Z_=<9N7)U(Y\(X]-MVW)6[NC&:YMTHNNCV=@V
M+/#.,)2BTS<>V,8@B_HV;%J9Y7AV/I<MLJ6-XMN[(\^:INMU\F7->;K3@/7<
MI?&$;,O3I9;<<<E/;376([4-.8UA(&&SFR4SI<Q1*FD+7N.3B/3SI$O;PC9L
MA[A8</3:K+)4L536:=^Z1FT"XXQ6_NSY5K3M-?,J1$&UV>W;%8N]-6QVEI6C
M$AA@;V]O,F,:J2X=FZ3HPW;0;AV)GPVM?YJ#98%OP[!?T*8WDLS/N@*Z@#6N
M]F%F 6\Z3C54NMD[CG0QL[=JSBLHAQW3 A)*B5TB>1-EVP]\99\RU,.F([[T
M^MEMT\1>V.Z+"1B$MVEX=;<0ZNULTP+<80YSML7.IG,^ZERM3+YT+(;W3?SK
M4X7&(O\ I3C-$N&0Y8)+XI+I=I,@;K2<O7SI9]%ERDZ:8V2YIC#=/<LF9PN>
MF:\R00W> B1CT#L5ZGW7VEU&77,-H/N]RUYPY]I)MUUQ;*9+#B!&\^A9L^CE
M]WK9K]5N.F  _&1>,23DM&;G/A31.\1T(&/+),Z3EY-&'B)%^0MMZ"I*MVP?
MF_<<'"-^/(+7A+QCRFJ"J=3%MN(Z+!DL=L+)97<'!&L3)U6R5O7O:+]H27+6
M<O<73M*%5I7B$C\DT^B.*2YN"Z='<<:.V6Q^/ON-GW%OASSFO5?B"B<)DXAI
M^++FYE+?J9N5?TJC>9X&Z1;B#LVK-:[<.]^$=(\3PR01:/5LVI['#O73-" E
M\W<()=KCZ-BITQ[/=:QQ,,!'/),5FZ:K>%ZRK]YDN9:,0<^;:G'^6>W#1G</
MUE%-&]+F7B-AR]BKA*M&D3)M.6AS7"%AYP!L1<U<?S\V1*BX?"/8DBW>XKT_
MC:6V:6B$+;QD>A:FIMGRG-*XEE59 +@+K^=3M9X:ZSS5R$R5.EES7MA#8>=-
M8PSVN*HG$5.'RG %I-MVV&1V))LSET_.TZ8)Q]T_%&XYX*]IY632;T^DFR]U
MI8X1&14D)M=*22]K1O X8<RSVYTMF8Y5,WP03<;=@A$00Z_17I^MNIW#WAG8
M=G>DC=^Z6TSC-[' ;P@'#U;5TQBN6<\.V=)XX>U@.\(;HQ. !6?DEL;ZRY2%
M1YCF41[X%AO=T9A?#_)MX^[W?%<7:*J?,DSI9'BLC"'Q>U>7IG+U7:A:CQ<^
MI>\>*P[T8>][<U[.EN&+)*T*.;,K)K27@@NA?GTKITM:DF'9NDZ.7RV.+A>,
M=G>5Z>MM)(N,B@9(;[Q$01&,+>Q;GMG35PF:/5)-(^TMLA?LAW+U];<83$B0
MJ>.I-*WW9C!NV7CGYE<V'\E7K/,.14ES3,8;8?$,>8K-MMTOKA5*[79=5OG>
M:0[;L*Y_)>UX%-KGB9$M-ZY6LXRK50UUL,X+R_+:O7&<-=DJ8YP CZ5POM>M
M:MB4IZ6?&R,8#E>O+WMC&,K-0R*ACVDDP@%CXI?9+C"[2-0=3R+2(@9F,;8+
M[_XV^NWB^3E%3>(GM>6EV)QY8%>B\L]9K*6H-:\0MBYMKA><#T[497_3*QKX
M.!%IV=RMF!>:!WB&-\2.6"S+EKF:6)E$)@$<18;/7%&OLT:VDE261WA';#"/
M,IA-.GN*]4ETPFM#VQCGZ^E61G-CI+4-:;-FS 7-MVY]*6X:Q;RU)-2U]H<!
M8<LQL4ERJ.U+5!*80'-^$XVV=*TSF33IW6M;>^>YK77$XY$(ELIIDZ94;L;>
MG,[5*U.%BJJ=_P!7RO[(J0ZSZNC^*IDQGC"WXCCS9*YVQWQ.KI^>9TR<X0=;
MW\RFWR^W*1I*"9,A$&V/++%+77K*GI.CDVF.7*S8I+AVZYD8:O2]QIL,89=W
M.I=UU^/M<X4O4:1P) %MN![UE[>OU0 H'N(B.73%3#K,YTEZ#17OFLL=:?5S
M+&'6VNW=!X? 8RRV'<K%ES^JX.T\T[(Q$ #Z!L4[?8DVK]=7ODQ -@!SCBKU
M^[C\EPJ,_6'[YCZ\RMX<.UMZI33=0,QX$1AL-L,UKKKEXNV<NX-!F-<UA+A\
M/9!:EVY]I;':&G[CFM)(-D1;DKV>:2];M::&GE/(C=O9=\5F._Q_^J1K=/IS
M(= 6P. RYE9G+VR7&'6>L4DJ63N_>NO VW0@M?<\8=:ZD6,,(CZ7HZ4LN#"E
MU4QI)MN)Q&SUE3..5D0\QS2Z^_N&20MSPY,IVOPOZ_2=J+)_ZI2FTQI<UT#>
M+>0VJ[D2W>EK;-93TQ:<&N'9FL\\%N8Z:XKK-Z<Z$<<N?+8M2R7:3EUG+89\
M\B!M=MSAL2M8B_Z1H9F 6'WH9;5%U-IVJX:A)<[=PLLZ,U6,S+K;5-&\-S_=
M=83<.C)3A;<S"M,HMU\-TV6W ^K:KSRSG&FZY@EMB&GJAM4:G.4=-F%]EHN4
M=9]6JZ7O'"V"1<UO4M*YUS2>@XQV[5JS>3E9:*B=9!I'Q7B&6U,X+/*=;ICG
MCX76Y 0["K+E9FZ:53PU-G@P8XQ&1-O0I:TA9G!SF.WH&,2;1RS4G6TU&VS3
M'T[-SH[,MBUB1SO.N&K/H'7PPV[3FLY;E0U1+=+ZH=1Y\DMRRAYE6Z03LAZ\
MDN[HR\,U5PC$Y9]ZVB7I-0=,(!(Z]@&96>WV6+#(.^+XQN]*YYE:SBN4RF>3
M$9M-@6IK3EVFU@TACV0O'(=&"U/NSGP[-T^M$I@CDWT=2NK2S+;G:XQH-V5V
M84NDD5^KU]I+AF2,5"(&HKFU,1F!=TYJLV;1$ZB,TFS.[;#G"F,M>TD-/T)W
MCA\+G X8*_8Q_P .UM+HC*E@0N;E;Z()9HMQ=)IH>PB_ESW+,TU.&&K+G2\?
M0K*SVY=6\14Q?XMEXR.8VK5F-I<\.D]9H8/)(.%]RQVV8PBJ&C.^T0%_K.U)
M*ES)EVOH5$0T$C+ Y'O5W5EE=C4]. T$V6;>]),.WQ];G+'4R!;"VS;A YJN
MEQ4#/IX;Q@>HXCG523?V:(800(7'+:GKI<2M^4V$.:/+H69G*XPE94P"RV[U
MQ6L,Y2,FI#;-G=F%S[1,(;6ZT-D/,<#B,#L4F5RH='J;C/AO-L.9S"W@\+<Z
MJ+Y;0#@,8Y\ZO\27"N5S'S"[; #J(PNN4R>R+9IIF$V>CO!6CFO,S2# W\NA
M$N.$;,T<AQ,#?Z8DY+/8ZXK>HM-<P@]O-LADI.N8G;6ENI"V5N@\RN&NJ4$^
M6,NOV)%:\V>QK28W6WA7$7MN("LJVV]&(Y8)SIG,BM5%6"8"/HV'),8J<M>7
M&8X&V!-O3]U,KX3]+IGC!I@8^J&VU9NV<>&S-H_J@C \N97/K'2:0=37F!;W
MQLMOZ5,PY5ZHFE\3$VWJ\\,6[Q$3,= &-\4XY/6^$:^>6DVF_&&2U-K;82ZF
MV\8XCN4S,DNK:MFEGQ(&(N!Y025F[JZ&2UU.2(1W=NPYI/NLE4.M$)[A#Z2U
MR6)G3)0<&DXP[L"IQH]5QDT8+ 01;L/>I6NNN6*?3AH(LN)NRLS1JSR@YDC>
M='ECM"=JY7EL4M'O.PY'G*Q6I=87"ATD3 +#: <#AWK4X4U*B%'+).&:O*V8
M=5Z_J/A"< 19V=:U=1F3-VZ%XCU%TR8X WC".,89K%NFO7&U9HJ<SYC3 W]I
M.S:IUEQM+VDN'<.A:6ULL&!$ #AW)>6.:L\PB0V&,!RR21<(T5?O@1-XY7+7
MAJ3,6G3)[MZ61RLYE)]UG7#L"FU LE@8[8]Z9_X3.'"IUAS08$=>Q,'KY5FL
MUIQ%IP.)6F,;0)U(S'0Z(VYPVYH7,3%"PSH1V7\_0I;A9?\ E9)= "T8<W.<
M(%3V:RPU&G -^EAZ]BO\B3ZJ9J-"6O) , (6C".Q364U*UJ6H-/ 8@]'H4N9
M<L\U89&KQ@(C+T\ZDVU-5SGSQ.99B%N2Y2_16:N01%T+23@=G.%K">V--"55
MND3!9<<=NQ2M=;F9J]:/JL#+$1AV<ZNL)-NPI,YM9* B(FP]JSG!9BY1%?0M
ME;SVE9I:A&UCF.W8X@&/W1@IDZS"V:3+-40(\C%=9?JF<K3,X>;,EX&PD8_<
M6>UF71U_K?#YE%S@,3=S]*Q;GA+,Z4=U#,$V$,=OWW.M8OA*LM!I)=+WB#<,
MMBN2]XUGT)ESX0LWL>0"TS+;=+]I^E^)2@G+9"X;%&LZPJFOZ,V%WWV&T;%F
MQ.'5S])+:G'XCZ]B9U@\?=<*2BW9;2!<,L$Y6,-53&!&[@1<=N?,C51U-0N=
M.;O PC&R^T'-:<YNZ=N<*Z421".%_P!Q;ED3OQ]W8U?3NIY#B2  R/H//DM<
MO/WKU6\QM1<P/ <+WXF^_-3,CI\6>:]9)]5X]2\&_>CZ2I-NUL=X\!TK)C)9
M(O;'#9SH]/Q<.ZA)9*D" PCZ#S+&9:[2Q2=3F-;,/+$<ZE>OIC"7X/\ ?KZ<
M@6>.SM"C>\Z?LY\G-FJTW^<TOX05FWIZZER^OKY</]D9'^:R/Y,+A\G\7H^'
M^3OBJ^,<W<OG]GU)PU5E1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B
M).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&YI_\ 3J3^&9^$$G)>'IW]
MHS_=I6G+3ID?^,NDX<_%QR^ SYW)L-;U6T_T:HP'_*9KMQ'SK<_)_E^!G%DP
MG7'6_ODW+-9S&\SA3-2<=TD&V)]:N927%UPT:283>;0<N?O6<8JW'E*[F\ ;
M/2M>T8:[V.B+.W/F6I,Q9VZY;C*4$1A@+@"LV7P6Y>72RR,468\."+;C=99;
M8P)S6;GPS[;TV M3A!5&PL]5%I'-E_0MR?5.W#F;EN.=X>6I3HR"Y(=^?\-N
M1=RS4O+$Y;*KHSAP-Q0<FM!<+,^PIFF6^V78+KMN%BLM\I[8<MV PL5S/\I[
M98_$ %A]"F_*XG-</&AB>72F95QUKD*C,]GK*6U;AR^L0QY="F<\I)*RB<V
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MD3]5/,>Q&+)MU;4_E'?MG>I=8P\+ (" @(" @(" @(" @(" @(" @(" @("
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MQ$QPOZ%S[=6>]DFDC+J0S$]8Y8KG<^5Z8QMNMUEDG$?X6WI7*Y67;,SBAC7
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MUQ$Q^< UHM-G<D7M?$^K0F:HW>-N/=M4MP8\QN4U4R; 61B-JUC+.4NR2V9
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MGRFF>FU3P#NQ.78$N:6K70ZOOP!=;9?]THDD2LZJ$V59T<W0M2S"R?5U=Q0
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q
MF^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&YI_].I/X9GX02<EX
M>G?VC/\ =E7_ -G3?\9=)PYO@%^=[_7>J?YM4?\ TU=NW#YU_G7X&<5?Z\=^
MWF?A!<O*>5.U(P'.8=JW.'6<(NE<2XG(CEZ53.(GF'W1T]JN&?9Q<2"$LRS9
M*WZ=V\VTCT+-TG7,<W-!)YU<9C=N2 "LF&,.8%B-R3#FUN)C842_9S23",@;
M&^*F;X:LCF&@*X2W+@2Z-UD3@DZ[8[W3S>NWASSG3S<G*_QX9&F(Z56;;=MB
M6\M3US%Z26[;+1&*SF]72WZ,I")9AY:8%;G9F_9G\6 O;=RQ6?)X>#-CDJF:
MQEYC9!+<K.-N)<3DK,+G#-+;&,8J5:VFB)A;T*\33%K::V %AC *;9V%D3<8
M[$,5D:P-;C&V_I4S9?LLEY>0Z&2U-\K9&G430UANPS6.UVLSC-5FJG1+N6>Q
M)^YCM+:K\]XB;1AZEO."<(Q\2.E9OU:EWM):4/QS;,1ZT-9V[5H6CPK1AS+-
MREENIPWVL:;O05KK]V9,)"7*#;3F/1S*^6I,LI"MDP737F,$(@8I,89DDJ,F
M2PZ_/EDLW7#IV:KY0]ZS#+8LS-K.?"(GR?>)VGEZ5N9E+,PDNW3L[XJXSRY6
M2<)VDFP#;<(8Y[$MPQV6"DJX$6XC$[,PN?9)<+!(GA[1TY]RLN(WYURWY;R(
M70ABNED[1<MCQ !&(6?LG-PS2JB&.)S[E;$O73,ZIB#;@<3W++,F$9,FDNL.
M8]/,M8_:EF:Q![ACV=RG7EJ7#<E.)'0/6KB+B<LCHN!%J8A=32#K9$0;[+/5
MGL7/&TFXJ5;2Q8;,3EZRM8-NJM=I2'/@#><-HR*Q9*]'6WAU]64T'.LQ]1VK
MGFQTQI#3)8)@<"5.6;^UC8(&VP0A;8JRV9<TM(RV<_2HU*L5!6%I$,8$V[=L
M$B]E^TO4! 1)C9R%JNKPS+BNRM(JQ-W!$W ".T=.*EXR59'R@Y@,+^G J<]L
M&)Y5C4J0$.YLA[5J\)UN\>'6^L44-XY-.'/F C5DPZYKY8:3LC'MYE#$PUZ.
M9N/OO.!RAESJI<_X=F:+6@!M]P%YQ'L47&*[@X=U&$V4"3<+H9<ZWU8[2/8/
M0JS>D2B3>W,+U?''SOFN*G73M\G88\K MY<L2L3[03MCZ4:1D^P&'/Z$NG.Y
M:'BN'(=R9:]6S(F$D<\>WFR53&TW):"(9GO"C5RV3);RCWH6X>1*;RCWI8O7
ML\&4(6<NLJ+G+#,DB!CB.6.Q"W6D9-E $W^J]6<LYQPQ"6(CGV]ZUD]NS=EB
M!'/CU+$OU:ZS.V]&Y:C/:5R,P80Z>03+-Z61R!+NVQ2K,S<Y<7ML-AP]2FVY
MB\\M"<PD&P\ONID])S&D98VJY9L9Y0W;1Z46V8PD9<R\66*Y8G7.V8SHBWEZ
M%,M7J\>(#=Z^X*LXDY9&S80!ACRNBIEKUF,QL,G- '3GW)C>6.*S-F@V[=O<
MESXX:SXK*)@-T/2DTF(S-F 1Z,^Y/;)ZO)F[N7+K5S*Y]_HRLG@P$<-O<I7'
M&VY+?O0NQ]$4SX:SF8;TNT#I]:$^[9;+B+CRZ%K4;QAE;+$+8WX\@LWE+,N+
MFAN?2C#"79P6YIN1K.F$$VV1V)>S/%<'3K#:.169<U?;Z-2:[>!NNPY;5JUF
M9]OLQR1%^.'85G7+>EOTX0W58U<>%QDN&X.CL4PQ8PU !!)Y6A7!UTA3*&_&
M%D3V=:EU/NQWVYL9!P@"LYKG;,8\MZ6RP$@XIFFL88Y]EW*Y7-9G.4+4?2Y8
M%5OQ$<JQ>6[3X<P["ABIEOPCI[54>=T1C"V,<5*LY;,H"SG/+K69)EJS$S&S
MXF[EG;]U:\,YWEP=40A;GRN4FRW+1F5-UN?J_8JZ1B$Z)L[.\)6^O;;:ES#
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M4DZ>&K\NM*Y*D$.+K;2/3>G]<8_OLTW3.=*;8;AZH>I2]"?+E"5VNND!\";
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MZVRB?M'+F"S?LW<QS;/+LO0F'/O-,K''>%V/8CGZQ+4SB8='J5AB1.2!8.6
M6C$J18(@#G[U+/*]M.9 "DF4ERP3+AS]ZB=N6D\1"V=KB-1\39M[U,9K$MO+
M"ZX\L5<8:G+#>8;0I>3LVI$NV-M^60*E9ERLM 8;L<$EVW%A9/ :!RN&PJUN
M]MZ'SFD=/,GMAC^35#HN]J7C+/R3$9&?$.E)-/+Y;C3<%+,.F-9:]1R_XJ2:
MRDY0=2;7 <K"ETUGB-""GM3UC?IA&'3Z M5;<:3#1SP4E9U:\XK1Q64&#>:/
MK6+RN?#@9F6[=RQ6XG=HS9L!; 0!Y7J6S_+*+F3S&$1 1Q'=L2*\2Z@@WX;#
MW):;B0E3][=MRRP,%G+=N%KTZ9$FRZ!OV%*S+E/$@=22MW'A$5TV#'0AVK76
M5B62XKK[4WEQ-UZ6-2XFE<+"YXAL'I4EQ6;G*R:9*<-R-EHVXK4LI>,.R=+]
MT-'-Z^],;RDN%HWX--T('UJ-RS#3>X1)LYHK/EFM=\P@X7<L5K&M+UX:\V;
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M$1S^A</DN)EV^.90LWXC^V':O-+G_AZ,8=L^77^L6?M6?A-6ZWTY?21]G_\
MTO2/\WD_XBD;[/L6^4W_ %)H_P# CL*W>'J_'?HM3?T>6O-U_E_EZ/DX2(N6
MV9PTYQW(PV^A9[:>CKOJ@=3G.,D[(C#:G7KG:U0)IC-//ZUVXCAV^CRL(("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#-(_*-04_SI_V
M G_P,W^3*3EGO_%\87V@C-ZKUHV_ZPJ;OV\Q;NGS^UF</EB\_9).IZI_#F_G
M&U3/AS[W6GH_JLLMGO(Y\>6*LF.7&?=#N,!TJ].2S(''9<NC768C-*G.:X6V
M= Q&Q.9@L\IJEJ3O !QN:I-7#.UGIW%X$<('T16A(NDAS3838;^9,[:]<S*&
MJJ8D.L L.)SYU;CLDLZ\J[.D0=#&W/8L=I9^C4N>7 RQ"%N'H]*>%:<U@!(M
MY$]RO6Y9[3RQM; B!Y05)?"7HWG>;:!?V[5(WVZZRONDO,6Q-W,C$KL_2)X(
M9$]@QV!5G<Y=A4#P6B[KV%+4QC:8\-LR(S'<KU^K';MEQ-*.1/8MXMK&*QND
MM;R/>E@TI@$#'(^D*S59[:X1<V:UI@3=%:SB),WE%SJA@A ^B/*Y6;5KF?$7
MV;8!9TO#P9A<(66Y+65RQ^&\VPO3)ER;+>,,>6*EVEEJ1DL=''JYU)-;+VQI
M,2&D0V>PJW1?JD #D>I6+ J96\--[B219>K=31'*6(D<\>I9SE+RWY<X,(CL
MV[%J3)AG^LLB(GT>U7$PSMD$^6;BLJVI4Q@(.SEVJ]9O?U:[<:3$F8P",>5H
M6M68G+.?#9):X7WKG9BY\C6?+;:0=JU+:M[-*;98+59N[6;N49.L$>6"EO@L
MRC'F)6+;E+,7# 23?@M]9AEL21O0PALYQZDO(F),LN@.;TK&-MR82\FG( )P
M&<< DOAGMF<-D#<(Y<KUWZ]GE^7=2$J9$78PONY16ZY==-C?&8ZU,-^S2GSA
M<(8CT^Q5C/LT@PO,!RL*DWM,^6[)I71!A'IZ>U7+4F=U+R&%D 1RL2+VDDTS
M33 1Y7JN>?#=TZ88BP7^M-?Y%NDSVE@C9 "X<Z?^PB=0K=V(!(CL4NUQ%:G5
M)>;XQ)L/1@DV;E;%+$P,,1AS(LN:E0=T1R'J6LZPS>6N^N+#N[RBR9<'/,QI
MB8XQQL5CGVY0\Z423"V,1=M*G;#-U,M-E.XN/3B,^96S29J0E4S[(CZ.?L4S
MI9<L_@. YMJSD]<LLMAL$#?"Y629RN,:25-+(@=N7/M5M2W">D'=:-D/02DU
M6?9SG3"87<HJV967*8TEQ<6["WM1IV1IY 9U8["F<&)2JG-:2.?;=%2W-+^U
M&_7&[POO&&1YEGA-5M"J;NQB;C@K,>3QA%SYWB6#/+EDM9PEB!U!CG,= 8.]
M:S(SXTH\ZBF.F.,#:3@I<^%;5+23)9!@;HK76Y693+)CI4";+CTV=RTTF:+4
MFL()>;(>B"S:S:N%/JTMS0-\W##9[%)SDEPC=0KF3#$N!QSVJVUJ;:TB?+MM
MY6=ZS;:-HU S/5[%O#%T\>)$Q$#CR"JR>6:68D'G]:S>&FZPP V=ZS.2_1G$
MX,OYUOB,^N69NH"7C"WF6,KJ-'4=4#Y9:'7@@VYE;ESRY]IE2C)%1-))CO<K
M4LRY752DC16/M@+",.G:LS59OV6"DTUE.8V6VQ"O:X=(G9+X  0(M'J6)NY+
M6T:#ZTTQ$8V#L6S6,HNKX?):7!HMM[<H++&<U7)E#,IIHAAV1[DNENMK=I-2
M0U@>3;WFW98419FRF5 B<1VCV+4;SIQF:4QS38/1S8JL^V4%5:<R4=X 7GT<
MRQ<Y6=469_U=P@80[O1>LR[6R9;DC4R[W2ZRWU+IX$O(\.IA&Z*E[89YY673
MJ"2($AM^0SYE<1/.$Y/I9 E.^'T*9C>%0KZ.219"S>CZ.=3AGA3:ND:+@+SR
MN5^Z9VJE7^)+MA(]7:KSPZ2S*KUVJ&4'#>,!WP]:9PS<*9J&LE^\ \W9GO23
MRF,(/2]0F&NEN+C#Q ;XXE2_1K&8]M."M;E,HF-<1&#<N6*QO_*=L32^5>N
MRSN'##I.Q:F.5G#K_6-:F $ASA?<3F$R62JU2ZP]\X;SS>+R< 4FTQ'9.DSI
M<]K-YUX'IM]2N#"TBDD. A ]\.=9MOE;,L#J "):86G'G23))(RR:IU(1%Q
M!'5&*W=3#GV7?2N(&AL#,)L M=S[5SCGZQ:AQ!+W/RGT<]FV*U.K.+E7-3UE
MDS> ?&)/?ZE;%]KE39X%2XD6[T8>E3B_9>6,:1X@L8,+_:%<)?VZ5[5-*\%K
MCN"(;'E""J7+KRJ9N3B#F>U#G36>UKF0)RQVH6^/"+$MA=".)QY]JF&<+5I-
M.P.:0;X=AV[4M:G6.PJ66QK&VW 8^W8K.U7+?-6).Z0XB'M5QE9<K'I'$KJ1
M[-V8X0(-YOCSK/KAF;KN_AKS&FR-P?6)@]YMQ,+P,X)]VNUV]D>&O,TN8T.J
M9AL:+7$X\ZO7ZN-Z[R[#?YD$2 14.NP,,LBK;A/+IOC#S3GR9<[=J9ECC](]
M5Z3:62W+U=XF\VJE\Z:#53+_ +XY\ZG&CA2'<?3:]Q:9[W;T!>>>%^:3KA)R
M\3)[ZUH()=$0MMY%9EWEM%S- G3W;PEQZ^15G.&?5EE<-5<N#A+/([.9:UC#
M-U<K7I&FULB8R##"RV&VU228+78<N94RI8WB1 0Z1'F2"#K]5F-W@7&S:1?$
MYJ]C-5P:H7N(+L3C'MYEG^,RO#R7-G7F^ST9="N?,=).MA*TQLQT0T&V/H5F
M_P!4[7'Z+=0</P8';HL -P3$RQ9F-J=3-I_=, ?N+T=)'S_DZ[1T^2Q\MUQN
M';SK=LCG,S2AZQ2F$PM&R_8I+,M65UM54\T3;!FNNDDL3NC-GAS;#\4/2%,I
M+;=NV=-=/$L"W#U>H)<39>NTA/F3@V\W>H[4]LQ6A+DOFN,1CCS>Q2=DS<Z;
MWYO+08-VJ96SRA:V2]K7 #EBNFJ=)AUUK$F=%\!"(/8L6[++E0:FAJ)COA-^
M7,L>L9WPL6@Z'/F/$6D^\T=J9PNYI[2<#<-%P8'L'PMP&S8I;,G;K8]I="X<
MDRZ=CMQL0P8;(J7.&_CWVPCN()0II;VLLW2>[TKS]LOK?%=?_7W>NO%LV9^.
M()LY=JQSRZ<Z\.DYE3,;5&)N<#Z5<X2R1V-PSJ9EN;%Y$' Y70ZTFSV=IOXA
MW)$!,< &PO(PBJDW776M\0;[2WQ7$$D?%%"\J0*]LV8??)!(/7FI:OK]%RTJ
M>P,&T'#G6>3U9=1A-;$8^JQ:R8:E)3N!:<C&_G*9)RLTN<9<LBZS9DJMDJJZ
MK5S"8 GZ7J1+<:4BJ-6]Q+ 3:3V)IG:+F2*XM)W779>R"&XC#+K ^#@877;2
ML=N*MXSY672Z?Q'M!$8FT+QY^KR=O;V=R</Z"RH$OW ?>& YU/;%)MW1H7!C
M9I9^(:?>;AM]J[3<:\.]N%_+EDYS8TTL_#]$8CF73K%W8[\TGRLEN8T_566@
M?1&7,NT^AQ&KKOEDQDD_S66"#]Z,CL77K,));MZU\9\ "2^:[ZNT6G <V2ME
MRUVZYX=(ZGPVR0V>#*;[HA<, =BLWRF'KAQMI+-Z?!HL838!M6L8_1J]</6G
M7: RWN@V%_+T+EVDRJDOE%I@<"-NV]8O#/;Z)"A9[XC'#O7E[=MN>+*[6T&0
M#N0$;&YYVXK%J[NW95/2DRP8#K7*W#-C3J)!9&-T%U^'M,X7I*B9P8(B-O/S
M+UR/9TX0\^4UV-P(Y6JR%VB)M.SWK(V^OG2R2Y2ZK3=(9$X<N=7$LR23R\ME
M- A?;M[U,KZ_1X,D.N%W.ID]29(C+?&-VWVJ]K)-&HZ]U6E?XA@,>]8ES<I.
M66AEOEM!(Q&V]::SM9Z:?,;"W'U H8DN4K*J9CH6XA,LV92U.Z8Z^.=V4>Y&
MI,)(M(P1<M6<^#71ACL5LRSV4O6ZJ7*:YQ,(-)[5GC377_U=0:K72Y[RUKHV
MPZXJZFW7&FK0@[T6\K^Y.:F<+5+GSV- $80'*Q:QY,V\*YJU35&8;77V7Y\Z
MI]DCHDZ>9K-Z.&W%9[5),;=_<-/#V2O$-]IZ1W!27+I,KW/D4_@.= 6-CUC-
M:3&'6&M5DJ5-+&D>BZY:LTDWMUUJ$P3@2.4?NKGC.UL\JE-I9CWV"-I[>X*X
MC.VY3Z1,FN'NV7X[5>NEU*M5)H+B&Q8!8,-HQ*B^L3DK1@P6L$.89<RSQ3.&
MTVBE,O $(>CJ73.-IE.Z>V6" (7C'8I<7;%J[T5&)A%D0<STK-ZN?M5SH-%$
MT@^&TV VC)63$9W;]EPHN'&>X3+;=D-BC>,32S2-(ERF@[C1"& Y\D3K_P#:
MPUC62&.@(>[W*IRZYUG4/"<_=/T2>JWUJ9:LE=;SJ\SYL"ZPV+/:YT36G%]$
MU[#-(M-O?8M=;K!;Y1,TMEXXE2Z3-K2=7[@L?%2=KG#7K+M4=<U,[DP;VSL7
M3QEG^,TZ+XDU$E[S$_">U1,9VZ\96ETT#>-^62EX7/A?-&FQ M'*"=:QVFEA
MF5,YI&Z39#T05L=?CW-I&DJZB%N]UG(K,M=]>$RR9/<TDDW$8;5H1<^3.=&(
MC&()3&9GRE19H7DQ,8\NY27>%PG-.H3O"(^D!UQS5Q.6,V?H[/TC3V;OP@^T
M)>NUQ_RNDJAE"6(AL(9#N4LPMSRUGR) (  ]"EM:ZXO+))$J5;=S*2VT[29;
MPU>53M/O0A9Z%U8E5[5>(I+FN'B8&RP+GVBS#J76M0;4.,'1O%MU\?6KX7LI
MPF%KXV0B/3 XI*YK5I6K"4]N\^'P^I;O9UZS.W;>D:Q+?)8=\GW #_@A9F&;
M;*\ZAJ4IX(WOI8PN5XC.[NJ573F/WR#>.RQ8[<M]>-JE5L:YQNPV[<]BUX6\
MM%M*PF$ LV,X;LBA:"# 6]X[DAA.4U'+C=@.5RWVXTSC"3,P4HW@80'LZ%B=
M6\YB#U#5B\%H<;X7X7;5KU8SX5"HFOFS";3&[TA23RU(DZ*EF/A[IM('6?:K
M)A+V6B3I\66MP'I4L+$3J6F ".Y]]GL"F27#KG5*4RRZR !<.K[J967*MLG&
M5.!C"'<DC-S;A=-,U<L:WWG6#E8"%J39G"VR-8WFP#HG[F5JTGW;GYR/WRSZ
M>6O:LTJO)<+3RL4QCAJ8O*?I*AKK-L+N62O)=5EJYDL,M-JEES]F.W+KC7*R
M3+:Z+OI.](/<M219,QT!Q9/%0Z:&&-I@I?N7JI>G43S/:;?B"9RLF([EX>TZ
MQGN_3]04X3AW)I=*UC![N7HVIC*XRE*IC1*-ES1GD=JLZL\50=1:TO,3](X]
M*S<K<H(R&DV6]?>M1J?1+T%,-YGMY8H72V,D0E@#/;ESK.\L9N6E.&Y&W''H
M[U>W#HBITTB)B+_45.N9MC.*T753S$1-_84NTMMKPV8Y]^)AM]20;DJF\0B(
MZ[+H]RU;C1;FI%NEM>W>W>4%G.&^L1->PTUC;(6]JU)K+-GT09JWV@G'EB%4
MM9)-5,,QMMBO@E7+2ZEY,(F\=I7.S:RXJ_T$]VZ.C+/F6Y,:+<U(3)[BT^Q6
MX\$FU4U*<[=F=&6?,LVV<-6959DT^)!V9]B=KEG&.$W(=)<T G"V/2?4L28V
M2X99E/+() '(+6[HY5_4*<M:2T8DWX)ZKQI3*CQ&.,+!'#G]J>J><.$F9-)A
M$]7+-,^IJ;B9D2ILR%A,=G,K*EVDCIDUK=\--@CCV*6Y6W,0&H:S4:>"QKG"
M %V8[%(3E49O%E:]_P 3[P,5NW!PF]*UNKG/$2XVBR)69,[75=QZ&R;4!N^V
M\8\RN,,S&=KJ=.:)0<6B,"GANW.HH?$,J7+9,]Z&[ ]:32>KI'6Z[PB\!YQQ
MAB/4JKJO5V3*\EH),2;XXK4<?DF'G0>%YCIK7&6#!P-HYMFQ6SR\WG#V X<T
M;P=T&6 ( W<H*^'?I-.P1I/B%I#&FP8#+V*RZ=.TPDJ>G-( 0(0MZEGAZOAN
M8QU6O?5V/:7N%A%G,(8W*/1+,[4+4-6;5/(#HQBL6O5\?6+5P3(#ZZG<+?Q[
M/PABI,WEOL_:;Y/6;FI4N?CTW:%GMR[]=3+ZX/EP_P!E)'^9R/P N'=W^+^3
MV&J;V_M5X>_+['Q_P:B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1
M)PP(H@(" @(" @(" @(" @(" @(" @(" @(" @W-/_IU)_#,_""3DO#TZ^T9
M_NTK?[/F?XRZ3^+GXKX"_G@_USJG^;5'_P!,723+YO;_ .1^ _%)_P"W7_MY
MOX05X:MUA3=2'Q=*Q;M9-(F3\7+(JHE@ZP6>E:E7&=M9]XYE/9&_(= "S,WY
MA2KA)M='99FM2>6>7.(S'6JN* @$&(YDYF$];G+,TQ'2IQI7)5&0&"S9ETLR
MS7I*FJP/;"V.*Z=>7/O]&,6&*[9SIR]64&(49KS%%EPRLM!YTDVEN6PTPBMN
MDF6Q>.I<;R8]-N0$+5+5SF,$QWO$0Y"SU+4XPE8]X[$PSAD88PY^Y,:.-,ZR
MRV&&,>A=)<:;DPWI=_1W+5OE6V#8.8*99RVI=K>A9NZS;[:)E@Z(=JN<:)]$
M)5SMUIV<L]BFW28BK5E1'>B2/>&/M3#-OT5>JGVV$F_'GVI;EK&8T&S"3 V]
M:A+A+R&;P!R]8]JU/N58=.9!P,,1AG Y*W$VSZW*^TSH,',/6L^V5L;37[,4
M9SZW#9;-W1#EZD/6,N_L]*IB?4+]GI2)9KEK/?O$B&/8B34PPF]9XK-Y<'-W
MHF."W-Q.-H^>TP]G,HUSM%.)!YDRSWN]-ZGGD%H)-A&.SG2;9PL5+4^ZVW/'
M9^V43SA8J>?%M_ISMS6=Y6633?$S>:.88\RN;&I<N<N_I/8M3=RQW9S:M=G.
M9> S;Z%CMMTZ5FER[;\,MH727$:J4DM@(QY6KG\ERPVH*2Z:]7@L!O/1!;G"
M\->IDA[( 1YQW!2W"QUGKU'^,=[L;<MHVKCVN9ATZNN-2HK'G<NV9V++5F%%
MKZ;WG0$+#AM_:J6I%;GRBTV"SF.S8DVWC7W14V(CA;%.S#$R8X.A&^S'O4C?
M$3%-4&-YN:/3#-4YCM#AFKW2SWH>Z,>;G59XE=P4-8/#9[X-@Q_:Y)X3:98\
M36';ES=*Q9C:R^%<U2E#Q,(;&#3AS\RV68=3ZW1G>=[F#\.?:A.<^'7=5(,M
MQ," #EMCASI$[3;G2O+;CRB5+PU+]5TTBL+9K#OPA 7Y6>I:Z7-PS\G\7=^@
MZSNMEC?P'I!V+V?'N/E?+_)VIH^HM?N^_:3S"X+=<^78U!/#V"T$W6'FS4Y;
ME]9_E,.DAS>B-OW$P>^4?44X@8##+G&2C6)AHAFXZ&1MY6*LV-IDT 6V&.8V
M(H^>!"W/&.6T(F)X<Y4\$F.7+%,%[8F(W&SM[MO]I5RSZSECF/OLRQYMBE;Z
MH^=,^*S+':-BBUJF9;=Z?8M.=Y<F.WCTA2W!UM\MIQ@/0C368^#KK]J&$K)M
MZO7[$:Y;8N',%7.ZK#--AYO6HLN(T9EO4G!-UH3#:.9"UR8[>C9!6G5BF$DP
M&!.:==<KZ^1K7$#VI>6;UL9&L((]O<HO,PS,!B+#BBXQ,,P:8CG"N6?6\MIK
M#S6J5KKIR#2Z[!&NS*QI%^2LKEVF6W+O'-ZEF\L<)6G^CRR5CGV3E.ZP<WJ"
MF6?9*,/NCEB5K+IER5MPK5FG>AAR]J28&HV_H3&6>W#*)>]>+.93CRS>NM-6
M8SWB(^C:KX)QAA\.V_T*,V9N&[); CEFDVZ>F(E&/#-EO-DH299?K7[+T^U0
MR\_6OV7I]J&?_K_ZC-*FEUO-VK<K';:2880/H2W3AC%9PX0CSV169?"M2H,1
M'E@M$0DU_O&STK/9?77^&J';/2F,-=>NTK28?\).RIF-D%)&<;RPN= PAZ5N
M,]IEXC%IYBI>6<XTQ$P!5O#<OBHV>XD':#V%<_\ J+$<XQ/,2MK)@9?T>L+%
MN6FY+.Z6XW>D@HQ>5KTZ9 FR$=T7[.A+Q"3*<=467X#'VK77K/*<5#5<V+79
M68QPYUKC@O7VVJ5:W>+K<2/0LVYN&NK0E20Y[<;<N?84]%MBU4,BQA A @W9
M$;%)<5FRK=1@L B,H<NA;Y9X2IGP;;][ZN=3PUB_X:;J@;T(V68\W[)9L_Y:
M\/#GAUW+M26SE/;34F$FS9M6I)-KJ;:A83BG;?#-N7)M.7860C=[%F\+CS.6
MW*I?AL]'/L2&$O3TT /=]&P;%LQY6.C=+E,M.[=ED#@LW3MTF7FIU"2P0#[H
M8Y_<6O&6YSE U.J2HN_&?2..PK$FUMS$+-U)A(@\X\KEJ,X:[M38T1\0W\LD
M]L5</#-<8UP'B7&&&:J\S"2E:VQT!XN&S9S*9Q&),=L5YGZHQ[3^,P4]JZ63
M,PK5;J-KMV9>183UJR^T2RJ;J.HS(N =&.77ZDD7MB169M1-FN)B<,\.8%;]
M8PV:>CFS=UVZ3$W?=6,;3&%XTO27.#8RQ9!.VN'27$=F:5I360!8?HVX9X%<
M\VQGU_ZEWD4<IC0-T79;-J<':?MSY:U5)8!<,,.?G6L9?/[_ ,E;JY0&] XG
M#9T+3-N4'-]TYVG9GW(O,89;R'6)AF]K:EY!CT6=BL:E;,3FM*\%!ISP76 +
M+$GEJRY3FGGV'9L6;/*\I.5*<;87PS[DE),I.3*=E@,\CL2W%:O&&\V2ZPVW
M;>Y73/MG3DZ4Z'W<^9:DEB\5B,MPP]![EFQ<X<'RG$1R!P/<IA/9'3&S 86V
M<_+!6&?HY2I;R>C;W*Y+PFZ>4^RS$8',[$DRRME%3G=!A;$8>Q2ZK>-+#3R3
M 1L &W(#),IZQF<-RR."%MDQ&E,J-T@$[+_;'%$EL<I4\/C;'IYMJ+RXS!$]
M)1)&Q):UL#=CA@3WKG=F;*G)<]C67BT9[ M33=F8A-4F-<# B\F_G"TQAUMJ
M4ISR0 3;&[H]:SC998BI5!,WP[<NAEW+1+C2TZ=1O.X"TW##:L]G7XNN5B?I
MH:P.+(&^[,*YP]?63F(&K$N23$@6D]%JTW9I"OU>3),?%A"-D<H]R))GEHS^
M+J>1_P X M.(PYHHUZJ3K'F')DM,*P"!SCU6;5;PRZ/XG\T0"_=K8>_@>C+8
MN<A^CHCB7S0F/;-A6'9;?;S)G"R9>N7%/F!4SIKX5)=$.,(QR*)YPHS>(:NK
MM,QSMZSK PZ%,M>L;4F1551WMPNB0-N7J6L:,>%KTSA:?4/$:<F,/2=JLC%F
M+EW%P[P(]SI>]2@Q:#AC Y[5>&L9>PW#' 36^#O4T( Y[<8K&<T\.]-&X/E2
MQ*C3BR\GJQYEJW6DG+N#AOA^GD%A,H"W"%F$;.=3VQIGM<+MJU/3R*,P CN'
M']B=J2[8]JZ$X@K94MQ$1B>P8<ZWC&SWRZ^=J3'3"T.L)S/W%GE/:_5;='GM
M>1C8,0>Y"=[79-  6MAE'T^Q&IWPW9X]PVX'U)-']BK53G!QLRSQ4QE>W:O%
M/,=$&)O&.TIC#'M>%HI)SX"W',YC:IATG;3?G5+F2HQ(LAU69K4TQ[U0-8KC
M"9%^+H6\_.K=I[V.J=3J#-=,&]&+L]L%G"SO>5<%.Z8\61B<L_4M8S^B^V4[
M1Z.26$L%I':.]2[7^S2^Z+IO@D'<A=;RCDLW49O;*]28RX '*/H6NNV9<7*:
MDU#FM!M/+GVI>K':YNF&H?OCH[%N<%[*AJ4IT'\XP.W8LV9Y94'4J<ASH##+
M:=BGM2W" =)<,,\^Y:ERYYS4CITE_BM/[(8'9L4M9M\.QZ9A^KMLP.!QN4^S
M.<:1U1)?Z2;CB>93*6X1CI+C$P-VWN2?1BW+E+E.+A8;\CF-A5G[8YV6))K2
M!"]3%RU;ER C8ETEN&-]D<;E9?+&<7+@V:YFP#V;57K^'Q7E]22#;AG[5FS;
MTY:OC.S[>],Q?:.<N<8VG+$]Z9\);GA*29L1=?#LCF4N"3+?#]GI4FT8IEH)
MVCN6O480GKM9VTQ3G@-(S&>VU2_8RA9QL.V!]*V6Y1CC P6;,U),QF$R&"S-
M++AS,X0Y#UJRVU<2-*=.)WL1SQVYK58S[5$3W[V]9RB1ZTBV81[V.=& R]26
MIG%>&RGVV>@^U)PMN61K'"-AZCW+FMN7*T8+<B2LC70MV)AUG;3)O[/3[%BS
M;1O[/3[%9,7*L+[8G8M9=.DSO[L486J.U>'3!9"WI2IUE\L!=##TK6727('Q
MV=*EX5YWP.0[UBR\NDLPPOF .)PLMCL6NO!?K&(U !A'+'_YY6ZAFXS6&;4
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MG.V<6.QM'D>*&C=WHN N5\IY=Q:5H^]3!WAF);&$5FW-PG91^(],GRYON2C
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MG7;K"IU#\<YOB0%]_+)?0\.OMC37?7C=/OG#':%6HCIM;%Q@8]/+-:YZI>&
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M*>N=K+IX,R-\8P3&$NW!QC!&9,#1&/0K+AJ7#3GNW>7,LM6RM5SP01;:KO\
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MW=_A_D]AZF]O[5>'OR^Q\?\ !J* @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MK+^93&TQ<IVGTF7( >X0%E_,%=,]JU-6-&9+F^[$#*VP)+.'&Y=4ZE2R"^(
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M.^%8J=)W22 ?NPV*5N8L0\W3W!T(71P"3/EFS?V9:?39A>VPWB%@5RF,NQM
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MNQNL]A5ZYRG?M$I24+GVBP<Q[UW\//V^JL:^QU.7&ZV.6*D=.G7RS\,ZJ99
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$&YI_\ 3J3^&9^$$G)>'IW]HP"?+2MA_P!WS/\
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M88[?:L=M:/3*"J*BTVV1/:-J>&^O7%1\RH -APV=ZL3M&#Q XWQ/0M,^MK,
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$!
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M:^!#H6/&(*W/NU)'K/Q/YH.#YP$Q\ \P_&86E2Y\)ZR;>O\ Q3YFS7B<!,?
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M0/I.AT="Q9EO$0<FEFL?;'#,*X,K30R7N;!T?AVX1V+-Z3.DS9RG&4K&-#G
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M" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @("
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M&^LSRUWS <1>IMJV3AB=:#"WF4G+'+%X<;2#RZ%K+<X>-P9%2[B_=%50+6P
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MS4C4\8PEEGBOM$(;T<]JU,\U<NL^(]:94RYI<28Q-XQ@%K+-F'1.K54F;.F
M 78PPYHJR?4D^J"-/*F7 <H;5,M:;$C3&N,0!Z8QB2LWAG64@*#<!L&)LYEF
M9C6,(^IEE@Y86[<5J]K;A-5 36O>2('JV!+<4L\QA^I3'"P7Y]6 *L2VU&5.
MEQF-+FMOQ&1YEJ8JS$7OARGER_#BT"#LH706;-M2X=U::Y@E@0%PAZ=EJLPQ
MWN6'5)37L, +B<,@5;;A.LMY=4:S1MWG&&+LN]9S]6[J:4.=+;+F$0%CC?#
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$!
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MRE4I8;1MQCAAT)G"X^J<I7B6=G<$NTYTGI=86@0<;+/3SJ2+C%9_K\S[_P!
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MRYT9QCE8&SY>["R[U)AF]<UP=.EP-UV:UEF]<,'UIK,L[3ES)[:<\YN'%VH
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MZ^.*N<I+@;6@XCK*6+U[9TW)%8# 6$QSRA<I)MK&\KAIWO0===8EO@RN%.X
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M! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$! 0$! 0$! 0$!
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MGU=,:2M,Z$,;\>=6;8L\K1I[[C;<K<&8M5//&[;'K.S8LHVG.!&-ZLN!@>Z
M(QL[U+9E9URUC>5&\8T\M$2"GW9[721E/W1C'[JU.V7B^7EF$T[>M+BL2X;
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MBL;I!-PMCE[5.&LYU6]2TA,##+ _L5TZS0GJ>CA G(8;1FNWKB?=,K!3R0(
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MT'^OO5ZDN&,6E:O"7[,PEQ@8!822O/@1PZ@?44E>CIUT?5]AZCWJK9AI3I1
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MV+'5EISZ)UMF6'-M6^5]<[BNU5*8PAZ#GSJRX,XTQ21X=G. K[1F\K7IT\M
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M+-N'67_A]5WRWC_X3D7?T63^ 5CY+GJ[_%?WQ[ 5 @6_M5\[OR^MUN8UUE1
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV*2RKZ[S6I,XF8TCWF_X8V*W//A455\5- ,'MN/TAG!28J\*5JG%@ >=YO\
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M"K*%A!@,3Z%F\K,R*M/H!$V8G YA6W$3&ONQ,H6@VC+E;!)?9/.TQ34;6CF
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M8;M-3AY$1@#WJS7ZI]TQ+H6@1AV*VK)<[9'20S&R&)AV+&;;ITN/".J&Q!,
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MT'LO2\:-Q83PZPR-_P!WX8W8P.,0F;Y)=NK.(*4TTXAH-YNYXQ6;EJYYB(I
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M" @(" @(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @("
M@(" @(" @(" @(" @(" @(" @("#<T_^G4G\,S\().2\/3[[1;^[6N_LZ9_C
M+I.'.\5\!?SR_P"N-4_S:I_^F+MB8?.N+WN?J^>KC.81KKK?WR9VG)%UG$4>
MNF[V\(VQV^M1J:C#2#9RM2KUOU2Q<0+#V)%[8:[G1(MB;E)/JD[WBMF6PD=
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MMOY13$9G6XPN]!^. C:>]7!Z3.TUX#6MZ(\NE1;\<\(^IJ?J["1M3+73I/\
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M$P]2N3%SGPU)LL'# 8[5<MRS+7\&VX]83:=I+PWI4D9&-F(P6>;]F=RI*6P
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MKG]4G*#G0C&W;RP3[>&NTD_5F--O1.PWK/%8G6VM6=2V1LC#!:RUZ(Y[)C3
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M" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @("
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MK-CY_>7BL$YV];G'EZ4]LL28J-<V)-ZKK+<:;<J2#;LY8[%6+;;I(-D1;9?
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MRX\]RUF./:;RZNJ?RCOVSO4ND8>%D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$!!FD?E&H*9YV?W?3_X&;_)%$[_ ,7QR_/-)#M0U@__
M 'PJ#_QYFU6:N7S/EO[\/G2\[I'\]U&P_E3Z\RM7]S'>:>EVHTL:EYMO/;SK
M%F+IPSBM*HD!LLV8'T#G@M?'SE%,U5HMAMVKOUOU2QU[J3(FTPM/58K>#K)P
MK7AP?88VG#VK'EK&UCTZ07O%AL ]6U63&S7^78VE4Q ;9Z!WK69=);(N%'3'
M[VZ& RYT9F$@^2=T^YEV\Z1JQ7ZZ0X@^[@< K<>$ZW>%$U2F=N_#]]@,^=1;
MRZ[U"G+7'G/;SK%Y)<?H@7,B3RP5P8E<VVQZ%8>N.&\S'H]:J,BDQD<V@6VV
MQ5EN7K^*^',DP/,ND[/1OAJ3)I$;L/4KQLWC#7=.)OAT\@G*9\,)F\W0EZX<
M;VPYBH.8ZQW)N++EG94[<.[8I:QVN&[35,7MMQ O.9V03K]4G&5_TAX< 8QN
M]:W]W/MG+LS2S8W]JU359O"]TA]UL,AV05M<;GPEZ<G>Z>Y2[,U::%\ (PL/
M>I)ABQ*/F^Z>_P!BUEG.57U";:39"![$FZMO[<3E4:JN,N-N-PY *6//9O:M
MU&HO<XVG&_GV*R8<NVMPI:^8)@MCU[-B7KE):O6G:@0T6QL&>Q3[%]O"6FZ@
M7,< 3&%EO=%,1O<5JMJWN<ZW"%Y[N95+M6YDUY<;>WG6.V:C=H2\O;&-I':M
M=<%WIV#ITMI:T[!Z+5,[),).=) ;:.Q:X7E7:EK0XFZT]D5&N'&15^&;,+>5
M@0Q&:9J,6PMOV=Z)9,9:?UG>-]YY8*IG/Z+!0M+VPPMARL4Y:SB::5;I7BS8
MV7DV\\0NW7A,Z26G:,(B,.70K=TN+5KDZ6T,%UPS[DN4ML8JFB;+:;+K<"K.
M"7ZJM4L:##EDC6,\HYD \',CM"EW&;UQPF*5H<1^UCUJSAGBK'*D!S1".'8-
MJJ\W:+U*4YC77@=&5F:)<8^ZCU,YS'F+B+?:IC+.,N='4DN;%QPS[MJG;6F^
MJVT,XD"V-PZ>D+77;=6*6\NOR/:EY2,JBN+A$$(C6;2ESP;3;L[U#&-IN2SP
MVMS$.Q:QA/:\-YTXM:+L!RO1,UJ"H)<#MSAZD3%FUATZ?[PB8]?<F%O;*SMK
M   2+LLT91%;J(,=@/WO-FBHEL\SR<H]MOH@I+GDXN4)JL@@$QV89<^Q4M5^
MF;NS1$X\UH/I4L;G9V#H]46-%U_=LVJX9]MI^JK0YI$1:-FWG3!;E1:YY=,)
MCCRP4M:Z]9>6_I3 9K8\K8I*N,:=NZ33M?)8(80N'.KG+-S.&[-HV %Q%T3A
MWYH2U ULIK=^ N46S*HZ@UH!A?;CM5Q]4_C<Q5)S03TCL1+;6%C&[P[]BG!)
M]5BHF@%O,.7I6IBI=+=2[H8 #@,0LUKJXU%*V=?;&_E%4[7+%)TJ7&X=9R*)
MA*LTYK+8"$.5I2G7[MN72AH%F&01<9[8<C+8T0QY]N2+N7'AQ$ALPPYAG?',
MJ);9&=FE,F&[FOSV""++EN-X;9.L+6GHS@KX<^\^C%/X38QI(8T0C<-G0I/J
M\UE]OLKM5I?U:X7$D0S![%:34^[5EU$R48# ^O)1;N)!E?,(;;D+CS9*Y23_
M );39[GCWLX7H3'_ *,LN6QQMV(<M]E-*#2[$6^@'G1,XTP_G%E),W0X^Z;,
MK$,>:NNCZ[+<!$@W8H+I+U.3,9'NC@K.6NO&6M-?(FDDD#' ')2Z2\M5PIF&
MPM-F<<PI#-K'-K::2V$0#SC([=BJ8JNUVO4TMKXNA9&PYQ.Q,RDS'5O$7%,M
MF\)<QX]V%A&5]A3A+MUR[C"8R9$37Y0B>;-2YK&?"-KN+*J?$->\BW$XI)]5
MUC*HSFU6HS227&+HVQS6N#K;G[.P^%N"W5,QCG@'>$3$;1"^Q37#>-/9;AG@
M:3+D2RZ7+) M]T9;0K+A,8;NN<.RI$F8&2V" -PM]$48N'KGQ#IDQE2[=L .
MWN0LTT:2BF,EB).!LC'U(33?,V;(S]L1SH3=<#K4V48![P!D>O%3+?'ZMN1Q
M--#@#-?<?I';M52VK;I?%$PNE_C'_P"$3&Q)NK8[:T+6?&$O><XQ[^M9O5G.
M-1VEIM5XC;[(PMM[PDDPMW/NW*]H<PVX+-A,\53:JC:8VF^WILSS2=K+]DQ$
M%.IMTD@F\Y&X@9IRN<7'APEO,EP,3V8[%OKLN?"PTFIN8&B)PRS&:8\D[+%3
MZCX@O.6RSF*EMX25F<?%V\H>I)ITLE:<W3]^+H#.XC/(%+QERL_=I$U5% $;
MMH.61/*Y2<KQ4#,TUQ<XV8Y\^2W6LSP\2Z1TD@W\ML%C;.+Y2 U%\@ 0N]4#
ML6L97#5G\1NEQ!L^[S'!2ZX68B+F<3N(O,2<SD=BMF1YE:^^9 6VV>F"F"LD
MUIK&QA&(CV[%FUQ[3+K_ %O3S*),!>;MO4MS#C9CA3#-=*FPRLY7J69K<F8M
MVEU[FF6-D,<N9.K%U=+M2U[W,$ #??T;,@K9EK+;+R\JPB6H:8/=$QOY8J5K
M$M;U;*;(E%X. -O-%2ZA9Z[42HG&?,+3='#[BG4U4C0Z6Q[FF(Z;_1%+4XX=
MB:/(93>%^QAZ?NJ]<TFX[%I-38V7ND=F7.GK$SZW")U(RZK?R,1A'!7!;:Z]
MU'2&.)(@+\]HYL5*N9(JAIG4TPN!-EFSI6O":O*X:;Q ZGE^''"'>IX+<5N3
M:SZY[RN(LGLYR@QCM[$0A;]W)9DL7U66@UKP-QH-@/JZ5>4XVNM#K7UH!O1Z
M/:GKCE)N9O*QR:-LYF]S'!.*W&XQHI/>%D .WV+-F:S=7*!U6O\ ':6Q/Q0M
MR@M)[5$T$WPG$QY6="(DZG5&^&1D#EWIC&UL^BFU]>'..$#GMV%"<L$G5Q*:
M1$W8WW]R+;FX5[6-4\80#C\/+L4_5<8CJ?4Y+ILPNB?BB>E3$8WDTUID3 >W
MG6LY77EVKI&MND2@,FJ=IC@XFEBH>)BV:TAQ'O#$C+8KFWE)F.U]"XT+&L!F
MO%H'Q;1M3.&Y/*^3>-R^F(\:8/<^^]J<IV^KI3C7B9T^4Z$^9\+H>];:#'$I
M;&<X>IW$.I39LQX$V9:\WN.).U6-17Z1\QSOB)MSV9K-D2Y\M75J9TP@F-OJ
M&:F<TSX2O#4OZO-ENN,1CM@M(]B.&]5;3L8"XV.SVC/8LY63-=BRM?86_'AG
MSJ\K8TZC4F3B8$G*[-,?1KK<;J%GN#R2.5JF&>V]M2(%Y6IIG%\L@JF-%_8>
MY4:-;6?BW0(-A]>Q1<.M-8GEYF&(N/I'0B9SI0*AQWXBV_#:A;K%8FEQ(&>Q
M&I)A(R&'T#+O4QE)]DW3R2ZS/FV[5<+;>4_24[@6FV)!-P[T9YTME"[PV .P
M-GIRBBXEY9JFI: 80OV[-F:NBR>%<J9[#?D['V),I,H4S6;W3G[%&L3_ "W*
M=["Z_+MYEK6%YFU@E%A;?GFL)?MPU*B4QS3&%\?7ZD[7Z,JAJ0;*+H 0AS+&
M<5N3"E56H'>+0<N6>"KM.W_#0^L.>8;QM/+!6:,IJ@-HMB;/3%:,U=:2T".0
M[8*>V!N3)0<( <K,H*S-Y2UJ'3/$)(A?&U7"YI^CP?=AZTP2UP=PV& F LV*
M4WQ4+J-(*:6ZS##FZUG/@W'37$%6X/(,!?GZ@MYS$Z\J&)IF3HQQ@>O:(J+Y
M7/399<&$9#L&T*6^"K?1TQ=NB)NLNY\]BN)X3:]Z)I6^YL3>0,<1'):^QBNP
M)7#C)DL1ARYUGM<KG#:D\-L8;AU<_>LR-91VI:.V2"1#V!=,3_T3&=JJX&2]
MUL+1#HZ5F);A<=%U7P@T1,0!Z1;BM3%C4TL,[6=^4YI<;>;)+&;V^CJOB1YJ
M2\M)][NAV+.<+FV.L?S2\SVNQ#H\K%,UFS;L[0Y(DR6M-\0#RZ$G;%:VN J(
M-OPCCES*R)EH558=V$<\\DLWEJ54:V:7%T#CV]"MVDN4493G&-OHY\PL]:P\
M3I#FMB(V1.&S;M3V7A6-0:]ILCT';#/8DN;@^ZS<-R'3(1C?Z@,U<82U?YM
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M! 0$! 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$! 0$!
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M<^%JQ8U*E]*T_?@[=M/M4NM'9>:/3@ +!88^@K+*XT-.& "$! 9WFS8M2B:
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M"/(%JSVF8Z=;;KPUYC 7&^_UKAQ6K'=WE<(:C+ _8?A-6:WT?2O\@7])T?\
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M7/4)C9E.6MM)'J[UFW+I_**,:>8UY<1C'EFDD8XTG*.I;*+04LR3A/R=2@!
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MZ#W*S:S->N-3JLPU/O./Q'FO7HFHU)XJQZ96L>1$X>Q<NURZ3KA,39<F<X
M7"/7[%&DYIFF->00T6BR_G25UZ3>%^I-*+)8(;A9?>LRVNT\-ZEI'B>RP_$.
MWF4QAVFX]@^ Z8,=3DW^*W/ @>I:SE,;?J=\K3@W7) _Z1(%I_917.S-=</K
M"^7%P/"4B']5D?@+A\UQU=O@F.[OFI^,<W<OGOK3AK(H@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @(" @(" @(
M"#<T_P#IU)_#,_""3DO#T^^T6_NUKO[.F?XRZ3ASO%? 5\\W^M]4_P VJ?\
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M[11&TPE3X%L+879$YJ6^#.%ZTMK"9?,,LEG>,&;C"\26-:QL,0,NY1&Y(KO
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MY1M;/<T^[8+/4MXPG+<T">Z9.:'??#U*-9Q'<VG/8UEIR]2L^J>TX2<^?*W
M8CX1?#(K$Y:QE3-2F2YA,""03MR6[E+I5:H18Z&8[%BW;./*D:C)F$O+1R)5
MR6YTK'@3S-$ [XB,<RM3B)9A;M/DSQ+%CKR<<H>M9[$;TRJ,FPN@I(29VQMK
MP?I<NM7<:\X9F5HA\0OR5QY2\X9V5X;](8;%>8W--V7JH!)WQAB%SVEN$S1:
MN"6Q>.L;.9,LR9VM%+7,>+7 V9CG]:LVEM<:NI: =T_1/7&Q-RM9TBQ4.)A&
M,=BW+EF\L%0\N$3RN"QV676%,U)Q#G0.*LB^$"V+GCGQYU;<)Q5ETV7'=C##
M:I9]&URHY+8"/WO-FK99,LUOS&,8PDP%BS[927*B:_5RI<LP<V-IO&'4DF8L
ME>O/$]<'[X#F_$;H'""O\5M\.NI7OSR=N*LW,Q,R.P]#+F!A%D+ENW,2KDZL
M>UD(Y=H6&NN]-=KYDYPQBZ/;W*I?VUV!H5/,#1$&WU6)<8PSE;S-,IHBZ'.N
M?%;F+RU7ZD&@^^.N'*];FUC6.J#[\=85C':YK&_46N'Q ^G-9Q23+6?/#A&^
MWE@HDVT'N$2<%N)6G-F[I)$>02W"QC95F(&]C&ZQ8M6[J0;/! C;UY\RUREU
M6"9,  @3<?5>K.R8RB*B<+;\<\25+N+UZWE7JF:2[H&/L69IKEJMFD$7WC%;
M),;6"C>2.G/H4X+GE<:(P8(Y#EZ%BW-2;;#YH$P6D"S-:G#K+A8*&J8&CW@#
M#$[0/6G/+5[:TRU5:!+<-]MQR[T)N.O-4JB7N@<Q=F()-K.N+FJT9[MXD9I)
MMK/AG;/?NBU;T8C#/G/.-D(]J:PS9]$0]Y#X1-L.P!9\&,Q*4<DSB(@F.WF3
MK9#"RRM):6 [MO-L"LVM[8:E11ME1BV%MG,2A+$09,780B%<:2W:7I*%CX1;
M&V&&SN6)]2=L18)-"R6 =V%@2W/"ZQEQJ)XE-A$!6'6>4'45%KC&^)NV<VQ1
MC>?LT&U>\0 08[%9,7;HG:1@FBW;>LL6Y:^JT#/"<=T6M.7-FI95SK#HSB=K
M)(,!"_FL"U.MPDY=>TFH@3S[X@'9[5<XTV[VX0J9<TRP7-,6M&%T4RSEWI2^
M"VG9"'PJ\KS/NJ'$,Z6ULP1&.S!2LW+J+4*M@FV.$.OE<IE9&UID]KW-MO(/
MI&Q:MTMX=DZ9+8]D2+P#Z"LY3&DM-HY89& BX=6*,Y5*OW96\3]'U&VU!7'U
M#7O@#S#G,/4DN--3M8WI# \ V96C):SK#?;&&XX0;S0]2QZV;<^4%6M,"?V/
M<JETJL]CB_H&7>ERLOEEI9+R80P[U9/JNJM5'1O(;%IN)ZP#ZUI9)$RVA-AW
M77\ZS)A6ZVD#1 M,><*>6+?HXFA!)@V\QP1',:;&!W?0G"R2UL-H=T0W#9BL
M8:Q]&.=30%@ZX'$;5J3'+-U4%42BV)@+H88A:BS:.=-=+N-P[(]RUB+7.74O
MF$ ''E>I6'F<R="-L+>T%3&FL3##)G/8YN%OKCZTY9DVM^G5CP?B[<PLW35F
M\I.KFS9DNPD^Z>6.:3>F:ZNUJCJ9SGP8XB.16K,'7.=JLS3:ALT$L<,[#GS+
M4ZRS[M8M7G3*)S9?O-=8.;N6;U95_B&F:6S/VCL=G,K&Y71FJ:>'5)(;>[UE
M3SAJW7W6GA?2_P </<Q:M5F9SOA[5<+Z6!*9%OT I>/NO;'A?/S2'M'N60-V
MU3&9ESWEJ?F<1CX9OC<5.+IJ5(2-/$MMK(0Z(1("F6\84GC#PY5.XF ]PW[!
M#U+KT.7J]Q!/ENF$ B)B+#''F7;34U4+0RW/=[HC$]A6/7;<LJ_:31/,UI+'
M&SN"SC%6<N^.&*8RV2S B+6W\RSVSG;OU7Z;5>#3GWH0;#IM5SAUQEUKJVKO
M;4.A,%^?/DL<7;47?@;59[JNF&_$&>P8X$=Z8S&K9X?LI\HCG3-4IGF\SZ?M
M"Y]OHZSKK+ZV_EM8?T5DFS^B4_X"Y=_XX\NWQ_RCV-J+V\Q]2^?VEE?7Z?Q:
MB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @("
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M[#+8N5SG+<X:TW3F&R%XRVK1B29B%J-+E6V'##9S+4QY9S51U>@8R5,(A&W
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MF7V-_*3_ *ET;^!"QVX>GIXC])*)I^K,Y_6Y9RZ^E8IHMY9!3MULV[].$G)
M\.[#UA;Z[ZN?>WV:&JG^;$;#U00G%KJNI_*._;.]2W&7A9! 0$! 0$! 0$!
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M>,WT\KEC&5SX:M1IH?$P-IRYU<>4Q]&G*TB5XC?=-_+!3[$ESM;V:5)E4Q<
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M7$Q]^.)CC8I=1QS]7:?#>JM:YL2V]N(Q)2#O+2-?W P1'P"\X""-2S"_Z?Q
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MW^/^67L+4WM/[$KYW:[?6Z2>K5440$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6=I%5J96X3LL,.A9QA+VETAISX.(V]_,KG#G?CMW&KO[?0M9E:_KOT9Y4R!
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MM<ZA;%CDUDM[;3A9;M[EG,EURS:5$X%IW3@5J=\LSMFX\(">\Y\K5,NFB14
M6$\K5+<7+%^.]^&U^5L"W[1QOXO:7+R:![[0%FWZ.G]%X!1/E^]"[U)+]3^C
ML/JQ3-.\80OM@LYQ73^GM)I4M7XFDR6F+K8.Q&TYK4[']/;ETWKO%["2 \PM
M%CNY3/EUZ]-ND^(N)]X/@]WQ'Z6SG5]I9]VIUVZ8U;7O$<\;SHDF%IS]BQ[.
MJF5%9,G.(B;[]A@M>TBSMB[;>GTKYKVFTQ=ESJSOXKM[3#LO1]!=4%@#8@N
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MW?#M6;UVSB-)TUI,.A=)U3.-,\F6"X&%G/M"ZQF86"FW0!$"PG#-3#42)?+
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M?N[%BW-T>OEUQKC0YSX8DW77A:C.:H=113)KB +Q#KRA%.4O.F?3]&>R8QY
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MZGN[]N!'IBDY=<:TJ595>)O1,;(VV7IZUJ7&E=>-YYYU,;=>9E(TM,3;#/L
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M,<@8]:N3&W.Y7D_B\J-"#FU\,,(+-ZY+ME#XBZ]9QBY9G+DTVA6]G3.(RF;
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M:+,TEB3.4;.?$&S#/F2M6:RC'/(=U8JUQS;6[)FG>$+K,=H6:Z];K?*9DS3
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M;75=6GJ7]%/-ZD__ !,7RZMJ?RCOVSO4HYB @(" @(" @(" @(" @(" @("
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MO C@<\%.%8V39CB(G(F_U*VZRQN:K?!,!S!9S;=F:YF5O@6[>5^:$F:QNIQ
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M=4QEMOTJ5+^C#'E!;ERGJRT[*>3 V1 AV[8(2)>3J[*9L&O CM4RN</+N)C
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M9Y1PWP++;.6:@\^)^VY=*#FR:-M_<I9G;4;+9@&>"L7M,MMLQI"293C37G5
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M+I4''Q@<^L]ROJN,O/BY ]*F$G:Y;TB9"$8Y]O>KAKU\MX3K!?<KC!EIU4^
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M$U7"II)=O=^U0SO+4 E2OI 0OB5G.TNVQ^<)4N7#?;9G#):RU.JJZMK+6L<
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M[(^LT$F/XLWG/[U,-^RIU6@F/Y,X_A*S29:;>'R2/Q9O"ENTO:3PE:7AISR
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M9R[?#_)WQ5?&.;N7'L^K.&JLJ(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:F\L3EO-G6@1LY%.-NEFLMILRP6X9)FW]&9C.65LZT"-D1VIZ^6Y)6RV:01
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M6J7=>^ ($3RN*9:Y5P4A=&P_=Z K9.4D^J)KJ;=:ZPW=^8@LV^$L4Z;3GQ3
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M9%$TNNQ]84M^C7:^:M^GZ:UT#L^]. 5SI)?*>=1MELASX9JRZ:LSN*[7@,)
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M8?\ &&'0L[NG:/KQ^6P@\'R8?U.1^ K-1W^'^3OFJ^,<W<N79]2<-5940$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MAEES7 @1SSY\UJ5J=L-QE4YI$2>O):EETN/:93]!4;S@8GIM4O7"2XBPMFQ
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M@QO@IQPJ(FRHF,"+3TK5NU8V,(,0#@B6Z2+#8(Y#8LV?1G%S]G$P66M6.(:
M8IFGK'DL:;PMSA9KAY# !$!-<%[>'@JS$X8[<LS'D Q(OQZ%GM9;I,4;5.;<
M2>OU\RKIC+EXKGF,<SG>LZ9LP;Y%Y]'<B8R\B9'$15]95G73F",QUK%F+I+I
MS;,W<1?%)FU'+ZSNXGKAVKMC!+645[F7$]<>Q<]]G2SZLLNOWS!Q)Q]!6L)B
M-\36.;8<#CU)I/6Y5S5YGN$ BYV!Y7J61>TN'KOQ>YQ+[<78#;L622XVZ'U
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MW\NA1?6-CQ)LRT1^ZKFKC"0IYTQGQ$^N)CT*,W-_1)_70;/\;VH3'^6&8_Q
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MR6[-973L&@X E;H(8R,!]'H6=9VEN-1:*;@IC-V,MEEWNV61V+?JDJ6'"[&
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M!ND"R&2OLLN&W/T:26%VXV(MN&W9M4]E]E6J*,RW0#!?AL5DS4[=T?/IG$?
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M6MB0#=&WJ2%OLFI>G"F:( " LA#!7$\-3AAFU$UD6@&$88Y06I<\LYN47/\
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MAD;<.95F,C+QSK-;ZMR7A^V[E4O+<#H8*6)G-;"-B#F+@N5U6:\JRYJ"H("
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M-1IO>, #'U+.FNL1-;7;C'6FSO'>F?#IC#K?6=6:!-]X@PS'>M2>6G4>MZU
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M.THN)]T71Q[MBQ/NC!+T@L=$MRPV\P761>4I(D?58&ZX\W*"<'6VZ2TO6O
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(
M" @(" @(" @(" @(" @W-/\ Z=2?PS/P@DY+P]-_M'?[LJ[^S9W^,NDX<W\_
M;YY?]=:K_FU3VO7J_P"E\WM_.OGIXP_VA=_"S/PES:JHZA\)Z>THC0IL>?U%
M42A^$\Q69PJ"J_C//WK W*;X>OM"Z3A&5UYYT:O#(VX<RK,9&6$';[%FMSAO
ML>"V[/UK&=I):R2[^D+IX.S;!7.7#4VY+8(" @"\<ZEX*R+$N6!4$!!F'NM!
MO]OW5+,C$3$Q5FAX0<@8+4JRX; Q2+U;LLV= 6O*VX;$LVJ)9[1G4<L;PP3#
M;#F6I<1N=,7+A"-JF3O=D8IC!TF!&VQ+_P 7N58O+=;<.8(2X9FW#I6?^HNV
M07*M3AY11!S$PC/K4DP28X;#)D#=@M=8QS6\UX(%F"M),L[7^Z+.45+N%U7E
MQWFQV=BSC&F.W+2?9U1[5)IF3#6>^,+$MP6X8S-(A:>M6;3V<F3C'&[,YA+H
MRWI4XF%]H OY9*2K+E(,,0#L]2TG_4YE1;P\-$3!5F3+>E2P!$V\@EVMOA(,
ME-MZ,!M1EN>$W >@'N09/!+0';!Z=D$REW#!5/\ I87X\W>IY7JTWNMZ.]=9
MIJ]F.,5J,^WLYHZ..YO=JF+-L\;8GRKP>SIR22\I>^&G-E@ BSJ',M>%G[MM
M"9+OMO&2UU:FJC*CW3$8 ;%+,L]K;<O%/,,>G,_L5)IG:S44\^Z(?2Y8K-:]
M?,66FFB SY_VRN-,YLJ5:_>@+;1[<U)]#?\ ALCX.6:W.2<LDH=JM=))RW&>
MON7+LQVTR1[5R[1X>_;>&%PCZ5TMQ$FFG,8(.Y\AFL<M>U0-9(B# ?1.'L.2
M8)VOA3-3I/=)@;\AD=B<QVEUAU[J5/#>LSP_^=34B>UE4RK; N_;>N"GJWG-
MRK58PVP(O/8CIUJ+N*CJEJ9\ !#$8[3L6)RJ[Z3/\.!NZ>97R8T[>T2M]QMH
M^CV+K.&?+LW3:R+1%P^',[5B\MWKI9)=5$ 1OVG,JX9G6LCYUGM@DUP7KI&O
MGD&$?3[5Z,YZO)V_DX>,766\NDJ)+AE8XQ&-V*WS,-3:1EG>AA]Q8X9XN6Q"
M Z"GD\M:98#S'T!:6]<HN8\!QB,^TJ6+)B88/&!OY=94QCA.V&U*FML_:YC9
MM1B92,J8+(W;N>-BEF>&OU9'3&[IM[.]3ULVC7,X"R,.GVK>/JN)3QQ@8\WW
M4Q%Q&[*J(1B80A>3WI)%FF\VH!O<.L]ZF,,_)<1F#VNLO4DLOL\/?M_[CF->
M""+3S=T5?NG6VM6;0RW-^&-FW;WJ9VWORJU?I;""=SZ4?01GL5)NNO\ 5=.9
M[_XNX^I3'ET=<:G0AI?[A^X-JLK4[6:4JLIBTV-/4,U/NZ<;1!DO C ]7M27
M+3B'N;9ESY\ZI^K<D5KY</>AZX=:DY;FUJT[5W![1OV0V#'N6[PUZ.P=-UD^
M[^,.&(6,'HO%'K-C/QGI'WQ6Y=+>NM?1/LU;>  ?ALR6/.6YUUM;-'U*+A%V
M(RY8JN7;K%R=6,?+/O",(WY=*9Q,O-VZXN$7-F-<2(CD8J>Q)CEC:QKA$C'9
MW)>PW9# X].65JWB"6EM@.@*)&Y"*-29>'" BF2]6GXX:^!(%MQ)Q59QILRY
MP,/>QC?ET[%-+)AM"> +Q9&\Q4Q]%:SIX)M=U'O*TS:U7U L]X8XG9M3]"20
M94"/Q"[,J6X6R-^54--[@?=S/M6.5\,GC-)OS]:UAY?FK(UP(4KS];.'DF"2
M.DYRX$JVX;MRP/=&%F:TS;A@<Z-D+BLR85P#8GKP5SIZ.LQ,LK&#>%W4EMQE
M<Y;K;(%9FXZR8ZL$ZIW6WPPO.*GG+77JJ&KZF);)GO 6'+U\RUS<QUZ]<\NE
M^(-:@9L)D+,QB%K.=-SIK#IO6=:+BZ$S!V.<5FYCKUZ2Z4.HU%\QQ&]&$1UK
M,KI.LG+6;,?,/7B>6*=K@]9X2U'(>]PBTVPPSL27,>'Y]7+LS0M+\0L]R)+0
M<>;#G5FW.7+O#AW0VN\(^'@,(9<ZL9[<NWM-T9C&,]RZ&',C4F(GA3MDBP0N
MLY<Z2Y<_+*R:6D8 ;=BF5\-Z3-+B(]NT=ZUG3E=I%D\-AD,3["LF-,PJ@?I#
MK/>JS9AQ-2!](=9[U)'+MIB=/#L8VX>TJ6V<,;M^S3F3!;9]+O5DRB.G&(.S
MVK<F&_"/>VTJ8VS-3+6=+.]'FSPZ%9SA;B[2M,8"&T=I6^LPQ9FY2$N_J[5H
MO"8IKV<X[ JYIF7\/+,JQKJSGX>@)Y/+$YT 5?."WPUGNCAA#EUJ>OABW>$5
M/F$1LP..SVJX=)&H)S@<;LSWA:B=FY*J(B^-@Q/>N=EE9D^K>;.C<8V8$K<Q
M@O6]6<3"8689J8VQO+GO1$(>E:XC?7EQA%3PUVGDW=JSACV9)/Q<LPKC$;ZI
MFG^CSK'E>W/^$U+$6CEB4,X<RVPV^A$SG30J&"!A9T#:M2Y,[:'AMQM/,$O:
MRX:>-QN7H'<F6<MN6-P9\AW)C)C+'.<0.G/;<DC**F.QNMS2W%PUG3$'D9]:
M&6W)F71L$3CL6=YTN-?=MMG0&S/D4_7E,.$R?<08V&X^U63.CU_X:3YY,/;W
MJ\<K;(P[YS/6F9]$]G(3",/2F3+*V? "_ETIC.R8SGRRB<;+[\SGSJ8\+;X9
M1-!O[4LQPSC>(Y;^ST^Q3*^KR#%:LPEF&QOPNCUP5DQRN&K,F.MO^+,[5JX2
M3;3?,))%O/%9TZ<3#&'D&%]HQ3'ESMN6<%.6N7$J5*T)S2ZT;<]O>DLFF;PT
M)D<=O:$7X\YVT7/W8X=*EKV3KF(+4Z_=8?> .Z;N963RU-3%=.\05V\'>\#:
M;^O!2\I;'6[YA?-)S=GM3<F$F%TT*(?+,<_6I#L[IT1\9;,+L>9+<,KG)FD"
M'KYUT]M+>L9 8NCSE3.4QG3F';%8U.K!-F7PRSYUGLF-M"8\FPY=ZSE;UTTG
MBT*L33S+%O1ZPHW)Y2E.=T<WK2+VZYTSS)QW3?U[#M6DQ(UA,<3"WK*3EF\,
MC7W"^V^*M<V116.9AT^I!IN, LV9:M1TV>1LMCCW[58EE:\JIB\>]ECM&U'2
M3*PRYP,NRVS [ FV;SCPCZAXRQ/;!5GA%3?\7O0SFL3+#'*';[%(O9)RGB $
M,NQ6L]9FMUGJ[EEVNHR%5BM::=PDW\O8DU&,;1\Z:3&&6WGS1N21'S'VPA>,
M^?8A)AA11!X-R)>$=-OZO6K6>O+5WH.NQ"BV>6W*F&RS'-,X9VE93HB.V/+J
M1TK*YP(3+.,(Z?B>?T%9MS<'57ZI]XACG^U5QF-(I\P G"TX[59&>ULFG#QX
M'9RVJWZ,SCVO+-+FQAC:,5Q[<KFUORWV78YK*XRW&&)ZE)&9I(2VV7W@<O2K
M5G[GEX]T\L0BV81TQT(\_M4RG6YK2F3(1/-BIY;N+IIS)P(-N%T?:5KF,77'
M# PVQA=!3"282+'6<UGH3#4N-,KG1%V*O*_QVTIQOYU.$[=D:]\2;(6YJI-/
M#9D,(]*%VS,F1P4PDFV[+,6Q2Z>SXI^UKSB .6U)/+M]T3-<!UE:S.%E\(N;
M,%L<\UFZX9N<_9HNGF) C?RQ3#7C#G+F;Q$1GV=*8V8UAGWMGI6Y]&;-.;5:
MG3AJU4PL:>8\KPIX:EWA4J^J(WC$"-O*U9Z]=K>OMPK4^K),(QYNC:EF-I.N
M&COESK<3RS4FZN&[(IRX EIOC<-F:5FZY2#)#A"#2+0;N;(*+C66P)9;@!;S
M>I"7#RM.S(#!1NS+.PVQV=RKG=,J$V\$PBJEOA@>ZVS+O4M:Z]6 I%[.,8K%
MN69<A2';AQ1F3-PQN=?9R"Z3C#MZXZN&]L5PF' F"6EN'$E92W+PL]N$8B3$
MWWKCETDT\1.9ZTS]C$(G,]:9^QB.+C>GW2WPX!X MCRZE%DPTYDP60&>S+G1
M6BYV]"R$$'*6(NY<_J4MPEN&\V7 "W#))]2?5S#(&,8]'M55R=<>9!HS'6\P
M]JF6<L#W1A9GZDMPU;(TYC[K,\>963#F\,?:;,,]HV*V9&<6@%<U>4!!B??T
M=ZWUX1Q5!!K.-IYRJS:T)CMTFR-H[%;<JUW.O,,NY96;8HQ<#M"C?$9@8&*U
M&&Z#$12S \/NZ?45!'3C"/.>V'K2C PQ<>;-1J5H57Y0\_>I6^O+N3RO_P!9
M2_\ V?:U:ZNDY?3Q]GA_2]%_S65V,71V[</M&^43_46C?P 7+OR[?#X?HI+_
M "(Y9*>'I91<L/1.&47#F6&;RB]5_(="7AFNM9_Y4\_K68Y=N!5! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09I'Y1J"G^='^P$_P#@
M9O\ )E7KRSW_ (OCD^?#^FZQ_G]1^$]=_P#\3YOR?R_R^<+S=='5-0V3BF&>
MUT]>9CHO-GI5SAY^SD]P:VWE<M=);PD0==-;NWX'+O76U<YKKO57#>)PBY3.
ML'-PH5?,$3?>[T1[E9&L^$2)^[&V%UY]JTYW[<)>CK-PPWA<1ROS2DNL59Z6
MO(A!X&/9WK.<LV9G^$_2:BX%GXRYVS,):YXO6KS1ZJWP8&8,++%9]V+MCGUC
M9KC[PAS^OG1,:PUVM$T]4.S)9K'&DE3T5H,#U#:B75RF9=&0VQILV#!:EQ$M
MRYOE;F$.A1(BZIV['H]/W%7-&D;QZ8J2Y,XVD*:4! XV8<W,M:QAJ7*>I9.]
M''W1A["L><+;A+"E!'JY!+G+77MX:4ZD MW39'T="LTZ2Z1$ZDB;CCAET;5;
M25&SJ0@&#3><!FDNFIVKQ2TA,RUIOR&95[=L-6VIR?IS72#^+P[SFN>,M=,N
MM-;TQHWO<Q=FMS6G7WVZLU.A#=\[A^(GTJF;:I%9(AO'=A G =URQC>'HZ]L
MZJKU#"QQC[<U<8F5MUE&OBXQ&9]*F#+9DV #8IVFDMSILL!WH\L$Z_5TZ=L1
M:]+GN9"W+;ZUUTZ>,NR-+GE_AC,#LYUFU.78%'0FH8VR,=E]A.%JS+CEF1O3
M="]PGPB8;%?:\':*MJ>D^&'1ED6;<(J9\QR[=;RZOU:D<PD!N>'.%<LSJHU5
M(>V)@;\N=%[:C4D%S7W]N%JLQ7"=LU=]*FNWF6_1;GD=J9.SMC1*@_B[3AG]
MZ-JCGC.G;.D57NL$<KB<AM2[9O7"[4LXD0SCZ#',K4X<JSS#O GE8G:Z91,\
M1)'*\K,Y+PP-EN)$!&T71[EVZ;<KPVF-+1 V6K53JUYKG%IC9S1R*97%\JY4
MM<77'#/([%BY:D:DJ6_?'NG#M"VBSTC2&@$8M4DQMC&;I-2V%P YNSF5^Z[Z
MZ\IBBDP.R&7L3]3&6_62 YE@PR&W8C7&U7GTWO&SZ66S]JB2Y8&R(7>C[B%9
MQ3W9D=/8@TY\L@D9^HD9;$&BZ023CRYDS6,8KDV00(AL+<NX*<W*XUEX$XRS
M".7*]:\$[8J3II^^1C$C'.!S1>TJR4IBWK]2BRY9YI :3RS2';55ZKFL%L1\
M.>SI2G7AI4\]GB1B+#GS!3*6Z773)S#"T?"<>;8M)+A-3MR8(1!ZL.="[1;Y
M;6F[$X#N3).NML;'-#AAU9(OK4S3O!$+>1*A+X;98US3'+9ES*I;G2&JJ=I,
M?V1ZNI$ND%-I!$X7FWFYE+)5RPB4&'##U[ DT29VWY<08C""-^,)!DUS;(GK
M/>C-CGX[MOI[U4LPQNJC MC;9SYYID];=O#*AV\+_3E^V4632;I)SB6VX[=N
MW:JSA:J.8=UL>W:,\D'BNGAK70,+\<B<BA_[JO/=O$G.SJ*+C646YAWB;+^Q
M$GU;M.[=ARV*<-2^U6.FF@M )P'*T[5>88G6MMUH/,4B6YX0M4TDNAF>PJV8
M)9P@*L.:# 6P(LCFLYB=NM:=.Z:]X !,2!CM&>U:<[]TXVDFO:';IM&1S2\$
MPCZJEF,B=TP!RVG8LR93.\.-'*>7P@<.U6:K/;EV1H]*7,9%I^$6V+5Q@ZQ.
M5= X2HP] [MBSEJW#K36)4QDTB!O[DQ<Y:ED<=/9,.Y8ZUP]*TEVMU)(<Z]I
M^B;ALS4DWEFS*TTLG<&7+FVJ=KHEPL=%5ME$ NA"%D8;,UF)>5MD:C+< W>&
M&.SGV(WG3%75##*?[PN&,<4LRPZAXDF_E",CRL6NI/NI^F.+J@1Q*,]OLOTA
MHW(P&&&Q/7.W&]LW"4IW-;",![(=RGJLEJ0%5+:/B A''[B2;7U\>&M/U"7N
M$;XB=OM2\L\*?J-8R#_?!Z=HVJR-<*-J-3O;T+1#,]^U3'U3'E 4CR:AL;??
M&?WW2KRU>LY=[\.T[)E,PD?>\K%),;9QB:7672L:871C='U\REVGZLKI#!9L
MV+4NA@=3RA:1UJ<KRTIC)38=.(]:JZB%KGL8'0.&S;WJX^IGZ*+J5>6.L>+X
M^G:LYRS>R5T'4)CW ;T8FV&T0V*<).$_J%4YC-L.6*9MVUUF;E6&ZI,8_P".
M'O'9L6\M=IM;-,UI\&1F8#&"EZL6VW2V,U#Q)<'.C&!MYB,%DVKFH0?O$';G
M>MK[*E52R#8<?4%&N8R43BPC&T=J?9F]L+Y0/,QMOWHO^Z5BZN#[IZ721(,#
M;;=LCDF<+RW3*$IL=O3:K[9IF(#4:O<:Z#ATVXY6A:FYAFU0M1G^(YUL;,"8
M7^U63!C*!;:Z/.5+P>4A+G[@O@('$Y1SO6<8BXUE2M; GS";[^F)%U^2N5]H
M:-3[C@80LQ [E+<PR[&H9I8&D8 #MYE>)AK&8FA7N:( PZ0HQED;5/F8[>OF
M*U(5N2Y+IMT2#[;^I:9;K=+#Q:R)YBLV-2^&&=H\ 2)<+L#?R"SPETTV4CFD
M#=/Q# ;(X+<N5PSFG<+@1T#V)^J65C<QTN^(CT<KDER.;)SF9^GO4PLN&_*J
MB<<.6*N&IVSKRPU,]Q%F6W:<]B,S=5V?,>9A]O>I=S#6LLTH>[%9]*SVK5G2
MW$&R\1QRADKC>5Q&HV2XN @;QAM6DLPL-!2QW/=AT<VQ8O))E;J22P"Z^&64
M,MB&/"4=+:UMF V8#F6YP3EIO<!$6V!9O5?*A\0UGA,=!T(6[>Y.J=E*H=6C
M40,P0YQFM);K#N'ARHES!*!<+?4>G))V69CLJ7*ES)5A%VS9WJTF%4U>2T$@
M;<!L.2YV6)-W2O26%A%MY]8[E.5N95HHIX#($P]T7DKI-I^KG5SV&6?> ,(W
M\Z6X6?\ JI-94AKR Z-^)4S[)G>V&4[?AM]<.]7"VIBGEB$<MF41ZUFM9Q'*
MJ9"7T9; LIGV4;4FDN_PNQ7.L)9A&TLB,VV!N[>90\.U.'J1A#(B/NM[ >U:
MD3AOZW3,8T0%_3@<UKP*E+:);HX V]"QS2;2$NN;*'Q#KY\SM6L&9*XS=7#0
M1XH]"S:W*B)VKQ)_&#+#,IURG%865WBNM<,/39@KC;2<I#+);$B_9M[UISX2
ME3*DOE&XV<LE+B.GQ2V_90=2DM#YAPNN';!3[/=)B12-3J&2FOM$0.HPBKAK
M&75NM:H&1(F ?%B.G;@F=$PIHU_<=$S1?GM]BSGR63.%FT[BW=+?QX$(=G2M
M3ZK)A?\ 3N-@&LC4?1]0V*V972?_ $WE[AC4BXV]?[%3&(Q>=*=KG'[);9A%
M4+1ZAL6<^&O7ZNHM9\P-_?A5 P#KCG:MQ<1UKJ'&SG$D5 MCC!9\LXQM6I_&
MTT PJ<_I;"J8RA*GC6>X0^L8GZ0QL43$BMU/%$^82/%WHF-_,4C<ZRS"/=J<
M^:2=XD$C'G2Z/7U<9GCSVP@7681Q6:Y=N6LS2*A[]XL=;' [=BQ7&<IVDT1P
MM,HVD8'8I9DSO"?D\/EP!\$V;,H#;FL[2WPV/T==A)(/,>X(B6H=!>V8TF4;
M(X'EBI+D=T<+:<93I/N$0:+.C:MS<PLLE_R]D.&93 R5& NR[EG"]G;>F4+9
MF[[N][P'H6KHFUT;0;LJQI A=".S%)M+?"L5M.6/@!CELV!.Q)I%SF.:QUD;
M-O<L8S4NJJU>)GOV$#IVK4U%E<=(B9S8Y^M.QV^SL^DEA\H$PN]0[U)&.$%K
MM(&-#MG:M=;LQ;M#Z)[LX<_K7?'[<N=MER[,9- 8V,1 7\BI-M3M5>U*>(_%
MB;S[466H=DUI!,?2.]5+FM>HJ8-(CG"WGV[$27"I5TY[BZV\;<>E3#><M&2Y
MX>"<Q;;RQ3:2KQI]:&, +A&..P1Q.Q"V\)0ZF($;S;LPKA);*BJO4";GV96;
M!ZU9,S:5 S:QSG$QC]P+.EG[6>FJ7-=;G'LVHO\ *96*16C<M<+S<3WA5F7%
M;+JAA!M%QQV<RC6,Q3M6F-<3#E>L6;2:JF3&>\;>7(+G+Y6W,PPD0*UC.V6U
M36.4[;:X3D@^[T>H+%ULMRWVS@W9S^PK29K5J:K=C[P].0.,4JRM:FKSXGQC
MXN6"1>USK[+O25+72XEPL$;S@B2X>9E0T&.\+HWE-L[1LZ>UT1$6[=D%(U;:
MC9DUEEN$<,?N*HY,(B#@1'K"LLG*58*1S&P./NY<L$O_ *)+;I;:6:P-O'(*
M3;<XPQU$QKG$ QM5XK7"=TQH<(')+N+-5(5=+*,NX8Y^HK$Y7E2-2HI49A#1
M=F<ENW"XS,NO-8E!H<T66&V&Q99\NJM1.[,(OQ6^8C+I ,R>.=9LPU,<NS)3
MOJ\K>!P';'8I$SMDI]2<9C1XGTARV*YT6Y6RB>)P:"8W1Y':IYRGC"4-%+>W
MX0XD1ZQU(285_4=*9[Q\/ E*G6W*E5E.)))W87FT<RN/+KK"&?7&3<Z$+88V
M88Y)G%<[RSR>('-@WQ?24SDQG28DZF:AL-_>].$>A=>KOTFF&<2^/[*.>4/6
MM9TOJC)U*YUN[&WOV%%DPCGTCVFQIO(N]@1;,[ U\L1@1"SE!5SPSLJBR$3
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M>>?V+7#CG;(RC?,E3"&FQL;L>I'6<9=/<52YLFH>"#CGG!.&LYTKFF-=,<!
MFVWK&:EVR[ATB3X<@&$" V\)(U>R8-7X;@V(%RU-.=[6IBBF^,6VQ/?<M9ET
ML[;3TVDC+WMTXX#**YW]K?9%TTH>,6NP/*\+77L8S$ZZBEF58T1AMR(NYUW8
M5RKH]V,&GX2;A>47.L*[/8]A)@1?ZRAAKMGEMA,+8WG9M6;V7U9F3VN(!<+Q
MB?7S*PMPS/IQ4-$!&/I!QLYTLR=>V-,$S1-X1$J-D;B<%<21;O<0-9ISI!W=
MR&-V4<^9,1)<1#S*8F)+3U#UA0DPTYC1+B,!T8P1;,Z8#4-9]+"-Z)-:8C6@
M7.'3R*L3MR?6'/NP],>8[%%DPRL$W>N-VWO5R>J4I9E1+(+=Z-AZS$YJ+CPG
MVU57NBUW(E7+-F#QJE[K=Z)SPL7/OE9,K/I(F%PW@;MNQ8S:SC';3M/2Z<NE
M"(PRV1Q"YVXN'HZ7RX:A3D->0TV1P'<F,NU4^:^;+F61%^?0N5ZXKI(NW ^H
M50U"G;O.A]8EB\X$*+9(_;OY.)CIFH4KG7^/2]JTKZXOEP_V5D_YI(_ "QWX
M>KX/YQ[#57Q,_:^LK@^O.&J@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#/)OZ3V($W
MUCL1)PP(H@(" @(" @(" @(" @(" @(" @(" @(" @W-/_IU)_#,_""3DO#T
MW^T=_NRKO[-G?XRZ3AS?S]OGE_UUJO\ FU3VO7J_Z7S>W\Z^>GC#_:%W\+,_
M"7-JJCJ'PGI[2B-"FQY_451*'X3S%9G"H*K^,\_>L#<IOAZ^T+I.$977GG1O
M&8R"X<R,<,C;($J5OKPV&.!ASPY=:DF&\S&&Q$A5EE#R8W]:NF+,.6\<RAEY
M#CF>M2M];&8&R*Q<Y6_4O6YPQG->8J?9K/AYB<RF(:9(@W+.,)V$9$'F)NB8
M(.)< EFEDR\;PVJ3K;M<.0,5IFS#.TQ69F7*V6-V6=T6VV!=)<DGEG!Q"-.4
M3FAC>?+P@X$G E:D<N]S7B*,YKD"IAUG:,K(QO-@S4:Q&\UX@+[N6*3+.,W#
M,PQ(OA;9UJIPVFBXX+-JYU@=?T)%CPJKF('#T+.XS<QQ!@?0MS:W<;<J9<+;
MLTNF-S39:^,!;ZE,^72;F60.-UL+<?4IS,N?>8N6M.-MYN]04YCGG32?AT^I
M.K#4+CC:M2);AY:[=/1"]7!+G20DVPV?<7/RUU_^U,R+N6Q:;O+8*)>'AI@8
MJLRI*00;-H]$(]J(E9;Q"&(AV*69&VQP:;5?"5E\5O0IA,5JSI@]Z$<.T*M8
M^K0F3;7?%=ZN=6<F/#2>\DXW9KK.OM,KZQS;&]6N=TVFD.]J28;F;&RUD1@+
M K;'/MEPF,$#='.'1ZTSI9/JT)K( W=6?W5-QJ:N?#0F,ONNRV),UOV153*O
ML'*";+9&I+9!PNPV8A9W69,IVD.Z!S]H]JM^K:;IYI!C;#GYUJ76''M;=)F5
M.#H0)]/,EZNDFL>6^R98!;RM4\99XK,)H:(=./<4SETETSRIX)A;?F>Y2\99
M[V3JVFS&D1MY +EVNWSN^^SC,>("$>A9F:PURX"TQ6OLWG+1GM#P<K1VI>5Z
MW>%8U*G#FG9T8';M5E=LX==ZI30C9GC'UK-V9GE0*ZG@76#XCD<>=/9TBL5D
MFUU@QP4N^&^MR@72G FZ\\K(J2Y=FU)<! ;?64ZS!9E9Z&? "TW\L%;UQ<KC
M3L72*P@CWK+,.9:ZW3?7KK_+LO2JUQA[QPS5M6S*[4E27!L3&P896^M3#=ZI
M%\VRR/7LYE>F^7/MUQ$:YQ>XQY>A=KB/%VZ[S&5C3$77*2X9MUAO2&VB,#]U
M=+,\'7/*8E-^&$+O4N?C[K;&<M,#8+E9@EF6K-8=ER9\-=MS2%JFFV$,?\96
M,S*)<2P]8ZDLRF+>6S)<;+3=GE8L?9)I(B:[=%]V<=N(5AG89CH'FV=RN5SG
M35F37-MV#NR6KP3KAXEU!)@8WA<\TLK?;-,(C&&/LVK47#:9.<8<P[.;8KV<
M_D[8G^6[+FF/1RP6<Z>*R5O2)L2(QZ]JOA)VG6M_XF]"YK>V=HJJE@@Q[.;O
M6Y<UN*1JE*#O0&.>R"Z:+<UUUJFG;Q?!ANRV!9FV^MSM2:O2G.<?<-PP.84L
MQMUE^J!GZ=N"!8<<#AT*8=.NT%44I9:!"R-_/S)BMZ1CA!W5W)G6#&M-B34&
M6;"1RV)EOIGRM6G:GNP!< =L/6DKI=Q=:/5MT-&^+#F,3'_&1,+!(UD"$7CK
M&W8I-M7K;-+=I.M@.'OC#$;=BN'G^3/7*Y2M=!OF"$"/2K9F.&<W+9;JK7F.
M^,[Q[%CACM;4I(K [Z;3;LR/<GEKK?JFZ6I;$6BT$BT+?C[G:?1.R9C2+\!G
MES;5FW+-B0:0=JL^B]<\N<\#<-@N/J4ZM9JJU!(FV''U%:1L27N #HX#L]J#
M8\9W*'<@U9LUS!$$W'EZ$&@9[N5OJ4K4VX,G.!Z-FS8I[9+,-R74OB+3=#U+
M77:68F6\RI(A$^C9')'C^;]UK:;4W&..7J@H\^,:9A5@BV_F@M3#?6UQ-0,S
MUGN1OLPF=M/65,M3;BV9$F,;O6I<UNR8TV&$''!63ZM]96R'!K03RQ5LS,1T
MZ3]S#-JV,^D!9B1M6),.V%;U'5&-!]]N6',G+?7K<.K]?UH-;-A,%\+PM34;
MQ;PZ-X@UK>,T;X-F8RYDY;Z2Y=5UU8Z8\P=L],;U/:6[=^(U933-<(8FWI4Q
MY/6U8J/3W/A[IPS-\#EL4QGETQ9%STW222/</T<"M>N'B^;K]7;7#VFACI>\
MTCW1>(8@XJR?1Y.+AWMP_0L#95EPAAE[%9,1K..78U+*:QF:QV+=,-5"V&?<
MK$N,(@N(,+>OI4QO*623+<D380OZ^62EOASOV;9G^Z;XP.)[E9UTGA@%2Z[N
M3+/JY>,X\AW+I&;OEE\0\ON+EZL^D>;[<TX,>'$@6V!5SK7F-$3=A@M3C+-_
M]&'<$8\NU,W.3VUB-F6!D+UVG#$Y;<OXNKM1N\)BG^ASCL"KFF)9LARO*2K+
MX9=\0A;ARO5\F=Y:\QP&]?\ =2WZ,]IFM*88F N@%9?).GE$U!M/,>P)>V'5
MI)+D9);B">;-+,IA(27D$7VC/8DOA>>4BTW'9[%7._9MR[0#SK-9F<LX2.LX
M'" M@EWP3%:@F!KA;CMS27ZL=KBI6FFV-M-Y[%9BW#6=)Z3-$(1/(E7$)BL[
MG@"))]*S<+IJ3)@='F6;IF\M1Q@5J6867#Q>JNJS-,8I"3#!-':I::J)F7]7
M8IX2L$/>CM*W+'.WPSLB80L^XDLRZ=>&:)#81M@<>=+BKG&F$DG%16%Q@LXS
MPXV5BMS5]6M"68')IM'2K+K!;IF!Q4O)+Y<M\X1ZU<M>S;8^-\8QYU+/,:9;
M5)?JEF7 S=R\F^&*WRFXTYE0+;3\69V[$665K&<+;3Z4PM[3CRYRW@P-OQ=R
M,XRD91#@!M2V1G<; :!@.H+-N5MRUYDAI'7RO4)-HNJDAH<8"RVY67+IUDE_
MRK%4[=).PI9AZNFHH6N5>ZUP!N!%VR*SE++;ETYK%27$B^!)RO1<:^ZNR073
M+KR/0%6+IV%H4HQEV"\9;5<+C+MW2&%K6]%VPE2P]5KEFR&P<O2H6I*4R(PN
M73.)GRSMQFB$5,Y=.N<9:$PP)/-ZDO"S=:[[>J':I(<5C#<X'TI9DMRRL:+;
M!A@IZ[2Y\-F799L[%OUQ!QG& /+:L=N7/ORU@^T7J8QMC-\L[3$@[0F<NTQZ
MMEMW2M1RO+C,PZ?4EX1&5!(CLMZB5.HAJET;HW]RM7KGRC9<QS7BTX8[0HUG
M>%CD5$)5M\".5B96]<[\L$Z9O&%O7S*L2;S6LZ)!YBHN-L(1N3+>E'=Z.7J4
MYN3M/HD)3XG&[V^I+PY9O#::8=2<QNS6&I46QV^O>5XC")F$ D;/8IG+IZV1
MJ.:28V7*CCN'9RZ$27+*V41&,#S\BF$]F)["(W7\L%*O,1LYI&5G<2M,S5:#
MS DY'EZ5&_+E+F1SOS^XH=L>$K*F0;>>O:>]67+/MEE\7:[ETHK1GS1[U^/:
MF/*9TK]3,;$QCZ=B?9/;%VA9KKS;8M0SGEKF9;<5.W+>L8\-F1-.V_/G7+M/
M+%Q.$E*)7/VSI>MN4K(.&WN3/D[:F$FQP %]WJ"UC)TF'B9,&Z;\.T*8.U14
M^8!G=R]"S6IUG_JAY\[XKX>WFR5C.V@Z:23ERV*_8]<\MR4X$=/L4MPSE(R[
MNGU)[1?NY.= 6Q4M^BHZ?,(SOSV!67+.<H][HDPB+56I,;K@'6Q)46V8TR"9
M"Z,.>"ODD\MALZ A$]/3L*T]?QS,:\Z?9")MY\CL4G#K]D3.G67F]3FKA$39
MQ-T;QCLVA+,Z366K'WH\ZL+MMR;80Y16;NLXLF6\T6 61CZT3.6=K=T6PS0G
MV1.H/&ZZW//G3*W2AZC- +KU9<+UMRKCGAQ-]Y2W-6[VW*9H= PNAWJX6+'3
M26P'-RQ4L\L=[FI!LENZ#E'#:=JA]G%[!"R%QP2QJ3%1KQ;RS*N<:KK.TDV\
M G$E:PZ2^6=KB +[ACS+/E+)64.)%YZT8QC3BYYM%MV>Q,K.OEKNOAL5G#><
M1X%E^*EL<^W9C<^%T>Q2=4ZQAWRM::S/+QOE-&9.'@NA;:I><QJ=LZ8S,YTE
MK-S[,9>1F;,U<RQO&=N!F$Y]JF28>-\[>SL4NTLEX<UYVIP(/!, B6^/+"3$
MWE"3Z\M:<_<C"-T+^KGO16F7QOCUQ4L2S+"2I:EK9DD&S8M>"3ZI%&A!P>X
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M:ZHZL:)C7'G-WW%SLQRMOA$4LL-GBZUV61YRL)C2\21^(;#"'=VHF,7#6G3
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M\TD?@!8[\/5\'\X]AJKXF?M?65P?7G#50$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!
MGDW])[$";ZQV(DX8$40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0;FG_TZD_A
MF?A!)R7AZ;_:._W95W]FSO\ &72<.;^?M\\O^NM5_P VJ>UZ]7_2^;V_G7ST
M\8?[0N_A9GX2YM54=0^$]/:41H4V//ZBJ)0_">8K,X5!5?QGG[U@;E-\/7VA
M=)PC*;SSE1TG#*+AS!5B\LC+QT]B5KKPSB ZXV**R;XV\NE5G%>0[(E,X2R^
M3Q#F?0F3U<VOQ)-H2[.&4/,(Q,%CSLY!,)LB?0MYP>N-LC7YQ)BLW>X99KPD
M;YFGEIA%3M+>&9*R*((/!.&*LBR>7!::$"*#,TF.*QC,TS-MYGO=0O6I^WDL
MO^&RP&[(+5X9ELN^'/&"C<[2O!,$+9.7 D15SCEBSVW'$O:/N+/M?"^OU<@%
M96,5D:3A%+IUE;C;AS*LMB4X B,<463.ZW \;MD<5G&\EY<8G,K2.)=#-3,6
M9H)L,^H*XB9KRUV\<<T_1J2\^&8/ SN6;+3C=963+C$XIZZPEL9VS-Z MC:G
M&F+_ .CC,OZ%/#/AJOPZ4ZN;4<TB"VG:?1X:TDV(DERD9-G;ZUSX;G_VI>G<
M(='<%KEO/ELDV'F*)F,43F>M)5Q&]*>6QM/;?#/F5S,,V).3-%L2>4$C.,1M
MF;M/19W(.#YT&FTX=O4KA+VQIJF=&(CRZE,DZV[:KYGO&UV'9SI&KIQ^*T<V
M"]'3C!+]6=H2QB]:VI=AMY<H)8U-3#=:]MRQBVG;6V.808PV>I;DQ&<[:4SZ
M71ZE*WULX:3[SS)%LF&A/:"#8(W]01)M'ANZ;8)(720DS  +;1W(O,2DMX,(
M'!+JN?&_*1D38$"WD5T\->V4HR;$"TQAZES)8YE^))L3"^PV=:+^E$N+&_+F
M^Z+3<,MJY=N7S/D_DXNFVWF\Y+$9KQXD;SZ$NCKR\.>(&U.5WE%U; YIVQ/6
MF'29RHVJ2!EG<D=NLTZ^U&G^.P_$[ JWJUE3*J7 NB,3V%9W7:3&X@YTJ!C
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M" @(" @(" @(" @(,TC\HU!3O.G^[^?_  ,[^2*UT_DG;A\;GSY._GVLQ/\
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MB;1#'8>=1<^&:?K)#8 [;^=#.4+.U$N-]]M_.KNM22HRIG.F-<8J%^D5.L:
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M,SY<6RX&.[@K6L-EK80LP]2SS^JXG^6Y)=ND1,/NI,DE;P<'"^)(*V68OV>
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M3[.Q]%J8EEN&S/G5X,.U-,>2&&)N:K+EUZ97:E;O!L,0/6K+/+/RR7K4LR1
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M%;F^$5-<-XVCT9J74^Z[X8MX9A8EMU!M2RTY7C!69RQ^Z\\-A::Y8WN %AA
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MNU3>=K+,9:1F>(81C'#ESK7C*>V=.,QA:(@$1R68X]IAGI]\POO&>9"KG4C
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MX2Q5*^D+-Z&<,LMD<%F9\+,_X0TN2\DP&6?<M<G:,CZ5SH$@\NA2:-R,TBE
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M8U=3I*>5+<(-N. '-FL=L^&>TUMU9J\N2]SP-VT'+:,EQ>+M+G7"CSJ!LUP
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MDD2WE\"#:0,=O.GM$PM6GTI<+1CW;-J96XC:J:3=$89&U<^].K!*ED& ';C
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MH:=+?*C'#N"Z:PY_UUHNJQ*)!,.6P+.,5/6RL3M7(A!YZU)(Z3XLM1VKS'F
M>;R>5ZMPO;XK..&Y2S'3B"XDQ./*Q9CG.F\+EIDH VC+E>M9AVZ[=A:>6M:
M0,,?NI;IF=4QXLMHN%Q7/-M:],<(RIJY0!C#'UK<FFY+A5:ZOE>\++MO+%7F
M9<[T4W4*ECR19=!9F83KE7J9L9Y(MMPYRM)>F\NPZ$,$KWK/=&)V)EKUSIM[
MTL8>DJ7=7UPCJJ?+W#;=#UIAG?E0M5KF,$RT7^M,1/5U_6ZF#,,'0[.5BG;]
MK4Z,5)/=->+8_=R*=1=].TQ]1 PQQZ.I:LPG6+)*TN;(A#&'I@L^VSMU\U/T
M+7RKRZR M)S4O;+G_9C46RDJPT-!,##E>L^V\K/JEFS&S&CEA[5?=?:-69+8
M(G;GSK7MI&I,>&QAG!+WA[3&*U'322;>5V2>Q[3&$+J3WF62";S=9FM9G).V
M.$%1L<^;$EQ,1?$[<]JY^_@O[EXHJ=SFMON5]\M=<)"=(+&QMLB<,.G:L^S*
MOU#R'$<WK*WG!,9VPM'B <K;EGVQ<G;7#RZE>X$ 'D%KWRD[8: HIC9\8&_8
MGM&O>.T]!JV2)36N^] [4]DMS4Y4U#)C+(9*9\F)U5&N? /*U[1;950J*D!T
M(Y=G-L4]V-N%,XO>(6V@=J>TPN5HI:-[@'0/*WU*>V--2)66UTEMMED%+VS4
MNE:UFJ>6.#7$7XG")N4]L$MO*K4LZ9XQB]QMS.:L[6[,.U.'ZX4XE%QML6_?
M6(U;)^KLN1K<OP=VRT0PV*>R>RFZ]-%7O[IP)POML]*>T\M>,NLZG3YOB1&?
M>/6LWMD^Z5TYTRFAO.<  !><$]L1B]K%XT[7/">T%[H0SVCI5G:-=;GE=J;6
MI<U@M),,<CC"-JLV3KMH5V[4!Q%H,>[8E:]<.M]9H71>0#8#V!7KPSZ_\J/.
MGFE?&)$.BZ*8S3%SAOT/$ ;87F,<]O.M<))?9=*35Q/ $;@DWRW>F,I$R_'@
M81/*&627G2R)C3Z=DF#G@"Z/6%)I+TWILUM1(9+==9O0ALN6;4];74W$6K2Y
M/C&, UI,;,EKK@]7KAQ=QFRG,P>*X0:Z$#M.VQ:[8:G7UT]<N(?,(DD"HF "
M(^+VKEC%VEW74NH<6S*EQ G//OFS>)LOQ*UPO7KI!OJYL\GWW&.TK4Q5],MR
MCHYDQ[8C &WG6-YRZ=>N+F.RM#T$U+I;=QIB1AMYEK.ON]4^33O;ACR\=4;C
MC)88N%[=A.1S2_59\_U=T4'EEX<O>-/+N'T<K<E&?[=L.I<%,IF&,F6+#]$"
MX0R5FUORX4B?HTJ4YP\-GQ9"Z*F?"]?DS-K?P[0R636CPV0 & V)-']D>RG"
MDJF;)EQER[LADEM7^^+%7RJ=\"&,L)-PS/>KFR8)\DRV=/KY%)"(:(6V0%UR
M6,^^TZWBBG9$1'H6L$^62L4SB"1/N-YV7\@LV5K^Z-)[VSSO"VV*B7Y<H#46
M;C'.MN'H^ZK-K/DUEU+KNJFF$T;[K#"_*)2S&*7Y<W;HSB?B8N,QGBNB0<=G
M/M3M<QCO\GAUU1ZC,G58(>XQ<,3B8+GC3P]K<NZ>&&.F0)C>WT],5+&IP[\T
M65N-!YN5YR6?5O2X&J;*8!&YH/(IZXB;M5G4ZYKP8.NY^6"F*QVES8HU8PU#
MG"$8]X/K5]&NM]4<=%WP7%@)A&,.I:G7+5GOM&S:;ZN\B$(&$,(7*>OU6ZC:
M8=Y@MP]OK6,4RX-'AS-[(\LUJ=&?;.EDIM=^KR]S>,(0OV#UE:OQ_P#+4TB=
M0USZPUX#S;MS&Q2=/JQVN*KU/-(FEQ-T3UQZ5,-R>5WT_6&2@P$W$=D$]5F%
MIHM6E3R&B!M[]I6O7$RQWZ^R<,V1",& PB+!DK,N-ZH+4'-F!T(7F[EM6Y9C
M:>FL*;52"Z)MQ[1M5D),7U\-1E.X1VPY7K5C7KC3D:5QPY=:S,1+\=\-ZCEB
M2]I(N,>5JFF?2WE<WZI+DTCA_P F1_Q2FFO73I+B+4W3JIP8\VF$(JS3-Z8V
MC*.BG50B23$7F)Z%+=Z)TSNK31:',;:1@+P2LKZV++(TTRP!NBS8K$],QL&B
MC<WT0[8JS,.GQYY<Y.DN>X$M&5VQ;Q,9\M3IO:?H])+3&&WTE2R8+\<L>:^3
MX33$8+EA)TPHE=J+9)(B.45/4OQ^RN3-:#W[H<81@;=L/4GI]2?%)4OI[S4V
M"V,%F]<+>N5[H-',QK7$7PC8KC/)_7A+_FWP&GW;MG-F%F=:7IY0U7,9()C9
M?ZUKTN4O6\*QJ&J,#81MARL5]/HO7KC:F3:CQG$"!]H3UPUSIFET3ID++_;@
MF,IVZY;LK27"V&.S8GK&)\<B6D419"(NARP4O6Q>W6I-DL,L21.O7##.F-:"
M+.0!5O5J],H"?J#&.(B+3#M2=&/3>'*0X5'O#*R'.GKFNW7KA8*:<VG%IA8+
M[\#=T*7HW-U(,U"6ZR(P6I)C[ETS"8UUQ'6L65G*.KW>X_\ :^HK76-29=7Z
MN]Q>[F[T],DU568YPF7X^L*SIC;5J\Z34W".'<+X+-F6)<+2^>UK!=:,\X;-
MJ>I=[: F^*0!L'I2=&N9BN9HGOA8?NIZI^B-GR9M.3:X"ZPPM6O7))]6S22Y
MDX@1<;A;;>-JSZV5;K<6:3I#RR)RV[-FU/6U?;_E%5C!2O@ZR$>RQ:Z]<:3G
M;6;JLMK2+-EWK73BNO7C*.J*IL\PC>.;%-C5;1&:Z(;&(O.TQ5M\$;S-*+8N
MW080PSB%%PS.E^$V[L%P)PYT3]434U;&X@$=Y&*"M553XE@,;3DA-7*$F2W$
MGEM6<;=;VS$MIE,7D1RSAZRM.7*X2)/A,;9RO]:96]<7+3K-1931!-N.Q9=)
M+4$[4FSS &V//&)6LN=OU25+1.J;L3RN69LRF&Z2Z2T.(RP(VK1S6G4U@I@0
M[FZXH6?16ZVN;-#R#<?4N=A.<(FG>#.!LOSVK/HU;<+E+>#)',!ZO6KZLW>U
M1ULEC7._8GL]BGJOC#J;5:L$PWL2+MH4]+E<13)],:IQ Q)[3DM3K6:F=(T1
M\N:"1#+I$5+*DF'>O"C!3ME[XA" [%?5=QV-,JI?A@"%L,=BDZK=.#&M?;"\
M<_:M[X9M;[:7> L^CD%G&ULUIHUE"0TG=VV=?K5PN=8JFUDHRWW&\\WK4]?J
MDN&.G)WH<N5JGJENTN98>PQCCV+?I,:3.D#4R0QQ)LL$.45SO6Y3RT6U3)5Y
MAAVJ^B^N6U)KF/(MMNP5LLX,8N/#?W]\68PY8).OGRQ9MXW2EE/6S8 <%B=-
MM<M^33&8+C=S;%J]'.RSAK5>EN+2=V-D+0M>N&ITEY4W4J<2@1N@61]$%GTY
MK7IAU_6$^*<+UG^MG$;&GS'M>($VPV76*SKXIB^%_HZJ$D FV Q.27K8U)<_
M9AG/,R(C?W<P5G32=HVM-E;LUA,3CVJ2;)%KKR'TX:V^ NY@NG2:^[4Z8F5)
M;2S#/C PWN6"Z6:;U.%STVC!:W>:#<;87J25B]I_E<Z2EDL$2UMV0P@M^IEN
MS)TF2VP-%F&, GH7M*K%?K$N6' $6;1&STK/K2=[>59G:LV8\VXDW]'J6.W;
M$,QKS:CQFN M7*=VIW\*W.T^9-FQVCOPYTOS1/;&XLM)139$@']C&[8%B?+F
MLWLAM3U1TAIE[Y$+(1R^XO3+[19V\NOZRJ=/>?>)&\>5O.K)FX7WEC%32BZ:
MTX$C!>OK^+>W7*]>^-+U2.;3L83@V/3R*Z_'^%V[W"WL[!X7HCKDP26M#O>
M@1U+V]?]3VLS(Y=KFY=@:OY9SY%+]8,EL(;T=TY#8O'^1^!V^&9QMJ7/7'V=
M45M =,<X$ 0.&8*^9=:8L0<Z>9\6M<80@8$XQ6+MVZ3&_*%J-/J'.W@Y^.)V
M+/V:SMLT7C4KQO.<(1%I.Q8[=;G3M.WAV9H6HGW YY-]A)6<M8P[:T*LES'2
MXF]T/2%S[/1UDG#O_@QLM\^0X-;;.EVP$;QL6I,3[IFY^S]6_E28W\]4]X_G
M%-VJ9\.T?67\M[ .%)%]M+)_ ]BY]Z[?#_)["57Q-_:^M<7U8U440$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M1LZ>E+=.7:MMCH=?<L?R23+>9,@+O2IP<.3W@M@1#IV%6K=1&N/O'G4RGL\
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M]\BU%QU_RVI>KO%N^Z_!,I)Y;TO6G1_*.L(1>4O3ZXX 1FW0OC^Q3)ZIB1Q
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M:G\H[]L[U*.8@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M]@?+X.%331!'X]F>;5C=U"9MWP_9GY1/];4W^<4WX;5;KJZQ]:WRY?[*R?\
M-9/X"X]N'?X?Y/8"J^)O[7UKF^K&JBB @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @SR;
M^D]B!-]8[$2<,"*(" @(" @(" @(" @(" @(" @(" @(" @(-S3_ .G4G\,S
M\().2\/3C[1S^[*N_LZ;_C+?AGJ_G[_/1_KG5?\ -ZG_ .F+K.'C[_S_ ,OG
MBXQ_V@?_  DW\(K'EI1-4^$\_>MSEJ<-*ANZ?6ME;\SX>@I>/\IU0\[X^OM*
MYP[-NA^/I1+Q%BD_#RS*G895D$! 0$!!DEF!5FV.\TR[XV\NE;]:Y<&^-O+I
M3UH;XV\NE/6AOC;RZ4]:&^-O+I3UH;XV\NE/6AXD+H]B>HSRWQ C''M4LPLN
M+]F6(N5FHWC,R\A25),/*TK*#O789K&,)9DN1AD#Q"V/+I4QL8WF,3A9ZEJ<
MK.6)::$')N*E3LY+++.N:O*Z3A')I@X*PY;(=[N-Q]:U<_X3U_<PN<3:8W9Q
M69?#I)C3AO#:M9:]:R,FVXW9J1>TF&T' W15[<.#D$E:G+F'$(MDK,R9=??F
MKC.W+M)&[)=;&V_O"6:<<XN$FUP(QO6.&Y7DE2TM:SCNFW,K<X9<1,!,!%7"
M9;DET"-OL[ES[7Z-YQ$I)F POY!69RO,;:TS*\Q4POM'E%ERY-=NVIDLRV6/
M#@+XP58NKAS0>+K59R,;G1-D5VZ\( K4JRN8F0S[$TEPSM=&%]REF>%YU'.\
M+/K4OT>"("*88PPN> <>15D;Z]<JUJDP$.OP[4S72W"K ASS#$^OVH>/NDY#
M3%L(8>KU)F,7.5BI&@AMW5E'O1K.(GY A9M"LA>,I)AL',FZY[L>7&/4D3&(
MPNO',K5ZLK)<8QAVK&<-6_1D$J.74K+DF:\>'^UY="J9IX9R'+H0S7D2CL5S
MBM3/+(V3&V OR'L3VRKGX4+8-LV*,X1%<R(<-OK"U@]5$U:6"'8=&WG6;I?6
M.N=18-XBRZ^&TGU+G9O*VXF(K$QNZ3="SL5FYAAC3BC8IS!_/ >F/J6Q<M,F
M"+;#@A+<YKLO0ZB#I?0?0(X*1OO=:=O:74CPV1./+#:DS'FS/*TRIGNQB?3F
M49\DQQ<#?G?DBYTC)SP-Z,<.WG5Q>4:XF"(OOY8J+'ETSG6Y(O;+$7<ZSVE/
M:1DENOA&Y:DT>VF0@WI*Q[9K"YPM$+<UGMG+4^_#&7  K/WI>TXC6>^V%MRU
MC,23'/+$IZUOVCGX9V)A0M+;3RN4LL<[??4<FOA?EFK%O3398^(LCRL5WUVU
M)B89VS"(#E>K[)>LSEDWR,2IF&96L^9O$7]:U[,]KBZ:TQ]@A'%8S5DS6G Q
MC'TJ>[4[82\CX>CO2;J_=NR[QT^M6\L7ENL^$=/:4)MD 2?5K&!TN.6/+!71
M.TC2G208=.SUI-)FUH/D-N(C'EFC$ERU'T+7X8QP[U7;KRU9FEM.] =IO'.L
MV2MV2Q&3=(M)W#G<<^=61C/A!U.C F.X>H[-J7;<T@*G11[PW#8<CDD.UR@*
MK0]Z,&''#(G.W%,X6(>;H1%FX>K9T9J<S*7EINT$B+MQU^73L*DQP--^D[I,
M&'J/+!:^Q9C;6F:803[ANR*89]IEHS: @_";O;ZU+--^TOT:,REA@;,X\^,%
M.OT),L E'+L[TVG:2/!E.'(=Z298FWC<<.0[UN%F-N)C&"723->%)<K<QYM5
M)FO,2/NK-F>$LH'',]:F<-0),+SUJ^RWAQ6N6'D$"U2\->VL)&EJRQP;&%@[
M>A3."7>'8&CU^[NVWM;?9M4MRU;CEV[H.IM E1<+88A7.4SEVMINHC=EP>+=
MO,M83,BX2*P%MX-V69]2BRRMDU46PC@,(>E3U9O+ 9T2;^M63!F8Q6>5/ OC
MAC[%;'B_(^S/]9&$?3W*2/+UMCQ]9VGT]RN%]G@U.WM[E+GPG;L\BJ=]]Z"L
MS1*VY-6;+<L#F5OA.W:92DJHWBVT\K+NE9QY(V2^(-_+I4RU.OE'S([W+F]2
MU:MF>&N\P@LS22X<0<EJ5=5L2GP.-T$MRQVF-QL[\19%8J];:UII^*_#T06N
MMQ,-6Q'OF0=>?N6)E,P94[A$#EA]Q2[;EMVD9-5'T8>Q:QH]DO(G1A&-L!Z.
M929TDUNI:6Z+8@GD3W*K>64NLOMLS5UAC%S]FM.= &)-L.7H6<^6\R1&3)MI
MM/IRYE>8DMNO##'>-FP=:D,8'-A","J,/A[&]7L3$:M^AX?[7ET)IG-9Y;(;
MMW5FIDS;<)&4V !LZLPJU=3#+"-F=G6C+B9,,N72DS6L=;MIS&0A=C%=9H]M
MX8&N .*U=QC'E*4\P66G#UI&]1*MGB M-V9[EIAH5E39"..W(8J+C&U<G5%]
MIO.)S&Q2::C3\?:>L]RJ8;#)M\8X*+<1S\4X159YK,)M@ON&*8B;>?%_;=:8
MB;<@XD1B;4'D&"8;G;#,UUEL5EO&>&4&"699LRV=_:>72N.4]7%TT 6QZ>10
MQAB,T81Z.00\,3YMAOC9ZE/*9\/#)MEL;^Y+R9K)X@V\NE4S7-K@XP$5&\MZ
M2TWV7#UIF5CM-LSFDCI6F>-UB?[H/,>P]RC4VAZB:8D&,+O3W%"Z:?C 66IE
M?7+/*F#>@(X'J1,U.TUW1^Y18DP8".P+4LQA<^LRJVN3?Q3K_A=^"LELNXZ(
MXAG0)%OTNT(29W5#^L /Q^+;B>9-EPNVB5?O7X#!3B))C<=M:3518R!PR]BD
MNVIO2?F59#+[MFPK64O7/"%J:HEU]O-#+842:Y:[9^]83MY6+.+2W&XX.G&)
M NY;%9#VS/NQ^)SJIMX+P<[E4LMN7")S/6H8C)OC;Z.]%<FOB;(BQ%EQSPV!
M,$!&-RF%]F1CA$'G]:?99<MAI%APM0O#RXQ-F2$TP31%O7V'O4I9G:+F,,8V
M+7A)<::,R:6V#/V^M&7&74F($?1MYD,67/A(,?%N.7H")<VY8GDMB?7T*-S&
M&M,=OCH-YC>%6;_Z-!XMZ.]%DRPOPZ?4I5ZM=Y@.GO53.*Q[RF%]ZYMG;MF7
MLV+-Y>CX[EMR9\3>>S Y!;E>J=6^'Q$8FU3VRNL,$XQ:>GL*MTY6RU7JDD.M
MV>M/;6%DQM%.?#.!VY*6U+SF,DL[T",O8KG2YU]V1SH-/,IR>VD+53^?'E=L
M5U'.9NT#.F$G&Z-^SV)ETS]&NUP) $>GG4O#/Z)FD)]W]LI+&IM/2#9CRBM9
METN/HWFNQMN3[0N</!<(IG"9QJL;G@&%JEM\)?J\@J<G7MH6K?HC2G8\_K*3
MAJ(B?CS]RE(C#\1YU$\LTOU>M:ZZ=+_%O-NBEN7'&:%PVJ<-7K:*N0@PS/7W
MJXS'3K<-1T23SJ8U]V[OAKO:;39@I=)]O+$1?S)#<K@' 66JUW^/AD:^,8QP
M6?T:[=6UOC;RZ59,<L.+W@M-_(\Z69(CZAX@;^03B;++P@:AUIAB3Z?N+4[$
MZZ1,Z9&-IL![%,MR^L1DTQ,+;1Z;0L72>Q3M@[##M"WC65E3<@P'IZU.-%VW
MFF/5%2Y<YULV.= '.Q2?5N=<U@-KET_Z5LQIYO*YRXVUT_BV (!.=N=N6NL=
MOH.#[NGU%9&HZ\\ZC5X<561 0$&M,)@+5'3B9B.>8PYRHG_NUW&%\;U.:S7E
MIC#).+A9RV9=@!YUJM7AF\0M&,!M@I$FFJ]V]U8F*J^&($ VJ=9EGKRWFFQ6
M3;OUN)L<X +4B_RU&LX%Q+L/:I>V#&(P/$(\RS+GA/+%&&:UA;9Y<24SAFW+
MB7C:IC+79A-ZTP\(,K#8!S^M2\Y\+C662*F8U*$V'F*9,QA)SBJ:C@JPX/NZ
M?44'%J3EUZ/+K^6U3MPS\O#CBN';EYYRX.O6^G#E\O\ )A?ATK/_ %,SBM1_
MPGI["OK_ (KEVYK3HP6U+3^SC9SKZG2\./E[2>459"ODMC9X\OM!V+[?P8]6
MX_8[RYF-?PVTG_(,V_1YEWMG#4GEZS^>I:*6:=KL-CO6GAUEQ'Y)<?50;J=1
M#_+OVXNYEY/GF.M^COTX5&15EQ;[UEF!V<Z^%\EWIWZ_1(3' M&WN7S?R]]&
M^O[;GPA:ID+1#JADO@]M]G>6V(J-O05V^.[</FX:X_+?\)>IYYP]A_*?_64O
M]K*_":IY=.KZ=_L^/Z3HW^;2>QJTZ/LM^4;_ %-HG\!ZBGAZ/CY?IE0?T9G3
MVKSUZJP3OB//Z@NOAOJVI%H7*M=V+5+*0C8>Q2O/]74=5^6/[8]JLX=)PY*,
MB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @S2/RC4%,\
MZ_[OJC^!G?R3E>NJSW_@^.GYY+-2U?\ M"?VO7HG:8?.[:[8KYX?.L_SVO\
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M3?A ^I6UJ2X?6A\N'^RDC_-)/X"Y=WH^'^3V!JOB;^U]:Y/JQJHH@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%_7BJ291$Z<)CK"#==# (U)Y>91+;=OH4:DE2,JJ#+_2>=2':2338.I- M<
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M5#R.89\ZK/%9_K#H>TH:Q]V"94.,1 X7&*EB]>V&L7N,3;:K(E[;8B]PSNQ
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M#_)[ U7Q-_:^M<WU8U440$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]X"'*(6I)(FXFJ4"/7Z(01TQK*1+8 V)I)>V4?,^)&NS7>2(0VK&;EFS+"'
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MTC\HU!3?.O\ N_J/X&=_).5Z\L]_XOCK^>7=^OZO='\X3^?XWKO,^.'S^_\
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M\78<L%?'W:D:%91FVS/&&',L]MQTZXS]U!UBGW0[IC$QQ&Q<V[+76NH,+=^
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M=HZ/,!;+B1=A'-5,>5RE$;@Z.P*-RR\.3S9@C6$9-8"3 6QS[U7/.-L081;
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M^O\ BN?;RTZ#^E-_;^M?4Z>'GO+VL\I)#?KLAP _+RCZ0OM?C[Z[;S>'Z_<
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MYLYM_P"RV[=BK'W:;WQC=:?:FFL8F8Q.(<"(W# [/:IG%^ST?'G&4=/LC#E
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M0V\O2B3?*O37OCTG!2M]ICAKLFO#^:-\=JOAF9\I.FF3"1SY;8K-6_9.R(D
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M[3&G?X?Y/8"J^)O[5<WU8U440$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:7,9'[T7\MJ^#VO[K?N]?3C+S532T1&'M[EXORKGKMN=I;BM"75DNA$W9A?
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M[XPA;B.].=Q=U RM3J*>; .<+<\!#-/*+QI.I39OAASC[T";5J=<;;S'9NE
M/:UQO!;WI(+G33=RR-D;;;+8I5\928>QX ,+=HRYUF[<^=M6=2RR#=='T^Q7
M.!%SJ>6TQ@+!CRVK,&NT@69P6JU<)*1 PC<81ZE$EPE&2I8@?=NY8J8:G;+/
M]:9*!#3=9VJXTQG/9$UD]\TQ:3CZ8KC7?K,17*JE?-!WFQQZ25/&6E&U72G
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!N:?_ $ZD_AF?A!)R7AZ<?:.?W95_
M]FS?\9=>G#$\OY^'SU?ZZU;_ #>I_P#IBZWAX[_)\\7&/^T#_P"$F_A%9G+=
M4#4KW+?;EN(ZGO//ZBL>6NR2?=T%.S%YB,F?&.?UJSBI?":HA[HY8%.+EBS*
M7!C8M<S#6,1Y6+I! 0$! 0<FF"N=,]M1S",QY0$! 0$! 0$')IA ;5+#&V59
MEPHUT(V1BMV9<V99EP"V@@(/*#.TQBN=F'23$<UL&FWH[ECOPSG+(DX1Y"LY
M.69MPY8I>3AY4!!E:815ZUNS+,#NX16NW##(+;<[5.M9O471FZ<VW!9O+%Y;
MDB[I':5&;PD9=QY^Y6L]>651MK.O/.JYUY9\056)"3>WI[5SO+I&TJV(-J28
MD\LN](G#<58>05&I?#RBW3BJQ=@,"#D@VF'>%T%Z.G"QKS;QS=ZL2.4LQ@-@
M23;K)B92,LAK;>5Z=HS>6I6.#FD6V#EVKG)<Y%-K#?SGL57.D#,'O'EBM>"3
M3:HQ:!SJ8PEBP26>['E@59<'7524H0Z$_DMN<I:3=T>M.-.5Y;;38!L]2N%Q
MK+G%0EP%$MRXD1*N5EPY %3+7;? 0C-F'A$>08&*#988P-R>5S)&W+>1 ;<^
M97UE9ERWFS2++;\_:GK&[(XS)ET8X[<EF3#+2>;.GO5SFL^R'J;CS'L"5KKR
MHVIB+G<L%)JNLF-NN-1;[QMQ6LLWZJX[XCSKG>6(\*#?H7;LQO2.76KVU"\.
MP=,G !HCCB=G/FMRYCE=KYILX.LB#[UPON"C"^Z>^( AEBKQ<-=;BK"SX1RP
M"6;;[;>7-B#'L5DVS)A'S9<#&."S2S66NC)%:]D<@8IG+4KRC4VYAA-H[%B\
MKJ:KP95L3"/,DMC-DO#@1 P727+#BL+FL+G[PA#TH/#3 JP;LLQ YESO\EZS
M#9EX<Y[%N)W;+2E3I<0)20[=IPX@*L29:\RSK(4=)<-1SHQ&U239EX;\02\$
MOU2$IX@-AY=B39;Y35-ARS525/2?AY9E8\_Y:MTS+;+2GX\Y[5CRU$3.QYUN
M,=G"6[W@(7=_M6KJ.6=I20XB'?RR6+N-2MKQ1E9SJ]>$M^C6G3(@0[>=)K=)
MOEIN?"&*G\EU'@3>?K6L21)BLC70(=TWYA3.\--MLR($0;L\E>.!RC$14L\L
MVSAX*C+ANG8M3;7M&4!5F3+88=V!OL[DLS#AM,G"XV6<L5BRSAN8LWR\. F'
M83'J'2K-0NG)LAH$>GJZ-BSG]V$SIL2P +A?EL"U9BLMA@%O1ZUOP-D0.'6
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M[UJ?C'-W+#ZTX:R @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# B
MB @(" @(" @(" @(" @(" @(" @(" @("#<T_P#IU)_#,_""3DO#TX^T<_NR
MK_[-F_XRZ].&)Y?S\/GJ_P!=:M_F]3_],76\/'?Y/GBXQ_V@?_"3?PBLSENJ
M!J5[EOMRW$=3WGG]16/+79)/NZ"G9B\Q&3/C'/ZU9Q4OA-47PCE@5+RRF$S5
M$00$! 0$'*-D%G#'>:>57,B4,TB4,TB4,TB4,TB4,TB4,T!3*RL@$1%7*YA
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MBC(;'=(LOMV[$U=$[8J GN=*<5+,.TLK/15\QKA[W(>Q1K47S2]8+#+&^/\
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M,-EV##/U69)45'4:5[FOAV'H[%K.FMR*K]5F-FN<0<;P<5HF/":E3'2F 1A
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MQ2_AK-CIU_B^OSY<O]D9'^:2?P%QO#T?#_-WI4_&.;N6'UIPUD! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\NU5-X;4B9 BTVDY\L$NTK=$_:+\_4IC$TDN(D9$ZT6[>J*DC>=)+Q(_2Y=
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MIR[9Q8WF_".8+-Y>J<.!O/.JZ3A&ZG^0*G;AGMS_ (=;S_RIY_6L1P[<"J"
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MW.&Y'U[?+E_LA(_S23^ LWAV^'^;O6I^,<W<N;ZTX:R @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MEQIR"Q_U+,R.0<;+;(JZOZC=D&)$+H\O2I)95EN4F !<%6F!XNZ?4L,88'-
M%@Q5Y&-,6 @*R^!Y#8VP6LIK+EO 7G:I7?KP.?$7Y[%)(8WII3'P!!./K4Q:
MZZLPK]6Z\Q^^5[8D^Z68X5J88N)Y8J1FYY>&"+@%:LY3]*R$+,NPK&2S.XEK
MEM&-SVYYJ[\-1C<1"PB]3KC+7#%$*^T3)$)[1,PB$]H9C(QP OQBEF>%9V.#
MC?B-E_4I=3;-GT;.\!B.L+CV:EQ-M>:6D1$,?3#)9L.+]FL\M -HZ]JC6)RT
M9KA[UHPQYD&MO-S3@-]N8ZQWI-I[0WFYCK"83VC(V=NQY>M9_0NGAT\G&%O*
M\IDMQ&%T^ CMY8I)O*1A=/B#EGR*UC7W+<5@F3P 897\BK/NEN=M<U!@;<.7
MTDQ$S&L:C/O]:U<+);PQS*D!L?5L.U962RHF;6 .A;><MFPIG+OTU&NZK!^Y
MW06>*;Y8)E588$88#UE)?W+C7W:;JDQ)]0RYUK*XF-\L3JF.(NV=ZSVV<73"
MZHA>1T?=6>N^"X:OUCER*Z=<I<WEISJC=,8XGT0&:M9N^.6 58^^Y=:S<DER
MQOJ8DVWPMZMJFXN&%TXX'EUK4NMK.N\L1F.-ZEF6L.!<XXGTK$F#$:WO[5IF
M\O$MK]['KV':D=>J0#7[HB#<+UN6-W$GW<V-(MY^Y9[W3CVK)N.-L##I7*.-
MN_LRRVN N/4>Y7U<NUVXO:;+#U%)-L,18X--F![%]/\ '9[=I6&F!^L-L^GW
MKW?'RY=GL_Y/?TZ3_#2NU?H?Q?X.=?M/Y<C_ .%6?YNW\$KVU.LKT^^8'\A/
M_;3/\9<Z]/7A^2W&0/YTJ3_R[OPBOF?E\/3TLEVBZ<$AL-GJ7Q^UDKK+(S58
M(9T=Z^?^7+AU^&S/^45*'OKX?;^3OVX3<AMAB,%V^.[T\W?>I]$%JK3: ##>
M^XO5S'"3#N_R9'_:<N-WXK/-JO6XCIA]6'V<[?Q^B0'_ #.3^"U+;:Z:QM]G
M_P I@)T313_R#?6I9F.OQ5^CM,0:>6.?\)<Y+'JZ]<W:0#2&@X0"Q>7>6<1B
M-YYUITG",U,CP".=3M?#/:7_ -'7$_\ *GG]:S)7G[<" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(,TC\HU!3?.H1\OZB'^1G?R15Z
M\L]_XOC%^?\ EN-;K5EGYPJ/PYF2]/6SR^=W^KYF?.FF_P"T]0L_?SV\R.%S
M7JU74H\4Q&5\<N8+&=X<K=N%/26V <HYKITRMQ4LVF+;860Y8!=YVQ'*S7W<
MXB7LA]U+<QF3/+D*P"R)LLV*=9AJS'#(*X"R)ZQ[5>T9Y_5E^M;V,>7.N>V=
MN(#GW6K3?+E]3><#RZ$FUPVV2G-$(;+QGT(F?#F93B+L.6"S4QEISI+K0-E_
M059G"XQPP2J4EUHRO(V[%3CE/T5+=8/AV;=B(G)=,=T0&78-BLQY:ED<9LB#
M8$=?.,PI9"]OH@*BG)==F+_8I?LGZM#ZD_>L%F]ZTD3-_P )>EHSE@U;G#<L
MQI8I,G=9=&WEDL_:L<H?4J;>8^SE9L6K6\Y=8ZC3G??L&?L4DY,R(V0TRWQR
M]1CL6;R7:V:=5D$6XCE>569]%QDU.\T =F8&U:G&:WC.V&H+S=V<R9R90=0U
M\"3@%&*C6N<'"&?K6L,_Q6/3ISANQ]?>I--3-W%KD/)%YMY]J;SLQ6P6N-XC
MTA,S"330GB#C9RM7'MO?AUZR6Y<I#081S[UEJI)H:&B['+,K%SEKF-"I:T@V
M8^LK2=5*U26#OPQ Q.!)0=<:O)OYL#SYHU9IUWJ,L6P&:EZXVU(K;FB)!%Y]
M:L9S<L9DQM LARP5S5EQRX[NZ;H%9MJZK<DSMUP$;+,\QS)3K,+5I=9NEN/H
M[U9LLQP["TNN%EWQ9C9^Q1+<QV!IM8T[L3EC'N1G-X6IE0TM L-APZ<\E9LQ
MK"OZ@&O)NO/<NDE9LTJ5=3AX<88V6G$(DPH.H4)C,A=;AMYUO&(LQX4RMHB'
M$[.[GS65Y0[I1;>.75M4G/W:G6699Y4TL@(XD]NU71F<).36PW1&WGV9#F4S
MC+-D2,O5',  CUY=&Q;SDX2E+K4P0))@ 1\1S*O:2DN=)ZFUV! )MLQVC:LX
MPL62EU]H:(G$WG85F99[1-R==:XWY"_,^Q:QMGK+>4W(U5A@1"^%ZCI99$S3
M5S7P,=M\<ALR5O#-FDJR8'C:>6U,^&9SME8R-L!UBQ5T[-UKX B('4F(YW'A
MR?,L^+'/VJ3.6\Y\-!^Z28D7D7\LEJ;2YD !"-G/8IY276WE%:L^<UO+FVA2
MY2WPJFI5P9$"WIA==FK@TJ\[4;7&&!^EM*?9KF(J;J1-FT_2VJ:FT\HR9J&\
M2"80.?L"O+6)& U!<;#?#E>IG"XS'D;[K<^7.MS%CG9&1K'&\8J4F'ETMPPS
MY6I$[.4IKP<;^Y=(\7R<IZCG3&P$38.6-ZU)AQ[8QKE8952_= B8PM].U-I+
M+JN$^<XMC;>,.<YJ<W!;X5JK\1[C", ;;[C +6$S6O+I9LPB ,.F'8I6^F^5
MAHM)GO@X;T(9'!2-=KA+,H7R(%T<+Q"XB(QBM.?;%_5*TS1 "&9ZXJ>5Q,+)
M220^P<HB. S5\92Q+#3@\ $"Z)LZ,TR8:-3I31<!'8W9'UH27RCC1!AA?T0]
M%J%F]).FEEINNL6+?H87'27;A9'/UQ5EODG5<G3FB4#ROCFM9+UJ*FU@!A$W
M\KXJ-RZ^[E)JP2-AQZ.9$L\IN3/W@ 3R(YREXQ$WRYS '9'D.Y)G#,U<HZ8P
M@B PSY\U':W,<-UXNB.GVJLMIK1NF(ML[1W*N>;E5-3E-<]X MOY6%%S:KC:
M-V_"!Z_9FLXVUG2T:;IKG0VPP]<=BI+[<+Q3:5NL&<!>,8':K-QB\LLVA$L1
M<!8#A##I4OV)4'.:UCB#" VJ^"9SI&3&MF&R!S/?C@HWC+:I9.X8D8BWH4:Q
M+/\ "7#SNV9%7$NW*S%1M0TOVW^DHLPU/ A;ERR1K$J8HB6@!QR[5+F;C.4J
MM9RC%.I@YI.S G*&2(K<^D_&7<K=D4;DS&U34MUF'9#8L7//AJ8EVME#*W(1
M%P%O*"U-L=\9TL#7 -$3GVJIBHNM>VVT7G$8V)=0L52KF#>OR6=Y:YY:;'P<
M#'/;@M99WY3U&6O%\?1W)ACY,XTUZXEL2,^RQ76/NY3K6G3U)8ZR(Y$YJ3AO
MB8JPR:UVY")^[$6]2:8[?9X?.+C8;^WK2;.MUMNTPWK3:38M<&,W[)-\H%AL
MP]2S:Z7$FN55K6AKS 6B/:%&,UI,?!P .?<A9;NK!1R@\;8>H;"F#'E.RZ>#
M0>GTG8DLB];MXF.W!@+X\NA:Q*U>/NCIM3@3CRQ2S#%Y:8FE\0+,3"R-^U91
MR;)+R+,8\K"M8T>OF-R73N:( 'T[-BY]M/1\<J6I!-!!MP$>8[5SR]4F:L,F
M<YC&Q-P'HCM4S*688Y^J-EM,869NOLVK-F$5'4.(Y<O?!($ /I=&:W,8R9PI
MU9Q=):2-X?X8S]BS:NKM!.XQE1/O#_#"N=$D:=3QC)#3[PM_9C %6\?<LVK<
M_C,%T ZR/W^ A!<^$X059QA$1WC>"??.S8K-\+RJ%9Q;O;XWCC9OVXJSKA9I
M4*_B-SMZ#C=]\<<HJV,^52JM:FS+B<?I;>E.-U=>$'-U*<ZR+K+/B.U2]CKB
M_JTW5LVVUV./M4]LQ=Q'U%;.)(B^,,XY)$TC)CI\TV[UL,Q;:ABN4NBG37"Q
MUMEQ.(/K4EL:Q(L])H\TL;&-NPY$K49DRF&Z',('NG_!/<I9BY+RXNT":2?=
M=A<#L4JS$87</3(_"8V7C;S)$O+LO@_A!U1-9%L; ?AC;SJRH[ZI. 2V7+<6
M7@'X>O!:[<'K<INEX/,IP);8/V'3S+$TN%TT[0F2=T0 A _".X*Q+GPLTBF9
M)%H'5#KO3-A)/*0E54N41$@B/KS3<6\K)0:[+EN%HA9CS<RG*87%G$TOZON
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M" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @("
M@(" @(" @(" @(" @("#<T_^G4G\,S\().2\/3C[1S^[*O\ [-F_XRZ].&)Y
M?S\/GJ_UUJW^;U/_ -,76\/'?Y/GBXQ_V@?_  DW\(K,Y;J@:E>Y;[<MQ'4]
MYY_45CRUV23[N@IV8O,1DSXQS^M6<5+X35%\(Y8%2\LMYS@,0DBR9<?$YO2M
M8:]#Q.;TI@]#Q.;TI@]#Q.;TI@]#Q.;TI@]#Q.;TI@]&1I!MS"DY<?DF)_ES
M5<A 0$! 0$'D&!BG(R@@BV$3@L685Q(R"LK4H#!,+9EL,%A6<N=GU>#>>=;=
M)PY-=S7*6)QN.9(A>.169-M=;]7AI$+QUI<K61H:0;NOVJRV.?:?1P6T9@8W
MP6+%L<UM,6 ,$LRC,UT8716+&I?#(K)K#3D#G!8O7%TS=.2J.0=N]*69:ZS+
M*""I+4QAY51R!(1<ZPRL,3$Y]R>'/MRWFO(NA?Z5KKSMRX2$MT1;!;TS7(NA
M= J))]6,N$;QUJ-N381CL52\-N2^T 0L]G>I3JW(K&6\O"B,\NXK;?AG9?T>
ML(-U 08GS-TFZR&:EJ6L&_O/CA[$Y)]4M*_)]:[_ !L]N6M-^+K[2M]G6<,!
MF<W45/5RO6QIU,RR,1RAW)KA,8F^57K)FT#XO6KXP=>4)O OO'Q9C-8VVE*4
M!QSN[>Y:3'_*W:<QHW;, ;]D46S$6(6 <RKG^CAO'8KIKU<P8J,O()CL6LNF
ML?=S1,O(!B+,0ELPF8SM!!$!B%SF(NIPDY;R&PLY!:RQ<UP<_&(O5MTS);RT
MWF)LMO4DSR[2^L<<+>5JQY<^UR\1&:K @Y!3%:G#RK-*SRW1C=@KA>KD52RY
M0E<UI-V>)R*F+6HZ]U5EA(&)]:UXP94"M:8FPWG Y+&)4O* >"'&(A=V*YPT
M\-F!S@(CTY[5G&&>VXE9 , 8'%2[<.W*>H9NZX G';S8<RWU6S_AV)I-1&%]
M^9R"U6;J.RM,G1<+86#/9FL&<3*]4LWW6V@V>HJIN\-M[G&'3AS+6H2?5J3&
MD@"!MCR]*7&,^6<91SY<86''U9K%YTW+]7%LFW'K"8R6R,[!N$ V#OM5PG.V
M4O$+Q<I=+F\->9.A8"(P3)ZSE&S27&W+#;9ZE<>8F<M5\N,( V1QYLU)GR-:
MT8*V)C+,TW71@DTNXV&.L LBGM5ES=LS2;,H^M68NZUF-AKH660BEF=C)$9C
MK6<48'&,%<2,V8<(C,(F*P/ ='G6L3#/;-:3VD.-AY%9)QMQ%XYPHOAO4[B"
M+<>])9Y(GI#R TQ$8=I6YZUJSZ-OQ79]O>M_M5X,XB\CIBI<7A9K;DQP-I(M
MRV16,YTX?-QEN,<"! X+&=X>=RB!B%O.!C?,#0;18(J6Y/'W:$R=&RR[M5RF
M<L&^,QUIYRS[5(T\R( B+>XE/;&F\:RWR;+$C.<\M9S!O1.SE>KDS9QP\0@;
M%B\M];/7;*QY A9?CT*ELSIRWSF/0B9AXAS] [DPOO&3>B+Q%(SVOEQW8GG]
M:UEG-2U%*B6Q&66Q+=?=TZW6TH9&P=0[UE;9X87T]N%V0VHS6)U,#; 6;%+6
M;V^C"Z3=9ZONJ8.W7#"6[I-D+8+4C.)/U<-X#$)5C*R8(@1$$E\M2YNV]+$8
M<LTSG;5GF-IMD,HK=^IF\,X?EZUG.6;,<N$QT0 8*8PG5'S6QC 1M3&5[5$S
MZ8$FP8B[VJ)UJ,F4(=&P;+#RQ5Q&L8W$)6:()EI:+S]%';I,QUUK>CB67P:(
M1,;-N=]RU(ZNL=3IO"+K!?@.CUJ699D_=]E?;-\.8"3B=EBRZ8^B[:)JA:6"
M/TABEA)]7;VA:B3NQ)O:;SD"KX<^UQVT[1TZLW@#;8!"WG*FX9TGS.BTVX9K
M76ZRN&K&-J6WRN,:>%#&7,MR!])4F?*=7-K=F&U)G)S=\,S7$<T(+6XEZRQE
M9-]X6A.69,7#,:F AZ^^U/L691D^?;?AM6,N'>X_5'/G1A:,;U9,L9:,QQ=R
MZ5O[)AI.;$6@V++=OTY1\]L(V&_O537GEJQA;DI;_P L\N#INZ;\,#Z@K+K:
M8WINT<^+@8FR)M.WV(WGPL$F=8 3VPN"EX9[:24N<+;L,"LY(WY<ZZ&6$0M>
M$[3/#>;/$!S;8]:JY\-J7.B!;G?':F5O7,RS>)S>E7+/H>+M'44EVLZV-DS@
MT$F'9AM77KP8N4)73['PC<+CS]"M:ZQ5:NIB2+;SCT*2;.T\H9TV)-HOVK;'
M7,VRRI@S%_<IRU;GE,TTR)$2/9:A)%ADN&Z($6]Y6;M;^W48*HQ]/K2:3S&@
MJTRM;=?==T(F;=>&[*$ .8]JC5QXY9E4>$2\,3@8W&Y*=660/>Y9A9IVE2K7
M%H%UP7.W++5G>]O$YGEU+-UP80\^4#$ &P>L]Z;.43.DD%UZL*T)DH@QMN4T
ML[>&!&R!R/4B9B3IVV6A5C.]-JY2ZV9^K$Z;NGFYXW)S"\9C$:J$;^M)%EF,
MT^MG-W6$VL]:\_6LR>M3*=ICAQ\=SKC=SX]2LF$<A.+8VGTJ7-3:OZS4?BW&
MVUIQYEI<.G]8FDV@F,288V(36T#(]YT#F#Z47/U733)42T &Z/*-BEX3LM\B
M69;&D1NY9J2[,):3,(LCS6<PR6URDV.C&)RA@HG+FABM:HNZ.]!"O<=XV\HI
M9$ET\L<;XV@K/%TJ6DO+@!E8M8TL[>/#::#;8<$6[X<X$7@HRTZF69@(Y6P2
MK),Y1[J<B-G4(>U&;RPF5# \NA%;M.(0CF.TH1)L?NB-E_<C5WJ,AF../H"8
M8DPP/),8YHWB8RT"]P>3'D0B3G;:;.BT PNA<<NI"P-H.-B(U3+(-QZPC4F7
M&UF%D,;<\D2S#D:CER"F2Q@F3"_'ER"K$SG;#NQL4QB::_5P,&Y"&:DR]'QS
M,C(P[PSYE?U=^&9K(BT&_N0S&":R+;C<>SVK>,1J9053*^(P-@CZ2L5*A)WN
MF'*P#O1+PU'$FS:B2>7.42#RV)EKUS<U,2S[H,;NZ*0[?9S$TY\NI7%27')X
MO[(^E,M9KR)A-Q[?6K+]4S7A[S"TXK-OT2YK7>]PN.7*Q0G#7?-A$DF-F>Q;
MDF!@=.B# X0MB<U+]AKF)OYDD^H\0@K>WT/7# XG#;M69;Y=)CRXB,5<M6S&
MFP+AS!1RO+RDY1LT[R#"SE$KIX(E@^RTCETK%N&LL3W"RT8X\RS&9EA<8C"]
M;F$EOEBB,QUJ6YTI$9CK"@;PS'6F<;'GQ !>+%J;F3US<N&^#:2.SM2N\X<'
M.A"!&W%16G.=[I,;;4E29_PKU6^,19CV*7>V\ZP@7&T\L$G#.?#G*^,<L0K5
MD_X62F%T ;AV%.LC7"0?!H,;+#>K<,W'AH%PB;1>5,V-2:8C,(M)]'<EQX''
MQ1F/2LX/7)XHS">IZO(F"(M"8,8VRAXS"LMX)O;F'PN(^XEOU,R,_B%UQ%F7
MM7'LN/JQ/< +Q>IE;/JCYLZV\7[5BUG+3?-OB1Z2;U?"YTP&8+;>U.7.]KG#
MAXPV=16I,*>,-G44&'QX",3_ (22#"ZL'IS2SRDEO+6?5Q)!C>?I<^U%QAK/
MK (CF^ES;4EDI-L#JRP\Q^E[4[7/#7K&N:T 'F^^]J&)G%:SJNW'_"]JS<G#
M#-JQN&!...Q3?EN8J&?4%SC;"W$E;FG3$<3.,/B])[TJVS&' S\#'GC8LX98
M7S[[<,_5>K.ND[5KNGWVX8$CT+-(UW5!LB3UE.MDX5C=/LO[>Y7?AJ-9Q<^V
MW[JUEJR3?EX:PDV@HF3<.]"V'L3,,L@DDD7W[%,W.CPR"GM'..5ZLFONS[.;
MJ8"$+>7.$F3K<O(I.;J/K4RU;7)M/NDV#H;M5Y)6P)40!#"_[MBN,;O#7:YZ
MY9A)&["%O0N?9QO#R),("'+FC!98^S()0A=V*S+G9]6-\H6>[GCS+<YVY3'A
MJ/880A8OI?CX<^^)7"1)_',,/I#TE>OXM]L.>KP]E?)^6[\X21 P\>7VK]%^
M-KHGZOVJ\N&?_"K 0?Z.W\#O*]=VO6[^ST^^8)D),^P_$_UI?XNV?H_)3C,#
M\YU(A_SAWX17R/R\O3UGGRCJ5EC+#\([0OC]\9VWB^62K;%IB+AWKP?EW6G?
MX)<_9%2FC?Y="^%\FK_EWW4[3,)P-R[_  S.W#OUQ_PB=4E_L3\0SVKO<QYW
M=/DY*_[3EV&^5^$%O+OG3ZLOLYI7X[1+#_1)-]GT6<RJ5]G?RF,W=#T4?\B+
M^9/#T?#);'Z.43!X$LD8GM*Y9SF/7WOK/VI. (A@N?E);RTWP:3@MQZ>MS$/
MJCAX1M&/8L67*VZ=>3ORIY_6M3AY>PL@@(" @(" @(" @(" @(" @(" @("
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MPV>GN0Q6K-J0+(XY<^*EN&NDSRC'U0&)OR^XI[6Z:QBM5U5:;3><#WJI;G3
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M "3N7T5,VI5#F?E3^V':KX<>W+DL((" @(" @(" @(" @(" @(" @(" @("
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MN8V)@DQM8Z#ANI?N>[&VV(.(.Q)S]E7O2N#ITP@F6+QAD!L6KQIC.=5V5IW
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M,F63E;ZTSG@YBI:C7N:;'NQSY8JX3U1]!7N?. +C:ZXQA;!2SZ+)AV)137-
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MU9?J R6/9=MV31[L/=%T;CC]U:YTC<%&(#W1=D5,XT//U6 ^$=13.:U+X<?
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MV9'*WTK76,R>$GI>I"2X F$2#VC!=?1?5V3I^JMGM:(QL;Z^]9]=L_U8J7-
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M*B1 $6]AYEC#&-K!2:2(6@W]^Q2ZN%]:RU&B%XL!^Z(9)RFXJE;H,R4[Q1&
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M7,3X9]9[E+*3/ES;-C&TV=*UE)F.8FDV=WJ4S8U+CER!MBKGS2;N7**OM&W
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M=X:3S%QY;5(U.' W%4YTQ.)-J:\&/6,9,56;<B9PF,N#[NGO4SDW&)4;,H1
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M90*S@F?+NK0^'9+ QKF&_(9<VU5;/H[4T_0) :+,LLQL@EJ223*>'#].6BS
M99*9N#5F7#\PT[/H[<%?U),N3=/DR+;[1T01;V<G3&2_I-$-N5NW%$]FI,KF
MW!PO.6"LX91\ZNO@X7D+.*LMB*G53C]*X=ZUB+E'?6SXA$;R<.="S,RLM$YK
MF F'HR5D<>TWADJ9H#"0<N6*S8SQ%.U&I=^,$<^SH23,2WZ.NM3?-<Y\ 3S?
M<5G7Q"YQE4I]/.<ZQCL<]BO!G,8A2SA;NGJ/M6;NKG6&9LN8T6@V1S5];4EL
MJVZ,7![2Z-P]2DUI;SAV923ANMM](QYUO.%N(E6U#0($CK]BS:EM:4^K9='$
MX].2F:LMC696,!!WA?F,^9:F<DGG*?I*^7N_$/B&+<^98O*I=E7*<![PNS'.
MAG-PCJ_PWR3 @WFSV*><L^76E?(/CD@1&]EGUY+I*M2E(-UK8X 1]!2Z)$A,
M>S<O$;,EB[IQ=H2H8'DPA?RO@K&.]S&D)$R,0TF^X)Y3=CEX,W[QW45<IZU&
M5=.\1L.&&<.Y)725'"07WB[85E<M^13N:0<H8'+,JLV[3\AQ9#,1-^=FU$2T
MN<3U;,^9:DTW)K:1D.WMWE>?:F$N/"38(@ +++8-*YPCF.GT%%R,I(&XX&\X
M=2MJVH_4W"7*>#@V/H/>LY3&'6E16%M0Z#B.C8KE<63*8HZQSQ")MLZ,594E
M:>KRC,E&()L=Z!8IB6EW<NKM1I0USH"$''MZ%;^V&?"M3IQE@@&&!RC'V)UQ
MRU-*/J\Y[YP$2;1LY6K4D9[5=^#*(3GRRX&\'T\Q6+-Z:DT]F.':27)8P0A[
MS;>C8MX7/AW%ILYLN6"2!=LVXK-J9O$;L^O;"&^V[9M"FTSC31-8V/Q#K'<L
MXN2S.QU2T@Q(N./L6DGV0-=/9!UOTL^9+I<55YSV/<;1".S:KUNMK+CE@<QI
M'Q"^/*U6R0O"+G@"($"(C#8L2U;)_E&S6DQAL6_&7"Y:QE.)^YWJ++X9)<IP
M/2%9C#<F?U2$J6;8G),RM282$F6VV.4+HW_<6.V^&;9695&I.DA_./;M"8;\
M-)U&'1]WTIEF/#*,-(LQ5I=M@4W+D59IJ1Q=($('EZ5+V2R=HT)]$QQN%L?7
MWIES]2GT]H=8(78[>=)<-RXF*LU-)$NRR(Z=B6EK9F33+'5Z3ET).2<J]6S'
MS ;;B<L4I51JJ)T\N&Z3;&P9JR9,HIVA.<8ECL[E.TV9:<S17,!.XZ\X0L'-
MSJ'6X1C:)\N;'<(@3>#"^Q7&8U5UT]I,MK>:*>KG[>%II=-;.A88PP$<K;E)
MRUC,S5HI=*;*@2#<#:(70*WF)PYU $MC@+(9=:EF5F:I>HSB2\1./:-BQ)]3
MMN85MLT^)_PCRN6NMV7K)M9].J=V$3B+X90]2O:$LFG86FU >T;SA:-F2Q;K
M3M++P@^(9K&DP(^E=9<05KJMSPZ4UFK <^!%C]F704(@Z:JC-%MVS[JCIFKG
MI\W>:R\W)$[=?*PRV;S8V<N96IF331J:>\PZO^#D42<HX28/)AB;QWE3"Y^K
M.VP +4^C-QG3(UI,+KP.Q7B81N2Y0A$@"!NZLBLC(01"%E_J4_4DK!.<X-O]
M>(S55"U3RX$'(]@69-K9A4ZIKB[&'/M*K4X;-'9?EV#O0O"R4\QIAS#T CU*
MLYUA("&Z0=O8I<Y)&(RFFWU>U1NX\)6BE-!!R)/5TK3FN%$YH$+E&N8EG5+
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MR=^6K:A:R62,+B>76L3Z,8GE37-W:KI[3%>_X\8,SA;Z:H+9%YNY8+V?!_\
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MM?\ L=*_S.3^ L=N'2<N\JSXV\Q]2\ST1I(H@(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @(" @(" @("#<T_P#I
MU)_#,_""3DO#TY^T;_NRKO[.F_XRZ]>&>K^?O\]'^N=5_P VJ?\ Z8O1X>/M
M_/\ R^=?C3_:*;_"S?PBLNDX434/B/3V%<E1<OXV\ZI>&Y.O;S%:C,X:KOC;
MT=JPTL%'\ YNY;C/5QJ+SRR3R3EJJM" @(" @VI.'+-9\L]^&<WK3S7EX1!
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MI]*8D@.A?=SK6-.OQM8,+3"!O!QV)ZUTK.PD$7WA*D^Z3DO<(&.21F\M\/
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M)&-RQ+I+VWKAA\:T#>Q&7W5I+,W-6#39HA:1=F.],X)/_P E+S)^Z!:#;F,
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MYCG;Y;?U_P 4;L8J;K%WPPNIO&M()CZ;H)OP=<-29H(FWM-MMQQ6VJTYW#C
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M-BV\WY?L0IE)=JU,F0<8D^J\I=W3>)>6W2,WW#GQ*U)B;3'KQRN5%2@AI$;
M,-OM6,INIH-,MFP##F2W"3&/NK]>\[S[3<5.5]MJ;5$E]D<=N*W&LRQPD;T<
M;3ES;%;-,7E+RYQ;#ELP6<.GK,,PJB".?,JS.$LPD9-6<(1B,>99F[MFYS]F
MZZL@+2WK77I9-,=^&I-U*PC>'6O1.'B[;ND=-JM_$=?>M];BL[CC+F D$D7[
M%U\'MM/T<S]E][AS;%BMV?1::1T6B)Y!<^V4LQ$@V$,+]B\OR\I,L<T-W<.1
M"YR:JY0D^_EL7E^3EO,PT*EA,LF&'<5B3+-EO"B5)W*B-WO>M>SI_%F2R[2
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M! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:SXV\Q]2\KO&DBB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,9U4_ENI62QL (6^NQ3&&^O,;HIP[#+!JL.UG#8;0M.'H[E7.6\5BFZ>&@D
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MHUVG0WHBX0N4PUVU-*G64^XXPPB;+,(*,RY04T$")&,>U%K7WBLY9S4Q2.;
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MO:U2)0+ 8=B25G=5[6I8:'PR]0"UUA<^76M6?QAY^]+;E'*EO'..TJ)>%CE
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M.K4L+?Q]+^$L5Z?CX?8K\M?^QTK_ #.1_)A9[\.TY=XUGQMYCZEY7>-)%$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML&IG^:$9-)] 7>N%G+JBI$9KC^R=VK<,BR" @(" @(" @(" @(" @(" @("
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M<-AU*\M/NQNQVA1;FZ0=723(?#GC^Q23--S:K5-*\&XXGMV;5/+4XRU@XRQ
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M^]+,1%3F0C?R@MSZPZS-8FB )Y6)[65KM&U)GN8X6PYML I<VZ8SI;*"KBT
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MYF'7E<R!(&9[$O"3K:CY!+)L1L4FFI]%TT^IAN6_1:+]G/M736%LPO\ I58
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MA&#B=I7&9]G7F-?4K:1Q_8GL79PNK8ZJJ?RCOVSEN(\+((" @(" @(" @("
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M7^6L_P#P=*_S.1_)KGWN':;KO*L^-O,?4O.[QI(H@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+F"J\[62D8! _L1@DB9DN%CD",.CUIE?5(LSVK4F8SV9(@8>@+-ZX8Q7ASH
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M#&/>KJ+)EN-D1'PX[.Y.5XX;DNGOBV%U\-NQ8E9;3*<1-F&S,;%;,NC>92"
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MN($SU8[ "JRK<R8Z:;3R@B\LE/IWUEX]R))RZ>=:;X7W2.$W/ <)!@8<KUG
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M['R?\SD?@+EW>GKX=\UGQMYCZEP=XTD40$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M73]#?.0/G<&NW8VTINLMW%\3_:7]ERMF'XJ^9M-,EUSRX7.F$]?,OQO?'O\
M9C.W4NG54J4\!T/BAAGF<%R[VYS'3JO])72GM $+MD,<EGF?=MHZE*$Z):(D
MQ6.VN77X[F95B;I\Z,1=S'G7/+M+X;5 PR)C";/>]?0N%S;]GHZO8?RXU*6R
MKI6QOJ)>6;;E?&^723.W[K?)?.\75*4@V>/2]JY67EUF.'V+_+3_ +'R?\SD
M?R87'N[]?#OFL^-O,?4N#O&DBB @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @SR;^D]B!
M-]8[$2<,"*(" @(" @(" @(" @(" @(" @(" @(" @(-S3_Z=2?PS/P@DY+P
M]./M'/[LJ_\ LV;_ (RZ].&)Y?S]?GJ_UQJW^;5'9,7H\/#_ /I/\OG-X\_V
MA?\ MYOX:RZSEU_5_&>?O4;\,M%Z_6I6.W+=GW='>K5Z\HQ]_1ZRL7EIFEW=
M [$C/8-YYUM9P\(H@(" @(-B2\@P4MPSVF8W-_F4Y<?4W]HY=*8AZF_M'+I3
M$/4W]HY=*8AZF_M'+I3$/4W]HY=*8AZN;'VX7<L5+/H>K-OG8K+I/6&\=BN3
MUAO'8F3UAO'8F3UAO'8F3UAO'8F3UAO'8F3UC,Q]@!(Q]>U7*6,L1F$3%$1S
M80(Q.7K4[*R$16<K+@:3C8.I+/HWF5Y#H&(@48O+*""(F$>?VIDS3W=G7[4R
M9KS!NSK3)L@W9UIDV0;LZTR;(-V=:9-D&[.M,FR#=G6F3-9F&$!9"*U*LF>6
M6+<QUH8A%N8ZT,0BW,=:&(1;F.M#$(MS'6AB$6YCK0Q')L(B$+\TM,1L*2Y4
M5'(&*YV>O#-C(#!;EG;E&9IN.,%FZ_0ZX\LF^<[.A.O.6LSCP\AWO Q"Z>Q<
M8TWY;K!:+[>M3;S]LYVSQ!N,49<'W#G1/+0GW=)[0HZ3A"S+ST=B1.W#@# A
M5)RWI#KHD7_=]"QMTTEY)+H<X[5MS[;2#! 6Y]R(RLQZ/6K&>S8EW]'<HLX;
MC; .8+'EJ7#,QT"+E<9:QG=;C9T !$*<)G#EXL0;EKKLS6"(-L0NF,*(9@AF
M"&8(9@AF"&8T)V'1ZUM9,L;!;T=R%F$E)NZ.])RY6;;['" B1<K+MKKF\MN6
MX0 B(*KVZ_1F!R5E9S8\Q3)EKSC%N%WJ*N,NF<:BOU4F)<=@6)^VY9X5VKDV
M$0SPV!:YC%NU0K)4'$0-SN99XK7/57Y\NTBWDXI;]$FOT:3O=/-"]29L:MC/
M+?9:1&*G%QX3LV6O.\+<1EF%<2IUNUITJJW"V_K.4-B1K*_Z?5EP!MM=F<@K
MB,9N5OIYV\+\K^8)^B67EM1B%)SM)=XK'N1<+UNV>&\R<-C<L@(E9QE:U'LA
M"^V/JV+>C3A+:-[H6+$YY;^"1JS$PXFY+PYWA@?ZAVJ]3JPE6\NEX<%&'F)2
M:7->8E7)FO(> ;Q%2VX^S4X9VOB!:(V^@J23.4Q&Q+>1"VR*U;$LVWV3(P$1
M?#EUK-GGR73*70A:KUWRDL8WOL$(7K>,->L:Q.< LVY9SX&N][!-,6M@ 0'>
MLY<_9X.[ W1YU93-8C:EY,Y8YF'3ZEJ8C-X:S\.GU+%3JX(VUG6D\L%9ITG6
M8RY,!$+"K.7/OKA(27FP66'L4[<L]=I>0^%T,>P]ZG'*YPEV3H"\7]RS;]%Y
MU7-\V($"+#RR6XLDZHZ>Z,;KSVI87:.<(QC&]25F7#?IO= AA[%+<KEMEY.5
MT$P6Y87BWH[T6366$M!OBK)AER$N-T5K/U;E;$L%D.;'F@IR9N4E+N!V>M,,
M]IYG+R\^Z;>4$F&9;+MH3+ST*WATN,,:RP1@KG"LTMP!PY6*68W&M6-]ICU(
MY28K<E81P'+M5S;IMM-?<+(9\W2HC)O#,=:N;(-&>\D&[/J@F&L:1;B0>A2Z
MI)]6S*<21&'*"O6XAQ^J2:^ O'3]U+<U*QSB'M-QYN8[5$X5BME1P-Y]:::M
MS%-U.C$QA$!&VR%M_<$27&E JM,(<\P'Q'# GG27;40-71%H.0B+N<>M,Z+V
MLJNU#'2C#EVQ4EV6^6K]8+"+3'"T^U3-Y9QY3-#7.!%IO&(Y8K4VU)A=].K2
M;23]'$;$NK]F>TN<+M0U<3T#&.'24,+SI\X$,_:CTCF6<8:ETL#(. .</4MR
MZ3$_RW UL!9RZ%*SC#F98 M'I]JU>TLP8:4YL(P':I),;:Q/*-G2HDF&7+TJ
MW&,1KVF,-4T\;8<N@A8VSGJAZZG)!S$.5A6NFH7KFH04SB388<WM5I;9&04[
M\0>KVK,2?=S^KV6\O^,B5QW8696=5BN-+BN+FG=-AY%)$8;0KZQ<V,,X'=C
MY=:PDY0%0XDD;>_O3-RWZQYI61>+[^7:MRZV8D6BCEV"PW-[5G.R]IX6ZDE
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MA_'_ (1F/V2\O?\ 9=O^;M_ *]'9GSMZC^??]'F_MW]A4G%='Y-\:?ZUJ?\
M.'?A%>/\K^*>44SX&_M0OSOR?RK-Y:\_UE>3\S^-_1TZ<-:5\2^'VY$[*^%;
MZNO5%U]YYQZUTB=^'<WE#_K25_[/\,*QTZ</JC^SI_+Z)_FDCL8KU6_R?9[\
MI'^H]&_@!ZU;P]7Q\OT=I/R$M<:Z^6PCTSB,HN',%6;RBM5_(]'K6+RE=9U'
MY1W[9WJ7;IPYO"@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @("#-(_*-04[SI_P!@)_\  S?Y,I$[_P 7QT?/8!]?UC_/I_X;PM77#YGR
M7][YM?/0 UNI1_RSNTI6.]QAZ75+&_6IEF/K"S&>UT5<!*$+("/H"[_'//W<
M)S_E773/>-WI7KU8ZZFF,NC:F9(N8\)+D<@"<%1G;*B#85G/U2V,S9 ,;.72
M2I:M[_1F;(V89#9M2\98[=LLP9"RVZ"G/*[LPSL9<;8V^M69SCPG#:EMM$<S
MV156=M:;0L(AFG*>6=LT"^'1R*7KGA:Y^.T<O8G);ZN)J6C[OL2:7K?JU)[_
M !01LPOPV)7+Y,_X1$R5"-AP])"CC*P^' W.Y="*SRV%SKCRB?4K+A*G*66
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M425)-W7-M ]MNU3/K5DRN^F546BW&-W,M<G:6<+Y0S"6B,,.Y63"3MI-,?&
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M5E\,XN?LQ$04I9AX1')HC%+VL6:K>E.PY8J39VF-MUKHP%D(>I67%,:RS!Q
MA8M8SM OPLY=*8DV->:[L*2[+VN<--XMCL2S+K)IX8^!(LN[%?73E>6[XAP
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M_*-04WSJ,/+^?_ SOY(J)VX?'%\]TX-K]8C_ -X5(SN>]7+YGR_SR^;#SWJ
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M5E^\8XPMYR/6KZIAI&<2<$OT&[2S"'"[%7"V96FCG1#;KAV]"QBKC'*R4L^
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MZEP=XTD40$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$!!N:?_3J3^&9^$$G)>'IQ]HY_=E7_P!FS?\
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M*K[SSCUKI$[\.Y_*'_6DK_V?X85CITX?5%]G3^6T3_-)'8Q7JM_D^S[Y2/\
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MS\().2\/3C[1S^[*N_LZ;_C+<X9Z^7\_3YZC_P!L:M_FU1_],72=K=/%;_\
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ME:LSMBEVC9[ +H6;(8$K?N8RBGRH[T876=2=N^=1/+6>S='+8DJ]K.(U  3
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M"/+J4]FO7PB7S7.,3B.7:I[82]&'QMBU[5GU<#-<2;<>97V/5X\0[>M/8]'
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M NM*GM5SC3QO)[4R;T%/>YP9<#-,<>M*EYTPS9Q#2;;CC'N3."7>$.^K?O&
MY1*E[QZ.OQ9C:E3R6] ]8S"Q>V6OZI&7Q>7(J9QPO]<&S03!:S3^K3.T-="T
M6F&&<%9WTG]38;3,,#$<UF"L[>Q_529(EV6C'+8MI_4U9C&B$' W[,DEPO\
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M2>U=O@_\7G>YO5CY/SO69R[+T#R_G5[FQHWNW@#\)QM7TNG_ (C+USZO+?\
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M[+9A4]0;X#H@W<O4I>R291_Y[,KW=[///VK,[86:8OKAJH'F'6E[F,UG;*B
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MY>$S1^6DR;.:31S+2/HG"SU+I/\ QR==X9OY2SS_ "\F4E/O_5GB#?O2NO\
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MD"$.Y?3_ !;&>\CWC\I=5IY=7IK#,;;,:+QS9+ZL[2X>?O\ 9^Q'E+14NI:
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M,*9T\ORR\M:N>#<5(Y3-1#90>0-O+$9+99A)LI 6DPOVVJ1.NM5%5M((.]W
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M]7.KF\.&-[8)S8-(Y7)-EGT13W!I(.9[2K8N<1)T%1 BW+NR5DF#.786EUD
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MJ&33;PE@0;9 +S=N\EPU.KS+\N:674-:&1M^]Z<ECO9C)ZM?B3@)C*)^[+=
M-,/=]EB^?WLY8NN'HYYF\-"CJ*DB6X;L;80P&Q<N]69KMGY1Z6&O4[8#^D#\
M/G7G[M=.O[GZF><]'N\".)A_0S_)G:OS'^Z_@]WP8E?A=YK09J,R)QF=I7X'
MY-U]&?9T;2S1XD(XG+/V+#I.OE<Z2#FC$0[UBS#?7<:M<VR(PZ,/:L6^'7K,
M(-SRTP,>M3AT;=%,)F-O^(>@^U<L[=_C[:P]C_*\;U;2C.IEW_MFJYQMUCZ
M/DED@ZA2W?EZ3//G7.]MY=IR^QSY;).[P=))A_0Y'\GSE2VWAUZ]=N\:R&^W
MF[ERKT=6FC0@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @("
M @(" @(" @(" @(" @(" @(" @("#<T_^G4G\,S\().2\/3C[1S^[*N_LV=_
MC+I.&)Y?S\OGJ_UQJW^;5'^.I'BO_P G^7SH<>_Z^?\ PDW\)6\.CKN=\?\
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MT9 Z-H/J4,1D8\@VDX+/:95L!^1/I6IKECVPV!,B![QNVJ2;^R3?#*)@@!'
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M65FLV;24J=OM%MO7RN6II<1R>21;;854N)M$SP[>B(W[=JC4Q9ARDDM<#;9
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MZTQZVNH:VJ>Z9S',YP0W%@T$.FS&WD%O;!%E>P7"LF#9!.0S4RUR[AHO#;)
M.[$>U,IZSE%US);B?AQQSBE7KC*N^"T.C9?%"R92<@AK8W6>H%2I?LQ5-3NM
M(!%L<881P3*SC[JW.K(.O;<,8W)G-:QK[MZAKH.%HNARZUK#,ES]ED=4F;+
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M/25=L]KIH/D$P@(7[<N=;9<? _8]JF6M.0D$6P6M87,X>'M+6]"6K/7#0FS
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MKMU::-" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MBYI$H9I$H9I$H9I$H9I$H9I$H9I$H9KPJC$Y^1Q5=)U^KA?:5+<);9<3AX)
ML6=V_9-W=<8G-;Q%Q'@VV'E%6=?H<.7U66XQL'.MSK<-2Z8S)EM-T.KN5];&
M\Y8';ES;X^A;DTRQG> B.7(*8[9,QK3)\UD2#=#E>M7K1P;6S00;;UKK[1,S
MPW&:G/!#1&$0/2MX[%K-,K9KVB,8G[I6I['M(P>._,^GO6L]D]SQG9]O>M3/
M^27VK&Z?-B8$PZ>]7-+B.'UIXO)5QV0-4\@P)R5D[9VLF6L:J:/I%=9]VNV+
M7D5,R88&('M6>T9[=I(V)3-Z^_[J\]MSOARES?LVWR/=-_H[ETZY8L1TR2,
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MY]2BS*$87%S1$WIZMV3"?HI1="S!3C3'KY3(I21A#FBMSA9,S:/JJ;<:2(1
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MTUEJ3PVXPY16N69F95RM(!L-D3=TJ[Q]W28PKKYD7BTW^SU*S7*=)M+TC&N
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M9YM^EZ^=<\7RO67.7;&B;Q#8Q/NC;DLWZSAW3]4R+!8;]JYVNLUPK%3*!<1
MWG/;FI8M;&ETX\>5;]//:-BQ:[_':]LO*NG J*2 _?Y?X0V!9DCMO+]X_DP>
M6:I2@&'X^ES^^V*8V[]?KX?8G\M<USN#I-O_ #.1G_DTL:ZV9T[VJB2]L<NY
M<>TP]DX:JBB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6519-=^V/H76<8<KMX600$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MW>*:B,QV]#&-V94DA79?#],)3V1& ]!A>I<L^LY\NZ]$FM8V7L'IB.A$Q?\
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MG#565$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ME>1?&'_=C[O\F[N7#<X<=Y;[?(SB^ _[-?</WL]RZ;JSEY_^8?Q@V[37V?\
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MIC>,/#7P/]GVSU_P]'P\OQ'\TQ+F5[V$1._,_"7Y/M/WY>UTE24DKQ?A'Q'
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M_'4CQ7_Y/\OG0X]_U\_^$F_A*WAT==SOC_P5.JMVCO'0LUSO+;J/AZNU&HC
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M,F81"9,PB$R9C@]WN]*9/9AW21&SD5.4YI IA9+EE:86;5)'3&F5;8 @V&S
M;-BQ.ME2QSWAM5PF*\BU$% 0$! 0$!!Y6L9'D!3%63RY@$J]9AJW#(M.;F'
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M-P]KG$8YLV(,!?MV*3M<+/NUKQ%65+=LDLP_PNY6W!EL>*T6<NPJ9RWU9!-
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MEI'YZ%O_ "H[T_LZG?KB:5ZI^9C5C,!&M6?PHSY\E9\W6UR_KM2^G_,]JK0
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MQ_Y-9[68PUTS;_EWQ6?&WF/J7%ZYPTD40$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\"MUM+:;,3GESJ31>MSI%.E.:;.BPK<VN?#(6N:V+KH9Y;%G&5F%>U"< #'
M)=+>OE5G39;GPAW\K4SY<\7VPE*9AL@+_:L^6[%@I7.;"WD20KSHDPFI$]PL
M)-FWFV)9A;PEF3P1;A#E<K&*YNF,(]B6%F&E,W3O68^M,>3U\M1TJ)B %FQG
M&W,%[1 >I<[%QMK3=^,#B-G0LX\MXS/NTS+=$'NS5ETO$9VV#H"E.KF"39[%
M-FF*=$@YCN/>JGG2)?)+G&(Y'I"BR^*J^JTX#38(Q/KVJ;R75^SKZLDD.=#,
M>O:JLJ+<"TP*%MY<03%5)OE)4TRZ)/**G*8]4[33[;[^X[-BN<+C*XZ=4#>
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MO+MTT^R#Y;_]C9'^94_\FLUUZ<N[JSXV\Q]2YO5&DBB @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M0+,^?O6L962X>0Y\Z&[D<<$]<<M2?5P?037@&U2W&DG6YTT9M!/8<;RDV8K
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MWF/J6'IC211 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD)B(G$7GI6++DZRXTL5-$PAD,KHA-9VZ_P#NL$B7O0LRQYRM6R3$8QB[;S9
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METJ:J9K&:HVVV<MJUX^ZS'+ ZJ-HB89X=J23_)Y:[ZO=Q,(<L2E7USPQFL;
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MK_%G/U:U=2/\$O%WL5ZYZ]L4S.%)FN+9A:;+8>FU=<2S+%WP+*" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @S2/RC4%.\ZC#R_J";O
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M5K&\M8S&,T6_9=&S'O@E);-/'YK=RBIIK]&RS2C;8.70I?LF+>6VS2S;&&&
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MVM]>.Q9[5</'U^&7H4S4QEY_.(A?Z5K.ON>M<3.,^$"8':=O1BLF/#-+IG.
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M9O$^C3?4[MT+^_8HN)C;@VN@X77Y@8JZ_P KC7V3%)J@!%]S<=JAA<M.U41
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M&<>=#CEQG:8TL]T6B.%]H0U_A S](M=[K<<.?8BW'A%OT:))+!><-O,F"=O
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M%?EI/_P=)_S.1_)K';.?L[=9N.]JSXV\Q]2P],:2*(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M8I-MSAO2]-+H#E98IY+<-YFD76GK5FOT9F[]FPW280Y^5JUGZ.EG6S[MEFF
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M ("W#-3[IZ^7(4?A>]'9Z/8K"3#&ZK<T[L 8>JQ/57'ZZ_[T=?L3U'D53WX
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M2R727[Y&/<IG:Y\.Q=#KHO:PPN [.Y4=FR'-\)IW!:(\K%SO+IU5G7)P8QT
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M ZS[[+GR6#&W6=;4O#S8/C/*Y6S64QO#C2U+@\1A&TPLV*1J]5STZK?[I@+
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MG@[61_S%W443%>6<):RTQ%"_H!/J3+4Z[2,OAS6&M ^H/_P0IP]72:<CP]K
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MUF:-[Z@^[[TYG)&I<N7Z&ZS_ %!_^"47&7EW!VLD?T!]^3E,99LPP_H?K/\
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M]2Q_5BY:RP5U&6TU\+#AL.S:K.LESY9SC==?SANS3C[Q]"Z\S#%N18! 0$!
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MV=.VMM2+7I_YW8 / >(0P7+Y.V6O7+/7NU@R[),SI'.N'MBDZ.JM:EZT_?\
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MJ[/_ (6K+_\ (O\ W*SC:9MWAL,^36JA;PO67X29FS8$[<IF_1S_ /)K5?\
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M6&1_1NJM'^2?S_>K6(?N^BL5_P N5<S>APW67G]ZF=RSK.,FY>$73?+Y7MF
M?HW5_P 4_9L2QO-OAV;H7R\UCY8WN'*OX3^]/V;%,3_*9LO#/JGR\UC 8<-U
M>/[T_&T8+760MO.%,G_+]6[W^S=7_$OR"E3WN>&%OR^5N\/_ (;J_P"*>FF?
M:_1-4OR_5L!_\-U?\2_9L4]<DMYPEV_+S6%L?T;J[K?Q4P>I6S#>[X87_+O5
MG_\ %NKN_P D_N5]?+/M9K##_P"7.K_^3=7_ !3^Y2<IF_1EF?+E5[I_^&ZN
MW_DGY'8L]Y(U+>;$1/\ ERK0?]G*N$?\G,V;%PN(6VWA'GY=:V)_^'*R_P#R
M<Q7$9SV^C:I_EUK8_P"S=7?_ ))_['8IB-_V=L8PWO\ R[5W_P G*O\ BG=R
M>O5CV[?1JS_EUK;OT<K+C^]3,@KAJ=K]&D/ERK(_[-U?\4_N5]:9LWA(2OEO
MK' G]&ZL7?O3^Y9NKL]L^&*=\N];*B/T;J[(?O3^R"6:.MM\:0TSY>ZW>/\
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MP_\ P[5_Q3\CL5T6]L9JK:EY!5KFC_X<K+B/R4S('):U@]K]%&J_E^KHN_\
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M#Z[_ .3U7_%3.Y.6KW[3PUYGDA6V@<.59M_R,SN5G3-VQ[]OHT9GD77N!_\
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MK\[Y<:USS#ANKL)_>G[-BGJQ;;XK-2?+?6APCPW5VD'\D_;L5QX26R\5-_\
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MIX3%#]F?H%,!&E,!9^19^X1/7IC[I&9]FUP^YI:*4V@_O+/W"7:]9U\H*?\
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MN$]NR>GQN0^S'T(?\U/\2S]PGMV^JSI\<XC+_P"F5H8NI3T26?N$S6?7J?\
MIDZ%_53_ !+?W"U.UPGIU^C$[[,;022?JA_B69?M%+V[+/C^.;QMQ_\ 3%T+
M^J'^*9^X4]NR^O3Z./\ Z8>A&^E/\2S]PK[]FL=/HYM^S%T)I_HIO'[RS]PI
M>W:LWI\?B,W_ *9.@_U4_P 2W_W:9K/IT^CP?LR="A92G^);^X6KV7KTZR\.
M/_ICZ#C2G^)9^Y"GM72>KP[[,702"/JA_B69_M5/:\K^WZ-9WV8.A.C_ #0V
MP_>F?N%?:^5EZ3PXC[+_ $&!_FAC_!,_<)[7/*WMTSPYR_LP=!;&-(8Q_P D
MP_XB7M4O;KG38;]F+H(C&D_^@L_<J]>]\K>W7PY_^F1H/]5=_$L_<K7NGM'C
M_P!,?0H_T4_Q+/W*E[VQG,RXN^S&T$@_S0_Q+/4U8]JUGK]&N[[,'022?JA_
MBF?N$S4MZV8<#]E]H)_YH?XIG_NU?9F>KC_Z7N@_U0_Q4O\ <*^S6>KE_P"E
M]H0NI#_%,_<)[7RO6]9RRM^S#T(?\T-T/R+/W"SEJ]^K9E_9D:"S_FINM_$L
M_<+77M8Q?6N9^S+T(@_S7 _O+/W"W_;:QZ]/HUC]F+H1)/U0_P 2S]PG]O::
MAZ]/H\M^S&T(#^BG^)9^X3^RWE+T^.^&9GV9.A-']%/\2S]PG]EA.G3Z.?\
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M3RS,^S!T)L?YH?XEG[E2]JU)\<\-AGV8^A-C&E_^@L_<*>U2SKX<G_9D:$1
M4O\ ]!9^X6_?"2=?+"?LQ-"(A]5/\2S]PL^URUCI]&%_V8&A.NI#_$L_<J9[
M))\?T:Y^RZT(NC]4.'[TST'<6O?MC"X^.;CG_P"EYH7]3/\ %L_<+/MV:ST>
M1]E[H7]3_P#H3/W"9[+.W2.8^R_T(?\ -#_$L_<A):=N_7MR\_\ I@:'_5#_
M !+.Y7*9Z'_I@:'_ %0_Q+.Y,F>CP?LP-#(_HA_B6?N4R2]'C_TO]#_JA_BF
M?N%;V7VZ/'_I>Z%_4S_%2_W"QGLOM\?T>6?9?Z$T_P!$.'[TP_XH5S6;>K,?
MLP]"A92G^)9^Y3VIU[=)60?9BZ$ /YJ;A^\L_<JSO8W[]7+_ -,?0_ZJ89>"
MS]RI[7.4O;I?#S_Z8^A?U3_Z"S]PK[UG]CB[[,?0R;*6'_L6?N%/:I^SZ,#_
M +,+0C=2F[_(L_<JSM?)GI]&$_9>Z$?^9G^*9^X2]KX:O;HYM^R_T,?\T.'[
MTS]R%?:_5+>E<V_9A:$#;2&[_(L_<J7M4ST^CB_[,#0W$_S0V_\ ),'^*GM<
M)^S.6!_V76@N!_F9C_!,_<)._:?HUGJQM^RWT$7T9C'_ "3/W"7M<M>W1E;]
MEYH0$/J?_P!"9^X5][Y9ST<A]E[H0_YF?XIG[A9M[++\?F//_I?:%_4S_%,_
M<*9[+[?']''_ -+W0OZG_P#0F?N%?;LSGH?^EYH7]3_^A2_W">W8ST/_ $O-
M"_J?_P!"E_N%9VN=F>@?LO-!-]&8_P $S]PM>]/;K_AQ_P#2ZT'^I_\ T&7^
MX6?=?;I]'@_9<Z%9_-+O^2E_N$O:^$MZ5D'V7NA 0^J'^*9^X"3M?+C_ %_&
MR-^R_P!"!'\T/\2S]RE[7PU.OQSPV6?9C:"W_FAL$/R+/W"SGLEZ=+X9?_3+
MT/\ JKOXEG[A;SK[IZ=/I#_TRM"-]*>F2S]PLYIZ=/I&-_V8^@NA_-"?_8L_
M<!,WP3IT^C7=]F#H1%E(?XEGK8K[?5N]?CLX:C_LN=">8_5#>?WJ7C_P%+VJ
M>GQ^'AGV7.A-/]$/\5+A^ K.UPLZ?'S6TS[,#0VV?53_ !+#_B*6Y3MU^.^'
M,_9A:% _S4_Q+/W"C/I\?T87?9?:$Z^D/\2S]PMSMA;TZ9^S'_Z7>A?U0_Q3
M/W"S;5]/C/\ TN]"_JA_BF?N%?:GI\;-+^R_T)IMI#=#\DS]PK[W'W2=/CEX
M;(^S&T(6?5#9_P BS]PL^W8]/C^CRW[,?0@0?JA_B69?M$S4]/C^C+_Z9.@_
MU4_Q+?\ W:2U/3K]#_TR=!_JI_B6_N%OV/3K]#_TRM"_JI_B6_N$]E].L\'_
M *9>ABZE/1)9^X6;3TZLKOLR]!@?YJ?XJ7^X5G:\)Z=?HC9GV8.AO<3]4/\
M$L_<K-[6M^OQ_1C_ /2^T+^J'^*9^Y26Y/7XWG_TOM"_JA_BF?N5KV/3XWC_
M -+[0_ZH?XEG[A7WL9_KZ?\ U_\ R/\ TOM#_JA_B6?N%?[+]3^OI_\ 7_\
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MA,TO3X[X8_\ TP]!_JG_ - 9^X6O?LOK\?T/_3#T+^J__0&?N$]^QZ_&\_\
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M9^X6I\,C4[2./_IA:#_53_$L_<*_TP]^K*W[,;0FW4A_B6?N%>OQ827JY?\
MID:'_53_ !+/W"UZ1<]#_P!,C0L:4_Q,O]PKZS!GJ?\ ICZ#_5#_ !$O]RIZ
M'MU/_3&T'^JG^)9^Y3U/:'_IC:#_ %4_Q+/W*>M/:/'_ *8V@_U4_P 2S]RM
M26%O6N)^S$T&R%(1_P"Q9^Y22I[=7G_TQ]" LI3_ !+!_B+6V.W7X^W,V?\
MICZ'C2G^)9^X3:3I\4\//_ICZ%_5#_$L_<*->OQ?1R'V8^@0MI#&W]X9^X5V
MSZ],N/\ Z8V@?U0_Q#/W"N:N.CR/LQ]!'_-#_$2_W*9:GK.'G_TR-!_JA_B)
M?[E1<QQ=]F/H1']%/\3+_<J9[2K.W6.0^S'T$ ?S4W?Y"7^Y6LU+>I_Z8^@_
MU4_Q,O\ <K<[:,P_],?0?ZJ?XF7^Y3V,P/V8^@D?T0_Q,O\ <I[K.TC#_P"F
M'H7]5/\ %,_]VG]C?]G4/V8>@_U3_P"A,_\ =J7O?"_V]7C_ -,+0?ZI_P#0
MF?N%F]K8?V]7'_TPM"_JA_BF?N%&??J?^F%H7]4/\4S]PA[]3_TPM"_JA_BF
M?N$/?JR-^S$T$"VD/\2S]R%FRLWMUKE_Z8N@?U0_Q+/W*F*9ZG_IBZ!_5#_$
ML_<IBF>KS_Z8N@?U0_Q+/W*8IGJYC[,C001_-3_$R_W!6_"6]:Y_^F5H7]5/
M\2S]PIMG'7Z'_IE:%_53_$L_<)LQU^A_Z96A?U4_Q+/W";,=?H?^F5H7]5/\
M2S]PFS'7Z/(^S+T'^JG^)9^X2Y9[=>M\.7_IEZ#_ %4_Q4O]RIMGTZ?1KS_L
MQM FMA]4-Q_>9?;N),Y:G3X\<(:=]EKH,S_FA_BF?N%KEF_'TRUI7V6&A2YN
M_P#5#_$L&)/WBEAZ=,N\N"?D6TC@8RYDNE(\-K1^2:,LFIUZVM7IU\/:;A;@
MF1PO*DR93-WP1NBP#'N5O[=-]>KL>7J$R2P &$"5),JV1KTX" ?9SK6)-4Q7
M ZS.=>Z,?6LWJW[63#7FU[YONDW[<;>=3TDW#V:)@3&"N:S=T1! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<FG=(-O0@T]<HF:[IKM
M-F EKF.;#G;#'G27>V>TMXY>G7&7R1:/QO-G5$RE),Z8Z;'PP?B<3]Z<UNS3
MGZ3.^73%=]F#H57,<[ZI\1)_),_<9KGBEZ=+,,=+]E]H<AP/U0B$/WIFS]@K
M)IF?#\?F)6;]F;H;V!OU4X?O3#_B*YLXY7I\7QR[FFB/LPM!!C]5/\2S]PM7
MMVOZMWI\=>3]F)H1_P":G^)9^X4G:PG7XYX!]F)H0_YJ?XEG[A7W[%Z_'>8S
M-^S(T$#^BF/\"S_W:3M?+']?Q^(RM^S+T$1C2G^)8.U@5]L+Z=;X91]F;H0_
MYK_]"E_N4]ZEZ=:XO^S-T)S2/JO_ -!E]/T<D]Z?U]4)4?9=Z%-)<*0_Q3,_
MVB>]:].G#%*^RXT-MII#?_DI>S]@I>U/3IPV1]E]H?\ 5#_$L_<*SMI/Z^D_
M3_Z^SS_Z7^A?U0_Q3/W*>S7KT>/_ $OM#_JA_BF?N$]D].@?LOM"_JA_BF?N
M4]B]/C\1Q/V7FA'_ )H?XF7^X2]ZD^/X_+0G?99Z',_YF?XIG[A;G?!?B^/Z
M$G[++0F?\S/\4S,?L%+\ESIG^KXV^W[+S0F@#ZH?XEG[A2?)VB_T_%]-LS/L
MP=#:(?53?_D6?N%K^VI?B^/Z#OLP=#)LI3=_D6?N$_M/ZOC^CP_[,#0G ?S4
MW_Y%G[A8_L[$^+XYQ'#_ -+W0OZH?XEG[E7^SLO]7QLH^S!T( #ZJ; /WEF7
M[1/[*S?A^/Q&4?9C:&&[OU4W0_(LR_:).]ERU/BZ3PQN^S#T,@CZJ;01^19^
MX6K\UI_5\>>&#_TO="-](?XEA_Q5GWI_5\?EB_\ 2YT+^IG^*9^X3^SLG]/Q
M_1LL^R_T)L?YJ;8?O+/W">]+\/Q?1D_],+0OZJ?XEG[A:_MJ?T_']&"9]E]H
M;_\ FAP_>I8_Q,UG^RX:_J^/Z#?LO]#:V'U0_P 4S'_@*SY*U.G23&&O.^RX
MT*9;]3,?X)G[A7^VDZ]9IC9]EKH303]3/\4S]PI_95]>N6[)^R_T)E](=GXE
MF?[0+7]U6SI.(YG[,+0S$?5# G_(L_<K/]E,=,<-&;]EOH3S'ZF;?^29L_8)
M/E[97'2QP9]EKH37 _4R/_9,_<*WY*GKU2,G[,'0I<#]4-W^29L_8*?V=EL^
M/'&VZ?LR]#@?YH;O\BS]PM3Y:Y^G5KO^S%T-]](;O\BS]P%+\U\+.O6<QKG[
M+_0S_P T/\2S]RG]M+TZ7PPO^RZT(_\ ,SC^],_<*?V7PO7ITCB/LNM"%U&?
MXEG[A)\E\UKUZ?9G'V7VA@?T3_Z$S]PK_:Q>G3G#(W[,'0A"-(?XEF7[53^V
MM8Z8QAS/V8FB84ANA^28/\19O>UB_'\?;F.'_IA:(;Z4],IG_NTG;#G_ $?'
M.'C_ -+_ $'^JG^)9^X4]J?T]/H?^E_H/]5/\2S]PGM3^GI]'G_TP-"_JG_T
M%G[A:_LJ_P!77Z.+OLOM!(/\T/\ $L_<+-[6K/BZ9W&K.^RXT)XA]3.'[TS;
MAN).USM?ZOC\1FI/LO="I_\ FA%W[TSG^\2]KX9_I^.^$H?LR]"-AI'0_@6?
MN%/;LU/B^*>'C_TR- _JI_B6?^[3/9?Z_C^CR/LR]";=2G^)9^X"O6WRE^+X
M[X<C]F7H)%M*;81_$L_<)>U2?%\<O#2?]F%H3C_13_$L_<*^].WQ?'>(PG[+
M_0HV4IA_ R_W*>Q/A^+Z//\ Z7V@PMI3&W]Y9^Y4]KD_I^//#&?LO-"/_-#_
M !,O]RMSO?J7XNGAKS/LM]"==1F__),V_L$GR=O*SXOC^CA+^RUT(&)HS_%,
M&?[!+\E3^KHWI'V7^ARG1^J'#]Z9G^T5GRW&UGQ?'G.$LW[,[0F_\T-W^19^
MY*E^2UJ?'TCR_P"S/T-PA]4/\2W]PK/DLC/;X^EJ.F?9AZ$^,:0W6?B69?M%
M;\U/ZOC^C5=]EYH9-E)_]!9^X4GR]H?U?%]&)_V7&A$#^9G^*E_N%G^SM?)_
M5T:Y^RTT+^IG^)9^X6O[*7XOC9I?V6^A-A_,S=_D98_Q%B]^V5Z_'TC-_P"E
MWHG]5/\ %,_<K<^6X2_%\5O#D/LO=# _HAC_  3,_P!JI?E[92_#\>,89Y7V
M86AL,32G^)9MR9M5GRWRD^'XYX;COLR]#+8?5#_$M_<I/EN"_#T^B+F?9>:'
M,))I"8QC^*9^X6?[.S7]/Q?1K_\ I:Z#?]3/\4SLW%K^[LG]/2ZPWJ?[,#0I
M))^J&\?O+/W"G]G99\7QSB)-WV9NA%I'U3#_ "3.;[Q)\ESDGQ=$54_9?:%.
M']$-IM_$L_<*?V7.5OQ_'>(CF_9::$UT?J;KX_DF90^\6[\E9_JZ+'0_9EZ'
M2M#?JAL$/R3!_B+']G9?ZOC<JO[,W0YX(^J&W_DF'_$R5GR]HL^+XYX0[_LO
M-#<8_5/_ *#+_<)_96?Z?C^CPW[+O0P0?JA_BF9?M5/[.R_U?']&U+^S"T-D
M/YH<?WEFW]@G]G8_J^/Z-MOV9>A@ ?5/_H+/W"L^2YV?U=#_ -,O0OZH?XEO
M[E;_ +:S?AZ5Y'V9>A1'\T-_^2;^Y3^VI_3T<G_9F:$X "D_^A-/^)%3M\N8
MW/B^.1J3/LQ=#?\ \T-_^19^X7&VV_8OQ?']&'_TO]!_JI_B6?N%?:L?T]/H
MY,^S"T-AB*4P_@F?N%?:XPL^'X_,9O\ TQ]#_JI_B6?N%GV[-?U?']&-_P!F
M'H;C_13=C*9^X3V[)?B^/G#A_P"F!H7]4_\ H+/W"W_93^KI]&P/LQ]#;8*0
M_P 2S]PI>^3^KX_HUYGV8.B/C&E-I_R3/W"S>W8GP_'+G#2_]+C0RZ)HS#^"
M9E^T6O;2_P!7QL[?LN]!;"%&00/\C+_<K,[7R?U?&SR_LP]#8?Z(;_\ ),R_
M:+7N?U?']&<_9CZ&1#ZH?XIO[E3V2_%T^C4=]F!HCKZ0X_O3+_\  2=J?T_'
M]&O_ .ESH<?Z)_\ 0F?N$]J?T_'GALROLO\ 0I9C]4P_R+/W"L[V7[-SITC;
M/V9&A[L/JAN'[RS]PNM^;2SK\><L9^S%T,WTEG\"S]PL_P!M+UZ9U' _9AZ'
M&RD,/X%G[E2_)E9.GF.#OLP=$/\ S0_Q3!_BI/DPSVZ]+=1X;]F#H@_YH?XI
MG[E7^VDZ]/,;;/LR-#;_ ,T.'[RS]PI?EK<GQR-D_9G:&1#ZH8?P+/W*?V4L
MZM"=]F'H4RWZH8_P+/W"7Y;6/7I]&#_TO]$_JA_BF?N5)\G9/7K]&>5]F'H3
M('ZH8V_O+,H?>K7]MJ^O3Z-D_9E:%_5#_$L_<*?V5/Z^C6?]F)H;C_1##^!9
M^X3^VNF/CQBQB/V7^@_U,_Q4O]PG]E2]?C\,?_I=Z#'^AG^+9^X3^WM]5QTQ
ML=]EYH1$/JA_BF?N5/[+CEQ[_#\?;PQ?^ESH<8_5#_%,_<*SY+&)^/\ '/#+
M+^R]T-A_HIOC^28</VB7Y/HO]'3Z-@?9AZ(+/JA_BF?N%9\N%GP?%YA_Z8FB
M?U1W\4S]PI_;5_H^'Z,9^S T,WTAZ9,L_P"(G]CG?Q_C<Y?V8>B,/]$,/X)D
M/0Q7^VXTL_'^/Z-UWV9FAN9NFD./[TW;^P6?[.V<G_;_ !_1H.^S T,DGZH?
MXIG1]!:_NJ7\;X_$99?V8NALOI#_ !3,OVB?VW*S\;XIX9O_ $R=#_JG_P!!
M;^Y5_NK7]/Q_1B?]F-H;@(4A_BF>MJG]M_PO]'Q6;FVN[[,#1#_S0_Q,O]PI
M?EOAB?C_ !SPR2_LP]#81_-#8/\ ),_<9I_;5_H^/Z)&5]F=H;;Z3_Z$S]PG
M]E2?!TC6J?LQ]"G$PI#>?WIF7[19O?M:W/A^+&XT3]EYH1OI/_H,O]RLWM<Z
M:_J^/&'C_P!+S0OZH?XEG[E/;LG]7Q?1LM^S#T-HA]5/\2S]PK[5G^GX_HV&
M_9E:&V/\T.'[RS#_ (*E[5?ZOC\1Y=]F7H9!'U0_Q+<_VJF:O]71IO\ LPM$
M<3_-# P_>I?[A6=JG]/Q_1K.^R[T,DGZI?\ \DS]PM7MF+_5\?T<F?9>Z(T?
MT0_Q3/W*SFK_ %_']&_*^S)T1D(TG_T)F<?O%?:N=^#IG+:_],_0_P"J?_06
M_P#NU,U;\/2\N+OLS=#(A]4_^@M_<!,U9\/3_#3F_9B:%,C_ #0VF/Y)G[@E
M)VL+\/Q^)MJO^R]T-T84AMA^],V?L$S5GQ],,/\ Z7.B1C]4Q_R3/W"SFY2_
M#\><X;3?LP=$: !2'^*E_N,EOVJ?T_']&5OV8FAB^D-_^29^X3VI_3\>>'/_
M -,70OZH?XEG[A3V[-?U?%]&Q_Z9>A?U0_Q+/W*9J?T_&Q.^S(T-T?YH;X_D
M6?N5KV7^KXYX8'_9AZ&284AP_>I?[A/>X2_#\5\,+_LOM#</Z(;O\BS]P$]Z
M3X?CDX:$S[+70WFVC)_]BS(?L-BGM2?#\?T9)'V6^ARC$49'_L6;/V"3MB+_
M %?&W_\ TP]%@!]4-G_)2_W">U9_I^.^&.9]E_HDP6TA_BF?N$]EGP_'/#$W
M[+K0FD$4D/\ V4O]PI.UB_U_'>4E(^S)T259]4/\2S9DS8M7LE^+X[Q&69]F
M9HCQ#ZH2/X)O[A9RG]/QX1$S[+O0WNWOJG_T)G[A7WJ?T?']&9OV7^AM$!2&
M'\%+_<+<^6P[?C_%;J,G_IAZ'_5#_%2_W"7Y+6Y\/Q3P?^F'H?\ 5#_%2_W"
MG]E^I_3\7T/_ $P]$_JA_BF?N%J?+96;^/\ %?!_Z8>B?U0_Q3/W"M^;,PD_
M'^*7AY_],/1/ZH[^*9^X6?[*U_1\/T<#]F#H9_YH?XIG_NTGR6,=OQ_BMX<V
M?9A:&TQ-(;P?R+,/^ K_ &W#/_;?']&2;]F+H3@ *0_Q3-O[!9GR=O+?_;_$
MTI_V7FAS&V4ACC^)9L_8)U^2YV?T?%]&LW[+C1 X'ZF1 XR6?N%O^TGX_P 7
MT2TC[,;0Y5GU0W_Y)FS)BS/EJ7\?XO$23?LTM##0/JIN_P DS+]JE^7LD_'^
M/S-M"H^S(T.<UP^J&V'[TSIO8K?DJ_\ ;_'YB&=]EOH9>3]3-I_R+/W"G]G;
MZK/@^.<1M2?LO=#EP_FALA'\4S+]HI_995OP?%]$M)^S-T.6 /JALC^]-_<0
M6[\MPG]/1M'[-/0R(&E/\6S]RL?V=FK\72S"/J/LR-"FQA2'9^*9M'WBU_95
MGQ?'C<VBG_9<Z&^,:0F/_),Z?H+/]G9)\/QXX8V?9;:$TQ^IG^*9ZV)?D[5.
MOQ=(WY?V8.AL 'U0V$?O3-G[!6?+?+5^'XOHV6_9D:&TQ^J?_06?N$_MI_5\
M?T9O_3-T3^J'^*;^X6O[$_I^-K3OLQM#F&RD-Q'Y)F0_8+-^7MPL^'X_HT?_
M $N]$WH_5,8_DF?N%?[;C"?T_%]&=OV8.B- 'U0G_P!E+_<*?V5/Z?C^C!,^
MR\T1X/\ -#=_DF?N%/[.S7]/Q?1BE_9<:$QT11D?^R9F/V*?V=C^GX_,24O[
M,70V"'U0V ?O+/4Q;_NN$_J^/'#,[[,K0R(?5#?_ )%G[E+\M\,?]O\ ']'#
M_P!,?0_ZI_\ 0F_N%C^WMY7_ +?XOHX.^S%T,@@4A_BF^MBU/ELJ?]O\7T<!
M]F)HG]4=_%,_<*WYFI^/\,\'_IB:)_5'?Q3/W"S_ &5?Z/A^CP?LP]$/_-#_
M !3/W"U/EL9[?C_%>(Y,^S%T1L8TAMA^],/^*IV^7+$_%^.>&7_TQ]#_ *G_
M /06?N%G^RM?]O\ %]&,_9B:&3'ZH?XEG[A:_NK/_:_']'!WV86B&,*0_P 4
MS]PK_;_RO_;?'CC;A_Z8.B?U0_Q4O]PI?DI_VWQO/_I@Z)_5#_%2_P!PI_96
MO^W^-M,^S(T)HMI'7_Y)G[A/[:G_ &_Q?1G9]F;H;8_S0B,/WENW)A6_[<\G
M_;_']'&9]F9H;Q#ZI_\ 06[/V 6;\MR3\?X_HTO_ $P]$B3]4-Y_>F?N%/[*
ML_'^*<QD;]F+H8']$/\ %,_<)_99M+^/\5O#:D_9F:$RSZI_]"9MQW%+\G:G
M_;_'XC:_]-+0Q_S0_P 4S]RG]E/Z.D>#]FCH1$#2'^*9^X3^RK_3T1]1]F/H
M<V,*2\#]Y9ZV+?\ ;<)_V_Q_1&G[+K0R2?JE_P#R3/W*S_;V)^/\7F,[?LOM
M!#1_-#$?\BS]PLSY.V=E_'^*SAS;]F#H8/\ 1##^!E_N%K^RI/QOB^C(?LQ-
M"@0*0_Q+/_=I_95_[?X_$8O_ $P-#QI3_$L_<)_96;^-\?T8_P#TOM#_ *H?
MXF7^Y6O[JO\ VWQ?1D'V8&AMNI#_ !3/W"S_ &VD_'^/S&W*^S)T27#^:?\
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M+?W*&#]*M6SE_P 2W]RA@_2O5_V'\4SN4/7]#]*M7_Y/^*9W*GJ?I5JV<O\
MBF]R&#]*=6SE_P 4WN0P?I3JV<O^*;W(8/TIU;.7_%-[D,'Z4ZMG+_BF]R&#
M]*=6SE_Q3>Y#!^E.K9R_XIO<A@_2G5LY?\4WN0P?I3JV<O\ BF]R&#]*=6SE
M_P 4WN0P?I3JV<O^*;W(8/TIU;.7_%-[D,'Z4ZMG+_BF]R&#]*=6SE_Q3>Y#
M!^E.K9R_XIO<A@_2K5LY?\4W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5
MLY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\
M2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]R
MA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2
MK5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY
M?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W
M]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@
M_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5
MLY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5LY?\2W]RA@_2K5\Y?\
M2SN0]3]*]7_8?Q3.Y0]?T/TKU?\ 8?Q3.Y#U_0_2O5_V'\4SN0]?T/TKU?\
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M !3?W*&#]*M6SE_Q3?W*&#]*M6SE_P 2W]RA@_2K5LY?\2W]RA@_2K5LY?\
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M !+?W*&#]*M6SE_Q+?W*&#]*M6SE_P 2W]RA@_2K5LY?\2W]RA@_2K5LY?\
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M (EO[E#!^E6K9R_XEO[E#!^E6K9R_P");^Y0P?I5JV<O^);^Y0P?I5JV<O\
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ME_Q3>Y#!^E6K9R_XIO[E#!^E6K9R_P");^Y0P?I5JV<O^);^Y0P?I5JV<O\
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M" @(" @(" @(" @(" @(" @SR;^D]B!-]8[$2<,"*(" @(" @(" @(" @("
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M/.+G!Y ;++CB< D[VZ8[=?3A^B>H4HHZR?3"Z4\M'->/05#>,M) 0$! 0$!
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M>66JR^/N$I/$S';[9]))J&NOMF,WS$VJVY9[?M[830,8[#!95Y500$! 0$!
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MN;3R@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M5S+B/;?Y._M://KY5^)M#J*OB/B+4:?1)K:>HES*N=,<QDGW2'RS-WG.!;:
M%,>6_?Q7]$O[)K[:[@#YS^&^']%XUUZGH=?J*)E*UM2YK)LZ>T.:SQ"83'@D
M 8E6=MIVZ8FG[T:OI,@T_P"=].(FTT\-FRWMM!E3 "UXQ+71LBMW%C,N.5::
M20(WPM'H6*T\Q O("!$9CK0$"(-Q!Z4'D@B\0YT'&(S'6$'E!X=A^V"BNH?G
M<E.G?+#Q9+EO,I[M*EAKVF!;_,)]T,RJS/Y/X['VB<K5:3YC.*Y3]4J9K9FM
M:BQC3.F-#'.JH V$6))AOY<Y?T"?U6*AJZ/R*?\ 6ZV;6.?HDN#IKBXC\7*C
M>I$[\8?4YKY'UJIM _'S1?D\A;[<,=>4 "#<8K$X:%0B#B$'@F B@L.G::VI
MERGF'O.W;>E:DS,LVOEE^VV^U<XK^16NKZ#AF?5BJ94_5Z>52O<TOG/<)<M@
M((:"YY%Y6,V:C?'+\_/LJ_MX_,_YI/-.DX)XP.I2'S:Z73.E5+S, ;,)+#O,
M>^68M(-A5U%ZWWER^X3AYC=2X%TOB%Q'B5=+)J#&^$P[M_.HQ_U8\+-P4=Y]
M8;#%C.;XRK#MP^+G]9PD5S/+O5)])7SJ7\3J _%O<V^6<BL^727]CXOOLI-.
MU'6?G"X G,U.IDLH*F0^8SQII$[QZN1"(+X>[X!ZUMRZ\O[)?RYMW?*+@YK_
M 'W-X;T\%QO,*66#UH=N4A-(^LSK1\;\?V2C3P@1&8ZT! 0$! B,QUH"!$"\
MP0(@W$% 03_"O^MV_P %._!*)>'R@_K+5#63N =:G4M=-I2V7,)\-Q;=3F-U
MZSVF\NGQ_P 7P3?9QT^JU_SC<#,&JU3/JW$)\<^-,/CDU[0"070%LL]:M8ZS
M-K^R]Y"-+/EV\L6..\YO"NFM+C>2'S;3M6^C';E.S?RKN<^I9O+<X<(C,=:
M@1&8ZT'D6W6\UJ#Q$"\@("!=>@1!N(0$"(S'6@(" @1A>@1&8ZT'F!R/4@\1
M&8ZT"^Y -QYB@N?"9'U:LB(V>HQZUOK-?Y<?E[8?'[^M.:;6:EY153:2NG41
M;H]08RG.:;)4S[T[%FS';+MSTCX<OLLW:E6?-%PO+EZE52F_6],\1OC3'"9O
M5;@(Q<80@>M9[<+\7\G]A7Y0I+I/D7HK'N,QPTJGB\VD_P S=GS*SA._\G8C
M;W<_K*#F@1 O,$"(S'6@\P.1ZD'&(S'6$'E 0$! 0(C,=:#S Y'J0>(C,=:
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MB$OM^VOY_P!]M3]O=Q'J?$^L>5?E;KM>ZFE5]91S'Z?/,MLJ5)<^47;S7L:
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MYWK>)P]A?D"^U#\\?E6X[T[3JSB7B"L:=1I*04]355$PLF,G "5,;OF#X67
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MM8/%?"6H:752IAF,KJR53S1)G1 #736QCNXM$(WJV9F&-];E]3'V/?V]7&_
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M" @(" @(" @(" @(" @("#/)OZ3V($WUCL1)PP(H@(" @(" @(" @(" @("
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M0'GQPWJNG:U/TJGJ-7TR5-DM):"]M4V)@!9[I]"=KB:3IOE_8.^0WS4'G/\
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M!RW9D"+0KC%3-11XH\IFNW3QGH(=E^>J./:KNQ,UO4L_R]U0AFG<1Z?5S'?
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MB?1S(4\F=-D&);-\-^Z1G& %R87*',08.L-T#?')11!FDTU543&LDT\R8UQ
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MY0$'G>>+ XAN(VH-EG#_  +J\HCB/AR@U2=C,JZ674-.!BUY QVJRI9?#R.
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M:F5-B;H08 ;UC#6;58,0YPA[H/NN^^&:*8PQRQ0;5)0UE6]H;332PFUS9;G
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MI_$_E/+.Z_C+0FG(ZU21[;%J;X2]_5GDZQY8UQ:RFXKTB>YQ@T2=7I'N)-P
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M;+T>EW1"-Q-I6L8TSBUX?P5Y2\029U!4\&:#.DU,MTB;+GZ33-WV3&EKFA[
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MYE1(TN773::HK)<N8_<IG3'-,)C7VP5]K>6._29T^5?[0C]:"TWB#5=:X/\
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M6S7B8T/8-V$QS6DPP 6/;%:G3UZ^]?%E\T?ZPUYS>9G$M56<#:O74]+,=/\
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M59BT.!@-UQ%RN\83VZYX?J3\C7ZR+YE>4'%]%-\T:FIJ*'Q*5LW\X/G.9 3
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M9;7;L;-X8P@K.N.6.UWB/AI^W_U73W_,]Q=IVBRQ3Z4S5JOP*=MC6-$YP:
M  !!27]SK>V>N'Z/_JM AYKZ<#_WE2?A+?7ES^3^#^D-Q4Y[9LDRSNN\" /_
M  WJ5B*@[2^%^(:2;I?%5#*U&CF"#I%0SQ)+L"'-A$B&2U.VL+99N<,&C^7?
ME%P7XE1POPSI>DU3XN$W3Z:9*F%]I!+G@"]7VUX9LO:\UN3]5U&<7--5-=*C
M!K7.LW<+.98=,1H'WC%T"XWE :^9*F2W2CN'>%HL-X3.!5OFCI=+U#R<UV1K
M;V_5)NCUKIH>1NO?]3%KHQ!(B>M+PG6?NT_CI_:P4.D:?\V'%=/HP8*,3]0(
M\.&['Z\[*RY)PG?/MM]/7ZL-4ZJRFT=DMCQ3?4J2) (L#I:EY=>O_P ;^@EQ
M 91TW2)54"ZEFRV"IE_?M$F28'.$2M2XKCC,N.5// 7DY-JF:E-X6T=^H,W7
M,JGT<TU(<+0X/!W-Z*6Y.L[282-=J]4?YMIL^9*HI31*D2FD"$IOPM,!: VQ
M7,;ZR3E#'ZU,MF2IDQV+BQSH]*R:>"V<+J=]\/R;O4%%UX7WAF75R?%GU3W2
MZ8R8-;-.XP.WFG>]Z $&@]:Z68C%[2_M\O@1_6KM7X*E\75DN5J%%7:F^IG&
M9+ES94Q\J>7.<]D6DG\6^(7*W;KUUUW]'S)_8\Z%JNK?-OP?44-!/J:<:K21
MF2V.<UG\Z83$BRP%6W>&.NI?H_L5^7\IU)Y/\!RIP+7RN'M&:\$0()I"8$?\
M);XY^C'-:TRU[CM6/.6W!4$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>
MQ F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 02ND_
MEV?PC/P@K\;/9^#WZQS_ +J\_P#L74OPYRS>6NC^5GY<L,SSFT]HL_\ B5E_
M^>!/#?7?9_8,^Q;H13?)UPXXSV/^L2-*:6M<"9>Y0/M<(F&]XEG,M2ZCEWG[
MGZ@SN$3-=O?76C_@D=A4)<,)X,,+*YO44P>R2HM%HM$E/KJVME!E*UT^9/FE
MLN3)9+]\S'O>X -:!$W+4N)A+<\/C%_68OM#^"*7RZJ/*CAG5=-J-3IZ&?0S
MG4U2R;-,Z?43&V[KS#XQ8LZKI)>FZ_GV^2'#>L>9?G'PT)%-4UDV=Q%0SYQI
MV.F&+JL.;$@.NBI=1,>_;/A_8:^R.\MYO 7RA\-,J9$V14U5#2P;.:6S&^!1
M,<;" ;WK736V.\O\7OCYV^:_#_DCY;ZMYDZ[44=-(TJB+RZKF,EB833/FP;O
M.:3N[EO.K>R=9=1_, ^VN^V'\R//WS-UO@GRWXE$CA^1K-92SF4,^;,!EMF3
MF;K)<J;[SG6 <_0L8SR[=L=9KEZ>?9T?8^>=WS\\22.)JW3=:_-.I3CJ52]U
M/-::H3)@=O39CF%Y#FX1A"PQ5<\9N:^S/Y?OU;+RJX4X:TBEXSX5;.K94F7]
M8,ZE8X[VZ(QWI1-I29=??K.N/*3\^/U;?RCXJT#4Z;@_A5DBKFTDUL@RJ66U
MWB%CH0A*OBEESI)VZXV^/;[27[$?SL^1>JF<;:5INLNT>D+M3E,;(F.%.9$T
MS&.DO:UKI9$!9'=69<ZK&-YCM_[&'[7'S4\AO-?2N#..^)O$X9FU^GTS)5;/
MG2FLEB<)3F/ES9WNN9<4N9=<-R_V:O+^G'PSQOPY\VOD&_5>'9]/54NO:93&
M8*:8V:T5%11ES@-TF$7/= +<Q6/X=LOD@^=;]6XXE^8[S"JN-M(TNL'UO4ZF
MJ<^5+<-Z5->YSK6M^$E9LN=.E[]>W+Y(?M2/LXJSY"^(AH%;23*:;]:ETOXQ
MI:=XS&M-X&:U-<N7R3>N%-^S2^1&=\ZO%D[AF32OJIAJ'2&AC=XQM:!<<5*U
M\>/+Z7>!OU5#BR1JO#G$<_2:XTM+7TVI/89;]TMIY[9K(@MP<Q)+VN#VZ==U
M]H?R!_+<_P"6SRIT[R_FR74YT>33L+'MW3%DL,%X'WBOKZTO:7J_,O[:S[5'
M0/E;\K-9X7X3UJ@I^+7T^I,+VU;1/#VRQ+8&ALP$0(/25FWQ#KTU[5_,I\Q/
M./S_ /GW\WF:'65NH:[5:SJU0ZEII'UFH;*E5%0 R9.(>YI#C -%D8F]),<E
MM[:G#ZC/LVOU:7B[B71].XZ\V]&KJH:E14M6655,6RV-GM;,$N7+=*W6M:'<
M^9*7?"]<=>7[YL_5V/E]&@2*0\'R/KK)+6O/U65'? A&/A*V:Q%]^C\COG:_
M5?ZK4]"XEXG\M-%JZ0Z513J^0:.26N_$-!@ R7;'$7$+,EG*WMT[:\OCRXJT
MGY@?L^?.J;HE//UK0:G0-;D57B3I51)DU8I9[?$8XL\)C"YK+[!&U:SF,7/7
MCA_1/^P-^U9D_,]P3HOEQQ?K=!4:ZQ])1SA.J 9Q=X4ICH[\PF)<%,[7MC&N
M7U-4E"REUJIF26ALJ91,B!" <9C>W<6G/P^&G]9ST>FU/3]9$^4V9&;71B3@
M7F\&-ZS>7;IGU?#Q\K7GY2_+KQ-5<8T4N'$%)5-=13VEWBM;3N)EM8001!PZ
MREVQ+.NGO;Q=YA_-]]JYQ+H'"FGGB"NT65,932Y8%7-IC+EQ8T%H)8YGNW7'
MF23>VL^W#]:?(3]5<\]^*:+A;BKB&1K#Z><9-352)DIS)>^WWK6-EM$ 1<M>
MO:S[,9Z=;OE]A'V5_P!G15_)#1TU%5TDVGFTY G%[-V(W-T@DM&"2>&N_:=N
MNGN_]H+\WO#?RB^4&L<::G7T%-63-+KW2FU$YC)A\*23+<!OM/Q-L6;<,]/O
MP_E0?:+_ &F7G9\XWFSJ.EZ!K];4\.SJZLI*:@TY\^>:AT^H=*9+#63'!K87
MF":QFK;G4>^OV9WZO;YL_-7IM)YC<4Z5JXT?PZ:N^KSY#V2MV>]CG.<'2P9C
MCO7NB;5,V\<+ZSKNOJR\K/U<CR/T'1:"FXBX2E3:N322Y<YSZ6629@8 Z^5?
M%,5;VZVO7#YKOU9[@;C+AC66>7W#3J:L,ISZ<T].UK@0( MW)8(,4Q8OMTNG
MQ:_.Q]G+Y_?9R^83M:GTVKR*?1*YL^AU!]/.#Z>4'@@S)K!++Y3;(QM@(Q6N
M7+?6YCZ,_P!7\^VBXFTGB/1_*OS?X@D3Z)U;)H94NMJG [DQS)<6"9-B"1<I
M/VNNODGW?T"]"UG2^/\ A^CXUT6=*GT&H4S)\E\IX>V#)3)GQ-L)(>MRYCC9
MBX?G/]L=(94_)KQ)*F-#FNI*Z(/]GMYD\4Z;[3]'\>CS0$GA#S?U35J65N_5
M^(JVL\,%T/$EU+CO-$8@DGK6.OT\.GR:N9R][O)&J^;'YP]4T[RT\MIFOR]!
MK9+*1[:0U1D>$XMDP]P[D""FHL]N\?1S\I/ZK1Q[54NC<9>:.EU]7,U:6RNG
MBK8]\'3OQCSNS&F&\XVI<W@Z7KTF.W+]*^+/U9W@.MX7G4.E\-[FH&G+6.93
MMWM_=(L_%QC%,4O;KX?+U]J1]AGYA?)A(K>+Y&GZG+TLTKZT,\%QDF6(NM'A
MP^'$6IG'+-QVF7YL?9Q?,WQE\N7GMH$_1]0-!2U&JT,JHE3)CY09.95P?'\8
MT1=O&/,IV^J]+>+P_K[?(GYK3/._Y=-"XRKI[*NKJ=.IVS)C7;\'&AWVQ,28
MQBM3ACM<=OT>SVD:=+H'?G34'M91EDUY=-(#![KB(DV"Y63RMN=1\F?V^OVP
M+?E_T/5O++R_URAI]6J73-.9]6J0)@>6N8?R<P$'>"EERU,=)9>7\]>HU[ST
M^=+S4;IU?4ZOQ%7<1ZU-G@29=1/DTPFS7>& XF8UY99TB*?^[.^VO#Z>?DB_
M5D/,?C[0^'N.N---U2=3Z@R74.;4R"UK99;OP##*:QH(R"G:5K$Z\OV<H_U:
M'@&7H,RDF\.1K722T/-.R._NPC^3S3%PL[]<_P"7X[?: ?JSG'W /#%7QUY>
MZ7J,@4<FKF[E-3ES7BG:V9N/EB60YIWN?(JR5.UZ]OX\OGA^7?A7YE_EW^82
MBX.X;T[B+3JUFL2::H?)D54F272ZE@+ANP ),8V+-Q_E>LLN+P_K$?97ZGQW
MK_R\Z1-\R9E54ZV-.TO>-67F9NFG@X>_[UZUUM9[S%S.'=OS@_,[PC\J_DOQ
M3Q5JM?04NH46F57U=M1.9+=XQ#W@P+FDD,2U.O7._#^4Y]IQ]J3YS?.!YNZ_
MH.@Z_43^''ZW6:=2TE#-G3C4>#5/II,B4QDW=&\1?< .D)/JO;MO]KV4^S&^
MP;\X/G#K-*XXXHTG5AHM1-_.#Y4VGF-E3&,C.?,F%S(S'.@;R0L[MQ&IUG69
M[<OKH\KOU<3R3T'AB10<0\)RINH-:P/>^EEEQ(8T&^4<0M26+>_1TI\QOZL[
MY?<9Z-44W W#/U>I?2SI;#)IV-/B.:X-,6RP1:5GM+G2>W3#XM?GT^S+\^/L
M\N/9NH4]%KLBBHJFH=)K&R)Q-/+E38V3&M:7,  ,"2;+%9?%+TN/;KP_:+[!
M'[8_C[A#C[0?)WS+XFEU5+4_5J2F=6U+P'RY4]DB6XB9-@"YCK0F-I.TO7?+
M^DGPIKFD<;:1PQQ3H\^FJ)-;1R:]SZ9[7-W9],P@'=)L!<MSASXT_"/[=7Y8
MN-?F*\G]?;PG+JIS-,TLLG2Z4/+G&5(@X0;&-H7/MG+I\>W\N3COY2_,OA[S
M?K. IG"^OO?.UUU.'_49Y]R;4@3/?\/]D8%671?CN7]$/]72^3[S \B>$M(X
MKXDIZZDTZL$F8R55MF-@U[&P$'@0A%)ROR63J^J7B:>V?J<6VADIC,Q$;\>U
M6\L==]<H!%$! 0$%IX2^.K_@SV+?Q_\ VN/S</G&_6,/]WJL_LFO_D"I\O\
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MLS3=5>08XLW<#^Q5OU8ZV8QY?R=N N*QY2^<E+Q6& -T+7:Z=(;$_B]RK)9
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MR5Y \5Z%H6C\95VDNKY^[+?.^N"5-:20(Q\6!Z04S)RQVZVW/5^T?E/]I!Y
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M2ND_EV?PC/P@K\;/9^#WZQS_ +J\_P#L74OPYRS>6NC^4]H.KR>%O-&5J]5
M2*76753HF W65.]>>9+,KGUK[?\ Y#/U@GRD^7[R2I. M7K:-D^CHZ9LMKZU
MK")DF4)=V<%9P6];R]KG_K//E07 -U&C _S\;%-G[4M2_K,'EA5TSITO4J+W
M22?^T!< FT_8_/7YO?UE74M8X<U[3O+K5/QU72S:>4*6O>7$3&;IAX9C;%9L
M[.F>F/N^0;S\^8[S,^:CC^=K/%E55UU9K.HRV4E)XDZKF!\V;!GNEQWB"Z)
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ME2I;6PEL:(V 2W,%YPQ5U(Y[M5G4=7JM2 ;.W T @-8W= !VDDFU1J3$^Z(
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MKIFJTE/7 .;)DZ=-ECWK3O/?OS"8[0M7-_BQ.OU=Z<6_JRGS&:%IU=5R:37
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M?*/2Z-H<BDXBIFSI-%32)[65<H &1)9+%@?^Q3:?LSE!?_9)WRK_ /RBD?\
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M$2XW1"SNQOM=YK^@5]F%]N3\J7RV?+=0^6_$.KT%-6T5!2&6!.E2G^/(D.E
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MFSYWCNE->)T\/>^UYC'?>GDZXQ7U$ZA^LB_*9(:YM-Q%(&[,>&AM9) W=ZP
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M7M[^JU_WJ:7_ &C2?AK73^3G\_\ \;^CYQC\=+_!N_"*UX8ZMC0_Z)(_;N_
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MKN\T61NLQ55R0$! 0$! 06GA+XZO^#/8M_'_ /:X_-P^<;]8P_W>JS^R:_\
MD"I\O\G3K_\ ''\PGR*_OITW^W9G_P"$%B\-_'R_KU?8N_[KFB?V;I/\BY6<
M)\G\GZ/SOZ14?PKOPG(.""<T*]W[9OX06^O#/9\Z7ZRO_NZ3_P"PJW^3G+GV
M:Z_Q?S</D1_WE=$_MN1_^$)B>%Z?R?V&/L]?]V_0?[-H_P#0GJSA._\ -["M
MO=S^LH)C0O\ 7%'^W]3D+P^<#]9*_N9K?[$;^"%.S7Q\5_-]^4C_ 'L.&_\
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M6OBW4^,.%-.HY6D,FZC/\6CD-8S<\3?O:UHL 4\KB=I[7E\_GV?'F%K'E_\
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M;RZ]?X/MWJOR=)^W9_)E;G%<9R_G9_K67^T&I?YZ/PFK$Y=+P_'_ .P'_O\
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M/_*-5\.7_4WS\+.?_&"C<Y=>?-]_<%K?]E/_ - <K>$Z?S?Q[/M3O]Y?B/\
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MJ&EIZ4:9HNF2',IY;98,Q]-O3#[H%L3 K4QEB_ONW&8\SICISH[SR7'I66W
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MRG'?#1)/O&,(&:V%N!BM,5_.@_6=. ="F>96JZ^RCI*:L%97S/Q3&-='>C@
M3:L9V[23U?B!]B!J=30_-KP\V3.FL!KM.<&L<8$F>(V1 M@M9Q?\.?7A_8!X
M!G3:_P NN#9T^+G'ARA=O.O)%))9&W&Q=.9GRSVF+B(:80V=-$8>^>TKFV\
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M3+ZEZS3= I)<J9+X7TZJ9-$8R-+H(-$ 1OQD@B(-EBTQ(BG3>&6$A_"U$TC
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M$??6ZQU\JAOSO\L_K/>BO&_.-\YYZ3WH/%N)B<R@()WAW\K._:N[%>O*=_\
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M:;,J:MS'O873:FWWR?>]VTFY+PSTN\7A_7S^SQ^7FD^7/Y?- X%;0"BJVT-
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M'?A]<-#547%>G2-;TN<RIIIE))J1,ED$'Q&!]D-BW9+MGBX1X,8["1U+"O*
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M\UN-J.>=3F5M-6&;7M+9F[),N8&,$S= :W( !3&6IVG1]F?"U')X*X>D\),
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M>T0)!8![T3FDTG;M[?Q>T.I:C.KJB:1,<:1Q/A2W&P,C%HALBA_[I_@T09J
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MW\7V?<7ELRNIP"#N4[8P,;?$F.PV.5K'5&Z17MD5!97.+Z%\MTMTHVM(+2T
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MLIM5I$QI:Z4]H>"UP#' AP<+6C)#4W.71#OL]_E"?J!UMW .FG4B_P 8U?\
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M%>7VDNT[@JEIM/E;K6-DTS&;H:VP _BVBQ9X+[751M3655>_Q*QYF.;8R-@
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M=0_.E7P71S',<UX:ZCI6;SFN#A%SI! %BO.U[=^LXY?H+PYY2^5_E?02-.X
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M/#)DR2X3)1@]MK3M04WC#R6\LO..0^F\R=*D:K*<W=,J<V6X/ @V&],ES0!
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MWVX_$GR>^5/DCJ^I<5T'#L[BZKH-2+8?5G3XS),)<26;^^71L4L7KF;[<8?
ME]EWY!57S,?/=2ZGPCH]>SA,<4B9),BG>:;PGU;7-]X,W-T!JEXPO7'M[>']
M;7R)\O9/DYY9:5PD6&6^GTRF9NN :=^53F68@"^+E9PQVN>V4P/B><W'M/>B
MO* @RMGSF2YDACH2I[2R<(FUC@6.$,?=<4->737%'R>?+?YEU+M3XUX5HM5K
MYP)G&<RG88N))]Z933(Q)5Q[':ZQ.%4D_9V_)W3L\.1Y?:9+9?NQHC;_ -2"
M>C,[.9^SQ^3XW^7^F'_J7_W$GJ>[Q_Z>'R>__P!/]+__ #+_ .XD])]#V/\
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MU-SO$-3,%)+=OD[Q]U]&]T8G-7PS;79/"7D-Y3>4<N6SR\T>GTL2X%LJ2R6
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M -&Z 2)31NP43]SE6ZG6Z@]PJIF_+:XF6  UH!V-@+D:QAI  7! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\NLIGP884'A 09VU,U@W6FSEM"&(QOF.>8NYT,." @X[HC&WK4$E3:K647Y
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MH:"V S8">N"9M2=)-1AG\0:C4MW)CA V6-W1V *YL/65$/\ ?=O.B2HUP("
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M/K4[E_\ E)[4]8?6IW+_ /*3VIZP^M3N7_Y2>U/6'UJ=F?1WI[4]8QNFO?\
M$5,Y:X8T0(!O0>6?BSO-C$6J'*5D:]J-,W<ENLYH]ZUFIZQL_I3JN;/XL=RA
MB(ZIU2KK(^.8@\MA"MMI))PC]P1Q45R0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 09Y-_2>Q F^L=B).&!%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 03&
MF:HZA=-$8-FLATM#H>ERLY,9?A)]J)]CSP'\W&A5W%^G2)%1Q/.I:V9NBG;-
M?XTT%P_9?$I>MY)WDOK7P&_-3]AY\T_DCQ!J&H<.<-ZA5Z;*KZ@2!+I*F6^4
MR6XF7-D3I0WF0:,NI6,^MO'#U T/2OGE\F)IHZ&3Q=);1$T[9;IM>\,$L[H:
M'$-) W;(VJ8;D[^5DU7S8^?7BVF=I,\<6;DX%ECJ_'I6=-_OLTB>!OL]?G$^
M83B&EF57#^N5L_4:@!U9J+:ZK=+WB0?#E.:UC++!#IBM3'AR[=>W-?5/]E%^
MKM:W+UCA_B3SOTALHTFI4]<':A06D2YDM]OBM A[JF+;AO/3IU?=EY8^5G"'
MD-Y>TW W"4BCD4U')9*EBGD2Y+CX<ILL$M8(V;MBW;ARW;GPD)T^95O\::3O
M$XG*"SG+<TX(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(-[36L.H4A?\ ")\F.4/$;%68O(_&S[>9
M_'LSY>YTKR]^MNU0Z-6[_P!3W_$!<Z?N_D[8[I"QW/CY?R^_,GA/YM:CC?4G
M/=Q9X\^9,DL#)E8T;KYLP$0+76VIK&VNWO;I=O(C[,3YK?F$XRH)+>%]4>RL
MK*9];7U4NLJZB8R9.!>'.F2QNB&T@"P *^/VL8N?W/Z/WV.GV2_#ORH\#:?Q
M1Q=IU'(XKD:?1/ FT;&31/ERPYT2X!P@X*],R[^K7;OK$?OEKVIC41(EL$&R
M+@RP1.Z# ##W5JZN&.N?*"66A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$!!;>%:F33S*OQ7;N^QI%WT7.C><BKG1VW'P5_K%_R.^>'GOQ
MO6Z_Y;Z34ZC+_.,^H,J5(FO;.9X@<9;GRVN+0\"$8&"Q)FY7_HUR]>OL!_D$
M^8#RA\UZ3B3S"T.KTND9J$B:V1,D3PV2QLUA+1,F,82!#(*]M+U_CB\OZ*FK
M5$F;HFC26.B^734X>,BVFE-(O^^"K'755=%$! 0>02+0@TJ_AK3.+I+]&UIL
MI]!/&Z\3FA[($0-CK#>A><^6;AGRB\O_ "YES:CAW3M*ESWDN+A2T[9A)MB#
M++CBM3"7MVLPD*S4)^H'PIONRY=C +&P!P'0KV[;2=9&J++%AH0$! 0$! 0$
M! 0$! 0$%IX7JI5*RO$UP:7RVEL86EK7V7[49OT?%9^L-_)UYQ^>U#7U/EQI
MU363)C:N#),B;,WM]\=V,L$@$=*3ZUUS^W$Y?B-]C#]FY\R/EY\R.F<9\;\,
M56BT%-5T#/!=(GEL)%07NFF9,E2K7!\(0L@LVWPSUEC^G[PU/;2<)<.T<RR;
M3Z'22)@N@]LB6'#H(727$PQ<VH4_&\X%UGI66A 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0;%+4NI)\NH;?+,?01ZT/&'K-\VORD\"_.!Y>ZWH'%_@NJ'4CY%*V
M:QLPDAH:V =G!6]<PE]>7P!?:*_J[7FKPMQ-Q/Q#Y1Z//G43'3JZ0*>AF.ES
M"/HO;+ #FN:W-9F9JM=IUNX_!*M^5?YU_('5YE-2:1Q1I;Z-^_N4LW4!3DRR
M+6R7,@SX<" K9/+,G>77U721YV_/Q04WYO8.+/#+/"^*ONNSV*8F'3/=U_JG
MDQ\ZGG]6,IM6TSBC5 YX'U6?-U 4Y,UV[^,8&/$P;#8F)RYWWNGZK_(M]@%\
MP_FEQ3I^I^8G#L^FX?GLIW3)<S3YW@L9,>QYB9@.\88V<RLS?T3K),^W+^AO
M]G+]G%Y8_)9Y?Z-)HJ+3&:M+TRGE3C]4DRYC9NZTOM(WHQ5URMOB/T?I]0=6
MZA(D38"FD5;'2P+&AHF,@ +@(!7E,8_5\\'ZQO(\Q:[R*E2?+CZ\=1&D3O%-
M#XN_O;TXM_)6QW2%CMG&%Z9ET_FF<2\#?-GJNN3J:<>+7SZ@ND!C9M:P%KGO
M&[\+B(QO"23&VNWO:]J_E)^R.^9_YBN.M/.J\,ZC*TV96TOUF?52*NKFU+)T
MP;[ILV<P6!L;+5?&F9UN<]N'],+[+3[,_@+Y.O*?2I];044KB<4=&7GZI*ES
M&.DTYW]]Q@Z)F76%)/)V[;]9P_5#4]2?J;V;\0V23N_\*'J"M3KF<HY11!S$
MUVX^G)C+J1X<V)LW# &.R!4,95V5\OGEA6Z@W7JW3]+J-0F3/&<^=34KR'QW
MB"7D.B"M63+,O:3'A>Y];+TBE;H6F2::502VF4WZO+$MF[$"QK8 6!2U9,;\
MH)K0T0&9-JBO*H(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.
M$V-0SZG,MDO/O W6@CJM5GU7PT9'DKY=UU7)UNNH=*G5\IPFM?.IJ=SFO!WH
MDO@Z_**7;$O::BV:CJSO EZ53R9$FEI0V7*^KMW6;LL0;NM%@$,EK,,(01@(
MWX\ZPT(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(.#V;X C"!BBRX3^FZZ--89;Z9M0QUX, 0-A+2K>UQAS]-^S2XJX!X%\
MTM+F4.O\-:+4;X)WZNDIILX;X+3[W@M<XVXK4Q)E?;MUN'I#Q9]EA\O7%E34
M555P[HDMU1-=-<&Z9*L+B3@P9K+?]E56B^R&^6^BGMGLT'1BYMP.EROW*EF2
M?+8]I_*WY-/)GRD=3S])X6X?>^D<)DMTS3J=MK;1:Z6;8J]9AGM\G;L]@YW$
M%#I[?J=!I=/3LE@L8)#)4N2P7#<ERI3&B"O&V?7VERJ4^8ZIG&<XD1,=W"U9
MMSMJ3UF&-%$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$')KS+(>VPM@0=H(/J053C7RNX?\[*&=I/
M%4BGJ*5\ET@RJJ6)H+2"(!K@8Q6L2Q,WK_%Z8:G]D1\N.J:J-6G:%H_C"89D
M/S9*,27;U^[FL>K7]MCVL\H/E'\H/(=IJ^'N&- =.8&[CW:?3L>TMC LWI3H
MN"LF&.W>]W=VIZ\RL8)$BF;3,;$60B;!9%K6@ 9*YP2*VQFY&V,3%2W+3D@(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(//B/EQ+"03[I
M@86&])R-69Y;<'\7@_G[1M)KRZTFMIY4UQC?\;'6KIB2,^UETXR_*K@CA(!^
M@Z%HU"[.CII,MX@2?H,$#8L3=V9M;>^YWNDDAEC03$ 6W="5H4! 0$! YC#:
M@\0=B]QV&/K)0>4! 0$! 0$! 0$! 0$! 0$ O<SX21$$&!A$$*P\,#^ N%N+
M1X6NZ3IE<RV/UV3*F1B?V;'7I8SFRL<OR7\O.&A];T?AW0J*>TQ#J:DD2GQC
M&(W& V%:DGK?J>_;./#;:X@!@L;+]UH%P:+ (="YM"H(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" 1$$9H-BBJ#0S63@T3-PQW7"(,"#:,;E?;!=K0=0T7B*3,H
M=4T2AJ94]CI4UE9*D3I+FN!!$)DEQ MSL3KCMRQWEZ[ZO4[S*^0+R-\SZR=J
M&I\,:!+F3VN#O"TZ0YOOF)M#!FEQ6NOR=L.@)GV0'RW3'AYT+1@0[>_U7+SC
M]ZIC6&O[:[4X$^S3\@>!*QM;1<-Z',>PL=[VF20/<,1>R%Z89][E[JZ;I_"W
M 5!3Z3H>@Z922*>4R4!02*>1O!H 'B%DG><1"XDJ^&=VHC5=3.JN#A+%.UM@
M:S*&,(14;DPT9<UTF!;>V!!QB(=R9P*'YB^2?"OGY03]-XPIJ6JIS*,KPZN4
MV=%N[N>ZQP,58OMZO3MWV0?RWNU65JIT+1O%ES!,#?S9*@2';WWBF#^VO=+R
MK^7/RN\B*!QX;X9T-DUC0&3&4-/*G#=$&N83*= @8X)PE[7OIV!JFL'52T,D
MBF9+!:&M-X))B8 6JYQP>LZW,0[6AL;8Q46W+DB" @\0=@]P&43WH/(YR=I0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'@AV#W 9 GU
M$(/* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(,\F_I/8@3?6.Q$G# BB @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @\ATQOP3'-V D=A0<O&J?ZQ,_PW=Z&CQZK^L3?XQ_>AB/!FU!OG//
M.YQ[2AIQMQ))Q)Q0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'D%[?R;BPYM,.Q!R\>J_K$W
M^,?WH:>#,GNL=.>1D7$]I0<4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$!!YWGCX'N;S&"!O3#\<QSMA)/K0>$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$'G>>/A>YO,4#?FGXIKW#(DGM38\(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @1</A<6G,(.7BU NGS /V[AZT-//CU7]8F_QC^]#$
M>/&J?\O,_P -W>H:>(O-KWEQVVJCP@(/(<]MK'N8?V)(["@Y>/5?UB;_ !C^
M]#$<2^<[XYKW#(DF/64'A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&>3?TGL0)OK'8B3A@11 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!GDW])[$";ZQV(DX8$40$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 09Y-_2>Q!QF&,-MO58APQ(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @("#-*,.BWK$$&X\4V#AU&'9!58Q0I
M_OF]2#S"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U(
M$*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]
M2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[Y
MO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^
M^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I
M_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($
M*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2
M!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO
M4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^
M;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_
MOF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*
M?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!
M"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4
M@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;
MU($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_O
MF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?
M[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"
MG^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@
M0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U
M($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF
M]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[
MYO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G
M^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0
MI_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U(
M$*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]
M2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[Y
MO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^
M^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I
M_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($
M*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2
M!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO
M4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^
M;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_
MOF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*
M?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!
M"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4
M@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;
MU($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_O
MF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?
M[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"
MG^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@
M0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U
M($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF
M]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[
MYO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G
M^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0
MI_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U(
M$*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]
M2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[Y
MO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^
M^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I
M_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($
M*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2
M!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO
M4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^
M;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_
MOF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*
M?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!
M"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4
M@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;
MU($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_O
MF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?
M[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"
MG^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@
M0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U
M($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF
M]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[
MYO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G
M^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0
MI_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U(
M$*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]
M2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[Y
MO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^
M^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I
M_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($
M*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2
M!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO
M4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^
M;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_
MOF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*
M?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!
M"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4
M@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;
MU($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_O
MF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?
M[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"
MG^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@
M0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U
M($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF
M]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[
MYO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G
M^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0
MI_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U(
M$*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]
M2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[Y
MO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^
M^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I
M_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($
M*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2
M!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO
M4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^
M;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_
MOF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*
M?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!
M"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4
M@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;
MU($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_O
MF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?
M[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"
MG^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@
M0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U
M($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF
M]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[
MYO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G
M^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0
MI_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U(
M$*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]
M2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[Y
MO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^
M^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I
M_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($
M*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2
M!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO
M4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^
M;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_
MOF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*
M?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!
M"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4
M@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;
MU($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_OF]2!"G^^;U($*?[YO4@0I_O
GF]2!"G^^;U($*?[YO4@0I_OF]2#Q"G^^;U(,LL4V+F]5G9!-*__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2132809d4-bc_serum4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-bc_serum4clr.jpg
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ML<%0T?'A8'#_V@ , P$  A$#$0   =_@()
M   -;28\V;IYJ[#J)(.T                @Q<3CKU91:)\(        "%
M           ':?:     :O$Q7-Z:^P8-FM5,PJR C*=:E
M(,>&KCKTY!:%)E3@ $ D$   $D').*B0D*  ) (  !!)  .U/J4    #"A,<
M#*E<O#$1,6ZOG'DRWUK(X                '64XE3J
M ,4^]]'HSY]ZD.J]KNAL[OV_/OVQ^[Y:F^?<R$LNKIU     0:@DQ&/T9KV
M Q&*K,C@               <0<"FTJE0                !Y._L?-+W[.[
MYZ\I?ELXR^WJT^O*    !\1K'3JK:-+V  Q&*K,C@     > 6Z.)5Q6Y(
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M      $' F.NJ82KE   %('VE1   $$EM(N ?74'!+?+<4        (4
M #3%=-)QO&FKG0 Q'*J,C@    #\?EVL'K !ZB_NHT[M4      Z@82-5/[T
MSWV=-#'O $ $@I,^P]\D!2 6A[+U[%O(/0?%TWVM4^G1KSQP_EKMT:J!+@D
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MUZYCQ 6$^_;W-P_FST5]&C<H N%$'($ DM#V/K^KK/.# "[:O/&?JXXKE!)
M!]1[*@    :O4L ;O5[#K(B:Q**K,C@    #\?MVL'; !ZI^Z?3O50     "
MU&C51.]M9":-?*)JF$JV6#"O)>.L$,I8Q1)W] R'['Y=_J6U01+MA]A^+;A]
MDZL !B]WCI>MW,>()6$[>/Y*X_Y6_JVVMSH7Z8V$^D?,-[>^8^@ DLUV/KVJ
M#/.#9B*&X;SSGZON)Y5  5!( !$47P?8*TYSK\T!J)2UAO%E[* &(Y51D<
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MP    (/Q^W;P>ND >JO[I].[5      *:E[KI]]1UE-V51*,*\E8ZP0RCC&
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M<_5]Q/*@       #40EN3=PO:0 8CE5F1P    "?C]NW@[8 /47]U&G=J@
M   &#>G7<W?V*BT;E(-63>G11A4JC#7)..\'<IXP2K._'^0_8_+S]2XU:9EB
M7:?[#\65_P!DZN""3&7O'3-=>9,/S-1.?&\G[OY+_KI&QO FQKU'Y/OGD/&P
M(!:#L?7]6.>,&R14&W7SQG^N>*Y0 A2=R^B     :_DM2;5%Y@ Q&*K,C@
M  $_'[=O!VP >HO[J-.[5  ()   !!9FO*MOIITTD5.L&&.2L=8,Y2QBE6=^
M/\A^Q^7GZEKHE>,U;5O87BRX/9>K@ 8P]XZ7KHS'B&+I+SXSE/>_);]<XV=X
MHV0>H_)M]LAXV  L[V/KVJO/&#96$+MZ\\Y]KSBN5  ',^L    !-;*V@3<"
MO8 #$8JLR.     /Q^W:P=L 'J+^Z?3NU20264+/)5I?1:J)   !UE-I5"C"
MO)..L$,IXQ0KNZ!D/V?RZ_4N-4E$NV#V%XNN)V7JP &+O>.EZW<R8@0.SC>3
M]S\EOUT;6\@NROU%Y-OSD3&P %F^Q]>U/YXP;)!%FX?SSZ K[B>4
M&H9+4IO+:NP &(Y51D<     ?C]NW@[=( ]4_=/IWJH*#37;U[-OU[7VVM2Z
M2BYG(](SWY7'H  B(KK*:2JU1A5DO'6"&4L83*._H.0_9_+K]3(U:1"[8?8/
MBVXG9>K  8O=XZ7K=S)B (Y\;RGN_DM^N<;.\2+=E?J'R=?K(F-@ +-=CZ_J
M@SS@Q$U%;A_/&?J]XGE0 !!(    !KK2@S:8O8 #$8JLR.     3\?MV\';
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MU[^C-C9U\SIEP1U:O;U[?S;.NY?T;%/;&];=>)590<?75.&Q%I]J@
M    .F)J(DBN1V'SGGE"E92]5E+%9E()<E>!Q*./N.XHPK8HTN822=@   .!
MB%MZ^[?^?MVOJ^W7L>LO@M7M24YO[>6VQN<P  #K.P      @QHFGC=7TE#Z
M]JXNC=MGJV\SM.XCE0               &,A@8GP)]ZTH=A2QF2;$5[ 8QIA
M.6?J(JD]\W&J    !PC5%M[OT;OQ>AM_?17V?%3>QO7*FY:3=^?,+?VL[OC^
MGD          (PRFWCAJUT]7R[^GS_FWZQ^OX]LOR_1(
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MQ= U!27^)BQH?A27012J+U%D2O1RI+&%#5Z: Y?Q,$RH/\H#&J)08Q0Y=_E
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MT-2#B]RZ&C@$1PP5,!T)V(Z8&WF*G?#4Q>H52X0<7N70T< B.&"I@.A.Q'3
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MCZR>R2OM_P!#&>"XMF2G&L[6RKQ.IN=:O3(>]#$O82I]&KD]R[/5[^( 5]P
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MR)>H0E+=T\#%=]%JA[QYE'8YT"I2X*TZ.941[055].8]"/Q*BN1N);>[I(\
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M7=9I>NA+[UW+2&AEQC.B/P2D%($18ST^I(1CEU+D1-IUUC4&%(Y5,!3A51Y
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M5WQZBE!A46;29M*H8*36VI,CDF2V,AU!SJQ5([1*\)I&''C5'=*U6:3)9)H
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MB&$)0MA*NS@9K<:Z5^3O^^%Y41=C:4$UV-_L)LK25=V-I2?P3AK)!E,9*"G
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MX7Q0NF92 R,5L-'L]U<V[=?PJ+_1 4#. 5(^8.:0!R67TI$*OXDZ>AB4?0*
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M$@W>K(C?72*6$@M3B][]OU;^&/$N&I#AJW#.&:&DFSK2%!J_602SEXK2]R#
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MV*-4GR'$)16UXEZU%":E)JW8M:L1N6A"4Q@?M(6L<K>4U1MRW-*P]A3'3_\
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MK%XXN*=1-34U-36?SY.O[JZ;NY%TFM34\9Y@^5Y)X3Z$$7<"T%[$8WBC^+M
MK&7:2U3BG)M^_31T#:L'CBXKK&W-E\^3K^ZNM[N)77-_00X_._S5A=P9[*6]
ME8%5\)B+>@AX](VK!XXN.?&7SY.G[JZ9NY.H;^EA7S/\U)'*>X"(:3+.[0'0
M*U&,>+++L14V%[(V>Z7D]%'0-JP>.#3BNM;<V7SY.O[JZ+NY.H;^FGRO\XY'
M<?QM[ZU%F6>VV?KE^$<G6-JQ^.+BNL;<WR/)U_=72]U:<>J;^FGR/\E/T@.@
M;5B\<7'/CY7DZ?NKJF[DZ!OZ:?,_R$Y;0W:5_KJ_U5?ZZO\ ?4F"3+)'T..D
M;5B\<7%=8VYOE>3I^ZNF;N3KF_IY\S_'E= WY?@OSSGI$O,*"&]OMG,>-/11
MT':L'CBXX8BHJ*BHKY7DZ?NKIV[D/6:U%145%1S!\K4<(J*BH_B3-= WY?AO
MSSIV_'MJ4W8D>#,&QVY?A<CI&U8/'%QSX^5Y.O[JZ9NY.J;^FGS/\>5T#?E^
M"^A(Z1M6#QQ<5UC;FR^?)U_=71=W)US?TDFOF>2?H'Y]+M%():ZN_5?[6O\
M>4F3\VNKOU3@D.1SZ9FN@;\OPWY^A!TC:L'CBTZQMS9?/DZ?NKHF[DZYOZ2-
M02%+<#7^%I?^G7^-J*T(@C3ZK%Y?0F9KH&_"./P7Y]  %SO[[]D;<HFPF.U?
M[I7^Z5_JE%N^N!.] GZ&O\QK_(:8?T-+.!).W,I0K+5_LE?[)7^R4?$ QJ10
MNB1PZLU_D-?X#7^8TIE&YB_,(RXQ7^R5U)74E/\ FT/*P(R&ZO\ ,:_PFO\
M(:GX1.*WTMN'<Q!FO]2O]6O]#BI3XD2KEY)J:FIY7CS;VK_$K_.K_$K_ !*>
M5'*/0P&'_P!7N4B-[GV"E[$-41O1^ C!AY6"C-O5XU)@[S%,@S,HA8VO6,_8
MB@J$-\HR.T\^M-L[%2TM8^\?;!O4CIZ.5N9I+038VT2H.98>Y-!"J?[B-2XX
MAWG]5OPR.LOZJTKYWR*TP07S^JBKL2'<Y:QK@[Q+9]SBV)J&=-1J5"K4_:.
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M]*"D1*)\I]CK_#G;Z'__V@ , P$  A$#$0  $ (
M        ,8)(                (R DDD DDDDJDDDDDDDDDDDDA      ]
M!-30              !*1@ !:!;)?0'(/[)( ))2*2K&     'I*6P
M          !.                 ![KWL     )D  +
M((P                 $6H@0    !$( !8      ((       (O^V^TV[:\
MC4CDDRTDDZXIFY8P    (B0 !      )DZ      !+ K20"2";:!33;8122:
M#I^Y-(     &P !0     *>+T        $    >    ( #      !(!
M !M0 (      Y(!      ! @P        !F%8        "      *T  (
M  /))(      (=TV^X&_ZX6UG;/7^V3S6_WIGP    !L8 +     #Y))
M  %\YQ *H,.@  $30$         (     +!)'(     7))(     !L ,);#-
M#X  +EQ#    !(          #((]0    "Y)+      "H(]&FV3:MMM<_P!V
M;;;9B8?;;2      X!3N     %@22      1\A6B!/TA*23E?N3=+]Y +VBV
ML     ;P'R0     .20P      :8=:[-6M"VVSCA-(B2A!QD))"  #!@![@
M&     "B2&      ,@1@$]HL\   L-F64  3D)    #D?7@;0 "P     "20
M@     #_ ,#$!/5J0  !8X[I8  -?+   ($Q+\<&   @     \DA      $X
ME"_F;5:'6"",[")2@'!98243 'W%)AZ  L     & D@      5T' H,R22
M&?>-[X  U+-   H$^?-(5@ $@    $TD@      !P$ !7VW:P  ##7#A   1
M:8    NYA&;0  L     #DD(      \!F)MV(7B!)CA;"LI))I3*))(  @$4
M 0@  @    !<@!@     #>IV1.8[PPHMFVHK9MMK!9.>JN  #] 'P'T/
M %DD(      X$' ]V75    :?WI(  ONB   @  $  1("SH     HDB
M "  P3QZJ@H  #+1PR  #C:H        &4$ T     +DD@      'B.0Q!=H
MCB=( *.R E-C<J"EE(     S@ %@    !\DD  $    @#ZD**#*822R$T8A2
M26R^X22%     *\  L     #DDD$ K$    G 08AW.  &F[X<8  ?>\
M    7   @     4DA@)SVX  "@80I9))P   ;%'C  &F((  $     'X  T
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MF8G&']5)?/FS^JA9<:,2AI%JT"/D3P3E#,5U'^ZZB_==,_NNHOW747[KJO\
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MGD27).B'!)LT/>#+1Y[?B?W44U\Y_%/DP9\42)?[48'NGP5]M^"ML=D#1MS
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M8=17/  D,LU)RRI+L0L,L]*I8<CLS:NQ%$H2N9]_T?;BXM(0KDJR$DHHYU/
MEP05TF9K00N(5"6,'ZH;6\\:_LQ4C><TL&YC>H+@E)G!#=&$*3Q.G_"DUAW8
M:8<6BB73JQ1E$_#_ %09,DVR9?"?S45@&P ,MP7J3<^] )6"N@ZL?#PCCD4@
M(&2&F0RE&*;Z-\G^Z=F?>U;:CO4DQC>="8'PQ4Q:&W;A:[B1;']RI-S[E2;G
MW*4+K5JX[M.(D#*@UR;-J:2([Y1** 0DA+X2O>F9R<RI/99H6!50-T8H72HW
MT[$7[KBCC^WCH,!>:MS<]BI[9[E5_FJI-%6"2S$9R- 6_*.\\,AWOV** Q#+
MDCV4+&!DR9%&&D=:C_=<?,G^-JWET^5&:LS^QQ/:6T$M@.$;;J5779R:M-2Z
MYX!"]">VBE6OX4@@!KQY<W@\+]4_W--E_L_-'8<1(30<TFB,&V1N1KYUWWA7
MKG,AF[$1/:S28G 67 #IRE=(1P(+O_=HFG*P!4*)IPY_Q],P51NP,I;DCTYU
MFPU QA1$B>S1$#@ZMC;0'95F:;3< 12,8##@07-GK)9MEW_7;B<3*BO4IT*
M2TE++$ILG$IC&(H@2&?4_#0"$Q+FM'9;='AV$06XU580:?..W;DR6X1DA9H)
MC-]FTH/W%&,O"JK."?S6F_I]]1?YSZ1,A"42G 4L0FM9ALF9=2?C@4U1,9F
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MK2:Q:-7[7@:$/>=R$_\ ,'Z#0R5;(E<G\[!%*8D,Z(BV"6XCI6B-&;@+Z"*
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MO0_;^%?X5ROP,BD)?M2-THMEMWS%J(36)$I3"R4)#!K1<!&AEEA=SS@0BI(
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M87:L6IG E&Y:@,0#6NRM 4!D9L(#01$C#";^JV9:\.OO]_\ .9Q6OJ,-J[_
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MHLF/WUVUY:7[7%>:L7J/9I25)4E25)3Q;J,'CA%'[J%')4E25)4E2<O;BP[
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M4C]PEX+,3!9G:+T>_%ER)9/+D[5&J".V0F]V%P5,W/7&)'W")UOQ(5A2E6H
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4M].O&],S?D\5?KKS5XX,0;<O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2132809d4-lc_dosing4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-lc_dosing4clr.jpg
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M ^LOJ      (.GG1(\YLRI74.QW ,I
M                !23"AI^N.X&92
M               0:WT\)3ZUVYRZ0>%Z[;)S_(^OI," !2)(I$@BA,14P !!
M) H3$4$210"%3$5,14D  0I"IB*$Q!)% "1 @DBIB!00)(%"8'UK]
M(/%DQE+AGHNC_K/=;#.;Y[+[=TU0$!0       "%   (4           A0
M 0H!"@$*0H         "D@DT_L<N-'?9,\KSW<,-L@
M                  $$1-2      #B35'<>T2[-UT<W'<A,\3)V6=UZNH
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MPFB%CZXNWN70GECNGE]+(,==?:?9SO.^_<7G2   I    J8@      $$@
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MGU+0GP'IZZ3DR^,\EU])A:;NY?S\Y8[LI?8P"#$7'LO7.=YGUWA]K4@
M*2%E    (!((64   BV9(64   $$@    $+* %A.H<[H_+.\\+D%Y7ZM(!]!
M>4     #&".3K(LM@DU 7'<!,JP 6#7/RL-B_&?1,P
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M678ZO!I]*_=&H3+'<!,I  !!X/J[+S;N_$9@=3Z2I0
M         !2F)_M_A^5WB/M]QD    *01$U!) )!)^=>X[.IEG6?GQLYB3>Z
MR_//<-V\S]M0  "DUY\BYS9]5V?B]I,%(  4@  !2 I    "D*0 %(
M   (,=O6?)O8_/?0NS<3MY   /J6^      0"#&LY5/?UT_W'<#,I   (.$P
MW:[^Z\ULJZCOZ@                          "#RWN?&\3OX'M/G_ *"
M           (!)I^N.X"92   "#%K'G1W/B,I>H]34
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M<K6&RWAE-ES/"]MUTXVNRSALM:]A*K+^W3"S9$RLZ]E&.55ES/"K9HQJ]?\
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M/<;M/%^^\#W;K_0>D]5ZP              6C759Q$NQ\TNW'<C,N?0
M#BYLU!<WBY==SX.M+N6*XW,M-RXW;A*7+A4ERR6-RX5)4>*:M^06S3]N.QAM
MK7Z)>0T\WLW$[CL_![KF='/^C'8)     !!!:RQX[9Q.+W\+@N5U?"\CKN&W
M\/A<-&2OG/J4@      J6H       L&IA*3:RNB.X[I9EZ&  $*  0#6AT7U
M?,SL_#<[EHM,K$MA?GF7S3.A86@HEA86DIEUS]-].V_^E^(<G=8 (4 @*
M   0% (4$* 0% (4 "\70      """"LT_7'<!,I
M                          !!BVG0%S<33]9N#F5X
M              $$@              $& !BVFX!="R;/#U!()40 A9 (25A
M  )6$$K 0L))!*R0 $E82%D)*P@$K"%( 4 @$K"%()4=[KO$ 20  %( !]"W
M@      ""R"34RF::6P" 2  ""0     =$7B$^Q?K.#.13L2^+'HJ<FO"U]I
M1'HB2           0>IV^ER@              "#'),B5U+&:UQH @* 0 !!
M)T0[W41( )(H=$CA5X,^P^LZ:#NZ<$O<JZG)"]L/0D@   DZ,=X%  3$ $D
M ^M<CU D@D @ D@%)Y(>NQ-       6#0.F]Y=5*<2H$$PH0 218)@O6SLA
M )(!,*)"R0D+U\[$02A8"2L D@ ".NUV,$ D$$@@D $'3$[)4D$@A$JP%")(
MH9.1G^M0      !!\A0?224%PN( "@@*/C+Q(+)]:%!"@@ H7YB^24GSEP^D
ME   (+4MHOD5;2):[+X   !:6R7B"DI(/K"   4K8B*K)A51 !!<))   !!A
M28Y)\IZ&=?K9K+RP    -0J=0/7S)Y=.=Q_1Q,@   !\QH(8^]KWLR^73ZQV
M++GJM8  !!AZF%5G=I>SGOYBJ>E&QQ0   .CFEJSWJ.X&6*ZFKCZ%+NE4
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M%'U=8=CYOCW4<R5?T&!R;2-5X(5XWCO3KL2DJ\ :S/&Z#!O3/@__V@ ( 0(
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MJ&V9T>,XX9?85C/CUD/'J^2MSY^S0:VR,E%]@&HDDP3F36OT",]L.['I$[[
MNY#]G,BQF8<?Z"Y%7;0H,OF,?7K^V.MC4=5Z9%^$25&7RY&9'<>67OKLR8Q
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M$*;1 ?I-:^E7J:WL,UNE!M.W>*>8?%KS'V&YIM+=KP:QA$TC#G\D;<495&E
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M3[:O%]=K&%S*6JW$]ALH0;B[ZR9:TG:U)EPV?1^S J_K^'4FCQ=D<7$ZP.)
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MDH R4E^!6).YL/\ 4/'_ ,<=/RR3:=.3&B Y HE34RH1DI*2CFHYJ:FH1DH
MR4BN-1S4U,J$5",E(J7EA\,CJ7]-VTMG^S4'J\CLU&L-6]IG4JM]E[9'R6;@
MHU:U-OV@NM<TOO!=]K<@)_8H4VUG'B85_3V-X[[*]UX95^T8+J6-%O\ %4_N
M79L6??/^8KKW=NP_5IQ_ZE[WQ2H/X6-"VQO'D_ZO\WD&4%[OQ6XYVM*ZOB4>
M6DST+J75L[EID?L4C8NYG^E=:WLW<CG#]KEUK"D>2JNOX94YG17O?#;H<R][
M:7C/L+KMKM^P5-[QRL=Z%\0Q2NJ/W@O=UZ1^T%)[.D(6/AQ#_%*QU6CV8^L4
M*#9UC-[LW/.)X2UF]H*K_N?P _UKFC:T82JO'K<1*_+Z?WBOR^G]XK\OI_>*
M^ IC[17P5+[Q4[*ETE?!4NDKX.D.<KX2CTE?"T>DKX6CTE?#4!SE?#V_2NXM
M^E=Q;]*?XCU&;)S1J^J8XGFS76KVS/LQ77\0 _A8/0O?>(W!Y T+WUS=N_\
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MB8Y,\RT\I\PG,&>$6K<@)HH)D22(&8I"%LE#0'[I BM-JS\5RB8!IK([DI
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M_P %M$Y5"6C%M%&86B&LF#\@A^#%E;I_PWP*^PTGC>J?#^G+O6R):JKB9!4
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MMJWY=I1466UX-5'JV+,A"&JBO55.W1.H'(<R11-D]8Q04'M!03IE+Q,<<$.
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M*CAM*H*$P^_JA%06\RY8RD83*!,0G(8*4H2*4MDH9@ H!( CX/C9+,V*@M9
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M)G;HVMHI(\BV0F,YEGD@X-'J:PIA:/(#A9 ?UBAR1Y=L^256ZW4 %)]7M9R
M&2/)B_2\S;V>RDI.W^C.Q*/+N7R22LBC8$%!&1NSF((983!V]31VH33M <;0
M!^J48(Z7=I U7  *<Q3B4X'#]&R(]8(0JM'4%?"&(5E1 B-H$D5!GYQG9$"@
M!DAZZ4'79O4ETTP 3F+:D$PM>DO) I-'R2RA0M"4 4 9?RB $>22?I&<VC$V
M0 I.T28F"8DEDE'DUGZ1'$RALQ!2<S]G*!!#+!4W;Y)$Y@M% 0./5Y>J4826
M<NTTTUKLP@<;62?H*/H@K\7B?E#9EI'EVK&:S:[4*.D'B9T$I[10 /(MD)CG
M* P<K-ZFL*8 )Y <) .;M%"/+MWZ2BW6]F * /4[6<@!DCR1GZ0.K8)[*2D[
M8A, G8LYA@$'3Y)%60&L""@C(V;LD'/"?FWJ:.U":<P.-H/Y)1A-ZH]3*V5E
MLU1 \C3S9BS@S\KU,6A)VUI'D$ALCDLVL\*J-7B:I$;P0 X6<EKO%#T0*31\
MDLH4MH2E!28!R]8@1Y)-^D9S;,3924G:),3!,22R2CRB[])-QU V8@I/KA,N
M8@AUIP4CM\DB8Y;10,!Q$2\O5*,)KN'B:22UV<0/(TPM9)%$<T _\ZGY,?Z:
M1Y=JSFLVNU"CE!XFH@E/:* !Y%D$QSE 8.5F]37,F "8  X2 <W:*$>7;/TE
M5NMU !2?4[6<@!DCR1GZ0.;8)[*2D[8Y@G8EF@$'3Y))60#8$%!R&S9B"&6$
MA=O$T06GLQ$#C:LRG*R4?TH(]4>)E:J2L*B!Y&GF[L_1!WQ'B9FJ=JVM(\BV
M<ALEFUDA4S1ZFJ5"0JB '"Q.8A.T4.2!1:/DEE"A:$H H&3^40(\F1^D9S;%
M/924G;+.83L2]$>47?IIN.J&S$%)]?LYB"&6"INWR:)CEM%*(*#,,T^J4827
M<O$TTEKLX@?K3">211'-'WAYU/R?^ND>SVK&:S:[4*.6[Q-1%*>T. 'D603'
M.4!S08C-\FL9, ,8"@<) .8>L4(\LW?)*+];V8%4 >IVLY #)'DC/T@<VP3V
M4E)VAR@$[$LL BZ?I(JB &L""@C(<W9((0D9V\31!:>R$0.-N0 (]DH_I0F]
M4>IE:JRL*R/(T\V2S/T0=\1XF9JG:MK2/(MGM3"S:R0J9H]36!  %40 X6;0
M"(3M%#]&!1:ODUE0 1$@ H R#]8@!'DBOTA=;04ME)2>T#.6=B7HCRJ[])-?
MJ^S$%)]?L9B"&6"$>/4T3*!:( @H-H,T^J483=N7R23=7*14UJR("%H.[DR0
MKBJLF!##](5%O06RY3"196<E*BHG(9B(REH]$*N&[Q-1%&>T. ' "R"T,YE
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M=5!X[J[5LD<[X@@JFV025G8 0M&#+#;/PZ.4<HW9<_U_1_&$N(ZS6V*='=L
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MTW@J%):L+9,THI"U/Q.DYJZ/PX=,DV;"F;)B[HWG1%W6@58M2TU)?S4PV)3
M;^+'P00PMCVHE<TTF*CX/?EH3TQL14TZY38B0<MW5/ E/!'JE RH)&'NS^B_
M_]H " $! P$_(?#0^=#(VK72,2"''&E6"XD75TQ@% Y!01VN6!F5(-4:H5M0
M=R-BT/35WJ]M!UT(;RVXF?\ C$*%+A<L6+%FS.,:!=AQ+LT)=*Q8H6)%*EPD
M6' N10<4+YDJS#90I6*'ARY4W&'Z^#!Q8N,/U/&'[^HXL6)S"Q9,]F!#AN6&
M*"T[9LR;E0:+ T64K6P?0+ARLCZF(-(84$=4?!8'5BJLXI0#A^6^N8Y0% %
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M#)1&9^EAA?)+RD765+#4"L@_QMU+)K\]6C.P!JVBFZE31X[/6US G1Q!"EZ
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MOE82I=5_@UJ-ID$5H^F*%D><#'6(72"CB.%\UEROQUU8G#E)(P8#*B=S,YZ
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M*L6;*!&XL+VC$SCRSC&2B?A?D5#'BYP3*-55GN^\SH7 K4$7+6]&.P\_^V2
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MW4!RA8)D%E('3F9? 78RR%:Z"YA5645PY\J'>HZ'/9YPT^9^%^:) S1!%?\
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MJ5*E2I4J5*E2I4J5*G0E/%OE$3VFUE2I4J5*E2I4KZ/;YS+28=/0[ECJ=?\
MK#8#_P AZS<_<'+8'8^(4D6TY5K7%&^<38*HKX!HU.O/&L=0"7AT%N?O%368
MAIC--F;N@%=)95<JUH+Q$$-I\5\MWE<T\G)G66)F%8V)O5*.#68@.J,U70WZ
M0.C-F ]?JF^G3O+"P5U^:?-R>X=IM3RTBU>01V[_ /4%L.K8#5F/'$?F??X\
MV?VX'D1IZ+'DB6%X#8-W:K<EYK>%X1LT2MF6N"\EAE;O!=8 P6I9S@Y]%F]4
MIT263*4!T*FR3JW,$;ED^K65J89G.>!HZ(;7=>:HO)'0<&Y$K3-@W'R?C7$
M]L&JUJPJN=!L+89-&YV-5Z;=(+EEW'-C0^XJ[Q=8@[3<&X3#G51HMQF.S6MG
MD$?CYBC:"%2"T+T^TRLE-6IKMTF5$AJNW3: QM8-Z>1-6Z1O/VB02_76M<KU
MEQA-3%:[3*F6EX^Y-0TX#MKJ2F[J)?1I4Q?@PWOIH1-A-VO/V)6N+4IO3:#
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M0"29EC4+32181;!*2L<J0+2:B      !%B%0
M                      (@)0
M            .]S*W_[W>W:ZVV^_:[>[;ZZZ;;??7:^[;2WW7[?W[6T
M !*\;H D        $   $           $    @ @ @@          (>]
M                                 !-       !61&=?]??;M_[=V?\
MWW^W?[_^_P!O_P#[;?;]M[?[];;W3@      (^C': *4L[;IH+ $D4D&;!=-
MGL4@MB,ML+:FYG*4H(.       (P!8)@
M       >H        R+!O@  !  "   "                        !7
M     ( UH\@UMK<+;KTR[W;_ ']++_:JZW+:[7Z_OK;976VC@>  B1T2C^"T
M4 K@                                 0(  =+(4,2^*"P ?@$ "@ $
MTD DDTD@$ B@ $     &@$ TD"@/0  6"J.,@,3.7NOM7WON]V[[_P!MO_[N
M=K]<>_\ _P#_ +__ +V[];Y\SV:      %92   *V
M            +-0         1A(  )2
M   IP        $04_P"GLIELVW6ZTOZFVMODTVF^UW]^DVZ&[>TZLT?6WX <
M/P7K3(      ;                   !         2 P    7A_KR^ 6L4
M  ),                            !T@    0<4402"3FYMMMLR--MM-M
MMM-IMMMMIIMM-MMMMMMMMMN/-MML       "!@D   3"
M           "1              @T   ";0
M ">             +UJ;21*>@2"":2"0222222222;22222222 !.22221@
M     "#<@     V                          0  ?ER)L>WS@   004
M    +0                        !<  ?=E'>K'_    =KAA,_+52O]/-'
MFV9+W%W6$.A/\=1=>? P>;-L[ >A7.:    "64C^5"<E,#<BH\DK=FNK1S#;
M#F_)@]^?AX2^%Q;:J[7M/I@   2 0      )   "   0 1YE_!I;R**V\Z'V
M4              "74PDDLDDDV_"(BIG@*<K?W.4DDDDDFV?_14DEDDDDF
M      )* 9(4)9?^W!1NBY"(%)3J*])+)+)+>A+@5)>Y+Y)*       "2 4
M                                             "6<@
M                   "                )I)\"2P 4?\ _'HG7]1)E/TX
M_H\O\F]H\_"FM>DMVM[P       AD^24R226222222'6SWZ@222222222222
M4@               $HUDVD"V>Z<^VRD^W^#T?8^VVR>DDBVRVVT,$ $D$D2
M       $2X2B"2@M:"DF4B#PZ@C6IT4DF@&@4"P2$=$ N-DZ@4       $$H
MD)) ) $@! (!), $,!)))N2!5)))),$DA!)))' =$, @   $BR,     U((
M    Z X@   C(O2    %ETD    +SR 3A@    $<      ('8    $H_M
M  I%9    !=$H    @ (O'4@     @       @       X
M @     BK-LD                                             "N<
MSP    __V@ ( 0$# 3\0CD1NJ;IITV2D8[VHE[1+I=9A!1]O2/%78[V"J1-X
M5<*29V " ."P!P9+3*#=6V5M5CE2R4L@%W9--0LZV4"I0.?@(?Z7A'I_"D-T
M_,AYIP;P<DX-H>;<&_B.-.G]/Y4\%W"/[M\SX)9?+A'\\9,A'5/ <J-/MG@>
M_P#E?R1'6(OT^S?ISW1_8\?W+BG](EO$?</R"+PV'32'G#'Z3X#O=C]UG2Y[
M]WCW)X=GAG\L.0<&\O-.#?P,O9G]L]V?TPY)P;1U3@W\#+I_3^%9U#K_ $M\
MEE^NFP08/[:L+T_I2<,?JT. /S6&_+.RTCNIYT6>M(<H[>E#LMY'@)7[JFJC
M4<6I2CCY[H]F!^A!+'W.C,LS$Y8P'NCZJRS'TJ61USV2WDM9CS3@&(08% Z1
MH]RDIG_/V=^NI=5KK<'T;*8&IJ:ZES[]6C7EKK,]9*NJ77/72(0@*B(B-2)J
M-03!9=&+_P ];!K:K++K%EV^YX$?"BSZ)X;"-,R=$(^*C8BEH;0_R?Q@F,-F
M4FK#DY.A'..P0$OXW>S6W L8+22]HTXK(A/*R[A_OXXL6KAOMX7]W#?>:N'^
MTW<-]_H<4?-BQ1XN*+BQ8L6#ABU<-]O"+NX?[^&+5Z/IS=ZOK?0X,$>+%S1\
M4?%%LA8L6/J\&CZN&^TW</\ ?PQ:O1]*;O5];Z3%@P1XL6+9Q8K^*+BY18L?
MAKU\MIY/A,7=ZOK^.+%1Y9@6P+I6HQ\_4Q>'!JXT);=I4+M=!"-XP9C:,NHY
MO 810)#[#Y2A4!#KVI4&RI(-!L&@.4N[W;G;X7,(JJR\BZ7:3]+4%JEB2@FH
M.>#_ #RT+RS@5\@M8,6%P.,M)8UK5,%+K1FVPKF*9ZM(K0.M5=-8::I!CNHM
M I&K[6945P629M()+3&98';46 0@1',$=&^->S_C$:FKZ->;H0;1_#C;.,9@
M@LT\S]_/*#Z5L^18Q2&\9N3P@>QC1BF(#A-*<85*-055%Z7;,A^*"#G-><*T
M$FC_  +#2X)3TF4W)B4&+1Q*S%75A ,ZNVK*U2D78I8TJ6%X_-[_ %'3\^_=
M.W[]^_=.G3]T_='W3L^/?J_^+[]V_?OW[MVZ?NW3]T]?OWK]T_?OS[U^[?M7
M[]JU=NG3YW1\>O=OW[]T[?OW3\@AK\GZYK A,#UU0"F 64 ES/%@8Z&U3%G
MJ[U7/V#'+3Y_D:4AQ.10W(F?$JH*UTAPI1US9ESR^1*KY3;Q;\>A6@TND,%
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MI8+>";4Q H"A2Q:P2H:'1&P3?H)K!1:0D!2TEK4";3SVX80XC)+[IPI8VP9
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M;*8@\<&>P4MD\?&U6C7KUZ+L]Y4M_MX5_A!WG(H B.-UOTC3*,'9]EH AA\
M-$,9A)KA(4'_  JOVK]J_:C6K]J_?O7[VK5JU7[6K5?M:M6K5JU:K7JOT=JU
M7KVK5JU:M6K5JU7[5^_1%KHNVHZO+#UI[,#8[)-=>T+;/-E]YQ # ^75JU:K
M5[5JU7NFYJ]*-9G5\SZ!L*X#MDS<1 F8X^E7L!L5&5E"$8I8L<Z6[X&T5U^Q
MZ WJ& H1L2OT!EI("BNJ/D)H3>J(6]/EGOXZ-[T90M4,W"C_ #5$^(5Y%.)^
M$Y^N?^J^+E^A6+@B&DXQ'H7,5HO7#V(@KX='\N_QI"6^AD)B7LY7=1GQ\$@T
M;%2,JPF,QDW847)6>YQLE#5<B&WD'#L>%EUA3FAK/,)=X*_(B935P+#3*J4Y
M7R*'$SY0CK6Q?0S9,5M%V862HL[A#\N!9UJ @XLTAC15!79PP2W091S/LHP?
MA!#A+Q*$X])NQ. W"+A.;M18=ENJ$(1$01*1$PB81/DV<S[RSG+.9X/C0['S
M$(6C'0/8UNRRLHCRQ_K N:.BW;94T%ZT6<G\[^%G/_@W] U% "N@"ZD+*:"'
MN* 50*M+&5++OB/'%,)7^B+I=E@?M@-A8^;V(LKCH":A=60*&5T@"8B,E@@4
MZQ!J%=V&PR!=1F,0-+:V;F<%,K):B@$N$QO_ $#JGEN\IE9&8"62ECU P ?7
MS@:R "X6RX+_ .\DNM:!;I$LTRT BXONX* YCUKW;<;[6- L-8\LW=0O%U\H
M"NFMG6AH1,+M;K8!I#BHZU NX$'R-M,U?SX:-UFH=$E_5K:XE30(&UW>LX52
M(:VN5*+=!%.A6$T0;E4=%VAT)0V*N+=RT?3=K&! \6]351UG0AB(5IA1YT=%
MX\YL,@OHW(X!=S!OU6Q GD7 UF]#D7B69*SUZ15;FP#TT;R7#_9K:-Z5AI>D
M9/84F1+DH/V1^2O3XZ)UN^'67/V(!P.:8-0U#9GUKPP W5,3@B(+B,2LK53!
M/3$&II/(&B04/\P8D1<KH)6LO/$6&UHCD;A<&8V*P-A>.,2OIO?0N I.<.<1
MHDMJ\)@;+&:%?1WT0S:" %ZR_#YFN1SG25CD-G1:\-I7&6>^'K7*S%Z9@HB5
M&4E1;(<YK$JLSKA8<41O&441GU+AQ?U%J,_)&\- =CF5HEVIL"-EH0_JD%=
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MCEM6E"[MC#W>K<Q/H>E@QXHX$P+=%7Y@K,!K*U$4AR""[\55*UKN5>4M@AF
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ME@! -%<S[18A#6CC((UL=$UO8<ZW!J\%YZP,2BPR;CY]H&K4I44*'LI<825
M05@@65]NZ*&2VE5U3#4(W,+D4-AU,L#5*YRWG!RG6X.4ZEAE-]K&QH PKH%;
MX2B L,"T6W9"$9*NAZ%9$KFLW"C0?9Y01!0,?7XY8\SLQ(%P+<K URP%ZCHY
MA0EL:X;'X'05CU(_Y2FH^6!--U<P>X_4!G;-*):'OF,H@*!H_.2)$B3!@P)$
MB1(D2*[1QWH$"AV>A$P&?'L#@U$%4@@;Q>]I>=F(C%"QH37)/ S5GM01G;L#
M7/PUJC5:T#G@EV*^MOXU2B .AED+*4ZF1.X2M##=4M%^#]S<@;.:RC*S%^_X
M]870 NRUS1T".!W5&%YXM;!&%%6O#HI<*I9G;,<9&L!=E=6!@H9M4%JKZL7L
M5>K84%WHQ7'324!9 -BJAI6LQ[:Y0)UB#@$F+9=WG)4/HP#HZ67KJP: J(S3
MU6%B8JJ!RJICZ"%F2)$B1(D2)$B3!D\)[%;6WHFP'J1TIH);ZRS(VLAW9$M8
M-V/Y,Z&7>4)ALH(5NGV2%H!JCLZ@'R!4R7E9C52M&[8B28+Q5C3W&<ML"%?S
MQ)$B3)@2)$B3!@2),!JE#2FCK2I!KZ D6(#,0HXA46>8B.B]66J8W$Q3SV'#
MD%H"#,'E4.# BV@J7KO$FSB^4A\IUZK:ZI*54JHI=;0^?$,$"!2P4"A3 3QX
M\ ;M95.WH$2]K,LL1KS$+*LRP@5-"P:/77A4"%)438CBP8:18U?6,7YO4HOD
M&1\A'GY1I:OVP>?9$6P690<9T;>RI&O'W[]R,48W:W2\3.ESV]+ZMC?S\DD#
M]1??*+J*-T5(Z:35FEL#>V7 )>!W2C2DJZ@<Y!:E5%L0&@QK/_&"A0ICP$,!
M;'@*%"A# 4*4,!0H4QX\! H7Q$"V H4)X\?),!2G@P%($ M= E:@+ +:*^@4
M!7 "KR#+,E9MSHZ9SIIB8%LN##2U>'Q<&AV/\^EB<Q)0?-6XQFCM5*+<3@JK
M)D410V(CV+ZG T&$U)8!''D+"F&M:2Z(0HF&#9Y/_?O7HU]O^ ;.ZL+SBQSA
M''266">"'25R!:BRN$.?\R8AF;5!4 "=!^=P&T"5O7U^)]H&'L1ETQDHWJ^C
M6$]M?R>POY/;W\GM[^3VE_)[2_D]A?R>ROY/;T>WH]O?R<"_D]M?R<"_DX%_
M)P+^3@7\G OY/;W\GL+^3V%_)[>_D]M?R'_@OY'DN3SNA@_\($LJI;P(.QHT
M662S.K=8%UK5@1 M(+M0"BK5!H=]H-=+5_8HE58V:-,]O?R):XBT$@NM0ZH>
M<U\]7>AW-HM70@E%/.GXQDZQ.[$,K2@"UL$TE.&S>ZT[C9MTQ.D]Q_(-T;O4
M*2U.0;TL&+A6?GJ^9H9P+^3V]_)P+^3@7\GL+^3VU_)P+^3VU_)P+^3@7\G
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M&OI.-?2<:^DIX;\3C7TFWPO:$:KRT&@%!I4+&"([4J!4W"$B<-=7,YK 7K&
MF"#*N:$&BK+"PK/$DA2VI6LIIB. 9QAVLA- 0BH^#;EYB*@U,J=S1N7L4X*L
M#<.@Y<A%I0\6!IBF:-'8M'5NW)F2LF6D"$J6E8"4]CT01&>*Q1I%J0GBK)*]
M8;B# VV&=;KIO.-/2<:^DXE])QKZ3C7TG&OI.-?2<1>D.O(],/UG5NZG&OI.
M-?2<2^DXE])QKZ3C7T@O#?B(\)^)QIZ3C7T@NG#=)7PGXG&OI.-?2<2^D/\
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MEFB76%JMARO:9*Y33IOM=C6;D%#6O-H<&F2^4L<0. 9$ 7.,;YL^6:- 7*H
M66O88#M.DOK#9UL'&*=H7 R5)?2\49E@L1TJFK19Y+494-:O FM% C^^EL_Q
M1MT3:;!N+2C \#DJ(!UK-7K"*B7>$IPI]L?(<"T8%^TI!&Q5#2!2EKC,PM=0
M$\TU76LS=CN:,8QD;MZ701IKH!P84W-"'6I26:R5=!0#M6MRFD-H1;0];QFZ
M@>X06D"H:*:.ORF*0+0"JN\T!^H(OQ3ZZN\!FKYXEJTN0L%-TXL'-T<TBB[I
M2AG7%F*UK/:.^X$>6A@"[:*F7"$=A@YB\V%7K&P+9E@U9SY3M\FG8"N YO+
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MYF J*J">M!Q$C@246*PYYH'E4R%7,VT0[L32LEF%IB1O&1/ +C3BTB= A/\
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MTKK*E=9765*E=9765*E2CG*ZRI77P4<Y1SE'-E'-E'/P#.L0YRNLKK*E2I3
M-WZ''G,Y@H5O$*Q#_062SQU?Y]TE%8UN(9)C&<QPUN32O:]WA-&A;1V9S,V$
MT39.G*="=!G096Z4RMDZ$Z$Z#.A.A.@SH,Z$Z$Z$Z$Z#.@SH,Z#*BEG09T)T
M)T)T&="="4FLI:3H3H3H3H3H3H3H3H3H3H3H3H3H3H3H3H3H3H3H,Z$Z$Z#*
M364M)T)T)T)T)T)T)T&4SH3H2N24LZ$Z$HE+*=X"Z3H3H3H,Z#$37Z#3$78E
MYZ3M*'RP; % =#UA%5F3E'X/5SQ\-O+Z+/R,_49^3GX,_!GPS]1=Z0F&6U S
M;J#?N&$(V>D$! L$PB(DWK?_ !MGT+I3#2L2C?6'XJ-"BT9Y><N+$3N%KYIO
M>UF"9E,IE,IE,J4RF4RI3*93*93*93*E,IE,J4RF4RI3*93*94IE,IE,IE,I
ME,IE2F4RF4RF4RF4RF5*E,IE/C3*93*93XTRF5*93*93*?"F4QGI(&JKTV-5
MY1"#X  +-,UL2VV:) H^@L"I>)A<P;Q/./E)#JRUV7 W2.(65%?3[8"NV&C\
M5LMELMYRWX+>?A;S^&_"V6RV6RTELM\+?&WQMY^%O-EO.6RV6\_"V6^%LMYL
MM?&V6RWG+9;\-LMEOA;SELM\;8JZ^.>LN6/!9.+#D<K<JC:$D=595>K]#9XZ
MO'3)E!?*C6TJFMS25VVZF1-1-PI'<1E?XBX2-YHY:3=HTTL,4&BJ/0:)T/NY
M^A[:Q/O$+JX_</$(K"DYC%JFJ;GJ7<\N=5C^?^M?T2'9[6AY=<%&EZM0@V0)
MJ%B]PV482LOH-Z\.^DN<TQKNQ,MERX2XU+8_?6 ZS-UUS]D7A-:IJD\+ERY<
MN7+^"_#[2V6RTM\+EOC<OP^TN7+ERY:6RY?A?A?C<MERWPN7X7+\+9<MELME
MRY<N6^%R_&_!!! "U5H E?B% I- R4-#^LMWE_)O-1Q\-7QQ^93-<1SKXZO@
MNH,$_9#KNFT*.%+KEJB@]D3_  O[C\(/L99J#(FM,:Q4C:<VEOY?B$RL*<3R
M.4Z\\0A&Y,H!:MUZ8U%V2KF>Q@;<R[&\-+W@31XX]9BYU@7&[*S?AB\8E<O@
M>FD)M\ K6X?1.2.1U$$TE-(6FA ;FJ(:FLAO_", B: )P.[OK(:9AH'8+0@_
M+U[$KXQ$M1 >0-=%C,&GA6*C3K!3)X6A1I._CFL^%XSAF-IFX-E[2Q>OA?@-
M3.Z"NC+<2VVE$C.5?/Y!/D>H,Q3;POPN63$L\+E_#9RERY?QW+)?A<OQOQLY
M2SE+EG*7+ERY<N7+EG*7X7X7X7X7T\;.7C?B]9!;M=V095[0]W8"PC8=W<P'
MA<OZ *R1,Y1^!S"_C 3EO>?-VW8&.EQ&:A$<(FHG/_ '6$RH #*KH'58F4I)
M.3XN:)R:YO<E5]'?''&8Z\_#,S'':#X\LGA<*V[9 2!Q&$HV5RM6EQ_@0?K<
ML]0ZJ[;Q";C-ZJZ+V- V)>WT?2:=_!JH.^TJF J('CB8\!"49G#H:',#:CAO
M'5!VA+:<D+Y!-3P8^#$QXX^#$Q,?%C>8VF-YCQQ\6)CPQX8F)YICXL3'CB8F
M/@QX8\,05UYM Y ]"@[LH7%5QH#6FXNNTOX,3'P+42BEU!>N+Q#7.DI93IHQ
MQ-LSOK&R9-?#'/,:QS\?UX"W\@";C67B+&WL=<+0[S:-:@4L TCM\ZOIJ\*\
M*/I:QMAMG56@%JT 5A$VD.;A>Z%&VQBSI\IPJ%9A=]R4ZG]<6F7(K3EI'#V%
M(FF51M+'>==Y=X)BYF]L\<<Y9M+LQ+_<_D>GAM#)CPU?);R<PBB\A,+@;BQD
M!M"/;VO=-H8ZX_[8*W&$5NKYV#D&BZ5TEVJZOY^91*/AKP,:>&+(X83,[3:
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MXZT!?VG57@!^]2Z_JJ7??6-=5$']D4&D,6#7W(AO'000[&DU(O(5STTER8U
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MV2WE.SX0[/@%]/E "W+Q.R=GRP OIX+>4MY>"V$;DLP4HP"=4!$X\'@
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M-@HZC-2LQ-ABG\]!;[>F+>"W-1S+]F1?5UK\Q*W&IW:I!PW[:?)GE/,]HO(
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MTE=(V-Y;FR_-E^;+\V7YLZC+\_NEN;!&[+\V!;LL[LOS9?FRVZPHWO->_P!
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+WXY<:^<Y=_E?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2132809d4-lc_optic4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-lc_optic4clr.jpg
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MQE8C/TI8W&5E-Z<<>(Q,<;V<ZK9EO-O:7-?/>6O4KD
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MBQ9MK]86,[4/99%+T&RSNYOKSE<ENNEM]!.=P9<:W/
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M68X>UG/_ ('EY9\_C>I             AX498HCE=,YNPROH.0_]V"F2
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MW5=R=75X\E$SK:NRV,73NTVQ@VU6;J5[%R-ER+NFM+=CI7P?/3GY'(N9P
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M?FS!DYLY:U"-3O4*9/IZ    !XA.X;W'#<]QVFU/G'$/H?2.X.A\YO'L@
M*!O$6S&,>2AA>,(5-&7S*^/_ %AT%^N_DN9_F,G%DF(F2$@ *2.,PKX.ZE 6
M;G+WH^ZUN[L9F>NB+(QMJU)8TY61%Y:^VPTE+HWMGL\QBHUU8B46CK-+MUOW
MS+6<Z]BBF7.U\WYYF_%WM=C=VY-ZV7$:V/9.XUL+N5%VK!S]*EJ&UJ]F5-36
MUCGMAAI(#&EJ,H165"-QUM;&KJD93+"KRKB_)STK66Q]!/,OZFZU(   &AIG
MY[_8:W37R?O+U/ G9L<FV-698Z*:P      /#"C/BA9]&[*S\SXV8>^[=1X/
MU(     '@%LTY692,E/,#F>YD3W/*\4\^;] &GDETO.:!&0."G"APRB%MFZE
MQ*GC;@=7ZI,[NRIK*&NW;<?:OU^!-S"OL(C&=/M6NQS]2.&PPNG4FM?1U&YI
MR=\]@F,JW7YV+L6[;0;?19CO]%V^?*0NV;K7V>$H/9K9.[0W'+Q4^IJ-!CJW
MMG69JFEK)H7&&;?QAEX9[3&MM,Z=U.QNEUU+K5["G;&FPTY"1?U'U.?//7UP
M  #Q&OQRXI^KU9]?/_J<K^G\V05N-,'134        !BX9<2]CZ5U_Q^7\M:
MOIG8G+YN          %IBV->['OF^IC5V_%= JIBK,/=#D,3%.JZ;<1QC)6R
MG@,'G?PTV^LX,[SK1@LD:RZ]T\2<C/5[FWOZKT[L8/MSM=I=W<T]FNDMK-7<
M^&QWZDU9JM!L\??9[C@1T=_ATU)7EI)*$3EBJ(PJZH_SJ(O7YB/TM)BYXR=I
MNV.=6FQR5V&RM(VGHG;D+C9NHVH(/.(%7L\]J7FSUTU=JQ\:':#B\_JCJ9
M 'A9&FPVF3XWNI/]OYVK)>@        !Y#"G'B_K_0.EEOB(CT^QZ=;/AP
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M7/I7LJZ[:<V[8ILPP\HZ)\+@2:T^/4D  +9J$\_-+T/17>\W?QRJD
M  !Y#'F($ZGMH_5\[J-L:"ZOY0          !2(?&8*\CW$NNSX5+"T3&Y"M
M)A)]  (Z3L?.IL=7$RTTW;A:V\.I/$S75&;FS#:6XQ3V\W>JP:%KPKLN>'.Y
M#;53&9:B?MPQB2F/5Z$;7I*-S9R+[M,H0^O"DFE?:>MB[W3P:-=20;*R=C-U
MFO=C?J^2AE7YK48XNK5;1'6Z$;?9=ZKH9V;.JIU=M6Y8Z2&MONUVS=T X'F9
M:Z'&]2   8I$AC+YE6           %J<8P:/HN=%?9[6;OBL^RL
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M<+5)%C>6596.5C8KU%=2PPLR<U&<)_*JS?2@:,US3;T<\WY27'/Y-]@'H'@
MQ\/60$23%2/ ")(>3'LC&0)CP]D%I.HUK[-=FXW-/B0Z?;^SEW4@    ($^G
M@  'J \3Z RZ$JF1R+2<D   (ZW[4#;O5-WH:3;SJ);=R?G9VX<XZD/J.*X4
MPV>QCO,I<&-C93LN)G?+G+IJ7+H54T1LUM1!Q5I]K5?CI=M[,^C;G6JMLT)D
M&_AGX6(.YMJ[MACSFFN.CAL8T8WAQ*X;&,J+R<9*2S/452I:XWR[1[$IW"5%
M@Z$><\7+?1X?L@ ,0YX(W@FQ0B=-V8!9-L:9*@$Z*1"<-\E/(W9KBT;HT HD
MZ1&0<J)QZTQAI5N<63&-R:%*B0GA1"<%$)PVI;,%.\1HA1";%()PVI49DFPA
MU.3Z  !'.[9XT];U"2C%L7):%2F+=9P:+MEJY9<Y-Q91NV6HRE-8U>85;+.Y
MR<MU48RA:\-E%[AW9K[:V9+7=+?4X)/8W;Z1.0BNS!KK2[QV,?6QO;&.EM;"
M+,-.ZKC<TQ>PC#2D-BI254+"K%'Y946RB4Z2Z.H?F?*S2U>35( #PL&*B-Y)
M@:HO"/%N+D8U+Q3"&@ZPT*7=0U8N1-&,.$,H/0( =)+-CN,6S9*M&G,"3AP:
MT=8:X=,:<=E+2(6Y@2TL'(&K'<&H'8&<D[L3=0UP@DR4/0  ,/'+46SCX95L
M!%"<B9H+Q80(L'J;:!'J?2B%9>G+Q-2;L1<S!5.-HJP8T+]DVXB_AE1*K*,>
M%V%,KDQ45%R,L>9I*"]@P)C=QCM&(  !X1W1R31W?9;(Y>(2QUJ3;1Q!)HD]
M$Q1.?".LJ73./Z&S.Y:;:."9T_)9)9Q$ H=*)+4YRRCU$]FCV8^>*)Z$G1@C
M><_D=41PTP%1 \[T)\1QU)0IG6,X<*$?04+%(     'A[ "0          !X
M" ]2'B ]3X"!/H     !X>A#R8]2    QZ(!3'4.,MXB$PW)TB/$P\0AR?9H
MR'*)8I69' 8@Z%E!S<'+)KF@3 M'0=.Q&!1%PZ.@F$*%<F6IJ!CIAX8*I*=1
M&9,N$>D.R\2_-"1() #K)
M #P:9$5Y3GAMQEB,B.@:1,9)Q(F3@TB81HZ&I5ASY0UQU730<IT3')*)J "@
M@:AN$]."E'*(DU*9$2QJ(#G2T7R86(:,Z6@<@QVCI&ECD0W)I#T)
M                                 /#'1=+B:$6DWSTME"+Z?!&H6*:C
M&&W0Z*01XID920 *2DJ/3PH14FLH*$7$U%"*$W3TL(K3<*"D]+@
M                                      !06T4IOE@OE0 >%A%:;H 4
M%E FE%:4:A3IV(#=H<%-T
M                *#C-.-V)D4)84IN#:2L0<HA_,.U$WA"3#Z1*:(ZFE$3)
M_8;P<8CDBZG72Z8P=%(
M             !:1R+,0V(YI$"4[(,%,;6)=J8<%+1#:H3$3*TV!'B61!KY2
MEB;Z(ZCIS$DXF))TJ2J@
M               MHQF5J<;^,VI4PRY8Q651-N8\F/2I&/&68QL3%3*J)J1:
M*T^(\*B\F\            !__]H " $!  $% LCNV,<IO_<+#2!?F)A8_P#<
M/"Q_[B86/_<3"A_[A868JLL^Z5OWA>U-RHQ]Y683=J-?W<PFR4H*LUI'W)PR
MC7GJ"^XJ'W,PJV-(5D!DHK_<$VRS!6:C!6YJ5]S4%6RDDFV,Q]S4#M#'W10^
MYJ'W,Q]T6#MC('<:!-PHPFY69_=U!5RLC^\'H=V:05^L??A(RE,=$KDF%#&(
M90O*(O\ '[.-'EP2XVX[4,EI:&DMV95.IS(?[58_)IIG'%A8?VWX\2HHS++3
M9%MV]-BUF;2TAU9MLUCO?B;0HM ^^S#")4=\GIL1MS4]RS_FQT[22G0M>J4%
ML+H4C:-G30QM"TK;2@E;77.C!$DBT</:@PZA6U!;D*3HGYPX:A\NCSS4=J^Y
M!CQ%_N.?9S($*7-/ 6]M-_!3$?(*27.4HB$3D3DOD6WL>3:+$8$CDS"8M%%Y
M>PFTK\#YVQO*,5C\MX#)ICY2QO)L;X7O+7)../:,QEG*&(X7-=YBX_9H<?R&
MHR>N]F9_VZ2-L.1XCZ6J>H;*365-DZU"J6U+0E221\BB,@1'J:3"MW<G(4MF
MAU[/<;(B-"D9Q$?N*/$,]LJ#);"LFW#L(G":)M:%1G3U/JKM)VM*"B(U=O<[
M\I!>@0A[=IH#3N3H9)V)2#0G:1ZD1+W;C2-#="?D/0E"ROZ^K1E5G96SM/A=
MIDMCD]9QO11K7+Y]U6<1'8*QW^"*U&:\>WV4V>-?C+R;7YOAN#7.-+PE[,N$
M9%RUDN,\CN<9Y=%X[7A]@7-,''LH3PQR)@D]K$8M3D&9Y/P9565+QA[!CD*X
MOZ#%N-,HY#RF+SQD'VK')M31<8Y]^-K#Q8M[,K_827S'J1$1::DH+;U"-R%?
M/JO10VF8-:5HW]=4D;?=B+:L)$P/0I*7I37<CW&"8_92ZMIB/"DQ5&O>E0;:
M-L)5J",PE1:*ZA1Z*U(/&9*2K>%GH.XZM*9"6QWR,;S(&Y\C*M4PR(WB0CU&
M]:8M?:3[=BDQN^L;_N8Y?2+++LT@5E]-8K*7$%0K6AXG-\Z/^"F9$-R1N2#>
M:,S61#5.N]LC!J00+0%H-Q#4AJ0=>:8;9?9D-\A_T1Q)_CF745TY^UHJB]8C
M1F8C?LRS_D-N&;B#Z*1J#0H$HE$: 6NIH('J1:_(MM"D=O:DT&Z&H[:0\P1K
M[+(>CQW"997'$=Y3R5$1JW;FB5N+5*@:T)'F%LJ6"/4&G4E*2V9(689WA\DZ
MI-L;4I2:4D6OS1G^W(F9K4T)2<]1Z!K(8/'E<O+:I=+C+=9C4:/<XW38^U<T
M=U4TF08U & _:RKOT_@:N@SC/X6*1Z?\BLL?FX]EU;D+G'V'S<_.VY%R&3Q]
MC>2WKN*5W'UY;<8\4YC/R;BWC;&;7EZJO^3[RJO9W/R$XNGEW)K6KPKF3+Z/
MAV1S7;P:&YY0GY#BG#&Y7%O(7]$\2?XZ]QDTZ1!I:S.X:V84^+.:2_\ S$J"
MV3T<4XD]B3"D&I[Y0G4))!K<T6ED]JE),RVI(EQS4289$3[2DHCDMI!*V&TV
MAII+9)/0U&G3:1="/4)-4<$YT4:R/HV1FHSZ*0II"R0@]A&9"1)8;3FO);-<
MW8V]]9RVI#E;2/9+E>1VN/U;-&MI]\A+9F,D]'-A#DG:OB59N4WZ?#[B&]/O
M+2F@VT6NX!P*LG,Q&F15\0<LX\N;P.\WC4#A6377+'#_ "S#QO&,2KL5QBHX
MFY,PAVXXISV%E!<#6,:B3Q;8+SIC@W./[;<@<76N4,1>&<IG%@..R<3P_D+^
MB>(_\<[B&Y(U(_:Y"ERH.)TN?2GWK63&@S*W.;Z+$J,PI[,B>U3H9'W%$I"D
MF%L&- ;>QW<YJE1&?U EMA*M09$DB:WD:.V.RE1?*E*= D^K;:4J<=;;)N>E
M;K1KU<5N+3<#:,@E9$KO%NTU2HS066\D5V/$G(LAS9V"B#6)D%-O;G!D1IE+
M,QM=8<K_ )R(ZW&FF[61&#R9$();)^/Q.E*:7X?46-S7U)L7U3**\YBP/&["
MIMH=U ]P9Z#4@3[2E[B"^3<#1.FY!2UJ2R"E5:O<@X5&LWYT2/&+EOC=00^T
MZWN($HC"Y,=I>](W$*;,:&_MN0_Z)X<R:@F85S9ELYS.(]LO/[3@+(;JZQGV
M<Q3OQQ5.R<J^H;"TLJ"<:LHRG'$:56?Y#0*QO.Z7(&DO$8W-@E[#7M"F^XTR
MYM2LC2HC>!H2D-RB.1W$!2]0ZSN)#0)LC4H]$-*(+3M"DMJ+TK:'&]2-PTZ$
MC<#)*22HDD6NKBC(9AEQFJ6T]/LJ[(50:^@XZM;X2<9H*ELFC?E1CMX3SC:8
M#TM,QI$^#$LEO.;D3[*)5QN"I[MACGP6I#4AO(;R$JWK8";7DRFC"]M<BRB-
MB6*2;Y[\C,DIJ#-<5EPIV/[B&I>V9:C-,<SFPFXW3<\'FF'8_EM,]Q)AN(Y+
M7R;"V>XOQB:VCC&CX]X_D<"\%.R[SB.LPO$?_8V+DG)%WRFYS/R)<6/*?)F2
M5-AGEEE>9RLWY-SEC,I7)?(EXU^/C=DUR%R$>F$\,XCCD##L[XL/++>5P%6-
MU^"X36X'2>&I#4AN(9GM+&[LK&32U[<MR+]KBJ>HXL>IN:FUAYH35%5W0Q_.
M;S&Y$"QK;F.3;:TI:- W;A/:49:R"#+KA%]1&1;30D=$DCJDDD#1U<\D(4%D
MDBC[G&R1L<4O0]WS$^WJM"UJ^4CE2FH4:]RVXM&Y'H'8C],QD5EB^$8_3INK
M93">U(1(I)B6;6*S*_=$Q]45OD!IYS*76TJ2U^\)K5I59#ZCADH;59\!^HZ:
MR[:O@IL^4*>(H\]O\FL(O&ME,76890UA9+G.!XJY.Y3PBIQ3/F&OW'6T63XI
M%1R_?66?Q$K3'&29)78K58AS+A><6,FPA0RBV,"<KP,M1M&PPO\ '''U3;;B
M#%K*J:XIQ]C+B_&W$T*K:V)4P6./*N/GE'Q_5T65/<$TJ;K)N L8R2YMN$<=
MM<8R#A"FNYU]PO0Y!58%Q71<>S>0_P"B.(_\=>P8Y:MLIMLIM\=SCA0_4)]#
MF>IXY FICOK?ERU&AT@N%_-2V^VE%5=Q&8ZG+6OE-VN%N8?R1$LC0ZAPB09F
M@UI!?.;>O<W*02=JAO,S-)&"7N&\@>X&Z:#]1L2;YK=2Z9'W-5*TVF@U#8A
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MR*'Q%QW70_R:P>%A%MPMFW(=%@7+?(-MD&:<79CC=IC6\@1Z^]Y#_HCB,_\
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M3#TNH*)H$,$05%U"8^T?2"/>"2#Z @?@@>8U&H6>H0R1A+!$?;+3M#MZ#0:
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M\=!KH)OU?$,1%/AR%):!EM_@K'U_21F.H\QVPI!C8>NAC3P(:^YU]T8W$$A
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MM/"U )U H*M97;7R44DZBMO?7I[Z5OI5EGC;;6WU6-#6Y'A^;2DE2;Z:T D
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M2:\G&G-170 ;)4.:=HX$C76U*2EEY25KY:.4%77;WC:CBDPYDYH?6-+0IPM
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MM'7L=>3M?95J'&S[25]^E2D]'\K&//.[IDD>WQ!LV>R]1HV;1'\^TT(\B<H
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MGKYB6? PZAQ1<T*;CC7W;]=_><W)8C2>G)\-61DP'5[7DRGDQUOLMH66'I+
M'$:UF<B[&>BP\WU)E,GBD/-EI:L<^]N8=+1MR^8.RP_#T[TCTIT]T]G,ADX$
MF:/MY+&QI#*]=BWO8%0U2/N^^[=F.E]I3[C*X1<;;WC>MJQ!Y@1P]-'PHYO*
M]B_P^9M]C=]#=63?8?3'6VS?F*%P+'N.AI:YV78>0YL=#<&.@.#:1_:"A)MI
M7GNB<D[YJ,VV7DS#>"&T@%:5(-D@DU(C9U46+);Y80IC5I:E>TM"AQ\793LE
MY6QITI4TK?HX%6V]NEQ2>=&V;B/C,J]H?I>NFMH-N+9X:=N[U5O$[E)=XM2+
M#S"OHLBF5""AU"=4-O<">\6[:+CC[R'7RD/-_L6SP&SZ-J>Q^3CEUA]!2V6U
M;VGPH>$."UJ:'2;086N0A19Y>X*W*%VQH/#KK3K60Q;33K;:5.28(VKC]Y%O
M>I.(;0K+MQVP7)+R5%]"/>2I?TA7FVIG*0$WD-NFW+[T@=]%]J4VZR3X"I0X
M::=]-(0^E+O$G2UNVE.L.-NH5[X(MZ?RTJVJ?FM24CU5HH;:*N!_GKPW]-6)
MO1T[+GT4.SM/"P'ST4K>2XXGBANRB#Z:;+2&Y$MSPMQ]IVW.B>9Z+TPQ#DON
M9>4MM0B-7,>*TLBVP#L%8R#*93(S"&64)>'UD=P;0I: /9*.-1^G,DWYQ<1I
M*6\A(_:.6)0V^?? -3<GFX./<D-/+^RW&&;-H8W?#NF_';7[X\^IN593S+ '
M+V\3X;>&N8G<IM2]HBJ404$=MO>H\@<OL24#5([NVOC%2OUM5;1V;J^T4ES8
MM.W:Z-R4J[;4W!=<2TM[P,/G0'T*5VBNIT12T929["4.M#>E7[TU?;W':*B8
MC&)BGK'%8.%E8C#S3:G)# 2CGMHOJJ^M0'Y>-99S4GI9*E@-I'+)8W.H4FW$
M*K*M15NQHR9[ZU16GU<G19]H>X2:C2,;(CP8CB4I3%DMINNR1=?85I72UOP&
M&^I'V5!UH)'D79%M'TIMH;ZTZ[.5YSXQ4M-K[0I7LI] I+JY)A3+HW)%BVYW
MMI^6L@[&;4VT)QMN]XD<1Z_Q]:WR9+;(X^-6OS7HMPDJR#H_U=PB_K[:Y6-A
MF$RO3<&]MAZ7%CT]U<[/Y1]Q1XMH7O\ 3:]P!\U(Y<-+SB.#K_C5^858: <
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M[S<MU"VVG ZM/P$MI2$C2FU3H,666]&S(80Z4#CIO!MK7EX3#49@$D-,H2A
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ME.25:E1<>:)^&G6I(S&,.)FR\L^[Y=;7+5R@EM*-W$Z@5V_D^;A4?K?'-JY
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MVD7L=H'?4.7S4K#UN<RKV@#QI[F-6:<45;M#Q[:=Y2T\D$&ZK?RO7+BH2%6
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M%=-K7G,6K+2H3++T1,U@R#*C#D/)#._>3X*ZF_NB7_NZZ5_NQG\:"O/1U%R
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M6U)63R462XKWZ#NQ2PMW:@A/S4W/D3&4MA5U\SW#W4G=);=::&R+&0KP\O\
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M+KJ4=1O(&45U$G<5+'@QX6CE@^C915BG4?X9.)CA:0M(C[>4.86[:%5-Q9#
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M*B(1_HH 'Y/XID</(6I#&2A/PG5H]M*7T%!4/2+UBLP,SDI1Q*PMEATCEE2
M4HO^B!74W]TR_P#=UTJ+C_EC-2<JUB)N:<:"MD."C>L[1NWN'W&TC4GN%8_K
M^9C'FW\H\Y#A85I?,?>G)DKC(82KM)4BLITUG,%)Z:ZDQ;;<AS'R%AQ#T1T
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M"MQ=B;)';8:T'H<AM]LCBV;]G"W$&LY'X\S&RA:W;RE5]PF+5J8L[,/K'_\
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M3VLDZ+H@(6D*]AIL;OGHQ%XIB%K</GP+='I-Z2W,:46T$:MJM\QI+,%W;C[
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M%$>G6H."@*6N+CT%ILNG<YM4M3FOI\5/X+(K<1%D/17U*9T<WQ'TR&O_ -Q
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M7SDP*< RK"P)OD^WM!BXD/6-*[P'0OBLW97K IPOLYZX.M0?P>.A@"&;<0?
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M-2N'F.):Z!S#R_ <^KS&N!#XBKTK17#V857=8KU/: 5&3+A7+F43D%%T7@W
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M>"9:!GAD:":R0\PH'1S#-MXJ3-+7,C2RN((1@>9M6*(F44&@@$7<+RW,VYZ
M+$;=VYA8K%US=?A*PPM*\Z:%<K>@@9 WTBS,XRP[" +<>'1EHRT>YX@+U\*[
MA8CZ0O5[!.P% 8F67W=2L^/.>K(\CX<)6FFTO<*!P+,[K4+B L5D!WBWA74W
M9!1BTQZ5918PQL^F$RQ7<+82*4 9EH\,M%2L43)S-1:%6K:K\).I]L?:7X,K
M,*-57G$2BS?&JW)5J,T&FLYL(O"L=:U<NGC/=\XE+$^#@1"L.R]:^X)@2M4!
M!G.&)B#))C05US?\!*WZ';%_>YF7KGWC.U.U O-%G48,M@*_*%/!;FV8_P B
M8F4Y1\5B753''TL510*S'MDPZ!+-MQ%-A_D;XP/;XO-.J8>=PRCIYY[070LX
MY^\O5CVX]<V7X6HKC/G,IQ]9P- ! &%#WB46LMLJ&%&D.&?TY;GD6I:3:PHY
M&1'*H9WB'+6!,SJYG$P?')\*[6%:'<XN6!=M!0H 8-S&RC EAKH#7/32%%PQ
M0&3G!M,X6SB_F:=3.^D5M;6R C EGI4L5W)"BP!H.,R\#^T;;"K>D9==78#*
MCU7J9$MF^4,&E[F!!NRN9!T'K D.[$Q2@27:Q#JF4]EU6 08"Z>38AQIMZSD
M1]W&!9/>0'2'BDRW@'4<D%$9'OA:E.)Q=H%@JOD!EA+KB'""Y$ .)2* Q<.9
MF7N(<3:%O752.]S3A VPQ3:5C*=X%87'FX@L"Q1&;JJZHD%U,3!%::RZ!+-'
M.KWJ +,-+.;H.BI4L1\4EBR\5<]Y2@O<: M8X8BQ%J>3.HNN*E&>? !.@+MB
MI2<V16P6TC;/&K*5E%=5'VL$0$X%E;RP<+/YX983I'O+)K4FC2@/54[G8FC
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MOKC)-,-N%*%K7/9#09\:P-!8/)<>\,T),-#< [YN7 9V R5E;(_09D6B9P-
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M$MA3GR?FS$7GG<\L,[0 HH,5\OY31Z'V38H?O1,=Y3!>^Z'[1F?8UW/+_,.
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M@MKS;#.L7Q!;':6BE18:KDP"+YK*[2[BO(DL3C+4*A790!8%K4JNUV<F1MC
M9B02&#!6 5',4D!PF'-@TRFZJF6332Y*ZK];Q9-P;@2W^AE1 2'K"5L7H@N
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M@,!T#EN%ZAT@BNQJ&<97=1PV*%E+&!STCPN7@; HM^LL7!0"FBE<R\E=4"*
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M8!VU<PV,Z]8I!5DM=AB?2WT;B#"W=XJWKAZ0H=[O*KZ6U&]'2[^^?B],9D@
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M9B*@2LO% 5=ZT,R>(92SJPJ>\*2?<M^VJW&#U9MJS(OA%!AA.I=I3W8+8N*
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MYW"YI;AQQ>58EQ+C0%@N1*V&?,J\]6X;.QOUQKTF]\VP%CZ57 >L6?9BQ)$
MI,I@5,!4Q_!-M2%(?+\:32]\Q+-#61U=/"#+O!;)9;P]E75 \L  T!4%B73U
MZ2S?=-EY!TJ5%ESV&A^44S39\"S*0$2.EXMRV#E2+5QJ0JI%XNBNJ]R)W_\
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MMC2V;WX,>9676-03J<<_*6&->LPEF(H[?7_SS^D:?7X*6_@;/ 5P0U!CB_\
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M= Z>T/JRT!AKVCJA480,^14<[AA3P4?P-403;&OLG-<1!7:#63<=_'0YYG>
MW$4*D8UT8T!<&U(V:FH@N BUZBQWK?S\D=H2B4RV7M'U@[G, M$#&_">P\*Q
M[2RDN2A+BY1,3T^ ,$N'6RK">1'9,R#:I:\'9X13*-J0)"L*B5BN&DO#X/OL
M/X&6#OE#M)\PS''F?Q";L-QV<GK!:K7:) K^-TS)NB3,NQ :S!^6YF?RM9BW
M.R;<(%2D;^IE4-I[?PL/@2IJ#<0,X7&\*@N1ZB8(H<),<RFA-G,#O*'><3;
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MX2LO E?!=?$*^$JXQA<X \%03+41@K<-8F.IRM7YXE'69FKB8*CJYE$8/O\
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M-7X26S*CJ*&HNGTG:-S;>$$5+9CVQS"I*=1<</1?7M*TOD_4NUF_:81=^O@
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M.X                 '8Z^\;8 $J!8  4OE4%N;K2 /D.!]C"84"]9+\
M              #Y4N'_   ':7*  +X_:50ML\@I?U[3V?\  E\(BR$
M           "=['/438JC@   "Z+4-U8?8D4(##";$@[!:'&B@         )
M0*B    *JF3-9I_[B"@ !2#9XE=,Y7#_ !Z9*Q)8@3P09-          6J38
M   0%7I/*K0A74X  L=VK]BC%IUM[^&A/=^_HD:0E       &&,[_6DH  N-
MFU2:_;3[$H@#\"MU_DF-GI=*?D:;YIFME DH        YA'P4:(ML +(>\:[
MH_L  DJBX$8%2PWXSC =RN#DX>-$%7.     3%%G2MD41<:3^D8      $
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M/BV#Q  =Z=M/23 P  93KW-D7'KX!".6:8OMB['7_;O$   =)+Q3=5AR ?\
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M: \  <[\       #5D@        0CL>P !8G[<"4+/Y!WF]GSS BZ-_\[<
M">         %H          #IT0 !4*=$%4H2!'(U1T%Y>"-AQW^^1TTBA+M
M+9<4*9:,         #U7T@ "P55O'Y7O' %**0O_ *(O]N9=71"$Y?V\SA^U
MV'VS8         O\    [2I$&D*?>/&2.Y8WY!?:P#6H,)H%%4&8#B'YGT0\
MD  E@D$1, L,   3\QRC'7,V/E,0R!$EY5M!5VA  &?_ &_5(2LPS<X2_5UW
ML_\ #\NLL6  "EL'&6M*&%"/6! 1[,.($0F/X  !YUME&Z9M['M5S:/\]A,G
M]/7,@  "'Y+@&D$R;&KK6S;H20>]4CR   !,1*=.2P<SYA_F; *!4-!<1?@
M   5(        "/@-B/     0+@  !V,YBL]U_\ ;SUT^L, C#7?UK8
M                         $L+W\+^T&^C$ $0ATEU%);\[X
M                     'H^@G \ ($8 $@@\ <'D%@D
M                     +PD $H  ^X4@<
M                G??T>J5JS&7_ !0
M            &ML,H1#MI@D"P@
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MM]4U$ O&87?E^C8*4%)7,IMGJ*P[L"+.XX+"$!958=4:N7 6$UPS8BL7:-Q
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M2="@KNA4F-W.ZO0S'T(Z$FNF- #>&T!W1?2D&Z&Q>5E9!6^JO2D6UW"PX]8
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M"EA72D4<=*G\2[K0SB/0P/@$6\:JI='T(0I:;@,D$&]>!03.FQFS#>*O7O\
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M=%H27Q$0(+@E8N+_ /5VQ610F%$=01+0@N[!*; ",BCNAQ(8R:2^L3Q6\E<
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M?0174"'CK86DK00)9FCM!KD15YB7Z]7 =G!XG='O*ZU&D2((46;)N)IPQ&'
M\+F$4E(2Q1-(]A1E4<2T?U*-@HS 8PA3 1P7)X?8HSY,?CXS_ES6KM J71"$
MP?I/X><!LP:F\9/<L8.,7@1PN&#=TF:5.WE( YM+LI$8D$)<HFY@2NX)"R N
MBCG0:#(08-):YP0(2-F[:$;O#4(6C4%JM!A,0Z*##)W4PPV%%W%$JRTZU& 7
M  DQ,6R@)V@9=36(JZ/)?Z E5!=E<ZMPL(AU5HM59GO-UI>JW5Z@      H
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M#]"40B+-3(#!&3]S5-HQ[QB5B[-]+Q5NN98>=&:I,%02X[$\H-JV6"B/T).
M%A7=,( QJXGPC%10/0(!PQ_'8@F&&/=;9UE04:SESWAYU0BM2#!!+G]H%8H2
M[CMV[=1<-A$80Q46JB!PD/P\?^SA"X%YF(G%V*D6B\F)/M?&KE#04N]1LE#5
MF=LUJ]$$(!M/;ULU;S" NV!&&N,..)F_.]G@*36,U%?K%E*KA;MZ2P8/URAA
MR,=8OXRF$,1:;<"-.$XE;0)MLTB$-RMJ79T6S<'8E.OC&[.&LPKWMW1J ABR
MWF#$G9"6=Q=F.4^5RC"TO2!9<G#3*DJS![2X!T=<"%@TS$ &,HK9[JY;!B 1
M0*(NRO:#;HE2:IZYK$HKK2Y*T;C6\UCBL.&^1-RQ3R.,VM;*X_@)(N/1'1\<
MA<U^)B%O">$*I;)1\P,+PQ@6TJ!BINE?II (P:LI0Q^Y@%%J,6G&8 D\10J]
M3T@F)56DG$M2VN!\ZKU ?23D82L   T **X_D<B=1^T%HR3!I3WCF'?OI704
M*M;2NF=&;!.(KY<#FH.#R,, W1_%1=UGKS*.A\I1T/ETU,IJ0 *II5),A/\
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M8*VQ:70!K5!8L:<V,4WMEY7&K!*]9:Z68';85Z .D_I/+-6$()*UN4!:EOT
MVD5C0IM@  OE4=(/MV 9X;253B086@PNK-4.:UGXMALA15K5N.,-O2H9)&'3
M A;H* D+EB6U(P45M$HSB4T;N)@.1=7QUEX@KW6ZO7K&SC244)N>@(',[.Y?
M@2FCA<IAYNTP)8+%$6L/,I[5 #"NH/HX,%3&D[(Q=\1["B:F>^U-F"8PV#H;
M96QA=06A 4(FP+SW85BJ"<D6E&\7" B*I7P0]I;1U-VPN)5[I>RVP= A19\I
M?=:+1JFSX)BYF>":\*"+AMR,O+J-8NBJI5I>*.):?0(@(&'':-N.V(":4QWJ
M+7@*KQ"*@C$?(80 -<!';F R#U4U>Y(JJJ*O.BAF>6@(6BPP;0Z&"Y8T8@D@
M)CN -D5,A;T.!U06S'PHYRW.I(78P'FLJ(!Y@"L3;YJ7GG9-X18Q#KW',XUM
M0UH<0=0LY5P[0,.4Q*FTL0%J=$X;C[0W@KI 9JI>V0NPHT@KL^A$>(*YY0+M
MEO4@=CE*]8>6F4Q4"1*\H&#C=#@QX>!HFB4H 5VLLZ %^TH 668(Z,B1MBMD
M!KYRO%8!#AWP,=;EWE8%HNZ9@&B#X)^6PQ1&EUF6F2.?X=Q-A*8].:( )6%+
MSN%*X;;U2 *AN4)?MNRQ('1:RXU!;UVV.MEDW^WW/BP70M)B""@U[1'V71C0
M'%&NLNNMJ$5K(NS*B!&2]=%H, 2M8 GT?O\ T73Z,[P9M<#$FW$$0),-K!QD
M>YV&3>*;NYJI%;1"49Q=?TZ(;":5:+LR5$0[L:@Q-C&&S,MGYDS+,FHOPVI#
M;!Z6#[D1@]XNOM9!K I90+51;RW/H7/J/G*01>!%Q5_*_"C3J P!#6:("Y1*
M'4Y9_P")6NUB'16'LRBY9P=$6%0,Z4//%P=#7$*JP[77RT+;4,M2"_I%:&]3
M#R@R1J%Z %VQ8(%UBD-+K4M5].*%W(-T00G[/$#%X\PCQ%3MCNBDF4"-# E\
MWE0HF#><$%(Z:[5!'3E!FZ]ZE!DJ#P0Y;P:-*'CX"+;",=1>4:M@<*\K%<#Q
M=THJT0L*?6-]&'C"L4N6K'@!F-UU @J$"]%P4QK8L!!Q/K*"[@8<-@H<M$<@
M$&!3 4&<MB2F\RKB\@%@=8CC*J)0=77"K(^,A\PJ@?+873 "RT\ X+U7$PKK
M3*^<S80@9^J^)<CC"TE\AH%1T8R@VFR$2_7%10JEJ$ZQQ\1)>C]Y:!8VS0#Y
M6M3>BUC<A"^#@2('AE_1F:4-F07U)0O"RJ0,$$IME3O0'!A] W'@K& #*;L$
MH@+74JD+Q20E+O/^V8PZ$O!V4^5.;H]ES!+(=J9($UF!E5A@WDI1KB9*KZP6
M=4*-7<P9)*..*33NAJ"4UM4"Z/6'#S:P(ISF4[ \P=*!RU62,M!7$-1SB@<"
M>U%<$.W\H5MKE*45Q4,[+*ZV)7C7VF7R_<^(WQ:"^T6'HZ,?H!96RVJI>L>[
M$<8.?,MH>X@1BAC-R@0-BG$]^G]%T^C+J$JQZ17ET2(E7(%* C*BG+PMO6*0
MAIX%E.!)/7^F%$VD5NU!7O%U.!6*5EU7%"+.";)&V(1H%&)0X:+@M#"#=!,B
MXTA.A6B6](K-'8TIWYR6ADAQ(BC09DU1,^DI4TG&S13@NVFM01I&[+/3#^?A
MOFG@L@T\7PF60@_:&U%6F=RR9AB9@ .Q=A'+B)55:'1;C',I9E\+)\2R'"5C
M@L7K=# V,IB6>6P$*B$%-E);CFB%O![[I=,J-2+>PH@X@7#-!!VV)2T(V%4Q
M\GZX)P=4-9E#'0 5\0X'-'66C>DFM"F.1"_1@#A^ZY66R[_RS4M&4,"8@:6U
M:VW"T4:L2VM+ NV:H1Z5<%Y"8;1>1OBV(KD'C"8&L,E;E! /&Y L^;(L@6B7
MML0AI0/$A&H%%N252X)>U3U9=7)6:EC1B^DX31:7<<#/4T4^^8/26K9F,J0S
ML-<Q&.&Q14)<VB7OF!H+Y$[)"9#ZRA?64[ 0&*%V@R$PH[@$JZU6V&Y;M0N@
M(Z9=% 7E(AC-T,. #5*3GM3/,D9IOA@4XY3[60I?*$F?59%*J7%3*:A$(Z0B
MR'$KD)6X(LPK0<DQ,^Y+@ WU=XBJ*"\(%!AA!OM.I.J];"$TMU$?@'W*$[*X
M[T@=ZF6(I5KA14U%NS#;&"0D FAF)HV=T.AVQTD F1)U8BMH5QJ!JTDBC(('
M(',7S!L""HSF[UWG'QVVE;VK U$-*O9-LB>>Y$8/@I@ %K#+1;O@;/Z3C/2!
ME8<'KM^T=0 629 C)9UERB8N@$C)LM,P9B@!@ "4U=/Y?UF0!8EFQH>-Q?>O
M6;E=E@JC-0V@_!B?!<R(T00BF!B: 90X*C^!>=].[R"&@JPB=%*,8>3'H?"L
M!T1;"N(!K7$3_"9RP."2\0542$2VSL86=8GR+4H+065EU-TGIJ!=LF9H3AI@
MH&BNS)[0'-MRY!F\>LQNQQ:1M,8N&8D%P>E#H'I20(,\^A,A1E3I%8OXRQHL
M(X+N439RV7(B>#:)%==42(OW&!H6"(NPEKER>E(4FONKOPJ6++,+WM0,!JM:
M:Q':4-@)IJKQBO>8A^)=7 %&\8A$*D4.N#E4?6,P ;1QOH.%+,:"B#TP >R*
MM6UD')MC@+O$H;K9HTY304SB B<MK' .^(_C:&RP9F&D<11/3*BC!2:!F800
M9%UFC@6T);(R,UN@V@521Y9(8N%QQ$E.)7D0A)0Q(Y9HAJO<YL)A#@%:NX/@
M9C8 ?BF"#<*QZLL"!%!F<D&!T,T04.H##6')2EY<0O$>H=$MEF-67%MPK09$
MA@MIE,0_ES=@96[[FN9<XDBJH*:(.RU4-*D[LB?E#RU;U@2QL]&O+MVK$=!B
M>(+H+.\&$K]\Y^$!7O92YE//\8Q2!*X(K&$:VYTO"^L9PN9Y/H:+6Q)52 *M
MER.W'-2K0B4%V;]-Y9VD[S\G]3IB^+U??M"[:=LO;.YWHB6T#;O[0RG@>!=W
M*EHXBNFEQ%[)A# B,/A-I5IRQUE7/RS]I9S\Q/O!Q1ZY/RI)?_$_E@YNO1:]
M[GKGJ/XG=_'WG9'GM'/%?<_Q*^5VNHBT_=+L_8Q)T_=KYSR3]IY)^T\T_:(E
MB/5_4NQ_A&11H6AH(GYJ-+%J&MH$C\[_ &7" *R)8><E!D%1F!MK$J["&<BF
M#-$/ZFL*1.P04Y=(E81W'.%,EWH1Z@9QFI$:,%A2Y@--A4=8N$ ("5NCELJF
M.(H489-TM$[M@*(HY>A*NM.#7?XB9KN#[T68XT5 47$":XE&R;6I%71RRG9%
M/XB$*1KF JHD5A9029CI@!FAP/J$90%-@E9CA-_:, \U; 2I7UG<1H>#YT!@
MEQTE%H:V"PA"71< 0.1A(&J[(1A+J9=(S4,M0W)P: 70)$TNY:B,&Z)U0NUU
M&\VHH*8J)EWJ6CNPD%--OO!@,X3+8K"4'7$?&>*3*"%B7Z(8&QBR416P3VB6
M.432(Q*.C<K,*%BMULR#ZS!',<ET!D=L5ERHZ;80"B")43<NRF"4WF$AUS*B
MCFNTPF5HP.I^=FB#%O/.# 0 3$4$ZD_@(@M8].\I6E#L$HSH>"+P762>+";L
M2W")*H4G?K*Q7@!5.Z(9OA"P*:, @K7JLQ3PT,I8##:W,M&<Z(;2DM[RM: 7
M2@KM^IN!7; Z1%OS]$P1M^,UA=WU'FQ['HT\"&ZW7\T4Y J_>58VY,P7%@U'
MLV:I4U9(>>\4H%;0B]!Y'O+>L!BZ8LUL@&ZJ8.!+P-7 MA<T4NJHYU ]/4U6
MZ0AH](-4Z(.G>^E3LCR]8B,$$BXTYZH%0+%Q@\5>.)W'W7TJ<&$I^E6:>>T*
MKV+M1W >%N*G&Q35G=AS,T9S#<[:-K94,&)?+>NT.6ZUFR^\4V<UD/6W?@SM
MV3O^ @SWY7UB3O\ 2G[I8T]B+BG?(^T/-]=]02-K3=QGL+3PZ]69K_U_7;PO
MW8V1N!9AFZ^UUB%8%4-!JJ%EKJ$I50ATK<&T+2XQS[6B^54L;99/<I=%='30
M:.L8^YV'+74I/Z@A =/@7*JNUGB;_M:5\("V4$33TG71'JRN"9)YE?POT_5%
M'F@88@E8((,K*H417B6PXD=C,JS*C@L1UTW&"+6(#HLROQ"9D=B"PA#PI, J
M :Q:%Y@#?%K26H\AI5WB( @-$ 2WP&26,5US"WQX!ZP1@E"N"8<*O>H%[T0(
M%L.,J7%((%5<'5V!6KB9#W:!0A(3&,9B<H1J2W:'R+9+E'PJ,H"A8J#2Y?+>
MP4B2FLO>.64SK;:Y0;R(Y8=?!00$0$S>2.9HN78*BK"TPK%1U[2IP=R&;<0)
M-!>(* 9-YF:X<$:6RD D=+)&VQU250Z0CAF70,-7Q@A3^TF:12OBS:&,0@>$
M-*0:VM1 ,P &J1=#J"1)P0@,C4)S@HW3/US1=N:NDP#A?A.A''I4XASE-YV&
M%RH#;#_#6?V*MO73B/(<U@@<0R%ZK$"B=4':Z%"G$6]E4UM05/47%0C3 4=@
MYB15=3UD)3U3"I"QZ:33F'5 /K#:U@:& @TA,-8BE *VR"#)PY-2@_@57"T/
MI$W"XL5@,. /:,*J,:D@'1[/&HB@..PDATK!'G6N62U(<!C5 $@(78+S=9C;
MMZ2Q*S(4IAW!P3*Y \*TVGF,]I'?^K]SO?5_LZQ^GZG*5T(*[XA;%/> UPG%
M,_23J/R9[C\H4]QHW\W,BWH+*ZUR(?LW^6*QA=C^1E6WWA#P7]+_ $3M_/\
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M:1"&B-$Y4(E1%==F$:F"$'X\V\=H%_\ @"973T:UF(%0W464&X9%Q@;X)%4
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MBH3]&SDJG*279#:_\6%*A AK:3F)$+35!TW9]M!\S02HJ-)A\L4,.CG&5(R
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MZ7T.!ZS" 3T6?E,'&(?X%#<WJ5P@[_6A#3I+-.41NF&^)O/$]=>%._"NLZ_
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M*@+AE])R1"#-;E7&;9FD1N+"6Z2HO<^\L;A W:G#,(!8.5Q44!:NG9C'KO\
M4<RQ1]XG=&!K5S@0>O',U.&\ 7=6(;3*0NX441V%=_QVL/5A!> ^YO415\R7
M3FN/>7Q&'0_2NLP90L(6:N^J?*5'^P(W#+P5C4<J6NRV_<E'<O<"]+Q]"7%%
M55S=:SG,1(VK*XO[5"^+V@\DB<UCSJ9';JICL#",^KTWB'6ZF<D K%#<9B$&
MF@\X<Z](*VR"%%9Z%7G'5XAMCG5YX7]1!71X"C\YN7=I=!U>((=%'0'V N.K
M-^]>V[EH7;* ;]N_WB<G/(#V>DP>_P ^L2LSBY6+CAKP/K*)Z2L5-5]X%D^=
MXB;JH#I"$K$3T/HS/N;E:[!V](>!6WUQ %AG#C[?2Y<&%]:K7,$<7N=N\(=9
MZ?N6"1^C-OV])C&OK^(3Y"ND:;0"X"N/H9AA>>T6:^I^YB9<^D6FX)CB".I5
MMO>%RHN2S]PETOW!6@9RUSJH0*M#,35RSOZ>\&K;M72N7I$&36M5SN']3K'*
M3+.6@U67>#+:>_\ D> Q1U_45H?C[QK17>X#1AZG[E2T$OSB<)Y^4(PIQZZY
MB65\*&</4G1G#L^I%ERNK#ZN(W>@MPM?*X/0(M*.KQ*1*8&LM-2Z Y!6F#ZW
MVA!<V".,;[)Q+' <*D]K$$@$JJK&M^D#0HK6[RP&WV<$HB4#8630([*7VQ'2
MML A&\+=FBAI-1,?69C0[BJU'%F46!+H%U6FNLSH#*+9EJA2R#,F>8GI<'ZG
MTC9-:!H6:/;>XHR9\DN%%RH_>"0JZ:4BKV6.?3B$5%=%6WI6E8SGE,09^SZ>
M%-C)JO6";ZWWDQO)S6?27I4:5S?#P&JA9$-I:JXA.L!"OEVQDYEA5"&87'3?
M0?:6*<6$MFO>39N\=(NTHT#WN^-UOM!B;]!3TM*^T&HL.MG\9^)>.TXQN#FX
M^*<2N.G@,?2.K="%U8N<S,;&88X/!Z4%^$"!PS'4>((&/6_U#Q&&LOWNYAO-
M9R[^<!4>?G!P&GL[]YJ_V_<(^;,0JN/U^YZ]#C&(7,$+QPUTFK7V_4ZV8;_4
MKQ!A;K'G<SK9?SX@;?,_<86<>>8;K91]B!3LJO\ L QZ&/-S2\7$AK6/)/\
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MDS6QZS07,!4^>\W+CVEV1DK1-Y$=CC767E<;^WK$1WS913]XQA#+8JVJIKB
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M.A7,S_ S.TJWMX6N'4H\;8'4H4OU+S6<](Z-J2@40H711*TZB("RQPM;Z(A
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MDZHSWG:_.6Z%3H"=I-O!XI VP5.PB=F? #4%2[A\XN1R/':W$9<%^I'X%'>
M5P;P09JO;@Z^LR>7P2&P?]?Y$TI?WO\ J N?'D?X<)*R'2&<3)-SP#Q&OG.&
M^\ ]ROGTE7O4MW F]1K,9<$"083:EA=)KVE+329\-_BLNAO"5]XX,>';N0'%
M+/-.C/$RC>$-<'\1;HX^I!_H,WRQ$@V@OKQ+BYO(=+H>OAAU!H>L_P!^=<TA
MP?3.@^;.A "F_E#T5.2IB%=>@JXS# P@6>LWJ^=FL+:G1^R;;"7+G>0MZN\W
MXE(ID34JKN?WC_VXU%'S)H[+P:G=+;UEQ_WY/-\^72^=)ZGTW*IF@+@]Y'^]
M)(<N_A,S$&PYET_G3_[<A&%?>2JWGJPHT.[+S CP8NE,;0I)CQRX-X+FQ-']
M0<R\4S]?Q!?9 *-O2>IY]X"94;G3?+_LPT%U/?KVG!2.%1[:<\82&:9ZT_$T
M,88KUZ2UAOTCETY\/%\XGMB*'E<J*U-)KO MH@5=0S',":'=> 7 JK\\062?
M3]3!0O/I%QHP=HH6?2,2A:Z$P5>I)8B=<F33S>OK$O?0RL!ZW[F;\4"JHYNZ
M^\;)9Z/[C9DLX>C.'\E@:BG%P>[W@&$?-G:*HOS3'7R&5M8/1F6T^K]S8AO+
M4Y)^K]S2R6BP5?,.P^K.U\S.Q\S.U\[.S\[.Q\[.U\[.W\S%./G9V/G9T?OG
M5'[L_P"UG8@?,'I@V4?G;G8^J K;[Y5JB-&C[S+Z/F9T4K>#G8E%13JU<?WW
M#RK-UBM,+A!S3MV.D5@#[QKMQ*A:YC]/BU\#CXJ^+B;?X=1Z,5D,TS'9?UA
MM5\WY])?3OSZ0FK(1=?ZRKD[[_N6^:]_W-D5&X_(A8EYX>;!CS\Y=Q7T_4'C
M"9W*0U*BVO2PIJ4W+UO,Z;Q,TZC+>T2Z2-P>GWF.FWQ'&:,N-3YZIGZ2H]3$
M.<1Y? 2G#W<P+E4N8;IBCH_=%?PGA=9_$OI+7P7KY^<NI:^%A%\,^"UO<7K+
M\UX6<3/A?7PS&G/GYRSWAN*PO<R^67F7<M)=^!G4]?$68E\>%G7POT\-^#?R
ME\<?&5K5,PUA<:N3TB>RZSKI##P7,HI/:"Z/E&LU.ARG&$XV7-\P+A!W;?!*
MHXN7+N45J7*=$%+@E*^9!EAZB>I>LP2CPAL1[*399J"T&86(+9B'?I%*,2GG
M,16ZF*&!ALF(W"P8#2+ZG:4810;@3E]Y@&H1V@V4SF!YS%LH!?5G!\6LSCM-
M^&9V9D;-3NCF:S,UX9G&-W,[9BJ@W@U!O',XB])Q+S+BR[S+<RZP3B^(76.D
M;J;U"O653VF/>9=36.9D9<M8"/OXMD^T^\]9U>\$J<5X'?X]B I ?6=[YHMA
M:>L[C+%*SOL[[.^SO/SGJ_.=]G>9WF=QG??G.X_.+]?G/7^<.NSOLIQ<=Y^<
MU?>C_K3_ +$:?SSN_-*+![S_ +4SU[ZS_H1C^1C_ +L>?YLS;^:?EA/^I/\
MJ3NJ]69K^I.M\R4X*/6//\Z.K!ZL_P"A%<G;_ /6&KXCT\/E'OX#4^WGKX\X
MFO/GS7CDUSY\_.-\.? :A^(UIWX:S-Y-3%>#K&:E=L7%-2G.I7REOAQ+S\'=
M\GGZ>!X;M=>?)X-3UE8O^2I1*_HT>%G28\;.DLZ>..DQ_)1_%J=WS\XX8C4K
MB7SS*B0.93 6<3NV3'$K%Q\O/RE#EJ5;1*F*%ENN(2_G/67X%FH=\$X[SF^2
M<3MXM5W\ZCX8KO&,(4[G#X5-/?SY^\S_ / UG,=U+;G&-S4Y\-YG$N$=<^.*
MF=^/WAIQ\.H_256?&L>-_..>_C9426N]PEL]/#) J:W_ / W'/C?P7XW\&/@
MO%?'GQOQN7?KXW\?-N_"_P#XNNNYCF_X-;U\6#<KEU*\ ZSG'@0JLP_^5OY1
MC7&IC;'4#KX($K-2LU-,KYRL884S3;&&(&8F*F#ZS-9EQ?G!N:]HZ_\ EL>\
M>]SJ=0R\C,^]^>_TF#Y1[RQ])K,O%\1HG-UGSY^?2;U,KS/6'3<KG.//G,*K
M>//WC6Y=F8I?GS^9]IQY^?G,VX\'_P"5(0W[^W_.DYX_,V]O;ST[QX]?R?7I
M#?GZQWY\^D=>?-_[../;\=H:CIWOVCKV]X0VZX\O:?OS4Z;U^'7YCSY\_NX:
M0CSZ'XWWGN]H_KS^_>?M^[Y>_P#7_]H " $# P$_$#W(J6^?K*G@KUAN&4AU
MAUW<V+]HY87?:7W;])H%F3*Q"E;\]YT%N8[+N9LOV@4"_3]R_5P4,^?G.Z_2
M"0RZ[2YR_2/,_;]Q+"M3N,2EO/:6K?V_456WZ3N/TENK])W'Z3+O[?N5NXDY
M?I.=7T_<=&7/I+IM^D,6K?M*.7Z2EPM>T<]M^T6:%^G[@3"_3]Q5%">D"/V(
M^<41QQ-C_P!^@(2ZZOM  ?X@E6X,;YZ1]H'MTS*+D[?B,9K725-L"E=90:C5
MNHGDJX-B9Q.RX%9ZSB&I:6J5;7R88TCEQJ ([RETF)3ZQHYB7UF"QQ,V8P68
MF.:EN]Q!Z0N(OI9-**L.N^3%TTPZ-2DS$G),G:9J*@O"?9E*U/48?+V)AV@A
M(F?S/_&OZS.IS,OSE^Z+\HME\P?E"OG. _A4EDSS\6N"T=5]HXZ?B8@=^>GZ
M@30XZ>2&"/7[0:QHEYS#-L:JRZATF*J59%T)EB.@K<1LLQ"#U,H4\11QS%6A
MMUE%/=A%XZ1#Y^%#](/SB:7&M$0]X]IGZ$LXX@\DK/6 RG-B &JEW)4*I$:Y
M1"ZO\LKC]G[BG75Z>-]E@ TNO/+'?>7_ ,;)Y\XANYZ?B8KOY\_N5Y\_F:WU
MC\YA._GS]HXSQY\]L3'7S^+^_K,I\3K$M&I@,Z_$OYRL_$5HZP$,&IS67"LJ
MN4%PV$18<S#O,#JRH!U*#<H+&YE,10BEX@-V9(@S<"U)Y^DP82_/>6T'F=$*
MVSEB(Y%15E5R^J**.*CG$8);ZREVN(!P;F+E'*4.<2QR5++N6*JA!+$<QS!=
M:[?Y&:4765Z#AKU/O-LCS=XZ_P"=H=#/=?NX.Q$@2 YZU;^MP!8>G.']<1YD
MI<_3_P 6R4T\#\RS[N64%WKO<0&'EF&<DR9E9F4LN%82 3CK\%LSJ,J9CY\_
MF;;Y^( '7^12'I-I="^LLNB!%!K4XANR5MZ3F"TZEYN&7WB\>'7A3ES/74YO
MF?>=7:5OUF.)EC+;FB8NI4T1.28-<1OB7?K+SF=P,+S=S@FU14HP?Y%T$C\X
MJ6.<_*&!9'3HU^)V2 E:H_[- %!Y]I839B;_ /B (ZN W!SW=*NM[P<^]E./
M59#V@HUPWBNI]53@(==K?L(5/(&44WYYCGSTBD-8S*IC7G]?*+P2SG<REZ*F
M5OB7=NY4=3C^&N.GWEJQFWV]9LU]HNK.;\YE_4]']1>VH+81H6:EE=X"RQIJ
MYGJ#39 -,0]8';(J4-PN4V7.T.\535$X[.)3L@G,JL-Q-C4I14NAD:@!O<NL
M.H, N90U<TBX]Z?4_<*F//SE:^8/W$F-0,2R@^7N01'+?GUBG!GV@I6B=&!8
MJ"31;OZ:BIMU_6OPQ7B>"+_B%&YL?AHJFKK#AV[ZQSER!Y*<USW:AVEN6Z^O
M%RM6RR[]?O$RVJNT,7"[[>?K.Q*^\S&^(K+X\^?SVE%0.<PWZGGK'$.DXOB5
M$K?Q.[=F [HJ=3YSWEGU>OY8!>?GO!C7#?VB"ZEWB6,D!69]IFLI5L)9<TQO
M9._,%6%KT\&S4MV$VATB_.!R0#4TAQJ73?,Z)FH,#S,*@5//XB:(X5[$\,-I
MT_<L=_\ LM;J^=SLWGUE%LU'HP/NP4<)83B[CK^LV%P<A&D0^,'"\O9F'IUN
MK*]K@U-14L_B$W+]\4<<DQS$#/$]9K$N<\SH=9<V=ICY0SX<U',V>TSLWY]_
M;7&(]N(?3XA!LK7UE>4I7OC[Q.#<P#P151]XT/SBITR%LA[I1AKYQ OB#<%]
MI8Q<#6/S0;QQ*E5Z0^D7RC;DE2HUQIE(2G4,$LWJ*<37-98A6T#O-7-^DSF:
MEITJ.\2PJEOXB&E@<A7TC$$8:+8V1^)9B;\]V#+:KUC0M4W!O"?.'=DI]MRL
M5_0YKP*<67ZP(MR=LP&YWQS\I:H^:_4L+E&#T="L]8TA5V#W#J K+AD+0I5L
M%O:5A++$V987&Y\ZG!O$/_$3BY=_$1W+Y50W]*_,Q JY-_/_ "  *6O2H:SN
M._/GSF7BWTS,>WDFN\O/>::XE_.8BVS-4F+AOWGIJ_O''K<[G2<=Y765SSXN
M-^%RE\V_9C/G,RWO-PGZI_DT#)WB3?SF#71O"],LM746V$PYF&(=S31!;<S,
MWZ1BL4'WAVEE^#N72H'&("G2Y;1"LE>H28&/I_D476SSTF-<"M5Y])Q-QCOO
MSQ HUKCW@]7[DH\3.<,8%Q#]]^D/.\3#.KYW+6_U]XEEM7]&S<RZNY]"-GYA
M3N))\RC[7'1Y>(!C)BNN90DZNW+NA+C%'246-O%D4<C;1H/:92*S5KUL^I%D
MLJEKEC=/<P_28MU5I8OG#T^C,<YCC>H.;Y\])SX/:9YE_ 33,NRF<KUE9E1!
MUX4W<]94KY2BY1Q*A=YJ/7O#7P^D-USY\]N9KLWY_>ISWA%=%_:$#"D<]GM&
MG-3%XW!Q7Y[PHP=5?I*VLS>=V._O+5%-]O2$WA_;TC'"0$-)6XGJ5$KDKM$:
MN!>.(WIU-EW<Z.94*J5Z,<JDJY;3*Z;E1(&9<0ZQ5R0#-:Z0 &",9J61:\U+
MMC+Q+XV&663CSJ'Q7[1VKT0#U<G[@T,4Y5>/DA* ]A^H&LV/3IVKF+\K\RVL
M7EJ.:('GU@L.;'\KL N.%B,%7: G$*Z&X<Q]3=,M&:P<QR=+L&6>ASU@0I1+
MF5-L81W*RQSLT\ERXG&ZA1@ZWY,U6XL.%T.+O)>SJ^8\$K4NU5WFS?+O+-J%
MC X]+/H>L ]C6[K]_6!NU3A'YSW^>XDT&O.XV(@XC/(:E9\'VEM8N(M("%.?
M#UF&]^#7'\V![PU\3T>(KY]M]ZWSC,HKM4= [,]Y-)17/IE<VQ]X\FL0-)ZS
M$(T_R)?%DL0I;N'<N>J0PI@5GAB9[,H(XG>-3$.TK&-S9F%7-2S+-P-N4>YF
M.L3)5&BX-)U7G$%'&.6)64YE&N)J<01K,<<9D>TR'F6EPH:M*_,#Z[?QV0LU
M,!Y:_,//#AM3[N((.P%D_48/WR=$+K T?.,EI1F4P9H>+BHYHOATPQ6R<E#V
MVN\5-T5NUH]?E[2T9PIKS<$Q6X+EC]/^2W3B4NN)0X.TPJ;;J(:+,7,H0N_#
MT@+W3+AHB9N.#<,RC*"!F&?YLOG./#H89\/74MYC3EU+S,5PM, EVN_^1QKC
MZ_Y#1#B/@8%HQ4Q06'B9>_I[PJ#A_$>4NH$'([]8F$J$#'2#E1?28.H>D0EX
M1FV8T</T@4O[&)'/T1 H,K6X%Y^DIQ]$!8O[S/3$"F?:8@ W5?[#E&WI,-O?
M6_Q-"^O^03=%WJ8&[E%"*UK,HJ8" KW!C92>>D5-D\O;PXV3Z%B*D_)CI^DP
M4Y0@!GI*;S^;XJ)B6Z/2X.2P](K+'KW]"V%P9G>OO+&RMB#IH<NL$<W;(6=,
MF)$;<-[IQQ$-:,)=6FNTPQ=HBJQ] 0H8&U5;?^QNL*=N)P ]HG(LYU^<5P^\
M&5DM%OW]WM7:$Q<2Q-^<YRRS8M]L?\B!;"TIJ_/6:TV9SY_40'GVET=I6M3F
M%?\ M=X.ILCBNO/U^4.?7P!GJ/B#W_40X#LCX&,,+./]A2:Q*PS?GYP<GU>>
M8;%2MDHK?\;KWF;ZL-^?-1U1N"O@RY=MRH?L,POT(_+B H->?:62HP%QPK7*
M#G.H/)NH%7S$K[_.=VY3(P':;\$NN:\YE;5/S_V+#T/M%-<^TK.GM#S5+O>6
M.-$Y>/E EGX@0-15(=DQ*?K;WB#&ZEQ\'NMN6.V*[3]3UW* [P3!S*&[@<^7
MIEKF-EYKR>OBV%X&91F@P+^4=HT2N-K?AT2RQN#7J[/>C6=POW0#7/+1Q'PD
MM16-%5W[RCT[&S(< PXX.9C"YN^IHYH.*]80L^!/W?E4>(;UL^>_G+UBVZ!,
MJ:)HUB6 XOI$9[KSWC]PQKL=XX9U](BCI^D,XWY\](K8=G_/E!;Y7L?:5EE)
MWN4IT@#?3S_W]52^OADSO$A0],<R@U\!B%N-2\NO>GSV(%;6[O[]?^RW(\8Y
M.)2I9_!Y](N:Y_CPDJ5CG[?;X->DM)3+J6X)5R6JARJ*\%VES@G58B5MQF_D
MRM6;,3%7.=RC3 7M>(6'6;@[8#5;BZ(LL56KK$5I#;,U1$%N#[36$J,8FTR@
M,."*L$=ZMRVMF<"2UZV^TNFT89D-LS\L!$OI\Y\"1AN%\17.*@X[EXH/G&S8
M '_HS#*0R)#Z37X?;OWEK,<0(X<;<1A2X"O8'UU]XW K?S"4-6GI!692PRE
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M5-4 *J8#/27)3:D0*#8.@X(@?!@GS5G6K IOY]ZG53"AXEB$MU*<AN6<M2O
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MXW+"'NC*@9-B*)<9Z00,:@]2Z>4V.=WF7B@R28#"O3I$Q' HP<!;M+G/M*J
M*K;=??\ V*\JKW5^\!Y&"- [*OF3\X9?FS/J_-G9K\14M3 J[\6X4+=U,(1K
MQST,1OB7E%FE6Q8CL.<PN5-9HIIT;SRQ^;"L+#5X"<,[Q$2S&^H;Z#JPPT#
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M6K74:QB %KN14Z /D$,]#=:^Q]("4*'N_F ,&IZ:\+AG\^%018,X>&A?L_B
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M);'L?2S/OC^D"EV!SHXG&EM<@4SRJ^T;"M=Y0N]; E   #=ERZU95>G])!B
MK25+JPITH%7>"RPZM$%\,2(-I"XS1*V9,> U\++XZ>?+.X;EXOB5:Z1RN[=.
MGI/^*_4$.B_#:W+'XBG6_/>*_,9O$J\<XY_<V9CW_<9#H=7OWG'?/GF+HO\
M?W9<:OZ_[,T<CYYE+W*%J\]XG9GZ^=0IS/ *37+"<[]_W'-7B_UW8]; _*Z-
MXENB8E!OAQS><0]UC?GF( ._/6>9'Y@TVUT[=HI!ST_R9# ?B7EQ?(07+7K_
M +*6MR^>L%M<Q)PJXQE<P08^?>4K>?/>.CCSZ3VWM^I6'13[](/4N:_;[1U\
M1XV./5K\PRC%=%9['?HRB4?&C4PX^JU](_,J_>?A_2Q]V"91_:2IO+\P%AC-
MX]XC]?Z;IC]Q9T/'9YCNW0.S2)P$R&BKJ:](?"YE5@F8&R6"]LQ8ZFMC%Q3V
MO>"P"X#-G/M^R-F$CG%7!+ W-"RIC!P8N1#\*8EZ8\C!:,+O\?B90UA@NBGR
MS7Z#%25O:6QL7,^(ML(#Z]8=B_3MY^;'="O/,#$-T^0S?13]5%@7@PG@7*PW
MC^(S6,6E<M'O,L9N4H-, "ES*+S,%;N9T,U+"9_J-S6:)J+*@[0YECP=TAFT
M3,L'VCKX@;0.B_3?>&2E7ZO:%:@A-*;&7*\0+?2X[Q_1-Q%[2,5O37RE!&9J
MW.P?O%@_J2G0 ?TZO&KC?!QMNBMWU@37<2EBA:X9ZQQ'=.(MXEGO\3"48(E.
M:@U-Q7O"/8\2HRLIT\_2%G->>TONSSQ*/;V_475!-]<2;,C?X&:S]G]3A<*?
MKZ=8)B6KA!GSGM+XV)3F)?;4WOB84W[RP2&V3"^:S"08)^1ZPX->>\KX=4!>
M5HZ_R,SNJBA.?WU8SQ]NKWA!>:])4D!1U73OWFYQY]8&GG[S/Y_<3/R?.)QS
M"^97C<4#BS'4UUO$?C.IS*_ID:]Y2[P _+$J]^U !N4_UG$RM;EUG?D_4KE)
M?/3XJ0W4TA3>M<\1J"X]XFL_>.KY_./Q!]7OUA:J#[?B#C7R;E-?^DQA;]&*
MU=.O?O-6?/\ V<*Z/(DQRM^\9(7+?7/=Z2[F4F_KEW.HBFDH%O28ZS@]!$7E
M=#K73O$0O%]/\F"?V/Y(M5SPX_R>X]/\C]6'3_(-AY]IE96C O;07,15/-Q#
MT+!<F?8ZQTM\SKU9<7YZ6_9E2OTO1Z0L.#/J-;(+Q/5^H,8^0RC7R&5^]Z^T
M=S?)TB@*_1F'#Y.D&TH/-B*>1>T5 $]3M$Q;G8G;^L[4[<[$[$Q*&I1OR[QZ
M6(-Q$N(-Q'B)U"= G8G8G8G8G:G8E_$[,[<[,!17X" :M4#?=)FR5ZG.DPQP
MM*Z6+#+KED:X[2UK"ZKZ_;^H].9GWBZE61+GI*^*Y#7&R+734]BA^LR!,J,"
MAN'A\TXG!]S6&9E;,Q7=9F<)F*X_<0:PZR_!*!,, NR5'5"=0&C?X7^(4,VY
M^<L4+L5%>;R_1F(N;R]\XK[><P&FZF+Y\[A!5[W[X]" 6LD>Y3DY2?Y&*2&_
M2.A'H?N**U:Q!;Q>D55*=HX9]B%@*:AT/R(/^4H$S7[0^%!7':!K^1C-<-](
MJY^1"1;Y;YYSW37^==8[/Q[IU&M>F>J9EF#<G96*I4D/%9NT%QX8#8]]K\LI
M:9]G,?(*],]A-MR+G9H5/L/EGL/EGL)]I\L]A-(4LGM(3TF1\X,ZERZ]%5BR
MJO5JJA?K5=#+KH5%J</R2Q>W]2N97GO+(:_AH[G\I?:*]IB13Z$8*,<T0;&/
MK_DJ5YN?\G #L^G:<> \8^\XZ^?>#E*\*KIZQRM'?'VC#;'&7\RB5B$2HZL9
MU=]):B@:SY[RW010!Q^.TJ:#$#NLL9;A:FZY?3]QN!13[8FL$]68AL5UELG7
ML]>TY*7Z$/7'H3H9>A'HK&-2Q'L?\E\@NBWK':;?S,*X[]>L#S\R5F"A?F(:
M+?5B^'[J9K%G"N(7]PCK/]=DX)6%^Q(-@(-B,%.&/]).;?6_KWE<<WO/1+Z)
MZ)Z9:B,G6R0 W7TAV2^CZ3L?2):)B8)B'7]H^=3'%UZ3$.N[])[_ )3'&IYU
M,3'> 4;.UP36;JKPIAZV.1ZD$K"4"J#L0=YN+Q O.%?,6_KQ$#-7X[E?!K<N
M;\+\;\+E^%G@DXE_P<C,Z&T\YAOW0_/>9=F*'SOG?WA,OZ_[$,IY9YA;GP=M
M+^8,? ]_27^DK;(W.,P.'O\ [*&QGT_,K8/D_!.W^D3''TB;BO;]2T#0S!,\
M?B9IZY@MN%&;KWAI;KW_ '*U L95LS,^&IY;O'7#)_G:507'=X!Z_6.C,IQD
M^<O69?6!;'ZP+F(>Q%]KP-KRMGH?3]1#=?3]3JU7M^I17O*Q\5W-XE==2@R;
M^4:?/[E=//RF'>IAJ8@$OI,/6YA<_B8A0F!Q/G,,S[>>_A>)KUF\>?.(974J
M(_* J49ZS%0"-:F"'O/4E)FM8EWUEW'<PS4:Y_'ADE2IWEO-S'ACDAFNK*#)
M\8&6JAI9CB,0UY8DB7F<<$+HGNZ2W37O'O5&B0@9$AVAB5F6L3&;FS/M$]J'
MKV)I%AR58)D;]8]+O.8\.7I 9R6(CF4!S5YXETO48E569G6J@VA/T0&H\P4Z
M1U5>?2&ST^>)GQY?:4Y\ORGF?\C5X?/:4ZG@B>G/YS"JN;.\>/[P';YS'S?K
M+NOSGK_.5A0%,QH5\7:8])C1"5+YA3AE3L0H*=S<.LP2ZF-$S$K?K+Q##7$S
MMF(9*E2CF"P53U\]8 FA 7>YR2B\SG$XIE>TS5\SUU-;F\\1S KPV5/2IJ;<
MZE_.?:5##7$RXX@9S$N9XG%?$/+&% */6;5Q7*Q7F"K%&!<IU5F/:<LN=^'(
MMSOQ;UEL Y9WICVSO0+2)CI4 *%/9I8W:?\ 2@95XIMQ0V@?*R',[AR->_[G
M35QZVYW\[N=S.XBG. <ZG0D-15ZS'5XIS@;A2[G*F&^K$OXW<K3FIO-394S%
M==X:N(.X7Y\^=ZA]/"\3.0GKX6>?/G4'G&O!+F.L!J_!F3#Y\[AC#N+4SZ/:
M#RUKP&+NF6^_Z^_Y]X5[>%IJ9JS"JQX7,/GS[<W+N(OI*O#Y\]I>,;^OKYQX
M U,:'SWG/?\ CQ_:IE/7^E7\#VW.QY_'SEXKO!+ET7Y_7SG-,-7+Q?$7CCSY
M^?&)CSZQ:W,[-Q6ZX\_:$&VH.?/GI.<?/SF76Y?RA>C?RA3EWY\_2+7K.*XE
M'$\^?/2;WJ;WD\^<0N];\[\U+MYG%&TBYQQY\ZEWGP^\M'MYW#Z>&>-0.<8\
M_P#(1Q$\^?/K,6=//UAJ7>)5GGSYQB!_\!73<N!N453&KS"^(:\'&MQW9Y\_
M[*CUY@YKPQ-O>9NO&OE.GPU<SKF9=QW<9KVF:\$=D,=B'A5L-VZ@5J/:'6.7
MOX4$<XXAV_\ @:Z2@UX)<H^"CQKY? #5/P4?%Q7CN5\%?+QJ.6WQKX<?_%$O
MI-ZU-SU^+/Q9K$>G,OKN8B)BO%>G_P N7OB#Y>?26KB<YU++[2X++Q;N"L;X
M@OM4OY3"*:-RT1+@I[P7?GO,&>(I='GS4U*SVG)4W]/^2LP[[_\ E7Z0O3GR
M^LWDW?GM$KDOSJ/%U6I2G7[^?/2!T_SS]86/IY\_[-X[_GSW^L*NL6,WGGSY
MZRL;\^?I769-ZCKM=>?U])S?GB.>*@J-[\^<1&\:F:J;>?IY_,SY\^>)B^\K
M/GS_ ,B49\^?/$O-2JW_ /*L/5QKS\IQ[<>?)/)Q'3U]_/7M-O+A_P"NTX?C
M\3S]O+VAH\_+M_D???/G<=\\_C?G=1WQKWFG<\K\ZG'GMKOUG/&O?WG77EY_
H$T//7SZ5-GSY_4?;G[?>&CSUUVAY/GYPWSOS[3IKC[>:[0\W_6__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2132809d4-lc_reduct4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-lc_reduct4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X )D%D
M;V)E &3      0, %00#!@H-   WX   H:$  .(S  $^OO_; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\( $0@!@ ,2 P$1
M  (1 0,1 ?_$ 3H  0 !! ,! 0             !!08("0(#!P0* 0$!  (#
M 0$              00' @4& P@0   % P0 ! 8!! $#! ,    " P0% 1,&
M$1(4!U D%1@0,$!@%@@@(3$7.)!!(RAP(C0E,C4W$0 ! P("!@4'!@@)"04'
M!0 " 0,$  41,S'1$I(3!B&1,I,405'A(D(T!V%QHM05-Q @,(%28B-#4&"Q
M<E,D=!:V0*&"PM)SE)4VLM-$-1?!8[-49*0E@Z.$I282  $# 0,&"0L"!00"
M P    $  @,1(1($,4%1D2(34&&!H<$R4A0%0&#P<;'1X4*2(S,P8A"0\7(D
M@M(T%4-SHL+B$P$  @$"! 4$ P$!  ,    ! !$A,5$0\$%A<8&1P?$@,*'1
M4+'A8$!P@)#_V@ , P$  A$#$0   =_@.!J,3RP]@K*27)LQ03,0[@H(  4@
M* 0I 62  @  *"%!"@A00    H(  4$ +*0"2        HE("C[P 084ICI5
MY1E@>QKHU<=\SD    "%(4@!0         "%!"D*     " H  (4     A0
M" %(60 #B2(4C3)>.YMRD
M      Z35,G ^DR]/<%T,./Z#5   *0 I  4@   *0    H(  6$D  *"
M  I  "D     $$@ +"<E[0 08")B,GJJYH'NJZ-W'>NY<@  $* " H(4   $
M*    0%("@A0  0%    !"@A2%        !"PGUJ !P ).4:8[QW-N4@
M                                        '$ULIY&58SAE]UK1>X[W
MUD$D$@A9(0LD()(!) 4$*0  H !!) !*P@E8" I 4"4@!00I "DE80  %( "
M@@*200 2O>#@228F)Y6>-F>*^IFB%QW]KR(4 "2 20202$+!* L$D$H(42 D
M+) !(0%(6"2 20"4$*!* 0LD$D$H"B 2@*""%  D)"@2$A9/I!KN2WS9 OV
MB.5=AIC<=S;E(                                           !A<F
M/AM#75.G25<SD/:5TE>Z\%N$\QZF^NL[,0H("@   2A8"%! "B4@!0 )(0 L
MD! 42@$*     0"5@()6 "4A0    )"0LD',&F%-B9D(NL)/%"NF?AZ^NBG]
M+_F39OJS:F9.N]C  ""0 ""2"002   0"0     02 ""0" 2   0"0  ""0
M       "3[%&NI+<-DR_9' FN1V1IEW;I#+OSGH\X=;;,
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M>C^M>1^:&\=L,N?JP<(BN1SC0CWWGMCWI?/YH:]V"
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M0?<H_+O>.Q"7;PL'$$@TP\OGY-^HORUOM_+_ .I?L^?T
M                   XG3RX8D>\\'X/ZCR^1?DO6Y3^']QV3E(    .@Y)V
MK\9K%2^C*Y?6S3&X^X;CTWLMTYN:4D*2 "5) !*P@E0"%A  ) 4D  E80 "5
M A!(40D@@$J"02L( )6$E825A)"\4I/W^&$VQ]<V+VG4Y8>%]U[UY?U(E20
M "5   XFL-/+[,HYRRI/SW..P'=>E-E>G-RUC'^X
M            $59?8]=A-L;6_1]OEF9KK8WI'3]Q,I     !]Z@ #K.)V@TQ
MN/;^A/SQM0TGO#TCI^Y                                @\A[_ *##
MG8&OJO\ #[YT:SV9<N'FB0        #X3 \^Y,MY;YK3&XY,;4U;F]KC8US8
M6<                              !;N7B>"^H\MC5[#QWJ72=[FAKS8?
MW?+ZB0         #Q9-#]F1\N9!E:?GGLVU[)UKZST?>9$>1]>   A0E80
M2L(         )40@$A80       6MG8.'OO_  &$>R]89XZOVGFIKC9/* A0
M       DJ"@ 04"7LLK)R-,CCF!L?6]"RL7/G5VU
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ML20                        4G[_#6;N33.<VL]G>P]!W\@
M      L1/S>69P1D8N9J_GDO#])\Y2?#]?GKPVUJ38YJ#;\@
M            Q7]SX;%WVOAMI.D=Y2       6SU/;_;]_ARY<87[OOCTS$R
M_K^_PJ65B\8^3X_?[?O\!\_S^G'CR^K[?'[R84!!:A14OI?L-,;CN;<I.)KZ
MVKJG-376Q;SZ_L0                       *=]?CK.W)IK:!I;=7)0
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M65$Q%"0"$F6*D  0 H0"2"0021$TA0@DB)J"8BA,*@\X[?I]7&Z]([B/S_\
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M]JA\<C[OC]['[3J<H_%>UN;"S*?]?E0LK%UD[DTQ?W6=KF?KS8OJW1=[(
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M6"2";$I)!$"D=MU6$VZM)V;V/6[:-%[Y]2Z/N^2@     @!0" % !"@
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M                       !UF&29:+70
M                    ? :E[,8I/:%Z4ME=XZU$
M                         '2:TTR*6AICZ>G5G/+40
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M:L'<G+J1:$=,*2;9CE%7[J3R6L8Y=2ZC2/BII26HAE55WLM/'B52RZAHN*R
MTLLOE-6[V5FE(FC274=Q\9DM91Q(9/6.=2,LK&-8N94E4FF4U=NY3(C12[1P
ML[0_BLDFX2C^F.M(N7RGK+"<T<,(]G%M:CNVG_D)2GPT^&4P2.1P/2^1.&OQ
MT^&G\]/F:?#3XZ?#3^>GR<JR1IBD)$S:G<'829*$)\O3^6G\]!H-/F&-0A6>
M<XA(2,OEV,P"R2R:Y!W=7_R%_A4=T+UQ3-.J<Y>YQ!^&.7*#1";EICN6>P?J
M&&PJ2\'>H-G3.=A\%G\QQ2#QK,<Z_5U])/NILM7GFN-R$KVC*=XW%QO7&]P-
M[@;W RC$8C+V^DITED\;+H2[.XN+BXWN!O7&]P-[@;W WN!O<#>N-[@;W WN
M!O<#>N-ZXWN!O<#>X&]P-[@;W WN!O7&]<;W WN!O7&]P-ZXWN!O<#>X&]<;
MW WN!O7&]P-[@;UQO7%Q<24PWAV4C)Y-W/*8] ,L9C=[@;W WN!O7&]<;W W
MN!O<#>X&]P-[@;W WN!O<#>N-[@;UQO7&]P-[@;W WN!O<#>X&]P-[@;W WK
MC>N-ZXWKC>N-[@;UQ0ZVO\9%BA*,(W]9NL8ASF'2."9K)P\/&P$97^H[MI_Y
M"?RE8EA-,7'7^?8 ]-WP[BVV#]UP^05:RT6\I_/7YNOT.H[6["<80PQZN1]V
M3$5$Q\*Q\*.X12"TDR;*T-K\.[O]A?D9=B$7F<3'= 8:V;+?KSC>[_"4\QK7
M .WV@]*[_:"LAW^T'YEW@@#=H]HMA3NO*41(]_95669]_8F=-KW9@#D-^S,&
M=!+*\:6!)2.5&1YSC6+)Q601$RP5FXA .<YQ%H%NVL 1"O>. )"5[_Q5%ECO
M["MUJ_Y]PD?Y]PH?Y\P8?Y\P8?YYP,?YXP$%[UP&H+WC@)@7NKK^HIW'U]6I
M>W.OS"7[RPJ-5B)AA., X=-VB;Z=AXUK,?L++<Z%ZCD,O-BF%P6&,O"J_P!N
M](/(6V=0&,1/9I_U\GY7)>J,LDY.&QR5S;-,M[N]>9#UYD/7F0]>9#UYD/7F
M0]>9#UYD/7F0]>9#UYD/7F0]>9#UUD/7F0]=9#UUD*SC&HDL/Z_E991GAJU%
M\9Z[<!QUWUDN%NI.MU ;I_#AEO42R-(#IYCZ<GT_@X;=7=9MPCA/6B 3Q_KY
M,2>,X#)L<8P#!<:KP<+'!PH>F8./3,&'I."#T; A6#P"HK =?5%<9Z[,*XEU
MO6A\*ZT..U<;9P>0=>=H.\$;*?L6GZ?FV4Y5V4GUWU*K-,_\*8=ZP0]LMXPO
M&%XPO&%XPO&%XPO&%\PO&%XPO&%\PO&%\PO&%XPO&%\PO&%XPO&%XPO&%XPO
M&%XPO&%XPO&%XPO&%XPO&%XPO&%XPHL:M?Y9MU]%YR?*_P!?\>R6;@H2-QR(
M'?7].^OG%_J:-F<QEFK3)XY6(:Y)"/&OY1&NF7Y9#MT:Y'"TBX[((F65FI:9
M0F8[(W*3N.R&(EC+9;&JMY')H2)7?3L3'-87(4YJ0^<^Q]IE#17]><F+6"Z.
MS&0D\2Q2/Q"&TT\3[[__ +U\XG_YXY.^B1IHJ0C4GA&^1/N7(O&F/,W*<^FU
M<LF\9((R>8Y'"UF,GGL328P$=1.6E2,5RX.@]+C4G',GF.4QM6KN<^=#?_/T
M&GB62Y+%XG$8QDT7EL5ED]7&,<[$[H<Y=V/[F7P]S+X>YE\/<R^'N9?#W,OA
M[F7P]S+X>YE\/<R^'N9?#W,O@C^TQG)_<R^'N9?#W-/Q[F7P]S+X>YE\/<R^
M#_\ 8MS((Q_[ 'CE/<R^'N9?!S^T:C-,G[.NU"^YE\/<R^'N9?#W,OA[F7P]
MS+X>YE\/<R^'N9?#W,OA[F7P+^U%3N/<R^'N9?#W,OA[F7P]S+X-/VA?M5_=
MP_'NX?CW</Q[N'X]W#\+?M\Z030_<!RY3]W#\>[A^/=P_'NXD![N) >[A^/=
MP_'NX?CW</Q[N7X]W#\+?N*HV4]W#\>[A^/=P_'NX?CW</Q[N'X]W#\>[A^/
M=Q(#W<2 ]W#\>[B0#;]QE'@]W$@/=P_'NX?CW</Q[N'X]W#\>[A^/=P_'NX?
MCW</Q[N'XCOVY;'DVKM-XV_D8A#T*0A*&_K3*>J('+,QHDD+20M)"TD+20M)
M"TD+20M)"TD+20M)#">J8#!)RTD+20M)"TD+20M)"TD+20M)"TD+20['ZWA>
MRX"#AFD)$6DA:2%I(6DA:2%I(6DA:2%I(6DA:2$;U%CT7V+:2%I(6DA:2%I(
M6DA:2%I(6DA:2%I(9ABD=F&-X3AT7A&-VDA:2%I(6DA:2%I(6DA:2%I(6DA:
M2&:]4X_G,]:2%I(6DA:2%I(6DA:2%I(6DA:2%I(&23'6W4^/]9TM)"TD+20M
M)"TD+20M)"TD+20M)"TD.R^KH+L^,8-"1[+Y%?[9'WF_:3.(Y/&9ECWRCGHG
M3$.^([-.P_E5_MGO;$GCF6]7]CI=B1WRNU>V83JR(==N92[8=8]DMNR(?XY3
ME,3AT)UYW'&YQBG4W=5.T)7XGKMHS_8" E.R8CO'),E>EKK\K/LWR#&%X;OB
M+4Q[%^\))[/?)J,B[ORN"&7=K0F+X1U=GE.R,2^3F^3/,4@,:[@DULGK^R,K
MP?7&7R#?VCY]ST_(=!XG)X7U=\KMF#RG)<'QK'.R\=[H^4;^W>A$C=I?K2G)
M(8[\KNR);/NNYWMG(<$ZU_7[\91Q;XR<<PDVF/X)GF58ITHQS]IW1\3::9OC
M!UN]2L5(S$8VCJC#Y/>':TIUW'(8XWS/J)_/N.Y\I^28=G=L.L[R')L1S?()
M/]6F^4M< I\GLC-OP#%>I\J<97EQFA31=_(/DU(2OS-!I3YE2$,*4I3Y>E*C
M804*6G\:4I0:4_CMH-A-?E5*6HH4M!0A"_+MD&E!2E*?*TI4;"4%M/=XB8U"
M%K^P'4U';)^TD6_W Z_^-T#B^(36$X%ECC&,!PC),X7S(G:N69!B^29GG,-F
M3=0JR7VX<E%"5_5S!#JRG4.%R.'075$5BT]U5UQ,?Y(EOU_Q>8>-D$VR/AG_
MV@ ( 0(  04"_P"8-GC[UXB[:+,EON''W1G+#)JJUDON'$SKU+DZ2Y7WVLBV
M7<5,4Q:_)Q=9P5[DY77+^U*%J:K/'7:XCCQ,>6<<(.9#Y.//.*_REY4Z_P!I
M)(JKF:XZ;:>3B8RCN5>O?F1G])#)J?\ V?V@V:.'9D<?1;%5GF;1-R^=/#?-
MBTE%G^4M5:+_ &<TC7CVI8:,CBN,CME676<'^?&/JQ[O*'1N/]F,X5\\K1I"
M1-'>1.%*'.=0WT-/ZAQ&MG+$U-*_9%*5K5GCSYP*'@H@/9YZ[^F1655QC['3
M245,UQM4Q?48B)H]F'S[ZB$:JK0JJ9T5/L1!HX=51Q]%N56<8L:.G[MY7ZG'
M']%63]Q5T\^PFD8]>@D1&QU'&1T3*LX6<&^KQ4WF'--KCQ]-!98,H)\\'$@X
MD.\D=JT,8QS?6XN4]7\RS6:O/'46R[BK?&UJECUXAJG-3*R[GP#&WO'=Y.]O
M./&DD55C-\:?JCB8_'!;)*)E<O73LW@40FHK(9)%UKXRBD==1/'8PB2F1)-J
M.I-\\\&:N5&B\HNO(0OB[=NJZ5,HTQYNI,R*J?A&.N&OI\[$K7ZTK2OBE*5J
M$2IX\P55.NIX5C+Q&K7)J$I)^)IIG5/'0OIII%^I(N?"R&,0TN4LE&>)P#95
M9_-SC91O] =^R3,5TV.FDX07!'#=4Q%$U J[:H&2717I\$U4U2_"IBEH0Y%"
M_/QQP0]';<S5QXB0AE#.E"P<9]#-,XQNW4:G;,G+,D?+G0=Q1H=Q'&1G3-RS
MD8L1%REDSDIU)*4>N6,@NRCUI=5O),W4^[I'\^JK>2<T;4EWZ*?K$NA37YK9
M<S=?($"KI>(P+1-!)\[.]<_0R4961/)1B<B@SAE$W3F'(\,QC5D'"T9=DT80
MB)FL*[;G4@URNCX[6K-&!-?:0[YH<L0L1V: K1).!-;<PG(:Z?(.>V1L_3<G
M7DDVZJ[LC=)L[(Z(C*)+J-I]NDT7<<=%J](['JB55G3Y-I6CPAFK603='5E4
MDE'3PC2B+PBR#>22<JN))-LJJ[(B@U>$=E3E4E574@FU.9X0K9J^3=UK*)77
M3U-H$WA%&S:03=*+2B2"CIV1J5!V1PDA)I.%7,BFV44=D2;M7I'8+*)'6=/T
MVI^63C-7Z;LYY5(BKIZ1H$G9%D&\DDX57DTFZKAV1LFV=D=$1E$EE7,BFU4.
M[(1LU?$=U]52NNGQ&E:.R5;-9!-V=25235HI0BDE/(/6Z$FDX5<223=59V1%
M!J\(Z*E*)*JNI!-H?F$XK5^F[-652HJZ>D: CPAVS:03='6E$D%7+LC4C=X1
MRFA*)+J.))-LHH[(FW:/2.P242.JZ?IM#<PG%:R";LYY5(BKIZFT"3PBK=O)
M)N5'$FDW4<.R-DVSPCHB4HDJJYD4VJB2E%4_GLG)FCK(6A3^'L6:CYRNVI Q
M5=:U\1QXO-CIR-3C7'AA"&.9L@WQ]M)3R\BCXDRD'+ VJ61LED54%/"D457"
MB2+3'D'3M9XMXH@NJW4+*1<HG^,)K'DL<7; [==/P>#BB22CKB8ZW775<J>+
ML'ZT>NME+\YRY6Z'Y(V4'JD"<7\64%K%CCT_&S#T2&./QQD8)8NQH@IB[VE3
MXY*$!H:3**L'A15!:@:1CQ[5=HX;JT;.# D8_.*04I44QN3J$,7>&4=XK4H_
M%Y ?B\@/QB1'XQ(C\9DA^,R8_&9,?C4F/QV4'X_*"L%*4#?&Y!8J[=5LJ"$.
MI5)JX6.ABK>VXG4F ?2+F04^PDIJ000H^>4!9:1*"S\H4%R:1H/REV&&3H'#
MK*/^]7*7H-D<F85FY2HK*2%0C+/T5'D\^=CGO1SWH]0?#U!\/4'P]2?CU*0'
MJD@/5I(>LR8];E*"!D>8UE89.2-3$_\ NQS)E$5EYZC93\ED+%:ZU^W&3H[)
MS3*F0<Y''I(OWRK]Q_S3?__:  @! P !!0+_ )@WN0,F:S-VB]0^X<A:E;R&
M+T1I&_<.6IMZ5Q99 [#[67<MVU*&*:GR<I1;F8XN9IQ/M2IBEH]R)H@)(DN_
M/!-UVT?\G(F='4?BS*B:'VDJLB@5UD1=21LM)U:13)G\R5__ %V-5_\ K?M!
MR[;-"K9 NY,E /':C5BU9E^;+*IHQ^*O$C(_9SN29LJ&F)21,WQRX9%!%N3Y
M\HPI(M,79THY^S'DTP9TJZFY:K3'6Z=2)D3+]#7^@;R;EL^+74OV16M"T>9$
MQ;BI)R8#. 9-:Z:?2K(II9/]CJ*II%=Y(F4WITO+590[%C]1-NTD)I)0BR?V
M(N[;-:+9 JXJG!O7U6L>T9T^H_ZY)'U1>Q[>C5G]A.Y-DR!Y>2D:ML<,H9%N
MBW+]7E)-46QMS?Q]1=%$/9UBT'*G)8-,;:)5(0J9?K<H,0K"%>HNF7CJSENW
MHYR5&AI)O,.U(6%10;?V^O\ ^N3,>0TQAC9;^-*K)(%<9*P2'+GY&B.-5.9L
MQ:-*>!2ZB24=C<K37QA94B":F1RAUDL=5<U:Q;!GX,Z;)O$(I!".FO%W#A)J
MD5-YD3A.%CDE/",C;._4(*71HA2M*T\4K6E*+F4R%^BDF@GX5D[-:CO&*GK%
M^)J*$2)(3GJ98U@G'-O"SD*H6(,:-D_$Y]RDBQ@X)R1Q] 1@^5*=JZ346;.6
M]5&KE$ATU$PBS=N"JH+H&']0HDJB;X4(<U5$U$C_ #\C;G+5HX*Z;>(G.5,C
M9(TY*?0X_(S3AR1\1W(MGRLM %<LY<DTUDR+XU1X;'9I%1PS7Q-I5-.)AV#*
M4C&[^60@TW43(,L:8FDRQE$744T,]/"1JQZP,(L;3YKE CE#'ES(*^(SSM1=
M5BS(Q;?0Q$SZ22(EU8IP_GD5632:.RI(2J+AJC+68AQD!W!'L\Q=E2R%N=D3
M*:>HKY&7BOIR/?$/.-U&9<EH99;(RW6^0U0>Z_(3)=4>1:C-)K$JND6S([I9
MVQ.S47AUFZ*^.N%W;=KR7#V/49"L.K1NRCE'M#,CE>/(M1DFC#++HLF)WM5V
M1T'#J)5:(M8E5VB@R.X</&)V1E899%!G&*O4RL3F>/8Y1E2D,K5NRCU'H59'
M2=/(M5FFWAUG*+-D=Z=RQ.U6<Q"K5!I%*O$D61UG3U@=B#PZJ:#.-4>DX1^8
M\C5&1$X991!FP.]JNR.@Y=Q*K1)M$*ND6K([M5VQ.S47AUFZ#.+5>IILCJ.G
ML>HR'HRUAE'*/J58GH\>1BC)-&&561HB94L=CZS%TYB%6B36)5=HMV1W+AXQ
M.R.M#JHH,XQ1ZG1D>KQ['*,BEAEJMV4>H^"C(Z3MY%JLTV\.JY1:,CO%';$[
M15Q$*MD6D4J\219'6=/6"C(*0RJ;=E&J/259'H\>1BC(B<.JJ@S8*/0LR.@Y
M=Q2K-)M$*ND6K([M5XQ.S.M#JH(,XM1ZFLE5%7Y[UM1XVQYX8GA[YXFP;-W)
MIZ5II2GB.1'X,C!2:LDW\,.<I"N5W&0N8R 0CEO$GT<UD"Z+8V]163<)^%++
MI-TUEG>0+M&B+)'Q1=!)RD>+E(M2N4*(DC<D;N@1PW4\'G98\:FTJ\R-P@@D
MV2\7?L$9%!#%F*9#XHVK7\;<DJ:+GR"B&4IBJV4ICGY&6E9R9(/R)\4*Y2^J
MX3R=G6B>1QAQ29C*UH_9&%'"!@\DV;*B#MNX2JZ;%!Y2/3%9R-I0V2QA0XRA
MF1)GE=#C\GCQ^3QX_)XX?DT</R2.'Y/&#\FC!3)8RH_(HP4GHVHI-QM0YR1@
M@9NNDZ2!SD3HJZ;HIN,L<76\"K(!C'-HY/["6A(Y=>K!E4'B8XX- 1E0?&8\
MX_%6@D,8<%#7%ZV:8JR!<=CBBD)%T%(N/*%XE@NFR@&+0>GL1Z>Q'IL>/38\
M>GL1Z<Q'IK >F1X])C1Z-&#T.+J,@CN$ZBIM2,)7+O\ M23U]+TB($SE/\9C
M^12E*4^W'K0CUM7$W@;8U(*K,&*4>W_]']1K_'7Y6OTFHU&HU&HU&HU&HU&H
MU&HU&HU^&HU&HU&HU&HU&HU&HU&OPU&HU&HU&HU&HU&HU&O_ !<__]H " $"
M @8_ OYP>_%UK#DJC!.*/'G$ YM+FSZZ+[@HVX+OJ_K7SBDCL[L-=?<A)(:Q
MN;L\5,WFO2!CGD: KKK'#](PQ_@<-KBID.NQ!TM.[TV:<]>/S5HVTJ_B/M0\
M>74CA()6EV4DG*G28?JV6Z?T@RE6R[//84,'399;K\T[D+2YW$M[XB\11*YX
M?&'R]KXK[KS<T"P?J0_^QOM7^@>:-S#M+BM]XK(&MT5].9;GPJ,>LA7L0\N_
M6C;$*NO \@3<7_XKM.6WS/\ L,-W3F6]\3DO.[/I:5N?#(VQQZ:=&1;R=Q<_
MC\@&(I5N0^HJ.%GXI+:^KS-L;=CTE5Q3A-B-&7F6ZP@W4/%E5YY)=Q^1M@EM
MN,L=R953S)H,JOR_:BX\NKWJC?O8H<OP"N-.[BT#W^3/VC>8:<FC5YD7(P2[
MB6]QSMU'SJ[X>S>3]KX^Y4D=2/LBP?'E\HFBI^0F[JHC%(*/'F+=@87+?>*2
M!C-"W7A40KVE6=Y(T9M7E7=R-N(:PGSTI5WF']AANZ<@UK>>*R O[/PRE;GP
MR,,CT_!7YG%SN/RR5FF/I3VZ'GV^8'VFN=30KU+D6DJN).^Q&CX>];O# 11\
M67X*^\DNX_+B0-BX:I[I!L/<2.'J0,<X\06\QKQ%&CA\-(RS+;E1CPLA&%&C
M/I5O &X(V9;.5#"TLCX;N0M+G<0JJS4C;QY=2_R9-[*,PM]EFM;OP^)K&^F9
M7IWEW <0BZUZNI'Q%A]8Z>&1'&*N* D:2X934K<^&0M:STT+[TANZ,@U<#">
M'KM39X,_6 X8$,(J\K=LH_Q$A&)\AN'@G=7@'BM05WS"-OP/[-OLS*AR\*T&
M5;Z:G_829!HXN3.C+*:O/!?=7.^\'9#T(W138%>/CZ.%!&P5>4?$/$"+L8J!
MZ<R,[^KD T#@P/98\*+Q2/\ (T4=TZCPHV1G49:2GX/#[3S83F\AN22QAXTN
M",K)&&(934458'M<!H-461O:YXT%?;(-#F5V>1C'<9 5Z%S7-XC7^-^(AS.+
M^-2; K\9!8='D$GALO4D%G2GP.RM=PD&,M<2A@X_^9(+?3F\BDQLK!OC[5A<
M&[9&)EJ_E+0-0YU%#@JM9,RA'-7TT*-SVQLD:US:@]:OS'B'&NZX%U2S+80;
M<]NE1.Q;2Z#=6@?ZE/XAA&O;X8UF?2F2S.B,+G6M'6 U=*GC\/#.[PV&]GRC
MH*PS(:4DE(*EADIW:.(NXZT'O3<4UL7=GYN+2L6,1<,=#?\ 72RBPV \/:WO
M4C*VY +?<L3!BPWOL#+P(R'TJ%#B<2(^ZRFEF7]9L[.LTJ/Q2'JO KPD[Q;%
M=1G5]_0G8A^?V>11WGTA8:TTH1DW)&]4C,N^XZ4S8AHH.)2OQ#MN1MT?M'IE
M3L7B9+\Q;=L%!0)GB-[J-I=U^]3,#_\ #F^31ZBFLWX[JPY+C:D:":=*DGP,
MYB9-UA3TTG6H\.R6DL3B0::4^?&3&4R1EKK*94UC<4[N;#4-IS>G( II6R_X
M\P-6T],BA.'E+,9"*!U/32ISB)2_%SMNEVCTLU"Q08:_3<G1E_1+S6@"N-9*
M+/F:0$871S$C.&$C6A*YLA!T-J=2,C6R- [3:(1".<$Z6$!2>$8F+$2$MV;D
M9?[-"W\C)/[;IO?2C=9(VG::0MQNYZWJ5N&FO0@',D=7LM)7>[LEW1=VM2N-
M9*W^YI",1CG)!S,)"!<V1U>RVJ,X;( ,Q;0ZENFQS-)[3"!K6Z=',X_M82$,
M06R$',&U.I%S6R-IVFT0B$<X).=AHKCF2N_M:2N]79+NB[M:D0UDC:=II"W.
M[GK>IU#37H0O-D=7LM)1Q(;(&BMA;M6<2W;62M/[FD!&(QSDC0PD(.<V1U>R
MVJ,K6R #,6T/($(6QS G.6$#6MTYDKC^UI(0Q);(6FE@;M6\2-ULC:=IM%N=
MW/6M*W#36KCF2N_M:2N]79+NBFUJ18UDK:#YFD(Q&.>H-.H:(%S9'5[+:ZT<
M0&R!HS%M#J6Z:R8']S" C$8YB1G#"0A*YLC@>RVI1>ULC0.TVB$(CF!.EA U
MK=N9*XTKLM)"&)+9+IS4VM2(8R1M.TTA;G=SUO4K<--: <R1U>RTE=ZNONZ*
M;6I7&LE;0?,TA&(QSD@YF&FM,OQS/B)MW;"\@>H(08)DL>$BRM<TM=4<7I:A
M$V.8$Z6$!;IT<Q/[6$C6A.6R%IS 5.I%S6R- [3:(0B.<$Z6$#6KCF2NJ/E:
M2N]79+NB[M:D6M9*VG::0MSNYZWJ=0TUZ$+S)'5[+24<3=DNBMEW:LXENVLE
M:?W-(",1CF)&AA(0>YKW ]D51E:V1H':;0H1".8$Z6$!;IT<SC^UA(0Q);)=
M-+ -JWB1N-D;3M-(0A$<]2:6L--:#7,E=4?*TE=ZNR7=%W:U*XUDK?[FD(PF
M.<D&G4--:%YLCJ]EM4<2&R!K0;"W:LT#V+=-9,T_N:0%NG1S./$PD(2N:]P/
M9%2B]K9&T[3:(1".<$G.P@:UNW,E=_:TD(2 $ C/8?(&3C,>9-\3P]L3Q;T<
M'C#QY2GNPULQ^;UV<RJ<O"4F$Q.UAZTZ?Z(-A)W;FUMS<&W&"KBN]XFW&N%@
MZ/>5W>Z&1Y^/A.]ASES9E;1OB,?IJ*,4P(>."Q%""Z0K?8BC_$"+!H]-*,TY
MJ?9PJ)831X0B\4;<F[7QS>Q!V&G#L/K0=A+TK.<+[C'#U@\#N,I^TU7L*RN(
M?DJC-,:R'AC?0ZLQ0,08QNC*J211G6.DK[^&:=1]H6WA:<@Z%M1D?5T%6.<W
ME/2MG$.'^H?[5L8KG:OMXGV>]4D<YTI^:OL"^VYC@NJ#RA6Q.5L3]2M:[4B(
M&Y$896F^%LL=J6S$_4OQE9&ZP@)R&QY\Z'<WUTWO@LK-:RLUKY-:^36OEUK(
MW6LC=861NL+JC6%^/G"_&42^C/6C#,*/'\+K 25NXV.+TUV)>_>9Z4IZEW3P
MN-H:TY3Z<ZWF(.3(!D\P^[L?L<X5DLFLJR9^M?DKZU;</(MJ-A1&,:(]%$1A
MXVNCTE;+6!96CD7Y7*V9^M"02.--)L0 .[:.RORR?45^63ZBOS2?45^:3ZBO
MS2:ROS2:U^:36OS/UK\SU^9R_,Y79G5Q UIKZW7#V(UD^SSK=OD;WAVF@L6Y
MP%POSN6Y-V_VLZJ<OFZW$,RA;3'J_ [>2:+>='$26='\Z?\ _]H " $# @8_
M OYP>X-YT@T(8B U8?.(D.J7[5/6OMG:+S>]=G13SB9+;WD^SWHQQBDC7;7'
MQ\U.3S7KB'M8#I*O--6G]+?2?F!V>/BU5*<V&N_KM5YN3S5JZP*YA_NR\636
MABYXG!IL% ;.E-CQ'7J;-'Z1=6CHMKFM".,KM/LY/-._,X-;QK=>',,LBWF/
M>61'-\%6-@WFDVG]2?\ ]3O8J:'GH\T;^(<&CTR!;GPJ,N=IIT>];[Q20^JM
MNO-R*[AV ?K2NE.S<(Y38$_"_P#EO7N2@\S_ +SQ>T9UNO#([K>UGY[ M]XG
M(Z2317VG+[%NX&AK.+R X>M'91ZU)*\_=CLIZ_,VUUY^@*F%:8L/JY_<M[BS
MO9N;XJ[& &\7D;IX;+[C4>LUHJ^9-3D5V'[LG%DUY^2JJ[[.%/)\2MX_[DVD
M] \F9LBX^AY2"/:/,B_*0UO&MU@6[V3F5[Q!^[P_9_\ S_N58VWI>TZT_#D\
MHADKU V]Q;5?84)8S5A\Q:SO#5N?"XRY^FBWOBDA]7I8%2!@!TY]?E7>:[$I
MYU'!6M&^8?WWB_HRG4MWX7&0SM?'(%OO$I"^31\5<@:&MXO+(7')O.@J-VE@
M]GF!]US6^M7:WY= ]ZIAAN<.<^3G]ROXDF63F^/*KC  T9AY< 3MWQ1,9&=M
MC0#P]6=[6CC*W6":9)/3E0Q&)C?;DLR(28N,'$G3FT6*@X [P#0Q6\B.*)J9
M.;AN_,YK6<9HOM5D.H:ST+_&CW46G)[;=2WF/E+G<7O5V!@;P'*9NK=IK7_7
M/&4DM/1PR99#1H1,;J-.0 #W+?>)2N=)K]JK#&+^DVG6>!CAYNH4Z#$4J*W2
M>&#-,:,"WCZL\/!]/64)6QB^."3)=)C=2A'IE7=,8ZY.WM6<EN?B51DX5J<B
MW4/_  (\_3RYN)"*,48."^]-;]ES<HZ5MFNV:<7%T\O"ADD-&!#P_ !U9#0G
MTYT(6];*XZ3Z9.#"Q]K#8I/#)>HX[/1K'..%'1/Z[[ $S&XC98VT#/Y#?CAD
M<PYPTH1/C>)3D%#74J3L<PG2"$))6/:PY"05]P$5&=7H(WO;Q E79FN8[C%/
MXW)6EK]!L_B&M%7%&.4%KQF/D$?B,778:'HYTS$-^9O"1>^QH1QDG_#C-G0.
MD^11>&X>5S<..9N=8[Q..CG86"D?/4ZU/B?$ON28:1KFD^STTJ5D;I9(WN:Z
MZ18RGR-XSQ+O6/9=#S90@BS-LDY-"F& >V/$[^PDT&1JPWA>/>Q_C3Y,HS-4
MD&';.W$,:2'NI<<1FY5AYO%'2=ZQ&TV[\H6,=-7[6':X4_M4&(BKWR;$;OB3
M\$7SG&1Y3F)T+P\X7>-F-VX?VWK:\:QOB/BCY#@X9*6=9Q/]5A,7@7//A^)E
MN$'K K%8/"NE[Y ";<GJ_6=!)U'!2>%S=9I-.GW\)-\)PMKW=;W=)3<.S-[?
M(I=W'>Q$C:!U>JC*&B2)XH]ISA?]=X; ,/A'.J[22H68=@N1NO._>>/DR)N!
MPD9CPX>76FIJ>A2>%7.O)>O5R9,W(L.\L_S\/DDT@:0GR]V(QL@R[QUT'M!N
ME18;Q##-FDP_4-2+.-2XR6 &&:,-+:Z.-1X7 0" 13![;:Y-/2GROP;/^PD%
MKJFGK TK#POA_P K#D4=7,#7G6(&*A#\!B75<RN0Z05AFX6 1X'#/O!E<IXR
ML5C-W7O (I7)7D_1$8H"XTMR<JWKI8'6THUX<=2$[9<.T',YX!U(PM?&TC.Y
MU!K0C<^)Y=V'7ARHSF;#N S-D!.I,\7PTV%B =1V\D#/;I7=XY(L^U>%RS]V
M1"_)$^O8<'+O&^P]+M:;P7O533Q(EDD++O;<&ZEW._'>KUKVQ]2WCY('BOR/
M#BA.)L, 1D,@!U(M:^)E.VX-0PQ?$YQI:'5;;QHS.EP[@,S7@G4M\V7#M&AS
MP#J1PP?&UPK:74;9QH->^)]>PZ\C.9L,0!6@D!.I;QLD#!7YWAI7<K\5ZO6O
M;'U(%\D+Z]AP<N\;[#4NUIO!>U:4ZX^)EWMN#=2&$+XRXTM#JMMXUO'2P/%?
MD>'%"8389H.9T@!U(L:^)E.VZZA"Y\3B[.UU1RE&=TN'<!F:\$ZEOFRP,%<C
MGAIU(X0/C#A6TNHVSC0OOB?7L.#M:[QOL,1=K02"]JTHO9)"RG;>&KN5^*_6
MEZ]L?4@]\D+ZGY'ARWXFPX!%:&05U:4X,?$R[VW!NI#"E\;G&EH=5MO&MZZ6
M!XT->''4A,V7#M!S.> =2,+7Q-(SN=0:T(W/B>3V'!PY49S+AW 9FR G4MZV
M2!@K3;>&E=T#XPX'K%VSK0OR0OKV'!R[QOL-2[6F\%[3DTHEDD++O;<&^U=R
MOQWZTO7MCZD)'R0/!--AX<4)A-A@"*T,@!U)XCD@CF LWCPP$^LK?8R2&3%2
MY'->'MH<]X6?!;UTN'<!F:\$ZEOFRX=HT.> =2.'#XVN%;7.HVSC08Y\3Z]A
MU[6CB#-AR *T$@)U(R,DA8 :;;PTKN=^*]VKVQ]2#GR0OKV'!R[QOL-2[6F\
M%[U4THW)(F7>VX-U(80OB+B1:';-O&MXZ2!XK38>'%"<2X=H.9T@!U(Q-?&P
MCMNNA-A<^)Q<,K77ARE&9TN'<!F:\$ZEO6RP,%<CGAIU(X4/B#A6TNHVSC0O
MOB?7L.#D<09L.0&UH)!>U:47LDA90_.\-7<[\=^O6O;'U(/=)"^I^1X<4,0)
ML. 16AD%[5I1N/B9=[;@W4AA2^,N)%H=5MO'[5O72P/%<C7AQU(3MEP[0<SG
M@'4C"U\;2,[G4&M-8Y\3[W8=>'*C.9L.0!D$@)U+>-E@8*_.\-*=$2"6G*+1
MR>0/@.<<Z=X9B/RL)ITCDX/.(DM 3&XFR$5L'%FY509.$H\7A:MQ!%3[/ZIS
MI@-ZQU+,]G!I>\T:%W3#68)IR])Z N\7B^3-Q<)W<0+1GSJRKO#W^FL(2PD%
MAX+,LYNQA;G#U9@!E/O]R$,(H/;Z^%3#,*L*,OACK\/9^&?VHMQ4);B-7,;4
M6XR[$_F7VWL/J(X':(1]YW,KN*?2!EIIT>O2A#"*1CAC<S<ASA4D<]S].3TY
M55DLE>.Z>@*L.)/_ ,A['+[6*/U._P#L"ORU^CI"ZK7<C>@A;4##_I=_N6WA
MAJ>ON8:@]9]RK&&MA'RTKS_T0WK7-*ZSAR%4WK:JR5FM6/;K0,SLNBU":)PN
M%;3VZUM2LUJN\J%E?])1= "Z7-F1[XRFB[\5\R^=?,OF65R^?4OG^DK*_P"D
MKK.U%=?F*_(@UM7^I":$UC/\+SR %O97M#$YN'8S=YJUKZ\J[WXI(Z\X5 'I
M9Z@MWAP;<I.7S#[P]FWS%6Q1_2%M0L5C*>HK+)K6S(\:D'8,[SUV(=YD+9-
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M_O/16<_O^BLY_O/16<_O^BLY_?\ 16<_WGHK.?W_ $5G/[_HK.?W_16<_O\
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M%VWWBT=HUZ/D_P BMB/SB9@P7TD.Q!:VO%&*IAM&IILC@GFIJ,3SD*1$="1
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MZS%:(G* 6UOF0A\2SP,2C_UAQD'<Q$Z<*^,W]_?LOQ*L1R@?WC\/L?W;X/\
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M*^S*+A)M+L,%ZQ*6'1YZ&(W;+G&(A,N+-MTJ,PFPF/2Z:8(J^2BB';+G)(0
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M#"O/NH*_M/$2%,3!U?U=E$IM9L6Z1'5$>(GAN( GAZVR0$JD*+28W1R/C_\
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M'Y,.WB*[*OO\%LU(TQZ!KX@VOE\>8KQSW.>M7,E_GWFVR83EWDQ9S<HX<+Q
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M^?\ ?X#_ %YQM[WI"P77'9UA^6R#1ZZ$2ZLJH9X1;^Y: @ H;F^*24#FSPD
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M81;$\SL>N &B%  &55T AYX-785F.DO#.QZX^1@*PEMK&,@S"*@=AT5\"8L
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M3@63?%GF.<.8JTJ:[SNNW!1H(G1/HP%@M[94S5JP0+7CU!^XU0/:Q7B64<@
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M=T^YUG]_;TX:_:J=NG ^TS^__GKIQZ?]!7I*X=97\=__V@ , P$  A$#$0
M$ !M!+_I;;9_IOO\I);[;-]/)Y+_ '^W[>W_ $_^?I]]MMMM]^S^0  <)S&V
MVVV\^_LDVVVTFVTFVNWWFVVVVV_VTV^DVTFV^VV_L^  $"&4
M                                  21'?;9:;2_:!3;;*;;;9Z3_;5;
M+:3;:2+2;[Z;;)Z;;K?:H  G^X8$@@8@1,#@D@D(D$@@;A,#D$$9 D),$<AA
M0$  ,DD  <X  L@6@
M  AU47]-)@L'I_/TLO\ _)MK3_Q^-[+=H?\ :R^[CV_V?^R7ZD_V 0 G@:F;
M;"802$0D00F0 P38$PB"0:$S0DP00F#0D F22 S8'(":6L!
M                                6E.F($S>[;;  B?#^R'\23#_ ."_
M@),DPD@@_P"->,,9-))-H#@ /0'.)&VV^VV^^WVVVW^VVVVVWVV^V_VVVW^V
MVV^VVVVVVVVVV U/R6(
M *F%@.2Y9)I))I 3 )(9I)-)MA,3@)-))(9,#-L9B)))))))H"LI1N$79'^M
M]O(YMIOFYI&I'')Y-G_'(VO\G)))(W(VW]]IDX]WAV"Q% C0
M                          !]M,  N+L:/[;0!+;: (!0!: *!!*+0+8
M+0*  )1*+8+;:  &"VA; &@.K%O_ *W;5][:VVW;M^VZUU&VNG6[_OFVW^O;
M:M_6WWY3]^N@7"2&%4                                   1JG@
M #,!< ]4@VT&VBT $6VTD&VT6VT 6D"DV@&BVT444C_'F@VVV@   &P,5MMM
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMF]&IMMMMM\  "01N@
M                  "5ER         "!L*
M       )\60          <:T2VVVWVBVVT6VVVVVVVVV@6TBVVVVVVVVIT&^
MVVVVVVVV@ ";".T                            "-SP
M12I&0                           ;T               "<N>K22/2/2
M29R223^/[221R29R=R21^XYQR223N?R221O2<  22KK2@
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M$IXJM9-=4KLJR!0\'#'HK6$0@  D&&@ 2(                     #YH
M           !(!  $6HK;=@\G3;;3;;;;;;;;33;3:;:]#+:3;;;;3;;;;;;
M?2:8  FC'@ #&7@0$@Z     #@      $4_                     4P\
M  @SMW.U6I(&6X1?A/I/A;R@                     B%DVWW^/.53^"\H
M^A9C/FYQD.[P=1)"6[:Z2>R26QM"(H20  $G [2[-YV:S6SJS6DVGJJY3:[_
M #&      20 20 "         !!%$]]O[WC>EM7E+UA?#/-ME"%4
M                A36R,53 A3]6D\[3TB$$CN$KK;8;:I;;+<-;!<J)MK;;
M;E0  )\:           +     !   (  "    ($ !   !X(    *    "P
M  ,H    %>    !F ![@!-"    *$    (R0   !1"   *T     T     +P
M    *F /0 'C0   !^    !S00   $SP  !      )     )      " !) !
M!     )     (0    !)@                       !/
M                                  !/N@
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MX<&),ART,9E5AH= O/'+65NL'6ZY[33URAIU6LNA!8&JC#3DK7-1F.]\MP$
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M7AEX3NNMU44V8@GZOK &:1BP E-P*?$^"BQ@X$LS]^:EP!F+C:BS.Z9E&U<
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MX?['<G (,9B(9W5NMQ- RL+!*AG4O"G-BL.%E(P6$!@GKG"V])F[!H3\>'Z
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M0;1<"LH6AEJ+*)-1N3$ !XN#,^F;6V+J>3C$6A8%]4I&H* 2Z4H-U"T=K>&
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M)(/]$ D;2S;Y?A3$= ]3B KI966Z&Z(,79VAN9N@5JB,[_M+N.A)$.AG2O\
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M\C[?V[=NW;MV[=NUK[^B.WJBY-#6%TOY)D$*K.2_KK:?F_4).H8PQF^I/DH
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M**K--8Q*,&,J8M@XE"M'5!?3[3!=AN^@"NC-UIB]+(\'K>BB$*J,P0E#7L^
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MZ<<7WE5AE)K&^D\B#+LHK),-$8L$)JX8:&HLO7V$TT7Z+_\ !9]%_8O^#O\
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M)=K0M[&K$MHME(0-% '<03!8- *4[.I_Q&(C!P J7  95= +=(*-\M)B&\S
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M-85,PZ%O:6;+TA4J!7]XX7E*M0K=@DI-8!2J7;3(B&PE.K?N,2^J]=>\,P"
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/6>?.!DLPZXYZ$Z?QO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2132809d4-ph_babys4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-ph_babys4clr.jpg
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M 0 " @$# P0# 0$!      $ $2$Q05%A<1#P@9&AL<$@T>'Q,$#_V@ , P$
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M6S:(JS-:-US,VIGTCQ?4@[TV":.AXZ \2/;'!Z +Q+_/5[3P6)PB,<F*X[]
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MNC;$&U#X#T9W<V*-H#8%.P-39P%Y@5JM4"@5N1*K/#D8-0VOI+/ 'J>(QN^
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MM/.VZ1G.2)/$>_Q_@RE^O(?22K?V5NOHUS5MQ^RX?!2(VAUTI&).^^@'Y_Z
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ML; 8QF3%<O*,>),>+G1[OU2=OI/CJ6%OG'_^V"?TJ62[;B ?#Z>[3A3M[0[
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M.C2328PZ=-/ Z2VVY/M#NDW'4")=:AA^[!;-?.;E38NQ=L,,#<I\F>9!X(Q
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MW1F5B=O :T.3S [,;\-NT:<3\VLC'9 86LC2[M$?=Y1VR%J7IYQ)^3D%^9)
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M,B3)EG]DP(3V>V>9CI=4C):I/NIUR#W:6#&?]R=2"F3'ZE' AYH=[[8IMH!
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M'(1*K2\F3PG(<R)K;PBI<?)B2:*>,QR(XNKQD;=I *^&U,(<=\O[M]6R9\C
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MM>NHY>+CAY,:,OC^'?'.-O,WIM%S=.%NVH\B#%A;)>&-@LH9!XPO,7F)9XR
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M3"M[]95;-XZ@6B7OEG$"]GX@3(=6O,R,&,+=Q%JA'#%A:V'R:]TO+O%26-8
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M$Y^L0GX+L;>,+&TR<S \787*4+ F,!$+T<EG($"B_A**IRH6;([JFJS&:5[
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M,:EB326P@I3K*RI0/M'I+S8*TUPRSN+0UR4 !]EH'*3([&AI79WE3!*]C0^
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MN TI4OPT!8LQ.>&--:^^KAR&5K(K@5;1L*8H*U%B!A5 +"BAA BM7*EH\"8
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M5P;C_(4^8):X!R;4O)4KRZKUA\%W >:DK%(Z=TRA?8 K8NTR7*PKIUS&O(,
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M:(908+EABF"4Z4 Y^./,T^D(9J) -WG\0T77$N#I7BI9F7XIT\0)9FK>%YN
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M+T=IO75:A]9Z]-"ASYRD?I:>"5NU)'B0&)@T(V=G@R@RH,\UW<N4V#RAWB6
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M/5UZG(D\2>R_R4,+"S<-R88]#Z)Z=X-.8R@B2"[B!$1U_.-V/075]9H88[Q
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M4X^+,@S-=9U^EVD%#K?EB(T\?]E2V-0EUCWN9YD5Z;/HV)59)F;^_K+-)"'
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MP6RT\)@Q&-5[=8<?,7_U$(S\I3/B ;5]?7K%GR0T;97O$%!0H?L0VI"U7?\
M4)@SD,?$"XRZ\2MK52JI4)F#,U$#70ZN[(TL'1OCJYFG@@:X3HR^OAO?B-Q2
M"^!T?LRJ@+=%D+TVWW^)15]!_P!@LF[AZ07N0H]TPBI9G#BG<'=W.# <5&1B
M(P$!]3#4DHOF:Y<P!H)J*I2TVNT7@OZ&KJ79&M"M-8M-1E[?B!#3 @"I1ZTR
MF'>->GC<5[(O<NX>:B[4/D9GV4TQZ.!4;R>>Z *#G!UO^^L]X_N5(XAF,!Q
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MC9!$"*7;_-DS3F!%3NQ$6T(SB73J0472)B^$FL 4!G+4S+@3UJ;P?2T0+V/
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M_<8]GB/Q[?B<<3Z3B&GOZ3ZIQ[+GU?V.L^D-0_@QZ1ZG_]H # ,!  (1 Q$
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M(,PZP_07:MV6GCH[C(@Q\_1]#[[(B _JCPU0@[DI%N#^J_!:694Z+\CS'_\
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MI.8+ZHK+W;GWXV-B *M"6F%FDU7[A)S,TB2VV,)5VT:U"<T!;Q>"]ERR4G6
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MX1H^O"MNBA3#A*?/@K1!<;TRBD?,#4%$@KZ"/U(.A'Q!(CB"!8J!\&?%8*P
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M<:S&TY'2LZ?M$[W1>+UTX(QU[/B'(7T?U*C#WVA[UJBCC[$$'._ ^H1$5-4
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M>6&LLS6T*R')=<A[RY!E=,W6X3O*Y8PI1<RY I8#7U4$TILZ"'@,]J8D\VF
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M@)$1PWF)0XR*ET5BAV5&ML2QP#=D5WR6:95C0[1!&LJ(1@LV-Y,$I"AK(&,
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M@$P<!7%Z1]4XX UM+60[")T2&1SUL0@GEBX".;A<<#@4M665@%NJZ4J&+*;
MWKS5Z&2^T<7 <&0K62*#KN5;K>0"T 2*ZNI6/5B)5++4<FI2S./(A^KN35YA
MHR#Z* S3M0EKMF7TBA3'=<JW"*R.JRP "LQJH$Y)&DJVV!$4'3:,YS3&R^92
M@DPU -"@HLI=%H&G2,#5N2T%*1:&;VJN_;N#YNB!Q[IL@XBK&L8EL9NB9%AP
M"Z(,LL- $H4!6B(6Y=.*@L[ (SH"Y1($L2"U)8A6K(SGU.#H[Q5C0 V+=P#J
MH#M>-6.UO<T&JBH+6WH ,S654768&Q3B'0A(VA(%ZSU,QX>8)38 LRH&K)@
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MEH,&;?LE&D@N5T<Q#S@B5$J*0=J7BX"JL6W2A>Z8+F1OMLZL,?;@;I,IT[4
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M=](_(Z"95HQROFA1(.S,9[;W%011+GK$"],(UY%$5K$.Y-+H#,!!M@&@CW:
M'P%@[)69@KV)Q#5!2<QFVZVSJ]678(]CD?EH!C,Z@B&C(NH"2[44;OS+6.35
M$ZBJ^L->R#21+U"M>3,38%1!"3$*, 745&(/+B#5DLIA4X5$PM';*K-JE1]O
M+6<_<%>1=QW5:G;S N$MU)G9<[*7 9H-L'D"Q7 .R;X4P2KO&XS8%M:AX<B(
M:6) _HA>9:XEYR. <H?7D70H50+=;#!DXPO2[XP-P0=I#AZC$PU# ,</<+%+
M7 $*[1^6&:J*K+E[Q8F'<Y:T.X@O7-&YS5 -MO,<R:8+0@*RXF-QN0P,)FUQ
MC<"JH$:Q LP5!D3M#$'#BREYC"I6O$"CTN/PR>&$:PCGKS"UG !%!W@B\ZBA
M!$*: MA+);=>9G@)$!R!DS'QXZ"IL-96;".66 :T[:*0X[+F=JQ8IRN!GE*;
M<Z?"'+R!S43L7B;L TZ6OO 6R0V&* MX\>F495VEPT/+XL0@1FU(6IR;77V@
M=:X:!*,U3LME"ZR,>[1?B*P=80,D+7-E-0T.2Y2H"FQ;<D4 'WRY@BN*/+"T
MU"*E*D=$!:3;$,T8+(("4E-,S919NL@7+H'!%S;Y!"%FL")0G*"1:C"8K:T2
M$+F0W./H,B$=+%L?(RD)[K;RH!Q&@T/3TT2M48^D(^#$48+6RIH+1#3BQ?X$
MVM <"!G1YWNHQ=&/(+I1R>I=F?\ >R  4^0U=0BDN^$E9;@ \4P4& 4*J-$Z
M[F-<\?<EIRH;,V:@]=Z#U( <I<BL=I92A0TEZ67$RFZ \%,#76OFHV)Y64 Q
MZ!3/6&Z6N>%4BWMY,U*KW!'I"4&LJYGB8&^X6IZ&4*N"':&A5B-N 'I"7_&2
M!K+P$=@P)<-9T:\%7:'(\04?JY#6%Y"H,LI]3 \Q><"%88Q(#Z(VM%3"'Q3#
M$ER?8&-[(ZP.&M%^+Z'"DO 4730Y13MP)UB"LI06B@UBUNNC,VXBQXP-8<BN
ME$IV-P*& ;P!UW">8(Q80!":79B9[KB86O)7.51D;0&VCC$HO-(<@(7A6(L=
MS:=!:%#&(; @5V5)=!6P[;& %  #1D&;0P>9Q26&A50Y 5.\P ,!?)19'79J
MI8?:&!-- 'E4Q&%8>86#0$V@(9YQE4:L.B6O+I#L9C.ALOL[%&(&%@X7DO7#
M&C$OU\PGRGB8-(/%'!7HL, C=MI"M<T.X=B"7PIB)AP(.%A)RC52Z0J"F/6^
MIEE=1.8@5$K!73Q8=5(B I!6@;0KOL.SB!.9VY L7DEGFXS7#])D5"7JLPXU
M( Y!@M.E%HAT@V\K%RF0-0Z:8*@(+858IT,I*PH_5)60TP#!0XP%:!1.6!+&
ME8M'QJ!;N=#:_&TA2*HV-:%K,)RYBQ4&V Y#"8+*XK4NI^%J;)IJVL9:%CP"
MAKF*%J92KOF-ME;D0-;"TNE.\SCLROI;(;#:/"C4DAVJ$Y-ROQF',\H@$ 5"
M:Q<<P57$,EG,XYCD21645>:WF)WNQX+:,SDHG$-WQ373ZO34W&E'&ME70/)>
M(C<*\C2H5W:EB<P($+>RZ_<@[U"2Z4!JD5<;.[A;&Q2P&0)5HFUESA1I@I;4
M%N8/@UP7D;K(=X<'H$@L$7VW4L0=Z7V"RB#1!@B,S62E:QW:(($XB: U1$7B
M^\NDB:DW]5,.#F'7&-DPC&$:?2*1YGM"OX(I5N)7U/)PU=N1@H8*+112@P&\
MRRU$8I6,=."<H%< PC-6D=E)N&C$L6 (L:Z3"0,U"3"E@AQB5;HW532X!Z8A
M9?H04M12\98N7:BT\Z!MM6\RR]NMRVP%%A[3"#Q#8BE2D>J&S*>EK3C"B+W2
M8;X0N$\9;+J%#0C"L>HZ2CXE:"(Q%"&#XA37A&F^QEV'HJ3!C'1+>!)V8V)H
M6;@I9R3$Q3P*2A=6P5+-:Y"P9T,H;0W D8CL<ERAWQBLJA!8*P-RZM>P)B-T
MCDBU0ZX)(ZA$(9O) =<**DZ$5JVV$-,($WE/TMY^$C,+%F5#0R!=8]RJ>  M
MB+5K6&"=CP<0)"TFA&("-UP5P-(Q5SD*_P  JX"SJ5J$A34@W5F8FTM*+0J5
MF<!)-P.VFN(90L&ULL6C@8F,41T#?HX:[ZE.$6JN.$>"<U 1MG?:\, *[C!A
M78.PJJV\QK 0!T*#RU$9%J$;PU,$E9"K ,HIQ'8Q+%C(O@,2%H EH!6X2CK*
M3*C5UJ9 F6TQT]_K Q41IHP':N&*MLX"M4+:FM^!>"8?PMZW,!G&:GC:(5#[
M:0N(PW&%V3:I7N=D!M\PS!=!O!08NS*%N8RQ6(668=.G1;N 29D^0*K9@ 6H
MS3!Q0KZT# 0YW$<*VVE')5EP7]S:+NPGTU0#!NE15U<6"E_<=Q(*HS=4B84D
M&NA>8]+B]N=P\K!@6![345AJ^?%FV%7SRH%P<X6I>W":#>!<EKA9<K10MC!*
MS317O+2%3/(K:7M*BI#5!+SFE3D(91Q\.[%P!H0V^>MR&6M(BL4B:0%.]J(
MJ6(U2.N[<!=6MOHJV=4;A0@HMZS 8FE_L#ZA ;#10N+X'3*AV*7B+J64!:E\
MRTVPPJ4PP /6N&XQDJXC- "[7%ZH-3&#FTA(-J&F#69(#O3>@%Q/+&4*"-3%
M>C78!(HN8Y7*P$90V(+4/0Q$]>):"&;:EJU+W*A*K4!;@X(K">TK*%&3((C@
M\,'*@5W5J(9:!UY,!G3,-+"#? I6<JBPWG(Z@!AXL3I'1 .S)1YQ+$^"AS:;
M2C1"#(BC!-855 )>3-* <=M)38MD-<//U*@JH50;H:EA@9)&VG%LE>T%4BA
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MNV[U+0H-,U5.6S3*(W3^(X:%((0T4@F@W@K#$FD;P$J@O'"95*-$1LWPZPB
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MXQXSB9W%:XI^>T5 M>?\@5)89P.,S,(,]H+/6B*D>GIJ?A-(.X]M_P"D^_\
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M!,L=7MB<YP>V"6XX>]<]R90YRYY^95=%/>V<9TGUY@9W,KN\X^WZF!\QG?\
M\4L^DW$.\3/E'S]_F)U=!])L]_;T4GI(D:8'YE@M"];<0&E+1LK%=[YC$#@\
M+R]^DS5S,GCK_6XW@MW/Z)9-RIG&GVG5)M\%&CX>[UE.H%L+NU*KM7>X6-#S
MW@VU0/\ 4>(L-=<(<9Y&+]7SV[R^S!6"\%_W!X,VWC'1^D792D:WW>8/9A;2
MOCBN5B_:4OC9 !L#ZQ/9[?6\/9GV]DYU*MW&BFF=/'R'YF$Y2&:.->^TWLQU
M#PPEY?W-#_[$. ZOS+PFK(ADOQ I+@S0.^8=AEVP3[C_ '$TF[&8 8A6L$I@
M(157OK[SWB@W?N= &._TB!E<9UW6UZS+FY:EC32;,;B=!?[O$<;,>C_?VF"@
MAY+UC%//?4P;KSW?'NYT@G[5-X/I\?U#2YN=5,&7+.&T+1M+.6U"LYLK[#*@
M8_[,XLU8XO\ MB7^W]RK!N4;J(0V=5J\]RN(!7B86</'5J9AR7*JRT/AC>J;
MH]+L/QB8M^&8V^XYYSU@4[)]_B8'H6$&]?P"L;E&H91;IS)/T@K2KGE$TYGW
MWG:.1,.3?O\ ,5Z]8*!N'[.):ISS\_\ (7;\):H_^5FY@5Z(N!M:8]-PZ\?3
M"=D9[KEB?"BZJ_*<](' $7@_8WW^L-D,_O\ [,Z9,OYMG728+H7]87M:)4,X
MZ,U9]OZB1"Q_4?3?^2P[5?NGK&+VZB2%ER^R%OY@H:7"7C,ZS%_U$-=W^I:N
MIA?S&?DB*"+[_MZF<M?CQTEMRX-VV]_C53P;_D*MB/<U,D[OYBH+H8Q/?AZ>
M$2EP37B*$Q/X\]I72UM#>!?U1*G>()=,!CW<6-@/S/LP7YX89BK'Y<N[Z]9A
M"4YKN]#K"*1<1]N:_?Y])W.A?ZF:6H49)KC4^^/1/@Q*)VA3TM_$L'A8F X8
MN+EK)4KQC\D7Z)T'BOK+A,:L\B=3K#@MQ]5KCOUF"!$7PX\2T]#.E/NB7YFD
MOB-\:GF;Q5;I,)6?,MEK1HXJ4^1^IFCO_4Z.6CD_J> _?,3H-7Q?;OZ,A!W/
M_"\U.LJ99(',)RJ6TZOP08R8] ;4&T86<-XXYF>P*^1^,9F,P+L<+Y%TZ06;
M:(:4;S%1N& *^M=H($4*93IXE ?@O]S)*IN514(K%U=7"K$/WFJ;B%I"."]/
M?K*F5ZJ';5ND/N!Y.W;M,6,\WV.*E'%%]KY[]:Z8U#'68;]X1\I;/-XUQ+F9
MC+>C.==YWYRC=7+>BQ*6'GQ+VKGKV^.D=:-AV5S\Q^2[.*U:_8?I*20#E?2]
MWU(Y!<$.&QARM WS\01WE0<^(9L^#F^O)Q^98BKQK^XDIZ;Z7G4V*7Y\Q&5W
MGZPJ[D7XE&J_G_)7;K5>8M).3KG+6O%RJ@]<O;$IRHB[\]HF;GY(O:@05BI?
M9HB952WK'<SXB76 >6QI\]8%*C ]:QKON&UV3/\ R4Z4;71U6WI'S5-4Y8,9
M#I#-K/8X.T-J"VPTYK&-N)10.OR^_P 1Z] K:F6X*..Q%F_MG; ]?\E"!8]9
MD93]9D43O_DI*'7^D,J]7C%0%VS+.AAE/,3LL1TH$6_ _<D%O@<-W74JHJD@
MTJ]/[E@@0X5=([\.DKM(*MU"^=](T1=UO\A,!Y6+ZU,CJUJMH/>5JU,&X]\=
M'I6?3:F2#B:TE#2,]96L9Z2LR&=5$Z7%D*UW\2I4H&WXKM-@JRF!&'L WWUS
M"C6@-8 >^SQJ( %+JNU]8E%N7M6'Y9MSW\1Y+D'H9\2_X>9W].(J;/&7%M3/
MI^T V7=U.%^KT85(T>57;58T.N)7J..,T]8KDN$B!9>&.-P."MQYP])K=/![
MYE ./-5LCH]#9':NQFN []);):*O-E%<'OO&:\1KIC^O3E8W1Z]#O$1]\P,G
M<6GCWWBX&#^7O'KQ!E_M.:Z#K#@(K:?GGI#3+&+FH/4]O:70-Y_':9Z9O]09
MD T+.8@6PRJOIDJCE=#'?@/"Y?Z6>F!"^5/')Q #5LN.+=7B.<!Z#^.H(Y"[
MBK+'C;[4]YSL/5[=YJ*6[>Z0.@8.XI^H5>HJ6B&CK*)KC^O,KZK7OF#8$P<*
M5^.TJS2#V;IW7>8X08&T(E"Q?[\0>TGL/HYC<5CH^X,02\KU62= Z<W*A 4Z
M+P'3MUC55(!G5]X"1@76ASQTB(/ ._1.TUJ30\5U><8(/5Z\Q/,:?'_82XJ0
M1H.?^S+/6 0M$\?_ -BC&FGW)5B&N-?N/18_\C*V_M!Q L/QV[16XFG\>(09
M8LANYTE>W .:R[\-0@X I787%<PH*F59Y8V]'65H+\']$4C);^80'F/I]8:S
M!9"^8,QQN7+?B#!8ZH#%L<"+DO<:!O R2(2;#IV[2Y'(GU#M#66;8O67EA3\
MQBFWOP2\720+B[?$EZDS7[_4\,CSI_Q+FYJ7,R[B^)Y9^(]O09>^D=5&3RS9
MW[92S>_QVCJG%^..IZ&,(+9[M'-+-M\Q"S%5S!HE&1'50A>S&&BM-+A' *:-
M5@-U;@Y6)VOR>AVBA%FWU^ZK!@<>7^Y4'8#X*Z?M\Q0F"\8_8PJB_P""#8G!
MZF:.@=(;E#=;=^&!0N\]'XN6Y]6U]DJ#@1<M'-IBJU7,NJ=V/QXG,@R9>CU(
M%@;>;,&F^1Y/&;BMIS!LI_Z(9S,<O?O,N-)KSU_;6OM"BVMV0RLTML.$ZQWE
M8(!G00T+/1KF'*$-Y5S>BMCI&X AH5D'1P0#?GU>_$2=SO%'3ZPZJ7W;V[_J
M E:!T<4GS8?O$,+PQP=?&_W"CD'QXT>)G2)H;P8657Y@<@T'=\$0P_D_FHEF
M(Y;WS7VE44\W\9CG+A2Q6'-G7?6#[(,)4!SE6DJW'+%$@UU\_IYE4P?,$HG+
M XKL:^*B_P!013>FK!BS 0_5H#=AE&]DXP<!&:-=Z&\+%[6#6A+;=O.&PA[6
MS0-E<"9UH^;_ #*K*4^KXE=;IO73I\Q8K7Y>$TV/ _D]_A.Y$=. =IE4_*?C
MYF3[?'_)NX4UVZ2D:G-KST3]2[H,\G3I7665G9G^KEE4T3Z@L=/&(O!?3X#R
M;=Y14T<'./F$C<_)^$@%&GU_-RS0K@0:ZX4&R^R[,A!K@A:14Y4PNGS&F'"5
MWBI4J*N%:-Q[4JX4X;I1ZMP-(+N>>>(E&ROUG@_R"9.6_P"_ZAL^B\&K@,B5
M+OF;$ G";E^/ZA(]BX1S^Q^Y2AW[[2I$'OM&@7$M(\,&;'A\QVU7.!X.7,)D
MO25)4\IUZ,1:@K:_E8S<AST[U9=;JYG7+FT>ET6&':(7R[*0J*6;)PV6VPW6
MZ-+5;ZHK8"^_3K$V\^V&TQ,T>DRX(A$=15"637HHE00M?01LO9"H,E<O4[QB
M877G<'.YU>LXQGN\P%WA?X?1$)3"0CDK%&=&8/@H*FZ'KP^$<4X?,%$SES_;
M &RV4BW*$JX!2T@_6)>T7U3J=X18..W0/PS [8Z!HN_HB;.KJ%8.B+8'@-^\
M1 /+C';VS"EU^BF!<'/>4Y$*U!8>8\9[G6/AA!^?(<G$8>%^_P Q*F:/P0'0
M!,0/$OGKWY@3,<K79:N[)HB-M1H*I=JS!=QM;[HR/A\^>K+/I<)>R_\ D7 X
MF9^/HD#K7/W,:]ZE(=:.-@\=3]P(ET=PJG$@)S^./\CHXV'YOJRUAHX.A%Z(
MTP<+L1*09?E[PB[?Z#U_'UCAV5.>%[IQ! WDAVA8?KQ!I72(SG/[I .MR_3/
M7M&RK'5>7?O&XG;\O9 M7)>?[8'2U?\ 4 !U[[QN:(J01%S=_J?7_P"NT4 7
M\=^T KBOM]D)F::ZZH[1YG9GZ'6^L6B-=NOB6X,\!R+VZ1K0,]/'>8_"P_=P
M.A$3):_UU>D#M\_L\QRK@]ZEE7?]RY3A!I,.0F:&I2HA6-T-MA#'/T2I.3?=
M@F,7NR[CD&FG[C^W2+T9M]7S*8ES[W<O6T8B8=YR<2CX(0+Z1MW$8KO^X(HE
M:-H#70_J+"!F-3%+]_6&+;:^WF93NY6WK_'9+$>_Q,SS S!"/CF7C&-/-0N
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M,@4"J!:"YVZ-Q#O27T-= ^955Q;\N)80H5\Z@K;62]\S&.AY[^1U_P!ACR"
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9_<^J>V=?=VA'L-3W'H()]A'<Z>?$?1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2132809d4-ph_disease4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-ph_disease4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X )D%D
M;V)E &3      0, %00#!@H-  !XD0 !&2,  9LG  )OFO_; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\( $0@!E ,V P$1
M  (1 0,1 ?_$ 20   $#!0$!               " P8!! 4'" D* 0$  04!
M 0               0(#! 4&!P@0   & 0($! 4$ @,  @,    ! @,$!081
M$A A$P<@,#$B0%!!,A0C%18(,R5")"9@%T,T-1$  @$"! ,$!@0)!@T"!@$%
M 0(#$00 (1(%,2(305$4!F%Q@3)"(Y%2,Q40(#"AL6)R0R1 \,&"4P=0T>'Q
MDJ*R8W.C-*06DR72@[-$5)1D8,+#="82  $"! 0$! 0% @8# 0     !$1 A
M,0(@,% 206$B T#P43)Q@:$38+'!T6*10G#A\5(C!'(S%$,3 0 " @$"! 8#
M 0$!      $ $2$Q05%A$/!Q@2"1H;'!T3! X?%08/_:  P# 0 "$0,1   !
M]_              !-$PC#RM74;67SB;)S]7?U45B:E4TA6H
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M!-J6Z&%P,KEGG^S@N9M-U9./AK.Z\QMG%Q=LX?6=9.\G$]3MCX[N6_H;JNH
M           &YAJ3=),PU"M%3<PE!1-M52D0E$H7K\[PG\P^@-4\_P"@Y3&G
M(6&2Q[60QXNK>5B<J,)FQC;],2V6%OSJO(/<#O\ QQ^LVAF80BD31-I-*!-N
MEN*6U24,)M)II$)FI$$1*:H;2DMZ2)EN)[$SK@           U:-XU1-4%Y[
M=\F:_NKO>6(!F9O..1E<C=+K^P-4]".7K\A<KK>M]KYWZL7O.LF$J@
M     W,-2;I)F&BENI,PA!0MZH2)3;VY\8?,_<>4^)]DS.)=SV!7?6)O+9RW
M3D,<Q<JP&?1']A3"-OCZ^VW/>D7;>)^I'8<!;VK*$(F!4B%G-*1-%+=-+:4P
MMTL(;F$S+<$Q**B"D3;P1,-Q/8>==           &;:WP)P.LSM?ZCH>.W9X
MO<[&);W'U)N['F[M^<]6N.V2]?M. M_;S^5SWTEZS@8?BMH95MQ
M   W,-2;I"$#5-29A-,%"WKA"$JN<.:Z+PB\J^F=C<_U,LU-R]L6[BTRV'5E
M\*&;E%C?O1S:6H]L8AFXQ]>[K717>\+]&7H/@4US]0A6A;2N(56LTH0FB&Z:
M6TI&$VT0B81-3=*LPW)M-(FW0W$MS/8F;<          (4&+<P+G.AY%UGI&
M)SL'$457F[R=8;K'\Q>NY7*8V-ZS\5UL#Q]KYJ]CR_/6XYOZ8>,T^C--LO1S
M::2_J@    *  0) ! *"9AJ3<*3":9;IE%4(B$6S-<4&ZI\@_-?8>,//_?\
M9G-9LTT=#5<2C2W5L>XH,5V\9EW\%L46VT1+;XT'W&/KK;<KZD=_X1Z,])P#
M*^F:"+B55I-"!-%+5-*$H&4VJ*(1-35(F&YE,$IMD(@W-78F;<
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MH;].JM/Z#K+SWU&[[K7\+==IO-_JN"WAS^YV+Q'1;^\UZ3UD[?RKI?K./7(
M     +>(JBLR@;B;I"HD"J&),TFA-,I0B82,Q":)LKEN$X&P^=GR;Z6S//\
MINT>5W&6PZI7I<==6OQ^3&%SZ+>[;Q&93ALR]&=I$+V?-[ WWFWO3Z7X0]E8
M[,RA;I$I56TPTA--#40#<RW0:3:U&ZB*84EJD@;B6!"&T]AYUT
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MM3%%I,5T5VDPA":*6Z:6TIB;>5L4B$5&X W)$2DMQJ)2GL/.N
M! DS$1RJ_P %T[[/48>\K-G'R@.3=YRC([MM:[>E>$[735-0      &J8USH
M=EROYIW\US,+=7;<E(M_BM3.:8]_D6ES*YI0E,4I2W3+:$HLQ,0X-3*$MB:;
MB*Z+/'O<J<_U?+.HZ/5-G;O18V=M>>ZNVO,=(;3GD7+:5=O$6\2W3<9FFD6Z
M4W$17:54IJA-%+=-+:4Q+$Q:B1,RW$50S-380MQL;5=B9MP
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MV=)V[>L8,'2\PA+:>PLVYY_(QDMP0C),)C5T3*B6RL8=9I   &*:N/?)_4M
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MHLPTQBHFU)0=I)R("3C6QT?B#LO6.>NQX^%9.L]']%Q_OMR]KCKC?8]FV<3
M])AZDR:.0.@QN+-GK<7J-QFN:VO7V/M>TK_)>BFT\[N)IL:)A==GCWJ^:T-F
MW87Y)] ]\]UXO=Q.A_"O4L9Y=Z5-*]9+K^')<C%RE5@1:8Z.W[VO]C@1RO/@
ME^G7^'T^-TN_PF;M/1GVGP+I+I>-PM$W]W6Y/(A('GKQ/?\ E?YC](TKZ#=7
M$Q/^9N9O5U9/"G"[2C"[&N/;6G#YU-AD6]9=+K==;CFHKF<;[L>A^+].;OGF
MIG KD,D]##3,SB.2Z*>A*:;FY7=S.+ED2&VDM1'5%ZG'F(+PO"V):=C9MU*
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MA;(1,IDU$@W)!2)MBW0T=E9MX             "B$JF:K2XE5%:H*K
M  (H::Y'>Q_"OR#>N4."]6T/Y]U\=TVP9MVV+F1<W<3?_8<UT_Z3Y%O/L^1R
MV1 H;B442E#<Q:PM47PQ,H2VEN%$%N<?17J76[#5.-G/U9&W(UT^V^I;RK):
MMVR;6)3$IFXS-!%M U*W5)2BB&Z:4I0,)MHA*43#::#<D%(,%J-P[)SKP
M         $"3,1I_$VG/^)O)=<Q>@<G1S#)Q'%545F:@     %$6F/7R?YIV
MN=HHE/H7-YJSDZ^U6_BF#L+S-;BVG*3_ '>EO5%Q2:N4)2BDW34A#4PV6!>P
M9DF#55QFFG 6,GRWYKKO.WG^QUSK^OE>'TDDPLBZBKH"YH>U>Q\B[D[7S1W*
ML64T4LY+<FU(MMS*$VJ4I3;I;BEM*1A-J@B&ZI1!"4S#2:Q-O"UF&X=DYUX
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M5L3#40FFEBF$I(6TK42A$RW2H4F&55(6Z;>8;B.O<Z]&$2@J1PE0M(
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M2\I96JU;?TT2R,+"38O+M5BHE$5[[L;EO9V=:YF)[Y:.)+J,WU%W&BRTP
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MJ6Y9MD8-7.$8N9P<,S-Q5,*HHWZCL3-N\^&=)&1U+QA4;U-=$*,Z8<GY.TJ
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M#!IB9UM%<@5189)72AM*_KBDL,HB\)]-=VG%VSZ(VGIT5-JV@E+4.Q,ZZ
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M2;FF 13!%4)5W$L_!FA!*4DF<:C:RW,E*2LRQ$ S,MI(BWBIN:41/8>==
M        $'G-G9O@-U71=/Z_'])>6T&G+<:8BU),;?<S.LP=%[FW+P-D7;O:
M&?RGT!X6ED,6U2$@       4 J "1FJ$1"8(@BFIM")@&(A"$JJ5+>NCC'D.
MD\0>&]@M\7KI1A]!D;.3FL27J+N$R\7#Y.LP-_G9AL>:]LO1/&]][S16].3;
MT4M*10*[9+<D%M1-*21J*K6;+:D@W,LQ),(DTD@Q$MS#:KL/-N
M  ".6;F9XM;/K<5K[_K?B<W!8QLM+15.]\K:M[LK2QZ\7>;]#=SR]ZD
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M$"IKJMLW2(^H6J9#()Q)C7GS\)\'C<(B+@?@-.H4PVXG(.S.#7@G?UR,@_\
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MB77NPXLU#M6U(K%8^WD^/=P9\V-"[>8E<VB,3[&53#K:207PI^ ^!@P?$P?
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MHY#VCVCVCVCVCVCVCVCVCVCVCVCV#VCVCVCVCV#_V@ ( 0,  04"^'3'4H'
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MG[/_ ,JO77PG\AJ"W-H]B=XD'R<>VFZ_J'?<&V2,-H)(69!LS,.)$8M)+:M
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M$_<;1S8/;4W*LE&6@S&VB28Y:8]U<N<7N-J++0GY$TF.TX[D1[.(_"#6F_\
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MR!H.S'C)0_36Y@>HX59CG]*XMYY]R\-,\*&1+C4O,BA6 Y<ZTQ;[W">NB[U
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MKXXTZPYF(3A356NAJFE%/?@Q0V[3S*55V>A1)%Y2I?5H*Y98C><"U7[*L4%
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M!XK3N.([BVL8HI8C6-EU<I[P*TKA&O;2*9TR62E'IW:AG3"VUM!%! HH(HU
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M)8KT7LL+S!6M3]E&"2Q'"F6+?=]GOY/NZWE9KO;XE,0-Q^\>.H#"OQ1\,?\
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MO@[;BMC;9-_\R3F">P#"QV5M'$ /?TAY"WUC*U78^O!/:?4#]-2<?TUK^DG
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M7.GB5SFA450$/Q!;LQY<LM<-T;&=!.KGJO %MV<3S2#5ID#K6I[\);>-4,P
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MDEM3M=O&+F(-SQ:U0.-=<>9+';_-"VFP^9[JXN[RW^[X7W",O)(ZVRWC+2&
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MZ\/LV]V[R6-]9-<MU98RPZ4<R/E45:F-ZLH-LLMFEMO.VWV_F-(KLW>Q=2Z
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M[U.E"",S(ZY9<:J#A+RX'\;N3>*GU4U+"U.A'Q^%..!^C%<^8_C^*L(T^_\
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MWIP/]FWY#ACLP'8%;5?>DI[]/A&%C1=*J  OJ[?R3?LMCS&>)^_-SKZ_%/\
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M&\+F(C*Z^A?C'W03WG9EM?J-IZ[!%#^)J\HH %BYR2#R5O=2G 8 F!;5KE@
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MLV=/B"M>W,<-ID35IGL7B)W 7B-]G49EU7N#!W@4%R2^V"N:Z1VVV& 8W?:
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MI(]E>^_7O;AOM3EE]0(.\;/6RT-L?-:=86KO?%?RB( /K$?$8AT'6X2/@V<
MID6RI9-&;SM!2+LZ'+8!TX.3<6G.#7ULC/N%A\Z9%1&[\(BIG49KEW422P]J
MEV3!:N$5IF%V',[9(EH42N:Q,,BA!:[K+(RMU=5B%G 5.8 VPHY9"BJVS$]/
M?SO^/%?)>5'Y+8(JN&[@Y +,:3Z3TU%LR'6=8ZCF[Y%/QXW7CKXF<?$BY P1
M-G6#&@#EA6_-%!>V*4:NY<XF!L[XWH[0:[0^GMNH&PBE,!PHJ*TL-^EUU83*
M.!T*]'G$MR^(U3WW,1O^IV>8%AP,K/GFXX+;IGY"(PJVRP%6V\P2-=*KK"='
MA)'F5827,!56"UM(IJ!*SV'C)Z3E],:IDEH&+IFDR*[U[=)26QM\<);N469$
M*N"J &T:CQCDM7;+F2*PYE516E =K(DZF(@R$"PN43KU2BT#-C68>RZN,"4T
MY[;LF !J4.II@V3[T&K0 B_=D!Q0-K.JZJE0BP%S$M*"%N'#;7ZLF(UD)[I(
M(W6TD5"EFN2-6%HM(:L4M9J[_P#%493A8<B^NO:5&E>%G,+&FPIJ9JJ*7FLD
MRT)Q.U-)P\*7J@R<">]--T/@,@(FMLO$Q" C'V=@K$%#TBZ$V;5J&-*EV@-<
M& N<^]9TM:^7S?Y4 +V/D'O$47J-*W7-C_B()HBI[LM]MPHV6A8>F;]1#\]E
MWH+47L^['RN*D^YE32IR;?U+!SJ:E]0J?I+>I3[:E66-J!=HU=IS+0J$KDLN
MQWCI$:[+=R(.Z EH5KVQ;92"[P6P([M -:X='\A9O)[2_:>E]?W/2^O[BN&>
M?]'@,>#%HF6&/@J(8*9PR@\M&+[2DC8(H)2U1>D<R,*"L?(EPB.%0JN^1E,F
MIS!I%2V"X0#9QEG87&N\<&COEY7Q])1>J*/6^83[ -?4& ZL0;7!4RJZD*?3
M*E2@FT&/+[ ,MO<4I&.L6Y2C/O031MYV@F"[P]PI1LM-&7+V@::*LK.HU;W)
MEJ=NBWM%T&,/MS*!GC+70^<8&9!BV%IK$QUX+7C6/58V9G07<B4? 0B6W@M+
M>@*R&@(4 K $LT9;5CY<.#JW!%")46&YDV1*8NQ-%6>4]ZMH!,VP)(*EH0&8
M#LDB"(=)">32:25N=T 9AUQ"-ET]' D!Z D<F'% JZ*;K?O'72-[8]K.]U<'
MI&M&@53>DQQ!AI QLJ4(.;:B_,6OVSMD6:2UX*3BWVC\X<P+;E*FQX"41.W1
M?(&+ (\\;-I0)D$8;?;>K$S("P]/"MO,D^J'":7@2,(7#!P.DJ!7FNI"[YBP
M@Q@!W8^))7HK_9D=*06V<WB)HT%Q>.E&*@P=D7#-1QG3&N"LOX+4U"?Z'0A+
M@&F:%X0+*F)AM!LFIJM1*1=L*V]!(M$;MHHVK\Y8#6:BRIWX#-ZSJ.C68:X]
MB -M4/: +DK9C%][,Y38\0)Q3%\%M76!P[J L-%P3KT([3&MGN%3H2IIZ_P+
M6.C(._#QR[ U&2*VCV7*!9,KK93\O@OCQQP5^D%D(^^ 9FS+O_QQ&>59*]+;
MC-81P1\=V<UVCM[QA74Y<9$ZIZ]@Q=,GO.A"PHGYA<(@F (6E]L"F:@2TR!T
MQLOAJ8YU>A*/7$(LO]S.8F[P\P8+VL;<I-X8PS:"[$;N6.O34%^WC.76@VK5
M(*;;J-:P6VPJB:"+6N]0<LIB7+L%5I<WE8RGO,7N#H?)WD7'%XO[G':I]2_F
M$_,1C!0" 83IQU8KU;0@D! !8H;0*C@.#7&:CQ\$5I-H90P@5C .)@XT>.BL
M<%T<3("IH+NG@S17%:Q 06U16R<R:?*!34HG\W@P8>4IL,2O-K<VR27!D=BA
MT!;%JMA1+H#,V:JI Q7)J>.?,YW*IK2NY*V,K:!A)EK+60K:]D$;R@"MTF:G
M&<'J04B!9"PV+WC:XT5B1EXHOB+HSR\1<T/K/I2B$*B@+A*&QQF6-[BC0N>N
M%#"96>.89+C>W=YFUD;WF3X6Q9<Q*_F(,#NNNL;?MA \=(T!>(9@ZGF&,2S5
M(X2MD7'=AH*J-:+T:G'#D8&);X#I;(V',^C O $4@-G?0&H*2)<<"9H"45;-
M$DX*.<5G;+2VV:Q?IZ>-_;F9N!:@TTYIF*0*F\]%HU&&#8U-\S=6.IT$8%HA
M2HU"3%@'75_1-IQ;]XOBBCN:\Y7V]U=KUF?AR^6V7OA&$4*O$:KXE!FY1NAS
M"D+><VX5^VK),FD$06J%', 5C^ AB0)G)5KA(B;DFK"KHP5>^DTA5\UG/)[,
MZWF^'->G2#E7,?@QG#/:<T'R$2_%JRRR'J0/5.E.%?/&:PCQ'QV9R1[6\'=P
M17CECV.O02LNE1EK15*8VU" )L4$"[B.FH_0#:,!0JL$RXR<&KRXQQF&*IM"
M:+0>1YAD&<584ML:@!T0*PZ4*F'7TH=1\GM+J2 091:*8  :BJ>6RHZ3!#Q;
M]HR</68IOVUV,NX#;W!55K8<Q28&BOQH8@"M93T<%]=3Z2ZZU;COB6+K9# R
MA;NUI,RI!EHO1PD#?,J)%, X1O%0JI!_D4R%E2JUY<1PK):;G6)992TKG0E9
M%%$+1S%/)=@[O.WH ;CK!@N:\)NIVZC?DHQG+',"G-QO3:S=7["^-=5%,VNB
MJW69:N.MNJ=LS*EI'+?U4.#A( 27&.X(3PU-M=I=@1='FT2UM\P9"V47>?\
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M3ZV<QR QLE=.L!+ =V_Q'\Q?I3%J=8^82^"-):XS>B'4(YKSJLZ*VZE"RFC
MI*UDNIL!HLP0JX4-"]<0<!)!1E,KU&#=;92+J0.PM7E[(M+T+9[#I8MG(MHG
M;>:ZEM=)<+;P]<.0\&,FQEOZ1K>T'*[ I9* L1IJ-%4#UZZXX<2Y="KKLM&G
MC:!N3.S9?!N^I6X,@VC>Y-L@S%&^?\KZD I"J5Q@MVT85E!C%9,VF\M^Z58+
M);+-7EJXZOG;^CIZ(KGL&9[!'!0/((=6L@9S C#!L<S1 :5"GD'. .WRX.J;
MDQF:FU<%*R]5#5\L,&\KSM?/PB\MM;J_G'M@I@K:WZ1T2=+*.Q9;U7;%=*(
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M],S-UW\X2Y=K39?68*"O(8Y#BG$T8A3--;PRB35M&^6_6 Z.H>K.>&M2Z"-
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M]4\2:1A_ %N\#8E^N:X#V_4;7=](P[E^\8QOSTC-P7OT?;M!7^"/';_Q=;C
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M/$LCSM@RC*=GV\&U1NI690-H*V0;-(,N)=A=I90!$&)E$@<M4_P$G'POA?\
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M(Y S'=5P"U0PM%7J_J%33'1]H( 7AO;Z<1\,HJ,,OU>6HL3DXXC\G/PFGZ^
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M E=,['W1H[S0.9:G2"N#$M1:2KNFLQA<#W/X&4PU*2R4C<I_MOVIE4$-M?\
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MB4A+8Q&8[CRWO661G!N-0Y"+E4&N)"M_LA*/G<3!4O09N;_/+_9?@TEO3_L
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MR7+/Y*X2SF-4I;]E$_#*,X!\O6-:<>T$[G4@X>",RGL(9G>J?:6&MT7Z=;3
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MI(QX!\+OX#X>)S_%OPO^)2D=IS!;^Z=?!-IT0^'G<53&5Q&9ASN 11QP_J7
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MM3D& EK*5SF#6?-_E@AG448:BOX!_# T"A!2A^Y>5:EWB4->%G'@L8@9J;B
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M5/AUE2^#/>9!MED6WI%+XD.D76-1S-Z!Q"/,EB?Q6? I*> G\EO1!IYW$CR
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MG/\ \)CQ85X8F/''ACPQ&IB'3"IB8^#O5.C&JS_6YCZ'_]H # ,!  (1 Q$
M !           !4DOM8         #'ZV*Y3PYBP0_9RN1#^7<Y(F^W@
M   !18WOA^@         8G?_ /8),K1MBMMV;%)F&)*"7KR         6S49
MZ,^          UHZY'6,5_L?*OFMG)J8!OJY-8P         4/9::O\ *
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M=/SKY\ !&B]ZK\6ZRCU$K-D:T,X4 \YK2Q2?=NAR_?!9[3MP"NN-")!^_@
M9YI\NA!.;;KD1(_ZO\&CV:VJOJ$+W:<=+:SYR2X 6!H4U$AXJ     ,[#;B@
M^=L?NLL%C>;P[71/U3-/J<F@        ".L=G3H#@    !:X^#-EZD[E@;)6
M#$.F0H8'#:T2OR4        !1;OO3_U0    !=S,/)@]<BC6!QK8UF0S6;Q2
M$CF)]0P        'KI2-#UP     $>9)D(-KHM6$W+304>O)T('%9C;?YD
M       @-\\*,Z     $VO-8.4$H.XC4TV^O_&;M- \J\*U52
M/%?8      )D8YX>0L2;.C6)-V@+*X@S47$(<X^>8          !'J!
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MHX        'W(N/$ F #^O.95>&:N=)X6RCWON=?GCC>7D/RN4F%B
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M<0YP        $6\@[&BD    !XS*.(4T#V\DL[Z'KSOGSVX'7O\ 0TMK@
M     *UK)_TY@     4 Y$2T-EC-^^[U];@:O1NLT(29]K]=-_L     "X><
M&R"B\    #J;]C6JLHG>JVL<SG;F+B=1?;H#WI-UA*     #:E@\5XK.@
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MBD]3U4>2    !"&SAJQK-;U:\"^=BD;8$4RZZ[2_S?P        ^K[9CQJ-
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M(0"(KVCS*O:G(PJ40,*QS[)'R.'<L6D&J<RK W$U6  M>#< #%4B*;%0"G+
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MT@46@ TWJ]0):NL+1UW;AL"H9 :'5\PO=;>D[5IB>MJSG'7%ZA:A5'0;J6@
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M>KMS9Z0B  WE=AS%@XD#.J>B!4!8J:;O';,M7%-S:7FHH;>A BZ5&*8J63
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MG4 )SM^C7U(Z^OX7^FW<H;3YS,TV?MJ98.C(7>:.:F*8<._IY+9 " CJ+(C
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MT?-&ZC86F@<0-RP6RH?*]?>'XRP\AR':4%RF@*A;7-P"%L%*WE79J&JB(Z5
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M<BK3.Q#2"$_5:NA-#7FAKGHY/CMF(JQ&65;Y%2+&'[764,+V(/A>=U M HP
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M*WI7)%6E.1)@%PRKNJNU0(\W9"H0I(CK%ZB#+4M4 5$8$2.(67,:A2YUOFH
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MI5O$4S"%4ZZX]-A O-P8]7O4T&\1T@PHK< 1WG.K.(%2W.A>^_EMP6)D[88
M6P;"D"H$MP72P%KI 01;H57UXS"46GL?;7,[7U?W$B.;"=2RHAM(T+Q@-I=W
M,:"J@LN#Z7RN:%.>E)PL3Q&T(BAA@G "D.'!(%,M-LOAZ10-3'5"44S0#+^8
M*@EV@D+!T5'/4F%:81$6ZZ!!4:%H&F#2SA?LV.X,.9%^/DGHB6P=8%S7H?:
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M<8H0R%/=-R^]9&J4=ULKS#]T !49!U6F(HN^ULJ%4<XE;9F("IB-89ES7/N
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M8ALL(<%2+_,=:ZEMMW7;J-%7D)@.8NX73(<A5+P5VMC-YK@SI*+EUN[B/KM
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MK>\;T<7&=VB6>.F(0J[8<->!O5< 8>W,JK87$DTG*FJL9$D(T+@XRU+21LN
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M&S2SO_3->\=>.GAM-TW\69:VV#W_ .1B5E5^?Z@VEO[AV]8B<2M]IQSA?"U
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M_*8JI72;IS<#!V2BI9=SUNYJ8^"L^T/ PV3%S%>!00J6U1J'>8A#7P*;<0(
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M#*0:YOI^X,40Q2?:,[899SX:0Z0*S&%.8^%\3U\<0%G4>"$.A9.THQK[/XG
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M#(PDGR]IU2HX.A U='T_!**Z_P B_OQ^&=&ARFVJW !6XO8]'J]8 XWV\\^
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M*Z:E',KB5.Y*+\^>\XE7Z^-R\4RY<OY_R)I5^?W%K5W[L3%&KXK'?/VB4H'
MWUL/8-L6K875<'0^\-EI7/;K<H-SL>GT@D [%9Q ?$:896L->TL%F]FNGHP1
M0KGB4&OAZW^EP'*R<^G^GS@WEX=JSN758L9@)V5X"Z2[@Q;9RW+\P%.\@^[.
M0(NC.;Z2X@.N3Q%]D7HV*^Y&2L\\WM'HH@TBM9J5FXLW>YW)O."$K2,(R4AF
M@[FO^RNPMU?*.CU_V!U34XQA;1@:9K&,0A?WQDM_ *VSZ108/CI@_4K)H:@'
M!N<C;'QI25I41$JIX\YE FG)XJ+6*%;ZRFV8:B2I#G_-)$P1F@P'< N[Z#</
MI0( H0I0TEA+N#@/W!HMXBGIY^<JM@T?)OZV>T#%5?7O.($?K*=LL^4XHEYA
MMP7B= J*J.&=SP^Y EK4[#7AS',L]X>!N6?TP><W/[@FWW?L1I1H5?<T:O+'
M6(E=?7V^D)EVL%XU'"FXLZ&!.DH"M_\ .TL,H%]<KO$I4X\]I@EVUUZDN%/)
MW=H%"*5^OU@TZ /IK;+SXC4H*EY.!/QV8A.(V8&.AN%-1)J]+]B#<-<#]?2,
MNQTZ#\0U1K_)F&CT@ +@?K"Z-P, M=?Y-J:SYXN(-#T7CZ0 $*\G8X+T]Z>2
M-%0^B?O[>LNS1X.@W:G%Z.:SI%VO/G\00;P-]SN0-J0Z<!U>CS,9E?."I6?$
M>(\T0S0ZR9UK)PLZRL 4\ 5!ZN,]:O&Y>' Z;EQ5AXI(LQA691*R5'V]X^[0
M$/0V/K!.E8S&_<Q %#3 "S,4 HXJM80"\#HZ7#9NL?.4[RSPOO\ >+T$-RHE
MSUE?*>L=Y\ 5ELR.93*69 LI>\;MZ1&;PRF$9Q[R_P"G=$I^*L\GTSYQ*$M<
M*,!\Z'G-QL8J]0OC/./E* %X; Z<NI:I5Z9^TI\GGI4YV% 0(,]3]L"XI7IK
MHRWA7Q;\,HBE=O6".R_+\'26RU%/A0=Q*$',R+==0E5>C=U&)';1:\R\%2]0
M@P5L'.$2?767\Y5D%]...KCZRGJU5ZO'6Y@^D;$WT[/\>+*>\1EE+LK7H_1>
M>T " UIZ8X?)!* .>WV@%LQTSQZ@/7DZ2C045K:^N/3BL8""1Z.L/\#JOMF/
M 3BKNC !=X"@(E9>8]L[A0H.\S[#?'34;*8*<_E97::U-;@^-7%J(I_U^/\
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MPTW+;/J$N!18.!C8\UN8(2$ M]!_$W^9+=U\F"0;#&$\J\WX%Y-PCF!G$5^
MW[(%1AJ$Y\#X%*C#O*_J*&X"JH8P^K_(EOR_R&UMN8+B9-SOX\]XC6):9K'3
M_8;5E[0M+/2NN-\2_-A](78YAG^/%:BP,6.>1Z)UFP<=^?4.I\H (2]1F;6A
M3DX>WI *L"JJ!X&#PNV;0U%WXXYE=-1.)=8BX&FXT=/BZZ=GKG&O66.IA>5
M6UT=(ZHL][3F4"AM0>@<LMU'D8 X#-7RWGM&2\F!]_)#(K<ACOJM_:)5"Q'J
M#5E!AA9H.7OWE HG2\1^H+3R/3!+5D.+;/G^)L*G(7AQ=."[F3/3OD=NGU[3
M!RS=_P"?[#<VU#=Q@>.WMX,XE?B+\%^"%189CK^IH2[!+UAG<HQ#W+$88$Q-
M1VG=H'&'QE?V9;$EHKB#6/Y,+](OK=W]8ARGK^XF(%?[WB81M/UX&HZ\!J.Z
M31"<Q:ES?@QHVE/RG;.OR0WINE0+M*7" F]KJ.E30P[Y;B6[P(^ +W8X^4%K
M!2^;;/ITD\:Y3HZY^T2505WQ$ATC<Z>#R7UETG$NK=4'G@QQ%J['3G9V8M9!
MH^N_UI]N8RZ^ PW-> Z3GPT>.R>7M._@:\;IEXBPW'7@%Q,7*XYCVE8[RC^1
M:8Q/?DCN0FUNY;0EU+R0*YEJH=2J966=H@5IB$"F\_9@S1PUKT[0;' Y[\;@
M%Q%J.[?QZ)VBI@8ANU9W&<?SYN'-0SX:1UXZ1AX/AQWF3P(C2MJI7MFYBJ>8
M):G,+A@L\WUC+P+%#:N<YA8BN>>HZ5$I,CE]Y41;.Z?;4RM(7;N=HT3%FZ,G
MGI!2=&\X_.)=D0+H"-8K+>L51 !I6W+09I4L.:'1<7HS"5GHQKH,2PR<W[P@
MCR/>!:NX;1JINF-<ZA0U'?>:]8I:RK@>97F8MLKWGK42G%RE3U)@NY9>9;EC
M.8^'VA1CF<5N5Y\^?M!=SC^1W,#+LXB4K@X5D@!F5,UEIECK-WFYU@QKJ)^8
MQ*Y3]I=<%K_(9;[[]8[;FC['\?-[1W\"N#7@/'A5,"X:C-=X>%7X:.K]S$\/
M^,-NI@MSFW/6.VEU!@V.5M<;P]^D4M,57V''I4,AU@SWRLLKY:.B\5S]94$N
M)CTEE9[ER'JYWYJ)_P CH47:;?*5"Z3#++X@D%?,%"'//K"CM"G;D@VKJB+^
MR0-C;<N.&JU5QP8E/4\KV]-?.($,-2='I[[.T5V9.7P1D^OW8D&IE,ZCA'$P
M0NI8[,0YJ<.OGS]^)69Y\_Y$OT\_J-7F7GM'3T_<X\^2&6N&7F<Q\#+-'I'!
M<U"K\*E3C&YB8F)5_ @W*+ENG:X[%:U\OW&[)'"OK<) ,?\ )2XW &H%J4:E
M( -]()L9@RZV?;,2LJ>I!!DQ[=*E&'&]WPOZ@)]/\'%^&( 7U/%7RAN9;A+#
M@FVJ5!YELN;1+3=D3OU@:>',88!JU'/@+@]6-AZ05_,(451!ODK[&(B)MY6N
MD0JPK\,MVG%NO!]9UVK\1;4*K/2/;!9X!H*X[3&Q:0X.<-=$C7D#0]P^;Z2X
MN:.5X -@BXE<[C"L\]80)IK'I*;9R]WA?L0355N.TRCSJ;7K+"6?*5\]3B8/
M#>9J4$04(]N%5?7PQX=24OI*,1(LW-[E<3TW.W6>DS7GSJ SLS =IAN<8F=3
M,:]I2XG<\6:.DJ:8O\)65;=H>0/Q! =-,PQW#Q9WE7K$3T_>)EYU!A(U/G4N
MF5+IKGEXE((UY_(_P<P"!CGPV>OAV9@?#;Z3\8&B;QQ$.)M/O$U]_&;\-L>8
M[I0%PK"W3A!'L[.S4Q1=QLNBZQW:VZCG :+7'8A6T.4OW]8R:&3,6%OZ("WK
M7D-CC)B(*@LKSM>FKJI@-V;<-4KL2TY(:3FLW$C$8C  :\P+O+S&;K(YWGM+
M&4SZW&@X+KO,;J?IN:YR34$7I#;,W,\S-=YZ3CWF>9>UP*.TR)IE\SC._/YF
M;J\Q6Y?<\UY^<M>:Q+S7$-RIMA4]91[3>YKUBVYF)>9OF=MSGQ:C@E6$6FT^
M=)*@!GEZL9+#S\YV]!Q*LI8L,Q:U+.(P[H<:80Y3-XI7V1&[+L=NT*8+.QDU
MIXCQ@TP-4&T71R_>.[;_ (760#@Q"K.YBSN^.WOX&T=H&[Q43?$>LNX-0[-7
M -(IW,PQN8U [:N 7:WW3GI;4'1G*@*N$C2W@X:Y[=M3KA +IN2[KVEIJZ.L
M&FH\U!S8825^C8D.+-E>XZS<+: S6G31=?2("IHZ_P"S/E%7CB_KCM&SYH*"
M,"'MP4/K,?,[^<Z'A$+XH#*[+E]V,)S +2*D<5^67F9X//YB7Y\_;Y2KEUCA
MCKM,WF!?K'.86WZE4=Y8#TF>973_ &';G\?C]8E9S,ZC>^GGSZ2UIVF;^"Y;
M_)8'6.*;GNE]V&+,10=&/]E^-D07UE?@RBQY>GA#"N?P0!!*C,8RY7\Q['3\
M'GV_B;C9&9NK,^!OP+*@&C!#?AW\-80WX/@,W)^HJM"M<,<],_=+P-) O11^
MT<W#ZB'-3J SO&.A&*6,EHX:NKJ!!-AK='-=8R0V4+[\WGVO$PJ1"!@;H!R_
MY#-A8&E3KVQQ-RA+4XZO2H5-%W?U#4<BRIQ1K5-O !,R;B&TV^_WCUFMS/.Y
M9=33<,>DQ'./#=TFH:/3QW@G,MCB9J_Z>2#J,8/9Y]6( 9PQ_D2_-6X8X'VW
MN_3B$YJ>JQV^N^VIN%MF"^)<&J%=ZC41EAXJO/:(J/H0LJ4VA>^KVEE4$&SG
MV0 FLWAZ-W:6MN'^/&D@DXMJ>I'1X KG)#H>!OP?I"87.LS,]80R0OB9YFHY
MMVX@51OQ,FN!<'-O0<S# UA[2E)E?9=U!V>6&^(4UKC@NUU".'$Y3Z/1Q,X6
M:O!?)%! KLRL6X7Z-9[370P>0[O<J 4,4=.O;K%@"W1]X7?6YD+E'D4:(42T
MS7R@&G1$MG,?#/A=-1J4XJ69S&KO]8,RV9E,X('RF<=(V-,NRK,E7.Y'J<Q3
M;X<^W]$:;G(;?2$;R?G>_P#B2B@XX3YYX<G,JT4,V5>, 8-;X71%?C;1QMF0
M3H?:7^&QZP;#F&@RF9Z#5"X['V=H&B3_ (].LS;9;"\)Z_:/ W3?IV$UAH_D
M%+RQHS:6-<$PAKP-QUX%\2_S$U>LUE$TQ\"&+PC@<?)CGCJ5SLX#/I%-*#9[
M9^LH)5JCZS@E+K$M[@,5@)@S:[!RISW-LRZ-AM\YA*JE$-4W^)F5P5C?#V>8
M;RVF+4>UU  J5[1@ZG4^6@J\<K5M,'0@!J\[P?:,);,$,MZF$S,>?)*?)+ZU
M!AZS#<Q[^&(U[1,XF+E9UX=?'[_TAJ ,MG(->\$!J>]O_.\>5HIWS46J#OCN
MRRZ)Q*@K02@-.^K^X2S\QBHN\-P.)+A3V#@O\3!/D0L/CE"OO48:*Z,?SV.0
MJ5\!*.GB;\*OP$3,,8EKOP_4X\=*MFG4<L*:!WT&]UW]85-.6>H#[P%IY-0S
MH.(E?.QZ3"0HUC76HU2K%59\DI39R#<N(J8MK&?65<+3+V_<Q&DJ7=\=-FN]
M=Y2P.P'/9W\W,P 0WX.<3B)\Y7RG&8&[[0U+)5RWJRX5O<MN7\!U.OK#<:K^
MI>*(PJ:<].SVAVFAS9ZF.\50;OTVR^D+5W?F8^T5[RA?G[Q!<5^\>15GB*I4
M+^R=(5PSW^^NWG,Q4[@#7]0WX<7U\-)^X>/!Z>)=^4%$AN!8^@Z$10<-=NMX
MR=H1 M._]9;.0RN]5,I41W&"IT/H0Q2SWEXI1U@%1[O7CI  !DP=/HOKKB#T
M>WU.LT17G_8K+[R^87MU&'AZ3,^Q"-5C<)?AZZG!X\1U/WX?:<^W]76VCCS<
M&9V?YVE)'-OG499U_P![LY[PJXGR[Q+>G/L2IEWYZ1KRR_J)U>O?U)D_K&YJ
M56.OAI'46?!\2<1@64=T+OY_*P?<?4B^3O[9:Y4:YB$O]7/!+!+2XP.W,\P%
M, M#B_:Q6%4G!NO3BO/7':"F_&[OC-V_B$X/ .\)KGP=0W.)I/L>#\'W^ CJ
M/Y\>?ZM$^\*@42H&EL2T%N/D:@K;I#0,SA_US<=>.D=33P?$\;'=!N$Q%WR5
MR>=R\(*]ZZO7O%2@%[W]VX+ 8\]XN6$>GY97E%#UK[,R]?G_ +**-1)H-01.
MT(_7@-Y8([CVF8:ED1?MXFH;G,J_3X+(F(_GP>__ *QN-U,^B9CK,QW\!\(,
M3$V\#EG?O//<,<1KF:=IK_V;X_,<<W]89XN_>;]_>>^_?O-^_O/?]9CVKWGN
M^L[_ .LTS=3/M?O.Z^L>N_K/?]9[_K'U_6'3?UGO^L]_UGO^L]_UGO\ K#IO
MZPPQJN\?7OO/?]9[_K/=]9__V@ ( 0,# 3\0_K%J"W5UW*]=O;Y_\1#L/3CW
MJ5H(G6'!F)C^OSX.O#;QGT\68=X>";FB(%Y[1,M-':E.YP\RRVAM=Y:"5="%
M];A058!K6+PYNN\.HF?/>:@?3_8=7>*EZ^HC5 #A_*F>V>C!A8T4KD5A>O4$
M.6&UDKS]I0K-/>&\'@.+8%L5W'\1G?F.WP-PVG/@[A.W/@Z>(Z\'0\Z_JJ&X
M%ZS%<=\]X5$+J_OS&O$*73>Z\]H_M([Q>.+F>K%X-1=OCP6[])<D8X3\1;5*
MVFBT"[#:GSC1AP_USX[?$&X:ATE!D9?T4T+C)>!Z->\3,+-FJWJ]3"/!:FG2
MQ,2S8'=#[PO(OJ3DBAZPC)YS&H"\Q+@^9YY@/HT=:;_<928-VARYP8$].E'W
M)BK!OF <M5.Z0@]T%=YE[<1T^*U^!OSUAMYYG/O\&93X_A*.LQ_5"6QK%A_D
MQWA&G7/2(FM,<?+BJYE 17U^>" NAZ;].T)4Z?\ 84H$"^N'I*&CYD(=7TNG
M4.D8U5^&[ND[$7MQ_KG7BKP<SGV8[FH:FMRWJ*0=16!FW3T\\#VADHM 7=M5
MOVXALX'I_DX7;7FI5?\ /\@[B8%(FU3(HT=7]2V$U>9A6Z9?&Z_4<\FDPO(K
MS^DJP&^1Z=G?ZS(=W7SN-\S0F]$N;B84\&WC;PWYZQW[L=SUA5?#I[>./;_/
MZ:]A,5Y1MJB5258Z<PJ(T$\YE6%4*2K5\<WJX'O=CC&RM],0JE]>([+CLP#!
M4<?]AS(<E'W^FIH(NK^%C]T,V&L?I4M\$5*3^J=>&WB)I&KS&:0>QL9\Z^DM
M# -XLT*^_._6+@@NJ[J\ ;Z2W!OJ_P"0,>3$>M10R3</)J+^V(#BWOF-6L0!
M?1/?HK!F=7RJ8-/(FSI+1 A:"J"FAD6SSRM$0N4L._E!,C9-;A'+ :-QQETC
MN$WQX&_:$'YCN5 Q\!OP79X<>WX_IIV9?!%050:,Q3D^IWXC&#)]HFZ(IA_W
MWBAJMTR;\D<A+%]H:%;CZPK@LZ]^/.X8%37$ *\?Y^Y:VQ_R8.\T/H$O9U&M
M?U3KPV\1&;>&D)6PWS?: A37\L=#%?N(WB-$ADXA?L8]6HC2<LJQ1Q,-P0[P
M?])L1%)E4A\PFLQ]\OIN"KA6;>&_AM.?/6?N??P->';B=_ _$-YW#<X_I4Q[
M A@=PHIY#F4PRCN]L/4()V HQFAT:Z_.5]Q2MWK'$6EXI6/3#?>7)5=%^Q_4
MW>$:..XB'N*/8K+\V +BL-95B^>]]?JQ.^Q>O2[O4:,I.'5]EU>):N!;Z;]:
MZ3HX7OA7>94EAR>KF,QY&GNF];'G^+O_  ?B<W".O ,^&>?!U<88)!ZMJOIZ
M34@F0W0.Q>>D%FJK<G#AIWC4>OPFDOAPT[ZD;I:[/ZBG+(QA_4 LK]'[E!BY
MN7QC;IA@F\K]G]1L<'[QNS$I_=<:ZDXB.OES5?6(ZF;TH[R[VCQ3^J^L?S3V
M@64AI9HQS\!M.7GF?N._"_#/B<R_#GW_ *(W1N6>B6MP6UHK/2"G95Y7+U+
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M\/K%5MAM.7I50 5V^6?QKO5RSBC:JNU5\BQM<_.,IR^>NI5KQZ?F?@'W[(Z
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M9ODJ4M)@:P$9 @DPWV[=\?[*0P+Q6H^*_+Y\U!+NP]!8UV6Y6>WO#3SQAG$
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M^O68(\3B,*14%X:E;T@5^=D7<Q_D6N/RP4\1;([Q]H"IK4H=PJX5Z3,/G?\
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M "/U'<E!UY4O7D<1VJL]=NR9:5;SJ"3,GUO\>"OO$JDUG\&4>[O,"MC_ !@
M.9G3$L8ZXC\ZE3SB$&G:.=]PR'F*0%\N<Y9F5J7:=6"J*K^"&*FR(IZLGT'[
M0S,C4>OGS^*E/,JM[@5]H%]873<_4=1>LV;U XXC.[+KWEMU#<O!N?K]QU"M
M$1,\/GSZ?(M+\_648,0,&SSY_?AVB7F-M>>LR:E]=^??UEWCF'B<HN%(X'"!
MY\U9':5ZL<3Z$)^(0-CS*7:.-WS"U V7/?9^L(-W1'?8&OW C4KDKKVCM"?/
MT[P'*=A?M<H%?/<[8CE*KZ.^9F28:Y^6YBH/5CA\PU"I[^G[A3D.^>?/$5+
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MP/;_ "*H+1I&"8#&,L@S@_[VB-N+Q?7LP-:I=,U6:ZJU[O29]K_G8Z3_ &:
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M_P H"Z;0 J$]'3A9A2@HMXKR=!P1T=WF"BN5;./=FY09S+9.WP F)3'P,9^
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M?>"@+ZR_+MSQ^$L(V&>X0Z2&, (+B^:W$4E-1M#34UGB5=2G9T@:M<"=8'K
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MN!]N?3&_I&H5I^I[174NVM;]?GWE5"ROL)="EQVH;QUS484591*#^HSMX;?
M=1\-(L6^Y//^])=:L]A5\WSF7\;S9U3IQI.)MN:/.HQ9='X@#1P0;M?/_(K)
MLZZ^T,1\OE#L&+ZU8UZ7VB5CBM\].[MN8>SZ[TYP2A1?K+[NYK$Y.\&4%6;U
M4I-ZEPC#?:)G$V^+X/$X(;A./>>NY^OQ_4H@X/;S8FFOI\WF'NBL:X/<=[IE
MB#'KOET=>GM+\'G4-^3S[P'GK/R]X&KC]^SZ=H];VAZ"K4]6\0:VNL_-H[2_
M)YMHIR.GHW,B_/E^7]=S%OPVA%X/B:\%U+I2"E57"6?<CW'VE"T1E7%'S;W=
M=)?C@^T#"'+YYZ0II?GM+UY?2#.<4QE+%>W/I@%Q+8/?E;]Q&4MKTH.@ 8[N
M8XYT]_$*YA7'@Z?2$9OX;/I'<->\=_"/#3V\#^OI/6.BX&3@[U&KH[OEB=?B
M;C3#.0[&[FHB ZXSV@8MFO.)D>S^RZ\#<O->)GI&&H> WV1K8IG5HOB"!0=K
MOYCTQQ++%#BN-8)4SEZ'Z@29/^=HRJJG2\>Y-L?/:J@N6;N&<'S@'U3\HP;9
M:R,=7+'.)?*HJ,5KX+OP/+YQ_,9?CZS$YAX$Y_\ 7:O._ 5>/"G,Z$*K&HY>
M JICP<=I^4QX,&?#WNN\PXUX''.IY[CAG\QZOS,6U>\\^YZ9/+<>J_K#+F'A
=O5^9[H=-ZF[N_#[OK/+<_#OXAC#+&_?QV=I__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2132809d4-ph_lbs4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-ph_lbs4clr.jpg
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M<8'1DC- 4/"1L2,48*'!0E)B<H(%X?&R0W.#HL)3)(#2\F,T%7"SXI,&$P$
M @(! @4$ P$! 0$!   ! !$A,4%181#P<8&1H;'!T2#A\3! 4&!P_]H # ,!
M  (1 Q$   'W\       1\'<Z<?        !MT/N'C<
M
M                             CAJL-N       !\'<J<?        !MT
M/N'C< ;#3XMQCTX)0;8'A@.AFX&$ -6BVR&,CJ0SH-9"SX=R&$ H(XK8>3@
M $&LQ9\.>     58/!.         D*D5B-T-3BV&.W  T "F"Z$X,
M                               ,"U4/;@       ?!W*G'P
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M&       $,&@L0  *4+H(@,!9!2BN!J     "B  @   ! D   8;
M      "B     $  P  "  8; P $%$#  0 HI1\NYF8H[V:GB:'3"R 9@VTZ
M!1.?.GY?3?3\KV3YSZA9QFZ!M$G(:N*['PU6S;@  !(),XB)OX/Y4X^X]'^.
M^HB6:'7%]7*NA.JOYF]G\OVX'W#1M     Q@                   ""0$
M @FPP(  # " "0;"$    ! 8     4)! 8      P @@, !@ ,*(0S  $$RD
ME'YLFMN6/UJ@82#0LI#7(9(.S#IMQ4/DCTOS[GOK>.[<\+]OT_&<T<(,E#IE
MQNJ['Q:KD;<(DPT(A8 2!!\(5E./N/0_B_IR[:HM=3]>F1HJDTZ.:/:_+]NA
M]P"L,"& 4#B8     "$8P           2F46  )0EB4R VE#,1H4P <X):(
MPDP 8  !!B %78L&T  PDR!(+$IBP C828   ($I@0 ,ITJG,G)I_; P" ,
M0&!L,34)-%KSJ.40!@:9LM*;'6:RE':<@HA1#C8 2"&?"191C[CT?Y'Z547Y
M)5;63@::+;+IYT]9\ZVZG]OM=@80$ARP< T&!C3$C1N,#8N, P <$&'(.2"%
M-$FTF0(&0!@K"<@,* 8 .08+2*< ! !&Y'- 00;9 (A0#5C8 $L*+$4H !@)
M@8I"@( A33;9((  !04U1S#_ "X]I:>^R5_]$/)XS-1$9@UCZ9M1AQ@NPV2+
M<TH@ F #0 !856K#7,X[,0N+2FV2),()KX3+J* C(=R1  DMLQQ53MU/[>:[
M" F!-4TIA@X#J$5RA9[3) 92BL (,5$-)=@J479Q(<6$DR#0D #<6: F9$-F
MP2#$ $H*$!$!,-A  4PP$0E(B24TIDPT%%*B!@;4P,6 $0&)($,A@1# C""*
MIX4P.9Z"H.)@V); .&A\' 4QYHT$PD& 8$2J["#7]E>QX!$@2 BC-,637PHZ
M,E         #;J?VX5V&"&B 3'06"PF#:IE38=:A&)5B6-8U22FC(@';(R;8
M$$&JQN24F3$H '%B"-!2!8S:-()'8B<4D2! @!@H8 !J$?,!/?PM_J0A(!@[
M..T\ZK76\E*DU@8UB,B!$"4(;(D (1C &DJ$3E:E,P2 $0 ! *#.U&VL$NMP
MB )"4$"9RC3C@UM>?Q#&:FI"(#9:W%>;@H\0[$  SG68@)(7+?H@"BLF)&8*
MD.,<">-%%N-\O>&+FE !*<7:T;A(E$R3]U<S=6U%UV?0E2D%8!MC< X@$4@#
M4AZ=8 @1;!N41,202P H5$G?LY64O$2%]9$<#L8-CA!#B8,6 D=Q1?LI4W;V
MLBN$2M Q*$@F F $&!C *!8@ ;#FU!H2 *2 $!-G(.T=KK4! EM,4D"8Q*&#
M::\\$:9J22:JTW5>Q5:BD A(4VN2<LJ6HK((DD6(K$U- 1,-(2'F+%9$DUV8
M9QNZX5N2I4#C:QNF=R2-M^%<RZ,_HT-DZ;GWB ]-)M30F:9$23&9E;CBXTN=
M;B96)-E;5B0*GMC@080GC0:V#9@>:T+.:E9ZP.&)#Y\1O9K6Z=8%J&DXRT9&
M?T-YY;658FGII4Q;;321)4FZFF(;1). H% DL4XM.Q%<FXI,4V6MH4"YUJ!T
M'9TJ8;92B41L!)Q68EIIS90#D9)-=AQ&\E[!)K/8"P ) F3+<JRL$!8DSBW-
M-6L$4N)H-J0AT5JYE"S ?.=Y8E X"B#Q2NV;Q7(E4J4IMU5KU\C;E1<O82FN
M%!:),*3-=IPBF",F))V=;UM3D8"RO'K8:ZT1UTU32)[4T+06!IYZUY69]'/+
M7;\XWR3;,C#:0],A;!SG7/FU2]XJWL"4:>4<?E7C-K@CG)60KERRBF6P\MM*
MI9(-8&"VJ>>;3_6\U5SSY'FZ.S>)Z9^O6P19$ %M8$X)VU/13ED2LK))%8(V
MI;HMV?*7%V(F(F-QY[(V><2%Y$C4@   _;G4JI"I5I29D9C6N!J*76:9M2"4
M@5Z29KTZZ\WW5#,'2#Z@LBY8G&I!!V)::,5QVJ&I1Q;C]=-=;MM*7*#SKL*_
M-O0H/A/4B^6L5HA/^DYLN_2?+RG[#@IK\.+Z4VXWP[T'9U)8@%C4(F^.:K/'
MFNQIR$UO62RNB<Y3YLRROO);,']]RNK\^GVBR6/DG <2?U9:ZQ81::^LJU=)
M8O.+\"=7+H++IVMFO@6YO/'Z'\*XS]K\:1;7))5LZLCYW:[[^??>NOO#_5XZ
MBW$8D&Y&YBRI]Q<4"N@I)=8X7')Q>CDR* L%IB,V<NJ-GNCB%+*MI!YM4I.E
M9NMR=;N^A#3$DC14RX(<2& E"DLR2,FZ->L/*^F6TN<7"AP;HY)G7)O3E)EF
MM;\M[W<C,EA_%ZY13\"J\Y9K#^=?HWOGN\J&46NQ(1'UU6/ZHX>R?VGYZPOD
M>G-'L3(O+J_/S4+U7#?<6 <$[7;S@CBCXIZ39%T>MO58M0?BOWV8_HC@X)^=
M._JK[1Q<^_2OFNU(.S3D$3E&2XBZO%91\>M-#LY>O&6\1AH[3FTSNC&J?9/+
MU>7/V+\M\[^H^<99EZ.29^C-KE3:)8MIY>)SYWHC\I_2'9O@?LL6VV+$2XIL
MJ3;!UM9)<H3!/1),!Z4W^ES\@@E$GB19=,/+>A1:IL;5B(V)&ZHNQBY/.N25
M*2MN065LV0BVP1*+<X@' >%+#*E)O)KU/Y7V"G YUN$7 >"0ZI4JGW7((6>J
MC)_1<A%$\$XG60YR+:M:?@_O<]> U<W?4<76WQ;I[*\CHXA_0?(V)Y>^)LAU
M1\;W9G_1WR,W[#CJM&*!JCYHR7$<H>[RE\HTH?7I5+(@=0(3<C/GS\_^BUY^
M.O?B]'FF!$W,^D\_9WZ3\QM'Z+@M;B64/2@Y;64Y?-CV.=WS?51HXFHN^@#-
M>Z1<J%MZSZ?"\9/N?XJV-1V.N?(_5J^S-N?C>DQW;FQ&VGBKUWQTL?:^@+XQ
M^O[>VI $ $&C80* P6&K.;LIXZ;GI\N^C!9-S--&?9'KL35:Q&46-PC!->AT
M@\1D%3I :*ROPG90W;.+K@VHMN(M1INLFD<N4U9->F/(^N<A-R,G#.ZXN-/V
M9Y<X2+(26K351EWI>0S4\!\[VD2C)LAJO^;WI-(<@X<_1G%%L^BOF_0XU^O<
MK(J#2?T3G^\?\X?=S/WCX[*?TES2=$+2>&^BKH>R/L.I?'&X?0&I;#9M1"XS
MR;A7Z-_+WLZ3\W^I)LTP,AFZA?3OC^AGB<_Z-9W8];;L]#HJUIKR_/#=#Z;(
MNH#YVZY_3CDUS:4[ 6S&]W.\C_L7Y/>OQ]^^"^Z:QZOE\ZYW?N3?;\WI>6GT
MK\ZS\?3^@CY3^K;^<:>NQVP2"0<<6QF@QW!#0?,U8UFU9=U.?:BD,5FL;S[&
MZK6<]\*O2U7(E$29N+C4F%<HK7HH3?0-&=%\8MZ9*F%$IHPD#ELS4M&+=I+Q
M?KS0MM\B\5O.MZR$D4HC*G7<;<>:>KXC%4=<^;]"R2D[*<-_)_2QC\C=C']*
M8O,R\_=CO1ABW7KE61V#S7F?],/*7WL*3OR(OCH&_-\TNZOIQ//X+VU'K5O7
MLABN&R_SCZ_%?R#[LB7F]^G?%]7?(^WQW]EX67\NOKKXWZ?9OE>ADGZ+\]LS
M[+R*/Z!Q]#=WF9'".W<U_%<%Y.[J&!>PO,W>B.#2B+2F3<&<?.[ZQ^=.-O??
M$\GP[<BKW.<_V%33IQ6_/0[O.^D'QW])^D=/IGK)^9G+^@MRKP_+VID\#TK\
M:AHR*W%N33RO0W=X7G/F;,;S:<WZG/N5%YH\^AO/L37*%CU1Z;V:!+"0N9(8
M_*M\A(T8RT)%^8K:(NMQ5G8:;0;'T3&]A.UO#NT)X;VJY#LHNNMU.0I/VYY9
M7(=<VRJZV8\Y]=PXU;UGYGTS4)/Z,Q9WAGY+VU_Y1Z\O'8JN1,3="-[K)D_[
M?XFEOM',W;3'(;J1="+HS5FJ&()98AM$9O7\C5#9?,NS/_ ?THE+P8_H'\T]
M8?R-[+C+[;P\9Z=7J5^4_:9;PM)VUWGZ.\]@?ZU\!G&:S;V/;L['>])XS?0S
M"-Q%M246&E"EB)3KC1#?N*7)7T'Y)QM[OXUKKL^3C652\VW;_F_?=@?-?OF7
M^8]IU]ZCA9#?4@D9$,:!"29#BD8I2?,G,VXOFU;)ZG,LA/J2\VF+DT)C=BF3
M:>6Z"$ ':Q 3DW952-5;TL4BUC11.NRT%CE.*]V<5UD#P6#-J.=9BZ?._P Y
M]NJ<WK&[;G<(22,M0D.4J5,RV-YJQ[ ]GYN+3+5OF?3HC)_1E H[*[Q=]-\I
MUU'G5:!,]_7>_7LTGHT.E*-6;'KZ<FE6[IIB60A.#,X$ !3-.?G[UN)?EGV)
M>>Z&(>@Y?D+^O_&[;\YL9KJQ_7'TH_,OL=F>7U6?Z@\WN_[]PK)ET3E.J1HK
M7.)RK9=42,HD9UP\5)Y&[9M4)46N2$BEUX<0OYV3<ST,"G=BI'%(0[+]7YKF
MNZO.@CADXL1!T*-E^A ^B@Y>YF_%<VK:/4YMA&N73,\VJ/7?&HT\Z9=V)<_3
M-&!U48TH9D*!.K)[H2;L]!<D2-R:N5GVO-I:C=MGJ\M$8)26&5-["+:?)OYK
M^;_01&+Q&18Y3C((2W5)FI<JIKA>;^?LCW'G8%$M4^5]055C^S$N)"@0X7M1
M>A/3>?V?Q^GF./?*KKD[\TB5$B^+NK%BTJY>G-8VP@RBS.M(S&H=%CMP3YEV
M,"_&7OW//[!.MN^K&>C3EG%WAUJKE)^R\O??ZNX%BU.VTR2F;?2].";JC55>
MI8O"R'&=PV%):0@Z;#VM#]+GZF5R8VV-='1G.Z51+/0:<?;GKO,ZQNICA-'D
M00Q80#@7 S%O(?+O*Z&'Y=6V.MRYU<)M4RIVQZ;8F3;S-EW8IBLW&2SA6)JI
M>DY,R3;3+GFF:<\C1F&F@M%.-N$RYLZL[,8I(+'L8GDI?39-7,7R[Z4$G"+U
MA*2ED9=F:9*$V<)RIONGR]F>^X4'+/4GEO2-0<^_.$5T%$KTL17._N?([(XO
M3V3Y_N2).7?EF68GM496O*F551JR4&B%VXM3@@:G-:E)K(>>?.G\]?J:?(;M
M=>FQ>-'[\^9]H>KQ\Y_$O0^S/X@^@,?7^?M/],\7-^NIDB??CGSKDWYY=E:=
M%;4:\*4K.$W:[(HP"PU-Y'VGFM\._76!_1?C-OFZF\O'^PU[UN7JZS3UCVO%
M]I?6_P ]=?\ K/-: <='!;A8AG(:-9DB>U UDUVXGRWR.GAN73MSK<FQ;D9&
MB&N/EVP,<]=9-RZ-$2J_(JPA&HS'&3?5.OSS+L\S1!W7A+3C;LA#T*O<$J+<
MHS9FPBR\<J7F[>4OF/TT1'R+I7)9,D3+,TUJ:E-MS9'T.=M#WOEX%6C4?D?2
MH)3+Z6HN#"<:%C$9:B]?Y3.//][*\&R:X2;L=AJK>TTS]%(T8B*(.JC#M1.1
M8E04E0G(JL63UUYGHZV^ >@\L=5&)?J_Q'U#PG\8$X^W_P#.KZONSTCW+^I>
M386TS95S-66ST0GVYI-M=1?"M*\A"&60J[V8HH)0:?\ &^X\O/D?Z>]!/K_Y
M<.NSFY;>R,U?C]Y/[/VINX7K_P#H#\LV\XU[&0U>+"0DAFH10VV-03 Y6Y'2
MPS/JVYUN59Q).23->V/GT5V2ZNR;8.;7#HNB02 ?:E.N=95/T56&C-(T43=.
M0M.5-M4737"48TX1V91)Y42N5+'N?T.2_E'U )K(R1291ERA+E18.$]USK,^
M2=7!M?WWE*O-?J'RWIPG)T4H)1U*#GLB5O4_LO)9GY_NY9SNA,DIT\D_77/U
MYING.J_$)5,ZJ(FE8Y&-?*.1@[7?)J'2:<^S4?Q_I>=7S#I<+?LOPGT3H^9*
MNSWT^3>ZF_/-.V?J^>U'.E3/T46FJNRMRXYHHO+*[>RID<2-D2-D6*1%J2U+
MX[V_FS\,_6^I_;_.]Z>(]UAW4Y.DO9>(V-YGV73'<\7VI]J_-_8_I//R)(@\
MSFN>$NF&]7!F:7IX26 #ECE=#$LVK:76YEY$>PV,5;H],ZG-IKLVRNQ;8&:Z
M/$;BG+'+E18RIL="LM663HS6.C,+\Z]&:-IIAA&LJ)RR4E>A;1>-X>IR#\@^
MI&FL)(/2KESKFE<UQLY1L)X,F[.';OOO(U.*_3_G/4!$O54ARY,]$<Y=F"64
M&_G3<VNQSZ'R/H/XA;&A&UUX96K,_=B%L2TT0],(T(1+&3&\]M!AZ":9,.>-
M<K74XY<4>RXW//2YO>/ ]#T+R>BW7:,VHQ2:9Y-*.5;\4BW):Z<DV=9:8,H:
MA.,.(DB X!0*'E]S6FN/,6K+6J6TL5^TN1V:66?%M>/OSVWCLGTT\)"N&1T7
M;(J,4#( [3',#F'F;<3S;-D]/G9*HGCL1'?!R3J<VJLS:ZS%MK\UT." &.;*
MBPMC::<]GIHGZ,UAJS'ISN:<C=\8E<6K22RR:NJ;+-K&N9T^-/D?UE,(KA&3
M;7(DI4H3G"P<9TH6IGRCL<_<7T/P]13LT[Y3U+DZYVJI"7FG[I8KW.3?D]77
M6=28^?4,T7IW^A?S/H[SHKLKL=GHRR-N5=E!:J84+<&HUUCKXYF\FT49-JQT
MKCL%JU''%32-)(?#9H5X]ABKD\K4M>470^5U=^X=]HJ<\TTV6C,<5&$S$90E
M(%Q@LD53Q#;1CUJMO.]?%ZK\0KT8=5+O?W7B\MU9^>!:_#+ U2S.$9,-T71X
MP',_/UXQ1IS[H\_+JI%1./1LB9+Z>G969KZK%MK\MM>I-N3\8SW5870LM.>T
MTT65V.PUYG=4'M&(:*XL&W-O"GCMX.P9B_*ZO$_QCZ^V"XPDSJE2A+G":1FS
MIL9QM-->7='B[G^D^*J,^G4OEO3ND)NVEN*\T/<K47?P;_A1IVS7MJG*Q%:9
MU:_1KYMNWIBC;:<-IHS/:\[5U&NLFVKZ6'*-V)=BY5A'%FIA*$B]9F88Z&1"
MT\.V"U2K&9J/# GAAR,C'V3*!0LQ_%O?Y6[8,X7-V9F4V8!5Q$;-([[?)/V'
M1*$F$XLX.1E%JEU9Y71T3Y%]V^Y\9E>FA(<+AC(C9: :.]AN  YWP:L<SZ<H
MZ.'.<[)2B8]4/)JIX[JS-958M=;FLA1M8+'B%@5V%U=EIHL=.>TUX+#1FEZ6
M_;D+14VI-R2@GJ5BXS(RK,FK@7XA]I8RW.HDV52I5RY4SA399K"2LYY]A^J\
M[MWZ!Y*JSW8%P^Y7Y]-AHSLAQ1Z:/,?;N0B/TL*\.UR,G ]*?"9]JTEGKS6>
MC+5:(ZW%EO>X8D%&1BYR1KIJ6&+CO@P45.$X>S ?"B%C 86&Y!X@+>H: 'Z'
M   *E''^9T\OYW0S75D8 2$UG.6_1XN^QZ_:'-Y.N-%_36+# 2YNV;\Z\YT>
MPO$/MGV_C\IT4 & 4#8&"@= P :*P:L>SZ;KI8<VKD5,HM&N!1.JIW5..<#/
MLKJ[H<!FL7)2)*Q<;#3GL].:VT89NF,_3%_1E(1"0#C)83&IL92ZY<6_(?J6
MI/)^L<(/6U2Y1G2A,LIGN$YY;:R'0OU'YYD_=YE31?38=6*X^D_=G;)1J)P(
M615.A[_'G<3IS\]LMPL+JK+3DL],+.W)JFR[)>]PR;(1C(6'HQ5JG'>!/"H%
M)'3BN09#888:C#69^FACX6@LE&EAH,8(XWS.SN&"E65ML-'-^Z_Q@]5T^U.;
M@Y]V;MH9<[ M57:-]^<O[-\@]D='F/RIBW,I5KE5(E&5.,JZ,R2L)*:XX]1>
MDG+TX\MC8E)J.JOPVP*;ZFFVMIOKJK8<6BN:F2@G2A.ORVFG/964S[Z)]R7I
MSA@:2#H2T3FID'+A+',VSAWXM]7PS@^CD%<N4)DX3;L=A;78SR[T]WXS<_O?
M*P:94]-];3;6+5#@V4X=3APOA5NG[7)F<KJRJK)SA,NIL-6:UNKGSHU)?'*.
MOR1%J0326<\(XL%#'E*2@Q%F;DLCBM*PVRFNH[,&BR;HKA&V1ZE:VZ/LD$L4
MF0&XPL^G*\O1R?1E)@#6EEGGKU^D(SQ0KJR&69>A$A3T%Q'NWB1IG* 6Q72I
MQ79&9KSV-E5E+/9ZU9N-D5V-ED]M^W&U5I0026PJ=,7*0(ZJREU=$HCD=5H(
M/$9-E=C)6NE6NNF9/&J<%SK<D"8@%0)$2S98M2FFA0\MVDO&>NPKSO;;3<45
MV&0=#G[;]1YO,N_Q8DKZS-=65:8E*B3&:K9L9P(V0ZY0W*OZ/+D<SIO)RI1F
M6NQOHL(T6-M6M,FNR[W DW1.+)FH6J(1)Y,UB"(S+%.F8BG4W'HXXX;"T<>R
M2UZ.U%9 P&R TJ/J\ P()F+<+M[FZ&$K$$T IJJ39KEKF5>#N&W<'7BTS;JG
M6PLJ101-J*R"KJQ?&9?7.LIEW.<X27"8A<XY!;GA5ZEJ"871ZYQ%*!1*OA;7
M*4.,FZK% ^T_?58"L6K2VN;92Y;4]8FR)$6F$AX)MI+;>D$!C*2>C A)!(R;
M5"81#;AYY0Z;F8WLJ(HFI3A#A46Q90CZ\9Y-3D9RE*7?7-T1L(0G:<RI9]=X
M.S&U<O)-N$2CRK%QV1Q!-YE:*^3S1K7ZEM%QTL.(* &P00GAC+-&?,CATD)4
MH5&'? YW5V5V.9)4FG% +!(0 ;IKP&5>(2LVIDZ;,!$)1:)Q!QQH!T@5L2LI
MEWDJ=<J^F0 :3-@67E&.1ODQ0C(3MCDH53KL]E<G!DXM-H<)<H3R,Z<K*<IU
MM,LJ==13$M,N,<(Z%CR2<+1N5(6%3"6O8RA.9#, ("F$<X@6\B)$AI1(7QZI
MIC6PYP96P:'!0S?0FJY2<D)JKL;XS77+L3I45LJFFW#>=N:NSW.G);:L@<0P
MX2YGE#FT,VA/"G',I"R- RI4F!>EZ8C([*RC./5?CN'6[1NR?9EO]V9J$F90
MBH0,F+0L3I#12,)C5U+3MC0E INB.R,)F-8G)P4J4)=[F61?EE6V@"!B4F7'
M.E1K8T242( +FT1&5\;*^A5P1Y6A#Z4\IL).SD3+<LL'1MC:D1)D8("LKG-P
MJV_*%I*N@IOT/%Q4P &8@,A ;J-T3CD<X0JBE<HKF_618D)2A5D)(:% IF\I
MS"<VNJ;I4IPESI= @:''(L%N/4V5F729!:3EE&)2KI!YI?1&LJO;*X4B\S7Z
MTSZ&U9GZM2!Y[S4K.VC,MV-RV!2DRW&"&G&!L #HUM2*UAJKQ HW+'H-)QB4
M,(\1F+*RQQDE1E2IE$77!5@RQH(B<4CM4SZ;-<L)@&Y$B$.L"O)05*,-,21$
MLBFP3LD3[ZI3#0ED=$,<$G5N3*LCD-GSS;$E#1N;3B0S$M7!AH#J(202%W);
MRG76#PU-]CI)B"@UV8KLYNBN[\^Q33PS>C8G)]=N/C^VM*Y37.<5OV5O#:$T
MR.G#;;0EHD/#D5S=HLKY1I".A^EX?6W2\RTX9_S_ %&]./[G(++9+@N<9LU*
MDI*B^"@#(HH@1%*$)D8!4AZBRKV<72_>^?85LY%G5;LKD>UVUQO;LA'),EJ"
M,@C*(2+)3"A8P#0H01+""GO2&;GTWSV6(UJ!! 97J5:.N)14SBGHEH0LIJSD
M[ A-$9!L<(( Z]RH5.H)Y"&>RQ[=G#G;-IK22QJC+#K;,6E*]C1G2#A%#;LH
M= 6UUL37Z=@2=E&++-PS[?XCRC[+X?9.^TIU,6%39@ML/8[T^;_IG>?"]W.*
MY4Z5R(R>/3MBIP'9&$A,1G:LMU5,B^>?1_+.#_H?YT8OP6U.U2=1=A*K3VEX
M']%])>2^KO2<^1+E&;&%98FVFPCIP0K7I;<Y%527-R5''_NOS_S#ZWXK87:+
M2C2U6J37S,@Q=SO+YI^F<_XGNF6IA8\*85R93L'6\PQ1PKP@2(:?1,,?.AMF
MA-"0PD:B"H+JL2!R@NVL)"[9<H;1>E-F1VD)L< =<3K@HB6)*>1DMMSQ[?G5
MSOFU5Q)1/2TI:;TZ3;*J.RX1Z"JRD2597O\ OIK*C7"E8$U54<8^[^(\@^Q^
M([#Y_:;TU6L=&=\WNZGZ_F*:S!B%U'JO\A_9>>8.RT9Y[?/VS7Y2=SN2X-4$
MH"'#E+N'G<_M3F<[5G>\-YF_4OR/?UW9YE[EI7MV'SNUB6G#K[=YS6G1X/H_
M\E_7&VN+[VW3LDYZEXC>F[F.6R"8$&$+9N6GU%\_QA&7*GN?@?)'N_S]E5?2
MV#SO2Y?BWE;+6>WS]/?S^:_/_2WOF_Z(O"OM!;>U2Z:G8-3).5-&B*$$< 42
M)TW'%S.;; )821DY<X*42Q-HQ!AHSE/'(D>Q6H0D7<GO>%>?0JU^Y.EMH0K"
MVA4\8)6[CN>63<D\_.^;76DJVV?)-^U P(("EU%GP97%G.O?U]-76]9*Z>HN
M6ORE^M?C;8>#5U#P_IU<9<4U\[H_B>SP+1ALDO*#Z/\ G/MWYS^D=C>2^ION
M$TGJ/3J\^_0>F]8^!YRKLFJ$HTI^<7;['7G)Y7:7,YG%/O?@7)/N?A/0WGO?
M][>-^Q<W]_Q73_G_ 'U7.'FU[SX)JWI>;W_XW[-TE\^^^7SG))+2\K_1^JC3
MN])N3P+YFM2SSYZO;V153ZP>>\S7V7^9/US\<XKT?,^BGSW]!75D;NJ]\T8M
M'/SSZ3YCXA>)^]?15QO59N+Y_79]!2Z4TA8!.9)F$TV2A(@UD4.H7BYG6^R(
MRQ2&PI<6$L1E+9084+6)/=J50ECTI;D:U0W<J.^HU[]56"CKR>1J-:6T;EC*
M>6LV;/)N257/.;16D\9G+EG3N- $3DJ)T1GR;"C!<Z]]W4U4):RC;8.#E<_.
M_P"H?E_5G7\!NWE>TSSG]77O2X&QL'>D+33OG<-^N^4^HOR3]A[/Y7KH3CD,
MI<Y7:O+ON=K;E&7&[K,WKBI+36O9V-Q^?V9SN5SWZGY3P;])_+/0W%]WT#P/
M:Z?ZOG=J\_OS%/D_TGS/5?7\_P!S_+/U)NKS/U'*B;P[%KQ>]%W*FVWI'%DJ
M9*!.>C=&S8=57I?YWB-TOBOZA^7].>B^6]R^0^NXUMP6_#]E=\SV4R*YP]K\
M9\G/,?2O</R_T?,''R56CVL6V<RS%8A*FEB0.(B#$B"ZB,?-)TK A+(21H;J
MU9&%7A6DH"FZQ:+5HR.1E<T&!7B41D4(25<[:49!9D\]EDW'*//>:VN<VR7)
MFS95IF!!(C#J^C)91:[*]]6U5M;U@KIY!R!BW0Y/FM]-_*F"=CQN29NC:*YD
MC26XZ#1F[$^?_H+KKQ?W">#R8;Q9K0&C7#D19D8L0F V?ES[&K<N67A/Z+^:
M]#>N^0W^?;=9M9I4^C%CFG)OSR/UWLKY[^F)-<[,<\5E*&@MVRN44!%"$B$6
M3T;4PT,.%1KYG%WOOR_W9^=_N.]_!?0>=OJGQ[9/G/7YQY/VND?:?/N;OLO
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M9UJPXF! 2$#6)MM()   ")-V?V6[WPORTX7V0#0,  4F;@!@: 0-M"8B00T
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MVVYKWLL_L_[@<@S-R^RS62^X/N-AN4=H>[/WGRK/Q^TYCE^#_:9Q+M9R?F7
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MN]MM%R3[A^\OWI_ZO^X?_COV\XSE^7_:?V4YWS3C%A]G#G6?='C'_*?[L_\
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MK)V6C^M96QAP5C[&QX.B^_P')78B>.1LK.G<[MSS?G_)\SV[[L9FYQ7'^?\
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MK)7MGRWBF0O(>Z^&PN 6P?@+._O<1C69+AV5L\/R+DN!X_CL)S27U[;7%^W
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M;QZ]J^,#NUW&D/[8\;%[:<</[:\</[:\<,%Q_'<>B::6O3EG!)\9+&\CF&W
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M3S_%L-?7_P!,2ZC5RWL;5[A\PRW&R_S"8_$\?O'<C[B)VH[8'?:QL,'W=O\
MDD^?[6X?2IVAX3@\UPGC?".*7..LN$<5FL)^"<9@[;<=MVP8OC& NN19+C7
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M[1/I=Z0X>:D-HD(K9%-N0VWFAYMO-MYMO-#S;>;;S;>;;S;>:'C&/U4/_]H
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M?CDJSI<?KT\%"G6A3JY*I0H*A0H4*%!4*%"A0H4-)0TE"A0H4*%!1W1%*U^
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M]:41Z^Q/)C4SY[5@C9#R /PTC  '8YK/K%&HPQ;:7L"MY>"7XO/EJ>!(5I/
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M8F6F4[<(EIN)E'8CLG;G;A#O,F59==QND6W<1#<MX*I2'&G%;UIIWBM)CDL
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M5!EJR&NE::45<1G;&D5+.Y=>6CMB06Q9AI!('5BI%: 0!MC<TTHB(B)B^?\
M%4C^[X&+W_;'(_\ Y=Y9QR+_ &+=?Z<QC]%/]C_H_P#_ "LSCFG^V+A_>=MQ
M^E/QVC^[[WB7_8M\_P!,SZT7['ZF.:K'^D" 5ME7>9-&U<Z2'9#45Z!,E\6W
MQ@._1^&E4;7?I16'-0N99BSS?R99GX5AL$CTA>.8W2D+Z8.+#;@,DHN?1HBR
MM(@RPG7)H2<+I0;J$BR"Y!MDRWP;E=5<B$K:W&-#-M[AW4WSD5D9@(:U51&J
MTIA''5;91EI);'$6QUDR8?3?1WH;:Q]X[QN[\WH2KA#2E4I@&D-7WP=W S.
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MD-=U<IL<&I#\&XL3$6,,(A>CW&=,X@_."39EE7=-5=EOW06O.<OG;6&;G<Y
M6[@94-;D-71CH^<J$T3*$0U/5UJ57#"-WEN(;))O1;NMV>&XN!!FQ9$I]]66
MW(KUT)\4=T">[1-6HR1$Q!FUC1HS<JYO/PV;O<)<=MB8]<'FV8[#]O8%UY%D
MMZG",!5 1-- #'LZ<Z^7'[+#GR#^U7'YN^L7'^7S/Z0YW(?36P6;/O\ T?%]
M\/,%M_T)XY$_D5V_I;&.>?[$:\OTMNB>7#MXB4;N5RNY6P)B4WT:(Q&W[J,*
MJ+NG'C-$54STXO\ :;HZY.W%HE76WO25WC\.3!4%) ?6KJ-O(5%&JHJ=SDG_
M (NY;_OF'_Z$+Y,5<<%M/LU1$]U<:@)"%>D514]SN>U[F/9[N/9[,\?KK[%[
MFSV;>[Y<=%?=QL_7RIGW^Y[7N;/4>7#GR"]['YN^L7'^7S/Z0YW+8[.NXV2Z
M0(35M=5Z%-EQY<:-7AW6RA-/FV\@FJ$A)3$?EVS2CG@DU;E<+@;#D87W]VK+
M#45EU&W199 E7KI55PQ9;S.6W2K9(=?MTU8TB3&)F2B*[%DA&!V0FEQ%5%%/
M!B?:K3/6YSKR<;CI8QI,6+'BQB5P6F!DMM/.&Z[2JJF5,2>7+Q(.$V<L;A!N
M(,N2.'E(TK+H26FT)PF9#2_ 2J*F+HU;KIZ:NMTB<#O&XDJ+$APS("D$JRVV
M'7'G$#2E,D[G)/\ Q=RW_?,+_P!""IX-OM+A_CM6_1PTZVQ!KU$;KEHIAH8E
M5!:I)3/1N:+52Z-294P=AC&XOI4&[S G"QJX"W6MI2O\)2W1MJZX45D&E*IZ
MK@JT5&J8C!<F8(,.>C]]+XUDACM28$IXG+D\VYIARRE1T#0ZU'JIJ@:^AN+%
MC,LHJVO60I66VX\YRX^_]%)\WCA/1KP8">[%*MY$N+NQ-O[UB>AI"6P6YA(A
M!?&7H[9./TD0I#T]TK@CL<FV"18[;*.D@Z]6((/0(4V2MM*<\30R@=?;8Y:C
M7K<@WV4G2'W%:Z KT98X>%&L\UL&.)6Y1UG.0)*<7R[&)B+N]6IV,=[)'%U$
M*&RJ9+U1?)Z#;M_$;?K"5R2,N:+$6YO.W6&B:J6I@[=H-23)=2:JZ4*-PGHF
M5 9M=[ES'(G$/0I_#2.3":&+)1249D1J\26ZU)M215HO9&+&CP(#CLN8RR\T
MCDDW;3K<N8G!N.F@I<]-OJB5!.MFFPB*7+BQXM68;P@S)CNNL.2FB=?@3&&I
M$AV-+@KI0M>[4E+YL:*GK'EPY\@O>Q^;WK%Q_E\S^D.=S2M?(M$\J8V98]GN
MX\'>QV4\GLZ<4I[67<Y)_P"+N6_[YA^M+_R+M_5.S+'GXS;JITF"*OMX5&F0
M;1?B B>WGGCI]GA[2KXU7'ZR>#IV[$QT]/0F/UD\'?JJ;.C'3X_^?PXV>S+P
MYX=8?:%YI]LVG6W!$A<:<14-LQ*J$!ZEK6NW  (:1 4!$38@BFE$3;3+%<Z^
M3ZE%QL[_ +N?OXV+CLKCLKC8N-F-F-BXIX<.?(+WL?F]ZQ<?Y?,_I#GK/)7_
M !;RW_?$/N;/6%_5VS&SU:>FKFVPZ25"&V#DF8?R6&!(@1?C'I%>_BC=KO#C
M=5\XHQAZM=N[WQ^^F!9@W(&)I9>CYP\+)K_D]:JR_P#L#+R=WV?K8XN\W&-;
MV<Z;\NN:IM1MIL2>>5*? 1<:(ELNDYI%IQ%&HB%WR%EY2>0?E(*X"/(?DV=]
MPD /2#/F")=@\5'5]IO_ *S3@7&G!<;,4(#!1,214JBB0U%4\O\ R(?R"]['
MYO8V^J]GZV'7W8=]WCSANG2]/4UN$IDM$#+K+C[SOOX[?_>X^\[[^.W_ -YC
M[SOOX[?_ 'F/O.^_CM_]YC[SOOX[?_>X^\[]^.W_ -YC[SOWX[?_ 'F/O.^_
MCI_]YBWW6%$O:2[9.B7"*IWEXP21"?;DLJ8*%#'>-I5,9^_7W<J^LEZK;C;W
M-OJ5]:V^MO,M/AQ#!FV]&.@/MF!J!)NJ]FJ;4JBUQ[/97"-PU$KS=$-N"E47
MAVTIO9I#7K""K0$Z2P],G2'94J0XKCLA]PG''#-:KJ,^LJU7N";9J)"M1,"5
M%$DS14(5115,!#E</?&6@T,G<5>XH01*")R6W-;].^6>/R?M'E>E_O\ +#C;
M%GM$9TDH+U9+V[\*-DZ@JJ8<N%WFOS9+GPGC54!.AMEOL--I\441,>SW^Y'Y
M?NLDG;'.<%B.K[F5KDN'YLQU=48KAKUQV(JZMM>YM]8S_51_)7WL?F[^JS\7
MK:=U?)^H/K8\_):;7+JJ::\_L.U3"[D'Y147LINVZ[**;E"K^Q5,%N(30BJ=
M17'#(DRVE1!0L4TP_P#,'[V]I@KFM&9"FB&K&MJCH@.DDZV75'H7Q[4J+5T#
MBFD1!WS*"$A/"H=5IW]RN)S[1J<6(S'@0ZHJ:6FAWKG5^"I//$J]SDA8$:SF
MC]^N0WQ;A$MKIRK.#]Q)]IM93+DEQT=**FZZZ(G>KBQV^Q3(=I";S3S:MI>.
M$X\Y-8C<9*!E#:TJ$<6(Y*BN$B"E$1%P5P],P?2:6(N91L^X?J5E%[=<3QO8
M0U3/1HQS?R\W,@W6_+>N5(QF,0V2MLNX2;68Q@D/(2FV34E%(@I5*]6N6(<5
MGF.*ZR],N5LER$M\@>"N-LC+)<91DGDXEDA DWB*.:;,\-R&^8HYV8[&[>BN
M86V83HMM21BN-!;D-7W%$BJI5R1,TV5LEL:N7+QA/YINMJ;N\&VF],<6%$DR
M=X5P26WQ,0P9R;04T+\):8LTL;LS=6+P=V:;-J*]%W;MFDLQ)0T=,R<!7GNJ
M65:=RP7!Y=3TBW1]Z6W4XV.Z,E^R(@S[G:']LGU\=H=OQD[OZZ?J/I]8Z>X7
MR5]['YN?JLU\"^O+Y/7O//#J^('7/Q4&M,*,9@? ;JJJT[^D51$RPHG(=74M
M=VU417*B=1M.]CJ0Y*I7;H5$\NI*)A/HJ)7I*1%]WSRE[F/..1@1>E#,_P#H
M(GNX(Y-PH@U4MVRA9)FNTE^KA&X45UF V3J,.3#W-1)<Y!@:"6MW3F@CEDF$
M*X2S<7^)BIH!5RI5PT-Q4_8CBZQFVU;CO;B9&124O,OLIFA*JJO7;T^-%QY4
M]_'(]O(9O%V#F"=.N:C'!6RMTP+DT:1S5Y%-W3,'*B8Y8%EJY\%8^8N;KB0)
M#80D@7R!<8T!EH.*TD39S10DK1!'IQJ1BY+?$Y-_P:,8FHZ6]8W$(8W I&_W
MN]1KX.FF+].M[=V<NE\N_*MX*)*B,M16';$Y:1D,-R1D&:HXS )14A2I+WEQ
M MUF"XKQ%RYCYCF.3F6&>'<F6UQOA&-S(?1\45P^NNGLXL,9I_F&.SRW:WX4
M:[,,QAE+.=G(Y(;?MZRN'E0'&14-)&E/#EBS.QX-PAQH'-ETO;D=J,RJ)$F0
M)+#>Z3? B.D\[4@R1._CEB! &4C]HE\TOR]^R+8*-YN3$N)NE%P]2HTTNJJ)
M1<>SIRQ8(SLIYAP;<R;C2"G45]-]I[:=9%<SQ7CB4OL@7;^Q<QU)+1+X5<#W
MTICYHG,\]V\)^UUAQYP)+:CTJAT2GA'4F6$1)+Z4^S+O*FQ?'CJRB5,NVB%V
M?'BAHP]E3K@J=.WJ*/1ECST(:9U5LU3Q40M6 WAN1R+)4-M2$%^4-<EPAM.-
MN M%UMDBIG[:U]K#$)U4!9+2N,F7851/3HKWRQ_S>HURI#$<%72AOO-,BI;4
M%%<(14M&=*UP*/7Z*YK0J<($F=33M0RAL2!#;\+2N/Z[7\6W;\ Q2#?()$1$
MB-OF4-Y= ZRHS-2.YIITTI@7&G&W6B2H&T8N :=\#')1]?+Q+C\W/U5Y<.?)
M];'NEY/4:W"1L4Z27+]=<*,9DC7XYJHAY$[6/GMWX&Q%/J+C[[D>1TT]Y43'
M5EO?LBU?;5QUT!].G+=E3QCTXTEYASXCGPO$>28RQI2KSJ[&@Z%^*M*JF%H*
MQ6^A-2LU3O%2AGY<5?DDO?%H=.?W0JDJ?L,(O#HYFA>=(G-G1HKH45QI::!L
M:UTM@(IG\D41,>SV5Q[/97'L]WO>H;NML:WEXM3:IN0"KLZ'JU&P*IFKS*JI
M GRDZ<$V8D#@JHD!BHF)"M"%17K(0JF:='<^M@9D*V*W#<1%;DS3&&VZ*IVV
MD<H9MKT$B*BXT(%KK_:35?M,UP3[4:,9"*]6+<&]Z24V#FTE?+A;/P$I+IKT
M%$-LP<#[,ZIU6OL^S3$)B6^T^4N-OU5I%1&S1PFR9S55-$H.>6W'ZWU-M,,W
M"<P86""XCSKKK?4G/-N(H1&JTWJ*HU<7H3+'B]F7<R[OGHK#E-BFV/3MSI7'
M4%QA<^P>7D$LE7"\+);=3HWJ*T7R55-0U3!"]$?'3VE%LC#QZ@33A<:XS[K*
MC_%F2?MD3*GCQ%=?44=C[P1=;1 -:$E%R1%U)CAI"TFM#LU?/MCM<[ZGW^X[
M+EOM1XL=LG7GW2T---B*JI$:Y)X/#A8G*C2QVM)BY<Y38D^JG1$X2.75;1M%
M7K.56OP<LU?N4Z9/=):J<N0Z_M^+O#+2B:UHB(B)C9C8G<K:KI,BAF2Q]]O(
MI$5-6J.YJ9U%NTJ6FM,,6R\,!:[B\J-LOB]] F.K1 ;'6@+%?=5=(BJDAK\*
MJTQ[/9EZZ7R5Q^;?KFWU[RX=^3ZV/=+NJX=<LD%-IET"F$=D+U?@-_ %%\'?
M]6$60\7#EU4-*(:5V 1TR''F@0?#M+]NM2]17H3-?!3V>WA^U<OPWN:I\<E;
M>D,/A&M#)BN8C+\Z<PT+^+#13X?1A/2O);'"*M#6WW-SB1!>D4D,JT9IWEHB
M^#!7'ER:KA-:4EVZ2@L7*"9#5!DQ]9#0M*T,2,"Z%VT]0<MU@[?<BJI3H*H!
MO%WY+2U9?7PT1<2F'[O(=<JG#/-,@RC8UK1QNI(YUJ=[ 2+HPY=Y;9:FCETX
M1M>A4B-Z6C5/L]5,(S%4=2IH$01$01I1*(.24QKU%O*UU5^IC=*.I:40_)2N
M"F. VLD@T;[2.\W>7F]?:TY8@:;BD HK;J+JCK(W@FJ+_&MT5%3 /W25*NZ@
M2$C"TBQ2IFB.@TJN&/@U)7IKAN-%::CQV1T-,L@+;8#WA%-GJ-N-N)5XO4UF
MW6V$&\DRI): !.@>G6X?P13,EPXQRIRL]<8S:J@S[O)X%'U1>VU$CBZ\#7>U
MFA+TB.&HW-?+$BUL/&(+<+3)X]N-J6BG(BOHT^K*5JN@B*FP5Q$NUHF,W"VS
MFM['DL%K:="M.C)# DTD*YH2*G1CS\1@E[Z!H+VPHN*!Q)/J2$D=IQ=.C5UA
M(S;/31-F$ZH-BB4!IL=(@B43PD2E3-555KAN0P:@XV2*BHON*E<Q7"/HJ"ZV
M.F2"J/4-$ZQ4KDVM*Y]&'K9!=5NP1'?- F7'/M+H.6_UEU@+S:[E-FFA4KV4
MR]W'UD5<>SV4Q^MW%PE*HNU%JO?K5*=^B8+ERXN*<N$R4B%(,R-V1%%U!-HU
M/M.1M8HG2K?R:]W;ZC;C;[WU\;?9[>/^;NE\E?>Q^;7ZI3">-</?)];'NGY.
MZC7\&PB)3H4RZQ%B7=K%8?3LB+'E2'D.0U'B6^-%C'(=FS-3S3S[+:!\VTN\
M-<DQ8N<H7+4*=+N5JC3[E*4W&;%:B?<!I!6*4]+E(WAGU0%VJ;5+%HNO,5UM
MMG2YQ(;HK+D!%:-^1&:>-MC?GJ)!5SOKEAF5&=:?C26Q>8?:-#9=:-*BXVX-
M1,"3IQ=^1^5X_*N[M?+C5_%Z]Q[L3LCKPVCB[^'=(S+>IR:FDMW1$3.N&N<+
MRL/EYH7Y$6=Q$K1#9>8/3J;?D:2W;@T5$7/HQ9N8>57K/>6;IS-:;+Q!D[,A
M<-.64,AQHH4N-](:5C*I*B=*+CR8#?.(AMJK2J2YKN]B^42Q\[J\ B2_O4Q1
M&G"3OY![^K&3):>^I9HO0FRE,1N7K610[AS*ZZQ+?;-4<;L[ _2@;)-BRW'!
M#Y&K%QBWFUVZ[11Y9FO#'N4*-.8%T9D 1=1J2VZ".(A+G2N>.=I,?D[E:/(C
M\H\R/,/L<OVEIYEYJS33;=:=;B";;C9I5%3-%Q;>8[>X>F.Z+5PCB5!G6UPP
M67$<38:&(5&OPQ1<,R(LMEYE]IMYHM5$)IP4-LNMI6ABN6,O9Y:]S:B^+'MX
M0D^$BIY=J>]CIQT8KCWL=. >;2NC:G?1<"CC1)[J?\V$<'I]2JDJ#3I)41/=
MP7*$236R<KK'U VJ[N3>7HR.R)!?&*(W(W"=Y4+OXG2[QRY8;M+3FZZ,I)N=
MHM\^0C(6VRD#2/2H[KB-"1JJ#6B*JXLLJS<O6.TR#YG8:-^V6F! >-I8$XE;
M)R*PT1-J0HM-F'N4ICANV:_M/.QF5/[UN\<=X+C6JJ",N.! ??5![V%\VY3]
MC[2X34!]'4HB^7O95QUFV_\ K&$]^BX^]X9;,MV%<O(G?Q?KC;8X,2D@.1VS
M;50TE*I$![*J*3&_U#X1QI^IB';(NC?2WD:%7%T@.52,B^*")5<6!Z7<8%PM
M4Z[%;W'&P=0%DQS=$HA@5'"WBQS!%1*(H^+$V-;#;=9WBKPD5IWZ#L1(YU';
MTU3+%\>B6B'<KJU.:&*W)@MRW*Z8VL-#F=-*JNU,6B!;F(5MN$RUI)NS0>:C
M17A2IJ30?-[<D3;CE3B78-YM5Y9N;T=X65.,\C5KFJHFU(1:Z5TKLVXNH *
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M5XR-$?!=J28[3PK3OHX*I@#8LMA1S2"[QNW6]"U**+U2%K4JU\.-+8 VB=
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M4;B(3P'$+J>[CF!QFUS)4RR6R[W%F/OH8LSALTB/&G!OF)$I8BLNR@*CHH9
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MJ1*?OC!6Q9SO&V^T6Z?&)F1;'[;PLP+%&<4=Q4'FT(%'9B;;VN,;C3H]DCO
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M5RJV-]?A3;,MELG,4NWF^PD*3.<AQ>7>6[KK9CR[S;VK@C<JZ/H[N"5Y10$
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M.4W#9ZRUW+$1LQ!H%Z:DX1*2YK7P?J!%Z!S7NS/N2^^/K;7C[KGD]33N /\
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M0FJ%(%1[.'G%GQ!",^$621/M:6)+A"(L.EK1&G%4DZJYXE([,CMK" 7):&Z
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M-DRCDS=LPS=9@M.R$!7531K33FHKBZ6Z$_!@/,O7*7<'8EL=C6^9.M[+DNZ
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M"$POFXSUCF1'K_/:!%_@#2J4IV5QG[/=7U"F\X#0)M-PD$?VVS&F Q*N1_\
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MWU*US71'Y1169 (GEQ%D7ACEZ;*A%KANW>/"61'*NI%8](LB;2H:(5.^F.8
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M<4<C<"1'H09D&H="[PG6CD +-2IM1<MF$>AL6Y\%[+K#4=W9M'6*$M1Z<=0
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M44IX/;9;YF/C+J]%0(\P#\V!NQ-+2TW3*.5916]FU>GN07#)!!N9%-PB7JB
MR&B,ER+2FD<97FV_SKZZ8RN]M_G8_63&5UMO\\#&5RMJ_P#OC6%I<+;_ #QK
MZZXRFV]?_?&< +FDD(&W!4"1QMP'4JA@:9*.?CJF/:Q.?M0LE/;,'&!D(JM%
MHM;9&BHBI4M*9>'%YYDG/Z[B)*V32 @I]+VNY;,@T(F.8DL#\=EW@I'%H]3>
M.QE>5";C*33@B\5>G3X\<RQ&&G&I32"<TG#0D=5QYA&S;H(J"((:=.>?3A;7
M <MS-F=GD;KCZF,E7 45)*B+G43):43/'+'(Z2Q;CD\,BY2C7=#N$><=/4JU
M04<?<(O(F+WNWV!8D[V/ 5"1 >K):1H&?C5!,L-Q7N5WH\0I&Z*83R*@LZE3
M?::?%2N+Y;DFN0@><G;]QD=3AL"31&R(U%.NM/:Q;N7Y7I"X6V! B11APB07
MWM,!3U@"N-M[Q7J*6:+I3%_:O3,MI+?)9DVD9*DFG>*C!Z,R0@W9[-E<76XM
MH22Y[3H2"4E452-/<!K2&P.KWL<KI_\ -+G[KCF+*W&>DJ+\.$Z^3SQ.FX4B
M$9/(1+3J$O1L3'.-XGOR'9MO)@HI[Q405=FN 2:4RTHV%$1*(F.39$MPGGD<
MFM*X:U,A9>!L-1;55 %,79MO,O1F\HFW0PC;Q^-= +BVQ[]=;O:.;+;=8=TL
MHB]%]%7A8$EF4W$17&=XW+$VLPU><#LYY8JM-O1WL7:]NW2\3>>^8W&Y V>*
M]$]'VT&8T:(W+N'F5>;:-MCJ!76X5=@YXYC;04+B7E<BHJFGG8+8NK32BU6J
M43OKA$Q:+*EJ=D.0.85O+\@9J-!)C.L$P["W/#GI(@/M:ES2M,)$+ER8;4?F
M:7S+ 1F[-LHRY(-TV(SU(9*\#2.9THBKABU.0$8DMWZY7MV2CX$T23BD$,4(
MZ,B0[GB$34I573B^<J/,^EAGV-NQV7=PK9O;8PUO&W=>BW'(N0JPNGSAZ@7K
M(NK/#(S6W&G6C="CFCL:U4*:.^"IMHN&@O,AIB,D>0XR+\@HT=^6#=6&9+R*
M-(ZKFJ51%ITX_1X3MPLR+%:N,69Z-D,\%%=<C@T@I1?,LZLA4M*+B\M6^XPG
M&Y<TI9/16X5Q8<1XS>:H^^PXJ&(/]9!HB+BV.(ZF_'FF,LB."IOSC/N5=K''
M2='&M2CE1=/3CGJ(W-B(SS%9$E6^43X\$1.[QET7)2*K+5)CFG-4IB'#63&4
M+3R!-M+TI'$2,<^+PZRH[;IZ1)UEEM#5$551"S1,."HEJU9(J44MXJJVOPNT
ME/J8;8HB&V%'>KI572+4YO.L55;7J(M!ZHIEZTU]T#[9,?F]_P D)ZFTI:HO
M%+%.:KU7XS.C>I$T??#K5=6A>_LQ<K3<+)'BIZ(W$,FIL4R>?;W+0-E],,0U
M@*KG3$KEQNT1FHT^9Q$B4<Z"K@HH1Q4$W<PNHO#)7JJN+=;(;K97*WO.2EJ>
MEIUR0GGFP->S14&BK1,L0;SS#'C00MP,)YAU@SD<+\UU6I$CKF1=8J^3'LV;
M:=[9EAGF7ES=O21W.IHG&&S:=8:W*.)Q1 RZ!MCB[RKVJ!+N[+C!M-N ZH"\
MKBNN.&WJ!7"<+8BKB798@LN6J9*;=<>XB*('NOFG3$W$DA0=HTQ9(-M=!V=9
MA-*&:-B_OSWSPB9]45%^NFN5.G#7,O,4>-!X8!TQV'FGMXXVPK36G=OR- H:
MZUJ5:IL]5M[MO7_Y5;\__=A3">3ZF"OO"?[K)U%XCB(O9X$6?FE=WZ=?['%R
M,H=+-*XD&I"2(B]5'%<C*K6^WR5&HKU>G%R?@66.X<]IR/K>FP?--FYK1T!&
M>'71%Z<7R(: ]=;LVRB1FW6Z C3HF#9/F0,J5:JN=/#C@[BQP[_%/.[O>LO=
M4M%%0F'70S\>!>N-OC3'@;1H7'@(B0$K0=HHB9^'$^=*MC;=O;)QRUFKL9S<
MFCJ;@@;!XG!)![XXRQ<[T_%TVZ3QN[>WT8M>]5K=INA=5W/1\7#',MC8CSG!
M: "C/.@SH<1@XJJFMUFK>Z+XU:XOT&4;8W&\4<!G>:P85H@<!LG UAYPD5,J
MHF+KR[*MS -[A?1VB3#5YYYZ5OG1<=2838@.:I5 Q8K8W;ZS84V<](9XJ$F@
M'2-6RWBR$ ZZNA57%HNO!5@1HMO:?>XB)5LF8I-NIN]_O#TDO0.>+]"M\2+-
M@WHV_I126FC;!M]7PZCCS!B77H74+P8Y<ML!D9SENX@Y9"_'9 3?,7%0.(<9
M(LZX%IP47S2 8K2B]322=ZBX](VL7U@;])$=^/JW\%T5W@ZMTN\:5HTJ!Y>W
MA^T3H''<ZQT&';+ZY]YN1E'3QUR9KK=N$9$V#U'2HJTSK(N,HY,R3/E+)N=V
MF:E36Z>IUPW2R(J5TBG>HB8B6Z(FEJ,*"A;")Q5U..DM4Z[A%7P5\&"FQ6_]
MV33WK:B- CO.$2N150>S3:/11?!CM=[RX3K8WJJK,-"1%+.KW00MYHF7?7+&
MAAD!38I4J1='7/,CQ0TJGN^/R812 MWJ5 /H733.J=DNG&WR8VY^WX\;O?OH
M&DP1M'CT(T\J*\UI143=NZ4U)TTSQKXN7JWB.:^(>U;Q&]TCJ%7YP6>HB] Y
M;,(#<B7L:;$1>=7JLKJCMBB+32R76%-@KGAY^9J>G$3B(+W7W9.T)V29ZEK+
MU[$5.H:57/'N^7W?6F?NK?VR8_-W]6Y^VN.K4U\"Y8ZHB/[K&WW,;!+QICKM
M^4?K8ZJY]Y<EQG^K&%W2B3,9B-\XBH6Y!&]5-W\(1QM^M^HJ?\WE3I3&\.T6
MPW%75O"@Q".ORMS7" T -@*4$6Q%L41,D1 %*)EWJ=QV)+:%^.\FEQLTR7O*
MB[1(5Z4SP3]BE";:D2I#D*H&WE72,C4H.YY)5!PW%N,.;"B#K5Z2Y'=!LD;^
M TZ8BV1.+LHOAPRPT.EMH! 1[R"F2=VBHBITHJ9+FF2ITI@ETF!:>INSH"%1
M$J39"YJ'+8BCGGA:/JJ(%:DT0DI?%H!N)Y<&TKPLZ6S=J:$M1;$C.FE%S01P
MA.E(=54<U- C<80+3YHT>7B%>2JK5-V"]XL$+#+; %IR%$(^J1'\^X)/!4RS
M051%TI7'L_7S];9^ZM_;)C\W?5%$5PQ<%](ZD3#VZ1XD10;5_1N=1(OQJX=E
M[Y$CLF^VZX=102CFK;NW.B$GEP^:/[M(S>]>1]MUA0:+LN4= 2(%IM1,\2'M
MZ8C% 77D-IUMQ&BV.HV;8D8%T4[^'WU?W814$GT?;<8< 36@>9< 7/.%D.6:
MXXIQ9 LZ]!JL24BM+355P590@"G2N6&MZ4@-ZVKR(L23J%H34"-T=W5H45.G
M Q!-UQTUC_-QWW01)--RI.-@H A(72N';>#M9; "XZUTB!:?(JT-*IT8CR1D
M>:EO\,QU"U$]6FC3T4RS\/J-&HFG!)'67@54)IT=A_%+PHN6"A3$W<]H=14^
M;DM_^(87O+TC\%?64T[%+K83U.66-+O6'97I' D.8KL]8<DO*J--#J-1126E
M43WUQ'1T'W3DN[EIJ.V3CIFC;CRT"G91MOIPE E$^LHX20DCDDSB6F]^XWN2
MI32QUZUTTQO!!YKK$"A(;5IU"#;45JE/"BJF&V020@OFZU&DFRHQ9+K"GO08
M=KFH[HMJ(A:5IAMH$?0'WG8\>4;))%D/,?.ML.IJUJW1>CK4RPTV(2A"0XZS
M%DFP8QI3K0FI@PY1:KYHJ504*F%874A"V#JDH*C>EQPVPH:]75J#-*UPPA.)
M])>6.T24(5=0#-4(D6@)I;7;A77")6TCR)6ML%<'=1D$G,PJB$B.)XUP3E5<
M02$%%D=Z:$1(--(KMSS[R8=5MYLD9>*.[UM.EX:(H5*B+VL5Z*5\GQL^BF-Y
MO W>?G-8Z/VW9R\>$(C%!782DE*5S7;T(N%H85&FKK=E2V5RV*JI@'%/4#C[
M,85;H?G9#@M-CDN77<2O>P2:PU!F0ZDJB?99]6N.U\'4FSLY=:E>SGMQ'$GF
MZRS5N/0M2.F+;CRH)=FB-M*N!=JK8F1 .]3=$JB>FFD\ZET8ZQ@-5HE33-5[
M(IWR7"J2HB#M4LD\:JO93$=3U.%*=1F,VS1PWS5%)-WF(JFD5Z<"3[,L@)6Q
MWC#!.-ZWG$;:;U?QCA+2G?7#&]A7(>)-&VDX0NLZM?-;?G,J^+#@E&N-6&&Y
M$FD0BX9MT"<17D0JHJ""JJ)79@# Q('!0FR3-#%1UHH_&33FG33!NE4A;$R5
M ZYEHS(6Q'MDB(N29X<#>5-I^/'<"BZFWI* K*'6FE%1T:]["F):@1%6H=;)
M*]Y=J8C]26T$L26*Z]&,&G]+:NJ+;F8J>@56G>Q%H$MEJ=]Z/OQB!EY=!.:1
M.I)JT-DJ=^F(@BW+:XY%6(;\<VFY"HTKJBT?6ZVC/.F)D5@B)R"K8O\ 5\W5
MQ741 /X:B3)(7>5/:]8I^O[]<?)R]O"83N;.XN&G!6B@X*KTU&O72GR<O+AT
M6_FT-=UWE;KU>E5V>NL?=6_MDQ^;WJG)J/QQ:<GLS-DE7T1H1'0B;WA5U4VJ
M"JE<3;<\]'2+(>D267&VW-^#SLM);>]U&K9@"IT(.)+EP?C"^<-(3'"-N(V&
MEY).]<WQEKUO F54%$KB84R1$&0];RMK/#M.BR($^#YO.ZW'#52)O8BI2N)K
M\QV [*DQ680 D=[@MRT\3^ET3=X@R,BS*J4Z,\7&W'(;19OS("KYQX@T!-#:
MO.NNJ)*-5SVKEA7QDDPJ0%B @DZ*$>_1WS^[7SD=P$42'+;CCFUBHU2 *M*L
MH2 88H!;O=/MMDBHF2&BX:N''(;_ !DE^2WND0"9DU0VQ<T[U5!&FZ5JF66&
M$XD%5D8:Z:'N]^S(;*0\"5R5]A@1[_D7U&L6G'W2)&V66DJIN+T:EH+8I\8L
MDQQTPMY-(% 0#YB(V5/-1T7:N76-<R7UE1),L>;<R[RICM#[N,S3R)C(Z^YC
MK J)W^CN=&,]FI=%?B^L3&8S2NON-4;;0@#6NL2T5<( V#\9,6\_1,]L8L\G
MG6VIL!F0K90Y+>MMQNXTR-Q$7K5\&'PDVF6\R=U<EQP&X,^EH@G&;:W_ !22
M$%PE,%2B.ZD#+/%)$R2PR,A] CO\++E.02INFI,D-0;Q!JG56M"S6J8M%M>A
M&RW:98O.SM\PK+[<9MYN/N$:?W^\?W@UJ(Z,ZKBTVER&H-VB2RX5PWK",/LP
MT/A5::1U9.I_+4*@BAG5=F(3G!R&W6I<IZ:^_(8<MNY?1W.!%!X]P^I&.G2V
M*B.I"KTR5&/O6'6+&"HI@B%PEZ65)%45W5U&,_LDV8T\"SP'IH)>Y\PC&X]&
M;DBW"$*:>(Z*5SK1</,1XB".XYJ:8; V  4GR&C@B(Z^HC@"OR>FF)'"6I;<
M'#1F76U.$G&/MSX\C>)N']!)&: J&:ZCUKXL342TOBOI4IS3\4+08OBZVYN]
MY&E.($D6B,D5"%%'75,-Q>':;DZ8ROQ&=#3;@,O XY%14<<9;WS(:<ETY[<1
M'F[#NHC,TW)=K1( ')'@]VU*W/$'#+<NEV2+5E7$99%O:X8?3Q-0W"CN##2:
M4/@V53>&RE=!%U*B%>C%>#;;_P!QQHTNBM KLSCHRH#I"53.BKU\_&F#?BVQ
M;=%XBQJL35$;WIPKGQ,J7NX[YLH@1U$4SUGIP!2V)3K[#D]UV0(6I&9Z/;^B
M%(%1G.H^AIU'-BTKLQ*;6(CY2!C[OSD9_A(?%[UZUM!*-0<<8!5("+S9$F?P
M:L.G:R?98Y@=EMLNC:]^,)^RC%0]TT;<4-$_K*(Z5JFJE<1RF6KTDR$.XL#$
MUPSX:3(N#[S;VE]\0493!BBD)*;>G-,31D16Y$E;#%AQ7")IPAEM#)ZK;CAI
MH)M2;H67CRQ!5(_&LQI8O2H-6D22WN7FAIO3%LUCNF+B"I4)4Q ?*W-MQVKY
M(FMQG.&)8,,HABBH(&0-J]*1'% %722^#"M1V];BR[6YI0A&K4>Z0Y+O6<<%
M*"RRJ]]<6Q66]>XN3#[RZT32R O(1]<DK36F6W%UD1CDMHZU!1IAJ2TRU< :
M%Q)4=Q=6\94D6@E4,\1UMS"!,@%'D08Y& (BM)NW(Q'K4$%8IF':ILHJXFQ=
M.]9:M=PX%2<;U/W.ZPQ:?U:W$T[MUHUU+1*O>#$\?18J$J?9Y7$?1!!QEE(H
MR6W*.@Y7> 9$BC1?+G= 1@6&7I[ST5H-V@;DXL4$TB"T;J^)9=6F+43_ !$H
M&H) <=V0UIMLY&- .M() +K9"JAM-1K79BR5@RX[D%468[*GL28FCA7FB2-&
M;EOJ+Q&2:%00TI7OX@"_)EA/BPB!D77FWH\*2XP;"FVTV*"YNP<6G77:N>)#
M8R8;+'!0&&Y$>&:N$<=R:1KHD37_ #GTBKA&G7UY;%P(F>]-!1"<H@ZU3:6E
M$01U=[UERO05/K83#3X(VIM'J%'6Q=;JE::VS10(5U=.&K4D&W#"*W;]6_1\
M.NM6G"U:T9KVA3#3ZQK4I'=I(R=Y"C]:*U5#;8'=*J'I%*4Q-X4=,?B7MR.E
M1TMZUTI1<TRPN%PF726?B+UUG[JW]LF/S=_4?L]B^OTHE/"E<9)NU^QV>UBI
MDKE-B4HGEPE$1$38B;/6">?<;99;34XZZ0@ )6E2(J(F&=4^(/$9LU?;3>)K
M)K4/6[&\%4KL54Q(BMF)OQI42*ZWO&Q75+W.@DUDE4$GJ*FVJ8X=F;&=>43+
M=MNB14;^<V+M!=O>Q.?9E,2U@QW9+K,=YLW";9%5-0HO6&HTU)U:].-[*=:C
MMUTZW30 U=94365,UTX"*LR,DAQ!4&=Z.LM?S:"E<R<1<DVKA\1G12*.A$^B
M/ N@0R,E6M%0"R7O+A*JAEOH#1@BIJ;2XRDB,.FG0&NOD%<-K'= VR?FL$6]
M:3=%"WJFI"1H1(:,JHTKU:+AW<3HKNX;WSJMO 0@S_&J2+3=^'9@DB2F)*@*
M&:,N(:@!$8B1(F:(2@M._@CDOLQ:/2V@1QYM2<6&\C#R@@$M:&J9;:8XXY+
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M2^8IXE^I$Y0P31=2S/NJ]!'1;^BA(=EEIK4#T,(U<P'(A!#AS#DVOK3&5H&
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MZIJ-4S%&;Y,P&@+P+S69Z]$F5V2+WE[NW\S FZNU  '&#U,-;P#SKU8$Y5Z
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M#"$<;G-]XBWG5,>,]J[YXZSGZ>97!;6P%  MJ.RHSQW841-Y,90L [8#I!=
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MH:R:W9>6\6=(NW!,!P[$8MU+0JN;O<W'!B4UYUX#L/+1-QYXC@/ E=_#DV*
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M?JR*."I /HPHM1.D"[BEC3"1A]&KM/T/CWQ!R0"@S3ESX#WYH<WAG!<IJ#E
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MFWX80Y=S.I3GJ:7Y8]_'M1!>'F.UH2^AE1E#4.L162B::056"JEIJ\W@;[E
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M1O G4GM]$*@WJ%]AWK[,,>@^0P;.N/>8N)!O(!G,KLJRX6HBTAOA@BRZ6@'
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M'_%C#^)X\_\ %G'@>//_ ,O,J)%NLN^AE_Q?_@'\#^)X\^/'@?P9Q"'\&/\
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MJ9#.3X_4L;9]@F/#'AJL*CU\6T*"7;PK/^0A1;U2MO2-8;[91SN%("B3PH#
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M1,=/"_YBX=IE/6#YZ1&]9Y+8 W]6&[=);([A?R-?R-1U_P#  W+9?PM/'/\
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M1;-3%5,J,P_B,R0J@ <,RO2(7*)4=_QJ7+R2H%J<M1XEKP,W!,ZKTB-5 ](
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M\>%8U!7@/Y(%3$[OV\.F'63:,SDF@@L@."!99(R=GZ\.:'@%2OK'P?Y"=*L
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MN(7<+ZU3$18M6B.<9C+JZLSH?6" ,$2UO&I7CF_X4+CI?_:1)IXY_P 0;33
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MM6T_/'XFSU^\[7@Q&_5\;KQKOP%CI.D /WF 0F9_ )#4.LLC6CZQ"CO^&O\
MX^6='Q%_DO\ Z#X*@U"\!-I:+XJNLM+=66ZLMU?XG#CP7-J6[V#]HNL5L9=<
MS&&/M%E[GIB(3#O-NF_7%?=7?@2$O-8<(-;GWE"35GI=31BHOOC J.-=VYK_
M &(1A==_Y+A3%?/K,EQD]<?U#W3B,<GM$!TWU@DHF_O7$!>5.;8!6A-*FRGG
M@PYC6?XF#4W]7]S4-:F1M]9N/-_N)@$-_7]RB+"VQ2LCBN)Q!5N[S+7VABNV
MIDR8OUG>7+BS'\+3'$0L2/$/:0MBN-_VDKTC %'F9L-9OP<7Q-_K_*_#/\?-
M.G@\D_F'FG[SSS^?'EZ\\_F>2?S#RS]YYY_/CRY>>?SX<O//YGDG\SRS^9YY
M_/AR\\_F+>9^L\D_F$!*Z\OW@8+S+^8!Y'ZP?^/CV-FQ*?P%"A0O,?Y\(7EC
M]_#%Y!_,6\C]9Y!_,\H_F><?S'Y['?[8UC5^AY;UB8%WW7KW4<K%!A%/01-[
MM/:!FV!LOAGN34IDN;*[08BG@G#.=7'4ZO0VGPE8J5=S<<90^V(KUN/K,P'1
MK25P^\49 Z>/>"#@6R4<9ZRHJ,S@:-_2#MS%TX;S%)[_ -&HZK-N]7S'>$UV
MOM*=4'925Z5VB!*_<+ZNC7@ M1\ZZQ,7<.M'4V1OVJ_,M-I>?]I3CR/K/./Y
M\.7GG\SSS^9YY_,\\_F>>?S///YGGG\SR3^9Y1_,/(/W\.7GG\^/+EY]_,.:
M2H>>3S&@J$5:7U?Q1A+/+UC'05BM7.:G5GEYGE'\SRK^9YU_,\Z_F>4?S/*O
MYGGG\^#+SS^9YY_,\\_GPY>??S&(U^)]9?S.^.OI/__:  P# 0 "$0,1   0
M   1DDDDH                                             $    ,
MDDDE C!HD@C*4, '  E   D    CD( @E                 (   !DDD@H
M$<PNP .Q+@-: $4  &P    %@0&Y@      0V$9!/KWU98    $EMLE@A'=?
M@6.RY M+M>%CSN<!<RKL8:!12T    'P-.KWKOZUQ     DW2DH$0I/Y/1PH
M@ ]JR>@Q]?\ ?I#C.WNSB.P    /%J.6S)=>_ 4  +:X0+)0,.>NX(-GPA@)
M[&&GTU/ L,T)!8BT>&0    4NM!+V_N I#@ -QX@!HK    (    8  +?_W;
M8      +;;_;?Z@![?R.FFO04+D==  /$K(QUS7ML         OZ1&4+Z+MM
MEML&VRX._P"T^DNLX FP9>>R$KAUVQ^23>D_I8  #@    " !78@H)M%,";8
M*\I9Q>2(=%D2$]'N+MVWC%&R1@S!\TVF>#,;$9:='7/K#3Z59E:H7B/KX+;5
MG69S/]R215& (!(4<RJ4G"1!*W+5(;?$7#ULZ!AY[@FP2INC83H9 =FJ(AZ)
MQDR))V>Z1C.U_81JYR0225*G.\'$EIP(HO4E"IJF-+;/;<68P6CKHVVRAQC9
M.GQ[ GLOZ&#+)DHEM5G:;57E^KJN$O?)(PV<^K5^3P("S9DH71)MN;VC<2+;
M[A]""(,K'H$$OTAW:VHC+-V>/X7'8OZK:-:RYPU+) S][LL] 9D4+\Y"5H79
MP:A3#;M V"(_C?@S1J.W=YPZ1-:<H JFWTB0UT'2]8_1$_+RU9.*@\5N/K*
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M7:U0"U=263'2$?LA9J0@G"Z:S6"MQ7LM(*:/F@2@X1LT@CD: C)ZB"M_P<*
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M<@QI"&V9V22&P+_%DK###02;J%BPLL,@68MB3*PM"\;Q_P 1TIEM#7=H(T
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M$-$7#BP0\[0B&KH6P(.'5C5? "6&F8BZX,0'%L ;H%TS_P!J9=T@AD8MZO\
M/LLM---B;\L^7PKZ8?0ON\5??/*KDB[D]<>5]/U?"7VERG@FFX[?!%"B8O\
MZAGD)UP4$,5$JAJ%6]%F3GUCF$IQ$J5>","M2$ND;-:0<XJ0AJ0?X7S1Z'@_
MD^YXG&4$B:.<""X&)Y11F&>%@#(H8DJ5BRF9LB F4KQ$(ZLHA$*.N7,E(2.B
M@[*@BB"K    !QQ#!(%H<N>]#48@;%Q-)_'UDT><),>QSV SN+!4:QJPUAO\
MN8_^B\@GY_?K6@3PI5,?KOQNQ'%0C2]'2U8Y$2I@%"G9?[D6*E2CD1;)'U1I
ML- JI:7!0/\ R]6;P0!1))DO[A^Q,J[PE%[F\'6Q=<L>5@ZT=OYF81:"K61&
M[T4T!NLI=0OLO>OWT4_; GJ $060MSEP%&Y'ADP?TT"[:W7??_XCB@&QYPZE
ME7=6*%<";*:>@->X%A-I*O.PU.FLI@JKMRL)6^: BP_P5E,)^/H2BB&Z</2#
MA7'0<5Q%Z%'&D'<RTMG($N:2]1G5@\[BC:\R)+MD5-P@4H8"]@7\=H?R%P*<
M&-FN$"5#+EIN,D*4U C*78M^F X+^,23Z#6LE\D':S-$DFY3[D,DG?!S6N:0
MEXL"]!9ON8A\2 -BRDH)&Q(!+):.BK58 EHNO]<,XO@/(@Q0DLX.K,+*"%O$
ML10>RI;D%&]7(Y@?L!M$&/#(_"!GWWG!3@BM.=F@*OM!H$$!M^0"V]&83",<
M'%P).+L50T[X(G?1ROPH_P#(,-@$*7:@;"YU2F+C]E'Q'S2D3!HC4+WMAK0=
M5!@.7M26W> LKY4%9%P=)UJ9,!77 Q*##48A #?LL-5@T*;7(:$DU"J19]+^
M<5N.#JQ?0P@L ^X .J=;2=C4]QG(.I"-R,0\C=3FF09FH#+N8;U1Q;"H#.&;
M!P ;'9*$+0=@!J X(7@>H:2ZUEI0&/CL.G+A#A8K@P4@H0@B@A:EP .'.'HT
MBW0QEAI:*P%DE@58)+0*E+@H1K*!Q[3$V>7'_6F?5'D-8%&10HY"G$(VS;RA
MR%0N##=8:R&,DT?AS"4)FTS9:(M]J?X7S(/7P=>Y]SQ7 N?<A $#8E)%I0M
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M:BMG1S 33]OW$MJM]L'WC5L^"-^OI1'*+#'5FO1 "+>N#/EF'2>K_<1UKTI
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M[)D<5+(EA3MYL@3=8H$B,SMK"8J-1Z:+Q5$!B\^6 YYP)6+%?.CI+(AK5>1
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M8_N$G+SP=7N1+DHN:YIQ&@7;?;WQCB$[H?:M0(.PX'CMFYMS7N_4MU^C,Q^
MX^9LI\O>5-[WJ_JC$*1SV[<J(HL.-[^EP:HW:W9'O*C5IKTE"'27.!*[1)7H
M?1@AZ!]QEF0="&*%KTO+*BA:"LN^/664VB+"LJ%JQ>6/:JNG:X(8YXH@Z"+$
M::BKI5ZM$#T.U(&$.+#-_=:04*]YA.\'+>"&JHYFQ\F.HJ'Z841"U) "$LD2
M@':(&6HKUTN4UI4*P5KH:<V=, S%JA#<J@'5(+"!4\^AE FH&8$+.'3?KU(X
M:$HG'N932S,J3/7 =/G 3">;4Q1[;@$-(31,PZ*!"W; 8C*$C!?> H8S>9D9
MKZ5;/]H+MN5(!9 N(I"G25KR;<U_24- HF:CDZ$YCT)LB\<WES@E(ADW2B@<
M!AZS 46@(MU&]G0BQNK*P+*V\E-1QS1FNGI[LPN]VIVNPM8I(#1I1JS5/2T+
M"(NUA;\C0!OK 2Q5=*M6V.H9)5;? ):Z6,W--^>&5#.@:[:X<W&0QI=)FSJL
M_<N6!M!G"89R"MI#<";COP,5;K+#Y*\-JO2@ %*SKV21%$+<X"5)1N&>WR:J
MHI:FYTU3@$2E<E6)%D11?1+[RF[4);IAJO6QYZ'K,!3:J:)-"YM YX@&G8VD
MTDRR-(!VLVBB$:J#30"T 5T?#=&$= , %;$&.HT$00?;/HVJ'T2(%>*W-,&8
MIV39KI=@7! <_I_[8 ((UY.:PER=K^=S 8T++N>28.'   "I5#/ 9UTRW,6%
M,/>I<FP@=#$W)]_PA6[R;\!@!_*PY/K1Z ^\%M_+$:AE56CC'H@M!](!DN^1
M>QR(:J&2UJ2TJSB72M?SNST_'N+E_7]\Q:5@6Z5V<W!T:)=<::>CN5'%NJXR
MQ@LJL.^>YC^4-#!@@7?%RZ:..?SB=\^D+OZ9;LK&NF/K+0R/2VY8E([T.Z>L
M!40>WK>K@6K)C/76.N&6X ';R_$P*:]%@!;;.'BQV14O'7VS\Q &CN^W3F7,
M+3Z/TEJX^+?6'HKU8^T8K)?9PY?>. H!0/=K%7UE!38'=.RK(NP!UQ2W48%K
M7OT]4#PUZJ?:8V>O5S[15%F:X8EEHXY/M%0!O,$L:KR[L%V,>TMH5M_WVE2N
M1C_9<@I6]0LF%7C\Y:F]N_Q:?:7LXT=:EC,[R=VH $6"@;H"_6A$%+/Q%.%$
M5ZY6=6%*9-FK*QZXQ$5G 1>HFD7 =JCV3R[,#.K=K+B+MO;'FQT". $@L?30
M!'J.XL!;*6W@T5W*O EF_249M-.8'576A18 &2@P!K.8W *#=9+L4M8B)2 "
M(F6G,E+?!&6+>Z&RU18%$^</!;L)Y%N^S X@AK=^6A)67%\-J/2-Z@<&O,*,
M[W?7R 8Z+HH-)Z2]#%KQ;I/#4XUSV4QK#5D>LI;N:#L4A:TL)\;6B+P: U=!
M(3]@L1^F$T1:(<:@!75:!'#I,2IZ"*L1P!TQ:%UT/%TYWUEC%5F2,5L"IK'7
M9B&8%1<<#W VZ("J"T,$@<*WTJ6'6),)NQHW886RGHQ"E!N[JZYUUA6<4V:%
M&-NB"W-FRBZW@OBXZGMV=^:C/S>DF&Q.KVQ7S&)Q?!<HY-9AB@JKJ91A!L5W
MV@D0EG ."@4P#!#%;M^Q0?#28S5F%!/-%C"&4A?=84^67>0>5JHI<T@24E1"
M0OA%"RIM?22L*XCEN5W#UZPNX,"X>L$WJ3( 7Q$R55H/$5S6#'\E,>1>D 2+
M%ZMYU4H9$)-N8[:/$J(!16%RI&3\<^.XT5F4(4V9?0]X4521\TA3H 6!P1[6
MX#MSIYN>T'^+)A934&Y8L*" ].>$QH)YD++47F(I*++<JQ$1AAXY#.-!BUI-
M@7H Q;<Q86[$E*@W%W=%V7@*VP*]70H2*.\+#+605(D?1!W&BAAA9ZVJE*[S
M 7H: %A9B5AD58H]&,Z,&X*^3 HX4-D#032(H-)2#=/2$"TQJ7!R/002R4?X
MU"@ Q>M979PT*:M)8^CS,CT3H8W!S4O=%%SN_6Y3MY%P#H'GI0NH_P $U=]^
M8+C!O'3+WYN,N3P:[=<0J*9..M[^*E@BQ37Z)8X'4?C-QVJ;9NZ[2W?YBL14
MXSCJ/'1 J6WR8Z>LRHIQG7OWE:VW;BO;*P;_  .-XPW,;Q>W<$ZIWW*B_AQ7
M7UN&:E+5H7EOAJ=6,'/H=(E!6[VW%"W]]XOZ$LE61D56NQ_$H:RYN^?7$QRZ
M&+VV>D?$.KGM2-;T6AJ_B\0%&8R*I6X4 ^5/U+E'%-?W@JCGM?L0#->N>OZF
M;;T4K[3,U]7]QPV;-D92]G'7WCWKP]O<Z$N-*HOZGI+#15F;,8>T,BNAZ1BH
M*Y?Q,"UM5JFUP-],3 <VC22HQ3244%P(U<:64W@M!$8V*5T:M+[ K1!"8\2D
M;\[U!."%G4XE4-*P!1 3/.DG?)OH6,3-J5V5;H=865F\P+G'Z:\"TL AB5N'
MI4LXMAW+14$)HO4,(,5JTL!L30+'(UD$B,($!*Y:LJ7NW]XQI;9Q:(]H@XQ>
M?R%33,086P,'K.B&*RL8V[ WY*#EKFEBBR:+!Q*P@5J9MC&'R+#"VA>H3<#A
M[T?I<]RXCB%_)ULZ5F+P'88P(YCMV^J"#I=3W"HNP"XN !:;=KM=*!2%D*H6
MEB<VQ4;P)K,TTV91'6.![-0KW!S%5S5PD)2@%[/$P''UF#EF3P0NS#?6$PUF
MC1TTE4(->!L*V3X#HO$OTF&8-RD=G"BB8*49L ',$>FHPE<#P((T2%GN1PN*
MY[ZS?*OD::E!D'B94P,FTE69L^J@U@K P&=@.)FG/*LR8C+NA067W<M/.?FN
MQ(.*@(#*1@# "GE^QL%5[92-(UW477.K[G$4O2RG)KYN>J?48^8:%DQF7A$M
M;--%%O$6@]K$E40$0,?\9\D=J;K:@R,',"I%'!*Y"<4) S-P96,YJ:15"1!+
MDJX!,!4&N9+LYRT!9P)!%\]48*HS<V8&4+:?4M)- %")%(-50A^W! 9"WO1S
M54X8/)4)LV0U-*0QF%%',L&&C=Q AL8M]^X\"1EUL6%I5LIE!]GXS;:DMBK1
M]Y3GMLP<R\'G)%%F8$HB^<75?TC"0&#FZAS_ /6@0"R:QB$VF["XJ6J=.N'L
M3G Z12W&;JI2;F5$.8J2CUH3N-VJV;;W$Z FPH-TXJ,W,.QJWF=SZM_J6$KK
M^&8*F>D@+O=W@BFS]CBI9_O],,-8#WX[YA[MT8&:W9J;1RLJS%<7C<]7X_IF
M-[Z%Z>LP#>^:/B@@0>AQ<<!*^@XZW+6G =G?I,S+#?'S]8H4ZX1H]ND0I]2W
MDXQ,UN3BO1CM&P*?A&-G:].TW'C]9XBVB.APK\1AO/C.;K]1UMQC6.((1L Y
MI$V]3$U *;SD7' R"O;B]X.BWATK_)USFG)ZZ@46WN&H9KT.D$M6>T877A?8
MUQ*3QFG3ZP71]8K"XZ&(9D]7TYA^I5^*ISV/5Z]NTU.A9]NT*J_,^81EDO\
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M@ZO:$OR@F@MD),<P_0<1G;314)%Y-6SYT/EDIO:*P( $[!39VI0%>23C06*
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MM6*!&S %-C< 6.0<@PX>J]*3Y=Y2%>]T[7A\W3F[U."[+KVRW[QEK1KXK\S
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MCF]OJR@,AB[*?5Q!87OUZ02%HNP5BI3=![PLD8[MJB;X,3H3,WB@'KD;^D>
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MP,$CNP<K;]C= LJ$U8O)="\M*53;B"QY'5DR:R&VK#&D4F"!BA58.DU04 4
M!1NCW8)AE'-NT]:W!#M=9K5/Y(;&*UAHU;^8S:KPC&MI\10S6=T.'O ]T^#]
MS"971G&^NH\@9Y9&:B@DT3,2XBH;JN\LJ5-M^@"1 $%UC$UB'IH%-*$[6&D6
ML"I9JKV5C6Q8>FOX)#% -*!Q,JQ0YVLL(/Q,5!2)B9 %+*.D03AM!('84JR]
M8!3>BK: UFH_C X"I!7:%6<:UF!G,YQ<K]=<< 57J8'8%Q Y$J Q$WS59%F1
MF(08HFN0V=2D4Z$*5%V@+SGA[T,Y4CA6H+>K7*PL\YL4&(756#7+2#*"TU2P
M[ZS9^A+92C#W^>5V_M*+L%;== KWA?E>/C?I<!)0"\O>JE+6P^X_:#+SNA^T
M_--GH7\GYFU<K7Z1P+CJ[_%D%: O2X??_$U.PS$]VCX7[3;X?:989R^P^\8L
M-6XP.F6+!BNA5MGR,UJK^V\5=8G"+ N[T?-\RTM-=^GYE0STP.SXYC+(M%>H
MO@T05/5#-OWQ"0*CSGG/$0RQ='>S^XK!Q6\YLN.N@68SGEJR+SR-F[])L$G5
M'Z8A@I*W=O/M#"AO=9<O$I*\N^)?'[D[/>8HO?>OM$FK@QG#!*&A?5K+S4S!
M;/?IS#1=JCA1FO:"%NLM]8[,NK]']RU-R,.=YATM3'=B7L!UB%%LVX^26M.'
M7H!GV/BBD;X^G&C: C4;<-8WPPD,!44CP'W(+!XIL#H2H;<F2:@T]IXP0](?
M)>YH:HRZ[,HGWEV<CD8C*!P%L#6+RUSS./7'W(51=<_!BH05@*:Z-GQ%T)FL
M:WCGB4D+<K[RXI5$+4D%MU>X,_V:"'J7*%'06/OTANH#" AJD2,#1!!$NUA8
ML+P%$R.VYD[U@SRVC%Y&BC&?IU B'I1691UVB$R88,^_J"F: *"#&^"*N45C
M";E(/S@AOK(%"HPBY=M@.6O>0&NU33=2*UW'@._]+!@8C=NF%WDT^=E:,ZY0
M&]U.UR04*S@=JI\: 7"I&4G.(>^-$LN&M!V@+8)0\6MI  ;;W)80O540>%4$
M/&PC 2;H1JEO6,.P"=%UX=Q#JM)18G";8BXD!X%8"B@K1XO7#>#=!8O2DBNE
MLE1.BWIP0L%AU)=CC<#;1T2\[,',7;'N/XAN+JD+5<G2ZAE%;OGO/);.QY^)
M<OFM%6VA@!6KMW05P+*"\IU.4 E#8,<P$\CAJE*.C4K4A+C@YP6L1 %@ , M
M%TAF*6V"E70SRZ!++> MV)249MV02EB$$0@X7(GYAI38C7;N',- [+((.P?4
MO6HK4$>$=$B!@B$?ZOOH!(7!7@-5VI9GI4<N WJ# #^FCLB.HL0%=QYB-IF6
MHAF>]TH:E."?FE-<X-0*H,JCP0&0='Z]S0;^4OP]ICRZZS?AKBNE2A6Z N:S
MC1TE5;J\==)+@75CQVQA_AT3[W%MU7QU*ZRPMW8?1_J7)ZOJ(S;JWT*'/TG
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M2VUZ7U<=HY'8^U3)=Q6KKDSIZ0GT/3=UE5]%5I;F"SEH?=.*#1<CG0E"DZG
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MS'%A+4/;]5%*IM')>AEC2P!>+R]>F835E78-!Z>DZCW+C?'=B17U_&T. '2
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M1%7B@4"B$4QUB@  0+"&J$K+\PT*+L+=!+[P.<]X#*VRT(,&"U4=[A[LPM\
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M +A9FAT;?S+8OJH8]<LNY?E9]#$5R/G^YZ,>;_43P5W9PD\])W/4_+6^\O\
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M8>K2)2GVHD>AJY\@Q +H,>I7]_#P)AU<0D]]08S?1*J[,[+GI."_8+XQL^7
MWR4@E7[_ -:*"'!7J^HCAS^]"[=G@)_8<\?EG9V]VY_&"8]E ].R-V!KG?Z3
MU4GIS;QZ':+-T5U/^T5CS#1/6GWZ)U_8?\8$/JP@5DKW^STP:XL&ZF^/3&+<
M&MK?+]<\X?E!>Y: * ""T752Q?D"B"5K/= A@7YM=6O-P,FFE]+2$C&:3*BP
M7C).+2BH(60J4ZAIC5G@C)HC$.C9:*Z)*")YR50K=!(RLI 6O21O69E(A"O3
MX)S[Y465%F6^4L'^ZKB$Y Z#6H@IY#2)(W'>\*[.O1L0,+16&WP0.O>5$(H
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M&457+0@!%4['+7 7&HL:B'(MR0]<?J R#H<L#<H -E59:2/4V=E7F8N7,/\
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MUF-W$#*7<PTYG";AW$RTL7(A=;A.R%.)>.68&>64Z/GVE>C\_P!2UP5/3*U
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M\2YN57CKP55!EXN+<97$<2V9*[QE1Z>'.9SVG*<QW7C:JHK2ZAUB6ZQR-R_
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M#Z#,=,EMMZU]N?:&"BJ>_KC]P5@8X?&#XZ5F8\,B,$&L?B5:Z:W[DL#1,^T
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MH=R@/*&Q$ZV&.D?Q/:L'&T9(N=\3J6Q'T%:WM% -  1-492CBG&'TC^_#S9
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M"YE0?!I=S3>&U":[P>$E;<P<>949@:XFS1*]80-9HB#215L^>E6W$5Q P=W
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MZ)N3M^\?&</S!+Z@FHM^L_.:,3;ZL5#UBYE"=YIW\.:@S-XXG$PSYS+7L_!
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M'49OM'2KEC51FF]1V1.L;!F>KPJ&'7@!6+NF7<&1ZRVYJHG7F6[65ZC;>X^
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MM5S$!*%P<6H,[SEY91X)PJI5:(<-7U7Q,> 7?2Y7.<QZ.85R$P&M/N,<=>H
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MA881;:4 KHH[4VYF\R,L8M%A"YK#20KDAA"A!U$<K@UF ZVWM:R;T44?$&#
M!+=7R;) =JS8M"4!@E_!N'6+BBEPJRRF-%U!!L/5#9EE:(1,G#S'!HJK226,
M!+FSIF9<*(Y'(WE%@K"1U*:K&%_3TEDTID=BJZZ[>THEU@T7:CGHJ:W37$%2
M](%,E8L7G.B"UN3P7?XQFU+'A2KTI?-*OCU:M7B\*M6^%$Y_BTIUZ=&?17A)
MX2E%;+J+!U["#"POD#C)G/3B/T[P:!;KHF<O=<*Z[Y(M>'8S_24KA]V-\JD*
A5RO/XG7I4FL7C2G5X?X5Z]/I@"@$54&-Y^N'W/EJ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2132809d4-ph_segment4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d4-ph_segment4clr.jpg
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M\SVU]WF/DG98(J)
M =5JO _.<O*NHM??O<6.?QUW^1=;@;L^FN2^/27/ALL@Z6R
M                                !TVF$>6;6.GQ_P"@R/\ M/SW!O(=
MY]NVQ,G]#U,=OCKTR1?V!YUGGI^I
M             I$<*:_FMSTV& >1;C0'Q7ZC\'#;>MZ<H]=Y3;/T]PVS/:-%
M]N5'9536L!0CHC#(2V3W2I#C40Y1%$\2DJHJGD@4!6B>JF>:2GB=U3E6
M                          %*'18JP#S3:X=YYN+9Q>VU3\G]TLWZS-<G
M&WG]R^97KL-7L'T/4??O;/*L (5TKMRW3:N7;'D1;SXLB-)9^#(3797PV+OR
MR^68X+6IMSKMLZS.N4J1/9*PYT;#T6QDYRFZXUUUFUMWON!R39X8
M                      0ZL:K6OD^VP7R?>_/SV?K+YA]!X8TUJ5NX^VOJ
M_P YP#A=YMOZ"XW<7O\ S_?=I $.*&T?-/1K9@[3D4HJX3'GKV?+>A7)]+V8
MUY72JCBB$G5Z"26EVVQ]=D<IJK2Q[9ZR)&QU\V.<Z0BE%K<WI/G&1[7!
M                           0Z+;KM5ZW\;V\>OA7V/YN7R:TVNWI\:3?
MZ$>1Y;WNEN&RIK<GD@ 0WMQM+S3T:UX>UYBBKC33Y\]IS,^N;WWVX&2JFLQU
MU4Q'ZG0[@TVSVSK,KG55Q48?N-9#3>:R:/*[O*L7.K1;W)Z5YQDFTP
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MFJL&1G8[3:V%<OY5Q=GIV.)K?JLG*K-&H6))_C<S<NIV6YO2_,<DVF(
M                          $$A0^:S7VU1VW*:0HGE,  "&U$;1\T]'^#
M VB9I71%WH-1J7>X-H9$B.:R9"Z?;]E%N.'0ZG3O2T]5#HU-,]>2VW=-.K][
MC0$Z+23VYK=[8Y[,K7=W)Z7YGDFTP@
M        (;41M+S3T:V86UYG&J.E$:.MYBV59&W-7>I>M1ZZ74X7>CX[47_"
MOR$U^=@6WU]IPLCE;:)WM.W=+>V1K[\E^8WNZ/2/-\CVF D
M                         (;T1M'S/T:W8>V%LOV81=ERN+96/K.XEOH]
MQKK8:R.73Z;&YJF)H-M&G8:V[78G3P^[C1MXV51&NLC#G_RO4^>W4<_Z'<%U
M.ZO2/.LCVN"                                      !#BAM#S/T:W
MX6T2Q>_C^?O;:'>N#7=>-Z&[8^=V5V8+]UQ^.='I-U:S+E_H]_I6Q;VQK=WK
MBFQKCO.0AWLL:8/.Y^]M-MY(Z#<;H](\YR/:8  H=9V@
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M( XG72PRY;47\JFFV0NT1;:IN]+MJIK$UERA67%-44*@ %$D4!:)?="5"?H
M     ,4H>7]O+UC3=P+8:^TY=FWQ.QL'.R_%R9<3C3CO8OV)  AO$;1\P]'M
M>'L^,M*;>QY?9_I4?J:)$[KRN;/.7,AJMZ"V&]A!A]QZD6O/I;:K'C/EX^&8
M]^)W24QZM>@SIQN+]'-'9^JW=X43N;TKS3)-IKP*0B2B5$H?IF6CDGD
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MO:^XS%00VHC:7FOHUKP]M6J8][+"\3<[T;%J[.V<OSGWSX_81FW&/X;;7O[
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M YW>?4FL@   *4N)!GYH[G9OK>DDSWVAXT58AQV3D.XM<:YMV$N^<TAX9O\
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M<WDFD,<NVO#CT'AO<SSGNK_-P     "E*W44PT\?ZK9_?:N173ZSL0
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M(I"),QN ZS.*K'G=C^0QMU7G&"XFBX9N5*[,]0]&-CZ_GMO8@
M #A3'S(\T>FTOIMS6\YS%4BA%PE(             "&],8+R'K44.M\_QCI.
M-DCY9[QYN^E^+<JK4L]-W$B^!].\]<36?'Y_V.4=OP6H_;?%_KQJ=W1OMS^;
M]3Y[9OG.01F>J.%[% GTCR3"<K02KTGI7J_K]/%'8:F?:11$23<!US&UZ9^>
MJ.,4?#3/FIN=?Z@Z;:<ZG,             '$CQ>PL!RHF/K\X 41%R$I)D
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M1>:G=$V\^R7=$_>          <2TH^0N1VQ.K\G'V+CW_A/N/J/M2(M(E*D
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M* '3;F"'4<]O_2;3>>)E]E4@         "A2EQ1%?-QI#X>1YM53Z@1/T@J
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M\C'4_9%0      ZT17CCX3:WQ[7-CF_KF]@>XZ?V%N>W[CM[OQ]JH]CHJ^@
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M^VYB?;5B?951]E6%]%45O4]\VNY1VK/8IJL\YCE$YK<MY;5'(
M $-H>/OG/V[K75=K<[=GFJX*.E3U3<YY-G)]IP?7K/1<YV/!8_E<OJ/>>0:(
ME15?IIXS%AO8/PW=5V1E:\KC]3=_E9JW[%0=!!.8V*F5D.0 @$A1%$DUB*(4
MS28JGIB.,N%<<J7><3B=D5<9=,4]AVS/*)I!(4F>2*RX1%3E,H)
M       "&T3Y8>3?HQK;0>L5J)IZTU5JW/'U=+V%V9NL^WH?'XT;[Q:.^1K>
M%*M!6J<[3AD44.$1^J/=^8S1O:T =9UH[TU
M          *'GI%4"?.OM3%=3Z#RBFM,<5SDE39JL\+UWZ]_XAHK;\/I[(U'
M"JBD3QB.52HF.5%7"'7%O](6UX*7F5K@
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MF\]R1I.*9!$DR=S);T*PN)OLZ5?8G,L1F5<@<2Y&R@F85U:=0ZWBQ_V3-_\
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M)<A+9)DJ6%K,^N?<BI WUH)$TR$7P\I,QI+3O30A5'HQ\"U N@EF$NC60-9
MUD#/B*@CZI]SQ'SOY$99$HTF:FZF'5)2VGVHQI(__;BB"2(&=%E[395=T^NI
M5 U[<LZ],3X/H->C49BB@51_)Z3!-K4#0I(KTI]8^2X*:0H^A)J095<4.\5(
M7)U25%(=(X=QXDHEEZ$H](YVHP1BHJ*C6#4*BHJ*BH2]ZW4?^,?>.X,.&HDT
M23ZS48;.AUUEQ,*HEM?$RX$E9H-MS6A5=1DELG3J8,1/@]N==1I.A*2?78?-
MD.3VWDT*M4CU0TZVVI<LC"U5/J%Q&I"3>6AHI3?//PB@EG2J(?NO0I2M#<:K
MA]->Q6OENI.J>F1\;^:#O**8;35+Q%J"2]9E9:DD6E2S6>GHX!A1\SO#[ADI
M7101?@]L7$--$8><29'+\/)5(:(<Q!BHJ%*TEJX&::))!C4/Y-5#-2$CG-#6
MD$JIFJ@J#=;()DLB1<D^*G)4]'\2LB\2H@VHU*C%1OT*X+HIGU$U%145%1J%
M145%145$K@N*K4UTO_&_]!(A)JHBX/QU#2:0CO;2HW:Z0^CEGTL%[R@D?&7W
M]$7X/;--E1UP'Q$VWHDCZ<[0V);04Y<PEZX$+Q-NC+6/2)LUN\<TH\>YW% ^
MI3C#=VF$/JDUQV<_+6W$>E\S(5RD0+7.N2H_/GF.9<3!1I+@.VO*4N+RIK:-
M4>1;$K-JT$L)M#41/NR!'44]!G_&3W"O9RZ"&H]'2_\ &/VAQU1$4*5/:A$N
M_M:8=QC2S1$,@A+2#-LC7.2JI-K'+'JK$9LVUI5K.17G*[Z=$;X/:5HF*T:@
MZOI(B+IKT*0E8T)&A)D<..8\(R'F(311XT<<EH*B1S!H0:4-MM C%>CG(2#_
M *BY,<&I,K2;+KZ ^^_(2AA:5F^ZRIA[GEZ!//WR3]6HJ*BHJ*BHJ*BHJ*B6
M?"#['2_\8^\-%[PBY;=S?4[)<<;2I#G(<B337$0HW#<<TG(/43SO*1(N)F:9
M;C1VNXE("74-KEI]Z?M=$;X7:(:YJWE<A)GVA]V=2Y+#5G<6<$&>DFKJTJ3X
MUG6N:RDDW)E0\8R8O=T=B2K,R3@IPD1:JUJ4.<9 I)@T+D*C,\@O0+JC4XVO
M45145Z*BO345%142#U*A)TL]+WQUG0TMU'],DKM.4MAS4X*J"U%6%-Y10YB3
M=E'K<;2G3?%H2E= 9\+=(-MQ@TNE*2.-1_$?X/:-)Y*7%ZE]KG?L8\?]NJ8D
M$M3;UJF)>*!-HW:YFANURPNWS2#=E:D1X$+P2>CEI,<IIM-M@,2"=9\$[_/H
M$U&N-&/21<0? 5%145%145%14:AQ=>;3I1TO'[\DZEJ:-)>';'*01R8?-=;M
MB$AVTH4N-:6%$FW)0\ZP=5)68G6XI#+EJ?);UO>:3$BN/B+XAD')08451W#^
M(_P>S0DW#DJX]MGGL61PF;7]6)"RN["R=NS&E-UCZ%W)'*8O#>@[Q&,+N,=9
MMW>.IQMYMPAQ&D0W#9<GO-/-^@T+3,84R^A? SKT5%145%145!F'#X0HQF"[
MNEQHUO,,GSGT4#FKF?PG5I-XUFS0PRM#27=)!*B<"(VIUR*ML%I0)#3,@)93
M#6LRI$2V9+:(S<;IT1_@]DLZ!A.AI9FH%VV>?#LR.99UVA:S<L[Q%]$E&M-@
M=TM6U3;3MD?==3C[P^AN&2; [KAQ%QNI6@U&?H5*G,92\TM"FC(P= :B($M)
M]6AA9D099-U3*20V72?=XE*78YMOK?CJ)"SUF]$>2E-O+P)Q5MMDHTFIQ2C7
M(<Y<%2$*]TM)<M#4A;))>61K2AIYMQ1!*RK&,EA^V^[=;4@XWP>R,J@W5&WV
MW\9[\/'3_MA%04'+34%P+H(4%/29$<G"6RIHW:D5QE/-"%.>6<19K1_(IP-T
MDAJ*<DVF";1U7^7SHE42KN\YIA_TZHLQJ6:I:$(GRFU(5ZQD5#6'$J4+>\I*
MICE&5OJ!U,1S]4R]XPAI2F8R*<QODW"*1!CX?I1=V>^QCO\ C?T-;272>AH9
M5)C$ZIBUE5J.38=2D@:](+GNIBVXE!+9(%>L[\=CYFY]_'5;3HY<^ .M>DA&
M^+,^7/O$=/JK^)JH<.0LERYBFD/SC=#!ZFO2\[]C'O\ &]NTUS"I3T-U5$N&
M;JFHJ='AT4\&550&E$F(V@$DAH+HIQZKOQVOF+EWD0@5YMT[N\4,4%.)"/P=
MFD91M)]$=!DTZDR=621%/2Y<.+)I(RC?![+2JE2[?^,[]C'76_I_;Q3,*]OT
M*056XC)J<[NV=^.P59%S*AEW0=7-N"34RBM 9<"5QKQC,+6J4DW(SZ3;$9-5
M%P#J",+[XOQ)Y>Y7W1O@]BDBUJ0T412DZNU,Z!:=:;W8/'B%%8@,]O#^,[\S
MZ$95&DB[8^YY/O8++CDB]1S0:?:MK'%]G6V\CEG4*<H#C+T(15<*/1+D1247
M%KBP5#2KBZ'N"H31FN6DW&G6Z".7NNQ_GG%X$B+5V%>BHKT&=!='G&64W"2I
MIF7*=D(55(KVL+XSWS)?H)A?%^ WX=,EEN<4N,423#0E;<EI/*N!$2P?M)T\
MI!TDV]2:R%H)JXG4(516N@U:A36N!$U!^+H;N!:78_PNQ(5]Q3L3H0YC8U(&
MI )Y)@U)HHF9!?3X:G&8C+;NHB'-20)YI0JD&^TD)E-J69]C"^,]\R7=^@K3
M_5-U2RM:%KOK?+%OD$J._+JB6LEK,&1&12E$2*"VR:AZ2OER'^8L:JI,Z!-"
M%J?))3'DFS.H;K?!KKG1(.6T@+N!D?U%TP4U83.;<%.O..C##T@'+FZSF3 F
M7="!7*XUM;TA9R?%)F,29*%RIL\B.;<UDA^60<F7 @[*N!E:W)!J1Q3V$7@2
MN*OT):M+\-XGF6F4M)NDGQ2K09I.69Z5'ZYBM")LE*_\VQLR-U&IMYKE+]H:
MAWE_XMSQB4\HFG73<-KX7766I%%)=HS0N20(V@HDJ#32THZQI)1'$:(RB1R,
MXS )L''01E&9(%$:U>$9U&@<E(\/'(<EL<D@4)OF4H77_ELM+9^U^@GW23HN
M#*6VY+G*0PGUCMS'*"D:TRH^@^X*-NGBV2-FCRHZ.6SK)0N$?4VRF@4I*#)Q
M!DE1\NVM'5].MN0VII;!U:Z]:!;9+"X1&"MZS4JW.)#4=+0,Z^FF/:-Y>EC]
M"/ND<%VV!K7=HVLE$:7ZT;;=H)Y$:%D%M5;>1QM6HEEP)1Z3>5K82E6HXJ%H
M0PTEM"1&22&JF8GMITL?#["HXCF:%2-2F3KZ?#1K=DJJO]"/NE_$M?PG=*TS
M&Z3E>VCXD[N7WMLI=+Z8U5IM#;JE N^07N*F(9*-,LJ!A55H^$1\9WPV/8[)
M15#3A&WZ<8;+E)4=3_0Y1>\A&:&5.J,I:OZQ1^\0VK5/7Q56K9*U&GAP)TNY
M+1&4I?+:(-S(Z2E+HW$.J]?ND$9B730T1$CLR*A^GJ<4I'Z&8>XN1TD48U>M
M*36:37O#>)A4Q.ITRXMF20A=1HJ\3>E&NA2_>B6?N&G_  [C<MN3'BM44ALS
M0EO0BX.<6#JW^T)'ML\PX[C(>63<^9<-+JYGNN;S$&'54$9_0;3Q&Y*EE0GO
M=M.:A*]9IBWU5"3RS@_'=439+=*CYZDM_#[3N*';N>W):\,OTBG$PTR;B=.G
M]&D'[RV_ FL\Q+[:O&S:+DO),D-)]RH*3J"RT",9"6O^I]EN/W=X)"J-)TJC
MU)V?(<,E+=)MHU&RW[':?Q$F.,BY);DLUZ:^A$=>HV50XLD)14R_17B]Y%>0
MW%\:A:'>,QSY^3[#7P%KXZJ&Z51'JE4FOB73/DQZZ-5%:ZAKB;'!<E579!T1
M'.J4=W:J(U$W)Y*7)K-3N"2'U%(3-:4",E%Z 9I0%2VT#Z@D%<$&&YS-#,E?
MHZD&ZX3;G+=CNQB9]XMT_P"JDJ]1E7N%D>JE3608]8/K]^ZKW,3BE9441AGO
M;+UW2]\\G6W&*C:.[MI:WB4SRU$E+(Y+9F\T24VYQPR/T">ZM"V"(UDVR%H:
M(.*H<)QQ9'^C1B)3JJD<Q;E(YGJ67O9)>HW\!: 2J&XLJ12X2"]^]\&%[+GM
M)#)<6_;=^,KX<?X;?=VI@TH4E4)53BOAMB4:O /&&VTM%Z N*4AQ^VJ0KPCQ
M#PKQA,$)2E"?T4Q&71YM95G**C'%:OB2*FA'RZ^[N-:",HH=+5(4SZD5.@/D
M$'ZK1F:D>VNIR)"3)$?X;?=VU!4^C49!J5P5%)T*94V*J+M22M9E'4D)>;9"
MW%+54_THC,I#55"6GU8Z#JZ?OE%5"4*Y5#JMGBZ9D(Y'I>)7B3)>B&2JK34>
MLDXZ>)%1;O!^2YZD?X37=Z%0)=6@-OD1K41GV-.B&TE:G)$>(E^0I]1^OUJD
M0X?HJD>M&70G_6)HM ?CT<[CU51H"_95WL=SWQO_ #%30]-!(2(B*!9:W'4^
M]?1ZL9KW"4T]&J#U"BAQ'$<1Q'$4,4,>L**!&M(-6H^N[P"S]1/L_H9AOO7P
M(ZK.2?JK/2&O73PHM/J'Q4RBB75?U))J&2"A)(TE#JH).BW]1O.)6M,6O(*O
M8>L**% =1Q%3%3&HP;HYP\00\20\40.60\80.<8^H&/J2A]34/JACZN8^L#Z
ML/JACZD"N!CZ@1EXTAXLAXM(\8D%)(QS1S1S09FLU^RA>HN(]844**%%"A@O
M33"C,CKZG_I:=04UJ;;3I;"DF8)J@H;9+<D+?9;51!4!A:26EMLD O=N/2G3
M<YSNEA1J;[,^H8/H/H,^@P9@S!F#!U!U%3!*,$HP2C!*,$HPE0)0))F.4"09
M DF-)B@3[1T,$5.@OT(U'6A&#[@0KP_@5H#X@@=!45Z"Z$42>ID<YD*45>S5
MU#Z#,&#!D.X&HPE&LW8ZR(VU!+9U[UF7'2#;,@A"AI'<$@@094D:TC74R-)#
M4D52/5' $*%^AJ[P9\"Z3[,Q32>I X&"[,^H?0?08,&##!D2EN)(C>8!O,49
M<9U+<8):5,&%.L!+K!EK8$HT*! @0XI-)@E\:U'$$DP1"H28J"_0E**O"G$:
MS(<PQS#&NH]0QW#48]8P=1H($@AH(:"&@N@Q0:>))ZU!04%!0:1H'+'*')'*
M'*'('AZCPC8.&V8\$V/!-CP38\ V/ -F/IK0.V-#Z8T/IK8^FMCZ<T"M[9#P
M+8\$V/!-#P38*&@AX4@4>@Y(Y0)H:"&D4%!04%!0%Z;-D+2Z=R=07U9X?4GS
M'U%\?4GQ]0>,-SUF#EO(3XY]1LSW@4I];NM0YBAS5#F*',4"74>L/6!:@1^B
M4%!04%.B@IUJ"A"@H*?IDWYBA&>E(]4A5(HD%I'LFIY1AH@;1&&FR2@'U",R
M',,:S&LZHXE^T)D1TW? O#P3X^GO#Z>\/I[P.WO#P#P3"=#<!9DU%Y(-!FK0
M8T&.68T&-!C0-!C28T\4?M N]WL/Y('V1]Y?KW__V@ ( 0,  04"Z\9HUJ?;
M-"_W 0;;4X:VEMF+8E)"Y(+70(2:S6DTG^W2[XJ]#LE4<VN5S%-PI"2=BR T
MW[QJ/';:DJ)3O[=K0$&C<?-B*AI))H-*5"=$314A3:>.KT6HX=!$9BABBA17
M[!XF&X;CA.6_DLV9@EFVJO2X9&+FR@G%07^4:%)Z[,7FI.WF/ &/ &/ F0<9
M"(!F7@#'@#'@#!P#"HID&X)J3]/48^G*'TY1#PVD,-),$P@<A 6RC2^5%_KY
M&&9:VCD7'FM6=S2;:"+HJ#147.A/HFM)AR'FU]>'\#J/?'3W=1X,>S_/0\&"
M.O08D_%_8%>AE:FE(>2M/<*D)#Q-IE.\Y[4=>O$^7Z:D'2,WDK2*]1X,&6GH
MU)(.K280N@0Z1],GXW[ _B&WSG)45A##<U;!M7,*N[&E4IR6Y]/0F.M.ESKQ
M/E^A?!*WE!)K,$DPE9D$]P6YI)3AJ61J2$.F9]Y.U,]*JDT%HTDVLZ%W2OC?
ML%I[E!R6ZYT6^.A\7!AI@)5H-BXK(2E)6KKQ/E^AWV66B,>[($I-5IT*2? S
MH%$:PEI*#+28>1I)E6I/#F+20H:0?LMTU?Q(.KW[$@O\M4U[FN=!\>PB?+EW
M!WV6UT'$P@M)R%ZEH*A+#9\334(30Y1^I&]A1&2TN%361AU6HF6S('W/_&_8
MA*-(,S/LXGP.@R)0<:4D(D&V#=4Z$-5,&%$2 F3I!R-8(GG A.A)IU!3222D
MSJVA (SZ)/QOVA#^!T%WJ61!]3;H:6E)'(TCQG!R<9!,@W 9<4/MM@YZ*>/-
M1^+,'*,P@<TTAM^ID=2D_&_:$3Y?H6K23AFL^4Z024A1I2='B))F6H)/2"D5
M#B#,(;UF<?U6-*!XEM*DN\U]Q)$B*5%UJ)/QOVA$^7Z'2JDJ)"7C4(B5ZU,$
MHW8:-/A'"-32D&TCC1"B;CKU<E9DF$'HI(<+2TXIY;@B,J2*"3\;]H1/E^CO
M#R*!)&E3/!!K.K=5+N5$(]=9MMZ4,NIJG0:5*H$<2F(*K;&LT,(2.!=$GXW[
M"]8<1QZ*I[*)\#H(R)2T*<.8P3:(;Y+;Y:3"%-I$APW5\DVPBA@Z$M%'$&VL
MSTK0'U)4;5"Z*=$KXWH]%#4-*J<1QZ./0=>CAZ?0)9J#(B"ECF G$A)LF-)
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M0@-E*((*>)#*ER'%M@1TV3O\SI]V@+NT3>-/<)L8:Q'+D&:U\I2437:*>(^
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MZ[#L*8RW(C/M&TZVX*&)"8Z=*HN6Q?/3#LSANXQ?!PJJ]2NK^Z<CC4NBS+T
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MV"G*M;JNL-N[QL]3!$O21*+@^+263'FS++*L%ZBQR;&%?+=+ &]%S;4%)PF
M"C95J.+9+=OE_OT>P19<3A^U7J4S)M]H9FB3;R, VPV;AI'<)L2<52$2HF6+
M"ZW?N)7('"MY6\<.V5V:R=MM9FXKIQF6EC:CCZURJ2J.,_FI_K\MQ@UZI>%K
M,8]I&7%7"+\VRGR6U-IZJ<QZ!HN.,"3N5OEJ9"GKFF$)S]R?D^.#]8;GO':<
M2OL[GE ;C])JQ(B"NU-45U6VT2F57Y3W[G###7=D.LRY2=)5WKA<NHBQK4B[
M-"7#D1WI ;:JBKR*G^O!6B4\;5D;%RY2(#9:!DN#H PY@9):*:(G2P\XS'9A
MPK=$<<W$<!CM@  N2-HB4QQ#Q3/"L2W(Y'9J-6SG707=ZG2R^Y6"JO9),<4\
M(R^@LEUY8P;*RK<^XWI1%V[Z,Y7$>'!:21=KB:M0FS5=RR ])Z=+5.DC+0[$
M]4:B/+A9-Q7PI<2S=DS*'0ESHT!:A8;]:*;,*V[#BD*\[;1=CE#+$.+$FR>I
MNR@91M\S=B0 D5'>QJKWKDU<V+O+--<R-#<G))<&K[AM )J(Y9-D"KAJ*:]*
M(KD9*KM1FB(OU/E&/8KZ:^5\:_QRC_F[9\<7?%J]^]LC'!WQ6L'O5%\M+NT]
MQ&XD*.X\X2EZP2TB%::C=7)$Y\2/&%Q(V0VZ,YN[' --31D"J**B'5$;CZ,Z
M=TYBGS9?)9&]9:<T\/VZF\;$Z?=MPV:D6F)C;;8B"<17M!$ 00'[L78*)1$P
MG:PJ]C!,MN)JZ2)R5T40Z>Q7'=C1/5:DIY^*[P=E>Z38G+@!$T+4!N(:+T>]
ME14KC,Q3DS5,-$*F8G#(6V]=&R>5Y=*ER;.7!RG7!>ER54Y#@K5$4J+NAS7H
MABX6AQ5;2=&=9WB#JT$J)H73EJH=%\S"VN^12CNHJH$BA=6E#W"/1GU%!<14
M2M,E1:IR8"!U:*<,&(K.Z5OI:HK@O-/;RM5/?IJ7#[&Y9W$IZ2\^UO#5#WPA
MRUR0"2J>=@I3$:,R\XX#THA-2)YQB+U:/J7>= 0#D1-N(Y33WAPF5:1\S-=]
MJ/74U<JJJ.JF(EY=C/1+);GQD"\\VH%.?&JM-QD),VP<&IJO8P*<R(GG9>CY
M7QI_'-KWBM>+% X>?"%=N+N)K1PM'N3@[P;6-S=479PMU'6^T"=!%RKC@F,]
MQ?=^,+%QE/DV:XQK^3)2H5Q;9;DMW"W.1Z(VP2"2$V54'+'#'$K?#\FG$W%<
MCA2/"Z\UO&)#+TMA))N[C20.%#[GLXOU^XLX?[^G&3W#7#L2-<XH)-G.7)Z&
MS;#=,=,5FU[I$=DGD:5*B8G75[AF4Y>+5Q+:^&+E8;9=8=RI*N[$EZ#(A7)@
M.KS8[J1Z)1$SKB#<;S:'+!<I(&<FSNR1ENPJ/.@T)OBTTAJZP GLRU4Y/*Q&
M#]JO]AN5OZ6PGK6XA(/N:35.UB1%<32Y'=<9)%_BC4?1^29XMZT[W$W\QU>1
M$:8<0*]MTDPEPI_C7$5RG)SK'CB,5GT65\GQP_K#<]X[3B;_ &EWZ[R/,KYW
M^O$N%;%\)7DVG&(T2&._W3K@DUO7W0[VRC>JN:XF7GB-V.+LB0,E&-\A.*::
MM).5VT4U6B9:L**4W=$$11>3;GRHJX[NJ<E<J=C+%>Z-4HJ\R<J)@+O;I[EN
MN+0GNWVE:5:&B(39@\)MFVM,TQ=K7)B1IO7& !)\$%8=0!= WE>BD2MFK@I3
MH8MJJE'KA)GW"0J*-2=<?T !DFPFVA1*=C%IX\M*(#IRF=_3N4G0T#3KIL"8
MP-"^BQ^4T(7/!R6V/#:4Q44!\:OS&:<S3Y(->PF!JN1#K["JNU/,POS4[6'
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M-KKV+JJE,<$,SH;;\F3Q#<X,Q\U/>28MFZZZTR_I,4<3[F!%5<U1-N#A6:)
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M/NCVQ.9SO=23'PQL"94R?#9V>]9[.U@__5W#^H^[7?U4TY-7>U543SL;N-Q
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M!M^ES>;QM"JE KCAVWW-EZ/.BP-U(COT5QIQ)$@NF0U135"Y_DGFIZ:8D?\
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MY,)\O7BY(>F0K"1H:5HI2I?>6T'--1"A*7F8COO)25>9#ETD*J=)=Y1IFO\
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MP^BO0W+@ZUIW*493(L2-:.-KN(O>G54C'HIM(D2M<6->=ES^G>QXG_['Q?\
M>#/E/&O\<H_YNV?R$XS '#X6XE6) XM!M%(+5<&=,:#Q(Z*)NVHR1@1J2=:(
M*(2[,-O,NMNM. CC;K9(3;C9(BB8$F1":+5%QM\KMQM3&U,;4\DHETM\:<P:
M*BA)9%RFK)=*TU 793-,+<> [U<.'IHN;X8ZR7UC*2+70+J:WD:54[DJCV,-
M.\6/#(ND-E]R<ZUNTWC;.>L-",BO13F3'6.&HHR6FAO34T+A47&Y=L""XV =
M7=<;5EYJ:BUKBU0XHO7D)[EP&=*M!L2(]F"U0SF3GK@2/(K2,"/2';GGB 0P
M>(1:N!0$"0=NTM,#=S,;2<U2>5&!N8,&;.5=VV2Y)@GFHU\S*V#&;. K;TT+
ML<@(4F-OGD%6'.JG125*TRPW;[DW.WIVFX7U]YB-O8L&TVP2*9+FO:JL@UDG
M+4EQ;&[+;[J^5U8XB4GWV$W-N>L,%J<?6]#QJ31M2!*K:KT<(W/C7<I+,1M9
M<J';3*V%)6T1[VZS&>-Q2<T6Z1O:*E41%Q(MD#2[:HUEN4]RY4)&SDVZXVZ(
M[U=S5N7HPC,7I)GJ'$B3%6YR 8G182"U#"KG7M\+#P'O19",6X+,B0JY4SQ/
MD7BWWJVMQ.(+E86$=894YQ6LC69(8TO9MQVAJ0]WTDRK@S*+>GF N46UC*8@
MJ,1V7(8&7H;D./,"B-QB15JJ9JB9KBSQ[<LUCK=Q&2_-CLN+U1N$*/-HXXT*
MHT1O&E*[=.')PON3&E=*._>[N^;HI2@NM1FZJ6H>1$1!PV3<-F;=%S>N;S#9
MOJ2T6C5:HR"*G)GA/(V^4ALW>]6JV.W!S=06KA<(T1R6XE*A&!]T-ZJ:DV<^
M/'O<KI-BV^!&ZL3\V8^W&C-"MP0$5Q]T@;%-2TS7#,^V38L^%)'6Q+A2&I,9
MX*JFIIYHB;-*IR+Y1>DGG_-GAKQ;\//J4B=NY'&,Z.I&U9N&T/1*BJZ.H6+G
M=:[MMONM%2Q%M\-E&(L*.S%CLCW+;# "VV IS((X7BF!P7PYQC:RX;C6T8G$
M$Y^*$>8U)>?5X!8"I*@E3;RX\1C+'!ECMUWMWY<F'"\"21VH&6TMA"D>4^"B
M#[C-2'5EK7%DNDV#"B2Y7C7E\>W:U,R*Q[3;WK6MO"*PB-[MU^HZBTIRXD\+
M.61AH8/C7C<5QYAS0)JY6=V_2+E()!%%5MV.PXE1+NU7+'C8DP!8C-<1S^![
ME81"1N%EN<.(^4MI[O2I&4M[T%IW2)CC%UZU2(M\XCN7"JM-W?B!;M<'8=AE
MLFX[/DHPW%;,0!=WHJNBB+CQI/P(T5YR_P#$W"%_L;!223KC=A&/UIERH;N.
M9;M=*+4<>-.X3[1;[?,XTM7!$2UV\9V_1OP%)?.8W+<1E&A7=G7)%15QXRIL
M6%!ZOQ'XK(G"EGJ8A_>S,$XY@2;KO+6O8>/R4W8^%OR(\!TU=ZZ_X&ZG[9H[
MCK'+3Y3\</ZPW/>.TXXIG.*V;@7R<YDB$K36^51!E#V2'%3,MB)BZ'(AW2XB
M$VK74YB-;C4-3$T)P$7MX=48=RADK9(H39(OBX&\:S"AFFK$F&PSNQ(R1LDJ
MTHHFTB0"H;A<ZUQ=+849;DW#%N4Q%-231OC4'G5,%#UB5KSXF@O#L(!6*YTD
M,M8T&NK,MJ8>"JKIY]JTY^3%-2J[KZN1_0M5<5/IM2>8F%=,B)474*JM:<J?
M2U]# :[S EJY'AFL1B+NI.9M*G?,NYY<2-+A)K%-BY+DJ;,7[?37X#"3(ZI)
M81TSWA@XI,I0DHBH*5[6,^*+LN>=&S7E3DWB8<CC'<ZU"<(&W'$(0<!U>E)1
M$<)!<- SY<,2!R<> 9*BNRM=+;19UW=455P2/#*<1QMUPTB$HYH8YG1%[P*G
MFG-B*XT2@2PHR:@V4%ITJ+LJE7:]O$UH3 >^D9./%I;'0UJ)57G7D[."W+<6
M4XDR2J,R]*0J((=^0C?$=?-V,*BQN&!% 6M#:5Q*BNRKU-7-B<01VS-R&PVW
MO4%5!-UTUH)ET^;'#;R[2C/5[:27Q]-,>)_^Q<7_ '@SY3QK_'*/^;UG\B1$
MF,M2(TEAR/(CNBCC3S+HJ+K;@E5#!Q"V+@W.&V7.*>#%U&?#1O4OUF(SUKX!
M>>TQY-N:%*)&,D,:]%<;J3=$L,],G+9Q&WX%GMK5$TJS,T:]*Y5%2%>?&IN\
MVLQ78HSXJHO_ +7'^*V[W;&^V8_Q6W>[(_VS'^*VWW;&^V8_Q6V^[8WVS'^+
M6SW;&^VX_P 5MGNV-]LQ_BMM]VQOMF/\5MGNV-]LQ_BMM]VQOMN/\5MWNV-]
MLQE=;:O_ #\5/^+B1!DW"V.Q9;#L60T5PBT<9>%0<%>^HM%%<'%:."+;BR5)
M"O#3B_=3$>.YTM>6IF*V/80<-ORIEO%QN-<(>N-<8\97&+K'*+,!Y&W!WN\;
M+-5SRPQ*?D0MY&8@QVP:NP-QU&VQGHD!PV!>0')$5A\A$U2J(6$ WX2LZ[4I
MQQN[8,NMV5A&+>PX".4-F-34(T1-6>'9=QE6Q]R19I=A?1R;&4'+9<%0I;!-
MHY2I4V\F($<)["I;G9[L4W+RT3HC<H?4)D<CWE7([\7HZ-F2<V-3#]L%T7">
M;WEP9>;%_P "C84(@)Q-8>#@0*<N+/;V+G;I#UKLDBQK+<F1JRF)LL)TQ7F]
MY0M]*!%[28?M+<UH+=(D#(.(%Z;%KH*2@P(H:(D6IKT<.ZI4=LG9QW)-U>FV
MNKRW6$BR7(O?#W'6F4[Y3NE1*X>MDB7%6%)N2760P%X;:&1+W 1E611Y=XV3
M3:=&FW"1RFVDFA%&T ID,QW8B@('2<5%2B<V'_!S]EA=8<WKS<65#;!PZ4UJ
M*.".I>7"?WK;=G_?8WVS'^+6SW;&^VX_Q6V^[8WVS'^*VWW;&^V8_P 5MONV
M-]LQ_BMM]VQOMF,KK;?=L;[9CA)^&_%D.ML7UO4P\VX3*BS$D-E5LJ@50JB[
M<<2ZI<AU+W<K(5P5TM2SABL2I")+KDXB/ AYY:AQPJT[<+='<6&ZZXT4I@"1
MQV7)<*H$0JBKJQ_BMM]V1OMF/\6MONV-]MP77^)K.T>=&1FL//FO,##1FZ:K
MV$PY X'M<BRVMVK,GB_B.*]"%&%J+KO#]L*LF5+TE5IQU!9KG@XT+6_)DEO[
ME=)1;VXW285-Y)FR%34X:JF2=R/)Y+;YLMFZS7<.D JZSKR/=FJ:F]:)G3;\
MM^.+]83GO%:<<3$N>J\3U7Z62X-,7.!("0\R:]9W$(U;E.O-Z0%&M)#JVKE@
M@CQ+G#U 6\:NBEO"[XS16T)2TCEZ&"7G(U\]5Q<F9)3A&3;%,$M^G?F3#Z*:
M+JKWM!+"HC'$F8Y*Z0[O/E/H]SSXNS8TR>=[FFG-<M*#1,5YY<A?.$$^?@NU
MVO1Q;0WD-%466T FT&<Z;;E2(745-38B.'BY-B>8F?HXNTF,$1Y^1.4$&X V
ML5&H[8 K@[PP1'-:JF5<L*2Q^&!TU55T15I1.;>9XFOD@HKK\A: *""*/K$3
M8-5PV'K&(P]CVD%7]TN#;D/NQFCB.B;S"BCC**]'17<Q]K'U6%99=1YJ+"!H
M7T'1O<M(G3Z(4Q<51<S(U^E317TL )1W)@=:>7JL<]#ZEH%$<UBW7==*FWEP
MJ_DS)#)5U%+.J+3;G2M%P[6O]7;&I*O3[U2J*2"N6+8TO_8Y5PC^8DMTT^NQ
MXG_['Q?]X,^4\:_QRC_F]9\#X(?@,NZ^^+/9D/!HIZE&7F\\?UWA=43GAW-/
M2DX[KA1SZ2ZM^COB3%+QP_XO[JFS[M8F/K3F[\T:\O/A2_(GQ>IV \(#]:T*
M>ACX#\!_SUP3TV5Q\!^ OYZ?]JQ\!N _YVX?:L? ;@7^<G_:\? 7@9?Y6=]K
MQ\!.!OYR;]KQGP'P3YCDW]YCX!<$?SDW]YCX \&?SLK[5CX!\%?52U7^C3'P
M$X*IV>N_.ICX"<$_43U_XB8^ G!'\S<?PA,? 3@GW-<%_P#B<9\"\$^Y9_X7
MC+@3@GW)/_#,? 3@E?\ DYOX4N/@#P5[DF_A./T?\&>YYWX3C/Q><'?S4W[;
MC]'G!_U,Q/GXK_\ CSA#SY?S\9^+OA)>T4E/G8R\77"7\Y)_>8_1[PDG\K(^
MUX^ '"'\[)^UX_1YPAYCTA/^%C+Q><(^Z9'VK'Z.^$/=,C[0N/T=\';/^]R$
M_P#A\43Q>\&>ZY/VC&7 '!*=N1+^T8N<Z#:++8X=K&=:(#5LWM9KJ.;N7,?5
MTZZ$W6EKHIT<70'([XA#NMG:E$;1@+&]8E-"C]43=;TEHFK;B3P5(X7X4N,Z
M#'=N$*Z7+K:.38G6"WS+JQU(-_$(^9*CV<? O@$>2BK<]OF(G)BB\(>+WZFZ
MDN$=@<.>+F"^FQYNTS#>RS3OI&)[<)]V<,-TV:(-R+2G,GW6 T3M8SO5B'V-
MHDKZ*SL=+B* *_Q=FR_=S"P:7&XA<'%*HF$,8F@?6Z1<<U?+GCA_6&Y[QVG'
M%,;D&]3_ -U(<7Y^&WV6B<4BT+IVMHX2#O-29BHUP2B_<IB:%:5RX;PE274%
MW;2FB5CIS[,4%:H.5>>F6&[M"DFS,:;=9J-<FGE'>"B?1(.&GF[Q=C-T>^MG
MK;:^B175TIIQ,)AP'3<4S)6UU %?4B?JL*GK7G/1I^Q@@3-=O[.6W A)=:44
MUO4>;$4%"7HD).)K4Q^AP]NLQ0:"OKJ^JIV<0V)+)S:RK@Z<&.?W4CA22H]1
M&S+=Z>SB3HL$^/(("%A7S/NBRKI)L:TP0KD0"6KV2]T.Q-F%IR"Q_0-825(:
M1Q=BH3:. B445)!YU1<^?#O4FC%M<RUBFHR1%0:(G<B*;$Q?)2@0L]3?1I]%
M&BF2B2"F:EJ0$6N66+?<;J[>6D>KO9$*X'K1W0V6@8R'W)YK6G)BH/\ &>K0
MN:S7!15Y%(JT$<N7"G;REH^V_ 1%.><D4%QP*Z#0B0T-%QJ78=UG$/:UT^NQ
MXG_['Q?]X,^4\:_QRC_F]9_*_M^3R^?C]O'[:^3M7SUQ_KQR^1M7'+A?*\OD
M;<;<;<<OGKC;Z>-N M[UQA,SG-"C$=E- ^:.=RH-D:$55RP_'9NEO=>B(Z<I
MEN;'-UA&$7?J\ N*0"SI527D1,*Y;9\*>VVJ(X<.4W)$"5*T-6B715-E=N.M
M3Y 1(XJRTKK^L WLAP6F0U:::G''$1,%(A26Y+#;K[!NM'J 7HKAMR&U7D5L
MVR1>94QO&S%QM4J+@.(39)6B*A"2HJ%R87B)[K^AR:-P<L0/MI:G)6\0U,HV
MA5W3SR(9#6BX\;CG%UN1>&.-NI)!<&6PXX^L6>DIIP4:(W8[S!BBCJ1*8G3[
M:]<)]PFMBQUZYN Z_'B">O<1=#;>EIPUZ=$524<.NRY,>.U&CNRI"NO@&YBQ
MT[[(<'6I"RT*=(]B+AMUKOK;K3;P&&M0-MT4)LA*FE=2$F!D7*2U"8.2S$!V
M06@2D/D+;+0\IDZX2(-*HN&F+Q>[3:GGAUM-7"?&B&Z"JHB8"\X&H27!"SQ3
MP\Z8-DZ8-7B"X0M-HI&ZJ"^JHV(I6NS+!2;1<K?<V /=F[;YC$QL#TH6@S8,
MT$])(M%Y%^7?'#^L,_>.TXXK7_QZZ-+VVY1?]5<(^*=-$VHNE=J+MPVT#:[T
MA$3>=/40)3/0G9QZ&$WCK0>R<02PC;<TR:V: >Z'F:%P[[ E7SJX/[,YZ?D(
M.]<44V"IDH^=6F%5\A1/HBW:+VJXU6^7+C.)74D22BIFM5J-4VKC=H4B6YR2
M)CI:FU7UK2*J>;AXW"4E5"6JUVYUVX/M-?T+>/1QI-]H>PICJ\U.;%YC@,<V
MG;?*74B(M*M+FV0Y(N+<$6:W&U1&#Z3;2T4@&M"<$MNG"Z^)(X N6;<9:5["
M-X?(9#D^<]-A*[*4 :9!!D!DT*<^.'5';(29(+^4F/?L8\3_ /8^+_O!GRGC
M7^.4?\W;/\F7R5PK; *X6G5I'-=*=TJ\R)AQ762;W9HV>L5%1,D51!:\I(F-
ME?F]E6N%;9;5PD;-V@Y4%M%(]M>Y%,)I]5I1%IETZ(FK/H]):8)MU-)@6DTR
MR+UNVF,_.IV*TV[<-(Z&A76D>"O*T25%S:O1*F%+=%3=[Y%5-.IJNG4-2J0H
MJ83FR\WT<<J>9EYF:^2F'KM&C+(A,R.&7BCHVWO90Q'7%E*S*6KC)Q]2*J)D
M6+V\-MDBDAOC@2-\8S,<V;TQ)&W]2=:^Z77W)"BBBYT13#<F/<(L:[7"+8V;
MC'D6L>K,QK<RZ!10:8D!JG$;RZGRK6FS%Q%RW788+O4C*(^^<B)UV'Q1#DB[
M%<=DN;P/!H*6I$!$[FF55XCA1C:9&2?&[K5LW!!=)+UQEW%VV/1)PR-VUOA<
M%=*CGSXN3MG/B:)X#X>LT/ANUOS>^3)\C6Y?9CS6]4'),<7E%@=B+B0F^XQ@
MVHY%[EMQ7[QKNB185C!BU0UD"2H!W6\..&0\B(B88<OI7Z1"B<+PX\M^Y.JS
M&:O3;,=IT+?HD.MW<)BDX;AD(&R8<M<<;7*VR[Z4Z5Q=':@P6YKAC^1[3=L>
M>*SQ!>849+LDGD+IBI *HBXM\P4XKNUS?X"XRLK$A\QBNQKI)D..61F\6_KD
MD19*/T$7>.$2H-<TQ:KM'E7P3;XFMT,X;T]2M \/?D,K4MQ^(BB"Z.(Q&J^N
M3 M2(?$1LLKPBY=X]\G#-ZYQ)!OY2+E<K(UO>]6MJ$.7<(7(F6.#UN4:T\02
M;=XPK-<)+T2U-Q^J\-L//DXU(ZR]()U&4)-=%TDO)CQF2+1PY%1BZ\!0K;9G
M(T2*SO+HCLWK#<;0*(V[NW!S]5CB2)=HO3G%9)D:Y,LM1(DA@+0Q%6$L1GH-
M3+>^!HX7\)J3Y=\</ZPW/>.TXXZ"M%C<77$_Y-T^E^Z3'.E*8W9(JJB]%?,V
M8=,4Z0@XH\N>FNSMX5QPE4RS*J\^=,,HVOMBEO Y*47/#M=FDJ80"R(JN=M"
MV>2]O"[@R$0Y$&B80VB5#%:I3GYO-P*E2JB)+VU%.3L8=]@OI8/^1_H&L.FU
MW=1;[0E7I)BJK5>=>?%Y9K5GP7*<5/6GHI1,6S^P1OK,<V%%%S63%7MJCPTK
MVL</NV+Q@V*T6<F'2A1#X?8ER6@ZP^A ^\Y'+7TEKCAGB_C+CN-Q*/#[5R;C
MQ6[0Q;E:\(1MR>@H[;>\39W7-Y3QK_'*/^;UG^2KYOD^?Y#SCV[T'$>9[Z*F
MWK.BAO$J*J"JG)AQQ\247)<5XT%M=WK8B.L;QL24BZN#^E4'E2N*JZWUQ(C+
M97+J2;I:2=;X)'0:HI-='53$KJ](H.^%]Y%6,AG(ZTW]R/"\B5C@RB44,(P+
M[<:0CIG)18N]66P6A6Q;)4562;0<6X$:;6$DZ?)N0]5 E-LB0K<=536HQS/-
M$VX;<N4UN0]'N!3') 6U029'<B[K= T :6]V2)B,Y)><1&H,.*ZSND)IY&M]
MOA549UJ0.$.GN15-M<,BZYJ!NV/P^J)'T*#W75>1Q7%3N'(RHB=G&JK;JB<L
MX=(2-I$8)E0C17$4:.$#J=K##S*)JZHP$B@;M%D"E'5T^R\A/)1>SY'S<B8]
M''S=G]G&?S5V^GCS:^;Y%:)7&Q,DHG:V4QL3F]/]G&Q,9(F-GR[XXOUA.>\=
MHQQI%DW"'9N*DXHX@8N#DF6TR<P%N#AL$3,LAC3(Z-F*)3-*8_NJ5 FMTZ+D
M6YL A)R4CR"+=]I#TXZ5KE&B<K0PI->UN9ZJN*':+ML_^32R2G,NZWV-26B\
MM*2]+19;GI5?8DQ1,:H]FNCCRI34=ME-+3FU/JR(X1DX,2U1UR5Z;<(J&B;%
M58[#SCI9+LVKLQ$2%**]*TSI-Z,D<9+9(M=WU,Y(I)81%Z)"6L>;&D^&[X\B
M9:FK9)H7:0!(?.QTN%^)/Q/<%]%(ZX5Q>%^) =7)3&T7 %.GKJQTV8U_DW?C
M-.YWUKGT%?8BQC_ KPBKE_A5Q)$YEJK0#L[.%:;M P6"2A2[FX$;2*Y*HQD(
MY1EV*8WP6PIL?0VA+;#ZU[6V@*XD9%;E-H2!LTKA6YEKFM:NB8OQI$<>TO6&
MFL:DWS:>LWK*HG:J[EBZM,CI(X,@5+4!$56U3-1,EQ;&^^..#"8%4!LR5*"F
M62+GC3&M-ZD$NQ&+7.=KV*BPH^CCPG-LK]KMXS(+"N3Y# .;R5)!E@EBJXKP
MCO#S6F6+%;W";.1;4DPI),.(_')X)3ZZF) ][?:7G'+ROC7S3X91_P WK/@6
MVKC-MZBYJWD%Q&S-/6DJH51Q\*K]_.1_M./A7?OJXWVC'?.)^(3[4L6OZ-M,
M?"'B3\:G^]Q5OB7B(/93]]^Y,*8RXMO/T[<)WZ]A<9<5W-.W$MZ_\''PMN/F
MP;>O_#Q\+9_N"W_:\=+BR?[AM_VO'PKN/N.!]KQ\*KA[BA?:\=+B>>O_ "L+
M[7C/B2XE_P O$3_AXZ=_N2]H(WSFUQG?;HO\PG_"Q5R]795[!,I_P\9W:[_S
MC7[S'2N5V+^5$?K0Q_7[NO\ +_M8SF7?^>_:QG+NONA/V,?U^Z?SXXZ-SNJ?
MR@?L8Z-WN?GL_L8RO-R^HC5]$<=&^W#^8C+Z08ROT_W/&^UXH/$,]$^P1OWF
M/A'.]SQ?M>,N))_FQ8GI;O&7$LSW'"_>X^$\_P!R0?M>,N*9]/[) ^UX^$]S
M]S0?M6/A3=/,C0$_X.,N*;K7[!!^TXRXKN:?\K ^TX^%MR]QV_[3CX67+W';
M_M&/A;=/<L!/^#C/BV[>8Q!3_@X^%U[\P(*?\#&?%E_7M.L!]:RF$U\1\2'[
M&XFW_1A@VTEW&7K-#U3YKTLD[ DZJZ1['RYXXOUA.>\=IQQ3)?BBXZ]>YSAD
MKKJ9F[J7HC1.7'>V";]A+EM^@A+CH.2P[ W*=^_3']8G?C6X_O\ &;LQ?_Y2
MX?O\9E)7MW&:O_6QW#OFW";^SBHE)#V-PF[:I1:ZQ5*)7$"9)N$QL;F#[L=E
MJZSU<;::+3WXNL#57.QCHW>[)3_Q:8O-EFZNS#34OB2Z1X:(\X^OA60A.BPW
M[6!+K355?-PC+7%%W;WSXM-F[.51!7G!;;)2,$1=WO$KB3:;)QI>9T2*Q&!Z
M0<H3K+4*OB) E-VG)S8SXFNR_P#,GBJ<379/^:/%!XHN2I]'NW/KQQTN())>
MR8B%Z;.)4&3>7'8\MAQA]I8T2CC;@J) JBR))JKR8CPX]]G,,1F&X[+30,:6
MVFAT@(KNM2HB>;BA\27A47D1X@^MPHS)T^6JJA*DB0^X'1V9&[HKYF6.$*4_
MJ;^S^V2>=!\HE,<83&>#)/%%CXFND>[LS+'<[>W<89#;H4%R,_;I[D5#T]4U
M:A<SKB/$<X$X]A.OO-QR=DV>"L:/O3T;U]]F[.4: MM*X3Y)L\G9Y79CFQM]
M#R.3&W'/C9\@V8V>C_T+XXOUA.>\=IQQ+5'O\8E]RI:>Z39C8_\ 5%CN7_/+
M'<O>>7[..Y>\\L;'_//&Q[ZH\;'O/<7TC3 ZT><TCI3>JX[I%,]V&LET!7#7
M66G48UCUC0T2N;G4FO0B9[.;DQ?+O9>'G!X>M75W"+> UNVR3<H>Y>0G=X;B
M*JIM1,\6"S0[;X-8LPNF^[K0CFRWLB>32B*VBYKMVKCL\_EJKC9BJ8X2[$5_
M[\D?Z(>->UW>YP;;<9_&BW*)#G/I&>D07+/;F0E,"[IW[).M*-1Y4Q?WHEMG
M3 D7>4L9V+$>?:DB3E 5HP0D+53'P9O_ .)YOI[I$Q\&;_\ B>;^\Q\&>(/Q
M/,^UX^#'$'XGF_:\?!GB#\3S?M>/@S?_ ,3S/M>/@QQ!^)IOVO%%X9OZ5_\
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M=\L7MF!,E,,ZT5!NB8P*OK_%9U)9UE/0=-/O9,;XS[-6<\#F[952LEFP$(E
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M7#?4Z)>X9]C,4\B&F#L"6C-*V,D^CYB$MG@)=GV1R^EM3J!'^G@Z_*VH@"N
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M'_C4Q2WJ,D1+%V9A,X7LMZ"8P)0&2LV,<?R:^WU0B@WR?W>O#B9[A+!*"O/
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MR!.NE56MU_%C)E#1Y?!<, RI'H4CU1UREP==3U0#,.'.+#1 :'E>@4[M//\
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M\&=ZZ=_BYX=)H\HFZ<>8IHJAH;)CD%RUZ2E;'G!5S+$*D:OLPD6BE!7>UF6
MK-^M#5Q? K?]J''7%%_VSXP(WL/E'U/7O^$FJ4^!ZP%IL+N>UQ3^]^\M*='X
MXHK66:Y& 99,-[A<V6J;?CBG[!C#T"-X+Z 1&%BC=6\XUGM_*4B@*$L"50Y*
M@?WK.ZV[@<7%153RH:BP9#T#$LQ!""+OHM1D7",:ME_!Z"K0@L\ND9<]F85
M0 DM0((;AG1PU=;\@=91(R+IP&S%WM-8AIL?IA6A5ZRUED*+,0($F:QY!EMP
M.%52@"NSXV=3X<W29?->]N8'7Z,YMN(:TS#O[J//UZ0P9_1@8[)+FO:SFRY[
ML,:QY09CDY^PL77#>A2)(WSC,![3?AN9^$XE9YS>O(E$NSKZ^/FDV?QC[;4E
M>V-1VH)JPP4ZYU'N'Z6^ZSI#Y&60&ELO)]8[3KV>?SP=$<KM:%$5+8(8Z_F1
MW=26V+25!*0178EME@;%!#K(,\8UH27:V[GH,.#(^0BE"7D]@^H:7!)FG^RB
M/XFNU,A+(+:[85ITCP8&K*[A!!55$:K^33X,Q W ]61H\OYO.ST\GV@-X(H_
M)>Z$@!;')OD%WO+#!*)4L:]G_:V;Q4?9>!FY<L(CP(&?8O?&+HO*9W_-7,BK
M;I\M-U=',!9"Q%*]L%Q*V2^T"E[5OG XQTV97_6%X6N3UFK$0>C#+C=Y9BB=
MH]T^682K(. IMZIE4*Z.PBI/1YU&K_.4,:)58L-(%7WG%5CQ^C^\@^*>\7C7
M\S,,K5.GZQY">*H.? PNR0V% U#FP\GK.YD.)BZH\B7>U]E,G5D>'Y8</]!I
MYZ-\.KI ZEA]2./5KWBYXF7Q_L91H"/HK67NRYZ_D)-2X].^,YF]X2/]+2YB
M[TK[!]R(U0JR!N:('*M$N:,,0'EF(HLB-D7A8GG.BZ(&$8Y<O1.+Y#B&SS4+
M'W=Q-X^1]B>GR^?S4$ _,F=GH%SS4.X4@5@;UT/Q4@H-D.:;K&:G=9&8%HV%
M9>#.LPU'OI/O_/M;7763-7H0?^+SF4=$E/1B3T,ZRC62P#>2&CR_GP+I1T,/
M$_MW&#T1O/Q=BZ5+T0GTD"9F8+"P<CY?YM"VI02_Y RJP$*K!1ZH92K;DX_@
M(+$QW;J[K_28S'MCUBNUMJN2+O+1S_''J',#9Z]9^PME\8P!WSIN.%YAZ>VQ
M<&^3"^<: ,E7HET-7B65ER:>;6<&93B^G'[@=ZFAD164;()LZ75-35VPNVR(
MV%#+,UK"L=)IEX[C. X2["[K:9HB0V)5) I *5 /""VK2VTJSJ40)Y?T1AY$
M"6)&2N XR3R,Y9="&NH=K)T /0EWW_*+[+%%U%=_@3UZW 7\WG3A_)C2NF/H
M9)EYYX//YJ-?0E.1Z[@J%-UD7;I%H'=\<7/W@/7+!9F--\5-<+%&]F-0[<3>
M$9.366OYF%F"*+RP5;O'9(@2;"37>^?," .A31E=3=+DRT0\A17NZ!SG^=6^
MI-IU#>')U4+WC7\4J.OCU@8 !M$8X+_,_P Q5MUQ0];]U#@>;R7]J+AHO.-]
M?Y=B.Z+FK=;$2 RCV'U7: 6B7</70(M=UNP\BM7*2VR#H^:BWAY,P=.$6\4=
M6@*!&8^Z2"M=< OZ-5S&A14U8Q9?+=+$V9K%=571C- ]9E0JT:T$RC0*T(:#
MS1L?HKV"\U&ZRRP6$Z*#Q7"@-(R64-0U=?$QI QY>MEVA1@LN(619-B*KA3B
MQE9RQ)BOBX6&ZRX0)#NKLZ-LER+.9(UBAKOIYS+[B7<@I:?0P'^D/)F55D -
M!97C=_R[;%'*6R1:&>*W=X,_6.VZE]/\?/1J_5ONGY^+P9%9KD,N/2(76JOM
M)#+HJ8HWBBN?X[^+^2$Q97= ;3/!AN5YZ-'A,2#K:5@ +9@B_ %<C$_G#@YH
MOXWXN>-_QUS]CSC<&"7^D]/R>Y3Z?X_O0R23&X$T387***E%&?S$&YK !.;;
MB*WOUP+ TFX1W]7\IM1 !(3EG47+18% 76X@=WIX.-O)BVL#K@5Y.T+C$6(N
MTP]!/J#,N&_4VN6>C;JH\,(V;0*Y45K[RW@AQ=1_1E$!#/-K&VA>X"T-/I^B
M<Y'^8](VP$>1PMT74:Y.&P8+^/"A<VNF)(X#L2$9ZW!6/.2-BXL6<P4Y&J,D
M3J*#U*J#A,>7B5?GAV)!<9?8CX3+]9EG5N:!U%C]^^M^?F0GU)^GV/8OA5O!
MYX@C:]64J\6K6TS'&='H:UFJF MZF6\=D4'^&NL5L>,K?2 7326O*88:O=')
M,7^0+X^GF2HNRKE)\E@2PPLG1)<ZC+5W@NEVXN"[3EB$=4@,E[@=+#'I$H^(
M0"C .K-EQ>J5HR4ZEM6=X$/*P'(= [MS&A[?PZQ]1X3/7X)X IT^OW^3Q_K_
M )_O)A2<I0/S:T$2RCC')!XFTM=2VAS3E4J]Q!R:D:'0="78UV!_IHKI7,;@
MR=V,,L582P?6VMNCH4J/)%%[='N/AT,RY&0[%U".$8%;@+6G;T]X7 'T@.0
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M_8HNXCO[-NO5E!!A@A&C!QK2^06VQ]%&OLPK,*R]G"KQ1F0A"4UG5O-"L\6
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M8&-HIPI&B&8@\7QR[ZB6A6N BU<:T-55R^D5G]'$6TKG=P_8-Q%J&"G!S#H
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M Q;5WB/*"HEV7N3H(%'[.64,%:T F;RQ!Z+V@[976#E2XYQ8#H(3%++^A+H
MT<4',.]$: U4),FQ%_\ KG;=16:MAE;7>IO3T/\  8!C%WX](F\NNK^YZ_=/
M,^[^YJOY9RS[DY9?=^YSRX\&X^[SR]?.9G]O[F;HMQ_I,RMUUZ/.> ?S<?4\
M^-35^I_DS,^[_(MKN_>/3GB"6-G/647 CU=([S&8;07\>DOU/JGVJ TC_#O&
MIE[_ +1U,G&K>V-PUG%O6)P=*-QT-A!T2:B*D%J[8P#M9,%'%YJY9,<PST!+
M%9JN!P4%RTT9$(9-O9)912+%CJD7+DF/.F+O$L4P6 9 NQM5+UQU@N92[W"B
M544N@6"<6%3N17C"&7;R>+1IA;9$]UU'N&KN6X ;.) '">6XN'6%VNPJN"G9
M4B/US.)H_O)\R73W-15^1+(##7AP.JR7:E)+#CF9EVRY9P*,<"A]"+V?-I;I
MA=2NA"R:G13[R[*[#E;V?6;'7V\";R[F2:VP.@T"#N]S3V&=LCG-05Z:YEQM
MCY9LH@)8(@XMS%=_%:L2S8O!Z,G 7JS@ Z1*X=]F;*(/NB3FE@&'2ZN&Y+)W
M%(-''$I-NP7RX=V$QC@X&NF1V)0Q=]&]M-M'^!O!2S,3##.F<R:,Y119/)@S
M-GFP;=#]Q,ZBL]7\QY@[*1'@*.4YN48K(;,"[F/%FYJOJ6'T1U;?DFK7S&HJ
M9VVRK9H71RQ&5M;(@<L[F7DJ;ZF:4[(/I!^B*C-9 + =8(1-=BY3Y#B4:-BF
MKMTUH?6$:I*-U]11B2H><_><^>%KP0)@*:_AJ(1ABR?[V3DNXS:;J%LW@KZ-
MI14%A)0^0D*:(89X+#3!0X=/[&M+B^MU0MA0S%"9Q,>*6T#_  HW9)4[+I0K
M^QMAN@L/L"C4=<<!<9-](RLZ[= ]D77>3>0XHCF#$P== BO,Y35HS9A)<E4_
M^;K-UFY'P03FKII&&81 1C2PA/-IU#^Z#^VT#ON8F>$ ]=/G"'V1K2O1"]),
M<"'F(4=:C**MV L4JA 5>Z[XAYYI(VX^T Q87<MOI&#$[436"ML2FC1 #(O.
M1R.32!I1$X13L4:V^%1(FI+QQL11W!PPLE;;D>IOSB<Y,E0D XFI#*3W 42C
M**%Y"&;% !YR@D3:IEAL!HM%7H;-U^=#JQ\BAMG*8W'<X^3/L$^HC5G*:>'6
M;^.L30[CEJ+B"*.Y9FK4.*95&VX'F^T4Q6_9MB/+'S?$0ERT5"")?%/C1<5F
MIF 5B;#*#IF,9^R;4IDA0<7N(^4-9:70)>02F1C9*#8;!NC*PT39DU":K=RX
M6&4+R\ 9>1B']?U"H5XN'#R_4H$X*]+NO>-SF7?G]QD[4?F69Z/V ]B &#?N
MSF 50%57:@%>0_>=,;$3J6H^=H!-%-G>E7YT0M45=OFE7[0)T&1K(I5^TJS!
M15@K@[40U.ZK5E!H>0OW@;>;R(;2O. ]_.=I[=<?W?"MV'I 8R^;=)3\>)F)
M6K['=]!Q[)4(0#OKGE>4*&$*-HI6\AYC9BJ+8VV-%9[=((1A[HQA76J;137+
MB.V9<W&_9:KC=C8J\.*@9)=1B_1ZW' )6S%] ?>8</O2M&2SA>Q"U8M;-MX\
MYA X=D&B!375-\."(P?+A*8&V,[,Z2]:5G@T>9NA#VHFY"US#HVG%1N=W%L=
M"K-/$&YLMHZW!-./2B$WW$ID[G#4/#94Y9G9[TA3@.YMY0T?%0VAY^<J6319
M-H#FVA@VZ9' GNWWGJ/ZL+XGHPSNQ^D\>_:>- 98>ZAR8O $>D2_*<?5(>4%
MV@;-R^7?Y%B?PP^T3^8+HTK<]+ZHK] J_9%?3$\GV//LQNS;-;CHFQ73\VL%
MWW7\5(DM1TJ_2%7U!A'QM*">5VBK=GFK[I<_..#\IUSZ7?1K ^!G&0'=H99P
M3H_=$UQ\',&T!H1\_?-;B[^OJF6,\63U0N<^*W_M@Y9O&0/*\)OST%U^<%Q5
M[/WPH9O0("OH7^D< OGONTEU0OF7)S/)GV?D3T"32OT>1 K\7@L-'K;?23&&
M.Z1\Z*]Y=#XJ.4N3UD89@#MY?3C^WQ.A->7Z!S#ZPFD#&@]#RI@ -T9?6[Q]
M)WCM*CHS>8PO0UWU8Z[KBX5N#QGI?!!>K<R/!",39@51J CI;([):;?25,U=
M%$0Q+OI,$"O@!;BD5C^\P%C*:5M>D:M[N&_*!% W?X:IG" L_O,7-@]P7K 7
M$\(-E I:$@%G2,F:1;6T;;] /K^U1VY9@L4N5#'-F7.!:9-#0E*7N_)B@<YM
MT.TZLSI]L5>L07T"/[*%509V#$9U,DU@P^7F_P +Y?65V^OP\%_Y*E=KE0JL
MQ.YX]YWOK+PM]E_UGD1YAZ+_ "3P?]3N'M%!+'D9G?\ CUBWO;QUGADA*2NT
MJ5VAY5\+_P"I#P6_^*;.>-R+M+ 3:I7'Q/18?X5^\NS[OZD\?]WP17)_!RDK
M%QW>;*5V,TIC/RX*'='6%%L3Q?5](W.64J2ZF@G;"UZMD( +S0% _:6X]$>3
M/N?=<\]95?(C]H\@O'Y_$KQ?Y!G%1$?]'?[?EM;OVP^_,';C74\7K_Q+@?*#
MBY38SO(HI+)7&>JR%/5*5FUQKP)=L^5PY_=IKAOW_P !B"Y_7^\=;P'01 R!
MO'W(&I\^,$Q333:Y049@8MP+;TP*:.O^$\#_ +1P>-])X+_$\,?B>+_Q"2.$
MT^+41WXCM*6'K7^,9Q+0V3Y-N<_^0\,F'Q=?@G_>)6N?@Y^/\:^#MY"')^O%
M^+NPUV^#;R?/5X6,3]# U_\ =__:  @! @,!/R'XIMVEE'?PO?E+_? 1CN2?
M<_,[S&YA_P#/)PVJ!4)T%Z=!ABDEZ;.\!+PCHG0S]DK?J ] Z="6%V5'>Y!;
M] 3\?^>26B F(N.DL/3#I62099G?>=RAI?O%B6:Q^L9% ._1\HEN0!:M#L^D
MV/!]/_G%#+KX#7=K48:UTAGS4%@=!D:(L [+S\^LX@??_*A%!I]H47!/JZ$B
MW.T <8QWYZI7X"I]B$ ;=OE:EDSQ,S,J>4KX&9F4S,SS*>)4)3$.J#/O$[T[
M^91_^^(TZG#:#E+SV=?*5@8IR,(ZC%^=PYAP^&5 W.JQ^9ME:^ITA[@(TZS3
M"^DIR^8-%7SX^D\'@F7Q^O@@%GY?W68/'TEI_#B@7S/'X)3\?J,=V(A7AF*+
MMG>8W=CE_P" 42/I+?X5'GT[R@VC5=8#,T^\J_@,[JU.4'?,#6@^XF;JY.[O
M [AW;T[RP,C\N^8S,E!A\'<$<L;O/^)[_P #7PVO,OPI'D<3++:ELYB7BW3[
MR_;F#W'P<"IH>?\ P*&S48T4-^DQ'GI6X=<PVXO<-L61!B&XA0)QW)B=3SS:
MNT;VX>3YMGP3M\,,\0Z('P.D"YDC!8EDW0,Y[B2R[Q\ Z*NTKS%G$1J6Q^@\
MD=US"@N:?_ HLM()L@#V_P!G#DP>;8PX+/U[SPD/>#7:AXW,[0)Z%]83T:8]
M@8MCE^T?GV_#.WQH5:50W,LU"D56/@E\=8(N9=V(7=^(+02GAQ.[Y>&[1\)%
MU6:?_ WT=-Q1!9'-^!*X6,]N*&,.)?%7=[=!+96MRW=^:]94LMLKS_<:3+==
M .@<D7,X7>,4Z]OGWPU)R_ 2KO+UFV=WW1Z-W-@EQ4:=O%_V46# C4LLEPO*
MS+U"QZ3M3#AF=)*WC5_^#SN0**EJQN*]Q\^W9E7K(_YG,TA9+1+QF_AH[_#(
M=Y5OR=85F\Q'E+GX(YG@_.'\/3XP('5\!&"35_X&ODQYN&T*/A4HW\^V._%T
MB%Y1+J1&MZ3<@/I$_B.C^@I?D8Q1:E("ES"B&RCD)G+V9YLLX/U/ !Q._7I_
MD56F S5_Y#;\([?#3,1>6(?%=Y0Z]_\ 9S_L_<H'0\<P9@/H3*A[?Y#-'&$8
M7QZS,?V_<O'ZCOIZ03D4>4TDX_':&-;OM+-^OAG1_P"0VSZJ._P[,N6F;AF:
M/@3D?^,<2!4[80:F+T'$:&K?&X_'.8&G?CM/1[\0_,#VE)SJ5,T_^0V_!._P
M[U)B^F5@X\=Y0:W27GQ^DON'CVF\?0G(O4J*5ME@$KS)?$5=Z[3>GIG/</CB
M5F.NGZF#<RA]7[EX6:TK_P CMOP3O\%EBO',<PU:?"U[$]X6);]Z@LT*@6PO
MXH@;-N?[&A6K^!,D_P#"+ZO@Q,?"UQK^ W280^+K=+Q&.Y^&#% J55S"9UB-
MHC-$%:_ZN7;74L^%X^";(I],/.$7YF=Q[(/!\+L_@U?SXYE\FI3L88,9@DJ4
MQRQ/3*8V%Q4M@BHKA4SSOX5_#7]-5\(2.I:+"/%UAA\]U/&])S\"6]!*FU4.
MI'@_]@VG'CO*EPW%>'YEG<7O#=^-1K@RNO'UA/4\_P!]I4\3GRYXE.'G?PV/
M[&TMM.@7N?\ $*L?5V>Z"HYRGK!Y3X XZT/RS,MGU\9F##[2QC;^[9,W$IA4
M\H!:7ZPZYS([J"7TEDOY=LSN\8(;?!G9D*HZN)\$KDZI<)2<BX<!J5O-*&R4
M.B)L<0@I9Y4F!>)A()8"[_?P=DT_TW6-Q2M39^E<#VF3$=(_E9;5<?.7KMN-
M#R[S6'FB0B\GMQ'%_D*Y50_Z)5ZE5_4>25ZQ#,037$X5G=@^8KF7]DQ\&;/R
MYU^$M*Y9&B1X,'/%%J9C 8V\PHTY9Y0CT$!=$8H0Q.1,%HACHF5,$L=?W\'?
M]%4\1HW*2^9PL13;E&&$ -YF^F;J)2^KXCF8[N)58LZ.H9BI@L#TH/'>:W#*
MC<.M"&K]V9&1-=W?]F\J_ITK=1^"4$K\ 1OX+/BU^.6?Y?&])O\ @*YH/$&#
M+1U\6T96%T1H(4#;+O!E?&"CD922>77\-B:?Z"J-/@@Q#9-:^;,9DHD/'O+)
M."7%PJ8&4N@V?)CZ(U2F6I:BKCFA_M+FQRS ](W],7_1Q-AH./.R7+E_!<M@
MRY<N7"*%Y)5=GR>%Y$2W\..J)9AU_L3,P++B'#+J3,XKI/\ 9QH#-KB77:57
M4!X'$0T9EA3>O@WIF/\ -+1+<)E.@E8]3/VWWF:-;5#6&'7J4AV;8'B3(@$U
M1<VJX+\->0503(0Y*#O#<I3FX$%RVIKR+*J3<W%N^Y*(E0IF1)P[3'[S*\?Z
M;S##YWY?K\[YG!1%&]'XOPW+X;1Z9_<7$EF'<CN<!CZJ#YOR7>O]3C/OOY^)
MP31_-5X@(PK!>:CVW_);3P/29*S[SM@\XW7W0*5XNV5A2COT.K%]XU0>BU<*
M5C[PE8^\%:.>\968.O;O"HM+W_<O7VU?1Z)!0/- Y;ZQ?P??^YDF_66WUC_(
MUY6Y]R'T\^Q-"RO'$8K/CTA#G.WAN*>>H&L4;_HL3!65NI?P7+ERY<N7+EP<
MPT'G_DQ8_P# ^0DA2KX&N+M,(F#SX]^T<Q#X\XJ#T9\^\7>1F+$EBS*5-1F>
M(@+05 :M[)6&A_D5PX(=G?\ ,JQ2440?RBI)^T>"5L-'P7497X6RTMFB7,>&
M(V$@K7Z_N<=*]95SS6ONSGDTV_N=;[YH'W?N5%ATG"*Q/3X%QDF902U)E+^T
M!+@(G3%^/:/_ (_ZF.T:QVZ$R;7P2+M<X?6_U'^A4+W<QOX\&O#*8WCI M_#
M!\GC>DVRR$T>I+E8.K'$?G@L4!?K\$+15\?>&LUOP?"].>D*(+6)=GZRBE[P
MP,QZ^7;O*).GW](1<Z_N?:^'3SFG^5#'6!U\C+<'^):BJT<G@'/=EXH\^[X&
MNHE308Y\NT46(=Y3R>LSE^[_ " :V=X2O7R76^B^D"$BT=>?\^ 7F@JO?]S9
MHAJ"U%-"OQV@5$,2VT^E_N._Z"CQ)2]OD%_$N7\@,Y6<IB>OX'R>)Z1J#F7K
M97>"]_+RFFD\-]HUHFCFP_@Z2J'=XS#DJCC_ )%["?B<2?\ (?46[B,<0/\
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M6994T0RWP!?@Z3'\H*]<T?Q)'&XD#C]2_/Y@"V8<U*1E(Y?!F-KKUZM]NO\
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M,>5<$Y/QUECTN/85%<F$+8;-0?\ D;[S[L-?!8WL<_#1G)?"WVK,W(,J9-W
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MU+=(:1<%Q+PDOQ.Z68[A17ROOONPU\$CRX.(8>.9D,K_ +%SL#O(&*1?T/\
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M H4;@ 7K\#OX*G#]$.Z1+;BY@_(7>-Q!4Q'8)XLF.9E3SM2F&/';O.'EOO\
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MIUJ(.PCP=UWSF:8</9B3Y57Z_LCZ4=CUQ.)5?)1M-J$[$3I)7#7_ )!@LA@
M/)U>\0-?SA_W85M8_.!_KP_[T.X#K#]VP%OKYP1X[JQ7'>X(K#@<<=^T;WH1
M,^[ ?^/W%/\ C]SQJ_<\*OW/"K]SPJ_<OW]G[G?/<_<L%_;]Q"?_ "&C#Z'&
MIJ^#S\0Q[S9]L\WX..9[SWGO/>>\]X>L?6<<S;_[W__:  P# 0 "$0,1   0
M !MX$@                                              &Y^:W
M                                           %LP'\
M                                 !F.8+3# $-!QSR !V#$_8
M                        #@8OO_.  \<3^PB#R!R,@
M               "4B?FE6  &K_F3.<=H(KX
M       7.7GA,  [I'9\4:1T:RH                                -
MNIU   JU^<3QNKE_)(                               &K;CA   3-7
M9*I47Y6*@                                ><6!   DV6[CH37<9+8
M                               " " T   N4*+96R2=#'P
M                              )IQ#5^WAKTBR
M                     +6'%RSC3^P>8
M            &1?!6*N#1.[(  @                             ##@
M   RARN]>PQ.CY0 >0XADDD D$C;.,.BADDA$$#H       HDI-   O/BQIC
MA-[63H %LBL<%^&<UB@S3C# -"5*MXT      %4*IZX  5X('VV068F-@ S<
M<     'D+@C_ ,R,  !  !^      ?+ON:N@ $*/H&P8I+@74 -=   )() W
M<?9P$&<P##   !     +C214*+_ &X&QY29;87F2 (>0  /K]!FV#EO(7ZF^
M20  !@    .1O%L, :@/L26_C,\ HW. "9P  .GXO #&^3L_^(%\P  (
M &L-I6&P/H.M:!J-E53TR^ )7@  ++(<6P+&VGPV?V^L  */A@  *ZTNSE[S
MZ#N4M2T0<VV+  -7@  &%M-(J73&+$?QP[N  ('^>  /$^G#Y,ED"MGRC(HL
MU?-8 ((0 !G]01U'2\@@K_E$5+]0 %)B  %^#2* )/4/.;EJO;?H7)" !40
M [X    -!>EIWQFEN]0!%W0@ %%5WS&S 8+DW<02*V69A4@)(@ )V     $W
M&ECMD*'@0 (7)LP@.IG75=*M8"#."@RVG8MH: )*@!D$     % :S@F%./:
MVY<!'AP*/4<LHS\@'H@)1 J35<L$ (S@ $6     $0M*/))1]:_W/.6VWX"$
MA(QGN5@.?X9O!)33@B4 )AL7'WQ8Z>9>+_;!"!-W:[I/RX^=X *LN: 1V %$
M/=-;_$75V  /1<#*4R::6@"B6-2(1: ;>QD     !!>[H)^ !/;0]-!=DO%F
MR -1 67_ $     -D@      >N!<     ",W*-\QK9P@':D?DS69H@#6, !
M     #)9       14 0     "'YCP   #[M"HGR4!7G+@"7\8U@     "B6
M      0("4      ?H     ";NI&"<&^9Q+ "QH2N@   >6QNXKEX    /L
MD             "4%FH)SXI1G8@"V(#30   '=@/G/W3@   (D"$
M      3NM@^XM73-4I7,7_P[@  *GTLJ3]K   /-L"P             !;3-
M"7:V:"VH401\OEF   1F]4HFB^   8B8"P             !G=?]2^!WWQ3X
M#5[V@]@             <D,"              #%R!T^UD^/6PT"AD9JZ@
M           40 "L             #/.I0+_ ,S6349 U* $8
M   #^  !              EOSX@?JAK+[0 S? >O_L           ?[E_8!
M             Z2B=Y5W<:XW] U; ;H#\          #C^.6X!
M    P]P-I?FKXF.$ WA DFDX          $K:D@ $@D@@          1'?@!
MIR+&8B* W?  %8WI)       3E=%3  ABX-8          G[GR6"T8$9BO !
M9   %5MI       LO.H(  AR;2\          3GVYK6+6X[_ /@(W0  !X1
M      !MK1F.  (3?;P          !FABIM_Z(Q3_P "=\   3K=<      2
M<L-?   EI';(         !Y)Y4"5II$X=L /L   <Q%.@    +U2HB9@ !<N
ME$X<        #IUHQ$?2L-4]T 404/\ [:0S'JRL$G>QGP]]6P[\VZ/0
M     ($?]S+]308[$ Q<](6.8Q% , M[C+8O*)P<( H@            M1I.
ME\\5'G03 GL[KT]#$<9ZJFC=F >H?Z_OR\             2[SI#,O[2],E
MU 4$"@C&ENCL]G*GR(&$Q@R+              H(=?)6F,PM=X % 8]Z[_KE
M=SHS#N-_].,6J':              2'_ 'NUL\K*<:0-PMV</W_W\9:_=6D/
MLA+*%%\              +V3]RX;J(T3M -8E(_(QQM-R;DF5D:1=W!?]AG@
M            )IA(5(,1M86_ -;  D!8,VUQ*3&4PC3&&P@
M   #EBDAN"*\GWH !'                                   !)*WTG1
M[]H)O:                                      !'3_ +5>HW@0*UP
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M.:YA5P.+5X*%S#4+-HD,ID*#4O5"0%  ,&FB+7MG-77+JQV17%N.W^S-E?\
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M]TAL# Z"CZ%T&IMI*PC.+@$W-0>+7A=0%*'1^C>#==@VH#9@Q^S?-K8DC92
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M,?N];6%IB*6PO(F6$V%A?8J8S(Q@Q<T_'RNF2,.XL] "#!+*L\HEQYPP=QJ
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M/*9H,E.H@[4%PIL-E2SP+9M]I%#R]Q9Y'E@G2PSQ8.RZ# ,,#%1%91NEV40
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M,ZQLF&*YE>DKS)2L%%"BO,<L4""R_P!"M*LPLVOK09X+G=&B 4T<DO%=YCE
M- S L6&@SV@ !"J"@K5%45,0<JDN+'/7)*W ZH/&XEM5ZG83Z'S#_$0L*(M0
MM(1J[EK)E70<0RJ/:JF.W6XM2)DL+>(R[/NFMJ!4M6661KY9FDX= 6BZ$O6"
MU8P"6:G!X07[ 6&M0!50H"S.F<:N0 NWD(X )3 R0Q+<L0FN''2'<P%NJ(/S
MN,1!@>J7-)+)S[[;,J15-4KL_IDPPMG!1%MX"5 F-*A>S:L=(6!<:*.)B7"F
MT2QVY8_^.8%&$ZP:KN--"0JVTH[0N6N*4PW3: .!F8T%/O ';0TQQN)R<$?J
MJ)5H+PRUF.T8#EZM%#1J&=9V=5$9MM'1%*DJ6 97 F+= V2H!LXO]RH5E,2V
M9$R8/$6E98EX^U2AD!<[* L<B5C@X3@)0Y3-E9O"6_+DT:T<-EN9M=VW/VV;
MD<TW#XH#.U&"5=TJ5#$8:PM&0X-]$N.)<[)T*J5<O-*PH;0AI;./8WH9B!^C
M[A&2J' <0]PE#9@$'(U7SC:J60.>18P-VQ$9NP]B:"Z)I27A5Y<8=6E^"ZD'
MH@?JSP9^9X,_,J\-]9X:_,\9?F>,OS"FXJZ3[1:D6P)7HO6W$L$-FM723,;(
M,I0Z^1TGIL!I,F*@WG21)ULS;B&"?OV7PD(V0!*K#73'Y4%M@U#P;%# RE<@
M*3J.3MO'+^&JH@C!\+ @2%YL)APJ^-,)2S$AS3X]@=0-*!$%!Z3?B[L--D,)
M2Z,:RH8K&#M@/H<Q;&D+"4O:,Z:2+LZ0$ $)/3>)!MAA 6/T1F=DCO3-;5)$
MT2V\I*#Z16Y9G-" 0HL:0(&1L;4,F+[SP-^99KQG>?\ .?N7@>C;1 &=JHYC
MZBDJN!JCJ=628&[)@!;29+9(W#I"*=K<M 78S_L'[EG4B I !54 #*JX )9(
M+!,*4XHAD<#29J(D)#># _X5D)?5IA;@M'W+2[6#7$YF8-74-P&/0-M1$NZ3
M?SN'0\%AKB?Z%@.96YN=HM0.4.#=LPYJK78&#J6 D#B40QG(202V^.Y.3#"L
M J,@B:NJ'^\N8$5LPUA2I 39T!+P:[5>T7(%5HQ-5K^D1)S9&+ZL9LY1\X?,
MW@6VKN$#!H[RR<!-H[.'6NB/!5G-V&&1EF51K]]0E (&DIFT,^0UP\C TT8M
M6]/ KBL<D6H7J2%C0:$Q6X+& N%0&=MB@[+N"OK/23%0!H &*G*S/5JE7"RG
M"NYP8KU,H9TK5PE2:I2M"<(Y[-![:8=A1=#VF.2 D2FG6H!II*E# W"C8 .8
MH,D7UL8 V$7:B&$/8LTB O+S<H;0 [+_ $M(+*-Q87IK$)@ C</B -+C#(1V
MT#(IVCERFTLV:LT:I0AWBD1C:$:&YN<?<^,_DCP=):(Y"WBLCO%<P,; Z.L-
M$EC36X@%!8?=VU>*C% B[O1F"PT(P0M5GJZ$A!V2_;NOV"OQY2# ">H#Z@^$
M+7RM87TD?(IV@_6(/M+I.9Q?Z!:XC:F'(7NDN5*(R\5Y%]B+2N33&$TV$)=1
M?@CK8$H*8.27,G F2L2*D2*4%J\JE?ZU]]#E96#S_F]^M!.D$1;?<>(^ ZD(
M F!!H:QW()0@VNS4Z)?1TH!9S4($\LLQDE5UB)?L6_=MH;&KWEISZGQCH\FG
MEJN"R\NE"< #?(A>KZNMCUEIB.89YW(LG84',+M1</$81#1)CM!\;N,SZ92Q
MGGUPRA5Y.I_>55+=Q#[HD6UQKC)2*RF\.7M'T3K*>^00@C:+<'-VSJ%]!MQ!
M$P@SZ7IM#P A.M9JP/<9<,Q Y-^A#1RHCP['OI@%:B8;-8E$HJ-;PFHHJAW7
M;XD7.9P8,-V#ZW*"D3+38& MXMFQ-M$:R 6@.@HT>7]IM8H]W6'-9XCH[BDU
MC"C*XN^E YR5IKH0,'@]8H*U%%P8\8" "T=]%+YW ]!90?\ 9 %*<$KVCQ #
M=P6"FPRJ2GJ8"U.;+8;@'*;HX?U8K8=H KJ 5:K$ E71*C>P1K..0:M=$%C*
MH7"R;JZZ6,9"[UQ93)( K%@+2.DYP<#6:;LC)9=C/<(K051U63:+,0 Q?)^O
M6 ,I3TCCUE8V40E^Y%P4 '!L5P5%Z+>"WQ5@;=Z]HS3*QVB!LJ4FK"&TH46B
M(1'U&,%&;[LJ\O;.3"QV7>XJSM;V::@R]KV^(_D^]QVW5??]4\UWC0QE_!IA
MTCE+-R*K53.94W!98E8(,4SE&IPE.5W*X EYW*,(UO Q"#  !@N78'NU+B]F
M0Y7HV)V4+Z$)LR#M.#@KF:#G4+ZJ365WJ.YA,3OS1KXWAER^]B:Q@$G7LY(X
M9'-;BPV"HF&=574(I*#6FT25#,4%HM>FU=6%9 S6=5F@/*O6,-C:DK&E#?:)
M 91RC:(WK<,"VL*4K.X0Q3J[R'\$"NEOAJJ]1Z2R3V$^\J1^JU5#@IQW=X30
M!6/=<G!.K7>5TS'-0];UQT7>4,]J/I<.PI,H5EW;!/:4H%Z 9:SM!A&JOCIK
MNE0,1&'9'3%(7=KJ@/G;=XR#)2Z6\N)JM05XI?:I1H0=!&3F[S.4$#!9-H'+
MT(>M,0!182 #.G,5=.U73QSW : @RYQ)U.(E$!0(XD:EI&J<E-A0KO*2$4:,
MXI=,HI[TC+MXCZ0^VD<)5* 5 NHFXPE!;6&@! =B%L$TM>/5@7R1C?"C/8<&
M-.JK&[@$I!8+L'!D%G"H  8#^V/-Y&1-#VT@;(IU$6BLF4'R&NH#T)!SV2]-
MU(S/AMO?R,-.EK%4)C*UDRXQ .EVM* [+?5'L:.B"Q84XVG<"-TVX%VG*0#/
M$2[+=Z^M,92@"\-38EC"C,?Y;IX%E>:)6Q"K2;EE(+%A14I\"#?JQ@UTJDH8
M 26'59UD38)K#$&I0(QQ9111JI42PBMBV$>.97AUKQ0X;L;"S$K:?^V*$6#X
MJ)JL;#Q?;B%LW!A)OHE]6$R32-$I#"'G=8I&R!')\RN,Y&IBHLY,KI>YPE!X
ML^0._F"O"YOS\=@GBKH^QB M^G?_ %B<6UJP]7K$HJE%Y[F(ILW3C9376%1Y
MJ]P.\2 MI#3>:V1:J#V<E2A5Z]GTCG&8RUZN7AXKB84$$ BAH#+%1X4W5598
MC$)M6V2[=;T4;@[LQ=*'2_=,VR97'=O'1 @NHZ.G,-L6WV[V?>(:UC3/0NMQ
M3<&,V[E'J=6K/>,KMM]5/ND4%Y,@LZE/K 1PL$Z\===X(6Q7=8_4H*O%U6CC
MAN5!6.*/4=>3&@$'0=8REHPO5/JW8'4A@JXH-HN9@Y0=NM@T2L,)/4-X#%:F
M%1J"Y0MM9#J,8U0>!QX<@V-ZH V(:$,%1D:1;$!<#N^Y*2_[2%&='"^9ZLBN
MX:1'WJXP_O6D1@UAV5SE@N-SMSLM%J#HB1I4@-4)J@'9.^P@H(2V);0&+,()
MX:H2C5+HQ8-#D:4J.\@;!6I\ /O$[0CWNBE"ZJS_ '77G/O9->8[6WH5$M]\
MP3XP81)(2@.;I,0A"BNDP!+F!%EH7HZ,=@T%5'2&*/ M*RM*X8=#U$.(#)+:
M98#HM>J>T/-<U5P43E#V9G5 EV ' NLT*UBL,LP]+'UYLO ! HTL6KA%D<5B
MX]0$@]6!$7,-D(JJ0LM+(: CF,1+VI2PBI7:,(4=G_G"%BMB^++FUY+@5_;P
MKRT"GI,-ZLJ**J+H&.8:\-A2J5MIGU;%\5U.!;L4@1PC4<#Z,;P:!! P5<?@
M$$%8K6LCI_!XHDQP%QC4!\A]"H9DOIEXSB;]"4P6<%IZ4/WGT!]B+'N]DB ]
M]^D:OA;W;@7WX("G@,],_F 4;1.A1[M386PNCO\ J6%AV0X*?:+510H8S5L7
M_06A+C:"PIN'-DN11R1%>EDODU$)%&#/T'B<K X%OXG3*7VCVROZ&1AIVLI;
ME9SF(N9J&RV-8JYAE>F9*R$(!2KM<HDD'98B.@XL<RRAZ[G"D@6N4J(HU:;E
M169J\HX3+HU"M*H><$*E5>[J\T1"J\BN??$P%LUN'BZ%"XZD+(6,6D60<NG<
M8W?6Z)H>A#H"*C-3>Z0?X2$I+2,V4Y OD6##::B6;J7%YBI@,M@_5-O1FU"I
MBPP-WVU2T,+ EN<@'0-?.%BT6+ZA X!"$A-+>%H_;4PC7;. *8U2#K!Z-$0$
MPQF("]FP"BT$$\+]\1^$2T>B(=S6NA12JH;<OOAYRNJQ+=)2VR^$I/[F>5+.
MS9BPQ_6'>'/'F[QU;A2$%N$S6S8?I&30;5L#E7#S7>9CCP%]5@1'0L0")6U,
M5Q AD">A8TA.>T>;A0P.5Z::\F ^=!H5)7.;ZRR!C%NWOIFS#Z2U;]2#*]LM
M<<LH5><N8!5"UV8$^\%(QBZ9]>\3#3CWG]<$/@HO V'DP:JW<^0(BFXX6$LJ
MFT5JMF!&]Z%:VBB.(*:K(X<,M\Y@%T(58 H^1 1,-ZB= I;C4 ]XX1Y)Z[DZ
M9I:3/2-2_?$+:/B_GY*9EM2UY]_I*TV[7KG?GN6+T@;_ ! Y:I>Q>N)IY#\1
M%G'^D!5Y_:$547L]H,CP-7\#9CV?LP!@5EF[S^R"6>45[Y9AXS@YNU"**UJX
M65-:M3:\ZPJNNV:P3S8BG(6"8?,'MPI97!F$_P "Z+4YCLEQ&)9%,_R ;J"(
M0HF:!:T8E&7Y03!JC2=Z!U$BAWOD1XGH2%8S%\IZJQ<3,B;25-D89PZ+*Y/$
MO4@U;)Q7Z1E!1?EMQ!H ,"O,]&+CT0;%46@UC6_G"+@@)HYXWU^\VC03A$P2
MJH%]XC$%AEK"NUPAY$K"QN:+2T2<@RNB"LHQOA93GFA.($PL"0<F9YL2C>@H
M! \>B+Z0IO*U8;##E%0SG:T4!!K;'*]Q@@ X!'D39@&ILA&K4(<6ZQC6PR9Z
M;+K.',(2Q7I"XRHC3AI4PPBSYHR@NN6WS_N"RK-Q=U11K.1[1I)]\R96@Y%4
MERXM00(L))370&5,\@[ [(U>J460VKO$D;UZ&JO$9>FRUMP!30$L&]G[*4W=
MDL6=8$4%'56)*TE8'99_VXV\"!GM2*.<&& X[:*+:W)1I=*LH;JSL\+I"IJ$
M 0 M!WAOO$^P*>S*IE@&*/$66_*:T&^$!Y94U8*=3:H%051H;OBJ27S7VLBK
M"XLR_2N<Q6MR[3>9E$W,*7,W.0:HLK$5 2LM([VJ5<<P6BB34$-0@V7J-7]=
M' .-]DQV9@L%.XI_@;% ,5="17* 6KM2[CZ ^WQK,@E6"\#EZP:B52)>D7;J
M5<[:T!\:NF/0:I38,F<F#O'C#H^4Q;3SQ'B8U,-&Q&L<,ZQ+]J\X2^H4D E^
M"R3>5YA<0FPBZ&I( T@<P3.* %[I&XAK(:O2CC>L7Z#4Y@9@L>HH$2-H<A=+
MTL]H$M*YQ;*[QSU@RTSEO5J['2(KQ')-ZIP,;M)T/;NQ05UJ,B_6@P+:)6O>
M%3"# V#S Z0-K&T-Q>2Q<]>(F7]T$>8^9Y2-7I!%L?)U%RQW8#/2-V."C;PL
M&=QLKU9KP #:4%0=8G &.*;T)I/6A9>EM>L:B5,<T8HB57=PBM9ZF'88=<F,
MX&"[KVB"KM7*7UBUKL46BUU:^$"IO(MW89[63&DL,+'9WXZ3I8IA%:?[Y5E*
MM#Z@8@H,04"#:'Z,'UF?:H%8-6\XFJ&BI=UDH<,+:0R7T*G97UXAFG%=)=<J
MJW76!*0O:^/=S! Z&$&]" >4:4K5M#K1E7E%B32N%=*2ZE4';5+LJJ;X9;=J
MQ*LN]T\85Q"$]-\=&)\:^G<"E0@*"AC0, Z<?V[/*17BFKOJ/:#;.MV*B41N
M6@\%5P,X-K2+"7G\SHH4@#"*#/ B93Y([#*-XTQEXL=[Z1WJ#FAK//9F2]N,
M<^1+Q+1.&FI@"4(4'>J(JGS=T%UN-;B[$ 6K 3'4MG!;5$Q0ON@T7FX! *"P
MS0K"GI2P!L11E\<LG4PV0.A1%!FN:#E10S4J'&&T<9$M&EJ478*/H="JXZQ^
MMD-H*TP5SOUC( 8\TAUGY8XE<;"OCZG"M*MQ!>@B]&L<&N$)9GZM0*2SQ%M0
MZ+",68!8TF9M(:/(^+N-9*JE;5)HJKVR\Q,9 G<+;(4-@4ML3ON\W%[T8U 4
MNA2*%$ $\WS_ (*@<;>HENJ<@8Z<^+EK"*?/](J[*\J_[!BX>:C]SR/<_4:I
M1#!V*ZGPZ[G[?V2Z TE"K><_:E?Z3]1T<$JC+S=X)V/MD$"RBKIFL7OF$1";
M$'DV5%MKYMRR[4 6A57W;N4\4\'(P8+*>F'[8G9\>\ITG?$2:+[8/Q'S>UA7
MM!1W-7?K\')MWW16+H<NCTHO_P"*"&G[MVA%??,VD !0ZQK+&]MC&NRA(WD;
MYR@S9X(JY'<>M_:B!32U?3YFWP>E]1BM40W7U\"92(!%@*9(:O8K>*I@2926
M6"WL#3E<178R#YCJXZ8[FRSZT56MW!$D^/$?PQL3RR KJVKG*&UY07.-I51;
M*::?/X&H-(]$9A7N.'G![DX1+R^1U#SCVC-Y2BL6'2N\M)^.05CCY=E88*LD
MG*&AV2+BAM;IR"+8@C;2LXJ!0'0K_P 0E 6B0SE"ZP+GR837&C<\TINL+)3T
MIN#GZSE*M5F8YZ+=*)BBY*"5=N_*>:98K&?N><SX]$E]:!44*$>C5"UZE4>N
MI2#7:\Y8&A8T7&@!#;UAXKOMMYDVT2EQ\9FN(B]8L->)>8:#%1JG%+L@6T35
MO)GJZ0V'-?/KX=8H(QU'/>:N2N(1)JXH>.Y4 %AD&N\YPO3**ATR_E&&1YH7
MOODQ:E6UD1*4( F(:/\ QSI\F> _PK\'MC_S5XM0\"/T/QQ#;X\Q\74?':<O
M)^9XIV==ND/Q?_E=.T\!7B3M/R]?2;NYK>R/BQG@^W7PNORU'P-SEY8^T\].
M^T\!/<[=/6:/(^W_ -W_V@ ( 0(# 3\0^(I?;]8 (>!#!1J,IPM><8L'"L?=
MYRYH_P ;>+.&N$&D7HS_ .>'4O-]98RRD' F^B2(8M"+$5P#K'YNE]#WBFO"
MPB\N/SC5*P=PXZ>XRK4"NL!9QUEAZ%OTBI^/+P+Y'_GFW*H]G\]Y8B&-6NNE
MSBCF'B(0($54 P@:E4H)L=;(-ZY6<'M5'&<C_P E"N0@5B^"MU"4&6A&!]+R
M":-$QBQC%D7S0*497EMLS:\]?_.#VU%NF%DN-#@YN_QN6,K+9!\Z+S76#F<\
MC31:%!;:VK*M_4 :QU?>@FR/-C[A CH 56B:N^"LWB-)XH @BT\&_=B;#(!8
MJXPV5M>N*O4EKL<C,0K?3]Q&0?*H+X@YO,+\*E1]$MZ1'S>.D.Q*VQ*;H^OZ
ME>OUAR1*8@0LCM_>&L,^L;T/K$:H>.\*+?>)V?N?N68#ZC]PZV>.G_W_  G5
M$* >K^Y9F*\7(Y73I!T,,;R'!YOF(9.RY)>.IT@%K'W(]^T,0-MK^T2)&GM1
M][".M;$V0,C;91BFJ.G650UZ*Z='N0PG#Y;*CA+AZ^O2#=<T<D5[/J0=9[D%
M4,N-G/I.1YY=NT24^I^IXK/U#P)^I@_T_4?/O':*48 ?<.W>4IJ^I^I>ARY.
M/3O..OJ0TX^I!BI:-CEKI%:HW^4OCW/@@DP>?^3?1I_'_P!]U$MKZA^Y,<X6
MNK>3@2;-,. .:#K!;85WW7SW@IF05\A_<(  8J7)66GC&)5"\%K>EWTF%TVF
M'2SU(W ; -9<QI0PE8'S+RN);!$RK=^ORI$-U$J&XWG@ZQ< !Y2CI,,(E8#Y
ML4*X,N77-FQ>1GT^&<40BC(YYVQYT=5316'TC-YP/Q%E4*K+CRG??>$*(:ZO
M>'=@3;%GR.<\L=4!;IVE':)8Z;X\X;]WY]X:_P#OK"*!%5UYEHI!<!:U;XK,
M9P-B Y4%BN>B0<#I0A6<MATETW6"YL &'#8/Y(9BJQ)25V#J_K*HO="IM866
M]','@+&MBB)GO$#0P\=Y1\OTGYEO6/L?%&UO5&+GY1CKG6.=<?2+TA?1Z37$
M\X'*=R8W=7[Q;0Q?X(7/T,N.#_8L9+57?<XOB!^E(N,W/I',NP['GY1/J6U5
MUW70F%_I@@$;_7PYK_P FIC3O>_:'.=7EN5%-ZQLS@TB\YHYE.ZCB\E[ /.\
M1#=TS&,=6]9=XE72Y:%^N6^;@$R!JUST3#'<I "DL<CSN9%&7)SPJ]?G^B_,
M^L/L36^"GL77O_V$1SA?KWER3P.\1V&L:#U_$$E;'X8\:.W?](W.//:I2_#,
MTV+>F'+WB7^&/_;^X&KFF/.O69<&(N!@7UU^8B U_A$-NZ]I@O\ X$D%05;U
M3C"=HFL"7:%HR<]]2!)=22K'6_+S*:J,4/U7T@O5&BL\NY>(/)1*!@T4M'/$
M4D[0(B!*I-=$*X$%9NQ3OH^N<QLG$48)@6Q8KYS?D1;G4^Q"U2G2&]&F_,E6
M2@&/*OS#/A\.LIA:LYU%<"Z_4 "*BE"$J@ &P/N.\=;"<!YPS+,&5PP]-WOQ
MB*F45KS8A5T_),QG3GRG=?2%B_5$A<GIT(F:U^PA_P#!6L0 &@J(-X,1":<H
M=73T9WAV!H#E-'B8$E=+H#U+?O$XA[H\^_?Y]OE,/./L17Z7P N5/N2U."_M
M/*/'2R6'D_B/N5SJ2GRGVF%EU V='[EV<V_>!5M/Y[H.K;4SG'2KIG?XCS3_
M (=X4#N[_P#!%#E^0JB?4^R2LP2J)J4&^6 *-OSI&YJ,!ZGVC3.D[41L#=]=
M><*BU''JX.)H0]#][ZQK4>]?2XJBRU7;VN8P.RO^H;J>U_@@A!A6*Z]HVKH6
M<8OG'O";#'E^X% 4.F^GGU@,#8YR<KQ77I,YB^]].HQ8>R!?:+?BIG+O+&N>
MD3.T6T.$X'5Y@VQW^H;+L3Z6'_C_ **?4'V/BG@[?N7%A<>]RRY?5[?ACX8>
MS\R;P^L4Y;%BSO.6QW7GR9?5E\#BNG=*!BX6JKT.#J1P>Z\S[IES5E9]6U+;
M2Z\=P : \_[@Y6 [X9ZRFN0X$,0^;R57;J1(*O\ 3SE1QNXY&O\ Q_T4^@?8
MGV7YC*Y: SW3SZ](3&DS[>G5CWX#]R\,EK1T:YA=T\='SB)CM7HU^8'J*(TG
MFOO9T[RZ1XKO'NR6?9E51#7!?X3D$U^'?K*J,;-[X^CK,84!;?X$#@H3]W/6
MHYR;J\O3M$5T:]IX?I_Y#PO.?4'V)]E^?@)8&'ZGGTZ33"8<<G:NA-23NO,$
M*NU5QG]RBBM<A^5!MH8P%5FL@.L:C727^WG"TI?R.IVB0EG%5MYKM/##G:<#
M8BM>1ZL8;W=M^G,%>Z60#9I>Z7X%V]4-R*UR=1[0@QCQ;OV\=(&<'4K%'^\R
MEM$/=JX7_P '4DQ*^%?P_1?F;7<^Q!\!6=;]HZ6X/M%SZ?>=&>_6B8:B4H_]
MDSLV-YY@O6;:QP?ME")N'-X;_'6/W577L]Y9?9QF^G=C5IL'W]9?&/+7K^B/
M;D++SKU=H.B;OJ]?*)[-]7HPAD>CB^2(*X,DR?"IW_H5*E?"_FQ_-7]'SA@6
MOLG;=1X9CT:AU*0!Y11\X*M)%PBS?D1;2_ H*R^/O-$M)[/[.D6_H>& PPL-
MFZ\NT]8\N_O,OV#([S?,40?H[.U\=9:RLX<G)Q3QUC5&O,!R[R==,.%I=+X[
M=X7A9_!=_34%B558].[,$8TBT^F>2&"( SE! _\ 8VT]+ WWOF*8#H7?WBCP
M0UYDQ\KY+J<RV=D[=IF9E,STF>TS 9GI,]"4RI3XN54L>/Z8CP?U$V0]D(N3
M.^O;_8TW'H)U[LH:\?> 4I[?[#L^K]RRJRIX\?>7@K'G,,M^?^,76XZY^T6S
M]!_< E5\FOO\+3/:4S/PSVE2F4QBNWPYJ.N_\XO,;9BE-+!APO><7[F-?F9*
M*?,3K=8_-E1F/G'V@V](PTKH?9/3B$,958ST_P!C,N/\.TI"5=[KKW(*U%>;
M!,W+?/N^\-,'CO+S9>QO//D@ J66^I\N9I*].L&V7IEY.R=)@H-]6"BJJ]^;
MFOLA"#2P!P3:W%\P%/&^7F^//$/-KGX?4?KY=T\_P_#1F7+?XZ/@H;FB+Z?J
M#3IUL:[\5 "2A;0Z+Q1OH$+[P/7G1W,3!BA62L+^79OF(!@TO!QXQ+3&,8@^
MZ\ZWUQ G7V\>T'!UO+[S2#S9]EN+6V[''3PJ(M,<VK[?<(KH2GWU\U?/4M-3
M;?/\NLRC<";:JF;FI9Z+1P=(S&PAUGNS?>XW0?27(&#0="',FK_,[\HGRJD-
MU")R;( D!VE] J>^?W/( N.8ICV#]0%@)]2G,0-N^OG&);!G/'=A@7DXE: C
M(M*:YS&&S"LYUT@W ?+RF6'3%XA\0MTUUB6E=.>_[G3%'R<=(ET3+!@YXA\1
M#( ^J/'E/KOU\I=GCCX=H]OY&B1=(/Y*M6C\_0@[MENC%T%OEWBA--*"]]KC
M0P;"AA> #/XC-W.NO]F]7MXE 8U\;?@50;J(P =WKYX@9;<:1K5Y^\R179?U
M1\<Q40OB(C60.@U>8,%9:#!O52F5?P2OKI:>O298&SS2KR?>&A_@N_Y+GCB<
M"&'N2H/7%W X\O> @3.)1PAMIS-8+EVW?^(7W4O58FNL01,:^0J#+4-8.S['
MP3N0%8/7TB@VBV>L2H*?\AB*B>XXBM%"X>NY0$*IU-#+KB'T)C^I:G4?*(Z%
M=^T6J^J%'MS[S@9O/I%(QIGRYG7F>>.?W M[PAW-4^@^8Q'?CI_ -YX\<RS2
M/+BDQ[PPQID\>4!4E]7'VC[=SU:]I=RIUA,G4L /R\?3O!K,[2TP'4B-R=LI
ME,2CJ='K^H(@C?4_V$L;N,H&QTXB=BIQTP%.#&.J1.-Y+7.ZWLT1I+A$; %U
M%6 LW-GT6"F2_P"B3$%GE?W'$N@;=\F70]X 0TD_@/XS34(666^7&99Q,1?,
MZD),VTRG6&0_4K$WVAVI3K"N<:[3(!5UQWCV^+J8^<?;X@'%[G9(&NS'+O\
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M8E(NK<G/>!NG)$HH&$LO+?,LQMI]CYS>94@<S@(.TO/WQ,79%OFK]V."4?\
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MZO#76O2$5N3ZUKV^8_NY*?2XBSQDQLUXZ0_J%?\ W8!JK7Q_$8LW3?UO,+V
M^@Q/N@&A9Q?EWQGF)%*');X^S 1,09Z?2,:P'';RB$[+XZ3&N ;H\WY@\WM)
M2,)1VLK\UV7M%3%%[%FNG?,N3U?LS H4MQT_QC^ ^L7C!?G<Z_6!OXO'G^&'
MYG$V]/DHAT?T_B,5O(9T8L_/FLQ_>5-BM -/J\^45EG_ .&>L=3Q5-W !O-
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MZ2GPWJ;X P6WTZ\0P,S:?ZS5JCB-./X*K^-@>B99Z?\ 8*N ED!72=W?CM$
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MU@I()PA)#)0LIM6VR(!*3 '(T-FN"L%3';0"CG7=7H=:KY^NQOI"E[>THZF
M]BH=7,N%[Q&&?G!.4\XFPQ[RX_)!SFXCG9K,+=_>;Q3>M?G&9QF]_P #53<6
MD*G\.8,W8^2/[PUGI =DST!&N:[0']+CMYQ"[44XKA>!!0H9=AZ$&;MLG>SB
MNT*#:1SU[^76!+G_ #O- TWAITX]92?$XH];JEOWS-LY:WK-:[/_ ",8K;K]
M24'0_%/GQ%BMI/,MS7!.<,^Z XXN6B9_--!\T7YC=-NW(1KVJ_N]+ZRH6T?H
M=R 8ZGVCL^0>.9S+1)O,K'J0"?4?>.U#8'"JBARG.CK%OHY'U(9E!*II17NF
M'&NN$]=(-@$+%G#W9QH:[01:: +2\M!:W^O[KJ7E]("J:<>MU"J=!!17_P $
M-G>.?I'M:*<)56IT<^.D<"TG!]P=(A"E-U>.DCZQX@49HJ12JJTTZXU YO:-
MZHTM+F^'O,J431W:C^[S</36O'$MAS8*7GGV@ANZ>?9H^L?*"#+E/(/3K,JF
MP>^6" 'HMO[0$<I<.<<]&6?KK>G2X*6UE7F?B9"9#CJ=XQQD;['BKOUJ&[JM
M/*S@%-*;WVACA8NCCLOHRDF%-@&%JE>,8E[<C[?['9\6!FYS,JK<#77VEZN3
MM4&6OHB BYRZ_,L$"W7DZAQ+7 E4M\G]TH<Z@<A0%%T[M.+]:C %45>\7LR<
M]7_X8I]99^'$VC_J7ZF38^.M]#_(I"G:^UWB;HK[_?O&**I3IPKZ<SDRR^\K
MIJ*1!MA9G'5H-7Z1!Y(Z'V ?S 1MK.$Z<.8^@7^_CQB#' EC91^^='804K2?
MG_L* QM]3Q]I6GB)N7=UX]J_,IE%7UY\?Y CJU[3]"^TY^/>$YFGR"4Y9E)\
M^7/CZ5#^]8BK&6_T.*ZP:!7S.?[MM.L\<>)V[8OW=O7TK;*<#3RKWK)TYXN%
M" BJO8X758BVQ7'6[XOF*$[Q+8F6^<;]*YC2X=;S>.;U&Z4C; >QT*1JXBX"
M*U>BSK1F8!DM1:U=X.NKCVT7=M%V\Z,]Y=*)=9[CY<T](".RTY6N3H];YC-&
M#Z+V[5N&/=&G[UXYXF*V%UT;COL=6.)I2ZUQJ_.. FYU7\8N V#EMO/5A!'4
MC\7$.LYA\5J&Z03@?\G(2\S[R^D\_P"M]IWXE\.Y<&U](#0Y%LXT/D17?*79
M9X\?67+^//\ =T5UB"\-2^6L_*QX[S8ZGX]X1;*]E\NG66R"WW\^C$)I@Z>1
MY0J:#]SOWBR.TN6H-U29>(X*48+>*[/7Z0F=AUW'U("'#)URJE[Z^DX+'PUV
MCW;68ZAU^U@EZWNKT[PIEQES'8V+W-7OOY]H[+K\7EE0=FGCOXQ%7PM_SOT]
M9;"75]'L3>='XCQ^0U.9I\7<)FKF;Q*LQ.?'C_>TR9_KL,^/'CKOX6)7CQ_D
M=0Z&Y@[S[X\>//R$#OX\$IW_ / Z^<J7\-0W>7J=A>?MYQ]1@OF^C^8@9$^L
MO[E36;V>',4"WAW1QTS^R'Z);F$NA^EVZRM^AU&:>H:NO:6R''+A'IGCW@6"
M-X/U' 7:OUKUC$9)7HG?RC60: ?RB>@:=/>@XOK*KKC6>:=?]AT.?N'OTF5E
MBN>H_B(JO9+<\MNYVRF>4C\7$-? U\U@^4J-; ?-!T[PSDL=OP$R:Z?V+Q4H
MVP^P/'2(JX>.)?27_%3\-Z_K]?.'E38:XZIX2$??I* [?1]VI?!)6PJBW"CP
MN!@J;)>-W6M[>DM6GF?N5H47Z.:=)V@]3]Q'$VZV%:1Q"AYBTI>#D&U\>4"R
M'(P4W9P+NS4-!@K<8SVRYQB-(67XW+T=WW2],$30*;--.7A4K)#8;"LAK)S7
M>.IE>O0 K0M9:WG$JXTE7[BSKS#QR:<.;."^+C6<QP]NTLDNKA,]V%T0_$?D
M&IS#7S [MQ*KBA;&+#6:W0^D+U1M;,/7"ZJ([[BAN)6%D1,NH+D]C$![=S[;
M_H&I P>%Q=87$;[P])7%88,M^QYK[1+;=8[LSFO4@ +'GSE.R".O'CKS\V&*
M\,MXU4QNIIS.%=P>L-?ULO5^)SR_!%1?U%E*_#'AVAN5]N'3M>X-EI?;#JE5
M*+0)]A,R5B/0O!]?<EKWE#L4_=AZI4ZP.8U=?2G[)5VH3% !+QR.I$Y%[#H>
M50U=55_ZSZ4^Y+9V9?N+Q,)+],_$=/BP;G,-?/8;58OMF5N!Y%LYO/5BT]:A
MGEA6KS[#>+Z5&8'_ "Q5)YA%YQ1BIP@X,>:O/3,&Z"W5+4,VC:JK.,DLE;UX
M\J_G4R8KKAWKR9;#B5EBVM:;'U.".2"^)+<AK/VO7,5+Z%&$UGC'>'4++1L&
MZZ^\7#%P+\ICYJ18CQSX\>"4<3,K-RK8P48X_K;/CB.<DL6Q\OXEU36#3;F^
M/6%N%%&2GN.LN!CZ!UL]>(!+NF'FU?;K#&;Z?["ZSH]SO$9%2TRCO4.C$H!L
MWN,F9I!^;O*3);Z?[+H+66KRP8'//)J(%)%XU?71];@]AHPQ7U7/O $:CGV=
M8[ST@?<@[^?W "[V0533+U)A]B<GQYJ$YA^?G3!"THO1-YU4,@'!R+YS %0,
MNHE*;: :#YQ,*E445T%5*%KOBU9F'2A ',VY#"WH BS PSM2A+EI+-G6 19*
MF% :IZKQ*E5ZV!E1_P"<:_F,T=0P&S,;,L-ZWZ3%6 @0Z.%MMNX;I5#=Y4.1
M1K34U]!"!8I$!@713HJK9"KBZU&CN>9BV"-%!KEMQYWU;BG@#C1Y&&[R71<8
MCFZ9KQ^OX&V9NIWY@CJ7FOAY9C#7]6TM-RFJU>CAOA&"VY]_^3+^\W6=%W_5
M^91FK]C+SGQF/4\5(8^S]2RG%Q#N^"*>!_<RMP,]^W:&[+!IZ]SO%P\3>++*
MUD>RN9?$9KC/F[^ED"87KT^CB#VC[D[V[_<TYY/AGZ)]B/R".,P,7W^=YMP1
MBYT%MVYOG.\6W-*SH!CRY;*8,3;JO^..F8J<(6EOTZ^^KJ$?"-JH2Z4U>K[P
M&M*F!**X;;##LEV]=?S:S!;MRZ6PWZ09P"U87E8L"K-H^<2B2K"][/3R9Z,U
M=ZU3ZRG4;=)GLGIFL-S+XE:M3VT^OWBQE( 4(>?KY8-TD,*?,_"N80''C]S%
MT:\,<>/'TN.N_CQ<3:&L_P!4*(;@G!8#.N7M+K)D=^DKI;_: >7?G)T2_N94
M6@<_F4F)$QT!B8[@U=9BIRIRX;['25%!EFLPSX<Q+V1]S,MM"I-BG"C2_*V.
MX"*60Z13P'M /:N-I6&#/M**V1J-]LE=?+M/,?\ <336R"H+4]FS=/L1WZ_%
MAJ.)K^!!PZBI9;$B*ECQ<1467%==-0"IRH!]0_$R^@ZW^XNBK.,?: :256/X
MR+5$J\\SIV].L4HT59Q>,NWI4H9WUX]J^LMF&\/U%;4^+B T%V'ZAC $P@$F
MD5\Y+($K=_"[<5+\>/'68O/,P.#$P7 Q=XAJES+7T?GQ]/K_ $J%:O\ 4T)-
MVM0535U7IS:K@CNK_,X ")/HN!W+*PLYYU&5"GJP!)319@1[2L:A=?@N)Q4*
M73!?[EJPZKQSSJ!SN0%%[U 6D:M,W;J3]\G[@@DEV\&:VZ+S5[IB2%!5@O'6
M<]8W7X8=:4LUZ=HB5*E71KE=RX989Q7+<0$7+/'/.M2DRV1"Q7R@/4CI%+)D
MU'P]_BPU\%#*@\<^4&Y((Z^%DLEDLE.I+'7PK,980X7U@.R(7970J]>_X@VB
MT[QV] =P3G\1RMC?K"CJP&_#]X]M34SOCQX_V6[X\>.\-#JNW'CCB,UK1Q6?
M;QKK#R<D-&V:;I=RUMBK+>*U=!#P+K]?!9\+)9&0CM!0\ZU& AV%?I JBNC7
MT^.LL72RX(UX/'BYJ4^'XCJI3QTB*[Q$IQ,LKKN5P2CZ3/\ 3&R]XU[2E[W^
MYQAL/K.T[^7]1J-W3^9OC(RM;?%$J^=5]9M.ZZQ!ZB4.RF ;W,4V0_<R.)7'
M+]DE-.:8E.SE8]GOB!QDUYWV1J=OP2C"O+Z?[!!YGXF<&5[J(KM8_).G,WHE
M8LK#7L>G^1%J]6('+[16VH[D[T4H;9Y?'M.S?#M%ACQVB@N7:OV8/Q_:_M%W
MH/-_<L[ 6'ZJX?I*&1;U\5#,";Z?M$*M?+U?Y %<4_;F.='T?OXQ'$,?1WZQ
MN(MOP]?<Z1(M*^/74H!S/'ON6-'U+57UO>./\+9]E0>V(/23@ 7G% 9NWUO,
M[#[/ZEW# %Y)9UB3S[1'<6EJ,2*.GKT[$Z-G3R\9@P*+_4\^%,06OS(+;5^/
M*+2I\=(AA=9_N%#?)<W+U2C'#] \H8),.3G;^X3,".'>V *<Y@V)&.JH,<ZA
M'BG:@Y]Y8*\L.KFC[D8>V&BZOK7ZC5>6/P0<NG8OK!G4+%;ILF+$Q"X:RP$G
M%DRWR!#,NJ.SY#+<R!4[2RSA6$Y\V9*/$\H 4+X<$& #Z?I +ZHJ1E?3@O1Z
MI$#13'ASTCLS[$:_VR,'N.T3_%)#$?F$Z,1>$V];<>4W?ZOVP5VR+V?7'A*X
M&JA>Z)TAU!8-)Y:&[!-J*[XS(61X-A$6J;V^E?5N)@^A&O-SDMEY:\M:U+$O
MZUB+'\MJ&J"6NBL2C%7=7X[8X5Q&+O'Y17*8:VA8*]A3QN"1N*6ME7=&C">?
M,>&@&6JRGH]'$&WVND5XW=[^E5+PJKL0>HG@5^!$J&O-5J6'[D9@-^72>$)8
M2TG]QY\=)=\>L-<7/JS?,9&0X:V\U&USX2P4?9_4OZ;]?U".FJG9-KJ96X](
MNT"F;K\D&VB>Y_R:'<_$'TRYY[]/.(0*\/6(62Z.D6"N'4=/.,HI5]OW 5\>
MOIYW]8=D?N^0U\7;4 6$J **AIJ$$P0B&"$7,5;1N"ERL6%U+Y?* U *K,Q>
ML6D* Z$**.8:'++=!.X"+&WM M+>TR&U$*K^C_8APJ.+=P$F5=IE7]'G/6K/
M4ZGM%:(GZ'NEM97<=WT6-EE7Y.W?TBMDO7S[PXJWF.G>5T.X,9WG%V9[S$@O
MBS)1N_+W"I4,=BG1ISAS>:XIEA16U:UGQ73R8IVQZ>/^DIIWA>\HM$&VC^[S
M#AI>N>6*)=^?+B-I^CG?6$-=(M"H]89B %1DS$F(6W?G RH_T,1P6\X9\>C/
M6%4T3$<2MIQRG;GQSBOU ::+W'W.I*E^E.53U<5HQ;UZQ*I7;\6&OBF""V1N
MIK?,RI^$#1-J$I\XVJC:/-1,'##%EQ#FH+!CJ4KRO7R>L*;" O0%V'6"S[L[
M?3ZQP\C$=5OJ1-H9&'%DI'R=:AS.EEW@;R%;_P"00!1[DHAT-/)2:@@=J6\^
MQLKM/OI'ISN.8'R8\Z^F9EEU+T>%0$VZ:ELDC"NG;=3[5$C:49Z4R9]\COM+
M9H[KR6%8+[UN/,;-U1=_HC3,7];[^.VYC[MJI[>^=>"*'WT*?N_Y!#-=5CP1
MAG?=[QX_$M4J\;^W>ND]C??F)6\N9LEZ@&1S!Y_N^#TEV!I^\+TE8CCE9[5,
M$[RKYP\MW!F5X7*.D:/K*4S'K/LIPNL_F*([QK#;B;VZ_$6-,^F/S*^/'O$/
M0_<E@<S//R&OB+8-2X[Q]1D/*:S48:(W/G/N37R$V/*;>G[F_P (1KJY.CFG
M)OUAU!DGGIK%;*R8@S=F4XWPW3BJBNS.[H('2MX\\\QX!IHT6-YLQ=.+(?\
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ME^H_C[/U+5 4KAA_Y"#B^,KU<^>\H;,3TD&:RJF:JN_RBS]$7*(<E;]<J?\
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LA]9]8WX]XP0->?X=/S^'W7R31WF]Z(P[?")=RZ^+V^%/#YS=O1O_ .]__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm2132809d25_ex23-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d25_ex23-1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! 4@# 2(  A$! Q$!_\0
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M_P#7G-_Z :Y*BBZB2CR[:'92<E2;<N;?4\Z_X75_U+__ ).?_:Z5/C2I8;]
M(7N1=Y/_ *!2?"C5M*T_1;Y+_4+.V=K@%5GF5"1M'(R:ZSQ!XB\*R:%>K/J6
MFW(:%E$<<J2,Q(XP!DYSWKLJ1HQJ."I-_-G#3G6G251U4O*R-7P[X@L_$VDK
MJ%GO5=Q1XW^\C#L<?4'\:K^+O$G_  BNC+J'V3[5F58O+\S9U!.<X/I7(_!J
M.5=&U*5@?*:X55],A>?YBM#XN?\ (F)_U]I_)JP]C!8KV?2YT>WF\)[79V.M
MT74O[8T6SU'RO)^TQ"3R]V[;GMG S6+XT\9?\(A#9R?8/M?VEF7'G>7MVX_V
M3GK5SP7_ ,B7H_\ UZI_*N*^-'_'GH__ %TE_DM*C2C+$<C6EW^I5>K..%]H
MGK9?H1?\+J_ZE_\ \G/_ +76AH7Q6_MK7+33?[%\G[1)L\S[5NV^^-@S^=7+
M/X@^#HK*".2Y4.D:JW^BN>0.?X:W-"\2:!X@N)8]*=9)85#M^X*8!XZD"M:D
M81B_W+7G=F-.524DO;)^5D:>K7W]EZ/>W_E^;]F@>;9NV[MH)QGG'2O-/^%U
M?]2__P"3G_VNN_\ %?\ R*&L_P#7E-_Z :Y+X00Q2>$[HO$C'[<XRR@_\LXZ
MSH1I*C*I.-[-+<TQ$JKK1ITY6NF]K[%:R^,MG+.JWND36\9."\<PDQ[XP*]'
ML[RWU"SBN[259;>5=R.O0BLCQ%X5TW7=)N+=[.!;AD)BF5 &1\<'/7&>HKC_
M (-W\DNFZEI[L2L$B2(#VW@@@?\ ?/ZT3A2J4G4IJS6Z"G.M3JJG5=U+9[;&
M_P"-/'/_  B%Q:1?V=]K^T*S9\_R]N"/]DYZUN>'M9C\0:%:ZG%'Y8G4DQ[M
MVP@D$9[\BN ^)]FFH^*_#5E(2J7$GDL1U 9U!_G4_P *+Y[7^U?#MTV+FTF:
M15/IG:^/H0/^^JJ5"'U93BO>W?I>Q,<1-8ITY/W=EZVN=1XQ\61^$M-ANFMO
MM4DTOEK%YFSC!).<'IQV[U)X0\2_\)7H[ZA]D^R[9FB\OS-_0 YS@>M>?_$#
M?XE\<PZ/ _[JPMFDE.>%.W>WZ!1]:Z'X0_\ (G3?]?C_ /H*43H0CAE/[6GX
MA#$3GBG#[.OWJQWU<1XO^(T/A;54T]-/-Y*8Q)(?.\L)GH/NG)[_ )5VLDB0
MQ/+(P5$4LS'L!U->/>%M*_X3GQ%XBU:Z3,$D<D4+./NLXPG_ 'RH_E6>&IP?
M-.I\*-<54J+EITOB?Z'J>AZM%KNB6FIPKL2X3=LSG:>A&>^""*T*\U^$]]+;
MKJ?AV[RMQ9RF0(>PSM<?@P'_ 'U7I59UZ?LZCBMOT-,/5]K24GOU]>IP%_\
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MZ--/YLSJT:C]I**U337R1R/@"VEU"T\4>(KH9EFBDC5CZD%G_P#9:Z#X0_\
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M\?>%I/%&B1Q6I07L$@>(N< @\,"?IS^ K8\/07]MH%E;ZGL^V0QB.0HVX''
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MSII4*=+X(V"BBBLC4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0;XE1L<_-E@S]N6/UJKK_@^#7_"EMHLLX22V\HPW/EY*,F 2!D=5W#&>C=Z
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm2132809d25_ex23-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2132809d25_ex23-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !  U(# 2(  A$! Q$!_\0
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M%YU[JE]=QVUM;V2QB2>[FDF91'&@+%MQVJ!C( K^6GPM^T#_ ,%#_$OPBO\
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M%O@_7K3P/XP\46B>(_$%E';>)-:CT#1O"=M::G<6]Q;6:64=]>VEF\T\SRW
M54(!_1C9M&(P[JF]45=B$,8EYR@"@\J,Y/7UQ5E8HP2_F&6(]$R6&1SEB20
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M>WU.YN[_ %">QF@NIK:.W279(H!_4E(LRLA$T8&$)B.UG"*?WA.<$EDX.02
M.,\57A>V6<16SA2$$X>-BQ,9(#1H@))5AV'&>W''\P_P%_:M^/'B_P#9V\.?
MMRS_ +8LOC?Q;XA^*&D^&]3^ 4'@C3-*^'WA_4?$'B#3-(G^'C.5F\43W.F#
M4_(37AJ?DM*T4S6I2-T?ZA_X)H^-/CY^T%\<OVE/B7\3_CYXPF\-?"']H+Q?
M\/O"_P )M/TWPS;^%WTF.WN5M;;4+]]*&KS?8!)YD+I?PLSP(9"X)4@'[FZI
M>:1:0ZS>:K+%%9V.G"\NIKN39#:6\:3227$N_"6ZJJLSSMLP%Y/R\>::?\;/
MA2OPUM_BA#X\\(Q?#;[+;W$7CQ?$%C<>&0)ITM2QUH3M:%GN9!$&,N7D.T?-
M5SXU-YOPD^*\Z A'\ ^)-Q!4JY_LRY0+YBL23&5;H /FX)P2/Y8O%Y\<_LN_
M\$O?AKH_B+Q)::O\ /CWX3^&UAX52"TE&M?#CQSJLMAXBD.K7,TLR:GI&N7D
M5_ C11QRVL\MG%Y9C9Y(P#^K_0_%/A[QWH5EKGA'Q+IWB/2-0!EL?$6CW$=[
MI]PB/LDCMKR%VBD&8V5MCY!4!N3SV#)))'$(]R*,,)!+LQA3AGCR"W. 588_
MG7\D/PQ\9_MQ?$WX7RZ%\!/C!X-^#GACX%^"]"U@1Z]JJ0_VM)KFM:W/-KFN
M:8?!^LRZEI=]!ISZ?96VFZKIMS:SVD\LXF66-5]Z\1?M2?M^_"2[^&]AXH^)
MG@7X@Z#^V-X5T'PA\$M?\):5<I<^!?BEXP\/+>#Q#?1:E:6$5SX4TS4+34I;
M&UF4WTEHUM',QE+&@#^EF6_CC>/<0^UUC8NOE1;Y,[3&2H620%"<+DX/7!KS
M^T^)?@&^\=7_ ,.3XX\/7?C/3XK>XNO"*7]I+K5C'=J]U:7-U8;Q=0QR1_-
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M!^$VMZH/&NF?#[P7IOAK4-6U Q7$FIPZ'8BUEU#4(&<F43K&S2#$@?.#NR*
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M4"KW_#>W[&7;]I?X,COQXYT0?RN>W;ZFF_\ #>O[&/'_ !DQ\&?;_BN=$_\
MDCBE_9'$'_1,<3_^&3-?_F(/[;RK_H:91_X=L"O_ ',;GPF_9%^%7P5TKQ;H
MGA2[^(VJ:5XUM8K3Q!;^-/B/XR\;&6VCANX1;Z?)XIUS59-+WK=2><]B]JTN
M(][,(U [+X$_ GX=_ #X>V/PL^&_AD^'?!6AWVJW^@:;->7>IS6LNLZA<:KJ
M+O>:A<W=T\D]_<SRX,S*B.B(%50H\Q_X;U_8Q_Z.8^#/_A<Z)_\ )-+_ ,-Z
M_L8\_P#&3'P:_P#"YT3G'K_I/;\:?]D\0?\ 1+\3?^&7-5_[I!_;F4_]#7)_
M_#M@/_EY]:"%H1;E%=2D7ELD*Q^4#E,[=REL  ^Q&<@UYQIOPC\&:7\4_$'Q
MBM-'">/O$OAO1_"&LZ\T]QNN_#FAW>IWVE6'V02"T1K6YU?4'\V.%)7\X!Y&
MVJ%\2_X;U_8QZ?\ #3'P:P,X'_"<Z)W]OM/&>^*3_AO7]C'_ *.7^#/_ (7.
MB?\ R31_9'$'_1+\3^O]BYK_ /,7R#^W,I_Z&N3_ /AVP'_R\](\5_LV_"3Q
ME\4]!^,GB+PM_:?COPSI4^A:1J$M]?+91:;<V]U#<PSZ8ERMC<++#>7,4GG6
MTC,LI!X KQOP-_P3O_9,^'GQ%U;XC^&/A9:Z;JVKRWUW)H1U'5+OP+8:GJ-K
M'8WVKZ1X*N;Z;PWI6K7MDK6T^HV.EP7<L,DT;RE97!W/^&]?V,?^CF/@S_X7
M.B?_ "31_P -Z_L8_P#1R_P9_P#"YT3_ .2:7]D<0?\ 1+\3;?\ 0DS7[_\
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M$'0_]?/_ .L\T?V3Q!_T2_$W_ADS7_YB'_;F5?\ 0UR?_P .V!_^7G!>&/\
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M7]C'O^TO\&?_  N=$Z=O^7GTH_LCB#_HE^)O_#)FO>__ $!!_;>5?]#3*/\
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M[;RG_H:Y1_X=\!_\N/LWSD]_RH\Y/?\ *OC+_AO7]C'_ *.7^#/_ (7.B?\
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MQQV_#K].IJG*S$%MLKLBX*C'S Y!! ..F3T[]<5\@?\ #>O[&/\ T<O\&?\
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M=-JDFJ<6[I-/6[ZZ<"X-X12_=<)\.8=/64*.%3A*6SE)\_QM6OULEZ'Y#_\
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MPM_T360_^$:_^3/Q_P#^'%G_  34_P"B#W?_ (7WC;_Y=TO_  XM_P"":O\
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MV'_(<K]@!-&RO*%3R5!_>+Y;+D>NTMDG(PN=Q/:J37<K-&8_LL<38)>8QH"
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MJ?\ 1![O_P +[QM_\NZ_9+[*/1/^^1_A1]E'HG_?(_PH_P!=?$/_ *.#Q/\
M^'"O_P#*@_U.X6_Z)O(?_"/_ .W/QM_X<6?\$U/^B#W?_A?>-O\ Y=T?\.+/
M^":G_1![O_POO&W_ ,NZ_9+[*/1/^^1_A1]E'HG_ 'R/\*/]=?$/_HX/$_\
MX<*__P J#_4[A;_HF\A_\(__ +<_&W_AQ9_P34_Z(/=_^%]XV_\ EW1_PXL_
MX)J?]$'N_P#POO&W_P NZ_9+[*/1/^^1_A1]E'HG_?(_PH_UU\0_^C@\3_\
MAPK_ /RH/]3N%O\ HF\A_P#"/_[<_&W_ (<6?\$U/^B#W?\ X7WC;_Y=T?\
M#BS_ ()J?]$'N_\ POO&W_R[K]DOLH]$_P"^1_A1]E'HG_?(_P */]=?$/\
MZ.#Q/_X<*_\ \J#_ %.X6_Z)O(?_  C_ /MS\;?^'%G_  34_P"B#W?_ (7W
MC;_Y=T?\.+/^":G_ $0>[_\ "^\;?_+NOV2^RCT3_OD?X4?91Z)_WR/\*/\
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M--DFFB<NL(FA81&)(T"S$%L2.P<*#L'S;5RW'0]*/]=?$/\ Z.#Q/_X<*_\
M\J%_J=PM_P!$UD7_ (1__;GY"_\ #BW_ ()J_P#1"+S_ ,+_ ,;?A_S'.]'_
M  XM_P"":O\ T0F\_P#"_P#&W_R\K]=UGN9'=1;^4@<I#*\>4FR&(!4;G0*5
M&YF5 3TSD&KZ_(L?FQ_O".=D>4+#&2"1P#V)P,<X]#_77Q$_Z.#Q1_X<*_\
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MW$_<) 8#D5;WNTA">2$:/=&S;26921)DJ,=UQ^.:/]=?$/\ Z.#Q1_X<*_\
M\J%_J=PM_P!$UD/_ (1__;GY ?\ #BS_ ()J?]$'N_\ POO&W_R[H_X<6?\
M!-3_ *(/=_\ A?>-O_EW7Z_"5MWF;5%J 06,8+.V#_JP "V<8&T<YQD]*4O+
MN8FW*1)@EBBNSALA=JQEV!Z9W!?P&:/]=?$/_HX/$_\ X<*__P J'_J;PM_T
M3>0_^$B_^3/R _X<5_\ !-3_ *(/=_\ A?>-O_EW1_PXL_X)J?\ 1![O_P +
M[QM_\NZ_7YYY(0P-N6:0(T2[8U+AF(V_,RC* 9.2"/?I0+B-G(A".L?RR$1D
M[9,9 W ;&"D,&*YP< @4?ZZ^(G_1P>*/_#A7_P#E0?ZG<+?]$UD/_A(O_EA^
M0/\ PXL_X)J?]$'N_P#POO&W_P NZ7_AQ7_P35[? >\_\+WQMU_\'E?L%")7
M$@E5-X D4I$<%'SM!!7EN.< 4,)F :*((BG+R2(H!1?O$ ?-R.1P#1_KKXA_
M]'!XG_\ #A7_ /E0?ZF\+?\ 1-9#_P"$B_\ DS\?C_P0M_X)J@_\D)O?Q\?>
M-@?_ $^4G_#BO_@FJ<Y^ ]Y[_P#%?>-CSVS_ ,3S\*_8%)HV,:@9DD61D/DL
MJ (5!R=H*\MQG&<DC-,D%PA60K"8MH# 1DL7/R@+@<*&P#NQW)(XP?ZZ^(?_
M $<'BA>?]H5]^O\ RZU\P_U.X6_Z)O(O3ZJO_EG^1^0'_#BO_@FI_P!$'N__
M  OO&W_R[H_X<6?\$U/^B#W?_A?>-O\ Y=U^P+3*N$$8EE7'FH@3,>\'#MR!
M@LNTX)P2,C!R*9O2UQY$4<89D8PL0LBR2(0KK^[+;1$YVMG')'7DT?ZZ^(G_
M $<'BC_PX5__ )4'^IW"W_1-Y#_X2+_Y,_(K_AQ9_P $U.WP(O/P\?\ C;]?
M^)YS1_PXL_X)J 8'P(O!_P!S_P"-\_G_ &YFOV%1AY6YPH<!=Z *7 8\J!GD
M]N,ENG)YJ$S C?&(XT*@J\\?ED-N8$,C8<9 )7*C.,YQ2_UU\1+Z>(/%"[_[
M?7_^5Z!_J=PO_P!$WD.G_4(O_EA^0!_X(6_\$TU!+? F\4#EC_PGOC8XZ<D'
M6^GKP::W_!"K_@FH71U^"%ZX"]!X^\;$\LH!P-<V[0"<Y')(YK]BR%D782@>
M1 0V%VL"HRR.#T(R 3C\Z\"^+^A>,=0\%3:;X1GN8C+?I)KLUGJ=_;ZQ%I4:
M22-+H5U#.DBZ@DR1%82YADC+I(C!@*:XU\0W=/Q!XHZ?\QU>5K-ZW]GZZ6\R
M?]3N%;J_#>1I:II8-.Z>_P#R\T?7OH?G?'_P0N_X)J+O,OP/NT#.4$G_  GW
MC54.3M55W:YPPX7CJPR,$U7N?^"'/_!,?3PMS??!:>RA+L#-=?$/QI'""H*K
MDR:Z(QG/?@GIVK"\(?&7X_S_ !#F^#=[XTTCQ%X3@U>2+3I?%"O9?$6TG65I
M;/2;Z98K.SN 94ACA=?-FEMY!YLKS,QKVWXZ?M7>$-'\/Q_#[QY'8V7B&^8V
MMU8^*M&NY-%OFB@>2YM%MXH'O!\N9+>[*+ DJ1,9E#+EKC/Q"7_-P>*&MW?&
MUEV_Z=K5OIWWZERX.X4][EX<R%726N#WLDE9>TMK]^FAY++_ ,$0_P#@F8T4
M;VGP.N;^T>X&9[;XA^,I(E!X,@E36W! ((*YV\< ')J#4_\ @BC_ ,$L],-O
M:ZQ\*;/3)Y(5\N#4/BAXKL;AT<DJRJ^O1NV<GYQGIC/!%?E7^S!_P4JLOV?O
M^"E(^ 6JZUKR_L]?'C3O#FD> M!U:XEU>RTGXIW&JMI\T/A=I;FX:QTJ>VN8
M);N*)BJ3,C2*I8 ^4?\ !?3PW^SI\1O^"@?P6^%7C[XP?&/P!\1O'OA7PAX=
M\,6'@*_GT[0UO=?U^YTO2[^_=+=P#]JN LTJ%G5%'&5JEQIQ]=J7B%Q3R-:.
M..JW?9-.G;OS/7R[ N#N$XN+7#60N6CYOJCM=ZO_ )>65FE;3H?MU:_\$0_^
M"8&HKYNF?!^+474%A'8_$CQ=<%LC!R(->8D8P1N!YP>QSFW7_!%7_@E1;3"#
M4?ACIUC>1#$MI=?%3Q5!<0NWS,DD,GB)9$89'!4'Z#%?Q;?M(^$/V_O^"(?[
M6'PYNM/_ &B?'/B;P=KE[;7-E:W'CC4M?TS5-"U"\-I'I]YIFIRQH=0$&V4B
M.W55P=K C%7/^"AOQ2_8Y\:_M7?$/X@?$#]H7X_>!/&_C.Q\'>)/$?AW1-5U
M2VT32KO6O"6BW\L&E6UO!-':R@W#/(H?:)'X)P35KC/CM33?B#Q6URI:8ZK>
M_P Z=[6Z=+!_J=PI\/\ JYD#?,VG]35DGNG^\?5W_P"&/[.U_P""+?\ P2F9
MU:/X9Z6\4,>^2X7XJ^*&CAVLJIYQ7Q$5&XGJY&3QUK5B_P""(_\ P3!O;:35
M+;X36MS8Q[TGU"W^(_BR2RC1 "ZO-'KYA1E7YBS.& ZD9K^"?5O'7P#T[]CS
M]JC5?V=OV@?C=XR\3VVF^"8[I?%_B754.GZ=-XNTHR3:9*/LLD=S,56*38_S
M1NZD<\><K^W9^UQ\//\ @G1\)/A/X(^(GCWPKX%^)GQ:\?2^*_&<6NWS:EJK
M0:9X7L9O#XU9KV6]2&WM;QKDVR%.;C>A)'!/C7CRSY?$#BO=-\V85;66EM*=
M]=_+T"/!W"G,O^,>R!65HR^IJZ=[W_B)6O\ /;T/]&K]G;_@E_\ L ? OXHZ
M+\5/@5X$L=+^(W@\7_\ 8NI6_C_Q!X@^PQ7=E/87$\^G76LW=O*KVUQ*@,T;
M;&=2"& -?IY;2%!+LRT:!%65&8EW+$O@L6! /4#\\5^._P#P1K_8W^!7P'_9
MF^&/Q&\!>(;OXC>-OB5X%TC6M>^(.IZO=:[>7B:U9V=Y>6,=[>'S%MQ<(,13
M*)5;()'?]CDM5CDCEV>1%!(P"DF-%WJ,;54A&#,>2=W)[5X^-S/-,SJO$9KF
M>-S?%.,8/&X^I[7$2A"[IPE*44W&ES24%;3F>_3UL)EN RZG[# 83#X*A&<I
MJAA:?LJ*G-)5)J'-+WIV7-*Z;LM$;*J" 2,D@$YSG)'/>BG]>E%>;[&E_)'\
M?\SMN_/[T<S)IES-<2DL&@DBVR1OA5F#( R2%<L01D94)CT:OP _:Z_X)T?#
M[]I7]L&7X+^/]<U*/X(?$(:+^T1XQ\)::I@O;SXA>$(+/P=;6T&I_<70]1T*
M&*.^L_)^TFXB$T=PH<@?T2UR.I>'_#T_B&TU^?2-/;Q!!926%OKC6\3:C;VD
MLJR-:)<%?-%O)(HD:+<$9E#$$BM-;+57ZNUU]UU^8'\]'[2WQ2O_  +\5/&?
M[,&G?%K5/V7_ (+_   ^!EOXW^&>H>&= 75M2\02>%=#@-E:7^HZG'J-K=Z=
ME);*71K2W@U6X^S Q72E\GR[_@G!_P %-?VCOCYJ'@WQ+^TQ=:1X)\(VOA+X
M^:1IVJ66A7F@6GBQO"ES\-I?"FLWD>JSW4J:I/;ZGK6VW@:..9 Q2#<F3_0C
M\2O@]\)?B5'91>/OACX,\:76GZC%<6LGB30=/OPD]NS31&"2[A;.XEAL#LBL
M[$KP:D\9? OX)>.= \/Z#XL^$G@/7_#NA:@MY8Z1?^']+DTW1;MH&B%U:6WV
M<11S%=D3-&!N5@&R *+:[Z>G_!_0?;TUV_1)?.WZ'\KUA^TY^TW^T9_P47_9
M*^!=C\=?&7A#X1?%3P%XJ\7ZI=^%M'TB&^U!+3Q=XZ;229M8TF\%LC:?I.G6
M[(T"R&,$X#L&']-_[5-J=+_9<^,ZPR7$\\'P^U:$W$NQ[BX>"R:/S2(D"LTA
MRS!8U&XG"@' [>P_9[^"&D>*]%\>:/\ "GP78>+_  ?8-I7AC7[30]/@U#2=
M,D$TK66G74<*R6=NSW=S^ZB94_?.2#NY]/U33[?5--ETW4]+L[^QU'_1M1L;
MN.*>WFLY5/F1SQ2!DEC8<,C AAU'8L1_+%\"_BY^T'X1^%.J:WX5\77VG^!?
MV>/AOX!^-_B+PAI^F0W-]XLT4^./C _B?P_9S3V:R1W>K6>CZ=&/E A:(%6^
M8D^D^._V^?VH/VB?A]XF^.7P#L-/\(_"'Q'?>#/A;\/W\13SZ//#%\0M8T^S
M\0^*M>NUTK6WTK4?#TEC<6&G7"6%[8PR:A]KO;:6* QG^B;2/A5\/=$76H=(
M\">%])CUC28M"OUM-*LHDU#0[=[NX@T^YC2()+9QW&I:A(ENX:,/<S';F1JS
M4^#7PLL/ M[\.=$^&WA2R\%:A;S65UX3@T"QMM N8;R0O=M+IJ0+;."S22GY
M S.S$,"<T ?S!:K>?MB>#_!7QY^%/QB^,7P]^(7@;Q)\/--\6:)8Z=XCO/'G
MB_2M8TCQ3H-NLB:O8>!O!.@0:=)!?S^=;SK->O,8#$/+CE-?/_[4'C'XJ_$C
M1OV./"LGB*2"Y\-_MB_LOZ)X-U&]TG[1#H45Y\/O"M[+=2VD M7G$5]?74X#
MS !V"D[5VU_6)X9_9Y^ _A/2=5T#PQ\(_A[HFC79A36M+M/#NF6]OJFV02PK
M?QF'/EQS+YD:2?(SJK $J,='?_ SX1ZM-HTUW\)O =^=#US2=<T]I-!TMWT?
M7-(MH+?3=;LI&@+6]_IMO!#!:3QE988HD6-@H% 'X.?&'XD_%[X(>._&_P"R
MWKG[0GC&W^'>H>)/@]?ZS\=]3T32;[QCX%'CF?QS#=V6EP6.GVVCBROM2\,Z
M-I-M+>V-R;)-3GFGDD"J5\?^.7[1GQ;_ &/OCIX!^$/P3_:(\0_M!>&/BK\.
MM=\0?$?Q9X]\/V&JZG\(=*AT[4%L?$^AWWA2TTG3)'N?+NKAM+OK>\G0V*@G
M$H%?TL^+?@W\*/&9\21^+OAYX*U^U\2V>EV7B5M8T73KX:[!IMQ//IL.I//$
MS3)IMQ<37%HLA/E2S2&,J6;/(>%?V;O@9X*L=6T_P3\*?AWX6T[5[:ZT[58]
M-\*Z4L>L6,T#1&"9C QDM@LTT;Q ^659P1AC@ _!SXR_&#Q_^QCXM\&-\$_V
MJO%/[1WBKXI_#WXD3:M\/_'FAZ1JNFZ'9:1\.-8\86OBC3[[PGI^BO92V>LZ
M=IUDMC?RSM/!?O%@3('K\DOV@_BCI_Q&_; _X),R6GQ]UOX\ZEJ7Q-O_ !IK
MTNL>$VT*7PG=7WBOPQI]QI=O+#;00I86\VES116ETLMZIC:X>=HIXU7^TWP%
M^S-^SM\/M5N-7\(_"/X;^']5N[*XTZ;4-)\-Z5;7HM;I<75@\JP-(UO<*")X
M=P21$(92N:S[3]D?]F.SOX=3A^!GPOBU_2=3N-:T76;?P/HUO>Z3J]TL._4M
M/NELQ);7+FVMR9H71M\"MG<,T ?2>F:_I.HQ0FQO8;J-HB5F@820DQ,89%\U
M"R;TE1D9,AE92",BOYY/^"A/QJ_:E\7?ME?\*&^$OC+PQ\,?#_P\^$,'Q0L]
M1UGQ3/X1;Q7>W6LSZ??03W4W@?QI;:G:Z2EK9LUA;'3+US?DI+( =G[L?#7X
M>>'/AQX-L_!OAJWG@M(;G4=1EM[F>:YE>_U+4KC4-1F^T7+22;)+V>9XXPVQ
M$*J@"J ,#Q_\$_@Y\6]5TR^^(_PQ\(>,KG11/%INJ>*=!L]1OK&1FBDDM[*6
MZ@-P()'B20K&QB+0AB.,T ?@-:_&G]K;X]?%WX)?"OQ7\:M/\!Z3XV^#<FO^
M)=9^$FAW-V=0U/3=)U2\AU#2[SQ?IMNU@;BXLD$\=UIDPF0G8L!8$>D>'M3_
M &@?A[\"_A9^USJ/QW\;^+?%EKXW^&_@.Y\ ZII.@VG@O6=(\6^+],\#7FIZ
MG96MA_;":E%IMXVIQR6^JQ6ZZ@NYH3!^Z'[MVWPN^&]C>:;K%GX.\-KJ^FV<
M6F6.IQZ/9-=V&FE3;_V?9RK$)+6S$+O$MO&RQA'90N"11<_#3P3>Z%)X=U#P
MKX?G\.QW5K<VFBMH]F]E;7=A=QWFG7<5IY7EK/97445S;R*F^.9%D4AAF@#^
M9#XE_MB_'/P*_P 7?C9IO[0\I\>>'_V@;[X4:'\(KOP6=9\*)X:^P6FK6GF6
M^F_9]:GU&:XN3"VJ+J2V4,,@@DM_.C9VFT#]I+XD^/O@S\7OVN_'O[4'BKX;
M?'?X4_$75O"MG^S=H7AO33X&&N:!K<6B>$/#4MEJ%A<^)-6A\5VW]F7-YJ%E
MK$44,FIR,KQ1PD#]P?@)^Q/\-OA)K?Q(\3^(]$\->-/$GC/XA:_XST;5]3\-
MZ:VH:#IVIO;RC2+:>2.1O)@FB$J,2'+-D8 %>P7O[-7[/GB?Q./B#X@^"WP[
MOO%IU.#4+?7;OPKI=SJDU_:R(+'4WG:V+R7,21QNDSAGBV*0PV @ _ ?3_VH
M?^"@?CS1?!'P7N;JV\-?%']JDR^.?!WBA-&CC@^'=AX*BU >)=+N+":XD6>T
MO3IWAM+427#W+MKE^X95MT \)^*W[77_  4Q^*]]X7U+P_IOAWX9> / FN6G
MP5\6^([J-[?3?''CX:A!X.\>:Q+?1KKEWX5@TG7_ +5+H-^=*U6U $-S>V\D
M*R(W]7%[X0\+7.LZ;KESX4T#4?$7AL3VOAS4FT^R^WZ1:7T:+>06-PL>^R29
M47S5C9/-"#(...;N/AQX(FT36O!1\&>&[OPEXCN=1N-<TFYT:Q.D7UYK,TD^
MJ27,+P^3=76H74TKW<YW2R3NSNQ<YH _G=N/C%^VA\%_@'^T3X'\1?%OP=K>
MHZ%8>!M9\+^(/#FOW'CWQ=H=SXCUJ?3;B>]UF/P/X1\.SZ;Y=K&4L(-/EO8R
M)GDEV/&H\\\;:_\ MC:Y\2/@I^SWX7_:!E2.]_9XT/XZZCXM\8>*=/\ AYJ'
MB/Q%XRU.]@UG2;741\-O%NE/I/AY--L1:V<D%E?*-09I)[@$;/Z1O#'P%^!W
M@SPW?>"O#WPJ\!:7IVI7%M)J6@VN@Z=:VFI/;.K+=W-JT(6Y%N5WP[PRH1N7
M!)-6/'?[/_P+^)7_  C]CXY^$'@CQE::'ITNGZ5_;/AZPO&T2S)BC6PL5D@:
M2VL9?*SY4;+ #'D+DT ?SQP_'O\ :=^(Z?"KX%_&_P"-OA;X9>#M5TSXHQ+\
M5_A+;:CJ^L^+_%WP_M+RVT'P=J^J^*?#]AI/DZCIL>IW=_J-CHUO'J-SIP%B
M;9;F-3[E_P &[VJW,?[,'QBM=3\5MJ]T/VD/%FG:?JVJ::-+GU$QZ/I4OE_9
MF:-;F1XUEE,D 53M)"X4BOVPOO@'\$M7\/:/X'U[X<>!]8\+>&+NVNM \-7G
MAO39=-\-S6J/%9R:=:F#;:RHDGE*\85G1FW$Y-7-$^$7P@\(6-CI7AOX?^$?
M#NE:=J\_B#3+7P]I%EI5O;Z\UL;234(Q8Q1+'?M:/) \I!D>!F5LKF@#WE,E
M%)Z[1G'3..H^O6G54L)OM%G;3E0GF0HVU6#A05  #C[W ZY.35N@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *#T-%% %"]!_=>60)V=53/(*[E:0$>I4'!]<]\ _"?[6_[:&A_LU>(OA]X
M+G\'W?C+7_B+<7<$-M!=BTMM*@M9+6$7.H3K%.\,,IN"R/Y9R(Y.<K7W==8$
MD#' 16^9\8/JJ[O]I@.,<]._/@<OP7\":]XS\8^-_&7AO2?%FKZO':6%F^NV
M$%W#I.B65OLAT^U^U*\<0>Y>ZNI&C"R.9P&R%7 !X7XF_;I^%^@>&M'UYH?$
M5_H^I6>@W^IZCI-M;M'X;M?$)M#I\U\;R2 O";B[@M&$ DGW2!C$ &*]U\;?
MVLO /P \/Z=X\^($5Z/!][X>?5IM5T^)KB[C=M2T;3-+L8[, ":6^N=:BS+Y
MD:1!"&^4DUP.I_L1^ -1\$?$;P+</=1:1X_UC2]7N(VFF6UTBVT?6H]6TO2M
M+C,NRTL[4)';Q06WEHL42(%VJ!7IOQ=_9P\+?%;PCI'A+6[)-0TW2](M],@M
MKA!)%)!:ZEHU_&[1N2I=)M+B9689&!@B@#SNX_;P^'FG:1K,GBCP[XL\'>)]
M-\/6OB#3_!>M6MA-JVNZ;JDUM9Z'-9W.F7M[90G5+R\M(8A<SJT7F;I40 UD
M:7^W9\,S\/O 'Q+UG3[RR;QEX;L_$LND6$Z7.H:-I-S&);NZO([N.R26ST^,
MM),86:Y<QE8H78@5T?QG_8T\)_$Z_P#$'B/[=/H7B2^^'NG>%-#U> M_Q);[
M1+JTU'1M0$/F)'*EE?64$S0R#RY50H^5.*XSQ;^PW\/=8\ _#[P'I,5E:7WA
MC2])\,7?B6^2/4M4UWP[:!/[6T=);F5I+:34($E87$3^= QWQG*B@#U:V_;!
M^&6I7%Q?6D&OGP?;6NES77C>>S@M_#<3ZIIUMJUO \<MPNH-(+._LVD9;9HP
MTRJK$JP',ZQ^W+\,M+T[7+R31_%,T.GW.D6'AU[*+39G\:W.NZS8Z#IT.@HE
MZS0>=JVI6-MOU46*(EQYC'8C,.)\/?LASIXS\6:)XEU6=?@ T7A[3M-^&^I2
M#4+&^;2O#^G:?/?_ &Z25KFW21[:VA6U8J@DM&F4%IF)K^$_V)+/P]XU\8ZK
M>ZK!=>#FUCPGJ7PX\/VFDV]F_A:U\/:]INOR6$MW#^_U87=SIMLPDNB6@6(J
MO#&@#N=:_;?\%>$_#/B"?QQX5\8^$/%VG&SMK3P+JT6F2:[J=SK%O>S:+':7
M.FWM]I@746T^ZB5IKM&B:+YT ()I:?\ MQ?"VX^&/@GQ==^?!)XJ\->'?%.I
M>'+!HGO_  ]I>LP6][<3WTUV\!FMK&"8S78BA%P\:L((WD**=WXS?L?^$?C+
M=>*_$-]J=U9>+KZQT&;0M6@FD6+P_JWAQ-6&EZ@+)9EAF:(ZM<%TD&) $#YV
M@CS/Q1^P)\,]3\*^ M%\-6\%GJ>C:9X5\.^*_$]Q9"_U'Q/X3T2&VMM2L7NK
MEB\<VI65L84O(',T!99(V+H#0!WNJ_MX?!70[Z]&IGQ+IWA&RUIO"2^-);*
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MPY\%M'CMUN%U+Q'<^"++PKXBU9(!:PW^I&XU?4]7U:"SC9H-/6\U#7;V<6T
M6.)2L:851C4_9L_9E\)?LY^&]3\-:(8M3DU7Q'J'B"?47MHY+VV-[&L31)=,
M))HT9@ 560;EW#&,T <;K/[:O@#39O&?D^$O%6MVGP[UVXTGQC=:3;63VVBS
M6T23OJ4LMW?6C3VZ6[HSQV\+2AB0%/6L;PO_ ,%"_@-XB\?'X77C>(= \3?V
MMHVAW\.K::JP6>L>+(S<^&+"66VN+C<^O6P>YM6BW)!&A6Y,;X4^I67[-7@W
M3_"_Q>\/RR%K?XP^(=0U?5G"D2+/>VL=H4#*2R@1Q*" 5^;)(!KS;Q5^P_\
M#/5_'K_$G[ L>NMXO^'_ (MNKF,F#9>> [&2RTR>0AU658HG8>6P*G<20V*
M/>M5^,WAG2/B9H?PHFM[VXUZ\TP:NTUK&&T^P^TM>+IEK<O(R2F;4HK'4I(2
MBF-/L3"5E+IN^9/$7[8'CS[7\6]*\-?!'S+SX<_$?PI\-](N/$?B>'3;#Q#?
M>*;_ ,.V)N99+&UU*XLH($U]YAB"=V%OC:"XQ[[JOP;L?$7QU\,_&"VU26VA
MTOP__8VL:-O*Q:SJ5@]RV@7+!W#6[:9;ZGK2M&J;;D7R,^3 F..^*_[,=WXI
M\+_%2U\$^++CPCXI\=^*="\:VNN&W6_71O$V@3Z//IU^EO/)Y$D<+:1;,\#8
MBD&X,.2* /)OVA?VY=>_9S\"WU_\0/AU86?C6&#1+G3M$M?$%S=Z#J6GZCXD
MT3PSJ%[_ &K9Z+<:BBZ?/KMM,D9TEIIUX"I\V-3X1_MT:9XG\ >)/'GCW2-(
M\,>'/#?AZ7Q ;W0M2U;6)[RTA-ZKV\5AJN@:%J+7*M9% J6CQL9%VR$9KIO#
M/[&GAI?#HNOB7XBUGXE^.=4N/#]_K/BSQ+J%UJ<"SZ'JUCKTMOH.EW4T]GH6
MG7U_812S6.GI%;.(H5=&6%,>]7'P,^'>J>*AXHOO#6@7T<6A6NCQVEWIMH]N
MD$!NI6_<M'Y6)!=,6!3!XSF@#EM#^,M@GPTT+XH_$&QM?!FE^)EAETX?;1J+
MV.DZS)]HTR36)H52&&[O+;[-]HCMO.CMKB4QK+(B[SP3?MJ_!H1:RFEWTMV^
MA:?KU^9'CD%N]OH<&ES74L+A<M$W]JP*CG&YTD"YVD5NZ]^S9X0\0?":]^#.
MI++?>$-4\16^IV]BUQ,R0Z7#KJ:U!HNGD2%K?3[:&-+"""%EBAM0L:J$4+6/
M)^QG\&XH/$5M8>%H-&M]3\%KX)CL(6DN([;399[FYN+A(]S;);N:8+/-\KRK
M;Q*S$1K@ ^>_"/\ P4EM_$NHZO;W?P9\5:?INA_%C7_AG!/%J.EW4VJC1-,N
M]1M]7T^!;@$K?FW5$@N'A\M)"\C#:<_8ES^TQ\/=-\%>$O&WF:I=Q>.]/34/
M"^C)#$VKZB#"DTL"PEE@1K=)4+YG*Y.0QQ7S/\(_V#$^&OC+Q'XEU/QC+K>D
M:CX[\1>.]#T>73XX$TR^\0Z7<Z.T:RARTHBL[N6- XX8AP P4U[)XM_9A\.7
M?PW\$^&M&U270O%7PYTQK3P7XR$33R:/]HBC@N"L<CF"4W$<2*R2$G &.I-
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M$=O!X@O+[2?%,'BMY8DL5\3W?BF^2^EU/4K)'"&^M/WD5I,R^; DKI&R!CD
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MC1?#?@CP%IT%GH$LTT&N:I++J/B9KJX>*6XO+CQ!=O)J<J%DCVI+.4C6- H
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5SGVI@:@   '0# ^@HH'0=J* /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
